SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

 

FORM 20-F

 

REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
   

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended March 31, 2020

OR
   
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
   
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission file number 001-36176

 

EROS INTERNATIONAL PLC
(Exact name of Registrant as specified in its charter)
 
Not Applicable
(Translation of Registrant’s name into English)
 
Isle of Man
(Jurisdiction of incorporation or organization)
 
550 County Avenue
Secaucus, New Jersey 07094
Tel: +1(201) 558 9001
(Address of principal executive offices)
 
Oliver Webster
IQ EQ (Isle of Man) Limited
First Names House
Victoria Road
Douglas, IM2 4DF
Isle of Man
Tel: (44) 1624 630 630
Email: oliver.webster@iqeq.com
(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)

 

Securities registered or to be registered pursuant to Section 12(b) of the Act.

 

Title of each class   Trading
Symbol(s)
  Name of each exchange on which registered
A ordinary share, par value GBP 0.30 per share   EROS   The New York Stock Exchange

 

Securities registered or to be registered pursuant to Section 12(g) of the Act.

 

None
(Title of Class)

 

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act

 

None
(Title of Class)

 

Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report.

 

At March 31, 2020, 127,116,702 ‘A’ ordinary shares and 19,899,085 ‘B’ ordinary shares, each at par value GBP 0.30 per share, were issued and outstanding.

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes    No

 

If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Yes    No

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes    No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes    No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer    Accelerated filer    Non-accelerated filer 
Emerging growth company        

 

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:

 

U.S. GAAP    International Financial Reporting Standards as issued
by the International Accounting Standards Board
  Other 

 

If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow:  Item 17    Item 18

 

If this report is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes    No

 

 

 

TABLE OF CONTENTS

EROS INTERNATIONAL PLC

 

      Page
PART I      
ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS   1
ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE   1
ITEM 3. KEY INFORMATION   1
ITEM 4. INFORMATION ON THE COMPANY   40
ITEM 4A. UNRESOLVED STAFF COMMENTS   71
ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS   71
ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES   100
ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS   114
ITEM 8. FINANCIAL INFORMATION   115
ITEM 9. THE OFFER AND LISTING   115
ITEM 10. ADDITIONAL INFORMATION   117
ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK   136
ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES   137
       
PART II      
ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES   138
ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS   138
ITEM 15. CONTROLS AND PROCEDURES   138
ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT   140
ITEM 16B. CODE OF ETHICS   140
ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES   140
ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES   140
ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS   140
ITEM 16F. CHANGE IN REGISTRANT’S CERTIFYING ACCOUNTANT   141
ITEM 16G. CORPORATE GOVERNANCE   141
ITEM 16H. MINE SAFETY DISCLOSURE   141
       
PART III      
ITEM 17. FINANCIAL STATEMENTS   142
ITEM 18. FINANCIAL STATEMENTS   142
ITEM 19. EXHIBITS   143
SIGNATURES     144
INDEX TO EROS INTERNATIONAL’S CONSOLIDATED FINANCIAL STATEMENTS   F-1

 

 i

 

Unless otherwise indicated or required by the context, as used in this annual report, the terms “Eros,” “we,” “us,”, “the Group”, “our” and the “Company” refer to Eros International Plc and all its subsidiaries that are consolidated under International Financial Reporting Standards, or IFRS, as issued by the International Accounting Standards Board (IASB). Our fiscal year ends on March 31 of each year. When we refer to a fiscal year, such as fiscal year 2020, fiscal 2020 or FY 2020, we are referring to the fiscal year ended on March 31 of that year. The “Founders Group” refers to Beech Investments Limited and Kishore Lulla. “$” and “dollar” refer to U.S. dollars.

 

“High budget” films refer to Hindi films with direct production costs in excess of $8.5 million and regional films with direct production costs in excess of $7.0 million, in each case translated at the historical average exchange rate for the applicable fiscal year. “Low budget” films refer to Hindi and regional films with less than $1.0 million in direct production costs, in each case translated at the historical average exchange rate for the applicable fiscal year. “Medium budget” films refer to Hindi, Tamil, Telugu and other regional language films within the remaining range of direct production costs. With respect to low budget films, references to “film releases” refer to theatrical releases or, for films that we did not theatrically release, to our initial DVD, digital or other non- theatrical exhibition.

 

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This annual report contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Exchange Act, and such statements are subject to the safe harbors created thereby. Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as “approximately,” “anticipate,” “believe,” “estimate,” “continue,” “could,” “expect,” “future,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “seek,” “should,” “will” and similar expressions. Those statements include, among other things, the discussions of our business strategy and expectations concerning our market position, future operations, margins, profitability, liquidity and capital resources, tax assessment orders and future capital expenditures. All of our forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those that we are expecting, including, without limitation:

 

  · our ability to successfully and cost-effectively source film content;
  · our ability to achieve the desired growth rate of Eros Now, our digital over-the-top (“OTT”) entertainment service;
  · our ability to charge and collect revenues from Eros Now D2C subscribers
  · our ability to refresh and update EN with new content
  · our ability to continue to monetize throughout the telco infrastructure in India;
  · risks that the ongoing novel coronavirus pandemic and spread of COVID-19, and related public health measures in India and elsewhere, may have material adverse effects on our business, financial position, results of operations and/or cash flows;
  · our ability to maintain or raise sufficient capital;
  · delays, cost overruns, cancellation or abandonment of the completion or release of our films;
  · our ability to predict the popularity of our films, or changing consumer tastes;
  · our ability to maintain existing rights, and to acquire new rights, to film content;
  · our ability to successfully defend any future class action law suits we are a party to in the U.S.;
  · anonymous letters to regulators or business associates or anonymous allegations on social media regarding our business practices, accounting practices and/or officers and directors;
  · our dependence on the Indian box office success of our Hindi and high budget Tamil and Telugu films;
  · our ability to recoup the full amount of box office revenues to which we are entitled due to underreporting of box office receipts by theater operators;
  · our dependence on our relationships with theater operators and other industry participants to exploit our film content;
  · our ability to mitigate risks relating to distribution and collection in international markets;
  · fluctuation in the value of the Indian rupee against foreign currencies;
  · our ability to compete in the Indian film industry;
  · our ability to compete with other forms of entertainment;
  · our ability to combat piracy and to protect our intellectual property;
  · our ability to maintain an effective system of internal control over financial reporting;

 ii

 
  · contingent liabilities that may materialize, including our exposure to liabilities on account of unfavorable judgments/decisions in relation to legal proceedings involving us or our subsidiaries and certain of our directors and officers;
  · our ability to successfully respond to technological changes;
  · regulatory changes in the Indian film industry and our ability to respond to them;
  · our ability to satisfy debt obligations, fund working capital and pay dividends;
  · the monetary and fiscal policies of India and other countries around the world, inflation, deflation, unanticipated turbulence in interest rates, foreign exchange rates, equity prices or other rates or prices; and
  · our ability to address the risks associated with acquisition opportunities.
  · the possibility that the consummation of the transactions contemplated by the Merger Agreement with STX Filmworks, Inc. (described further below in “Part I — Item 10. Additional Information — C. Material Contracts”) is delayed or does not occur, and the challenges, costs and potential disruptions associated with closing, integrating and achieving the anticipated benefits of such transactions, some or all of which anticipated benefits may take longer to realize than expected or may not be realized fully or at all.
  · our ability to manage geo-political and global trade risks on account of content limitations, tariffs, taxes, and supply chain disruptions.

 

These and other factors are more fully discussed in “Part I — Item 3. Key Information — D. Risk Factors,” “Part I — Item 5. Operating and Financial Review and Prospects” and elsewhere in this annual report. The forward-looking statements contained in this annual report are based on historical performance and management’s current plans, estimates and expectations in light of information currently available to us and are subject to uncertainty and changes in circumstances. There can be no assurance that future developments affecting us will be those that we have anticipated. Actual results may differ materially from these expectations due to changes in global, regional or local political, economic, business, competitive, market, regulatory and other factors, many of which are beyond our control. Should one or more of these risks or uncertainties materialize or should any of our assumptions prove to be incorrect, our actual results may vary in material respects from what we may have expressed or implied by these forward-looking statements. We caution that you should not place undue reliance on any of our forward-looking statements. Any forward-looking statement made by us in this annual report speaks only as of the date on which we make it. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by applicable securities laws.

 

 iii

 

PART I

 

ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS

 

Not applicable.

 

ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE

 

Not applicable.

 

ITEM 3. KEY INFORMATION

 

A. Selected Financial Data

 

The table set forth below presents our selected historical consolidated financial data for the periods and at the dates indicated. The selected historical consolidated statements of income data for each of the three years ended March 31, 2020, 2019, and 2018 and the selected statements of financial position data as of March 31, 2020 and 2019 have been derived from and should be read in conjunction with “Part I — Item 5. Operating and Financial Review and Prospects” and our consolidated financial statements included elsewhere in this Annual Report on Form 20-F. The selected historical consolidated statements of income data for each of the two years ended March 31, 2017 and 2016 and the selected historical statements of financial position data as of March 31, 2018, 2017, and 2016 have been derived from audited consolidated financial statements not included in this Annual Report on Form 20-F.

 

   Year ended March 31, 
   2020   2019   2018   2017   2016 
   (in thousands, except (Loss)/Earnings per share) 
Selected Statement of Income Data                         
Revenue   $155,452   $270,126   $261,253   $252,994   $274,428 
Cost of sales    (81,725)   (155,396)   (134,708)   (164,240)   (172,764)
Gross profit    73,727    114,730    126,545    88,754    101,664 
Administrative costs    (144,319)   (87,134)   (68,029)   (63,309)   (64,019)
Operating (loss)/profit before impairment loss    (70,592)   27,596    58,516    25,445    37,645 
Impairment loss    (431,200)   (423,335)            
Operating (loss)/profit    (501,792)   (395,739)   58,516    25,445    37,645 
Net finance costs    (8,779)   (7,674)   (17,813)   (17,156)   (8,010)
Other gains/(losses), net    (3,316)   288    (41,321)   14,205    (3,636)
Profit/(loss) before tax    (513,887)   (403,125)   (618    22,494    25,999 
Income tax   22,183    (7,328)   (9,127)   (11,039)   (12,711)
Profit/(loss) for the year (1)   $(491,704)  $(410,453)  $(9,745)  $11,455   $13,288 
                          
(Loss)/Earnings per share (cents)                         
Basic (loss)/earnings per share    (389.6)   (599.5)   (36.3)   6.4    6.6 
Diluted (loss)/earnings per share    (389.6)   (599.5)   (36.3)   5.1    5.2 
                          
Weighted average number of ordinary shares                         
Basic    107,533    70,707    62,151    59,410    57,732 
Diluted    115,770    72,170    63,482    60,943    59,036 
                          
Other non-GAAP measures                         
EBITDA (2)   $(501,646)  $(393,188)  $20,186   $42,548   $36,294 
Adjusted EBITDA (2)   $54,842   $69,378   $76,139   $55,664   $70,852 
Gross Adjusted EBITDA (2)   $119,293   $199,533   $191,424   $190,980   $199,155 

  

1 

 

 

   Year ended March 31, 
   2020   2019   2018   2017   2016 
   (in thousands) 
Selected Statement of Financial Position Data:                         
Cash and cash equivalents   $2,563   $89,117   $87,762   $112,267   $182,774 
Goodwill            3,800    4,992    5,097 
Total assets    607,656    1,088,902    1,410,319    1,343,365    1,247,878 
Debt:                          
Current portion    116,858    208,908    151,963    180,029    210,587 
Long-term portion    62,114    71,920    124,983    89,841    92,630 
Total liabilities    299,170    431,917    406,902    459,817    438,784 
                          
Equity attributable to Eros International Plc    249,119    521,456    865,689    804,457    740,332 
Equity attributable to non-controlling interests    59,367    135,529    137,728    79,091    68,762 
Total equity   $308,486   $656,985   $1,003,417   $883,548   $809,094 

 _______________

(1) References to “net income” in this document correspond to “profit/(loss) for the period” or “profit/(loss) for the year” line items in our consolidated financial statement appearing elsewhere in this document.
   
(2) We use EBITDA, Adjusted EBITDA and Gross Adjusted EBITDA as supplemental financial measures. EBITDA is defined by us as net income before interest expense, income tax expense and depreciation and amortization (excluding amortization of capitalized film content and debt issuance costs). Adjusted EBITDA is defined as EBITDA adjusted for (gain)/impairment of available-for-sale financial assets, profit/loss on held for trading liabilities (including profit/loss on derivative financial instruments), transactions costs relating to equity transactions, share based payments, Loss / (Gain) on sale of property and equipment, Loss on de-recognition of financial assets measured at amortized cost, net, Credit impairment loss, net, Loss on financial liability (convertible notes) measured at fair value through profit and loss, Loss on deconsolidation of a subsidiary and exceptional items such as impairment of goodwill, trademark, film & content rights and content advances. Gross Adjusted EBITDA is defined as Adjusted EBITDA adjusted for amortization of intangible films and content rights. EBITDA, Adjusted EBITDA and Gross Adjusted EBITDA as used and defined by us, may not be comparable to similarly-titled measures employed by other companies and is not a measure of performance calculated in accordance with GAAP. EBITDA Adjusted EBITDA and Gross Adjusted EBITDA should not be considered in isolation or as a substitute for operating income, net income, cash flows from operating, investing and financing activities, or other income or cash flow statement data prepared in accordance with GAAP. EBITDA, Adjusted EBITDA and Gross Adjusted EBITDA provide no information regarding a Company’s capital structure, borrowings, interest costs, capital expenditures and working capital movement or tax position.
   
(*) The Company has discontinued disclosure of adjustment towards significant discounting component and accordingly comparatives have been changed.

 

2 

 

The following table sets forth the reconciliation of our net income to EBITDA, Adjusted EBITDA and Gross Adjusted EBITDA:

  

   Year ended March 31 
   2020   2019   2018   2017   2016 
                     
(Loss)/Profit for the year  $(491,704)   (410,453)  $(9,745)  $11,455   $13,288 
Income tax expense    (22,183)   7,328    9,127    11,039    12,711 
Net finance costs    8,779    7,674    17,813    17,156    8,010 
Depreciation    2,568    1,049    1,265    1,082    1,154 
Amortization(a)    894    1,214    1,726    1,816    1,131 
EBITDA (Non-GAAP)    (501,646)   (393,188)   20,186    42,548    36,294 
(Gain)/Impairment of available-for-sale financial assets    1,253            (58)    
Net (gain)/loss on derivative financial instruments            586    (10,297    3,566 
Share based payments(b)    22,268    21,561    17,918    23,471    30,992 
Loss/(Gain) on sale of property and equipment    70    97    (2)        
Loss on de-recognition of financial assets measured at amortized cost, net    5,285    5,988    3,562         
Credit impairment loss, net    90,808    10,673             
Loss on financial liability (convertible notes) measured at fair value through profit and loss    15,987    21,398    13,840         
Loss on deconsolidation of a subsidiary            14,649         
Impairment of goodwill            1,205         
Reversal credit impairment losses/(gains)    (10,383)   (20,698)   4,308         
Closure of derivative        249             
Impairment loss    431,200    423,335             
Others        (37)   (113)        
Adjusted EBITDA (Non-GAAP)(b)   $54,842   $69,378(*)  $76,139(*)  $55,664   $70,852 
Amortization of intangible films and content rights    64,451    130,155    115,285    135,316    128,303 
Gross Adjusted EBITDA (Non-GAAP)(b)   $119,293   $199,533   $191,424   $190,980   $199,155 

_______________

(a) Includes only amortization of intangible assets other than capitalized film content.
(b) Consists of compensation costs, recognised with respect to all outstanding share based compensation plans and all other equity settled instruments.
(*) The Company has discontinued disclosure of adjustment towards significant discounting component and accordingly comparatives have been changed.

 

Our management team believes that EBITDA, Adjusted EBITDA and Gross Adjusted EBITDA are useful to an investor in evaluating our results of operations because these measures:

 

  · are widely used by investors to measure a company’s operating performance without regard to items excluded from the calculation of such term, which can vary substantially from company to company depending upon accounting methods and book value of assets, capital structure and the method by which assets were acquired, among other factors;
  · help investors to evaluate and compare the results of our operations from period to period by removing the effect of our capital structure from our operating structure; and
  · are used by our management team for various other purposes in presentations to our Board of Directors as a basis for strategic planning and forecasting.

 

3 

 

However, there are significant limitations to using EBITDA, Adjusted EBITDA and Gross Adjusted EBITDA as a measure of performance, including the inability to analyze the effect of certain recurring and non-recurring items that materially affect our net income or loss, the lack of comparability of results of operations of different companies and the different methods of calculating EBITDA. Adjusted EBITDA and Gross Adjusted EBITDA reported by different companies.

 

Exchange Rate Information

Our functional and reporting currency is the U.S. dollar. Transactions in foreign currencies are translated at the exchange rate ruling at the date of the transaction. Monetary assets and liabilities in foreign currencies are translated into U.S. dollars at the exchange rates at ruling on the date of the applicable statement of financial position. For the purposes of consolidation, all income and expenses are translated at the average rate of exchange during the period covered by the applicable statement of income and assets and liabilities are translated at the exchange rate ruling on the date of the applicable statement of financial position.

The following table sets forth, for the periods indicated, information concerning the exchange rates between Indian rupees and U.S. dollars based on the noon buying rate in the City of New York for cable transfers of Indian rupees as certified for customs purposes by the Federal Reserve Bank of New York. These rates are provided solely for your convenience and are not necessarily the exchange rates that were used in this Offering Memorandum or will be used in the preparation of periodic reports or any other information to be provided to you.

   Period End  Average(1)  High  Low
Fiscal Year            
2011  44.54  45.46  47.49  43.90
2012  50.89  48.01  53.71  44.00
2013  54.52  54.36  57.13  50.64
2014  60.35  60.35  68.80  53.65
2015  62.58  61.15  63.70  58.46
2016  66.25  65.39  68.84  61.99
2017  64.85  67.01  68.86  64.85
2018  65.11  64.46  65.71  63.38
2019  69.16  69.91  74.33  64.92
2020  75.39  70.90  71.66  70.10
             
Months            
April 2019   69.64  69.41  70.19  68.58
May 2019   69.63  69.77  70.62  69.08
June 2019   68.92  69.39  69.83  68.92
July 2019   68.81  68.74  69.03  68.40
August 2019   71.45  71.19  72.02  69.00
September 2019   70.64  71.32  72.20  70.49
October 2019   71.01  71.00  71.48  70.71
November 2019   71.75  71.48  72.12  70.76
December 2019   71.36  71.16  71.70  70.62
January 2020   71.53  71.27  71.86  70.69
February 2020   72.53  71.53  72.53  71.11
March 2020   75.39  74.55  76.37  72.88
April 2020   75.08  76.17  76.95  75.08
May 2020   75.59  75.67  76.08  75.03
June 2020   75.63  75.73  76.32  75.03

 

  (1) Represents the average of the U.S. dollar to Indian Rupee exchange rates on the last day of each month during the period for all fiscal years presented, and the average of the noon buying rate for all days during the period for all months presented.

 

B. Capitalization and Indebtedness

 

Not Applicable.

 

4 

 

C. Reason for the Offer and the Use of Proceeds

 

Not Applicable.

 

D. Risk Factors

 

This annual report contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of a number of factors, including those described in the following risk factors and elsewhere in this annual report. If any of the following risks were to occur, our business affairs, prospects, assets, financial condition, results of operations and cash flows could be materially and adversely affected, and the market price of our A ordinary shares could decline. Additionally, the pandemic caused by a novel strain of coronavirus (“COVID-19”) has had, and is expected to continue to have, a material adverse impact on our business, financial condition and results of operations, as well as those of many of our business partners, and local, national, and global economies. The COVID-19 pandemic has also amplified many of the other risks discussed below to which we are subject. We are unable to predict the extent to which the pandemic and its related impacts will adversely affect us. However, given the unpredictable, unprecedented, and fluid nature of the pandemic, it may also materially and adversely affect our business, financial condition, and results of operations in ways that are not currently anticipated by or known to us or that we do not currently consider to present significant risk.

Risks Relating to the STX Transaction and the Combined Company Upon Completion of the STX Transaction

We cannot assure you that the STX Transaction will occur on the timeframe that is currently contemplated or at all.

On April 17, 2020, Eros entered into an Agreement and Plan of Merger (the “Merger Agreement”) with STX Filmworks, Inc., a Delaware corporation (“STX”), England Holdings 2, Inc., a Delaware corporation and indirect wholly owned subsidiary of Eros (“England Holdings 2”), and England Merger 1 Corp. (f/k/a England Merger Corp.), a Delaware corporation and a direct wholly owned subsidiary of England Holdings 2 (“Merger Sub”), which provides for, among other things, the merger of Merger Sub with and into STX (the “Merger”), with STX surviving as the surviving corporation and a direct wholly owned subsidiary of England Holdings 2. Eros, as the combined company following the Merger, is referred to hereafter as the “combined company.” The Merger and the related transactions contemplated by the Merger Agreement are collectively referred to hereafter as the “STX Transaction.” The Merger Agreement and the STX Transaction are described in greater detail below under “Part I –Item 10. Additional Information – C. Material Contracts.” While the parties currently expect that the STX transaction will be consummated on or shortly after the date of this Report, there is still a risk that the STX Transaction may not be consummated, including if one or more parties fails to perform under or breaches the PIPE Subscription Agreement. If the STX Transaction does not occur, our ability to conduct our business in the manner and on the timelines presently planned could be materially and negatively affected, and such failure could have a material adverse impact on our stock price, business and our results of operation and financial condition.

Uncertainties associated with the STX Transaction may cause a loss of management personnel and other key employees, which could adversely affect the future business and operations of the combined company following completion of the STX Transaction.

Both Eros and STX are dependent on the experience and industry knowledge of their officers and other key employees to execute their business plans and the business plan of the combined company. The combined company’s success after the completion of the STX Transaction will depend in part upon the ability of the combined company to retain certain key management personnel and employees of Eros and STX. No assurance can be given that the combined company, after the completion of the STX Transaction, will be able to attract or retain key management personnel and other key employees to the same extent that Eros and STX have previously been able to attract or retain their own employees.

5 

 

Following the STX Transaction, the composition of the combined company board of directors will be different than the composition of the current Eros board of directors.

The Eros board of directors currently consists of seven directors. Upon completion of the STX Transaction, the board of directors of the combined company will consist of nine directors, including four directors who were selected by the Founders Group (one of whom must be an independent director), four directors who were selected by STX (one of whom must be an independent director), and an independent director jointly selected by the Founders Group and STX. This new composition of the board of directors of the combined company may affect the future decisions of the combined company.

The combined company may be unable to successfully integrate Eros and STX and realize the anticipated benefits of the STX Transaction.

The success of the STX Transaction will depend, in part, on the combined company’s ability to successfully combine and integrate Eros and STX, and realize the anticipated benefits, including synergies, cost savings, innovation and strategic growth opportunities and operational efficiencies from the STX Transaction in a manner that does not materially disrupt existing customer, supplier, talent, producer, distributor, employee and other industry relations and does not result in decreased revenues due to losses of, or decreases in purchase and/or viewership of its content and service offerings by, subscribers and other counterparties. If the combined company is unable to achieve these objectives within the anticipated time frame, or at all, the anticipated benefits may not be realized fully or at all, or may take longer to realize than expected, and the value of the combined company’s A ordinary shares may decline. The combined company may fail to realize some or all of the anticipated benefits of the STX Transaction if the integration process takes longer than expected or is more costly than expected.

The integration of the two companies may result in material challenges, including, without limitation:

·managing a larger, more complex combined business;
·maintaining employee morale and retaining key management and other employees;
·retaining existing business and operational relationships, including customers, suppliers, distributors, employees and other counterparties, and attracting new business and operational relationships;
·consolidating corporate and administrative infrastructures and eliminating duplicative operations, including unanticipated issues in integrating information technology, communications and other systems;
·coordinating geographically separate organizations; and
·unforeseen expenses or delays associated with the STX Transaction.

Many of these factors will be outside of the combined company’s control, and any one of them could result in delays, increased costs, decreases in the amount of expected revenues and other adverse impacts, which could materially affect the combined company’s financial position, results of operations and cash flows.

Due to legal restrictions, Eros and STX have been and are currently permitted to conduct only limited planning for the integration of the two companies following the STX Transaction. The actual integration may result in additional and unforeseen expenses, and the anticipated benefits of the integration plan may not be realized on a timely basis, if at all.

In addition, the combined company’s ability to successfully integrate and manage its expanded business and achieve the anticipated benefits of the STX Transaction may be materially and adversely effected by the ongoing COVID-19 pandemic, which is discussed in greater detail below. The ability of both Eros and STX to generate revenues from the monetization of film content in various distribution channels, including through agreements with commercial theatre operators, has been and may continue to be adversely effected by the COVID-19 pandemic. The full extent and scope of the impact of the pandemic on national, regional and global markets and economies, and therefore the combined company’s business and industry and efforts to integrate its expanded business and organization and realize anticipated benefits of the STX Transaction, is highly uncertain and cannot be predicted.

6 

 

The future results of the combined company may be adversely impacted if the combined company does not effectively manage its complex operations following the completion of the STX Transaction.

Following the completion of the STX Transaction, the size of the combined company’s business will be significantly larger than the current size of either Eros’ business or STX’s business. The combined company’s ability to successfully manage this expanded business will depend, in part, upon management’s ability to design and implement strategic initiatives that address not only the integration of Eros and STX, but also the increased scale and scope of the combined business with its associated increased costs and complexity. There can be no assurances that the combined company will be successful in integrating the businesses or that it will realize the expected operating efficiencies, cost savings, strategic growth opportunities and other benefits currently anticipated from the STX Transaction.

Current Eros shareholders will generally have a reduced ownership and voting interest in the combined company after the STX Transaction.

Immediately after the completion of the STX Transaction, each Eros shareholder will remain a shareholder of Eros, as the combined company, but with a percentage ownership that will be less than half of such shareholder’s percentage of Eros as of immediately prior to the STX Transaction. As a result of this reduced ownership percentage, existing Eros shareholders will generally have less voting power in the combined company after the STX Transaction than they did prior to the STX Transaction.

Pursuant to an Investors’ Rights Agreement and the Amended Articles of Association, the Founders Group and certain significant stockholders of STX will have rights relating to governance of the combined company that are different from shareholders generally.

As described below under “Part I –Item 10. Additional Information – C. Material Contracts,” the Founders Group and certain significant stockholders of STX (the “STX Parties”) will enter into an Investors’ Rights Agreement at the effective time of the Merger. In addition, as required by the Merger Agreement, we convened an extraordinary general meeting of our shareholders on June 29, 2020 at which the requisite percentage of our shareholders approved the Amended Articles of Association, key provisions of which are also described in “Part I –Item 10. Additional Information – C. Material Contracts.” By virtue of the Investors’ Rights Agreement and the Amended Articles of Association, for a period lasting up to three years following the consummation of the STX Transaction, the Founders Group will have the right to nominate four out of nine directors on the combined company’s board of directors and certain of the STX Parties affiliated with Hony Capital (“Hony”) will have the right to nominate four out of nine directors on the combined company’s board of directors. In addition, during this period, the board of directors of the combined company will not be permitted to take certain significant corporate actions, including adopting the combined company’s annual business plan and budget, without the approval of at least one non-independent member of the board of directors that was nominated by the Founders Group. During this period, the board of directors of the combined company also will not be permitted to hire or terminate any of the chief executive officer, chief financial officer or president (or co-presidents) of the combined company without the approval of at least one non-independent member of the board of directors that was nominated by the Founders Group and at least one member of the board of directors that was nominated by Hony. In exercising their rights under the Investors’ Rights Agreement and the Amended Articles of Association, the Founders Group and STX Parties may have interests that are different from or in addition to the interests of the combined company’s other shareholders.

Each of Eros and STX has incurred substantial expenses related to the completion of the STX Transaction and expects to incur substantial expenses related to the integration of Eros and STX.

Each of Eros and STX has incurred substantial expenses in connection with the completion of the STX Transaction and expects to incur substantial expenses to integrate a large number of processes, policies, procedures, operations, technologies and systems of Eros and STX in connection with the STX Transaction. The substantial majority of these costs will be non-recurring expenses related to the transactions and facilities and systems consolidation costs. The combined company may incur additional costs or suffer loss of business under third-party contracts that are terminated or that contain change in control or other provisions that may be triggered by the completion of the transactions, and/or losses of, or decreases in transactions by, customers and business partners of Eros and STX, and may also incur costs to retain certain key management personnel and employees. Eros and STX will also incur transaction fees and costs related to formulating integration plans for the combined business, and the execution of these plans may lead to additional unanticipated costs and time delays. These incremental transaction-related costs may exceed the savings the combined company expects to achieve from the elimination of duplicative costs and the realization of other efficiencies related to the integration of the businesses, particularly in the near term and in the event there are material unanticipated costs. Factors beyond the parties’ control could affect the total amount or timing of these expenses, many of which, by their nature, are difficult to estimate accurately.

7 

 

The market price of the combined company’s A ordinary shares after the STX Transaction is completed may be affected by factors different from those affecting the price of Eros A ordinary shares before the STX Transaction is completed.

Upon completion of the STX Transaction, holders of Eros A ordinary shares will be holders of A ordinary shares of the combined company. As the businesses of Eros and STX are different, the results of operations as well as the price of the combined company’s A ordinary shares may, in the future, be affected by factors different from, or may be affected differently by, those factors affecting Eros an independent stand-alone company. The combined company will face additional risks and uncertainties to which each of Eros and STX may currently not be exposed. As a result, the market price of the combined company’s shares may fluctuate significantly following completion of the STX Transaction.

The market price of the combined company’s A ordinary shares may decline as a result of the STX Transaction.

The market price of the combined company’s A ordinary shares may decline as a result of the STX Transaction if, among other things, the operational cost savings estimates in connection with the integration of Eros’s business and STX’s business are not realized, there are unanticipated negative impacts on Eros’s financial position, or if the transaction costs related to the STX Transaction are greater than expected. The market price also may decline if the combined company does not achieve the perceived benefits of the STX Transaction as rapidly or to the extent anticipated by financial or industry analysts or if the effect of the transactions on the combined company’s financial position, results of operations or cash flows is not consistent with the expectations of financial or industry analysts.

In addition, sales of combined company’s A ordinary shares after the completion of the STX Transaction may cause the market price of such shares to decrease. It is estimated that Eros will issue approximately 236,262,932 A ordinary shares, including up to 40 million share equity awards, in connection with the STX Transaction, based on the number of outstanding shares, including share equity awards, and the 10-day volume weighted average price of Eros A ordinary shares as of July 29, 2020. While STX stockholders who did not purchase shares pursuant to the PIPE Subscription Agreement described below under “Part I –Item 10. Additional Information – C. Material Contracts” will be subject to a contractual 18-month lockup period during which they may not sell the combined company’s A ordinary shares they receive in the Merger, those STX stockholders who purchase shares pursuant to the PIPE Subscription Agreement are subject only to a 75-day lockup period (with respect to both the shares they receive in the Merger and the shares they purchase in the PIPE Subscription Agreement). Such STX stockholders may decide not to hold the shares of combined company common stock they will receive in STX Transaction beyond the 75-day lockup period. In addition, existing Eros shareholders may decide not to continue to hold their A ordinary shares following completion of the STX Transaction. Such sales of combined company A ordinary shares could have the effect of depressing the market price for the combined company’s A ordinary shares.

Any of these events may make it more difficult for the combined company to sell equity or equity-related securities, dilute your ownership interest in the combined company and have an adverse impact on the price of the combined company’s A ordinary shares.

If certain U.S. federal income tax rules regarding ‘‘inversion transactions’’ apply to us as a result of the STX Transaction, such rules could result in adverse U.S. federal income tax consequences.

Under section 7874 of the U.S. Internal Revenue Code of 1986, as amended (‘‘Code’’), a foreign corporation is treated as a “surrogate foreign corporation” if, pursuant to a plan (or a series of related transactions) (1) the foreign corporation completes the direct or indirect acquisition of substantially all of the properties held, directly or indirectly, by a U.S. corporation, (2) after the acquisition at least 60% of the stock (by vote or value) of the foreign corporation is held by former shareholders and certain creditors of the U.S. corporation by reason of their holding stock or debt obligations of the U.S. corporation (such percentage held by such persons being the ‘‘Section 7874 Percentage’’), and (3) after the acquisition, the “expanded affiliated group” (within the meaning of section 7874 of the Code) that includes the foreign corporation does not have substantial business activities in the foreign country in which, or under the law of which, the foreign corporation is created or organized, relative to the total business activities of such expanded affiliated group.

8 

 

If the Section 7874 Percentage is at least 60% but less than 80% and a foreign corporation is a surrogate foreign corporation with respect to a U.S. corporation, several limitations apply to the U.S. corporation, including, but not limited to, the prohibition, for a period of ten years, of the use of net operating losses, foreign tax credits and other tax attributes to offset the income or gain recognized by reason of transfer of any property to a foreign related person or to offset any income received or accrued during such period by reason of a license of any property to a foreign related person and an additional minimum tax under Section 59A of the Code on certain ‘‘base eroding’’ payments to members of the expanded affiliated group that are foreign corporations. In addition, under section 4985 of the Code and the rules related thereto, an excise tax at a rate of currently 20% is imposed on the value of certain share compensation held directly or indirectly by certain ‘‘disqualified individuals’’ (including certain of officers and directors). Further, shareholders of the foreign corporation that are United States persons for U.S. federal income tax purposes may not be eligible for reduced rates on dividends paid by the foreign corporation.

If the Section 7874 Percentage is at least 80% and a foreign corporation is a surrogate foreign corporation with respect to a U.S. corporation, the foreign corporation will be treated as a U.S. corporation, regardless of the fact that such corporation is also incorporated in a foreign country. If the foreign corporation were treated as a U.S. corporation, the entire net income of the foreign corporation would be subject to U.S. federal income tax on a net income basis and would be determined under U.S. federal income tax principles.

[Based on the facts as of the date hereof, we expect that, after the consummation of the STX Transaction, the Section 7874 Percentage with respect to former STX shareholders and creditors will be less than 60% and therefore we do not expect to be treated as a “surrogate foreign corporation” within the meaning of section 7874 of the Code.] Determining the Section 7874 Percentage, however, is complex and cannot be made until after the consummation of the STX Transaction, and is subject to legal uncertainties and factual uncertainties. As a result, there can be no assurance that the Section 7874 Percentage will be less than 60%. Holders are urged to consult their own tax advisors regarding the potential application of section 7874 of the Code to the STX Transaction and its potential tax consequences. A determination that we are a surrogate foreign corporation for the purposes of section 7874 of the Code may have material adverse effects on the business, financial condition, results of operations and prospects of the combined company following the STX Transaction.

9 

 

Risks Related to Our Business

The COVID-19 pandemic and other adverse public health developments has adversely affected our business and results of operations.

In December 2019, COVID-19 emerged in Wuhan, Hubei Province, China. While initially the outbreak was largely concentrated in China and caused significant disruptions to its economy, it has now spread globally to many countries where we distribute films theatrically, including India, United Kingdom, United States, Dubai, Singapore and Australia. On March 11, 2020, the World Health Organization designated the outbreak a pandemic. Governments and businesses around the world have taken unprecedented actions to mitigate the spread of COVID-19, including imposing restrictions on movement and travel such as quarantines and shelter-in-place requirements, or nationwide lockdowns, as well as restricting or prohibiting outright some or all commercial and business activity, including the closure of some or all theatres and disrupting the production and availability of content, including delayed, or in some cases, shortened or cancelled theatrical releases. These measures, though currently temporary in nature, may become more severe and continue indefinitely depending on the evolution of the pandemic. To date, no fully effective vaccines or treatments have been developed and effective vaccines or treatments may not be discovered soon enough to protect against a further worsening of the pandemic.

The pandemic has materially and adversely affected our ability to generate revenues from the monetization of Indian film content in various distribution channels through agreements with commercial theatre operators, and may continue to do so unless and until the pandemic subsides or an effective treatment or vaccine is discovered. The extent of the adverse impact on our financial and operational results will be dictated by the length of time that such disruptions continue, which will, in turn, depend on the currently unknowable duration of COVID-19 and among other things, the impact of governmental actions imposed in response to the pandemic and individuals’ and companies’ risk tolerance regarding health matters going forward. Our business also could be significantly affected even after reopening of certain operations, should the disruptions caused by the COVID-19 lead to changes in consumer behavior (such as social distancing becoming the norm independent of any pandemic conditions) and also delayed in production schedule. For example, some areas may not re-open movie theatres or, if they do, some individuals may not feel comfortable gathering in public places such as movie theatres.

The continued spread of COVID-19 has adversely affected many industries as well as the economies and financial markets of many countries, including in many of the countries in which we distribute content, resulting in a significant deceleration of economic activity. This slowdown has reduced production, decreased the level of trade, and led to widespread corporate downsizing, causing a sharp increase in unemployment. We have also seen significant disruption of and extreme volatility in the global capital markets, which could increase the cost of, or entirely restrict access to, capital. This volatility and uncertainty have adversely affected our stock price and may continue to do so. As a result, to the extent we determine it is in our best interests to access the capital markets or refinance some or all of our indebtedness, we may not be able to do so on terms that are acceptable to us or at all. The impact of this outbreak on global, national and local economies is still uncertain and, unless the outbreak is contained, these adverse impacts could worsen, impacting all segments of the global economy, and result in a significant recession or worse.

Considerable uncertainty still surrounds COVID-19 and its potential effects, and the extent of and effectiveness of any responses taken on a local, national and global level. Infections may become more widespread and that could accelerate or magnify one or more of the risks described above. While we expect the pandemic and related events will have a negative effect on our business, the full extent and scope of the impact on national, regional and global markets and economies, and therefore our business and industry, is highly uncertain and cannot be predicted. Accordingly, our ability to conduct our business in the manner and on the timelines presently planned could be materially and negatively affected, any of which could have a material adverse impact on our business and our results of operation and financial condition.

We are monitoring the rapidly evolving situation and its potential impacts on our financial position, results of operations, liquidity, and cash flows.

10 

 

We may fail to source adequate film content on favorable terms or at all through acquisitions or co-productions, which could have a material and adverse impact on our business.

We generate revenues by monetizing Indian film content that we primarily co-produce or acquire from third parties, and then distribute through various channels. Our ability to successfully enter into co-productions and to acquire content depends on, among other things, our ability to maintain existing relationships, and form new ones, with talent and other industry participants.

The pool of quality talent in India is limited and, as a result, there is significant competition to secure the services of certain actors, directors, composers and producers, among others. Competition can increase the cost of such talent, and hence the cost of film content. These costs may continue to increase, making it more difficult for us to access content cost-effectively and reducing our ability to sustain our margins and maximize revenues from distribution and monetization. Further, we may be unable to successfully maintain our long-standing relationships with certain industry participants and continue to have access to content and/or creative talent and may be unable to establish similar relationships with new leading creative talent. This is also dependent on relationships with various writers and talent and has execution risks associated with it. If any such relationships are adversely affected, or we are unable to form new relationships, or if any party fails to perform under its agreements or arrangements with us, our business, prospects, financial condition, liquidity and results of operations could be materially adversely affected.

Our business involves substantial capital requirements, and our inability to maintain or raise sufficient capital could materially adversely affect our business.

Our business requires a substantial investment of capital for the production, acquisition and distribution of films and a significant amount of time may elapse between our expenditure of funds and the receipt of revenues from our films. This may require us to fund a significant portion of our capital requirements from our credit facilities or other financing sources. Any capital shortfall could have a material adverse effect on our business, prospects, financial condition, results of operations and liquidity. For additional information, please see “Part 1—Item 5. Operating and Financial Review and Prospects—B. Liquidity and Capital Resources” and Note [2(a)] and Note [31] to our audited Consolidated Financial Statements appearing elsewhere in this annual report.

Delays, cost overruns, cancellation or abandonment of the completion or release of films may have a material adverse effect on our business.

There are substantial financial risks relating to film production, completion and release. Actual film costs may exceed their budgets, and factors such as labour disputes, unavailability of a star performer, equipment shortages, disputes with production teams or adverse weather conditions may cause cost overruns and delay or hamper film completion. When a film we have contracted to acquire from a third-party experiences delays or fails to be completed, we may not recover advance monies paid for the proposed acquisition. When we enter into co-productions, we are typically responsible for paying all production costs in accordance with an agreed upon budget and while we typically cap budgets in our contracts with our co-producer, given the importance of ongoing relationships in our industry, longer-term commercial considerations may in certain circumstances override strict contractual rights and we may feel obliged to fund cost over-runs where there is no contractual obligation requiring us to do so.

Production delays, failure to complete projects or cost overruns could result in us not recovering our costs and could have a material adverse effect on our business, prospects, financial condition and results of operations.

The popularity and commercial success of our films are subject to numerous factors, over which we may have limited or no control.

The popularity and commercial success of our films depends on many factors including, but not limited to, the key talent involved, the timing of release, the promotion and marketing of the film, the quality and acceptance of other competing programs released into the marketplace at or near the same time, the availability of alternative forms of entertainment, general economic conditions, the genre and specific subject matter of the film, its critical acclaim and the breadth, timing and format of its initial release. We cannot predict the impact of such factors on any film, and many are factors that are beyond our control. As a result of these factors and many others, our films may not be as successful as we anticipate, and as a result, our results of operations may suffer.

11 

 

The success of our business depends on our ability to consistently create and distribute filmed entertainment that meets the changing preferences of the broad consumer market both within India and internationally.

Changing consumer tastes affect our ability to predict which films will be popular with audiences in India and internationally. As we invest in a portfolio of films across a wide variety of genres, stars and directors, it is highly likely that at least some of the films in which we invest will not appeal to Indian or international audiences. Further, where we sell rights prior to release of a film, any failure to accurately predict the likely commercial success of a film may cause us to underestimate the value of such rights. If we are unable to co-produce and acquire rights to films that appeal to Indian and international film audiences or to accurately judge audience acceptance of our film content, the costs of such films could exceed revenues generated and anticipated profits may not be realized. Our failure to realize anticipated profits could have a material adverse effect on our business, prospects, financial condition and results of operations.

Our ability to monetize our content is limited to the rights that we acquire from third parties or otherwise own.

We have acquired our film content through contracts with third parties, which are primarily fixed-term contracts that may be subject to expiration or early termination. Upon expiration or termination of these arrangements, content may be unavailable to us on acceptable terms or at all, including with respect to technical matters such as encryption, territorial limitation and copy protection. In addition, if any of our competitors offer better terms, we will be required to spend more money or grant better terms, or both, to acquire or extend the rights we previously held. If we are unable to renew the rights to our film library on commercially favorable terms and to continue monetizing the existing films in our library or other content, it could have a material adverse effect on our business, prospects, financial condition and results of operations.

In addition, we typically only own certain rights for the monetization of content, which limits our ability to monetize content in certain media formats. In particular, we do not own the audio music rights to the majority of the films in our library and to certain new releases. To the extent we do not own the music or other media rights in respect of a particular film, we may only monetize content through those channels to which we do own rights, which could have an adverse effect on our ability to generate revenue from a film and recover our costs from acquiring or producing content.

We may face claims from third parties that our films may be infringing on their intellectual property.

Third parties may claim that certain of our films misappropriate or infringe such third parties’ intellectual property rights with respect to previously developed films, stories, characters, other entertainment or intellectual property. Any such assertions or claims may impact our rights to monetize the related films. Irrespective of the validity or the successful assertion of such claims, we could incur significant costs and diversion of resources in defending against them. If any claims or actions are asserted against us, we may seek to settle such claim by obtaining a license from the plaintiff covering the disputed intellectual property rights. We cannot provide any assurances, however, that under such circumstances a license, or any other form of settlement, would be available on reasonable terms or at all. Any of these occurrences could have a material adverse effect on our business, prospects, financial condition and results of operations.

We were historically and are currently, party to class action lawsuits in the U.S. and may be subject to similar or additional claims in the future, and an adverse ruling on any such future claims could have a material adverse effect on our business, financial condition and results of operations and could negatively impact the market price of our A Ordinary Shares.

Beginning on November 13, 2015, the Company was named a defendant in five substantially similar putative class action lawsuits filed in federal court in New Jersey and New York by purported shareholders of the Company. On May 17, 2016, the putative class actions filed in New Jersey were transferred to the United States District Court for the Southern District of New York where they were subsequently consolidated with the other two actions. The Court-appointed lead plaintiffs filed a single consolidated complaint on July 14, 2016 and amended on October 10, 2016. The amended consolidated complaint alleged that the Company and certain individual defendants violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”), but did not assert certain claims that had been asserted in prior complaints. The remaining claims were primarily focused on whether the Company and individual defendants made material misrepresentations concerning the Company’s film library and materially misstated the usage and functionality of Eros Now, our digital OTT entertainment service. On September 25, 2017, the United States District Court for the Southern District of New York entered a Memorandum and Order dismissing the putative class action with prejudice. On August 24, 2018, the United States Court of Appeals for the Second Circuit issued a summary order affirming the district court’s earlier dismissal, with prejudice.

12 

 

Beginning on June 21, 2019, the Company was named a defendant in three substantially similar putative class action lawsuits filed in federal court in California and New Jersey by purported shareholders of the Company. The lawsuits allege that the Company and certain individual defendants violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 by making false and/or misleading statements regarding the Company’s accounting for trade receivables. On September 27, 2019, the putative class action filed in California was transferred to the United States District Court for the District of New Jersey. On April 14, 2020, the three putative class actions were consolidated, and a lead plaintiff was appointed. On July 1, 2020, the court-appointed lead plaintiff filed a consolidated complaint. The consolidated complaint expands the scope of the allegations. The company expects to file a motion to dismiss, which is due August 28, 2020.

We have incurred, and will continue to incur, significant costs to defend our position in the above-mentioned class action lawsuits. We are unable to predict whether we will be subject to similar or additional claims in the future. If we become subject to class action lawsuits or any other related lawsuits or investigations or proceedings by regulators in the future, or if the current actions are not resolved in our favor, it could result in a diversion of management resources, time and energy, significant costs, a material decline in the market price for our A Ordinary Shares, increased share price volatility and increased directors and officers liability insurance premiums and could have a material adverse effect upon our business, prospects, financial condition, results of operations and ability to access the capital markets.

Anonymous letters to regulators or business associates or anonymous allegations on social media regarding our business practices, accounting practices and/or officers and directors could have a resultant material adverse effect on our business, financial condition and results of operations and could negatively impact the market price for our A Ordinary Shares.

We have been, are currently and in the future may be, the target of anonymous letters sent to regulators or business associates or anonymous allegations posted on social media or circulated in short selling reports regarding our accounting practices, business practices and/or officers and directors. Every time we have received such allegations, we have undertaken what we believe to be a reasonably prudent review, including extensive due diligence to investigate the allegations, and where necessary our board of directors has engaged third-party professional firms to report directly to the Company’s Audit Committee. Having conducted these investigations, in each instance we found the allegations were without merit. However, the public dissemination of these allegations has adversely affected our reputation, business and the market price of our A Ordinary Shares and required us to spend significant management time and incur substantial costs to address them.

If anonymous allegations are made in the future, or if the current allegations continue, it could result in a diversion of management resources, time and energy, significant costs, a material decline in the market price for our A Ordinary Shares, increased share price volatility and increased directors and officers liability insurance premiums and could have a material adverse effect upon our business, prospects, financial condition, results of operations and ability to access the capital markets.

Our business involves risks of liability claims for media content.

As a producer and distributor of media content, we may face potential liability for:

  · defamation;
  · invasion of privacy;
  · negligence;
  · copyright or trademark infringement; and
  · other claims based on the nature and content of the materials distributed.

These types of claims have been brought, sometimes successfully, against producers and/or distributors of media content. Any imposition of liability that is not covered by insurance or is in excess of insurance coverage could have a material adverse effect on our business and financial condition.

13 

 

We depend on the Indian box office success of our Hindi and high budget Tamil and Telugu films from which we derive a significant portion of our revenues.

In India, a relatively high percentage of a film’s overall revenues are derived from theater box office sales and, in particular, from such sales in the first week of a film’s release. Indian domestic box office receipts are also an indicator of a film’s expected success in other Indian and international distribution channels. As such, poor box office receipts in India for our films, even for those films for which we obtain only international distribution rights, could have a significant adverse impact on our results of operations in both the year of release of the relevant films and in the future for revenues expected to be earned through other distribution channels. In particular, we depend on the Indian box office success of our Hindi films and high budget Tamil and Telugu films.

We may not be paid the full amount of box office revenues to which we are entitled.

We derive revenues from theatrical exhibition of our films by collecting a specified percentage of box office receipts from multiplex and single screen theater operators. The Indian film industry continues to lack full exhibitor transparency. There is limited independent monitoring of such data in India or the Middle East, unlike the monitoring services provided by comScore in the United Kingdom and the United States. We therefore rely on theater operators and our sub-distributors to report relevant information to us in an accurate and timely manner.

While multiplex and single-screen operators have now moved to a digital distribution model that provides greater clarity on the number of screenings given to our films, many still do not have computerized tracking systems for box office receipts which can be tracked independently by a third party and we are reliant on box office reports generated internally by these multiplex and single screen operators which may not be entirely accurate or transparent.

Because we do not have a reliable system to determine if our box office receipts are underreported, box office receipts and sub-distribution revenues may be inadvertently or purposefully misreported or delayed, which could prevent us from being compensated appropriately for exhibition of our films. If we are not properly compensated, our business, prospects, financial condition and results of operations could be negatively impacted.

We depend on our relationships with theater operators and other industry participants to monetize our film content. Any disputes with multiplex operators in India could have a material adverse effect on our ability or willingness to release our films as scheduled.

We generate revenues from the monetization of Indian film content in various distribution channels through agreements with commercial theater operators, in particular multiplex operators, and with retailers, television operators, telecommunications companies and others. Our failure to maintain these relationships, or to establish and capitalize on new relationships, could harm our business or prevent our business from growing, which could have a material adverse effect on our business, prospects, financial condition and results of operations.

We have had disputes with multiplex operators in India that required us to delay our film releases and disrupted our marketing schedule for future films. These disputes were subsequently settled pursuant to settlement agreements that expired in June 2011. We now enter into agreements on a film-by-film and exhibitor-by-exhibitor basis instead of entering into long-term agreements. To date, our film-by-film agreements have been on commercial terms that are no less favorable than the terms of the prior settlement agreements; however, we cannot guarantee such terms can always be obtained. Accordingly, without a long-term commitment from multiplex operators, we may be at risk of losing a substantial portion of our revenues derived from our theatrical business. We may also have similar future disruptions in our relationship with multiplex operators, the operators of single-screen theaters or other industry participants, which could have a material adverse effect on our business, prospects, financial condition and results of operations. Further, the theater industry in India is rapidly growing and evolving and we cannot assure you that we will be able to establish relationships with new commercial theater operators.

14 

 

Eros Now, our digital OTT entertainment service accessible via internet-enabled devices, may not achieve the desired growth rate.

Eros Now was soft launched in 2012 and as of March 31, 2020, Eros Now caters to 29.3 Million paying subscribers and has garnered 196.8 million registered users across global digital distribution platforms. We must continue to grow and retain subscribers in India (one of our key markets) where consumers also use traditional Pay-TV and broadcast channels for content consumption, as well as grow our subscriber base in markets outside of India. Our ability to attract and retain subscribers will depend in part on our ability to consistently provide our subscribers a high-quality experience with respect to content and features and on the quality of data connectivity (either Wi-Fi, broadband, 3G or 4G mobile data) in India.

To achieve and sustain the desired growth rate from Eros Now, we must accomplish numerous objectives, including substantially increasing the number of paid subscribers to our service and retaining them, without which our revenues from digital stream will be adversely affected. We cannot assure you that we will be able to achieve these objectives due to any of the factors listed below, among other factors:

  · our ability to maintain an adequate content offering;
  · our ability to maintain, upgrade and develop our service offering on an ongoing basis;
  · our ability to successfully distribute our service across multiple mobile, internet and cable platforms worldwide;
  · our ability to secure and retain distribution across various platforms including telecom operators and original equipment manufacturers;
  · our ability to convert free registered users into paid subscribers and retain them;
  · our ability to compete effectively against other Indian and foreign OTT services;
  · our ability to manage technical glitches or disruptions;
  · our ability to attract and retain our employees;
  · any changes in government regulations and policies; and
  · any changes in the general economic conditions specific to the internet and the movie industry.

Eros Now faces and will continue to face competition for subscriber time.

We compete for the time and attention of our Eros Now subscribers with other content providers on the basis of a number of factors, including quality of experience, relevance, diversity of content, ease of use, price, accessibility, perception of advertising load, brand awareness, and reputation.

We compete with providers of on-demand Indian language entertainment, which is purchased or available for free and playable on mobile devices and in the home. We face increasing competition for subscribers from a growing variety of businesses, including other subscription services around the world, many of which offer services that deliver Indian entertainment content over the internet, through mobile phones, and through other wireless devices.

Many of our current or future competitors are already entrenched or may have significant brand recognition in a particular region or market in which we seek to penetrate.

We believe that companies with a combination of technical expertise, brand recognition, financial resources, and digital media experience also pose a significant threat of developing competing on-demand distribution technologies. In particular, if known incumbents in the digital media space such as Facebook choose to offer competing services, they may devote greater resources than we have available, have a more accelerated time frame for deployment, and leverage their existing user base and proprietary technologies to provide services that our subscribers and advertisers may view as superior. Furthermore, Amazon Prime, Netflix, Hotstar and others have competing services, which may negatively impact our business, operating results and financial condition. Our current and future competitors may have higher brand recognition, more established relationships with talent and other content licensors and mobile device manufacturers, greater financial, technical, and other resources, more sophisticated technologies, and/or more experience in the markets in which we compete. In addition, Apple and Google also own application store platforms and are charging in-application purchase fees, which are not being levied on their own applications, thus creating a competitive advantage for themselves against us. As the market for on-demand music on the internet and mobile and connected devices increases, new competitors, business models, and solutions are likely to emerge.

15 

 

We also compete for subscribers based on our presence and visibility as compared with other businesses and platforms that deliver entertainment content through the internet and mobile devices. We face significant competition for subscribers from companies promoting their own digital content online or through application stores, including several large, well-funded and seasoned participants in the digital media market. Mobile device application stores often offer users the ability to browse applications by various criteria, such as the number of downloads in a given time period, the length of time since a mobile application was released or updated, or the category in which the application is placed. The websites and mobile applications of our competitors may rank higher than our website and our Eros Now mobile application, and our application may be difficult to locate in mobile device application stores, which could draw potential subscribers away from our platform and towards those of our competitors. If we are unable to compete successfully for subscribers against other digital media providers by maintaining and increasing our presence and visibility online, on mobile devices and in application stores, our number of subscribers and content streamed on our platform may fail to increase or may decline, and our subscription fees and advertising sales may suffer.

Our subscriber metrics and other estimates are subject to inherent challenges in measurement, and real or perceived inaccuracies in those metrics may seriously harm and negatively affect our reputation and our business.

We regularly review key metrics related to the operation of our business, including, but not limited to, our subscribers, key performance indicators and monthly active users, to evaluate growth trends, measure our performance, and make strategic decisions. These metrics are calculated using internal company data as well as other sources. At times, data may not have been validated by an independent third party. While these numbers are based on what we believe to be reasonable estimates of our subscriber base for the applicable period of measurement, there are inherent challenges in measuring how our service is used across large populations globally. For example, we believe that there are individuals who have multiple Eros Now accounts, which can result in an overstatement of key performance indicators. Errors or inaccuracies in our metrics or data could result in incorrect business decisions and inefficiencies. For instance, if a significant understatement or overstatement of monthly active users were to occur, we may expend resources to implement unnecessary business measures or fail to take required actions to attract a sufficient number of users to satisfy our growth strategies.

In addition, advertisers generally rely on third-party measurement services to calculate our metrics, and these third-party measurement services may not reflect our true audience. Some of our demographic data also may be incomplete or inaccurate because subscribers self-report their names and dates of birth. Consequently, the personal data we have may differ from our subscribers’ actual names and ages. If advertisers, partners, or investors do not perceive our subscriber, geographic, or other demographic metrics to be accurate representations of our subscribers base, or if we discover material inaccuracies in our subscriber, geographic, or other demographic metrics, our reputation may be seriously harmed.

Changes in how we market our service could adversely affect our marketing expenses and subscriber levels may be adversely affected.

We utilize a broad mix of marketing and public relations programs, including social media sites, to promote our service to potential new subscribers. We may limit or discontinue use or support of certain marketing sources or activities if advertising rates increase or if we become concerned that subscribers or potential subscribers deem certain marketing practices intrusive or damaging to our brand. If the available marketing channels are curtailed, our ability to attract new subscribers may be adversely affected. Companies that promote our service may decide that we negatively impact their business or may make business decisions that in turn negatively impact us. For example, if they decide that they want to compete more directly with us, enter a similar business or exclusively support our competitors, we may no longer have access to their marketing channels. If we are unable to maintain or replace our sources of subscribers with similarly effective sources, or if the cost of our existing sources increases, our subscriber levels and marketing expenses may be adversely affected.

16 

 

Privacy concerns could limit our ability to collect and leverage our subscriber data and disclosure of membership data could adversely impact our business and reputation.

In the ordinary course of business and in particular in connection with content acquisition and delivering our service to our members, we collect and utilize data supplied by our subscribers. Other businesses have been criticized by privacy groups and governmental bodies for attempts to link personal identities and other information to data collected on the internet regarding users’ browsing and other habits. Increased regulation of data utilization practices, including self-regulation or findings under existing laws that limit our ability to collect, transfer and use data, could have an adverse effect on our business. In addition, if we were to disclose data about our subscribers in a manner that was objectionable to them, our business reputation could be adversely affected, and we could face potential legal claims that could impact our operating results. Outside of India, we may become subject to additional and/or more stringent legal obligations concerning our treatment of customer and other personal information, such as laws regarding data localization and/or restrictions on data export. Failure to comply with these obligations could subject us to liability, and to the extent that we need to alter our business model or practices to adapt to these obligations, we could incur additional expenses.

Any significant disruption in our computer systems or those of third - parties that we utilize in our operations could result in a loss or degradation of service and could adversely impact our business.

 

Our reputation and ability to attract, retain and serve our subscribers is underpinned by the reliable performance and security of our computer systems and those of third parties that we work with. These systems may be subject to damage or interruption from many external factors including, inter alia: adverse weather conditions, natural disasters, terrorist attacks, power loss, telecommunications failures, and cybersecurity risks. Interruptions in these systems, or with the internet in general, could make our service unavailable or degraded or otherwise hinder our ability to deliver streaming content. Service interruptions, errors in our software or the unavailability of computer systems used in our operations could diminish the overall attractiveness of our membership service to existing and potential members.

We rely upon a number of partners to make our service available on their devices.

We currently offer subscribers the ability to receive streaming content through a host of internet-connected screens, including TVs, digital video players, television set-top boxes and mobile devices. We have agreements with various cable, satellite and mobile telecommunications operators to make our service available to subscribers. In many instances, our agreements also include provisions by which the partner bills consumers directly or otherwise offer services or products in connection with offering our service. We intend to continue to broaden our relationships with existing partners and to increase our capability to stream content to other platforms and partners over time. If we are not successful in maintaining existing and creating new relationships, or if we encounter technological, content licensing, regulatory, business or other impediments to delivering our streaming content to our subscribers via these devices, our ability to retain subscribers and grow our business could be adversely impacted. Our agreements with our partners are typically multi-year in duration and our business could be adversely affected if, upon expiration, a number of our partners do not continue to provide access to our service or are unwilling to do so on terms acceptable to us, which terms may include the degree of accessibility and prominence of our service. Furthermore, devices are manufactured and sold by entities other than Eros Now and while these entities should be responsible for the devices’ performance, the connection between these devices and Eros Now may nonetheless result in consumer dissatisfaction towards Eros Now and such dissatisfaction could result in claims against us or otherwise adversely impact our business. In addition, technology changes to our streaming functionality may require that partners update their devices. If partners do not update or otherwise modify their devices, our service and our members’ use and enjoyment could be negatively impacted.

Changes in how network operators handle and charge for access to data that travel across their networks could adversely impact our business.

We rely upon the ability of subscribers to access our service through the internet. If network operators block, restrict or otherwise impair access to our service over their networks, our service and business could be negatively affected. To the extent that network operators implement usage-based pricing, including meaningful bandwidth caps, or otherwise try to monetize access to their networks by data providers, we could incur greater operating expenses and our membership acquisition and retention could be negatively impacted. Furthermore, to the extent network operators create tiers of internet access service and either charge us for or prohibit us from being available through these tiers, our business could be negatively impacted.

17 

 

We rely upon third-party “cloud” computing services to operate certain aspects of our service and any disruption of or interference with our use of the third-party “cloud” computing operations would impact our operations and our business would be adversely impacted.

The third-party “cloud” computing service operator provides a distributed computing infrastructure platform for business operations, or what is commonly referred to as a “cloud” computing service. We have architected our software and computer systems so as to utilize data processing, storage capabilities and other services provided by third-party “cloud” computing operator. Currently, we run a material amount of our computing on the third-party “cloud” computing services. Given this, along with the fact that we cannot easily switch our third-party “cloud” computing operations to another cloud provider, any disruption of or interference with our use of third-party “cloud” computing services would impact our operations and our business would be adversely impacted.

We incur significant costs to protect electronically stored data and if our data is compromised despite this protection, we may incur additional costs, business interruption, lost opportunities and damage to our reputation.

We collect and maintain information and data necessary for conducting our business operations, which information includes proprietary and confidential data and personal information of our customers and employees. Such information is often maintained electronically, which includes risks of intrusion, tampering, manipulation and misappropriation. We implement and maintain systems to protect our digital data and obtaining and maintaining these systems is costly and usually requires continuous monitoring and updating for technological advances and change. Additionally, we sometimes provide confidential, proprietary and personal information to third parties when required in connection with certain business and commercial transactions. For instance, we have entered into an agreement with a third-party vendor to assist in processing employee payroll, and they receive and maintain confidential personal information regarding our employees. We take precautions to try to ensure that such third parties will protect this information, but there remains a risk that the confidentiality of any data held by third parties may be compromised. If our data systems, or those of our third-party vendors and partners, are compromised, there may be negative effects on our business, including a loss of business opportunities or disclosure of trade secrets. If the personal information we maintain is tampered with or misappropriated, our reputation and relationships with our partners and customers may be adversely affected, and we may incur significant costs to remediate the problem and prevent future occurrences.

Any significant disruption in or unauthorized access to our computer systems or those of third parties that we utilize in our operations, including those relating to cybersecurity or arising from cyber-attacks, could result in a loss or degradation of service, unauthorized disclosure of data, including member and corporate information, or theft of intellectual property, including digital content assets, which could adversely impact our business.

Our reputation and ability to attract, retain and serve consumers is dependent upon the reliable performance and security of our computer systems and those of third parties that we utilize in our operations. These systems may be subject to damage or interruption from earthquakes, adverse weather conditions, other natural disasters, terrorist attacks, power loss, telecommunications failures, and cybersecurity risks. Interruptions or malfunctions (including those due to equipment damage, power outages, computer viruses and a range of other hardware, software and network problems) in these systems, or with the internet in general, could make our service unavailable or degraded or otherwise hinder our ability to deliver streaming content. Service interruptions, errors in our software or the unavailability of computer systems used in our operations could diminish the overall attractiveness of our service to existing and potential subscribers. Our computer systems and those of third parties we use in our operations are vulnerable to cybersecurity risks, including cyber-attacks, both from state-sponsored and individual activity, such as computer viruses, denial of service attacks, physical or electronic break-ins and similar disruptions. These systems periodically experience directed attacks intended to lead to interruptions and delays in our service and operations as well as loss, misuse or theft of data or intellectual property. Any attempt by hackers to obtain our data (including subscriber and corporate information) or intellectual property (including digital content assets), disrupt our service, or otherwise access our systems, or those of third parties we use, if successful, could harm our business, be expensive to remedy and damage our reputation.

18 

 

We have devoted and will continue to devote significant resources to the security of our computer systems; however, we cannot guarantee that we will not experience such malfunctions, attacks or interruptions in the future. A significant or large-scale malfunction, attack or interruption of one or more of our computer or database systems could adversely affect our ability to keep our operations running efficiently. Our insurance does not cover expenses related to such disruptions or unauthorized access. Efforts to prevent hackers from disrupting our service or otherwise accessing our systems are expensive to implement and may limit the functionality of or otherwise negatively impact our service offering and systems. Any significant disruption to our service or access to our systems could result in a loss of subscribers and adversely affect our business and results of operation. We utilize our own communications and computer hardware systems located either in our facilities or in that of a third-party web hosting provider. In addition, we utilize third-party “cloud” computing services in connection with our business operations. We also utilize our own and third-party content delivery networks to help us stream content in high volume to subscribers over the internet. Problems faced by us or our third-party web hosting, “cloud” computing, or other network providers, including technological or business-related disruptions, as well as cybersecurity threats, could adversely impact the experience of our members.

A downturn in the Indian and international economies or instability in financial markets, including a decreased growth rate and increased Indian price inflation, could materially and adversely affect our results of operations and financial condition.

Global economic conditions may negatively impact consumer spending. Prolonged negative trends in the global or local economies can adversely affect consumer spending and demand for our films and may shift consumer demand away from the entertainment we offer.

According to the International Monetary Fund’s World Economic Outlook Database, published in April 2020, the GDP growth rate of India is projected to increase from 7.26% in 2019 to approximately 7.49% in 2020 and 7.43% in 2021. The Economic Survey 2019-20 has estimated that the growth rate in GDP for the year ended March 31, 2020 to grow at 4.2% with headwinds of Covid19.

A decline in attendance at theaters may reduce the revenues we generate from this channel, from which a significant proportion of our revenues are derived.

If a general economic downturn continues to affect the countries in which we distribute our films, discretionary consumer spending may be adversely affected, which would have an adverse impact on demand for our theater, television and digital distribution channels. Economic instability and a continuing weak economy in India may negatively impact the Indian box office success of our Hindi, Tamil and Telugu films, on which we depend for a significant portion of our revenues.

Further, a sustained decline in economic conditions could result in closure or downsizing by, or otherwise adversely impact, industry participants on whom we rely for content sourcing and distribution. Any decline in demand for our content could have a material adverse effect on our business, prospects, financial condition and results of operations. In addition, global financial uncertainty has negatively affected the Indian financial markets.

Continued financial disruptions may limit our ability to obtain financing for our films. For example, any adverse revisions to India’s credit ratings for domestic and international debt by domestic or international rating agencies may adversely impact our ability to raise additional financing and the interest rates and other commercial terms at which such additional financing is available. Any such event could have a material adverse effect on our business, prospects, financial condition and results of operations. [India has recently experienced fluctuating wholesale price inflation compared to historical levels. – still true] An increase in inflation in India could cause a rise in the price of wages, particularly for Indian film talent, or any other expenses that we incur. If this trend continues, we may be unable to accurately estimate or control our costs of production. Because it is unlikely we would be able to pass all of our increased costs on to our customers, this could have a material adverse effect on our business, prospects, financial condition and results of operations.

19 

 

Fluctuation in the value of the Indian rupee against foreign currencies could materially and adversely affect our results of operations, financial condition and ability to service our debt.

While a significant portion of our revenues are denominated in Indian rupees, certain contracts for our film content are or may be denominated in foreign currencies. Additionally, we report our financial results in U.S. dollars and most of our debt is denominated in U.S. dollars. We expect that the continued volatility in the value of the Indian rupee against foreign currency will continue to have an impact on our business. The Indian rupee experienced an approximately 8.3% decrease in value as compared to the U.S. dollar in Fiscal 2020. The Indian rupee experienced an approximately 5.9% decrease in value as compared to the U.S. dollar in Fiscal 2019. The Indian rupee experienced an approximately 0.4% decrease in value as compared to the U.S. dollar in fiscal year 2018. Changes in the growth of the Indian economy and the continued volatility of the Indian rupee, may adversely affect our business. As of March 31, 2020, we had an aggregate outstanding indebtedness of $179.4 million. There can be no assurance, however, that currency fluctuations will not lead to an increase in the amount of this debt.

Further, as of March 31, 2020, $49.2 million, or 27.4% of our debt, was denominated in U.S. dollars. We may not generate sufficient revenue in U.S. dollars to service all of our U.S. dollar-denominated debt. Consequently, we may be required to use revenues generated in Indian rupees to service our U.S. dollar-denominated debt. Any devaluation or depreciation in the value of the Indian rupee, compared to the U.S. dollar, could adversely affect our ability to service our debt. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Exchange Rate” for further information.

Although we have not historically done so, we may, from time to time, seek to reduce the effect of exchange rate fluctuations on our operating results by purchasing derivative instruments such as foreign exchange forward contracts to cover our intercompany indebtedness or outstanding receivables. However, we may not be able to purchase contracts to insulate ourselves adequately from foreign currency exchange risks. In addition, any such contracts may not perform effectively as a hedging mechanism. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Exchange Rate” for further information.

We face increasing competition with other films for movie screens, and our inability to obtain sufficient distribution of our films could have a material adverse effect on our business.

A substantial majority of the theater screens in India are typically committed at any one time to a limited number of films, and we compete directly against other producers and distributors of Indian films in each of our distribution channels. If the number of films released in the market as a whole increases it could create excess supply in the market, in particular at peak theater release times such as school and national holidays and during festivals, which would make it more difficult for our films to succeed.

Where we are unable to ensure a wide release for our films to maximize screenings in the first week of a film’s release, it may have an adverse impact on our revenues. Further, failure to release during peak periods, or the inability to book sufficient screens, could cause us to miss potentially higher gross box-office receipts and/or affect subsequent revenue streams, which could have a material adverse effect on our business, prospects, financial condition and results of operations.

We face increasing competition from other forms of entertainment, which could have a material adverse effect on our business.

We also compete with all other sources of entertainment and information delivery, including television, mobile devices, the internet and sporting events such as the Indian Premier League for cricket. Technological advancements such as VOD, mobile and internet streaming and downloading have increased the number of entertainment and information delivery choices available to consumers and have intensified the challenges posed by audience fragmentation. The increasing number of choices available to audiences, including crossover from our Eros Now online entertainment service, could negatively impact consumer demand for our films, and there can be no assurance that attendance rates at theaters or demand for our other distribution channels will not fall.

20 

 

Competition within the Indian film industry is growing rapidly, and certain of our competitors are larger, have greater financial resources and are more diversified.

The Indian film industry’s rapid growth is changing the competitive landscape, increasing competition for content, talent and release dates. Growth in the Indian film industry has attracted foreign industry participants and competitors, such as Viacom Inc., The Walt Disney Company (“Disney”), 21st Century Fox, Sony Pictures Entertainment Inc., Amazon.com, Inc. (“Amazon”) and Netflix, Inc. (“Netflix”), many of which are substantially larger and have greater financial resources, including competitors that own theaters and/or television networks and/or OTT platforms. These larger competitors may have the ability to spend additional funds on production of new films, which may require us to increase our production budgets beyond what we originally anticipated in order to compete effectively. In addition, these competitors may use their financial resources to gain increased access to movie screens and enter into exclusive content arrangements with key talent in the Indian film industry. Unlike some of these major competitors that are part of larger diversified corporate groups, we derive substantially all of our revenue from our film entertainment business. If our films fail to perform to our expectations, we are likely to face a greater adverse impact than would a more diversified competitor. In addition, other larger entertainment distribution companies may have larger budgets to monetize growing technological trends. If we are unable to compete with these companies effectively, our business prospects, results of operations and financial condition could suffer. With generally increasing budgets of Hindi, Tamil and Telugu films, we may not have the resources to distribute the same level of films as competitors with greater financial strength.

Piracy of our content, including digital and internet piracy, may adversely impact our revenues and business.

Our business depends in part on the adequacy, enforceability and maintenance of intellectual property rights in the entertainment products and services we create. Motion picture piracy is extensive in many parts of the world and is made easier by technological advances and the conversion of motion pictures into digital formats. This trend facilitates the creation, transmission and sharing of high-quality unauthorized copies of motion pictures in theatrical release on DVDs, CDs and Blu-ray discs, from pay-per-view through set top boxes and other devices and through unlicensed broadcasts on free television and the internet.

Although DVD and CD sales represent a relatively small portion of Indian film and music industry revenues, the proliferation of unauthorized copies of these products results in lost revenue and significantly reduced pricing power, which could have a material adverse effect on our business, prospects, financial condition and results of operations. In particular, unauthorized copying and piracy are prevalent in countries outside of the United States, Canada and Western Europe, including India, whose legal systems may make it difficult for us to enforce our intellectual property rights and in which consumer awareness of the individual and industry consequences of piracy is lower. With broadband connectivity improving, 3G internet penetration increasing and with the advent of 4G in India, digital piracy of our content is an increasing risk.

In addition, the prevalence of third-party hosting sites and a large number of links to potentially pirated content make it difficult to effectively monitor and prevent digital piracy of our content. Existing copyright and trademark laws in India afford only limited practical protection and the lack of internet-specific legislation relating to trademark and copyright protection creates a further challenge for us to protect our content delivered through such media. Additionally, we may seek to implement elaborate and costly security and anti-piracy measures, which could result in significant expenses and revenue losses. Even the highest levels of security and anti-piracy measures may fail to prevent piracy.

Litigation may also be necessary in the future to enforce our intellectual property rights, to protect our trade secrets, to determine the validity and scope of the proprietary rights of others or to defend against claims of infringement or invalidity. Regardless of the legitimacy or the success of these claims, we could incur costs and diversion of resources in enforcing our intellectual property rights or in defending against such claims, which could have a material adverse effect on our business, prospects, financial condition and results of operations.

21 

 

We may be unable to adequately protect or continue to use our intellectual property. Failure to protect such intellectual property may negatively impact our business.

We rely on a combination of copyrights, trademarks, service marks and similar intellectual property rights to protect our name and branded products and to protect the entertainment products and services we create. The success of our business, in part, depends on our continued ability to use this intellectual property in order to increase awareness of the Eros name. We typically attempt to protect these intellectual property rights through available copyright and trademark laws and through a combination of employee, third-party assignments and nondisclosure agreements, other contractual restrictions, technological measures, and other methods. Despite these precautions, existing copyright and trademark laws afford only limited practical protection in certain countries, and the actions taken by us may be inadequate to prevent imitation by others of the Eros name and other Eros intellectual property. Despite our efforts to protect our intellectual property rights and trade secrets, unauthorized parties may attempt to copy aspects of our song recommendation technology or other technology or obtain and use our trade secrets and other confidential information. Moreover, policing our intellectual property rights is difficult and time consuming. We cannot assure you that we would have adequate resources to protect and police our intellectual property rights, and we cannot assure you that the steps we take to do so will always be effective. In addition, if the applicable laws in these countries are drafted or interpreted in ways that limit the extent or duration of our rights, or if existing laws are changed, our ability to generate revenue from our intellectual property may decrease, or the cost of obtaining and maintaining rights may increase. We could lose both the ability to assert our intellectual property rights against, or to license our technology to, others and the ability to collect royalties or other payments.

Further, many existing laws governing property ownership, copyright and other intellectual property issues were adopted before the advent of the internet and do not address the unique issues associated with the internet, personal entertainment devices and related technologies, and new interpretations of these laws in response to emerging digital platforms may increase our digital distribution costs, require us to change business practices relating to digital distribution or otherwise harm our business. We also distribute our branded products in some countries in which there is no copyright or trademark protection. As a result, it may be possible for unauthorized third parties to copy and distribute our branded products or certain portions or applications of our branded products, which could have a material adverse effect on our business, prospects, results of operations and financial condition. If we fail to register the appropriate copyrights, patents, trademarks or our other efforts to protect relevant intellectual property prove to be inadequate, the value of the Eros name could be harmed, which could adversely affect our business and results of operations.

We may be unable to continue to use the domain names that we use in our business, or prevent third parties from acquiring and using domain names that infringe on, are similar to or otherwise decrease the value of our brand or our trademarks or service marks.

We have several domain names for websites that we use in our business, such as erosplc.com, erosentertainment.com, erosnow.com and although our Indian subsidiaries currently own over 120 registered trademarks, we have not obtained a registered trademark for any of our domain names. If we lose the ability to use a domain name, whether due to trademark claims, failure to renew the applicable registration or any other cause, we may be forced to market our products under a new domain name, which could cause us to lose users of our websites, or to incur significant expense in order to purchase rights to such a domain name. In addition, our competitors and others could attempt to capitalize on our brand recognition by using domain names similar to ours. Domain names similar to ours have been registered in the United States of America, India and elsewhere.

We may be unable to prevent third parties from acquiring and using domain names that infringe on, are similar to or otherwise decrease the value of our brand, trademarks or service marks. Protecting and enforcing our rights in our domain names may require litigation, which could result in substantial costs and diversion of management’s attention.

22 

 

Litigation may be necessary to enforce our intellectual property rights or to determine the validity and scope of the proprietary rights of others or to defend against claims of infringement or invalidity. Regardless of the validity or the success of the assertion of any claims, we could incur significant costs and diversion of resources in enforcing our intellectual property rights or in defending against such claims, which could have a material adverse effect on our business and results of operations. Our services and products could infringe upon the intellectual property rights of third parties.

Litigation or proceedings before governmental authorities and administrative bodies may be necessary in the future to enforce our intellectual property rights, to protect our patent rights, trademarks, trade secrets, and domain names and to determine the validity and scope of the proprietary rights of others. Our efforts to enforce or protect our proprietary rights may be ineffective and could result in substantial costs and diversion of resources and management time, each of which could substantially harm our operating results.

Other parties, including our competitors, may hold or obtain patents, trademarks, copyright protection or other proprietary rights with respect to their previously developed films, characters, stories, themes and concepts or other entertainment, technology and software or other intellectual property of which we are unaware. In addition, the creative talent that we hire or use in our productions may not own all or any of the intellectual property that they represent they do, which may instead be held by third parties. Consequently, the film content that we produce and distribute or the software and technology we use may infringe the intellectual property rights of third parties, and we frequently have infringement claims asserted against us. Any claims or litigation, justified or not, could be time-consuming and costly, harm our reputation, require us to enter into royalty or licensing arrangements that may not be available on acceptable terms or at all or require us to undertake creative changes to our film content or source alternative content, software or technology. Where it is not possible to do so, claims may prevent us from producing and/or distributing certain film content and/or using certain technology or software in our operations. Any of the foregoing could have a material adverse effect on our business, prospects, financial condition and results of operations.

Our ability to remain competitive may be adversely affected by rapid technological changes and by our inability to access such technology.

The Indian film entertainment industry continues to undergo significant technological developments, including the ongoing transition from film to digital media. We may be unsuccessful in adopting new digital distribution methods or may lose market share to our competitors if the methods that we adopt are not as technologically sound, user-friendly, widely accessible or appealing to consumers as those adopted by our competitors. For example, our on-demand entertainment portal accessible via internet-enabled devices, Eros Now, may not achieve the desired growth rate.

Further, advances in technologies or alternative methods of product delivery or storage, or changes in consumer behavior driven by these or other technologies, could have a negative effect on our home entertainment market in India. If we fail to successfully monetize digital and other emerging technologies, it could have a material adverse effect on our business, prospects, financial condition and results of operations.

Our financial condition and results of operations fluctuate from period to period due to film release schedules and other factors and may not be indicative of results for future periods.

Our financial condition and results of operations for any period fluctuate due to film release schedules in that period, none of which we can predict with reasonable certainty. Theater attendance in India has traditionally been highest during school holidays, national holidays and during festivals, and we typically aim to release big-budget films at these times. This timing of releases also takes account of competitor film releases, Indian Premier League cricket matches, and the timing dictated by the film production process. As a result, our quarterly results can vary from one year to the next, and the results of one quarter are not necessarily indicative of results for the next or any future quarter. Additionally, the distribution window for the theatrical release of films, and the window between the theatrical release and distribution in other channels, have each been compressing in recent years and may continue to change. Further shortening of these periods could adversely impact our revenues if consumers opt to view a film on one distribution platform over another, resulting in the cannibalizing of revenues across distribution platforms. Additionally, because our revenue and operating results are seasonal in nature due to the impact of the timing of new releases, our revenue and operating results may fluctuate from period to period, and which could have a material adverse effect on our business, prospects, results of operations, financial condition and cash flows.

23 

 

Our accounting practices and management judgments may accentuate fluctuations in our annual and quarterly operating results and may not be comparable to other film entertainment companies.

For first release film content, we use a stepped method of amortization and a first 12 months amortization rate based on management’s judgment taking into account historic and expected performance, typically amortizing 50% of the capitalized cost for high budget films released during or after the fiscal year 2014, and 40% of the capitalized cost for all other films, in the first 12 months of their initial commercial monetization, and then the balance evenly over the lesser of the term of the rights held by us and nine years. Our management has determined to adjust the first-year amortization rate for high budget films because of the high contribution of theatrical revenue. Similar management judgment taking into account historic and expected performance is used to apply a stepped method of amortization on a quarterly basis within the first 12 months, within the overall parameters of the annual amortization.

Typically, 25% of capitalized cost for high budget films released during or after the fiscal year 2014, and 20% of capitalized cost for all other films, is amortized in the initial quarter of their commercial monetization. In the fiscal year 2009 and the fiscal years prior to 2009, the balance of capitalized film content costs were amortized evenly over a maximum of four years rather than nine. Because management judgment is involved regarding amortization amounts, our amortization practices may not be comparable to other film entertainment companies. In the case of film content that we acquire after its initial monetization, commonly referred to as library, amortization is spread evenly over the lesser of 10 years after our acquisition or our license period. At least annually, we review film and content rights for indications of impairment in accordance with International Accounting Standard (IAS) 36: Impairment of Assets issued by IASB.

Ineffective system of internal control over financial reporting, can reduce our ability to accurately and timely report our financial results or prevent fraud may be adversely affected.

We ceased to qualify as an “emerging growth company” under the Jumpstart Our Business Startups Act of 2012 on March 31, 2019, and as a result, we are subject to additional requirements under the Sarbanes-Oxley Act (the “SOX Act”), including Section 404(b) of the SOX Act which requires our independent registered public accounting firm to attest to and report on management’s assessment of the effectiveness of our internal control over financial reporting in our annual reports on Form 20-F, starting from annual report for Fiscal Year 2019. As discussed in Item 15. “Controls and Procedures,” upon an evaluation of the effectiveness of the design and operation of our internal controls, we concluded that there were material weaknesses such that our internal controls over financial reporting need to be reviewed and updated, a process that we are currently undertaking.. Although we have instituted remedial measures to address the material weakness identified and will continually review and evaluate our internal control systems to allow management to report on the sufficiency of our internal controls, we cannot assure you that we will be able to adequately remediate all the existing material weaknesses or not discover additional weaknesses in our internal controls over financial reporting need to be reviewed and updated, a process that we are currently undertaking. Further, management continually improves, simplifies and rationalizes the Company’s internal control framework where possible within the constraints of existing IT systems. However, any additional weaknesses or failure to adequately remediate the existing weakness could materially and adversely affect our financial condition or results of operations.

Our revenue is subject to significant variation based on the timing of certain licenses and contracts we enter into that may account for a large portion of our revenue in the period in which it is completed, which could adversely affect our operating results.

From time to time, we license film content rights to a group of films pursuant to a single license that constitutes a large portion of our revenue for the fiscal year in which the revenue from the license is recognised. The timing and size of such licenses subjects our revenue to uncertainties and variability from period to period, which could adversely affect our operating results. We expect that we will continue to enter into licenses with customers that may represent a significant concentration of our revenues for the applicable period and we cannot guarantee that these revenues will recur.

24 

 

We have entered into certain related party transactions and may continue to rely on our founders for certain key development and support activities.

We have entered, and may continue to enter, into transactions with related parties. We also rely on the Founders Group, which consists of Beech Investments Limited and Kishore Lulla and associates and enterprises controlled by certain of our directors and key management personnel for certain key development and support activities. While we believe that the Founders Group’s interests are aligned with our own, such transactions may not have been entered into on an arm’s-length basis, and we may have achieved more favourable terms had such transactions been entered into with unrelated parties. If future transactions with related parties are not entered into on an arm’s-length basis, our business may be materially harmed.

Further, because certain members of the Founders Group are controlling shareholders of, or have significant influence on, both us and our related parties, conflicts of interest may arise in relation to dealings between us and our related parties and may not be resolved in our favor. For further information, see “Certain Relationships and Related Party Transactions.”

We may encounter operational and other problems relating to the operations of our subsidiaries, including as a result of restrictions in our current shareholder agreements.

We operate several of our businesses through subsidiaries. Our financial condition and results of operations significantly depend on the performance of our subsidiaries and the income we receive from them. Our business may be adversely affected if our ability to exercise effective control over our non-wholly owned subsidiaries is diminished in any way. Although we control these subsidiaries through direct or indirect ownership of a majority equity interest or the ability to appoint the majority of the directors on the boards of such companies, unanimous board approval is required for major decisions relating to certain of these subsidiaries. To the extent there are disagreements between us and our various minority shareholders regarding the business and operations of our non-wholly owned subsidiaries, we may be unable to resolve them in a manner that will be satisfactory to us. Our minority shareholders may:

  · be unable or unwilling to fulfill their obligations, whether of a financial nature or otherwise;
  · have economic or business interests or goals that are inconsistent with ours;
  · take actions contrary to our instructions, policies or objectives;
  · take actions that are not acceptable to regulatory authorities;
  · have financial difficulties; or
  · have disputes with us.

Any of these actions could have a material adverse effect on our business, prospects, financial condition and results of operations.

Eros India has entered into shareholder agreements with third-party shareholders of its non-wholly owned subsidiaries, including Big Screen Entertainment Private Limited and a binding term sheet for a joint venture with Colour Yellow Productions Private Limited. These arrangements contain various restrictions on our rights in relation to these entities, including restrictions in relation to the transfer of shares, rights of first refusal, reserved board matters and non-solicitation of employees by us. We may also face operational limitations due to restrictive covenants in such shareholder agreements. In addition, under the terms of our shareholder agreement in relation to Big Screen Entertainment Private Limited, disputes between partners are required to be submitted to arbitration in Mumbai, India. These restrictions in our current shareholder agreements, and any restrictions of a similar or more onerous nature in any new or amended agreements into which we may enter, may limit our control of the relevant subsidiary or our ability to achieve our business objectives, as well as limiting our ability to realize value from our equity interests, any of which could have a material adverse effect on our business, prospects, financial condition and results of operations.

The interests of the other shareholders with respect to the operation of Big Screen Entertainment Private Limited, Colour Yellow Productions Private Limited and Mr. V. Vijayendra Prasad, may not be aligned with our interests. As a result, although we own a majority of the ownership interest in Big Screen Entertainment Private Limited, and 50% of the shareholding of Colour Yellow Productions Private Limited, taking actions that require approval of the minority shareholders (or their representative directors), such as entering into related party transactions, selling material assets and entering into material contracts, may be more difficult to accomplish.

25 

 

We depend on the services of senior management.

We have, over time, built a strong team of experienced professionals on whom we depend to oversee the operations and growth of our businesses. We believe that our success substantially depends on the experience and expertise of, and the longstanding relationships with key talent and other industry participants built by, our senior management. Any loss of our senior management, any conflict of interest that may arise for such management or the inability to recruit further senior managers could impede our growth by impairing our day-to-day operations and hindering development of our business and our ability to develop, maintain and expand relationships, which would have a material adverse effect on our business, prospects, financial condition and results of operations.

In recent years, we have experienced additions to our senior management team, and our success depends in part on our ability to successfully integrate these new employees into our organization. We anticipate the need to hire additional members in senior management in connection with the expansion of our digital business. While some members of our senior management have entered into employment agreements that contain non-competition and non- solicitation provisions, these agreements may not be enforceable in the Isle of Man, India or the United Kingdom, whose laws govern these agreements or where our members of senior management reside. Even if enforceable, these non-competition and non-solicitation provisions are for limited time periods.

To be successful, we need to attract and retain qualified personnel.

Our success continues to depend to a significant extent on our ability to identify, attract, hire, train and retain qualified professional, creative, technical and managerial personnel. Competition for the caliber of talent required to produce and distribute our films continues to increase. We cannot assure you that we will be successful in identifying, attracting, hiring, training and retaining such personnel in the future. If we were unable to hire, assimilate and retain qualified personnel in the future, such inability would have a material adverse effect on our business and financial condition.

We are currently completing the integration of various supporting modules to an SAP ERP operating system, which could disrupt our business, and our failure to successfully integrate our IT systems across our international operations could result in additional costs and diversion of resources and management attention.

We have completed the accounting portion of the migration in India and significant locations outside India, and are in the process of completing the rest of the migration. For instance, we have not yet integrated supporting modules into the SAP ERP system, such as a module to manage our film library across the globe. This integration and migration may lead to unforeseen complications and expenses, and our failure to efficiently integrate and migrate our IT systems could substantially disrupt our business.

Negative media coverage could adversely affect our business and some viewers or civil society organizations may find our film content objectionable.

We receive a high degree of media coverage around the world. Unfavourable publicity regarding, for example, payments to talent, third-party content providers, publishers, artists, and other copyright owners, our privacy practices, terms of service, service changes, service quality, litigation or regulatory activity, government surveillance, the actions of our advertisers, the actions of our developers, the use of our OTT platform for illicit, objectionable, or illegal ends, the actions of our subscribers, the quality and integrity of content shared on our OTT platform, or the actions of other companies that provide similar services to us, could materially adversely affect our reputation. Such negative publicity also could have an adverse effect on the size, engagement, and loyalty of our subscriber base and result in decreased revenue, which could materially adversely affect our business, operating results and financial condition.

Some viewers or civil society organizations in India or other countries may object to film content produced or distributed by us based on religious, political, ideological or any other positions held by such viewers. This applies in particular to content that is graphic in nature, including violent or romantic scenes and films that are politically oriented or targeted at a segment of the film audience. Viewers or civil society organizations, including interest groups, political parties, religious or other organizations may assert legal claims, seek to ban the exhibition of our films, protest against us or our films or object in a variety of other ways. Any of the foregoing could harm our reputation and could have a material adverse effect on our business, prospects, financial condition and results of operations. The film content that we produce and distribute could result in claims being asserted, prosecuted or threatened against us based on a variety of grounds, including defamation, offending religious sentiments, invasion of privacy, negligence, obscenity or facilitating illegal activities, any of which could have a material adverse effect on our business, prospects, financial condition or results of operations.

26 

 

Our films are required to be certified in India by the Central Board of Film Certification.

Pursuant to the Indian Cinematograph Act, 1952, or the Cinematograph Act, films must be certified for adult viewing or general viewing in India by the Central Board of Film Certification (“CBFC”), which looks at factors such as the interest of sovereignty, integrity and security of the relevant country, friendly relations with foreign states, public order and morality. There may be similar requirements in the United Kingdom, Canada, China and Australia, among other jurisdictions. We may be unable to obtain the desired certification for each of our films and we may have to modify the title, content, characters, storylines, themes or concepts of a given film in order to obtain any certification or a desired certification for broadcast release that will facilitate distribution and monetization of the film. Any modification could result in substantial costs and/or receipt of an undesirable certification could reduce the appeal of any affected film to our target audience and reduce our revenues from that film, which could have a material adverse effect on our business, prospects, financial condition and results of operations.

Litigation and negative claims about us or the Indian film entertainment industry generally could have a material adverse impact on our reputation, our relationship with distributors and co-producers and our business operations.

We and certain of our directors and officers are subject to various legal civil and criminal proceedings in India. As of March 31, 2020, we were subject to certain tax proceedings in India, including service tax claims aggregating to approximately $56 million, value added tax (“VAT”) and sales tax claims aggregating to approximately $3 million for the period between April 1, 2005 to March 31, 2015. As our success in the Indian film industry partially depends on our ability to maintain our brand image and corporate reputation, in particular in relation to our dealings with creative talent, co-producers, distributors and exhibitors, any such proceedings or allegations, public or private, whether or not routine or justified, could tarnish our reputation and cause creative talent, co-producers, distributors and exhibitors not to work with us. See “Business Overview— Litigation” for further details.

In addition, the nature of our business and our reliance on intellectual property and other proprietary rights subjects us to the risk of significant litigation. Litigation, or even the threat of litigation, can be expensive, lengthy and disruptive to normal business operations, and the results of litigation are inherently uncertain and may result in adverse rulings or decisions. We may enter into settlements or be subject to judgments that may, individually or in the aggregate, have a material adverse effect on our business, prospects, financial condition or results of operations.

Our performance in India is linked to the stability of its policies, including taxation policy, and the political situation.

The role of Indian central and state governments in the Indian economy has been and remains significant. Since 1991, India’s government has pursued policies of economic liberalization, including significantly relaxing restrictions on the private sector. The rate of economic liberalization could change, and specific laws and policies affecting companies in the media and entertainment sector, foreign investment, currency exchange rates and other matters affecting investment in our securities could change as well. A significant change in India’s economic liberalization and deregulation policies, and in particular, policies in relation to the film industry, could disrupt business and economic conditions in India and thereby affect our business.

Previously, taxes generally were levied on a state-by-state basis for the Indian film industry. However, with effect from July 1, 2017, goods and services tax (“GST”) was implemented in India, which combines taxes and levies by the Government of India and state governments into a unified rate structure, and replaces indirect taxes on goods and services such as central excise duty, service tax, central sales tax, entertainment tax, state value added tax, cess and surcharge and excise that were being collected by the Government of India and state governments. Initially, under the GST regime, movie exhibition fell under the highest tax bracket of 28% (for tickets above 100 rupee). However, with effect from January 1, 2019, the GST rate has been reduced to 12% for tickets under 100 rupee and 18% for tickets above 100 rupees. Further, under the state-by-state tax regime in India, the state governments were levying entertainment tax on the exhibition of films in cinemas, including multiplexes. With the implementation of GST, the entertainment tax levied by the state governments was subsumed under GST. However, certain local government bodies levy local body entertainment tax, in addition to GST, within their state. Any future increases or amendments may affect the overall tax efficiency of companies operating in India and may result in significant additional taxes becoming payable. If, as a result of a particular tax risk materializing, the tax costs associated with certain transactions are greater than anticipated, it could affect the profitability of such transactions.

27 

 

Separately, there are certain deductions available to film producers for expenditures on production of feature films released during a given year. These tax benefits may be discontinued and impact current and deferred tax liabilities. In addition, the government of India has issued and may continue to issue tariff orders setting ceiling prices for distribution of content on cable television service charges in India.

Other changes in the Indian law and policy environment which may have an impact on our business, results of operations and prospects, to the extent that we are unable to suitably respond to and comply with any such changes in applicable law and policy include the following:

  ·

Under the (Indian) Income-tax Act, 1961 (“IT Act”), the General Anti Avoidance Rules (“GAAR”) have come into effect from April 1, 2017. The tax consequences of the GAAR provisions if applied to an arrangement could result in denial of tax benefit under the domestic tax laws and / or under a tax treaty, amongst other consequences.

As per the Finance Act 2020, Dividend Distribution Tax (‘DDT’) of 20.56 percent levied on the companies declaring dividend has been abolished with effect from April 1, 2020. Consequently, dividend is taxable in the hands of recipient and there shall be withholding of taxes on such dividends.

 

  · As per the provisions of the IT Act, income arising directly or indirectly through transfer of a capital asset, being any share or interest in a company or entity registered or incorporated outside India, will be liable to tax in India, if such share or interest derives, directly or indirectly, its value substantially from assets located in India, whether or not the seller of such share or interest has a residence, place of business, business connection, or any other presence in India. Value shall be substantially derived from assets located in India, if, on the specified date, the value of such assets located in India (i) represents at least 50% of the value of all assets owned by the company or entity, and (ii) exceeds the amount of 100 million rupees. However, the impact of the above indirect transfer provisions would need to be separately evaluated under the tax treaty scenario.

 

  · The Organization of Economic Co-operation and Development released the final package of all Action Plans of the Base Erosion and Profit Shifting (“BEPS”) project in October 2015. India is a member of G20 and active participant in the BEPS project. The BEPS project lead to a series of measures being developed across several actions such as the digital economy, treaty abuse, design of Controlled Foreign Company Rules, intangibles, country-by-country reporting, preventing artificial avoidance of PE status, improving dispute resolution etc. Several of these measures required implementation through changes in domestic law. As regards those measures which required implementation through changes to bilateral treaties, it was felt that a Multilateral Instrument (“MLI”) to modify the existing bilateral treaty network would be preferable as it would ensure speed and consistency in implementation. Accordingly, MLI was introduced to inter-alia incorporate treaty related measures identified as part of the final BEPS measures in relation to:

 

  · Preventing the granting of treaty benefits in inappropriate circumstances;

 

  · Preventing the artificial avoidance of permanent establishment status (“PE”); and

 

  · Making dispute resolution mechanisms more effective.

 

India signed the MLI to implement tax treaty related measures to prevent BEPS on June 7, 2017. On June 25, 2019, India has deposited the instrument of ratification for MLI with OECD along with a list of reservations and notifications. As a result, MLI will enter into force for India on October 1, 2019 and its provisions will have effect on India’s tax treaties from financial year 2020-21 onwards where the other country has also deposited its instrument of ratification with OECD. The interplay between GAAR (under the IT Act) and the modification of the existing tax treaties by way of the MLI remains to be seen.

 

  · An equalization levy (“EL”) in respect of certain e-commerce transactions has been introduced in India with effect from June 1, 2016. EL is to be deducted in respect of payments towards “specified services” (in excess of Indian rupees 100,000). A “specified service” means online advertisement, any provision for digital advertising space or any other facility or service for the purpose of online advertisement and includes any other service as may be notified by the Indian government. Deduction of EL at the rate of six percent (on a gross basis) is the responsibility of Indian residents or non-residents having a permanent establishment, or PE, in India on payments to non-residents (not having a PE in India). Consequently, if a non-resident (not having a PE in India) earns income towards a “specified service” which is chargeable to EL, then the same would be exempt in the hands of such non-resident.

28 

 

 

  ·

Further, the Finance Act, 2020, has expanded the scope of EL by covering e-commerce transactions. E - commerce supply or services include online sale of goods, online provision of services or both owned or provided by an E-commerce operator. However, EL shall not be charged in case sales, turnover or gross receipts of the E-commerce operator is less than INR 20 million.

 

Discharge of EL at the rate of two percent (on a gross basis) is the responsibility of E – commerce operator receiving consideration on the supply or services made to Indian residents, non-residents in “specified circumstances” or any other person using IP address located in India. However, any service or supply made by the E – commerce operator which is in connection to their PE in India will not be liable for EL,. If a non-resident (not having a PE in India) earns income which is chargeable to EL, then the same would be exempt in the hands of such non-resident.

 

Currently, consideration for the sale, distribution or exhibition of cinematographic films is specifically excluded from the definition of Royalty. However, as per Finance Act 2020, the definition of Royalty will be rationalized to include consideration for the sale, distribution or exhibition of cinematographic films (w.e.f. April 1, 2021).

 

  · The concept of Place of Effective Management (“POEM”) was introduced for the purpose of determining tax residence of foreign companies in India, effective April 1, 2016. The POEM is defined as the place where key management and commercial decisions that are necessary for the conduct of the business of an entity as a whole are in substance made. This could have significant impact on the foreign companies holding board meeting(s) in India, having key managerial personnel located in India, having regional headquarters located in India, etc. In the event the POEM of a foreign company is considered to be situated in India, such company becomes tax resident in India and consequently its global income would be taxable in India (even if it is not earned in India).

 

  · Based on the report of OECD on BEPS Action Plan 1, an amendment was made vide Finance Act 2018 whereby concept of significant economic presence (“SEP”) was introduced under the Indian domestic tax law to cover within the tax ambit transactions in digitized businesses. Significant economic presence shall be constituted in cases where:

 

  · Transaction in respect of any goods, services or property are carried out by a non-resident in India (including provision of download of data or software in India);

 

  · Non-residents engage in systematic and continuous soliciting of business activities or engaging in interaction with users, in India through digital means;

 

if certain prescribed thresholds are breached.

 

Further, if SEP is constituted, attribution shall be restricted to such aforesaid transactions and/or business activities/users in India.

 

The threshold of payments received and number of users (mentioned in the aforesaid conditions) shall be prescribed by the Central Board of Direct Taxes in due course after which one will be able to gauge the impact of this expansion in the provision.

 

In addition, unless corresponding modifications to PE rules are made in tax treaties, the existing treaty rules will apply. Accordingly, the above provisions would need to be separately evaluated under the tax treaty scenario.

 

Further, as per Finance Act, 2020, it is pertinent to note that SEP provisions have been deferred by a year and shall be effective from April 1, 2021.

 

  · The definition of “business connection” was expanded vide Finance Act 2018. Earlier if non-residents carried on business in India through an agent and such an agent had an authority to conclude contracts on behalf of the non-residents, business connection was constituted. After the amendment, business connection will be constituted even if the agent plays a principal role in conclusion of the contracts by the non-residents. The contracts referred herein should be –

29 

 
  · in the name of the non-resident; or

 

  · for the transfer of the ownership of, or for the granting of the right to use, property owned by that non-resident or that non-resident has the right to use; or

 

  · for the provision of services by the non-resident.

Our business and financial performance could be adversely affected by unfavourable changes in or applications or interpretations of existing, or the promulgation of new, laws, rules and regulations applicable to us and our business. Such unfavourable changes could decrease demand for our products, increase costs and/or subject us to additional liabilities.

Tax increases could place pricing pressures on cable television service providers and broadcasters, which may, among other things, restrict the ability and willingness of cable television broadcasters in India to pay for content acquisition, including for our films. Any of the foregoing could have a material adverse effect on our business, prospects, financial condition and results of operations.

Natural disasters, epidemics, terrorist attacks and other acts of violence or war could adversely affect the financial markets, result in a loss of business confidence and adversely affect our business, prospects, financial condition and results of operations.

Numerous countries, including India, have experienced community disturbances, strikes, terrorist attacks, riots, epidemics and natural disasters. These acts and occurrences may result in a loss of business confidence and could cause a temporary suspension of our operations, if, for example, local authorities close theaters and could have an adverse effect on the financial markets and economies of India and other countries. Such closures have previously, and could in the future, impact our ability to exhibit our films and have a material adverse effect on our business, prospects, financial condition and results of operations. In addition, travel restrictions as a result of such events may interrupt our marketing and distribution efforts and have an adverse impact on our ability to operate effectively.

Our insurance coverage may be inadequate to satisfy future claims against us.

While we believe that we have adequately insured our operations and property in a way that we believe is customary in the Indian film entertainment industry and in amounts that we believe to be commercially appropriate, we may become subject to liabilities against which we are not adequately insured or against which we cannot be insured, including losses suffered that are not easily quantifiable and cause severe damage to our reputation. Film bonding, which is a customary practice for U.S. film companies, is rarely used in India. Even if a claim is made under an existing insurance policy, due to exclusions and limitations on coverage, we may not be able to successfully assert our claim for any liability or loss under such insurance policy. In addition, in the future, we may not be able to maintain insurance of the types or in the amounts that we deem necessary or adequate or at premiums that we consider appropriate. The occurrence of an event for which we are not adequately or sufficiently insured including any class action litigation, the successful assertion of one or more large claims against us that exceed available insurance coverage, the successful assertion of claims against our co-producers, or changes in our insurance policies could have a material adverse effect on our business, prospects, financial condition and results of operations.

Our Indian subsidiary, Eros India, from which we derive a substantial portion of our revenues, is publicly listed and we may lose our ability to control its activities.

Our Indian subsidiary, Eros India, from which we derive a substantial portion of our revenues, is publicly listed on the Indian stock exchanges. As such, under Indian law, minority stockholders have certain rights and protections against oppression and mismanagement. Further shares of Eros India is pledged to secure indebtedness incurred by Eros India.  To the extent that Eros India is unable to service such indebtedness, or otherwise defaults on its obligations under such indebtedness, the lenders of such indebtedness may exercise certain remedies over such shares, including foreclosing on such shares and selling such shares. As of June 30, 2020, we owned approximately 62.31% of Eros India. Over time, we may lose control over its activities and, consequently, lose our ability to consolidate its revenues.

30 

 

Dividend distributions by our subsidiaries are subject to certain limitations under local laws, including Indian and UAE law (including laws of Dubai) and other contractual restrictions.

As a holding company, we rely on funds from our subsidiaries to satisfy our obligations. Dividend payments by our subsidiaries, including Eros India, are subject to certain limitations under local laws and restrictive covenants of their borrowing arrangements. For example, under Indian law, dividends are only permitted to be paid out of the profits of the company for that year or out of the profits for any previous financial year after providing for depreciation. UAE law imposes similar limitations on dividend payments. As per the Finance Act 2020, Dividend Distribution Tax (‘DDT’) of 20.56 percent levied on the Indian companies declaring dividend has been abolished with effect from April 1, 2020. Consequently, dividend is taxable in the hands of recipient and there shall be withholding of taxes on such dividends.

The Relationship Agreement with our subsidiaries may not reflect market standard terms that would have resulted from arm’s-length negotiations among unaffiliated third parties and may include terms that may not be obtained from future negotiations with unaffiliated third parties.

The 2009 Relationship Agreement was last renewed with the execution of the 2016 Relationship Agreement between Eros India, Eros Worldwide and us (“Relationship Agreement”). The Relationship Agreement, exclusively assigns to Eros Worldwide, certain intellectual property rights and all distribution rights (including global digital distribution rights) for films (other than Tamil films), held by Eros India and any of its subsidiaries (the “Eros India Group”), in all territories other than India, Nepal, and Bhutan. In return, Eros Worldwide provides a lump sum minimum guaranteed fee to the Eros India Group in a fixed payment equal to 40% of the production cost of such film (including all costs incurred in connection with the acquisition, pre-production, production or post-production of such film), plus an amount equal to 20% thereon as markup. We refer to these payments collectively as the minimum guaranteed fee. Eros Worldwide is also required to reimburse the Eros India Group pre-approved distribution expenses in connection with such film, plus an amount equal to 20% thereon as markup. In addition, 15% of the gross proceeds received by Eros International Group from monetization of such films, after certain amounts are retained by the Eros International Group, are payable over to Eros India Group.

The Relationship Agreement may not reflect terms that would have resulted from arm’s-length negotiations among unaffiliated third parties, and Eros’s future operating results may be negatively affected if it does not receive terms as favourable in future negotiations with unaffiliated third parties. Further, as Eros does not have complete control of Eros India, it may lose control over its activities and, consequently, its ability to ensure its continued performance under the Relationship Agreement.

The transfer pricing arrangements in the Relationship Agreement are not binding on the applicable taxing authorities, and may be subject to scrutiny by such taxing authorities. Accordingly, there may be material and adverse tax consequences if the applicable taxing authorities challenge these arrangements, and they may adjust our income and expenses for tax purposes for both present and prior tax years, and assess interest on the adjusted but unpaid taxes.

Our indebtedness could adversely affect our operations, including our ability to perform our obligations, fund working capital and pay dividends.

As of March 31, 2020, we had $179.4 million of borrowings outstanding of which $117.1 million is repayable within one year. We may also incur substantial additional indebtedness. Our indebtedness could have important consequences, including the following:

  · we could have difficulty satisfying our interest commitments, debt obligations, and if we fail to comply with these requirements, an event of default could result;

 

  · we may be required to dedicate a substantial portion of our cash flow from operations to required payments on indebtedness, thereby reducing the cash flow available to fund working capital, capital expenditures and other general corporate activities or to pay dividends;

 

  · in order to manage our debt and cash flows, we may increase our short-term indebtedness and decrease our long-term indebtedness which may not achieve the desired results;

 

  · covenants relating to our indebtedness may restrict our ability to make distributions to our shareholders;

31 

 
  · covenants relating to our indebtedness may limit our ability to obtain additional financing for working capital, capital expenditures and other general corporate activities, which may limit our flexibility in planning for, or reacting to, changes in our business and the industry in which we operate;

 

  · each of Eros India and Eros International Limited may be required to repay the secured loans prior to their maturity, which as of March 31, 2020, represented $71.9 million of the outstanding indebtedness of Eros India and $22.1 million of the outstanding indebtedness of Eros International Limited. Further, in the event we decide to prepay certain lenders of Eros India, we will be required to obtain their prior approval and/or prior notice of up to 30 days and this may also involve levy of prepayment charges of up to 2%;

 

  · certain Eros India loans are subject to annual renewal, and until these renewals are obtained, the lenders under these loans may at any time require repayment of amounts outstanding. As at March 31, 2020, short-term loans amounting to $5.75 million were pending annual renewal and the Group expects the renewal to complete in due course;

 

  · we may be more vulnerable to general adverse economic and industry conditions;

 

  · we may be placed at a competitive disadvantage compared to our competitors with less debt; and

 

  · we may have difficulty repaying or refinancing our obligations under our senior credit facilities on their respective maturity dates.

If any of these consequences occur, our financial condition, results of operations and ability to pay dividends could be adversely affected. This, in turn, could negatively affect the market price of our A Ordinary Shares, and we may need to undertake alternative financing plans, such as refinancing or restructuring our debt, selling assets, reducing or delaying capital investments or seeking to raise additional capital.

We cannot assure that any refinancing would be possible, that any assets could be sold, or, if sold, of the timing of the sales and the amount of proceeds that may be realized from those sales, or that additional financing could be obtained on acceptable terms, if at all. For additional information, please see [Note 2(b) and Note 31] to our audited Consolidated Financial Statements appearing elsewhere in this annual report.

Downgrade in our credit ratings could increase our future borrowing costs and adversely affect the availability of new financing.

There can be no assurance that any of our credit ratings will remain unchanged for any given period of time or that a rating will not be lowered if, in that rating agency’s judgment, future circumstances relating to the basis of the rating so warrant. If, among other things, we are unable to maintain our outstanding debt and financial ratios at levels acceptable to the credit rating agencies, if we default on any indebtedness or if our business prospects or financial results deteriorate, our ratings could be downgraded by the rating agencies. Our credit ratings have been subject to change over time, including a downgrade in June 2019 (See Note [2(b)] of our audited consolidated financial statements). We cannot make assurances regarding how long these ratings will remain unchanged or regarding the outcome of the rating agencies future reviews of new or existing indebtedness. Such downgrade by the rating agencies could adversely affect the value of our outstanding securities, our existing debt and our ability to obtain new financing on favorable terms, if at all, and increase our borrowing costs, any of which could have a material adverse effect on business, financial condition and our results of operations.

Our ability to incur debt and the use of our funds could be limited by the restrictive covenants in existing credit facilities as well as the notes and our GBP denominated London Stock Exchange listed bond (“UK Retail Bond”).

Our existing credit facilities as well as the notes and the UK Retail Bond contain restrictive covenants, as well as requirements to comply with certain leverage and other financial maintenance tests. These covenants and requirements could limit our ability to take various actions, including incurring additional debt, guaranteeing indebtedness and engaging in various types of transactions, including mergers, acquisitions and sales of assets. These covenants could place us at a disadvantage compared to some of our competitors, who may have fewer restrictive covenants and may not be required to operate under these restrictions. Further, these covenants could have an adverse effect on our business by limiting our ability to take advantage of financing, mergers and acquisitions or other opportunities.

32 

 

We may not be able to generate sufficient cash to service all of our Indebtedness, and may be forced to take other actions to satisfy our obligations under our indebtedness that may not be successful.

Based on interest rates as of March 31, 2020, and assuming no additional borrowings or principal payments on our credit facilities, the UK Retail Bond and the Senior Convertible Notes (as defined below) until their maturities, we would need approximately $117.1 million over the next year, and $62.3 million over the next three years, to meet our principal under our debt agreements. Our ability to satisfy our debt obligations will depend upon, among other things:

  · our future financial and operating performance, which will be affected by prevailing economic conditions and financial, business, regulatory and other factors, many of which are beyond our control;

 

  · our ability to refinance our debt as it becomes due, which will be affected by the cost and availability of credit; and

 

  · our future ability to borrow under our revolving credit facilities, the availability of which depends on, among other things, our compliance with the covenants in our revolving credit facilities.

There can be no assurance that our business will generate sufficient cash flow from operations, or that we will be able to refinance debt as it comes due or draw under our revolving credit facilities in an amount sufficient to fund our liquidity needs. If our cash flows and capital resources are insufficient to service our indebtedness, we may be forced to reduce or delay capital expenditures, sell assets, or seek additional capital. These alternative measures may not be successful and may not permit us to meet our scheduled debt service obligations. In addition, the terms of existing or future debt agreements may restrict us from adopting some of these alternatives. Our ability to restructure or refinance our debt will depend on the condition of the capital markets and our financial condition at such time. Any refinancing of our debt could be at higher interest rates and may require us to comply with more onerous covenants, which could further restrict our business operations. If we are unable to generate sufficient cash flow, refinance our debt on favourable terms or sell additional debt or equity securities or our assets, it could have a material adverse effect on our financial condition and on our ability to make payments on our indebtedness.

Our trade accounts receivables were $101.7 million as at March 31, 2020. If the cash flow, working capital, financial condition or results of operations of our customers deteriorate, they may be unable, or they may otherwise be unwilling, to pay trade account receivables owed to us promptly or at all. In addition, from time to time, we have significant concentrations of credit risk in relation to our trade account receivables as a result of individual theatrical releases, television syndication deals or music licenses. Although we use contractual terms to stagger receipts, de-recognition of financial assets and/or the release or airing of content, as of March 31, 2020, 40.1% of our trade account receivables were represented by our top five debtors, compared to 20.4% as of March 31, 2019. Any substantial defaults or delays by our customers could materially and adversely affect our cash flows, and we could be required to terminate our relationships with customers, which could adversely affect our business, prospects, financial condition and results of operations.

We face risks relating to the international distribution of our films and related products.

We derive a significant percentage of our revenues from customers located outside of India. We derived 71.1% of our revenue in Fiscal Year 2020 from the monetization of our films in territories outside of India. We do not track revenues by geographical region other than based on our Company or customer domicile and not necessarily the country where the rights have been monetized or licensed. As a result, revenue by customer location may not be reflective of the potential of any given market. As a result of changes in the location of our customers, our revenues by customer location may vary year to year.

We are currently growing our presence in China through theatrical and distribution of our films. If we are unsuccessful in the production, distribution and monetization of films not only in India but also in the international markets including China, we may suffer losses and it may materially affect our growth prospects. Several countries around the world impose restrictions on the amount and nature of content that may be distributed in that country. For instance, China has imposed an annual limit on the number of foreign films, as selected by relevant authorities in China, that may be distributed annually on a revenue share basis as determined by box office performance. In addition, in September 2018, China’s film and television regulator, the National Administration of TV and Radio, published proposed regulations that would severely limit the streaming and broadcasting of foreign film and television content in China, further reducing foreign access to the Chinese market.

33 

 

Our business is subject to risks inherent in international trade, many of which are beyond our control. These risks include:

  · fluctuating foreign exchange rates;
  · laws and policies affecting trade, investment and taxes, including laws and policies relating to the repatriation of funds and withholding taxes and changes in these laws;
  · differing cultural tastes and attitudes, including varied censorship laws;
  · differing degrees of protection for intellectual property;
  · financial instability and increased market concentration of buyers in other markets;
  · higher past due debtor days and difficulty of collecting trade receivables across multiple jurisdictions;
  · the instability of other economies and governments; and
  · war and acts of terrorism.

Events or developments related to these and other risks associated with international trade could adversely affect our revenues from non-Indian sources, which could have a material adverse effect on our business, prospects, financial condition and results of operations.

We may pursue acquisition opportunities, which could subject us to considerable business and financial risk, divert management’s attention and otherwise disrupt our operations and harm our operating results. We may fail to acquire companies whose market power or technology could be important to the future success of our business.

We evaluate potential acquisitions of complementary businesses on an ongoing basis and may from time to time pursue acquisition opportunities. We may in the future seek to acquire or invest in other companies or technologies that we believe could complement or expand our services, enhance our technical capabilities, or otherwise offer growth opportunities. Pursuit of future potential acquisitions may divert the attention of management and cause us to incur various expenses in identifying, investigating, and pursuing suitable acquisitions, whether or not they are consummated. We may not be successful in identifying acquisition opportunities, assessing the value, strengths and weaknesses of these opportunities or consummating acquisitions on acceptable terms. In addition, we have limited experience acquiring and integrating other businesses. We may be unsuccessful in integrating our recently acquired businesses or any additional business we may acquire in the future, and we may fail to acquire companies whose market power or technology could be important to the future success of our business. Future acquisitions may result in near-term dilution of earnings, including potentially dilutive issuances of equity securities or issuances of debt. Acquisitions may expose us to particular business and financial risks that include, but are not limited to:

  · diverting of financial and management resources from existing operations;
  · incurring indebtedness and assuming additional liabilities, known and unknown, including liabilities relating to the use of intellectual property we acquire, including costs or liabilities arising from the acquired companies’ failure to comply with intellectual property laws and licensing obligations they are subject to;
  · incurring significant additional capital expenditures, transaction and operating expenses and non-recurring acquisition-related charges;
  · experiencing an adverse impact on our earnings from the amortization or impairment of acquired goodwill and other intangible assets;
  · failing to successfully integrate the operations and personnel of the acquired businesses;
  · entering new markets or marketing new products with which we are not entirely familiar;
  · failing to retain key personnel of, vendors to and clients of the acquired businesses;
  · harm to our existing business relationships with business partners and advertisers as a result of the acquisition;
  · harm to our brand and reputation; and
  · use of resources that are needed in other parts of our business.

In addition, a significant portion of the purchase price of companies we acquire may be allocated to acquired goodwill, which must be assessed for impairment at least annually. In the future, if our acquisitions do not yield expected returns, we may be required to take charges to our operating results based on this impairment assessment process. Acquisitions also could result in dilutive issuances of equity securities or the incurrence of debt, which could adversely affect our operating results. In addition, if an acquired business fails to meet our expectations, our operating results, business and financial condition may suffer.

34 

 

If we are unable to address the risks associated with acquisitions, or if we encounter expenses, difficulties, complications or delays frequently encountered in connection with the integration of acquired entities and the expansion of operations, we may fail to achieve acquisition synergies and may be required to focus resources on integration of operations rather than on our primary business activities. In addition, future acquisitions could result in potentially dilutive issuances of our A Ordinary Shares, the incurrence of debt, contingent liabilities or amortization expenses, or write-offs of goodwill, any of which could harm our financial condition.

We may require additional capital to support business growth and objectives, and this capital might not be available on acceptable terms, if at all.

We intend to continue to make investments to support our business growth and may require additional funds to respond to business challenges, including the need to develop new features or enhance our existing services, expand into additional markets around the world, improve our infrastructure, or acquire complementary businesses and technologies. Accordingly, we may need to engage, and have engaged, in equity and debt financings to secure additional funds. If we raise additional funds through future issuances of equity or convertible debt securities, our existing shareholders could suffer additional significant dilution, and any new equity securities we issue could have rights, preferences, and privileges superior to those of holders of our Ordinary Shares. Any debt financing we secure in the future, including pursuant to the unwind described above, also could contain restrictive covenants relating to our capital raising activities and other financial and operational matters, which may make it more difficult for us to obtain additional capital and pursue business opportunities, including potential acquisitions. We may not be able to obtain additional financing on terms favourable to us, if at all. If we are unable to obtain adequate financing or financing on terms satisfactory to us when we require it, our ability to continue to support our business growth, acquire or retain consumers and subscribers, and to respond to business challenges could be significantly impaired, and our business may be harmed.

Risks Related to our A Ordinary Shares

 

Our A ordinary share price has been and may be highly volatile and, as a result, shareholders could lose a significant portion or all of their investment or we could become subject to securities class action litigation.

 

Prior to November 12, 2013, our ordinary shares had been admitted on the Alternative Investment Market of the London Stock Exchange (“AIM”) since 2006 and our ‘A’ ordinary shares have been traded on the New York Stock Exchange (“NYSE”) since our initial public offering in 2013. The trading price of our ordinary shares on the NYSE has been highly volatile. Since the listing of our A ordinary shares on the NYSE, the highest closing price of the A ordinary shares, in the period beginning November 12, 2013 and ended June 30, 2020, was $39.01 per share and the lowest price was $1.10 per share. The market price of the A ordinary shares on the NYSE may fluctuate as a result of several factors, including the following:

 

  · attacks from short sellers;
  · variations in our quarterly operating results;
  · adverse media report about us or our directors and officers;
  · changes in financial estimates or publication of research reports by analysts regarding our A ordinary shares, other comparable companies or our industry generally;
  · volatility in our industry, the industries of our customers and the global securities markets;
  · risks relating to our business and industry, including those discussed above;
  · strategic actions by us or our competitors;
  · adverse judgments or settlements obligating us to pay damages;
  · actual or expected changes in our growth rates or our competitors’ growth rates;
  · investor perception of us, the industry in which we operate, the investment opportunity associated with the A ordinary shares and our future performance;
  · additions or departures of our executive officers;
  · trading volume of our A ordinary shares;
  · sales of our ordinary shares by us or our shareholders; or
  · domestic and international economic, legal and regulatory factors unrelated to our performance.

 

These broad market and industry fluctuations, as well as general economic, political and market conditions such as recessions or interest rate changes may cause the market price of ordinary shares to decline.

35 

 

In addition, some companies that have experienced volatility in the market price of their stock have been subject to securities class action litigation. A putative securities class action filed in November 2015 has now been dismissed with prejudice, but on June 21, 2019, the Company was named a defendant in two substantially similar putative class action lawsuits filed in federal court in New Jersey by purported shareholders of the Company. Securities litigation against us could result in substantial costs and divert our management’s attention from other business concerns, which could adversely impact our business and affect the market price of our A ordinary shares.

 

Additional equity issuances will dilute your holdings, and sales by the Founders Group could adversely affect the market price of our A ordinary shares.

 

Sales of a large number of our ordinary shares by the Founders Group, as defined in “Part I — Item 4. Information on the Company — C. Organizational Structure” could adversely affect the market price of our A ordinary shares. Similarly, the perception that any such primary or secondary sale may occur; could adversely affect the market price of our A ordinary shares. Any future issuance of our A ordinary shares by us may dilute the holdings of our existing shareholders, causing the market price of our A ordinary shares to decline. In addition, any perception by potential investors that such issuances or sales might occur could also affect the trading price of our A ordinary shares.

 

The Founders Group, which includes our Chairman, Kishore Lulla, holds a substantial interest in and, through the voting rights afforded to our B ordinary shares and held by the Founders Group, will continue to have the ability to exercise a controlling influence over our business, which will limit your ability to influence corporate matters.

 

Our B ordinary shares have ten votes per share and our A ordinary shares, which are trading on the NYSE, have one vote per share. As of July 27, 2020, the Founders Group collectively owns 13.4% of our issued share capital in the form of 2,018,189 A ordinary shares, representing 1.3% of the voting power of our outstanding ordinary shares, and 21,700,418 B ordinary shares, representing all of our B ordinary shares and 60.0% of the voting power of our outstanding ordinary shares.

 

Due to the disparate voting powers attached to our two classes of ordinary shares, the Founders Group continues to have significant influence over management and affairs and over all matters requiring shareholder approval, including our management and policies and the election of our directors and senior management, the approval of lending and investment policies, revenue budgets, capital expenditure, dividend policy, significant corporate transactions, such as a merger or other sale of our company or its assets and strategic acquisitions, for the foreseeable future. In addition, because of this dual class structure, the Founders Group will continue to be able to control all matters submitted to our shareholders for approval.

 

This concentrated control could delay, defer or prevent a change in control of our Company, impede a merger, consolidation, takeover or other business combination involving our Company, or discourage a potential acquirer from making a tender offer, initiating a potential merger or takeover or otherwise attempting to obtain control of the Company even though other holders of A ordinary shares may view a change in control as beneficial. Many of our directors and senior management also serve as directors of, or are employed by, our affiliated companies, and we cannot guarantee that any conflicts of interest will be resolved in our favor. As a result of these factors, members of the Founders Group may influence our material policies in a manner that could conflict with the interests of our shareholders. As a result, the market price of our A ordinary shares could be adversely affected.

 

We will continue to incur substantial costs as a result of being a U.S. public company.

 

We became a U.S. public company in November 2013. As a U.S. public company, we incur significant legal, accounting and other expenses. Being a U.S. public company increased our legal and financial compliance costs and make some activities more time-consuming and costly. In addition it has made it more difficult and more expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage in the future. As a result, it may be more difficult for us to attract and retain qualified individuals to serve on our board of directors or as executive officers.

 

36 

 

As a foreign private issuer, we are subject to different U.S. securities laws and NYSE governance standards than domestic U.S. issuers. This may afford less protection to holders of our A ordinary shares, and you may not receive corporate and Company information and disclosure that you are accustomed to receiving or in a manner in which you are accustomed to receiving it.

 

As a foreign private issuer, the rules governing the information that we disclose differ from those governing U.S. corporations pursuant to the Securities Exchange Act of 1934, as amended, or the Exchange Act. Although we intend to report quarterly financial results and report certain material events, we are not required to file quarterly reports on Form 10-Q or provide current reports on Form 8-K disclosing significant events within four days of their occurrence and our quarterly or current reports may contain less information than required under U.S. filings. In addition, we are exempt from the Section 14 proxy rules, and proxy statements that we distribute will not be subject to review by the SEC. Our exemption from Section 16 rules regarding sales of ordinary shares by insiders means that you will have less data in this regard than shareholders of U.S. companies that are subject to the Securities Exchange Act. As a result, you may not have all the data that you are accustomed to having when making investment decisions. For example, our officers, directors and principal shareholders are exempt from the reporting and “short-swing” profit recovery provisions of Section 16 of the Exchange Act and the rules thereunder with respect to their purchases and sales of our A ordinary shares.

 

The periodic disclosure required of foreign private issuers is more limited than that required of domestic U.S. issuers and there may therefore be less publicly available information about us than is regularly published by or about U.S. public companies. See “Part I — Item 10. Additional Information — H. Documents on Display.”

 

As a foreign private issuer, we are exempt from complying with certain corporate governance requirements of the NYSE applicable to a U.S. issuer, including the requirement that a majority of our board of directors consist of independent directors. Although we are in compliance with the current NYSE corporate governance requirements imposed on U.S. issuers, with the exception of our Audit Committee currently having two rather than three members, our charter does not require that we meet these requirements.

 

As the corporate governance standards applicable to us are different than those applicable to domestic U.S. issuers, you may not have the same protections afforded under U.S. law and the NYSE rules as shareholders of companies that do not have such exemptions. It is also possible that the significant ownership interest of the Founders Group could adversely affect investor perception of our corporate governance.

 

You may be subject to Indian taxes on income arising through the sale of our A ordinary shares.

 

The Indian Income Tax Act, 1961 has been amended to provide that income arising directly or indirectly through the sale of a capital asset, including shares of a company incorporated outside of India, will be subject to tax in India, if such shares derive, directly or indirectly, their value substantially from assets located in India, whether or not the seller of such shares has a residence, place of business, business connection, or any other presence in India, if, on the specified date, the value of such assets (i) represents 50% of the value of all assets owned by the company or entity, or and (ii) exceeds the amount of 100 million rupees.

 

If the Indian tax authorities determine that our A ordinary shares derive their value substantially from assets located in India you may be subject to Indian income taxes on the income arising, directly or indirectly, through the sale of our A ordinary shares. However, the impact of the above indirect transfer provisions would need to be separately evaluated under the tax treaty scenario of the country of which the shareholder is a tax resident. For additional information, see “Part I—Item 10. Additional Information—E. Taxation.”

 

37 

 

We are an Isle of Man company and, because judicial precedent regarding the rights of shareholders is more limited under Isle of Man law than under U.S. law, you may have less protection of your shareholder rights than you would under U.S. law.

 

Our constitution is set out in our memorandum and articles of association, and we are subject to the Isle of Man Companies Act 2006, as amended, — see “Part II — Item 4. Information on the Company — Government Regulations” and Isle of Man common law. The rights of shareholders to take action against the directors, actions by minority shareholders and the fiduciary responsibilities of our directors to us under Isle of Man law are to an extent governed by the common law of the Isle of Man. The common law of the Isle of Man is derived in part from comparatively limited judicial precedent in the Isle of Man as well as from English common law, which has persuasive, but not binding, authority on a court in the Isle of Man. The rights of our shareholders and the fiduciary responsibilities of our directors under Isle of Man law are not as clearly established as they would be under statutes or judicial precedent in some jurisdictions in the United States. In particular, the Isle of Man has a less developed body of securities laws than the United States. In addition, some U.S. states, such as Delaware, have more fully developed and judicially interpreted bodies of corporate law than the Isle of Man. Furthermore, shareholders of Isle of Man companies may not have standing to initiate a shareholder derivative action in a federal court of the United States. As a result, shareholders may have more difficulties in protecting their interests in the face of actions taken by management, members of the board of directors or controlling shareholders than they would as shareholders of a U.S. company.

 

Our board of directors may determine that a shareholder meets the criteria of a “prohibited person” and subject such shareholder’s shares to forced divestiture.

 

Our articles of association permit our board of directors to determine that any person owning shares (directly or beneficially) constitutes a “prohibited person” and is not qualified to own shares if such person is in breach of any law or requirement of any country and, as determined solely by our board of directors, such ownership would cause a pecuniary or tax disadvantage to us, another shareholder or holders of our other securities. If our board of directors determines that a shareholder meets the above criteria of a “prohibited person,” they may direct such shareholder to transfer all A ordinary shares such shareholder owns to another person. Under the provisions of our articles of association, such a determination by our board of directors would be conclusive and binding on such shareholder.

 

If our board of directors directs such shareholder to transfer all A ordinary shares such shareholder owns, such shareholder may recognize taxable gain or loss on the transfer. See “Part I — Item 10. Additional Information — E. Taxation” for a more detailed description of the tax consequences of a sale or exchange or other taxable disposition of such shareholders A ordinary shares.

 

Judgments obtained against us by our shareholders may not be enforceable.

 

We are an Isle of Man company and substantially all of our assets are located outside of the United States. A substantial part of our current operations are conducted in India. In addition, substantially all of our directors and executive officers are nationals and residents of countries other than the United States and we believe that a substantial portion of the assets of these persons may be located outside the United States. As a result, it may be difficult for you to effect service of process within the United States upon these persons. It may also be difficult for you to enforce in U.S. courts judgments obtained in U.S. courts based on the civil liability provisions of the U.S. federal securities laws against us and our officers and directors. Moreover, the courts of India would not automatically enforce judgments of U.S. courts obtained in such actions against us or our directors and officers, or entertain actions brought in India against us or such persons predicated solely upon United States federal securities laws. Further, the U.S. has not been declared by the Government of India to be a reciprocating territory for the purposes of enforcement of foreign judgments, and there are grounds upon which Indian courts may decline to enforce the judgments of United States courts. Some remedies available under the laws of United States jurisdictions, including remedies available under the United States federal securities laws, may not be allowed in Indian courts if contrary to public policy in India. Since judgments of United States courts are not automatically enforceable in India, it may be difficult for you to recover against us or our directors and officers based upon such judgments. There is uncertainty as to whether the courts of the Isle of Man would recognize or enforce judgments of United States courts against us or such persons predicated upon the civil liability provisions of the securities laws of the United States or any state. In addition, there is uncertainty as to whether such Isle of Man courts would be competent to hear original actions brought in the Isle of Man against us or such persons predicated upon the securities laws of the United States or any state.

 

38 

 

If securities or industry analysts do not publish research or publish unfavourable or inaccurate research about our business, our share price and trading volume could decline.

 

The trading market for our A ordinary shares depends, in part, on the research and reports that securities or industry analysts publish about us or our business. We may be unable to sustain coverage by well-regarded securities and industry analysts. If either none or only a limited number of securities or industry analysts maintain coverage of our company, or if these securities or industry analysts are not widely respected within the general investment community, the trading price for our A ordinary shares would be negatively impacted. In the event we obtain securities or industry analyst coverage, if one or more of the analysts who cover us downgrade our A ordinary shares or publish inaccurate or unfavourable research about our business, our share price would likely decline. We have experienced such downgrade from two of our analysts in fiscal year 2016 during the period of anonymous short seller attacks on our stock. If one or more of these analysts cease coverage of our company or fail to publish reports on us regularly, or fail to maintain a favourable outlook on the company, it may cause investor sentiment to be weak, demand for our A ordinary shares could decrease, which might cause our share price and trading volume to decline.

 

We do not currently intend to pay dividends on our ordinary shares. Our ability to pay dividends in the future will depend upon satisfaction of the Isle of Man 2006 Companies Act solvency test, future earnings, financial condition, cash flows, working capital requirements and capital expenditures.

 

We currently intend to retain any future earnings and do not expect to pay dividends on our ordinary shares. The amount of our future dividend payments, if any, will depend upon our satisfaction of the solvency test contained in the 2006 Companies Act, our future earnings, financial condition, cash flows, working capital requirements and capital expenditures. The 2006 Companies Act provides that a company satisfies the solvency test if: (i) it is able to pay its debts as they become due in the normal course of the company’s business: and (ii) the value of the company’s assets exceeds the value of its liabilities. There can be no assurance that we will be able to pay dividends. Additionally, we are restricted by the terms of certain of our current debt financing facilities and may be restricted by the terms of any future debt financings in relation to the payment of dividends.

 

We may be classified as a passive foreign investment company, or PFIC, under United States tax law, which could result in adverse United States federal income tax consequences to U.S. investors

 

Based upon the past and projected composition of our income and valuation of our assets, we do not believe we will be a PFIC for our taxable year ending December 31, 2020, and we do not expect to become one in the future, although there can be no assurance in this regard. The determination of whether or not we are a PFIC for any taxable year is made on an annual basis and will depend on the composition of our income and assets from time to time. Specifically, we will be classified as a PFIC for United States federal income tax purposes if either:

 

  · 75% or more of our gross income in a taxable year is passive income, or
  · 50% or more of the average quarterly value of our gross assets in a taxable year is attributable to assets that produce passive income or are held for the production of passive income.

 

The calculation of the value of our assets will be based, in part, on the then market value of our A ordinary shares, which is subject to change. We cannot assure you that we were not a PFIC for the previous taxable years or that we will not be a PFIC for this or any future taxable year. Moreover, the determination of our PFIC status is based on an annual determination that cannot be made until the close of a taxable year and involves extensive factual investigation. This investigation includes ascertaining the fair market value of all of our assets on a quarterly basis and the character of each item of income we earn, which cannot be completed until the close of a taxable year, and, therefore, our U.S. counsel expresses no opinion with respect to our PFIC status.

 

If we were to be or become classified as a PFIC, a U.S. Holder (as defined in “Part I — Item 10. Additional Information — E. Taxation”) may be subject to burdensome reporting requirements and may incur significantly increased United States income tax on gain recognised on the sale or other disposition of the shares and on the receipt of distributions on the shares to the extent such gain or distribution is treated as an “excess distribution” under the United States federal income tax rules. Further, if we were a PFIC for any year during which a U.S. Holder held our shares, we would continue to be treated as a PFIC for all succeeding years during which such U.S. Holder held our shares. Each U.S. Holder is urged to consult its tax advisors concerning the United States federal income tax consequences of acquiring, holding and disposing of shares if we are or become classified as a PFIC. See “Part I — Item 10. Additional Information — E. Taxation” for a more detailed description of the PFIC rules.

39 

 

If the fair market value of our ordinary shares fluctuates unpredictably and significantly on a quarterly basis, the social costs we accrue for share-based compensation may fluctuate unpredictably and significantly, which could result in our failing to meet our expectations or investor expectations for quarterly financial performance. This could negatively impact investor sentiment for the Company, and as a result, adversely impact the price of our ordinary shares.

 

Social costs are payroll taxes associated with employee salaries and benefits, including share-based compensation that we are subject to in various countries in which we operate.

 

When the fair market value of our ordinary shares increases on a quarter to quarter basis, the accrued expense for social costs will increase, and when the fair market value of ordinary shares falls, the accrued expense will become a reduction in social costs expense, all other things being equal, including the number of vested stock options and exercise price remains constant. The trading price of our A ordinary share price can be highly volatile. See “—Risks Related to our A Ordinary Shares—Our A ordinary share price may be highly volatile and, as a result, shareholders could lose a significant portion or all of their investment or we could become subject to securities class action litigation.” As a result, the accrued expense for social costs may fluctuate unpredictably and significantly, from quarter to quarter, which could result in our failing to meet our expectations or investor expectations for quarterly financial performance. This could negatively impact investor sentiment for the company, and as a result, the price for our ordinary shares.

 

Failure to comply with anti-bribery, anti-corruption and anti-money laundering laws could subject us to penalties and other adverse consequences.

 

We are subject to the U.S. Foreign Corrupt Practices Act of 1977, as amended (“FCPA”), the U.K. Bribery Act of 2010, as amended (the “U.K. Bribery Act”) and other anti-bribery, anti-corruption and anti-money laundering laws in various jurisdictions around the world. The FCPA, the U.K. Bribery Act and similar applicable laws generally prohibit companies, as well as their officers, directors, employees and third-party intermediaries, business partners and agents, from making improper payments or providing other improper things of value to government officials or other persons. We and our third-party intermediaries may have direct or indirect interactions with officials and employees of government agencies or state owned or affiliated entities and other third parties where we may be held liable for corrupt or other illegal activities, even if we do not explicitly authorize them. While we have policies and procedures and internal controls to address compliance with such laws, we cannot assure you that all of our employees and third-party intermediaries, business partners and agents will not take actions in violation of such policies and laws, for which we may be ultimately held responsible. To the extent that we learn that any of our employees or third-party intermediaries, business partners or agents do not adhere to our policies, procedures or internal controls, we are committed to taking appropriate remedial action. In the event that we believe or have reason to believe that our directors, officers, employees or third-party intermediaries, agents or business partners have or may have violated such laws, we may be required to investigate or to have outside counsel investigate the relevant facts and circumstances. Detecting, investigating and resolving actual or alleged violations can be extensive and require a significant diversion of time, resources and attention from senior management. Any violation of the FCPA, the U.K. Bribery Act or other applicable anti-bribery, anti-corruption and anti-money laundering laws could result in whistleblower complaints, adverse media coverage, investigations, loss of export privileges, and criminal or civil sanctions, penalties and fines, any of which may could adversely affect our business and financial condition.

 

ITEM 4. INFORMATION ON THE COMPANY

 

A. History and Development of our Company

 

Eros International Plc was incorporated in the Isle of Man as of March 31, 2006 under the Companies Act 1931 commonly known as the 1931 Act — see “Part II — Item 4. Information on the Company — Government Regulations,” as a public company limited by shares. Effective as of September 29, 2011, the Company was de-registered under the 1931 Act and re-registered as a company limited by shares under the Isle of Man, Companies Act 2006 (as amended) commonly referred to as the 2006 Act. We maintain our registered office at First Names House, Victoria Road, Douglas, Isle of Man IM2 4DF, British Isles, our principal executive office in the U.S.A is at 550 County Avenue, Secaucus, New Jersey 07094; and our telephone number is +1(201) 558-9001. We maintain a website at www.erosplc.com. Information contained in our website is not a part of, and is not incorporated by reference into, this annual report.

 

40 

 

Our capital expenditures in fiscal 2020 was $265.3 million. Our principal capital expenditures were incurred for the purposes of purchasing intangible film rights and related content. We expect our capital expenditure needs in fiscal 2021 to be in the range of $150 - $160 million, a significant amount of which we expect to be used for the acquisition of further intangible film rights and related content.

 

B. Business Overview

 

We are a leading global company in the Indian film entertainment industry that co-produces, acquires and distributes Indian language films in multiple formats worldwide, and operate the largest Indian-content OTT entertainment service network, Eros Now. Founded in 1977, we are one of the oldest companies in the Indian film industry to focus on international markets. Our A Ordinary Shares are listed on the NYSE; symbol “EROS”. We believe we are pioneers in our business. Our success is built on the relationships we have cultivated over more than 40 years with leading talent, production companies, exhibitors and other key participants in our industry. We have aggregated multi-format rights to over 3,000 films in our library, including recent and classic titles that span different genres, budgets and languages.

 

Eros Now – the Largest Indian-Content OTT Network

 

We believe Eros Now has the largest Indian language movie content library worldwide with over 12,000 digital titles, out of which approximately 5,000 films are owned in perpetuity. Eros Now also has a deep library of short-form content, including music videos, trailers, original shorts exclusive interviews and marketing shorts. During fiscal year 2020 Eros Now digitally released a total of 630 films in 12 different Indian languages. Over the same period over 8,000 music audio and video files were released on Eros Now as well as over 500 units of short form and Eros Now Originals & Quickie content. Since inception, we have digitally premiered (first ever digital release) over 250 films on the Eros Now platform, and also introduced the concept of theatrical films launching on OTT prior to its satellite premiere, which is a testament to the strength of our platform and breadth and depth of our offering. As of March 31, 2020, Eros Now achieved over 196.8 million registered users across Apps, WAPs and the Eros Now website, and 29.3 million paying subscribers. Eros Now has seen a significant surge across matrices wherein engagement has risen 70%- 100% across daily viewers, time spent and repeat visits in a pre- lockdown to during lock down phase.

 

Having established over many partnerships and strategic collaborations globally with telecommunications operators, OEMs and streaming services providers, Eros Now is available globally through multiple distribution channels. These partnerships and strategic collaborations include our recent agreement with Apple to make Eros Now content available on all Apple devices in multiple countries outside of India, making Eros Now the first Indian OTT provider collaborating with Apple on such a scale.

 

Our Distribution Channels

 

In fiscal year 2020, we released a total of 30 films, including two medium budget films and twenty-eight low budget films. In the fiscal year 2019, we released a total of 72 films, including seven medium budget films and sixty-five low budget films.

 

We have a multi-platform business model and derive revenues from the following three distribution channels:

 

· Theatrical: The theatrical channel largely includes revenues from multiplex chains, single screen theaters, distributors and content aggregators in case of dubbed and/or subtitled versions. We are a leading player in a growing and under-penetrated cinema market with a consisent and leading box office market share. Based on gross collections reported by comScore, our market share as an average over the preceding eight calendar years to 2018 is 24% of all theatrically released Indian language films in the United Kingdom and the United States.

 

· Television Syndication: We de-risk our theatrical revenues while enhancing revenue predictability through pre-sales and television syndication which includes satellite television broadcasting, cable television and terrestrial television which are facilitated by our long-standing Eros brand, reputation and industry relationships. We license Indian film content (usually a combination of new releases and existing films in our library) over a stated period of time in exchange for a license fee, where payment terms may extend up to 2-3 years in some cases. We currently have television syndication content agreements in place with over 30 international broadcasters in the U.S., Asia, Europe and the Middle East, and includes long-term television syndication agreements with broadcast companies such as Viacom 18 Media in India, SABC in South Africa, E Vision in the UAE and Tanzania TV, among others.

41 

 
· Digital and ancillary: In addition to our theatrical and television distribution networks, we have a global network for the digital distribution of our content, which consists of full-length films, music, music videos, clips and other video content. Through our digital distribution channel, we mainly monetize music assets and distribute films and other content primarily in IPTV, VOD (including SVOD and DTH) and online internet channels. This enables us to prolong the lifecycle of our films and film library. A significant portion of the Indian and international population are moving towards adoption of digital technology. A recent Cisco Annual Internet Report predicts that there will be over 907 million internet users and 966 million mobile users in India by 2023. Given these growth opportunities, we are increasing our focus on providing on-demand services via Eros Now, which leverages its extensive digital film and music libraries to stream a wide range of content.

 

For fiscal year 2020, our aggregate revenues were $155.5 million.

Our Competitive Strengths

We believe the following competitive strengths position us as a leading global company in the Indian film entertainment industry.

Leading co-producer and acquirer of new Indian film content, with an extensive film library.

As one of the leading participants in the Indian film entertainment industry, we believe our size, scale and market position will continue contributing to our growth in India and internationally. We have established our size and scale by aggregating a film library of over 3,000 films. We have demonstrated our market position by releasing, internationally or globally, Hindi language films which were among the top grossing films in India in calendar years 2018, 2016, 2015 and 2014. We have released 36 of the top 110 highest grossing box office films in India from 2007 to 2018. We believe that we have strong relationships with the Indian creative community and a reputation for quality productions.

We believe that these factors, along with our worldwide distribution platform, will enable us to continue to attract talent and film projects of a quality that we believe is one of the best in our industry, and build what we believe will continue to be a strong film slate in the coming years with some of the leading actors and production houses with whom we have previously delivered our biggest hits. We believe that the combined strength of our new releases and our extensive film library positions us well to build new strategic relationships.

Largest Indian-content OTT Service Provider Globally

We are the largest Indian-content SVOD OTT service provider globally. Our OTT platform Eros Now has digital rights to over 12,000 films and we are collaborating with leading talents and strategic partners to create new content and expand Eros Now’s digital library. To maximize the reach of Eros Now, we currently have collaborations and partnerships in India and globally with market-leading telecommunications operators, OEMs and digital distribution entities to make available our digital service Eros Now across global audiences. Our partners include, among others, major telecommunications providers such as Airtel, Reliance Jio, Etisalat, Ooredoo, Vodafone and many more as well as streaming service providers such as Amazon Channels, Apple+ Channels, Youtube, Virgin Media, Roku, Sony TV and a plethora of connected devices. We are the first and only Indian-content OTT service provider to collaborate with Apple on a large scale. Furthermore, we have a unique and strategic relationship with Microsoft to further develop and create video technology. We believe that the scale of our digital library and the number of partnerships and collaborations with market leaders make us well positioned to take advantage of the increasing demand for digital entertainment content in India and other parts of the world.

Established, worldwide, multi-channel distribution network with access to China.

We distribute our films to the Indian population in India, the South Asian diaspora worldwide and to non-Indian consumers who view Indian films that are subtitled or dubbed in local languages. Internationally, our distribution network extends to over 50 countries, such as the United States, the United Kingdom and throughout the Middle East, where we distribute films to Indian expatriate populations, and to Germany, Poland, Russia, Romania, Indonesia, Malaysia, Taiwan, Japan, South Korea, China and Arabic and Spanish speaking countries, where we release Indian films that are subtitled or dubbed in local languages.

China is increasingly becoming an important market, and we expect to release selected successful films from our slate for wider release into China. We entered the China market in 2018 by releasing Bajrangi Bhaijaan across more than 8,000 screens, which grossed approximately $45 million at the box office in China since release. We also released Andhadhun in China in April 2019 which collected over $43 million in the Chinese box office in less than four weeks. Our partnership with iQiyi, one of China’s leading online video sites, also gives us direct access to Chinese viewers who have an interest in Indian film content. Furthermore, we are planning the release of our Indo-Chinese co-productions in fiscal 2021 in India, China and the rest of the world.

42 

 

During Fiscal Year 2020 Eros Now established a digital distribution partnership in China with Wasu Media, a large state-owned culture media group. The Wasu Group is one of the largest comprehensive digital content service providers across interactive TV, 3G / 4G mobile TV and Internet TV in China. Wasu’s services cover approximately 100 cities in 29 provinces in China with cable network as well as covering the three major telecom operators and several million Internet users.

 

Through this global distribution network, we distribute Indian entertainment content over three primary distribution channels — theatrical, television syndication and digital and ancillary platforms. Our primarily internal distribution network allows us greater control, transparency and flexibility over the regions in which we distribute our films, which we believe results in the direct exploitation of our films without the payment of significant commissions to sub-distributors.

Diversified revenue streams and pre-sale strategies mitigate risk and promote stable cash flow generation.

Our revenue model is diversified by three major distribution channels:

  · theatrical distribution;
  · television syndication; and
  · digital distribution and ancillary products and services, including Eros Now.

We bundle library titles with new releases to maximize cash flows, and we also utilize a pre-sale strategy to mitigate new production project risks by obtaining contractual commitments to recover a portion of our capitalized film costs through the licensing of television, music and other distribution rights prior to a film’s completion.

Television pre-sales in India are an important factor in enhancing revenue predictability for our business and are part of our diversification strategy to mitigate risks of cash flow generation.

In addition, we further seek to reduce risk to our business by building a diverse film slate, with a mix of films by budget, region and genre that reduces our reliance on “hit films.” This broad-based approach also enables us to bundle old and new titles for our television and digital distribution channels to generate additional revenues long after a film’s theatrical release period is completed. We believe our multi-pronged approach to exploiting content through theatrical, television syndication and digital distribution channels, our pre-sale strategies and our portfolio approach to content sourcing and exploitation mitigates our dependence on any one revenue stream and promotes cash flow generation.

Strong brand with fast-growing international reach

We believe we are a leading brand that is a household name in India. Through our partnerships we are also able to reach the large Indian diaspora globally.

Theatrical Distribution Outside India: Outside India, we distribute our films theatrically through our offices in Dubai, Singapore, the United States, the United Kingdom, Australia and through sub-distributors in other markets. In our international markets, instead of focusing on wide releases, we select a smaller number of theaters that play films targeted at the expatriate South Asian population or the growing international audiences for Indian films. We generally theatrically release subtitled versions of our films internationally on the release date in India, and dubbed versions of films in countries outside India 12-24 weeks after their initial theatrical release in India, sometimes after a long gap.

International Broadcasting Distribution: Outside of India, we license Indian film content to content aggregator to reach cable and pay TV subscriber and for broadcasting on major channels and platforms around the world. We also license dubbed content to Europe, Arabic and Spanish speaking countries and in Southeast Asia and other parts of the world. Often such licenses include not just new releases, but films grouped around the same star, director or genre. International pre-sales of television, music and other distribution rights are an important component of our overall pre-sale strategy. We believe that our international distribution capabilities and large library of content enable us to generate a larger portion of our revenue through international distribution.

43 

 

Dynamic management of our film library

We have the ability to combine our new release strategy with our library monetization efforts to maximize our revenues. We believe our extensive film library provides us with unique opportunities for content monetization, such as our dedicated Eros content channel carried by various cable companies outside India. Our extensive film library provides us with a reliable source of recurring cash flow after the theatrical release period for a film has ended. In addition, because our film library is large and diversified, we believe that we can more effectively leverage our library in many circumstances by licensing not just single films but multiple films. The existence of high margin library monetization avenues especially in television and digital platforms reduce reliance on theatrical revenues.

Strong and experienced management team with established relationships with key industry participants.

Our management team has substantial industry knowledge and expertise, with a majority of our executive officers and executive directors having been involved in the film, media and entertainment industries for 20 or more years, and has served as a key driver of our strength in content sourcing. In particular, several members of our management team have established personal relationships with leading talent, production companies, exhibitors and other key participants in the Indian film industry, which have been critical to our success. Through their relationships and expertise, our management team has also built our global distribution network, which has allowed us to effectively exploit our content globally.

Our Strategy

Our strategy is driven by the scale and variety of our content and the global exploitation of that content through diversified channels. Specifically, we intend to pursue the following strategies:

Scaling up productions and co-productions to augment our film library and focus on creating original digital content.

We will continue to leverage the longstanding relationships with creative talent, production houses and other key industry participants that we have built since our founding to source a wide variety of content. Our focus will be on investing in future slates comprised of a diverse portfolio mix ranging from high budget global theatrical releases to lower budget movies with targeted audiences. We intend to maintain our focus on films with various budgets and augment our library with quality content for exploitation through our distribution channels and explore new bundling strategies to monetize existing content.

We continue to focus on ramping up our own productions and co-productions through key partnerships. These include our partnership with the acclaimed producer-director, Aanand L Rai (Colour Yellow Production) and our joint venture partnership with screen writer and director V. Vijayendra Prasad. We have also entered into a distribution partnership agreement with Apple to make available Eros Now’s content across Apple devices in multiple countries including India. These strategic partnerships not only help us augment our in-house content production model but also expand our geographical footprint for content monetization.

Our focus is to become a global digital content company. Eros Now has rights to 12,000 films across ten different Indian languages and is rapidly expanding its content base. Eros Now enhances its consumer appeal through exploring dynamic genres to create unseen, relatable and contemporary Originals that appeal to a wide variety of audience. The launch of our Original digital series, comprising a broad mix of genres from comedy to horror and crime thriller, has enjoyed great success to date, with its original series Side Hero, Smoke, Metro Park, Modi and others winning over ten awards across different platforms. In April 2018, Eros Now successfully premiered its first worldwide direct-to-digital original film Meri Nimmo, in association with acclaimed director Aanand L Rai, to positive critical reception. Over the next 12 months, Eros Now is planning to launch an exclusive stable of feature films, made-for-digital originals films and original episodic programs, some including: Flesh by Siddharth Anand; Halahal by Zeishan Qadri; Bhumi by Pavan Kripalani; and a most awaited Season 2 of our well-known series Metro Park.

Eros Now Quickie, an IP that we launched to cater to high quality short form programming with stories that can be told within 80-100 mins and broken down into episodes of 8-10 mins has had fabulous pick up with Tier 2 audiences with IP’s like ‘The Investigation’ and Date gone wrong resonating very well with the youth. We plan to further scale this initiative across regional languages and build this culture with our viewers and subscribers.

Eros Now Prime - is our soon to be launched premium English Service is scheduled to go live in Q2 FY 21. We are excited about our plans to further penetrate the English speaking, higher ARPU market in India, and further leverage and seed this premium programming to regional audiences across the country. We also announced a strategic partnership with NBC Universal earlier this year and are looking to add other studios to our platform.

The digital music industry in India has been growing exponentially over the past few years, with over 25+ million digital audio streaming users. Film music is often marketed and monetized separately from the underlying film, both before and after a film is released. To further capture this market opportunity, we plan to expand our deep music library, which is an essential component to Eros Now’s offering, and to that end have recently established a partnership with YouTube Music in India to further capitalise on the digital music opportunity.

44 

 

To promote Eros Now, our OTT digital entertainment service platform, as the preferred choice for online entertainment by consumers across digital platforms.

The adoption of 4G is gradually increasing and now 3G and 4G constitute over 75% of the overall wireless internet user base. Initiatives such as broadband rollout and public Wi-Fi as part of the government’s Digital India campaign and the promotion of 4G data packs by leading telecoms will only help boost the quality of digital infrastructure in India.

Eros Now is increasingly focused on offering quality content including Indian films, music and original shows, opening new markets, delivering consumer friendly product features such as offline viewing and subtitles and adopting a platform agnostic distribution strategy across all operating systems and platforms across mobile, tablets, cable or internet, including through deals with OEMs. As of March 31, 2020, Eros Now caters to 29.3 million paying subscribers and has garnered 196.8 million registered users across global digital distribution platforms. While a majority of users are from South Asia, followed by North America and the United Kingdom we get paid subscribers from 150 countries. Out of the 12,000 films that Eros Now has rights to, 5,000 films are owned in perpetuity, across Hindi and regional languages. Eros Now service is integrated with some of India’s major telecommunications providers such as Reliance Jio, Airtel, Vodafone, Idea and BSNL, as well as streaming service providers such as Amazon, Apple, Virgin Media and Roku, and has partnerships with connected devices such as televisions and mobile handsets with companies such as Samsung to distribute in multiple territories. We continue to believe that Eros Now will be a significant player within the OTT online Indian entertainment industry, especially given the rapidly growing internet and mobile penetration within India. We will also continue to expand Eros Now’s reach beyond audiences in India through strategic collaborations such as our partnership with Apple to distribute Eros Now content on all Apple devices in multiple countries outside of India.

Capitalize on positive industry trends driven by roll-out of high speed 4G services in the Indian market.

Driven by the economic expansion within India and the corresponding increase in consumer discretionary spending, FICCI-EY Report 2020 projects that the dynamic Indian media and entertainment industry will grow at a 10.0% CAGR, from INR 1.674 trillion in 2018 to INR 2.416 trillion by 2022, and that the Indian digital media industry will grow at a 23% CAGR over the same period. India is one of the largest and most prolific film markets in the world as measured by output and remains underpenetrated compared to other established cinema markets such as the US and UK. Ticket prices in India remain at lower levels than other cinema markets globally and have room to increase. In fiscal year 2019 the average ticket price amongst the two leading multiplex cinema chains in India, Inox Leisure Limited and PVR Limited, was $2.70, based on information publicly disclosed by them. This compares to average ticket prices in the US of $9.16 during fiscal year 2019.

The Indian television market is the second largest in the world after China, reaching an estimated 175 million television viewers in 2019. The FICCI-EY Report 2020 projects that the Indian television industry will grow from $9.9 billion in 2018 to $11.8 billion in 2022. The growing size of the television industry has led television satellite networks to provide an increasing number of channels, resulting in competition for quality feature films for home viewing in order to attract increased advertising and subscription revenues.

Broadband and mobile platforms present growing digital avenues for content distribution in India. According to a recent Cisco report, India is forecasted to have approximately 907 million internet users by 2023, a large increase from 398 million internet users in 2018. According to a recent EY FICCI report, by 2025 there are expected to be one billion “screens” in India, of which 250 million screens would be television-sized while 750 million would be smart phones. This is expected to result in a continued growth in demand for content – both long form, episodic and short form – as well as provide significant opportunities for content creators currently there are approximately 550 million television and smart phone consumers in India, We aim to take advantage of the opportunities presented by these trends within India to monetize our library and distribute new films through existing and emerging platforms, including by exploring new content options for expanding our digital strategy such as filming exclusive short form content for consumption through emerging channels such as mobile and internet streaming devices.

 

Disclaimer: The exceptional circumstances brought about by coronavirus have led to the suspension of FICCI Frames. This report and the forewords were written before this development took place. We are not yet in a position to accurately quantify the deep impact which the coronavirus will have on the media ecosystem and we will come back to the investor community when we are in a better position to articulate the impact with updated future forecasts.

 

Further extend the distribution of our content outside of India to new audiences.

We currently distribute our content to consumers in more than 50 countries, including in markets where there is significant demand for subtitled and dubbed Indian themed entertainment, such as Europe and South East Asia, as well as to markets where there is significant concentration of South Asian expatriates, such as the Middle East, the United States and the United Kingdom.

45 

 

We intend to promote and distribute our films in additional countries, and further expand in countries where we already distribute, when we believe that demand for Indian filmed entertainment exists or the potential for such demand exists. To that end, we have entered into arrangements with local distributors in Taiwan, the Middle East, Japan, South Korea, and China to distribute dubbed or subtitled Eros films through theatrical release, television broadcast or DVD release. The MENA (“Middle East North Africa”) market represents a compelling market opportunity given the consumer trends, attractive demographics and Eros’ historic presence in the market and numerous distribution partnerships including with Etisalat and Ooredoo. Additionally, we believe that the general population growth in India experienced over recent years may eventually lead to increasing migration of Indians to other regions, resulting in increased demand for our films internationally.

Expand our regional Indian content offerings.

We continue to be committed to promoting regional content films and growing the regional movie industry. We will utilize our resources, international reputation and distribution network to continue expanding our non-Hindi content offerings to reach the substantial Indian population whose main language is not Hindi. While Hindi films retain a broad appeal across India, the diversity of languages within India allows us to treat regional language markets as distinct markets where particular regional language films have a strong following.

Our regional language films include Marathi, Malayalam, Punjabi, Kannada and Bengali films. Our Malayalam film Pathemari had won a national award for Best Malayalam Film. We intend to use our existing distribution network across India to distribute regional language films to specific territories. Where opportunities are available and where we have the rights, we also intend to exploit re-make rights to some of our popular Hindi films into non-Hindi language content targeted towards these regional audiences.

Slate Profile

The success of our film distribution business lies in our ability to acquire content. Each year, we focus on co-production, acquisition and distribution of a diverse portfolio of Indian language and themed films that we believe will have a wide audience appeal. Of the 30 films we released in fiscal 2020, eight were Hindi films, one was a Tamil film and twenty-one were regional films. Of the 72 films we released in fiscal year 2019, fifteen were Hindi films, seven was Tamil/Telugu films and fifty were regional films. Our typical annual slate of new releases consists of both Hindi language films as well as films produced specifically for audiences whose main language is not Hindi, primarily Tamil, and to a lesser extent other regional Indian language. Our most expensive films are generally the high and medium budget films (mainly Hindi and a few Tamil and Telugu films) that we release globally each year. The remainder of the films (mainly Hindi but also Tamil and/or Telugu) included in each annual release slate is built around films with various budgets to create a slate that will attract varying segments of the audience. The remainder of the slate consists of Hindi, Tamil, Telugu and other language films of a lower budget.

We focus on content driven films with appropriate budgets in order to generate an attractive rate of return and seek to mitigate the risks associated with film budgets through the use of our extensive pre-sale strategies. We have increased our focus on Tamil and Telugu films for similar reasons. Our Hindi films are typically high or medium budget films in the popular comedy and romance genres, supplemented by lower budget films, and our Tamil films are predominantly star-driven action or comedy films, which appeal to audiences distinct from audiences for more romance-focused Hindi films. We believe that a Tamil or Telugu film and a Hindi film can be released simultaneously on the same date without adversely affecting business for either film as each caters to a different audience.

We also believe that we can capitalize on the demand for regional films and replicate our success with Tamil and Telugu films for other distinct regional language films, including Marathi, Malayalam, Kannada and Punjabi. In addition, the key Indian release dates for films, during school and other holidays, vary by region and therefore our ability to release films on different holidays in various regions, in addition to being able to release films in different regional languages simultaneously, expands the likely periods in which our films can be successfully released. We intend to steadily build up our portfolio of films targeting other regional language markets.

46 

 

Our Business

Content Development and Sourcing

We currently acquire films using two principal methods — by acquiring rights for films produced by others, generally through a license agreement, and by co-producing films with a production house, typically referred to as a banner, which is usually owned by a top Indian actor, director or writer, on a project-by-project basis. We regularly co-produce and acquire film content from some of the leading banners in India, and continue to focus on ramping up our own productions and co-productions through key partnerships. These partnerships include our partnership with Aanand L Rai (Colour Yellow Productions), which has released a range of films across budgets, genres and languages; and co-production partnership with screen writer and director V. Vijayendra Prasad.

Moreover, we are continuing to focus on expanding the reach of our content by further penetrating the China market, which we believe is a significant market for Indian films, and releasing more dubbed and subtitled content to new markets beyond China. To that end, in April 2019 we released Andhadhun, a dark comedy crime thriller, in China in collaboration with Tang Media Partners, a leading Chinese film distributor. In addition, these strategic partnerships not only help us augment our in-house content production capacity but also expands our geographical canvas for content monetization.

Regardless of the acquisition method, over the past five years, we have typically obtained exclusive global distribution rights in all media for a minimum period of ten to 20 years from the Indian initial theatrical release date, although the term can vary for certain films for which we may only obtain international or only Indian distribution rights, and occasionally soundtrack or other rights are excluded from the rights acquired. For co-produced films, we typically have exclusive distribution rights for at least 20 years, co-own the copyright in such film in perpetuity and, after the exclusive distribution right period, share control over the further exploitation of the film.

We believe producers bring proposed films to us not only because of established relationships, but also because they want to leverage our proven distribution and marketing capabilities. Our in-house creative team also directly develops film ideas and contracts with writers and directors for development purposes. When we originate a film concept internally, we then approach appropriate banners for co-production. Our in-house creative team also participates in the selection of our slate with other members of our management in our analysis focused on the likelihood of the financial success of each project. Our management is extensively involved in the selection of our high budget films in particular.

Regardless of whether a film will be acquired or co-produced, we determine the likely value to us of the rights to be acquired for each film based on a variety of factors, including the stars cast, director, composer, script, estimated budget, genre, track record of the production house, our relationship with the talent and historical results from comparable films. We follow a disciplined green lighting process involving extensive evaluation of films involving track records, revenue potential and costs before green lighting by a committee led by senior management and business leaders. The Company also has risk sharing contracts with talent and key stakeholders to ensure risk diversification. Our primary focus is on sourcing a diversified portfolio of films expected to generate commercial success. We generally co-produce our high budget films and acquire rights to more medium and low budget films. Our model of primarily acquiring or co-producing films rather than investing in significant in-house production capability allows us to work on more than one production with key talent simultaneously. Since the producer or co-producer takes the lead on the time intensive process of production, we are able to scale our film slate more effectively. The following table summarizes the typical terms included in our acquisition and co-production contracts.

 

Acquisition

Co-production

Film Cost Negotiated “market value” Actual cost of production or capped budget and 10–15% production fee
Rights 10 years–20 years Exclusive distribution rights for at least 20 years after which Eros shares control over the further exploitation of the film, and co-owned copyright in perpetuity, subject to applicable copyright laws
Payment Terms 10–30% upon signature
Balance upon delivery or in instalments between signing and delivery
In accordance with film budget and production schedule
Recoupment Waterfall “Gross” revenues
Less 10–20% Eros distribution fee (% of cost or gross revenues)
Less print, advertising costs (actuals)
Less cost of the film
Net revenues generally shared equally
Generally same as Acquisition except sometimes Eros also charges interest and/or a production or financing fee for the cost of capital and overhead recharges

47 

 

Where we acquire film rights, we pay a negotiated fee based on our assessment of the expected value to us of the completed film. Although the timing of our payment of the negotiated fee for an acquired film to its producer varies, typically we pay the producer between 10% and 30% of a film’s negotiated acquisition cost upon signing the acquisition agreement, and the remainder upon delivery of the completed film or in instalments paid between signing and delivery. In addition to the negotiated fee, the producer usually receives a share of the film’s revenue stream after we recoup a distribution fee on all revenues, the entire negotiated fee and distribution costs, including prints and ads. After we sign an acquisition agreement, we do not exercise any control over the production process, although we do retain complete control over the distribution rights we acquire.

For films that we co-produce, in exchange for our commitment to finance typically 100% of the agreed-upon production budget for the film and agreed budget adjustments, we typically share ownership of the intellectual property rights in perpetuity and secure exclusive global distribution rights for all media for at least 20 years. After we recoup our expenses, we and the co-producers share in the proceeds of the exploitation of the intellectual property rights. Pending determination of the actual production cost of the film, we also agree to a pre-determined production fee to compensate the co-producer for his services, which typically ranges from 10%-15% of the total budget. We typically also provide a share of net revenues to our co-producers. Net revenues generally means gross revenues less our distribution fee, distribution cost and the entire amount we have paid as committed financing for production of the film. Our distribution fee varies for each of the co-produced films, but is generally either a continuing 10% to 20% fee on all revenues, or a capped amount that is calculated as a percentage of the committed financing amount for production of the film. In some cases, net revenues also deduct an overhead charge and an amount representing an interest charge on some or all of the committed financing amount. Typically, once we agree with the co-producer on the script, cast and main crew including the director, the budget and expected cash flow through a detailed shooting schedule, the co-producer takes the lead in production and execution. We normally have our executive producer on the film to oversee the project.

We reduce financing risk for both acquired and co-produced films by capping our obligation to pay or advance funds at an agreed-upon amount or budgeted amount. We also frequently reduce financial risk on a film to which we have committed funds by pre-selling rights in that film.

Pre-sales give us advance information about likely cash flows from that particular film product, and accelerate cash flow realizable from that product. Our most common pre-sale transactions are the following:

  · pre-selling theatrical rights for certain geographic areas, such as theaters outside the main theater circuits in India or certain non-Indian territories, for which we generally get nonrefundable minimum guarantees plus a share of revenues above a specified threshold;
  · pre-selling television rights in India, generally by bundling releases in a package that is licensed to satellite television operators for a specified run; and
  · pre-selling certain music rights, including for movie soundtracks and ringtones.

From time to time we also acquire specific rights to films that have already been released theatrically. We typically do not acquire global all-media rights to such films, but instead license limited rights to distribution channels, like digital, television, audio and home entertainment only, or rights within a certain geographic area. As additional rights to these films become available, we frequently seek to license them as well, and our package of distribution rights in a particular film may therefore vary over time. We work with producers not only to acquire or co-produce new films, but also to license from them other rights they hold that would supplement rights we hold or have previously held related to older films in our library. In certain cases, we may not hold full sequel or re-make rights or may share these rights with our co-producers.

Our Film Library

We currently own or license rights to over 3,000 films, including recent and classic titles that span different genres, budgets and languages. Eros Now has rights to over 12,000 films, out of which around 5,000 films are owned in perpetuity, across Hindi and regional languages from Eros’s internal library as well as third party aggregated content, which we believe makes it one of the largest Indian movie offering platforms around the world. Our film library has been built up over more than 40 years and includes hits from across that time period, including, among others, Pati patni aur who, Andhadhun, Boyz 2, Newton, Munna Michael, Subh Mangal Saavadhan, Ki & Ka, Housefull 3, Dishoom, Baar Baar Dekho, Bajrangi Bhaijaan, Bajirao Mastani, Tanu Weds Manu Returns, NH10, Badlapur, Devdas, Hum Dil De Chuke Sanam, Lage Raho Munna Bhai, Vicky Donor, English Vinglish, and Goliyon Ki Raasleela: Ram-Leela. We have acquired most of our film content through fixed term contracts with third parties, which may be subject to expiration or early termination. We own the rights to the rest of our film content as co-producers or sole producer of those films. Through such acquisition and co-production arrangements, we seek to acquire rights to 40 to 50 additional films each year. While we typically hold rights to exploit our content through various distribution channels, including theatrical, television and new media formats, we may not acquire rights to all distribution channels for our films. In particular, we do not own or license the music rights to a majority of the films in our library. We expect to maintain more than half of the rights we presently own through at least December 31, 2025.

48 

 

In an effort to reach a wide range of audiences, we maintain rights to a diverse portfolio of films spanning various genres, generations and languages. More than 55% of the films in our Hindi library are films produced in the last 15 years. We own or license rights to films produced in several regional languages, including Tamil, Telugu, Kannada, Marathi, Bengali, Malayalam, Kannada and Punjabi.

We treat our new releases as part of our film library one year from the date of their initial theatrical release. We believe our extensive film library provides us with unique opportunities for content exploitation, such as our dedicated Eros content channel carried by various cable companies outside India. Our extensive film library provides us with a reliable source of recurring cash flow after the theatrical release period for a film has ended. In addition, because our film library is large and diversified, we believe that we can more effectively leverage our library in many circumstances by licensing not just single films but multiple films.

Award winning content/franchise

Our film releases frequently receive awards and accolades. For instance, our Hindi release Newton was selected as India’s official entry for the Best Foreign Film language category at the 2018 Academy Awards. It also received accolades at the Berlin Film Festival. We have won 218 awards in fiscal years 2015, 2016, 2017,2018 and 2019, including Studio of the Year. Some of our films and original digital series from fiscal year 2018 and fiscal 2019 that won awards include Side Hero, Smoke, Mukkabaaz, Newton, Shubh Mangal Savdhaan and Munna Michael. Side Hero won three awards including Best Web Series and Best Actor. Smoke received Best Launch of the Year at The ET Now - Stars of the Industry Awards. Mukkabaaz won three awards including Best Director and Best Actor. Newton won 13 awards including Best International Film. Shubh Mangal Savdhaan won four awards including Marketing Campaign of the Year. Munna Michael won two awards including Best Social Media Marketing Campaign. Our films over the years have won various awards in multiple categories such as Best Film, Best Director, Best Story, Best Actor, Best Music, Best Special Effects awards, and Innovative Launch Campaign of the Year and Best Child Actor awards, to name a few. Bajrangi Bhaijaan won 37 awards including National Award for Popular Film. Bajirao Mastani won over 79 award titles including National Award for Best Director. Tanu Weds Manu Returns won 19 awards including National Award for Best Female Actor in a leading role, Hero won seven awards and Badlapur won seven awards. Our Malayalam film Pathemari had also won a national award for Best Malayalam Film.

Distribution Network and Channels

We distribute film content primarily through the following distribution channels:

· theatrical, which includes multiplex chains and stand-alone theaters;
· television syndication, which includes satellite television broadcasting, cable television and terrestrial television; and
· digital and ancillary, which primarily includes IPTV, VOD, music, inflight entertainment, home video, internet channels and Eros Now.

We generally monetize each new film we release through an initial 12-month revenue cycle commencing after the film’s theatrical release date. Thereafter, the film becomes part of our film library where we seek to continue to monetize the content through various platforms. The diagram below illustrates a typical distribution timeline through the first 12 months following theatrical release of one of our films.

49 

 

Film release first cycle timeline

 

We currently acquire films both for global distribution, which includes the Indian domestic market as well as international markets and for international distribution only.

Certain information regarding our initial distribution rights to films initially released in the three fiscal years 2020, 2019 and 2018 is set forth below:

    Year ended March 31,  
    2020     2019     2018  
Global (India and International)                        
Hindi films     2       7       10  
Regional films (excluding Tamil films)     21       49       3  
Tamil films           3       1  
International Only                        
Hindi films     6       7       1  
Regional films (excluding Tamil films)                  
Tamil films                 -  
India Only                        
Hindi films           1       3  
Regional films (excluding Tamil films)     1       5       6  
Tamil films           -       0  
Total     30       72       24  

We distribute content in over 50 countries through our own offices located in key strategic locations across the globe. In response to Indian cinemas’ continued growth in popularity across the world, especially in non-English speaking markets, including Germany, Poland, Russia, Southeast Asia and Arabic speaking countries, we offer dubbed and/or subtitled content in over 25 different languages. In addition to our internal distribution resources, our global distribution network includes relationships with distribution partners, sub-distributors, producers, directors and prominent figures within the Indian film industry and distribution arena.

Theatrical Distribution and Marketing

India Distribution. The Indian theatrical market is comprised of both multiplex and single screen theaters which are 100% digitally equipped. In India, the cost of distributing a digital film print is lower than the cost of distributing a digital film print in the United States. Utilisation of digital film media also provides additional protection against unauthorized copying, which enables us to capture incremental revenue that we believe are at risk of loss through content piracy.

50 

 

India is divided into 14 geographical regions commonly known as “Film Circuits” or “Film Territories” in the Indian film business. We distribute our content in all of the circuits either through our internal distribution offices (Mumbai, Delhi, East Punjab, Mysore and Bihar) or through sub-distributors in remaining circuits. The Film Circuits where we have direct offices comprise of a market share of up to 75% of the India theatrical revenue. Our primarily internal distribution network allows us greater control, transparency and flexibility over the core regions in which we distribute our films, and allows us to retain a greater portion of revenues per picture as a result of direct exploitation instead of using sub-distributors, which requires the payment of additional fees, sub-distributor margins or revenue shares.

We entered into agreements with certain key multiplex operators to share net box office collections for our theatrical releases with the exhibitor for a predetermined base fee of 50% of net box office collections for the first week, after which the split decreases over time.

We primarily enter into agreements on a film-by-film and exhibitor-by-exhibitor basis. To date, our agreements have been on terms that are no less favourable than the terms of the prior settlement agreements; however, we cannot guarantee such terms can always be obtained.

The largest number of screens in India that we book for a particular film are booked for the first week of theatrical release, because as a substantial portion of box office revenues are collected in the first week of a film’s theatrical exhibition. Our agreements with pan India multiplex operators is such that 100% of the entire first week of our share of revenues from all our films from such multiplexes is paid to us within 10 days of the release.

In single screens we either obtain non-refundable minimum guarantees/refundable advances and a revenue sharing arrangement above the minimum guarantee and with certain smaller multiplex chains we obtain refundable advances and a revenue sharing arrangement.

Pursuant to the Cinematograph Act, Indian films must be certified for adult viewing or general viewing by the CBFC, which looks at factors such as the interest of sovereignty, integrity and security of India, friendly relations with foreign states, public order and morality. Obtaining a desired certification may require us to modify the title, content, characters, storylines, themes or concepts of a given film.

International Distribution. Outside India, we distribute our films theatrically through our offices in Dubai, Singapore, the United States, the United Kingdom, Australia and through sub-distributors in other markets. In our international markets, instead of focusing on wide releases, we select a smaller number of theatres that play films targeted at the expatriate South Asian population or the growing international audiences for Indian films. We generally theatrically release subtitled versions of our films internationally on the release date in India, and dubbed versions of films in countries outside India 12-24 weeks after their initial theatrical release in India sometimes after a long gap.

Marketing. The marketing campaign of a film is an integral part of the overall theatrical distribution strategy. It typically starts before the film goes into production with the marketing campaign peaking closer to the release of the film. Our marketing team creates a 360 degree campaign with specific emphasis across various media platforms, including carrying out public relation campaigns and utilizing print, brand partnerships, music pre-releases, print and outdoor advertising, brand partnerships and marketing on various social media and other digital platforms. Each film campaign is unique and has a strategic, targeted approach based on the genre, talent involved, positioning of the movie, target group and overall strategy. In addition, prior to the release of a film, we introduce various film assets, including posters, teasers, trailers and songs to generate momentum for the release of a film.

Our marketing efforts are primarily managed by employees located in offices across India or in one of our international offices in Dubai, Singapore, the United States, the United Kingdom, and Australia. Occasionally, sub-distributors manage marketing efforts in regions that do not have a dedicated Eros team, using the creative aspects developed by us for our marketing campaigns. Managing marketing locally permits us to more easily identify appropriate local advertising channels and results in more effective and efficient marketing.

Television Distribution

India Distribution. We believe that the increasing television audience in India creates new opportunities for us to license our film content, and expands audience recognition of the Eros name and film products. We license Indian film content (usually a combination of new releases and existing films in our library), to satellite television broadcasters operating in India under agreements that generally allow them to telecast a film over a stated period of time in exchange for a specified license fee. We have, directly or indirectly, licensed content for major Indian television channels such as Colors, Sony, the Star Network and Zee TV.

51 

 

International Distribution. Outside of India, we license Indian film content to content aggregators to reach cable and pay subscribers and for broadcasting on major channels and platforms around the world. We also license dubbed content to Europe, Arabic-speaking countries and in Southeast Asia and other parts of the world. Often such licenses include not just new releases, but films grouped around the same star, director or genre. International pre-sales of television, music and other distribution rights are an important component of our overall pre-sale strategy. We believe that our international distribution capabilities and large library of content enable us to generate a larger portion of our revenue through international distribution.

Digital Distribution

In addition to our theatrical and television distribution networks, we have a global network for the digital distribution of our content, which consists of full length films, music, music videos, clips and other video content. Through our digital distribution channel, we mainly monetize music assets and distribute movies and other content primarily in IPTV, VOD (including SVOD and DTH) and online internet channels. Our film content is distributed in original language, subtitled into local languages or dubbed, in each case as driven by consumer or regional market preferences. With our large library of content and slate of new releases, we have sought to capitalize on changes in consumer demand through early adoption of new formats and services, which we believe enables us to generate a larger portion of our revenue through digital distribution than the film entertainment industry average in India.

With a significant portion of the Indian and international population moving towards the adoption of digital technology, we are increasing our focus on providing on demand services, although the platforms and strategies differ by region. Outside of India, there is a proliferation of cable, satellite and internet services that we supply. In addition, with the proliferation of internet users, we are increasing our online distribution presence as well. These platforms enable us to continue to monetize a film in our library long after its theatrical release period has ended. In addition, the speed, ease of availability and prices of digital film distribution diminish incentives for unauthorized copying and content piracy.

In North America, we have an agreement with International Networks, a subsidiary of Comcast, to provide an SVOD service fully branded as “Eros Now.” The service is carried on most of the major cable network providers including Comcast, Cox Communications, Cablevision and Time Warner Cable. We provide all programming for this film and music channel and share revenues with the cable providers. We also provide content to Amazon Digital and participate in a revenue share deal. In Canada, we have signed a Program License Agreement for various movies with Rogers Broadcasting Limited. In Europe, we have partnered with My Digital Company (France), ESC Distribution (France) and MT Trading Ug (Germany). To maximize the reach of digital content, we currently have collaborations and partnerships in India and globally with market-leading telecommunications operators, OEMs and digital distribution entities to make available our digital service Eros Now across global audiences. Our partners include, among others, major telecommunications providers such as Airtel, Reliance Jio, Etisalat, Ooredoo, Vodafone and many more as well as streaming service providers such as Amazon Channels, Apple+ Channels, Youtube, Virgin Media, Roku, Sony TV and a plethora of connected devices.

Market opportunity

Domestic: Our distribution capabilities enable us to target a majority of the 1.3 billion people in India. Recently, as demand for regional films and other media has increased in India, our brand recognition in Hindi films has helped us to grow our non-Hindi film business by targeting regional audiences in India and overseas. With our distribution network for Hindi, Tamil and Telugu films, we believe we are well positioned to expand our offering of non-Hindi content.

Overseas: Depending on the film, the distribution rights we acquire may be global, international or India only. Indian films have a global appeal and their popularity has been increasing in many countries that consume dubbed and subtitled foreign content in local languages. These markets include Germany, Poland, Russia, France, Italy, Spain, Indonesia, Malaysia, Japan, South Korea, China, the Middle East and Latin America among others. In all these markets, it is the locals who are neither English nor Hindi speaking who view the content of the Indian film in a dubbed or subtitled version in their language, similar to the manner in which they view Hollywood content. Additionally, there is a large established Indian diaspora in North America which has a strong interest in the content of the Indian film industry. Other international markets that exhibit significant demand for subtitled or dubbed Indian-themed entertainment include Europe and Southeast Asia.

In addition, China is increasingly becoming an important market, and we expect to release select films from our slate for wider release into China. We recently released Andhadhun in China in collaboration with a leading Chinese film distributor Tang Media Partners. In March 2018, we released Bajrangi Bhaijan across more than 8,000 screens, including in China, and collected over $45 million at the box office in China, which we believe indicates a clear interest in Indian films by Chinese movie goers. As part of our strategy to penetrate further into the Chinese market, Eros Now has partnered with iQiyi, one of China’s largest online video sites, through a content licensing arrangement in September 2018, making us the first South Asian OTT platform operator to have direct access to the Chinese market.

52 

 

Eros Now Market Opportunity: Eros Now is uniquely positioned to benefit from the fast-growing internet and mobile penetration in India. A recent Cisco Annual Internet Report predicts that there will be over 907 million internet users and 966 million mobile users in India by 2023. The adoption of 4G is gradually increasing and now 3G and 4G constitute over 75% of the overall wireless internet user base. Initiatives such as broadband rollout and public Wi-Fi as part of the government’s Digital India campaign and the promotion of 4G data packs by leading telecoms help boost the quality of digital infrastructure in India. We plan to take advantage of this growth and continue to grow Eros Now’s paying user base in India and internationally.

Eros Now

With a significant portion of the Indian and international population moving towards the adoption of digital technology, we are increasing our focus on providing on-demand services via Eros Now, which leverages its extensive digital film and music libraries to stream a wide range of content. Users can access Eros Now through APPs, WAP and the internet in India and around the world. As at March 31, 2020, Eros Now had over 196.8 million registered users and 29.3 million paying users worldwide, compared to 155 million registered users and 18.8 million paying subscribers as of March 31, 2019, representing increases of 27% and 56% respectively. We define paying subscribers to mean any subscriber who has made a valid payment to subscribe to a service that includes Eros Now services as part of a bundle or on a standalone basis, either directly or indirectly through an OEM or mobile telecom provider in any given month, be it through a daily, weekly or monthly billing pack. Eros Now users have demonstrated some of the highest levels of engagement in the India OTT space. According to a published report by Counterpoint, Eros Now users are the most engaged wherein 68% access the platform daily and 59% of Tier 2 and Tier 3 users are in the age group of 24-39 in Tier 2 and Tier 3 cities of India which is the highest amongst all Indian OTT services.

We believe Eros Now has the largest Indian language movie content library worldwide with over 12,000 digital titles, out of which approximately 5,000 films are owned in perpetuity. Eros Now also has a deep library of short-form content, including music videos, trailers, original shorts exclusive interviews and marketing shorts. During fiscal year 2020 Eros Now digitally released a total of 630 films in 12 different Indian languages. Over the same period over 8,000 music audio and video files were released on Eros Now as well as over 500 units of short form and Eros Now Originals & Quickie content. Since inception, we have digitally premiered (first ever digital release) over 250 films on the Eros Now platform, and also introduced the concept of theatrical films launching on OTT prior to its satellite premiere, which is a testament to the strength of our platform and breadth and depth of our offering. As of March 31, 2020, Eros Now achieved over 196.8 million registered users across Apps, WAPs and the Eros Now website, and 29.3 million paying subscribers.

 

To maximize the reach of Eros Now, we currently have partnerships and strategic collaborations globally with telecommunications operators, OEMs and streaming services providers to offer Eros Now content to their users and subscribers. For instance, we recently announced our arrangement with Apple to make Eros Now available on the new Apple TV app. Eros Now is also available to customers of Reliance Jio, a major Indian mobile network operator owned by Reliance and BSNL, an Indian state-owned telecommunications company in accordance with a recent agreement that we entered into with BSNL, as well as the Malaysia-based Celcom and Maxis Berhad, Mauritius Telecom, Etisalat and Indonesia-based XL Axiata. Under these partnerships, subscribers on these networks gain access to Eros Now’s extensive content including full-length movies and thematically-created playlists along with functions such as multi-language subtitles for movies, music video playlists, regional language filters, video progression and a watch list of titles. In addition, Eros Now has entered the Sri Lankan market through a partnership with Dialog Axiata, Sri Lanka’s premier connectivity provider, and will be available on the Dialog ViU app.

Eros Now is also available in the Apple App Store and Google Play Store for download and can be streamed on any device including Amazon Fire TV stick, All IoS enabled devices and Roku, making the entertainment experience platform agnostic. Eros Now has over 60 distribution partners around the world including Apple TV+, Amazon Channels, Virgin Media, Roku, Etisalat and xfinity.

Eros Now uses advanced technologies in the creation of content, giving each Eros Now original series or episode the same treatment a film receives in terms of detailing required from cinematography to production. In addition, Eros Now uses advanced technologies to allow its users easy manoeuvrability on its platform, including categorization, search ability and stacking of content under different domains.

In September 2019, we announced a ground-breaking commercial partnership with Microsoft with the goal of transforming the content streaming experience for consumers globally. This collaboration will help Eros Now develop a new intuitive online video platform to ensure seamless delivery of content across countries and languages. It will also create a host of new interactive voice offerings for customers including video search experiences, voice search for video content across multiple Indian languages, and create personalized content. This collaboration will help our Eros Now platform enhance and strengthen its reach across globe and increase engagement with consumers.

 

Eros Now has been increasingly focused on delivering product features to further monetize its growing registered user base. For example, we have launched Eros Now Quickie, a platform where viewers can access quality short stories to further supplement our existing vast digital content library.

53 

 

The Eros Now platform also partners with leading companies in various industries other than entertainment in an effort to create vertical synergy and attract more users for its content. These companies cover industries including banking and lifestyle. For example, Eros Now has partnerships with three major electronic payment platforms, Paytm, CashKaro and Freecharge, so Eros Now can have access and advertise its services to the users of these payment platforms and its existing viewers can more easily purchase Eros Now content. In addition, Eros Now has partnerships with other brands like Cathay Pacific, Emirates, ICICI Bank, Grofers and a host of other brands.

 

At Eros Now we have focused on the core of the video technology business actively and will continue to invest in development over the coming years. At. The helm of this initiative is our relationship with Microsoft to develop the next generation video technology backend to deliver language based content to audiences over the world, Our investments in remote villages in India wherein we enable Village Level Entrepreneurs to distribute Eros Now on Internet cards across the country, our relationship with Dolby and being the first partner to introduce Dolby Atmos and Vision on our applications for OTT customers, our strategic relationship with Epic Games and the work being done on Unreal Engine to revolutionize pre-visualization technology based content production.

 

The Indian audience’s propensity to consume content in local language has been increasing, and in recent times regional films are breaking language barriers as they cross over with dubbed versions to other markets especially the Hindi market. The regional industry also has strong releases in the next year and the market is only expected to expand further. Eros Now is well placed to capitalize on this growth given its strong regional content library and slate of compelling new regional content planned for release over the coming quarters.

 

Eros Now Originals

Eros Now’s various digital series, comprising a broad mix of genres from comedy to horror and crime thriller, have been well received by its viewers. Eros has a uniquely compelling slate of films and original series scheduled for release over the coming quarters, and we expect this to help drive continued growth in our Eros Now business as well as box-office revenue.

 

With compelling global concepts and productions in partnership with the best talent available, we believe that Eros Now’s slate of original films and series will appeal to a wide range of audience. Over the next 12 months, Eros Now is planning to launch an exclusive stable of feature films, made-for-digital originals films and original episodic programs, some including: Flesh by Siddharth Anand; Halahal by Zeishan Qadri; Bhumi by Pavan Kripalani; and a most awaited Season 2 of our well-known series Metro Park. Over the past few months, despite the COVID-19 pandemic, we have released several pieces of original content on the Eros Now platform, A Viral Wedding, Metro Park (Quarantine Edition), Date Gone Wrong (Quarantine Edition).

Music

Music is integral to our films, and when we obtain global, all-media rights in our acquired or co-produced films, music rights typically are included. Film music rights are often marketed and monetized separately from the underlying film, both before and after the release of the related films. In addition, we act as a music publisher for third party owned music rights within India. Through our internal resources and network of licensees, we are able to provide our consumers with music content directly, through third party platforms or through licensing deals.

We also exploit the music publishing and master rights we own, which involves directly licensing songs to radio and television channels in India, synchronizing of music content to film, television and advertisers globally, as well as receiving royalties from public performance of these songs when they are played at public events. Ancillary revenues from public performances in India are collected and paid over to us through Novex, which monitors, collects and distributes royalties to its members.

During fiscal year 2020 we announced a transformational alliance between Eros Now and YouTube Music Premium. This was the first time ever, in any geography, that Google/YouTube had partnered with a SVOD OTT player for a joint bundling and marketing opportunity. In addition, Eros Now developed the customer journey to provision access to both products and leveraged our new payment funnel. The campaign was supported by a robust digital marketing push from both sides.

54 

 

Impact of Covid-19

 

The COVID-19 pandemic has had, and is likely to continue to have, a severe and unprecedented impact throughout the world. The COVID-19 outbreak and resulting measures taken by the Government of various countries to contain the virus have already significantly affected our business in the first quarter of fiscal year 2021. Measures to prevent its spread, including government-imposed restrictions on social gatherings, have had a significant effect on theatrical exhibition in India and around the world. The content production sector has also been disrupted, resulting in delays in many ongoing productions. These factors are expected to impact future release of content across distribution windows including theatrical, television and digital. The pandemic has had a negative overall impact on our business operations. The continued closure of cinemas in India and around the world for an indefinite period of time has created an unprecedented uncertainty and as a result it is difficult for us to accurately predict operating results and cash flows in near-term.

 

During the period from March 31st, 2020 to June 30th, 2020, we had several theatrical film releases scheduled in India and overseas, namely ‘Haathi Mere Saathi’ in three languages (Hindi, Tamil and Telugu), ‘Shokuner Lobh’ (Bengali), amongst others. However, under the present circumstances of the COVID-19 pandemic, we have taken the decision to defer the release of these films indefinitely until the situation changes, so that the revenue opportunities from these films can be maximized and improve our cashflows to better serve our commitments to our stakeholders.

 

The onslaught of the COVID - 19 pandemic has changed the social lives of people across regions and economic sections. While traditional and outdoor mediums of distribution of content, such as cinema theatres, continue to be unavailable; the home consumption mediums, such as television channels and OTT platforms (digital platforms) have gained in popularity and viewership. Going forward, along with our industry peers, we have started to consider changes to various operational and legal aspects of the business, such as project timelines, production costs, schedules, legal commitments etc, in order to adjust to the 'new normal' being presented to the world.

 

Our OTT platform Eros Now, for which the majority of the content library comprises our own existing content and acquired content, has also started considering innovative ways of updating its existing content libraries. Given the rise in demand for content and increasing online viewership, and the disruption in production of new content, existing content is likely to become more valuable in the future which will benefit us.

 

We believe, but cannot guarantee, that the cinematic exhibition industry will ultimately rebound and benefit from pent-up social demand for out-of-home entertainment, as government restrictions are lifted and home sheltering subsides. However, the ultimate significance of the pandemic, including the extent of the adverse impact on our financial and operational results, will be dictated by the currently unknowable duration and the effect on the overall economy and of responsive governmental regulations, including shelter-in-place orders of the pandemic and mandated suspension of operations.

 

Given the above, while the media and entertainment sector is currently grappling with various challenging issues as people strive to return to normalcy, eventually our sector may be amongst the first to recover and continue to provide premium entertainment to consumers around the world.

 

Intellectual Property

As our revenues are primarily generated from commercial exploitation of our films and other audio and/or audio-visual content, our intellectual property rights are a critical component of our business. Unauthorized use/access of intellectual property, particularly piracy of DVDs and CDs, as well as on-line piracy through unauthorized streaming/downloads, is widespread in India and other countries, and the mechanisms for protecting intellectual property rights in India and such other countries are not as effective as those of the United States and certain other countries. In order to fight against piracy, we participate directly and through industry organizations by way of actions including legal claims against persons/entities who illegally pirate our content. Furthermore, we also deal with piracy issues by promoting and marketing our films to the highest standards in order to ensure maximum viewership and revenues early in its release and shortening the period between the theatrical release of a film and its legitimate availability on DVD and VCD in the market. This is supported by the trend in the Indian market for a significant percentage of a film’s box office receipts to be generated in the first few weeks after release.

55 

 

Recently, there has been a rapid transition of consumer preference from physical to digital modes of consumption of film and related content via on-line, mobile and digital platforms. This has enabled our OTT platform Eros Now to grow rapidly, which subjects us to competition from other such OTT platforms along with sites offering unauthorized pirated content. In order to tackle this issue of on-line piracy, we have adopted Digital Rights Management technology in order to ensure that our content is protected from unauthorized and illegal access and copying.

Copyright protection in India

The Copyright Act, 1957 (as amended from time to time) (“Copyright Act”), prescribes provisions inter alia relating to registration of copyrights, transfer of ownership and licensing of copyrights and infringement of copyrights and remedies available in that respect. The Copyright Act affords copyright protection to cinematographic films and sound recordings and original literary, dramatic, musical and artistic work. For cinematographic films, copyright is granted for a certain period of time, usually for a period of 60 years from the beginning of the calendar year following the year in which such film is published, subsequent to which the work falls in the public domain and any act of reproduction of such work by any person other than the author would not amount to infringement.

India is a signatory to number of international conventions and treaties that provides for universal provisions for protection and enforcement of copyrights. In addition to above, following the issuance of the International Copyright Order, 1999, subject to certain conditions and exceptions, certain provisions of the Copyright Act apply to nationals of all member states of the World Trade Organization, the Berne Convention and the Universal Copyright Convention.

The Copyright Act was amended in 2012 to allow authors of literary and musical works (which may be included as part of a cinematograph film) to retain the right to receive royalty for the utilization of such work (other than exhibition as part of the cinematograph film in a cinema hall) as mandated by the law.

Although the state governments in India serve as the enforcing authorities of the Copyright Act, the Indian government serves an advisory role in assisting with enforcement of anti-piracy measures.

It is pertinent to note that piracy continues to be one of the major issues affecting the Indian Film Industry with an annual loss of substantial revenues, to the tune of around INR 180 billion every year. In an effort to protect their Intellectual Property rights, filmmakers in India have started getting orders typically known as “John Doe” orders from court which is a pre-infringement injunction remedy provided to protect the intellectual property rights of the creator of artistic works, including movies and songs. We obtain similar protective orders from court for our films and also engage the services of a specialized anti-piracy agency to vigilantly monitor and take down on-line pirated content from our cinematograph films.

 

Trademark protection in India

We use a number of trademarks in our business, all of which are owned by our subsidiaries. Our Indian subsidiaries currently own over 120 Indian registered trademarks and domain names, which are used in their business, including the registered trademark “Eros,” “Eros International,” “Eros Music,” and “Eros Now.” However, certain of our trademarks used in India are still under the process of registration. The registration of any trademark in India is a time-consuming process, and there can be no assurance as to when any such registration will be granted.

The Trade Marks Act, 1999, (the “Trademarks Act”), governs the registration, acquisition, transfer and infringement of trademarks and remedies available to a registered proprietor or user of a trademark. The registration of a trademark is valid for a period of ten years but can be renewed in accordance with the specified procedure. The registration of certain types of marks is prohibited, including where the mark sought to be registered is not distinctive.

Until recently, to obtain registration of a trademark in multiple countries, an applicant was required to make separate applications in different languages and countries and disburse different fees in the respective countries. However, the Madrid Protocol enables nationals of member countries, including India, to secure protection of trademarks by filing a single application with one fee and in one language in their country of origin.

In lieu of the above, the Trademarks Act was amended by the Trade Marks (Amendment) Act 2010, or (the “Trademarks Amendment Act”). The Trademarks Amendment Act empowers the Registrar of Trade Marks to deal with international applications originating from India as well as those received from the International Bureau and to maintain a record of international registrations. This amendment also removes the discretion of the Registrar of Trademarks to extend the time for filing a notice of opposition of published applications and provides for a uniform time limit of four months in all cases. Further, it simplifies the law relating to transfer of ownership of trademarks by assignment or transmission and brings the law generally in line with international practice. Pursuant to the Madrid Protocol and the Trademarks Amendment Act, we have obtained trademarks in Egypt, the European Community, United Arab Emirates, Australia and the United States.

56 

 

In order to match the international standards of trademark protection and enforcement, and to speed up the trademark registration process the Trademark Rules, 2002 were replaced by the Trademark Rules, 2017. Some notable amendments were; reduction in the number of application forms; specific concessions in filing fees to Start Ups, Individuals and Small Enterprises; expedited processing of trademark application; registration of sound marks; etc.

Remedies for Infringement in Copyright Act and Trademark Act

The remedies available in the event of infringement under the Copyright Act and the Trademarks Act include civil proceedings for damages, account of profits, injunction and the delivery of the infringing materials to the owner of the right, as well as criminal remedies including imprisonment of the accused and the imposition of fines and seizure of infringing materials.

Competition

The Indian film Industry’s has experienced robust growth over the last few years and the same is changing the competitive landscape. By opening up and relaxing the entry barriers for foreign investments in certain key areas of this industry, including the relaxation norms for the broadcasting sector (DTH, cable networks, internet & OTT Platforms etc.), the Government of India has provided the sector much needed impetus for growth. Several segments of the industry (such as broadcasting, films, sports and gaming) have especially undergone unprecedented advancements on multiple dimensions. The use of the latest technology in all phases of production, digitization and globalization of content, the availability of multiple revenue streams, financial transparency and corporatization have contributed towards the paradigm shift that the Media & Entertainment industry in India has witnessed over the last decade or so.

We believe we were one of the first companies in India to create an integrated business of sourcing new Indian film content through co-productions and acquisitions while building a valuable library of rights in existing content and also distributing Indian film content globally across formats.

Some of our direct competitors, such as Disney, 20th Century Fox Pictures and Viacom Studio 18, have moved towards similar models in addition to their other business lines within the Indian entertainment industry. We also face competition from the direct or indirect presence in India of significant global media companies, including the major Hollywood studios. Disney has acquired 100% of UTV and Viacom Inc. has ownership interests in Viacom Studio 18, while other Hollywood studios, such as News Corporation and Sony, have established local operations in India for film distribution, and have released a limited number of Indian films. Our primary competitors for Indian film content in the markets outside of India are UTV, Fox, Viacom and Yash Raj Films. We believe our experience and understanding of the Indian film market positions us well to compete with new and existing entrants to the Indian media and entertainment sector. Based on gross collections reported by comScore, our market share as an average over the preceding seven calendar years to 2018 is 24% of all theatrically released Indian language films in the United Kingdom and the U.S. Competition within the industry is based on relationships, distribution capabilities, reputation for quality and brand recognition.

Litigation

From time to time, we and our subsidiaries are involved in various lawsuits and legal proceedings that arise in the ordinary course of business. The following discussion summarizes examples of such matters. Although the results of litigation and claims cannot be predicted with certainty, we currently believe that the final outcome of these matters will not have a material adverse effect on our business. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.

Beginning on November 13, 2015, the Company was named a defendant in five substantially similar putative class action lawsuits filed in federal court in New Jersey and New York by purported shareholders of the Company. On May 17, 2016, the putative class actions filed in New Jersey were transferred to the United States District Court for the Southern District of New York where they were subsequently consolidated with the other two actions. The Court-appointed lead plaintiffs filed a single consolidated complaint on July 14, 2016 and amended on October 10, 2016. The amended consolidated complaint alleged that the Company and certain individual defendants violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, but did not assert certain claims that had been asserted in prior complaints. The remaining claims were primarily focused on whether the Company and individual defendants made material misrepresentations concerning the Company’s film library and materially misstated the usage and functionality of Eros Now, our digital OTT entertainment service. On September 25, 2017, the United States District Court for the Southern District of New York entered a Memorandum & Order dismissing the putative class action with prejudice. On October 23, 2017, lead plaintiffs filed a Notice of Appeal. On August 24, 2018, the United States Court of Appeals for the Second Circuit issued a summary order affirming the district court’s earlier dismissal, with prejudice.

57 

 

On September 29, 2017, the Company filed a lawsuit against Mangrove Partners, Manuel P. Asensio, GeoInvesting, LLC, and other individuals and entities alleging the defendants and other co-conspirators disseminated material false, misleading, and defamatory information about the Company and are engaging in other misconduct that has harmed the Company. On May 31, 2018, the Company filed an amended complaint that added two new defendants and expanded the scope of the Company’s initial allegations. The amended complaint alleges that Mangrove Partners and many of its co-conspirators held substantial short positions in the Company’s stock and profited when its share price declined in response to their multi-year disinformation campaign. The Company seeks damages and injunctive relief for defamation, civil conspiracy, and tortious interference, including but not limited to interference with its customers, producers, distributors, investors, and lenders. On March 12, 2019, the Supreme Court of the State of New York entered a Decision and Order granting defendants’ motions to dismiss. On March 13, 2019, the Company filed a Notice of Appeal. The matter is ongoing.

Beginning on June 21, 2019, the Company was named a defendant in two substantially similar putative class action lawsuits filed in federal court in New Jersey by purported shareholders of the Company. The lawsuits allege that the Company and certain individual defendants violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 by making false and/or misleading statements regarding the Company’s accounting for trade receivables. On September 27, 2019, the putative class action filed in California was transferred to the United States District Court for the District of New Jersey.  On April 14, 2020, the three putative class actions were consolidated, and a lead plaintiff was appointed. On July 1, 2020, the court-appointed lead plaintiff filed a consolidated complaint.  The consolidated complaint expands the scope of the allegations.  The Company expects to file a motion to dismiss, which is due August 28, 2020.

Eros India and its subsidiaries are involved in ordinary course government tax audits and assessments, which typically include assessment orders for previous tax years including on account of disallowance of certain claimed deductions.

Eros India and its subsidiaries received show causes notices and assessment order from Service Tax Authorities in India levying amounts to be paid on account of several grounds of non-compliance with the Service Tax Laws. An amount aggregating to $56 million (net of monies paid under protest $1.8 including interest and penalty) for the periods under dispute on account of service tax arising on temporary transfer of copyright services and certain other related matters have been considered contingent. Eros has filed an appeal against the said order before the authorities. Considering the facts and nature of levies and the ad-interim protection for service tax levy for a certain period granted by the Honorable High Court of Mumbai, the Group expects that the final outcome of this matter will be favorable. There is no further update on these matters as preliminary hearing is yet to begin. Accordingly, based on the assessment made after taking appropriate legal advice, no additional liability has been recorded in Group’s consolidated financial statements.

Eros India and its subsidiaries received several assessment orders and demand notices from value added tax and sales tax authorities in India. Several revised orders have been received during the year. Eros has considered an amount equal to $3 million (net of monies paid under protest $0.1 million and including interest and penalty) for the periods under dispute as contingent. Eros has appealed against each of the orders outstanding, and such appeals are pending before relevant tax authorities. Though, uncertainties are inherent in the final outcome of these matters, the Group believes, based on assessment made after taking legal advice, that the final outcome of the matters will be favorable. Accordingly, no additional liability has been recorded in Group’s consolidated financial statements.

Eros India and its subsidiaries received several assessment orders and demand notices from Income Tax Authorities in India. The orders are on account of disallowance of certain expenditures claimed by the Company. Eros has considered an amount equal to $0.1 million for the period under dispute as contingent. Eros has contested the said cases and believes that there will not be any significant liability on the group as the misstatements were bonafide and without any wrongful intentions and do not invite penalty. However, uncertainties are inherent in the final outcome of these matters and hence, after taking appropriate legal advice, group has considered the amount as contingent liability.

 

Eros India is also named in various lawsuits challenging its ownership of some of its intellectual property or its ability to distribute these films in India. A number of these lawsuits seek injunctive relief restraining Eros from releasing or otherwise exploiting various films, including Bhoot Returns, Goliyon Ki Rasleela-Ram-Leela, Munna Michael, Heer Ranjha (Ishak Di Misal), Sarkar 3, Bajrangi Bhaijaan, Welcome Back, and Housefull 2.

In India, private citizens are permitted to initiate criminal complaints against companies and other individuals by filing complaints or initiating proceedings with the police. Eros and certain executives have been named in certain criminal complaints from time to time.

If, as a result of such complaints, criminal proceedings are initiated by the relevant authorities in India and the Company or any of its executives are found guilty in such criminal proceedings, our executives could be subject to imprisonment as well as monetary penalties. We believe the claims brought to date are without merit and we intend to defend them vigorously.

For instance, in relation to the film Goliyon Ki Rasleela-Ram-Leela, certain civil proceedings had been initiated in various local courts in India in and around November 2013, alleging that this film disrespected religious sensibilities and seeking to restrain its release or seeking directions for a review of its film certification. We have contested such claims in the local courts as well as by way of petitions filed by us before the Supreme Court of India. While hearings continue in some of these proceedings are pending, we have obtained stay orders in our favor from the Supreme Court of India as well as certain of the local courts where such proceedings are being heard. This film was released in November 2013.

58 

 

Government Regulations

The following description is a summary of various sector-specific laws and regulations applicable to Eros.

Material Isle of Man Regulations

Companies Regime. The Isle of Man is an internally self-governing dependent territory of the British Crown. It is politically and constitutionally separate from the United Kingdom and has its own legal system and jurisprudence based on English common law principles.

Isle of Man company law is largely based on that of England and Wales. There are two separate codes of company law, embodied in the Companies Acts of 1931-2004 (commonly referred to as the 1931 Act as the principal Act is the Companies Act 1931) and the Companies Act 2006 (commonly referred to as the 2006 Act), respectively. Our Company was incorporated on March 31, 2006 under the 1931 Act. Effective September 29, 2011, it re-registered as a company incorporated under the 2006 Act.

The 2006 Act updates and modernizes Isle of Man company law by introducing a new simplified corporate vehicle into Isle of Man law. The new corporate vehicle follows the international business company model available in a number of other jurisdictions. Companies incorporated or re-registered under the 2006 Act are governed solely by its provisions and, except in relation to liquidation and receivership, are not subject to the provisions of the 1931 Act. The following are some of the key characteristics of companies incorporated under the 2006 Act:

Share Capital. Under the 2006 Act, there is no longer the concept of authorized capital. Therefore, shares may be issued with or without par value.

Dividends, Redemptions and Buy-Backs. Subject to compliance with the memorandum and articles of association, the 2006 Act allows a company to declare and pay dividends, and to purchase, redeem or otherwise acquire its own shares subject only to meeting a solvency test set out in the 2006 Act. A company satisfies the solvency test if: (i) it is able to pay its debts as they become due in the normal course of business: and (ii) the value of the company’s assets exceeds the value of its liabilities.

Capacity and Powers. Companies incorporated under the 2006 Act have separate legal personality and perpetual existence. In addition, such companies have unlimited capacity to carry on or undertake any business or activity; this is so regardless of corporate benefit and regardless of whether or not it is in the best interests of the company to do so.

The 2006 Act specifically states that no corporate act is beyond the capacity of a company incorporated under the 2006 Act by reason only of the fact that the relevant company has purported to restrict its capacity in any way in its memorandum or articles or otherwise. A person who deals in good faith with a company incorporated under the 2006 Act is entitled to assume that the directors of the company are acting without limitation.

Miscellaneous. In addition to the foregoing, the following other points should be noted in relation to companies incorporated under the 2006 Act:

  · there are no prohibitions in relation to the company providing financial assistance for the purchase of its own shares (save in relation to a public company);
  · there is no differentiation between public and private companies, but a company may adopt a name ending in the words “Public Limited Company” or “public limited company” or the abbreviation “PLC” or “plc”;
  · there are simple share offering/annual report requirements;
  · there are reduced compulsory registry filings;
  · the statutory accounting requirements are simplified; and
  · the 2006 Act allows a company to indemnify and purchase indemnity insurance for its directors. Shareholders should note that the above list is not exhaustive.

59 

 

Exchange Controls

No foreign exchange control regulations are in existence in the Isle of Man in relation to the exchange or remittance of sterling or any other currency from the Isle of Man and no authorizations, approvals or consents will be required from any authority in the Isle of Man in relation to the exchange and remittance of sterling and any other currency whether awarded by reason of a judgment or otherwise falling due and having been paid in the Isle of Man.

Material Indian Regulations

We are subject to other Indian and International regulations which may impact our business. In particular, the following regulations have a significant impact on our business.

Notification of Industry Status.

Prior to 1998, the lack of industry status barred legitimate financial institutions and private investors from financing films. However, on May 10, 1998, the Indian film industry was conferred industry status by a press release issued by the Minister of Information and Broadcasting (MIB).

Foreign direct investment (FDI) in indian media and entertainment industry

Through the liberalization of the foreign exchange regulations, the Government of India has allowed 100 percent FDI in the film sector. For the purposes of FDI, film sector broadly covers film production, exhibition, and distribution, including related services and products. FDI in the sector is permitted without any prior approval from Government of India.

However, according to the recent amendments made by the Government of India in the FDI Policy, any entity situated in or a citizen of any country sharing a land border with India, including but not limited to China, Bangladesh, Pakistan, Bhutan, Nepal, Myanmar and Afghanistan, shall be required to get a prior approval from the Government of India for making any investment(s) in any entity in India (“Government Route”). This has been done to prevent any opportunistic takeover of any domestic firms amid the ongoing COVID-19 pandemic.

Film Certification. The Cinematograph Act authorizes the Central Board of Film Certification (CBFC), in accordance with the Cinematograph (Certification) Rules, 1983, or the Certification Rules, for sanctioning films for public exhibition in India. Under the Certification Rules, the producer of a film/person exhibiting the film is required to apply in the specified format for certification of such film, with the prescribed fee. The film is examined by an examining committee, which determines whether the film:

  · is suitable for unrestricted public exhibition i.e. fit for “U” certificate; or
  · is suitable for unrestricted public exhibition, with a caution that the question as to whether any child below the age of 12 years may be allowed to see the film should be considered by the parents or guardian of such child i.e. fit for “UA” certificate; or
  · is suitable for public exhibition restricted to adults i.e. fit for “A” certificate; or
  · is suitable for public exhibition restricted to members of any profession or any class of persons having regard to the nature, content and theme of the film i.e. fit for “S” certificate; or
  · is suitable for grant of “U”, “UA” or “A” or “S” certificate, as the case may be, if a specified portion or portions be excised or modified therefrom; or
  · that the film is not suitable for unrestricted or restricted public exhibitions, or that the film be refused a certificate.

A film will not be certified for public exhibition if, in the opinion of the CBFC, the film or any part of it is against the interests of the sovereignty, integrity or security of India, friendly relations with foreign states, public order, decency or morality, or involves defamation or contempt of court or is likely to incite the commission of any offence. Any applicant, if aggrieved by any order of the CBFC either refusing to grant a certificate or granting a certificate that restricts exhibition to certain persons only, may appeal to the Film Certification Appellate Tribunal constituted by the Central Government in India under the Cinematograph Act.

A certificate granted or an order refusing to grant a certificate in respect of any film is published in the Official Gazette of India and is valid throughout India for ten years from the date of grant. Films certified for public exhibition may be re-examined by the CBFC if any complaint is received. Pursuant to grant of a certificate, film advertisements must indicate that the film has been certified for such public exhibition.

60 

 

The Central Government in India may issue directions to licensees of cinemas generally or to any licensee in particular for the purpose of regulating the exhibition of films, so that scientific films, films intended for educational purposes, films dealing with news and current events, documentary films or indigenous films secure an adequate opportunity of being exhibited.

The Central Government in India, acting through local authorities, may order suspension of exhibition of a film, if it is of the opinion that any film being publicly exhibited is likely to cause a breach of peace. Failure to comply with the Cinematograph Act may attract imprisonment and/or monetary fines.

Separately, the Cable Television Networks Rules, 1994 require that no film or film song, promotional material, trailer or film music video, album or their promotional materials, whether produced in India or abroad, shall be carried through cable services unless it has been certified by the CBFC as suitable for unrestricted public exhibition in India.

There are several draft bills proposing to replace and/or amend the Cinematograph Act which are awaiting approval.

Insolvency and Bankruptcy Code, 2016. An act to consolidate and amend the laws relating to reorganization and insolvency resolution of corporate persons, partnership firms and individuals in a time bound manner for maximization of value of assets of such persons, to promote entrepreneurship, availability of credit and balance the interests of all the stakeholders including alteration in the order of priority of payment of Government dues and to establish an Insolvency and Bankruptcy Board of India.

 

Financing. In October 2000, the Ministry of Finance, GOI notified the film industry as an industrial concern in terms of the Industrial Development Bank of India Act, 1964, pursuant to which loans and advances to industrial concerns became available to the film industry. The Reserve Bank of India, or the RBI, by circular dated May 14, 2001, permitted commercial banks to finance up to 50.0% of total production cost of a film. Further, by an RBI circular dated June 8, 2002, bank financing is now available even where total film production cost exceeds approximately $1.6 million. Banks which finance film productions customarily require borrowers to assign the film’s intellectual property or music audio/video/CDs/DVDs/internet, satellite, channel, export/international rights as part of the security for the loan, such that the banks would have a right in negotiation of valuation of such intellectual property rights.

 

Labour Laws. Depending on the nature of work and number of workers employed at any workplace, various labour related legislations may apply. Certain significant provisions of such labour related laws are provided herewith. The Employees’ Provident Fund and Miscellaneous Provisions Act, 1952, or the EPF Act, applies to factories employing 20 or more employees and such other establishments as notified by the Government from time to time. It requires all such establishments to be registered with the relevant Provident Fund Commissioner. Also, such employers are required to contribute to the employees’ provident fund the prescribed percentage of the basic wages and certain cash benefits payable to employees. Employees are also required to make equal contributions to the fund. A monthly return is required to be submitted to the relevant Provident Fund Commissioner in addition to the maintenance of registers by employers.

 

Competition Act. The Competition Act, 2002, or the Competition Act, prohibits practices that could have an appreciable adverse effect on competition in India. Under the Competition Act, any arrangement, understanding or action, whether formal or informal, which causes or is likely to cause an appreciable adverse effect on competition in India is void. Any agreement among competitors which directly or indirectly determines purchase or sale prices, results in bid rigging or collusive bidding, limits or controls production, supply, markets, technical development, investment or the provision of services, or shares the market or source of production or provision of services in any manner, including by way of allocation of geographical area or types of goods or services or number of customers in the market, is presumed to have an appreciable adverse effect on competition. Further, the Competition Act prohibits the abuse of a dominant position by any enterprise either directly or indirectly, including by way of unfair or discriminatory pricing or conditions in the sale of goods or services, using a dominant position in one relevant market to enter into, or protect, another relevant market, and denial of market access. Further, acquisitions, mergers and amalgamations which exceed certain revenue and asset thresholds require prior approval by the Competition Commission of India.

 

Under the Competition Act, the Competition Commission has powers to pass directions/impose penalties in cases of anti-competitive agreements, abuse of dominant position and combinations which are not in compliance with the Competition Act. If there is a continuing non-compliance the person may be punishable with imprisonment for a term extending up to three years or with a fine or with both as the Chief Metropolitan Magistrate, Delhi may deem fit. In case of offences committed by companies, the persons responsible to the company for the conduct of the business of the company will be liable under the Competition Act, except when the offense was committed without their knowledge or when they had exercised due diligence to prevent it. Where the contravention committed by the company took place with the consent or connivance of, or is attributable to any neglect on the part of, any director, manager, secretary or other officer of the company, such person is liable to be punished.

61 

 

The Competition Act also provides that the Competition Commission has the jurisdiction to inquire into and pass orders in relation to an anti-competitive agreement, abuse of dominant position or a combination, which even though entered into, arising or taking place outside India or signed between one or more non-Indian parties, but causes or is likely to cause an appreciable adverse effect in the relevant market in India. The Competition Act was amended in 2009, and cases which were pending before the Monopolies and Restrictive Trade Practice Commission were transferred to the Competition Commission of India.

 

Indian Takeover Regulations. The SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011 came into effect on October 22, 2011, which was last amended on August 14, 2017, superseding the earlier takeover regulations. The Takeover Regulations provide the process, timing and disclosure requirements for a public announcement of an open offer in India and the applicable pricing norms.

 

Pursuant to the Takeover Regulations, a requirement to make a mandatory open offer by an “acquirer” (together with persons acting in concert with it) for at least 26% of the total shares of the Indian listed company, to all shareholders of such company (excluding the acquirer, persons acting in concert with it and the parties to any underlying agreement including persons deemed to be acting in concert) is triggered, subject to certain exemptions including transfers between promoters, if an acquirer acquires shares or voting rights in the Indian listed company, which together with its existing holdings and those of any persons acting in concert with him entitle the acquirer and persons acting in concert to exercise 25% or more of the voting rights in the Indian listed company; or an acquirer that holds between 25% and the maximum permissible non-public shareholding of an Indian listed company, acquires additional voting rights of more than 5% during a financial year; or an acquirer acquires, directly or indirectly, control over an Indian listed company, irrespective of acquisition of shares or voting rights in the Indian listed company.

 

An acquisition of shares or voting rights in, or control over, any company that would enable a person to exercise or direct the exercise of such percentage of voting rights in, or control over, an Indian listed company, the acquisition of which would otherwise attract the obligation to make an open offer under the Takeover Regulations will also trigger a mandatory open offer under the Takeover Regulations. Where the primary target of the acquisition is an overseas parent of an Indian listed company and the Indian listed company represents over 80% of a specified materiality parameter (including asset value, revenue or market capitalization) of the overseas parent company, such acquisition would be treated as a “direct acquisition” of the Indian listed company.

 

Indian Companies Act. A majority of the provisions of the Companies Act, 2013 read with Companies (Amendment) Act 2017, bringing into effect significant changes to the Indian company law framework, such as in the provisions related to issue of capital, disclosures, corporate governance norms, audit matters, and related party transactions. The Companies Act, 2013 has also introduced additional requirements which do not have equivalents under the Companies Act, 1956, including the introduction of a provision allowing the initiation of class action suits in India against companies by shareholders or depositors, a restriction on investment by an Indian company through more than two layers of subsidiary investment companies (subject to certain permitted exceptions), and prohibitions on advances to directors. Indian companies with net worth, turnover or net profits of INR 5,000 million or higher during any financial year are also required to spend 2% of their average net profits during the three immediately preceding financial years on activities pertaining to corporate social responsibility. Further, the Companies Act, 2013 imposes greater monetary and other liability on Indian companies, their directors and officers in default, for any non-compliance.

 

62 

 

Differences in Corporate Law

 

The following chart summarizes certain material differences between the rights of holders of our A ordinary shares and the rights of holders of the common stock of a typical corporation incorporated under the laws of the State of Delaware that result from differences in governing documents and the laws of Isle of Man and Delaware.

 

    Isle of Man Law   Delaware Law
         
General Meetings  

The 2006 Act does not require a company to hold an annual general meeting of its shareholders. Subject to anything contrary in the company’s memorandum and articles of association, a meeting of shareholders can be held at such time and in such place, within or outside the Isle of Man, as the convener of the meeting considers appropriate. Under the 2006 Act, the directors of a company (or any other person permitted by the company’s memorandum and articles of association) may convene a meeting of the shareholders of a company. Further, the directors of a company must call a meeting to consider a resolution requested in writing by shareholders holding at least 10% of the company’s voting rights. The Isle of Man Court may order a meeting of members to be held and to be conducted in such manner as the Court orders, among other things, if it is of the opinion that it is in the interests of the shareholders of the company that a meeting of shareholders is held.

 

Our articles require our Board of Directors to convene annually a general meeting of the shareholders at such time and place, and to consider such business, as the Board of Directors may determine.

  Shareholders of a Delaware corporation generally do not have the right to call meetings of shareholders unless that right is granted in the certificate of incorporation or bylaws. However, if a corporation fails to hold its annual meeting within a period of 30 days after the date designated for the annual meeting, or if no date has been designated for a period of 13 months after its last annual meeting, the Delaware Court of Chancery may order a meeting to be held upon the application of a shareholder.
         
Quorum Requirements for General Meetings   The 2006 Act provides that a quorum at a general meeting of shareholders may be fixed by the articles. Our articles provide a quorum required for any general meeting consists of shareholders holding at least 30% of the issued share capital of the Company.   A Delaware corporation’s certificate of incorporation or bylaws can specify the number of shares that constitute the quorum required to conduct business at a meeting, provided that in no event will a quorum consist of less than one-third of the shares entitled to vote at a meeting.
         
Board of Directors   Our articles provide that unless and until otherwise determined by our Board of Directors, the number of directors will not be less than three or more than twelve, with the exact number to be set from time to time by the Board of Directors. While there is no concept of dividing a board of directors into classes under Isle of Man law, there is nothing to prohibit a company from doing so. Consequently, under our articles, our Board of Directors is divided into three classes, each as nearly equal in number as possible and at each annual general meeting, each of the directors of the relevant class the term of which shall then expire shall be eligible for re-election to the Board of Directors for a period of three years.   A typical certificate of incorporation and bylaws would provide that the number of directors on the board of directors will be fixed from time to time by a vote of the majority of the authorized directors. Under Delaware law, a board of directors can be divided into up to three classes.
         

 

63 

 
    Isle of Man Law   Delaware Law
         
Removal of Directors  

Under Isle of Man law, notwithstanding anything in the memorandum or articles or in any agreement between a company and its directors, a director may be removed from office by way of shareholder resolution. Such resolution may only be passed (a) at a meeting of the shareholders called for such purposes including the removal of the director or (b) by a written resolution consented to by a shareholder or shareholders holding at least 75% of the voting rights.

 

The 2006 Act provides that a director may be removed from office by a resolution of the directors if the directors are expressly given such authority in the memorandum or articles, but our articles do not provide this authority.

  A typical certificate of incorporation and bylaws provide that, subject to the rights of holders of any preferred stock, directors may be removed at any time by the affirmative vote of the holders of at least a majority, or in some instances a supermajority, of the voting power of all of the then outstanding shares entitled to vote generally in the election of directors, voting together as a single class. A certificate of incorporation could also provide that such a right is only exercisable when a director is being removed for cause (removal of a director only for cause is the default rule in the case of a classified board).
         
Vacancy of Directors  

Subject to any contrary provisions in a company’s memorandum or articles of association, a person may be appointed as a director (either to fill a vacancy or as an additional director) by a resolution of the directors or by a resolution of the shareholders.

 

Our articles provide that any vacancy resulting from, among other things, removal, resignation, conviction and disqualification, may be filled by another person willing to act as a director by way of shareholder resolution or resolution of our Board of Directors. Any director appointed by the Board of Directors will hold office only until the next annual general meeting of the Company, when he will be subject to retirement or re-election.

  A typical certificate of incorporation and bylaws provide that, subject to the rights of the holders of any preferred stock, any vacancy, whether arising through death, resignation, retirement, disqualification, removal, an increase in the number of directors or any other reason, may be filled by a majority vote of the remaining directors, even if such directors remaining in office constitute less than a quorum, or by the sole remaining director. Any newly elected director usually holds office for the remainder of the full term expiring at the annual meeting of shareholders at which the term of the class of directors to which the newly elected director has been elected expires.
         
Interested Director
Transactions
  Under Isle of Man law, as soon as a director becomes aware of the fact that he is interested in a transaction entered into or to be entered into by the company, he must disclose this interest to the board of directors. Our articles provide that no director may participate in approval of a transaction in which he or she is interested.   Under Delaware law, some contracts or transactions in which one or more of a Delaware corporation’s directors has an interest are not void or voidable because of such interest provided that some conditions, such as obtaining the required approval and fulfilling the requirements of good faith and full disclosure, are met. For an interested director transaction not to be voided, either the shareholders or the board of directors must approve in good faith any such contract or transaction after full disclosure of the material facts or the contract or transaction must have been “fair” as to the corporation at the time it was approved. If board or committee approval is sought, the contract or transaction must be approved in good faith by a majority of disinterested directors after full disclosure of material facts, even though less than a majority of a quorum.
         

 

64 

 
    Isle of Man Law   Delaware Law
         
Cumulative Voting   There is no concept of cumulative voting under Isle of Man law.   Delaware law does not require that a Delaware corporation provide for cumulative voting. However, the certificate of incorporation of a Delaware corporation may provide that shareholders of any class or classes or of any series may vote cumulatively either at all elections or at elections under specified circumstances.
         
Shareholder Action
Without a Meeting
  A written resolution will be passed if it is consented to in writing by shareholders holding in excess of 50% or 75% in the case of a special resolution of the rights to vote on such resolution. The consent may be in the form of counterparts, and our articles provide that, in such circumstances, the resolution takes effect on the earliest date upon which shareholders holding a sufficient number of votes to constitute a resolution of shareholders have consented to the resolution in writing. Any holder of B ordinary shares consenting to a resolution in writing is first required to certify that it is a permitted holder as defined in our articles. If any written resolution of the shareholders of the company is adopted otherwise than by unanimous written consent, a copy of such resolution must be sent to all shareholders not consenting to such resolution upon it taking effect.   Unless otherwise specified in a Delaware corporation’s certificate of incorporation, any action required or permitted to be taken by shareholders at an annual or special meeting may be taken by shareholders without a meeting, without notice and without a vote, if consents, in writing, setting forth the action, are signed by shareholders with not less than the minimum number of votes that would be necessary to authorize the action at a meeting at which all shares entitled to vote were present and voted. All consents must be dated. No consent is effective unless, within 60 days of the earliest dated consent delivered to the corporation, written consents signed by a sufficient number of holders to take the action are delivered to the corporation.
         
Business
Combinations
  Under Isle of Man law, a merger or consolidation must be approved by, among other things, the directors of the company and by shareholders holding at least 75% of the voting rights. A scheme of arrangement (which includes, among other things, a sale or transfer of the assets of the company) must be approved by, among other things, the directors of the company, a 75% shareholder majority and also requires the sanction of the court.   With certain exceptions, a merger, consolidation or sale of all or substantially all the assets of a Delaware corporation must be approved by the board of directors and a majority (unless the certificate of incorporation requires a higher percentage) of the outstanding shares entitled to vote thereon.
         
Interested
Shareholders
  There are no equivalent provisions under Isle of Man law relating to interested shareholders.   Section 203 of the Delaware General Corporation Law generally prohibits a Delaware corporation from engaging in specified corporate transactions (such as mergers, stock and asset sales and loans) with an “interested shareholder” for three years following the time that the shareholder becomes an interested shareholder. Subject to specified exceptions, an “interested shareholder” is a person or group that owns 15% or more of the corporation’s outstanding voting stock (including any rights to acquire stock pursuant to an option, warrant, agreement, arrangement or understanding, or upon the exercise of conversion or exchange rights, and stock with respect to which the person has voting rights only), or is an affiliate or associate of the corporation and was the owner of 15% or more of the voting stock at any time within the previous three years.

 

65 

 
    Isle of Man Law   Delaware Law
         
        A Delaware corporation may elect to “opt out” of, and not be governed by, Section 203 through a provision in either its original certificate of incorporation or its bylaws, or an amendment to its original certificate or bylaws that was approved by majority shareholder vote. With a limited exception, this amendment would not become effective until 12 months following its adoption.
         
Limitations on Personal
Liability of Directors
  Under Isle of Man law, a director who vacates office remains liable under any provisions of the 2006 Act that impose liabilities on a director in respect of any acts or omissions or decisions made while that person was a director.   A Delaware corporation may include in its certificate of incorporation provisions limiting the personal liability of its directors to the corporation or its shareholders for monetary damages for many types of breach of fiduciary duty. However, these provisions may not limit liability for any breach of the duty of loyalty, acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law, the authorization of unlawful dividends, shares repurchases or shares barring redemptions, or any transaction from which a director derived an improper personal benefit. A typical certificate of incorporation would also provide that if Delaware law is amended so as to allow further elimination of, or limitations on, director liability, then the liability of directors will be eliminated or limited to the fullest extent permitted by Delaware law as so amended. However, these provisions would not be likely to bar claims arising under U.S. federal securities laws.
         
Indemnification of
Directors and Officers
 

A company may indemnify against all expenses, any person who is or was a party, or is threatened to be made a party to any civil, criminal, administrative or investigative proceedings (threatened, pending or completed), by reason of the fact that the person is or was a director of the company, or who is or was, at the request of the company, serving as a director or acting for another company.

 

Any indemnity given will be void and of no effect unless such person acted honestly and in good faith and in what such person believed to be in the best interests of the company and, in the case of criminal proceedings, had no reasonable cause to believe that the conduct of such person was unlawful.

  Under Delaware law, subject to specified limitations in the case of derivative suits brought by a corporation’s shareholders in its name, a corporation may indemnify any person who is made a party to any third party action, suit or proceeding on account of being a director, officer, employee or agent of the corporation (or was serving at the request of the corporation in such capacity for another corporation, partnership, joint venture, trust or other enterprise) against expenses, including attorney’s fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by him or her in connection with the action, suit or proceeding through, among other things, a majority vote of directors who were not parties to the suit or proceeding (even though less than a quorum), if the person:
         

 

66 

 
    Isle of Man Law   Delaware Law
         
       

·     acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the corporation or, in some circumstances, at least not opposed to its best interests; and

 

·     in a criminal proceeding, had no reasonable cause to believe his or her conduct was unlawful.

 

Delaware law permits indemnification by a corporation under similar circumstances for expenses (including attorneys’ fees) actually and reasonably incurred by such persons in connection with the defense or settlement of a derivative action or suit, except that no indemnification may be made in respect of any claim, issue or matter as to which the person is adjudged to be liable to the corporation unless the Delaware Court of Chancery or the court in which the action or suit was brought determines upon application that the person is fairly and reasonably entitled to indemnity for the expenses which the court deems to be proper.

 

To the extent a director, officer, employee or agent is successful in the defense of such an action, suit or proceeding, the corporation is required by Delaware law to indemnify such person for reasonable expenses incurred thereby. Expenses (including attorneys’ fees) incurred by such persons in defending any action, suit or proceeding may be paid in advance of the final disposition of such action, suit or proceeding upon receipt of an undertaking by or on behalf of that person to repay the amount if it is ultimately determined that that person is not entitled to be so indemnified.

         
Appraisal Rights   There is no concept of appraisal rights under Isle of Man law.   A shareholder of a Delaware corporation participating in certain major corporate transactions may, under certain circumstances, be entitled to appraisal rights pursuant to which the shareholder may receive cash in the amount of the fair value of the shares held by that shareholder (as determined by a court) in lieu of the consideration the shareholder would otherwise receive in the transaction.

 

67 

 
    Isle of Man Law   Delaware Law
         
Shareholder Suits  

The Isle of Man Court may, on application of a shareholder, permit that shareholder to bring proceedings in the name and on behalf of the company (including intervening in proceedings to which the company is a party). In determining whether or not leave is to be granted, the Isle of Man Court will take into account such things as whether the shareholder is acting in good faith and whether the Isle of Man Court itself is satisfied that it is in the interests of the company that the conduct of the proceedings should not be left to the directors or to the determination of the shareholders as a whole.

 

Under Isle of Man law, a shareholder may bring an action against the company for a breach of a duty owed by the company to such shareholder in that capacity.

  Under Delaware law, a shareholder may bring a derivative action on behalf of the corporation to enforce the rights of the corporation, including for, among other things, breach of fiduciary duty, corporate waste and actions not taken in accordance with applicable law. An individual also may commence a class action suit on behalf of himself or herself and other similarly situated shareholders where the requirements for maintaining a class action under Delaware law have been met. A person may institute and maintain such a suit only if such person was a shareholder at the time of the transaction which is the subject of the suit or his or her shares thereafter devolved upon him or her by operation of law. Additionally, under established Delaware case law, the plaintiff generally must be a shareholder not only at the time of the transaction which is the subject of the suit, but also through the duration of the derivative suit. Delaware law also requires that the derivative plaintiff make a demand on the directors of the corporation to assert the corporate claim before the suit may be prosecuted by the derivative plaintiff, unless such demand would be futile. In such derivative and class actions, the court has discretion to permit the winning party to recover attorneys’ fees incurred in connection with such action.
         
Inspection of Books and
Records
 

Upon giving written notice, a shareholder is entitled to inspect and to make copies of (or obtain extracts of) the memorandum and articles and any of the registers of shareholders, directors and charges. A shareholder may only inspect the accounting records (and make copies or take extracts thereof) in certain circumstances.

 

Our articles provide that no shareholder has any right to inspect any accounting record or other document of the company unless he is authorized to do so by statute, by order of the Isle of Man Court, by our Board of Directors or by shareholder resolution.

  All shareholders of a Delaware corporation have the right, upon written demand, to inspect or obtain copies of the corporation’s shares ledger and its other books and records for any purpose reasonably related to such person’s interest as a shareholder.

 

68 

 
    Isle of Man Law   Delaware Law
         
Amendment of Governing
Documents
  Under Isle of Man law, the shareholders of a company may, by resolution, amend the memorandum and articles of the company. The memorandum and articles of a company may authorize the directors to amend the memorandum and articles, but our memorandum and articles do not contain any such power. Our memorandum of association provides that our memorandum of association and articles of association may be amended by a special resolution of shareholders.   Under Delaware law, amendments to a corporation’s certificate of incorporation require the approval of shareholders holding a majority of the outstanding shares entitled to vote on the amendment. If a class vote on the amendment is required by Delaware law, a majority of the outstanding stock of the class is required, unless a greater proportion is specified in the certificate of incorporation or by other provisions of Delaware law. Under Delaware law, the board of directors may amend bylaws if so authorized in the certificate of incorporation. The shareholders of a Delaware corporation also have the power to amend bylaws.
         
Dividends and
Repurchases
 

The 2006 Act contains a statutory solvency test. A company satisfies the solvency test if it is able to pay its debts as they become due in the normal course of its business and where the value of the company’s assets exceeds the value of its liabilities.

 

Subject to the satisfaction of the solvency test and any contrary provision contained in a company’s articles, a company may, by a resolution of the directors, declare and pay dividends. Our articles provide that where the solvency test has been satisfied, our Board of Directors may declare and pay dividends (including interim dividends) out of our profits to shareholders according to their respective rights and interests in the profits of the company.

 

Under Isle of Man law, a company may purchase, redeem or otherwise acquire its own shares for any consideration, subject to, among other things, satisfaction of the solvency test.

 

Delaware law permits a corporation to declare and pay dividends out of statutory surplus or, if there is no surplus, out of net profits for the fiscal year in which the dividend is declared and/or for the preceding fiscal year as long as the amount of capital of the corporation following the declaration and payment of the dividend is not less than the aggregate amount of the capital represented by the issued and outstanding stock of all classes having a preference upon the distribution of assets.

 

Under Delaware law, any corporation may purchase or redeem its own shares, except that generally it may not purchase or redeem those shares if the capital of the corporation is impaired at the time or would become impaired as a result of the redemption. A corporation may, however, purchase or redeem capital shares that are entitled upon any distribution of its assets to a preference over another class or series of its shares if the shares are to be retired and the capital reduced.

 

Changes in Capital

 

The conditions in our articles of association governing changes in capital are not more stringent than as required under the 2006 Act. Our articles of association provide that our directors may, by resolution, alter our share capital. The 2006 Act subjects any reduction of share capital to the statutory solvency test. The 2006 Act provides that a company satisfies the solvency test if it is able to pay its debts as they become due in the normal course of the company’s business and where the value of the company’s assets exceeds the value of its liabilities.

 

C. Organizational Structure

 

We conduct our global operations through our Indian and international subsidiaries, including our majority-owned subsidiary Eros International Media Limited, or Eros India, a public company incorporated in India and listed on the BSE Limited and National Stock Exchange of India Limited, or the Indian Stock Exchanges. Our agent for service of process in the United States is Prem Parameswaran, located at 550 County Avenue, Secaucus, New Jersey.

 

As of July 27, 2020, the Founders Group holds approximately 13.4% of our issued share capital, which comprise all of our B ordinary shares and certain A ordinary shares. Beech Investments Limited, a company incorporated in the Isle of Man, is owned by discretionary trusts that include Eros director Kishore Lulla as a potential beneficiary.

69 

 

The following diagram summarizes the corporate structure of our consolidated group of companies as of July 27, 2020:

 

Eros Organizational Chart (as of July 27, 2020)

 

 

  (a) Eros India holds 100% of each of its Indian subsidiaries other than Big Screen Entertainment Private Limited (India) and Colour Yellow Productions Private Limited (India), and Eros International Distribution LLP.

70 

 

D. Property and Equipment

 

Our properties consist primarily of studios, office facilities, warehouses and distribution offices, most of which are located in Mumbai, India. We own our corporate and registered offices in Mumbai and rent our remaining properties in India. Four of these leased properties are owned by members of the Lulla family. The leases with the Lulla family were entered into at what we believe were market rates. See “Part I. — Item 7. Major Shareholders and Related Party Transactions” and “Part I — Item 3. Key Information — D. Risk Factors. We have entered into certain related party transactions and may continue to rely on our founders for certain key development and support activities.” We also own or lease five properties in the United Kingdom, the United States and Dubai in connection with our international operations outside of India. Property and equipment with a net carrying amount of approximately $8.2 million (2019: $6.7 million) have been pledged to secure borrowings, and we currently do not have any significant plans to construct new properties or expand or improve our existing properties.

 

The following table provides detail regarding our properties in India and globally.

 

Location Size Primary Use Leased / Owned
Mumbai, India 13,992 sq. ft. Corporate Office Owned
Mumbai, India 2,750 sq. ft. Studio Premises Leased(1)
Mumbai, India 8,094 sq. ft. Executive Accommodation Leased(1)
Mumbai, India 17,120 sq. ft. Office Leased(1)
Mumbai, India 1,000 sq. ft. Film Negatives Warehouse Leased
Mumbai, India 100 sq. ft. Film Prints Warehouse Leased
Mumbai, India 2,750 sq. ft. Corporate Owned
Mumbai, India 900 sq. ft. Film Prints Warehouse Leased
Mumbai, India 1200 sq. ft. Film Prints Warehouse Leased
Delhi, India 600 sq. ft. Film Distribution Office Leased
Punjab, India 438 sq. ft. Film Distribution Office Leased
Bihar, India 633 sq. ft Film Distribution Office Leased
Chennai, India 841 sq. ft. Branch Office Leased
Mumbai, India 4,610 sq. ft. Executive Accommodation Leased(1)
Delhi, India 994 sq. ft. Branch Office Leased
Dubai, United Arab Emirates 2,473 sq. ft. Corporate Office Leased
Dubai, United Arab Emirates 2,473 sq. ft Corporate Office Leased
London, England 7,549 sq. ft. DVD Warehouse Owned
Secaucus, New Jersey, U.S. 900 sq. ft. Corporate Office Leased
San Francisco, California, U.S. 2,315 sq. ft. Digital Team Leased

 

(1) Leased directly or indirectly from a member of the Lulla family.

 

ITEM 4A. UNRESOLVED STAFF COMMENTS

 

Not applicable.

 

ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS

 

A. Operating Results

 

You should read the information contained in the table below in conjunction with our audited consolidated financial statements and the related notes included elsewhere in this annual report. The tables set forth below with our results of operations and period over period comparisons are not adjusted for the fluctuations in exchange rates described in “Part I — Item 3. Key Information — A. Selected Financial Data.”

71 

 

OUTLOOK

 

Our primary revenue streams are derived from three channels: theatrical, television syndication and digital and ancillary. For the fiscal year 2020, the aggregate revenues from theatrical, television syndication and digital and ancillary were $10.6 million, $7.1 million and $137.8 million, respectively. For the fiscal year 2019, the aggregate revenues from theatrical, television syndication and digital and ancillary were $69.5 million, $77.5 million and $123.1 million, respectively.

 

The contribution from these three distribution channels can fluctuate year over year and period over period based on, among other things, our mix of films and budget levels, the size of our television syndication deals, the growth of the user base of our Eros Now OTT platform and other factors:

· Theatrical: Theatrical revenue largely includes revenues from multiplex cinema chains, single screen theaters and distributors situated in India. We anticipate that, as additional multiplex theaters are built in India, there will be increased opportunities to exploit our film content theatrically. Growth in multiplex cinema screens in India combined with an increase in average ticket prices will be the key drivers for future revenue growth. In addition, in India, we cannot predict the share of theatrical revenue we will receive, as we currently negotiate film-by-film and exhibitor-by-exhibitor. With a focus on creating intellectual property in-house along with delivering wholesome entertainment to audiences, we have entered into key co-production partnerships with writers, producers and directors. This co-production model gives us better visibility on actual cost of production ensuring capped budgets and exclusive long-term distribution rights.

We also believe China to be a significant market opportunity and currently growing our presence in China through theatrical and distribution of our films. According to the PwC Global Entertainment & Media Outlook 2019 China was the world’s second largest box-office market with revenue of $11.0 billion in 2019. In March 2018, we released Bajrangi Bhaijan across more than 8,000 screens, including in China, and collected over $45 million at the box office in China since its release, which we believe indicates a clear interest in Indian films by Chinese movie goers. We have also entered into film co-production arrangements with several well-established Chinese film companies and we also released Andhadhun in China in April 2019 which collected over $43 million in the Chinese box office in less than four weeks.

In addition to our global expansion, we expect to increase the number of Tamil and Telugu global releases in our film mix, which will allow us to expand our audience within significant regional markets in India. As we expand into other regional languages such as Marathi, Bengali, Punjabi and Malayalam, we may see the composition of our film mix changing over time in order to allow us to successfully scale our business around Hindi as well as regional language content. At the same time, the distribution window for the theatrical release of films, and the window between the theatrical release and distribution in other channels, have each been compressing in recent years and may continue to evolve due to the growing importance of digital distribution.

· Television Syndication: A substantial portion of our revenue is also derived from licensing fees for television syndication of content to media companies such as satellite television broadcasters, direct-to-home channels and regional cable operators. Because of increased demand for Indian film content on television in India as the number of direct-to-home subscribers increases and the cable industry migrates towards digital technology, we expect demand for premium content such as movies to continue. However, as competitors with compelling products, including international content providers, expand their content offerings in India, we expect competition for television syndication revenues to increase, and license fees for such content could decrease as a result.

 

72 

 
· Digital and Ancillary: The remainder of our revenue is derived from digital distribution and ancillary products and services, which was our fastest growing revenue channel and we anticipate it will be a principal driver of our revenue growth for the foreseeable future. With a significant portion of the Indian and international population moving towards adoption of digital technology, we are increasing our focus on Eros Now, which leverages its extensive digital film and music libraries to stream a wide range of content. Users can access Eros Now through APPs, WAP and the internet in India and around the world, and we have partnerships with the major mobile network providers in India and several other countries, as well as television and mobile handset OEMs, to offer Eros Now to their subscribers. Eros Now is also available in the Apple “App Store” and Google “Play Store” for download and can be streamed on any internet enabled device, which makes the entertainment experience platform agnostic. We also recently announced our arrangement with Apple to make Eros Now content available on its new Apple TV app. Our OEM partners also include major device manufacturers such as Sony and Samsung.

Eros Now has been increasingly focused on delivering product features to further monetize its growing registered user base. For example, we recently launched Eros Now Quickie, a platform where viewers can access quality short stories to further supplement our existing vast digital content library. During fiscal year 2020 we announced a transformational alliance between Eros Now and YouTube Music Premium. This was the first time ever, in any geography, that Google/YouTube had partnered with a SVOD OTT player for a joint bundling and marketing opportunity. In addition, Eros Now developed the customer journey to provision access to both products and leveraged our new payment funnel. The campaign was supported by a robust digital marketing push from both sides.

Ancillary revenues also include all other revenues that are not theatrical or television, including licensing to airlines and cable operators, as well as provisioning of VFX (visual special effects) support to customers.

We expect that our costs associated with the co-production and acquisition of film and digital original content are likely to increase over time as we continue to focus on making content-driven films and originals with appropriate budgets in order to generate an attractive rate of return. In addition, increased competition in the Indian film entertainment industry, including from international film entertainment providers, is likely to cause the cost of film production and acquisition to increase.

 

In fiscal year 2020, we invested $265.3 million (of which cash outflow is $132.2 million) in film content and fiscal year 2021, we expect to invest approximately $150 to $160 million in film content.

 

We anticipate our administrative costs will increase as we expand our management team, especially to support the expansion of our digital businesses. Although aggregate spending will increase, we do not anticipate that this will result in a material change in aggregate administrative costs as a percentage of revenue.

 

Going forward, along with our industry peers, we have started to consider changes to various operational and legal aspects of the business, such as project timelines, production costs, schedules, legal commitments etc, in order to adapt to changes and disruptions caused by the COVID-19 pandemic to our industry. Our OTT platform Eros Now, for which the majority of the content library comprises our own existing content and acquired content, has also started considering innovative ways of updating its existing content libraries. Given the rise in demand for content and increasing online viewership, and the disruption in production of new content, existing content is likely to become more valuable in the future which will benefit us.

 

We believe, but cannot guarantee, that the cinematic exhibition industry will ultimately rebound and benefit from pent-up social demand for out-of-home entertainment, as government restrictions are lifted and home sheltering subsides. However, the ultimate significance of the pandemic, including the extent of the adverse impact on our financial and operational results, will be dictated by the currently unknowable duration and the effect on the overall economy and of responsive governmental regulations, including shelter-in-place orders of the pandemic and mandated suspension of operations.

 

During the period from March 31st, 2020 to June 30th, 2020, we had several theatrical film releases scheduled in India and overseas, namely ‘Haathi Mere Saathi’ in three languages (Hindi, Tamil and Telugu), ‘Roam Rome Mein’ (Hindi) and ‘Shokuner Lobh’ (Bengali) amongst others. However, under the present circumstances of the COVID-19 pandemic, we have taken the decision to defer the release of these films indefinitely until the situation changes, so that the revenue opportunities from these films can be maximized and improve our cashflows to better serve our commitments to our stakeholders.

73 

 

SIGNIFICANT ACCOUNTING POLICIES

Overall considerations

 

The significant accounting policies that have been used in the preparation of these consolidated financial statements are summarized below. Financial statements are subject to the application of significant accounting estimates and judgments. These are summarized in Note 37.

 

Significant new accounting pronouncements

  

Adoption of IFRS 16, "Leases"

On April 1, 2019, the Group adopted New accounting standard IFRS 16, "Leases". which specifies how to recognize, measure, present and disclose leases. The standard provides a single accounting model, requiring the recognition of assets and liabilities for all major leases previously classified as “operating leases”.

 

The Company applied the “Modified Retrospective Approach” on the date of initial application (April 1, 2019) and made cumulative adjustments to retained earnings. Accordingly, comparatives for the year ended March 31, 2019 have not been retrospectively adjusted.

 

As such the Company recognizes a lease liability and a corresponding right of use asset, at the lease commencement date. The right-of-use asset is initially measured at cost, based on the initial amount of the lease liability. The assets are depreciated to the earlier of the end of the useful life of the right-of-use asset or the lease term using the straight-line method as this most closely reflects the expected pattern of consumption of the future economic benefits. The lease term includes periods covered by an option to extend if the Company is reasonably certain to exercise that option. In addition, the right-of-use asset is periodically adjusted for certain re-measurements of the lease liability. There is no impact on transition in opening balance of retained earnings as at April 1, 2019 because of the transition method applied. Further comparatives were not restated.

 

Basis of consolidation

 

The consolidated financial statements of the Group consolidates results of the Company and entities controlled by the Company and its subsidiary undertakings. The Group controls an entity where the group is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power to direct the activities of the entity. Subsidiaries are fully consolidated from the date on which control is transferred to the group. They are deconsolidated from the date that control ceases.

 

Inter-company transactions, balances and unrealized gains on transactions between Group companies are eliminated. Unrealized losses are also eliminated unless the transaction provides evidence of an impairment of the transferred asset. Amounts reported in the financial statements of subsidiaries have been adjusted where necessary to ensure consistency with the accounting policies adopted by the Group.

 

Business combinations are accounted for under the acquisition method. The acquisition method involves the measurement of all identifiable assets acquired and liabilities and contingent liabilities assumed, in the business combination at their fair values at the acquisition date, regardless of whether or not they were recorded in the financial statements of the acquiree prior to acquisition. On initial recognition, the assets and liabilities of the subsidiary are included in the consolidated statement of financial position at their fair values. Transaction costs that the company incurs in connection with a business combination such as finder’s fees, legal fees, due diligence fees, and other professional and consulting fees are expensed as incurred. The excess of consideration transferred, amount of non-controlling interest in the acquired entity and acquisition date fair value of any previous equity interest in the acquired entity over the fair value of the net identifiable assets acquired is recorded as goodwill. If those amounts are less than the fair value of the net identifiable assets of the business acquired, the difference is recognised directly in profit or loss as a bargain purchase.

 

74 

 

Changes in ownership interests

The group treats transactions with non-controlling interests that do not result in a loss of control as transactions with equity owners of the group. A change in ownership interest results in an adjustment between the carrying amounts of the controlling and non-controlling interests to reflect their relative interests in the subsidiary. Any difference between the amount of the adjustment to non-controlling interests and any consideration paid or received is recognised in a separate reserve within equity attributable to owners of the Company

 

When the group ceases to consolidate the subsidiary because of a loss of control, any retained interest in the entity is remeasured to its fair value, with the change in carrying amount recognised in profit or loss. This fair value becomes the initial carrying amount for the purposes of subsequently accounting for the retained interest as an associate, joint venture or financial asset. In addition, any amounts previously recognised in other comprehensive income in respect of that entity are accounted for as if the group had directly disposed of the related assets or liabilities. This may mean that amounts previously recognised in other comprehensive income are reclassified to profit or loss.

 

Segment reporting

 

IFRS 8 Operating Segments (“IFRS 8”) requires operating segments to be identified on the same basis as is used internally for the review of performance and allocation of resources by the Group’s chief operating decision maker, which is the Group’s CEO and MD. The revenues of films are earned over various formats; all such formats are functional activities of filmed entertainment and these activities take place on an integrated basis. The management team reviews the financial information on an integrated basis for the Group as a whole. The management team also monitors performance separately for individual films for at least 12 months after the theatrical release. Certain resources such as publicity and advertising, and the cost of a film are also reviewed globally.

 

Eros has identified four geographic areas, consisting of its main geographic areas (India, North America and Europe), together with the rest of the world.

 

Revenue

 

Revenue from contracts are recognized only when the contract has been approved by the parties to the contract and creates enforceable rights and obligations.

 

Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration which the Group expects to receive in exchange for those products or services. To ensure collectability of such consideration and financial stability of the counterparty, the Group performs certain standard Know Your Client (KYC) procedures based on their geographic locations and evaluates trend of past collection from such locations.

 

Revenue is measured based on the transaction price, which is the consideration, adjusted for any discounts and incentives, if any, as specified in the contract with the customer. Revenue also excludes taxes collected from customers. In case of variable consideration , the Group estimates, at the contract inception, the amount to be received using the “most likely amount” approach, or the “expected value” approach, as appropriate. This amount is then included in the Group’s estimate of the transaction price only if it is highly probable that a significant reversal of revenue will not occur once any uncertainty associated with the variable consideration is resolved. In making this assessment the Group considers its historical performance on similar contracts.

 

The Group recognises contract liabilities for consideration received in respect of unsatisfied performance obligations and reports these amounts as other liabilities in the statement of financial position (see Note 24). Similarly, if the Group satisfies a performance obligation before it receives the consideration, the Group recognises either a contract asset or a receivable in its statement of financial position, depending on whether something other than the passage of time is required before the consideration is due

 

The transaction price, being the amount to which the Group expects to be entitled and has rights to under the contract is allocated to the identified performance obligations. The transaction price will also include an estimate of any variable consideration where the Group’s performance may result in additional revenues based on the achievement of agreed targets.

 

The following criteria apply in respect of various revenue streams within filmed entertainment:

 

  · In arrangements for theatrical distribution, contracted minimum guarantees are recognized on the theatrical release date. The Group’s share of box office receipts in excess of the minimum guarantee is recognized at the point as the box office receipts gets accrued.

75 

 
  · In arrangements for television syndication, license fees received in advance which do not meet all the above criteria, including commencement of the availability for broadcast under the terms of the related licensing agreement, are included in contract liability until the criteria for recognition is met.  Further in arrangements where the license fees received in advance is for a period of 12 months or more from the commencement, the company computes significant discounting component at imputed rate of interest on advances received and recognizes within net finance cost in the statement of income.  Accumulated contract liability (deferred revenue) is recognized upon commencement of availability for broadcast.
  · In arrangements for catalogue sales, the Group recognizes revenue if revenue recognition criteria’s such as a valid sales contract exists, all content is delivered and the customer start generating economic benefits from them, the Group is reasonably certain on collectability, and the Group’s contractual obligations are complete and are met. Considering the arrangement with catalogue customers provide for a contractual deferred payment terms up to a year and in many cases the payments often fall behind contractual terms, revenues from catalogue sales are recognized net of financing component calculated at imputed market rate of interest on the gross receivables. The re-measurement of such financing period at each balance sheet date and related gains or losses is recognized within administrative costs in the Statement of Income. The unwinding of the such discount is recognized using effective interest rate within net finance cost in the Statement of Income.
  · Digital and ancillary media revenues are recognized at the earlier of when the content is accessed or declared. Fees received for access to the specified and unspecified future content through digital and ancillary media, including usage of over-the-top platform developed by the Group, is recognized on straight line basis over the period of the service contract. Billing in excess of the revenue recognized is shown as contract liability.
  · DVD, CD and video distribution revenue is recognized on the date the product is delivered or if licensed in line with the above criteria. Visual effects, production and other fees for services rendered by the Group and overhead recharges are recognized in the period in which they are earned and in certain cases, the stage of production is used to determine the proportion recognized in the period.
  · In arrangement for production services, including visual special effects (VFX), and other technical services to clients, the Group recognizes revenue if revenue recognition criteria's such as a valid sales contract exists, IP is delivered and the Group is reasonably certain on collectability. Revenue is recognized as the services are delivered based on acceptance of the services performed by the customer.

 

Other income

 

Dividend income is recognised when the Group’s right to receive the payment is established, which is generally when shareholders approve the dividend.

 

Interest income is recognized on a time proportion basis taking into account the amount outstanding and the effective interest rate applicable

 

Intangible assets

 

Intangible assets acquired by the Group are stated at cost less accumulated amortization less impairment loss, if any, except those acquired as part of a business combination, which are shown at fair value at the date of acquisition less accumulated amortization less impairment loss, if any (Film production cost and content advances are transferred to film and content rights at the point at which content is first exploited). “Eros” (the “Trade name”) is considered to have an indefinite life because of the institutional nature of the corporate brand name, its proven ability to maintain market leadership and the Group’s commitment to develop, enhance and retain its value.

 

Content

 

Investments in films and associated rights, including acquired rights and distribution advances in respect of completed films, are stated at cost less amortization less provision for impairment. Costs include production costs, overhead and capitalized interest costs net of any amounts received from third party investors. A charge is made to write down the cost of completed rights over the estimated useful lives, writing off more in year one which recognizes initial income flows and then the balance over a period of up to nine years, except where the asset is not yet available for exploitation. The average life of the assets is the lesser of 10 years or the remaining life of the content rights. The amortization charge is recognized in the consolidated statement of income within cost of sales. The determination of useful life is based upon management’s judgment and includes assumptions on the timing and future estimated revenues to be generated by these assets, which are summarized in Note 37.3.

76 

 

Others

 

Other intangible assets, which comprise internally generated and acquired software used within the Group’s digital, home entertainment and internal accounting activities, are stated at cost less amortization less provision for impairment. A charge is made to write down the cost of completed rights over the estimated useful lives except where the asset is not yet available for exploitation. The average life of below intangible assets ranges from 3-6 years. The amortization charge is recognized in the consolidated statements of income within administrative expenses as stated below:

 

    Life of asset   Rate of
amortization
% straight line
per annum
Information technology assets   3 years   33
Other intangibles   3 - 6 years   17 – 33

 

Subsequent expenditure

 

Expenditure on capitalized intangible assets subsequent to the original expenditure is included only when it increases the future economic benefits embodied in the specific asset to which it relates.

 

Information technology assets

 

An internally generated intangible asset arising from the Group’s software development activities that is expected to be completed is recognized only if all the following criteria are met:

  · an asset is created that can be identified (such as software and new processes);
  · it is probable that the asset created will generate future economic benefits; and
  · the development cost can be measured reliably.

 

When these criteria are met and there are appropriate resources to complete development, the expenditure is capitalized at cost. Where these criteria are not met development expenditure is recognized as an expense in the period in which it is incurred. Internally generated intangible assets are amortized over their useful economic life from the date that they start generating future economic benefits.

 

Impairment testing of goodwill, other intangible assets and property and Equipment

 

For the purposes of assessing impairment, assets are grouped at the lowest levels for which there are separately identifiable cash flows (cash-generating units). As a result, some assets are tested individually for impairment and some are tested at the cash-generating unit level. Goodwill is allocated to those cash-generating units that are expected to benefit from synergies of the related business combination and represent the lowest level within the Group at which Management monitors the related cash flows.

 

Goodwill and Trade names are tested for impairment at least annually. The Group has impaired Goodwill and Trade names in its entirety during the previous fiscal year. All other individual assets or cash-generating units are tested for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.

 

An impairment loss is recognized for the amount by which the asset’s or cash-generating unit’s carrying amount exceeds its recoverable amount. The recoverable amount is the higher of fair value, reflecting market conditions less costs to sell, and value in use based on an internal discounted cash flow evaluation. Impairment losses recognized for cash-generating units, to which goodwill has been allocated, are credited initially to the carrying amount of goodwill. Any remaining impairment loss is charged pro rata to the other assets in the cash generating unit.

 

Film and content rights are stated at the lower of unamortized cost and estimated recoverable amounts. In accordance with IAS 36 Impairment of Assets, film content costs are assessed for indication of impairment on a library basis as the nature of the Group’s business, the contracts it has in place and the markets it operates in do not yet make an ongoing individual film evaluation feasible with reasonable certainty. Impairment losses on content advances are recognized when film production does not seem viable and refund of the advance is not probable.

 

With the exception of goodwill, all assets are subsequently reassessed for indications that an impairment loss previously recognized may no longer exist.

77 

 

Property and equipment

 

Property and equipment are stated at historical cost less accumulated depreciation and impairment. Land and freehold buildings are recognised at fair value based on periodic, but at least triennial, valuations by an external independent valuer, less subsequent depreciation for freehold buildings.

 

Any accumulated depreciation at the date of revaluation is eliminated against the gross carrying amount of the asset and the net amount is restated to the revalued amount. Increases in the carrying amount arising on revaluation of freehold land and buildings are credited to other reserves in shareholders’ equity through other comprehensive income. Decreases that offset previous increases are charged against other reserves.

 

Depreciation is provided to write-off the cost of all property and equipment to their residual value as stated below:

 

    Life of Asset  

Rate of
depreciation
%
WDV
per annum

Freehold building   60 years   2-10
Furniture and fittings and equipment   5 years   15-20
Vehicles and machinery   3-5 years   20-30

 

Material residual value estimates are updated as required, but at least annually, whether or not the asset is revalued.

 

Advance paid towards the acquisition or improvement of property and equipment not ready for use before the reporting date are disclosed as capital work-in-progress.

 

Inventories

 

Inventories primarily comprise of music CDs and DVDs, are valued at the lower of cost and net realizable value. Cost in respect of goods for resale is defined as purchase price, including appropriate labor costs and other overhead costs. Costs in respect of raw materials is purchase price.

 

Purchase price is assigned using a weighted average basis. Net realizable value is defined as anticipated selling price or anticipated revenue less cost to completion.

 

Cash and cash equivalents

 

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term highly liquid investments with original maturity of three months or less that are readily convertible into known amounts of cash and are subject to insignificant risk of changes in value. Bank overdrafts are shown within “Borrowings” in “Current liabilities” on the statement of financial position.

 

Restricted deposits held with banks

 

Deposits held with banks as security for overdraft facilities are included in restricted deposits held with bank.

 

Financial instruments

 

A financial instrument is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity.

 

  i. Recognition, initial measurement and derecognition

 

Financial assets and liabilities are recognized when the Group becomes a party to the contractual provisions of the instrument. Financial assets and liabilities are initially measured at fair value. Transaction costs that are directly attributable to the acquisition or issue of financial assets and financial liabilities (other than financial assets and financial liabilities at fair value through profit or loss) are added to or deducted from the fair value of financial assets or financial liability, as appropriate, on initial recognition.

78 

 

The transaction costs directly attributable to the acquisition of financial assets and financial liabilities at fair value through profit and loss are immediately recognized in the Consolidated Statement of Income.

 

A financial asset is primarily derecognized (i.e. removed from the Group’s statement of financial position) when:

 

  a) The rights to receive cash flows from the asset have expired, or

 

  b) The Group has transferred its rights to receive cash flows from the asset t or has assumed an obligation to pay the received cash flows in full without material delay to a third party under a ‘pass-through’ arrangement and either (a) the Group has transferred substantially all the risks and rewards of the asset, or (b) the Group has neither transferred nor retained substantially all the risks and rewards of the asset, but has transferred control of the asset. .

 

A financial liability is derecognized when the obligation under the liability is discharged or cancelled or expires.

 

  ii. Classification and subsequent measurement of financial asset

 

For the purpose of subsequent measurement, financial assets are classified into the following categories upon initial recognition:

 

  · Debt instruments at amortized cost
  · Debt instruments at fair value through other comprehensive income (FVTOCI)
  · Debt instruments, derivatives and equity instruments at fair value through profit or loss (FVTPL)
  · Equity instruments  designated at fair value through other comprehensive income (FVTOCI)
  · Equity instruments measured at fair value profit or loss (FVTPL)

 

The classification depends on the entity’s business model for managing the financial assets and the contractual terms of the cash flows.

 

Debt instruments at amortized cost

 

A ‘debt instrument’ is measured at the amortized cost if both the following conditions are met and is not designated as at FVTPL:

 

  1. The asset is held within a business model whose objective is to hold assets for collecting contractual cash flows, and

 

  2. Contractual terms of the asset give rise on specified dates to cash flows that are solely payments of principal and interest (“SPPI”) on the principal amount outstanding.

 

After initial measurement, such financial assets are subsequently measured at amortized cost using the effective interest rate (the “EIR”) method. The effective interest rate is the rate that exactly discounts future cash receipts or payments through the expected life of the financial instrument, or where appropriate, a shorter period.

 

Amortized cost is calculated by taking into account any discount or premium on acquisition and fees or costs that are an integral part of the EIR. The EIR amortization is included in finance income/other income in the Consolidated Statement of Income. The losses arising from impairment are recognized in the Consolidated Statement of Income.

 

Debt instruments at fair value through other comprehensive income

 

A ‘debt instrument’ is classified as at the FVTOCI if both of the following criteria are met and is not designated as at FVTPL:

 

  1. The objective of the business model is achieved both by collecting contractual cash flows and selling the financial assets, and

 

  2. The asset’s contractual cash flows represent SPPI.

79 

 

Debt instruments at fair value through profit or loss

 

FVTPL is a residual category for debt instruments. Any debt instrument, which does not meet the criteria for categorization as at amortized cost or as FVTOCI, is classified as at FVTPL. A gain or loss on a debt instruments that is subsequently measured at FVTPL is recognised in profit or loss and presented net within other gains/(losses) in the period in which it arises.

 

Equity instruments

 

All equity investments in scope of IFRS 9 are measured at fair value. Equity instruments which are held for trading are classified as at FVTPL with changes in the fair value at each reporting date recognized in the Consolidated Statement of Income.

 

For all other equity instruments, the Group may make an irrevocable election to present in OCI, the subsequent changes in the fair value. The Group makes such election on an instrument-by-instrument basis. If the Group decides to classify an equity instrument as at FVTOCI, then all fair value changes on the instrument, excluding dividends and impairment loss, are recognized in OCI. There is no recycling of the amounts from the OCI to the Consolidated Statement of Income, even on sale of the investment. However, the Group may transfer the cumulative gain or loss within categories of equity.

 

  iii. Impairment of financial assets

 

In accordance with IFRS 9, the Group applies the expected credit loss (“ECL”) model for measurement and recognition of impairment loss on financial assets and credit risk exposures.

 

ECL is the difference between all contractual cash flows that are due to the Group in accordance with the contract and all the cash flows that the entity expects to receive (i.e., all cash shortfalls), discounted at the EIR of the instrument. Lifetime ECL are the expected credit losses resulting from all possible default events over the expected life of a financial instrument. The 12-month ECL is a portion of the lifetime ECL which results from default events that are possible within 12 months after the reporting date.

 

The Group follows ‘simplified approach’ for recognition of impairment loss allowance on trade receivables. Simplified approach does not require the Group to track changes in credit risk. Rather, it recognizes impairment loss allowance based on lifetime ECL at each reporting date, right from its initial recognition.

 

For recognition of impairment loss on other financial assets and risk exposure, the Group determines that whether there has been a significant increase in the credit risk since initial recognition. If credit risk has not increased significantly, 12-month ECL is used to provide for impairment loss. However, if credit risk has increased significantly, lifetime ECL is used. If, in a subsequent period, credit quality of the instrument improves such that there is no longer a significant increase in credit risk since initial recognition, then the entity reverts to recognizing impairment loss allowance based on 12-month ECL.

 

ECL impairment loss allowance (or reversal) recognized during the period is recognized as income/ expense in the Consolidated Statement of Income.

 

  iv. Classification and subsequent measurement of financial liabilities

 

The subsequent measurement of financial liabilities depends on their classification, as described below:

 

  § Financial liabilities at fair value through profit or loss

 

A financial liability is classified as at FVTPL if it is classified as held-for-trading, it is a derivative or it is designated as such on initial recognition. Financial liabilities at FVTPL are measured at fair value and net gains and losses, including any interest expense, are recognised in consolidated statement of income.. Financial liabilities are classified as held for trading if they are incurred for the purpose of repurchasing in the near term.

 

  § Financial liabilities measured at amortized cost

 

After initial recognition, interest-bearing loans and borrowings are subsequently measured at amortized cost using the EIR method. Gains and losses are recognized in the Consolidated Statement of Income when the liabilities are derecognized.

 

Amortized cost is calculated by taking into account any discount or premium on acquisition and fees or costs that are an integral part of the EIR. The EIR amortization is included as finance costs in the Consolidated Statement of Income.

80 

 
v.Offsetting:

 

Financial assets and financial liabilities are offset and the net amount presented in the statement of financial position when, and only when, the Group currently has a legally enforceable right to set off the amounts and it intends either to settle them on a net basis or to realise the asset and settle the liability simultaneously

 

Derivative financial instruments

 

The Group uses derivative financial instruments (“derivatives”) to reduce its exposure to interest rate movements.

 

Derivatives are initially recognized at fair value at the date the derivative contracts are entered into and are subsequently re-measured to their fair value at the end of each reporting period. The resulting gain or loss is recognized in consolidated statements of income immediately.

 

Provisions

 

Provisions are recognized when the Group has a present legal or constructive obligation as a result of a past event, it is more likely than not that an outflow of resources will be required to settle the obligations and the amount can be reliably measured. Provisions are measured at management’s best estimate of the expenditure required to settle the obligations at the end of each reporting period. date and are discounted to present value where the effect of the same is material.

 

Leases

 

Measurement and recognition of leases

 

The Company considers whether contract is,or contains a lease. A lease is defined as ‘a contract, or part of a contract, that conveys the right to use an asset (the underlying asset) for a period of time in exchange for consideration’.

 

To apply this definition the Company assesses whether the contract meets three key evaluations which are whether:

a)the contract contains an identified asset, which is either explicitly identified in the contract or implicitly specified by being identified at the time the asset is made available to the Company
b)the Company has the right to obtain substantially all of the economic benefits from use of the identified asset throughout the period of use, considering its rights within the defined scope of the contract.
c)the Company has the right to direct the use of the identified asset throughout the period of use. The Company assess whether it has the right to direct ‘how and for what purpose’ the asset is used throughout the period of use.

 

Company as a lessee

 

At lease commencement date, the Company recognises a right-of-use asset and a lease liability on the balance sheet. The right-of-use asset is measured at cost, which is made up of the initial measurement of the lease liability, any initial direct costs incurred by the Company and any lease payments made in advance of the lease commencement date.

 

The Company depreciates the right-of-use assets on a straight-line basis from the lease commencement date to the earlier of the end of the useful life of the right-of-use asset or the end of the lease term period. The Company also assesses the right-of-use asset for impairment when such indicators exist.

 

At the commencement date, the Company measures the lease liability at the present value of the lease payments unpaid at that date, discounted using the interest rate implicit in the lease if that rate is readily available or the Company’s incremental borrowing rate.

 

Lease payments included in the measurement of the lease liability are made up of fixed payments (including in substance fixed), and payments arising from options reasonably certain to be exercised. Subsequent to initial measurement, the liability will be reduced for payments made and increased for interest expenses. It is remeasured to reflect any reassessment or modification.

 

The Company has elected to account for short-term leases and leases of low-value assets using the exemption given under IFRS 16. Instead of recognising a right-of-use asset and lease liability, the payments in relation to these are recognised as an expense in profit or loss on a straight-line basis over the lease term or on another systematic basis if that basis is more representative of the pattern of the Company’s benefit.

 

Company as a lessor

Lease income from operating leases where the company is lessor is recognised in income on straight line basis over the lease term. 

 

Taxation

 

Taxation on profit and loss comprises current income tax and deferred income tax. Tax is recognized in the consolidated statement of income except to the extent that it relates to items recognized directly in equity or other comprehensive income in which case it is recognized in equity or other comprehensive income.

 

Current income tax is provided at amounts expected to be paid (or recovered) using the tax rates and laws that have been enacted at the reporting date along with any adjustment relating to tax payable in previous years.

 

Deferred income tax is provided in full, using the liability method, on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the consolidated financial statements. However, deferred tax liabilities are not recognised if they arise from the initial recognition of goodwill. Deferred income tax is also not accounted for if it arises from initial recognition of an asset or liability in a transaction other than a business combination that, at the time of the transaction, affects neither accounting nor taxable profit or loss. Deferred income tax is provided at amounts expected to be paid (or recovered) using the tax rates and laws that have been enacted or substantively enacted at the statement of financial position date and are expected to apply when the related deferred income tax asset is realized or the deferred income tax liability is settled in the appropriate territory.

 

Deferred income tax in respect of undistributed earnings of subsidiaries is recognized except where the Group is able to control the timing of the reversal of the temporary difference and that the temporary difference will not reverse in the foreseeable future. Deferred income tax assets are recognized to the extent that it is probable that future taxable profit will be available against which temporary differences can be utilized.

 

Deferred income tax assets and liabilities are offset where there is a legally enforceable right to offset current tax assets and liabilities and where the deferred tax balances relate to the same taxation authority. Current tax assets and tax liabilities are offset where the entity has a legally enforceable right to offset and intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

 

Employee benefits

 

Defined Contribution Plan

 

The Group operates defined contribution pension plans and healthcare and insurance plans on behalf of its employees. The amounts due are all expensed as they fall due.

81 

 

Defined benefit plan

 

Gratuity: The Group’s liability towards gratuity is determined using the projected unit credit method which considers each period of service as giving rise to an additional unit of benefit entitlement and measures each unit separately to build up the final obligation. The cost for past services is recognized on a straight-line basis over the average period until the amended benefits become vested. Re-measurement gains and losses are recognized immediately in the Other Comprehensive Income as income or expense and are not reclassified to profit or loss in subsequent periods. Obligation is measured at the present value of estimated future cash flows using a discounted rate that is determined by reference to market yields at the Balance Sheet date on Government bonds where the currency and terms of the Government bonds are consistent with the currency and estimated terms of the defined benefit obligation.

 

Employee stock option plan

 

In accordance with IFRS 2 “Share Based Payments”, the fair value of shares or options granted is recognized as personnel costs with a corresponding increase in equity. The fair value is measured at the grant date and spread over the period during which the recipient becomes unconditionally entitled to payment unless forfeited or surrendered.

 

The fair value of share options granted is measured using the Black Scholes model or a Monte-Carlo simulation model, each taking into account the terms and conditions upon which the grants are made. At each statement of financial position date, the Group revises its estimate of the number of equity instruments expected to vest as a result of non-market-based vesting conditions. The amount recognized as an expense is adjusted to reflect the revised estimate of the number of equity instruments that are expected to become exercisable, with a corresponding adjustment to equity reserves. None of the Group plans feature any options for cash settlements.

 

Upon exercise of share options, the proceeds received net of any directly attributable transaction costs up to the nominal value of the shares are allocated to share capital with any excess being recorded as share premium.

 

Foreign currencies

 

Transactions in foreign currencies are translated at the rates of exchange prevailing on the dates of the transactions. Monetary assets and liabilities in foreign currencies are translated at the prevailing rates of exchange at the reporting date. Non-monetary items that are measured at historical cost in a foreign currency are translated at the exchange rate at the date of the transaction when the fair value is determined.

 

Any exchange differences arising on the settlement of monetary items or on translating monetary items at rates different from those at which they were initially recorded are recognized in the income statement in the period in which they arise.

 

Non-monetary items that are measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value was determined. Translation differences on assets and liabilities carried at fair value are reported as part of the fair value gain or loss. Non-monetary items that are measured in terms of historical cost in a foreign currency are not retranslated.

 

The assets and liabilities in the financial statements of foreign subsidiaries and related goodwill are translated at the closing rate at the date of that balance sheet. Income and expenses are translated at the monthly average rate. The exchange differences arising from the retranslation of the foreign operations are recognized in other comprehensive income and taken in to the “currency translation reserve” in equity. On disposal of a foreign operation the cumulative translation differences (including, if applicable, gains and losses on related hedges) are transferred to the consolidated statement of income as part of the gain or loss on disposal.

 

Equity shares

 

Ordinary shares are classified as equity. The Group defers costs in issuing or acquiring its own equity instruments to the extent they are incremental costs directly attributable to an equity transaction that otherwise would have been avoided.  Such costs are accounted for as a deduction from equity (net of any related income tax benefit) upon completion of the equity transaction. The costs of an equity transaction which is abandoned is recognized as an expense.

82 

 

Earnings per share

 

Basic earnings per share is calculated by dividing net profit after taxes attributable to the owners of the Company for the year by weighted average number of ordinary shares outstanding during the period, adjusted for bonus elements in ordinary shares issued during the year and excluding treasury shares. Diluted earnings per share adjusts the figures used in the determination of basic earnings per share to take into account the after-income tax effect of interest and other financing costs associated with dilutive potential ordinary shares, and the weighted average number of additional ordinary shares that would have been outstanding assuming the conversion of all dilutive potential ordinary shares.

 

Current/Non-current classification

 

The Group presents assets and liabilities in the statement of financial position based on current/non-current classification.

 

An asset is current when it is:

 

  · Expected to be realized or intended to be sold or consumed in the normal operating cycle (*)
  · Held primarily for the purpose of trading
  · Expected to be realized within twelve months after the reporting period or
  · Cash or cash equivalent unless restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period

 

All other assets are classified as non-current.

 

(*) The operating cycle for the business activities of the Group is considered to be twelve months except in case of catalogue sales, which have been ascertained as two years for the purpose of current / non-current classification of assets.

 

A liability is current when:

 

  · It is expected to be settled in the normal operating cycle
  · It is held primarily for the purpose of trading
  · It is due to be settled within twelve months after the reporting period or
  · There is no unconditional right to defer the settlement of the liability for at least twelve months after the reporting period

 

The Group classifies all other liabilities as non-current. Deferred tax assets and liabilities are classified as non-current assets and liabilities.

 

Year Ended March 31, 2020 Compared to Year Ended March 31, 2019

 

   Year ended March 31,       As a % of revenue 
   2020   2019   Change %   2020   2019 
   (in thousands)             
Revenue   $155,452   $270,126    (42.5%)   100.0    100.0 
Cost of sales    (81,725)   (155,396)   47.4%    52.6    57.5 
Gross profit    73,727    114,730    (35.7%)   47.4    42.5 
Administrative costs    (144,319)   (87,134)   (65.6%)   92.8    32.3 
Operating profit/(loss) before impairment loss    (70,592)   27,596    (355.8%)   (45.4)   10.2 
Impairment loss    (431,200)   (423,335)   1.9%    277.4    156.7 
Operating profit/(loss)   (501,792)   (395,739)   (26.8%)   (322.8)   (146.5)
Net finance costs    (8,779)   (7,674)   (14.4%)   5.6    2.8 
Other gains/(losses), net    (3,316)   288    (1251.4%)   2.1    (0.1)
Profit/(loss) before tax    (513,887)   (403,125)   (27.5%)   (330.6)   (149.2)
Income tax   22,183    (7,328)   (402.7%)   (14.3)   2.7 
Profit/(loss) for the year   $(491,704)  $(410,453)   (19.8%)   (316.3)   (151.9)

 

83 

 

The following table sets forth, for the period indicated, the revenue by region of domicile of Group’s operation.

 

   Year ended March 31,     
   2020   2019   Change (%) 
   (in thousands)     
India   $41,119   $100,387    (59.0%)
Europe    26,927    63,196    (57.4%)
North America    1,309    1,759    (25.6%)
Rest of the world    86,097    104,784    (17.8%)
Total revenues   $155,452   $270,126    (42.5%)

 

Revenue

 

In fiscal 2020, Eros film slate comprised thirty films of which two were medium budget and twenty-eight were low budget as compared to seventy-two films of which seven were medium budget and sixty-five were low budget in fiscal 2019.

 

In fiscal 2020, the Company’s slate of thirty films comprised eight Hindi films, one Tamil/Telugu film and twenty-one regional films as compared to the same period last year where its slate of seventy-two films comprised fifteen Hindi films, seven Tamil/Telugu film and fifty regional films ..

 

For the twelve months ended March 31, 2020, aggregate revenue decreased by 42.5% to $155.5 million compared to $270.1 million for the twelve months ended March 31, 2019, mainly due to a reduction in theatrical and television syndication revenue which was partially offset by increased revenue from our digital and ancillary business.

 

In the twelve months ended March 31, 2020, the aggregate theatrical revenue decreased by 84.8% to $10.6 million, compared to $69.5 million for the fiscal year 2019. The variation in theatrical revenue is primarily due to the mix of films and release of fewer number of films compared to fiscal 2019.

 

In the twelve months ended March 31, 2020, aggregate revenues from television syndication decreased by 90.8% to $7.1 million, compared to $77.5 million for fiscal year 2019. The decrease is mainly due to the Company’s shift in business strategy to reduce the licensing of our content to third parties and increase our focus on premium digital content and drive greater value to the ErosNow platform, where the Company retains its position as the largest provider of Indian local and regional language content.

 

In the twelve months ended March 31, 2020, the aggregate revenues from digital and ancillary increased by 11.9% to $137.8 million, compared to $123.1 million for fiscal year 2019. The increase in revenue is primarily due to contribution from OTT (over-the-top) digital streaming revenues and ancillary business which includes revenue from providing producer support and VFX services to customers.

 

Cost of sales

 

For the twelve months ended March 31, 2020, cost of sales decreased by 47.4% to $81.7 million, compared to $155.4 million for fiscal year 2019. The decrease was mainly due to lower amortization costs, lower marketing, advertising and distribution costs.

 

Gross profit

 

In fiscal 2020 gross profit decreased by 35.7% to $73.7 million, compared to $114.7 million for fiscal 2019. The decrease was mainly due to decrease in revenue, which is partially offset by lower amortization cost and lower marketing, advertising and distribution costs.

 

84 

 

Administrative costs

 

In fiscal 2020, administrative costs increased by 65.6% to $144.3 million compared to $87.1 million for fiscal year 2019, the increase in administrative cost were mainly on account of credit impairment loss amounting to $97.6 million in fiscal year 2020 compared to $ 25.7 million for fiscal 2019 due to higher expected credit loss (ECL) provision, which was partially offset by reduction in other admin cost such as reduction in legal and profession expenses, Impairment loss on advances to content vendors and other expenses.

 

Net finance costs

 

In fiscal 2020, net finance costs increased by 14.4% to $8.8 million, compared to $7.7 million for fiscal year 2019 mainly due to lower interest income on account of unwinding of credit impairment losses, lower bank interest income and higher interest on borrowings cost.

 

Other gains/(loss), net

 

In fiscal year 2020, other losses stood at $3.3 million, compared to other gains of $0.3 million in fiscal year 2019, the loss was mainly due to reduction in reversal of expected credit loss (ECL) by $10.4 million, which was partially offset by a lower loss on financial liability measured at fair value amounting to $16 million compared to $21.4 in fiscal year 2019.

  

Impairment loss

 

We recorded an impairment loss of $431.2 million for Fiscal Year 2020. The impairment charge was taken as per IAS 36 under IFRS accounting rules which require companies to re-assess the carrying book value of assets both on a regular annual basis and also in the case of irregular events. Examples of these “irregular events” include: a major change in market conditions or technology, expectations of future operating losses, material change in listed equity value or negative cash flows. As in our prior fiscal year, the significant reduction in the stock price and corresponding decline in market capitalisation was the main driver for the impairment charge. This was also compounded by exogenous factors such as the COVID pandemic and changes in business conditions, including delayed theatrical distribution of some films and disruptions to content production schedules. Accordingly, we recorded a non-cash impairment loss of $431.2 million, net of taxes, as an exceptional item within the statement of income/(loss). Management believes this is a conservative and prudent action, and does not believe this impairment materially impacts the near term or long-term business or operations of the company, as it is driven by compliance with accounting standards. In addition, to the extent that in future periods there is a material positive change in these business conditions, Management will be able to write-up the value of assets according to the same accounting standards.

 

Income tax expense

 

In fiscal 2020, income tax expenses decreased by 402.7% to $(22.2) million, compared to $7.3 million for fiscal year 2019. Effective income tax rates were 49.9% and 11.6% for March 31, 2020 and March 31, 2019, respectively, excluding non-deductible share-based payment charges, impairment loss and gain/loss on fair valuation of derivative liabilities. The change in effective rate principally reflects a change in the mix of the profits earned from taxable and non- taxable jurisdictions as well as unrecognized deductible temporary difference and carry forward losses in Indian listed subsidiary.

 

Net (loss)/profit

 

In fiscal year 2020, net loss was $491.7 million compared to $410.5 million for the fiscal year 2019, the increase was mainly on account of decrease in the group revenues and change in impairment loss in fiscal year 2020.

 

Adjusted EBITDA (Non-GAAP)

 

In fiscal 2020, adjusted EBITDA decreased by 21.0% to $54.8 million, compared to $69.4 million for fiscal year 2019. The decrease in Adjusted EBITDA is primarily due to lower syndication revenue and few theatrical releases and deferment of film releases in last quarter due to COVID-19 pandemic.

 

Trade receivables

 

As of March 31, 2020, Trade Receivables decreased to $101.7 million from $196.4 million as of March 31, 2019, primarily due to accounting of expected credit losses as per IFRS 9 standards, including the potential impact of COVID-19 on the credit risk of certain debtor’s businesses and our ability to recover contractual revenue from them.

 

Net debt

 

As of March 31, 2020, net debt increased by 21.6% to $176.4 million from $145.0 million as of March 31, 2019 because of reduction in cash and cash equivalents.

85 

 

Year Ended March 31, 2019 Compared to Year Ended March 31, 2018

 

    Year ended March 31,           As a % of revenue  
    2019     2018     Change %     2019     2018  
    (in thousands)                    
Revenue   $ 270,126     $ 261,253     3.4%     100.0     100.0  
Cost of sales     (155,396 )     (134,708 )   15.4%     57.5     51.6  
Gross profit     114,730       126,545     (9.3% )   42.5     48.4  
Administrative costs     (87,134 )     (68,029 )   28.1%     32.3     26.0  

Operating profit before impairment loss

    27,596       58,516     (52.8% )   10.2     22.4  
Impairment loss     (423,335 )         (100% )   156.7       _

Operating (loss)/profit

    (395,739 )     58,516     (776.3% )   (146.5 )   22.4  
Net finance costs     (7,674 )     (17,813 )   (56.9% )   2.8     6.8  
Other gains/(losses), net     288       (41,321 )   (100.7% )   (0.1 )   15.8  
Profit/(loss) before tax     (403,125 )     (618 )   (65130.6% )   (149.2 )   (0.2 )
Income tax     (7,328 )     (9,127 )   (19.7% )   2.7     3.5  
Profit/(loss) for the year   $ (410,453 )   $ (9,745 )   (4111.9% )   (151.9 )   (3.7 )

 

The following table sets forth, for the period indicated, the revenue by region of domicile of Group’s operation.

 

   Year ended March 31,    
   2019   2018   Change (%)
   (in thousands)    
India   $100,387   $98,073   2.4%
Europe    63,196    27,028   133.8%
North America    1,759    1,244   41.4%
Rest of the world    104,784    134,908   (22.3%)
Total revenues   $270,126   $261,253   3.4%

 

Revenue

 

In fiscal 2019, Eros film slate comprised seventy-two films of which seven were medium budget and sixty five were low budget as compared to twenty four films of which one were high budget, four were medium budget and nineteen were low budget in fiscal 2018.

 

In fiscal 2019, the Company’s slate of seventy-two films comprised fifteen Hindi films, seven Tamil/Telugu film and fifty regional films as compared to the same period last year where its slate of twenty four films comprised fourteen Hindi films, one Tamil/Telugu film and nine regional films .

 

For the twelve months ended March 31, 2019, revenue was adjusted by $34.5 million as significant financing component that arises on account of normal credit terms provided to licensees of our content catalogue (on account of IFRS 15 “Revenue from Contracts with Customers) and the net revenue was to $270.1 million compared to $261.3 million for the twelve months ended March 31, 2018, due to an increase in digital and ancillary revenues.

 

In the twelve months ended March 31, 2019, the aggregate theatrical revenue decreased by 12.1% to $69.5 million, compared to $79.1 million for the fiscal year 2018. The variation in theatrical revenue is primarily due to the mix of films and release of more low budget films.

 

In the twelve months ended March 31, 2019, aggregate revenues from television syndication decreased by 20.3% to $77.5 million, compared to $97.2 million for fiscal year 2018. The decrease is mainly due to mix of films and lower catalogue revenue during the year.

 

In the twelve months ended March 31, 2019, the aggregate revenues from digital and ancillary increased by 44.8% to $123.1 million, compared to $85.0 million for fiscal year 2018. The increase in revenue is primarily on account of contribution from catalogue revenues and digital business and an increase in revenue from OTT platform on account of an increase in subscribers by 138% when compared to the previous year.

86 

 

In the twelve months ended March 31, 2019, revenue from India increased by 2.4% to $100.4 million, compared to $98.1 million for fiscal year 2018. The variation is due to the mix of films, partially offset by an increase in revenue from digital and ancillary business.

 

In the twelve months ended March 31, 2019, revenue from Europe increased by 133.8% to $63.2 million, compared to $27.0 million for fiscal year 2018. This was due to higher contribution from the monetization of catalogue films from one of our subsidiary in Europe, including digital and ancillary business.

 

In the twelve months ended March 31, 2019, revenue from North America increased by 41.4% to $1.7 million, compared to $1.2 million for fiscal year 2018. The increase was due to increase in revenue from digital and ancillary business.

 

In the twelve months ended March 31, 2019, revenue from the rest of the world decreased by 22.3% to $104.8 million, compared to $134.9 million for fiscal year 2018. This was due to lower catalogue sales during the year, partially offset by increase in revenue from digital and ancillary business.

 

Cost of sales

 

For the twelve months ended March 31, 2019, cost of sales increased by 15.4% to $155.4 million, compared to $134.7 million for fiscal year 2018. The increase was mainly due to higher amortization costs, higher marketing, advertising and distribution costs.

 

Gross profit

 

In fiscal 2019 gross profit decreased by 9.3% to $114.7 million, compared to $126.5 million for fiscal 2018. The decrease was mainly due to an increase in marketing, advertising and distribution costs and adjustment on account of adoption new accounting standard in fiscal year 2019.

 

Administrative costs

 

In fiscal 2019, administrative costs increased by 28.1% to $87.1 million compared to $68.0 million for fiscal year 2018, the increase in administrative cost were mainly on account of credit impairment loss amounting to $21.4 million in fiscal year 2019 and impairment of loans and advances of $7.3 million in fiscal 2019.

 

Net finance costs

 

In fiscal 2019, net finance costs decreased by 56.9% to $7.7 million, compared to $17.8 million for fiscal year 2018 mainly due to unwinding of credit impairment loss reserve by $13.2 million and which was partially offset by lower capitalization of interest.

 

Other gains/(loss), net

 

In fiscal year 2019, other gains were increased by 100.7% to $0.3 million, compared to other losses of $41.3 million in fiscal year 2018, the gain was mainly on account of reversal of expected credit loss of $20.7 million, a credit from the Government of India amounting to $2.3 million and a foreign exchange gain of $5.6 million which was partially offset by a loss on financial liability measured at fair value amounting to $21.4 million compared to $13.8 in fiscal year 2018. In addition, there were other losses in fiscal 2018 caused by a one-time loss on deconsolidation of subsidiary amounting to $14.6 million.

87 

 

Impairment loss

 

The Company recorded an impairment loss, totaling to $423.3 million, mainly due to high discount rate and changes in the market conditions, including decrease in projected volume primarily on account of recent credit downgrade and expected investment in film content of $150 - $160 million as more fully explained in note 2(c) to audited financial statements. The impairment loss was firstly allocated to the carrying amount of goodwill and Intangibles - trademark totaling $17.8 million and the residual amount totaling $405.5 million was allocated to Intangibles – content.

 

Income tax expense

 

In fiscal 2019, income tax expenses decreased by 19.7% to $7.3 million, compared to $9.1 million for fiscal year 2018. Effective income tax rates were 11.6% and 20% for March 31, 2019 and March 31, 2018, respectively, excluding non-deductible share-based payment charges, impairment loss and gain/loss on fair valuation of derivative liabilities. The change in effective rate principally reflects a change in the mix of the profits earned from taxable and non- taxable jurisdictions.

 

Net (loss)/profit

 

In fiscal year 2019, net loss was $410.5 million compared to $9.7 million for the fiscal year 2018, the increase was mainly on account of impairment loss of $423.3 million in fiscal year 2019.

 

Adjusted EBITDA (Non-GAAP)

 

In fiscal 2019, adjusted EBITDA decrease by 8.8% to $69.4 million, compared to $76.1 million for fiscal year 2018.The decrease in Adjusted EBITDA is due to increased cost of sales, administrative cost and Profit/(loss) before impairment loss and tax.

 

Trade receivables

 

As of March 31, 2019, Trade Receivables decreased to $196.4 million from $225.0 million as of March 31, 2018 after considering expected credit loss reserve upon adoption of new accounting standards during the year.

 

Net debt

 

As of March 31, 2019, net debt decreased by 23.4% to $145.0 million from $189.2 million as of March 31, 2018 primarily on account of additional equity infusion during the year amounting $54.7 million. The equity infusion was primarily received from promoters’ group $8 million and Reliance Industries $46.7 million at $14.7 and $15 per share, respectively.

 

Exchange rates

 

Our functional and reporting currency is the U.S. dollar. Transactions in foreign currencies are translated at the exchange rate ruling at the date of the transaction. Monetary assets and liabilities in foreign currencies are translated into U.S. dollars at the exchange rates ruling on the date of the applicable statement of financial position. For the purposes of consolidation, all income and expenses are translated at the average rate of exchange during the period covered by the applicable statement of income and assets and liabilities are translated at the exchange rate ruling on the date of the applicable statement of financial position.

 

88 

 

The following table sets forth, for the periods indicated, information concerning the exchange rates between Indian rupees and U.S. dollars based on the noon buying rate in the City of New York for cable transfers of Indian rupees as certified for customs purposes by the Federal Reserve Bank of New York.

 

    Period End   Average(1)   High   Low
Fiscal Year                
2011   44.54   45.46   47.49   43.90
2012   50.89   48.01   53.71   44.00
2013   54.52   54.36   57.13   50.64
2014   60.35   60.35   68.80   53.65
2015   62.58   61.15   63.70   58.46
2016   66.25   65.39   68.84   61.99
2017   64.85   67.01   68.86   64.85
2018   65.11   64.46   65.71   63.38
2019   69.16   69.91   74.33   64.92
2020   75.39    70.90   71.66   70.10
                 
Months                
April 2019   69.64   69.41   70.19   68.58
May 2019   69.63   69.77   70.62   69.08
June 2019   68.92   69.39   69.83   68.92
July 2019   68.81     68.74     69.03     68.40  
August 2019   71.45     71.19     72.02     69.00  
September 2019   70.64     71.32     72.20     70.49  
October 2019   71.01     71.00     71.48     70.71  
November 2019   71.75     71.48     72.12     70.76  
December 2019   71.36     71.16     71.70     70.62  
January 2020   71.53     71.27     71.86     70.69  
February 2020   72.53     71.53     72.53     71.11  
March 2020   75.39     74.55     76.37     72.88  
April 2020   75.08     76.17     76.95     75.08  
May 2020   75.59     75.67     76.08     75.03  
June 2020   75.63     75.73     76.32     75.03  

 

  (1) Represents the average of the U.S. dollar to Indian Rupee exchange rates on the last day of each month during the period for all fiscal years presented, and the average of the noon buying rate for all days during the period for all months presented.

 

This volatility in the Indian Rupee as compared to the U.S. dollar and the increasing exchange rate has impacted our results of operations as shown in the table below comparing the reported results against constant currency comparable based upon the average rate of exchange for the year ended March 31, 2020, of INR 70.90 to $1.00. In addition to the impact on gross profit, the volatility during the year ended March 31, 2020 also led to a non-cash foreign exchange gain of 2.7 million principally on retail bond foreign currency in the year ended March 31, 2020 compared to non-cash foreign exchange loss of 5.6 million principally on retail bond foreign currency in the year ended March 31, 2019.

 

The following table sets forth our constant currency revenue (a non-GAAP financial measure) for the periods indicated. Constant currency revenue is a non- GAAP financial measure. We present constant currency revenue so that revenue may be viewed without the impact of foreign currency exchange rate fluctuations, thereby facilitating period-to-period comparisons of business performance. Constant currency revenue is presented by recalculating prior period’s revenue denominated in currencies other than in US dollars using the foreign exchange rate used for the latest period. Our non-US dollar denominated revenue includes, but is not limited to, revenue denominated in Indian rupee, pound sterling and United Arab Emirates Dirham.

89 

 

   Year ended March 31, 
   2020   2019   2018 
   Reported   Constant Currency (Non-GAAP)   Reported   Constant Currency (Non-GAAP)   Reported   Constant Currency (Non-GAAP) 
           (in thousands)         
Revenue   $155,452    155,452   $270,126    265,792   $261,253   $249,406 
Cost of sales    (81,725)   (81,725)   (155,396)   (152,364)   (134,708)   (126,836)
Gross Profit   $73,727    73,727   $114,730    113,428   $126,545   $122,570 

 

The percentage change for the data comparing the constant currency amounts against the reported results referenced in the table above:

 

   Year ended March 31, 
   2020   2019   2018 
       (in thousands)     
Revenue    —%    1.6%    4.5% 
Cost of sales    —%    2.0%    5.8% 
Gross profit    —%    1.1%    3.1% 

 

The Indian Rupee experienced an approximately 8.3% decrease in value as compared to the U.S. dollar in the fiscal year 2020. In the fiscal year 2019, it decreased by 5.9%.

 

B. Liquidity and Capital Resources

 

Our operations and strategic objectives require continuing capital investment, and our resources include cash on hand and cash provided by operations, as well as access to capital from bank borrowings and access to capital markets. Management believes that cash generated by or available to us should be sufficient to fund our capital and liquidity needs for at least the next 12 months.

 

Our future financial and operating performance, ability to service or refinance debt and ability to comply with covenants and restrictions contained in our debt agreements will be subject to future economic conditions, the financial health of our customers and suppliers and to financial, business and other factors, many of which are beyond our control. Furthermore, management believes that working capital is sufficient for our present requirements.

 

   Year ended March 31, 
   2020   2019   2018 
   (in thousands) 
Current assets(*)   $118,405   $351,597   $339,562 
Current liabilities    225,280    318,672    239,327 
Working capital   $(106,875)  $32,925   $100,235 

 

(*) including trade receivables classified as current asset based on operating cycle of two years.

 

The decrease in working capital as at March 31, 2020 as compared to March 31, 2019 was primarily the result of reduction in trade and other receivables, Cash & Bank balance and restricted deposits by $97.9 million, $86.6 million and 51 million respectively. The short-term borrowings have also reduced by 92 million to $116.9 million as at March 31, 2020 from $208.9 million as at March 31, 2019 due to repayment of senior convertible notes and short-term borrowings secured by restricted assets.

 

For additional information, please see Note 2(a) and Note 31 to our audited Consolidated Financial Statements appearing elsewhere in this annual report.

 

Indebtedness

 

As of March 31, 2020, we had aggregate outstanding indebtedness of $179.4 million, cash and cash equivalents of $2.6 million and short-term liquid investments of $3.8 million. As at March 31, 2020, the total available facilities were comprised of (i) secured credit, bill discounting and overdraft, secured term loans, and vehicle loans of $71.9 million at Eros India, (ii) secured overdraft amounting to $22.1 million at Eros International Limited. In addition, Eros International plc has debt of $62.3 million in relation to a retail bond offering for £50 million in October 2014 and Senior Convertible Notes amounting to $23.1 million issued in December 2017. As at March 31, 2020, there were undrawn amounts under our facilities of $0.1 million.

90 

 
   As of
March 31, 2020
 
   (in thousands) 
Eros India     
Secured credit, bill discounting and overdraft   $48,777 
Secured term loans   $22,975 
Vehicle loans   $127 
Total  $71,879 
Eros International plc     
Retail Bond   $62,274 
Senior Convertible Notes   $23,100 
Total   $85,374 
Eros International Limited     
Secured overdraft   $22,118 
Total   $22,118 
Total   $179,371 

 

Certain of our borrowings and loan agreements, including our new credit facility, contain customary covenants, including covenants that restrict our ability to incur additional indebtedness, create or permit liens on our assets or engage in mergers and acquisitions. Such agreements also contain various customary events of default with respect to the borrowings, including the failure to pay interest or principal when due and cross default provisions, and, under certain circumstances, lenders may be able to require repayment of loans to Eros India prior to their maturity. If an event of default occurs and is continuing, the principal amounts outstanding, together with all accrued unpaid interest and other amounts owed may be declared immediately due and payable by the lenders. If such an event were to occur, we would need to pursue new financing that may not be on as favourable terms as our current borrowings. We are currently in full compliance with all of our agreements governing indebtedness.

 

Borrowings under our term loan facilities and overdraft facility at Eros India matures between 2020 and 2023 and bear interest at fluctuating interest rates pursuant to the relevant sanction letter governing such loans.

 

We expect to renew, replace or extend our borrowings as they reach maturity. As at March 31, 2020, we had net undrawn amounts of $0.1 million available.

 

The Notes

 

On December 06, 2017, the Company closed a registered direct offering (the “2017 Offering”) of $122,500,000 aggregate principal amount of the Company’s Senior Convertible Notes (collectively, the “Notes”) and a Warrant (collectively, the “Warrants”) to purchase up to 2,000,000 of the Company’s A ordinary shares, for an aggregate purchase price of $100,000,000. The Notes and Warrants were issued and sold pursuant to a Securities Purchase Agreement, dated as of December 04, 2017, by and among the Company and the buyers party thereto. The 2017 Offering was effected pursuant to a prospectus supplement dated December 01, 2017 under the Company’s Registration Statement on Form F-3 (Registration No. 333-219708), as amended (the “Registration Statement”). The Registration Statement was declared effective on October 02, 2017. The Warrants expired on June 30, 2018 without being exercised.

 

In connection with the issuance of the Notes, the Company entered into an indenture, dated as of December 06, 2017, between the Company and Wilmington Savings Fund Society, FSB, as trustee (the “Base Indenture”), as supplemented by a first supplemental indenture thereto, dated as of December 06, 2017 (the “Supplemental Indenture” and, the Base Indenture as supplemented by the Supplemental Indenture, the “Indenture”). The terms of the Notes included those provided in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939, as amended.

 

91 

 

The Notes would have matured on December 06, 2020 unless earlier converted or redeemed, subject to the right of the holders to extend the date under certain circumstances. The Notes were issued with an original issue discount and the terms of the Notes provided that they would not bear interest except upon the occurrence of an event of default, in which case the Notes would bear interest at a rate of 6.0% per annum. The Notes were senior obligations of the Company. 

 

The Company made monthly payments consisting of an amortizing portion of the principal of each Note equal to $3,500,000 and accrued and unpaid interest and late charges on the Note. Provided equity conditions referred to in the prospectus supplement were satisfied, the Company was permitted to make a monthly payment by converting such payment amount into A ordinary shares. Alternatively the Company was permitted, at its option, to make monthly payments by redeeming such payment amount in cash, or by any combination of conversion and redemption.

 

All amounts due under the Notes were convertible at any time, in whole or in part, at the holder’s option, into A ordinary shares at the initial conversion price of $14.6875. The conversion price was subject to adjustment for stock splits, combinations and similar events, and, in any such event, the number of A ordinary shares issuable upon the conversion of a Note would also be adjusted so that the aggregate conversion price would have been the same immediately before and immediately after any such adjustment. In addition, the conversion price was also subject to an anti-dilution adjustment if the Company issued or was deemed to have issued securities at a price lower than the then applicable conversion price. Further, if the Company sold or issued any securities with “floating” conversion prices based on the market price of the A ordinary shares, a holder of a Note would have the right thereafter to substitute the “floating” conversion price for the conversion price upon conversion of all or part the Note.

 

The Notes required “buy-in” payments to be made by the Company for failure to deliver any A ordinary shares issuable upon conversion.

 

On or after December 06, 2019, and subject to certain conditions, the Company had the right to redeem all, but not less than all, of the remaining principal amount of the Notes and all accrued and unpaid interest and late charges in cash at a price equal to 100% of the amount being redeemed, so long as the VWAP of the A ordinary shares exceeded $18.3594 (as adjusted for stock splits, stock dividends, recapitalizations and similar events) for at least 10 consecutive trading days. At any time prior to the date of the redemption, a holder had the right to convert its Note, in whole or in part, into A ordinary shares. The Company had no right to effect an optional redemption if any event of default had occurred and was continuing.

 

As of June 30, 2020, all amounts due under the Notes have been converted and no principal amount of the Notes remained outstanding. 

 

2020 Notes Offering

 

On September 30, 2019, the Company closed a registered direct offering (the “2019 Offering”) of $27,500,000 aggregate principal amount of the Company’s Senior Convertible Notes (collectively, the “New Notes”) for aggregate net proceeds of approximately $24,500,000. The New Notes were issued and sold pursuant to a Securities Purchase Agreement, dated as of September 26, 2019, by and among the Company and the buyers party thereto. The 2019 Offering was effected pursuant to a prospectus supplement dated September 26, 2019 under the Registration Statement.

 

The securities purchase agreement provided, as consideration for the securities purchase agreement and pursuant to the provisions of the Notes, for the Company to waive rights to make redemptions or repayments under the Notes in cash, and for the holder of the Notes (the “2017 Holder”) to waive certain specified rights and terms under the Notes, including certain rights to cash payment of any installment amounts then-due under the Notes, and provided for automatic election by the Company to pay each installment amount in the Company’s A ordinary shares. Additionally, with respect to an aggregate amount of $9 million of installment amounts as to which a conversion notice was delivered by the 2017 Holder but a conversion did not occur prior to September 26, 2019 as a result of the mutual agreement of the Company and the 2017 Holder, the conversion of such installment was deemed to have been voided by the 2017 Holder as of September 3, 2019, such that the installment conversion price was automatically adjusted in accordance with clause (A) of Section 8(b) of the Notes based on the VWAP of the A ordinary shares as of August 26, 2019.

 

The New Notes will mature on September 30, 2020, unless earlier converted or redeemed, subject to the right of the holders to extend the date under certain circumstances. The New Notes were issued with an original issue discount and do not bear interest except upon the occurrence of an event of default, in which case the New Notes shall bear interest at a rate of 6.0% per annum. The New Notes are senior obligations of the Company.

92 

 

All amounts due under the New Notes are convertible at any time, in whole or in part, at the holder’s option into A ordinary shares at the initial conversion price of $3.59. The conversion price is subject to adjustment for stock splits, combinations and similar events, and, in any such event, the number of A ordinary shares issuable upon the conversion of a New Note will also be adjusted so that the aggregate conversion price shall be the same immediately before and immediately after any such adjustment. In addition, the conversion price is also subject to an anti-dilution adjustment if the Company issues or is deemed to have issued securities at a price lower than the then applicable conversion price. Further, if the Company sells or issues any securities with “floating” conversion prices based on the market price of the A ordinary shares, a holder of a New Note will have the right thereafter to substitute the “floating” conversion price for the conversion price upon conversion of all or part the New Note.

 

The New Notes require “buy-in” payments to be made by the Company for failure to deliver any A ordinary shares issuable upon conversion. Holders of New Notes are entitled to receive any dividends paid or distributions made to the holders of A ordinary shares on an “as if converted” basis. If the Company issues options, convertible securities, warrants, shares or similar securities to holders of A ordinary shares, each New Note holder has the right to acquire the same as if the holder had converted its New Note.

 

The New Notes prohibit the Company from entering into specified fundamental transactions unless the successor entity assumes all of the Company’s obligations under the New Notes under a written agreement before the transaction is completed. Upon specified corporate events, a New Note holder will thereafter have the right to receive upon a conversion such shares, securities, cash, assets or any other property which the holder would have been entitled to receive upon the happening of the applicable corporate event had the New Note been converted immediately prior to the applicable corporate event. When there is a transaction involving specified changes of control, a New Note holder will have the right to force the Company to redeem all or any portion of the holder’s New Note for a purchase price in cash equal to the equal to the greater of (i) 105% of the amount being redeemed, (ii) the product of (A) the amount being redeemed multiplied by (B) the quotient of (1) the highest closing sale price of the A ordinary shares during the period beginning on the date immediately before the earlier to occur of (x) the completion of the change of control and (y) the public announcement of the change of control and ending on the date the holder delivers the redemption notice divided by (2) the conversion price then in effect, or (iii) the product of (A) the amount being redeemed multiplied by (B) the quotient of (1) the aggregate cash consideration and the aggregate cash value of any non-cash consideration per A ordinary share to be paid to the holders of A ordinary shares upon the completion cash flow of the change of control divided by (2) the conversion price then in effect.

 

As of June 30, 2020, all amounts due under the New Notes have been converted and no principal amount of the New Notes remained outstanding.

 

Sources and uses of cash

 

   Year Ended March 31, 
   2020   2019   2018 
   (in thousands) 
Net cash from operating activities   $18,738   $74,966   $83,243 
Net cash used in investing activities   $(80,546)  $(157,733)  $(185,420)
Net cash from financing activities   $(24,286)  $84,117   $77,415 

  

Cash flow movement for the year ended March 31, 2020 compared to year ended March 31, 2019

 

Net cash generated from operating activities in fiscal year 2020 was $18.7 million compared to $75.0 million in the in fiscal year 2019, a decrease of $56.3 million, or 75.1%, primarily on account of reduction in trade and other receivables.

 

Net cash used in investing activities in fiscal year 2020 was $80.5 million compared to $157.7 million in fiscal year 2019, a decrease of $77.2 million, or 49.0%, primarily due to increase in the investment of intangible film and content rights in fiscal year 2020 to $132.2 million, compared to $107.7 million in fiscal year 2019 and decrease in restricted deposits to $4.8 million, compared to $ 55.9 million in fiscal year 2019.

 

Net cash used in financing activities in fiscal year 2020 was $24.3 million compared to net cash inflow of $84.1 million in fiscal year 2019, a decrease of $108.4 million, or 128.9%, primarily on account of reduction in the proceeds from debt/increase in repayment of debt by $64.7 million and reduction in proceeds from share capital by $49.7 million.

93 

 

Cash flow movement for the year ended March 31, 2019 compared to year ended March 31, 2018

 

Net cash generated from operating activities in fiscal year 2019 was $75.0 million compared to $83.2 million in the in fiscal year 2018, a decrease of $8.2 million, or 9.9%, primarily due to decrease in working capital movement of $65.1 million, mainly attributable to increase in trade receivables by $88.5 million and increase in trade payables by $23.4 million and as a result of lower operating profit before exceptional item generated in fiscal year 2019 as compared to fiscal year 2018.

 

Net cash used in investing activities in fiscal year 2019 was $157.7 million compared to $185.4 million in fiscal year 2018, a decrease of $27.7 million, or 14.9%, primarily as a result of investment in restricted deposits amounting to $53.5 million in fiscal year 2019 and offset by the decrease in purchase of intangible film rights and content rights in fiscal year 2019 was $107.7 million, compared to $186.8 million in fiscal year 2018, decrease of $79.1 million, or 42.3%.

 

Net cash from financing activities in fiscal year 2019 was $84.1 million compared to $77.4 million in fiscal year 2018, an increase of $6.7 million, or 8.7%, primarily as a result of the proceeds from the issuance of share capital and an increase in short-term borrowings in fiscal year, 2019.

 

Capital expenditures

 

In fiscal year 2020, the company invested over $265.3 million (of which cash outflow is $132.2 million) in film content, and in fiscal 2021 the company expects to invest approximately $150 to $160 million in film content.

 

C. Research and Development

 

Not applicable

 

D. Trend Information

 

Standards, amendments and Interpretations to existing Standards that are not yet effective and have not been adopted early by the Group.

 

At the date of authorization of these financial statements, several new, but not yet effective, accounting standards, amendments to existing standards, and interpretations have been published by the IASB. None of these standards, amendments or interpretations have been adopted early by the Group.

 

Management anticipates that all relevant pronouncements will be adopted for the first period beginning on or after the effective date of the pronouncement. New Standards, amendments and Interpretations neither adopted nor listed below have not been disclosed as they are not expected to have a material impact on the Group’s financial statements.

 

IFRS 3 “Business Combinations”

 

In October 2018, the IASB issued amendments to IFRS 3 “Business Combinations” regarding the definition of a “Business.” The amendments:

 

clarify that to be considered a business, an acquired set of activities and assets must include, at a minimum, an input and a substantive process that together significantly contribute to the ability to create outputs;

 

narrow the definitions of a business and of outputs by focusing on goods and services provided to customers and by removing the reference to an ability to reduce costs;

 

add guidance and illustrative examples to help entities assess whether a substantive process has been acquired;

 

remove the assessment of whether market participants are capable of replacing any missing inputs or processes and continuing to produce outputs; and

 

add an optional concentration test that permits a simplified assessment of whether an acquired set of activities and assets is not a business.

 

The above amendments are effective for business combinations for which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after January 1, 2020.

 

The Company is currently evaluating the impact of these amendments on its consolidated financial statements.

94 

 

IAS 1 “Presentation of Financial Statements”

 

In October 2018, the IASB issued amendments to IAS 1 “Presentation of Financial Statements” (“IAS 1”) and IAS 8 “Accounting Policies, Changes in Accounting Estimates and Errors” (“IAS 8”) which revised the definition of “Material.” Three aspects of the new definition should especially be noted, as described below:

 

  Obscuring: The existing definition only focused on omitting or misstating information, however, the Board concluded that obscuring material information with information that can be omitted can have a similar effect. Although the term obscuring is new in the definition, it was already part of IAS 1 (IAS 1.30A);

 

  Could reasonably be expected to influence: The existing definition referred to “could influence” which the Board felt might be understood as requiring too much information as almost anything “could influence” the decisions of some users even if the possibility is remote;

 

  Primary users: The existing definition referred only to ‘users’ which again the Board feared might be understood too broadly as requiring them to consider all possible users of financial statements when deciding what information to disclose.

 

The amendments highlight five ways in which material information can be obscured:

 

  if the language regarding a material item, transaction or other event is vague or unclear;

 

  if information regarding a material item, transaction or other event is scattered in different places in the financial statements;

 

  if dissimilar items, transactions or other events are inappropriately aggregated;

 

  if similar items, transactions or other events are inappropriately disaggregated; and

 

  if material information is hidden by immaterial information to the extent that it becomes unclear what information is material.

 

The new definition of material and the accompanying explanatory paragraphs are contained in IAS 1. The definition of material in IAS 8 has been replaced with a reference to IAS 1.

 

The amendments are effective for annual reporting periods beginning on or after January 1, 2020. Earlier application is permitted.

 

The Company is currently evaluating the impact of these amendments on its consolidated financial statements.

 

In January 23, 2020, the IASB issued amendments to IAS 1 “Presentation of Financial Statements” (“IAS 1”) to clarify the classification criteria of liabilities in the statement of financial position. The most significant changes are listed below:

 

·Classification of liabilities as current or non-current should be based on rights to defer settlement that are in existence at the end of the reporting period

 

·Classification of a liability is unaffected by the likelihood that the entity will exercise its right to defer settlement of the liability for at least twelve months after the reporting period’. That is, management’s intention to settle in the short run does not impact the classification.

 

·‘Settlement’ is defined as the extinguishment of a liability with cash, other economic resources or an entity’s own equity instruments.

 

·Clarifies that if the right to defer settlement is conditional on the compliance with covenants the right exists if the conditions are met at the end of the reporting period,

 

·Clarifies that if a liability has terms that could, at the option of the counterparty, result in its settlement by the transfer of the entity’s own equity instruments, these terms do not affect its classification as current or non-current if the entity recognises the option separately as an equity instrument applying IAS 32 Financial Instruments: Presentation.

95 

 

The amendments are effective for annual reporting periods beginning on or after January 1, 2022. Earlier application is permitted.

 

The Company is currently evaluating the impact of these amendments on its consolidated financial statements.

 

IAS 37 “Provisions, Contingent Liabilities and Contingent Asset”

 

On May 14, 2020, the IASB issued amendment to IAS 37 by specifying that the ‘cost of fulfilling’ a contract comprises the ‘costs that relate directly to the contract’. Costs that relate directly to a contract consist of both the incremental costs of fulfilling that contract (examples would be direct labour or materials) and an allocation of other costs that relate directly to fulfilling contracts (an example would be the allocation of the depreciation charge for an item of property, plant and equipment used in fulfilling the contract).

 

The Company is currently evaluating the impact of these amendments on its consolidated financial statements.

 

The amendments are effective for annual periods beginning on or after 1 January 2022. Early application is permitted

 

Interest Rate Benchmark Reform

 

In September 26, 2019, IASB introduced amendments, which modified specific hedge accounting requirements, so that entities would apply those hedge accounting requirements assuming that the interest rate benchmark is not altered as a result of the interest rate benchmark reform.

 

The changes will mandatorily apply to all hedging relationships that are directly affected by the interest rate benchmark reform.

 

The Group does not expect the amendment to have any significant impact on its consolidated financial statements.

 

The effective date for adoption of this amendment is annual periods beginning on or after January 1, 2020, although early adoption is permitted.

 

IFRS 16 “Leases”

 

On May 15, 2020, the IASB issued amendments to IFRS 16 to make it easier for lessees to account for COVID-19-related rent concessions such as rent holidays and temporary rent reductions.

 

The amendment exempts lessees from having to consider individual lease contracts to determine whether rent concessions occurring as a direct consequence of the covid-19 pandemic are lease modifications and allows lessees to account for such rent concessions as if they were not lease modifications. It applies to covid-19-related rent concessions that reduce lease payments due on or before 30 June 2021

 

These amendments are effective for periods beginning on or after June 1, 2020, with earlier application is permitted. The Company is currently evaluating the impact of amendment to IFRS 16 on its consolidated financial statements.

96 

 

Quarterly Financial Information

 

The table below presents our selected unaudited quarterly results of operations for the four quarters in the fiscal year ended March 31, 2020. This information should be read together with our consolidated financial statements and related notes included elsewhere in this annual report. We have prepared the unaudited financial data for the quarters presented on the same basis as our audited consolidated financial statements. The historical quarterly results presented below are not necessarily indicative of the results that may be expected for any future quarters or periods.

 

   Three Months Ended 
   June 30,
2019
   September 30,
2019
   December 31,
2019
   March 31,
2020
 
   (dollars in thousands) 
Selected Quarterly Results of Operations                
Revenue   $42,252   $31,371   $48,736   $33,093 
Cost of sales    (16,544)   (16,919)   (22,113)   (26,149)
Gross profit    25,708    14,452    26,623    6,944 
Administrative costs    (25,970)   (29,082)   (19,784)   (69,483)
Operating profit/(loss) before impairment loss    (262)   (14,630)   6,839    (62,539)
Impairment Loss                (431,200)
Operating profit/(loss)    (262)   (14,630)   6,839    (493,739)
Net finance costs    (2,147)   (2,253)   (1,158)   (3,221)
Other gains/(losses), net    8,051    (11,326)   (19,822)   19,781 
Profit/(loss) before tax    5,642    (28,209)   (14,141)   (477,179)
Income tax    (1,834)   (891)   (3,991)   28,899 
Profit/(loss) for the year   $3,808   $(29,100)  $(18,132)  $(448,280)
                     
OTHER NON-GAAP MEASURES                    
EBITDA(1)   $8,404   $(25,278)  $(12,344)  $(472,428)
Adjusted EBITDA (1)   $17,380   $6,748   $19,953   $10,761 
Gross Adjusted EBITDA (1)   $29,257   $19,140   $39,971   $30,925 
                     

 

OPERATING DATA

                    
High budget film releases(3)                 
Medium budget film releases(3)            2     
Low budget film releases(3)    12    11    4    1 
Total new film releases(3)    12    11    6    1 

 

  (1) We use EBITDA, Adjusted EBITDA and Gross Adjusted EBITDA as supplemental financial measures. EBITDA is defined by us as net income before interest expense, income tax expense and depreciation and amortization (excluding amortization of capitalized film content and debt issuance costs). Adjusted EBITDA is defined as EBITDA adjusted for (gain)/impairment of available-for-sale financial assets, profit/loss on held for trading liabilities (including profit/loss on derivative financial instruments), transactions costs relating to equity transactions, share based payments, Loss / (Gain) on sale of property and equipment, Loss on de-recognition of financial assets measured at amortized cost, net, Credit impairment loss, net, Loss on financial liability (convertible notes) measured at fair value through profit and loss, Loss on deconsolidation of a subsidiary and exceptional items such as impairment of goodwill, trade-mark, film and content rights and content advances. Gross Adjusted EBITDA is defined as Adjusted EBITDA adjusted for amortization of intangible film and content rights. EBITDA, Adjusted EBITDA and Gross Adjusted EBITDA as used and defined by us, may not be comparable to similarly-titled measures employed by other companies and is not a measure of performance calculated in accordance with GAAP. EBITDA Adjusted EBITDA and Gross Adjusted EBITDA should not be considered in isolation or as a substitute for operating income, net income, cash flows from operating, investing and financing activities, or other income or cash flow statement data prepared in accordance with GAAP. EBITDA, Adjusted EBITDA and Gross Adjusted EBITDA provide no information regarding a Company’s capital structure, borrowings, interest costs, capital expenditures and working capital movement or tax position. However, our management team believes that EBITDA, Adjusted EBITDA and Gross Adjusted EBITDA are useful to an investor in evaluating our results of operations because these measures:

 

  · are widely used by investors to measure a company’s operating performance without regard to items excluded from the calculation of such term, which can vary substantially from company to company depending upon accounting methods and book value of assets, capital structure and the method by which assets were acquired, among other factors;

97 

 
  · help investors to evaluate and compare the results of our operations from period to period by removing the effect of our capital structure from our operating structure; and
  · are used by our management team for various other purposes in presentations to our board of directors as a basis for strategic planning and forecasting.

 

there are significant limitations to using EBITDA, Adjusted EBITDA and Gross Adjusted EBITDA as a measure of performance, including the inability to analyze the effect of certain recurring and non-recurring items that materially affect our net income or loss, the lack of comparability of results of operations of different companies and the different methods of calculating EBITDA. Adjusted EBITDA and Gross Adjusted EBITDA reported by different companies.

 

The following table sets forth the reconciliation of our net income to EBITDA, Adjusted EBITDA and Gross Adjusted EBITDA:

 

   Three Months Ended 
   June 30,
2019
   September 30,
2019
   December 31,
2019
   March 31,
2020
 
   (in thousands) 
(Loss)/Profit for the year   $3,808   $(29,100)  $(18,132)  $(448,280)
Income tax expense    1,834    891    3,991    (28,899)
Net finance costs    2,147    2,253    1,158    3,221 
Depreciation    391    454    415    1,308 
Amortization(a)    224    224    224    222 
EBITDA (Non-GAAP)   $8,404    (25,278)  $(12,344)  $(472,428)
Share based payments(b)    3,666    5,717    4,317    8,568 
Reversal credit impairment losses/(gains)    (1,287)   (1,987)   (2,902)   (4,207)
Loss on de-recognition of financial assets measured at amortized cost, net    270    726    1,625    2,664 
Credit impairment losses, net    10,805    13,089    12,642    54,272 
Loss /(Gain) on sale of property and equipment    4         2    64 
Loss on financial liability (convertible notes) measured at fair value through profit and loss    (4,985)   14,142    16,590    (9,760)
Impairment Loss                431,200 
Fair value of receivables   (306)   306         
Net losses/(gains) of available- for- sale measured at FVTPL    809    33    23    388 
Adjusted EBITDA (Non-GAAP)   $17,380   $6,748   $19,953   $10,761 
Amortization of intangible film and content rights    11,877    12,392    20,018    20,164 
Gross Adjusted EBITDA (Non-GAAP)   $29,257   $19,140   $39,971   $30,925 

 _________________

a) Includes only amortization of intangible assets other than intangible content assets.
b) Consists of compensation costs recognised with respect to all outstanding plans and all other equity settled instruments.
(2) Includes films that were released by us directly and licensed by us for release.

 

Our revenues and operating results are significantly affected by the timing, number and breadth of our theatrical releases and their budgets, the timing of television syndication agreements, and our amortization policy for the first 12 months of commercial exploitation for a film. The timing of releases is determined based on several factors. A significant portion of the films we distribute are delivered to Indian theaters at times when theater attendance has traditionally been highest, including school holidays, national holidays and the festivals. This timing of releases also takes into account competitor film release dates, major cricket events in India and film production schedules. Significant holidays and festivals, such as Diwali, Eid and Christmas, occur during July to December each year, and the Indian Premier League cricket season generally occurs during April and May of each year. The Tamil New Year, called Pongal, falls in January each year making the quarter ending March an important one for Tamil releases.

 

Our quarterly results can vary from one period to the next, and the results of one quarter are not necessarily indicative of results for the next or any future quarter. Our revenue and operating results are therefore seasonal in nature due to the impact on income of the timing of new releases as well as timing and quantum of catalogue revenues.

98 

 

E. Off-Balance Sheet Arrangements

 

From time to time, to satisfy our filmed content purchase contracts, we obtain guarantees or other contractual arrangements, such as letters of credit, as support for our payment obligations.

 

As of March 31, 2020, the Group has provided certain stand-by letters of credit amounting to $Nil (2019: $53.6 million) which are in the nature of performance guarantees issued while entering into film co-production contracts and are valid until funding obligations under these contracts are met. These guarantees, issued in connection with outstanding content commitments, have varying maturity dates.

 

In addition, the Group issued financial guarantees amounting to $0.03 million (2019: $0.5 million) in the ordinary course of business, having varying maturity dates up to the next 12 months. The Group is only called upon to satisfy a guarantee when the guaranteed party fails to meet its obligations.

 

The Group did not earn any fee to provide such guarantees. It does not anticipate any liability on these guarantees as it expects that most of these will expire unused.

 

F. Contractual Obligations

 

We have commitments under certain firm contractual arrangements, or firm commitments, to make future payments. These firm commitments secure future rights to various assets and services to be used in the normal course of our operations. The following table summarizes our firm commitments as of March 31, 2020.

 

   As of March 31, 2020 
   Total   Less than
1 year
   1-3
years
   3-5
years
   More than
5 years
 
   (in thousands) 
Recorded Contractual Obligations                         
Debt  $179,371   $117,097   $62,274   $   $ 
Operating leases   1,553    723    830         
Total   180,924    117,820    63,104         
                          
Unrecorded Contractual Obligations                         
Film entertainment rights purchase obligations(1)   450,469    85,893    138,183    92,427    133,966 
Interest payments on Lease Liability   163    99    64         
Operating leases   623    229    394         
Interest payments on debt (2)   23,741    17,500    6,241         
Total   474,996    103,721    144,882    92,427    133,966 

 

(1) The amounts disclosed as Film entertainment rights purchase obligations are mutually agreed terms and are presently disclosed on best estimate basis.
(2)

The amounts shown in the table include future interest payments on variable and fixed rate debt at current interest rates ranging from 1.8% to 16.45%..

 

G. Safe Harbor

 

See “Special Note Regarding Forward-Looking Statements” at the beginning of this annual report.

 

99 

 

ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES

 

A. Directors and Executive Officers

 

Our board of directors presently consists of seven directors.

 

The following table sets forth the name, age (as at June 30, 2020) and position of each of our directors and executive officers as at the date hereof.

 

Name   Age   Position/s
Directors        
Kishore Lulla   58   Executive Chairman and Group Chief Executive Officer and Managing Director
Prem Parameswaran   51   Executive Director, President of North America & Group Chief Financial Officer
Sunil Lulla   55   Director, Executive Vice Chairman
Dilip Thakkar(1)(2)(3)(4)   83   Director, Chairman of Audit Committee
Rishika Lulla Singh   33   Director
Shailendra Swarup(1)(2)(3)(4)   75   Director, Chairman of Remuneration Committee and Nomination Committee
Dhirendra Swarup(1)(2)   75   Director
         
Senior Management        
Ridhima Lulla   28   Chief Content Officer
Kumar Ahuja   41   Chief Operating Officer, Eros India
Mark Carbeck   48   Chief Corporate and Strategy Officer
Pradeep Dwivedi   49   Chief Executive Officer, Eros India
Ali Hussein   40   Chief Executive Officer, Eros Now

______________

  (1) Independent Director
  (2) Member of the Audit Committee
  (3) Member of the Remuneration Committee
  (4) Member of the Nomination Committee

 

Summarized below is relevant biographical information for each of our directors and executive officers.

 

Directors

 

Mr. Kishore Lulla is the Group Chief Executive Officer, Managing Director and our Executive Chairman. Mr. Lulla received a bachelor’s degree in arts from the Mumbai University. He has over 36 years of experience in the media and film industry. He has served as a director since April 2006. He is a member of the British Academy of Film and Television Arts and Young Presidents’ Organization and is also a board member of the School of Film at the University of California, Los Angeles. He has been honored at the Asian Business Awards 2007 and the Indian Film Academy Awards 2007 for his contribution in taking Indian cinema global. In 2010, Mr. Lulla was awarded the “Entrepreneur of the Year” at the GG2 Leadership and Diversity Awards and in 2014, Forbes Asia featured Mr. Lulla in the list of ‘Best under a Billion’. He was also honored with the 2014 Global Citizenship Award by the American Jewish Committee, a leading global Jewish advocacy organization. Mr. Lulla also received the Entertainment Visionary award at the 2015 Annual Gala Dinner from the Asia Society Southern California. In 2015, he was invited to attend the “billionaires’ summer camp” in Sun Valley, an annual gathering of the world’s most powerful entrepreneurs and business executives. As our Chairman, he has been instrumental in expanding our presence in the United Kingdom, the United States, Dubai and Australia and other international markets. In 2018, he was featured in the Variety 500 list of “influential business leaders shaping the global $2 trillion entertainment industry”. Mr. Kishore Lulla is the father of Mrs. Rishika Lulla Singh and Ms. Ridhima Lulla, the brother of Mr. Sunil Lulla and a cousin of Mr. Vijay Ahuja and Mr. Surender Sadhwani.

100 

 

Mr. Prem Parameswaran is our Executive Director, Group Chief Financial Officer and President of Eros International Plc’s North American operations. Mr. Parameswaran joined us in June 2015 and was appointed to our Board of Directors in December 2018. Mr. Parameswaran has close to 30 years of experience in the Media, Entertainment and Technology sectors. Prior to joining Eros, Mr. Parameswaran had over 23 years of experience in investment banking, advising clients in the global telecommunications, media and technology sector, including on mergers and acquisitions and public, private equity and debt financings. Mr. Parameswaran previously served as the Global Head of Media and Telecommunications Investment Banking at Jefferies LLC. Prior to Jefferies, he was the Americas Head of Media & Telecom at Deutsche Bank and also previously worked at both Goldman Sachs and Salomon Brothers. Throughout his career, he has executed over 300 transactions. Mr. Parameswaran graduated from Columbia University with a bachelor’s degree in arts and received a master’s degree in business administration from Columbia Business School. Mr. Parameswaran also serves on the boards of the Columbia University Alumni Trustee Nominating Committee and the Program for Financial Studies at Columbia Business School. In 2018 Mr. Parameswaran was named one of the “10 most Dynamic CFOs to watch” by Insights Success magazine. In January 2020, Mr. Parameswaran was nominated by President Donald J. Trump as a member of the Presidential Advisory Commission for Asian Americans and Pacific Islanders. He was officially sworn in as a Commissioner on January 27,2020 and is the only Indian American on the 13 member Commission.

 

Mr. Sunil Lulla is an Executive Director in our Company and is the Executive Vice Chairman and Managing Director of Eros India. He received a bachelor’s degree in commerce from the Mumbai University. Mr. Lulla has over 25 years of experience in the media and entertainment industry. Mr. Lulla has valuable relationships with talent in the Indian film industry and has been instrumental in our expansion into distribution in India as well as into home entertainment and music. He has served as a director since April 2006 and led to our growth within India for many years before being appointed as the Executive Vice Chairman and Managing Director of Eros India on September 28, 2009. Mr. Sunil Lulla is the brother of Mr. Kishore Lulla, uncle of Mrs. Rishika Lulla Singh and the cousin of Mr. Ahuja and Mr. Surender Sadhwani.

 

Mr. Dilip Thakkar is an Independent Director in our Company. Mr. Thakkar received bachelor’s a degree in commerce and in law from Mumbai University. A practicing-chartered accountant since 1961, Mr. Thakkar has significant financial experience. He is a senior partner of Jayantilal Thakkar & Co, Chartered Accountants and a member of the Institute of Chartered Accountants in India. In 1986, he was appointed by the Reserve Bank of India as a member of the Indian Advisory Board for HSBC Bank and for the British Bank of the Middle East for a period of eight years. He is the former president of the Bombay Chartered Accountants’ Society and was then, the chairman of its International Taxation Committee. Mr. Thakkar serves as an independent director of six public limited companies and five private limited companies in India and sixteen foreign companies. He has served as a director since April 2006.

 

Mrs. Rishika Lulla Singh is an Executive Director in our Company and Chairman of Eros Digital, which covers all of the digital initiatives for Eros including Eros Now. Mrs. Lulla Singh has been instrumental in spearheading the creation and development distribution of Eros Now within India and internationally. She graduated from the School of Oriental and African Studies with a bachelor’s degree in arts in South Asian Studies and Management and completed a postgraduate study at the UCLA School of Theatre, Film and Television. With over five years of experience in over-the-top platforms and content, Mrs. Lulla Singh has been a key contributor in driving the growth and penetration of Eros Now, both with technological developments and relationship management to stimulate platform penetration. She was named as “Young Entrepreneur of the Year” by the 2016 Asian Business Awards. In 2018, she won the award for “Women Leadership in Industry” at the “Times National Awards for Marketing Excellence”, “40 Under 40 Business Leaders” by BW Business World and featured in “Top Women CEOs” by India Today. Mrs. Lulla Singh is the daughter of Mr. Kishore Lulla, the sister of Ms Ridhima Lulla and the niece of Mr. Sunil Lulla. She has served as director since November 2014.

 

Mr. Shailendra Swarup is an Independent Director in our Company. Mr. Swarup is a practicing lawyer in India since 1965 and has over 53 years of experience as corporate attorney in India. He is senior partner of the law firm Swarup & Company, New Delhi, India. His vast experience includes advising Indian and foreign with respect to transborder transactions, acquisitions, joint ventures, technology transfers in diverse sectors and industry. He presently serves as an independent Director on the Board of 7 public companies and 3 private companies. He was one of the members of Confederation of Indian Industry ("CII") Task Force which formulated for the first time in India the Code for corporate governance. He was member of the Committee constituted by the Reserve Bank of India for governance of public sector banks and financial institutions in India. He advised National Council for Applied Economic Research on and reviewed the draft Bill of the new Electricity Act. He advised National Highways Authority of India and the Planning Commission of India on development of documentation for infrastructure Projects through build operate transfer model and public private partnership. Mr. Shailendra Swarup is a cousin of Mr. Dhirendra Swarup (i.e. son of the elder brother of the father of Mr. Dhirendra Swarup). He has served as a director since July 2017.

 

101 

 

Mr. Dhirendra Swarup is an Independent Director in our Company. He is a government-certified accountant and a member of the Institute of Public Auditors of India, Mr. Swarup holds a postgraduate degree in humanities. A career bureaucrat, he retired as secretary of Ministry of Finance, Government of India in 2005. He possesses a vast experience of over 45 years in the finance sector and has also worked in UK, Turkey and Georgia. He served as the Chairman of Financial Sector Redress Agency Task Force appointed by Government of India, he is also on the Board of several listed companies besides acting as a member and the Chairman of several committees. In the past, he has held many key positions and responsibilities like being a member of the Board of the SEBI, a member of the Permanent High-level Committee on Financial Markets, chairman of the Pension Funds Regulatory Authority, Chief of the Budget Bureau of the Government of India, a member secretary of the Financial Sector Reforms Commission, chairman of Public Debt Management Authority Task Force, Vice-Chairman of the International Network on Financial Education of OECD. Mr. Dhirendra Swarup is a cousin of Mr. Shailendra Swarup Swarup (i.e. son of the younger brother of the father of Mr. Shailendra Swarup). He has served as a director since July 2019.

 

Mr David Maisel retired from the company’s Board on March 26, 2020.

 

Mr Shailendra Swarup will retire from the board upon the closing of the STX transaction.

 

Senior Management

 

Ms Ridhima Lulla is our Chief Content Officer, with a core focus on the creative expression for Eros Now, the premier Indian OTT platform controlled by Eros International Plc. She has previously worked for STX Entertainment, Credit Suisse and was integral to several Eros film projects including Ra.One and Dr Cabbie representing different roles. Ridhima has been strengthening the original content strategy for Eros Now, the leading cutting edge rapidly growing OTT (Over-the-top) platform of Eros Digital. Ms Lulla has degrees in Film Production from University of California, a bachelor’s degree in Business Management, Liberal Arts and Sciences from Regent’s University London. She also did several Diplomas in Digital Film-Making from New York Film Academy. Ms. Lulla is the daughter of Mr. Kishore Lulla, the sister of Mrs Rishika Lulla Singh and the niece of Mr. Sunil Lulla

Mr Kumar Ahuja is Chief Operating Officer of Eros International Media Limited, our majority-controlled Indian operating subsidiary. Mr. Ahuja has over 22 years of experience in the media and entertainment industry. Mr Ahuja assumed the role of Chief Operating Officer in 2019 to lead the company’s initiatives in Media and Entertainment and to organically build and grow businesses around the content ecosystems such as Films, Music, TV, Digital, Airborne and various other revenue departments. He has been instrumental in negotiating and securing the company’s distribution partnerships which remains a key focus area, including spearheading Bollywood and opening various new markets like China, Korea, Taiwan and Hong Kong among others.

Mr. Mark Carbeck is our Chief Corporate & Strategy Officer, with management responsibility for Investor Relations, Group Merger and Acquisition, and Corporate Finance. Mr. Carbeck was formerly a director in Citigroup’s Investment Banking division in London, where he joined its New York office in 1997. He has over 23 years of experience in the investment banking and corporate finance. Mr. Carbeck previously led the European media investment banking coverage efforts at Citigroup and has deep media industry knowledge and strong relationships with major global media companies. Mr. Carbeck graduated from the University of Chicago in 1994 with a bachelor’s degree in history. Mr. Carbeck joined us in April 2014.

 

Mr. Pradeep Dwivedi is Chief Executive Officer of Eros International Media Limited, our majority-controlled Indian operating subsidiary. He is an accomplished industry leader with over two decades of experience in the advertising, media, technology and telecom sectors, with established credentials in digital infotainment business as well as print media, news television channels and experiential events. He has a demonstrated track record in revenue growth, sales and marketing, value creation, joint ventures and partnerships, corporate investments, business operations and general management. In the past, he has been CEO of Sakal Media Group, Chief Corporate Sales & Marketing Officer of Dainik Bhaskar Group, and worked in leadership positions with organisations including Tata Teleservices, American Express, GE Capital, Standard Chartered Bank & Eicher Motors in India. He is an active participant in many media industry associations, such as Director of IAA (India Chapter) and a managing committee member of The Advertising Club of India. Mr Dwivedi holds B. Sc and MBA degrees from Panjab University.

102 

 

Mr. Ali Hussein is our Chief Executive Officer of Eros Now, the premier Indian OTT platform controlled by Eros International Plc. Mr. Hussein has over 18 years of experience in the media, entertainment and digital space. Mr. Hussein has previously been a Board Advisor to Discovery Networks and other start-ups in the media and technology domain. Prior to that, He has worked with Google/YouTube where Mr. Hussein ran the charter for content and product partnerships in South Asia. Mr. Hussein was an early employee of the Joint Venture between Network 18 and Viacom (Viacom 18), where he was responsible for the digital media strategy for all consumer facing media brands like Colors, MTV and others and prior to that with Hungama Digital Media where he managed the portfolio of global content acquisition and distribution. Mr. Hussein joined us in January 2018.

 

B. Compensation

 

Compensation of senior executive officers and directors is determined by the Remuneration Committee of our Board of Directors. The Remuneration Committee reviews the performance of our directors and each of our executive officers and sets the scale and structure of their compensation. Where required, the Remuneration Committee engages the services of external companies for the purposes of benchmarking of executive remuneration or such other remuneration related matter. As part of its role of overseeing the scale and structure of the compensation paid to our executive officers, the Remuneration Committee approves their service agreements with our subsidiaries and any bonus paid by our subsidiaries to such officers. The current members of the Remuneration Committee are two of our non-executive directors, Shailendra Swarup and Dilip Thakkar.

 

In determining the scale and structure of the compensation for executive directors and senior executives, the Remuneration Committee takes into account the need to offer a competitive compensation structure to attract and maintain a skilled and experienced management team. The Remuneration Committee creates competitive compensation programs by reviewing market data and setting compensation at levels comparable to those at our competitors. We believe that a compensation program with a strong performance based element is a prerequisite to obtaining our performance and growth objectives.

 

The main components of the compensation for our executive officers are a base salary, share awards, annual bonus and stock options.

 

The Remuneration Committee reviews these three compensation components in light of individual performance of the executive officers, external market data and reports provided by outside experts or advisors. For information about service contracts entered into by us, or our subsidiaries, and certain of our executives, see “Part I — Item 6. Directors, Senior Management and Employees — C. Board Practices.”

 

The compensation of our non-executive directors is set by our board of directors as a whole, after consulting with outside experts or advisors.

 

The following tables and footnotes show the remuneration of each of our directors for fiscal 2020:

 

   Year ended March 31, 
   2020
Salary
   2020
Director Fees
   2020
Benefits(1)
   2020
Total
   2019
Total
 
   (in thousands) 
Kishore Lulla   $1,360   $   $   $1,360   $1,432 
Vijay Ahuja(3)    73        4    77    221 
Sunil Lulla(2)    804        17    821    778 
Dilip Thakkar        76        76    78 
David Maisel        93        93    95 
Rishika Lulla Singh    480            480    445 
Prem Parameswaran    450        35    485    485 
Shailendra Swarup       51        51    52 
Dhirendra Swarup        46        46     
Total   $3,167   $266   $56   $3,489   $3,586 

 

(1) Health insurance, except for Sunil Lulla (see Note (2) below).

(2) Sunil Lulla’s fiscal 2020 compensation consisted of the following (Indian Rupees translated to U.S. dollars at a rate of INR 70.79 per $1.00)

(3) Vijay Ahuja retired from the company’s Board on December 20th, 2018.

(4) Mr. Dhirendra Swarup was appointed as a Director with effect from July 31, 2019.

103 

 
Particulars for Mr Sunil Lulla  INR   USD 
Basic salary    51,446,124   $726,712 
Reimbursements car/entertainment etc.    39,600    559 
Company rent accommodation    1,200,000    16,951 
Total India    52,685,724   $744,222 

 

The total share based compensation paid to our executive officers in fiscal 2020 was $24.2 million (2019: $16.2 million).

 

The following table and footnotes show the cost recognised in fiscal 2020 in respect to all outstanding plans and by grant of shares, which are all equity settled instruments, to our directors is as follows:

 

   Option
2014
   Option
2017
   June 28,
2016
   February 2,
2017
   November 22,
2017
   November 11,
2018
   March 3,
2019
   July 11,
2019
   February 28,
2020
   Total 
Kishore Lulla   $   $   $80   $   $249   $1,733   $   $1,560   $268    3,890 
Jyoti Deshpande            64        66           $   $    130 
Sunil Lulla            64        199    990       $858   $147    2,258 
Dilip Thakkar                        151       $23   $    174 
David Maisel    88                           $   $    88 
Rishika Lulla Singh        287    40        199    990       $892   $153    2,561 
Prem Parameswaran                61    363        2,089   $1,181   $    3,694 
Shailendra Swarup                        151       $23   $    174 
Total   $88   $287   $248   $61   $1,076   $4,015   $2,089   $4,537   $568   $12,969 

 

Eros India Incentive Compensation

 

Pursuant to the Board Resolution dated May 29, 2015 and May 26, 2017 passed by the Board of Directors of Eros India and Shareholders Resolution dated September 3, 2015 and September 28, 2017 passed by the Shareholders of Eros India, the commission upto 1% of the net profits payable to Mr. Sunil Lulla and Mr. Kishore Lulla has been approved for the services rendered by Mr. Sunil Lulla and Mr. Kishore Lulla to Eros India, in accordance to the applicable laws. Mr. Sunil Lulla is eligible for commission for the term of 5 (Five) years, until September 26, 2020 and Mr. Kishore Lulla is eligible for commission for the term of 5 (Five) years, until October 31, 2022. The Nomination and Remuneration Committee of Eros India will take into account the incentive bonus paid to both Mr. Sunil Lulla and Mr. Kishore Lulla, at the time of determination of compensation payable to each of them.

 

Share Based Compensation Plans

 

The compensation cost recognised with respect to all outstanding plans and by grant of shares, which are all equity settled instruments, is as follows:

 

    Year ended March 31  
    2020     2019     2018  
    (in thousands)  
IPO India Plan   $ 145     $ 1,198     $ 1,572  
JSOP Plan                 615  
Option award scheme 2012                 197  
2014 Share Plan           47       (22)  
2015 Share Plan(*)     1,976       3,059       100  
Other share option awards(**)     7,829       5,346       7,283  
Management scheme (staff share grant) (***)     12,318       11,911       8,173  
    $ 22,268     $ 21,561     $ 17,918  

104 

 

(*) includes 674,045 options granted towards Share Plan 2015 during twelve months ended March 31, 2020 at an exercise price of $ 2 per share and average grant date fair value of $ 0.82 per share. In February 2020, the exercise price of said options were modified to GBP 0.3, resulting in incremental fair value of $ 0.55 per share. In addition, includes 233,364 and 622,035 options granted in prior year/s and wherein the exercise price was modified to $ 2 per share and GBP 0.3 per share, respectively, resulting in incremental fair value of $ 0.55-0.63 per share and $ 1.18 per share, respectively.

 

(**) includes Restricted Share Unit (RSU) and Other share option plans. In respect of 4,899,280 units/options granted towards RSU during twelve months ended March 31, 2020, intrinsic value $ 1.94 per share approximates grant date fair value. Includes 873,000 options accelerated for immediate vesting as against original vesting period of 3 years, resulting in incremental fair value of $ $1.64 per share.

 

Joint Stock Ownership Plan (JSOP)

 

In April 2012, the Company established a controlled trust called the Eros International Plc Employee Benefit Trust (“JSOP Trust”). The JSOP Trust purchased 2,000,164 shares of the Company out of funds borrowed from the Company and repayable on demand. The Company’s Board, Nomination and Remuneration Committee recommends to the JSOP Trust certain employees, officers and key management personnel, to whom the JSOP Trust will be required to grant shares from its holdings at nominal price. Such shares are then held by the JSOP Trust and the scheme is referred to as the “JSOP Plan.” The shares held by the JSOP Trust are reported as a reduction in stockholders’ equity and termed as ‘JSOP reserves’.

 

The movement in the shares held by the JSOP Trust is given below:

 

   Year ended March 31 
   2020   2019   2018 
Shares held at the beginning of the year   384,862    1,146,955    1,146,955 
Shares granted            
Shares exercised(*)            
Shares forfeiture/lapsed   (384,862)   (762,093)    
Shares held at the end of the year       384,862    1,146,955 
Unallocated shares held by trust   1,253,656    868,794    106,701 
        1,253,656    1,253,656 

  

(*) During the year unallocated shares held by the trust were issued to the content vendor at $3.6 per share.

  

Employee Stock Option Plans

 

A summary of the general terms of the grants under stock option plans and stock awards are as follows:

 

    Range of
exercise prices
 
IPO India Plan   INR 10 – 150  
2014 Share Plan     $16.25–$18.30  
2015 Share Plan     $2-33.12 & GBP 0.3  
Other share option plans     $16.00  
RSU      
Management Share Award      

 

Employees covered under the stock option plans are granted an option to purchase shares of the Company at the respective exercise prices, subject to fulfillment of vesting conditions (generally service conditions). These options generally vest in tranches over a period of one to five years from the date of grant. Upon vesting, the employees can acquire one share for every option. The maximum contractual term for these stock option plans ranges between two to ten years.

 

105 

 

 

The activity in these employee stock option plans is summarized below:

 

        Year ended March 31
        2020   2019   2018
    Name of Plan   Number
of
shares
  Weighted
average
exercise
price
  Number
of
shares
  Weighted
average
exercise
price
  Number
of
shares
  Weighted
average
exercise
price
Outstanding at the beginning of the year   IPO India Plan   757,886   INR 32.17   1,624,035   INR 28.85   2,108,063   INR 34.96
Granted                   863,320     10.00
Exercised       (121,496)     10.00   (536,263)     10.00   (1,113,160)     32.19
Forfeited and lapsed       (156,775)     10.00   (329,886)     51.66   (234,188)     10.00
Outstanding at the end of the year       479,615     45.03   757,886     32.17   1,624,035     28.85
Exercisable at the end of the year       325,740   INR 61.56   289,002   INR 68.13   501,122   INR 65.14
                                   
Outstanding at the beginning of the year   JSOP Plan   384,862   $ 11.00   1,146,955   $ 16.22   1,146,955   $ 16.22
Granted                      
Exercised                      
Forfeited and lapsed       (384,862)     11.00   (762,093)     18.86      
Outstanding at the end of the year         $   384,862   $ 11.00   1,146,955   $ 16.22
Exercisable at the end of the year         $   384,862   $ 11.00   728,736   $ 11.00
                                   
Outstanding at the beginning of the year   Option award scheme 2012     $   674,045   $ 11.00   674,045   $ 11.00
Granted                      
Exercised                      
Forfeited and lapsed             (674,045)     11.00      
Outstanding at the end of the year                   674,045     11.00
Exercisable at the end of the year                     449,363   $ 11.00
                                   
Outstanding at the beginning of the year   2014 Share Plan   399,999   $ 17.79   399,999   $ 17.79   723,749    $ 18.06
Granted                      
Exercised                      
Forfeited and lapsed                   (323,750)     18.39
Outstanding at the end of the year       399,999     17.79   399,999     17.79   399,999     17.79
Exercisable at the end of the year       399,999   $ 17.79   399,999   $ 17.79   289,583   $ 17.67
                                   
Outstanding at the beginning of the year   2015 Share Plan   1,290,399   $ 14.68   211,250   $ 16.21   233,750   $ 16.23
Granted (i)       674,045     0.38   1,305,399     14.86      
Exercised (ii)       (132,013)     2.00   (10,416)     7.92   (10,208   8.71
Forfeited and lapsed       (233,333)     16.18   (215,834)     18.23   (12,292   14.64
Outstanding at the end of the year       1,599,098     2.69   1,290,399     14.68   211,250     16.21
Exercisable at the end of the year       1,549,098   $ 2.72   981,545   $ 14.66   181,354   $ 17.36
                                   
Outstanding at the beginning of the year   Other share option plans   500,000   $ 16.00   500,000   $ 18.88   500,000     18.88
Granted                          
Exercised                          
Forfeited and lapsed       (500,000)      16.00              
Outstanding at the end of the year             500,000     16.00   500,000     18.88
Exercisable at the end of the year         $   400,000   $ 16.00   300,000   $ 18.88
                                   
Outstanding at the beginning of the year   RSU   505,945       837,590       182,725    
Granted (iii) (iv)       4,899,280     0.06   211,567       1,044,290    
Exercised       (2,088,181)       (450,541)       (366,491)    
Forfeited and lapsed       (37,447)       (92,672)       (22,934)    
Outstanding at the end of the year       3,279,597     0.1   505,944       837,590    
Exercisable at the end of the year       311,740       34,416       119,150    
                                   
Outstanding at the beginning of the year   Management Scheme   2,593,333       1,513,333       1,130,000    
Granted (v)       10,230,320       1,400,000       700,000    
Exercised (vi)       (7,448,320)       (320,000)       (316,667    
Forfeited and lapsed       (320,000)                
Outstanding at the end of the year       5,055,333     0.01   2,593,333       1,513,333    
Exercisable at the end of the year       890,000     0.03   516,667       173,333    

 

(i) includes 233,364 and 622,035 options granted in prior year/s and wherein the exercise price was modified to $ 2 per share and GBP 0.3 per share, respectively

(ii) the exercise price of said options were modified to GBP 0.3, resulting in incremental fair value of $ 0.55 per share

106 

 

 

(iii) Out of the options granted, 619,000 RSU were converted from A ordinary shares to B ordinary shares on October 7, 2019

(iv) Out of above, 873,000 RSU were accelerated for immediate vesting as against original vesting period of 3 years.

 (v) Includes 6,808,320 B Ordinary shares granted on July 12, 2019 and February 28, 2020, respectively and 1,238,000 shares converted from A Ordinary shares to B Ordinary share on October 7, 2019.

(vi) Includes treasury shares of 6,808,320 B Ordinary shares exercised during the year, wherein vesting schedule is in equal instalments over three years from date of grant. The following table summarizes information about outstanding stock options:

 

    Year ended March 31
    2020   2019   2018
Name of Plan   Weighted
average
remaining
life
(Years)
  Weighted
average
exercise
price
  Weighted
average
remaining
life
(Years)
  Weighted
average
exercise
price
  Weighted
average
remaining
life
(Years)
  Weighted
average
exercise
price
IPO India Plan   6.30      INR*     45.03   7.70      INR*     32.17     8.11     INR*     35.0
JSOP Plan           $   3.05         $ 11.00     3.93         $ 16.19
Option award scheme 2012           $           $     3.75         $ 11.00
2014 Share Plan   1.25         $ 17.79   2.25         $ 17.79     5.96         $ 17.79
2015 Share Plan   5.00         $ 2.69   6.01         $ 14.68     6.06         $ 16.21
Other share option plans           $   1.87         $ 16.00     2.87         $ 18.88
RSU   9.36         $   6.00         $     5.60         $
Management Scheme   8.94         $ 0.1   6.00         $     5.56         $

 

 *INR – Indian Rupees

 

2015 Share Plan

 

The following table summarizes information about inputs to the fair valuation model for options granted during the year:

 

   Inputs 
Expected volatility(1)   108.2% 
Option life (Years)   2.6 
Dividend yield   0% 
Risk free rate   0.3 
Range of exercise price of the granted options at the grant date(2)  $0.38 

 

(1) The expected volatility of all other options is based on the historic share price volatility of the Company over time periods comparable to the time from the grant date to the maturity dates of the options.
(2) Fair value of options granted under all other schemes is measured using a Black Scholes model.

 

Joint Stock Ownership Plan Reserve (JSOP Reserve)

 

   (in thousands) 
Balance at April 1, 2018  $(15,985)
Issue out of treasury shares    
Balance at April 1, 2019  $(15,985)
Issue out of treasury shares   15,985 
Balance at March 31, 2020  $ 

 

The JSOP Reserve represents the cost of shares issued by Eros International Plc and held by the JSOP Trust to satisfy the requirements of the JSOP Plan (Refer Note 27).  On June 5, 2014, the Board approved discretionary vesting of 20% of the applicable JSOP shares. In the current year Nil (2019: 868,794) ‘A’ ordinary shares held by the JSOP Trust were eligible to be issued to employees.

 

The number of shares held by the JSOP Trust at March 31, 2020 was Nil ‘A’ Ordinary shares (2019: 1,253,656 ‘A’ Ordinary shares).

  

107 

 

C. Board Practices

 

All directors hold office until the expiration of their term of office, their resignation or removal from office for gross negligence or criminal conduct by a resolution of our shareholders or until they cease to be directors by virtue of any provision of law or they are disqualified by law from being directors or they become bankrupt or make any arrangement or composition with their creditors generally or they become of unsound mind. The term of office of the directors is divided into three classes:

 

  · Class A, whose term will expire at the annual general meeting to be held in fiscal year 2021;
  · Class B, whose term will expire at the annual general meeting to be held in fiscal year 2022; and
  · Class C, whose term will expire at the annual general meeting to be held in fiscal year 2023.

 

Our directors for fiscal year 2020 are classified as follows:

 

  · Class I: Dilip Thakkar and Rishika Lulla Singh;;
  · Class II: Kishore Lulla, Shailendra Swarup, Dhirendra Swarup and Prem Parameswaran; and
  · Class III:  Sunil Lulla.

 

As more fully described below in “Part I — Item 10. Additional Information — C. Material Contracts,” pursuant to the Merger Agreement entered into by the Company on April 17, 2020 and related agreements, upon the consummation of the transactions contemplated thereby the board of directors will have nine directors, of whom four (the “Founders Group Directors”) will be selected by the Founders Group, four (the “STX Directors”) will be selected by STX Filmworks, Inc. (“STX”), and the remaining one director will be jointly selected by the Founders Group and STX (the “Jointly Selected Director”). The foregoing directors will be divided into three classes, each of which will serve for staggered three-year terms. One Founders Group Director, one STX Director and the Jointly Selected Director will be allocated to the class of directors initially holding office until the Company’s 2021 annual general meeting; one Founders Group Director and two STX Directors will be allocated to the class of directors initially holding office until the Company’s 2022 annual general meeting; and two Founders Group Directors and one STX Director will be allocated to the class of directors initially holding office until the Company’s 2023 annual general meeting.

 

Indemnification Agreements

 

We have entered into indemnification agreements with our directors and our officers that require us to indemnify, to the extent permitted by law, our officers and directors against liabilities that may arise by reason of their status or service as officers and directors and to pay expenses incurred by them as a result of any proceeding against them as to which they could be indemnified. We believe that these provisions are necessary to attract and retain qualified persons as directors and executive officers.

 

Service Contracts and Letters of Appointment

 

Kishore Lulla has entered into a service agreement with Eros Network Limited to provide services to us and our subsidiaries. The service agreements is terminable by either party with 12 months’ written notice. Eros Network Limited may terminate the agreement immediately in certain circumstances, including upon certain types of misconduct or upon paying the executive an amount equivalent to his basic salary (inclusive of any bonus and benefits) for a twelve month period. The service agreements expire automatically upon the executive’s 65th birthday. The service agreements provide for private medical insurance and 25 paid vacation days per year. Upon termination, compensation will be paid for any accrued but untaken holiday. The executive receive a basic gross annual salary, reviewed annually, and is entitled to participate in any current share option schemes and bonus schemes applicable to their positions maintained by the employing company. The agreement contains a confidentiality provision and non-competition and non-solicitation provisions that restrict the executive for a period of six to twelve months after termination.

 

Kishore Lulla also executed a letter of appointment for service as one of our directors. Under the terms of the letter of appointment, Mr. Lulla received an annual fee of $93,750. In connection with our initial public offering, this letter of appointment was terminated, and for so long as Mr. Lulla is our executive officer, he will not receive compensation as a director.

108 

 

On November 11, 2018, with effect from November 1, 2018, Kishore Lulla’s gross annual salary is amended and revised to $1,359,600. All other conditions of the employment contracts remain the same. Kishore Lulla is also director on the board of Eros India.

 

Sunil Lulla, our director, has entered into an employment agreement with Eros India pursuant to which he serves as Executive Vice Chairman and Managing Director of Eros India. Sunil Lulla is entitled to receive a basic gross annual salary, as well as medical insurance and certain other benefits and perquisites. Eros India may terminate the agreement upon thirty days’ notice if certain events occur, including a material breach of the agreement by Sunil Lulla. The agreement contains a confidentiality provision that restricts Sunil Lulla during the term of his employment and for a period of two years following termination and a non- competition provision that restricts him during the term of his employment. Mr. Sunil Lulla is also entitled to salary of GBP 60,000 (w.e.f April 2019) and 1,191,000 A ordinary shares awards in total, which will vest annually over the next three years.

 

Mrs. Rishika Lulla Singh, our director, has entered into a service agreement on July 3, 2015 with Eros Digital FZ LLC, pursuant to which she serves as the Chief Executive Officer and an executive director of Eros Digital FZ LLC. On November 11, 2018 with effect from November 1, 2018, Mrs. Rishika Lulla Singh’s gross annual salary is amended and revised to $480,000. Mrs. Rishika Lulla Singh is also entitled to 1,238,000 A ordinary shares awards in total, which will vest annually over the next three years.

 

Our non-executive Director, Mr. Dilip Thakkar, has entered into letter of appointment with us that provide him with annual fees of $76,112 per annum (equivalent to GBP 60,000, as per Board Meeting dated June 28, 2016). Mr. Shailendra Swarup has been appointed as non-executive Director with effect from July 25, 2017 and annual fees for his service has director for Eros International Plc is $50,741 (equivalent to GBP 40,000). Mr. Dhirendra Swarup has been appointed as non-executive Director with effect from July 31, 2019 and annual fees for his service as director for Eros International Plc is $34,626 (equivalent to GBP 26,667) The appointments are for an initial period of one year, and there after terminable by either the non-executive director or by us with three months’ written notice, or by us immediately in the case of fraud.

 

Mr. David Maisel, our director, has entered into a service agreement with us, pursuant to which he serves as a non-executive director, which provides him with an annual fee of $93,000. The service agreement is terminable by either party with 30 days written notice. The service agreement is for a term of five years and three months from November 2014. Mr. Maisel was granted options to purchase up to 500,000 A ordinary shares at $16 (modified from $18.88 to $16 as of September 18,2018) as part of his service agreement, such options vest in five equal tranches commencing in November 2015. There are certain conditions under which, if the agreement is terminated before the relevant vesting date, the unvested options lapse. Mr. David Maisel resigned on March 26, 2020.

 

Mr. Prem Parameswaran, our Group Chief Financial Officer and President North America, has entered into an amended employment agreement with us as of June 9, 2018, which provides him with an annual salary of $450,000. The employment agreement is for a term of three years and is terminable by either party by giving 12 months written notice. Mr. Parameswaran is also entitled to 1,590,000 A ordinary shares awards in total as part of his employment agreement, which have varying vesting periods over the next three years.

 

Mr. Mark Carbeck, our Chief Corporate and Strategy Officer has entered into a service agreement with Eros International Limited to provide services to us and certain of our subsidiaries. The service agreement is terminable by either party with three months’ written notice. Eros International Ltd may terminate the agreement immediately in certain circumstances, including upon certain types of misconduct or upon paying the executive an amount equivalent to his basic salary for a three month period. Mr. Carbeck receives a basic gross annual salary and is entitled to participate in any current bonus scheme applicable to his position. The agreement contains a confidentiality provision non-competition and non-solicitation provisions that restrict the executive for a period of twelve months following termination.

 

Board Committees

 

We currently have an Audit Committee, Remuneration Committee and Nomination Committee, whose responsibilities are summarized below. We believe that the composition of these committees meet the criteria for independence under, and the functioning of these committees comply with the requirements of, the SOX Act, the rules of the NYSE and the SEC rules and regulations applicable to us.

109 

 

Audit Committee

 

Our board of directors has adopted a written charter under which our Audit Committee operates. This charter sets forth the duties and responsibilities of our Audit Committee, which, among other things, include: (i) monitoring our and our subsidiaries’ accounting and financial reporting processes, including the audits of our financial statements and the integrity of the financial statements; (ii) monitoring our compliance with legal and regulatory requirements; (iii) assessing our external auditor’s qualifications and independence; and (iv) monitoring the performance of our internal audit function and our external auditor. A copy of our Audit Committee charter is available on our website at www.erosplc.com. Information contained on our website is not a part of, and is not incorporated by reference into, this annual report.

 

The current members of our Audit Committee are Mr. Dilip Thakkar (Chair), Mr. Shailender Swarup and Mr Dhirendra Swarup. Our board of directors has determined that each of the members of our Audit Committee are independent. The Audit Committee met eight times during fiscal year 2020.

 

Remuneration Committee

 

Our board of directors has adopted a written charter under which our Remuneration Committee operates. This charter sets forth the duties and responsibilities of our Remuneration Committee, which, among other things, include assisting our Board of Directors in establishing remuneration policies and practices. A copy of our Remuneration Committee charter is available on our website at www.erosplc.com. Information contained in our website is not a part of, and is not incorporated by reference into, this annual report.

 

The current members of our Remuneration Committee are Mr. Shailendra Swarup (Chair) and Mr. Dilip Thakkar. The Remuneration Committee met five times during fiscal year 2020. Our board of directors has determined that each of the members of our Remuneration Committee is independent.

 

Nomination Committee

 

Our board of directors has adopted a written charter under which our Nomination Committee operates. This charter sets forth the duties and responsibilities of our Nomination Committee, which, among other things, include recommending to our Board of Directors candidates for election at the annual meeting of shareholders and performing a leadership role in shaping the Company’s corporate governance policies. A copy of our Nomination Committee charter is available on our website at www.erosplc.com . Information contained in our website is not a part of, and is not incorporated by reference into, this annual report.

 

The current members of our Nomination Committee are Mr. Shailendra Swarup (Chair) and Mr. Thakkar. The Nomination Committee is an ad hoc committee and met three times during fiscal year 2020. Our board of directors has determined that each of the members of our Nomination Committee is independent.

 

The table below summarizes the composition of our committees during the year.

 

    Audit
Committee
  Remuneration
Committee
  Nomination
Committee
Shailendra Swarup   Member   Chairman   Chairman
Dilip Thakkar   Chairman   Member   Member
Dhirendra Swarup   Member    

 

As more fully described below in “Part I — Item 10. Additional Information — C. Material Contracts,” upon the consummation of the transactions contemplated by the Merger Agreement, it is expected that the Audit Committee will consist of four members, two of whom will be Founders Group Directors and two of whom will be STX Directors; the Remuneration Committee will consist of three members, one of whom will be a Founders Group Director, one of whom will be an STX Director and one of whom will be the Jointly Selected Director; and the Nomination Committee will consist of four members, two of whom will be Founders Group Directors and two of whom will be STX Directors.

 

D. Employees

 

As of March 31, 2020, we had 340 employees, with 316 employees based in India, and the remainder employed by our international subsidiaries. All are full time employees or contractors. Our employees are not unionized. We believe that our employee relations are good.

110 

 

B. Related Party Transactions

 

The following is a description of transactions since April 1, 2015 to which we have been a party, in which the amount involved in the transaction exceeded or will exceed $120,000, and in which any of our directors, executive officers or beneficial holders of more than 5% of our issued share capital had or will have a direct or indirect material interest.

 

Family Relationships

 

Mr. Kishore Lulla, our director and Chairman, is the brother of Mr. Sunil Lulla, and father of Mrs. Rishika Lulla Singh, each of whom are directors, and a cousin of Mr. Vijay Ahuja, our former director and Vice Chairman (upto December 20th,2018)and of Mr. Surender Sadhwani, our President of Middle East Operations. Mr. Sunil Lulla is the brother of Mr. Kishore Lulla, uncle to Mrs. Rishika Lulla Singh, and a cousin of Mr. Vijay Ahuja and Mr. Surender Sadhwani. Mr. Vijay Ahuja is a cousin of Mr. Kishore Lulla and Mr. Sunil Lulla Mrs. Rishika Lulla Singh is the daughter of Mr. Kishore Lulla and niece of Mr. Sunil Lulla. Mr. Surender Sadhwani is a cousin of Mr. Kishore Lulla and Mr. Sunil Lulla. Mr. Arjan Lulla, our founder, was the father of Mr. Kishore Lulla and Mr. Sunil Lulla, grandfather of Mrs. Rishika Lulla Singh, uncle of Mr. Vijay Ahuja and Mr. Surender Sadhwani and an employee of Redbridge Group Ltd., he was the Honorary President of Eros and a director of our subsidiary Eros WorldwideMrs. Manjula Lulla, the wife of Mr. Kishore Lulla, is an employee of our subsidiary. Ms Ridhima Lulla, is the daughter of Mr. Kishore Lulla and an employee of our subsidiary. Mrs. Krishika Lulla is the wife of Mr. Sunil Lulla and an employee of Eros India. Mr. Swaneet Singh is the husband of Mrs. Rishika Lulla Singh and son in law of Mr. Kishore Lulla.

 

Leases

 

Pursuant to a lease agreement that expired on March 31, 2020, the lease requires Eros International Media Limited to pay $4,000 each month under this lease. Eros International Media Limited leases apartments for studio use at Kailash Plaza, 3rd Floor, Opp. Laxmi Industrial Estate, Andheri (W), Mumbai, from Manjula K. Lulla, the wife of Kishore Lulla. The lease was renewed on April 1, 2020 for a further period of one year on the same terms.

 

Pursuant to a lease agreement that expires on September 30, 2021, the lease requires Eros International Media Limited to pay $4,000 each month under this lease. Eros International Media Limited leases for use as executive accommodations the property Aumkar Bungalow, Gandhi Gram Road, Juhu, Mumbai, from Sunil Lulla.

 

Pursuant to a lease agreement that expired on January 4, 2020, Eros International Media Limited leases office premise for studio use at Supreme Chambers, 5th Floor, Andheri (W), Mumbai from Kishore and Sunil Lulla. Beginning January 2015, the lease requires Eros International Media Limited to pay $82,000 each month under this lease. The lease was renewed with effect from January 5, 2020 for a further period of five years on the same terms.

 

Honorary Appointment of Mr. Arjan Lulla

 

Pursuant to an agreement the Group entered into with Red Bridge Group Limited on June 27, 2006, the Group agreed to pay an annual fee set each year for the services of late Arjan Lulla, the father of Kishore Lulla and Sunil Lulla, grandfather of Mrs. Rishika Lulla Singh, uncle of Vijay Ahuja and Surender Sadhwani and an employee of Redbridge Group Limited. In the fiscal years 2020, 2019 and 2018, the Group paid Arjan Lulla $ Nil, $186,000 and $270,000, respectively. The agreement made Arjan Lulla honorary life president and provided for services including attendance at Board meetings, entrepreneurial leadership and assistance in setting the Group’s strategy. Arjan Lulla passed away in December 2018. Red Bridge Group Limited is an entity owned indirectly by a discretionary trust of which Kishore Lulla is a potential beneficiary.

 

Lulla Family Transactions

 

The Lulla family refers to Mr. Arjan Lulla, Mr. Kishore Lulla, Mr. Sunil Lulla, Mrs. Manjula Lulla, Mrs. Krishika Lulla, Mrs. Rishika Lulla Singh, and Ms. Riddhima Lulla and Mr. Swaneet Singh.

111 

 

The Group has engaged in transactions with NextGen Films Private Limited(*), an entity owned by the husband of Puja Rajani, sister of Kishore Lulla and Sunil Lulla, which with effect from September 19, 2019 ceased to be a related party, each of which involved the purchase and sale of film rights. In the period ended September 19, 2019, NextGen Films Private Limited sold film rights $ 393,000 (2019: $1,109,000 2018: $7,760,000) to the Group, and purchased film rights, including production services, of Nil (2019: Nil and 2018: $Nil). The Group the period ended September 19, 2019 advanced $2,113,000 (2019: $6,192,000 2018: $19,025,000) to NextGen Films Private Limited for film co-production and received refund of $Nil (2019: $Nil, 2018: $6,114,000) on abandonment of certain film projects.

 

The Group also engaged in transactions with Everest Entertainment LLP entity owned by the brother of Manjula K. Lulla, wife of Kishore Lulla, which is involved in the purchase and sale of film rights. In March 31, 2020, Everest Entertainment LLP sold film rights of $18,000 (2019: 1,260,000, 2018: 166,000) to the Group and purchased film rights of $ Nil (2019: $ 314,000).

 

Mrs. Manjula Lulla, the wife of Kishore Lulla, is an employee of Eros International Plc. and is entitled to a salary of $147,000 per annum (2019: $144,000 and 2018: $139,000). Mrs. Krishika Lulla, the wife of Sunil Lulla, is an employee of EIML and is entitled to a salary of $121,000 per annum (2019: $123,000 2018: $133,000). Ms. Riddhima Lulla, the daughter of Kishore Lulla, is an employee of Eros Digital FZ LLC and is entitled to a salary of $300,000 per annum (2019: $213,000 2018: $90,000) which is borne by Eros Worldwide LLC.

 

All of the amounts outstanding are unsecured and will be settled in cash.

 

As at March 31, 2020, the Group has provided performance guarantee to a bank amounting to $Nil (2019: $8,000,000 2018: $8,000,000) in connection with funding commitments. under film co-production agreements with NextGen Films Private Limited and having varying maturity dates up to the next 12 months. The Group did not earn any fee to provide such guarantees.

The Group has engaged in transactions with Xfinite Global Plc, a subsidiary of Eros Investment Limited on which it has significant influence. The Group has accounted $12,776 (2019: $1,413, 2018: $ Nil) as revenue during the year ended March 31, 2020.

(*) With effect from September 19, 2019, NextGen Films Private Limited ceased to be a related party.

 

Relationship Agreement

 

Both we and our subsidiaries, including Eros India, acquire rights in movies. The 2009 Relationship Agreement was renewed with the execution of the 2016 Relationship Agreement between Eros India, Eros Worldwide and us (“Relationship Agreement”). The Relationship Agreement, exclusively assigns to Eros Worldwide, certain intellectual property rights and all distribution rights (including global digital distribution rights) for films (other than Tamil films), held by Eros India or any of its subsidiary or the “Eros India” group, in all territories other than India, Nepal, and Bhutan. In return, Eros Worldwide provides a lump sum minimum guaranteed fee to the Eros India Group in a fixed payment equal to 40% of the production cost of such film (including all costs incurred in connection with the acquisition, pre-production, production or post-production of such film), plus an amount equal to 20% thereon as markup. We refer to these payments collectively as the Minimum Guaranteed Fee. Eros Worldwide is also required to reimburse the Eros India Group pre-approved distribution expenses in connection with such film, plus an amount equal to 20% thereon as markup (“distribution expenses”). In addition, 15% of the gross proceeds received by the Eros International Group from monetization of such films, after certain amounts are retained by the Eros International Group, are payable over to the Eros India Group.

 

No share of gross proceeds from a film is payable by the Eros International Group to the Eros India Group until the Eros International Group has received and retained an amount equal to the Minimum Guaranteed Fee, a 20% fee on all gross proceeds and 100% of the distribution expenses incurred by the Eros International Group and the distribution expenses for which Eros Worldwide has provided reimbursement to the Eros India Group.

 

The initial term of the 2016 Relationship Agreement expires in April 2021. Upon expiration, the agreement provides that it will be automatically renewed for successive two year terms unless terminated by any party by 180 days written notice on or before commencement of any renewal term.

 

112 

 

Lulla Foundation

 

Prior to our listing on the NYSE in November 2013, we issued the equivalent of 282,949 A ordinary shares to the Lulla Foundation (formerly the Eros Foundation), a U.K. registered charity, for no consideration. Such shares were granted by our Remuneration Committee to Mr. Kishore Lulla as compensation, each of whom directed the issuance of such shares to the Lulla Foundation. Mr. Kishore Lulla and his wife, Mrs. Manjula K. Lulla, are trustees, but not beneficiaries, of the foundation. The Lulla Foundation sold 76,000 A ordinary shares between May 20, 2014 and June 8, 2018 and now currently has 221,949 A ordinary shares as of June 30, 2020.

 

C. Interests of Experts and Counsel

 

Not applicable.

 

E. Share Ownership

 

The following table sets forth information with respect to the beneficial ownership of our ordinary shares as at July 27, 2020 by each of our directors and all our directors and executive officers as a group. As used in this table, beneficial ownership means the sole or shared power to vote or direct the voting or to dispose of or direct the sale of any security. A person is deemed to be the beneficial owner of securities that can be acquired within 60 days upon the exercise of any option, warrant or right. Ordinary shares subject to options, warrants or rights that are currently exercisable or exercisable within 60 days are deemed outstanding for computing the ownership percentage of the person holding the options, warrants or rights, but are not deemed outstanding for computing the ownership percentage of any other person. The amounts and percentages as at July 27, 2020 are based on an aggregate of 177,277,956 ordinary shares issued and outstanding as at that date.

 

   Number of A Ordinary Shares Beneficially Owned
   Number of B Ordinary Shares
Beneficially Owned
 
                 
Directors  Number of   Percent   Number of    Percent  
   A Shares   of Class   B Shares   of Class 
                 
Kishore Lulla (1)   *    *    17,723,085    81.7% 
Rishika Lulla Singh   *    *    2,662,666    12.2% 
Sunil Lulla   *    *    *    * 
Prem Parameswaran   *    *    *    * 
Shailendra Swarup   *    *    *    * 
Dhirendra Swarup   *    *    *    * 
Dilip Thakkar   *    *    *    * 
                     
Senior Management                    
Kumar Ahuja   *    *    *    * 
Mark Carbeck   *    *    *    * 
Pradeep Dwivedi   *    *    *    * 
Ali Hussein   *    *    *    * 
Ridhima Lulla   *    *    1,314,667    6.1% 
                     
All Directors and Senior Management   5,542,655    3.56%    21,700,418    100.0% 

  

* Represents less than 1%.
(1) Kishore Lulla's interest in certain of his shares is by virtue of (i) his holding ownership interests in, and being a potential beneficiary of, discretionary trusts that hold our shares and (ii) serving as trustee of the Lulla Foundation, a U.K. registered charity that holds our shares.

 

113 

 

The Founder Group, including Kishore Lulla and his direct descendants, by virtue of the B ordinary shares they own, have different voting rights from holders of A ordinary shares. Each A ordinary share is entitled to one vote on all matters upon which the ordinary shares are entitled to vote, and each B ordinary share is entitled to ten votes. In order to vote at any meeting of shareholders, a holder of B ordinary shares will first be required to certify that it is a permitted holder as defined in our articles of association. Following the adoption of the new Amended Articles of Association, Mr. Sunil Lulla, the brother of Kishore Lulla and the current Chairman and Managing Director of Eros International Media Limited and a member of the board of directors of Eros, and his descendants, will be within the scope of permitted holders.

 

Options to purchase A ordinary from the Company are granted from time to time to directors, officers and employees of the Company on terms and conditions acceptable to the Board of Directors.

 

The following table provides option details with respect to the directors and officers as at June 30, 2020.

 

Name  Number of
‘A’ ordinary
Shares
Options
   Date of
Grant
   Exercise
Price
   Expiration
Date
Prem Parameswaran    300,000    Sep-15        $18.30   Jun-21
Mark Carbeck    70,000    Feb-15        $14.97   Mar-25
Ridhima Lulla    250,000    Sep-18    GBP    0.30   Mar-25
Rishika Lulla    242,035    Sep-18    GBP    0.30   Mar-25

 

ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS

 

A. Major Shareholders

 

The following table and accompanying footnotes provide information regarding the beneficial ownership of our ordinary shares as of July 27, 2020 with respect to each person or group who beneficially owned 5% or more of our issued ordinary shares.

 

Beneficial ownership, which is determined in accordance with the rules and regulations of the SEC, means the sole or shared power to vote or direct the voting or dispose or direct the disposition of our ordinary shares. The number of our ordinary shares beneficially owned by a person includes ordinary shares issuable with respect to options or similar convertible securities held by that person that are exercisable or convertible within 60 days of July 27, 2020.

 

The number of shares and percentage beneficial ownership of ordinary shares below is based on 155,577,538 issued A ordinary shares and 21,700,418 issued B ordinary shares as of July 27, 2020.

 

Except as otherwise indicated in the footnotes to the table, shares are owned directly or indirectly with sole voting and investment power, subject to applicable marital property laws.

 

   Number of A Ordinary Shares Beneficially Owned   Number of B Ordinary Shares Beneficially Owned 
                 
Major shareholders   Number of    Percent    Number of     Percent  
    A Shares    of Class    B Shares    of Class 
                     
Kishore Lulla   1,041,404    0.7%    17,723,085    81.7% 
Beech Investments Limited   318,818    0.2%    8,046,048    37.1% 

  

  (1) Kishore Lulla’s interest in certain of his shares is by virtue of (i) his holding ownership interests in, and being a potential beneficiary of, discretionary trusts that hold our shares and (ii) serving as trustee of the Lulla Foundation, a U.K. registered charity that holds our shares.
  (2) Beech Investments Limited, c/o SG Kleinwort Hambros Trust Company (Channel Islands) Limited, PO Box 197, SG Hambros House, 18 Esplanade, St Helier, Jersey, JE4 8RT. Beech Investments, a company incorporated in the Isle of Man, is owned by discretionary trusts that include Eros director Kishore Lulla as a beneficiary. The shares currently held by Beech Investments Limited are being held as both A ordinary and B ordinary shares. The B ordinary shares would convert into A ordinary shares (pursuant to Section 22.1 of the Articles of Association) upon being transferred to a person who is not a Permitted Holder (as defined in Section 22.1 of the Articles of Association).

114 

 

The following summarizes the significant changes in the percentage ownership held by our major shareholders during the past three years:

 

  · Kishore Lulla’s interest in certain of his shares is by virtue of (i) his holding ownership interests in, and being a potential beneficiary of, discretionary trusts that hold our shares and (ii) serving as trustee of the Lulla Foundation, a U.K. registered charity that holds our shares. Since July 30, 2019, Mr. Lulla’s aggregate ownership of our A and B ordinary shares, through both direct and indirect ownership, has increased by 1,149,493 shares. The change in Mr. Lulla’s ownership was driven by several factors including, but not limited to: share grants received through executive compensation schemes, a decrease in holdings of Eros Ventures limited and the conversion of certain amounts of B ordinary shares into A ordinary shares.

 

The Founder Group, including Kishore Lulla and his direct descendants, by virtue of the B ordinary shares they own, have different voting rights from holders of A ordinary shares. Each A ordinary share is entitled to one vote on all matters upon which the ordinary shares are entitled to vote, and each B ordinary share is entitled to ten votes. In order to vote at any meeting of shareholders, a holder of B ordinary shares will first be required to certify that it is a permitted holder as defined in our articles of association. Following the adoption of the new Amended Articles of Association, Mr. Sunil Lulla, the brother of Kishore Lulla and the current Chairman and Managing Director of Eros International Media Limited and a member of the board of directors of Eros, and his descendants, will be within the scope of permitted holders.

 

As of June 30, 2020, approximately 140,631,271 of our A ordinary shares, representing 95.0% of our outstanding A ordinary shares as of June 30, 2020, were held by a total of 2 record holders with addresses in the United States. The number of beneficial owners of our A ordinary shares in the United States is likely to be much larger than the number of record holders of our A ordinary shares in the United States. No B ordinary shares are held by individuals with addresses in the United States.

 

ITEM 8. FINANCIAL INFORMATION

 

A. Consolidated Statements and Other Financial Information

 

Please see “Part III — Item 18. Financial Statements” for a list of the financial statements filed as part of this Annual Report on Form 20-F.

 

ITEM 9. THE OFFER AND LISTING

 

A. Offer and Listing Details

 

The high and low last reported sale prices for our shares for the periods indicated are as shown below. We note that the periods are split between when Eros International was listed on the Alternative Investment Market (“AIM”) and when it was listed on the New York Stock Exchange (“NYSE”) on November 13, 2013. With respect to the trading prices on AIM, the prices are adjusted to reflect the one-for-three reverse stock split, which occurred on November 18, 2013, and a translation from British Pound Sterling to U.S. dollars based on the prevailing exchange rate between the British Pound Sterling and the U.S. dollar at the time of the applicable trade. Amounts on the NYSE share price table below are for the period November 18, 2013 to June 30, 2020; and on the AIM share price table, for the period April 1, 2010 to November 18, 2013, only.

115 

 
   Price per share on NYSE 
   High   Low 
Fiscal year:          
2014  $16.07   $8.94 
2015  $22.44   $13.65 
2016  $37.60   $6.81 
2017  $19.23   $9.65 
2018  $16.10   $6.85 
2019  $14.50   $7.04 
2020  $8.97   $1.24 
           
Fiscal Quarter:          
           
First quarter 2020   $8.97   $1.35 
Second quarter 2020   $4.44   $  
Third quarter 2020   $3.39   $1.30 
Fourth quarter 2020   $4.44   $1.37 
Month:          
April 2019   $8.97   $8.00 
May 2019   $8.59   $7.44 
June 2019   $7.66   $1.35 
July 2019   $1.82   $1.48 
August 2019   $1.69   $1.24 
September 2019   $3.51   $1.72 
October 2019   $2.32   $1.30 
November 2019   $2.67   $1.91 
December 2019   $3.39   $2.45 
January 2020   $4.44   $2.41 
February 2020   $3.14   $2.29 
March 2020   $2.52   $1.37 
April 2020   $3.05   $1.43 
May 2020   $3.32   $2.45 
June 2020   $3.84   $2.90 

 

   Price per share on AIM 
   High   Low 
Fiscal year:          
2011  $13.37   $7.51 
2012  $13.11   $9.54 
2013  $15.02   $8.05 
Fiscal Quarter:          
First quarter 2013   $15.02   $8.50 
Second quarter 2013   $11.53   $8.05 
Third quarter 2013   $11.81   $8.90 
Fourth quarter 2013   $12.16   $10.44 
First quarter 2014   $11.36   $8.79 
Second quarter 2014   $13.45   $9.06 
Month:          
October 2013    $11.05   $10.27 
November 2013   $11.05   $10.27 

 

Our closing price on AIM on November 13, 2013 was $11.18.

 

B. Plan of Distribution

 

Not applicable.

 

C. Markets

 

Our shares are listed on the NYSE under the symbol “EROS.”

116 

 

D. Selling Shareholders

 

Not applicable.

 

E. Dilution

 

Not applicable.

 

F. Expenses of the Issue

 

Not applicable.

 

ITEM 10. ADDITIONAL INFORMATION

 

A. Share Capital

 

Not applicable.

 

B. Memorandum and Articles of Association

 

Eros International Plc was incorporated in the Isle of Man on March 31, 2006 under the 1931 Act, as a public company limited by shares and effective as of September 29, 2011, was de-registered under the 1931 Act and re-registered as a company limited by shares under the 2006 Act. We maintain our registered office at First Names House, Victoria Road Douglas, Isle of Man IM2 4DF, British Isles; our principal executive office in the U.S. is at 550 County Avenue, Secaucus, New Jersey 07094.

 

At March 31, 2020, Eros International plc has authorized share capital of 180,100,915 A ordinary shares at a par value of GBP 0.30 per share, of which 127,116,702 is issued share capital, and authorized share capital of 19,899,085B ordinary shares at a par value of GBP 0.30 per share, of which 19,899,085is entirely issued and outstanding.

 

Our activities are regulated by our Memorandum and Articles of Association. We adopted revised Articles of Association by special resolution of our shareholders passed on December 20, 2018. The material provisions of our revised Articles of Association are described below. In addition to our Memorandum and Articles of Association, our activities are regulated by (among other relevant legislation) the 2006 Act. Our Memorandum of Association states our company name, that we are a company limited by shares, that our registered office is at First Names House, Victoria Road Douglas, Isle of Man IM2 4DF, British Isles , that our registered agent is IQ EQ (Isle of Man) Limited and that neither the memorandum of association nor the articles of association may be amended except pursuant to a resolution approved by a majority of not less than three-fourths of such members as, being entitled so to do, vote in person or by proxy at the general meeting at which such resolution is proposed. Below is a summary of some of the provisions of our Articles of Association. It is not, nor does it purport to be, complete or to identify all of the rights and obligations of our shareholders.

 

On 29 June 2020, at an extraordinary general meeting, a resolution of our shareholders was passed that, conditional upon the completion of the Merger described in the accompanying Circular, the Articles of Association be amended as set out in the marked-up version of the Articles of Association provided to shareholders as part of the proxy materials for that meeting. As at the date hereof, completion of the Merger has not taken place and the amendments are not yet effective.

 

The summary is qualified in its entirety by reference to our Articles of Association. See “Part III — Item 19. Exhibits — Exhibit 1.1” and “Part III — Item 19. Exhibits — Exhibit 1.2.”

 

The following is a description of the material provisions of our articles of association, ordinary shares and certain provisions of Isle of Man law. This summary does not purport to be complete and is qualified in its entirety by reference to our Articles of Association, See “Part III - Item 19.

 

117 

 

Board of Directors

 

Under our Articles of Association, the 2006 Act and the committee charters and governance policies adopted by our board of directors, our board of directors controls our business and actions. Our board of directors consists of between three and twelve directors and is divided into three staggered classes of directors of the same or nearly the same number. At each annual general meeting, a class of directors is elected for a three-year term to succeed the directors of the same class whose terms are then expiring. No director may participate in any approval of a transaction in which he or she is interested. The directors receive a fee determined by our board of directors for their services as directors and such fees are distinct from any salary, remuneration or other amounts that may be payable to the directors under our articles.

 

However, any director who is also one of our subsidiaries’ officers is not entitled to any such director fees but may be paid a salary and/or remuneration for holding any employment or executive office, in accordance with the articles. Our directors are entitled to be repaid all reasonable expenses incurred in the performance of their duties as directors. There is no mandatory retirement age for our directors.

 

Our articles provide that the quorum necessary for the transaction of business may be determined by our board of directors and, in the absence of such determination, is the majority of the members of our board of directors. Subject to the provisions of the 2006 Act, the directors may exercise all the powers of the Company to borrow money, guarantee, indemnify and to mortgage or charge our assets.

 

Ordinary Shares

 

Dividends

 

Holders of our A ordinary shares and B ordinary shares whose names appear on the register on the date on which a dividend is declared by our board of directors are entitled to such dividends according to the shareholders’ respective rights and interests in our profits and subject to the satisfaction of the solvency test contained in the 2006 Act. Any such dividend is payable on the date declared by our board of directors, or on any other date specified by our board of directors. Under the 2006 Act, a company satisfies the solvency test if (a) it is able to pay its debts as they become due in the normal course of its business and (b) the value of its assets exceeds the value of its liabilities. Under certain circumstances, if dividend payments are returned to us undelivered or left uncashed, we will not be obligated to send further dividends or other payments with respect to such ordinary shares until that shareholder notifies us of an address to be used for the purpose. In the discretion of our board of directors, all dividends unclaimed for a period of twelve months may be invested or otherwise used by our board of directors for our benefit until claimed (and we are not a trustee of such unclaimed funds) and all dividends unclaimed for a period of twelve years after having become due for payment may be forfeited and revert to us.

 

Voting Rights

 

Each A ordinary share is entitled to one vote on all matters upon which the ordinary shares are entitled to vote, and each B ordinary share is entitled to ten votes. In order to vote at any meeting of shareholders, a holder of B ordinary shares will first be required to certify that it is a permitted holder as defined in our articles.

 

General Meetings

 

Unless unanimously approved by all shareholders entitled to attend and vote at the meeting, all general meetings for the approval of a resolution appointing a director may be convened by our board of directors with at least 21 days’ notice (excluding the date of notice and the date of the general meeting), and any other general meeting may be convened by our Board of Directors with at least 14 days’ notice (excluding the date of notice and the date of the general meeting). A quorum required for any general meeting consists of shareholders holding at least 30% of our issued share capital. The concept of “ordinary,” “special” and “extraordinary” resolutions is not recognised under the 2006 Act, and resolutions passed at a meeting of shareholders only require the approval of shareholders present in person or by proxy, holding in excess of 50% of the voting rights exercised in relation thereto. However, as permitted under the 2006 Act, our articles of association incorporate the concept of a “special resolution” (requiring the approval of shareholders holding 75% or more of the voting rights exercised in relation thereto) in relation to certain matters, such as directing the management of our business (subject to the provisions of the 2006 Act and our articles), sanctioning a transfer or sale of the whole or part of our business or property to another company (pursuant to the relevant section of the 1931 Act) and allocating any shares or other consideration among the shareholders in the event of a winding up.

 

118 

 

Rights to Share in Dividends

 

Our shareholders have the right to a proportionate share of any dividends we declare.

 

Limitations on Right to Hold Shares

 

Our board of directors may determine that any person owning shares (directly or beneficially) constitutes a “prohibited person” and is not qualified to own shares if such person is in breach of any law or requirement of any country and, as determined solely by our board of directors, such ownership would cause a pecuniary or tax disadvantage to us, another shareholder or any of our other securities. Our board of directors may direct the prohibited person to transfer the shares to another person who is not a prohibited person. Any such determination made or action taken by our board of directors is conclusive and binding on all persons concerned, although in the event of such a transfer, the net proceeds of the sale of the relevant shares, after payment of our costs of the sale, shall be paid by us to the previous registered holders of such shares or, if reasonable inquiries failed to disclose the location of such registered holders, into a trust account at a bank designated by us, the associated costs of which shall be borne by such trust account. A prohibited person would have the right to apply to the Isle of Man court if he or she felt that our board of directors had not complied with the relevant provisions of our articles of association.

 

Our articles also identify certain “permitted holders” of B ordinary shares. Any B ordinary shares transferred to a person other than a permitted holder will, immediately upon registration of such transfer, convert automatically into A ordinary shares.

 

Untraceable Shareholders

 

Under certain circumstances, if any payment with respect to any ordinary shares has not been cashed and we have not received any communications from the holder of such ordinary shares, we may sell such ordinary shares after giving notice in accordance with procedures set out by our articles to the holder of the ordinary shares and any relevant regulatory authority.

 

Action Required to Change Shareholder Rights or Amend Our Memorandum or Articles of Association

 

All or any of the rights attached to any class of our ordinary shares may, subject to the provisions of the 2006 Act, be amended either with the written consent of the holders of 75% of the issued shares of that class or by a special resolution passed at a general meeting of the holders of shares of that class. Furthermore, our memorandum and articles of association may be amended by a special resolution of the holders of 75% of the issued shares.

 

Liquidation Rights

 

On a return of capital on winding up, assets available for distribution among the holders of ordinary shares will be distributed among holders of our ordinary shares on a pro rata basis. If our assets available for distribution are insufficient to repay all of the paid-up capital, the assets will be distributed so that the losses are borne by our shareholders proportionately.

 

Minority Shareholder Protections

 

Under the 2006 Act, if a shareholder believes that the affairs of the company have been or are being conducted in a manner that is unfair to such shareholder or unfairly prejudicial or oppressive, the shareholder can seek a range of court remedies including winding up the company or setting aside decisions in breach of the 2006 Act or the company’s memorandum and articles of association. Further, if a company or a director of a company breaches or proposes to breach the 2006 Act or its memorandum or articles of association, then, in response to a shareholder’s application, the Isle of Man Court may issue an order requiring compliance with the 2006 Act or the memorandum or articles of association; alternatively, the Isle of Man Court may issue an order restraining certain action to prevent such a breach from occurring.

 

The 2006 Act also contains provisions that enable a shareholder to apply to the Isle of Man court for an order directing that an investigation be made of a company and any of its associated companies.

 

119 

 

Anti-takeover Effects of Our Dual Class Structure

 

As a result of our dual class structure, the Founders Group and our executives and employees will have significant influence over all matters requiring shareholder approval, including the election of directors and significant corporate transactions, such as a merger or other sale of our company or its assets. This concentrated control could discourage others from initiating any potential merger, takeover or other change of control transaction that other shareholders may view as beneficial.

 

C. Material Contracts

 

Agreement and Plan of Merger

 

On April 17, 2020, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with STX Filmworks Inc., a Delaware corporation (“STX”), England Holdings 2 Inc., a Delaware corporation and indirect wholly owned subsidiary of the Company (“England Holdings 2”), and England Merger 1 Corp. (f/k/a England Merger Corp.), a Delaware corporation and a direct wholly owned subsidiary of England Holdings 2 (“Merger Sub”), which provides for, among other things, the merger of Merger Sub with and into STX (the “Merger”), with STX surviving as the surviving corporation and a direct wholly owned subsidiary of England Holdings 2. Eros, as the combined company following the Merger, is referred to hereafter as the “combined company.”

 

On the terms and subject to the conditions of the Merger Agreement, each share of STX preferred stock issued and outstanding immediately prior to the effective time of the Merger (the “Effective Time”) will be converted into the right to receive a number of contractual contingent value rights (“CVRs”), without interest, based on the liquidation value and, if applicable, the exit payment, of the respective share of STX preferred stock (the “Merger Consideration”), and such CVRs will in turn entitle the holder thereof to receive, on the settlement date of the CVRs, a number of A ordinary shares to be calculated in accordance with certain agreements governing the CVRs (the “CVR Agreements”). Each share of STX common stock and each STX stock option and restricted stock unit award issued and outstanding as of immediately prior to the Effective Time will be cancelled at the Effective Time without consideration. The aggregate number of A ordinary shares to be issued to the former STX stockholders upon settlement of the CVRs (the “Aggregate Merger Consideration CVR Shares”) will be equal to, and will in no event exceed, the total number of ordinary shares of the Company outstanding as of immediately prior to the Effective Time on a fully diluted basis. The calculation of the fully diluted number of outstanding ordinary shares for this purpose will include (1) the aggregate number of ordinary shares subject to issuance pursuant to then outstanding in-the-money (based on the volume weighted average trading price of A ordinary shares for the 20 days prior to the Effective Time) Company stock options and (2) the aggregate number of ordinary shares subject to issuance pursuant to then outstanding Company restricted stock unit awards.

 

Pursuant to the CVR Agreements, the applicable CVRs issued as Merger Consideration shall be settled in A ordinary shares on the date (the “Settlement Date”) that is the earlier to occur of (1) the later to occur of (a) the first time that the A ordinary shares issuable pursuant to the CVRs have been registered for resale pursuant to an effective registration statement under the Securities Act of 1933, as amended, and (b) the 75th day after the Effective Time and (2) the date that is six months after the Effective Time. Each CVR will entitle the holder thereof to receive, on the Settlement Date, a number of A ordinary shares allocated from the Aggregate Merger Consideration CVR Shares based on the respective classes of STX preferred stock in respect of which the applicable CVRs were issued. However, the total number of A ordinary shares issuable pursuant to all CVRs will not exceed, in the aggregate, the Aggregate Merger Consideration CVR Shares.

 

Each holder of a CVR (other than any such holder that is also a purchaser under the PIPE Subscription Agreement (as defined below) and delivered a PIPE Lock-Up Agreement (as defined below) in connection with the PIPE Subscription Agreement) will, as a condition to receiving any A ordinary shares issuable in respect of such CVRs on the Settlement Date, be required to execute and deliver a lock-up agreement to the combined company (the “CVR Lock-Up Agreements”). Pursuant to the CVR Lock-Up Agreements, each holder of a CVR will agree not to, without the prior written consent of the combined company, directly or indirectly transfer the A ordinary shares issued to such holder on the Settlement Date for a period of 18 months from the Settlement Date.

 

120 

 

The Merger Agreement, among other things, addresses certain post-closing governance matters, including, (1) that Kishore Lulla, currently the Executive Chairman and Chief Executive Officer of the Company, will be appointed as Executive Co-Chairman of the combined company; and (2) Robert B. Simonds, Jr., currently the Chairman and Chief Executive Officer of STX, will be appointed as Co-Chairman and Chief Executive Officer of the combined company. In addition, effective as of the Effective Time, the board of directors of the combined company (the “Board”) will have nine directors, of whom four (the “Founders Group Directors”) will be selected by the Founders Group, four (the “STX Directors”) will be selected by STX, and the remaining one director will be jointly selected by the Founders Group and STX (the “Jointly Designated Director”). The foregoing directors will be divided into three classes, each of which will serve for staggered three-years term. One Founders Group Director, one STX Director and the Jointly Designated Directorwill be allocated to the class of directors initially holding office until the Company’s 2021 annual general meeting; one Founders Group Director and two STX Directors will be allocated to the class of directors initially holding office until the Company’s 2022 annual general meeting; and two Founders Group Directors and one STX Director will be allocated to the class of directors initially holding office until the Company’s 2023 annual general meeting. At least one Founders Group Director and at least one STX Director will each be required to satisfy the independence standards of the New York Stock Exchange with respect to the combined company as of the Effective Time.

 

Effective as of the Effective Time, the Audit Committee of the Board will consist of four members, two of whom will be Founders Group Directors and two of whom will be STX Directors; the Nomination and Governance Committee of the Board will consist of four members, two of whom will be Founders Group Directors and two of whom will be STX Directors; and the Remuneration Committee of the Board will consist of three members, one of whom will be a Founders Group Director, one of whom will be an STX Director and one of whom will be the Jointly Designated Director.

 

The requisite majority of STX stockholders have adopted the Merger Agreement and approved the transactions contemplated by the Merger Agreement and related documents. Although not required under the Company’s organizational documents or Isle of Man law, a majority in voting power of the Company shareholders have approved the transactions contemplated by the Merger Agreement, PIPE Subscription Agreement and related documents, including the issuance of A ordinary shares pursuant to the Merger Agreement and the Equity Financing (as defined below). Pursuant to a Voting and Support Agreement entered into concurrently with the Merger Agreement, the Founders Group further agreed, among other things, to vote their respective ordinary shares in favor of the transactions contemplated by the Merger Agreement and the Equity Financing, the adoption of the Amended Articles of Association (as defined below) and against any alternative proposals.

 

The completion of the Merger is subject to customary conditions, including: (1) the expiration or termination of the applicable waiting period (or any extension thereof) under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, which condition was fulfilled on May 11, 2020; (2) the receipt of any authorization or consent from a governmental authority required to be obtained with respect to the Merger under certain non-U.S. antitrust laws, which condition was fulfilled on July 8, 2020; (3) the absence of any order or law that has the effect of enjoining or otherwise prohibiting the consummation of the Merger; (4) the substantially concurrent consummation of an aggregate of at least $110 million out of a total of $125 million of equity financing for the combined company (the “Equity Financing”), consisting of (a) the transactions contemplated by the PIPE Subscription Agreement, together with the related subscription for a new class of preferred stock of STX by the purchasers under the PIPE Subscription Agreement, and (b) the arrangement by the Company of at least $50 million of additional equity financing (the “Additional Equity Financing”) from new investors and/or through drawdowns pursuant to the 2020 Equity Offering (as defined below), of which Additional Equity Financing of at least $35 million of gross proceeds must be funded at or prior to the Effective Time (with at least $20 million of such $35 million of gross proceeds at closing required to be drawn pursuant to the 2020 Equity Offering), with any remaining balance of the Equity Financing required to be consummated within 90 days after the Effective Time; (5) the approval for listing on the New York Stock Exchange of the Aggregate Merger Consideration CVR Shares; (6) the continued effectiveness of certain consents and waivers by STX’s existing senior lenders under STX’s existing senior credit facilities and by STX’s existing mezzanine lenders under STX’s existing mezzanine credit facility with respect to the Merger and related transactions, which was delivered concurrently with the Merger Agreement; (7) the execution and delivery by the parties thereto of the CVR Agreements, the Investors’ Rights Agreement (as defined below) and the Registration Rights Agreement (as defined below); (8) subject to certain exceptions, the accuracy of the representations and warranties of Eros and STX, respectively; and (9) performance by the Company and STX in all material respects of their respective obligations under the Merger Agreement.

 

121 

 

The Merger Agreement includes customary representations and warranties of the Company and STX and each party has agreed to customary covenants, including, among others, covenants relating to (1) the conduct of its business during the interim period between execution of the Merger Agreement and the Effective Time and (2) its non-solicitation obligations in connection with alternative acquisition proposals. In addition, the Company agreed to call and hold, as soon as practicable after the date of the Merger Agreement, an extraordinary general meeting of shareholders for the purpose of approving the Amended Articles of Association to reflect certain governance arrangements set forth in the Investors’ Rights Agreement and certain related matters. At such extraordinary general meeting, held on June 29, 2020, the Amended Articles of Association were duly approved by the requisite vote of the Company shareholders.

 

The Merger Agreement provides for certain customary termination rights for both the Company and STX, including in the event the conditions to their respective obligations have not been satisfied by August 17, 2020 (which would be automatically extended to November 13, 2020 if the only remaining unsatisfied conditions relate to obtaining antitrust approval).

 

PIPE Subscription Agreement

 

On April 17, 2020, concurrently and in connection with the Merger Agreement, the Company entered into a Subscription Agreement (the “PIPE Subscription Agreement”) with certain purchasers, pursuant to which such purchasers will purchase newly issued A ordinary shares from the Company for an aggregate purchase price of $75 million in a private placement transaction (the “PIPE Financing”). Each purchaser under the PIPE Subscription Agreement is an existing stockholder of STX.

 

The purchase price for each A ordinary share to be purchased under the PIPE Subscription Agreement is equal to the lowest of (1) $2.60 (the “Base Price”), (2) the weighted average of the purchase price of all purchases made by the purchasers pursuant to the 2020 Equity Offering prior to the Effective Time and (3) the volume weighted average trading price of Eros A Ordinary Shares for the 10 trading days immediately prior to the Effective Time (the “Pre-Closing VWAP”); provided, however, that if the Pre-Closing VWAP is greater than $3.25, then the purchase price per Eros A Ordinary Share under the PIPE Subscription Agreement will be equal to the average of the Base Price and the Pre-Closing VWAP.

 

The consummation of the PIPE Financing is subject, among other customary closing conditions, to (1) the substantially concurrent consummation of the Merger pursuant to the Merger Agreement (without any amendment, modification or supplementation of the terms of the Merger Agreement in a manner that would reasonably be expected to materially and adversely affect the rights or economic benefits that the purchasers under the PIPE Subscription Agreement would reasonably expect to receive thereunder, without, in each case, the consent of each such purchaser), (2) the prior or substantially concurrent consummation of the Additional Equity Financing, with aggregate funded proceeds at or prior to the Effective Time of at least $35 million, and (3) the accuracy of the representations and warranties made by the Company to STX in the Merger Agreement to the same extent so required to be true and correct under the terms and conditions of the Merger Agreement.

 

Concurrently with the execution of the PIPE Subscription Agreement, each purchaser thereunder executed a lock-up agreement (the “PIPE Lock-Up Agreements”) pursuant to which such purchaser agreed not to, without the prior written consent of the Company, directly or indirectly transfer the A ordinary shares issued to such purchaser in the PIPE Financing and the Merger for a period of 75 days from the Effective Time.

 

Form of Investors’ Rights Agreement

 

Pursuant to the Merger Agreement, at the Effective Time, the Company, certain former stockholders of STX who are purchasing A ordinary shares in the PIPE Financing and the Founders Group will enter into an Investors’ Rights Agreement (the “Investors’ Rights Agreement”), in substantially the form attached to the Merger Agreement.

 

122 

 

The Investors’ Rights Agreement provides that, until the third anniversary of the Effective Time, (1) the Hony Investor (as defined therein) will have the right, for so long as the Hony Investor beneficially owns at least 50% of the number of A ordinary shares beneficially owned by it as of the Effective Time (giving effect, prior to the Settlement Date, to the A ordinary shares underlying the CVRs issued to the Hony Investor pursuant to the Merger Agreement), to nominate for election or appointment to the Board each successor to or replacement for an STX Director, and (2) the Founders Group will have the right, for so long as the Founders Group continues to beneficially own at least 50% of the number of ordinary shares beneficially owned by the Founders Group as of the Effective Time (excluding for this purpose shares issued in respect of new equity awards granted at or immediately after the Effective Time), to nominate for election or appointment to the Board each successor to or replacement for a Founders Group Director. In addition, for so long as the Founders Group has the foregoing Board nomination right, with respect to all other directorships to be elected in an election of directors to the Board, the Founders Group shall vote its shares proportionately to the vote of all holders of shares who are not members of the Founders Group; provided that, for purposes of determining any such proportional vote prior to the settlement of the CVRs, CVRs shall be deemed to be outstanding A ordinary shares and to have been voted in such election.

 

In addition, for so long as the Hony Investor has the foregoing Board nomination right, the hiring or termination of the chief executive officer, chief financial officer or president (including any co-president) of the combined company will require the approval of a majority of the Board, including at least one director nominated by the Hony Investor.

 

In addition, until the earlier of the third anniversary of the Effective Time or the date that the Founders Group ceases to beneficially own at least 50% of the number of ordinary shares beneficially owned by the Founders Group as of the Effective Time (excluding for this purpose shares issued in respect of new equity awards granted at or immediately after the Effective Time), the following actions by the combined company or any of its subsidiaries will require the approval of a majority of the Board, including at least one Founders Group Director that is not an independent director (the “Founders Group Protections”): (1) entering into a change of control transaction; (2) initiating a voluntary liquidation, dissolution, bankruptcy or other insolvency proceeding; (3) making a material change in the nature of the business conducted by the combined company and its subsidiaries; (4) hiring or terminating the chief executive officer, chief financial officer or president (including any co-president) of the combined company; or (5) adopting the annual business plan (including operating budget) of the combined company and its subsidiaries.

 

The Investors’ Rights Agreement also provides that, until the third anniversary of the Effective Time, the Founders Group will not, without the prior approval of an independent committee of the Board, acquire beneficial ownership of ordinary shares, or convert A ordinary shares owned by the Founders Group from time to time into B ordinary shares, to the extent doing so would result in the Founders Group beneficially owning more than 50% of the total voting power of the outstanding ordinary shares (the “Founders Group 50% Limit”). Following the third anniversary of the Effective Time, the Founders Group may acquire ordinary shares, and/or convert between A ordinary shares and B ordinary shares, without limitation.

 

The Investors’ Rights Agreement provides for the following minority protections (the “Minority Protections”):

 

·From the Effective Time until the third anniversary of the Effective Time, the prior approval of holders of a majority of the outstanding A ordinary shares will be required before the combined company or any of its subsidiaries takes (or agrees or commits to take) any of the following actions: (1) amending, supplementing or otherwise modifying the combined company’s Memorandum or Articles of Association in a manner that would affect the relative rights of the holders of B ordinary shares vis-à-vis the holders of A ordinary shares; (2) effecting any transaction or series of transactions providing for consideration to the holders of B ordinary shares that is in a different amount or form per share than the consideration provided to the holders of A ordinary shares in such transaction; (3) any action that would have the effect of increasing the relative voting power of the then outstanding B ordinary shares vis-à-vis the then outstanding A ordinary shares; (4) issuing additional B ordinary shares (other than upon conversion of A ordinary shares held by the Founders Group subject to the limitations in the immediately preceding paragraph); or (5) entering into non arms’ length related party transactions between the combined company and the Founders Group.

 

123 

 
·From the Effective Time until the third anniversary of the Effective Time, the prior approval of an independent committee of the Board will also be required before the combined company or any of its subsidiaries takes (or agrees or commits to take) any of the actions described in items (1), (2) and (5) of the immediately preceding bullet.

 

·From the Effective Time until the Settlement Date, all of the actions described in the preceding two bullets, as well as any election or removal of directors by the holders of ordinary shares or any other action generally requiring the approval of holders of ordinary shares, will in addition require the consent of the holders of CVRs corresponding to a number of shares that, together with outstanding shares actually voted with respect to the action in question and assuming the conversion of all CVRs into the respective number of A ordinary shares issuable thereunder as of such date, would be required to approve such action pursuant to the organizational documents or otherwise pursuant to the Minority Protections described in the two preceding bullets.

 

Except for certain fundamental reserved matters that will be subject to approval by a majority of the whole Board, all matters relating to the management of the combined company’s Indian subsidiary, Eros International Media Limited, will be delegated exclusively to a committee of the Board consisting only of Founders Group Directors.

 

Pursuant to the Merger Agreement and the Investors’ Rights Agreement, the Company convened an extraordinary general meeting of shareholders on June 29, 2020 at which the requisite majority in voting power of Company shareholders duly approved an amendment and restatement of the Company’s Articles of Association in substantially the form attached to the Merger Agreement (the “Amended Articles of Association”), in order to reflect the Founders Group Protections, the Founders Group 50% Limit and the Minority Protections. In addition to the foregoing changes, the Amended Articles of Association also expand the definition of “Permitted Holders” therein to include any descendants of the late Mr. Arjan Lulla, who founded Eros and was the father of Kishore Lulla, the Company’s current Executive Chairman and Chief Executive Officer. “Permitted Holders” defines the specific categories of shareholders who are permitted to hold B ordinary shares of the combined company, which will continue after the Effective Time to carry 10:1 voting rights as compared to the A ordinary shares of the combined company. The change to this definition will bring Mr. Sunil Lulla, the brother of Kishore Lulla and the current Chairman and Managing Director of Eros India and currently a member of the board of directors of the Company, and his descendants, within the scope of “Permitted Holders.” As provided in the resolution pursuant to which the Amended Articles of Association were approved, the Amended Articles of Association are conditioned, and will take effect only upon, the Effective Time.

 

Form of Registration Rights Agreement

 

Pursuant to the Merger Agreement, at the Effective Time, the Company, the former stockholders of STX who are entitled to receive CVRs in the Merger and/or who are purchasers in the PIPE Financing and the Founders Group will enter into a Registration Rights Agreement (the “Registration Rights Agreement”), in substantially the form attached to the Merger Agreement.

 

Pursuant to the Registration Rights Agreement, the combined company is required as soon as reasonably practicable after the Effective Time, but in no event later than the 60th day following the Effective Time, to prepare and file with the SEC a registration statement on Form F-1 or Form F-3 (the “Shelf Registration Statement”) providing for the resale from time to time of all A ordinary shares issued (1) at the Effective Time to the former STX stockholders who are purchasing A ordinary shares in the PIPE Financing and (2) on the Settlement Date upon settlement of the CVRs issued to the former STX stockholders pursuant to the Merger Agreement. The combined company must use commercially reasonable efforts to keep the Shelf Registration Statement continuously effective until the earliest of the date as of which all A ordinary shares covered by the Shelf Registration Statement have been sold, such shorter period as may be agreed by all of the former STX stockholders holding A ordinary shares then covered by the Shelf Registration Statement or the four-year anniversary of the date of effectiveness of the Shelf Registration Statement.

 

The former STX stockholders will have the right, from time to time, to cause the combined company to undertake underwritten offerings or sales of A ordinary shares covered by the Shelf Registration Statement having an aggregate value of at least $20 million (each, a “Shelf Take-Down”), in each case at the expense of the combined company. The combined company will not be obligated in any calendar year to effect more than four block trade Shelf Take-Downs or one Shelf Take-Down that is not a block trade.

124 

 

In addition to the rights of the STX stockholders under the Registration Rights Agreement, the Founders Group will have the right, from time to time after the three-month anniversary of the Effective Time, to demand registration, at the combined company’s expense, of ordinary shares having an aggregate value of at least $20 million. The combined company will not be obligated to effect more than five such demand registrations, and such demand registrations are subject to customary “piggyback” registration rights in favor of the former STX stockholders.

 

Important Note Regarding the Merger Agreement and Related Agreements

 

The representations, warranties and covenants contained in the Merger Agreement and other agreements and documents described above were made only for purposes of those agreements and documents and as of the specified dates set forth therein, were solely for the benefit of the parties to those agreements and documents, may be subject to limitations agreed upon by those parties, including being qualified by confidential disclosures made for the purposes of allocating contractual risk between those parties instead of establishing particular matters as facts, and may be subject to standards of materiality applicable to the contracting parties that differ from those applicable to investors. Investors should not rely on these representations, warranties or covenants or any descriptions thereof as characterizations of the actual state of facts or conditions of the parties or any of their respective subsidiaries or affiliates. Moreover, information concerning the subject matter of the representations, warranties and covenants may change after the date of the agreement containing them, which subsequent information may or may not be fully reflected in the Company’s and the combined company’s public disclosures. Accordingly, the agreements described above are described in this filing only to provide investors with information regarding the terms of such agreements and not to provide investors with any other factual information regarding the parties or their respective businesses.

 

2017 Notes Offering

 

On December 06, 2017, the Company closed a registered direct offering (the “2017 Offering”) of $122,500,000 aggregate principal amount of the Company’s Senior Convertible Notes (collectively, the “Notes”) and a Warrant (collectively, the “Warrants”) to purchase up to 2,000,000 of the Company’s A ordinary shares, for an aggregate purchase price of $100,000,000. The Notes and Warrants were issued and sold pursuant to a Securities Purchase Agreement, dated as of December 04, 2017, by and among the Company and the buyers party thereto. The 2017 Offering was effected pursuant to a prospectus supplement dated December 01, 2017 under the Company’s Registration Statement on Form F-3 (Registration No. 333-219708), as amended (the “Registration Statement”). The Registration Statement was declared effective on October 02, 2017. The Warrants expired on June 30, 2018 without being exercised.

 

In connection with the issuance of the Notes, the Company entered into an indenture, dated as of December 06, 2017, between the Company and Wilmington Savings Fund Society, FSB, as trustee (the “Base Indenture”), as supplemented by a first supplemental indenture thereto, dated as of December 06, 2017 (the “Supplemental Indenture” and, the Base Indenture as supplemented by the Supplemental Indenture, the “Indenture”). The terms of the Notes included those provided in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939, as amended.

 

The Notes would have matured on December 06, 2020 unless earlier converted or redeemed, subject to the right of the holders to extend the date under certain circumstances. The Notes were issued with an original issue discount and the terms of the Notes provided that they would not bear interest except upon the occurrence of an event of default, in which case the Notes would bear interest at a rate of 6.0% per annum. The Notes were senior obligations of the Company. 

 

The Company made monthly payments consisting of an amortizing portion of the principal of each Note equal to $3,500,000 and accrued and unpaid interest and late charges on the Note. Provided equity conditions referred to in the prospectus supplement were satisfied, the Company was permitted to make a monthly payment by converting such payment amount into A ordinary shares. Alternatively the Company was permitted, at its option, to make monthly payments by redeeming such payment amount in cash, or by any combination of conversion and redemption.

 

125 

 

All amounts due under the Notes were convertible at any time, in whole or in part, at the holder’s option, into A ordinary shares at the initial conversion price of $14.6875. The conversion price was subject to adjustment for stock splits, combinations and similar events, and, in any such event, the number of A ordinary shares issuable upon the conversion of a Note would also be adjusted so that the aggregate conversion price would have been the same immediately before and immediately after any such adjustment. In addition, the conversion price was also subject to an anti-dilution adjustment if the Company issued or was deemed to have issued securities at a price lower than the then applicable conversion price. Further, if the Company sold or issued any securities with “floating” conversion prices based on the market price of the A ordinary shares, a holder of a Note would have the right thereafter to substitute the “floating” conversion price for the conversion price upon conversion of all or part the Note.

 

The Notes required “buy-in” payments to be made by the Company for failure to deliver any A ordinary shares issuable upon conversion.

 

On or after December 06, 2019, and subject to certain conditions, the Company had the right to redeem all, but not less than all, of the remaining principal amount of the Notes and all accrued and unpaid interest and late charges in cash at a price equal to 100% of the amount being redeemed, so long as the VWAP of the A ordinary shares exceeded $18.3594 (as adjusted for stock splits, stock dividends, recapitalizations and similar events) for at least 10 consecutive trading days. At any time prior to the date of the redemption, a holder had the right to convert its Note, in whole or in part, into A ordinary shares. The Company had no right to effect an optional redemption if any event of default had occurred and was continuing.

 

As of June 30, 2020, all amounts due under the Notes have been converted and no principal amount of the Notes remained outstanding.

 

2020 Notes Offering

 

On September 30, 2019, the Company closed a registered direct offering (the “2019 Offering”) of $27,500,000 aggregate principal amount of the Company’s Senior Convertible Notes (collectively, the “New Notes”) for aggregate net proceeds of approximately $24,500,000. The New Notes were issued and sold pursuant to a Securities Purchase Agreement, dated as of September 26, 2019, by and among the Company and the buyers party thereto. The 2019 Offering was effected pursuant to a prospectus supplement dated September 26, 2019 under the Registration Statement.

 

The securities purchase agreement provided, as consideration for the securities purchase agreement and pursuant to the provisions of the Notes, for the Company to waive rights to make redemptions or repayments under the Notes in cash, and for the holder of the Notes (the “2017 Holder”) to waive certain specified rights and terms under the Notes, including certain rights to cash payment of any installment amounts then-due under the Notes, and provided for automatic election by the Company to pay each installment amount in the Company’s A ordinary shares. Additionally, with respect to an aggregate amount of $9 million of installment amounts as to which a conversion notice was delivered by the 2017 Holder but a conversion did not occur prior to September 26, 2019 as a result of the mutual agreement of the Company and the 2017 Holder, the conversion of such installment was deemed to have been voided by the 2017 Holder as of September 3, 2019, such that the installment conversion price was automatically adjusted in accordance with clause (A) of Section 8(b) of the Notes based on the VWAP of the A ordinary shares as of August 26, 2019.

 

The New Notes will mature on September 30, 2020, unless earlier converted or redeemed, subject to the right of the holders to extend the date under certain circumstances. The New Notes were issued with an original issue discount and do not bear interest except upon the occurrence of an event of default, in which case the New Notes shall bear interest at a rate of 6.0% per annum. The New Notes are senior obligations of the Company.

 

All amounts due under the New Notes are convertible at any time, in whole or in part, at the holder’s option into A ordinary shares at the initial conversion price of $3.59. The conversion price is subject to adjustment for stock splits, combinations and similar events, and, in any such event, the number of A ordinary shares issuable upon the conversion of a New Note will also be adjusted so that the aggregate conversion price shall be the same immediately before and immediately after any such adjustment. In addition, the conversion price is also subject to an anti-dilution adjustment if the Company issues or is deemed to have issued securities at a price lower than the then applicable conversion price. Further, if the Company sells or issues any securities with “floating” conversion prices based on the market price of the A ordinary shares, a holder of a New Note will have the right thereafter to substitute the “floating” conversion price for the conversion price upon conversion of all or part the New Note.

126 

 

The New Notes require “buy-in” payments to be made by the Company for failure to deliver any A ordinary shares issuable upon conversion. Holders of New Notes are entitled to receive any dividends paid or distributions made to the holders of A ordinary shares on an “as if converted” basis. If the Company issues options, convertible securities, warrants, shares or similar securities to holders of A ordinary shares, each New Note holder has the right to acquire the same as if the holder had converted its New Note.

 

The New Notes prohibit the Company from entering into specified fundamental transactions unless the successor entity assumes all of the Company’s obligations under the New Notes under a written agreement before the transaction is completed. Upon specified corporate events, a New Note holder will thereafter have the right to receive upon a conversion such shares, securities, cash, assets or any other property which the holder would have been entitled to receive upon the happening of the applicable corporate event had the New Note been converted immediately prior to the applicable corporate event. When there is a transaction involving specified changes of control, a New Note holder will have the right to force the Company to redeem all or any portion of the holder’s New Note for a purchase price in cash equal to the equal to the greater of (i) 105% of the amount being redeemed, (ii) the product of (A) the amount being redeemed multiplied by (B) the quotient of (1) the highest closing sale price of the A ordinary shares during the period beginning on the date immediately before the earlier to occur of (x) the completion of the change of control and (y) the public announcement of the change of control and ending on the date the holder delivers the redemption notice divided by (2) the conversion price then in effect, or (iii) the product of (A) the amount being redeemed multiplied by (B) the quotient of (1) the aggregate cash consideration and the aggregate cash value of any non-cash consideration per A ordinary share to be paid to the holders of A ordinary shares upon the completion of the change of control divided by (2) the conversion price then in effect.

 

As of June 30, 2020, all amounts due under the New Notes have been converted and no principal amount of the New Notes remained outstanding.

 

2020 Equity Offering

 

On January 27, 2020, the Company announced a registered direct offering (the “2020 Equity Offering”) of up to 13,888,889 of the Company’s A ordinary shares to be effected pursuant to a prospectus supplement under the Registration Statement. The A ordinary shares will be issued and sold from time to time pursuant to one or more subscription agreements entered into with the purchasers.

 

Subject to certain limitations set forth in the subscription agreement, each time the Company wishes to sell A ordinary shares under the agreement, it will notify an investor of the number of shares to be sold and the minimum price below which the sale will not be made. The per share purchase price for sales will be an amount equal to 95% of the lowest daily VWAP of the A ordinary shares on the New York Stock Exchange for each of the five successive trading days beginning on the first trading day following the date of the Company’s notice to the investor. However, if the VWAP on any trading day during this five-day period is lower than any minimum price specified in the notice to the investor, then for each such trading day, the number of A ordinary shares to be sold under such notice will automatically be reduced by an amount equal to 20% and that trading day will not be included in the final determination of the per share purchase price.

 

The Company makes certain customary representations and warranties in the agreement, including with respect to certain capitalization and securities law matters. The agreement also obligates the parties to indemnify each other for certain losses suffered or incurred by reason of the other party’s breach of the agreement.

 

As of June 30, 2020, the Company had sold an aggregate of 9,472,522 A ordinary shares for aggregate net proceeds of $ 31,087,500, before deducting estimated expenses, which the Company intends to use to fund investment in new content, with a focus on digital, and for general corporate purposes. Such proceeds of the 2020 Equity Offering constitute the Additional Equity Financing and satisfy the related closing condition under the Merger Agreement, as described above under the heading “Merger Agreement.”

 

Reliance Registration Rights Agreement

 

The Company entered into a registration rights agreement with Reliance Industrial Investments and Holdings Limited, dated August 8, 2018 in connection with the purchase by Reliance Industries Limited, or Reliance, of A ordinary shares. The terms of the registration rights agreement required that the Company register the resale of the A ordinary shares held by Reliance as of the date of the registration rights agreement and also requires that the Company register the resale of any A ordinary shares subsequently acquired by Reliance. The Company filed a Registration Statement on Form F-3 (File No. 333-227380) on September 17, 2018 as required by the registration rights agreement. The SEC declared the registration statement effective on October 9, 2018.

127 

 

D. Exchange Controls

 

No foreign exchange control regulations are in existence in the Isle of Man in relation to the exchange or remittance of sterling or any other currency from the Isle of Man and no authorizations, approvals or consents will be required from any authority in the Isle of Man in relation to the exchange and remittance of sterling and any other currency whether awarded by reason of a judgment or otherwise falling due and having been paid in the Isle of Man.

 

E. Taxation

 

Summary of Material Indian Tax Considerations

 

The discussion contained herein is based on the applicable tax laws of India as in effect on the date hereof and is subject to possible changes that may come into effect after such date. The information set forth below is intended to be a general discussion only. Prospective investors should consult their own tax advisers as to the consequences of purchasing the A ordinary shares, including, without limitation, the consequences of the receipt of dividend and the sale, transfer or disposition of the ordinary shares.

 

i)     Direct Tax:

 

Indirect Transfer:

Based on the fact that we are considered for tax purposes as a company domiciled abroad, any dividend distributed in respect of ordinary shares will not be subject to any withholding or deduction under the Indian income tax laws. As per the provisions of the Indian Income Tax Act, 1961, income arising directly or indirectly through the transfer of a capital asset, including any share or interest in a company or entity registered or incorporated outside India, will be liable to tax in India, if such share or interest derives, directly or indirectly, its value substantially from assets located in India, whether or not the seller of such share or interest has a residence, place of business, business connection, or any other presence in India, if, on the specified date, the value of such assets located in India (i) represents at least 50% of the value of all assets owned by the company or entity, and (ii) exceeds the amount of 100 million rupees. However, the impact of the above indirect transfer provisions would need to be separately evaluated under the tax treaty scenario.

 

Dividend Distribution Tax:

 

As per the Finance Act 2020, Dividend Distribution Tax (‘DDT’) of 20.56% levied on the companies declaring dividend has been abolished with effect from April 1, 2020. Consequently, dividend is taxable in the hands of recipient and there shall be withholding of taxes on such dividends. The withholding tax rate under local laws is 10% (excluding surcharge and cess) for Indian residents and 20% (excluding surcharge and cess) for non-residents / foreign companies. Benefits are available under the relevant tax treaties.

 

Equalization Levy:

An equalization levy or EL in respect of certain e-commerce transactions has been introduced in India with effect from June 1, 2016. EL is to be deducted in respect of payment towards “specified services” (in excess of INR 100,000). A “Specified service” means online advertisement, any provision for digital advertising space or any other facility or service for the purpose of online advertisement and includes any other service as may be notified. Deduction of EL at the rate of six per cent (on a gross basis) is the responsibility of Indian residents / non-residents having a permanent establishment (PE) in India on payments to non-residents (not having a PE in India). Consequently, if a non-resident (not having a PE in India) earns income towards a “specified service” which is chargeable to EL, then the same would be exempt in the hands of such non-resident.

 

Further, the Finance Act, 2020 has expanded the scope of EL by covering e-commerce transactions. E - commerce supply or services include online sale of goods, online provision of services or both owned or provided by an E-commerce operator. However, EL shall not be charged in case sales, turnover or gross receipts of the E-commerce operator is less than INR 20 million.

 

Discharge of EL at the rate of two percent (on a gross basis) is the responsibility of E – commerce operator receiving consideration on the supply or services made to Indian residents, non-residents in “specified circumstances” or any other person using IP address located in India. However, any service or supply made by the E – commerce operator which is in connection to their PE in India will not be liable for EL. If a non-resident (not having a PE in India) earns income which is chargeable to EL, then the same would be exempt in the hands of such non-resident.

128 

 

Tax on sale of films as ‘Royalty’

Currently, consideration for the sale, distribution or exhibition of cinematographic films is specifically excluded from the definition of Royalty. However, as per Finance Act 2020, the definition of Royalty will be rationalized to include consideration for the sale, distribution or exhibition of cinematographic films (w.e.f. April 1, 2021).

 

Place of Effective Management:

The concept of Place of Effective Management or POEM is introduced for the purpose of determining the tax residence of overseas companies in India. The POEM is defined to mean a place where key management and commercial decisions that are necessary for the conduct of the business of an entity as a whole are in substance made. This could have significant impact on the foreign companies holding board meeting(s) in India, having key managerial personnel located in India, having regional headquarters located in India, etc. In the event the POEM of a foreign company is considered to be situated in India, it becomes tax resident in India, and consequently, its global income would be taxable in India (even if it is not earned in India).

 

General Anti Avoidance Rules:

The General Anti Avoidance Rules (“GAAR”) have come into effect from financial year 2017-18. The tax consequences of the GAAR provisions if applied to an arrangement could result in denial of tax benefit under the domestic tax laws and / or under a tax treaty, amongst other consequences.

 

Multilateral Instrument:

The Organization of Economic Co-operation and Development (OECD) released the final package of all Action Plans of the Base Erosion and Profit Shifting (BEPS) project in October 2015. India is a member of G20 and active participant in the BEPS project. The BEPS project lead to a series of measures being developed across several actions such as the digital economy, treaty abuse, design of Controlled Foreign Company Rules, intangibles, country-by-country reporting, preventing artificial avoidance of PE status, improving dispute resolution, etc. Several of these measures required implementation through changes in domestic law. In order to implement the measures which entailed changes to bilateral tax treaties, Instrument (MLI) was introduced to modify the existing bilateral tax treaty network and ensure speed and consistency in implementation. MLI inter-alia addresses following treaty related measures:

 

  Preventing the granting of treaty benefits in inappropriate circumstances;
  Preventing the artificial avoidance of Permanent Establishment status;
  Making dispute resolution mechanisms more effective.

 

On June 07, 2017, India signed the MLI to implement tax treaty related measures to prevent BEPS. On June 25, 2019, India deposited the instrument of ratification for MLI with OECD along with a list of reservations and notifications. As a result, MLI will enter into force for India on October 1, 2019 and its provisions will have effect on India’s tax treaties from FY 2020-21 onwards where the other country has also deposited its instrument of ratification with OECD.

 

Significant Economic Presence:

Given the digital age, the need for physical presence in conducting business is steeply reducing giving way to interaction by way of technology. Having regard to the report of OECD on BEPS Action Plan 1, an amendment was been made vide Finance Act 2018 whereby concept of ‘significant economic presence’ was introduced under the domestic tax laws to cover within the tax ambit transactions in digitized business. Significant economic presence shall be constituted in cases where:

 

  Transactions in respect of any goods, services or property are carried out by a non-resident in India (including downloading of data or software);
  Non-residents engage in systematic and continuous soliciting of business activities or engaging with users in India, through digital means;

 

if the prescribed thresholds are breached.

 

Further, if SEP is constituted, attribution of profits for taxation in India shall be restricted to transactions and / or business activities / users in India.

 

The threshold of payments received and number of users (mentioned in the aforesaid conditions) shall be prescribed by the Central Board of Direct Taxes (CBDT) in due course, after which, one will be able to gauge the impact of this expansion in the provision.

129 

 

Further, unless corresponding modifications to PE rules are made in tax treaties, the existing treaty rules will apply. Accordingly, the above provisions would need to be separately evaluated under the tax treaty scenario.

 

However, as per Finance Act, 2020, it is pertinent to note that SEP provisions have been deferred by a year and shall be effective from April 1, 2021.

 

ii)    Indirect Tax

 

Goods and Services Tax

As far as introduction of Goods and Services Tax (“GST”) is concerned, it has been a little more than three years since its enactment. Most of the indirect taxes under earlier regime have been subsumed and only one tax i.e. GST is being levied at national level. In India, there is a dual GST model which grants power to central as well as state governments to levy GST on interstate and intrastate transactions, respectively. To a large extent GST has curtailed various exemptions and concessions which were prevalent in the earlier tax regime. The benefits of GST such as, elimination of multiple taxes and levy of one tax has reduced the cascading effect and has consequently reduced the overall incidence of taxes.

 

Under GST regime, the entertainment tax which under earlier regime was levied by state governments in most of the states has been subsumed under GST. However, in certain states the local authorities have been given powers to levy and collect taxes on entertainment. This may be said to be a back door entry by state governments to levy taxes on entertainment.

 

On the other hand, the government through its GST Council meetings are also trying to resolve various issues that had surfaced under GST, thereby resolving ambiguity for the Media and Entertainment industry and avoiding the possibility of probable tax litigation. However, the impact of GST on the media and entertainment industry are both positive and negative. The industry stands to benefit considerably with the introduction of GST, due to single tax levy on licensing of copyright, fungibility of credit of goods and overall reduction of cascading effect of taxes having a positive effect on the cost of production and profitability. However, certain concern areas still remain open, for which the industry seek certain amendments in the law and clarifications from the government. The industry awaits a positive response from the government in reference to such concern areas.

 

Summary of Material Isle of Man Tax Considerations

 

Tax residence in the Isle of Man

 

We are resident for taxation purposes in the Isle of Man by virtue of being incorporated in the Isle of Man.

 

Capital taxes in the Isle of Man

 

The Isle of Man has a regime for the taxation of income, but there are no taxes on capital gains, stamp taxes or inheritance taxes in the Isle of Man. No Isle of Man stamp duty or stamp duty reserve tax will be payable on the issue or transfer of, or any other dealing in, the A ordinary shares.

 

Zero rate of corporate income tax in the Isle of Man

 

The Isle of Man operates a zero rate of tax for most corporate taxpayers, including the Company. Under the regime, the Company will technically be subject to Isle of Man taxation on its income, but the rate of tax will be zero; there will be no required withholding by the Company on account of Isle of Man tax in respect of dividends paid by the Company.

 

The Company will be required to pay an annual return fee of £380 (US $495) per year.

 

Isle of Man probate

 

In the event of death of a sole, individual holder of the A ordinary shares, an Isle of Man probate fee or administration may be required, in respect of which certain fees will be payable to the Isle of Man government, subject to the fee. Currently the maximum fee, where the value of an estate exceeds £1,000,000 (US $1,300,000) is approximately £8,000 (US $10,400).

130 

 

Summary of Material United States Federal Income Tax Considerations

 

The following summary describes the material United States federal income tax consequences associated with the acquisition, ownership and disposition of our A ordinary shares as of the date hereof. The discussion set forth below is applicable only to U.S. Holders (as defined below) and does not purport to be a comprehensive description of all tax considerations that may be relevant to a particular person’s decision to acquire the A ordinary shares.

 

Except where noted, this summary applies only to a U.S. Holder that holds A ordinary shares as capital assets for United States federal income tax purposes. As used herein, the term “U.S. Holder” means a beneficial owner of a share that is for United States federal income tax purposes:

 

  an individual citizen or resident of the United States;
  a corporation (or other entity treated as a corporation for United States federal income tax purposes) created or organized in or under the laws of the United States, any state thereof or the District of Columbia;
  an estate the income of which is subject to United States federal income taxation regardless of its source; or
  a trust if it (1) is subject to the primary supervision of a court within the United States and one or more United States persons have the authority to control all substantial decisions of the trust or (2) has a valid election in effect under applicable United States Treasury regulations to be treated as a United States person.

 

This summary does not describe all of the United States federal income tax consequences applicable to you if you are subject to special treatment under the United States federal income tax laws, including if you are a broker, a dealer or trader in securities or currencies, a financial institution, a regulated investment company, a real estate investment trust, a cooperative, an insurance company, a pension plan, a tax-exempt entity, a person holding our A ordinary shares as part of a hedging, integrated or conversion transaction, a constructive sale, a wash sale or a straddle, a person liable for alternative minimum tax, a person who owns directly, indirectly or constructively, 5% or more, by voting power or value, of our stock, a person holding our A ordinary shares in connection with a trade or business conducted outside of the United States, a partnership or other pass-through entity for United States federal income tax purposes (and any investors in such partnership or other pass-through entity), a U.S. expatriate or a person whose “functional currency” for United States federal income tax purposes is not the United States dollar. The discussion below assumes that we will not be treated as a “surrogate foreign corporation” under section 7874 of the Code as a result of the STX Transaction. The discussion below is based upon the provisions of the United States Internal Revenue Code of 1986, as amended (the “Code”), and regulations (including proposed regulations), rulings and judicial decisions thereunder as of the date hereof, and such authorities may be subject to differing interpretations or may be replaced, revoked or modified, possibly with retroactive effect, so as to result in United States federal income tax consequences different from those discussed below.

 

If a partnership (or other entity or arrangement treated as a partnership for United States federal income tax purposes) holds our A ordinary shares, the tax treatment of a partner will generally depend upon the status of the partner and the activities of the partnership. If you are a partnership holding our A ordinary shares or a partner of a partnership holding our A ordinary shares, you should consult your tax advisors as to the particular United States federal income tax consequences of acquiring, holding and disposing of the A ordinary shares.

 

This discussion does not contain a detailed description of all the United States federal income tax consequences to you in light of your particular circumstances and does not address estate and gift taxes or the effects of any state, local or non-United States tax laws. If you are considering the purchase, ownership or disposition of our A ordinary shares, you should consult your own tax advisors concerning the United States federal income tax consequences to you in light of your particular situation as well as any other consequences to you arising under U.S. federal, state and local laws and the laws of any other applicable taxing jurisdiction in light of your particular circumstances.

 

131 

 

Taxation of Distributions

 

Subject to the discussion under “—Passive Foreign Investment Company” below, the gross amount of distributions on the A ordinary shares will be taxable as dividends to the extent paid out of our current or accumulated earnings and profits, as determined under United States federal income tax principles. To the extent that the amount of any distribution exceeds our current and accumulated earnings and profits (as determined under U.S. federal income tax principles) such excess will be treated first as a tax-free return of capital to the extent of the U.S. Holder’s tax basis in the A ordinary shares and thereafter as capital gain recognized on a sale or exchange. Because we do not expect to keep track of earnings and profits in accordance with United States federal income tax principles, you should expect that a distribution in respect of the A ordinary shares will generally be treated and reported as a dividend to you. Such dividend income will be includable in your gross income as ordinary income on the day actually received by you or on the day received by your nominee or agent that holds the A ordinary shares on your behalf. Such dividends will not be eligible for the dividends received deduction allowed to corporations in respect of dividends received from other U.S. corporations under the Code.

 

With respect to non-corporate U.S. Holders, certain dividends received from a qualified foreign corporation may be subject to reduced rates of taxation. A foreign corporation is treated as a qualified foreign corporation with respect to dividends paid by that corporation on shares that are readily tradable on an established securities market in the United States. Our A ordinary shares are listed on the NYSE and we expect such shares to be considered readily tradable on an established securities market, although there can be no assurance in this regard nor can there be assurance, if our shares are considered to be readily tradable on an established securities market, that our A ordinary shares will continue to be readily tradable on an established securities market in later years. However, even if the A ordinary shares are readily tradable on an established securities market in the United States, we will not be treated as a qualified foreign corporation if we are a passive foreign investment company, or PFIC, for the taxable year in which we pay a dividend or were a passive foreign investment company, or PFIC, for the preceding taxable year or if we are treated as a “surrogate foreign corporation” within the meaning of Section 7874 of the Code. Non-corporate holders that do not meet a minimum holding period requirement during which they are not protected from a risk of loss or that elect to treat the dividend income as “investment income” pursuant to Section 163(d)(4) (B) of the Code will not be eligible for the reduced rates of taxation regardless of our status as a qualified foreign corporation. For this purpose, the minimum holding period requirement will not be met if a share has been held by a holder for 60 days or less during the 121-day period beginning on the date which is 60 days before the date on which such share becomes ex-dividend with respect to such dividend, appropriately reduced by any period in which such holder is protected from risk of loss. In addition, the rate reduction will not apply to dividends if the recipient of a dividend is obligated to make related payments with respect to positions in substantially similar or related property. This disallowance applies even if the minimum holding period has been met. You should consult your own tax advisors regarding the availability of the reduced tax rate on dividends in light of your particular circumstances.

 

Subject to certain conditions and limitations imposed by United States federal income tax rules relating to the availability of the foreign tax credit, some of which vary depending upon the U.S. Holder’s circumstances, any foreign withholding taxes on dividends will be treated as foreign taxes eligible for credit against your United States federal income tax liability. The application of the rules governing foreign tax credits depends on the particular circumstances of each U.S. Holder. The limitation on foreign taxes eligible for credit is calculated separately with respect to specific classes of income. For purposes of calculating the foreign tax credit, dividends paid on the A ordinary shares will be treated as income from sources outside the United States and will generally constitute “passive category income.” Further, in certain circumstances, you will not be allowed a foreign tax credit for foreign taxes imposed on certain dividends paid on the A ordinary shares if you:

 

  have held A ordinary shares for less than a specified minimum period during which you are not protected from risk of loss, or
  are obligated to make certain payments related to the dividends.

 

The rules governing the foreign tax credit are complex and involve the application of rules that depend on your particular circumstances. You are urged to consult your tax advisors regarding the availability of the foreign tax credit under your particular circumstances.

 

132 

 

Passive Foreign Investment Company

 

Based on the composition of our income and valuation of our assets, we do not believe we will be a PFIC for United States federal income tax purposes for the 2020 taxable year, and we do not expect to become one in the future. However, because PFIC status is an annual factual determination that cannot be made until after the close of each taxable year and depends on the composition of a company’s income and assets and the market value of its assets from time to time, there can be no assurance that we will not be a PFIC for any taxable year.

 

In general, a non-United States corporation will be treated as a PFIC for U.S. federal income tax purposes for any taxable year in which:

 

  at least 75% of its gross income is passive income, or
  at least 50% of the value (determined based on a quarterly average) of its gross assets is attributable to assets that produce, or are held for the production of, passive income.

 

For this purpose, passive income generally includes dividends, interest, royalties and rents (except for certain royalties and rents derived from the active conduct of a trade or business), certain gains from commodities and securities transactions and the excess of gains over losses from the disposition of assets which produce passive income.

 

If we own, directly or indirectly, at least 25% (by value) of the stock of another corporation, we will be treated, for purposes of the PFIC tests described above, as directly owning our proportionate share of the other corporation’s assets and receiving our proportionate share of the other corporation’s income.

 

If we are a PFIC for any taxable year during which you hold our A ordinary shares, you will be subject to special tax rules with respect to any “excess distribution” received and any gain realised from a sale or other disposition, including a pledge, of A ordinary shares, unless you make a “mark-to-market” election as discussed below.

 

Distributions you receive in a taxable year that are greater than 125% of the average annual distributions you received during the shorter of the three preceding taxable years or your holding period for the A ordinary shares (before the current taxable year) and gain realised on disposition of the A ordinary shares will be treated as excess distributions. Under these special tax rules:

 

  the excess distribution or gain will be allocated ratably over your holding period for your A ordinary shares,
  the amount allocated to the current taxable year, and any taxable year prior to the first taxable year in which we were a PFIC, will be treated as ordinary income, and
  the amount allocated to each other year will be subject to tax at the highest applicable tax rate in effect for corporations or individuals, as appropriate, for that taxable year and the interest charge generally applicable to underpayments of tax will be imposed on the resulting tax attributable to each such year.

 

The tax liability for amounts allocated to years prior to the year of an “excess distribution” (including a disposition) cannot be offset by any net operating losses for such years, and gains (but not losses) realised on the sale of the A ordinary shares cannot be treated as capital and will be subject to the “excess distribution” regime described above, even if you hold the A ordinary shares as capital assets.

 

In addition, as explained above under “—Taxation of Distributions,” non-corporate U.S. Holders will not be eligible for reduced rates of taxation on any dividends received from us if we are a PFIC in our taxable year in which such dividends are paid or in the preceding taxable year.

 

If we are a PFIC for any taxable year during which you own our A ordinary shares, we will generally continue to be treated as a PFIC with respect to you for all succeeding years during which you own our A ordinary shares, even if we cease to meet the threshold requirements for PFIC status.

 

You will generally be required to file Internal Revenue Service Form 8621(a) annually if the aggregate value of all your directly owned PFIC shares on the last day of the taxable year is more than $25,000 ($50,000 on a joint return) or if you are deemed to own indirectly more than $5,000 in value of any PFIC shares owned by us; (b) you receive distributions on the A ordinary shares or realize any gain on the disposition of the A ordinary shares or (c) if you have made a mark-to market election (as described below). Other reporting requirements may apply. You are urged to consult your tax advisors regarding Form 8621 and other information reporting requirements if we are considered a PFIC in any taxable year.

 

133 

 

If we are a PFIC for any taxable year during which a U.S. Holder holds our A ordinary shares and any of our non-United States subsidiaries is also a PFIC, a U.S. Holder would be treated as owning a proportionate amount (by value) of the shares of the lower-tier PFIC for purposes of the application of these rules.

 

Under these circumstances, a U.S. Holder would be subject to United States federal income tax on (i) a distribution on the shares of a lower-tier PFIC and (ii) a disposition of shares of a lower-tier PFIC, both as if such U.S. Holder directly held the shares of such lower-tier PFIC. You are urged to consult your tax advisors about the application of the PFIC rules to any of our subsidiaries.

 

In certain circumstances, in lieu of being subject to the excess distribution rules discussed above, you may make an election to include gain on the stock of a PFIC as ordinary income under a mark-to-market method, provided that such stock is regularly traded in other than de minimis quantities for at least 15 days during each calendar quarter on a qualified exchange, as defined in applicable U.S. Treasury Regulations. Our A ordinary shares are listed on the NYSE and we expect such shares to be “regularly traded” for purposes of the mark-to-market election, though no assurances can be made in this regard, nor can there be assurance, if our shares are considered to be “readily tradable” for this purpose, that our A ordinary shares will continue to be “readily tradable”.

 

If you make an effective mark-to-market election, you will include in each year that we are a PFIC, as ordinary income the excess of the fair market value of your A ordinary shares at the end of the year over your adjusted tax basis in the A ordinary shares. You will be entitled to deduct as an ordinary loss in each such year the excess of your adjusted tax basis in the A ordinary shares over their fair market value at the end of the year, but only to the extent of the net amount previously included in income as a result of the mark-to-market election, although no assurance can be given that a mark-to-market election will be available to U.S. Holders.

 

If you make an effective mark-to-market election, any gain you recognize upon the sale or other disposition of your A ordinary shares in a year in which we are a PFIC will be treated as ordinary income. Any loss will be treated as ordinary loss, but only to the extent of the net amount of previously included income as a result of the mark-to-market election.

 

Your adjusted tax basis in the A ordinary shares will be increased by the amount of any income inclusion and decreased by the amount of any deductions under the mark-to-market rules. If you make a mark-to-market election, it will be effective for the taxable year for which the election is made and all subsequent taxable years unless the A ordinary shares are no longer regularly traded on a qualified exchange or the Internal Revenue Service consents to the revocation of the election.

 

A mark-to-market election should be made by filing IRS Form 8621 in the first taxable year during which the U.S. Holder held the A ordinary shares and in which we are a PFIC. A mark-to-market election would not be available with respect to a subsidiary PFIC of ours that a U.S. Holder is deemed to own for the purposes of the PFIC rules; accordingly, a U.S. Holder would not be able to mitigate certain of the adverse U.S. “excess distribution” federal income tax consequences of its deemed ownership of stock in our subsidiary PFICs by making a mark-to-market election. You are urged to consult your tax advisor about the availability of the mark-to-market election and whether making the election would be advisable in your particular circumstances.

 

Alternatively, holders of PFIC shares can sometimes avoid the rules described above by electing to treat such PFIC as a “qualified electing fund” under Section 1295 of the Code. However, this option is not available to you because we do not intend to comply with the requirements, or furnish you with the information, necessary to permit you to make this election.

 

You are urged to consult your tax advisors concerning the United States federal income tax consequences of holding A ordinary shares if we are considered a PFIC in any taxable year.

 

134 

 

Sale or Other Disposition of A Ordinary Shares

 

For United States federal income tax purposes, you will recognize taxable gain or loss on any sale or exchange or other taxable disposition of an A ordinary share in an amount equal to the difference between the amount realised for the share and your tax basis in the A ordinary share, in each case as determined in United States dollars. Subject to the discussion above under “Passive Foreign Investment Company,” such gain or loss will be capital gain or loss. Capital gains of non-corporate U.S. Holders derived with respect to capital assets held for more than one year are eligible for reduced rates of taxation. The deductibility of capital losses is subject to limitations.

 

Any gain or loss recognised by you will generally be treated as United States source gain or loss for U.S. foreign tax credit purposes. You are encouraged to consult your tax advisor regarding the availability of the U.S. foreign tax credit in your particular circumstances.

 

Information Reporting and Backup Withholding

 

In general, information reporting will apply to distributions in respect of our A ordinary shares and the proceeds from the sale, exchange or redemption of our A ordinary shares that are paid to you within the United States or through certain U.S.-related financial intermediaries, unless you are an exempt recipient. Backup withholding may apply to such payments if you fail to (i) provide a correct taxpayer identification number or (ii) certify that you are not subject to backup withholding or (iii) otherwise comply with the backup withholding rules. U.S. Holders who are required to establish their exemption from backup withholding must timely provide the applicable withholding agent such certification on a properly completed Internal Revenue Service Form W-9. U.S. Holders should consult their tax advisors regarding the application of the United States information reporting and backup withholding rules.

 

Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules will be allowed as a refund or a credit against your United States federal income tax liability provided the required information is timely furnished to the Internal Revenue Service.

 

Certain U.S. Holders who hold “specified foreign financial assets,” including shares of a non-U.S. corporation that are not held in an account maintained by a U.S. “financial institution,” the aggregate value of which exceeds $50,000 (or other applicable amount) during the tax year, may be required to attach to their tax returns for the year IRS Form 8938 containing certain specified information. Significant penalties can apply if you are required to file this form and you fail to do so. You are urged to consult your tax advisors regarding this and other information reporting requirements relating to your ownership of the A ordinary shares.

 

Medicare Tax

 

Certain U.S. Holders that are individuals, estates or trusts will be subject to an additional 3.8% tax on all or a portion of their “net investment income,” which may include all or a portion of their dividends and net gains from the disposition of A ordinary shares. Special rules apply to stock in a PFIC. If you are a U.S. Holder that is an individual, estate or trust, you should consult your tax advisors regarding the applicability of this tax to your income and gains in respect of your investment in the A ordinary shares.

 

F. Dividends and Paying Agents

 

Not applicable.

 

G. Statement by Experts

 

Not applicable.

 

H. Documents on Display

 

Publicly filed documents concerning our company which are referred to in this annual report may be inspected and copied at the public reference facilities maintained by the Commission at 100 F Street, N.E., Washington, D.C. 20549. Copies of these materials can also be obtained from the Public Reference Room at the Commission’s principal office, 100 F Street, N.E., Washington D.C. 20549, after payment of fees at prescribed rates.

135 

 

The Commission maintains a website at www.sec.gov that contains reports, proxy and information statements and other information regarding registrants that make electronic filings through its Electronic Data Gathering, Analysis, and Retrieval, or EDGAR, system. We have made all our filings with the Commission using the EDGAR system.

 

I. Subsidiary Information

 

For more information on our subsidiaries, please see “Part I — Item 4. Information on the Company — C. Organizational Structure.”

 

ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are exposed to financial risks, including credit risk, interest rate risk, foreign currency risk and equity risk:

 

Credit Risk

 

Trading credit risk is managed on a country by country basis by the use of credit checks on new clients and individual credit limits, where appropriate, together with regular updates on any changes in the trading partner’s situation. In a number of cases trading partners will be required to make advance payments or minimum guarantee payments before delivery of any goods. The Group reviews reports received from third parties and in certain cases as a matter of course reserve the right within the contracts it enters into to request an independent third - party audit of the revenue reporting. Further, in many of the catalogue sales, the trading partners have extended payment terms of up to a year and often fall behind contractual payment terms, thus payment cycle extends to 18 to 24 months. With respect to catalogue and other customers with a long trading history with the Group and who have contracted and paid significant amounts in the past without any prior history of bad debt, the Group closely monitors the same revised payment plans to assure collections. In case of new customer onboarding, the Group follows certain standard Know Your Client (KYC) procedures to ascertain financial stability of the counterparty and follows internal policies to not make ongoing sales to such new customers who are not reasonably current with their payments.

 

The Group from time to time will have significant concentration of credit risk in relation to individual theatrical releases, television syndication deals, music licenses, or producer/ VFX services. This risk is mitigated by contractual terms which seek to stagger receipts, de-recognition of financial assets and/or the release or airing of content. As at March 31, 2020, 40.1% (2019: 20.4%) of trade account receivables were represented by the top five debtors and for the year ended March 31, 2020, a loss on de-recognition of financial assets amounting to $5,285 (2019: $5,988 and 2018: $3,562) arising on assignment and novation of trade receivable and trade payables with no recourse have been recognized in the statement of Income within other gains/(losses), net. The maximum exposure to credit risk is that shown within the statements of financial position, net of credit impairment loss $112,323 (2019: $ 41,335, 2018: $ 10,193). The maximum credit exposure on financial guarantees given by the Group for various financial facilities is described in Note 31.

 

As at March 31, 2020, the Group did not hold any material collateral or other credit enhancements to cover its credit risks associated with its financial assets.

 

Interest Rate Risk

 

The Group is exposed to interest rate risk because entities in the Group borrow funds at both fixed and floating interest rates. The risk is managed by maintaining an appropriate mix between fixed, capped and floating rate borrowings, and by the use of interest rate swap contracts and forward interest rate contracts. Hedging activities are evaluated to align with interest rate views to ensure the most cost effective hedging strategies are applied.

 

Foreign Currency Risk

 

The Group operates throughout the world with significant operations in India, the British Isles, the United States of America and the United Arab Emirates. As a result it faces both translation and transaction currency risks which are principally mitigated by matching foreign currency revenues and costs wherever possible.

 

The Group’s major revenues are denominated in U.S. Dollars, Indian Rupees and British pounds sterling which are matched where possible to its costs so that these act as an automatic hedge against foreign currency exchange movements.

136 

 

We have to date not entered into any currency hedging transactions, and we have managed foreign currency exposure to date by seeking to match foreign currency inflows and outflows to the extent possible.

 

A uniform decrease of 10% in exchange rates against all foreign currencies in position as of March 31, 2020 would have increased the Company’s net loss before tax by approximately $6,952 (2019: gain of $7,036 and 2018: gain of $5,935). An equal and opposite impact would be experienced in the event of an increase by a similar percentage.

 

Our sensitivity to foreign currency has increased during the year ended March 31, 2020 as a result of an increase in liabilities compared to assets denominated in foreign currency over the comparative period. In Management’s opinion, the sensitivity analysis is unrepresentative of the inherent foreign exchange risk because the exposure at the end of the reporting period does not reflect the exposure during the year.

 

Equity Risk

 

We are exposed to market risk relating to changes in the market value of our investments, which we hold for purposes other than trading. We invest in equity instruments of private companies for operational and strategic business reasons. These securities may be subject to significant fluctuations in fair market value due to volatility in the industries in which they operate. As at March 31, 2020, the aggregate value of all such equity investments was $0.1 million. For further discussion of our investments see Note 17 to our audited Consolidated Financial Statements appearing elsewhere in this Annual Report.

 

ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES

 

A. Debt Securities

 

Not applicable.

 

B. Warrants and Rights

 

Not applicable.

 

C. Other Securities

 

Not applicable.

 

D. American Depository Shares

 

Not applicable.

 

137 

 

PART II

 

ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES

 

None.

 

ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS

 

Not applicable.

 

ITEM 15. CONTROLS AND PROCEDURES

 

ITEM 15A. DISCLOSURE CONTROLS AND PROCEDURES

 

Our management is responsible for the disclosure of controls and procedures that are designed to provide reasonable assurance that information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and such information is accumulated and communicated to our management, as appropriate, to allow for timely decisions regarding required disclosure.

 

In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgement in evaluating the cost-benefit relationship of possible controls and procedures.

 

During the evaluation of disclosure controls and procedures and our internal control over financial reporting as of March 31, 2019, conducted during the preparation of our financial statements, which were included in our Annual Report on Form 20-F for the year ended March 31, 2019, our management had concluded that our disclosure controls and procedures were not effective as of March 31, 2019 because of material weaknesses in our internal control over financial reporting relating to our Internal Control Environment.

 

As required by SEC Rule 13a-15(d), we carried out an evaluation, under the supervision and with the participation of our management, of the effectiveness of our disclosure controls and procedures as of March 31, 2020. As of March 31, 2020, and as described under the Status of Remediation of Material Weakness in Internal Controls Over Financial Reporting below, the material weaknesses were not fully remediated. As a result, our management concluded that our disclosure controls and procedures were not effective as of March 31, 2020. In light of the material weakness described below, the Company performed additional analysis and other post-closing procedures to determine if its consolidated financial statements are prepared in accordance with IFRS as issued by IASB. Accordingly, management concluded that the financial statements included in this Annual Report on Form 20-F fairly present in all material respects the Company’s financial condition, results of operations and cash flow for the periods presented.

 

ITEM 15B. MANAGEMENT’S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rule 13a- 15(d) of the Exchange Act. Our management has assessed the effectiveness of our internal control over financial reporting as of March 31, 2020 using the criteria established in “Internal Control – Integrated Framework” (2013), issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Our management concluded that our internal control over financial reporting were not effective as of March 31, 2020 because of material weaknesses in our internal control over financial reporting. A material weakness is deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis.

 

In connection with the preparation of our consolidated financial statements as of and for the year ended March 31, 2020, we identified the following material weaknesses in our internal control over financial reporting:

 

a)The Company’s process of performing customer and/ or vendor due diligence assessment prior to sale or purchase is not satisfactory, which could amongst other things result in assigning of inappropriate credit limits to customer and/ or vendor. Customer and vendor business particulars are among the key data which the Company should have documented in a Customer/Vendor’s master file.

138 

 

b)The management review controls designed by the Company, including review of spreadsheets/excel utility control assessment, did not provide sufficient and appropriate evidence to substantiate a level of aggregation and consistency of performance required to prevent or detect misstatements. To be specific, there was lack of documentation at the level of precision required to demonstrate effective management review, including review of the version changes on the excel utility.

 

Notwithstanding the material weakness our internal control over financial reporting, the Group performed additional procedures in connection with the preparation of the consolidated financial statements for the year ended March 31, 2020 which have allowed management to conclude that, the consolidated financial statements included in the annual report fairly present, in all material respects, the Group’s financial position, results of operations and cash flows for the periods presented in conformity with IFRS as issued by the IASB.

 

ITEM 15C. REGISTERED PUBLIC ACCOUNTANTS’ REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING

 

Grant Thornton India LLP , has issued an attestation report on the Company's internal control over financial reporting as of March 31, 2020, as stated in their report included in “Part III — Item 17 — Report of Independent Registered Public Accounting Firm Grant Thornton India LLP” in this Annual Report on Form 20-F.

 

ITEM 15D. CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING

 

During the period covered by this report, no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) promulgated under the Exchange Act), have occurred that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

Status of Remediation of Material Weakness in Internal Control Over Financial Reporting

 

The Group actively engaged a third-party independent expert to assist in implementation of the remediation efforts to address the abovementioned material weakness identified in our Annual Report on Form 20-F for the year ended March 31, 2019 and any other subsequently identified significant deficiencies or material weaknesses. Our management has taken and completed few initial action steps, with other remaining planned actions to be taken during fiscal 2021, to ensure that the material weakness is remediated in the coming year, which include as follows:

 

a)The Group has made continuing efforts to improve the design and effectiveness of customer and/or vendor due diligence assessment process by seeking additional details of customer and/or vendor business particulars, which amongst other things will also require timely documentation of the credit assessment of the customer and the vendor made prior to execution of the transactions. In addition, the Group has identified a plan to request for such additional information in respect of ongoing customer/s and vendor/s with transaction greater than a specified threshold in the rolling 12 months, once in a year, and re-validate the customer/s and vendor/s KYC information and/ or set-up amounts up to which credit sales/purchases can be made to such customer/s and vendor/s.

 

b)The Group has increased the depth and experience of the finance department in the fiscal 2020 and maintained adherence to password protection in respect of excel utility controls, In addition, the trail of management review of the excel utility and the journal entries posted on the ERP system was maintained, The Group will continue to focus on implementing an appropriate and formal training programs for staff, manager and executive levels to ensure policy in respect detailed documentation substantiating the level of precision at which the management review was being performed is maintained and of version change controls in respect of excel utility controls are adhered to. While Company will aim to further enhance the level of documentation trail of the level of precision of the management review performed, on long-term perspective, the Group also plan to automate the controls on the ERP system, including trail of review and approval on the ERP system, both comprehensively and consistent applied across all our subsidiaries.

 

As discussed in the aforesaid paragraphs, while management has initiated the remediation plan during fiscal 2020 and is focused to enhance them further through fiscal 2021, due to the nature of the remediation process, which amongst other things include obtaining additional information from external parties and conducting of the formal training of the staff, manager and executive, and the need to allow adequate time after implementation to evaluate and test the effectiveness of the controls, no assurance can be given as to the timing of achievement of remediation. Rather, the material weaknesses will be fully remediated when, in the opinion of our management, the revised control processes have been operating for a sufficient period of time and independent validation has been completed to provide reasonable assurance as to their operating effectiveness also. The remediation and ultimate resolution of the material weakness will be reviewed and approved by the Audit Committee.

139 

 

ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT

 

Our Audit Committee members are Mr. Dilip Thakkar (Chairman), Mr. Shailendra Swarup and Mr. Dhirendra Swarup. All the members are independent director pursuant to the applicable rules of the Commission and the NYSE. See “Part I — Item 6. Directors, Senior Management and Employees — A. Directors and Executive Officers” for the experience and qualifications of the members of the Audit Committee. Our Board of Directors has determined that Mr. Thakkar qualifies as an “audit committee financial expert” as defined in Item 16A of Form 20-F.

 

ITEM 16B. CODE OF ETHICS

 

We have adopted a written Code of Business Conduct and Ethics that is applicable to all of our directors, senior management and employees. We have posted the code on our website at www.erosplc.com. Information contained on our website does not constitute a part of this annual report. We will also make available a copy of the Code of Business Conduct and Ethics to any person, without charge, if a written request is made to Investor Relations at our offices at Unit 23, Sovereign Park, Coronation Road, Park Royal, London, NW10 7QP.

 

ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES

 

Principal Accountant Fees and Services

 

Grant Thornton India LLP has served as our independent registered public accountant for the fiscal years ended March 31, 2020 and 2019. The following table shows the fees we paid or accrued for the audit and other services provided by Grant Thornton India LLP and associated entities for the years ended March 31, 2020 and 2019.

 

   Fiscal 
   2020   2019 
Audit fees  $751,000   $1,133,000 
Tax fees   12,000    14,000 

 

Notes:

 

Audit fees. This category consists of fees billed for the audit of financial statements, quarterly review of financial statements and other audit services, which are normally provided by the independent auditors in connection with statutory and accounting matters that arose during, or as a result of, the audit or the review of interim financial statements and include the group audit; comfort letters and consents; attest services; and assistance with and review of documents filed with the Commission.

 

Tax fees. This category includes fees billed for transfer pricing study/certification.

 

Audit Committee Pre-approval Process

 

Our Audit Committee reviews and pre-approves the scope and the cost of all audit and permissible non-audit services performed by our independent auditor. All of the services provided by Grant Thornton India LLP and associated entities during the last fiscal year have been pre-approved by our Audit Committee.

 

ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES

 

As permitted by the rules of the U.S. Securities and Exchange Commission, our audit committee is currently comprised of three non-executives. We believe that our reliance on this exemption from the listing standards for audit committees does not materially adversely affect the ability of our audit committee to act independently.

 

ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS

 

Neither we, nor any affiliated purchaser, made any purchase of our equity securities in fiscal year 2020.

 

140 

 

ITEM 16F. CHANGE IN REGISTRANT’S CERTIFYING ACCOUNTANT

 

Not applicable.

 

ITEM 16G. CORPORATE GOVERNANCE

 

We have posted our Corporate Governance Guidelines on our website at www.erosplc.com. Information contained on our website does not constitute a part of this annual report.

 

As our shares are listed on the NYSE, we are subject to the NYSE listing standards. However, as a foreign private issuer, we are exempt from complying with certain corporate governance requirements of the NYSE applicable to a U.S. issuer. Under NYSE rules applicable to us, we only need to:

 

  establish an independent audit committee that has responsibilities set out in the NYSE rules;
  provide prompt certification by our chief executive officer of any material non-compliance with any corporate governance rules of the NYSE;
  provide periodic (annual and interim) written affirmations to the NYSE with respect to our corporate governance practices; and
  include in our annual reports a brief description of significant differences between our corporate governance practices and those followed by U.S. companies.

We are currently in compliance with the current applicable NYSE corporate governance requirements for foreign private issuers.

 

We believe that our corporate governance practices do not differ in any significant way from those required to be followed by issuers incorporated in the United States under the NYSE listing standards, except that the Dodd-Frank Wall Street Reform and Consumer Protection Act generally provides shareholders of United States public companies with the right to cast three types of votes: (i) an advisory vote to approve the compensation of the named executive officers, (ii) an advisory vote on the frequency with which shareholders should be entitled to cast votes on the company’s executive compensation, and (iii) an advisory vote to approve certain payments made in connection with an acquisition, merger or other specified corporate transaction. We, as a foreign private issuer, are not subject to these requirements and we do not adopt any such voting practices.

 

As a foreign private issuer, we are exempt from the rules under the Exchange Act governing the furnishing and content of proxy statements, and our directors, senior management and principal shareholders are exempt from the reporting and “short-swing profit” recovery provisions contained in Section 16 of the Exchange Act.

 

ITEM 16H. MINE SAFETY DISCLOSURE

 

Not applicable.

 

141 

 

PART III

 

ITEM 17. FINANCIAL STATEMENTS

 

See “Part III — Item 18. Financial Statements” for a list of our consolidated financial statements included elsewhere in this annual report.

 

ITEM 18. FINANCIAL STATEMENTS

 

The following statements are filed as part of this annual report, together with the report of the independent registered public accounting firm:

 

  · Report of Independent Registered Public Accounting Firm Grant Thornton India LLP
  · Consolidated Statements of Financial Position as at March 31, 2020 and 2019
  · Consolidated Statements of Income for the years ended March 31, 2020, 2019, and 2018
  · Consolidated Statements of Comprehensive Income for the years ended March 31, 2020, 2019, and 2018
  · Consolidated Statements of Changes in Equity for the years ended March 31, 2020, 2019, and 2018
  · Consolidated Statements of Cash Flows for the years ended March 31, 2020, 2019, and 2018
  · Notes to Consolidated Financial Statements

 

142 

 

ITEM 19. EXHIBITS

 

The following exhibits are filed as part of this annual report:

 

Exhibit
Number
Title    
1.1 Memorandum of Association   (c)
1.2 Articles of Association (as currently in effect)   (m)
1.3 Articles of Association (to become effective upon completion of STX Transaction)   (a)
2.1 Form of A Share Certificate   (d)
4.1 Relationship Agreement, dated as of December 16, 2009, between Eros International Media Limited, the Company and Eros Worldwide FZ-LLC   (b)
4.2 Shareholders’ Agreement, dated as of January 13, 2007, between Eros Multimedia Private Limited and The Group and Big Screen Entertainment Private Limited   (b)
4.3 Shareholders’ Agreement for Ayngaran International Limited, dated as of July 11, 2007   (b)
4.4 Employment Agreement of Sunil Lulla as Executive Vice Chairman of Eros International Medial Limited, dated September 29, 2009   (b)
4.5 Service Agreement of Prem Parameswaran as Chief Financial Officer and President of North America and Group Chief Financial Officer, dated May 26, 2015   (f)
4.6 Service Agreement of Kishore Lulla, dated February 17, 2016   (g)
4.7 Rules of the Eros International Plc Bonus Share Plan Unapproved Option Scheme 2006, dated May 17, 2006   (b)
4.8 IPO Plan Form of Option Agreement   (d)
4.9 Eros International Media Pvt. Ltd. ESOP 2009   (c)
4.10 Form of Joint Share Ownership Deed Measured By Total Share Return   (c)
4.11 Form of Joint Share Ownership Deed Measured By Earnings Per Share   (c)
4.12 Employee Benefit Trust Deed   (c)
4.13 Form of Option Agreement for Option Awards Approved April 17, 2012   (d)
4.14 Service Agreement of Pranab Kapadia as President – Europe & Africa of Eros International Ltd., dated December 1, 2007   (d)
4.15 Amended and Restated Service Agreement of Rishika Lulla Singh as Chief Executive Officer – Eros Digital FZ LLC, dated February 17, 2016   (g)
4.16 Service Agreement of Mark Carbeck as Chief Corporate and Strategy Officer, dated April 3, 2014   (g)
4.17 Service Agreement of David Maisel as Non-Executive Director, dated February 13, 2015   (f)
4.18 Form of 2014 Option Agreement for Option Awards   (f)
4.19 Form of 2015 Option Agreement for Option Awards   (f)
4.20 Trust Deed constituting the £50 million 6.50% Bonds due 2021, dated October 15, 2014   (f)
4.21 Relationship Agreement dated as of September 20, 2016 between Eros International Media Limited and Eros Worldwide FZ LLC   (i)
4.22 Form of Indenture between the Company and Wilmington Savings Fund Society, FSB, as trustee   (j)
4.23 Form of Supplementary Indenture between the Company and Wilmington Savings Fund Society, FSB, as trustee   (j)
4.24 Form of Senior Convertible Note (included as Exhibit A to Exhibit 4.34 hereto)   (j)
4.25 Form of Securities Purchase Agreement   (j)
4.26 Registration Rights Agreement between Eros International Plc and Reliance Industrial Investments and Holdings Limited, dated August 8, 2018   (l)
4.27 Form of Securities Purchase Agreement   (m)
4.28 Form of Senior Convertible Note   (m)
4.29 Form of Subscription Agreement   (n)
4.30 Agreement and Plan of Merger, dated as of April 17, 2020, among Eros International Plc, STX Filmworks, Inc., England Holdings 2, Inc. and England Merger 1 Corp. (f/k/a/ England Merger Corp.)   (a)
4.31 Voting and Support Agreement, dated as of April 17, 2020, by and among STX Filmworks, Inc., Kishore Lulla, Rishika Lulla Singh, Beech Investments Limited and Eros Ventures Limited   (a)
4.32 Subscription Agreement, dated as of April 17, 2020, by and among Eros International Plc and the purchasers thereto   (a)
4.33 Amendment No. 1 to Subscription Agreement, dated as of July 21, 2020, by Eros International Plc    
4.34 Form of Class E CVR Agreement   (a)
4.35 Form of Class D CVR Agreement   (a)
4.36 Form of Class C CVR Agreement   (a)
4.37 Form of Class B CVR Agreement   (a)
4.38 Form of Class A CVR Agreement   (a)
4.39 Form of Investors’ Rights Agreement   (a)
4.40 Form of Registration Rights Agreement   (a)
8.1 Subsidiaries of Eros International Plc   (a)
12.1 Certification of Principal Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a)   (a)
12.2 Certification of Principal Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a)   (a)
13.1 Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350   (a)
13.2 Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350   (a)
101.INS XBRL Instance Document   (a)
101.SCH XBRL Taxonomy Extension Schema Document   (a)
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document   (a)
101.DEF XBRL Taxonomy Extension Definition Linkbase Document   (a)
101.LAB XBRL Taxonomy Extension Label Linkbase Document   (a)
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document   (a)

___________________

(a) Filed herewith
(b) Previously filed on March 30, 2012 as an exhibit to the Company’s Registration Statement on Form F-1 (File No. 333-180469) and incorporated herein by reference.
(c) Previously filed on April 24, 2012 as an exhibit to Amendment No. 1 to the Company’s Registration Statement on Form F-1 (File No. 333-180469) and incorporated herein by reference.
(d) Previously filed on October 29, 2013 as an exhibit to Amendment No. 5 to the Company’s Registration Statement on Form F-1 (File No. 333-180469) and incorporated herein by reference.
(e) Previously filed on November 5, 2013 as an exhibit to Amendment No. 6 to the Company’s Registration Statement on Form F-1 (File No. 333-180469) and incorporated herein by reference.
(f) Previously filed on July 8, 2015 as an exhibit to the Company’s Annual Report on Form 20-F and incorporated herein by reference.
(g) Previously filed on July 27, 2016 as an exhibit to the Company’s Annual Report on Form 20-F and incorporated herein by reference.
(h) Previously filed on July 31, 2017 as an exhibit to the Company’s Annual Report on Form 20-F and incorporated herein by reference.
(i) Previously filed on August 4, 2017 as an exhibit to the Company’s Registration Statement on Form F-3 (File No. 333-219708) and incorporated herein by reference.
(j) Previously filed on December 4, 2017 as an exhibit to the Company’s Current report on Form 6-K and incorporated herein by reference.
(k) Previously filed on March 14, 2018 as an exhibit to the Company’s Registration Statement on Form S-8 (File No. 333-223643) and incorporated herein by reference.
(l) Previously filed on September 17, 2018 as an exhibit to the Company’s Registration Statement on Form F-3 (File No. 333-227380) and incorporated herein by reference.
(m) Previously filed on September 26, 2019 as an exhibit to the Company’s Current report on Form 6-K and incorporated herein by reference.
(n) Previously filed on January 27, 2020 as an exhibit to the Company’s Current report on Form 6-K and incorporated herein by reference.

 

143 

 

SIGNATURES

 

The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on its behalf.

 

 

Date: July 30, 2020 EROS INTERNATIONAL PLC
     
  By: /s/ Prem Parameswaran
  Name: Prem Parameswaran
  Title: Executive Director, President of North America & Group Chief Financial Officer
     
     
  By: /s/ Kishore Lulla
  Name: Kishore Lulla

 

 

144 

 

EROS INTERNATIONAL PLC
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

 

Report of Independent Registered Public Accounting Firm F-2
Consolidated Statements of Financial Position as of March 31, 2020 and 2019 F-5
Consolidated Statements of Income/(Loss) for the years ended March 31, 2020, 2019 and 2018 F-6
Consolidated Statements of Comprehensive Income/(Loss) for the years ended March 31, 2020, 2019 and 2018 F-7
Consolidated Statements of Cash Flows for the years ended March 31, 2020, 2019 and 2018 F-8
Consolidated Statements of Changes in Equity for the years ended March 31, 2020, 2019 and 2018 F-10
Notes to the Consolidated Financial Statements F-13

 

 

F-1 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

Board of Directors and Shareholders

Eros International Plc

 

Opinion on the consolidated financial statements

 

We have audited the accompanying consolidated statements of financial position of Eros International Plc and subsidiaries (the “Company”) as of March 31, 2020 and 2019, the related consolidated statements of income/(loss), comprehensive income/(loss), changes in shareholders’ equity, and cash flows for each of the three years in the period ended March 31, 2020, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of March 31, 2020 and 2019, and the results of its operations and its cash flows for each of the three years in the period ended March 31, 2020, in conformity with the International Financial Reporting Standards, as issued by the International Accounting Standards Board.

 

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), the Company’s internal control over financial reporting as of March 31, 2020, based on criteria established in the 2013 Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”), and our report dated July 30, 2020 expressed an adverse opinion.

 

Substantial doubt about the Company’s ability to continue as a going concern

 

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 (b) to the financial statements, the Company has incurred a net loss of $ 491,704 thousand in current year ended 31 March 2020, including loss from impairment of non-current assets of $431,200 thousand. Further, the Company has a negative net current asset position as of balance sheet date of $ 106,875 thousand and the credit rating of the Company’s Indian listed subsidiary had been significantly downgraded in June 2019 on account of delay in payment of certain banking facilities during the year ended 31 March 2020. Further, Note 2(a) describes the uncertainties relating to the impact of ongoing disruption due to the COVID-19 pandemic on the operations of the Company and the related financial impact. These events and factors raise substantial doubt about the Company’s ability to continue as a going concern. Management's plans in regard to these matters are also described in Note 2 (b). The consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

 

Basis for opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

We have served as the Company’s auditor since 2013.

 

/s/ Grant Thornton India LLP

  

Mumbai, India

July 30, 2020

F-2 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

Board of Directors and Shareholders

Eros International Plc

 

Opinion on internal control over financial reporting

 

We have audited the internal control over financial reporting of Eros International Plc and subsidiaries (the “Company”) as of March 31, 2020, based on criteria established in the 2013 Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). In our opinion, because of the effect of the material weaknesses described in the following paragraphs on the achievement of the objectives of the control criteria, the Company has not maintained effective internal control over financial reporting as of March 31, 2020, based on criteria established in the 2013 Internal Control—Integrated Framework issued by COSO.

 

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. The following material weaknesses have been identified and included in management’s assessment.

 

The Management has identified material weaknesses related to (a) lack of sufficiency in the level of precision applied in management review controls, including review of completeness and accuracy of the source data maintained on an excel utility and inadequacy of documentation that provides evidence of review, and (b) the process of performing customer and vendor due diligence assessment prior to execution of sale and purchase transactions is not satisfactory.

 

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (“PCAOB”), the consolidated financial statements of the Company as of and for the year ended March 31, 2020. The material weaknesses identified above were considered in determining the nature, timing, and extent of audit tests applied in our audit of the 2020 consolidated financial statements, and this report does not affect our report dated July 30, 2020, which expressed an unqualified opinion on those financial statements.

F-3 

 

 

Basis for opinion

 

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

 

Definition and limitations of internal control over financial reporting

 

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

/s/ Grant Thornton India LLP

  

Mumbai, India

July 30, 2020

 

F-4 

 

EROS INTERNATIONAL PLC

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

AS AT MARCH 31, 2020 AND 2019

 

       As at March 31, 
   Note   2020   2019 
         (in thousands)      
ASSETS               
Current assets               
Inventories   18   $   $435 
Trade and other receivables — fair value   19    94,749    125,229 
Trade and other receivables — amortised cost   19    12,504    79,916 
Investments   17    3,802    1,042 
Cash and cash equivalents   21    2,563    89,117 
Restricted deposits        4,787    55,858 
Total current assets        118,405    351,597 
Non-current assets               
Property and equipment   13   $9,234   $10,921 
Right-of-use-assets   38    1,512     
Intangible assets — content   15    461,889    706,572 
Intangible assets — others   16    2,935    3,794 
Investments   17    140    2,650 
Trade and other receivables — amortised cost   19    10,761    10,065 
Income tax receivable        1,975    1,284 
Restricted deposits        63    756 
Deferred income tax assets   11    742    1,263 
Total non-current assets       $489,251   $737,305 
Total assets       $607,656   $1,088,902 
LIABILITIES               
Current liabilities               
Trade and other payables   20   $90,941   $83,487 
Acceptances   23    1,858    8,366 
Short-term borrowings — fair value   22    23,100    68,349 
Short-term borrowings — amortised cost   22    93,758    140,559 
Derivative financial instruments   25        620 
Lease liabilities   38    723     
Current income tax payable        14,900    17,291 
Total current liabilities       $225,280   $318,672 
Non-current liabilities               
Long-term borrowings — amortised cost   22    62,114    71,920 
Lease liabilities   38    830     
Other long - term liabilities   24    8,258    13,898 
Deferred income tax liabilities   11    2,688    27,427 
Total non-current liabilities       $73,890   $113,245 
                
Total liabilities       $299,170   $431,917 
                
EQUITY               
Share capital   26   $66,727   $39,326 
Share premium        673,717    580,013 
Reserves        (405,665)   (2,202)
Other components of equity   29    (85,660)   (79,696)
JSOP reserve   28        (15,985)
Equity attributable to equity holders of Eros International Plc       $249,119   $521,456 
Non-controlling interest   36    59,367    135,529 
Total equity       $308,486   $656,985 
Total liabilities and shareholder’s equity       $607,656   $1,088,902 

 

The accompanying notes form an integral part of these consolidated financial statements.

F-5 

 

EROS INTERNATIONAL PLC

CONSOLIDATED STATEMENTS OF INCOME (LOSS)

FOR THE YEARS ENDED MARCH 31, 2020, 2019 AND 2018

 

      Year ended March 31 
   Note  2020   2019   2018 
      (in thousands, except per share amounts) 
Revenue   5  $155,452   $270,126   $261,253 
Cost of sales   6   (81,725)   (155,396)   (134,708)
Gross profit       73,727    114,730    126,545 
Administrative costs   6   (144,319)   (87,134)   (68,029)
Operating (loss)/profit before impairment loss       (70,592)   27,596    58,516 
Impairment loss   2(c)   (431,200)   (423,335)    
Operating profit/(loss)       (501,792)   (395,739)   58,516 
Finance costs   8   (20,771)   (24,093)   (19,668)
Finance income   8   11,992    16,419    1,855 
Net finance costs   8   (8,779)   (7,674)   (17,813)
Other gains/(losses)   9   (3,316)   288    (41,321)
(Loss) before tax       (513,887)   (403,125)   (618)
Income tax   10   22,183    (7,328)   (9,127)
(Loss) for the year      $(491,704)  $(410,453)  $(9,745)
Attributable to:                  
Equity holders of Eros International Plc      $(418,992)  $(423,867)  $(22,575)
Non-controlling interest       (72,712)   13,414    12,830 
      $(491,704)  $(410,453)  $(9,745)
(Loss) per share (cents)                  
Basic/(loss) per share   12   (389.6)   (599.5)   (36.3)
Diluted/(loss) per share   12   (389.6)   (599.5)   (36.3)

 

The accompanying notes form an integral part of these consolidated financial statements.

 

F-6 

 

 

EROS INTERNATIONAL PLC
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME/(LOSS)

FOR THE YEARS ENDED MARCH 31, 2020, 2019 AND 2018

 

   Year ended March 31 
   2020   2019   2018 
   (in thousands, except per share amounts) 
(Loss) for the year   $(491,704)  $(410,453)  $(9,745)
Other comprehensive income:               
Items that will not be subsequently reclassified to profit or loss               
Changes in fair value of investments    (1,860)   (24,687)    
Revaluation of property and equipment        1,745     
Items that will be subsequently reclassified to profit or loss               
Exchange differences on translating foreign operations    (8,031)   (13,934)   (1,153)
Exchange differences on revaluation of property and equipment    (156)   78    6 
Reclassification of cash flow hedge to consolidated statements of income            375 
Fair value gain/(loss) on trade account receivable (FVTOCI)    2,014    (4,664)    
Total other comprehensive (loss)/income for the year   $(8,033)  $(41,462)  $(772)
Total comprehensive loss for the year, net of tax   $(499,737)  $(451,915)  $(10,517)
                
Attributable to               
Equity holders of Eros International Plc    (423,130)   (459,321)   (23,106)
Non-controlling interest    (76,607)   7,406    12,589 

 

The accompanying notes form an integral part of these consolidated financial statements.

 

F-7 

 

EROS INTERNATIONAL PLC
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE YEARS ENDED MARCH 31, 2020, 2019 AND 2018

 

      Year ended March 31 
   Note  2020   2019   2018 
      (in thousands) 
Cash flow from operating activities                  
(Loss) before tax      $(513,887)  $(403,125)  $(618)
Adjustments for:                  
Depreciation   13   891    1,049    1,265 
Depreciation on ROU  38   1,677           
Share based payments   27   22,268    21,561    17,918 
Amortization of intangible film and content rights   15   64,451    130,155    115,285 
Amortization of other intangible assets   16   894    1,214    1,726 
Other non-cash items   30   100,118    58,438    50,119 
Impairment Loss      431,200    423,335     
Net finance costs   9   17,085    20,901    18,745 
(Gain) on sale of available-for-sale financial assets           (37)    
Loss/(gain) on sale of property and equipment       70    97    (2)
Movement in trade and other receivables       (87,885)   (179,784)   (91,317)
Movement in inventories           (99)   (219)
Movement in trade and other payables       1,995    22,166    (1,215)
Cash generated from operations       38,877    95,871    111,687 
Interest paid       (14,890)   (13,347)   (20,761)
Income taxes paid       (5,249)   (7,558)   (7,683)
Net cash generated from operating activities      $18,738   $74,966   $83,243 
                   
Cash flows from investing activities                  
Purchase of current investment      $(4,013)  $(1,005)  $ 
Proceeds from sale of non- current Investment      650           
Purchase of property and equipment       (60)   (380)   (913)
Proceeds from disposal of property and equipment       82    6    70 
Investment in restricted deposits held with banks       (8,530)   (53,507)   (27)
Restricted deposits matured       59,780    3,952     
Deconsolidation/acquisition of cash and cash equivalent in subsidiary               (9)
Purchase of intangible film rights and content rights       (132,249)   (107,722)   (186,757)
Purchase of other intangible assets       (338)   (907)   (321)
Interest received       4,132    1,830    2,537 
Net cash (used in) investing activities      $(80,546)  $(157,733)  $(185,420)
                   
Cash flows from financing activities                  
Proceeds from issue of share capital, net of transaction costs      $5,164   $54,820   $16,645 
Proceeds from issue of shares by subsidiary       17    77    556 
Investment in shares of subsidiary           (2,892)   40,221 
Share application money received pending allotment               18,000 
(Repayment of)/ proceeds from/ short term debt with maturity less than three months (net)               211 
Proceeds from short-term debt       56,337    103,365    48,249 
Repayment of short-term debt       (76,672)   (59,014)   (43,785)
Proceeds from long-term debt, net of transaction costs of Nil (2018: Nil and 2017: $384)                111,278 
Repayment of long-term debt       (7,553)   (12,239)   (113,960)
Payment of lease liability      (1,579)        
Net cash (used in)/ generated from financing activities      $(24,286)  $84,117   $77,415 
                   
Net increase/(decrease) in cash and cash equivalents       (86,094)   1,350    (24,762)
                   
Effects of exchange rate changes on cash and cash equivalent       (460)   5    257 
Cash and cash equivalents at beginning of year       89,117    87,762    112,267 
Cash and cash equivalents at the end of year      $2,563   $89,117   $87,762 

The cash outflow towards intangible film rights and content right includes, interest paid and capitalized $6,378 (2019: $9,607 and 2018: $11,722).

The accompanying notes form an integral part of these consolidated financial statements.

F-8 

 

 

Reconciliation of Liabilities arising from Financing activities:

 

   Long term
debt (*)
   Short term
debt (#)
   Total 
As at March 31, 2019  $147,254   $142,560   $289,814 
Impact on adoption of IFRS 16   (251)       (251)
Considered in cash flow (net)   (7,553)   (20,335)   (27,888)
Finance cost in relation to convertible notes and lease liabilities   4,245    1,272    5,517 
Shares issued in lieu of convertible note   (82,967)   (8,786)   (91,753)
Change in fair value of convertible notes measured at fair value through profit and loss   10,374    5,613    15,987 
Amortization of debt issuance cost   249    43    292 
Exchange adjustment   (1,998)   (8,890)   (10,888)
As at March 31, 2020  $69,353   $111,477   $180,830 
   Long term
debt(*)
   Short term
debt
(#)
   Total 
As at March 31, 2018   $188,909   $96,653   $285,562 
Considered in cash flow (net)    (12,239)   44,351    32,112 
Net finance cost in relation to convertible notes    10,682        10,682 
Shares issued in lieu of convertible note    (49,741)       (49,741)
Movement in derivative financial instruments        902    902 
Borrowing for purchase of property and equipment, net    424        424 
Amortization of debt issuance cost    415        415 
Transfer of long-term loan to short- term loan    (5,555)   5,555     
Changes in fair value of convertible notes measured at fair value through profit and loss    21,398        21,398 
Exchange adjustment    (7,039)   (4,901)   (11,940))
As at March 31, 2019   $147,254   $142,560   $289,814 

(*) including current portion of long- term debt.

(#) Including acceptances and derivative financial instruments.

 

The accompanying notes form an integral part of these consolidated financial statements.

 

F-9 

 

EROS INTERNATIONAL PLC

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY FOR THE YEAR ENDED MARCH 31, 2020

  

           Other components of equity                     
   Share
capital
   Share
premium
account
   Currency
translation
reserve
   Available
 for sale
fair value reserves
   Revaluation
reserve
   Reserves   JSOP
reserve
   Equity
Attributable to
Shareholders
of EROS
International
PLC
   Non-
controlling
interest
   Total
equity
 
   (in thousands) 
Balance as at March 31, 2019  $39,326   $580,013   $(64,179)  $(18,449)  $2,932   $(2,202)  $(15,985)  $521,456   $135,529   $656,985 
                                                   
Loss for the period                       (418,992)       (418,992)   (72,712)   (491,704)
                                                  
Other comprehensive income/(loss) for the period           (3,948)   (1,860)   (156)   1,826        (4,138)   (3,895)   (8,033)
                                                   
Total comprehensive loss for the period           (3,948)   (1,860)   (156)   (417,166)       (423,130)   (76,607)   (499,737)
                                                   

Shares issued on exercise of employee stock options and awards*

(Refer Note 26)

   3,505    4,896                (8,137)       264        264 
                                                   
Share based compensation (Refer Note 27)                       22,207        22,207    61    22,268 
                                                   
Shares issued in lieu of cash
(Refer Note 26)
   2,079    8,971                        11,050        11,050 
                                                   
Payables settled by issuance of shares  (Refer Note 26)   3,296    22,590                        25,886        25,886 
                                                   
Changes in ownership interests in subsidiaries that do not result in a loss of control                       (367)       (367)   384    17 
                                                   
Closure of JSOP Trust       (15,985)                   15,985             
                                                   
Shares issued in lieu of convertible notes
(Refer Note 26)
   18,521    73,232                        91,753        91,753 
                                                   
Balance as at March 31, 2020  $66,727   $673,717   $(68,127)  $(20,309)  $2,776   $(405,665)  $   $249,119   $59,367   $308,486 

 

*Includes issuance of 6,808,320 treasury shares

  

The accompanying notes form an integral part of these consolidated financial statements.

F-10 

 

EROS INTERNATIONAL PLC

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY FOR THE YEAR ENDED MARCH 31, 2019

 

           Other components of equity                         
   Share
capital
   Share
premium
account
   Currency
translation
reserve
   Available
 for sale
fair value reserves
   Revaluation
reserve
   Reserves   JSOP
reserve
   Share
Application
Reserve
   Equity
Attributable to
Shareholders
of EROS
International
PLC
   Non-
controlling
interest
    Total
equity
 
   (in thousands) 
Balance as at March 31, 2018   $35,334   $453,997   $(56,722)  $6,238   $1,835   $422,992   $(15,985)  $18,000   $865,689   $137,728   $1,003,417 
                                                        
Adoption of IFRS 15/9            (34)           (14,270)           (14,304)   (3,520)   (17,824)
                                                        
Balance as at April 1, 2018   $35,334   $453,997   $(56,756)  $6,238   $1,835   $408,722   $(15,985)  $18,000   $851,385   $134,208   $985,593 
                                                        
Profit for the period                        (423,867)           (423,867)   13,414    (410,453)
                                                        
Other comprehensive income/(loss) for the period            (7,423)   (24,687)   1,097    (4,441)           (35,454)   (6,008)   (41,462)
                                                        
Total comprehensive income/(loss) for the period            (7,423)   (24,687)   1,097    (428,308)           (459,321)   7,406    (451,915)
                                                        
Issue of shares (Refer Note 26)    1,948    70,718                        (18,000)   54,666        54,666 
                                                        
Shares issued on exercise of employee stock options and awards    302    7,299                (7,447)           154        154 
                                                        
Share based Compensation (Refer Note 26)                        21,118            21,118    443    21,561 
                                                        
Changes in ownership interests in subsidiaries that do not result in a loss of control                        3,713            3,713    (6,528)   (2,815)
                                                        
Shares issued in lieu of convertible notes (Refer Note 26)    1,742    47,999                            49,741        49,741 
                                                        
Balance as at March 31, 2019   $39,326   $580,013   $(64,179)  $(18,449)  $2,932   $(2,202)  $(15,985)  $   $521,456   $135,529   $656,985 

 

 

The accompanying notes form an integral part of these consolidated financial statements.

F-11 

 

EROS INTERNATIONAL PLC

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY FOR THE YEAR ENDED MARCH 31, 2018

  

           Other components of equity                             
   Share
capital
   Share
premium
account
   Currency
translation
reserve
   Available
 for sale
fair value reserves
   Revaluation
reserve
   Hedging
reserve
   Reserves   JSOP
reserve
   Share
Application
Reserve
   Equity
Attributable to
Shareholders
of EROS
International
PLC
   Non-
controlling
interest
   Total
equity
 
   (in thousands) 
Balance as at April 1, 2017   $31,877   $399,686   $(55,810)  $6,238   $1,829   $(375)  $436,997   $(15,985)  $   $804,457   $79,091   $883,548 
                                                             
(Loss)/Profit for the year                            (22,575)           (22,575)   12,830    (9,745)
                                                             
Other comprehensive income/(loss) for the year            (912)       6    375                (531)   (241)   (772)
                                                             
Total comprehensive income/(loss) for the year            (912)       6    375    (22,575)           (23,106)   12,589    (10,517)
                                                             
Share based compensation (Refer Note 27)                            17,316            17,316    602    17,918 
                                                             
Shares issued on exercise of employee stock options and awards (Refer Note 27)    277    8,894                    (8,955)           216        216 
                                                             
Changes in ownership interests in subsidiaries that do not result in a loss of control (Refer Note 4)                            209            209    40,568    40,777 
                                                             
Issue of shares, net of transaction costs of Nil (Refer Note 26)    555    15,874                                16,429        16,429 
                                                             
Loss of control  in a subsidiary (Refer Note 4)                                            4,878    4,878 
                                                             
Shares pending for allotment (Refer Note 26)                                    18,000    18,000        18,000 
                                                             
Shares issued in lieu of convertible notes (Refer Note 26)    2,625    29,543                                32,168        32,168 
                                                             
Balance as at March 31, 2018   $35,334   $453,997   $(56,722)  $6,238   $1,835   $   $422,992   $(15,985)  $18,000   $865,689   $137,728   $1,003,417 

 

 

The accompanying notes form an integral part of these consolidated financial statements.

F-12 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

1 NATURE OF OPERATIONS, GENERAL INFORMATION AND BASIS OF PREPARATION

 

Eros International Plc (“Eros” or the “Company”) and its subsidiaries’ (together with Eros, the “Group”) principal activities include the acquisition, co-production, distribution of Indian films and provision of related production services, including visual special effects, for filmed entertainment sector . Eros International Plc is the Group’s ultimate parent company. It is incorporated and domiciled in the Isle of Man. The address of Eros International Plc’s registered office is First Names House, Victoria Road, Douglas, Isle of Man IM2 4DF.

 

The consolidated financial statements of the Group have been prepared in accordance with International Financial Reporting Standards (“IFRSs”), as issued by the International Accounting Standards Board (IASB). The financial statements have been prepared on accrual basis and under the historical cost convention on a going concern basis, with the exception of:

 

  A) revaluation of certain properties and equipment
  B) certain financial instruments and assets acquired and liabilities assumed in a business combination that have been measured at fair value as required by relevant IFRSs
  C) Employee stock option plans which have been recognized at fair value
  D) Certain employee benefit plans, which are measured based on actuarial assumptions
  E) Trade receivables and Investments recorded at Fair Value Through Profit and Loss (FVTPL) and Fair Value Through Other Comprehensive Income (FVOCI)

 

The Group’s accounting policies as set out below have been applied consistently throughout the Group to all the periods presented, unless otherwise stated. The financial statements of Eros and each of its subsidiaries are measured using the currency of the primary economic environment in which these entities operate (i.e. the functional currency). The consolidated financial statements are presented in US Dollars (USD) which is the presentation currency of the Company and has been rounded off to the nearest thousands.

 

The consolidated financial statements for the year ended March 31, 2020 were approved by the Eros Board of Directors and authorized for issue on July 30, 2020.

 

2 GLOBAL  PANDEMIC, GOING CONCERN  AND IMPAIRMENT OF NON- CURRENT ASSETS

 

2(a) GLOBAL PANDEMIC
   

 

In December 2019, a novel strain of coronavirus (‘Global Pandemic’or ‘COVID-19’) emerged in Wuhan, Hubei Province, China. While initially the outbreak was largely concentrated in China and caused significant disruptions to its economy, it has now spread to several other countries, and infections have been reported globally including India, United Kingdom, United States, Dubai, Singapore and Australia where the group through its offices distributes the films theatrically. In response to the public health risks associated with the COVID-19, the Government of the aforesaid countries has announced nation-wide lockdown which resulted in the closure of all the theatres in the respective geographies and caused disruptions in the production and availability of content, including delayed, or in some cases, shortened or cancelled theatrical releases. The lockdown has affected the Group’s ability to generate revenues from the monetization of Indian film content in various distribution channels through agreements with commercial theatre operators. Also refer to note 2 (c), wherein the Group has recorded an impairment charge of $ 431,200 for the year ended March 31, 2020. In addition, refer to note 19, wherein the Group has recorded credit impairment loss of $ 103,109 for the year ended March 31, 2020.

 

The extent of the adverse impact on the Group’s financial and operational results will be dictated by the length of time that such disruptions continue, which will, in turn, depend on the currently unknowable duration of COVID-19 and among other things, the impact of governmental actions imposed in response to the pandemic and individuals’ and companies’ risk tolerance regarding health matters going forward. The Group’s business also could be significantly affected even after reopening of certain operations, should the disruptions caused by the COVID-19 lead to changes in consumer behaviour (such as social distancing), which the Group currently believes will be temporary.

 

The Group is continuously monitoring the rapidly evolving situation and its potential impacts on the Group’s financial position, results of operations, liquidity, and cash flows.

 

F-13 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

2(b) GOING CONCERN ASSUMPTION

 

The Group meets its day to day working capital requirements and funds its investment in content and film rights primarily through a variety of cash generated from operations, banking arrangements, de-recognition of financial assets and strategic alternatives.

 

The Group is dependent upon external borrowings for its working capital needs and investment in content and film rights. Under the terms of such banking arrangements, the Group is able to draw down in the local currencies of its operating businesses.

 

The borrowings (as set out in Note 22) are subject to individual covenants and a negative pledge that restricts the Group’s ability to incur liens, security interests or similar encumbrances or arrangements on its assets. During the current year, there had been a credit rating downgrade of our Indian listed subsidiary due to delay in repayment of loan instalments.

 

As at March 31, 2020, Group’s borrowings were $ 178,972, of which $ 117,097 is repayable in fiscal 2021. In addition, the Group has opted for moratorium as per Reserve Bank of India guidelines 2019-2020/2392 on account of global pandemic wherein all the instalments due from 1 March 2020 to 31 August 2020 will be converted  to short-term borrowing post moratorium period.

 

Further, the Group has reported a negative net current assets position on the balance sheet date.

 

The Group continue to experience significant net loss for fiscal 2020. The Group has incurred loss amounting $491,704 for the year ended March 31, 2020 [after considering the impact of an impairment loss amounting $431,200 as described in Note 2 (c)] when compared to net loss of $ $410,453 [after considering the impact of an impairment loss amounting $423,355 as described in Note 2 (c)] and $9,745 respectively for the year ended March 31, 2019 and 2018.

 

Despite these uncertainties, and uncertainties arising from the global pandemic, which have been explained in detail in Note 2 (a), the management continues to adopt the going concern basis in preparing the consolidated financial statements as of March 31, 2020 in accordance with IFRS as issued by the IASB, which assumes that the Group will be able to discharge all its liabilities, including mandatory repayment of the banking facilities, as disclosed in Note 31, as they fall due on account of:

 

a)On September 26, 2019, the Group entered into a definitive agreement with an institutional investor to procure additional funding of $25,000 through the issuance of senior convertible notes, resulting enhanced liquidity to the Group. Subsequent to the reporting period, the Company fully paid the outstanding balance of senior convertible notes by conversion into A ordinary shares.

 

b)On April 17, 2020, the Group entered into an Agreement and plan of merger with STX Filmworks, Inc, a Delaware corporation (“STX”) – a Company that specializes in producing, financing, distributing and marketing film, television and digital content. This merger will help create a pre-eminent global media company, which can develop local and international premium content at scale and across many platforms.

 

As the result of this merger, (i) new investors and existing STX equity investors are expected to contribute incremental equity financing of $125,000 (of which $35,000 is received as on the date of issuance of the financial statements] and (ii) a line of undrawn credit facility totaling to ~$ 100,000 from a large financial institution/s with a moratorium of 5 years will be available to the combined company.

 

In addition, the Group expects the combined company to be uniquely positioned to benefit from the accelerating consumption of premium digital content in the world’s most important growth markets with robust capital structure and experienced management team. The combined company is also expected to generate operating synergies within 24 months of closing of the merger transaction, stemming from integration and scale benefits, optimization of global content distribution and enhanced monetization of the Eros Now platform.

 

c)The Group have continued to generate a positive operating cash flow before incurring capital expenditures for the year ended March 31, 2020, 2019 and 2018, respectively.

 

2(c) IMPAIRMENT OF NON- CURRENT ASSETS

 

Impairment reviews in respect of goodwill and indefinite-lived intangible assets are performed annually. More regular reviews, and impairment reviews in respect of other non-current assets, are performed if events indicate that an impairment review is necessary. Examples of such triggering events would include a significant planned restructuring, a major change in market conditions or technology, reduction in market capitalization, expectations of future operating losses, or negative cash flows. The asset or Cash Generating Unit (CGU) is impaired if carrying amount of the CGU exceeds its recoverable amount.

 

The group performed impairment assessment as of March 31, 2020. The recoverable amount of the cash generating unit was determined based on value in use.

 

F-14 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Value in use was determined based on future cash flows after considering current economic conditions and trends, estimated future operating results, growth rates (which is lower than those considered in previous years) and anticipated future economic conditions. The approach and key (unobservable) assumptions used to determine the cash generating unit’s value in use were as follows:

 

Assumptions  As at
March 31, 2020
   As at
March 31, 2019
 
Growth rate applied beyond approved forecast period    4%    4% 
Pre-tax discount rate    20%    21% 

 

The Company considered it appropriate to undertake an impairment assessment with reference to the estimated cash flows for the period of four years developed using internal forecast and extrapolated for the fifth year. The growth rates used in the value in use calculation reflect those inherent within the Company’s internal forecast, which is primarily a function of the future assumptions, past performance and management’s expectation of future developments through fiscal 2024.

 

Accordingly, the Group recorded an impairment loss, totaling to $431,200 and $423,335 as an exceptional item, being significant and non-recurring in nature, within the Statement of Income for the year ended March 31, 2020 and March 31, 2019 respectively. Impairment loss is mainly due to changes in the market conditions, including lower projected volume when compared to prior year/s on account of ongoing global pandemic. The aforesaid impairment loss was allocated to Intangible assets - content. [Refer Note 15]

 

Sensitivity to key assumptions

 

The change in the key following assumptions used in the impairment review would, in isolation, lead to an increase in impairment loss recognized by followings amounts as at March 31, 2020 (Although it should be noted that these sensitivities do not take account of potential mitigating actions)

 

   (in millions) 
   As at March 31, 2020   As at March 31, 2019 
Increase in discount rate by 1%    52    54 
Decrease in long term growth rate applied beyond approved forecast period by 1%    67    30 
Decrease in projected volume by 1%    44    63 

 

3 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

3.1. Overall considerations

 

The significant accounting policies that have been used in the preparation of these consolidated financial statements are summarized below. Financial statements are subject to the application of significant accounting estimates and judgments. These are summarized in Note 37.

 

Significant new accounting pronouncement

 

F-15 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

New accounting standard IFRS 16, "Leases"

 

Effective April 1, 2019, IFRS 16, Leases, was adopted by the Group on April 1, 2019. The impact of adopting this new standards on the financial statements at April 1, 2019 are disclosed in note 38.

 

The Company adopted IFRS 16, Leases, which specifies how to recognize, measure, present and disclose leases. The standard provides a single accounting model, requiring the recognition of assets and liabilities for all major leases previously classified as “operating leases”.

 

The Company applied the “Modified Retrospective Approach” on the date of initial application (April 1, 2019) and the comparatives for the year ended March 31, 2019 have not been retrospectively adjusted. As of April 1, 2019, no cumulative adjustments have been recorded to the retained earnings.

 

As such the Company recognizes a lease liability and a corresponding right of use asset, at the lease commencement date. The right-of-use asset is initially measured at cost, based on the initial amount of the lease liability. The assets are depreciated to the earlier of the end of the useful life of the right-of-use asset or the lease term using the straight-line method as this most closely reflects the expected pattern of consumption of the future economic benefits. The lease term includes periods covered by an option to extend if the Company is reasonably certain to exercise that option. In addition, the right-of-use asset is periodically adjusted for certain re-measurements of the lease liability. There is no impact on transition in opening balance of retained earnings as at April 1, 2019 because of the transition method applied. Further comparatives were not restated.

 

3.2. Basis of consolidation

 

The financial statements of the Group consolidates results of the Company and entities controlled by the Company and its subsidiary undertakings. Control exists when the Company, directly or indirectly, has existing rights that give the Company the current ability to direct the activities which affect the entity’s returns; the Company is exposed to or has rights to a return which may vary depending on the entity’s performance; and the Company has the ability to use its powers to affect its own returns from its involvement with the entity.

 

F-16 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Unrealized gains on transactions within the Group are eliminated. Unrealized losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred. Amounts reported in the financial statements of subsidiaries have been adjusted where necessary to ensure consistency with the accounting policies adopted by the Group.

 

Business combinations are accounted for under the acquisition method. The purchase method involves the recognition at fair value of all identifiable assets and liabilities, including contingent liabilities of the subsidiary, at the acquisition date, regardless of whether or not they were recorded in the financial statements of the subsidiary prior to acquisition. On initial recognition, the assets and liabilities of the subsidiary are included in the consolidated statement of financial position at their fair values. Transaction costs that the company incurs in connection with a business combination such as finder’s fees, legal fees, due diligence fees, and other professional and consulting fees are expensed as incurred. Goodwill is stated after separating out identifiable intangible assets. Goodwill represents the excess of acquisition cost over the fair value of the Group’s share of the identifiable net assets of the acquired subsidiary at the date of acquisition. Gain on bargain purchase is recognized immediately after acquisition in the consolidated statement of income.

 

Changes in controlling interest in a subsidiary that do not result in gaining or losing control are not business combinations as defined by IFRS 3. The Group adopts the “equity transaction method” which regards the transaction as a realignment of the interests of the different equity holders in the Group. Under the equity transaction method an increase or decrease in the Group’s ownership interest is accounted for as follows:

  the non-controlling component of equity is adjusted to reflect the non-controlling interest revised share of the net carrying value of the subsidiaries net assets;
  the difference between the consideration received or paid and the adjustment to non-controlling interests is debited or credited to a different component of equity — merger reserves;
  no adjustment is made to the carrying amount of goodwill or the subsidiaries’ net assets as reported in the consolidated financial statements; and
  no gain or loss is reported in the consolidated statements of income.

 

Loss of control policy

 

When a change in the Group’s ownership interest in a subsidiary results in a loss of control over the subsidiary, the assets and liabilities of the subsidiary including any goodwill are derecognized and a gain or loss arising thereto is accounted within Statement of Income. Amounts previously recognized in other comprehensive income in respect of that entity are also reclassified to Statement of Income.

 

3.3. Segment reporting

 

IFRS 8 Operating Segments (“IFRS 8”) requires operating segments to be identified on the same basis as is used internally for the review of performance and allocation of resources by the Group’s chief operating decision maker, which is the Group’s CEO and MD. The revenues of films are earned over various formats; all such formats are functional activities of filmed entertainment and these activities take place on an integrated basis. The management team reviews the financial information on an integrated basis for the Group as a whole. The management team also monitors performance separately for individual films for at least 12 months after the theatrical release. Certain resources such as publicity and advertising, and the cost of a film are also reviewed globally.

 

Eros has identified four geographic areas, consisting of its main geographic areas (India, North America and Europe), together with the rest of the world.

 

3.4. Revenue

 

Effective April 1, 2018, the Group has applied IFRS 15 ‘Revenue from Contracts with Customers’ which establishes a comprehensive framework for determining whether, how much and when revenue is to be recognized. IFRS 15 replaces IAS 18 ‘Revenue’, IAS 11 ‘Construction Contracts’ and certain revenue related interpretations and the cumulative effect of initial application is recognised as an adjustment to the opening balance of retained earnings at April 1, 2018. The comparative information for the year ended March 31, 2018 continues to be reported under IAS 18 and IAS 11. Refer note 3.4 – Summary of Significant accounting policies – Revenue recognition in the Annual report of the Group for the year ended March 31, 2019, for revenue recognition policy as per IAS 18 and IAS 11.

 

F-17 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

To determine whether to recognise revenue, the Group follows a 5-step process:

 

  a) Identifying the contract with a customer
  b) Identifying the performance obligations
  c) Determining the transaction price
  d) Allocating the transaction price to the performance obligations
  e) Recognising revenue when/as performance obligation(s) are satisfied

 

Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration which the Group expects to receive in exchange for those products or services. To ensure collectability of such consideration and financial stability of the counterparty, the Group performs certain standard Know Your Client (KYC) procedures based on their geographic locations and evaluates trend of past collection from such locations.

 

Revenue is measured based on the transaction price, which is the consideration, adjusted for any discounts and incentives, if any, as specified in the contract with the customer. Revenue also excludes taxes collected from customers. In case of revenues which are subject to change, the Group estimates the amount to be received using the “most likely amount” approach, or the “expected value” approach, as appropriate. This amount is then included in the Group’s estimate of the transaction price only if it is highly probable that a significant reversal of revenue will not occur once any uncertainty surrounding the bonus is resolved. In making this assessment the Group considers its historical performance on similar contracts.

 

The Group recognises contract liabilities for consideration received in respect of unsatisfied performance obligations and reports these amounts as other liabilities in the statement of financial position (see Note 24). Similarly, if the Group satisfies a performance obligation before it receives the consideration, the Group recognises either a contract asset or a receivable in its statement of financial position, depending on whether something other than the passage of time is required before the consideration is due

 

The following criteria apply in respect of various revenue streams within filmed entertainment:

 

  In arrangements for theatrical distribution, contracted minimum guarantees are recognized on the theatrical release date. The Group’s share of box office receipts in excess of the minimum guarantee is recognized at the point as the box office receipts gets accrued.
  In arrangements for television syndication, license fees received in advance which do not meet all the above criteria, including commencement of the availability for broadcast under the terms of the related licensing agreement, are included in contract liability until the criteria for recognition is met.  Further in arrangements where the license fees received in advance is for a period of 12 months or more from the commencement, the company computes significant discounting component at imputed rate of interest on advances received and recognizes within net finance cost in the statement of income. . Accumulated contract liability (deferred revenue) is recognized upon commencement of availability for broadcast.
  In arrangements for catalogue sales, the Group recognizes revenue if revenue recognition criteria’s such as a valid sales contract exists, all content is delivered and the customer start generating economic benefits from them, the Group is reasonably certain on collectability, and the Group’s contractual obligations are complete and are met. Considering the arrangement with catalogue customers provide for a contractual deferred payment terms up to a year and in many cases the payments often fall behind contractual terms, revenues from catalogue sales are recognized net of financing component calculated at imputed market rate of interest on the gross receivables. The re-measurement of such financing period at each balance sheet date and related gains or losses is recognized within administrative costs in the Statement of Income. Unwinding of the such discount is recognized using effective interest rate within net finance cost in the Statement of Income.
  Digital and ancillary media revenues are recognized at the earlier of when the content is accessed or declared. Fees received for access to the specified and unspecified future content through digital and ancillary media, including usage of over-the-top platform developed by the Group, is recognized on straight line basis over the period of the service contract. Billing in excess of the revenue recognized is shown as contract liability .
  DVD, CD and video distribution revenue is recognized on the date the product is delivered or if licensed in line with the above criteria. Visual effects, production and other fees for services rendered by the Group and overhead recharges are recognized in the period in which they are earned and in certain cases, the stage of production is used to determine the proportion recognized in the period.
 

In arrangement for production services, including visual special effects (VFX), and other technical services to clients, the Group recognizes revenue if revenue recognition criteria’s such as a valid sales contract exists, IP is delivered and the Group is reasonably certain on collectability. Revenue is recognized as the services are delivered based on acceptance of the services performed by the customer.

 

F-18 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

3.5. Goodwill

 

Goodwill represents the excess of the consideration transferred in a business combination over the fair value of the Group’s share of the identifiable net assets acquired. Goodwill is carried at cost less accumulated impairment losses. Gain on bargain purchase is recognized immediately after acquisition in the consolidated statement of income.

 

3.6. Intangible assets

 

Identifiable intangible assets are recognised when the Group controls the asset, it is probable that future economic benefits attributed to the asset will flow to the Group and the cost of the asset can be reliably measured. Intangible assets acquired by the Group are stated at cost less accumulated amortization less impairment loss, if any, except those acquired as part of a business combination, which are shown at fair value at the date of acquisition less accumulated amortization less impairment loss, if any (Film production cost and content advances are transferred to film and content rights at the point at which content is first exploited). “Eros” (the “Trade name”) is considered to have an indefinite life because of the institutional nature of the corporate brand name, its proven ability to maintain market leadership and the Group’s commitment to develop, enhance and retain its value. The carrying value is reviewed at least annually for impairment and adjusted to recoverable amount if required.

 

Content

 

Investments in films and associated rights, including acquired rights and distribution advances in respect of completed films, are stated at cost less amortization less provision for impairment. Costs include production costs, overhead and capitalized interest costs net of any amounts received from third party investors. A charge is made to write down the cost of completed rights over the estimated useful lives, writing off more in year one which recognizes initial income flows and then the balance over a period of up to nine years, except where the asset is not yet available for exploitation. The average life of the assets is the lesser of 10 years or the remaining life of the content rights. The amortization charge is recognized in the consolidated statement of income within cost of sales. The determination of useful life is based upon management’s judgment and includes assumptions on the timing and future estimated revenues to be generated by these assets, which are summarized in Note 37.3.

 

Others

 

Other intangible assets, which comprise internally generated and acquired software used within the Group’s digital, home entertainment and internal accounting activities, are stated at cost less amortization less provision for impairment. A charge is made to write down the cost of completed rights over the estimated useful lives except where the asset is not yet available for exploitation. The average life of below intangible assets ranges from 3-6 years. The amortization charge is recognized in the consolidated statements of income within administrative expenses as stated below:

 

   Life of
asset
   Rate of
amortization
% straight line
per annum
 
Information technology assets    3 years    33 
Other intangibles    3 - 6 years    17 – 33 

 

Subsequent expenditure

 

Expenditure on capitalized intangible assets subsequent to the original expenditure is included only when it increases the future economic benefits embodied in the specific asset to which it relates.

 

Information technology assets

 

An internally generated intangible asset arising from the Group’s software development activities that is expected to be completed is recognized only if all the following criteria are met:

  an asset is created that can be identified (such as software and new processes);
  it is probable that the asset created will generate future economic benefits; and
  the development cost can be measured reliably.

 

F-19 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

When these criteria are met and there are appropriate resources to complete development, the expenditure is capitalized at cost. Where these criteria are not met development expenditure is recognized as an expense in the period in which it is incurred. Internally generated intangible assets are amortized over their useful economic life from the date that they start generating future economic benefits.

 

3.7. Impairment testing of goodwill, other intangible assets and property and Equipment

 

For the purposes of assessing impairment, assets are grouped at the lowest levels for which there are separately identifiable cash flows (cash-generating units). As a result, some assets are tested individually for impairment and some are tested at the cash-generating unit level. Goodwill is allocated to those cash-generating units that are expected to benefit from synergies of the related business combination and represent the lowest level within the Group at which Management monitors the related cash flows.

 

Goodwill and Trade names are tested for impairment at least annually. All other individual assets or cash-generating units are tested for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Management believes that due to change in the key assumptions with respect to volume growth and discount rate has resulted in impairment of Goodwill and Trade name.

 

An impairment loss is recognized for the amount by which the asset’s or cash-generating unit’s carrying amount exceeds its recoverable amount. The recoverable amount is the higher of fair value, reflecting market conditions less costs to sell, and value in use based on an internal discounted cash flow evaluation. Impairment losses recognized for cash-generating units, to which goodwill has been allocated, are credited initially to the carrying amount of goodwill. Any remaining impairment loss is charged pro rata to the other assets in the cash generating unit.

 

Film and content rights are stated at the lower of unamortized cost and estimated recoverable amounts. In accordance with IAS 36 Impairment of Assets, film content costs are assessed for indication of impairment on a library basis as the nature of the Group’s business, the contracts it has in place and the markets it operates in do not yet make an ongoing individual film evaluation feasible with reasonable certainty. Impairment losses on content advances are recognized when film production does not seem viable and refund of the advance is not probable.

 

With the exception of goodwill, all assets are subsequently reassessed for indications that an impairment loss previously recognized may no longer exist.

 

3.8. Property and equipment

 

Property and equipment are stated at historical cost less accumulated depreciation and impairment. Land and freehold buildings are shown at what Management believes to be their fair value, based on, among other things, periodic but at least triennial valuations by an external independent valuer, less subsequent depreciation for freehold buildings.

 

Any accumulated depreciation at the date of revaluation is eliminated against the gross carrying amount of the asset and the net amount is restated to the revalued amount. Increases in the carrying amount arising on revaluation of freehold land and buildings are credited to other reserves in shareholders’ equity through other comprehensive income. Decreases that offset previous increases are charged against other reserves.

 

Depreciation is provided to write-off the cost of all property and equipment to their residual value as stated below:

 

    Life of
Asset
   Rate of
depreciation
% WDV
per annum
Freehold building    60 years   2-10
Furniture and fittings and equipment    5 years   15-20
Vehicles and machinery    3-5 years   20-30

 

Material residual value estimates are updated as required, but at least annually, whether or not the asset is revalued.

 

Advance paid towards the acquisition or improvement of property and equipment not ready for use before the reporting date are disclosed as capital work-in-progress.

F-20 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

3.9. Inventories

 

Inventories primarily comprise of music CDs and DVDs, and are valued at the lower of cost and net realizable value. Cost in respect of goods for resale is defined as purchase price, including appropriate labor costs and other overhead costs. Costs in respect of raw materials is purchase price.

 

Purchase price is assigned using a weighted average basis. Net realizable value is defined as anticipated selling price or anticipated revenue less cost to completion.

 

3.10. Cash and cash equivalents

 

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term highly liquid investments which are readily convertible into known amounts of cash and are subject to insignificant risk of changes in value. Bank overdrafts are shown within “Borrowings” in “Current liabilities” on the statement of financial position.

 

3.11. Restricted deposits held with banks

 

Deposits held with banks as security for overdraft facilities are included in restricted deposits held with bank.

 

3.12. Financial instruments

 

A financial instrument is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity.

 

  i. Recognition, initial measurement and derecognition

 

Financial assets and liabilities are recognised when the Group becomes a party to the contractual provisions of the instrument. Financial assets and liabilities are initially measured at fair value. Transaction costs that are directly attributable to the acquisition or issue of financial assets and financial liabilities (other than financial assets and financial liabilities at fair value through profit or loss) are added to or deducted from the fair value measured on initial recognition of financial assets or financial liability.

 

The transaction costs directly attributable to the acquisition of financial assets and financial liabilities at fair value through profit and loss are immediately recognised in the Consolidated Statement of Income.

 

A financial asset is primarily derecognised (i.e. removed from the Group’s statement of financial position) when:

 

  a) The rights to receive cash flows from the asset have expired, or

 

  b) The Group has transferred its rights to receive cash flows under an eligible transaction.

 

A financial liability is derecognised when the obligation under the liability is discharged or cancelled or expires.

 

  ii. Classification

 

For the purpose of subsequent measurement, financial assets are classified into the following categories upon initial recognition:

 

  Debt instruments at amortised cost
  Debt instruments at fair value through other comprehensive income (FVTOCI)
  Debt instruments, derivatives and equity instruments at fair value through profit or loss (FVTPL)
  Equity instruments measured at fair value through other comprehensive income (FVTOCI)
  Equity instruments measured at fair value profit or loss (FVTPL)

 

The classification depends on the entity’s business model for managing the financial assets and the contractual terms of the cash flows.

 

F-21 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Debt instruments at amortised cost

 

A ‘debt instrument’ is measured at the amortised cost if both the following conditions are met:

 

  1. The asset is held within a business model whose objective is to hold assets for collecting contractual cash flows, and

 

  2. Contractual terms of the asset give rise on specified dates to cash flows that are solely payments of principal and interest (“SPPI”) on the principal amount outstanding.

 

After initial measurement, such financial assets are subsequently measured at amortised cost using the effective interest rate (the “EIR”) method. The effective interest rate is the rate that exactly discounts future cash receipts or payments through the expected life of the financial instrument, or where appropriate, a shorter period.

 

Amortised cost is calculated by taking into account any discount or premium on acquisition and fees or costs that are an integral part of the EIR. The EIR amortisation is included in finance income/other income in the Consolidated Statement of Income . The losses arising from impairment are recognised in the Consolidated Statement of Income .

 

Debt instruments at fair value through other comprehensive income

 

A ‘debt instrument’ is classified as at the FVTOCI if both of the following criteria are met:

 

  1. The objective of the business model is achieved both by collecting contractual cash flows and selling the financial assets, and

 

  2. The asset’s contractual cash flows represent SPPI.

 

Debt instruments at fair value through profit or loss

 

FVTPL is a residual category for debt instruments. Any debt instrument, which does not meet the criteria for categorization as at amortized cost or as FVTOCI, is classified as at FVTPL.

 

Equity instruments

 

All equity investments in scope of IFRS 9 are measured at fair value. Equity instruments which are held for trading are classified as at FVTPL with all changes recognised in the Consolidated Statement of Income .

 

For all other equity instruments, the Group may make an irrevocable election to present in OCI, the subsequent changes in the fair value. The Group makes such election on an instrument-by-instrument basis. If the Group decides to classify an equity instrument as at FVTOCI, then all fair value changes on the instrument, excluding dividends and impairment loss, are recognised in OCI. There is no recycling of the amounts from the OCI to the Consolidated Statement of Income , even on sale of the investment. However, the Group may transfer the cumulative gain or loss within categories of equity.

 

  iii. Impairment of financial assets

 

In accordance with IFRS 9, the Group applies the expected credit loss (“ECL”) model for measurement and recognition of impairment loss on financial assets and credit risk exposures.

 

ECL is the difference between all contractual cash flows that are due to the Group in accordance with the contract and all the cash flows that the entity expects to receive (i.e., all cash shortfalls), discounted at the EIR of the instrument. Lifetime ECL are the expected credit losses resulting from all possible default events over the expected life of a financial instrument. The 12-month ECL is a portion of the lifetime ECL which results from default events that are possible within 12 months after the reporting date.

 

The Group follows ‘simplified approach’ for recognition of impairment loss allowance on trade receivables, which do not have a significant financing component as per IFRS 15. Simplified approach does not require the Group to track changes in credit risk. Rather, it recognises impairment loss allowance based on lifetime ECL at each reporting date, right from its initial recognition.

 

F-22 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

For recognition of impairment loss on other financial assets and risk exposure, the Group determines that whether there has been a significant increase in the credit risk since initial recognition. If credit risk has not increased significantly, 12-month ECL is used to provide for impairment loss. However, if credit risk has increased significantly, lifetime ECL is used. If, in a subsequent period, credit quality of the instrument improves such that there is no longer a significant increase in credit risk since initial recognition, then the entity reverts to recognising impairment loss allowance based on 12-month ECL.

 

ECL impairment loss allowance (or reversal) recognised during the period is recognised as income/ expense in the Consolidated Statement of Income .

 

  iv. Classification and subsequent measurement of financial liabilities

 

All financial liabilities are recognised initially at fair value, adjusted by directly attributable transaction costs.

 

The measurement of financial liabilities depends on their classification, as described below:

 

  Financial liabilities at fair value through profit or loss

 

Financial liabilities at fair value through profit or loss include financial liabilities held for trading and financial liabilities designated upon initial recognition as at fair value through profit or loss. Financial liabilities are classified as held for trading if they are incurred for the purpose of repurchasing in the near term. The Group does not have any financial liabilities classified at fair value through profit or loss.

 

  Financial liabilities measured at amortised cost

 

After initial recognition, interest-bearing loans and borrowings are subsequently measured at amortised cost using the EIR method. Gains and losses are recognised in the Consolidated Statement of Income when the liabilities are derecognised.

 

Amortised cost is calculated by taking into account any discount or premium on acquisition and fees or costs that are an integral part of the EIR. The EIR amortisation is included as finance costs in the Consolidated Statement of Income .

 

3.13. Derivative financial instruments

 

The Group uses derivative financial instruments (“derivatives”) to reduce its exposure to interest rate movements.

 

Derivatives are initially recognized at fair value at the date the derivative contracts are entered into and are subsequently re-measured to their fair value at the end of each reporting period. The resulting gain or loss is recognized in consolidated statements of income immediately.

 

3.14. Provisions

 

Provisions are recognized when the Group has a present legal or constructive obligation as a result of a past event, it is more likely than not that an outflow of resources will be required to settle the obligations and can be reliably measured. Provisions are measured at management’s best estimate of the expenditure required to settle the obligations at the statement of financial position date and are discounted to present value where the effect is material.

 

3.15. Leases

 

Measurement and recognition of leases

 

The Company considers whether contract is,or contains a lease. A lease is defined as ‘a contract, or part of a contract, that conveys the right to use an asset (the underlying asset) for a period of time in exchange for consideration’.

 

To apply this definition the Company assesses whether the contract meets three key evaluations which are whether:

a)the contract contains an identified asset, which is either explicitly identified in the contract or implicitly specified by being identified at the time the asset is made available to the Company
b)the Company has the right to obtain substantially all of the economic benefits from use of the identified asset throughout the period of use, considering its rights within the defined scope of the contract.

F-23 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

c)the Company has the right to direct the use of the identified asset throughout the period of use. The Company assess whether it has the right to direct ‘how and for what purpose’ the asset is used throughout the period of use.

 

Company as a lessee

 

At lease commencement date, the Company recognises a right-of-use asset and a lease liability on the balance sheet. The right-of-use asset is measured at cost, which is made up of the initial measurement of the lease liability, any initial direct costs incurred by the Company and any lease payments made in advance of the lease commencement date.

 

The Company depreciates the right-of-use assets on a straight-line basis from the lease commencement date to the earlier of the end of the useful life of the right-of-use asset or the end of the lease term period. The Company also assesses the right-of-use asset for impairment when such indicators exist.

 

At the commencement date, the Company measures the lease liability at the present value of the lease payments unpaid at that date, discounted using the interest rate implicit in the lease if that rate is readily available or the Company’s incremental borrowing rate.

 

Lease payments included in the measurement of the lease liability are made up of fixed payments (including in substance fixed), and payments arising from options reasonably certain to be exercised. Subsequent to initial measurement, the liability will be reduced for payments made and increased for interest expenses. It is remeasured to reflect any reassessment or modification.

 

The Company has elected to account for short-term leases and leases of low-value assets using the exemption given under IFRS 16. Instead of recognising a right-of-use asset and lease liability, the payments in relation to these are recognised as an expense in profit or loss on a straight-line basis over the lease term or on another systematic basis if that basis is more representative of the pattern of the Company’s benefit.

 

Company as a lessor

Lease income from operating leases where the company is lessor is recognised in income on straight line basis over the lease term.

 

3.16. Taxation

 

Taxation on profit and loss comprises current income tax and deferred income tax. Tax is recognized in the consolidated statement of income except to the extent that it relates to items recognized directly in equity or other comprehensive income in which case it is recognized in equity or other comprehensive income.

 

Current income tax is provided at amounts expected to be paid (or recovered) using the tax rates and laws that have been enacted at the reporting date along with any adjustment relating to tax payable in previous years.

 

Deferred income tax is provided in full, using the liability method, on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the consolidated financial statements. Deferred income tax is provided at amounts expected to be paid (or recovered) using the tax rates and laws that have been enacted or substantively enacted at the statement of financial position date and are expected to apply when the related deferred income tax asset is realized or the deferred income tax liability is settled in the appropriate territory.

 

Deferred income tax in respect of undistributed earnings of subsidiaries is recognized except where the Group is able to control the timing of the reversal of the temporary difference and that the temporary difference will not reverse in the foreseeable future. Deferred income tax assets are recognized to the extent that it is probable that future taxable profit will be available against which temporary differences can be utilized.

 

Deferred income tax assets and deferred income tax liabilities are offset if, and only if the Group has a legally enforceable right to set off current tax assets against current tax liabilities and the deferred tax assets and the deferred tax liabilities relate to income taxes levied by the same taxation authority on either the same taxable entity or different taxable entities which intend either to settle current tax liabilities and assets on a net basis, or to realize the assets and settle the liabilities simultaneously, in each future period in which significant amounts of deferred tax liabilities or assets are expected to be settled or recovered.

 

F-24 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

3.17. Employee benefits

 

The Group operates defined contribution pension plans and healthcare and insurance plans on behalf of its employees. The amounts due are all expensed as they fall due.

 

In accordance with IFRS 2 “Share Based Payments”, the fair value of shares or options granted is recognized as personnel costs with a corresponding increase in equity. The fair value is measured at the grant date and spread over the period during which the recipient becomes unconditionally entitled to payment unless forfeited or surrendered.

 

The fair value of share options granted is measured using the Black Scholes model or a Monte-Carlo simulation model, each taking into account the terms and conditions upon which the grants are made. At each statement of financial position date, the Group revises its estimate of the number of equity instruments expected to vest as a result of non-market-based vesting conditions. The amount recognized as an expense is adjusted to reflect the revised estimate of the number of equity instruments that are expected to become exercisable, with a corresponding adjustment to equity reserves. None of the Group plans feature any options for cash settlements.

 

Upon exercise of share options, the proceeds received net of any directly attributable transaction costs up to the nominal value of the shares are allocated to share capital with any excess being recorded as share premium.

 

3.18. Foreign currencies

 

Transactions in foreign currencies are translated at the rates of exchange prevailing on the dates of the transactions. Monetary assets and liabilities in foreign currencies are translated at the prevailing rates of exchange at the reporting date. Non-monetary items that are measured at historical cost in a foreign currency are translated at the exchange rate at the date of the transaction. Non-monetary items that are measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value was determined.

 

Any exchange differences arising on the settlement of monetary items or on translating monetary items at rates different from those at which they were initially recorded are recognized in the income statement in the period in which they arise. Non-monetary items carried at fair value that are denominated in foreign currencies are translated at rates prevailing at the date when the fair value was determined. Non-monetary items that are measured in terms of historical cost in a foreign currency are not retranslated.

 

The assets and liabilities in the financial statements of foreign subsidiaries and related goodwill are translated at the prevailing rate of exchange at the statement of financial position date. Income and expenses are translated at the monthly average rate. The exchange differences arising from the retranslation of the foreign operations are recognized in other comprehensive income and taken in to the “currency translation reserve” in equity. On disposal of a foreign operation the cumulative translation differences (including, if applicable, gains and losses on related hedges) are transferred to the consolidated statement of income as part of the gain or loss on disposal.

 

3.19. Equity shares

 

Equity shares are classified as equity. The Group defers costs in issuing or acquiring its own equity instruments to the extent they are incremental costs directly attributable to an equity transaction that otherwise would have been avoided.  Such costs are accounted for as a deduction from equity (net of any related income tax benefit) upon completion of the equity transaction. The costs of an equity transaction which is abandoned is recognized as an expense.

 

3.20. Earnings per share

 

Basic earnings per share is computed using the weighted average number of ordinary shares outstanding during the period. Diluted earnings per share is computed by considering the impact of the potential issuance of ordinary shares, using the treasury stock method, on the weighted average number of shares outstanding during the period except where the results would be anti-dilutive.

F-25 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

3.21. Current/Non-current classification

 

The Group presents assets and liabilities in the statement of financial position based on current/non-current classification.

 

An asset is current when it is:

 

  Expected to be realised or intended to sold or consumed in the normal operating cycle (*)
  Held primarily for the purpose of trading
  Expected to be realised within twelve months after the reporting period or
  Cash or cash equivalent unless restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period

 

All other assets are classified as non-current.

 

(*) The operating cycle for the business activities of the Group is considered to be twelve months except in case of catalogue sales, which have been ascertained as two years for the purpose of current / non-current classification of assets.

 

A liability is current when:

 

  It is expected to be settled in the normal operating cycle
  It is held primarily for the purpose of trading
  It is due to be settled within twelve months after the reporting period or
  There is no unconditional right to defer the settlement of the liability for at least twelve months after the reporting period

 

The Group classifies all other liabilities as non-current. Deferred tax assets and liabilities are classified as non-current assets and liabilities.

 

4 ACQUISITION, CHANGES IN OWNERSHIP INTEREST IN SUBSIDIARY AND DECONSOLIDATION

 

Changes in ownership interest in a subsidiary

 

As of March 31, 2020, EIML has 479,614 (2019: 757,886), stock option outstanding under the India IPO Plan. In the year ended March 31, 2020, 121,496 (2019: 536,263) options were exercised at a weighted average exercise price of INR 10 (2019: INR 10) per share.

 

Deconsolidation

 

During fiscal 2018, the Group had divested its 51 percent equity interest in Ayngaran Group to the non-controlling investee. The sale of the 51 percent equity interest in the majority-owned subsidiary resulted in a loss of control of the subsidiary, and therefore it was deconsolidated from the Company's financial statements during fiscal 2018.

 

 

The Company recognised loss of $14,649 on the deconsolidation, measured as the fair value of the consideration received for the 51 percent equity interest in the former subsidiary and the fair value of the financial asset retained in the former subsidiary on deconsolidation. Of the above, loss of $457 resulted on account of recording the retained financial assets at fair value. The aforesaid loss was recorded within other gains/(losses), net in Statement of Income.

 

F-26 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

5 BUSINESS SEGMENTAL DATA

 

The Group acquires, co-produces, distributes and provides production services, including visual special effects (VFX) in respect of Indian films in multiple formats worldwide. Film advances is monitored and strategic decisions around the business operations are made based on the filmed entertainment sector, whether it is new release, library or services. Hence, the Management identifies only one operating segment in the business, filmed entertainment. We distribute our film content to the Indian population in India, the South Asian diaspora worldwide and to non-Indian consumers who view Indian films that are subtitled or dubbed in local languages. As a result of these distribution activities, Eros has identified four geographic markets: India, North America, Europe and the Rest of the world.

 

   Year ended March 31 
   2020   2019   2018 
   (in thousands) 
Revenue by region of domicile of Group’s operation               
India  $41,119   $100,387   $98,073 
Europe   26,927    63,196    27,028 
North America   1,309    1,759    1,244 
Rest of the world   86,097    104,784    134,908 
Total Revenue (*)  $155,452   $270,126   $261,253 

 

Revenue of $85,793 (2019: $81,409 and 2018: $103,263) from the United Arab Emirates and is included within Rest of the world and revenue of $26,927 (2019: $63,196 and 2018: $27,028) from the United Kingdom and Isle of Man are included under Europe in the above table.

 

   Year ended March 31 
   2020   2019   2018 
   (in thousands) 
Revenue by region of domicile of customer’s location               
India  $44,887   $116,078   $109,986 
Europe   94,887    2,345    7,739 
North America   6,078    5,682    5,147 
Rest of the world   9,600    146,021    138,381 
Total Revenue (*)  $155,452   $270,126   $261,253 

 

Revenue of $1,329 (2019: $62,527 and 2018: $67,993) from the United Arab Emirates and $5,240 from China are included within Rest of the world and revenue of $81,465 (2019: $1,180 and 2018: $5,200) from United Kingdom is included under Europe in the above table.

 

For the year ended March 31, 2020, March 31, 2019 and March 31, 2018, two customers accounted for more than 10% of the Group’s total revenues

 

   Year ended March 31 
   2020   2019   2018 
   (in thousands) 
Revenue by source               
Theatrical  $10,586   $69,542   $79,069 
Satellite Content licensing   7,112    77,453    97,168 
Digital and other ancillary(*)   137,754    123,131    85,016 
Total Revenue(**)  $155,452   $270,126   $261,253 

 

(*) the ancillary includes revenue from providing producer support and VFX services to customers

(**) Net of significant discounting component $5,558 (2019: $34,467 and 2018: $6,816 ). [Refer Note 19].

F-27 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Segment assets by region of domicile of Group’s operation:

 

   Total   India   North
America
   Europe   Rest of the
World
 
   (in thousands) 
Non-current assets (*)                         
As of March 31, 2020  $475,633   $152,340   $1   $25,860   $297,432 
As of March 31, 2019  $722,043   $336,431   $4   $34,217   $351,391 

   

Segment assets of $292,109 (2019: $295,685) in the United Arab Emirates is included under Rest of the world and segment assets of $25,601 (2019: $32,287) and $259 (2019: $1,903) in the United Kingdom and IOM respectively is included under Europe in the above table.

 

(*) Non-current assets include property and equipment, right of use assets, intangibles assets (content and others) and restricted deposit by geographic area.

 

6 NATURE OF EXPENSES

 

(Loss)/Profit for the year is arrived at after the following are charged to the consolidate statements of income:

 

   Year ended March 31 
   2020   2019   2018 
   (in thousands) 
Publicity and advertisement costs   $11,452   $19,779   $12,684 
Film distribution costs    1,320    5,462    6,739 
Amortization expenses [Refer note 15]    64,451    130,155    115,285 
Personnel costs [Refer note 7]    36,697    37,015    35,661 
Rent expenses    391    1,916    1,359 
Legal and professional expenses    4,615    6,980    8,204 
Provision for trade and other receivables            1,968 
Bad debt            2,772 
Credit impairment loss, net [Refer note 19]    97,551    25,741    4,308 
Depreciation and amortization of other intangibles    3,462    2,263    2,991 
Impairment charge on goodwill            1,205 
Impairment loss on content advances            353 
Impairment loss on advances to content vendors        7,284     
Others    6,105    5,935    9,208 
   $226,044   $242,530   $202,737 
Cost of services  $81,725   $155,396   $134,708 
Administrative costs  $144,319   $87,134   $68,029 

 

7 PERSONNEL COSTS

 

   Year ended March 31 
   2020   2019   2018 
   (in thousands) 
Salaries   $13,781   $14,591   $16,790 
Social security and other employment charges    617    831    916 
Salaries and other charges    14,398    15,422    17,706 
Share based compensation (Refer note 27)    22,268    21,561    17,918 
Pension charges    31    32    37 
   $36,697   $37,015   $35,661 

 

   Year ended March 31 
Key management compensation  2020   2019   2018 
   (in thousands) 
Salaries   $4,395   $4,010   $4,919 
Share based compensation    19,829    13,859    11,519 
Pension charges    23    21    16 
   $24,247   $17,890   $16,454 

F-28 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

8 NET FINANCE COSTS

 

   Year ended March 31 
   2020   2019   2018 
   (in thousands) 
Interest on borrowings (*)   $29,474   $33,530   $32,556 
Reclassification of cash flow hedge to consolidated statements of income            375 
Total interest expense (*)    29,474    33,530    32,931 
Capitalized interest on eligible film rights and content advances    (8,703)   (9,437)   (13,263)
Total finance costs    20,771    24,093    19,668 
Less: Interest income                
Unwinding of interest    (9,807)   (13,227)   (932)
Bank deposits    (2,185)   (3,192)   (923)
Total finance income    (11,992)   (16,419)   (1,855)
   $8,779   $7,674   $17,813 

 

For the year ended March 31, 2020, the capitalization rate of interest was 11.00% (2019: 10.21% and 2018:11.56%).

 

(*) includes interest expense in respect of financial liabilities classified at fair value through profit or loss $5,517 (2019: $10,682 and 2018: $4,338), significant discounting on long-term advance from customers $1,501 (2019: $458) and leases $ 184

 

9 OTHER GAINS/(LOSSES)

 

   Year ended March 31 
   2020   2019   2018 
   (in thousands) 
Foreign exchange (loss)/gain, net   $5,650   $5,610   $(6,250)
Gain/(loss) on sale of property and equipment and other Intangibles    (70)   (97)   2 
Gain/(Loss) on available-for-sale financial assets (Refer note 17)    (1,253)   37     
Impairment charge on available -for- sale financial assets (Refer note 17)            (2,436)
(Loss) on de-recognition of financial assets measured at amortized cost net (*)    (5,285)   (5,988)   (3,562)
Mark to market gain/(loss) on derivative financial instrument measured at fair value through profit and loss account (Refer note 25)        (902)    
(Loss) on settlement of derivative financial instruments            (586)
(Loss) on financial liability (convertible notes) measured at fair value through profit and loss account (Refer note 22)    (15,987)   (21,398)   (13,840)
(Loss) on deconsolidation of a subsidiary (Refer note 4)            (14,649)
Reversal of expected credit loss (Refer note 19)    10,382    20,698     
Liabilities no longer required, written-back   2,487          
Credit from Government of India    760    2,328     
   $(3,316)  $288   $(41,321)

 

(*) Arising on assignment and novation of trade receivables and trade payables with no-recourse. Derecognition of aforesaid financial assets/liabilities measured at amortized cost is to mitigate both credit risk and liquidity risk (Refer Note 31).

 

10 INCOME TAX EXPENSE

 

   Year ended March 31 
   2020   2019   2018 
   (in thousands) 
Current income tax expense   $1,800   $17,372   $5,556 
Deferred income tax (benefit) / charge    (23,983)   (10,044)   3,571 
Income tax expenses   $(22,183)  $7,328   $9,127 

 

F-29 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Reconciliation of tax charge

 

   Year ended March 31 
   2020   2019   2018 
   (in thousands) 
(Loss) before tax  $(513,887)  $(403,125)  $(618)
Income tax (benefit)/expense at tax rates applicable to individual entities(#)   (44,763)   6,814    7,358 
Tax effect of:               
Effect of unrecognised tax asset (*)   29,898        657 
Changes in tax rates on temporary differences brought forward   (7,476)   232    (168)
Items not deductible for income tax   5    688    486 
Adjustment in respect of current income tax of previous years       (762)    
Others   153    356    794 
Income tax expense  $(22,183)  $7,328   $9,127 

 

(#) Domestic tax is Nil as the Company is subject to income tax in Isle of Man at a rate of zero percent. Foreign taxes are based on applicable tax rates in each subsidiary jurisdiction.

 

(*) In view of tax losses on Company’s Indian Listed subsidiary, deferred tax assets on deductible temporary differences have been recognised to the extent of deferred tax liability on taxable temporary difference on account of lack of sufficient certainty of future earnings against which such deferred tax asset can be realised. Unrecognised tax asset, in respect of tax losses and deductible temporary differences of $ 118,793, is $ 29,898.

 

11 DEFERRED INCOME TAX ASSETS AND LIABILITIES

 

Changes in deferred income tax assets and liabilities

 

   As At March 31, 2020 
   Opening
Balance
   Recognized
in
statements of income
   Exchange
Difference
   Closing
Balance
 
     
Deferred tax assets:                    
Minimum alternate tax carry-forward  $88   $2   $(6)  $84 
Property and equipment   76    120    (9)   187 
Credit impairment loss   5,044    (3,740)   (918)   386 
Content advances and film production       11,791    (2,916)   8,875 
Others   3,281    (4,328)   2,167    1,120 
Total income deferred tax asset  $8,489   $3,845   $(1,682)  $10,652 
Deferred income tax liabilities:                    
Property and equipment   (624)   38    520    (66)
Content advances and film production   (34,029    20,100    1,397    (12,532)
                     
Total deferred income tax liability  $(34,653)  $20,138   $1,917   $(12,598)
                     
Net deferred tax (liability)  $(26,164)  $23,983   $235   $(1,946)
As at March 31, 2020                    
Deferred income tax asset                 $742 
Deferred income tax liability                 $(2,688)

 

F-30 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

       As At March 31, 2019 
   Opening
Balance
   Impact of adoption of
IFRS 9
   Recognized in
statements of income
   Exchange
Difference
   Closing
Balance
 
   (in thousands) 
Deferred tax assets:                         
Minimum alternate tax carry-forward   $927       $(778)  $(61)  $88 
Property and equipment    83        (2)   (5)   76 
Credit impairment loss        673    4,385    (14)   5,044 
Others    2,442        984    (116)   3,310 
Total income deferred tax asset   $3,452    673   $4,589   $(196)  $8,518 
Deferred income tax liabilities:                         
Property and equipment    (776)       142    10    (624)
Intangible assets    (41,815)       5,313    2,473    (34,029)
Others    (29)               (29)
Total deferred income tax liability    (42,620)      $5,455   $2,483   $(34,682)
                          
Net deferred tax (liability)    (39,168)   673   $10,044   $2,287   $(26,164)
As at March 31, 2019                          
Deferred income tax asset                       $1,263 
Deferred income tax liability                       $(27,427)

 

Deferred tax is calculated in full on all temporary differences under the liability method using the local tax rate of the country in which the timing difference occurs.

 

Deferred tax assets have been recognised on the basis that there is reasonable certainty of profitability to utilize the available losses and tax credits. However, in view of tax losses on Group’s Indian listed subsidiary, deferred tax assets on deductible temporary differences have been recognised to the extent of deferred tax liability on taxable temporary difference on account of lack of sufficient certainty of future earnings against which such deferred tax asset can be realised.

 

Deferred tax liabilities to the extent of $21,390 (2019: $49,163 and 2018: $43,962) have not been provided on the undistributed earnings of subsidiaries as Eros is able to control the timing of the reversal of the temporary difference and it is probable that the temporary difference will not reverse in the foreseeable future.

 

The excess tax paid under MAT provisions over and above normal tax liability can be carried forward and setoff against future tax liabilities computed under normal tax provisions. The Indian subsidiaries were required to pay MAT in the past years and accordingly, a deferred tax asset of $84 (2019: $88 and 2018: $927) has been recognised in the consolidated financial position, which can be carried forward for a period of fifteen assessment years immediately succeeding the assessment year in which it becomes allowable.

 

F-31 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

12 EARNINGS PER SHARE (EPS)

 

   2020   2019   2018 
   Basic   Diluted   Basic   Diluted   Basic   Diluted 
   (in thousands, except number of shares and earnings per share) 
(Loss)/earnings                              
(Loss)attributable to the equity holders of the parent   $(418,992)   (418,992)  $(423,867)   (423,867)  $(22,575)  $(22,575)
Potential dilutive effect related to share based compensation scheme in subsidiary undertaking                (197)       (475)
Adjusted earnings attributable to equity holders of the parent   $(418,992)   (418,992)  $(423,867)   (424,064)  $(22,575)  $(23,050)
Number of shares                              
Weighted average number of shares    107,532,584    107,532,584    70,706,579    70,706,579    62,151,155    62,151,155 
Potential dilutive effect related to share based compensation scheme         8,237,299        1,463,640        1,331,211 
Adjusted weighted average number of shares    107,532,584    115,769,883    70,706,579    72,170,219    62,151,155    63,482,366 
(Loss) per share                              
(Loss) attributable to the equity holders of the parent per share (cents)    (389.6)   (389.6)   (599.5)   (599.5)   (36.3)   (36.3)

 

The above table does not split the earnings per share separately for the ‘A’ ordinary 30p shares and the ‘B’ ordinary 30p shares as there is no variation in their entitlement to participate in undistributed earnings.

 

The Company excludes options with exercise prices that are greater than the average market price from the calculation of diluted EPS because their effect would be anti-dilutive. In the year ended March 31, 2020, 601,667 shares were not included in diluted earnings per share (2019: 1,957,035). Since there is loss for the fiscal year 2019, the potential equity shares resulting from dilutive options are not considered as dilutive and hence, the Diluted EPS is same as Basic EPS.

 

Further, the Company have excluded convertible notes 13,888,889 shares because of their effect was anti-dilutive (2019 : 7,567,962).

 

13 PROPERTY AND EQUIPMENT

 

   As At March 31, 2020 
   Land
and
Building
   Furniture,
fittings and
equipment
   Vehicles   Machinery   Total 
   (in thousands) 
Opening net carrying amount  $9,562   $199   $549   $601   $10,911 
Exchange difference   (480)   (8)   (29)   (7)   (524)
Additions   30            31    61 
Adjustment on Adoption of IFRS 16               (243)   (243)
Disposals       (2)   (116)   (2)   (120)
Adjustment of depreciation on disposal       1    28    2    31 
Depreciation charge   (579)   (49)   (132)   (131)   (891)
Balance as at March 31, 2020  $8,533   $141   $300   $251   $9,225 
Capital work-in-progress                      $9 
Net carrying value as at March 31, 2020                      $9,234 

 

F-32 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

   As At March 31, 2020 
   (in thousands) 
Cost or valuation  $13,408   $1,749   $1,244   $4,032   $20,433 
Accumulated depreciation   (4,875)   (1,608)   (944)   (3,781)   (11,208)
Net carrying amount  $8,533   $141   $300   $251   $9,225 
Capital work-in-progress                      $9 
Net carrying value as at March 31, 2020                      $9,234 

 

   As At March 31, 2019 
   Land
and
Building
   Furniture,
fittings and
equipment
   Vehicles   Machinery   Total 
   (in thousands) 
Opening net carrying amount   $8,481   $348   $698   $476   $10,003 
Exchange difference    (292)   (12)   (43)   (12)   (359)
Revaluation    1,745                1,745 
Additions    207    16    116    394    733 
Reclassification and other adjustment         (61)   2        (59)
Disposals    (449)   (56)       (65)   (570)
Adjustment of depreciation on disposal    367    39        61    467 
Depreciation charge    (497)   (75)   (224)   (253)   (1,049)
Balance as at March 31, 2019   $9,562   $199   $549   $601   $10,911 
Capital work-in-progress                       $10 
Net carrying value as at March 31, 2019                       $10,921 

 

   As At March 31, 2019 
   (in thousands) 
Cost or valuation   $13,858   $1,759   $1,389   $4,318   $21,324 
Accumulated depreciation    (4,296)   (1,560)   (840)   (3,717)   (10,413)
Net carrying amount   $9,562   $199   $549   $601   $10,911 
Capital work-in-progress                       $10 
Net carrying value as at March 31, 2019                       $10,921 

 

Property and equipment with a net carrying amount of $8,189 (2019: $6,685) have been pledged to secure borrowings (Refer Note 22).

 

Land and buildings were revalued as at March 31, 2019 by independent valuers on the basis of market value. Fair values were estimated based on recent market transactions, which were then adjusted for specific conditions relating to the land and buildings. As at March 31, 2020, had land and buildings of the Group been carried at historical cost less accumulated depreciation, their carrying amount would have been $4,337 (2019: $4,983).

 

Capital work-in-progress of $9 (2019: $10) primarily related to Machinery cost in Company’s leased premises.

 

14 GOODWILL AND TRADEMARK

 

 

Goodwill and Trademark

  Amount in US$ 
Balance as at March 31, 2019   $ 
Balance as at March 31, 2020   $ 

 

F-33 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

15 INTANGIBLE CONTENT ASSETS

 

   Gross
Content
Assets
   Accumulated
Amortization
   Impairment
Loss
   Content
Assets
 
As at March 31, 2020                    
Film and content rights  $1,835,263   $(975,774)  $(557,510)  $301,979 
Content advances   427,046        (274,325)   152,721 
Film productions   12,089        (4,900)   7,189 
Non-current content assets  $2,274,398   $(975,774)  $(836,735)  $461,889 
                     
As at March 31, 2019                    
Film and content rights   $1,675,406    (954,628)   (366,703)  $354,075 
Content advances    378,268        (38,832)   339,436 
Film productions    13,061            13,061 
Non-current content assets   $2,066,735    (954,628)   (405,535)  $706,572 

 

   As At ended March 31 
   2020   2019 
   (in thousands) 
Film productions          
Opening balance  $13,061   $10,867 
Additions   9,314    3,413 
Exchange difference   (751)   (775)
Impairment loss (Refer to Note 2 (c))   (4,900)    
Transfer to film and content rights   (9,535)   (444)
Closing balance  $7,189   $13,061 
           
Content advances          
Opening balance  $339,436   $349,568 
Additions (*) (**)   255,940    261,002 
Reclassifications       (65)
Exchange difference   (9,484)   (12,314)
Impairment loss (Refer to Note 2 (c))   (235,493)   (38,832)
Transfer to film and content rights   (197,678)   (219,923)
Closing balance  $152,721   $339,436 
           
Film and content rights          
Opening balance  $354,075   $638,108 
Amortization   (64,451)   (130,155)
Exchange difference   (4,486)   (7,542)
Impairment loss (Refer to Note 2 (c))   (190,807)   (366,703)
Transfer from inventory   435     
Transfer from film productions and content advances   207,213    220,367 
Closing balance  $301,979   $354,075 

 

Film and content rights with a carrying amount of $123,180 (2019: $310,996) have been pledged against secured borrowings (Refer Note 22).

 

(*)represents non-cash movement on account of de-recognition of financial liabilities amounting to $90,118 (2019: $160,615) [Refer Note 31].

(**) capital creditors amounting $24,513 were settled by issuance of A Ordinary Shares, [Refer note 26].

 

16 INTANGIBLE ASSETS-OTHER

 

Other intangibles comprise of software and other intangibles used within the Group’s digital and home entertainment activities and internal accounting activities.

F-34 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

The changes in other intangible assets are as follows:

 

   As At March 31, 2020 
   (in thousands) 
   Information
technology
assets
   Other
intangibles
   Total 
Opening net carrying amount as on March 31, 2019   $1,204   $2,590   $3,794 
Exchange difference        (137)   (137)
Additions             
Disposal and reclassification    (59)   (4)   (63)
Amortization charge    (39)   (855)   (894)
Sub- total   1,106    1,594    2,700 
Intangibles under development           235 
Closing net carrying amount as on March 31, 2020   $1,106   $1,594   $2,935 

 

   As At March 31, 2020 
   (in thousands) 
Cost or valuation as on March 31, 2019   $5,055   $6,466   $11,521 
Accumulated amortization    (3,949)   (4,872)   (8,821)
Net carrying amount as on March 31, 2020   $1,106   $1,594   $2,700 
Intangibles Under Development            $235 
Net carrying value as at March 31, 2020            $2,935 

  

   As At March 31, 2019 
   (in thousands) 
   Information
 technology
assets
   Other
intangibles
   Total 
Opening net carrying amount as on March 31, 2018   $1,449   $3,831   $5,280 
Exchange difference        (148)   (148)
Additions        907    907 
Disposal and reclassification    59    (1,090)   (1,031)
Amortization charge    (304)   (910)   (1,214)
Closing net carrying amount as on March 31, 2019   $1,204   $2,590   $3,794 

 

   As At March 31, 2019 
   (in thousands) 
Cost or valuation as on March 31, 2019   $5,114   $6,607   $11,721 
Accumulated amortization    (3,910)   (4,017)   (7,927)
Net carrying amount as on March 31, 2019   $1,204   $2,590   $3,794 

 

Other intangible assets with a carrying amount of $57 (2019: $92) have been pledged against secured borrowings (Refer Note 22).

 

17 AVAILABLE-FOR-SALE FINANCIAL ASSETS

 

   As At March 31 
   2020   2019 
    (in thousands)      
Non-Current investments          
Valuable Technologies Limited   $140   $2,000 
LMB Holdings Limited        650 
   $140   $2,650 

Current investments

Polyxo Global Limited

  $225   $1,042 
Plutus Opportunities Fund Limited    3,577     
   $3,942   $3,692 

F-35 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

The movement in the financial assets is as follows:

 

   Financial Assets
at FVTPL
   Financial Assets
at FVTOCI
 
     
As at March 31, 2018   $27,257   $ 
Reclassification (refer note 29)    (27,257)   27,257 
Additions    1,005    80 
Fair valuation gain / (loss)    37    (24,687)
As at March 31, 2019    1,042   $2,650 
Additions/(Disposal)    4,013    (650)
Fair valuation gain / (loss)    (1,253)   (1,860)
As at March 31, 2020   $3,802   $140 

 

Eros acquired an interest in Valuable Technologies Limited (“Valuable”) in the year ended March 31, 2009. Valuable manages and operates a number of companies within media and entertainment, technology and infrastructure. These companies include “UFO Moviez”, the leading provider of Digital projection solutions for cinemas in India and “Impact” whose business is theatrical ticketing and sales data. As at March 31, 2020 and March 31, 2019, Eros owns 7.2% of Valuable’s equity. For the year ended March 31, 2020 and March 31, 2019, management has used the latest available financial statements, which shows decrease in revenue and increase in losses compared to prior years. Accordingly, the fair value has been computed using the Net Asset Value method. Management has used an estimate of 30% for the discount for lack of liquidity (DLOL). DLOL reflects the ease of investor's ability to liquidate its business interest. As per Eros’s stake of 7.2%, the estimated fair value (Non- Marketable and Non-Control Basis) is arrived at $140.

 

Acacia Investments Holdings Limited (“Acacia”) is a dormant holding company and owns 12.97% of L.M.B Holdings Limited (“LMB”) which through its subsidiaries operates satellite television channels, such as “B4U Music”, “B4U Movies” and “The Movie House Channel”. As of March 31, 2020, and prior, the Group had no Board representation, no involvement in policy decision making, did not provide input in respect of technical know-how and had no material contract with LMB or its subsidiaries nor did they have the power to exert significant influence. Until the year ended March 31, 2018, due to the range of potential outcomes for the investment was estimated using level 3 inputs, using guideline public companies method with revenue multiple. The Management has concluded the sale of their stake in “LMB Holdings Limited” at $650 in the month of July 2019.

 

Investments in these unquoted equity investments are not held for trading. Instead, they are medium or long-term strategic purpose fair value of the investment has been derived based on the information and closing statement received from funds.

 

18 INVENTORIES

 

   As At March 31 
   2020   2019 
   (in thousands) 
Goods for resale   $   $435 
   $   $435 

 

During the year ended March 31, 2020, inventory of Nil (2019: $93 and 2018: $290) was recognised in the consolidated statements of income as an expense. In addition to the year the company has charged Nil (2019: $69) as expense in statement of income as a result of the write down of inventories. Inventories with a carrying amount of $NIL (2019: $435) have been pledged as security for certain of the Group’s borrowings (Refer note 22).

 

F-36 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

19   TRADE AND OTHER RECEIVABLES

 

   As at 
   March 31,
2020
   March 31,
2019
 
Trade accounts receivables at fair value (*)          
Trade accounts receivables   $138,869    156,026 
Credit impairment (loss)    (41,470)   (26,133)
Fair Value gain/(loss)    (2,650)   (4,664)
Trade accounts receivables net    94,749    125,229 
           
Trade accounts receivables at amortised cost          
Trade accounts receivables   $77,772   $86,331 
Credit impairment (loss)    (70,853)   (15,202)
Trade accounts receivables net    6,919    71,129 
           
Total Trade accounts receivables   $101,668   $196,358 
           
Balance with statutory authorities    6,568    7,672 
Accrued interest    92    2,188 
Advance to content vendor    1,373    3,462 
Prepaid charges    2,578    1,790 
Unbilled revenues    553    1,717 
Other receivables    5,182    2,023 
Trade and other receivables   $118,014   $215,210 
           
Current    107,253    205,145 
Non-current    10,761    10,065 
   $118,014   $215,210 

 

(*) Business model is achieved both by collecting contractual cash flows and de-recognition of financial assets arising on assignment and novation transaction. (Refer Note 31)

 

The age of account receivables net of credit of credit impairment loss are past due but not impaired were as follows:

 

   As at 
   March 31,
2020
   March 31,
2019
 
Not more than three months   $15,097   $44,687 
More than three months but not more than six months    11,764    15,948 
More than six months but not more than one year    14,896    15,310 
More than one year    4,899    8,796 
   $46,656   $84,741 

 

Trade and other receivables with a net carrying amount of $29,969 (2019: $83,991) have been pledged against secured borrowings (Refer Note 22).

F-37 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

The movement in the allowances for expected credit losses is as follows:

 

   Year ended 
   March 31, 2020 
   Trade
Receivables
   Other
Receivables
   Total
Receivables
 
Balance as on April 1, 2019   $41,335   $447   $41,782 
Charged to operations    103,109        103,109 
Unwinding of expected credit loss (included in finance income)    (9,807)       (9,807)
Reversal of expected credit loss (included in other gains/(losses))    (10,382)       (10,382)
Bad debts    (6,743)       (6,743)
Translation Adjustment    (5,189)        (5,189)
Balance at the end of the year   $112,323   $447   $112,770 

 

The movement in the allowances for expected credit losses is as follows:

 

   Year ended 
   March 31, 2019 
   Trade
Receivables
   Other
Receivables
   Total
Receivables
 
Balance at the beginning of the period   $10,193   $   $10,193 
Impact of adoption of IFRS 9    18,050    447    18,497 
Balance as on April 1, 2018    28,243    447    28,690 
Charged to operations    60,208    7,284    67,492 
Unwinding of expected credit loss (included in finance income)    (13,227)       (13,227)
Reversal of expected credit loss (included in other gains/(losses))    (20,698)       (20,698)
Bad debts    (13,031)   (7,284)   (20,315)
Translation adjustment    (160)       (160)
Balance at the end of the year   $41,335   $447   $41,782 

 

20 TRADE AND OTHER PAYABLES

 

   As At March 31 
   2020   2019 
   (in thousands) 
Trade accounts payable(*)   $21,030   $25,299 
Accruals and other payables (includes creditors for content assets of $29,937 (2019: $16,139))    43,809    32,888 
Contract liability (deferred revenue)    9,827    12,260 
Accrued interest    3,106    2,395 
Value added taxes and other taxes payable    13,169    10,645 
   $90,941   $83,487 

 

(*) Includes settlement of payables through issuance of shares (Refer note 27). and de-recognition of financial liabilities arising on assignment and novation transaction [Refer note 31]

 

The carrying amount of trade and other payables are considered a reasonable approximation of fair value.

 

21 CASH AND CASH EQUIVALENTS

 

Cash and cash equivalents consist of cash on hand and balance with banks (including balances in current account and demand deposits). Cash and cash equivalents included in the statements of cash flows comprise the following amounts in the statement of financial position.

 

   As At March 31 
   2020   2019 
   (in thousands) 
Cash at bank and in hand  $2,563   $89,117 
   $2,563   $89,117 

 

F-38 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

22 BORROWINGS

 

An analysis of long-term borrowings is shown in the table below.

 

   Nominal       As at March 31, 
   Interest Rate   Maturity   2020   2019 
           (in thousands) 
Asset backed borrowings                  
Vehicle loan  2.5 - 9.5%   2017-22   $127   $382 
Term loan  MCLR +3.2% - 4.50%   2019-22    6,843    12,947 
Term loan  BR + 2.75%   2020-21    509    1,083 
Term loan  10.39% - 13.75%   2020-23        251 
           $7,479   $14,663 
Unsecured borrowings                  
Retail bond  6.50%   2021-22    62,274    65,215 
Convertible notes(1)  14.23%   2020-21        68,349 
           $62,274   $133,564 
                   
Cumulative effect of unamortised costs           (399)   (691)
Instalments due within one year:                  
Convertible notes(2)               (68,349)
Others           (7,240)   (7,267)
           $62,114   $71,920 
                   
Long-term borrowings at amortised cost          $62,114   $71,920 

 

Bank prime lending rate and marginal cost lending rate (“BPLR” & “MCLR”) is the Indian equivalent to LIBOR. Asset backed borrowings are secured by fixed and floating charges over certain Group assets.

 

Analysis of short-term borrowings

 

   Nominal  As at March 31, 
   interest rate (%)  2020   2019 
      (in thousands) 
Asset backed borrowings             
Export credit, bill discounting and overdraft   MCLR +.40% to 6%  $37,755   $32,078 
Export credit, bill discounting and overdraft   Base Rate + 0.5% to 1%   3,442    3,533 
Export credit, bill discounting and overdraft   6.01% - 15.25%   28,773    26,719 
Convertible notes(1)   9.96%   23,100     
Short- term loan(3)   3.25% - 16.45%   16,548    70,962 
      $109,618   $133,292 
Unsecured borrowings              
Instalments due within one year on long-term borrowing       7,240    75,616 
      $116,858   $208,908 
              
Short-term borrowings at fair value       23,100    68,349 
Short-term borrowings at amortised cost      $93,758   $140,559 

 

1 Eros International Plc. (“issuer”) issued Senior Convertible Notes (SCN or convertible notes) on December 06, 2017 amounting to $122,500 principal amount and option to purchase warrants up to 2,000 of A ordinary share for a term of 6 months at an offer price of $100,000 by private placement. The notes are payable in equal installments of $3,500 per month for 35 months starting December 31, 2017. The installments can be paid either in cash or can be converted into A ordinary equity shares of the issuer at the option of the issuer as per the terms of the arrangement. The notes are fully paid as at the date of reporting. Further, Eros International Plc. (“issuer”) issued Senior Convertible Notes (SCN or convertible notes) on September 25, 2019 amounting to $27,500 principal amount. The maturity date of convertible is September 26, 2020. . The installments will be converted into A ordinary equity shares of the issuer at the option of the issuer as per the terms of the arrangement.

 

F-39 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

The holder of the notes can defer the payment of the amount due on any instalment dates to another instalment date as well as has the right to accelerate the payment on the notes as per the terms of the agreement

 

The Company has classified the instrument as a financial liability at fair value through profit or loss. The Company the Monte-Carlo simulation model to obtain the fair value of the convertible notes. Fair value of the financial liability outstanding as at the date of reporting is $23,100 (2019: $68,349)

 

The mark-to-market loss and interest expense for the year ended March 31, 2020 was $15,987 (2019: $21,398) and $5,517 (2019: $10,682) have been recognized within other gain/(losses) and net finance cost, respectively, net in the Statement of Income.

 

2. Secured by pledge of shares held in the Group’s majority owned subsidiary, Eros International Media Limited, India.

 

3. For the twelve months ended March 31, 2020 capitalization rate of interest was 11.00% (2019: 10.21%)
   
4. Borrowing agreements are subjected to covenant clause, whereby the Company is required to meet certain key financial ratios and those remaining unfulfilled resulted in disclosure of the outstanding balance with the aforesaid banking institution as a current liability as of March 31, 2020. Management is in the process of renewal of the aforesaid borrowing arrangement with the bank/s and is expecting that a revised loan sanction letter will be in place in the coming quarter/s.

 

Fair value of the long-term borrowings as at March 31, 2020 is $43,964 (2019: $140,968). Fair values of long-term financial liabilities except retail bonds and convertibles notes have been determined by calculating their present values at the reporting date, using fixed effective market interest rates available to the Companies within the Group. As at March 31, 2020, the fair value of retail bond amounting to $36,897 (2019: $59,313) has been determined using quoted prices from the London Stock Exchange and the fair value of senior convertible notes has been determined at $23,100 (2019: $68,349) by an independent valuation expert using Monte-Carlo simulation model. Carrying amount of short-term borrowings are considered a reasonable approximation of fair value.

 

Reconciliation of fair value measurement of convertible notes:

 

   March 3, 2020 
Particulars  (in thousands) 
As at March 31,2019  $68,349 
Interest   5,517 
‘A’ ordinary shares issued in lieu of convertible notes   (91,753)
Receipt from convertible notes   25,000 
Loss on fair value of convertible notes   15,987 
 As at March 31, 2020   $23,100 

 

23 ACCEPTANCES

 

   As At March 31 
   2020   2019 
   (in thousands) 
Payable under the film financing arrangements   $1,858   $8,366 
   $1,858   $8,366 

 

Acceptances comprise of short-term credit availed from financial institutions for payment to film producers for film co-production arrangement entered by the group. The carrying value of acceptances are considered a reasonable approximation of fair value.

 

24 OTHER LONG -TERM LIABILITIES

 

   As At March 31 
   2020   2019 
   (in thousands) 
Contract liability (deferred revenue)(*)   $7,793   $13,271 
Employee benefit obligation    465    627 
   $8,258   $13,898 

 

(*) includes significant discounting on long-term advances from customers $1,925 (2019: 458)

 

25 DERIVATIVE FINANCIAL INSTRUMENTS

 

   As At March 31 
   2020   2019 
   (in thousands) 
Current        
Derivative liabilities – Held for trading           
Interest rate cap   $   $(620)
   $   $620 

 

F-40 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

The above interest rate derivative instruments are not designated in a hedging relationship. They are carried at fair value through profit or loss. (Refer Note 9).

 

26 ISSUED SHARE CAPITAL

 

   Number of
Shares
   GBP 
Authorized        (in thousands) 
           
Ordinary shares of 30p each at March 31, 2019   150,000,000    45,000 
Ordinary shares of 30p each at March 31, 2020 (*)   200,000,000    60,000 

 

(*) The Company increased authorized number of shares to 200,000,000 on September 25, 2019.

 

   Number of Shares   USD 
Allotted, called up and fully paid  A Ordinary 
30p Shares(*)
   B Ordinary 
30p Shares(*)
   (in thousands) 
As at March 31, 2018   55,718,423    9,712,715   $35,334 
Issue of shares in the quarter ended June 30, 2018   2,747,645        1,138 
Issue of shares in the quarter ended September 30, 2018   3,773,385        1,471 
Issue of shares in the quarter ended December 31, 2018   1,659,767        641 
Transfer of B Ordinary to A Ordinary share   1,500,000    (1,500,000)    
Issue of shares in the quarter ended March 31, 2019   1,892,518        742 
As at March 31, 2019   67,291,738    8,212,715   $39,326 
Issue of shares in the quarter ended June 30, 2019   4,192,459        1,598 
Issue of shares in the quarter ended September 30, 2019   25,956,283    7,044,210    12,276 
Issue of shares in the quarter ended December 31, 2019   16,250,661        6,747 
Issue of shares in the quarter ended March 31, 2020   13,425,561    4,642,160    6,780 
As at March 31, 2020   127,116,702    19,899,085    66,727 

 

(*) Each A ordinary shares is entitled to one vote on all matters and each B shares is entitled to ten votes.

 

The Company issued A and B Ordinary shares as follows:

 

   A Ordinary   B Ordinary 
   For the year ended   For the year ended 
   March
  31, 2020
   March 31,
2019
   March 31,
2020
   March 31,
2019
 
Issuance to Founders Group (1) (7)       1,769,911    4,878,050     
Issuance towards settlement of Convertible notes (2)   49,185,958    4,411,359         
Exercise against Restricted Share Unit/ Management scheme (3)   2,728,181    770,541    6,808,320     
Issuance towards Reliance Industries Limited (4)       3,111,088         
2015 Share Plan (5)   132,013    10,416         

Issuance to vendors (8)

   6,475,600             
Issuance towards equity infusion from funds (6)   1,303,212             
Total   59,824,964    10,073,315    11,686,370     

 

(1) Average price of A Ordinary Shares at NIL price (March 2019: $14.69)and B Ordinary Shares at $1.64 (March 2019:Nil)

(2) Average exercise price of A Ordinary Shares $1.87 (March 2019: $11.28)

(3) 2,728,181 A Ordinary shares (March 2019: 183,000) at NIL(March 2019: $0.39) and 6,808,320 B Ordinary shares (March 2019: Nil) exercised at NIL price March 2019: Nil)

(4) Average exercise price of A Ordinary Shares NIL (March 2019: $15)

(5) Average exercise price A Ordinary Shares $2 (March 2019: $7.92)

(6) Average exercise price A Ordinary Shares $3.22 (March 2019: Nil)

(7) Includes 4,176,830 B Ordinary shares issued against advance received ($6,150) as of March 31, 2019 and $700 received during the year and $1,150 payables settled by issuance of 701,220 B Ordinary shares

(8) Includes payables settled by issuance 100,000 A Ordinary shares issued to a consultant at an average exercised price at $2.23 (March 2019: NIL) and 6,375,600 A Ordinary Shares towards payables settlement at an average exercised price at $3.14 (March 2019: Nil)

F-42 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

27 SHARE BASED COMPENSATION PLANS

 

The compensation cost recognised with respect to all outstanding plans and by grant of shares, which are all equity settled instruments, is as follows:

 

   Year ended March 31 
   2020   2019   2018 
   (in thousands) 
IPO India Plan  $145   $1,198   $1,572 
JSOP Plan           615 
Option award scheme 2012           197 
2014 Share Plan       47    (22)
2015 Share Plan(*)   1,976    3,059    100 
Other share option awards(**)   7,829    5,346    7,283 
Management scheme (staff share grant) (***)   12,318    11,911    8,173 
   $22,268   $21,561   $17,918 

 

(*) includes 674,045 options granted towards Share Plan 2015 during twelve months ended March 31, 2020 at an exercise price of $2 per share and average grant date fair value of $0.82 per share. In February 2020, the exercise price of said options were modified to GBP 0.3, resulting in incremental fair value of $0.55 per share. In addition, includes 233,364 and 622,035 options granted in prior year/s and wherein the exercise price was modified to $2 per share and GBP 0.3 per share, respectively, resulting in incremental fair value of $0.55-0.63 per share and $1.18 per share, respectively.

 

(**) includes Restricted Share Unit (RSU) and Other share option plans. In respect of 4,899,280 units/options granted towards RSU during twelve months ended March 31, 2020, intrinsic value $ 1.94 per share approximates grant date fair value.Includes 873,000 options accelerated for immediate vesting as against original vesting period of 3 years, resulting in incremental at grant date fair value of $1.64 per share.

 

(***) includes 10,230,320 shares granted twelve months ended March 31, 2020 to management personnel at intrinsic value $1.94 per share approximates grant date fair value.

 

Joint Stock Ownership Plan (JSOP)

 

In April 2012, the Company established a controlled trust called the Eros International Plc Employee Benefit Trust (“JSOP Trust”). The JSOP Trust purchased 2,000,164 shares of the Company out of funds borrowed from the Company and repayable on demand. The Company’s Board, Nomination and Remuneration Committee recommends to the JSOP Trust certain employees, officers and key management personnel, to whom the JSOP Trust will be required to grant shares from its holdings at nominal price. Such shares are then held by the JSOP Trust and the scheme is referred to as the “JSOP Plan.” The shares held by the JSOP Trust are reported as a reduction in stockholders’ equity and termed as ‘JSOP reserves’.

F-43 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

The movement in the shares held by the JSOP Trust is given below:

 

   Year ended March 31 
   2020   2019   2018 
Shares held at the beginning of the year   384,862    1,146,955    1,146,955 
Shares granted            
Shares exercised             
Shares forfeiture/lapsed   (384,862)   (762,093)    
Shares held at the end of the year       384,862    1,146,955 
Unallocated shares held by trust(*)   1,253,656    868,794    106,701 
        1,253,656    1,253,656 

 

(*) During the year unallocated shares held by the trust were issued to the content vendor at $3.6 per share.

 

Employee Stock Option Plans

 

A summary of the general terms of the grants under stock option plans and stock awards are as follows:

 

    Range of
exercise prices
 
IPO India Plan     INR 10 – 150  
2014 Share Plan     $16.25–$18.30  
2015 Share Plan     $2-33.12 & GBP 0.3  
Other share option plans     $16.00  
RSU    

Nil-0.3 GBP

 
Management Share Award      

 

Employees covered under the stock option plans are granted an option to purchase shares of the Company at the respective exercise prices, subject to fulfillment of vesting conditions (generally service conditions). These options generally vest in tranches over a period of one to five years from the date of grant. Upon vesting, the employees can acquire one share for every option. The maximum contractual term for these stock option plans ranges between two to ten years.

 

F-44 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

The activity in these employee stock option plans is summarized below:

 

        Year ended March 31
        2020   2019   2018
    Name of Plan   Number
of
shares
  Weighted
average
exercise
price
  Number
of
shares
  Weighted
average
exercise
price
  Number
of
shares
  Weighted
average
exercise
price
Outstanding at the beginning of the year   IPO India Plan   757,886   INR 32.17   1,624,035   INR 28.85   2,108,063   INR 34.96
Granted                   863,320     10.00
Exercised       (121,496)     10.00   (536,263)     10.00   (1,113,160)     32.19
Forfeited and lapsed       (156,775)     10.00   (329,886)     51.66   (234,188)     10.00
Outstanding at the end of the year       479,615     45.03   757,886     32.17   1,624,035     28.85
Exercisable at the end of the year       325,740   INR 61.56   289,002   INR 68.13   501,122   INR 65.14
                                   
Outstanding at the beginning of the year   JSOP Plan   384,862   $ 11.00   1,146,955   $ 16.22   1,146,955   $ 16.22
Granted                      
Exercised                      
Forfeited and lapsed       (384,862)     11.00   (762,093)     18.86      
Outstanding at the end of the year         $   384,862   $ 11.00   1,146,955   $ 16.22
Exercisable at the end of the year         $   384,862   $ 11.00   728,736   $ 11.00
                                   
Outstanding at the beginning of the year   Option award scheme 2012     $   674,045   $ 11.00   674,045   $ 11.00
Granted                      
Exercised                      
Forfeited and lapsed             (674,045)     11.00      
Outstanding at the end of the year                   674,045     11.00
Exercisable at the end of the year                     449,363   $ 11.00
                                   
Outstanding at the beginning of the year   2014 Share Plan   399,999   $ 17.79   399,999   $ 17.79   723,749    $ 18.06
Granted                      
Exercised                      
Forfeited and lapsed                   (323,750)     18.39
Outstanding at the end of the year       399,999     17.79   399,999     17.79   399,999     17.79
Exercisable at the end of the year       399,999   $ 17.79   399,999   $ 17.79   289,583   $ 17.67
                                   

Outstanding at the beginning of the year (i)

  2015 Share Plan   1,290,399   $ 14.68   211,250   $ 16.21   233,750   $ 16.23
Granted (ii)       674,045     0.38   1,305,399     14.86      
Exercised       (132,013)     2.00   (10,416)     7.92   (10,208   8.71
Forfeited and lapsed         (233,333)     16.18   (215,834)     18.23   (12,292   14.64
Outstanding at the end of the year       1,599,098     2.69   1,290,399     14.68   211,250     16.21
Exercisable at the end of the year       1,549,098   $ 2.72   981,545   $ 14.66   181,354   $ 17.36
                                   
Outstanding at the beginning of the year   Other share option plans   500,000   $ 16.00   500,000   $ 18.88   500,000     18.88
Granted                          
Exercised                          
Forfeited and lapsed       (500,000)      16.00              
Outstanding at the end of the year             500,000     16.00   500,000     18.88
Exercisable at the end of the year         $   400,000   $ 16.00   300,000   $ 18.88
                                   
Outstanding at the beginning of the year   RSU   505,945       837,590       182,725    
Granted (iii)       4,899,280     0.06   211,567       1,044,290    
Exercised       (2,088,181)       (450,541)       (366,491)    
Forfeited and lapsed       (37,447)       (92,672)       (22,934)    
Outstanding at the end of the year       3,279,597     0.1   505,944       837,590    
Exercisable at the end of the year       311,740       34,416       119,150    
                                   
Outstanding at the beginning of the year   Management Scheme   2,593,333       1,513,333       1,130,000    
Granted (iv)       10,230,320       1,400,000       700,000    
Exercised (v)       (7,448,320)       (320,000)       (316,667    
Forfeited and lapsed       (320,000)                
Outstanding at the end of the year       5,055,333     0.01   2,593,333       1,513,333    
Exercisable at the end of the year       890,000     0.03   516,667       173,333    

 

(i) includes 233,364 and 622,035 options granted in prior year/s and wherein the exercise price was modified to $ 2 per share and GBP 0.3 per share, respectively

(ii) Options granted in during the year, wherein the exercise price was modified to GBP 0.3 per share

(iii) Out of above, 873,000 RSU were accelerated for immediate vesting as against original vesting period of 3 years.

(iv) Includes 6,808,320 B Ordinary shares granted on July 12, 2019 and February 28, 2020, respectively

(v) Includes issuance of 6,808,320 B Ordinary treasury shares

F-45 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

The following table summarizes information about outstanding stock options:

 

   Year ended March 31 
   2020   2019   2018 
Name of Plan  Weighted
average
remaining
life
(Years)
   Weighted
average
exercise
price
   Weighted
average
remaining
life
(Years)
   Weighted
average
exercise
price
   Weighted
average
remaining
life
(Years)
   Weighted
average
exercise
price
 
IPO India Plan   6.30   INR* 45.03    7.70   INR* 32.17    8.11   INR* 35.0 
JSOP Plan      $     3.05   $ 11.00    3.93   $ 16.19 
Option award scheme 2012      $        $     3.75   $ 11.00 
2014 Share Plan   1.25   $ 17.79    2.25   $ 17.79    5.96   $ 17.79 
2015 Share Plan   5.00   $ 2.69    6.01   $ 14.68    6.06   $ 16.21 
Other share option plans      $     1.87   $ 16.00    2.87   $ 18.88 
RSU   9.36   $     6.00   $     5.60   $  
Management Scheme   8.94   $ 0.1    6.00   $     5.56   $  

 

 *INR – Indian Rupees

 

2015 Share Plan

 

The following table summarizes information about inputs to the fair valuation model for options granted during the year:

 

   Inputs 
Expected volatility(1)   108.2% 
Option life (Years)   2.6 
Dividend yield   0% 
Risk free rate   0.3 
Range of exercise price of the granted options at the grant date(2)  $0.38 

 

(1) The expected volatility of all other options is based on the historic share price volatility of the Company over time periods comparable to the time from the grant date to the maturity dates of the options.
(2) Fair value of options granted under all other schemes is measured using a Black Scholes model.

 

28 JOINT STOCK OWNERSHIP PLAN RESERVE (JSOP Reserve)

 

   (in thousands) 
Balance at April 1, 2018  $(15,985)
Issue out of treasury shares    
Balance at April 1, 2019  $(15,985)
Issue out of treasury shares   15,985 
Balance at March 31, 2020  $ 

 

The JSOP Reserve represents the cost of shares issued by Eros International Plc and held by the JSOP Trust to satisfy the requirements of the JSOP Plan (Refer Note 27).  On June 5, 2014, the Board approved discretionary vesting of 20% of the applicable JSOP shares. In the current year Nil (2019: 868,794) ‘A’ ordinary shares held by the JSOP Trust were eligible to be issued to employees.

 

The number of shares held by the JSOP Trust at March 31, 2020 was Nil ‘A’ Ordinary shares (2019: 1,253,656 ‘A’ Ordinary shares).

 

F-46 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

29 OTHER COMPONENTS OF EQUITY

 

   As at March 31
(in thousands)
 
   2020   2019   2018 
Movement in hedging reserve:               
Opening balance  $   $   $(375)
Reclassified to consolidated statements of income           375 
Closing balance  $   $   $ 
                
Movement in revaluation reserve:               
Opening balance  $2,932   $1,835   $1,829 
Net gain recognised on revaluation of property and equipment       1,019     
Impact of translation difference   (156)   78    6 
Closing balance  $2,776   $2,932   $1,835 
                
Movement in available for sale fair value reserve:               
Opening balance  $(18,449)  $6,238   $6,238 
Impairment loss on available-for-sale financial assets   (1,860)   (24,687)    
Closing balance  $(20,309)  $(18,449)  $6,238 
                
Movement in Foreign currency translation reserves               
Opening balance  $(64,179)  $(56,722)  $(55,810)
Adoption of IFRS 9 (net of tax)       (34)    
Other comprehensive loss due to translation of foreign operations (*)   (3,948)   (7,423)   (912)
Closing balance  $(68,127)  $(64,179)  $(56,722)
                
Total other components of equity  $(85,660)  $(79,696)  $(48,649)

  

(*) includes movement in foreign currency translation reserves arising on account of deconsolidation $Nil (2019: Nil, 2018: $502) of financial asset.

 

30 SIGNIFICANT NON-CASH EXPENSES

 

Significant non-cash expenses, except loss on sale of assets, share based compensation, depreciation and amortization were as follows:

 

   As at March 31 
   2020   2019   2018 
   (in thousands) 
Unrealised foreign exchange loss / (gain)   $(4,458)  $(3,329)  $5,466 
Credit impairment loss, net    82,920    26,283    3,376 
Impairment charge on available-for-sale financial assets    1,253        2,436 
Net losses on de-recognition of financial assets measured at amortized cost, net    5,285    5,988    3,562 
Mark to market gain on derivative financial instrument measured at fair value through profit and loss        902     
Loss on settlement of derivative financial instruments            586 
Loss on financial liability (convertible notes) measures at fair value through profit and loss    15,987    21,398    13,840 
Loss on deconsolidation of a subsidiary            14,649 
Provisions for trade and other receivables            4,740 
Provision no longer required, written-back    (2,636)   (120)   (124)
Impairment loss on advances content vendors        7,284    353 
Impairment loss            1,205 
Significant discounting on deferred revenue    1,501         
Others   266    32    30 
   $100,118   $58,438   $50,119 

 

F-47 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

31 FINANCIAL INSTRUMENTS AND RISK MANAGEMENT

 

The Group has established objectives concerning the holding and use of financial instruments. The underlying basis of these objectives is to manage the financial risks faced by the Group.

 

Formal policies and guidelines have been set to achieve these objectives. The Group does not enter into speculative arrangements or trade in financial instruments and it is the Group’s policy not to enter into complex financial instruments unless there are specific identified risks for which such instruments help mitigate uncertainties.

 

Management of Capital Risk and Financial Risk

 

The Group manages its capital to ensure that entities in the Group will be able to continue as a going concern while maximizing the return to shareholders through the optimization of the debt and equity balance. The capital structure of the Group consists of debt, which includes the cash and cash equivalents, borrowings and equity attributable to equity holders of Eros, comprising issued capital, reserves and retained earnings as disclosed in Notes 21, 22 and 26 and the consolidated statement of changes in equity.

 

The gearing ratio at the end of the reporting period was as follows:

 

   As at March 31 
   2020   2019 
   (in thousands) 
Debt (net of debt issuance cost of $399 (2019: $691))  $178,972   $280,828 
Cash and cash equivalents (*)   2,563    135,783 
Net debt   176,409    145,045 
Equity   308,486    656,985 
Net debt to equity ratio   57.2%    22.1% 

(*) includes $Nil (2019: $46,666) of restricted deposits.

 

Debt is defined as long and short-term borrowings (excluding derivatives). Equity includes all capital and reserves of the Group that are managed as capital.

 

Categories of financial instruments

 

   2020   2019 
   (in thousands) 
Financial assets          
Available-for-sale investments  $3,942   $3,692 
Other financial assets (1)   116,281    351,477 
   $120,223   $355,169 
Financial liabilities at amortized cost          
Trade payables and acceptances excluding value added tax and other tax payables  $79,630   $81,208 
Borrowings excluding Senior Convertible Notes   155,872    212,479 
Financial Liabilities at fair value through profit or loss          
Derivatives at fair value through profit or loss - held for trading       620 
Senior convertible Notes at fair value through profit or loss   23,100    68,349 
   $258,602   $362,656 

  

(1) Other financial assets include loans and receivables, excluding prepaid charges and statutory receivables, and includes cash and cash equivalents and restricted deposits held with banks.

 

F-48 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Financial risk management objectives

 

Based on the operations of the Group throughout the world, the management considers that the key financial risks that it faces are credit risk, currency risk, liquidity risk and interest rate risk. The objectives under each of these risks are as follows:

  · credit risk: minimize the risk of default and concentration.
  · currency risk: reduce exposure to foreign exchange movements principally between U.S. dollar, Indian Rupee and GBP.
  · liquidity risk: ensure adequate funding to support working capital and future capital expenditure requirements.
  · interest rate risk: mitigate risk of significant change in market rates on the cash flow of issued variable rate debt.

 

Credit risk

 

Trading credit risk is managed on a country by country basis by the use of credit checks on new clients and individual credit limits, where appropriate, together with regular updates on any changes in the trading partner’s situation. In a number of cases trading partners will be required to make advance payments or minimum guarantee payments before delivery of any goods. The Group reviews reports received from third parties and in certain cases as a matter of course reserve the right within the contracts it enters into to request an independent third - party audit of the revenue reporting. Further, in many of the catalogue sales, the trading partners have extended payment terms of up to a year and often fall behind contractual payment terms, thus payment cycle extends to 18 to 24 months. With respect to catalogue and other customers with a long trading history with the Group and who have contracted and paid significant amounts in the past without any prior history of bad debt, the Group closely monitors the same revised payment plans to assure collections. In case of new customer onboarding, the Group follows certain standard Know Your Client (KYC) procedures to ascertain financial stability of the counterparty and follows internal policies to not make ongoing sales to such new customers who are not reasonably current with their payments.

 

The Group from time to time will have significant concentration of credit risk in relation to individual theatrical releases, television syndication deals, music licenses, or producer/ VFX services. This risk is mitigated by contractual terms which seek to stagger receipts, de-recognition of financial assets and/or the release or airing of content. As at March 31, 2020, 40.1% (2019: 20.4%) of trade account receivables were represented by the top five debtors and for the year ended March 31, 2020, a loss on de-recognition of financial assets amounting to $5,285 (2019: 5,988 and 2018: 3,562) arising on assignment and novation of trade receivable and trade payables with no recourse have been recognized in the statement of Income within other gains/(losses), net. The maximum exposure to credit risk is that shown within the statements of financial position, net of credit impairment loss $112,323 (2019: $ 41,335, 2018: $ 10,193). The maximum credit exposure on financial guarantees given by the Group for various financial facilities is described in Note 32.

 

As at March 31, 2020, the Group did not hold any material collateral or other credit enhancements to cover its credit risks associated with its financial assets.

 

Currency risk

 

The Group operates throughout the world with significant operations in India, the British Isles, the United States of America and the United Arab Emirates. As a result it faces both translation and transaction currency risks which are principally mitigated by matching foreign currency revenues and costs wherever possible.

 

The Group’s major revenues are denominated in U.S. Dollars, Indian Rupees and British pounds sterling which are matched where possible to its costs so that these act as an automatic hedge against foreign currency exchange movements.

 

The Group has identified that it will need to utilize hedge transactions to mitigate any risks in movements between the U.S. Dollar and the Indian Rupee and has adopted an agreed set of principles that will be used when entering into any such transactions. No such transactions have been entered into to date and the Group has managed foreign currency exposure to date by seeking to match foreign currency inflows and outflows as much as possible. Details of the foreign currency borrowings that the Group uses to mitigate risk are shown within Interest Risk disclosures.

 

As at the reporting date there were no outstanding forward foreign exchange contracts. Further, in fiscal 2020, the Company did not hedge foreign exchange exposure towards foreign currency borrowings. The Group adopts a policy of borrowing where appropriate in the local currency as a hedge against translation risk. The table below shows the Group’s net foreign currency monetary assets and liabilities position in the main foreign currencies, translated to USD equivalents, as at the year-end:

F-49 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

        Net Balance
    USD   GBP   Other
        (in thousands)
As at March 31, 2020   (3,895)   (65,446)   (182)
As at March 31, 2019   (6,117)   (61,927)   (2,317)

 

The above exposure to foreign currency arises where a consolidated entity holds monetary assets and liabilities denominated in a currency different to the functional currency of that entity.

 

A uniform decrease of 10% in exchange rates against all foreign currencies in position as of March 31, 2020 would have increased the Company’s net loss before tax by approximately $6,952 (2019: gain of $7,036 and 2018: gain of $5,935). An equal and opposite impact would be experienced in the event of an increase by a similar percentage.

 

Our sensitivity to foreign currency has increased during the year ended March 31, 2020 as a result of an increase in liabilities compared to assets denominated in foreign currency over the comparative period. In Management’s opinion, the sensitivity analysis is unrepresentative of the inherent foreign exchange risk because the exposure at the end of the reporting period does not reflect the exposure during the year.

 

Liquidity risk

 

The Group manages liquidity risk by maintaining adequate reserves and agreed committed banking facilities. Management of working capital takes account of film release dates and payment terms agreed with customers.

 

An analysis of short-term and long-term borrowings is set out in Note 22. Set out below is a maturity analysis for non-derivative and derivative financial liabilities. The amounts disclosed are based on contractual undiscounted cash flows. The table includes both interest and principal cash flows. To the extent that interest flows are floating rate, the undiscounted amount is derived from interest rates as at March 31, in each year.

 

   Total   Less than
1 year
   1-3
years
   3-5
years
   More than
5 years
 
   (in thousands) 
As at March 31, 2020                         
Borrowing principal payments(1)  $179,371   $117,097   $62,274   $   $ 
Borrowing interest payments   23,741    17,500    6,241         
                          
Acceptances   1,858    1,858             
Trade and other payables   90,941    90,941             
Minimum lease payments   1,716    822    894         

 

   Total   Less than
1 year
   1-3
years
   3-5
years
   More than
5 years
 
   (in thousands) 
As at March 31, 2019                         
Borrowing principal payments(1)  $281,519   $209,180   $72,339   $   $ 
Borrowing interest payments   29,016    21,820    7,196         
Derivative financial instruments   620    620             
Acceptances   8,366    8,366             
Trade and other payables   83,487    83,487             
Minimum lease payments   2,956    1,480    1,360    116     

 

(1)   Excludes cumulative effect of unamortized costs.

 

At March 31, 2020, the Group had facilities available of $181,340 (2019: $290,353) and had net undrawn amounts of $111 (2019: $468) available.

 

In addition, the Group has issued financial guarantees amounting to $33 (2019: $51) in the ordinary course of business, having maturity dates up to the next 12 months. The Group did not earn any fees to provide such guarantees. It does not anticipate any liability on these guarantees as it expects that most of these will expire unused.

F-50 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Interest rate risk

 

The Group is exposed to interest rate risk because entities in the Group borrow funds at both fixed and floating interest rates. The risk is managed by maintaining an appropriate mix between fixed, capped and floating rate borrowings, and by the use of interest rate swap contracts and forward interest rate contracts. Hedging activities are evaluated to align with interest rate views to ensure the most cost effective hedging strategies are applied.

 

 

Currency, Maturity and Nature of Interest Rate of the Nominal Value of Borrowings

 

    As at March 31  
    2020     %     2019     %  
    (in thousands, except percentages)  
Currency                                
U.S. Dollar   $ 49,182       27.4%     $ 148,201       52.6%  
Great British Pounds Sterling     62,274       34.7%       65,215       23.2%  
Indian Rupees     67,915       37.9%       68,103       24.2%  
Total   $ 179,371       100.0%     $ 281,519       100.0%  
                                 
Maturity                                
Due before one year   $ 117,097       64.3%     $ 209,180       74.3%  
Due between one and three years     62,274       34.7%       72,339       25.7%  
Due between four and five years                        
Due after five years                        
    $ 179,371       100.0%     $ 281,519       100.0%  
Nature of rates                                
Fixed interest rate   $ 96,904       54.0%     $ 205,156       72.9%  
Floating rate     82,467       46.0%       76,363       27.1%  
Total   $ 179,371       100.0%     $ 281,519       100.0%  

 

At 1% increase in underlying bank rates would lead to increase in the Company’s net loss before tax by $ 895 for the year ended March 31, 2020 (2019: $1,029) on net income. An equal and opposite impact would be felt if rates fell by 1%.

 

This analysis assumes that all other variables, in particular foreign currency and credit ratings, remain constant.

 

Under the interest swap contracts, we have agreed to exchange the difference between fixed and floating rate interest amounts calculated on an agreed notional principal amount. Such contracts enable us to mitigate the risk of changing interest rates on the cash flow of issued variable rate debt.

 

The fair value of interest rate derivatives which comprise derivatives at fair value through profit and loss is determined as the present value of future cash flows estimated and discounted based on the applicable yield curves derived from quoted interest rates.

 

Financial instruments — disclosure of fair value measurement level

 

Disclosures of fair value measurements are grouped into the following levels:

  · Level 1 fair value measurements derived from unadjusted quoted prices in active markets for identical assets or liabilities;
  · Level 2 fair value measurements derived from inputs, other than quoted prices included within Level 1, that are observable for the asset or liability, either directly (as prices) or indirectly (derived from prices); and
  · Level 3 fair value measurements derived from valuation techniques that include inputs for the asset or liability that are not based on observable market data.

 

F-51 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

The table below presents assets and liabilities measured at fair value on a recurring basis, which are all category level 2:

 

    As at March 31, 2020
    (in thousands)
Description of type of financial assets   Gross amount of
recognized financial assets
  Gross amount of recognized
financial liabilities offset in the
statement of financial position
  Net amounts financial assets
presented in the statement
of financial position
Derivative assets      
Trade and other receivables   94,749     94,749
Investments at FVTPL   3,802     3,802
Investments at FVTOCI   140     140
Total   98,691     98,691

 

Description of type of financial liabilities   Gross amount of
recognized financial liabilities
  Gross amount of recognized
financial assets offset in the
statement of financial position
  Net amounts financial liabilities
presented in the statement
of financial position
Derivative liabilities      
Long-term borrowings at fair value   23,100     23,100
Total   23,100     23,100

 

    As at March 31, 2019
    (in thousands)
Description of type of financial assets   Gross amount of
recognized financial assets
  Gross amount of recognized
financial liabilities offset in the
statement of financial position
  Net amounts financial assets
presented in the statement
of financial position
Derivative assets      
Trade and other receivables   125,229     125,229
Investments at FVTPL   1,042     1,042
Investments at FVTOCI   2,650     2,650
Total   128,921     128,921

 

Description of type of financial liabilities   Gross amount of
recognized financial liabilities
  Gross amount of recognized
financial assets offset in the
statement of financial position
  Net amounts financial liabilities
presented in the statement
of financial position
Derivative liabilities   620     620
Long-term borrowings at fair value   68,349     68,349
Total   68,969     68,969

 

None of the above derivative instruments is designated in a hedging relationship. A net loss of Nil (loss in 2019: $902) in respect of the above derivative instruments has been recognized in the consolidated statements of income within other gain/(loss), net. Fair value of interest rate derivative involving interest rate options and cross currency swap is estimated as the present value of the estimated future cash flows based on observable yield curves using an option pricing model.

 

Management uses valuation techniques in measuring the fair value of financial instruments, where active market quotes are not available. In applying the valuation techniques, management makes maximum use of market inputs, and uses estimates and assumptions that are, as far as possible, consistent with observable data that market participants would use in pricing the instrument. Where applicable data is not observable, management uses its best estimate about the assumptions that market participants would make. These estimates may vary from the actual prices that would be achieved in an arm’s length transaction at the reporting date.

 

There were no transfers between any Levels in any of the years.

F-52 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

32 CONTRACTUAL OBLIGATIONS AND COMMITMENTS

 

Eros’ material contractual obligations are comprised of contracts related to content commitments.

 

    Total  
    (in thousands)  
As at March 31, 2020   $ 450,469  
         
As at March 31, 2019   $ 301,660  

 

The Group has provided certain stand-by letters of credit amounting to $Nil (2019: $53,565) which are in the nature of performance guarantees issued while entering into film co-production contracts and are valid until funding obligations under these contracts are met. These guarantees, issued in connection with the aforementioned content commitments, and included in the table above have varying maturity dates and are expected to fall due within a period of one to three years.

 

In addition, the Group has issued financial guarantees amounting to $33 (2019: $51) in the ordinary course of business, and included in the table above, having varying maturity dates up to the next 12 months. The Group is only called upon to satisfy a guarantee when the guaranteed party fails to meet its obligations. The Group did not earn any fee to provide such guarantees. It does not anticipate any liability on these guarantees as it expects that most of these will expire unused.

 

33 CONTINGENT LIABILITIES

 

1.Eros has received several show causes notices and assessment order from Service Tax Authorities in India levying amounts to be paid on account of several grounds of non-compliance with the Service Tax Laws. An amount aggregating to $56,064 (net of monies paid under protest $1,790 and including interest and penalty) for the periods under dispute on account of service tax arising on temporary transfer of copyright services and certain other related matters have been considered contingent. Eros has filed an appeal against the said order before the authorities. Considering the facts and nature of levies and the ad-interim protection for service tax levy for a certain period granted by the Honorable High Court of Mumbai, the Group expects that the final outcome of this matter will be favorable. There is no further update on this matters as preliminary hearing is yet to begin. Accordingly, based on the assessment made after taking appropriate legal advice, no additional liability has been recorded in Group’s consolidated financial statements.

 

2.Eros has received several assessment orders and demand notices from value added tax and sales tax authorities in India. Several revised orders have been received during the year. Eros has considered an amount equal to $2,631 (net of monies paid under protest $137 and including interest and penalty) for the periods under dispute as contingent. Eros has appealed against each of the orders outstanding, and such appeals are pending before relevant tax authorities. Though, uncertainties are inherent in the final outcome of these matters, the Group believes, based on assessment made after taking legal advice, that the final outcome of the matters will be favorable. Accordingly, no additional liability has been recorded in Group’s consolidated financial statements.

 

3.Eros has received several assessment orders and demand notices from Income Tax Authorities in India. The orders are on account of disallowance of certain expenditures claimed by the Company. Eros has considered an amount equal to $ 139 for the period under dispute as contingent. Eros has contested the said cases and believes that there will not be any significant liability on the Group as the misstatements were bonafide and without any wrongful intentions and do not invite penalty. However, uncertainties are inherent in the final outcome of these matters and hence, after taking appropriate legal advice, Group has considered the amount as contingent liability.

F-53 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

4.On September 29, 2017, the Company filed a lawsuit against Mangrove Partners, Manuel P. Asensio, GeoInvesting, LLC, and other individuals and entities alleging the defendants and other co-conspirators disseminated material false, misleading, and defamatory information about the Company and are engaging in other misconduct that has harmed the Company. On May 31, 2018, the Company filed an amended complaint that added two new defendants and expanded the scope of the Company’s initial allegations. The amended complaint alleges that Mangrove Partners and many of its co-conspirators held substantial short positions in the Company’s stock and profited when its share price declined in response to their multi-year disinformation campaign. The Company seeks damages and injunctive relief for defamation, civil conspiracy, and tortious interference, including but not limited to interference with its customers, producers, distributors, investors, and lenders. On March 12, 2019, the Supreme Court of the State of New York entered a Decision and Order granting defendants’ motions to dismiss. On March 13, 2019, the Company filed a Notice of Appeal against the said order.

 

5.Beginning on June 21, 2019, the Company was named a defendant in three substantially similar putative class action lawsuits filed in federal court in California and New Jersey by purported shareholders of the Company. The lawsuits allege that the Company and certain individual defendants violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 by making false and/or misleading statements regarding the Company’s accounting for trade receivables. On September 27, 2019, the putative class action filed in California was transferred to the United States District Court for the District of New Jersey. On April 14, 2020, the three putative class actions were consolidated and a lead plaintiff was appointed. On July 1, 2020, the court-appointed lead plaintiff filed a consolidated complaint. The Company expects to file a motion to dismiss, which is due August 28, 2020.

 

From time to time, Eros is involved in legal proceedings arising in the ordinary course of its business, typically intellectual property litigation and infringement claims related to the Group’s feature films and other commercial activities, which could cause it to incur expenses or prevent it from releasing a film. While the resolution of these matters cannot be predicted with certainty, the Group does not believe, based on current knowledge or information available, that any existing legal proceedings or claims are likely to have a material and adverse effect on its financial position, results of operations or cash flows.

 

There were no other material ongoing litigations at March 31, 2020 and March 31, 2019.

 

34 RELATED PARTY TRANSACTIONS

 

      As at
March 31,2020
   As at
March 31,2019
 
   Details of  (in thousands) 
   Transaction  Liability   Asset   Liability   Asset 
Red Bridge Group Limited  President fees  $648   $   $648   $ 
550 County Avenue  Rent/Deposit   156        499    135 
NextGen Films Private Limited (*)  Purchase/Sale               41,470 
Everest Entertainment LLP  Purchase/Sale   557        574     
Beech Investments Limited  Advance   592        500     
Lulla Family  Rent/Deposit   487    356    243    841 
Lulla Family  Salary   4,155        3,279     
Lulla Family  Advance           6,150     
Lulla Family  Advance   500        500     
Xfinite Global Plc  Sale   3,812        6,500     

 

The Lulla family refers to late Mr. Arjan Lulla, Mr. Kishore Lulla, Mr. Sunil Lulla, Mrs. Manjula Lulla, Mrs. Krishika Lulla, Mrs. Rishika Lulla Singh, and Ms. Riddhima Lulla and Mr. Swaneet Singh.

Pursuant to a lease agreement that expired on March 31, 2020, the lease requires Eros International Media Limited to pay $4 each month under this lease. Eros International Media Limited leases apartments for studio use at Kailash Plaza, 3rd Floor, Opp. Laxmi Industrial Estate, Andheri (W), Mumbai, from Manjula K. Lulla, the wife of Kishore Lulla. The lease was renewed on April 1, 2020 for a further period of one year on the same terms.

Pursuant to a lease agreement that expires on September 30, 2021, the lease requires Eros International Media Limited to pay $4 each month under this lease. Eros International Media Limited leases for use as executive accommodations the property Aumkar Bungalow, Gandhi Gram Road, Juhu, Mumbai, from Sunil Lulla.

F-54 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

Pursuant to a lease agreement that expired on January 4, 2020, Eros International Media Limited leases office premise for studio use at Supreme Chambers, 5th Floor, Andheri (W), Mumbai from Kishore and Sunil Lulla. Beginning January 2015, the lease requires Eros International Media Limited to pay $82 each month under this lease. The lease was renewed on January 5, 2020 for a further period of five years on the same terms.

Pursuant to an agreement the Group entered into with Redbridge Group Limited on June 27, 2006, the Group agreed to pay an annual fee set each year of $Nil, $186 and $270 in the respective years ended March 31, 2020, 2019 and 2018, for the services of Arjan Lulla, the father of Kishore Lulla and Sunil Lulla, grandfather of Mrs. Rishika Lulla Singh, uncle of Vijay Ahuja and Surender Sadhwani and an employee of Redbridge Group Limited. The agreement makes Arjan Lulla honorary life president and provides for services including attendance at Board meetings, entrepreneurial leadership and assistance in setting the Group’s strategy. Arjan Lulla passed away in December 2018 Redbridge Group Limited is an entity owned indirectly by a discretionary trust of which Kishore Lulla is a potential beneficiary.

 

The Group has engaged in transactions with NextGen Films Private Limited, an entity owned by the husband of Puja Rajani, sister of Kishore Lulla and Sunil Lulla, which with effect from September 19, 2019 ceased to be a related party, each of which involved the purchase and sale of film rights. In the period ended September 19, 2019, NextGen Films Private Limited sold film rights $ 393 (2019: $1,109, 2018: $$7,760) to the Group, and purchased film rights, including production services, of Nil (2019: Nil and 2018: $Nil). The Group advanced $2,113 (2019: $6,192, 2018: $19,025) to NextGen Films Private Limited for film co-production and received refund of $Nil (2019: $Nil, 2018: $6,114) on abandonment of certain film projects. With effect from September 19, 2019, NextGen Films Private Limited ceased to be a related party having a balance of $47,742 towards film content advances.

The Group also engaged in transactions with Everest Entertainment LLP entity owned by the brother of Manjula K. Lulla, wife of Kishore Lulla, which is involved in the purchase and sale of film rights. In March 31, 2020, Everest Entertainment LLP sold film rights of $18 (2019: 1,260, 2018: 166) to the Group and purchased film rights of $ Nil (2019: $ 314).

Mrs. Manjula Lulla, the wife of Kishore Lulla, is an employee of Eros International Plc. and is entitled to a salary of $147 per annum (2019: $144 and 2018: $139). Mrs. Krishika Lulla, the wife of Sunil Lulla, is an employee of EIML and is entitled to a salary of $121 per annum (2019: $123, 2018: $133). Ms. Riddhima Lulla, the daughter of Kishore Lulla, is an employee of Eros Digital FZ LLC and is entitled to a salary of $300 per annum (2019: $213, 2018: $90) which is borne by Eros Worldwide LLC.

All of the amounts outstanding are unsecured and will be settled in cash.

As at March 31, 2020, the Group has provided performance guarantee to a bank amounting to $Nil (2019: $8,000, 2018: $8,000) in connection with funding commitments. under film co-production agreements with NextGen Films Private Limited and having varying maturity dates up to the next 12 months. The Group did not earn any fee to provide such guarantees.

(*) With effect from September 19, 2019, NextGen Films Private Limited ceased to be a related party.

License Arrangement with Xfinite Global Plc

The Group has engaged in transactions with Xfinite Global Plc, a subsidiary of Eros Investment Limited on which it has significant influence. The Group has accounted $12,776 (2019: $1,413, 2018: $ Nil) as revenue during the year ended March 31, 2020.

 

F-55 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

35 MAJOR CONSOLIDATED ENTITIES

 

   Date   Country of
Incorporation
   % of voting
rights held
 
Copsale Limited   June 2006    BVI    100.00 
Eros Australia Pty Limited   June 2006    Australia    100.00 
Eros International Films Private Limited   June 2006    India    100.00 
Eros International Limited   June 2006    U.K.    100.00 
Eros International Media Limited   June 2006    India    62.31 
Eros International USA Inc   June 2006    U.S.    100.00 
Eros Network Limited   June 2006    U.K.    100.00 
Eros Worldwide FZ-LLC   June 2006    UAE    100.00 
Big Screen Entertainment Private Limited   January 2007    India    64.00 
EyeQube Studios Private Limited   January 2008    India    99.99 
Acacia Investments Holdings Limited   April 2008    IOM    100.00 
Eros International Pte Limited   August 2010    Singapore    100.00 
Digicine Pte. Limited   March 2012    Singapore    100.00 
Colour Yellow Productions Private Limited   May 2014    India    50.00 
Eros Digital FZ LLC   September 2015    UAE    100.00 
Eros Digital Limited   July 2016    IOM    100.00 
Eros Films Limited   November 2016    IOM    100.00 
Universal Power Systems Private Limited   August 2015    India    100.00 
England Merger 1, Corp   March 2020    U.S.    100.00 
England Holdings 2,Inc   March 2020    U.S.    100.00 
England Holdings 3,Inc   March 2020    U.S.    100.00 

 

All of the companies were involved with the distribution of film content and associated media. All the companies are indirectly owned with the exception of Eros Network Limited, Eros Worldwide FZ-LLC and Eros International Pte Ltd.

 

In fiscal year 2020, Group shareholding of Eros International Media Ltd decreased to 62.31% (2019: 62.39%) The change in shareholding was due to exercise of 0.08% ESOP by the employees.

 

In fiscal year 2020, the Group has pledged 38.40% of its holding in Eros International Media Limited as security for certain of the Group’s borrowings (See Note 22).

 

36 NON-CONTROLLING INTERESTS

 

Details of subsidiary that have material non-controlling interests

 

The Group has a number of subsidiaries held directly and indirectly which operate and are incorporated around the world. Note 35 to the financial statements lists details of the major consolidated entities and the interests in these subsidiaries. The non-controlling interests that are material to the Group relate to Eros International Media Limited and its subsidiaries whose principal place of business is in India.

 

The table below shows the summarized financial information of Eros International Media Limited and its subsidiaries (EIML) as at March 31, 2020, non-controlling interests held an economic interest by virtue of shareholding of 37.69% (March 2019: 37.61%). The change in shareholding was due to exercise of 0.08% (March 2019: 0.11%)  ESOP by employees. The summarized financial information represents amounts before inter-company eliminations.

F-56 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

   Year ended March 31 
   (in thousands) 
EIML  2020   2019 
Current assets   $170,724   $183,944 
Non-current assets    152,059    385,463 
Current liabilities    (147,004)   (158,182)
Non-current liabilities    (21,285)   (53,210)
Total net assets attributable   $154,494   $358,015 
Equity attributable to owners of the Group   $95,127   $222,486 
Equity attributable to non-controlling interests   $59,367   $135,529 
           
Revenue   $119,821   $149,969 
Expenses (including impairment of $ 208,931)    (313,660)   (114,709)
Profit for the year   $(193,839)  $35,260 
Profit attributable to the owners of the Group   $(121,127)  $21,846 
Profit attributable to non-controlling interests   $(72,712)  $13,414 
           
Other comprehensive (loss)/income during the year   $(9,861)  $(12,500)
Total comprehensive income during the year   $(203,700)  $22,760 
Total comprehensive income attributable to the owners of the Group    (127,093)   15,354 
Total comprehensive income attributable to non-controlling interests    (76,607)   7,406 
           
Net cash inflow from operating activities   $7,654   $50,470 
Net cash outflow from investing activities    (13,635)   (37,729 
Net cash inflow from financing activities    (12,901)   (14,462)
Net cash (outflow)/inflow   $(18,882)  $36,008 

  

No dividends were paid to non-controlling interests during the year ended March 31, 2020. (2019: Nil).

 

37 SIGNIFICANT ACCOUNTING ESTIMATES AND JUDGMENTS

 

Estimates and judgments are evaluated on a regular basis and are based on historical experience and other factors, such as expectations of future events that are believed to be reasonable under the present circumstances.

 

The Group makes estimates and assumptions concerning the future. These estimates, by definition, will rarely equal the related actual results. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the financial year are highlighted below:

 

37.1. Basis of consolidation

 

The Group evaluates arrangements with special purpose vehicles in accordance with of IFRS 10 – Consolidated Financial Statements to establish how transactions with such entities should be accounted for. This requires a judgment over control such that it is exposed, or has rights, to variable returns and can influence the returns attached to the arrangements.

 

37.2. Impairment of non- current assets

 

The Group tests annually whether its non- current assets have suffered impairment, in accordance with its accounting policy. The recoverable amount of cash-generating units has been determined based on value in use calculations. We use market related information and estimates (generally risk adjusted discounted cash flows) to determine value in use. Cash flow projections take into account past experience and represent management’s best estimate about future developments. Key assumptions on which management has based its determination of fair value less costs to sell and value in use includes estimated volume growth, long-term growth rates, weighted average cost of capital and tax rates. These estimates, includes the methodology used, can have a material impact on the respective values and ultimately the amount of any impairment, if any. The Group also compared the value in use determined above to the stock price on the balance sheet date plus a control premium for broadcasting sector based on 5 years historical period to validate the amount of impairment recorded in the consolidated financial statements.

F-57 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

37.3. Intangible assets

 

The Group is required to identify and assess the useful life of intangible assets and determine their income generating life. Judgment is required in determining this and then providing an amortization rate to match this life as well as considering the recoverability or conversion of advances made in respect of securing film content or the services of talent associated with film production.

 

Accounting for the film content requires Management’s judgment as it relates to total revenues to be received and costs to be incurred throughout the life of each film or its license period, whichever is the shorter. These judgments are used to determine the amortization of capitalized film content costs. The Group uses a stepped method of amortization on first release film content writing off more in year one which recognizes initial income flows and then the balance over a period of up to nine years. In the case of film content that is acquired by the Group after its initial exploitation, commonly referred to as Library, amortization is spread evenly over the lesser of 10 years or the license period. Management’s policy is based upon factors such as historical performance of similar films, the star power of the lead actors and actresses and others. Management regularly reviews, and revises when necessary, its estimates, which may result in a change in the rate of amortization and/or a write down of the asset to the recoverable amount.

 

The Group tests annually whether intangible assets have suffered any impairment, in accordance with the accounting policy. These calculations require judgments and estimates to be made, and, in the event of an unforeseen event these judgments and assumptions would need to be revised and the value of the intangible assets could be affected. There may be instances where the useful life of an asset is shortened to reflect the uncertainty of its estimated income generating life. This is particularly the case when acquiring assets in markets that the Group has not previously exploited.

 

37.4. Credit impairment losses

 

In case of catalogue and producer/ VFX services , the Group provides contractual deferred payment terms up to a year to the partners. Further, in several instances the catalogue customers fall behind contractual payment terms. The Group estimates credit impairment losses based on historical experience of collection from catalogue customers multiplied by the incremental borrowing rate applicable to the group of similar class of customer by geography. Incremental borrowing rate has been calculated considering applicable class of corporate bond in the United States specific to such customers and further adjusted the same for the relevant Country Risk Premium as such amount is invested in US dollar in those countries.

 

37.5. Investment in equity shares (Financial Assets) at FVOCI

 

The Group follows the guidance of IFRS 9 – Financial Instruments: to determine the fair value of its investment in equity instruments, which have been measured using net assets value method based on financial information of the investee company. The aforesaid financial information is available with the lag of 2 years. Further a discount for lack of liquidity of 30% is applied which reflects ease of investors ability to liquidate.

 

37.6. Income taxes and deferred taxation

 

The Group is subject to income taxes in various jurisdictions. Judgment is required in determining the worldwide provision for income taxes. We are subject to tax assessment in certain jurisdictions. Significant judgment is involved in determining the provision for income taxes including judgment on whether the tax positions are probable of being sustained in tax assessments.

 

Judgment is also required when determining whether the Group should recognize a deferred tax asset, based on whether the Management considers there is sufficient certainty in future earnings to justify the carry forward of assets created by tax losses and tax credits. Judgment is also required when determining whether the Group should recognize a deferred tax liability on undistributed earnings of subsidiaries. Where the ultimate outcome is different than that which was initially recorded there will be an impact on the income tax and deferred tax provisions.

F-58 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

37.7. Share-based payments

 

The Group is required to evaluate the terms to determine whether share-based payment is equity settled or cash settled. Judgment is required to do this evaluation. Further, the Group is required to measure the fair value of equity settled transactions with employees at the grant date of the equity instruments. The fair value is determined principally by using the Black Scholes model and/or Monte Carlo Simulation Models which require assumptions regarding risk free interest rates, share price volatility, the expected term and other variables. The basis and assumptions used in these calculations are disclosed within Note 27. The aforementioned inputs entered in to the option valuation model that we use to determine the fair value of our share awards are subjective estimates and changes to these estimates will cause the fair value of our share-based awards and related share- based compensations expense we record to vary.

 

37.8. Business combinations and deconsolidation

 

Business combinations are accounted for using the acquisition method under the provisions of IFRS 3 (Revised), “Business Combinations”.

 

The cost of an acquisition is measured at the fair value of the assets transferred, equity instruments issued and liabilities incurred at the date of acquisition. The cost of the acquisition also includes the fair value of any contingent consideration. Identifiable tangible and intangible assets acquired and liabilities and contingent liabilities assumed in a business combination are measured initially at their fair value on the date of acquisition. Significant estimates are required to be made in determining the value of contingent consideration and intangible assets.

 

During fiscal 2018, the Group divested its 51 percent equity interest in Ayngaran Group to the non-controlling investee. The Group recorded the financial asset retained in the former subsidiary on deconsolidation at its fair value and recorded a loss of $500. The discounting of the financial asset was determined using associated credit risk for similar instrument.

 

37.9 . Financial liabilities at fair value through profit and loss

 

The Group has classified the convertible note as a financial liability at fair value through profit or loss and used the valuation models i.e. Black and Scholes and Monte-Carlo simulations to obtain the fair value of share warrant and convertible notes. Key assumptions on which external valuation experts has based their determination of fair value includes risk free rate, weighted average cost of capital, future volatility, proportion of debt to be converted into equity shares. These estimates, includes the methodology used, can have a material impact on the respective values and ultimately the amount of financial liability.

 

37.10 . Leases

 

IFRS 16 requires Company to make certain judgements and estimations, and those that are significant are disclosed below:

·establishing whether or not it is reasonably certain that an extension option/termination option will be exercised - In determining the lease term, management considers all facts and circumstances that create an economic incentive to exercise an extension option,or not exercise a termination option. Extension options (or periods after termination options) are only included in the lease term if the lease is reasonably certain to be extended (or not terminated). The following factors are normally the most relevant
oIf there are significant penalties to terminate (or not extend), the Company is typically reasonably certain to extend (or not terminate).
oIf any leasehold improvements are expected to have a significant remaining value, the Company is typically reasonably certain to extend (or not terminate).
oOtherwise, the Company considers other factors including historical lease durations and the costs and business disruption required to replace the leased asset.
·calculating the appropriate discount rate – Incremental borrowing rate is considered for discounting the future lease payments, in cases where a rate is not implicit in the lease. For such assessment, the Company considers the market risk free interest rates, currency and credit risk premium.

 

F-59 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

38 NEW STANDARDS ADOPTED AS AT APRIL 1, 2019

 

Adoption of IFRS 16, "Leases"

 

On April 1, 2019, the Group adopted New accounting standard IFRS 16, "Leases". which specifies how to recognize, measure, present and disclose leases. The standard provides a single accounting model, requiring the recognition of assets and liabilities for all major leases previously classified as “operating leases”.

 

The Group applied the “Modified Retrospective Approach” on the date of initial application (April 1, 2019) and has decided to use the approach that allows the right-of-use asset to be recognized at an amount equal to the liability as at the date of initial application and hence, no adjustments to retained earnings were required. Accordingly, comparatives for the year ended March 31, 2019 have not been retrospectively adjusted.

 

As such the Company recognizes a lease liability and a corresponding right of use asset, at the lease commencement date. The right-of-use asset is initially measured at cost, based on the initial amount of the lease liability and adjusted for prepaid expense or accrued liability outstanding at the end of previous year. The assets are depreciated to the earlier of the end of the useful life of the right-of-use asset or the lease term using the straight-line method as this most closely reflects the expected pattern of consumption of the future economic benefits. The lease term includes periods covered by an option to extend if the Company is reasonably certain to exercise that option. In addition, the right-of-use asset is periodically adjusted for certain re-measurements of the lease liability. There is no impact on transition in opening balance of retained earnings as at April 1, 2019 because of the transition method applied.

 

Right of Use Assets

  

Gross Carrying Value  Premises   Equipment   Total 
On adoption of IFRS 16*  $2,531    307    2,838 
Additions   398    71    469 
Termination/retirements            
Balance as at March 31, 2020  $2,929    378    3,307 
Accumulated depreciation               
Balance as at April 1, 2019       62    62 
Depreciation   1,557    120    1,677 
Disposals/retirements            
Net Translation adjustments   36    20    56 
Balance as at March 31, 2020   1,593    202    1,795 
Net Carrying value as at March 31, 2020  $1,336    176    1,512 

 

Premises are under operating lease arrangement and Equipment are acquired under finance lease arrangement.

 

Lease Liabilities

 

Particulars Total
On adoption of IFRS 16* $ 2,618
Additions   469
Finance Expense   184
Payment of lease liabilities $ (1,579)
Premature Retirements  
Translation adjustments   (139)
Balance as at March 31, 2020 $ 1,553

 

*The difference in the number accounted on adoption of IFRS 16 is due to Prepaid expenses outstanding last year reduced from Other Receivables amounting to $ 164.

The Weighted average incremental borrowing rate applied to lease liabilities as at April 1, 2019 is 12% for India location and 7.45% for UAE location.

 

F-60 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

Future minimum lease payments

 

Future minimum lease payments due as of March 31, 2020 is as below:

 

   Lease payments   Interest   Net Present Value 
Within than one year  $822   $99   $723 
1 - 3 years   894    64    830 
3 - 5 years            
   $1,716   $163    1,553 

  

Future minimum lease payments due as of March 31, 2019 is as below:

 

   Lease payments   Interest   Net Present Value 
Within than one year  $1,480   $161   $1,319 
1 - 3 years   1,360    154    1,206 
3 - 5 years   116    23    93 
   $2,956   $338   $2,618 

 

39 STANDARDS NOT YET ADOPTED

 

Standards, amendments and Interpretations to existing Standards that are not yet effective and have not been adopted early by the Group

 

At the date of authorization of these financial statements, several new, but not yet effective, accounting standards, amendments to existing standards, and interpretations have been published by the IASB. None of these standards, amendments or interpretations have been adopted early by the Group.

 

Management anticipates that all relevant pronouncements will be adopted for the first period beginning on or after the effective date of the pronouncement. New Standards, amendments and Interpretations neither adopted nor listed below have not been disclosed as they are not expected to have a material impact on the Group’s financial statements.

Those which are considered to be relevant to the Company’s operations are set out below.

 

i. In October 2018, the IASB issued amendments to IFRS 3 “Business Combinations” regarding the definition of a “Business.” The amendments:

 

  clarify that to be considered a business, an acquired set of activities and assets must include, at a minimum, an input and a substantive process that together significantly contribute to the ability to create outputs;

 

    narrow the definitions of a business and of outputs by focusing on goods and services provided to customers and by removing the reference to an ability to reduce costs;

 

    add guidance and illustrative examples to help entities assess whether a substantive process has been acquired;

 

    remove the assessment of whether market participants are capable of replacing any missing inputs or processes and continuing to produce outputs; and

 

    add an optional concentration test that permits a simplified assessment of whether an acquired set of activities and assets is not a business.

The above amendments are effective for business combinations for which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after January 1, 2020.

The Company is currently evaluating the impact of these amendments on its consolidated financial statements.

 

ii. In October 2018, the IASB issued amendments to IAS 1 “Presentation of Financial Statements” (“IAS 1”) and IAS 8 “Accounting Policies, Changes in Accounting Estimates and Errors ” (“IAS 8”) which revised the definition of “Material.” Three aspects of the new definition should especially be noted, as described below:

 

    Obscuring. The existing definition only focused on omitting or misstating information, however, the Board concluded that obscuring material information with information that can be omitted can have a similar effect. Although the term obscuring is new in the definition, it was already part of IAS 1 (IAS 1.30A);

 

    Could reasonably be expected to influence. The existing definition referred to “could influence” which the Board felt might be understood as requiring too much information as almost anything “could influence” the decisions of some users even if the possibility is remote;

 

    Primary users. The existing definition referred only to ‘users’ which again the Board feared might be understood too broadly as requiring them to consider all possible users of financial statements when deciding what information to disclose.

The amendments highlight five ways in which material information can be obscured:

 

    if the language regarding a material item, transaction or other event is vague or unclear;

 

    if information regarding a material item, transaction or other event is scattered in different places in the financial statements;

 

    if dissimilar items, transactions or other events are inappropriately aggregated;

 

    if similar items, transactions or other events are inappropriately disaggregated; and

 

F-61 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

    if material information is hidden by immaterial information to the extent that it becomes unclear what information is material.

The new definition of material and the accompanying explanatory paragraphs are contained in IAS 1. The definition of material in IAS 8 has been replaced with a reference to IAS 1. The amendments are effective for annual reporting periods beginning on or after January 1, 2020. Earlier application is permitted.

The amendments are effective for annual reporting periods beginning on or after January 1, 2020. Earlier application is permitted.

The Company is currently evaluating the impact of these amendments on its consolidated financial statements.

 

iii. On May 14, 2020, the IASB issued amendment to IAS 37 by specifying that the ‘cost of fulfilling’ a contract comprises the ‘costs that relate directly to the contract’. Costs that relate directly to a contract consist of both the incremental costs of fulfilling that contract (examples would be direct labour or materials) and an allocation of other costs that relate directly to fulfilling contracts (an example would be the allocation of the depreciation charge for an item of property, plant and equipment used in fulfilling the contract).

 

The Company is currently evaluating the impact of these amendments on its consolidated financial statements.

 

The amendments are effective for annual periods beginning on or after 1 January 2022. Early application is permitted

 

iv. In January 23, 2020, the IASB issued amendments to IAS 1 “Presentation of Financial Statements” (“IAS 1”) to clarify the classification criteria of liabilities in the statement of financial position. The most significant changes are listed below:

 

·Classification of liabilities as current or non-current should be based on rights to defer settlement that are in existence at the end of the reporting period

 

·Classification of a liability is unaffected by the likelihood that the entity will exercise its right to defer settlement of the liability for at least twelve months after the reporting period’. That is, management’s intention to settle in the short run does not impact the classification.

 

·‘Settlement’ is defined as the extinguishment of a liability with cash, other economic resources or an entity’s own equity instruments.

 

·Clarifies that if the right to defer settlement is conditional on the compliance with covenants the right exists if the conditions are met at the end of the reporting period,

 

·Clarifies that if a liability has terms that could, at the option of the counterparty, result in its settlement by the transfer of the entity’s own equity instruments, these terms do not affect its classification as current or non-current if the entity recognises the option separately as an equity instrument applying IAS 32 Financial Instruments: Presentation.

 

The amendments are effective for annual reporting periods beginning on or after January 1, 2022. Earlier application is permitted.

 

The Company is currently evaluating the impact of these amendments on its consolidated financial statements.

 

F-62 

 

EROS INTERNATIONAL PLC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

40 SUBSEQUENT EVENTS

 

MERGER

 

On April 17, 2020, Eros International Plc (“Eros”) entered into the Merger Agreement with STX Filmworks, Inc., a Delaware corporation (“STX”). Pursuant to closing of the merger, STX will merge with a newly formed subsidiary of Eros and will survive as a wholly owned subsidiary of Eros. As merger consideration, Eros will issue to the former stockholders of STX a number of A ordinary shares equal in the aggregate to the total number of Eros ordinary shares outstanding on a fully diluted basis as of immediately prior to the effective time of the merger.

 

 

STX Entertainment is a fully integrated global media company specializing in the production, marketing, and distribution of talent-driven motion picture, television and multimedia content. It is the first major entertainment and media company to be launched at this scale in Hollywood in more than twenty years.

 

The group expects that the combined company will be uniquely positioned to benefit from the accelerating consumption of premium digital content in the world’s most important growth markets with robust capital structure and experienced management team. The combined company is also expected to generate an operating synergies within 24 months of closing of the merger transaction, stemming from integration and scale benefits, optimization of global content distribution and enhanced monetization of the Eros Now platform. In connection with the merger, $125,000 of incremental equity will also be contributed to the combined company by new equity investors and existing STX equity investors.

 

The Merger Agreement was approved unanimously by the Boards of Directors of both companies and the closing of the merger is subject to regulatory approvals and other customary closing conditions.

 

The Company is in the process of evaluating accounting implication in respect of the aforesaid merger transaction.

F-63 

 

Exhibit 1.3

 

THE COMPANIES ACT 2006

ISLE OF MAN

A COMPANY LIMITED BY SHARES

ARTICLES OF ASSOCIATION

OF

EROS INTERNATIONAL PLC

(adopted by resolution passed on 29 June 2020)

 

 
A.   Preliminary 5
1.   Model articles not to apply 5
2.   Interpretation 5
3.   Registered office 10
B.   Share capital 10
4.   Share capital amount 10
5.   Allotment 10
6.   Power to attach rights and issue redeemable shares 10
7.   Share warrants and other rights 11
8.   Commission and brokerage 11
9.   Trusts not to be recognised 11
10.   Renunciation of shares 11
11.   Increase, consolidation and sub division 12
12.   Fractions 12
13.   Reduction of capital 13
14.   Purchase of own shares 13
C.   Variation of class rights 13
15.   Sanction to variation 13
16.   Class meetings 13
17.   Deemed variation 14
D.   B Ordinary Shares & Share certificates 14
18.   B Ordinary Shares 14
19.   Right to certificates 14
20.   Replacement certificates 15
21.   Uncertificated shares 16
E.   B Ordinary Shares 17
22.   B Ordinary Shares 17
F.   Transfer of shares 19
23.   Form of transfer 19
24.   Right to refuse registration 19
25.   Notice of refusal 21
26.   Closing of register 21
27.   No fees on registration 21
28.   Recognition of renunciation of allotment of shares 21
G.   Transmission of shares 21
29.   On death 21
30.   Election of person entitled by transmission 22
31.   Rights on transmission 22
H.   General meetings 22
32.   Annual general meetings 22
33.   Extraordinary general meetings 22
34.   Convening of extraordinary general meeting 23
35.   Notice of general meetings 23
36.   Omission to send notice 23
I.   Proceedings at general meetings 23
37.   Quorum 24
38.   If quorum not present 24
39.   Security and meeting place arrangements 24
40.   Chairman 25
41.   Director may attend and speak 25
42.   Power to adjourn 25

1 

 
43.   Notice of adjourned meeting 26
44.   Business of adjourned meeting 26
J.   Voting 26
45.   Method of voting 26
46.   Chairman’s declaration conclusive on show of hands 26
47.   Objection to error in voting 27
48.   Amendment to resolutions 27
49.   Procedure on a poll 27
50.   Votes of shareholders 28
51.   Casting vote 29
52.   Voting by proxy 29
53.   Form of proxy 29
54.   Deposit of proxy 30
55.   More than one proxy may be appointed 31
56.   Board may supply proxy cards 32
57.   Revocation of proxy 32
58.   Written resolutions 32
59.   Approval Rights 33
K.   Untraced shareholders 34
60.   Power of sale 34
L.   Appointment, term and removal of directors 35
61.   Number of Directors 35
62.   Power of Company to appoint Directors 36
63.   Power of Board to appoint Directors 36
64.   Eligibility of new Directors 36
65.   Share qualification 36
66.   Resolution for appointment 36
67.   No retirement on account of age 36
68.   Staggered Board terms 36
69.   Removal by resolution 37
70.   Vacation of office by Director 37
71.   Resolution as to vacancy conclusive 38
M.   Directors’ remuneration, expenses and pensions 39
72.   Directors’ fees 39
73.   Expenses 39
74.   Remuneration 39
75.   Remuneration of executive Directors 39
76.   Pensions and other benefits 40
N.   Powers and duties of the Board 40
77.   Powers of the Board 40
78.   Powers of Directors being less than minimum number 40
79.   Powers of executive Directors 41
80.   Delegation to committees 41
81.   Local management 42
82.   Power of attorney 42
83.   Associate Directors 42
84.   Exercise of voting power 43
85.   [Intentionally Omitted] 43
86.   Borrowing powers 43
O.   Proceedings of Directors and Committees 43
87.   Board meetings 43

2 

 
88.   Notice of Board meetings 43
89.   Quorum 43
90.   Chairman of Board and other offices 43
91.   Voting 45
92.   Participation by telephone and electronic communication 47
93.   Resolution in writing 47
94.   Minutes of proceedings 47
95.   Validity of proceedings 48
P.   Directors’ interests 48
96.   Related Person Transaction Policies 48
97.   Director may have interests 48
98.   Disclosure of interests to Board 49
99.   Director’s interest in own appointment 49
100.   Chairman’s ruling conclusive on Director’s interest 50
101.   Directors’ resolution conclusive on Chairman’s interest 50
102.   [Intentionally Omitted] 50
Q.   The Seal 50
103.   Application of Seal 50
104.   Deed without sealing 51
105.   Official seal for sealing share certificates 51
R.   Dividends and other payments 51
106.   Declaration of dividends 51
107.   Interim dividends 51
108.   Entitlement to dividends 52
109.   Distribution in specie 52
110.   Dividends not to bear interest 52
111.   Method of payment 52
112.   Uncashed dividends 54
113.   Unclaimed dividends 54
114.   Waiver of dividends 54
115.   Payment of scrip dividends 54
116.   Reserves 55
117.   Capitalisation of reserves 55
118.   Record dates 56
S.   Accounts 56
119.   Accounting records 56
120.   Inspection of records 57
121.   Accounts to be sent to shareholders 57
T.   Destruction and authentication of documents 57
122.   Destruction of documents 57
123.   Authentication of documents 58
U.   Notices 59
124.   Notice to be in writing 59
125.   Service of notice on shareholders 59
126.   Notice in case of death, bankruptcy or mental disorder 60
127.   Evidence of service 60
128.   Notice binding on transferees 60
129.   Notice by advertisement 61
130.   Suspension of postal services 61
V.   Winding up 61
131.   Division of assets 61

3 

 
132.   Transfer or sale under section 222 of the Companies Act 1931 62
W.   Indemnity 62
133.   Right to indemnity 62
134.   Power to insure 62
   

4 

 
A.Preliminary
1.Model articles not to apply

No regulations for management of a company set out in any statute concerning companies or contained in any regulations or instrument made pursuant to a statute shall apply to the Company. The following shall be the Articles of the Company.

2.               Interpretation

2.1Definitions

In these Articles, unless the context otherwise requires, the following expressions shall have the following meanings:

A Ordinary Shares the A ordinary shares, each of £0.30 par value, in the capital of the Company;
Act subject to Article 2.3 (Statutory provisions), the Companies Act 2006 and, where the context requires, every other statute of the Isle of Man from time to time in force concerning companies and affecting the Company;
Affiliate with respect to any person, another person that directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, such first person, where “control” means the possession, directly or indirectly, of the power to direct or cause the direction of the management policies of a person, whether through the ownership of voting securities, by contract, as trustee or executor, or otherwise;
Articles these Articles of Association as altered or varied from time to time (and “Article” means any provision of these Articles);
Auditors the auditors for the time being of the Company or, in the case of joint auditors, any of them;
B Ordinary Shares the B ordinary shares, each of £0.30 par value, in the capital of the Company and which rank pari passu in all respects with the A Ordinary Shares save in respect of:  (i) the voting rights as set out in Article 50.2; and (ii) the conversion rights set out in Article 22;
Board the board of Directors for the time being of the Company or the Directors present at a duly convened meeting of Directors at which a quorum is present;
British Isles the United Kingdom, the Isle of Man, the Republic of Ireland and the Channel Islands;

5 

 

 

certificated in relation to a share, a share which is recorded in the Register as being held in certificated form;
Chairman the co-chairmen (if any) of the Board or of a general meeting of the Company or, where the context requires, the chairman of any such meeting;
clear days (in relation to the period of a notice) that period, excluding the day when the notice is given or deemed to be given and the day for which it is given or on which it is to take effect;
communication includes a communication comprising sounds or images or both and a communication effecting a payment (and “communications” shall be construed accordingly);
Company Eros International PLC;
Director a director for the time being of the Company (and “Directors” shall be construed accordingly);
dividend a distribution or a bonus payable on the issued shares of the Company;
Electronic Communication has the meaning ascribed to the term “electronic communication” in the Electronic Transactions Act 2000 and includes, for the avoidance of doubt, e-mail (being a system for sending and receiving messages electronically over a computer network);
employees’ share scheme a scheme for encouraging or facilitating the holding of shares or debentures in the Company by or for the benefit of:
  (a) the bona fide employees or former employees (including any such employees or former employees who are or were also directors) of the Company, the Company’s subsidiaries or holding company or a subsidiary of the Company’s holding company; or
  (b) the wives, husbands, widows, widowers or children or step-children under the age of 18 of such employees or former employees.
execution any mode of execution (and “executions” and “executed” shall be construed accordingly);

6 

 

 

Family Controlled Entity (i) any company in which Permitted Holders or any Permitted Holder hold (collectively or individually) the power to elect all of the members of the board of directors of such entity and hold, collectively, at least a majority of the value of its issued shares; (ii) any partnership in which Permitted Holders or any Permitted Holder hold (collectively or individually) the sole right to direct the voting of the B Ordinary Shares held by such partnership and hold, collectively, at least a majority of the economic interest in the partnership interests in such partnership; and (iii) any limited liability or similar company if Permitted Holders or any Permitted Holder hold (collectively or individually) the sole right to direct the voting of the B Ordinary Shares held by such limited liability or similar company and hold, collectively, at least a majority of the economic interest of such limited liability or similar company;
Family Trust trusts the sole beneficiaries of which are: (i) Kishore Lulla, his spouse, any of their descendants, spouses of any descendants and their respective estates, guardians, or conservators; or (ii) any other descendants of Arjan Lulla and their respective estates, guardians or conservators;
holder (in relation to any share) the shareholder whose name is entered in the Register as the holder or, where the context permits, the shareholders whose names are entered in the Register as the joint holders of that share;
Hony Investor collectively, Great Mission International Limited, Marco Alliance Limited, and their respective Affiliates;
Independent Committee as defined in Article 22.5 (Voluntary Conversion to B Ordinary Shares);
Investors’ Rights Agreement the Investors’ Rights Agreement entered into in connection with transactions contemplated under the Merger Agreement Related Transaction Documents as the same may from time to time be amended, supplemented or novated;

7 

 

 

Merger Agreement Related Transaction Documents each of (i) the Agreement and Plan of Merger dated as of April 17, 2020, by and among the Company, England Holdings 2, Inc., a Delaware corporation and indirect wholly-owned subsidiary of the Company (“England Holdings 2”), England Merger Corp., a Delaware corporation and direct wholly-owned subsidiary of England Holdings 2, and STX Filmworks, Inc., a Delaware corporation, (ii) the CVR Agreements as defined thereunder and (iii) the PIPE Subscription Agreement as defined thereunder;
Office the registered office for the time being of the Company;
Operator the operator (as defined in the Uncertificated Regulations) of the relevant Uncertificated System;
Ordinary Shares the A Ordinary Shares and the B Ordinary Shares;
paid up paid up or credited as paid up;
Participating Security subject to Article 18 (B Ordinary Shares), a share or class of shares or a renounceable right of allotment of a share, title to which is permitted to be transferred by means of an Uncertificated System in accordance with the Uncertificated Regulations;
Permitted Holder as defined in Article 22.1 (Holding, transfer and conversion of B Ordinary Shares);
person entitled by transmission a person whose entitlement to a share in consequence of the death or bankruptcy of a shareholder or of any other event giving rise to its transmission by operation of law has been noted in the Register;
recognised investment exchange as defined in section 285 of the UK Financial Services and Markets Act 2000 (an Act of Parliament);
record date as defined in Article 118 (Record dates);
Register the register of shareholders of the Company to be kept pursuant to section 62 of the Act;
Seal the common seal of the Company;
share a share in the capital of the Company being either an A Ordinary Share or a B Ordinary Share (and “shares” shall be construed accordingly);
shareholder a holder of any shares;
solvency test has that meaning set out in section 49 of the Act;

8 

 

 

special resolution shall mean a resolution passed or requiring to be passed by a majority of not less than three-fourths of such members as, being entitled so to do, vote in person or by proxy or (being a corporation) by a duly authorised representative at a general or class meeting (as the case may be);
subsidiary has that meaning set out in section 220 of the Act;
uncertificated subject to Article 18 (B Ordinary Shares), in relation to a share, a share title to which is recorded on the Register as being held in uncertificated form and to which title may be transferred by means of an Uncertificated System in accordance with the Uncertificated Regulations;
Uncertificated Regulations the Uncertificated Securities Regulations 2006 (as amended or replaced from time to time);
Uncertificated System a relevant system as defined in the Uncertificated Regulations;
United Kingdomor UK Great Britain and Northern Ireland;
US the United States of America;
writing” or “written printing, typewriting, lithography, photography and any other mode or modes of representing or reproducing words in a legible and non-transitory form.
2.2General interpretation

Unless the context otherwise requires:

(a)words in the singular include the plural and vice versa;
(b)words importing the masculine gender include the feminine gender;
(c)a reference to a person includes a body corporate and an unincorporated body of persons; and
(d)a reference to an Uncertificated System is a reference to the Uncertificated System in respect of which the particular share or class of shares or renounceable right of allotment of a share is a Participating Security.
2.3Statutory provisions

A reference to any statute or provision of a statute shall include any orders, regulations or other subordinate legislation made under it and shall, unless the context otherwise requires, include any statutory modification or re-enactment of it for the time being in force.

9 

 
2.4The Act

Save as aforesaid, and unless the context otherwise requires, words or expressions contained in these Articles shall bear the same meaning as in the Act.

2.5Headings

The headings are inserted for convenience only and shall not affect the construction of these Articles.

2.6Company acts

Any reference in these Articles to action by the Company means an act which is approved by a resolution passed by the requisite majority of the shareholders.

3.Registered office

The Office shall be at such place in the Isle of Man as the Board shall from time to time appoint.

B.Share capital
4.Share capital amount

Unless the Board shall otherwise direct, the amount of share capital of the Company available for issue is £150,000,000 divided into 500,000,000 shares designated as either A Ordinary Shares or B Ordinary Shares.

5.Allotment

Unissued shares in the capital of the Company shall be allotted by the Directors generally on such terms as they think fit but all shares shall be paid in full prior to or at the time of issue.

6.Power to attach rights and issue redeemable shares
6.1Rights attaching to shares

Subject to the provisions of the Act and to any special rights for the time being attached to any existing shares, any shares may be allotted or issued with or have attached to them such preferred, deferred or other special rights or restrictions whether in regard to dividends, voting, transfer, return of capital or otherwise as the Board may from time to time determine.

6.2Redemption of Shares

Shares may be redeemed for any consideration provided that such redemption does not contravene section 60 of the Act or the solvency test; the process for redemption of shares shall be determined by the Directors in their absolute discretion and the Directors may, for the avoidance of doubt, permit an offer to one or more holders of shares in accordance with section 53(1)(b)(ii) of the Act, subject to section 54 of the Act. For the avoidance of doubt, the A Ordinary Shares are non-redeemable.

10 

 
6.3Redemption dates

The date on which or by which, or dates between which, any redeemable shares are to be or may be redeemed may be fixed by the Directors and in such a case must be fixed by the Directors before the shares are issued. Unless otherwise specified in these Articles, the amount payable on redemption of any redeemable shares shall be the par value of such shares.

7.Share warrants and other rights

The Company shall have no power to issue any warrants stating that the bearer thereof is entitled to the shares specified therein. Subject to this, however, the Company shall have the power to issue warrants, options or other rights (including the CVRs (as defined in the Merger Agreement Related Transaction Documents)) permitting the registered holder thereof to subscribe for shares; provided that, following the date of the consummation of the transactions contemplated under the Merger Agreement Related Transaction Documents until the date that is the third (3rd) anniversary of the Effective Time (as defined in the Merger Agreement Related Transaction Documents), without the prior approval of the Independent Committee, the Company shall have no power to issue to any Permitted Holders any shares or warrants, options or other rights permitting the registered holder thereof to subscribe for shares if after giving effect to such issuance on a fully diluted basis (but, for clarity, not assuming any voluntary conversion of A Ordinary Shares to B Ordinary Shares by the Permitted Holders except to the extent notice of such conversion has been delivered by a Permitted Holder pursuant to Article 22.5), the Permitted Holders have or will have greater than 50% of the voting power of the Company.

8.Commission and brokerage

The Company may exercise the powers conferred by the Act to pay commissions or brokerage to any person in consideration of his subscribing or agreeing to subscribe (whether absolutely or conditionally) for any shares, or procuring or agreeing to procure subscriptions (whether absolute or conditional) for any shares in the Company to the full extent permitted by the Act. Any such commission or brokerage may be satisfied by the payment of cash, the allotment of fully paid shares, the grant of an option to call for an allotment of shares or any combination of such methods.

9.Trusts not to be recognised

Except as otherwise expressly provided by these Articles, as required by law or as ordered by a court of competent jurisdiction, the Company shall not recognise any person as holding any share on any trust and (except as aforesaid) the Company shall not be bound by or recognise (even if having notice of it) any equitable, contingent, future, partial or other claim to or interest in any share or any interest in any fractional part of a share except an absolute right of the holder to the whole of the share.

10.Renunciation of shares

Subject to the provisions of the Act and of these Articles, the Directors may at any time after the allotment of any share but before any person has been entered in the Register as the holder recognise a renunciation of it by the allottee in favour of some other person and may accord to any allottee of a share the right to effect such renunciation upon and subject to such terms and conditions as the Directors may think fit to impose.

11 

 
11.Increase, consolidation and sub division

To the extent that the shares in the capital of the Company comprise shares with a par value, the Board may from time to time:

(a)increase the Company’s share capital by such sum to be divided into shares of such amount as the Board prescribes;
(b)consolidate and/or divide, re-designate or redenominate or convert all or any of the Company’s share capital into shares of larger or smaller par value, into shares having a purchase price of another currency; and
(c)sub-divide shares or any of them into shares of smaller par value.
12.Fractions
12.1Power to deal with fractional entitlements

Whenever as the result of any consolidation, division or sub-division of shares any shareholder would become entitled to fractions of a share, the Board may deal with the fractions as it thinks fit and in particular (but without prejudice to the generality of the foregoing):

(a)the Board may determine which of the shares of such holder are to be treated as giving rise to such fractional entitlement and may decide that any of those shares shall be consolidated with any of the shares of any other holder or holders which are similarly determined by it to be treated as giving rise to a fractional entitlement for such other holder or holders into a single consolidated share and the Board may on behalf of all such holders, sell such consolidated share for the best price reasonably obtained to any person (including the Company) and distribute the net proceeds of sale after deduction of the expenses of sale in due proportion among those holders (except that any amount otherwise due to a holder, being less than £3 (or US Dollar equivalent) or such other sum as the Board may from time to time determine may be retained for the benefit of the Company); or
(b)provided that the necessary unissued shares are available, the Board may issue to such holder, credited as fully paid, by way of capitalisation the minimum number of shares required to round up his holding to an exact multiple of the number of shares to be consolidated into a single share (such issue being deemed to have been effected prior to consolidation), and the amount required to pay up such shares shall be appropriated at the Board’s discretion from any of the sums standing to the credit of any of the Company’s reserve accounts (including share premium account and capital redemption reserve) or to the credit of profit and loss account and capitalised by applying the same in paying up the share.

12 

 
12.2Sale of fractions

For the purposes of any sale of consolidated shares pursuant to Article 12.1 (Power to deal with fractional entitlements), the Board may in the case of certificated shares authorise some person to execute an instrument of transfer of the shares to or in accordance with the directions of the purchaser, and the transferee shall not be bound to see to the application of the purchase money in respect of any such sale, nor shall his title to the shares be affected by any irregularity in or invalidity of the proceedings in reference to the sale or transfer and any instrument or exercise shall be effective as if it had been executed or exercised by the holder of the shares to which it relates.

13.Reduction of capital

Subject to compliance with the solvency test and to any rights for the time being attached to any shares, the Company may by resolution of the Board reduce its paid up share capital in any manner.

14.Purchase of own shares

Shares may be purchased or otherwise acquired by the Company for any consideration provided that such purchase does not contravene section 60 of the Act or the solvency test; the terms and process for purchase or acquisition of shares shall be determined by the Directors in their absolute discretion and the Directors may, for the avoidance of doubt, permit an offer to one or more holders of shares in accordance with section 53(1)(b)(ii) of the Act, subject only to section 54 of the Act.

C.Variation of class rights
15.Sanction to variation

Subject to the provisions of the Act, if at any time the share capital of the Company is divided into shares of different classes, any of the rights for the time being attached to any share or class of shares in the Company in issue (and notwithstanding that the Company may be or be about to be in liquidation) may (unless otherwise provided by the terms of issue of the shares of that class) be varied or abrogated in such manner (if any) as may be provided by such rights or, in the absence of any such provision, either with the consent in writing of the holders of not less than three quarters in par value of the issued shares of the class or with the sanction of a resolution passed at a separate general meeting of the holders of shares of the class duly convened and held as provided in these Articles (but not otherwise). The foregoing provisions of this Article shall apply also to the variation or abrogation of the special rights attached to only some of the shares of any class in issue as if each group of shares of the class differently treated formed a separate class the separate rights of which are to be varied. Subject to the terms of issue or the rights attached to any shares the rights or privileges attached to any class of shares shall be deemed not to be varied or abrogated by the Board resolving that a class of shares is to become or to cease to be a Participating Security; provided that the prior approval of the holders of a majority of the A Ordinary Shares in issue shall be required prior to any such resolution of the Board.

16.Class meetings

All the provisions in these Articles as to general meetings shall mutatis mutandis apply to every meeting of the holders of any class of shares save that:

13 

 
(a)the quorum at every such meeting shall be one or more persons holding or representing by proxy at least one-third of the par value paid up on the issued shares of the class;
(b)every holder of shares of the class present in person or by proxy or (being a corporation) by a duly authorised representative may demand a poll;
(c)each such holder shall on a poll be entitled to one vote for every share of the class held by him; and
(d)if at any adjourned meeting of such holders, such quorum as aforesaid is not present, not less than one person holding shares of the class who is present in person or by proxy or (being a corporation) by a duly authorised representative shall be a quorum.
17.Deemed variation

Subject to the terms on which any shares may be issued, the rights or privileges attached to any class of shares shall be deemed to be varied or abrogated by the reduction of the capital paid up on such shares or by the allotment of further shares ranking in priority for the payment of a dividend or in respect of capital or howsoever or which confer on the holders voting rights more favourable than those conferred by such first mentioned shares but shall not be deemed to be varied or abrogated by the creation or issue of any new shares ranking pari passu in all respects (save as to the date from which such new shares shall rank for dividend) with or subsequent to those already issued or by the purchase or redemption by the Company of its own shares in accordance with the provisions of the Act and these Articles.

D.B Ordinary Shares & Share certificates
18.B Ordinary Shares

Any B Ordinary Share shall be capable of being a Participating Security.

19.            Right to certificates

19.1Issue of certificates

On becoming the holder of any certificated share every person shall be entitled without charge to have issued within two months after allotment or fourteen days after lodgement of a transfer (unless the terms of issue of the shares provide otherwise or the transfer is one which the Company is for any reason entitled to refuse to register and does not register) one certificate for all the certificated shares of any one class registered in his name and to a separate certificate for each class of certificated shares so registered. Such certificate shall specify the number, class and distinguishing numbers (if any) of the shares in respect of which it is issued and the amount or respective amounts paid up on them and shall be issued either under the Seal (which may be affixed to it or printed on it) or in such other manner having the same effect as if issued under a seal and, having regard to the rules and regulations applicable to the recognised investment exchange(s) to which any shares are admitted, as the Board may approve.

14 

 
19.2Distinguishing numbers

If and so long as all the issued shares of the Company or all the issued shares of a particular class are fully paid up and rank pari passu for all purposes then none of those shares shall bear a distinguishing number. In all other cases each share shall bear a distinguishing number.

19.3Joint holders

The Company shall not be bound to issue more than one certificate in respect of certificated shares held jointly by two or more persons. Delivery of a certificate to the person first named on the register shall be sufficient delivery to all joint holders.

19.4Balancing certificates

Where a shareholder has transferred part only of the shares comprised in a certificate he shall be entitled without charge to a certificate for the balance of such certificated shares.

19.5Restrictions on certificates

No certificate shall be issued representing certificated shares of more than one class.

20.Replacement certificates
20.1Consolidation of certificates

Any two or more certificates representing shares of any one class held by any shareholder may at his request be cancelled and a single new certificate for such shares issued in lieu, subject to the payment of such reasonable fee (if any) as the Board may determine, on surrender of the original certificates for cancellation.

20.2Splitting share certificates

If any shareholder shall surrender for cancellation a share certificate representing certificated shares held by him and request the Company to issue in lieu two or more share certificates representing such certificated shares in such proportions as he may specify, the Board may, if it thinks fit, comply with such request subject to the payment of such reasonable fee (if any) as it may determine.

20.3Renewal or replacement

Share certificates may be renewed or replaced on such terms as to provision of evidence and indemnity (with or without security) and to payment of any exceptional out of pocket expenses (including those incurred by the Company in investigating such evidence and preparing such indemnity and security) as the Board may decide, and on surrender of the original certificate (where it is defaced or worn out) but without any further charge.

20.4Joint holders

In the case of shares held jointly by several persons, any such request as is mentioned in this Article 20 (Replacement certificates) may be made by any one of the joint holders.

15 

 
21.Uncertificated shares
21.1Participating security

The Board may resolve that a class of shares is to become, or is to cease to be, a Participating Security and may implement such arrangements as it thinks fit in order for any class of shares to be admitted to settlement by means of an Uncertificated System. Shares of a class shall not be treated as forming a separate class from other shares of the same class as a consequence only of such shares being held in uncertificated form. Any share of a class which is a Participating Security may be changed from an uncertificated share to a certificated share and from a certificated share to an uncertificated share in accordance with the Uncertificated Regulations. For any purpose under these Articles, the Company may treat a shareholder’s holding of uncertificated shares and of certificated shares of the same class as if they were separate holdings, unless the Board otherwise decides.

21.2Application of Articles

These Articles apply to uncertificated shares of a class which is a Participating Security only to the extent that these Articles are consistent with the holding of such shares in uncertificated form, with the transfer of title to such shares by means of the Uncertificated System and with the Uncertificated Regulations.

21.3Board regulations

The Board may lay down regulations not included in these Articles which:

(a)apply to the issue, holding or transfer of uncertificated shares (in addition to or in substitution for any provisions in these Articles);
(b)set out (where appropriate) the procedures for conversion, redemption and/or purchase of uncertificated shares; and/or
(c)the Board considers necessary or appropriate to ensure that these Articles are consistent with the Uncertificated Regulations and/or the Operator’s rules and practices.

Such regulations will apply instead of any relevant provisions in these Articles which relate to certificates and the transfer, conversion, redemption and purchase of shares or which are not consistent with the Uncertificated Regulations, in all cases to the extent (if any) stated in such regulations. If the Board makes any such regulations, Article 20.2 (Splitting share certificates) will (for the avoidance of doubt) continue to apply to these Articles, when read in conjunction with those regulations.

21.4Instructions via an uncertificated system

Any instruction given by means of an Uncertificated System as referred to in these Articles shall be a dematerialised instruction given in accordance with the Uncertificated Regulations, the facilities and requirements of the Uncertificated System and the Operator’s rules and practices.

16 

 
21.5Forfeiture and sale

Where the Company is entitled under the Operator’s rules and practices, these Articles or otherwise to dispose of, forfeit, enforce a lien over or sell or otherwise procure the sale of any shares of a class which is a Participating Security which are held in uncertificated form, the Board may take such steps (subject to the Uncertificated Regulations and to such rules and practices) as may be required or appropriate, by instruction by means of an Uncertificated System or otherwise, to effect such disposal, forfeiture, enforcement or sale including by (without limitation):

(a)requesting or requiring the deletion of any computer-based entries in the Uncertificated System relating to the holding of such shares in uncertificated form;
(b)altering such computer-based entries so as to divest the holder of such shares of the power to transfer such shares other than to a person selected or approved by the Company for the purpose of such transfer;
(c)requiring any holder of such shares, by notice in writing to him, to change his holding of such uncertificated shares into certificated form within any specified period;
(d)requiring any holder of such shares to take such steps as may be necessary to sell or transfer such shares as directed by the Company;
(e)otherwise rectifying or changing the Register in respect of any such shares in such manner as the Board considers appropriate (including, without limitation, by entering the name of a transferee into the Register as the next holder of such shares);
(f)appointing any person to take any steps in the name of any holder of such shares as may be required to change such shares from uncertificated form to certificated form and/or to effect the transfer of such shares (and such steps shall be effective as if they had been taken by such holder); and/or
(g)taking such other action as may be necessary to enable such shares to be registered in the name of the person to whom the shares have been sold or disposed of.
E.B Ordinary Shares
22.B Ordinary Shares

17 

 
22.1Holding, transfer and conversion of B Ordinary shares

B Ordinary Shares may only be held by or transferred to the following persons: (i) Eros Ventures Limited; (ii) Beech Investments Limited; (iii) the trustees for the time being of the Ganges Trust; (iv) Kishore Lulla and his estate, guardian, or conservator; (v) Kishore Lulla’s descendants; (vi) any other descendants of Arjan Lulla and their respective estates, guardians or conservators; (vii) any Family Controlled Entity; (viii) the trustees, solely in their respective capacities as such, of any Family Trust; and (ix) any custodian or bare nominee for any person within (i) – (viii) inclusive (each, a “Permitted Holder”), and a transfer to any person other than a Permitted Holder shall, immediately upon the registration of such transfer, result in the relevant B Ordinary Shares being converted automatically into A Ordinary Shares.

22.2Ceasing to be a Permitted Holder

A person which was a Permitted Holder shall notify the Directors forthwith if it ceases to meet the requirements to be a Permitted Holder and on such notification each B Ordinary Share held by such person shall convert automatically into one fully paid A Ordinary Share.

22.3Transfer of B Ordinary Shares

A transfer of B Ordinary Shares shall not include: (i) the granting of a proxy to officers or Directors of the Company at the request of its board in connection with actions to be taken at a meeting of shareholders; or (ii) the mortgage or charge of B Ordinary Shares by a Permitted Holder pursuant to a bona fide loan or indebtedness transaction providing that the relevant Permitted Holder continues to be able to exercise all powers of voting in respect of such B Ordinary Shares and providing further that enforcement by the relevant mortgagee or chargee in respect of such B Ordinary Shares shall constitute a transfer.

22.4Voluntary Conversion of B Ordinary Shares

At any time and from time to time a holder of B Ordinary Shares shall have the right to convert any or all of the B Ordinary Shares which it holds into an equivalent number of fully paid A Ordinary Shares. Such right shall be exercised by the holder of the B Ordinary Shares serving a notice in writing on the Company to that effect which notice shall set out the number of B Ordinary Shares which it wishes to convert and which shall be accompanied by such documents as the Company may reasonably require. Upon receipt of such notice, the Directors shall arrange for such conversion to be effected forthwith.

18 

 
22.5Voluntary Conversion to B Ordinary Shares

A holder of A Ordinary Shares who is a Permitted Holder shall have the right to convert any or all of the A Ordinary Shares which it holds into an equivalent number of fully paid B Ordinary Shares; provided that, during the period following the consummation of the transactions contemplated under the Merger Agreement Related Transaction Documents and until the third (3rd) anniversary of the Effective Time (as defined in the Merger Agreement Related Transaction Documents), without the prior approval of an independent committee that has been delegated the authority to make such determination by the Board (the “Independent Committee”), no conversion shall be permitted if all Permitted Holders (on a fully diluted (as if all options, warrants and similar rights (including the CVRs (as defined in the Merger Agreement Related Transaction Documents)) have been exercised) as converted basis and after giving effect to such conversion (but, for clarity, not assuming any further voluntary conversion of A Ordinary Shares to B Ordinary Shares by the Permitted Holders except to the extent notice of such conversion has been delivered by a Permitted Holder pursuant to Article 22.5)) have or will have greater than 50% of the voting power of the Company; provided further, for clarity, that after the third (3rd) anniversary of the Effective Time (as defined in the Merger Agreement Related Transaction Documents), conversions pursuant to this Article 22.5 shall be permitted without limitation or the requirement for any approval. Such right shall be exercised by the Permitted Holder serving a notice in writing on the Company to that effect which notice shall set out the number of A Ordinary Shares which it wishes to convert and which shall be accompanied by such documents as the Company may reasonably require. Upon receipt of such notice, the Directors shall arrange for such conversion to be effected as soon as reasonably practicable.

22.6       Automatic Conversion to A Ordinary Shares

If the voting power of the B Ordinary Shares in issue shall at any time be less than 2% of the voting power of all Ordinary Shares in issue, such B Ordinary Shares shall be converted by the Company as soon as reasonably practicable into an equivalent number of fully paid A Ordinary Shares.

F.Transfer of shares
23.Form of transfer

Subject to Article 22 (B Ordinary Shares), each shareholder may transfer all or any of his shares in the case of certificated shares by instrument of transfer in writing in any usual form or in any form approved by the Board or in the case of uncertificated shares without a written instrument in accordance with the Uncertificated Regulations. Any written instrument shall contain the business or residential address of the transferee and be executed by or on behalf of the transferor. The transferor shall be deemed to remain the holder of such share until the name of the transferee is entered in the Register in respect of it.

24.Right to refuse registration
24.1Registration of certificated share transfer

The Board may in its absolute discretion and without giving any reason refuse to register any transfer of a certificated share unless:

19 

 
(a)it is in respect of only one class of shares;
(b)it is in favour of a single transferee or not more than four joint transferees;
(c)it is duly stamped (if so required);
(d)it is delivered for registration to the registered agent of the Company, or such other person as the Board may from time to time appoint, accompanied (except in the case of a transfer where a certificate has not been required to be issued) by the certificate for the shares to which it relates and such other evidence as the Board may reasonably require to prove the title of the transferor and the due execution by him of the transfer or if the transfer is executed by some other person on his behalf, the authority of that person to do so; and
(e)the holding of such share would not result in a regulatory, pecuniary, legal, taxation or material administrative disadvantage for the Company or its shareholders as a whole including, but not limited to, where such a disadvantage would arise out of the transfer of any share to a person in breach of any law or requirement of any country or by virtue of which such person is not qualified to own those shares and, in the sole and conclusive determination of the Board, such ownership or holding or continued ownership or holding of those shares (whether on its own or in conjunction with any other circumstance appearing to the Board to be relevant) would in the reasonable opinion of the Board, cause a pecuniary or tax disadvantage to the Company or any other holder of shares or other securities of the Company which it or they might not otherwise have suffered or incurred.

provided that where such share is listed on the New York Stock Exchange such discretion may not be exercised in such a way as to prevent dealings in such shares from taking place on an open and proper basis.

24.2Registration of an uncertificated share transfer

The Board shall register a transfer of title to any uncertificated share or the renunciation or transfer of any renounceable right of allotment of a share which is a Participating Security held in uncertificated form in accordance with the Uncertificated Regulations, except that the Board may refuse (subject to any relevant requirements applicable to the recognised investment exchange(s) to which the shares of the Company are admitted) to register any such transfer or renunciation which is in favour of more than four persons jointly or in any other circumstance permitted by the Uncertificated Regulations.

24.3[Intentionally Omitted]
24.4Neither the Company nor the Board shall be liable to indemnify, reimburse or compensate any shareholder in respect of any cost, liability or expense (including, without limitation, any taxes or duties imposed, paid or suffered under the laws of the Isle of Man or any other jurisdiction) arising from or by reference to any sale or forfeiture of any shares pursuant to this Article 24.

20 

 
25.Notice of refusal

If the Board refuses to register a transfer of a share it shall, within two months after the date on which the transfer was lodged with the Company, send notice of the refusal to the transferee. Any instrument of transfer which the Board refuses to register shall (except in the case of suspected fraud) be returned to the person depositing it. All instruments of transfer which are registered may be retained by the Company.

26.Closing of register

The registration of transfers of shares or of any class of shares may be suspended at such times and for such periods (not exceeding thirty days in any year) as the Board in its absolute discretion may from time to time determine following the giving of notice by advertisement in not less than two newspapers circulating generally in the Isle of Man (subject to the Uncertificated Regulations in the case of any shares of a class which is a Participating Security).

27.No fees on registration

No fee shall be charged for registration of a transfer or on the registration of any probate, letters of administration, certificate of death or marriage, power of attorney, notice or other instrument relating to or affecting the title to any shares or otherwise for making any entry in the Register affecting the title to any shares.

28.Recognition of renunciation of allotment of shares

Nothing in these Articles shall preclude the Board from recognising a renunciation of the allotment of any share by the allottee in favour of some other person.

G.Transmission of shares
29.On death

If a shareholder dies the survivors or survivor where he was a joint holder and his executors or administrators where he was a sole or the only survivor of joint holders, shall be the only persons recognised by the Company as having any title to his shares. Nothing in these Articles shall release the estate of a deceased shareholder from any liability in respect of any share which has been solely or jointly held by him.

21 

 
30.Election of person entitled by transmission

Any person entitled to a share by transmission may, on such evidence as to his title being produced as the Board may reasonably require, elect either to become registered as a shareholder or to have some person nominated by him registered as a shareholder. If he elects to become registered himself he shall give written notice signed by him to the Company to that effect. If he elects to have some other person registered he shall, in the case of a certificated share, execute an instrument of transfer of such shares to that person and, in the case of an uncertificated share, either procure that all appropriate instructions are given by means of the Uncertificated System to effect the transfer of such share to such person or change the uncertificated share to certificated form and then execute an instrument of transfer of such share to such person. All the provisions of these Articles relating to the transfer of shares shall apply to the notice, instrument of transfer or instructions (as the case may be) as if it were an instrument of transfer executed or instructions given by the shareholder and his death, bankruptcy or other event had not occurred and any notice or transfer were executed by such shareholder. Where the entitlement of a person to a share in consequence of the death or bankruptcy of a shareholder or of any other event giving rise to its transmission by operation of law is proved to the satisfaction of the Board, the Board shall, within two months after proof, cause the entitlement of that person to be noted in the Register.

31.Rights on transmission

Where a person is entitled to a share by transmission, the rights of the holder in relation to such share shall cease. However, the person so entitled may give a good discharge for any dividends and other moneys payable in respect of it and shall have the same rights to which he would be entitled if he were the holder of the share except that he shall not before he is registered as the holder of the share be entitled in respect of it to give notice of or to attend or vote at any meeting of the Company or at any separate meeting of the holders of any class of shares of the Company. The Board may at any time give notice requiring any such person to elect either to be registered himself or to transfer the share. If the notice is not complied with within sixty days the Board may thereafter withhold payment of all dividends and other moneys payable in respect of such share until the requirements of the notice have been complied with.

H.General meetings
32.Annual general meetings

The Board shall convene in each year a general meeting of the shareholders of the Company called the annual general meeting; any annual general meeting so convened shall be held at such time and place and consider such business as the Board may determine.

33.Extraordinary general meetings

All general meetings other than annual general meetings shall be called extraordinary general meetings.

22 

 
34.Convening of extraordinary general meeting

The Board may convene an extraordinary general meeting whenever it thinks fit. At any meeting convened by the Board or any meeting requisitioned pursuant to section 67(2) of the Act, no business shall be transacted except that stated by the requisition or proposed by the Board. If there are not sufficient Directors to convene a general meeting, any Director or any shareholder of the Company may call a general meeting.

35.Notice of general meetings
35.1Length of notice

Any annual general meeting and any extraordinary general meeting convened for the passing of a resolution appointing a person as a Director shall be convened by not less than twenty-one clear days’ notice in writing. Other extraordinary general meetings shall be convened by not less than fourteen clear days’ notice in writing. Notwithstanding that a meeting is convened by shorter notice than that specified in this Article, it shall be deemed to have been properly convened if it is so agreed by all the shareholders entitled to attend and vote at the meeting.

35.2Form of notice

Every notice convening a general meeting shall specify:

(a)whether the meeting is an annual general meeting or an extraordinary general meeting;
(b)the place, the day and the time of the meeting; and
(c)with reasonable prominence that a shareholder entitled to attend and vote is entitled to appoint one or more proxies to attend and vote instead of him and that a proxy need not also be a shareholder, and the place where instruments of proxy are to be deposited if the Board determines that place to be other than the Office.
35.3Entitlement to receive notice

The notice shall be given to the shareholders (other than any who under the provisions of these Articles are not entitled to receive notice from the Company), to the Directors and to the Auditors and if more than one for the time being, to each of them.

36.Omission to send notice

The accidental omission to send a notice of meeting or, in cases where it is intended that it be sent out with the notice, an instrument of proxy, to, or the non-receipt of either by, any person entitled to receive the same shall not invalidate the proceedings at that meeting.

I.Proceedings at general meetings

23 

 
37.Quorum

No business shall be transacted at any general meeting unless a quorum is present when the meeting proceeds to business but the absence of a quorum shall not preclude the choice or appointment of the Chairman in accordance with the provisions of Article 40 (Chairman) which shall not be treated as part of the business of the meeting. Subject to the provisions of Article 38 (If quorum not present), a shareholder or shareholders entitled to attend and to vote on the business to be transacted holding not less than thirty per cent of the issued share capital of the Company and being present in person, by telephone, other electronic means of communication or by proxy or (being a corporation) by a duly authorised representative shall be a quorum.

38.If quorum not present

If within fifteen minutes (or such longer interval not exceeding one hour as the Chairman in his absolute discretion thinks fit) from the time appointed for the holding of a general meeting a quorum is not present, or if during a meeting such a quorum ceases to be present, the meeting, if convened on the requisition of shareholders, shall be dissolved. In any other case, the meeting shall stand adjourned to later on the same day, to the same day in the next week at the same time and place, or to such other day and at such time and place as the Chairman (or, in default, the Board) may determine, being not less than fourteen nor more than twenty-eight days thereafter. If at such adjourned meeting a quorum is not present within fifteen minutes from the time appointed for holding the meeting one shareholder present, in person, by telephone, other electronic means of communication or by proxy or (being a corporation) by a duly authorised representative shall be a quorum. If no such quorum is present, or if during the adjourned meeting a quorum ceases to be present, the adjourned meeting shall be dissolved. The Company shall give at least seven clear days’ notice of any meeting adjourned through lack of quorum (where such meeting is adjourned to a day being not less than fourteen nor more than twenty-eight days thereafter).

39.            Security and meeting place arrangements

39.1Searches

The Board may direct that shareholders or proxies or representatives of shareholders being corporations wishing to attend any general meeting should submit to such searches or other security arrangements or restrictions as the Board shall consider appropriate in the circumstances, and the Board shall be entitled in its absolute discretion to refuse entry to such general meeting to any shareholder, proxy or representative who fails to submit to such searches or otherwise to comply with such security arrangements or restrictions.

24 

 
39.2Inadequate meeting place

If it appears to the Chairman that the meeting place specified in the notice convening the meeting is inadequate to accommodate all shareholders entitled and wishing to attend, the meeting shall nevertheless be duly constituted and its proceedings valid provided that the Chairman is satisfied that adequate facilities are available to ensure that any shareholder who is unable to be accommodated is nonetheless able to participate in the business for which the meeting has been convened and to hear and see all persons present who speak (whether by the use of microphones, loudspeakers, audio-visual communications equipment or otherwise), whether in the meeting place or elsewhere, and to be heard and seen by all other persons so present in the same manner.

40.Chairman

The Chairman of the Board shall preside as Chairman at every general meeting of the Company. For so long as there are co-chairmen of the Board, if at any meeting any one of such co-chairmen shall not be present within fifteen minutes after the time appointed for holding the meeting or shall be unwilling to act as Chairman, the sole remaining co-chairman (if any) of the Board shall if present and willing to act preside as Chairman at such meeting. If no Chairman shall be so present and willing to act, the Directors present shall choose one of their number to act or, if there be only one Director present, he shall be Chairman if willing to act. If no Director is willing to act as Chairman of the meeting or, if no Director is present within fifteen minutes of the time appointed for holding the meeting, the shareholders present and entitled to vote shall choose one of their number to be Chairman of the meeting.

41.Director may attend and speak

A Director shall notwithstanding that he is not a shareholder be entitled to attend and speak at any general meeting and at any separate meeting of the holders of any class of shares of the Company. The Chairman may invite any person to attend and speak at any general meeting of the Company whom the Chairman considers to be equipped by knowledge or experience of the Company’s business to assist in the deliberations of the meeting.

42.Power to adjourn

The Chairman of the general meeting may, with the consent of a meeting at which a quorum is present, and shall if so directed by the meeting, adjourn any meeting from time to time (or indefinitely) and from place to place as he shall determine. However, without prejudice to any other power which he may have under these Articles or at common law the Chairman may, without the need for the consent of the meeting, interrupt or adjourn any meeting from time to time and from place to place or for an indefinite period if he is of the opinion that it has become necessary to do so in order to secure the proper and orderly conduct of the meeting or to give all persons entitled to do so a reasonable opportunity of attending, speaking and voting at the meeting or to ensure that the business of the meeting is otherwise properly disposed of.

25 

 
43.Notice of adjourned meeting

Where a meeting is adjourned indefinitely the Board shall fix the time and place for the adjourned meeting. Whenever a meeting is adjourned for fourteen days or more or indefinitely, seven clear days’ notice at the least, specifying the place, the day and time of the adjourned meeting and the general nature of the business to be transacted, shall be given in the same manner as in the case of an original meeting. Save as aforesaid, no shareholder shall be entitled to any notice of an adjournment or of the business to be transacted at any adjourned meeting.

44.Business of adjourned meeting

No business shall be transacted at any adjourned meeting other than the business which might properly have been transacted at the meeting from which the adjournment took place.

J.Voting
45.Method of voting

At any general meeting a resolution put to a vote of the meeting shall be decided on a show of hands unless (before or immediately after the declaration of the result of the show of hands or on the withdrawal of any other demand for a poll) a poll is duly demanded. Subject to the provisions of the Act, a poll may be demanded by:

(a)the Chairman of the meeting; or
(b)at least two shareholders present in person or by proxy or (being a corporation) by a duly authorised representative having the right to vote at the meeting; or
(c)a person present in person or by proxy or (being a corporation) by a duly authorised representative who is the holder of B Ordinary Shares; or
(d)a shareholder or shareholders present in person or by proxy or (being a corporation) by a duly authorised representative representing not less than one tenth of the voting rights of all the shareholders having the right to vote at the meeting,

and a demand for a poll by a person as proxy for a shareholder shall be as valid as if the demand were made by the shareholder himself.

46.Chairman’s declaration conclusive on show of hands

Unless a poll is duly demanded and the demand is not withdrawn, a declaration by the Chairman of the meeting that a resolution has on a show of hands been carried or carried unanimously or by a particular majority or lost or not carried by a particular majority shall be conclusive, and an entry to that effect in the book containing the minutes of proceedings of the Company shall be conclusive evidence thereof, without proof of the number or proportion of the votes recorded in favour of or against such resolution.

26 

 
47.Objection to error in voting

No objection shall be raised to the qualification of any voter or to the counting of or failure to count any vote except at the meeting or adjourned meeting at which the vote objected to is given or tendered or at which the error occurs. Any objection or error shall be referred to the Chairman of the meeting and shall only vitiate the decision of the meeting on any resolution if the Chairman decides that it is of sufficient magnitude to vitiate the resolution or may otherwise have affected the decision of the meeting. The decision of the Chairman on such matters shall be final and conclusive.

48.Amendment to resolutions

If an amendment shall be proposed to any resolution under consideration but shall in good faith be ruled out of order by the Chairman of the meeting, any error in such ruling shall not invalidate the proceedings on the substantive resolution. No amendment to a resolution (other than a mere clerical amendment to correct a manifest error) may be considered or voted upon unless notice of such proposed amendment is delivered to the Office at least forty-eight hours prior to the time appointed for holding the relevant meeting or adjourned meeting and the Chairman of the meeting in his absolute discretion rules that the amendment is fit for consideration at the meeting.

49.            Procedure on a poll

49.1Timing of poll

Any poll duly demanded on the election of a Chairman of a meeting or on any question of adjournment shall be taken forthwith. A poll duly demanded on any other matter shall be taken in such manner (including the use of ballot or voting papers or tickets) and at such time and place, not being more than thirty days from the date of the meeting or adjourned meeting at which the poll was demanded, as the Chairman shall direct. The Chairman may, and if so directed by the meeting shall, appoint scrutineers who need not be shareholders and may adjourn the meeting to some place and time fixed by him for the purpose of declaring the result of the poll. No notice need be given of a poll not taken immediately if the time and place at which it is to be taken are announced at the meeting at which it is demanded. In any other case at least seven clear days’ notice shall be given specifying the time and place at which the poll is to be taken. The result of the poll shall be deemed to be the resolution of the meeting at which the poll was demanded.

49.2Continuance of the meeting

The demand for a poll shall not prevent the continuance of the meeting for the transaction of any business other than the question on which a poll has been demanded. If a poll is demanded before the declaration of the result on a show of hands and the demand is duly withdrawn the meeting shall continue as if the demand had not been made.

27 

 
49.3Withdrawal of demand for a poll

The demand for a poll may be withdrawn before the poll is taken, but only with the consent of the Chairman. A demand so withdrawn shall validate the result of a show of hands declared before the demand was made. If a demand is withdrawn, the persons entitled in accordance with Article 45 (Method of voting) may demand a poll.

49.4Voting on a poll

On a poll votes may be given in person or by proxy or (in the case of a corporate shareholder) by a duly authorised representative. A shareholder entitled to more than one vote need not, if he votes, use all his votes or cast all the votes he uses in the same way.

50.Votes of shareholders
50.1Voting systems including proxies

Notwithstanding any other provisions of these Articles, the Board may utilise, or approve the utilisation of, any telephone or internet based systems or any other electronic systems as they in their absolute discretion may think fit with respect to the appointment of proxies and/or the receipt of proxy forms and/or receipt of, or processing of, voting instructions for use at any general meeting.

50.2Number of votes

Subject to any suspension or abrogation of voting rights pursuant to these Articles, at any general meeting (whether an annual general meeting or an extraordinary general meeting):

(a)every shareholder present in person or by proxy or (in the case of a corporate shareholder) by duly authorised representative shall on a poll have one vote for each A Ordinary Share of which he is the holder; and
(b)every shareholder present in person or by proxy or (in the case of a corporate shareholder) by duly authorised representative shall on a poll have ten votes for each B Ordinary Share of which he is the holder.
50.3Joint holders

If two or more persons are joint holders of a share, then in voting on any question the vote of the senior who tenders a vote, whether in person or by proxy or (being a corporation) by a duly authorised representative, shall be accepted to the exclusion of the votes of the other joint holders. For this purpose seniority shall be determined by the order in which the names of the holders stand in the Register.

28 

 
50.4Receivers and other persons

Where in the Isle of Man or elsewhere a receiver or other person (by whatever name called) has been appointed by any court claiming jurisdiction in that behalf to exercise powers with respect to the property or affairs of any shareholder on the ground (however formulated) of mental disorder, the Board may in its absolute discretion on or subject to production of such evidence of the appointment as the Board may require, permit such receiver or other person authorised by a court or official, to vote in person or, on a poll, by proxy on behalf of such shareholder at any general meeting. Evidence to the satisfaction of the Board of the authority of the person claiming to exercise the right to vote shall be deposited at the Office or at such other place as is specified in accordance with these Articles for the deposit of instruments of proxy not less than forty-eight hours before the time appointed for holding the meeting or adjourned meeting at which the right to vote is to be exercised and in default the right to vote shall not be exercisable.

51.Casting vote

In the case of an equality of votes, whether on a show of hands or on a poll, the Chairman of the meeting at which the show of hands takes place or at which the poll was demanded shall be entitled to a second or casting vote in addition to any other vote that they may have; provided that in the event that there remains an equality of votes following the vote of the Chairman, the majority of the votes of the independent directors of the Board shall prevail.

52.Voting by proxy

Any person (whether a shareholder of the Company or not) may be appointed to act as a proxy. Deposit of an instrument of proxy shall not preclude a shareholder from attending and voting in person at the meeting in respect of which the proxy is appointed or at any adjournment of it.

53.Form of proxy

The appointment of a proxy shall:

(a)be in any common form or in such other form as the Board may approve under the hand of the appointor or of his attorney duly authorised in writing or if the appointor is a corporation under its common seal or under the hand of some officer or attorney duly authorised in that behalf or shall be contained in an Electronic Communication sent to such address (if any) as may for the time being be notified by or on behalf of the Company for that purpose, provided that the Electronic Communication is received in accordance with Article 54.1(b);
(b)be deemed (subject to any contrary direction contained in the same) to confer authority to demand or join in demanding a poll and to vote on any resolution or amendment of a resolution put to the meeting for which it is given, as the proxy thinks fit, but shall not confer any further right to speak at the meeting except with the permission of the Chairman;
(c)unless the contrary is stated in it be valid as well for any adjournment of the meeting as for the meeting to which it relates; and

29 

 
(d)where it is stated to apply to more than one meeting, be valid for all such meetings as well as for any adjournment of any such meetings.
54.Deposit of proxy
54.1The instrument appointing a proxy and the power of attorney or other authority (if any) under which it is signed, or a copy of such authority certified notarially or in some other way approved by the Board shall:
(a)in the case of an instrument in writing, be deposited by personal delivery or post at the Office or at such other place within the Isle of Man or elsewhere as is specified in the notice convening the meeting or in any instrument of proxy sent out by the Company in relation to the meeting not less than forty-eight hours before the time of the holding of the meeting or adjourned meeting at which the person named in the instrument proposes to vote; or
(b)in the case of an appointment contained in an Electronic Communication, where an address has been specified for the purpose of receiving Electronic Communications:
(i)in the notice convening the meeting; or
(ii)in any instrument of proxy sent out by the Company in relation to the meeting; or
(iii)in any invitation contained in an Electronic Communication to appoint a proxy issued by the Company in relation to the meeting

be received at such address not less than forty-eight hours before the time for holding the meeting or adjourned meeting at which the person named in the appointment proposes to vote; or

(c)in the case of a poll taken more than forty-eight hours after it is demanded be deposited as aforesaid after the poll has been demanded and not less than twenty-four hours before the time appointed for the taking of the poll; or
(d)where the poll is not taken forthwith but is taken not more than forty-eight hours after it was demanded, be delivered at the meeting at which the poll was demanded to the Chairman of the meeting;

and an appointment of a proxy not deposited, delivered or received in a manner so permitted shall be invalid. The Board may at its discretion treat a machine made copy of a written instrument appointing a proxy as such an appointment for the purpose of this Article.

30 

 
54.2Without limiting the foregoing, in relation to any shares which are held in uncertificated form, the Board may from time to time permit appointments of a proxy to be made by means of an Electronic Communication in the form of an uncertificated proxy instruction (that is, a properly authenticated dematerialised instruction, and/or other instruction or notification, which is sent by means of an Uncertificated System and received by such participant in the Uncertificated System acting on behalf of the Company as the Directors may prescribe, in such form and subject to such terms and conditions as may from time to time be prescribed by the Directors (subject always to the facilities and requirements of the Uncertificated System)); and may in a similar manner permit supplements to, or amendments or revocations of, any such uncertificated proxy instruction to be made by like means. The Board may in addition prescribe the method of determining the time at which any such properly authenticated dematerialised instruction (and/or other instruction or notification) is to be treated as received by the Company or such participant. The Board may treat any such uncertificated proxy instruction which purports to be or is expressed to be sent on behalf of a holder of a share as sufficient evidence of the authority of the person sending that instruction to send it on behalf of that holder.
54.3For the purposes of Articles 53(a), 54.1(b) and 57 the term “address” in relation to Electronic Communications includes any number or address (including, in the case of any uncertificated proxy instruction permitted pursuant to Article 54.2, an identification number of a participant in the relevant Uncertificated System concerned) used for the purposes of such communications.
54.4No appointment of a proxy shall be valid after the expiry of twelve months from the date named in it as the date of its execution except at an adjourned meeting or on a poll demanded at a meeting or an adjourned meeting in cases where the meeting was originally held within twelve months from such date.
54.5The proceedings at a general meeting shall not be invalidated where an appointment of a proxy in respect of that meeting is delivered in a manner permitted by these Articles by Electronic Communication, but because of a technical problem it cannot be read by the recipient.
55.More than one proxy may be appointed

A shareholder may appoint more than one proxy to attend on the same occasion. When two or more valid but differing appointments of proxy are delivered in respect of the same share for use at the same meeting and in respect of the same matter, the one which is last validly delivered (regardless of its date or of the date of its execution) shall be treated as replacing and revoking the other or others as regards that share. If the Company is unable to determine which appointment was last validly delivered, none of them shall be treated as valid in respect of that share.

31 

 
56.Board may supply proxy cards

The Board shall at the expense of the Company send by post or otherwise forms of appointment of proxy (reply-paid or otherwise) with the notice convening any general meeting to shareholders entitled to vote at the meeting. Such forms of appointment of proxy shall provide for at least three-way voting on all resolutions to be proposed at the meeting other than the resolutions relating to the procedure of the meeting. The accidental omission to send an appointment of proxy or the non receipt of it by any shareholder entitled to attend and vote at a meeting shall not invalidate the proceedings at that meeting.

57.Revocation of proxy

A vote given or poll demanded in accordance with the terms of an appointment of a proxy shall be valid notwithstanding the death or mental disorder of the principal or the revocation of the appointment of the proxy, or of the authority under which the appointment of the proxy was executed or the transfer of the share in respect of which the appointment of the proxy is given unless notice of such death, mental disorder, revocation or transfer shall have been delivered to or received by the Company not later than the latest time at which the proxy should have been delivered to or received by the Company in order to be valid for use at the meeting or adjourned meeting at which the proxy is used, or (in the case of a poll taken otherwise than at or on the same day as the meeting or adjourned meeting) not later than twenty-four hours before the time of the taking of the poll at which the vote is cast. Such notice of determination shall be either by means of an instrument delivered to the Office or to such other place within the Isle of Man or elsewhere as may be specified by or on behalf of the Company in accordance with Article 54.1(a) or contained in an Electronic Communication received at the address (if any) specified by or on behalf of the Company in accordance with Article 54.1(b), regardless of whether any relevant proxy appointment was effected by means of an instrument or contained in an Electronic Communication. For the purpose of this Article, an Electronic Communication which contained such notice of determination need not be in writing if the Board has determined that the Electronic Communication which contains the relevant proxy appointment need not be in writing.

58.Written resolutions

Any action that may be taken by the shareholders at a general meeting may also be taken by a resolution consented to in writing by shareholders holding: (i) in excess of fifty per cent of the rights to vote on such resolution or seventy-five per cent in the case of a special resolution conferred on such shareholders according to the rights attached to the shares held; and (ii) the requisite percentage of shares held by any particular class or classes of shareholders having the right to consent to such resolution pursuant to Article 59. The consent may be in the form of counterparts, each counterpart being signed by one or more shareholders. If the consent is in one or more counterparts, and the counterparts bear different dates, then the resolution or special resolution (as applicable) shall take effect on the earliest date upon which shareholders holding a sufficient number of votes to constitute a resolution or special resolution (as applicable) of shareholders have consented to the resolution by signed counterparts. If any written resolution of the shareholders is adopted otherwise than by the unanimous written consent of all shareholders, a copy of such resolution shall be sent to all shareholders not consenting to such resolution forthwith upon it taking effect.

32 

 
59.Approval Rights

In addition to any items which require the approval of shareholders under applicable law, until the date that is the third (3rd) anniversary of the Effective Time (as defined in the Merger Agreement Related Transaction Documents), the Company shall not, and shall cause its subsidiaries not to, directly or indirectly, take any of the following actions without the prior approval of the holders of a majority of the A Ordinary Shares in issue (for the avoidance of doubt, excluding any vote of the holders of B Ordinary Shares with respect to such B Ordinary Shares):

(a)amending, supplementing or otherwise modifying the provisions of this Article 59;
(b)amending, supplementing or otherwise modifying (whether by merger or otherwise) the memorandum of association of the Company or these Articles in a manner that would affect the relative rights of holders of B Ordinary Shares vis-à-vis holders of A Ordinary Shares;
(c)entering into any agreement or effecting any transaction or series of related transactions providing for consideration to the holders of B Ordinary Shares that is in a different amount or form per share than the consideration provided to the holders of A Ordinary Shares in such transaction;
(d)any action that would have the effect of increasing the relative voting power of the B Ordinary Shares in issue vis-à-vis the A Ordinary Shares in issue; provided that, for avoidance of doubt, this Article 59(d) expressly does not include the acquisition by the Permitted Holders of additional A Ordinary Shares from time to time (but, if such Shares are acquired directly from the Company or any of its subsidiaries, such acquisition shall be subject to Article 59(e)) and/or the conversion from time to time of any A Ordinary Shares then held by the Permitted Holders into B Ordinary Shares (but any such conversion remaining subject to Article 22.5);
(e)issuing additional B Ordinary Shares (other than upon conversion of A Ordinary Shares, but any such conversion remaining subject to Article 22.5) to any Permitted Holder;
(f)entering into any agreement or amending any existing agreement or effecting any transaction or series of related transactions between the Company or any of its subsidiaries, on the one hand, and any Permitted Holder from time to time, on the other hand, except for (i) awards of equity-based compensation approved by the Remuneration Committee and granted in the ordinary course of business to members of the Permitted Holders who are also members of the Company’s senior management, (ii) arms’ length transactions the material terms of which are approved in advance by the Independent Committee and (iii) any agreements, transactions or arrangements existing on the date hereof the material terms of which are publicly disclosed prior to the date hereof in the documents publicly filed by the Company with the U.S. Securities and Exchange Commission; or
(g)agreeing or otherwise committing (whether or not in writing) to take any of the foregoing actions.

33 

 
K.Untraced shareholders
60.Power of sale
60.1Untraceable shareholders

The Company shall be entitled to sell at the market price reasonably obtainable any share of a shareholder or any share to which a person is entitled by transmission if and provided that:

(a)during the period of twelve years prior to the date of the publication of the advertisements referred to in paragraph (b) (or if published on different dates, the earlier or earliest of them) no cheque, order or warrant in respect of such share sent by the Company through the post in a pre-paid envelope addressed to the shareholder or to the person entitled by transmission to the share at his address on the Register or other last known address given by the shareholder or person to which cheques, orders or warrants in respect of such share are to be sent has been cashed and the Company has received no communications in respect of such share from such shareholder or person provided that during such period of twelve years at least three cash dividends (whether interim or final) in respect of the shares in question have become payable and no such dividend during that period has been claimed by the person entitled to it;
(b)on or after expiry of the said period of twelve years the Company has given notice of its intention to sell such share by advertisements in a national daily newspaper published in the United Kingdom and a national daily newspaper published in the US and (if the last known address of such shareholder or person is not in the United Kingdom or the US) in a newspaper circulating in the area of the last known address of such shareholder or person;
(c)the said advertisements, if not published on the same day, shall have been published within thirty days of each other;
(d)during the further period of three months following the date of publication of the said advertisements (or, if published on different dates, the later or latest of them) and prior to the exercise of the power of sale the Company has not received any communication in respect of such share from the shareholder or person entitled by transmission; and
(e)the Company has given notice, if required, in accordance with the regulations of the relevant regulatory authority of its intention to make such sale and shall, if appropriate, have obtained the approval of the relevant regulatory authority to the proposed form of the said advertisement, if shares of the class concerned are admitted to a securities list and/or a recognised investment exchange.

34 

 
60.2Perfection of transfer

To give effect to any sale of shares pursuant to this Article 59 (Power of sale) the Board may in the case of certificated shares authorise some person to transfer the shares in question and may enter the name of the transferee in respect of the transferred shares in the Register notwithstanding the absence of any share certificate being lodged in respect of it and may issue a new certificate to the transferee and in the case of uncertificated shares exercise any power conferred on it by Article 21.5 (Forfeiture and sale) to effect a transfer of the shares. The purchaser shall not be bound to see to the application of the purchase moneys in respect of any such sale nor shall his title to the shares be affected by any irregularity or invalidity in the proceedings relating to the sale or transfer. Any instrument or exercise shall be effective as if it had been executed or exercised by the holder of or the person entitled by transmission to the shares to which it relates.

60.3Additional shares

If during the period of twelve years referred to in Article 59.1 (Untraceable shareholders) or during any period ending on the date when all the requirements of paragraphs (a) to (d) of Article 59.1 have been satisfied, any additional shares have been issued in respect of those held at the beginning of such period or of any previously so issued during such period and all the requirements of paragraphs (b) to (d) of Article 59.1 have been satisfied in regard to such additional shares the Company shall also be entitled to sell the additional shares.

60.4Application of proceeds of sale

Subject to compliance with the solvency test, the Company shall account to the shareholder or other person entitled to such share or shares for the net proceeds of such sale by carrying all moneys in respect of it to a separate account. The Company shall be deemed to be a debtor to and not a trustee for such shareholder or other person in respect of such moneys. Moneys carried to such separate account may either be employed in the business of the Company or invested in such investments as the Board may from time to time think fit. No interest shall be payable to such shareholder or other person in respect of such moneys and the Company shall not be required to account for any money earned on them.

L.Appointment, term and removal of directors
61.Number of Directors

Subject to the Investors’ Rights Agreement, the number of Directors shall be not less than three or more than twelve with the number to be set from time to time by the Board in a manner consistent with the Investors’ Rights Agreement.

35 

 
62.Power of Company to appoint Directors

Subject to the Investors’ Rights Agreement and the provisions of these Articles, the Company may by resolution appoint a person who is willing to act to be a Director, either to fill a vacancy, or as an addition to the existing Board, but the total number of Directors shall not exceed any maximum number fixed in accordance with these Articles. Any Director so appointed shall hold office in accordance with Article 68.2 (Re-election of Directors).

63.Power of Board to appoint Directors

Without prejudice to the power of the Company to appoint any person to be a Director pursuant to these Articles, the Board shall, in accordance with the Investors’ Rights Agreement, have power at any time to appoint any person who is willing to act as a Director, either to fill a vacancy or as an addition to the existing Board, but the total number of Directors shall not exceed any maximum number fixed in accordance with these Articles. Any Director so appointed shall hold office in accordance with Article 68.2 (Re-election of directors).

64.Eligibility of new Directors

No person other than a Director whose term expires at the meeting (pursuant to Article 68.1 (Number of Directors)) shall be appointed or re-appointed a Director at any general meeting unless (if applicable) such appointment or re-appointment is in accordance with the Investors’ Rights Agreement (if relevant) or such person is nominated in accordance with the Investors’ Rights Agreement (if relevant).

65.Share qualification

A Director shall not be required to hold any shares.

66.Resolution for appointment

A resolution for the appointment of two or more persons as Directors by a single resolution shall not be moved unless a resolution that it shall be so proposed has first been agreed to by the meeting without any vote being given against it and any resolution moved in contravention of this provision shall be void. For the purpose of this Article, a resolution for approving a person’s appointment or for nominating a person for appointment as a Director shall be treated as a resolution for his appointment.

67.No retirement on account of age

No person shall be or become incapable of being appointed or re-appointed a Director by reason of his having attained the age of eighty or any other age, nor shall any special notice be required in connection with the appointment, re-appointment or the approval of the appointment of such person. No Director shall vacate his office at any time by reason of the fact that he has attained the age of eighty or any other age.

68.            Staggered Board terms

36 

 
68.1Number of Directors

The Board shall be divided into three classes, each as nearly equal in number as possible, designated Class I Directors, Class II Directors and Class III Directors. Class I Directors shall initially hold office until the 2021 annual general meeting; Class II Directors shall initially hold office until the 2022 annual general meeting; and Class III Directors shall initially hold office until the 2023 annual general meeting. At each annual general meeting, each of the Directors of the relevant class the term of which shall then expire shall be eligible for re-election to the Board for a period of three years. In the case of any increase or decrease in the number of Directors, the Board shall apportion the number of Directors in each class equally or, if this is not possible, as nearly as equal as possible. The Board shall assign the Directors as at the date of adoption of these Articles to Class I, Class II or Class III.

68.2Re-election of Directors

A Director whose term is to expire shall be eligible for re-election and may, if willing to act, be re-appointed. A Director who is re-elected will continue in office without a break. A Director appointed to fill a vacancy (other than at an annual general meeting) shall initially serve the remainder of the term of the Director he replaces. No decrease in the number of Directors will shorten the term of any Director.

69.Removal by resolution

Subject to the Investors’ Rights Agreement, the Company may by resolution remove any Director before the expiration of his period of office notwithstanding anything in these Articles or in any agreement between the Company and such Director and, without prejudice to any claim for damages which he may have for breach of any contract of service between him and the Company, may (subject to these Articles) by resolution appoint another person who is willing to act to be a Director in his place.

70.Vacation of office by Director

Without prejudice to any provisions for the term of office contained in these Articles the office of a Director shall be vacated if:

(a)he resigns by notice in writing delivered to the Company’s registered agent or the Office or tendered at a Board meeting in which event he shall vacate that office on the service of that notice on the Company or at such later time as is specified in the notice or he offers in writing to resign from his office and the Directors resolve to accept such offer; or
(b)he ceases to be a Director by virtue of any provision of the Act, is removed from office pursuant to these Articles or becomes prohibited by law from being a Director (including, without limitation, by virtue of section 93 of the Act); or
(c)he has an interim receiving order made against him, makes any arrangement or compounds with his creditors generally; or

37 

 
(d)an order is made by any court of competent jurisdiction (whether in the Isle of Man, the United Kingdom or elsewhere) on the ground (howsoever formulated) of mental disorder for his detention or for the appointment of a guardian or receiver or other person to exercise powers with respect to his property or affairs or he is admitted to hospital in pursuance of an application for admission for treatment under any statute for the time being in force in the Isle of Man or the United Kingdom relating to mental disorder or, in any other territory, in pursuance of an application for admission under analogous legislation or regulations and the Board resolves that his office be vacated; or
(e)he shall be absent, without the permission of the Board, from Board meetings for six consecutive months and the Board resolves that his office be vacated; or
(f)he is requested to resign by notice in writing addressed to him at his address as shown in the register of Directors and signed by all the other Directors (without prejudice to any claim for damages which he may have for breach of any contract between him and the Company); or
(g)he is convicted of an indictable offence and the Directors shall resolve that it is undesirable in the interests of the Company that he remains a Director of the Company; or
(h)the conduct of that Director (whether or not concerning the affairs of the Company) is the subject of (i) an application to the High Court pursuant to section 3 of the Company Officers (Disqualification) Act 2009 to the Isle of Man High Court or (ii) a formal criminal investigation by the police of any jurisdiction and the Board shall resolve that it is undesirable that he remains a Director; or
(i)notice is given to terminate his contract of employment or engagement with the Company where he is in breach of such contract; or
(j)he has been disqualified from acting as a director.
71.Resolution as to vacancy conclusive

A resolution of the Board declaring a Director to have vacated office under the terms of Article 70 (Vacation of office by Director) shall be conclusive as to the fact and grounds of vacation stated in the resolution.

38 

 
M.Directors’ remuneration, expenses and pensions
72.Directors’ fees

The Directors shall be entitled to receive by way of fees for their services as Directors such sum as the Board may from time to time determine. Such sum shall be divided among the Directors in such proportions and in such manner as the Board may determine or in default of such determination, equally (except that in such event any Director holding office for less than the whole of the relevant period in respect of which the fees are paid shall only rank in such division in proportion to the time during such period for which he holds office). Any fees payable pursuant to this Article shall be distinct from any salary, remuneration or other amounts payable to a Director pursuant to any other provisions of these Articles and shall accrue from day to day but any Director who is also an officer of the Company or any of its subsidiaries shall not be entitled to any fees hereunder although such Director may be paid a salary and/or remuneration in accordance with Article 75 (Remuneration of executive Directors).

73.Expenses

Each Director shall be entitled to be repaid all reasonable travelling, hotel and other expenses properly incurred by him in or about the performance of his duties as Director, including any expenses incurred in attending meetings of the Board or any committee of the Board or general meetings or separate meetings of the holders of any class of shares or of debentures of the Company.

74.Remuneration

If by arrangement with the Board any Director shall perform or render any special duties or services outside his ordinary duties as a Director and not in his capacity as a holder of employment or executive office, he may be paid such reasonable additional remuneration (whether by way of a lump sum or by way of salary, commission, participation in profits or otherwise) as the Board may from time to time determine.

75.Remuneration of executive Directors

The salary or remuneration of any Director appointed to hold any employment or executive office in accordance with the provisions of these Articles may be either a fixed sum of money or may altogether or in part be governed by business done or profits made or otherwise determined by the Board.

39 

 
76.Pensions and other benefits

The Board may exercise all the powers of the Company to provide pensions or other retirement or superannuation benefits and to provide death or disability benefits or other allowances or gratuities (whether by insurance or otherwise) for or to institute and maintain any institution, association, society, club, trust, other establishment or profit sharing, share incentive, share purchase or employees’ share scheme calculated to advance the interests of the Company or to benefit any person who is or has at any time been a Director of the Company or any company which is a subsidiary company of or allied to or associated with the Company or any such subsidiary or any predecessor in business of the Company or of any such subsidiary and for any member of his family (including a spouse or former spouse) and any person who is or was dependent on him. For such purpose the Board may establish, maintain, subscribe and contribute to any scheme, institution, association, club, trust or fund and pay premiums and, subject to the provisions of the Act, lend money or make payments to, guarantee or give an indemnity in respect of, or give any financial or other assistance in connection with, any of the aforesaid matters or bodies. The Board may procure any of such matters to be done by the Company either alone or in conjunction with any other person. Any Director or former Director shall be entitled to receive and retain for his own benefit any pension or other benefit provided under this Article and shall not be obliged to account for it to the Company.

N.Powers and duties of the Board
77.Powers of the Board

The management and control of the business of the Company shall be in and from such place as the Board may determine from time to time. Subject to the provisions of the Investors’ Rights Agreement, the Act, the memorandum of association of the Company and these Articles and to any directions given by special resolution of the Company, the business of the Company shall be managed by the Board, which may exercise all the powers of the Company whether relating to the management of the business or not. No alteration of the memorandum of association or of these Articles and no such direction given by the Company shall invalidate any prior act of the Board which would have been valid if such alteration had not been made or such direction had not been given. Provisions contained elsewhere in these Articles as to any specific power of the Board shall not be deemed to limit the general powers given by this Article.

78.Powers of Directors being less than minimum number

If the number of Directors is less than the minimum for the time being prescribed by these Articles, the remaining Director or Directors shall act only for the purposes of appointing an additional Director or Directors to make up such minimum or of convening a general meeting of the Company for the purpose of making such appointment. If there are no Director or Directors able or willing to act, any two shareholders may summon a general meeting for the purpose of appointing Directors. Subject to the provisions of these Articles, any additional Director so appointed shall hold office only until the dissolution of the annual general meeting of the Company next following such appointment unless he is re-elected during such meeting.

40 

 
79.Powers of executive Directors

Subject to the Investors’ Rights Agreement, the Board may from time to time:

(a)delegate or entrust to and confer on any Director holding executive office (including a Managing Director) such of its powers, authorities and discretions (with power to sub-delegate) for such time on such terms and subject to such conditions as it thinks fit; and
(b)revoke, withdraw, alter or vary all or any of such powers.

80.            Delegation to committees

80.1Constituting committees

Subject to the Investors’ Rights Agreement, the Board may delegate any of its powers, authorities and discretions (with power to sub-delegate) for such time on such terms and subject to such conditions as it thinks fit to any committee consisting of one or more Directors and (if thought fit) one or more other persons provided that:

(a)a majority of the members of a committee shall be Directors;
(b)no resolution of a committee shall be effective unless a majority of those present when it is passed are Directors; and
(c)the committee may meet in such places as the members thereof may from time to time determine provided, however, that the Board shall ensure that the Company does not become, and is not deemed to be, resident for taxation purposes in any jurisdiction other than the Isle of Man.

Any committee so formed may exercise its power to sub-delegate by sub-delegating to any person or persons (whether or not a Director or a member of such committee).

80.2Powers of committee

Subject to the Investors’ Rights Agreement, the Board may confer such powers either collaterally with or to the exclusion of and in substitution for all or any of the powers of the Board in that respect and may from time to time revoke, withdraw, alter or vary any of such powers and discharge any such committee in whole or in part. Insofar as any power, authority or discretion is so delegated any reference in these Articles to the exercise by the Board of such power, authority or discretion shall be construed as if it were a reference to the exercise of such power, authority or discretion by such committee. Subject to any terms and conditions expressly imposed by the Board, the proceedings of a committee with two or more members shall be governed by such of these Articles as regulate the proceedings of the Board so far as they are capable of applying.

41 

 
81.Local management

Subject to the Investors’ Rights Agreement, the Board may establish any local group or divisional boards or agencies for managing any of the affairs of the Company in any specified locality and may appoint any persons to be members of such local or divisional board or any managers or agents, may fix their remuneration and remove any person so appointed. The Board may delegate to any local group or divisional board manager or agent so appointed any of its powers, authorities and discretions other than the power to borrow (with power to sub-delegate) and may authorise the members for the time being of any such local or divisional board or any of them to fill any vacancies and to act notwithstanding vacancies, and any such appointment or delegation may be made for such time on such terms and subject to such conditions as the Board may think fit. The Board may confer such powers either collectively with or to the exclusion of and in substitution for all or any of the powers of the Board in that respect and may from time to time revoke, withdraw, alter or vary all or any of such powers. Subject to any terms and conditions expressly imposed by the Board, the proceedings of any local group or divisional board or agency with two or more members shall be governed by such of these Articles as regulate the proceedings of the Board so far as they are capable of applying.

82.Power of attorney

Subject to the Investors’ Rights Agreement, the Board may by power of attorney or otherwise appoint any company, firm, person or persons (including registrars) to be the agent or attorney of the Company and may delegate to any such agent or attorney or any fluctuating body of persons, whether nominated directly or indirectly by the Directors, any of its powers, authorities and discretions (with power to sub-delegate), in each case for such purposes and for such time, on such terms (including as to remuneration) and subject to such conditions as it thinks fit. The Board may confer such powers either collaterally with, or to the exclusion of and in substitution for, all or any of the powers of the Board in that respect and may from time to time revoke, withdraw, alter or vary any of such powers. Any such appointment or power of attorney may contain such provisions for the protection and convenience of persons dealing with any such agent or attorney as the Board may think fit and may also authorise any such agent or attorney to sub-delegate all or any of the powers, authorities and discretions vested in him.

83.Associate Directors

The Board may appoint any person (not being a Director) to any office or employment having a designation or title including the word “director” or attach to any existing office or employment with the Company such designation or title and may define, limit, vary or restrict the powers, authorities and discretions of persons so appointed and may terminate any such appointment subject to any contract between him and the Company or the use of such designation or title. The inclusion of the word “director” in the designation or title of any such office or employment shall not imply that such person is or is deemed to be or is empowered in any respect to act as a Director or a member of any committee of the Board for any of the purposes of the Act or these Articles.

42 

 
84.Exercise of voting power

Subject to the Investors’ Rights Agreement, the Board may exercise or cause to be exercised the voting power conferred by the shares in any other company held or owned by the Company or any power of appointment to be exercised by the Company in such manner in all respects as it thinks fit (including the exercise of the voting power or power of appointment in favour of the appointment of any Director as a director or other officer or employee of such company or in favour of the payment of remuneration to the directors, officers or employees of such company).

85.[Intentionally Omitted]
86.Borrowing powers

Subject to the Investors’ Rights Agreement and as herein provided and to the provisions of the Act, the Directors may exercise all the powers of the Company to borrow money, to guarantee, to indemnify and to mortgage or charge its undertaking, property, assets (present and future) and uncalled capital or any part or parts thereof and to issue debentures and other securities, whether outright or as collateral security for any debt, liability or obligation of the Company or of any third party.

O.Proceedings of Directors and Committees
87.Board meetings

Subject to the provisions of the Investors’ Rights Agreement and these Articles, the Board may meet for the despatch of business, adjourn and otherwise regulate its proceedings as it thinks fit. Board meetings shall be held in such places as the Board may from time to time determine.

88.Notice of Board meetings

Subject to the Investors’ Rights Agreement, one Director may summon a Board meeting at any time on reasonable notice. Notice of a Board meeting shall be deemed to be properly given to a Director if it is given to him in writing to him at his last known address or any other address given by him to the Company for that purpose or by Electronic Communication. A Director may waive the requirement that notice be given to him of any Board meeting either prospectively or retrospectively.

89.Quorum

The quorum necessary for the transaction of business may be determined by the Board and until otherwise determined shall be a majority in number of the Directors. A duly convened meeting of the Board at which a quorum is present shall be competent to exercise all or any of the authorities, powers and discretions for the time being vested in or exercisable by the Board. Any Director who ceases to be a Director at a meeting of the Directors may continue to be present and to act as a Director and be counted in the quorum until the termination of the meeting of the Directors if no Director objects and if otherwise a quorum of Directors would not be present.

90.            Chairman of Board and other offices

43 

 
90.1Appointment of Chairman

The Board shall appoint one or more of its body as Chairman or Co-Chairmen of the Board and shall determine the period for which they are to hold office and may at any time remove one or both of them from office. If no such Chairman is elected or if at any meeting no Chairman or Co-Chairmen is present within fifteen minutes of the time appointed for holding it, the Directors present shall choose one of their number to be Chairman of such meeting. Any Chairman may also hold executive office under the Company.

90.2Chief Executive

The Directors may appoint one or more of their number to any office or employment under the Company (including, but without limitation, that of Chief Executive, Managing Director or Joint Managing Director but not including that of auditor), and may enter into an agreement or arrangement with any Director for his employment by the Company or for the provision by him of any services outside the scope of the ordinary duties of a Director and may also permit any person appointed to be a Director to continue in any office or employment held by him before he was so appointed. Any such appointment, agreement or arrangement may be made for such period and upon such terms as the Directors determine.

90.3Delegation of powers

Subject to the Investors’ Rights Agreement, without prejudice to the generality of the foregoing, the Directors may entrust to and confer upon any Director holding any such office or employment any of the powers exercisable by them as Directors with power to sub-delegate upon such terms and conditions and with such restrictions as they think fit and either collaterally with or to the exclusion of their own powers, authorities and discretions, and may from time to time revoke, withdraw, alter or vary all or any of such powers but no person dealing in good faith and without notice of the revocation or variation shall be affected by it. The power to delegate contained in this Article shall be effective in relation to the powers, authorities and discretions of the Board generally and shall not be limited by the fact that in certain Articles, but not in others, express reference is made to particular powers, authorities or discretions being exercised by the Board or by a committee authorised by the Board.

90.4Removal from position

Subject to the Investors’ Rights Agreement, the Directors may also (without prejudice to any claim for damages for breach of any agreement between the Director and the Company) remove a Director from any such office and appoint another in his place.

90.5Cessation of position on ceasing to be a director

A Director appointed to the office of Co-Chairman, Managing Director, Chief Executive or any other executive office shall automatically and immediately cease to hold that office if he ceases to hold the office of Director from any cause, but he shall not (unless any agreement between him and the Company shall otherwise provide) cease to hold his office as a Director by reason only of his ceasing to be Chairman, Deputy Chairman, Managing Director, Chief Executive of the Company or to hold any other such executive office, as the case may be.

44 

 
91.Voting
91.1Subject to Articles 91.2, 91.3 and 91.4, questions arising at any meeting shall be determined by a majority of votes. In the case of an equality of votes the Chairman of that meeting shall have a second or casting vote; provided that in the event that there remains an equality of votes following such vote by the Chairman, the vote of a majority of the independent directors of the Board shall prevail.
91.2Until the date that is the third (3rd) anniversary of the Effective Time (as defined in the Merger Agreement Related Transaction Documents), the Company shall not, and shall cause its subsidiaries not to, directly or indirectly, take any of the following actions without the prior approval of the majority of the members of the Independent Committee:
(a)amending, supplementing or otherwise modifying (whether by merger or otherwise) the memorandum of association of the Company or these Articles in a manner that would affect the relative rights of holders of B Ordinary Shares vis-à-vis holders of A Ordinary Shares;
(b)entering into any agreement or effecting any transaction or series of related transactions providing for consideration to the holders of B Ordinary Shares that is in a different amount or form per share than the consideration provided to the holders of A Ordinary Shares in such transaction;
(c)entering into any agreement or amending any existing agreement or effecting any transaction or series of related transactions between the Company or any of its subsidiaries, on the one hand, and any Permitted Holder from time to time, on the other hand, except for (i) awards of equity-based compensation approved by the Remuneration Committee and granted in the ordinary course of business to members of the Permitted Holders who are also members of the Company’s senior management and (ii) any agreements, transactions or arrangements existing on the date hereof the material terms of which are publicly disclosed prior to the date hereof in the documents publicly filed by the Company with the U.S. Securities and Exchange Commission; or
(d)agreeing or otherwise committing (whether or not in writing) to take any of the foregoing actions.
91.3Until the date that is the third (3rd) anniversary of the Effective Time (as defined in the Merger Agreement Related Transaction Documents) or such earlier date on which the Permitted Holders first collectively cease to directly or beneficially own at least 50% of the shares held by them at the Effective Time (as defined in the Merger Agreement Related Transaction Documents) (excluding for such purpose shares underlying or issuable in respect of equity awards granted at or as of immediately following the Effective Time), the Company shall not, and shall cause its subsidiaries not to, directly or indirectly, take any of the following actions without the prior approval of the majority of the Directors, including at least one Director nominated by the Permitted Holders in accordance with the Investors’ Rights Agreement who is not an independent Director:

45 

 
(a)entering into or effecting a transaction or series of related transactions (whether by merger, consolidation, recapitalization, liquidation or sale or transfer of shares or assets or otherwise) as a result of which any person or group of persons acting together for the purpose of acquiring, holding, voting or disposing of shares (other than the Permitted Holders and their respective Affiliates) obtains or would obtain ownership, directly or indirectly, of (i) shares that represent more than 50% of the total voting power of the shares of the Company or applicable successor entity or (ii) all or substantially all of the assets of the Company and its subsidiaries on a consolidated basis;
(b)initiating a voluntary liquidation, dissolution, receivership, bankruptcy or other insolvency proceeding involving the Company or any subsidiary of the Company that is a “significant subsidiary” as defined in Rule 1-02 of Regulation S-X under the U.S. Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder, as the same may be amended from time to time;
(c)making any material change in the nature of the business conducted by the Company and its subsidiaries;
(d)hiring or terminating the chief executive officer, chief financial officer or president (including any co-president) of the Company;
(e)adopting the annual business plan (including operating budget) of the Company and its subsidiaries; or
(f)agreeing or otherwise committing (whether or not in writing) to take any of the foregoing actions.
91.4Until the date that is the third (3rd) anniversary of the Effective Time (as defined in the Merger Agreement Related Transaction Documents) or such earlier date after the settlement of the CVRs (as defined in the Merger Agreement Related Transaction Documents) on which the Hony Investor first ceases to directly or beneficially own at least 50% of the shares held by the Hony Investor at the Effective Time (as defined in the Merger Agreement Related Transaction Documents), the Company shall not, and shall cause its subsidiaries not to, directly or indirectly, take any of the following actions without the prior approval of the majority of the Directors, including at least one Director nominated by the Hony Investor in accordance with the Investors’ Rights Agreement:
(a)hiring or terminating the chief executive officer, chief financial officer or president (including any co-president) of the Company.

46 

 
92.Participation by telephone and electronic communication

Any Director may validly participate in a meeting of the Board or a committee of the Board through the medium of conference telephone or other electronic means of communication provided that all persons participating in the meeting are able to hear and speak to each other throughout such meeting. A person so participating shall be deemed to be present in person at the meeting and shall accordingly be counted in a quorum and be entitled to vote. Such a meeting shall be deemed to take place where the Chairman of the meeting is located. Subject to these Articles, all business transacted in such manner by the Board or a committee of the Board shall for the purpose of these Articles be deemed to be validly and effectively transacted at a meeting of the Board or a committee of the Board notwithstanding that two or fewer than two Directors are physically present at the same place.

93.Resolution in writing

Subject, in the case of any matters requiring the approval of specific Directors or committees of the Board pursuant to Articles 91.2, 91.3 and 91.4 or the Investors’ Rights Agreement, to receipt of any such specific approval, a resolution in writing executed by all the Directors for the time being entitled to receive notice of a Board meeting and not being less than a quorum or by all the members of a committee of the Board for the time entitled to receive notice of such committee meeting and not being less than a quorum of that committee shall be as valid and effective for all purposes as a resolution duly passed at a meeting of the Board (or committee as the case may be). Such a resolution may consist of several documents in the same form each executed by one or more of the Directors or members of the relevant committee, including executions evidenced by means of facsimile transmission.

94.Minutes of proceedings
94.1Contents of minutes

The Board shall cause minutes to be made in books kept for the purpose of recording all orders, resolutions and proceedings of every meeting of the Board, of a committee of the Board, of the Company or of the holders of any class of shares or debentures of the Company including:

(a)all appointments of officers and committees made by the Board and of any such officer’s salary or remuneration; and
(b)the names of Directors present at every such meeting.
94.2Evidence of proceedings

Any such minutes if purporting to be signed by the Chairman of the meeting at which the proceedings were held or by the Chairman of the next succeeding meeting, shall be prima facie evidence of the matters stated in such minutes without any further proof.

47 

 
95.Validity of proceedings

All acts done by a meeting of the Board or of any committee of the local board or agency or by any person acting as a Director or member of a committee, local board or agency shall, as regards all persons dealing in good faith with the Company notwithstanding that it is afterwards discovered that there was some defect in the appointment of any person or persons acting as aforesaid or that they or any of them were or was disqualified from holding office or not entitled to vote or had in any way vacated their or his office or that the delegation to such committee, local board or agency had been annulled, varied or revoked, be as valid as if every such person had been duly appointed, and was duly qualified and had continued to be a Director or member of the relevant committee, local board or agency and had been entitled to vote or as if the delegation had continued in full force and effect.

P.Directors’ interests
96.Related Person Transaction Policies

The provisions in these Articles relating to Directors’ interests are subject to the Company’s Related Person Transaction Policies as approved by the Board from time to time.

97.Director may have interests

Subject to the provisions of section 104 of the Act and provided that Article 98 (Disclosure of interests to Board) is complied with, a Director, notwithstanding his office:

(a)may be a party to or otherwise be interested in any contract, arrangement, transaction or proposal with the Company or in which the Company is otherwise interested, either in regard to his tenure of any office or place of profit or as vendor, purchaser or otherwise;
(b)may hold any other office or place of profit under the Company (except that of Auditor or of auditor of a subsidiary of the Company) in conjunction with the office of Director and may act by itself or through his firm in a professional capacity for the Company and in any such case on such terms as to remuneration and otherwise as the remuneration committee may arrange either in addition to or in lieu of any remuneration provided for by any other Article;
(c)may be a shareholder of or a director or other officer, or employed by, or a party to any transaction or arrangement with or otherwise interested in, any body corporate promoted by or promoting the Company or in which the Company is otherwise interested or as regards which the Company has any powers of appointment; and
(d)shall not, by reason of his office, be liable to account to the Company for any dividend, profit, remuneration, superannuation payment or other benefit which he derives from any such office, employment, contract, arrangement, transaction or proposal or from any interest in any such body corporate,

and no such contract, arrangement, transaction or proposal shall be avoided on the grounds of any such interest or benefit.

48 

 
98.Disclosure of interests to Board
98.1Notification of interest

A Director who to his knowledge is in any way (directly or indirectly) interested in any contract, arrangement, transaction or proposal with the Company shall declare the nature of his interest at the meeting of the Board at which the question of entering into the contract, arrangement, transaction or proposal is first considered if he knows his interest then exists or, in any other case, at the first meeting of the Board after he knows that he is or has become so interested.

98.2Adequacy of notice

For the purposes of this Article:

(a)a general notice given to the Board by a Director that he is to be regarded as having an interest (of the nature and extent specified in the notice) in any contract, transaction, arrangement or proposal in which a specified firm, company, person or class of persons is interested shall be deemed to be a sufficient disclosure under this Article in relation to such contract, transaction, arrangement or proposal of the nature and extent thereof as so specified provided that no such notice shall be effective unless either it is given at a meeting of the Directors or the Director takes reasonable steps to secure that it is brought up and read at the next meeting of the Directors after it is given; and
(b)an interest of which a Director has no knowledge and of which it is unreasonable to expect him to have knowledge shall not be treated as an interest of his until such time as such Director has, or reasonably could be expected to have, such knowledge.
98.3Interested Director not to vote or count for quorum

A Director shall not vote on or be counted in the quorum in relation to any resolution of the Board or of a committee of the Board concerning any contract, arrangement, transaction or proposal whatsoever to which the Company is to be a party and in which he has an interest.

99.Director’s interest in own appointment

A Director shall not vote or be counted in the quorum on any resolution of the Board or committee of the Board concerning his own appointment (including fixing or varying the terms of his appointment or its termination) as the holder of any office or place of profit with the Company or any company in which the Company is interested. Where proposals are under consideration concerning the appointment (including fixing or varying the terms of appointment or termination) of two or more Directors to offices or places of profit with the Company or any company in which the Company is interested, such proposals may be divided and a separate resolution considered in relation to each Director. In such case each of the Directors concerned (if not otherwise debarred from voting under these Articles) shall be entitled to vote (and be counted in the quorum) in respect of each resolution except that concerning his own appointment.

49 

 
100.Chairman’s ruling conclusive on Director’s interest

If any question arises at any meeting of the Board or any committee of the Board as to the materiality of a Director’s interest (other than the Chairman’s interest) or as to the entitlement of any Director (other than the Chairman) to vote or be counted in a quorum and such question is not resolved by his voluntarily agreeing to abstain from voting or being counted in the quorum such question (unless the Director concerned is the Chairman in which case Article 101 (Directors’ resolution conclusive on Chairman’s interest) shall apply) shall before the conclusion of the meeting be referred to the Chairman of the meeting. The Chairman’s ruling in relation to the Director concerned shall be final and conclusive except in a case where the nature or extent of the interest of the Director has not been fairly disclosed and provided that any such question shall, for the purposes of disclosure of such interests in the accounts of the company, be finally and conclusively decided by a majority of the Directors (other than the Director concerned).

101.Directors’ resolution conclusive on Chairman’s interest

If any question arises at any meeting of the Board or any committee of the Board as to the materiality of the Chairman’s interest or as to the entitlement of the Chairman to vote or be counted in a quorum and such question is not resolved by his voluntarily agreeing to abstain from voting or being counted in the quorum, such question shall before the conclusion of the meeting be decided by resolution of the Directors or committee members present at the meeting (excluding the Chairman) whose majority vote shall be final and conclusive except in a case where the nature or extent of the interest of the Chairman has not been fairly disclosed and provided that any such question shall, for the purposes of disclosure of such interests in the accounts of the company, be finally and conclusively decided by a majority of the Directors (other than the Chairman).

102.[Intentionally Omitted]
Q.The Seal

103.         Application of Seal

103.1Use of seal

The Seal shall be used only by the authority of a resolution of the Board or of a committee of the Board so authorised. The Board may determine whether any instrument to which the Seal is affixed shall be signed and if it is to be signed who shall sign it. Unless otherwise so determined:

(a)share certificates and, subject to the provisions of any instrument constituting them, certificates issued under the Seal in respect of any debentures or other securities but excluding letters of allotment or scrip certificates shall be executed by a Director or by two Directors but the Board may by resolution determine that any signatures may be affixed to or printed (including by means of a facsimile of the signature of any person to be applied by any mechanical or electronic means in place of that person’s actual signature) on any such certificate by any means approved by the Board or that such certificates need not bear any signature; and

50 

 
(b)every other instrument to which the Seal is affixed shall be signed by a Director or by two Directors or by any other person appointed by the Board for the purpose.
103.2Certificates

Every certificate shall be issued under the Seal or in such other manner as the Board having regard to the terms of issue and the regulations applicable to the securities list(s) and recognised investment exchange(s) to which the shares of the Company are admitted. All references in these Articles to the Seal shall be construed accordingly.

104.Deed without sealing

A document signed by one or more Directors and expressed (in whatever form of words) to be executed by the Company as a deed shall have the same effect as if it were executed under the Seal, provided that no instrument shall be so signed which makes it clear on its face that it is intended by the person or persons making it not to have effect as a deed without the authority of a resolution of the Board or of a committee of the Board authorised in that behalf. An instrument or document which is executed by the Company as a deed shall not be deemed to be delivered by the Company solely as a result of it having been executed by the Company.

105.Official seal for sealing share certificates

The Company may have, for use for sealing securities issued by the Company and for sealing documents creating or evidencing securities so issued, an official seal which is a facsimile of the Seal with the addition on its face of the word “Securities”. The official seal when duly affixed to a document by or on behalf of the Company has the same effect as the Seal.

R.Dividends and other payments
106.Declaration of dividends

Subject to the provisions of these Articles, the Board may, subject to the satisfaction of the solvency test, declare and pay dividends out of the Company’s profits to shareholders according to their respective rights and interests in the profits of the Company. Each Ordinary Share confers upon the holder thereof the right to an equal share in any dividend paid by the Company.

107.Interim dividends

The Board may, subject to the satisfaction of the solvency test, declare and pay such interim dividends (including any dividend payable at a fixed rate) as appear to the Board to be justified by the profits of the Company and the position of the Company.

51 

 

108.         Entitlement to dividends

108.1Payment of dividends

All dividends and interest shall be paid (subject to any lien of the Company) to those shareholders whose names shall be on the Register at the date at which such dividend shall be declared or at the date at which such interest shall be payable respectively, or at such other date as the Company by resolution or the Board may determine, notwithstanding any subsequent transfer or transmission of shares.

108.2Shares passing by transmission

The Board may pay the dividends or interest payable on shares in respect of which any person is by transmission entitled to be registered as holder to such person upon production of such certificate and evidence as would be required if such person desired to be registered as a shareholder in respect of such shares.

109.Distribution in specie

The Company in general meeting may, on the recommendation of the Board, by resolution direct that payment of any dividend declared may be satisfied wholly or partly by the distribution of assets, and in particular, of fully paid up shares or debentures of any other company or in any one or more of such ways. Where any difficulty arises in regard to such distribution the Board may settle it as it thinks fit. In particular, the Board may:

(a)issue fractional certificates or, subject to the law and, in the case of shares held in uncertificated form, the rules of the Uncertificated System, authorise and instruct any person to sell and transfer any fractions or disregard fractions altogether;
(b)fix the value for distribution of such assets or any part of them and determine that cash payments may be made to any shareholders on the footing of the value so fixed, in order to adjust the rights of shareholders; and
(c)vest any such assets in trustees on trust for the persons entitled to the dividend.
110.Dividends not to bear interest

Unless otherwise provided by the rights attached to the share no dividend or other moneys payable by the Company or in respect of a share shall bear interest as against the Company.

111.         Method of payment

52 

 
111.1General provisions

The Company may pay any dividend, interest or other sum payable in respect of a share in cash or by direct debit, bank transfer, cheque, dividend warrant or money order (or in respect of any uncertificated share through the Uncertificated System) and may send it by post or other delivery service to the registered address of the shareholder or person entitled to it (or if two or more persons are holders of the share or are jointly entitled to it by reason of the death or bankruptcy of the shareholder or otherwise by operation of law to the registered address of such of those persons as is first named in the Register) or to such person and such address as such shareholder or person or persons may direct in writing. Every cheque, warrant or order is sent at the risk of the person entitled to the money represented by it and shall be made payable to the order of the person or persons entitled or, where an authority in that behalf shall have been received by the Company in such form as the Company shall consider sufficient, to such other person as the person or persons entitled may direct in writing. Payment of the cheque, warrant or order to the person entitled or the person specified in such authority shall be a good discharge to the Company. If any such cheque, warrant or order has or shall be alleged to have been lost, stolen or destroyed the Board may at the request of the person entitled to it issue a replacement cheque, warrant or order, subject to compliance with such conditions as to evidence and indemnity and the payment of out of pocket expenses of the Company in connection with the request as the Board may think fit. Any joint holder or other person jointly entitled to a share may give an effective receipt for any dividend or other moneys payable in respect of such share. Any such dividend, interest or other sum may also be paid by any other method as the Board considers appropriate. If the payment is made on behalf of the Company through the Uncertificated System the Company shall not be responsible for any default in accounting for such payment to the shareholder or other person entitled to such payment by a bank or other financial intermediary of which the shareholder or other person is a customer for settlement purposes in connection with the Uncertificated System.

111.2Payment in currencies other than sterling

The Board may, at its discretion, make provisions to enable such shareholder as the Board shall from time to time determine to receive dividends duly declared in a currency or currencies other than sterling. For the purposes of the calculation of the amount receivable in respect of any dividend, the rate of exchange to be used to determine the foreign currency equivalent of any sum payable as a dividend shall be such market rate selected by the Board as it shall consider appropriate at the close of business in London on the date which is the business day last preceding the date on which the Board publicly announces its intention to pay that specific dividend, provided that where the Board considers the circumstances to be appropriate it shall determine such foreign currency equivalent by reference to such market rate or rates or the mean of such market rates prevailing at such time or times or on such other date or dates, in each case falling before the time of the relevant announcement, as the Board may select.

111.3Payments through the uncertificated system

The Board may:

53 

 
(a)lay down procedures for making any payments in respect of uncertificated shares through the Uncertificated System;
(b)allow any holder of uncertificated shares to elect to receive or not to receive any such payment through the Uncertificated System; and
(c)lay down procedures to enable any such holder to make, vary or revoke any such election.

The Company may make, or procure the making of, any payment in respect of a shareholder’s uncertificated shares through the Uncertificated System in accordance with any authority given to the Company to do so (whether in writing, through the Uncertificated System or otherwise) by or on behalf of the shareholder in a form satisfactory to the Board. The making of such payment in accordance with such authority shall be a good discharge to the Company.

112.Uncashed dividends

If cheques, warrants or orders for dividends or other sums payable in respect of a share sent by the Company to the person entitled thereto by post are returned to the Company undelivered or left uncashed on two consecutive occasions or, following one occasion, reasonable enquiries have failed to establish any new address to be used for the purpose, the Company shall not be obliged to send any further dividends or other moneys payable in respect of that share due to that person until he notifies the Company of an address to be used for the purpose.

113.Unclaimed dividends

All dividends, interest or other sum payable and unclaimed for twelve months after having become payable may be invested or otherwise made use of by the Board for the benefit of the Company until, subject to compliance with the solvency test, claimed and the Company shall not be constituted a trustee in respect thereof. Any dividends claimed by a member shall require the Company to satisfy the solvency test at the point of claim. All dividends unclaimed for a period of twelve years after having become due for payment shall (if the Board so resolves) be forfeited and shall revert to the Company.

114.Waiver of dividends

The waiver in whole or in part of any dividend on any share by any document (whether or not under seal) shall be effective only if such document is signed by the shareholder (or the person entitled to the share in consequence of the death, bankruptcy or mental disorder of the holder or otherwise by operation of law) and delivered to the Company and only if or to the extent that the same is accepted as such or acted upon by the Company.

115.Payment of scrip dividends

54 

 
115.1Authority to pay scrip dividends

The Board may with the prior authority of a resolution of the Company and subject to such conditions as the Board may determine, provided that the Company has sufficient unissued shares and undistributed profits or reserves to give effect to it, offer to any holders of Ordinary Shares (whether the holder of A Ordinary Shares or of B Ordinary Shares) the right to elect to receive A Ordinary Shares credited as fully paid instead of cash in respect of the whole or some part (to be determined by the Board) of any dividend specified by the resolution.

115.2Election mandates

The Board may also from time to time establish or vary a procedure for election mandates, under which a holder of Ordinary Shares may elect to receive Ordinary Shares of the same class held by him credited as fully paid instead of cash in respect of all or certain future rights offered to that holder under this Article until the election mandate is revoked in accordance with any such procedure.

115.3Admission of shares

If the A Ordinary Shares are admitted to listing or trading on any recognised investment exchange, the Company shall apply to the relevant regulatory authority for additional A Ordinary Shares so allotted to be admitted to the recognised investment exchange(s) and securities list(s) to which the Company’s existing issued A Ordinary Shares are admitted.

115.4Directors’ powers

The Directors shall have power to do all acts and things as they consider necessary or expedient to give effect to this Article 115.

116.Reserves

The Board may, before recommending any dividend (whether preferential or otherwise) carry to reserves out of the profits of the Company such sums as it thinks fit. All sums standing to reserves may be applied from time to time, at the discretion of the Board, for any other purpose to which the profits of the Company may properly be applied and pending such application may either be employed in the business of the Company or be invested in such investments as the Board thinks fit and so that it shall not be necessary to keep any investment constituting the reserve separate or distinct from any other investment of the Company. The Board may divide the reserve into such special funds as it thinks fit and may consolidate into one fund any special fund or any part of any special fund into which the reserve may have been divided as it thinks fit. Any sum which the Board may carry to reserve out of the unrealised profit of the Company shall not be mixed with any reserve to which profits available for distribution have been carried. The Board may also, without placing the same to reserve, carry forward any profit which it may think prudent not to distribute.

117.Capitalisation of reserves

The Board may:

55 

 
(a)subject as provided in this Article, resolve to capitalise any profits of the Company not required for paying any preferential dividend (whether or not they are available for distribution) or any sum standing to the credit of any reserve or fund of the Company which is available for distribution;
(b)appropriate the sum resolved to be capitalised on the date specified in the resolution to the holders of Ordinary Shares in proportion to the par value of the shares held by them respectively which would entitle them to participate in a distribution of that sum if the sum were then distributable and were distributed by way of dividend and apply such sum on their behalf in paying up in full unissued shares of the Company at a price equal to that sum and allot A Ordinary Shares or B Ordinary Shares (as appropriate to existing holders of such shares) credited as fully paid to such holders or as they may direct in those proportions or partly in one way and partly in the other;
(c)make such provision by the issue of fractional certificates (or by ignoring fractions or by accruing the benefit of it to the Company rather than to the holders of Ordinary Shares concerned) or by payment in cash or otherwise as it thinks fit in the case of shares or debentures becoming distributable in fractions; authorise any person to enter on behalf of all the holders of Ordinary Shares concerned into an agreement with the Company providing for the allotment to them respectively, credited as fully paid up, of any shares or debentures to which they may be entitled on such capitalisation (any agreement made under such authority being effective and binding on all such holders); and
(d)generally do all acts and things required to give effect to such resolution.
118.Record dates

Notwithstanding any other provision of these Articles but without prejudice to the rights attached to any shares, the Board may fix any date (the “record date”) as the date at the close of business (or such other time as the Board may determine) on which persons registered as the holders of shares or other securities shall be entitled to receipt of any dividend, distribution, interest, allotment, issue, notice, information, document or circular. Such record date may be on or at any time within sixty (60) days before any date on which such dividend, distribution, interest, allotment, issue, notice, information, document or circular is declared, paid or made but without prejudice to the rights inter se in respect of the same of transfers and transferees of any such shares or other securities. In the absence of a record date being fixed, entitlement to any dividend, distribution, allotment or issue shall be determined by reference to the date on which the dividend is declared or the distribution, allotment or issue is made.

S.Accounts
119.Accounting records

The Board shall cause accounting records to be kept in accordance with the Act and shall keep such other books and registers as are necessary to comply with the Act.

56 

 
120.Inspection of records

The accounting records shall be kept at the Office or (subject to the Act) at such other place as the Board thinks fit. No shareholder (other than a Director) shall have any right to inspect any accounting record or other document of the Company unless he is authorised to do so by statute, by order of the Court, by the Board or by resolution of the Company. Such records shall always be open for inspection by officers of the Company.

121.Accounts to be sent to shareholders

A copy of the Directors’ and Auditors’ reports accompanied by printed copies of the annual accounts (including every document required by law to be comprised in them or annexed or attached to them) shall, not less than twenty-one clear days before the meeting before which they are to be laid, be sent to every shareholder and every holder of debentures of the Company and to the Auditors and to every other person who is entitled to receive notice of general meetings. However, this Article shall not require a copy of those documents to be sent to any person who under the provisions of these Articles is not entitled to receive notices from the Company or of whose address the Company is unaware or to any holder of debentures of whose address the Company is unaware or to more than one of the joint holders of any shares or debentures. If all or any of the shares in or debentures of the Company are listed or dealt in on any stock exchange, there shall at the same time be forwarded to the secretary of that stock exchange such number of copies of each of those documents as the regulations of that stock exchange may require.

T.Destruction and authentication of documents
122.Destruction of documents
122.1Documents which may be destroyed

Subject to the Act, the Company may destroy:

(a)any instrument of transfer after six years from the date on which it is registered;
(b)any dividend mandate or any variation or cancellation thereof or any notification of change of name or address after two years from the date on which it is recorded;
(c)any registered certificate for debentures or representing any other form of securities after one year from the date on which it is cancelled;
(d)any other document on the basis of which any entry in the Register is made after six years from the date on which an entry was first made in the Register in respect of it;
(e)all paid dividend warrants and cheques at any time after the expiration of one year from the date of actual payment thereof; and

57 

 
(f)all instruments of proxy which have been used for the purpose of a poll at any time after the expiration of one year from the date of such use and all instruments of proxy which have not been used for the purpose of a poll at any time after one month from the end of the meeting to which the instrument of proxy relates and at which no poll was demanded.

Provided that the Company may destroy any such type of document after such shorter period as the Board may determine if a copy of such document is retained on microfilm or other similar means which shall not be destroyed before the expiration of the relevant period and provided that adequate precautions against falsification and to share reproduction are taken.

122.2Presumption in respect of destroyed documents

It shall be conclusively presumed in favour of the Company that every entry in the Register purporting to have been made on the basis of a document so destroyed was duly and properly made, that every instrument of transfer so destroyed was duly registered, that every share certificate so destroyed was a valid and effective certificate duly cancelled, that every other document so destroyed had been properly dealt with in accordance with its terms and was valid and effective in accordance with the particulars in the records of the Company, provided that:

(a)this Article 122 shall apply only to the destruction of a document in good faith and without notice of any claim (regardless of the parties to it) to which the document might be relevant;
(b)nothing in this Article 122 shall be construed as imposing on the Company any liability in respect of the destruction of any such document or otherwise than as provided for in this Article 122 which would not attach to the Company in the absence of this Article 122; and
(c)references in this Article 122 to the destruction of any document include references to the disposal of it in any manner.
123.Authentication of documents

Any Director or any person appointed by the Directors for the purpose shall have power to authenticate any documents affecting the constitution of the Company and any resolutions passed by the Company or the Directors or any committee and any books, records, documents and accounts relating to the business of the Company and to certify copies of them or extracts from them as true copies or extracts and where any books, records, documents or accounts are elsewhere than at the Office, the local manager or other officer of the Company having the custody of them shall be deemed to be a person appointed by the Directors as aforesaid. A document purporting to be a copy of a resolution, or an extract from the minutes of a meeting, of the Company or of the Directors or any committee which is certified as aforesaid shall be conclusive evidence in favour of all persons dealing with the Company in reliance on them that such resolution has been duly passed or, as the case may be, that any minute so extracted is a true and accurate record of proceedings at a duly constituted meeting.

58 

 
U.Notices
124.Notice to be in writing

Any notice to be given to or by any person pursuant to these Articles shall be in writing or shall be given using Electronic Communication to an address for the time being notified for that purpose to the person giving the notice. Nothing in Part U of these Articles shall affect any requirements of the Act that any particular offer, notice or other document be served in any particular manner.

In this Part U of these Articles, “address” in relation to Electronic Communications includes any number, electronic mail address or other address used for the purposes of such communications

125.         Service of notice on shareholders

125.1Method of service

The Company may give or send any notice or document to a shareholder by any of the following means:

(a)by post, other delivery service or hand; or
(b)by Electronic Communication to an address for the time being notified to the Company by or on behalf of the shareholder for that purpose; or
(c)by publishing it on a website designated by the Company.
125.2Joint holders

In the case of joint holders of a share all notices or documents shall be given to the joint holder whose name stands first in the Register in respect of the joint holding. Notice so given shall be sufficient notice to all the joint holders.

125.3Shareholders outside the British Isles

Where a shareholder (or in the case of joint holders the person first named in the Register) has a registered address outside the British Isles but has notified the Company of an address within the British Isles at which notices or other documents may be given to him or an address to which notices may be sent using Electronic Communication, he shall be entitled to have notices given to him at that address, but otherwise no such shareholder shall be entitled to receive any notice or document from the Company.

125.4Record date

Any notice to be given to a shareholder may be given by reference to the register as it stands at any time within the period of fifteen days before the notice is given (subject to the Uncertificated Regulations if the Company is then a participating issuer for the purposes of the Uncertificated Regulations) and no change in the Register after that time shall invalidate the giving of the notice.

59 

 
126.Notice in case of death, bankruptcy or mental disorder

The Company may, on receipt of such evidence as the Board may reasonably require to show title to that share, give notice to the person entitled to a share in consequence of the death, bankruptcy or mental disorder of a shareholder or otherwise by operation of law, by sending or delivering it in any manner authorised by these Articles for the giving of notice to a shareholder, addressed to that person by name, or by the title of representative of the deceased or trustee of the bankrupt or representative by operation of law or by any like description at the address (if any) within the British Isles supplied for the purpose by the person claiming to be so entitled. Until such an address has been so supplied a notice may be given in any manner in which it might have been given if the death, bankruptcy, operation of law or other event had not occurred. Such service of notice shall for all purposes be deemed a sufficient service of such notice on all persons interested in the share.

127.         Evidence of service

127.1Present at meeting

Any shareholder present in person or by proxy or (being a corporation) by a duly authorised representative at any meeting of the Company or of the holders of any class of shares of the Company shall be deemed to have received due notice of such meeting and, where requisite, of the purposes for which such meeting was called.

127.2Deemed service

Any notice, certificate or other document, addressed to a shareholder at his registered address or address for service in the British Isles shall, if sent by post, be deemed to have been given at the expiration of twenty-four hours after the envelope was posted and, if sent by Electronic Communication, be deemed to have been given at the expiration of twenty-four hours after the Electronic Communication was sent. In proving such service or delivery it shall be sufficient to prove that the envelope containing the notice or document was properly addressed and put into the post as a prepaid letter or, in the case of a notice sent by Electronic Communication, to prove that it was sent in accordance with guidance issued by the Institute of Chartered Secretaries or Administrators. Any notice, certificate or other document not sent by post but delivered or left at a registered address or address for service in the British Isles shall be deemed to have been served or delivered on the day on which it was so delivered or left.

128.Notice binding on transferees

Every person who, by operation of law, transfers or by any other means becomes entitled to a share shall be bound by any notice in respect of that share which, before his name is entered in the Register, has been duly given to a person from whom he derives his title.

60 

 
129.Notice by advertisement

Any notice to be given by the Company to the shareholders or any of them and not otherwise provided for by these Articles shall be sufficiently given if given by advertisement in at least one daily national newspaper published in the United Kingdom and at least one daily national newspaper published in the US and, where the Company keeps an overseas branch register, in at least one leading daily newspaper published in the territory in which such register is maintained. Any notice given by advertisement shall be deemed to have been served at noon on the day on which the advertisement first appears.

130.Suspension of postal services

If at any time by reason of the threat of or of the suspension, interruption or curtailment of postal services within the British Isles, the Company is or would be unable effectively to convene a general meeting by notices sent through the post, a general meeting may be convened by a notice advertised in at least two leading daily national newspapers (at least one of which shall be published in London) and, where the Company keeps an overseas branch register, in at least one leading daily newspaper published in the territory in which such register is maintained. Such notice shall be deemed to have been duly served on all shareholders entitled thereto at noon on the day on which the first of such advertisements appears. In any such case the Company shall send confirmatory copies of the notice by post if at least seven days prior to the meeting the posting of notices to addresses throughout the British Isles again becomes practicable.

V.Winding up
131.Division of assets
131.1Power to present a petition

The Board shall have power in the name and on behalf of the Company to present a petition to the court for the Company to be wound up.

131.2Distribution of assets

If the Company is wound up, the surplus assets remaining after payment of all creditors are to be divided among the shareholders in proportion to their economic ownership of the Company. This Article 131.2 is subject to the rights attached to any shares which may be issued on special terms or conditions.

61 

 
131.3Distribution in specie

If the Company is wound up the liquidator may, with the sanction of a resolution of the Company and any other sanction required by law, divide among the shareholders in specie the whole or any part of the assets of the Company and may for that purpose value any assets and determine how the division shall be carried out as between the shareholders or different classes of shareholders; provided that the A Ordinary Shares and the B Ordinary Shares shall be pari passu with respect to any such division. Any such division may be otherwise than in accordance with the existing rights of the shareholders but if any division is resolved otherwise than in accordance with such rights the shareholders shall have the same right of dissent and consequential rights as if such resolution were a special resolution passed pursuant to section 222 of the Companies Act 1931 (which provision applies to the Company (with statutory modification) pursuant to the Act). The liquidator may with the like sanction vest the whole or any part of the whole of the assets in trustees on such trusts for the benefit of the shareholders as he with the like sanction shall determine but no shareholder shall be compelled to accept any assets on which there is a liability.

132.Transfer or sale under section 222 of the Companies Act 1931

A special resolution sanctioning a transfer or sale to another company duly passed pursuant to section 222 of the Companies Act 1931 (which provision applies to the Company (with statutory modification) pursuant to the Act) may in the like manner authorise the distribution of any shares or other consideration receivable by the liquidator among the shareholders otherwise than in accordance with their existing rights and any such determination shall be binding on all the shareholders, subject to the right of dissent and consequential rights conferred by the said section; provided that the A Ordinary Shares and the B Ordinary Shares shall be pari passu with respect to any such distribution.

W.Indemnity
133.Right to indemnity

Subject to the provisions of the Act and the Investors’ Rights Agreement, the Company may indemnify every Director or other officer of the Company (other than an Auditor) to the fullest extent permitted by law.

134.Power to insure

Subject to the provisions of the Act, the Board may purchase and maintain insurance at the expense of the Company for the benefit of any person who is or was at any time a Director or other officer or employee of the Company or of any other company which is a subsidiary, subsidiary undertaking or holding company of the Company or in which the Company has an interest whether direct or indirect or which otherwise is in any way allied to or associated with the Company or of any subsidiary undertaking or holding company of the Company or of any such company or who is or was at any time a trustee of any pension fund or employee benefits trust in which any employee of the Company or of any such other company or subsidiary undertaking is or has been interested indemnifying such person against any liability which may attach to him or loss or expenditure which he may incur in relation to anything done or alleged to have been done or omitted to be done as a Director, officer, employee or trustee.

62 

 

Exhibit 4.30

 

 

AGREEMENT AND PLAN OF MERGER

by and among

EROS INTERNATIONAL PLC,

ENGLAND HOLDINGS 2, INC.,

ENGLAND MERGER CORP.

and

STX FILMWORKS, INC.

Dated as of April 17, 2020

 

 

 

 

 

 

 

TABLE OF CONTENTS

Page

Article I THE MERGER 4
Section 1.1.   The Merger 4
Section 1.2.   Closing 4
Section 1.3.   Effective Time 4
Section 1.4.   Effects of the Merger 4
Section 1.5.   Articles of Association of Eros 4
Section 1.6.   Board of Directors and Officers of Eros 5
Section 1.7.   Certificate of Incorporation and Bylaws of Surviving Corporation 6
Section 1.8.   Board of Directors and Officers of Surviving Corporation 6
Section 1.9.   Withholding 6
Article II EFFECT OF THE MERGER ON THE CAPITAL STOCK AND EQUITY AWARDS OF SCOTLAND; EXCHANGE OF CERTIFICATES 7
Section 2.1.   Effect on Capital Stock 7
Section 2.2.   Exchange of Capital Stock 10
Section 2.3.   Certain Adjustments 12
Section 2.4.   Further Assurances 12
Article III REPRESENTATIONS AND WARRANTIES OF STX 13
Section 3.1.   Organization, Standing and Corporate Power 13
Section 3.2.   Authority 13
Section 3.3.   No Conflict; Required Filings and Consents 14
Section 3.4.   Capital Structure 15
Section 3.5.   Subsidiaries 16
Section 3.6.   Financial Statements; Undisclosed Liabilities 16
Section 3.7.   Absence of Certain Changes or Events 17
Section 3.8.   Compliance with Applicable Laws and Permits; Orders 18
Section 3.9.   Anti-Corruption Laws 18
Section 3.10.   International Trade Laws 18
Section 3.11.   Litigation 19
Section 3.12.   Benefit Plans 19
Section 3.13.   Labor and Employment Matters 21
Section 3.14.   Taxes 22
Section 3.15.   Intellectual Property 23
Section 3.16.   Information Technology; Data Protection 25
Section 3.17.   Material Contracts 26
Section 3.18.   Environmental Protection 27
Section 3.19.   Real Property 28
Section 3.20.   Insurance 28
Section 3.21.   Affiliate Transactions 28
Section 3.22.   Brokers 28
Section 3.23.   Sufficiency 28

ii 

 
Section 3.24.   No Other Representations 28
Article IV REPRESENTATIONS AND WARRANTIES OF EROS, ENGLAND HOLDINGS 2 AND MERGER SUB 29
Section 4.1.   Organization, Standing and Corporate Power 30
Section 4.2.   Authority 30
Section 4.3.   No Conflict; Required Filings and Consents 31
Section 4.4.   Capital Structure 32
Section 4.5.   Subsidiaries 33
Section 4.6.   SEC Documents; Financial Statements; Undisclosed Liabilities 34
Section 4.7.   Absence of Certain Changes or Events 35
Section 4.8.   Compliance with Applicable Laws and Permits; Orders 36
Section 4.9.   Anti-Corruption Laws 36
Section 4.10.   International Trade Laws 36
Section 4.11.   Litigation 37
Section 4.12.   Benefit Plans 37
Section 4.13.   Labor and Employment Matters 38
Section 4.14.   Taxes 39
Section 4.15.   Intellectual Property 41
Section 4.16.   Information Technology; Data Protection 42
Section 4.17.   Material Contracts 43
Section 4.18.   Environmental Protection 44
Section 4.19.   Real Property 45
Section 4.20.   Insurance 45
Section 4.21.   Affiliate Transactions 45
Section 4.22.   Issued Shares 45
Section 4.23.   Merger Sub 46
Section 4.24.   Brokers 46
Section 4.25.   No Other Representations 46
Article V COVENANTS AND AGREEMENTS 47
Section 5.1.   Conduct of Business by STX 47
Section 5.2.   Conduct of Business by Eros 50
Section 5.3.   No Right to Control or Direct Operations 53
Section 5.4.   No Solicitation 53
Section 5.5.   STX Requisite Stockholder Approval; STX Stockholder Notice 54
Section 5.6.   Eros Requisite Shareholder Approval and England Holdings 2 Requisite Shareholder Approval 54
Section 5.7.   [RESERVED] 54
Section 5.8.   Termination of Certain Agreements 54
Section 5.9.   Access to Information; Confidentiality 55
Section 5.10.   Reasonable Best Efforts 56
Section 5.11.   Indemnification, Exculpation and Insurance 58
Section 5.12.   Fees and Expenses 59
Section 5.13.   Public Announcements 59
Section 5.14.   NYSE Listing 60
Section 5.15.   Takeover Statutes 60

iii 

 
Section 5.16.   Conveyance Taxes 60
Section 5.17.   Employee Matters 60
Section 5.18.   Section 280G Matters 62
Section 5.19.   Certain Litigation 62
Section 5.20.   Merger Sub Actions 63
Section 5.21.   Spreadsheet 63
Section 5.22.   Management Equity Compensation Plan 63
Section 5.23.   CVR Agreements; Nonregistrable CVRs 63
Section 5.24.   Pre-Closing Class E Subscription 64
Section 5.25.   Eros Convertible Notes Amendment 64
Section 5.26.   Eros Pre-Closing Equity Financing 64
Section 5.27.   Provision Respecting Representation of STX 64
Article VI CONDITIONS PRECEDENT 65
Section 6.1.   Conditions to Each Party’s Obligation to Effect the Merger 65
Section 6.2.   Conditions to Obligations of the Eros Parties 66
Section 6.3.   Conditions to Obligations of STX 67
Article VII TERMINATION, AMENDMENT AND WAIVER 68
Section 7.1.   Termination 68
Section 7.2.   Effect of Termination 70
Section 7.3.   Amendment 70
Section 7.4.   Extension; Waiver 70
Article VIII GENERAL PROVISIONS 71
Section 8.1.   Non-survival of Representations and Warranties 71
Section 8.2.   Notices 71
Section 8.3.   Definitions 72
Section 8.4.   Interpretation 82
Section 8.5.   Counterparts; Electronic Signature 83
Section 8.6.   Entire Agreement; No Third-Party Beneficiaries 83
Section 8.7.   Assignment 83
Section 8.8.   Governing Law 84
Section 8.9.   Waiver of Jury Trial 84
Section 8.10.   Specific Enforcement 84
Section 8.11.   Jurisdiction 84
Section 8.12.   Headings, etc 85
Section 8.13.   Severability 85
Section 8.14.   No Presumption Against Drafting Party 85

Exhibit A Eros Shareholders Consent
Exhibit B STX Stockholders Consent
Exhibit C PIPE Subscription Agreement
Exhibit D Class E CVR Agreement
Exhibit E Class D CVR Agreement

iv 

 

Exhibit F Class C CVR Agreement
Exhibit G Class B CVR Agreement
Exhibit H Class A CVR Agreement
Exhibit I Eros Investors’ Rights Agreement
Exhibit J Amended Eros Articles of Association
Exhibit K Pre-Closing Class E Subscription Agreement
Exhibit L FIRPTA Certificate
Exhibit M Registration Rights Agreement
Exhibit N-1 STX Lender Consent
Exhibit N-2 STX Lender Consent

 

v 

 

 

INDEX OF DEFINED TERMS

Defined Term Location
Accredited Investor Section 8.3(a)
Acquisition Proposal Section 5.4
Action Section 3.11
Affiliate Section 8.3(b)
Agreement Preamble
Amended Eros Articles of Association Section 1.5
Anti-Corruption Laws Section 8.3(c)
Antitrust Laws Section 3.3(b)
Applicable Laws Section 3.8
Business Day Section 8.3(d)
Bylaws of England Holdings 2 Section 8.3(e)
Bylaws of STX Section 8.3(f)
Cancelled Shares Section 2.1(a)(vii)
Certificate Section 2.2(b)
Certificate of Merger Section 1.3
Change Section 8.3(jj)
Class A CVR Section 2.1(a)(v)
Class A CVR Agreement Recitals
Class B CVR Section 2.1(a)(iv)
Class B CVR Agreement Recitals
Class C CVR Section 2.1(a)(iii)
Class C CVR Agreement Recitals
Class D CVR Section 2.1(a)(ii)
Class D CVR Agreement Recitals
Class E CVR Section 2.1(a)(i)
Class E CVR Agreement Recitals
Closing Section 1.2
Closing Date Section 1.2
COBRA Section 3.12(b)
Code Section 8.3(g)
Companies Act Section 8.3(h)
Confidentiality Agreement Section 5.9
Contract Section 8.3(i)
control Section 8.3(b)
Copyrights Section 8.3(dd)
CVR Agreements Recitals
CVRs Section 2.1(a)(v)
D&O Indemnified Parties Section 5.11(a)
Data Security Requirements Section 3.16(b)
DGCL Recitals
Dissenting Shares Section 2.1(e)
Effective Time Section 1.3
EIML Debt Section 8.3(j)
Enforceability Exceptions Section 3.2

vi 

 
England Holdings Recitals
England Holdings 2 Preamble
England Holdings 2 Certificate of Incorporation Section 8.3(k)
England Holdings 2 Requisite Shareholder Approval Section 4.2
Environmental Laws Section 8.3(l)
Environmental Permits Section 3.18
ERISA Section 8.3(m)
ERISA Affiliate Section 8.3(n)
Eros Preamble
Eros A Ordinary Shares Section 4.4(a)
Eros Articles of Association Section 8.3(o)
Eros Articles Shareholder Approval Section 4.2
Eros B Ordinary Shares Section 4.4(a)
Eros Benefit Plan Section 8.3(p)
Eros Board Recitals
Eros Convertible Notes Section 8.3(q)
Eros Designated Directors ‎Section 1.6(a)
Eros Disclosure Letter Article IV
Eros Equity Awards Section 8.3(r)
Eros Equity Facility Section 8.3(s)
Eros Filed SEC Documents Article IV
Eros Financial Statements Section 4.6(b)
Eros Founder Group Section 8.3(t)
Eros Investors’ Rights Agreement Recitals
Eros Leased Real Property Section 8.3(u)
Eros Material Contracts Section 4.17(a)
Eros Measurement Date Section 4.4(a)
Eros Option Section 8.3(v)
Eros Ordinary Shares Section 4.4(a)
Eros Owned Real Property Section 8.3(w)
Eros Parties Section 8.3(x)
Eros Permits Section 4.8
Eros PIPE Financing Recitals
Eros Pre-Closing Equity Financing Recitals
Eros Requisite Shareholder Approval Section 4.2
Eros RSU Award Section 8.3(y)
Eros SEC Documents Section 4.6(a)
Eros Share Issuance Section 4.2
Eros Shareholders Consent Recitals
Eros Support Agreement Recitals
Eros Transaction Shareholder Approval Section 4.2
Exchange Agent Section 2.2(a)
Exit Payment Section 8.3(z)
GAAP Section 3.6(a)
Governmental Authority Section 8.3(aa)
Hazardous Materials Section 8.3(bb)

vii 

 
HSR Act Section 3.3(b)
IFRS Section 4.6(b)
Immediate Family Section 8.3(cc)
Independent Director ‎Section 1.6(a)
Intellectual Property Section 8.3(dd)
Interim Period Section 5.1
International Trade Laws Section 8.3(ee)
IRS Section 3.12(a)
IT Assets Section 8.3(ff)
Jointly Designated Director ‎Section 1.6(a)
Knowledge Section 8.3(gg)
Leases Section 8.3(hh)
Letter of Transmittal Section 2.2(b)
Liens Section 3.3(a)
Liquidation Value Section 8.3(ii)
Marks Section 8.3(dd)
Material Adverse Effect Section 8.3(jj)
Merger Section 1.1
Merger Consideration Section 2.1(a)(v)
Merger Sub Preamble
Multiemployer Plan Section 8.3(kk)
Multiple Employer Plan Section 8.3(ll)
New Benefit Plans Section 5.17(a)
New Investors Recitals
NYSE ‎Section 1.6(a)
OFAC Section 8.3(ee)
Order Section 8.3(mm)
Outside Counsel Only Material Section 5.10(b)
Outside Date Section 7.1(b)(i)
Patents Section 8.3(dd)
Permit Section 8.3(nn)
Permitted Liens Section 8.3(oo)
Person Section 8.3(pp)
Personal Data Section 8.3(qq)
PIPE Subscription Agreement Recitals
Plan Termination Date Section 5.17(c)
Pre-Closing Class E Subscription Section 5.24
Privileged Communications Section 5.27
Process Section 8.3(rr)
Processing Section 8.3(rr)
Registration Rights Agreement Section 8.3(ss)
Related Document Section 8.3(tt)
Related Party Section 8.3(uu)
Release Section 8.3(vv)
Representatives Section 8.3(ww)
Rights Agent Recitals

viii 

 
Sanctioned Person Section 8.3(xx)
Sanctions Section 8.3(yy)
SEC Section 8.3(zz)
Spreadsheet Section 5.21
STX Preamble
STX Benefit Plan Section 8.3(aaa)
STX Board Recitals
STX Capital Stock Section 8.3(bbb)
STX Certificate of Incorporation Section 8.3(ccc)
STX Class A Preferred Stock Section 8.3(ddd)
STX Class B Preferred Stock Section 8.3(eee)
STX Class C Preferred Stock Section 8.3(fff)
STX Class D Preferred Stock Section 8.3(ggg)
STX Class E Preferred Stock Section 8.3(hhh)
STX Common Stock Section 8.3(iii)
STX Credit Facilities Section 8.3(jjj)
STX Designated Directors ‎‎Section 1.6(a)
STX Disclosure Letter Article III
STX Equity Awards Section 2.1(b)(v)
STX Equity Plan Section 8.3(kkk)
STX Exhibitor Warrants Section 8.3(lll)
STX Financial Statements Section 3.6(a)
STX Group Section 5.27
STX Interim Financial Statements Section 3.6(a)
STX JPM Credit Facility Section 8.3(mmm)
STX Leased Real Property Section 8.3(nnn)
STX Lender Consents Section 8.3(ooo)
STX Material Contracts Section 3.17(a)
STX Measurement Date Section 3.4(a)
STX Mezzanine Credit Facility Section 8.3(ppp)
STX Option Section 8.3(qqq)
STX Permits Section 3.8
STX Preferred Stock Section 8.3(rrr)
STX Requisite Stockholder Approval Recitals
STX RSU Award Section 8.3(sss)
STX Stockholders Agreement Section 8.3(ttt)
STX Stockholders Consent Recitals
Subsidiary Section 8.3(uuu)
Surviving Corporation Section 1.1
Tax Return Section 8.3(vvv)
Taxes Section 8.3(www)
Taxing Authority Section 8.3(xxx)
Terminating 401(k) Plan Section 5.17(c)
Trade Secrets Section 8.3(dd)
WARN Act Section 3.13(c)
Willful Breach Section 8.3(yyy)

ix 

 

AGREEMENT AND PLAN OF MERGER

AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of April 17, 2020, by and among Eros International Plc, an Isle of Man company limited by shares (“Eros”), England Holdings 2, Inc., a Delaware corporation (“England Holdings 2”), England Merger Corp., a Delaware corporation (“Merger Sub”), and STX Filmworks, Inc., a Delaware corporation (“STX”).

RECITALS

WHEREAS, the parties intend that, on the terms and subject to the conditions set forth in this Agreement, Merger Sub will merge with and into STX, with STX continuing as the surviving corporation pursuant to and in accordance with the DGCL;

WHEREAS, Merger Sub is an indirect, wholly owned Subsidiary of Eros and direct, wholly owned subsidiary of England Holdings 2; and England Holdings 2 is an indirect, wholly owned Subsidiary of Eros and direct, wholly owned subsidiary of England Holdings 1, Inc., a Delaware corporation (“England Holdings”); and England Holdings is a direct, wholly owned subsidiary of Eros;

WHEREAS, the Board of Directors of Eros (the “Eros Board”) has unanimously (a) determined that this Agreement and the transactions contemplated by this Agreement, including the Merger and the Eros Share Issuance on the terms and subject to the conditions set forth in this Agreement, are advisable and in the best interests of Eros and the shareholders of Eros, (b) approved and declared advisable this Agreement and the transactions contemplated by this Agreement, including the Merger and the Eros Share Issuance, on the terms and subject to the conditions set forth in this Agreement, and (c) submitted the Eros Share Issuance, on the terms and subject to the conditions set forth in this Agreement, to the shareholders of Eros for approval;

WHEREAS, shareholders of Eros holding the requisite majority of the rights to vote on such resolution described in the foregoing Recital pursuant to the Eros Articles of Association have approved the Eros Share Issuance by resolution consented to in writing in the form attached as Exhibit A hereto in accordance with Article 58 of the Eros Articles of Association and the Companies Act (the “Eros Shareholders Consent”);

WHEREAS, the Board of Directors of Merger Sub and England Holdings 2, as the sole stockholder of Merger Sub, have approved this Agreement and the Merger;

WHEREAS, the Board of Directors of STX (the “STX Board”) has (a) determined that this Agreement and the transactions contemplated by this Agreement, including the Merger, are fair to, and in the best interests of, STX and the stockholders of STX, (b) approved and declared advisable this Agreement and the transactions contemplated by this Agreement, including the Merger, on the terms and subject to the conditions set forth in this Agreement, (c) directed that this Agreement be submitted to the stockholders of STX for adoption, (d) approved the proposed Pre-Closing Class E Subscription

1 

 

and (e) recommended the adoption of this Agreement and the Pre-Closing Class E Subscription to the stockholders of STX, on the terms and subject to the conditions set forth in this Agreement;

WHEREAS, based on the recommendation of the STX Board that the Merger would be advisable and fair to, and in the best interests of, the stockholders of STX, as promptly as practicable following the execution and delivery of this Agreement, it is expected that the holders of (i) at least a majority of the issued and outstanding shares of STX Preferred Stock and STX Common Stock, voting together as a single class on an as-converted basis, (ii) at least two-thirds (2/3) of the issued and outstanding shares of STX Class D Preferred Stock, voting as a separate class, (iii) at least two-thirds (2/3) of the issued and outstanding shares of STX Class C Preferred Stock, voting as a separate class, (iv) at least two-thirds (2/3) of the issued and outstanding shares of STX Class B Preferred Stock, voting as a separate class, and (v) at least two-thirds (2/3) of the issued and outstanding shares of STX Class A Preferred Stock, voting as a separate class, and (vi) each of the stockholders of STX specified in clause (v) of Section 9.1 of the STX Stockholders Agreement (clauses (i) through (vi), collectively, the “STX Requisite Stockholder Approval,”) will deliver a written consent and agreement of stockholders in the form attached as Exhibit B hereto pursuant to Section 228 of the Delaware General Corporation Law (the “DGCL”), (a) adopting this Agreement and approving the transactions contemplated by this Agreement, including the Merger, and (b) approving the Pre-Closing Class E Subscription, in each case in accordance with Sections V.E of the STX Certificate of Incorporation and Sections 9.1 of the STX Stockholders Agreement (the “STX Stockholders Consent”);

WHEREAS, concurrently with the execution and delivery of this Agreement, and as a condition and inducement to STX’s willingness to enter into this Agreement, certain shareholders of Eros are entering into an agreement (the “Eros Support Agreement”) pursuant to which such shareholders have agreed, among other things, to vote to approve the Amended Eros Articles of Association upon the terms and subject to the conditions set forth herein;

WHEREAS, concurrently with the execution and delivery of this Agreement, and as a condition to each of Eros’s and STX’s willingness to enter into this Agreement, certain investors (such investors and any additional purchasers who enter into the PIPE Subscription Agreement after the date hereof pursuant to a joinder thereto, the “New Investors”) and Eros are entering into a subscription agreement in substantially the form attached hereto as Exhibit C (the “PIPE Subscription Agreement”), pursuant to which such New Investors will, substantially concurrently with the Closing, purchase and subscribe for an aggregate of $75,000,000 of Eros A Ordinary Shares (the “Eros PIPE Financing”);

WHEREAS, at or prior to the Closing, (i) Eros, the stockholders’ representative thereunder, and a rights agent and registrar selected by Eros and reasonably acceptable to STX (the “Rights Agent”) will enter into a Class E Contingent Value Rights Agreement in substantially the form attached hereto as Exhibit D (subject to changes permitted by Section 5.23) (the “Class E CVR Agreement”);

2 

 

(ii) Eros, the stockholders’ representative thereunder, and the Rights Agent will enter into a Class D Contingent Value Rights Agreement in substantially the form attached hereto as Exhibit E (subject to changes permitted by Section 5.23) (the “Class D CVR Agreement”); (iii) Eros, the stockholders’ representative thereunder, and the Rights Agent will enter into a Class C Contingent Value Rights Agreement in substantially the form attached hereto as Exhibit F (subject to changes permitted by Section 5.23) (the “Class C CVR Agreement”); (iv) Eros, the stockholders’ representative thereunder, and the Rights Agent will enter into a Class B Contingent Value Rights Agreement in substantially the form attached hereto as Exhibit G (subject to changes permitted by Section 5.23) (the “Class B CVR Agreement”); and (v) Eros, the stockholders’ representative thereunder, and the Rights Agent will enter into a Class A Contingent Value Rights Agreement in substantially the form attached hereto as Exhibit H (subject to changes permitted by Section 5.23) (the “Class A CVR Agreement” and, together with the Class E CVR Agreement, the Class D CVR Agreement, the Class C CVR Agreement and Class B CVR Agreement, collectively, the “CVR Agreements”);

WHEREAS, as a condition to STX’s willingness to enter into this Agreement, Eros will obtain commitments from one or more purchasers (other than the New Investors or any other stockholder of STX) to purchase a number of Eros A Ordinary Shares corresponding to the aggregate purchase price of at least $50,000,000, of which at least $35,000,000 shall be consummated at or prior to the Closing (the “Eros Pre-Closing Equity Financing”) and the balance of which shall be consummated within ninety (90) days of the Effective Time, in each case in accordance with Section 5.26 hereof;

WHEREAS, at the Closing, and as a condition to each of Eros’s and STX’s willingness to enter into this Agreement, Eros, certain shareholders of Eros, and the New Investors will enter into an investors’ rights agreement in substantially the form attached hereto as Exhibit I (the “Eros Investors’ Rights Agreement”), which Eros Investors’ Rights Agreement shall become effective as of the Closing; and

WHEREAS, Eros, England Holdings 2, Merger Sub and STX desire to make certain representations, warranties, covenants and agreements in connection with the Merger and transactions contemplated herein and also to prescribe certain conditions to the Merger and the transactions contemplated herein as specified herein.

AGREEMENT

NOW, THEREFORE, in consideration of the foregoing premises, and of the representations, warranties, covenants and agreements set forth herein, and intending to be legally bound hereby, the parties agree as follows:

3 

 

ARTICLE I
THE MERGER

Section 1.1.        The Merger. Upon the terms and subject to the conditions set forth in this Agreement and in accordance with the DGCL, at the Effective Time, Merger Sub shall be merged with and into STX (the “Merger”). Following the Effective Time, the separate existence of Merger Sub shall cease, and STX shall continue as the surviving corporation in the Merger and an indirect wholly owned Subsidiary of Eros and direct wholly owned Subsidiary of England Holdings 2, and shall succeed to and assume all the rights, privileges, immunities, properties, powers and franchises of Merger Sub in accordance with the DGCL, and all of the debts, liabilities, obligations and duties of STX shall become the debts, liabilities, obligations and duties of the Surviving Corporation. STX, as the surviving corporation after the Merger, is referred to as the “Surviving Corporation.”

Section 1.2.        Closing. The closing of the Merger (the “Closing”) shall take place at 7:00 a.m., Los Angeles time, at the offices of Gibson, Dunn and Crutcher LLP, 333 South Grand Avenue, Los Angeles, California 90071, on a date to be specified by Eros and STX, which shall be no later than the second Business Day following satisfaction or (to the extent permitted by Applicable Law) waiver of all of the conditions set forth in Article VI (other than those conditions that by their terms are to be satisfied at the Closing, but subject to the satisfaction or (to the extent permitted by Applicable Law) waiver of such conditions at the Closing), unless another date, time or place is agreed to in writing by Eros and STX (the date of the Closing, the “Closing Date”).

Section 1.3.        Effective Time. Subject to the provisions of this Agreement, as soon as practicable on the Closing Date, the parties shall cause the Merger to be consummated by filing with the Secretary of State of the State of Delaware a Certificate of Merger reasonably satisfactory to Eros and STX (the “Certificate of Merger”) with respect to the Merger, duly executed and completed in accordance with the relevant provisions of the DGCL, and shall make all other filings or recordings required under the DGCL with respect to the Merger. The Merger shall become effective at the time when the Certificate of Merger has been duly filed with the Secretary of State of the State of Delaware or, to the extent permitted by Applicable Law, such later time as may be mutually agreed by Eros and STX in writing and specified in the Certificate of Merger (the “Effective Time”).

Section 1.4.        Effects of the Merger. The Merger shall have the effects provided in this Agreement and as set forth in the applicable provisions of the DGCL.

Section 1.5.        Articles of Association of Eros. Eros shall use its reasonable best efforts to cause the Eros Articles of Association in effect immediately prior to the Effective Time to be amended to read in their entirety as set forth on Exhibit J hereto (the “Amended Eros Articles of Association”) and, as so amended, the Amended Eros Articles of Association shall be the articles of association of Eros effective as of the Effective Time or as promptly thereafter as is practicable until thereafter amended in accordance with the terms thereof and Applicable Law. In connection therewith, as

4 

 

soon as practicable under Applicable Law following the date hereof, Eros shall call and give notice to its shareholders of a shareholders’ meeting to be held on the earliest practicable date following such notice, in order to vote upon the Amended Eros Articles of Association. Eros shall use reasonable best efforts to obtain the Eros Articles Shareholder Approval prior to the Closing and in the event the Eros Articles Shareholder Approval is not obtained prior to the Closing, Eros shall use reasonable best efforts to obtain the Eros Articles Shareholder Approval as soon as reasonably practicable.

Section 1.6.        Board of Directors and Officers of Eros.

(a)             Eros Board Composition. Eros shall take all action necessary (including, to the extent necessary, procuring the resignation or removal of any directors on the Eros Board immediately prior to the Effective Time) so that, as of the Effective Time, the Eros Board shall consist of a total of nine (9) directors, of whom (A) four (4) directors shall be individuals selected by the Eros Founder Group and reasonably satisfactory to the Nomination Committee of the Eros Board (the “Eros Designated Directors”); (B) four (4) directors shall be individuals selected by STX and reasonably satisfactory to the Nomination Committee of the Eros Board (the “STX Designated Directors”); and (C) the remaining one (1) director shall be an individual jointly selected by the Eros Founder Group and STX and reasonably satisfactory to the Nomination Committee of the Eros Board (the “Jointly Designated Director”). As of the Effective Time, the Jointly Designated Director, at least one (1) of the Eros Designated Directors and at least one (1) of the STX Designated Directors shall each satisfy all independence requirements under the listing standards of the New York Stock Exchange (the “NYSE”) applicable to members of the audit committee of the Eros Board (an “Independent Director”). The foregoing directors shall be divided into three classes of directors, each of whom shall serve for staggered three (3)-year terms and who shall initially be allocated by mutual agreement of the Eros Founder Group and STX prior to the Closing; provided that (x) one (1) Eros Designated Director, one (1) STX Designated Director and the Jointly Designated Director shall be allocated to the class of directors who shall initially hold office until Eros’s 2021 annual general meeting; (y) one (1) Eros Designated Director and two (2) STX Designated Directors shall be allocated to the class of directors who shall initially hold office until Eros’s 2022 annual general meeting; and (z) two (2) Eros Designated Directors and one (1) STX Designated Director shall be allocated to the class of directors who shall initially hold office until Eros’s 2023 annual general meeting.

(b)            Committees of the Eros Board. Eros shall take all action necessary (including, to the extent necessary, procuring the resignation or removal of any members of the applicable committees of the Eros Board immediately prior to the Effective Time) so that, as of the Effective Time, the initial composition of the Nominating Committee, Audit Committee and Remuneration Committee shall be as set forth in the following clauses (i)-(iii) until thereafter modified by action of the Eros Board (upon the recommendation of the Nominating Committee):

(i)              the Nomination Committee of the Eros Board shall be comprised of four (4) members, two (2) of which shall be Eros Designated Directors and two (2) of which shall be STX Designated Directors;

5 

 

(ii)            the Audit Committee of the Eros Board shall be comprised of four (4) members, two (2) of which shall be Eros Designated Directors and two (2) of which shall be STX Designated Directors; and

(iii)          the Remuneration Committee of the Eros Board shall be comprised of three (3) members, one (1) of which shall be an Eros Designated Director, one (1) of which shall be a STX Designated Director, and one (1) of which shall be the Jointly Designated Director.

(c)             Co-Chairmen and Certain Executive Officers of Eros. Eros shall take all action necessary so that, as of the Effective Time, (i) Kishore Lulla shall be appointed as Executive Co-Chairman of Eros and (ii) Robert B. Simonds, Jr. shall be appointed as the Co-Chairman and Chief Executive Officer of Eros.

Section 1.7.        Certificate of Incorporation and Bylaws of Surviving Corporation. At the Effective Time, the Certificate of Incorporation of STX and the Bylaws of STX in effect immediately prior to the Effective Time shall be amended and restated in their entirety to be in the form of the Certificate of Incorporation of Merger Sub and the Bylaws of Merger Sub, respectively, as in effect immediately prior to the Effective Time (except that references to the name of Merger Sub shall be replaced by references to the name of the Surviving Corporation), in each case until thereafter amended in accordance with its terms and with Applicable Law.

Section 1.8.        Board of Directors and Officers of Surviving Corporation.

(a)             From and after the Effective Time, the initial directors of the Surviving Corporation shall be such Persons serving as the directors of Merger Sub immediately prior to the Effective Time, in each case, until such director’s successor is elected or appointed and qualified or until such director’s earlier death, resignation or removal, in each case, in accordance with the Certificate of Incorporation and Bylaws of the Surviving Corporation.

(b)            From and after the Effective Time, the initial officers of the Surviving Corporation shall be such Persons as are mutually agreed in writing by Eros and STX prior to the Effective Time, in each case, until such officer’s successor is elected or appointed and qualified or until such officer’s earlier death, resignation or removal, in each case, in accordance with the Certificate of Incorporation and Bylaws of the Surviving Corporation.

Section 1.9.        Withholding. Notwithstanding anything to the contrary in this Agreement, Eros and its agents shall be entitled to deduct and withhold from any amounts otherwise payable to any Person pursuant to this Agreement such amounts as it is required to deduct and withhold with respect to the making of such payment under the Code or any provision of applicable Tax law; provided, however, that other than in respect of compensatory withholding or backup withholding, or withholding as a result of the failure to provide the certificate set forth in Section 6.2(g), the payor shall use commercially reasonable efforts to provide written notice to the payee no later than two (2) Business Days prior to any such withholding or deduction and to allow the payee the opportunity to provide any Tax forms, reports or certificates as may be permitted by Applicable Laws to reduce or eliminate such withholding or deduction from any payments of Merger Consideration made to holders of securities of STX pursuant to Section 2.1. Any

6 

 

amounts so withheld and properly remitted to the applicable Governmental Authority shall be treated for all purposes of this Agreement as having been paid to the Person in respect of which such deduction and withholding was made. In the case of any withholding from Merger Consideration, Eros shall withhold or shall cause to be withheld an amount of Merger Consideration having a fair market value equal to the withholding obligation to be satisfied with such Merger Consideration at the time such Merger Consideration is withheld (provided that if any cash is otherwise payable to the relevant payee, such withholding shall be made first from such cash), and shall be treated as having paid such amount to the Person in respect of which such withholding was made.

Article II
EFFECT OF THE MERGER ON THE CAPITAL STOCK AND EQUITY AWARDS OF SCOTLAND; EXCHANGE OF CERTIFICATES

Section 2.1.        Effect on Capital Stock.

(a)             Conversion of STX Capital Stock and Merger Sub Common Stock and Treatment of Eros Ordinary Shares. As of the Effective Time, by virtue of the Merger and without any action on the part of STX, Eros, England Holdings 2, Merger Sub or the holders of any securities of STX, Eros, England Holdings 2 or Merger Sub:

(i)              Each issued and outstanding share of STX Class E Preferred Stock as of immediately prior to the Effective Time (other than any Cancelled Shares and Dissenting Shares) and all rights in respect thereof shall be converted into a number of contractual contingent value rights (each, a “Class E CVR”), issued by Eros subject to and in accordance with the Class E CVR Agreement, equal to the quotient of (x) the Liquidation Value (as defined in the STX Certificate of Incorporation) of such share of STX Class E Preferred Stock divided by (y) $1,000. As of the Effective Time, all such shares of STX Class E Preferred Stock shall no longer be outstanding and shall automatically be cancelled and retired and shall cease to exist, and each holder of a Certificate or uncertificated book-entry share as reflected in the books and records of STX representing any shares of STX Class E Preferred Stock shall cease to have any rights with respect thereto, except the right to receive, upon the surrender thereof, Class E CVRs in accordance with Section 2.2.

(ii)            Each issued and outstanding share of STX Class D Preferred Stock as of immediately prior to the Effective Time (other than any Cancelled Shares and Dissenting Shares) and all rights in respect thereof shall be converted into a number of contractual contingent value rights (each, a “Class D CVR”), issued by Eros subject to and in accordance with the Class D CVR Agreement, equal to the quotient of (x) (1) the Liquidation Value of such share of STX Class D Preferred Stock plus the pro rata Exit Payment (as defined in the STX Certificate of Incorporation) divided by (y) $1,000. As of the Effective Time, all such shares of STX Class D Preferred Stock shall no longer be outstanding and shall automatically be cancelled and retired and shall cease to exist, and each holder of a Certificate or uncertificated book-entry share as reflected in the books and records of STX representing any shares of STX Class D Preferred Stock shall cease to have any rights with respect thereto, except the right to receive, upon the surrender thereof, Class D CVRs in accordance with Section 2.2.

7 

 

(iii)          Each issued and outstanding share of STX Class C Preferred Stock as of immediately prior to the Effective Time (other than any Cancelled Shares and Dissenting Shares) and all rights in respect thereof shall be converted into a number of contractual contingent value rights (each, a “Class C CVR”), issued by Eros subject to and in accordance with the Class C CVR Agreement, equal to the quotient of (x) the Liquidation Value of such share of STX Class C Preferred Stock divided by (y) $1,000. As of the Effective Time, all such shares of STX Class C Preferred Stock shall no longer be outstanding and shall automatically be cancelled and retired and shall cease to exist, and each holder of a Certificate or uncertificated book-entry share as reflected in the books and records of STX representing any shares of STX Class C Preferred Stock shall cease to have any rights with respect thereto, except the right to receive, upon the surrender thereof, Class C CVRs in accordance with Section 2.2.

(iv)          Each issued and outstanding share of STX Class B Preferred Stock as of immediately prior to the Effective Time (other than any Cancelled Shares and Dissenting Shares) and all rights in respect thereof shall be converted into a number of contractual contingent value rights (each, a “Class B CVR”), issued by Eros subject to and in accordance with the Class B CVR Agreement, equal to the quotient of (x) the Liquidation Value of such share of STX Class B Preferred Stock divided by (y) $1,000. As of the Effective Time, all such shares of STX Class B Preferred Stock shall no longer be outstanding and shall automatically be cancelled and retired and shall cease to exist, and each holder of a Certificate or uncertificated book-entry share as reflected in the books and records of STX representing any shares of STX Class B Preferred Stock shall cease to have any rights with respect thereto, except the right to receive, upon the surrender thereof, Class B CVRs in accordance with Section 2.2.

(v)            Each issued and outstanding share of STX Class A Preferred Stock as of immediately prior to the Effective Time (other than any Cancelled Shares and Dissenting Shares) and all rights in respect thereof shall be converted into a number of contractual contingent value rights (each, a “Class A CVR” and, together with the Class E CVRs, the Class D CVRs, the Class C CVRs, and Class B CVRs collectively, the “CVRs,”and the consideration contemplated by the foregoing clauses (i) through (v), collectively and as applicable, the “Merger Consideration”), issued by Eros subject to and in accordance with the Class A CVR Agreement, equal to the quotient of (x) the Liquidation Value of such share of STX Class A Preferred Stock divided by (y) $1,000. As of the Effective Time, all such shares of STX Class A Preferred Stock shall no longer be outstanding and shall automatically be cancelled and retired and shall cease to exist, and each holder of a Certificate or uncertificated book-entry share as reflected in the books and records of STX representing any shares of STX Class A Preferred Stock shall cease to have any rights with respect thereto, except the right to receive, upon the surrender thereof, Class A CVRs in accordance with Section 2.2.

(vi)          Each issued and outstanding share of STX Common Stock and all rights in respect thereof shall automatically be cancelled and retired and shall cease to exist, and no consideration shall be delivered or deliverable in exchange therefor.

8 

 

(vii)        Each share of STX Capital Stock held in the treasury of STX or owned, directly or indirectly, by Eros or Merger Sub immediately prior to the Effective Time (collectively, the “Cancelled Shares”), shall automatically be cancelled and retired and shall cease to exist, and no consideration shall be delivered or deliverable in exchange therefor.

(viii)      Each share of common stock of Merger Sub issued and outstanding immediately prior to the Effective Time shall be converted into one fully paid and nonassessable share of the common stock of the Surviving Corporation.

(ix)          Each issued Eros Ordinary Share shall remain an issued Eros Ordinary Share and shall not be converted or cancelled as a result of the Merger. Each certificate or book-entry share representing any Eros Ordinary Shares as of the Effective Time shall continue for all corporate purposes to evidence ownership of such shares.

(b)            Treatment of STX Equity Awards.

(i)              The Merger shall constitute a “Sale of the Company” (for purposes of the STX Filmworks, Inc. 2017 Equity Incentive Plan and the STX Filmworks, Inc. 2014 Equity Incentive Plan) and a “Change in Control” for purposes of the STX Filmworks, LLC Amended and Restated 2012 Equity Incentive Plan, in each case as amended, and all awards granted thereunder.

(ii)            At the Effective Time, each STX Option that is outstanding as of immediately prior to the Effective Time, whether or not vested, shall, automatically and without any action on the part of the holder thereof, be cancelled without consideration and shall be of no further force and effect.

(iii)          At the Effective Time, each STX RSU Award that is outstanding as of immediately prior to the Effective Time, whether or not vested, shall, automatically and without any action on the part of the holder thereof, be cancelled without consideration and shall be of no further force and effect.

(iv)          Each of the STX Equity Plans shall be terminated effective as of the Effective Time, and no STX Options or STX RSU Awards or any other rights with respect to STX Common Stock shall be granted or outstanding thereafter.

(v)            Prior to the Effective Time, the STX Board or the appropriate committee thereof shall take all necessary actions and shall adopt resolutions (which resolutions shall be provided to Eros reasonably in advance for review and comment, and which comments of Eros shall be considered by STX in good faith) providing for the treatment of the STX Options and the STX RSU Awards (collectively, the “STX Equity Awards”) and the termination of the STX Equity Plans as contemplated by this Section 2.1(b) and shall deliver notice (which notices shall have been approved by Eros, which approval shall not be unreasonably withheld) of such treatment to each holder of STX Equity Awards.

9 

 

(c)             Treatment of STX Exhibitor Warrants. At the Effective Time, each STX Exhibitor Warrant, whether or not exercisable, shall, without any further action on the part of any holder thereof, be cancelled and extinguished without consideration and shall be of no further force and effect.

(d)            Fractional CVRs and Shares. Fractional CVRs shall entitle the owner thereof to a proportionate number of Eros A Ordinary Shares upon settlement of such CVR as determined pursuant to the applicable CVR Agreement; provided that no fractional Eros A Ordinary Share (or certificate or scrip representing the same) shall be issued upon the settlement of any CVRs, and such fractional share interests shall not entitle the owner thereof to any Eros A Ordinary Shares or to vote or to any other rights of a holder of Eros A Ordinary Shares. Notwithstanding any other provision of this Agreement, each holder of shares of STX Capital Stock converted pursuant to the Merger who would otherwise have been entitled to receive a fraction of an Eros A Ordinary Share upon settlement of the CVRs issued hereunder in respect of such shares of STX Capital Stock (after aggregating all Certificates (or affidavits of loss in lieu thereof) delivered by or on behalf of such holder) shall receive, in lieu thereof, an amount of cash (rounded to the nearest whole cent), without interest, equal to such fractional amount multiplied by applicable price set forth in the applicable CVR Agreement.

(e)             Dissenting Shares. Notwithstanding any other provision of this Agreement to the contrary, shares of STX Capital Stock (other than Cancelled Shares) that are outstanding immediately prior to the Effective Time and held by a holder who is entitled to demand and has properly demanded appraisal for such shares in accordance with Section 262 of the DGCL if such section provides for appraisal or dissenters’ rights for such shares in the Merger (collectively, the “Dissenting Shares”), shall not be converted into or be exchangeable for the right to receive the Merger Consideration unless and until such holder fails to perfect or withdraws or otherwise loses his right to appraisal and payment under the DGCL, as applicable. If, after the Effective time, any such holder fails to perfect or withdraws or loses his right to appraisal rights, such Dissenting Shares shall thereupon be treated as if they had been converted as of the Effective Time only into the right to receive, without any interest thereon, the Merger Consideration upon surrender in the manner provided in Section 2.2(c). STX shall give Eros prompt notice of (i) any demands received by STX for appraisal of shares, attempted written withdrawals of such demands, and any other instruments served pursuant to the DGCL and received by STX relating to stockholders’ rights to appraisal rights pursuant to the DGCL and (ii) the opportunity to direct all negotiations and proceedings with respect to any exercise of such appraisal rights under the DGCL. STX shall not, except with the prior written consent of Eros, voluntarily make any payment with respect to any demands for payment of fair value of STX Capital Stock, offer to settle or settle any such demands or approve any withdrawal of any such demands.

Section 2.2.        Exchange of Capital Stock.

(a)             Designation of Exchange Agent. Prior to the Closing, Eros shall enter into a customary exchange agreement reasonably acceptable to STX with the transfer agent of Eros or another nationally recognized financial institution or trust company designated by Eros and reasonably acceptable to STX to act as the exchange agent hereunder (the “Exchange Agent”).

10 

 

(b)            Letters of Transmittal and Instructions for Surrender. As promptly as practicable following the Effective Time, and in no event later than the fifth (5th) Business Day after the Effective Time, Eros shall cause the Exchange Agent to mail to each holder of record of a certificate (a “Certificate”) and/or uncertificated book-entry shares that immediately prior to the Effective Time represented outstanding shares of STX Class E Preferred Stock, STX Class D Preferred Stock, STX Class C Preferred Stock, STX Class B Preferred Stock or STX Class A Preferred Stock, (i) a letter of transmittal (which shall specify that delivery of Certificates, if applicable, shall be effected, and risk of loss and title to the Certificates shall pass only upon proper delivery of the Certificates (or affidavits of loss in lieu thereof) to the Exchange Agent, and which shall be in the form and have such other provisions as are reasonably acceptable to Eros and STX; provided that no representations made therein shall be broader in scope than the representations made by STX in Article III) (the “Letter of Transmittal”); (ii) instructions (which instructions shall be in the form and have such other provisions as are reasonably acceptable to Eros and STX) for use in effecting the surrender of the Certificates and/or uncertificated book-entry shares in exchange for the CVRs such holder has the right to receive in respect of such Certificates and/or uncertificated book-entry shares pursuant to Section 2.1(a)(i); and (iii) an investor questionnaire in the form prepared by Eros and reasonably satisfactory to STX.

(c)             Merger Consideration Received in Connection with Exchange. Upon delivery of a Letter of Transmittal duly completed and validly executed in accordance with the instructions thereto, including a duly completed investor questionnaire certifying to the reasonable satisfaction of Eros that such Person is an Accredited Investor and such other documents (including applicable Tax forms) as may be required pursuant to such instructions, together with surrender of any applicable Certificate(s) (or affidavit(s) of loss in lieu thereof) for cancellation to the Exchange Agent, the holder of such Certificate(s) and/or uncertificated book-entry shares covered by such Letter of Transmittal shall be entitled to receive in exchange therefor the number of applicable CVRs that such holder has the right to receive in respect of such Certificates and/or uncertificated book-entry shares pursuant to Section 2.1(a)(i), and the Certificate(s) (or affidavit(s) of loss in lieu thereof) and/or uncertificated book-entry shares so surrendered shall be forthwith cancelled. Until surrendered as contemplated by this Section 2.2(c), each Certificate and uncertificated book-entry share shall be deemed, from and after the Effective Time, to represent only the right to receive the Merger Consideration as contemplated by this Section 2.2(c). The Exchange Agent shall accept such Letter of Transmittal and surrender of Certificates and uncertificated book-entry shares and make such deliveries upon compliance with such reasonable terms and conditions as the Exchange Agent may impose to effect an orderly exchange thereof in accordance with normal exchange practices. No interest shall be paid or accrued for the benefit of holders of the Certificates and uncertificated book-entry shares on the Merger Consideration.

(d)            Certain Transfers of Ownership. In the event of a transfer of ownership of STX Capital Stock that is not registered in the transfer records of STX, issuance of the appropriate amount of Merger Consideration may be made to a Person other than the Person in whose name the shares of STX Capital Stock so surrendered are registered, if the applicable Certificate or uncertificated book-entry share(s) shall be properly endorsed, accompanied by a duly executed stock power or otherwise be in proper form for transfer (and accompanied by all

11 

 

documents reasonably required by the Exchange Agent) and the Person requesting such issuance shall pay any transfer or other Taxes required by reason of the issuance to a Person other than the registered holder of such shares of STX Capital Stock or establish to the reasonable satisfaction of Eros that such Tax has been paid or is not applicable.

(e)             Lost Certificates. If any Certificate shall have been lost, stolen or destroyed, then upon the making of an affidavit of that fact by the Person claiming such Certificate to be lost, stolen or destroyed and, if required by Eros or the Exchange Agent, the posting by such person of a bond, in such reasonable amount as Eros may direct, as indemnity against any claim that may be made against it with respect to such Certificate, the Exchange Agent will issue in exchange for such lost, stolen or destroyed Certificate the Merger Consideration to which the holder thereof is entitled pursuant to this Article II.

(f)             No Further Ownership Rights in STX Capital Stock. All CVRs issued upon the surrender for exchange of Certificates and uncertificated book-entry shares in accordance with the terms of this Article II shall be deemed to have been issued (and paid) in full satisfaction of all rights pertaining to any shares of STX Capital Stock theretofore represented by such Certificates or book entries. After the Effective Time, there shall be no registration of transfers on STX’s stock transfer books of shares of STX Capital Stock that were outstanding immediately prior to the Effective Time. If Letters of Transmittal (accompanied, if applicable, by Certificates) are presented to Eros, the Surviving Corporation or the Exchange Agent for transfer following the Effective Time, they shall be cancelled against delivery of the Merger Consideration for each share of STX Capital Stock formerly represented by the applicable Certificates and/or book entries.

Section 2.3.        Certain Adjustments. Without limiting the other provisions of this Agreement, if at any time during the period between the execution of this Agreement and the Effective Time, any change in the number or type of outstanding Eros Ordinary Shares or STX Capital Stock shall occur as a result of the Pre-Closing Class E Subscription, a reclassification, recapitalization, exchange, stock split (including a reverse stock split), combination or readjustment of ownership interests, shares or any stock dividend or stock distribution with a record date during such period, the Merger Consideration and any other similarly dependent items, as the case may be, shall be appropriately adjusted to provide the same economic effect as contemplated by this Agreement prior to such event; provided that nothing in this Section 2.3 shall be construed to permit any party to take any action that is otherwise prohibited or restricted by any other provision of this Agreement.

Section 2.4.        Further Assurances. If, at any time after the Effective Time, any further action is determined by Eros or the Surviving Corporation to be necessary or desirable to carry out the purposes of this Agreement or to vest the Surviving Corporation or Eros with full right, title and possession of and to all rights and property of Merger Sub and STX with respect to the Merger, the officers and managers of Eros shall be fully authorized (in the name of Merger Sub, STX, the Surviving Corporation and otherwise) to take such action.

12 

 

Article III
REPRESENTATIONS AND WARRANTIES OF STX

Except as disclosed in the disclosure letter delivered by STX to the Eros Parties upon the execution of this Agreement (the “STX Disclosure Letter”) and making reference to the particular subsection of this Agreement to which exception is being taken (provided, that such disclosure shall be deemed to qualify that particular subsection and such other subsections of this Agreement to the extent that it is reasonably apparent from the face of such disclosure that such disclosure also qualifies or applies to such other subsections), STX represents and warrants to the Eros Parties as of the date hereof and, on the occurrence of the Closing, as of the Closing Date, as follows:

Section 3.1.        Organization, Standing and Corporate Power. Each of STX and its Subsidiaries is a corporation, limited liability company or other legal entity duly organized, validly existing and in good standing (with respect to jurisdictions that recognize such concept) under the laws of the jurisdiction in which it is organized and has the requisite corporate, organizational or other power, as the case may be, and authority to carry on its business as now being conducted, except, as to Subsidiaries, for those jurisdictions where the failure to be so organized, existing or in good standing, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect on STX. Each of STX and its Subsidiaries is duly qualified or licensed to do business and is in good standing (with respect to jurisdictions that recognize such concept) in each jurisdiction in which the nature of its business or the ownership, leasing or operation of its properties makes such qualification or licensing necessary, except for those jurisdictions where the failure to be so qualified or licensed or in good standing, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect on STX. True and complete copies of the STX Certificate of Incorporation and the Bylaws of STX, in each case as amended through, and as in effect as of, the date of this Agreement, have been made available to the Eros Parties.

Section 3.2.        Authority. STX has all requisite corporate power and authority to enter into this Agreement and each of the Related Documents to which it is or will be a party and, subject to receipt of the STX Requisite Stockholder Approval (which is to occur by execution of the STX Stockholders Consent concurrently with the execution and delivery of this Agreement), to consummate the transactions contemplated hereby and thereby. The execution and delivery of this Agreement by STX and each of the Related Documents to which it is or will be a party and the consummation by STX of the transactions contemplated hereby and thereby have been duly authorized by the STX Board. Other than the STX Requisite Stockholder Approval, no other corporate or organizational proceedings on the part of STX are necessary to authorize the execution, delivery or performance of this Agreement and each of the Related Documents to which it is or will be a party or to consummate the transactions contemplated hereby and thereby. The STX Stockholders Consent provides that it will be irrevocable upon delivery. The STX Requisite Stockholder Approval is the only vote of the holders of any securities of STX or any of its Subsidiaries necessary to adopt and approve this Agreement and each of the Related Documents to which it is or will be a party, the Merger and the other transactions contemplated hereby and thereby, and the execution of the STX Stockholders Consent constitutes such adoption and approval. This Agreement has been duly executed and delivered, and upon its execution and delivery, and each of the Related Documents to which it is or will be a party, in each case by STX, and, assuming the due authorization, execution and delivery of this Agreement and each of the Related Documents to which it is or will be a party by Eros, England Holdings 2 and Merger Sub, constitutes the legal, valid and binding obligation of STX,

13 

 

enforceable against STX in accordance with its terms, except that (i) such enforcement may be subject to applicable bankruptcy, insolvency, examinership, fraudulent transfer, reorganization, moratorium or other similar Applicable Laws, now or hereafter in effect, affecting or relating to the enforcement of creditors’ rights generally and (ii) equitable remedies of specific performance and injunctive and other forms of equitable relief may be subject to equitable defenses and to the discretion of the court before which any proceeding therefor may be brought (collectively, the “Enforceability Exceptions”).

Section 3.3.        No Conflict; Required Filings and Consents.

(a)             The execution and delivery of this Agreement and each of the Related Documents to which STX is or will be a party, do not, and the consummation of the transactions contemplated hereby and thereby shall not, conflict with, or result in any violation of, or default (with or without notice or lapse of time, or both) under, or give rise to a right of termination, cancellation or acceleration of any obligation or loss of a benefit under, or result in the creation of any pledge, claim, lien, charge, encumbrance or security interest of any kind or nature whatsoever (collectively, “Liens”) upon any of the properties or assets of STX or any of its Subsidiaries under, (i) subject to receipt of the STX Requisite Stockholder Approval, the STX Certificate of Incorporation, the Bylaws of STX or the comparable organizational documents of any of its Subsidiaries, (ii) any Contract or Permit to which STX or any of its Subsidiaries is a party or by which STX or any of its Subsidiaries or their respective properties or assets is or may be bound or (iii) subject to the governmental filings and other matters referred to in Section 3.3(b), any judgment, order, decree, statute, law, ordinance, rule or regulation applicable to STX or any of its Subsidiaries or their respective properties or assets, other than, in the case of clauses (i) (only with respect to the certificate of formation, certificate of incorporation, limited liability company agreement, bylaws or comparable organizational documents of STX’s Subsidiaries), (ii) and (iii), any such conflicts, violations, defaults, rights, losses or Liens that, individually or in the aggregate, would not reasonably be expected to (A) have a Material Adverse Effect on STX or (B) prevent or materially delay the consummation of any of the transactions contemplated hereby.

(b)            No consent, approval, order or authorization of, action by or in respect of, or registration, declaration or filing with, any Governmental Authority is required by or with respect to STX or any of its Subsidiaries in connection with the execution and delivery of this Agreement and each of the Related Documents to which it is or will be a party by STX or the consummation by STX of the transactions contemplated hereby, except for (i) compliance with any applicable requirements of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the rules and regulations promulgated thereunder (the “HSR Act”), and with any other applicable United States or foreign competition, antitrust, merger control or investment laws or laws that provide for review of national security or defense matters (together with the HSR Act, the “Antitrust Laws”), (ii) the filing of the Certificate of Merger with the Secretary of State of the State of Delaware and appropriate documents with the relevant authorities of other states or jurisdictions in which STX or its Subsidiaries are qualified to do business, and (iii) such other consents, approvals, orders or authorizations the failure of which to be made or obtained, individually or in the aggregate, would not reasonably be expected to (A) have a Material

14 

 

Adverse Effect on STX or (B) prevent or materially delay the consummation of any of the transactions contemplated hereby.

Section 3.4.        Capital Structure.

(a)             Section 3.4(a) of the STX Disclosure Letter sets forth STX’s capitalization table as of April 16, 2020 (the “STX Measurement Date”), which contains a true and complete list of the equity capitalization of STX as of the date hereof, including the authorized capital stock of STX and all record holders of the issued and outstanding shares of STX Capital Stock (and the respective number of shares of STX Capital Stock and the class of such STX Capital Stock held by such holder).

(b)            STX has made available to Eros a true and complete schedule, as of the STX Measurement Date, of each outstanding STX Option and STX RSU Award, the name of the holder, the type of award, whether such holder is an employee of STX, the number and type of shares of STX Capital Stock issuable upon the exercise or settlement of such STX Equity Award (as applicable), the date of grant, the expiration date (if any), the exercise price (if any), the vesting schedule, including the extent vested to date and whether such vesting is subject to acceleration as a result of the Merger, and for any STX Option, whether such STX Option is a nonstatutory option or qualifies as an incentive stock option as defined in Section 422 of the Code and whether (and to what extent) any such STX Option is or has ever been subject to Section 409A (whether or not subsequently amended to comply with or to be exempt from the requirements of Section 409A). True and complete copies of the forms of all Contracts and instruments relating to any STX Equity Awards have been made available to the Eros Parties prior to the date hereof.

(c)             All outstanding shares of STX Capital Stock are, and all shares of STX Capital Stock that may be issued prior to the Effective Time as expressly permitted by Section 5.1 shall be, when issued, duly authorized, validly issued, fully paid and nonassessable and not subject to preemptive rights. Except as contemplated by the STX Certificate of Incorporation, the equity securities set forth on Section 3.4(a) of the STX Disclosure Letter, each outstanding STX Option and STX RSU Award or as set forth in Section 3.4(c) of the STX Disclosure Letter, and except for issuances of STX Capital Stock pursuant to STX Equity Awards outstanding on the date hereof in accordance with their present terms or as expressly permitted by Section 5.1, (i) there are not issued or outstanding (A) any other voting or equity securities or interests of STX, (B) any securities or interests of STX or any of its Subsidiaries convertible into or exchangeable or exercisable for, or based upon the value of, equity interests, voting or equity securities or interests of STX or (C) any warrants, calls, options, preemptive rights, subscriptions or other rights to acquire from STX or any of its Subsidiaries, or obligations of STX or any of its Subsidiaries to issue, any capital stock, voting or equity securities or interests or securities or interests convertible into or exchangeable or exercisable for, or based upon the value of, capital stock or voting or equity securities or interests of STX, and (ii) there are no outstanding obligations of STX or any of its Subsidiaries to repurchase, redeem or otherwise acquire any such securities or interests or any securities or interests of STX or any other Person, or to issue, deliver or sell, or cause to be issued, delivered or sold, any such securities or interests of STX.

15 

 

(d)            Except as set forth in Section 3.4(d) of the STX Disclosure Letter, (i) there are no stockholder agreements or voting trusts or other agreements or understandings to which STX is a party with respect to the voting, or restricting the transfer, of the capital stock or other equity interest of STX and (ii) STX has not granted any preemptive rights, anti-dilutive rights or rights of first refusal, registration rights or similar rights with respect to its shares of capital stock that are in effect. No shares of STX Capital Stock are held by any Subsidiary of STX. STX does not have outstanding any bonds, debentures, notes or other obligations the holders of which have the right to vote (or convertible into or exercisable for securities having the right to vote) with any stockholder of STX on any matter.

Section 3.5.        Subsidiaries.

(a)             Except for the Subsidiaries listed in Section 3.5(a) of the STX Disclosure Letter, neither STX nor any of its Subsidiaries directly or indirectly owns any equity, partnership, membership or similar interest in, or any interest convertible into, exercisable for the purchase of or exchangeable for any such equity, partnership, membership or similar interest, or is under any current or prospective obligation to form or participate in, provide funds to, make any loan, capital contribution or other investment in, or assume any liability or obligation of, any Person. Section 3.5(a) of the STX Disclosure Letter sets forth, for each Subsidiary of STX, the amount of its authorized capital stock or other equity or ownership interests, the amount of its outstanding capital stock or other equity or ownership interests and the record and beneficial holders of its outstanding capital stock or other equity or ownership interests. Except as would not reasonably be expected to be, individually or in the aggregate, material to STX and its Subsidiaries, taken as a whole, all outstanding shares of capital stock or other voting or equity securities or interests of each such Subsidiary have been validly issued and are fully paid and nonassessable.

(b)            Except as would not reasonably be expected to be, individually or in the aggregate, material to STX and its Subsidiaries, taken as a whole, there are no outstanding (i) securities of STX or any of its Subsidiaries convertible into or exchangeable or exercisable for shares of capital stock or other voting or equity securities or interests in any of its Subsidiaries or (ii) warrants, calls, options or other rights to acquire from STX or any of its Subsidiaries, or any obligation of STX or any of its Subsidiaries to issue, any capital stock or other voting or equity securities or interests in, or any securities convertible into or exchangeable or exercisable for any capital stock or voting or equity securities or interests in, any Subsidiary of STX.

Section 3.6.        Financial Statements; Undisclosed Liabilities.

(a)             True and complete copies of the audited consolidated balance sheets of STX and its Subsidiaries as at September 30, 2019, September 30, 2018 and September 30, 2017, and the related audited consolidated statements of operations, stockholders’ equity or deficit and cash flows of STX and its Subsidiaries, together with all related notes and schedules thereto, accompanied by the reports thereon of STX’s respective independent auditors (collectively referred to as the “STX Financial Statements”) and the unaudited consolidated balance sheets of STX and its Subsidiaries as at December 31, 2019, and the related consolidated statements of operations, stockholders’ equity or deficit and cash flows of STX and its Subsidiaries, together with all related notes and

16 

 

schedules thereto (collectively referred to as the “STX Interim Financial Statements”), are attached hereto as Section 3.6(a) of the STX Disclosure Letter. Each of the STX Financial Statements and the STX Interim Financial Statements (i) are correct and complete in all material respects and have been prepared in accordance with the books and records of STX and its Subsidiaries; (ii) have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) applied on a consistent basis throughout the periods indicated (except as may be indicated in the notes thereto); and (iii) fairly present, in all material respects, the consolidated financial position, results of operations and cash flows of STX and its Subsidiaries, taken as a whole, as at the respective dates thereof and for the respective periods indicated therein, except as otherwise noted therein and subject, in the case of the Interim Financial Statements, to normal and recurring year-end adjustments that will not, individually or in the aggregate, be material.

(b)            Except (i) as reflected or reserved against in the STX Financial Statements, (ii) for liabilities and obligations incurred in the ordinary course of business consistent with past practice since September 30, 2019 (none of which is a liability for breach of contract, tort, misappropriation, or infringement, a claim or lawsuit, or an environmental liability), (iii) for liabilities and obligations incurred in connection with or contemplated by this Agreement, or (iv) for liabilities that, would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect on STX, none of STX or any of its Subsidiaries has any liability or obligation of any nature (whether accrued, absolute, contingent or otherwise) that would be required by GAAP to be reflected on a consolidated balance sheet of STX and its Subsidiaries (or in the notes thereto).

(c)             Since January 1, 2017, none of STX’s internal accounting personnel that are responsible for preparing the financial statements of STX and its Subsidiaries (including the STX Financial Statements and the STX Interim Financial Statements), STX’s independent accountants, the STX Board or any committee thereof have identified, or received any written notification of, any “material weakness” or “significant deficiency” in the systems of internal controls utilized by STX and its Subsidiaries. To the Knowledge of STX, there has been no fraud, whether or not material, that involves any management or other employees of STX or any of its Subsidiaries who have a significant role in the internal controls of STX and its Subsidiaries or the preparation of the financial statements of STX and its Subsidiaries (including the STX Financial Statements and the STX Interim Financial Statements).

(d)            None of STX or any of its Subsidiaries is a party to, or has any commitment to become a party to, any joint venture, off-balance sheet partnership or any similar Contract (including any Contract or arrangement relating to any transaction or relationship between or among STX and any of its Subsidiaries, on the one hand, and any unconsolidated Affiliate, including any structured finance, special purpose or limited purpose entity or Person, on the other hand, or any “off-balance sheet arrangements” (as defined in Item 303(a) of Regulation S-K under the Exchange Act)), where the purpose or intended effect of such Contract is to avoid disclosure of any material transaction involving, or material liabilities of, STX or any of its Subsidiaries in STX’s or such Subsidiary’s financial statements.

Section 3.7.        Absence of Certain Changes or Events.

17 

 

(a)             From September 30, 2019, through the date of this Agreement, other than with respect to or in connection with the transactions contemplated hereby, including the Pre-Closing Class E Subscription, the businesses of each of STX and its Subsidiaries have been conducted in all material respects in the ordinary course of business in a manner consistent with past practice.

(b)            Since September 30, 2019, there have been no Changes that, individually or in the aggregate, have had or would reasonably be expected to have a Material Adverse Effect on STX.

Section 3.8.        Compliance with Applicable Laws and Permits; Orders. STX and its Subsidiaries hold all material Permits that are required for the operation of the businesses of STX and its Subsidiaries (the “STX Permits”), and all such STX Permits are in good standing or, where applicable, a renewal application has been timely filed and is pending agency approval. STX and its Subsidiaries are and, since January 1, 2017, have been in compliance in all material respects with the terms of the STX Permits and all applicable laws, statutes, rules, regulations, binding policies or guidelines promulgated, or Orders entered, by any Governmental Authority (collectively, “Applicable Laws”) applicable to STX and its Subsidiaries or their respective businesses or properties. Neither STX nor any of its Subsidiaries is subject to any outstanding Order of a Governmental Authority that, individually or in the aggregate, would reasonably be expected to (a) be material to STX and its Subsidiaries, taken as a whole, or (b) prevent or materially delay the consummation of any of the transactions contemplated hereby. Neither STX nor any of its Subsidiaries is in material violation of any outstanding Order to which it is subject.

Section 3.9.        Anti-Corruption Laws. Except as, individually or in the aggregate, would not reasonably be expected to be material to STX and its Subsidiaries, taken as a whole, (a) since January 1, 2017, none of STX or its Subsidiaries, nor, to the Knowledge of STX, any director, officer, employee or agent of STX, has directly or indirectly made, offered to make, attempted to make, or accepted any contribution, gift, bribe, rebate, payoff, influence payment, kickback or other payment to or from any Person, private or public, regardless of what form, whether in money, property or services, in violation of any Anti-Corruption Laws; (b) to the Knowledge of STX, as of the date of this Agreement, neither STX nor any of its Subsidiaries is under internal or Governmental Authority investigation for any material violation of any Anti-Corruption Laws or has received any written notice or other communication from any Governmental Authority regarding a violation of, or failure to comply with, any Anti-Corruption Laws; (c) STX and its Subsidiaries maintain an adequate system or systems of internal controls reasonably designed to ensure compliance with the Anti-Corruption Laws and prevent and detect violations of the Anti-Corruption Laws; and (d) since January 1, 2017, neither STX nor any of its Subsidiaries has made any disclosure (voluntary or otherwise) to any Governmental Authority with respect to any alleged irregularity, misstatement or omission or other potential violation or liability arising under or relating to any Anti-Corruption Laws.

Section 3.10.     International Trade Laws. Except as, individually or in the aggregate, would not reasonably be expected to be material to STX and its Subsidiaries, taken as a whole, (a) since January 1, 2017, STX and its Subsidiaries have been in compliance with all applicable

18 

 

International Trade Laws; (b) to the Knowledge of STX, as of the date of this Agreement, neither STX nor any of its Subsidiaries is under internal or Governmental Authority investigation for any material violation of any International Trade Laws or has received any written notice or other communication from any Governmental Authority regarding a violation of, or failure to comply with, any International Trade Laws; (c) since January 1, 2017 to the date of this Agreement, neither STX nor any of its Subsidiaries has received written notice from any Governmental Authority alleging any breach, violation, or conflict with respect to any governmental authorization under International Trade Laws, the substance of which has not been resolved; and (d) since January 1, 2017, neither STX nor any of its Subsidiaries has made any disclosure (voluntary or otherwise) to any Governmental Authority with respect to any alleged potential violation or liability arising under or relating to any International Trade Laws. Neither STX nor any of its Subsidiaries, and, to the Knowledge of STX, no director, officer or employee thereof, (i) is a Sanctioned Person or (ii) as of the date of this Agreement, has pending or, to the Knowledge of STX, threatened claims against it, him or her with respect to applicable International Trade Laws.

Section 3.11.     Litigation. As of the date hereof, there is no legal, administrative, arbitral or other action, suit, investigation, inquiry, proceeding, complaint, indictment or litigation (each, an “Action”) pending or, to the Knowledge of STX, threatened against or affecting STX or any of its Subsidiaries or any of their respective properties or any of their respective officers or directors before any Governmental Authority, except as, individually or in the aggregate, would not reasonably be expected to (a) to be material to STX, or (b) prevent or materially delay the consummation of any of the transactions contemplated hereby.

Section 3.12.     Benefit Plans.

(a)             Section 3.12(a) of the STX Disclosure Letter lists each material STX Benefit Plan. With respect to each material STX Benefit Plan, STX has made available, upon request, to Eros complete and accurate copies of (i) such STX Benefit Plan and, to the extent applicable, the most recent summary plan description thereof, (ii) the most recent audited financial statements and actuarial or other valuation reports prepared with respect thereto and (iii) the most recently received Internal Revenue Service (the “IRS”) determination letter or opinion letter, if applicable.

(b)            Except as, individually or in the aggregate, would not reasonably be expected to be material to STX and its Subsidiaries, taken as a whole, (i) each of the STX Benefit Plans has been established, maintained, funded, operated and administered in compliance with its terms and in accordance with Applicable Laws, including ERISA, the Code and in each case the regulations thereunder, (ii) no STX Benefit Plan provides (nor has STX or any of its Affiliates promised to provide) welfare benefits, including death or medical benefits (whether or not insured), with respect to current or former employees or directors of STX or its Subsidiaries beyond their retirement or other termination of service, other than coverage mandated by the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”), or comparable U.S. state or foreign law, (iii) all contributions or other amounts payable by STX or its Subsidiaries as of the Effective Time pursuant to each STX Benefit Plan in respect of current or prior plan years have been timely paid or, to the extent not yet due, have been accrued in accordance with GAAP, (iv) neither STX nor any of its

19 

 

Subsidiaries has engaged in a transaction in connection with which STX or its Subsidiaries could be subject to either a civil penalty assessed pursuant to Section 409 or 502(i) of ERISA or a tax imposed pursuant to Section 4975 or 4976 of the Code and (v) there are no pending or, to the Knowledge of STX, threatened or anticipated claims (other than routine claims for benefits), actions, investigations or audits by, on behalf of, against or in relation to, any of the STX Benefit Plans or any trusts related thereto.

(c)             None of STX or any of its Subsidiaries sponsors, maintains, contributes to, is obligated to contribute to, or has any liability or obligation (including on account of their respective ERISA Affiliates) with respect to, a Multiple Employer Plan or Multiemployer Plan (including on account of a complete or partial withdrawal or liability under Section 4202 of ERISA) or any plan subject to Section 302 or Title IV of ERISA or Section 412, 430 or 4971 of the Code.

(d)            Each of the STX Benefit Plans intended to be “qualified” within the meaning of Section 401(a) of the Code has received a favorable determination letter or opinion letter as to its qualification, and, to the Knowledge of STX, there are no existing circumstances or any events that have occurred that would reasonably be expected to adversely affect, in any material respect, the qualified status of any such plan.

(e)             Except as set forth in Section 3.12(e) of the STX Disclosure Letter, neither the execution and delivery of this Agreement nor the consummation of the transactions contemplated hereby (either alone or in conjunction with any other event) will result in (i) the acceleration of vesting, exercisability, funding or delivery of, or increase in the amount or value of, any payment, right or other benefit to any current or former employee, officer, director or other individual service provider of STX or any of its Subsidiaries or (ii) result in any limitation on the right of STX or any of its Subsidiaries to amend, merge, terminate or receive a reversion of assets from any STX Benefit Plan or related trust on or after the Effective Time. Without limiting the generality of the foregoing, no amount paid or that could become payable (whether in cash, in property, or in the form of benefits) by STX or any of its Subsidiaries in connection with the transactions contemplated hereby (either solely as a result thereof or as a result of such transactions in conjunction with any other event) will or can reasonably be expected to be nondeductible to the payor under Section 280G of the Code (or any corresponding provision of state, local or Non-U.S. Tax laws) or result in an “excess parachute payment” within the meaning of Section 280G of the Code.

(f)             Each STX Benefit Plan that constitutes in any part a nonqualified deferred compensation plan within the meaning of Section 409A of the Code has been at all relevant times operated and maintained in all material respects in operational and documentary compliance with Section 409A of the Code and applicable guidance thereunder.

(g)            No Person is entitled to receive any additional payment (including any Tax gross-up or other payment) from STX or any of its Subsidiaries in the event of the imposition of the excise Taxes required by Section 4999 of the Code or any Taxes required by Section 409A of the Code.

20 

 

(h)            Except as, individually or in the aggregate, would not reasonably be expected to be material to STX and its Subsidiaries, taken as a whole, all STX Benefit Plans subject to the laws of any jurisdiction outside of the United States (i) have been maintained in accordance with all applicable requirements, (ii) that are intended to qualify for special tax treatment meet all requirements for such treatment and (iii) that are intended to be funded and/or book-reserved are fully funded and/or book reserved, as appropriate, based upon reasonable actuarial assumptions.

Section 3.13.     Labor and Employment Matters.

(a)             No employee of STX or any of its Subsidiaries is covered by an effective or pending collective bargaining agreement or other labor-related agreement with a labor union, works council, or other labor organization, and, to the Knowledge of STX, there has not since January 1, 2017 been any activity on behalf of any labor union, works council, or other labor organization or similar employee group to organize any employees of STX or any of its Subsidiaries. Except for matters that, individually or in the aggregate, would not reasonably be expected to be material to STX and its Subsidiaries, taken as a whole, (i) there are no (and have not been during the three (3)-year period preceding the date of this Agreement) pending or, to the Knowledge of STX, threatened, strikes, work stoppages, slowdowns or lockouts with respect to any employees of STX or any of its Subsidiaries, and (ii) there is no (and has not been during the three (3)-year period preceding the date of this Agreement) unfair labor practice, labor dispute (other than routine individual grievances) or labor arbitration proceeding pending or, to the Knowledge of STX, threatened against STX or any of its Subsidiaries. Except as, individually or in the aggregate, would not reasonably be expected to be material to STX and its Subsidiaries, taken as a whole, none of STX or any of its Subsidiaries has received written notice during the three (3)-year period preceding the date of this Agreement of the intent of any Governmental Authority responsible for the enforcement of labor, employment, occupational health and safety or workplace safety and workers compensation insurance laws to conduct an investigation of STX or any of its Subsidiaries and, to the Knowledge of STX, no such investigation is in progress. Each of STX and its Subsidiaries has satisfied all notice, consultation, bargaining, and consent obligations owed to its employees and its employees’ representatives under Applicable Law or labor Contract.

(b)            Except as, individually or in the aggregate, would not reasonably be expected to be material to STX and its Subsidiaries, taken as a whole, since January 1, 2017, STX and its Subsidiaries have been in compliance with all Applicable Laws relating to labor and employment, including those relating to wages, hours, collective bargaining, unemployment compensation, workers compensation, equal employment opportunity, age and disability discrimination, immigration control, employee and worker classification, information privacy and security, payment and withholding of Taxes and continuation coverage with respect to group health plans. Within the three (3)-year period preceding the date of this Agreement, there has been no material written claim (internally or otherwise) by any current or former employee or any current or former independent contractor of STX or any of its Subsidiaries, or by any applicant for employment with STX or its Subsidiaries, that an officer, director, or senior management employee of STX or its Subsidiaries has engaged in sexual harassment or similar misconduct. None of STX or any of its Subsidiaries has entered into any material settlement agreement related to allegations of sexual harassment or misconduct by any officer, director or senior management employee of such entity.

21 

 

(c)             Within the three (3)-year period preceding the date of this Agreement, (i) neither STX nor any of its Subsidiaries has effectuated a “plant closing” (as defined in the Worker Adjustment Retraining and Notification Act of 1988, as amended (the “WARN Act”)) affecting any site of employment or one or more facilities or operating units within any site of employment or facility, (ii) there has not occurred a “mass layoff” (as defined in the WARN Act) in connection with STX or any of its Subsidiaries affecting any site of employment or one or more facilities or operating units within any site of employment or facility and (iii) neither STX nor any of its Subsidiaries has engaged in layoffs or employment terminations sufficient in number to trigger any unsatisfied obligations under any similar state, local or foreign Applicable Law.

Section 3.14.     Taxes. Except as would not, individually or in the aggregate, reasonably be expected to be material to STX and its Subsidiaries, taken as a whole:

(a)             (i) All Tax Returns required to be filed by STX and/or any of its Subsidiaries have been timely filed (taking into account any valid extensions), (ii) all such Tax Returns are true, complete and correct in all respects and (iii) all Taxes required to be paid (whether or not such Taxes were shown on any Tax Return) by STX and/or any of its Subsidiaries have been paid in full.

(b)            The Taxes accrued as of December 31, 2019 do not exceed the accruals for current Taxes set forth on the balance sheet as of such date included in the STX Interim Financial Statements, and no Taxes have been incurred since such date other than in the ordinary course of business of STX and its Subsidiaries consistent with amounts previously paid with respect to such Taxes for similar periods in prior years, adjusted for changes in ordinary course operating results.

(c)             STX and its Subsidiaries have complied with all Applicable Laws pertaining to the withholding of Taxes and the remittance of withheld Taxes.

(d)            There is not in force any waiver or extension of the statute of limitations with respect to, or the period for assessment or collection of, any Taxes relating to STX or any of its Subsidiaries.

(e)             (i) No audits or other administrative or judicial proceedings are pending or threatened in writing with regard to any Taxes or Tax Return of STX or any of its Subsidiaries, and (ii) no Taxing Authority has asserted any claim, assessment or deficiency for Taxes of STX or any of its Subsidiaries that has not been paid in full.

(f)             Neither STX nor any of its Subsidiaries (i) is a party to or bound by or has any obligation under any Tax indemnification, separation, sharing or similar agreement or arrangement (other than (x) any such agreement or arrangement solely between or among STX and/or any of its Subsidiaries or (y) commercial agreements entered into in the ordinary course of business and the primary purpose of which is not related to Taxes), (ii) is or has been a member of an affiliated group of corporations within the meaning of Section 1504 of the Code,

22 

 

or a member of a combined, consolidated, unitary or other similar group for state, local or foreign Tax purposes (other than a group the common parent of which is or was STX), (iii) is bound by a closing agreement pursuant to Section 7121 of the Code or other agreement with any Taxing Authority or (iv) has any liability for Taxes of any other Person (including any predecessor, but excluding STX and its Subsidiaries) by operation of Applicable Laws, Contract or otherwise (other than pursuant to commercial agreements entered into in the ordinary course of business and the primary purpose of which is not related to Taxes).

(g)            None of the assets of STX or any of its Subsidiaries is subject to any Liens for Taxes (other than Liens for Taxes that are described in clause (ii) of the definition of Permitted Liens).

(h)            Within the past two years, neither STX nor any of its Subsidiaries has constituted either a “distributing corporation” or a “controlled corporation” (within the meaning of Section 355(a)(1)(A) of the Code) in a distribution of stock qualifying or intending to qualify for tax-free treatment under Section 355 of the Code.

(i)              Neither STX nor any of its Subsidiaries is, or has been, a United States real property holding corporation within the meaning of Section 897(c)(2) of the Code during the applicable period specified in Section 897(c)(1)(A)(ii) of the Code.

(j)              Neither STX nor any of its Subsidiaries has participated in any “listed transaction” within the meaning of Treasury Regulations Section 1.6011-4 (or any similar transaction under any similar provision of state, local or foreign Applicable Law).

(k)            Neither STX nor any Subsidiary of STX has agreed to or will be required to include any item of income in, or exclude any item of deduction from, taxable income for any taxable period (or portion thereof) ending after the Closing Date as a result of any: (i) change in method of accounting for Tax purposes requested or agreed to by STX or such Subsidiary prior to the Closing (including, without limitation, by reason of Section 481 or 263A of the Code or any similar provisions of state, local or foreign Applicable Laws); (ii) prepaid amount received prior to the Closing (other than in the ordinary course of business); or (iii) installment sale or open transaction made prior to the Closing.

(l)              No claim has been made in writing within the last three (3) years by any Governmental Authority in a jurisdiction in which STX or a Subsidiary of STX does not file a Tax Return to the effect that STX or such Subsidiary was required to pay Taxes or file a Tax Return in such jurisdiction.

(m)           Neither STX nor any of its Subsidiaries is, was or will be required to include any amount in income for a taxable year ending after December 31, 2017 as a result of the application of Section 965 of the Code, nor has STX or any of its Subsidiaries made an election under Section 965(h)(1) of the Code (or any similar or analogous provision of state or local Applicable Law).

Section 3.15.     Intellectual Property.

23 

 

(a)             Section 3.15(a) of the STX Disclosure Letter sets forth a complete and correct list of all film, television and other audiovisual projects (including any projects that relate to digital media, interactive entertainment, stage productions or live entertainment) in which STX or any of its Subsidiaries holds, or will as of the Closing hold, a material right, title or interest and which is anticipated as of the date of this Agreement to be released within the twelve (12) months following the date of this Agreement, including for each such project: (i) title, (ii) format (e.g., feature film, television series), (iii) scheduled or anticipated release date, (iv) anticipated methods of distribution (e.g., theatrical, streaming/digital service or platform, etc.), (v) current status (e.g., stage of development, pre-production, production, post-production, completion, release, etc.) and (vi) the name of the Subsidiary of STX that is developing, producing, financing or distributing the project or otherwise holds any right, title or interest in and to the project.

(b)            Section 3.15(b) of the STX Disclosure Letter sets forth a complete and correct list of all material Intellectual Property owned by STX or any of its Subsidiaries that is registered, issued or subject to a pending application for registration or issuance.

(c)             No claims are pending or, to the Knowledge of STX, threatened in writing challenging the ownership, use, validity or enforceability of any material Intellectual Property rights of STX or any of its Subsidiaries. STX and its Subsidiaries exclusively own, free and clear of all Liens (except Permitted Liens), or have been granted an enforceable right to use, all material Intellectual Property used in, and necessary for, the conduct of the businesses of STX and its Subsidiaries, as currently conducted, and STX’s and its Subsidiaries’ ownership or use of Intellectual Property in the conduct of such businesses does not infringe, misappropriate, dilute or otherwise violate, and has not infringed, misappropriated, diluted or otherwise violated, in any material respect, any of the Intellectual Property rights of any third party. To the Knowledge of STX, the execution and delivery by STX of this Agreement, and the consummation of the transactions contemplated hereby, will not (i) result in the Surviving Corporation or any of its Subsidiaries being obligated to pay any royalties or other amounts to any third party in respect of any Intellectual Property at a rate in excess of that which is payable by STX or such Subsidiary prior to the Closing Date or (ii) give rise to any right of any third party to terminate or otherwise modify any of STX’s or any of its Subsidiaries’ rights or obligations under any agreement under which any right or license of or under material Intellectual Property is granted to or by STX or any of its Subsidiaries.

(d)            To the Knowledge of STX, no third party is infringing, misappropriating, diluting, or otherwise violating in any material respect any Intellectual Property rights of STX or any of its Subsidiaries. STX and its Subsidiaries take and have taken reasonable measures to protect the confidentiality of material Trade Secrets and other material confidential information owned by or provided to them under conditions of confidentiality, including requiring all Persons having access thereto to execute written non-disclosure agreements or otherwise be bound by obligations of confidentiality. To the Knowledge of STX, there has been no unauthorized disclosure of any such material Trade Secrets or material confidential information of or relating to STX or any of its Subsidiaries to any Person. Except as would not, individually or in the aggregate, reasonably be expected to be material to STX and its Subsidiaries, taken as a whole, all current and former employees, agents, officers, founders, consultants and contractors of STX and its Subsidiaries who have been involved in the development of any Intellectual Property for

24 

 

or on behalf of STX or any of its Subsidiaries have executed and delivered valid and enforceable assignment agreements substantially in STX’s standard form (which form has been provided to Eros prior to the date hereof), whereby such individuals (i) irrevocably assigned to STX or its applicable Subsidiary any ownership interest and right they may have in any Intellectual Property created or developed for or delivered to STX or any of its Subsidiaries (or, in the case of any moral rights that are not capable of being assigned, irrevocably waived such moral rights for the benefit of STX) and (ii) acknowledged STX’s exclusive ownership of such Intellectual Property. To the Knowledge of STX, no current or former employee, consultant, or independent contractor of STX or any of its Subsidiaries is in violation of such agreement.

(e)             To the Knowledge of STX, no source code included in the Intellectual Property owned by STX or any of its Subsidiaries has been disclosed, released, made available, or delivered (and no Person has agreed to disclose, release, or deliver such source code under any circumstance) to any third party, and no Person other than STX and its Subsidiaries is in possession of any such source code or has been granted any license or other right with respect therein or thereto. To the Knowledge of STX, no event has occurred, and no circumstance or condition exists, that (with or without notice or lapse of time, or both) will, or would reasonably be expected to, result in a requirement that any source code included in the Intellectual Property owned by STX or any of its Subsidiaries be disclosed, licensed, released, made available, or delivered to any third party.

Section 3.16.     Information Technology; Data Protection.

(a)             The IT Assets of STX and its Subsidiaries are adequate for the conduct of the respective businesses of STX and its Subsidiaries as currently conducted, and currently anticipated to be conducted. Since January 1, 2017, to the Knowledge of STX, there have not been, and there are no known vulnerabilities or defects that would reasonably be expected to result in, any security breaches, unauthorized access, failures or unplanned outages or other adverse integrity or security access incidents affecting the IT Assets of STX or its Subsidiaries or any other Persons to the extent used by or on behalf of STX or its Subsidiaries (or, in each case, information and transactions stored or contained therein or transmitted thereby), in each case, except as, individually or in the aggregate, would not reasonably be expected to be material to STX and its Subsidiaries, taken as a whole.

(b)            Except as individually or in the aggregate would not reasonably be expected to be material to STX and its Subsidiaries, taken as a whole, STX and its Subsidiaries (a) are and have been since January 1, 2017 in compliance with all Applicable Laws, as well as their own rules, policies and procedures, relating to privacy, data protection and the collection, retention, protection, transfer, use and Processing of Personal Data (including Payment Card Industry Data Security Standard (PCI DSS)) (“Data Security Requirements”) and (b) have implemented and maintained a data security plan with commercially reasonable administrative, technical and physical safeguards to protect Personal Data against unauthorized access, use, loss and damage. To the Knowledge of STX, since January 1, 2017, there has been no unauthorized access to, or use, misuse or loss of, or damage to, any Personal Data maintained by or on behalf of STX or any of its Subsidiaries. Neither STX nor any of its Subsidiaries has received any written notice alleging any violation or failure to comply with any Data Security Requirements, nor is it aware of any reasonable basis for such a claim.

25 

 

Section 3.17.     Material Contracts.

(a)             Except for this Agreement or any STX Benefit Plan listed on Section 3.12(a) of the STX Disclosure Letter, as of the date of this Agreement, neither STX nor any of its Subsidiaries is a party to or bound by any Contract (all Contracts of the types described in the following clauses (i) through (x), collectively, the “STX Material Contracts”):

(i)              that contains any non-competition provision or other agreement or obligation that materially restricts the manner in which the businesses of STX and its Subsidiaries are conducted (other than standard employee non-solicitation restrictions) or, after the Effective Time, would materially restrict the ability of Eros or any of its Subsidiaries to engage in any line of business or in any geographic region;

(ii)            that obligates STX or any of its Subsidiaries, or will obligate Eros or any of its Subsidiaries after the Effective Time, to conduct business with any third party on a preferential or exclusive basis or contains “most favored nation” or similar provisions (other than such contracts which are terminable by STX or any of its Subsidiaries on ninety (90) days’ or less notice without any required material payment or penalty or other material conditions, other than the condition of notice);

(iii)          (A) that is an indenture, credit agreement, loan agreement, security agreement, guarantee, note, mortgage or other agreement or commitment that provides for or relates to any indebtedness of STX or any of its Subsidiaries, including any sale and leaseback transactions, capitalized leases and other similar financing arrangements, in each case, other than (x) accounts receivables and payables, (y) loans by STX to direct or indirect wholly owned Subsidiaries of STX and (z) advances to employees for travel and business expenses, in each case of clauses (x) through (z), in the ordinary course of business, or (B) that provides for the guarantee, support, indemnification, assumption or endorsement by STX or any of its Subsidiaries of, or any similar commitment by STX or any of its Subsidiaries, with respect to, the obligations, liabilities or indebtedness of any other Person;

(iv)          for any joint venture, partnership or similar arrangement;

(v)            that is a material broker, distributor, dealer, manufacturer’s representative, franchise, agency, continuing sales or purchase, sales promotion, market research, marketing or advertising contract;

(vi)          that provides for the receipt or provision by STX or any of its Subsidiaries of products or services in an amount or having a value in excess of $5,000,000 in the twelve (12) month period prior to and including the date hereof or any twelve (12) month period following the date hereof (including any such Contract that involves the financing, development, production, exhibition or distribution of feature films, television programs or other content (including with respect to any copyrights or other Intellectual Property therein));

26 

 

(vii)        that is a (A) settlement agreement or (B) consent or similar agreement with a Governmental Authority, in each case that contains any material continuing obligations of STX or any of its Subsidiaries (other than non-disclosure, non-disparagement or similar obligations);

(viii)      that relates to the acquisition or disposition of any Person, business or material asset (other than the acquisition of equipment or products in the ordinary course of business) and under which STX or its Subsidiaries have (A) a material continuing indemnification obligation or (B) material “earn-out” or similar contingent payment obligations; or

(ix)          that is a collective bargaining agreement or Contract with any labor union, works council, or other labor organization respecting labor matters.

(b)            Each STX Material Contract is valid and binding on STX (or, to the extent a Subsidiary of STX is a party, such Subsidiary) and is in full force and effect (subject to the Enforceability Exceptions), and STX and each of its Subsidiaries have performed all obligations required to be performed by them to date under each STX Material Contract, except where such noncompliance, individually or in the aggregate, would not reasonably be expected to be material to STX and its Subsidiaries, taken as a whole. Neither STX nor any of its Subsidiaries has Knowledge of, or has received written notice of, any violation or default (nor, to the Knowledge of STX, does there exist any condition that with the passage of time or the giving of notice or both would result in such a violation or default) under any STX Material Contract, in each case that, individually or in the aggregate, would reasonably be expected to be material to STX and its Subsidiaries, taken as a whole. To the Knowledge of STX, no other party to any STX Material Contract is in breach of or default under the terms of any STX Material Contract where such default would reasonably be expected to be, individually or in the aggregate, material to STX and its Subsidiaries, taken as a whole.

Section 3.18.     Environmental Protection. Except as, individually or in the aggregate, would not reasonably be expected to be material to STX and its Subsidiaries, taken as a whole, (a) STX and each of its Subsidiaries are and have been since January 1, 2017 in compliance with all applicable Environmental Laws, and neither STX nor any of its Subsidiaries has received any written communication from any Person or Governmental Authority that alleges that STX or any of its Subsidiaries is not in such compliance with, or has any liability under, applicable Environmental Laws, (b) STX and each of its Subsidiaries has obtained all environmental, health and safety Permits (“Environmental Permits”) required or necessary for, pursuant to applicable Environmental Law, the construction and operation of their facilities and the conduct of their business and operations, and all such Environmental Permits are in good standing or, where applicable, a renewal application has been timely filed and is pending agency approval, and STX and its Subsidiaries are and since January 1, 2017 have been in compliance with all terms and conditions of the Environmental Permits, (c) as of the date hereof, there are no Actions under any Environmental Laws pending or, to the Knowledge of STX, threatened in writing against STX or any of its Subsidiaries and (d) there has been no Release of any Hazardous Material that would be reasonably likely to form the basis of any Action under any Environmental Laws against STX or any of its Subsidiaries, or for which STX or any of its Subsidiaries has or may have retained or assumed liability, either contractually or by operation of law.

27 

 

Section 3.19.     Real Property. None of STX or any of its Subsidiaries owns any real property. Except as, individually or in the aggregate, would not reasonably be expected to be material to STX and its Subsidiaries, taken as a whole, (a) STX and each of its Subsidiaries has good and valid leasehold title to all of the STX Leased Real Property pursuant to Leases with third parties which are enforceable in accordance with their terms, in each case subject only to Permitted Liens, and (b) with respect to all such STX Leased Real Property, STX and each of its Subsidiaries is in compliance with all material terms and conditions of each Lease therefor, and neither STX nor any of its Subsidiaries has received any written notice of default thereunder which is outstanding and remains uncured beyond any applicable period of cure.

Section 3.20.     Insurance. Section 3.20 of the STX Disclosure Letter sets forth, as of the date hereof, a true and complete list of all policies of insurance maintained by STX and its Subsidiaries covering STX and its Subsidiaries and their respective businesses, assets and properties (excluding insurance policies relating to STX Benefit Plans). Such policies provide insurance coverage adequate to comply in all material respects with all Applicable Laws and STX Material Contracts and are in full force and effect, and none of STX or any of its Subsidiaries has received written notice of cancellation of any such policy, is in default thereunder or has filed to timely pay all premiums due with respect thereto.

Section 3.21.     Affiliate Transactions. Except for the STX Benefit Plans or as set forth on Section 3.21 of the STX Disclosure Letter, there are no, and since January 1, 2017 there have been no, Contracts or transactions between STX or any of its Subsidiaries, on the one hand, and any Related Party of STX or any of its Subsidiaries (other than STX or any of its other Subsidiaries) or other Person(s), on the other hand, of a nature that would be required to be disclosed under Item 404 of Regulation S-K of the SEC.

Section 3.22.     Brokers. Except for fees payable to PJT Partners, Inc., no broker, investment banker, financial advisor or other Person is entitled to any broker’s, finder’s, financial advisor’s or other similar fee or commission in connection with the transactions contemplated by this Agreement based upon arrangements made by or on behalf of STX or any of its Subsidiaries.

Section 3.23.     Sufficiency. STX or a Subsidiary of STX either has or will, as of the Closing, have good and valid title to or a valid leasehold interest in or valid license to, in each case free and clear of any Lien (other than Permitted Liens), all material assets, properties and rights, real, personal or mixed, tangible or intangible, including all rights and benefits under the STX Material Contracts, sufficient to conduct the business of STX and its Subsidiaries as currently conducted.

Section 3.24.     No Other Representations.

(a)             Except for the representations and warranties made in this Article III or any certificate delivered pursuant to this Agreement, neither STX nor any other Person makes any express or implied representation or warranty with respect to STX or its Subsidiaries or their respective businesses, operations, assets, liabilities or conditions (financial or otherwise) in

28 

 

connection with this Agreement or the transactions contemplated hereby, and STX hereby disclaims any such other representations or warranties. In particular, without limiting the foregoing disclaimer, except as expressly provided in this Article III or any certificate delivered pursuant to this Agreement, neither STX nor any other Person makes or has made any representation or warranty to Eros, its Subsidiaries or any of their respective Affiliates or Representatives with respect to (i) any financial projection, forecast, estimate, budget or similar prospective information relating to STX or any of its Subsidiaries or their respective businesses or (ii) except for the representations and warranties made in this Article III or any certificate delivered pursuant to this Agreement, any oral or written information presented or made available (including in any “data room”) to the Eros Parties, their Subsidiaries or any of their respective Affiliates or Representatives in the course of their due diligence investigation of STX, the negotiation of this Agreement or in the course of the transactions contemplated hereby.

(b)            Notwithstanding anything contained in this Agreement to the contrary, STX acknowledges and agrees that none of Eros, England Holdings 2, Merger Sub or any other Person has made or is making, and STX expressly disclaims reliance upon, any representations, warranties or statements relating to Eros or its Subsidiaries whatsoever, express or implied, beyond those expressly given by Eros in Article IV or any certificate delivered pursuant to this Agreement, including any implied representation or warranty as to the accuracy or completeness of any information regarding Eros, England Holdings 2 or Merger Sub furnished or made available to STX or any of its Representatives. Without limiting the generality of the foregoing, STX acknowledges that, except as expressly provided in Article IV or any certificate delivered pursuant to this Agreement, no representations or warranties are made with respect to any projections, forecasts, estimates, budgets or similar prospective information that may have been made available to STX or any of its Representatives.

Article IV
REPRESENTATIONS AND WARRANTIES OF EROS, ENGLAND HOLDINGS 2 AND MERGER SUB

Except as set forth in any Form 20-F or Form 6-K filed with the SEC since January 1, 2017 and publicly available prior to the date of this Agreement (as amended prior to the date of this Agreement, the “Eros Filed SEC Documents”) (excluding any disclosures in any risk factors section, in any section related to forward-looking statements and other disclosures that are cautionary, predictive or forward-looking in nature) (provided that it is understood that any matter disclosed in any Eros Filed SEC Document shall not be deemed to be disclosed for purposes of, or to modify or qualify, Section 4.3(b) and Section 4.7(b)) or as disclosed in the disclosure letter delivered by Eros and England Holdings 2 to STX upon the execution of this Agreement (the “Eros Disclosure Letter”) and making reference to the particular subsection of this Agreement to which exception is being taken (provided, that such disclosure shall be deemed to qualify that particular subsection and such other subsections of this Agreement to the extent that it is reasonably apparent from the face of such disclosure that such disclosure also qualifies or applies to such other subsections), Eros, England Holdings 2 and Merger Sub, jointly and severally, represent and warrant to STX as of the date hereof and, on the occurrence of the Closing, as of the Closing Date, as follows:

29 

 

Section 4.1.       Organization, Standing and Corporate Power. Each of the Eros Parties and their respective Subsidiaries is a company limited by shares, corporation or other legal entity duly organized, validly existing and in good standing (with respect to jurisdictions that recognize such concept) under the laws of the jurisdiction in which it is organized and has the requisite corporate or other power, as the case may be, and authority to carry on its business as now being conducted, except, as to Subsidiaries, for those jurisdictions where the failure to be so organized, existing or in good standing, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect on the Eros Parties. Each of Eros, England Holdings 2 and their respective Subsidiaries is duly qualified or licensed to do business and is in good standing (with respect to jurisdictions that recognize such concept) in each jurisdiction in which the nature of its business or the ownership, leasing or operation of its properties makes such qualification or licensing necessary, except for those jurisdictions where the failure to be so qualified or licensed or in good standing, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect on the Eros Parties. True and complete copies of the Memorandum of Association of Eros, the Eros Articles of Association, in each case as amended through, and as in effect as of, the date of this Agreement, have been filed prior to the date of this Agreement with the Eros Filed SEC Documents and the England Holdings 2 Certificate of Incorporation and the Bylaws of England Holdings 2, in each case as amended through, and as in effect as of, the date of this Agreement have been made available to STX. The Eros Board has not laid down any regulations not included in the Eros Articles of Association as permitted under Article 21.3 of the Eros Articles of Association.

Section 4.2.        Authority. Each of the Eros Parties has all requisite corporate and authority to enter into this Agreement and each of the Related Documents to which it is or will be a party and, subject to receipt of the Eros Transaction Shareholder Approval (which is to occur by execution of the Eros Shareholders Consent concurrently with the execution and delivery of this Agreement) and the England Holdings 2 Requisite Shareholder Approval, to consummate the transactions contemplated hereby and thereby. The execution and delivery of this Agreement and each of the Related Documents to which it is or will be a party and the consummation by each of the Eros Parties of the transactions contemplated hereby and thereby have been duly authorized by each of the Eros Board, the board of directors of England Holdings 2 and the sole member of Merger Sub. Other than (a) (i) with respect to the issuance of Eros A Ordinary Shares pursuant to the CVRs in connection with the Merger (the “Eros Share Issuance”), the affirmative vote by show of hands at a general meeting of a majority of those shareholders of Eros who vote on such resolution at such general meeting or, if a poll vote is demanded at such general meeting, the affirmative vote by a majority of the voting power of the Eros Ordinary Shares represented by the votes cast at such meeting, or if acting by written resolution, a written resolution consented to in writing by shareholders of Eros holding in excess of fifty percent (50%) of the rights to vote on such resolution conferred on such shareholders according to the rights attached to the Eros Ordinary Shares held (the “Eros Transaction Shareholder Approval”), and (ii) with respect to approval of the Amended Eros Articles of Association, the affirmative vote of a majority of not less than three-fourths of such shareholders of Eros as, being entitled so to do, vote in person or by proxy at the general meeting at which such resolution is proposed or, if acting by written resolution, a written resolution consented to in writing by shareholders of Eros holding in excess of seventy-five percent (75%) of the rights to vote on such resolution conferred on such shareholders according

30 

 

to the rights attached to the Eros Ordinary Shares held (the “Eros Articles Shareholder Approval” and together with the Eros Transaction Shareholder Approval, the “Eros Requisite Shareholder Approval”), and (b) the approval by England Holdings 2 as the sole member of Merger Sub (the “England Holdings 2 Requisite Shareholder Approval”) and the approval by the board of directors of England Holdings 2, no other corporate or other organizational proceedings on the part of any Eros Party are necessary to authorize the execution, delivery or performance of this Agreement and each of the Related Documents to which it is or will be a party or to consummate the transactions contemplated hereby and thereby. The Eros Shareholders Consent provides that it will be irrevocable upon delivery. Each of the Eros Requisite Shareholder Approval and England Holdings 2 Requisite Shareholder Approval is the only vote of the holders of any securities of Eros or England Holdings 2 or any of their respective Subsidiaries necessary to adopt and approve this Agreement, and each of the Related Documents to which it is or will be a party, the Merger, the Eros Share Issuance, the Amended Eros Articles of Association and the other transactions contemplated hereby and thereby, and the execution of the Eros Shareholders Consent and the England Holdings 2 Requisite Shareholder Approval will constitute such adoption and approval other than with respect to the Amended Eros Articles of Association. This Agreement has been duly executed and delivered, and upon its execution and deliver and each of the Related Documents to which it is or will be a party, in each case by the Eros Parties and Merger Sub, assuming the due authorization, execution and delivery of this Agreement and each of the Related Documents to which it is or will be a party by STX, constitutes the legal, valid and binding obligation of the Eros Parties, enforceable against the Eros Parties in accordance with its terms, except for the Enforceability Exceptions.

Section 4.3.        No Conflict; Required Filings and Consents.

(a)             The execution and delivery of this Agreement and each of the Related Documents to which any Eros Party is or will be a party, does not, and the consummation of the transactions contemplated hereby and thereby shall not, conflict with, or result in any violation of, or default (with or without notice or lapse of time, or both) under, or give rise to a right of termination, cancellation or acceleration of any obligation or loss of a benefit under, or result in the creation of any Lien upon any of the properties or assets of the Eros Parties or any of their respective Subsidiaries under, (i) subject to receipt of the Eros Transaction Shareholder Approval and England Holdings 2 Requisite Shareholder Approval, the Memorandum of Association of Eros or Eros Articles of Association, the England Holdings 2 Certificate of Incorporation, the Bylaws of England Holdings 2 or the comparable organizational documents of any of their respective Subsidiaries, (ii) any Contract or Permit to which an Eros Party or any of its Subsidiaries is a party or by which an Eros Party, any of its Subsidiaries or their respective properties or assets is or may be bound or (iii) subject to the governmental filings and other matters referred to in Section 4.3(b), any judgment, order, decree, statute, law, ordinance, rule or regulation applicable to an Eros Party or any of its Subsidiaries or their respective properties or assets, other than, in the case of clauses (i) (only with respect to the organizational documents of an Eros Party’s Subsidiaries), (ii) and (iii), any such conflicts, violations, defaults, rights, losses or Liens that, individually or in the aggregate, would not reasonably be expected to (A) have a Material Adverse Effect on the Eros Parties or (B) prevent or materially delay the consummation of any of the transactions contemplated hereby.

31 

 

(b)            No consent, approval, order or authorization of, action by or in respect of, or registration, declaration or filing with, any Governmental Authority is required by or with respect to the Eros Parties or any of their respective Subsidiaries in connection with the execution and delivery of this Agreement or and each of the Related Documents to which it is or will be a party by the Eros Parties or the consummation by the Eros Parties of the transactions contemplated hereby or thereby, except for (i) compliance with any applicable requirements of the HSR Act and any other Antitrust Laws, (ii) such reports under Section 13(a) or 15(d) of the Exchange Act as may be required in connection with this Agreement and the transactions contemplated hereby, (iii) the filing of the Certificate of Merger with the Secretary of State of the State of Delaware and appropriate documents with the relevant authorities of other states or jurisdictions in which the Eros Parties or their respective Subsidiaries are qualified to do business, (iv) such filings with and approvals of the NYSE to permit the Eros A Ordinary Shares that are to be issued pursuant to the CVRs to be listed on the NYSE and (v) such other consents, approvals, orders or authorizations the failure of which to be made or obtained, individually or in the aggregate, would not reasonably be expected to (A) have a Material Adverse Effect on the Eros Parties or (B) prevent or materially delay the consummation of any of the transactions contemplated hereby.

Section 4.4.        Capital Structure.

(a)             The authorized share capital of Eros consists of £60,000,000 divided into 200,000,000 shares designated as either A Ordinary Shares, par value £0.30 per share (the “Eros A Ordinary Shares”) or B Ordinary Shares, par value £0.30 per share (the “Eros B Ordinary Shares” and, together with the Eros A Ordinary Shares, the “Eros Ordinary Shares”). At the close of business on April 16, 2020 (the “Eros Measurement Date”), (i) 137,167,377 Eros A Ordinary Shares were issued and outstanding (for the avoidance of doubt, excluding Eros Ordinary Shares held by Eros in its treasury); (ii) 19,899,085 Eros B Ordinary Shares were issued and outstanding (for the avoidance of doubt, excluding Eros Ordinary Shares held by Eros in its treasury); (iii) no Eros Ordinary Shares were held by Eros in its treasury; (iv) 2,499,098 Eros A Ordinary Shares were subject to issuance pursuant to Eros Options; and (v) 8,334,930 Eros A Ordinary Shares were subject to issuance pursuant to Eros RSU Awards.

(b)            Eros has made available to STX a true and complete schedule, for each outstanding Eros Option and Eros RSU Award, as of the Eros Measurement Date, the name of the holder, the type of award, whether such holder is an employee of Eros, the number and type of Eros Ordinary Shares issuable upon the exercise or settlement of such Eros Equity Award (as applicable), the date of grant, the expiration date (if any), the exercise price (if any), the vesting schedule, including the extent vested to date and whether such vesting is subject to acceleration as a result of the Merger, and for any Eros Option, whether such Eros Option is a nonstatutory option or qualifies as an incentive stock option as defined in Section 422 of the Code and whether (and to what extent) any such Eros Option is or has ever been subject to Section 409A (whether or not subsequently amended to comply with or to be exempt from the requirements of Section 409A). True and complete copies of the forms of all Contracts and instruments relating to any Eros Equity Awards have been made available to Eros prior to the date hereof.

32 

 

(c)             All outstanding Eros Ordinary Shares are, and all Eros Ordinary Shares that may be issued prior to the Effective Time as expressly permitted by Section 5.3 of this Agreement shall be, when issued, duly authorized, validly issued, fully paid and not subject to preemptive rights. Except as set forth in Section 4.4(a), as or as contemplated by Eros Articles of Association, and except for issuances of Eros Ordinary Shares pursuant to Eros Equity Awards outstanding on the date hereof or the Eros Convertible Notes or Eros Equity Facility, in each case, in accordance with their present terms or as expressly permitted by Section 5.2, (i) there are not issued or outstanding (A) any shares of capital stock or other voting or equity securities or interests of Eros, (B) any securities or interests of Eros or any of its Subsidiaries convertible into or exchangeable or exercisable for, or based upon the value of, shares of capital stock or voting or equity securities or interests of Eros or (C) any warrants, calls, options, preemptive rights, subscriptions or other rights to acquire from Eros or any of its Subsidiaries, or obligations of Eros or any of its Subsidiaries to issue, any capital stock, voting or equity securities or interests or securities or interests convertible into or exchangeable or exercisable for, or based upon the value of, capital stock or voting or equity securities or interests of Eros, and (ii) there are no outstanding obligations of Eros or any of its Subsidiaries to repurchase, redeem or otherwise acquire any such securities or interests or to issue, deliver or sell, or cause to be issued, delivered or sold, any such securities or interests of Eros.

(d)            Except for the Eros Support Agreement, the Eros Investors’ Rights Agreement, as contemplated by the Eros Articles of Association or as set forth in Section 4.4(c) of the Eros Disclosure Letter, (i) there are no stockholder agreements or voting trusts or other agreements or understandings to which Eros is a party with respect to the voting, or restricting the transfer, of the capital stock or other equity interest of Eros and (ii) Eros has not granted any preemptive rights, anti-dilutive rights or rights of first refusal, registration rights or similar rights with respect to its shares of capital stock that are in effect. No Eros Ordinary Shares are held by any Subsidiary of Eros. Except for the Eros Convertible Notes, Eros does not have outstanding any bonds, debentures, notes or other obligations the holders of which have the right to vote (or convertible into or exercisable for securities having the right to vote) with the stockholders of Eros on any matter.

(e)             There is no shareholder rights plan, “poison pill” antitakeover plan or similar device in effect to which Eros or any of its Subsidiaries is subject, party or otherwise bound.

Section 4.5.        Subsidiaries.

(a)             Except for the Subsidiaries listed in Section 4.5(a) of the Eros Disclosure Letter, neither Eros nor any of its Subsidiaries directly or indirectly owns any equity, partnership, membership or similar interest in, or any interest convertible into, exercisable for the purchase of or exchangeable for any such equity, partnership, membership or similar interest, or is under any current or prospective obligation to form or participate in, provide funds to, make any loan, capital contribution or other investment in, or assume any liability or obligation of, any Person. Section 4.5(a) of the Eros Disclosure Letter sets forth, for each Subsidiary of Eros, the amount of its authorized capital stock or other equity or ownership interests, the amount of its outstanding capital stock or other equity or ownership interests and the record and beneficial holders of its outstanding capital stock or other equity or ownership interests. Except as would not reasonably

33 

 

be expected to be, individually or in the aggregate, material to Eros and its Subsidiaries, taken as a whole, all outstanding shares of capital stock or other voting or equity securities or interests of each such Subsidiary have been validly issued and are fully paid and nonassessable (to the extent such concept is applicable in the relevant jurisdiction).

(b)            Except as would not reasonably be expected to be, individually or in the aggregate, material to Eros and its Subsidiaries, taken as a whole, there are no outstanding (i) securities of Eros or any of its Subsidiaries convertible into or exchangeable or exercisable for shares of capital stock or other voting or equity securities or interests in any of its Subsidiaries or (ii) warrants, calls, options or other rights to acquire from Eros or any of its Subsidiaries, or any obligation of Eros or any of its Subsidiaries to issue, any capital stock or other voting or equity securities or interests in, or any securities convertible into or exchangeable or exercisable for any capital stock or voting or equity securities or interests in, any Subsidiary of Eros.

Section 4.6.        SEC Documents; Financial Statements; Undisclosed Liabilities.

(a)             Since January 1, 2017, Eros has, in all material respects, filed or furnished all required registration statements, prospectuses, reports, schedules, forms, statements, certifications and other documents (including exhibits and all other information incorporated therein, regardless of when such exhibits and other information were filed) with the SEC (such documents and any other documents filed or furnished by Eros with the SEC, as have been supplemented, modified or amended since the time of filing, collectively, the “Eros SEC Documents”). As of their respective dates or, if supplemented, modified or amended prior to the date of this Agreement, as of the date of the most recent supplement, modification or amendment, the Eros SEC Documents complied in all material respects with the requirements of the Securities Act, the Exchange Act and the Sarbanes-Oxley Act, as the case may be, and the rules and regulations of the SEC promulgated thereunder applicable to the Eros SEC Documents, and none of the Eros SEC Documents when filed (or, if supplemented, modified or amended prior to the date of this Agreement, when most recently so supplemented, modified or amended) and at their respective effective times, if applicable, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. As of the date of this Agreement, there are no outstanding or unresolved comments received from the SEC with respect to any of the Eros SEC Documents, and, to the Knowledge of Eros, none of the Eros SEC Documents is the subject of any outstanding SEC comment or investigation. No Subsidiary of Eros is, or has since January 1, 2017 been, required to file reports with the SEC pursuant to the requirements of the Exchange Act.

(b)            The consolidated financial statements (including all related notes and schedules) of Eros and its Subsidiaries included in the Eros SEC Documents or attached hereto as Section 4.6(b) of the Eros Disclosure Letter (the “Eros Financial Statements”) were prepared in accordance with International Financial Reporting Standards (“IFRS”) (except, in the case of unaudited statements, as permitted by the SEC) applied on a consistent basis during the periods involved (except as may be indicated in the notes thereto) and fairly present in all material respects the consolidated financial position of Eros and its consolidated Subsidiaries as of the

34 

 

dates thereof and the consolidated results of their operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments which are not material and to any other adjustments described therein, including the notes thereto).

(c)             Except (i) as reflected or reserved against in the Eros Financial Statements, (ii) for liabilities and obligations incurred in the ordinary course of business consistent with past practice since September 30, 2019 (none of which is a liability for breach of contract, tort, misappropriation, or infringement, a claim or lawsuit, or an environmental liability), (iii) for liabilities and obligations incurred in connection with or contemplated by this Agreement, or (iv) for liabilities that, would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect on Eros and its Subsidiaries, taken as a whole, neither Eros nor any of its Subsidiaries has any liability or obligation of any nature (whether accrued, absolute, contingent or otherwise) that would be required by IFRS to be reflected on a consolidated balance sheet of Eros and its Subsidiaries (or in the notes thereto).

(d)            Since January 1, 2017, none of the Eros’s internal accounting personnel that are responsible for preparing the financial statements of Eros and its Subsidiaries (including the Eros Financial Statements), Eros’s independent accountants, the Eros Board or any committee thereof or the board of directors of England Holdings 2 have identified, or received any written notification of, any “material weakness” or “significant deficiency” in the systems of internal controls utilized by Eros and its Subsidiaries. To the Knowledge of Eros, there has been no fraud, whether or not material, that involves management or other employees of Eros and its Subsidiaries who have a significant role in the internal controls of Eros and its Subsidiaries or the preparation of the financial statements of Eros and its Subsidiaries (including the Eros Financial Statements).

(e)             Neither Eros nor any of its Subsidiaries is a party to, or has any commitment to become a party to, any joint venture, off-balance sheet partnership or any similar Contract (including any Contract or arrangement relating to any transaction or relationship between or among any Eros and any of its Subsidiaries, on the one hand, and any unconsolidated Affiliate, including any structured finance, special purpose or limited purpose entity or Person, on the other hand, or any “off-balance sheet arrangements” (as defined in Item 303(a) of Regulation S-K under the Exchange Act)), where the purpose or intended effect of such Contract is to avoid disclosure of any material transaction involving, or material liabilities of, Eros or any of its Subsidiaries in Eros’s or such Subsidiary’s financial statements.

Section 4.7.        Absence of Certain Changes or Events.

(a)             From September 30, 2019, through the date of this Agreement, other than with respect to or in connection with the transactions contemplated hereby, the businesses of Eros and its Subsidiaries have been conducted in all material respects in the ordinary course of business in a manner consistent with past practice.

(b)            Since September 30, 2019, there have been no Changes that, individually or in the aggregate, have had or would reasonably be expected to have a Material Adverse Effect on Eros.

35 

 

Section 4.8.        Compliance with Applicable Laws and Permits; Orders. Eros and its Subsidiaries hold all material Permits that are required for the operation of the businesses of Eros and its Subsidiaries (the “Eros Permits”), and all such Eros Permits are in good standing or, where applicable, a renewal application has been timely filed and is pending agency approval. Eros and its Subsidiaries are and, since January 1, 2017, have been in compliance in all material respects with the terms of the Eros Permits and all Applicable Laws applicable to Eros and its Subsidiaries or their respective businesses or properties. Neither Eros nor any of its Subsidiaries is subject to any outstanding Order of a Governmental Authority that, individually or in the aggregate, would reasonably be expected to (a) be material to Eros and its Subsidiaries, taken as a whole, or (b) prevent or materially delay the consummation of any of the transactions contemplated hereby. Neither Eros nor any of its Subsidiaries is in material violation of any outstanding Order to which it is subject.

Section 4.9.        Anti-Corruption Laws. Except as, individually or in the aggregate, would not reasonably be expected to be material to Eros and its Subsidiaries, taken as a whole, (a) since January 1, 2017, none of Eros or its Subsidiaries, nor, to the Knowledge of Eros, any director, officer, employee or agent of Eros, has directly or indirectly made, offered to make, attempted to make, or accepted any contribution, gift, bribe, rebate, payoff, influence payment, kickback or other payment to or from any Person, private or public, regardless of what form, whether in money, property or services, in violation of any Anti-Corruption Laws; (b) to the Knowledge of Eros, as of the date of this Agreement, neither Eros nor any of its Subsidiaries is under internal or Governmental Authority investigation for any material violation of any Anti-Corruption Laws or has received any written notice or other communication from any Governmental Authority regarding a violation of, or failure to comply with, any Anti-Corruption Laws; (c) Eros and its Subsidiaries maintain an adequate system or systems of internal controls reasonably designed to ensure compliance with the Anti-Corruption Laws and prevent and detect violations of the Anti-Corruption Laws; and (d) since January 1, 2017, neither Eros nor any of its Subsidiaries has made any disclosure (voluntary or otherwise) to any Governmental Authority with respect to any alleged irregularity, misstatement or omission or other potential violation or liability arising under or relating to any Anti-Corruption Laws.

Section 4.10.     International Trade Laws. Except as, individually or in the aggregate, would not reasonably be expected to be material to Eros and its Subsidiaries, taken as a whole, (a) since January 1, 2017, Eros and its Subsidiaries have been in compliance with all applicable International Trade Laws; (b) to the Knowledge of Eros, as of the date of this Agreement, neither Eros nor any of its Subsidiaries is under internal or Governmental Authority investigation for any material violation of any International Trade Laws or has received any written notice or other communication from any Governmental Authority regarding a violation of, or failure to comply with, any International Trade Laws; (c) since January 1, 2017 to the date of this Agreement, neither Eros nor any of its Subsidiaries has received written notice from any Governmental Authority alleging any breach, violation, or conflict with respect to any governmental authorization under International Trade Laws, the substance of which has not been resolved; and (d) since January 1, 2017, neither Eros nor any of its Subsidiaries has made any disclosure (voluntary or otherwise) to any Governmental Authority with respect to any alleged potential violation or liability arising under or relating to any International Trade Laws. Neither Eros nor any of its Subsidiaries, and, to the Knowledge of Eros, no director, officer or employee thereof, (i) is a Sanctioned Person or (ii) as of the date of this Agreement, has pending or, to the Knowledge of Eros, threatened claims against it, him or her with respect to applicable International Trade Laws.

36 

 

Section 4.11.     Litigation. As of the date hereof, there is no Action pending or, to the Knowledge of the Eros Parties, threatened against or affecting any of the Eros Parties or their respective Subsidiaries or any of their respective properties or any of their respective officers or directors before any Governmental Authority, except as, individually or in the aggregate, would not reasonably be expected to (a) to be material to the Eros Parties and their respective Subsidiaries, taken as a whole, or (b) prevent or materially delay the consummation of any of the transactions contemplated hereby.

Section 4.12.     Benefit Plans.

(a)             Eros’s Annual Report on Form 20-F filed with the SEC on August 14, 2019 lists each material Eros Benefit Plan. With respect to each material Eros Benefit Plan, Eros has made available, upon request, to STX complete and accurate copies of (i) such Eros Benefit Plan and, to the extent applicable, the most recent summary plan description thereof, (ii) the most recent audited financial statements and actuarial or other valuation reports prepared with respect thereto and (iii) the most recently received IRS determination letter or opinion letter, if applicable.

(b)            Except as, individually or in the aggregate, would not reasonably be expected to be material to Eros and its Subsidiaries, taken as a whole, (i) each of the Eros Benefit Plans has been established, maintained, funded, operated and administered in compliance with its terms and in accordance with Applicable Laws, including ERISA, the Code and in each case the regulations thereunder, (ii) no Eros Benefit Plan provides (nor has Eros or any of its Affiliates promised to provide) welfare benefits, including death or medical benefits (whether or not insured), with respect to current or former employees or directors of Eros or its Subsidiaries beyond their retirement or other termination of service, other than coverage mandated by COBRA, or comparable U.S. state or foreign law, (iii) all contributions or other amounts payable by Eros or its Subsidiaries as of the Effective Time pursuant to each Eros Benefit Plan in respect of current or prior plan years have been timely paid or, to the extent not yet due, have been accrued in accordance with GAAP, (iv) neither Eros nor any of its Subsidiaries has engaged in a transaction in connection with which Eros or its Subsidiaries could be subject to either a civil penalty assessed pursuant to Section 409 or 502(i) of ERISA or a tax imposed pursuant to Section 4975 or 4976 of the Code and (v) there are no pending or, to the Knowledge of Eros, threatened or anticipated claims (other than routine claims for benefits), actions, investigations or audits by, on behalf of, against any or in relation to, any of the Eros Benefit Plans or any trusts related thereto.

(c)             None of Eros or any of its Subsidiaries sponsors, maintains, contributes to, is obligated to contribute to, or has any liability or obligation (including on account of an ERISA Affiliate) with respect to, a Multiple Employer Plan or Multiemployer Plan (including on account of a complete or partial withdrawal or liability under Section 4202 of ERISA) or any plan subject to Section 302 or Title IV of ERISA or Section 412, 430 or 4971 of the Code.

37 

 

(d)            Each of the Eros Benefit Plans intended to be “qualified” within the meaning of Section 401(a) of the Code has received a favorable determination or opinion letter as to its qualification, and, to the Knowledge of Eros, there are no existing circumstances or any events that have occurred that would reasonably be expected to adversely affect, in any material respect, the qualified status of any such plan.

(e)             Except as set forth in Section 4.12(e) of the Eros Disclosure Letter, neither the execution and delivery of this Agreement nor the consummation of the transactions contemplated hereby (either alone or in conjunction with any other event) will result in (i) the acceleration of vesting, exercisability, funding or delivery of, or increase in the amount or value of, any payment, right or other benefit to any current or former employee, officer, director or other individual service provider of Eros or any of its Subsidiaries or (ii) result in any limitation on the right of Eros or any of its Subsidiaries to amend, merge, terminate or receive a reversion of assets from any Eros Benefit Plan or related trust on or after the Effective Time. Without limiting the generality of the foregoing, no amount paid or that could become payable (whether in cash, in property, or in the form of benefits) by Eros or any of its Subsidiaries in connection with the transactions contemplated hereby (either solely as a result thereof or as a result of such transactions in conjunction with any other event) will or can reasonably be expected to be nondeductible to the payor under Section 280G of the Code (or any corresponding provision of state, local or Non-U.S. Tax laws) or result in an “excess parachute payment” within the meaning of Section 280G of the Code.

(f)             Each Eros Benefit Plan that constitutes in any part a nonqualified deferred compensation plan within the meaning of Section 409A of the Code has been at all relevant times operated and maintained in all material respects in operational and documentary compliance with Section 409A of the Code and applicable guidance thereunder.

(g)            No Person is entitled to receive any additional payment (including any Tax gross-up or other payment) from Eros or any of its Subsidiaries in the event of the imposition of the excise Taxes required by Section 4999 of the Code or any Taxes required by Section 409A of the Code.

(h)            Except as, individually or in the aggregate, would not reasonably be expected to be material to Eros and its Subsidiaries, taken as a whole, all Eros Benefit Plans subject to the laws of any jurisdiction outside of the United States (i) have been maintained in accordance with all applicable requirements, (ii) that are intended to qualify for special tax treatment meet all requirements for such treatment and (iii) that are intended to be funded and/or book-reserved are fully funded and/or book reserved, as appropriate, based upon reasonable actuarial assumptions.

Section 4.13.     Labor and Employment Matters.

(a)             No employee of Eros or any of its Subsidiaries is covered by an effective or pending collective bargaining agreement or other labor-related agreement with a labor union, works council, or other labor organization, and, to the Knowledge of Eros, there has not since January 1, 2017 been any activity on behalf of any labor union, works council, or other labor organization or similar employee group to organize any employees of Eros or any of its

38 

 

Subsidiaries. Except for matters that, individually or in the aggregate, would not reasonably be expected to be material to Eros and its Subsidiaries, taken as a whole, (i) there are no (and have not been during the three (3)-year period preceding the date of this Agreement) pending or, to the Knowledge of Eros, threatened, strikes, work stoppages, slowdowns or lockouts with respect to any employees of Eros or any of its Subsidiaries, and (ii) there is no (and has not been during the three (3)-year period preceding the date of this Agreement) unfair labor practice, labor dispute (other than routine individual grievances) or labor arbitration proceeding pending or, to the Knowledge of Eros, threatened against Eros or any of its Subsidiaries. Except as, individually or in the aggregate, would not reasonably be expected to be material to Eros and its Subsidiaries, taken as a whole, neither Eros nor any of its Subsidiaries has received written notice during the three (3)-year period preceding the date of this Agreement of the intent of any Governmental Authority responsible for the enforcement of labor, employment, occupational health and safety or workplace safety and workers compensation insurance laws to conduct an investigation of Eros or any of its Subsidiaries and, to the Knowledge of Eros, no such investigation is in progress. Eros and each of its Subsidiaries has satisfied all notice, consultation, bargaining, and consent obligations owed to its employees and its employees’ representatives under Applicable Law or labor Contract.

(b)            Except as, individually or in the aggregate, would not reasonably be expected to be material to Eros and its Subsidiaries, taken as a whole, since January 1, 2017, the Eros Parties and their respective Subsidiaries have been in compliance with all Applicable Laws relating to labor and employment, including those relating to wages, hours, collective bargaining, unemployment compensation, workers compensation, equal employment opportunity, age and disability discrimination, immigration control, employee and worker classification, information privacy and security, payment and withholding of Taxes and continuation coverage with respect to group health plans. Within the three (3)-year period preceding the date of this Agreement, there has been no material written claim (internally or otherwise) by any current or former employee or any current or former independent contractor of an Eros Party or any of its Subsidiaries, or by any applicant for employment with an Eros Party or its Subsidiaries, that an officer, director, or senior management employee of an Eros Party or its Subsidiaries has engaged in sexual harassment or similar misconduct. Neither of the Eros Parties nor any of their respective Subsidiaries has entered into any material settlement agreement related to allegations of sexual harassment or misconduct by any officer, director or senior management employee of such entity.

(c)             Within the three (3)-year period preceding the date of this Agreement, (i) neither of the Eros Parties nor any of their respective Subsidiaries has effectuated a “plant closing” (as defined in the WARN Act) affecting any site of employment or one or more facilities or operating units within any site of employment or facility, (ii) there has not occurred a “mass layoff” (as defined in the WARN Act) in connection with the Eros Parties or any of their respective Subsidiaries affecting any site of employment or one or more facilities or operating units within any site of employment or facility and (iii) neither of the Eros Parties nor any of their Subsidiaries has engaged in layoffs or employment terminations sufficient in number to trigger any unsatisfied obligations under any similar state, local or foreign Applicable Law.

Section 4.14.     Taxes. Except as would not, individually or in the aggregate, reasonably be expected to be material to Eros and its Subsidiaries, taken as a whole:

39 

 

(a)             (i) All Tax Returns required to be filed by Eros and/or any of its Subsidiaries have been timely filed (taking into account any valid extensions), (ii) all such Tax Returns are true, complete and correct in all respects and (iii) all Taxes required to be paid (whether or not such Taxes were shown on any Tax Return) by Eros and/or any of its Subsidiaries have been paid in full.

(b)            The Taxes accrued as of December 31, 2019 do not exceed the accruals for current Taxes set forth on the balance sheet as of such date included in the Eros Financial Statements, and no Taxes have been incurred since such date other than in the ordinary course of business of Eros and its Subsidiaries consistent with amounts previously paid with respect to such Taxes for similar periods in prior years, adjusted for changes in ordinary course operating results.

(c)             Eros and its Subsidiaries have complied with all Applicable Laws pertaining to the withholding of Taxes and the remittance of withheld Taxes.

(d)            There is not in force any waiver or extension of the statute of limitations with respect to, or the period for assessment or collection of, any Taxes relating to Eros or any of its Subsidiaries.

(e)             (i) No audits or other administrative or judicial proceedings are pending or threatened in writing with regard to any Taxes or Tax Return of Eros or any of its Subsidiaries, and (ii) no Taxing Authority has asserted any claim, assessment or deficiency for Taxes of Eros or any of its Subsidiaries that has not been paid in full.

(f)             Neither Eros nor any of its Subsidiaries (i) is a party to or bound by or has any obligation under any Tax indemnification, separation, sharing or similar agreement or arrangement (other than (x) any such agreement or arrangement solely between or among Eros and/or any of its Subsidiaries or (y) commercial agreements entered into in the ordinary course of business and the primary purpose of which is not related to Taxes), (ii) is or has been a member of an affiliated group of corporations within the meaning of Section 1504 of the Code, or a member of a combined, consolidated, unitary or other similar group for state, local or foreign Tax purposes (other than a group the common parent of which is or was Eros), (iii) is bound by a closing agreement pursuant to Section 7121 of the Code or other agreement with any Taxing Authority or (iv) has any liability for Taxes of any other Person (including any predecessor, but excluding Eros and its Subsidiaries) by operation of Applicable Laws, Contract or otherwise (other than pursuant to commercial agreements entered into in the ordinary course of business and the primary purpose of which is not related to Taxes).

(g)            None of the assets of Eros or any of its Subsidiaries is subject to any Liens for Taxes (other than Liens for Taxes that are described in clause (ii) of the definition of Permitted Liens).

(h)            Within the past two years, neither Eros nor any of its Subsidiaries has constituted either a “distributing corporation” or a “controlled corporation” (within the meaning of Section 355(a)(1)(A) of the Code) in a distribution of stock qualifying or intending to qualify for tax-free treatment under Section 355 of the Code.

40 

 

(i)              Neither Eros nor any of its Subsidiaries has participated in any “listed transaction” within the meaning of Treasury Regulations Section 1.6011-4 (or any similar transaction under any similar provision of state, local or foreign Applicable Law).

(j)              Neither Eros nor any Subsidiary of Eros has agreed to or will be required to include any item of income in, or exclude any item of deduction from, taxable income for any taxable period (or portion thereof) ending after the Closing Date as a result of any: (i) change in method of accounting for Tax purposes requested or agreed to by Eros or such Subsidiary prior to the Closing (including, without limitation, by reason of Section 481 or 263A of the Code or any similar provisions of state, local or foreign Applicable Laws); (ii) prepaid amount received prior to the Closing (other than in the ordinary course of business); or (iii) installment sale or open transaction made prior to the Closing.

(k)            No claim has been made in writing within the last three (3) years by any Governmental Authority in a jurisdiction in which Eros or a Subsidiary of Eros does not file a Tax Return to the effect that Eros or such Subsidiary was required to pay Taxes or file a Tax Return in such jurisdiction.

Section 4.15.     Intellectual Property.

(a)             Section 4.15(a) of the Eros Disclosure Letter sets forth a complete and correct list of all film, television and other audiovisual projects (including any projects that relate to digital media, interactive entertainment, stage productions or live entertainment) in which Eros or any of its Subsidiaries holds a material right, title or interest and which is anticipated as of the date of this Agreement to be released within the twelve (12) months following the date of this Agreement, including for each such project: (i) title, (ii) format (e.g., feature film, television series), (iii) scheduled or anticipated release date, (iv) anticipated methods of distribution (e.g., theatrical, streaming/digital service or platform, etc.), (v) current status (e.g., stage of development, pre-production, production, post-production, completion, release, etc.) and (vi) the name of the Subsidiary of Eros that is developing, producing, financing or distributing the project or otherwise holds any right, title or interest in and to the project.

(b)            Section 4.15(b) of the Eros Disclosure Letter sets forth a complete and correct list of all material Intellectual Property owned by Eros or any of its Subsidiaries that is registered, issued or subject to a pending application for registration or issuance.

(c)             No claims are pending or, to the Knowledge of Eros, threatened in writing challenging the ownership, use, validity or enforceability of any material Intellectual Property rights of Eros or any of its Subsidiaries. Eros and its Subsidiaries exclusively own, free and clear of all Liens (except Permitted Liens), or have been granted an enforceable right to use, all material Intellectual Property used in, and necessary for, the conduct of their businesses, as currently conducted, and Eros’s and its Subsidiaries’ ownership or use of Intellectual Property in the conduct of its businesses does not infringe, misappropriate, dilute or otherwise violate, and has not infringed, misappropriated, diluted or otherwise violated, in any material respect, any of the Intellectual Property rights of any third party. To the Knowledge of Eros, the execution and delivery by Eros of this Agreement, and the consummation of the transactions contemplated hereby, will not (i) result in the Surviving Corporation or any of its Subsidiaries being obligated

41 

 

to pay any royalties or other amounts to any third party in respect of any Intellectual Property at a rate in excess of that which is payable by Eros or such Subsidiary prior to the Closing Date or (ii) give rise to any right of any third party to terminate or otherwise modify any of Eros’s or any of its Subsidiaries’ rights or obligations under any agreement under which any right or license of or under material Intellectual Property is granted to or by Eros or any of its Subsidiaries.

(d)            To the Knowledge of Eros, no third party is infringing, misappropriating, diluting, or otherwise violating in any material respect any Intellectual Property rights of Eros or any of its Subsidiaries. Eros and its Subsidiaries take and have taken reasonable measures to protect the confidentiality of material Trade Secrets and other material confidential information owned by or provided to them under conditions of confidentiality, including requiring all Persons having access thereto to execute written non-disclosure agreements or otherwise be bound by obligations of confidentiality. To the Knowledge of Eros, there has been no unauthorized disclosure of any such material Trade Secrets or material confidential information of or relating to Eros or any of its Subsidiaries to any Person. Except as would not, individually or in the aggregate, reasonably be expected to be material to Eros and its Subsidiaries, taken as a whole, all current and former employees, agents, officers, founders, consultants and contractors of Eros and any of its Subsidiaries who have been involved in the development of any Intellectual Property for or on behalf of Eros or any of its Subsidiaries have executed and delivered valid and enforceable assignment agreements substantially in Eros’s standard form (which form has been provided to STX prior to the date hereof), whereby such individuals (i) irrevocably assigned to Eros or its applicable Subsidiary any ownership interest and right they may have in any Intellectual Property created or developed for or delivered to Eros or any of its Subsidiaries (or, in the case of any moral rights that are not capable of being assigned, irrevocably waived such moral rights for the benefit of Eros) and (ii) acknowledged Eros’s exclusive ownership of such Intellectual Property. To the Knowledge of Eros, no current or former employee, consultant, or independent contractor of Eros or any of its Subsidiaries is in violation of such agreement.

(e)             To the Knowledge of Eros, no source code included in the Intellectual Property owned by Eros or any of its Subsidiaries has been disclosed, released, made available, or delivered (and no Person has agreed to disclose, release, or deliver such source code under any circumstance) to any third party, and no Person other than Eros and its Subsidiaries is in possession of any such source code or has been granted any license or other right with respect therein or thereto. To the Knowledge of Eros, no event has occurred, and no circumstance or condition exists, that (with or without notice or lapse of time, or both) will, or would reasonably be expected to, result in a requirement that any source code included in the Intellectual Property owned by Eros or any of its Subsidiaries be disclosed, licensed, released, made available, or delivered to any third party.

Section 4.16.     Information Technology; Data Protection.

(a)             The IT Assets of Eros and its Subsidiaries are adequate for the conduct of their respective businesses as currently conducted, and currently anticipated to be conducted. Since January 1, 2017, to the Knowledge of Eros, there have not been, and there are no known vulnerabilities or defects that would reasonably be expected to result in, any security breaches, unauthorized access, failures or unplanned outages or other adverse integrity or security access incidents affecting the IT Assets of Eros or its Subsidiaries or any other Persons to the extent

42 

 

used by or on behalf of Eros or its Subsidiaries (or, in each case, information and transactions stored or contained therein or transmitted thereby), in each case, except as, individually or in the aggregate, would not reasonably be expected to be material to Eros and its Subsidiaries, taken as a whole.

(b)            Except as individually or in the aggregate would not reasonably be expected to be material to Eros and its Subsidiaries, taken as a whole, Eros and its Subsidiaries (a) are and have been since January 1, 2017 in compliance with all Data Security Requirements and (b) have implemented and maintained a data security plan with commercially reasonable administrative, technical and physical safeguards to protect Personal Data against unauthorized access, use, loss and damage. To the Knowledge of Eros, since January 1, 2017, there has been no unauthorized access to, or use, misuse or loss of, or damage to, any Personal Data maintained by or on behalf of Eros or any of its Subsidiaries. Neither Eros nor any of its Subsidiaries has received any written notice alleging any violation or failure to comply with any Data Security Requirements, nor is it aware of any reasonable basis for such a claim.

Section 4.17.     Material Contracts.

(a)             Except for this Agreement or any Eros Benefit Plan listed on Section 4.12(a) of the Eros Disclosure Letter, as of the date of this Agreement, neither Eros nor any of its Subsidiaries is a party to or bound by any Contract (all Contracts of the types described in the following clauses (i) through (x), collectively, the “Eros Material Contracts”):

(i)              that contains any non-competition provision or other agreement or obligation that materially restricts the manner in which the businesses of Eros and its Subsidiaries are conducted (other than standard employee non-solicitation restrictions) or, after the Effective Time, would materially restrict the ability of Eros or any of its Subsidiaries to engage in any line of business or in any geographic region;

(ii)            that obligates Eros or any of its Subsidiaries, or will obligate Eros or any of its Subsidiaries after the Effective Time, to conduct business with any third party on a preferential or exclusive basis or contains “most favored nation” or similar provisions (other than such contracts which are terminable by Eros or any of its Subsidiaries on ninety (90) days’ or less notice without any required material payment or penalty or other material conditions, other than the condition of notice);

(iii)          (A) that is an indenture, credit agreement, loan agreement security agreement, guarantee, note, mortgage or other agreement or commitment that provides for or relates to any indebtedness of Eros or any of its Subsidiaries, including any sale and leaseback transactions, capitalized leases and other similar financing arrangements, in each case, other than (x) accounts receivables and payables, (y) loans to direct or indirect wholly owned Subsidiaries of Eros and (z) advances to employees for travel and business expenses, in each case of clauses (x) through (z), in the ordinary course of business, or (B) that provides for the guarantee, support, indemnification, assumption or endorsement by Eros or any of its Subsidiaries of, or any similar commitment by Eros or any of its Subsidiaries, with respect to, the obligations, liabilities or indebtedness of any other Person;

43 

 

(iv)          for any joint venture, partnership or similar arrangement;

(v)            that is a material broker, distributor, dealer, manufacturer’s representative, franchise, agency, continuing sales or purchase, sales promotion, market research, marketing or advertising contract;

(vi)          that provides for the receipt or provision by Eros or any of its Subsidiaries of products or services in an amount or having a value in excess of $5,000,000 in the twelve (12) month period prior to and including the date hereof or any twelve (12) month period following the date hereof (including any such Contract that involves the financing, development, production, exhibition or distribution of feature films, television programs or other content (including with respect to any copyrights or other Intellectual Property therein));

(vii)        that is a (A) settlement agreement or (B) consent or similar agreement with a Governmental Authority, in each case that contains any material continuing obligations of Eros or any of its Subsidiaries (other than non-disclosure, non-disparagement or similar obligations);

(viii)      that relates to the acquisition or disposition of any Person, business or material asset (other than the acquisition of equipment or products in the ordinary course of business) and under which Eros or its Subsidiaries have (A) a material continuing indemnification obligation or (B) material “earn-out” or similar contingent payment obligations; or

(ix)          that is a collective bargaining agreement or Contract with any labor union, works council, or other labor organization respecting labor matters.

(b)            Each Eros Material Contract is valid and binding on Eros (or, to the extent a Subsidiary of Eros is a party, such Subsidiary) and is in full force and effect (subject to the Enforceability Exceptions), and Eros and each Subsidiary of Eros have performed all obligations required to be performed by them to date under each Eros Material Contract, except where such noncompliance, individually or in the aggregate, would not reasonably be expected to be material to Eros and its Subsidiaries, taken as a whole. Neither Eros nor any of its Subsidiaries has Knowledge of, or has received written notice of, any violation or default (nor, to the Knowledge of Eros, does there exist any condition that with the passage of time or the giving of notice or both would result in such a violation or default) under any Eros Material Contract, in each case that, individually or in the aggregate, would reasonably be expected to be material to Eros and its Subsidiaries, taken as a whole. To the Knowledge of Eros, no other party to any Eros Material Contract is in breach of or default under the terms of any Eros Material Contract where such default would reasonably be expected to be, individually or in the aggregate, material to Eros and its Subsidiaries, taken as a whole.

Section 4.18.     Environmental Protection. Except as, individually or in the aggregate, would not reasonably be expected to be material to Eros and its Subsidiaries, taken as a whole, (a) Eros and each of its Subsidiaries are and have been since January 1, 2017 in compliance with all applicable Environmental Laws, and neither Eros nor any of its Subsidiaries has received any written communication from any Person or Governmental Authority that alleges that Eros or any

44 

 

of its Subsidiaries is not in such compliance with, or has any liability under, applicable Environmental Laws, (b) Eros and each of its Subsidiaries has obtained all Environmental Permits required or necessary for, pursuant to applicable Environmental Law, the construction and operation of their facilities and the conduct of their business and operations, and all such Environmental Permits are in good standing or, where applicable, a renewal application has been timely filed and is pending agency approval, and Eros and its Subsidiaries are and since January 1, 2017 have been in compliance with all terms and conditions of the Environmental Permits, (c) as of the date hereof, there are no Actions under any Environmental Laws pending or, to the Knowledge of Eros, threatened in writing against Eros or any of its Subsidiaries and (d) there has been no Release of any Hazardous Material that would be reasonably likely to form the basis of any Action under any Environmental Laws against Eros or any of its Subsidiaries, or for which Eros or any of its Subsidiaries has or may have retained or assumed liability, either contractually or by operation of law.

Section 4.19.     Real Property. Except as, individually or in the aggregate, would not reasonably be expected to be material to Eros and its Subsidiaries, taken as a whole, (a) Eros and each of its Subsidiaries has good and valid fee title (or the equivalent in any applicable foreign jurisdiction) to each and all of the Eros Owned Real Property, and good and valid leasehold title to all of the Eros Leased Real Property pursuant to Leases with third parties which are enforceable in accordance with their terms, in each case subject only to Permitted Liens, (b) there are no existing (or to the Knowledge of Eros, threatened in writing) condemnation proceedings with respect to any such Eros Owned Real Property and (c) with respect to all such Eros Leased Real Property, Eros and each of its Subsidiaries is in compliance with all material terms and conditions of each Lease therefor, and neither Eros nor any of its Subsidiaries has received any written notice of default thereunder which is outstanding and remains uncured beyond any applicable period of cure.

Section 4.20.     Insurance. Section 4.20 of the Eros Disclosure Letter sets forth, as of the date hereof, a true and complete list of all policies of insurance maintained by Eros and its Subsidiaries covering Eros and its Subsidiaries and their respective businesses, assets and properties (excluding insurance policies relating to Eros Benefit Plans). Such policies provide insurance coverage adequate to comply in all material respects with all Applicable Laws and Eros Material Contracts and are in full force and effect, and none of Eros or any of its Subsidiaries has received written notice of cancellation of any such policy, is in default thereunder or has filed to timely pay all premiums due with respect thereto.

Section 4.21.     Affiliate Transactions. Except for the Eros Benefit Plans and the Eros Investors’ Rights Agreement, there are no, and since January 1, 2017 there have been no, Contracts or transactions between Eros or any of its Subsidiaries, on the one hand, and any Related Party of Eros or any of its Subsidiaries (other than Eros or any of its other Subsidiaries) or other Person(s), on the other hand, of a nature that would be required to be disclosed under Item 404 of Regulation S-K of the SEC.

Section 4.22.     Issued Shares. All of the Eros A Ordinary Shares to be issued pursuant to the CVRs will be, when issued, (a) duly authorized and validly issued and fully paid and (b) subject to this Agreement, the Amended Eros Articles of Association, any lockup agreement entered into by an applicable holder, and any applicable U.S. state and federal securities laws, free of preemptive rights and restrictions on transfer.

45 

 

Section 4.23.     Merger Sub.

(a)             All of the issued and outstanding equity interest of Merger Sub is, and immediately prior to the Effective Time will be owned indirectly, by Eros and directly by England Holdings 2. Merger Sub was formed solely for the purpose of entering into the transactions contemplated by this Agreement and, since the date of its formation, has not carried on any business, other than the execution of this Agreement, the performance of its obligations hereunder and matters ancillary thereto. Merger Sub has all requisite corporate power and authority to enter into this Agreement and, subject to the adoption of this Agreement by the sole member of Merger Sub, to consummate the transactions contemplated hereby. The execution and delivery of this Agreement by Merger Sub and the consummation by Merger Sub of the transactions contemplated hereby have been duly authorized by all necessary corporate action on the part of Merger Sub, subject, in the case of the Merger, to the adoption of this Agreement by the sole member of Merger Sub. This Agreement has been duly executed and delivered by Merger Sub and, assuming the due authorization, execution and delivery of this Agreement by STX, constitutes the legal, valid and binding obligation of Merger Sub, enforceable against Merger Sub in accordance with its terms, except for the Enforceability Exceptions.

(b)            Each of England Holdings and England Holdings 2 have no operations, assets or liabilities other than holding its equity interest in England Holdings 2 and Merger Sub, respectively, and immaterial liabilities related to each entity’s organizational entity status.

Section 4.24.     Brokers. Except for fees payable to Citigroup Global Markets Inc., no broker, investment banker, financial advisor or other Person is entitled to any broker’s, finder’s, financial advisor’s or other similar fee or commission in connection with the transactions contemplated by this Agreement based upon arrangements made by or on behalf of Eros or England Holdings 2.

Section 4.25.     No Other Representations.

(a)             Except for the representations and warranties made in this Article IV or any certificate delivered pursuant to this Agreement, none of the Eros Parties or any other Person makes any express or implied representation or warranty with respect to the Eros Parties or their Subsidiaries or their respective businesses, operations, assets, liabilities or conditions (financial or otherwise) in connection with this Agreement or the transactions contemplated hereby, and the Eros Parties hereby disclaim any such other representations or warranties. In particular, without limiting the foregoing disclaimer, except as expressly provided in this Article IV or any certificate delivered pursuant to this Agreement, none of the Eros Parties or any other Person makes or has made any representation or warranty to STX or any of its Affiliates or Representatives with respect to (i) any financial projection, forecast, estimate, budget or similar prospective information relating to Eros or any of its Subsidiaries or their respective businesses or (ii) except for the representations and warranties made in this Article IV or any certificate delivered pursuant to this Agreement, any oral or written information presented or made available (including in any “data room”) to STX, its Subsidiaries or any of their respective Affiliates or Representatives in the course of their due diligence investigation of the Eros Parties, the negotiation of this Agreement or in the course of the transactions contemplated hereby.

46 

 

(b)            Notwithstanding anything contained in this Agreement to the contrary, the Eros Parties acknowledge and agree that neither STX nor any other Person has made or is making, and the Eros Parties expressly disclaim reliance upon, any representations, warranties or statements relating to STX or its Subsidiaries whatsoever, express or implied, beyond those expressly given by STX in Article III or any certificate delivered pursuant to this Agreement, including any implied representation or warranty as to the accuracy or completeness of any information regarding STX furnished or made available to the Eros Parties or any of their Representatives. Without limiting the generality of the foregoing, the Eros Parties acknowledge that, except as expressly provided in Article III or any certificate delivered pursuant to this Agreement, no representations or warranties are made with respect to any projections, forecasts, estimates, budgets or similar prospective information that may have been made available to the Eros Parties or any of their Representatives.

Article V
COVENANTS AND AGREEMENTS

Section 5.1.        Conduct of Business by STX. Except for matters set forth in Section 5.1 of the STX Disclosure Letter, as required by Applicable Law, as otherwise expressly contemplated by this Agreement or as consented to by Eros in writing (such consent not to be unreasonably withheld, conditioned or delayed), during the period from the date of this Agreement to the earlier of the Closing and the valid termination of this Agreement pursuant to Article VII (the “Interim Period”), STX (x) shall use reasonable best efforts to, and shall cause its Subsidiaries to use reasonable best efforts to, (1) carry on their respective businesses in all material respects in the ordinary course consistent with past practice and (2) maintain and preserve intact their respective business organizations, employees and advantageous business relationships and (y) shall not, and shall not permit any of its Subsidiaries to:

(a)             amend its certificate of incorporation, bylaws or comparable organizational documents (whether by merger, consolidation or otherwise) other than with respect to the Pre-Closing Class E Subscription;

(b)            (i) other than dividends and distributions by a direct or indirect Subsidiary of STX to STX or one of its Subsidiaries, declare, set aside or pay any dividends on, make any other distributions in respect of, or enter into any agreement with respect to the voting of, any of its equity securities, (ii) split, combine or reclassify any of its equity securities or issue or authorize the issuance of any other securities in respect of, in lieu of or in substitution for shares of such equity securities or (iii) purchase, redeem or otherwise acquire equity securities of STX or any of its Subsidiaries or any other securities thereof or any rights, warrants or options to acquire any such equity securities or other securities, in the case of each of clauses (ii) and (iii), other than, solely with respect to the securities of STX’s wholly owned Subsidiaries, actions or transactions solely between STX and its wholly owned Subsidiaries, or among the wholly owned Subsidiaries of STX;

47 

 

(c)             issue, deliver, sell, pledge or otherwise encumber or subject to any Lien any shares of its capital stock, any other voting securities or any securities convertible into, or any rights, warrants or options to acquire, any such shares, voting securities or convertible securities (other than (i) as required by any STX Benefit Plan or STX Equity Plan, in each case, in effect on the date of this Agreement or entered into or amended in accordance with the terms of this Agreement, and (ii) solely with respect to the capital stock or other securities of STX’s wholly owned Subsidiaries, transactions solely between STX and its wholly owned Subsidiaries, or among its wholly owned Subsidiaries);

(d)            incur any capital expenditures or any obligations or liabilities in respect thereof, except for (i) those contemplated by the capital expenditure budget for the period from the date of this Agreement through December 31, 2020, and made available to Eros prior to the date hereof and (ii) any unbudgeted capital expenditures not to exceed $5,000,000 individually or in the aggregate;

(e)             (i) acquire, directly or indirectly, any equity interests in or securities of, or make any investment in or any loan or capital contribution to, any Person, or acquire a substantial portion of the assets or business of any Person (or any division or line of business thereof), including in each case by merger, consolidation, acquisition of stock or assets or otherwise, or (ii) otherwise acquire any material assets, other than in the ordinary course of business consistent with past practice, except, in the case of each of clauses (i) and (ii), for transactions solely between STX and its Subsidiaries, or among STX’s Subsidiaries;

(f)             transfer, sell, lease, sublease, license, exchange, mortgage, pledge, surrender, divest, cancel, abandon, allow to lapse or otherwise dispose of, or create or incur any Lien, other than a Permitted Lien, on STX’s or any of its Subsidiaries’ material assets, properties, interests or businesses, or grant any option with respect to any of the foregoing, other than the license by STX or its Subsidiaries of content for theatrical or digital distribution in the ordinary course of business consistent with past practice;

(g)            create, incur or assume any indebtedness for borrowed money or issue any debt securities or any right to acquire debt securities, assume, guarantee, endorse or otherwise become liable or responsible (whether directly, contingently or otherwise) for the indebtedness of another Person, enter into any agreement to maintain any financial statement condition of another Person or enter into any arrangement having the economic effect of any of the foregoing, other than (i) pursuant to borrowings under (x) facilities in existence as of the date hereof or (y) any refinancing, substitution or replacement thereof, in each case, so long as such refinanced, substitute or replacement indebtedness does not impose or result in additional restrictions or limitations in any material respect on, and does not result in any net increase in the outstanding or available borrowings of, STX and its Subsidiaries compared to the existing agreements, facilities or indebtedness so refinanced, substituted or replaced, (ii) entering into capital leases in the ordinary course of business consistent with past practice, or (iii) any inter-company indebtedness solely between STX and its Subsidiaries, or among STX’s Subsidiaries, which, in each case with respect to clauses (i) through (iii), do not prohibit or limit the transactions contemplated by this Agreement and do not include any termination, default or payment related to the transactions contemplated by this Agreement;

48 

 

(h)            except as set forth in Section 5.1(h) of the STX Disclosure Letter or as required by any Applicable Law or by any STX Benefit Plan or STX Equity Plan, in each case, as in effect on the date of this Agreement or entered into or amended in accordance with the terms of this Agreement, (i) increase the compensation or benefits of any current or former employee, officer, director or other individual service provider of STX or any of its Subsidiaries, other than (A) increases made in the ordinary course of business consistent with past practice or (B) any ordinary course amendment or modification that does not result in a material enhancement of the compensation or benefits due under the applicable STX Benefit Plan as in effect on the date hereof, (ii) accelerate the vesting or payment of any compensation or benefits of any current or former employee, officer, director or other individual service provider of STX or any of its Subsidiaries, (iii) provide any funding for any rabbi trust or similar arrangement, or take any other action to fund or secure the payment of any compensation or benefit, or (iv) grant or pay to any current or former employee, officer, director or other individual service provider of STX or any of its Subsidiaries any right to receive any severance, change in control, retention, termination or similar compensation or benefits or any increases therein, other than any such payment payable pursuant to the terms of a STX Benefit Plan or STX Equity Plan, in each case, in effect as of the date hereof;

(i)              hire employees with an annual base salary of $250,000 or higher or enter into a separation agreement with any employee with an annual base salary of $250,000 or higher of STX or its Subsidiaries;

(j)              except as required by Applicable Law, recognize any labor union, works council, or other labor organization as the bargaining representative of any employees of STX or its Subsidiaries;

(k)            implement or announce any location closings or material employee layoffs;

(l)              change any of its material methods of accounting or accounting practice or policy, except as required by concurrent changes in GAAP or Applicable Law;

(m)           initiate, settle, or make a binding offer or proposal to settle, any Action involving (i) injunctive relief or equitable remedies or (ii) the payment of any amounts in excess of $5,000,000;

(n)            (i) make, change or revoke any Tax election (other the making of any election in the ordinary course of business consistent with past practice), (ii) change any material accounting method in respect of Taxes, (iii) enter into any Tax allocation, Tax indemnification, separation, sharing or similar agreement or arrangement (other than (x) any such agreement or arrangement solely between or among STX and/or any of its Subsidiaries or (y) commercial agreements entered into in the ordinary course of business and the primary purpose of which is not related to Taxes), (iv) extend the statute of limitations with respect to any material Tax matter (other than in connection with an automatic extension of time within which to file a Tax Return that is validly obtained in the ordinary course of business), (v) amend any material Tax Return or (vi) settle, compromise or abandon any material Tax claims or liabilities if such settlement, compromise or abandonment involves the payment or surrender by STX or its Subsidiaries of an amount in excess of the amount accrued or reserved, as applicable, therefor in the STX Interim Financial Statements;

49 

 

(o)            amend, modify, terminate (excluding terminations upon expiration of the term thereof in accordance with their terms) or renew any STX Material Contract or waive, release or assign any material rights, claims or benefits of STX or its Subsidiaries under any STX Material Contract, or enter into any Contract or agreement other than in the ordinary course of business consistent with past practice;

(p)            adopt a plan of complete or partial liquidation, dissolution, merger, consolidation, restructuring, recapitalization or other reorganization of STX or any of its Subsidiaries (other than the Merger and the Pre-Closing Class E Subscription); or

(q)            authorize, or agree or commit to take, any of the foregoing actions.

Section 5.2.        Conduct of Business by Eros. Except for matters set forth in Section 5.2 of the Eros Disclosure Letter, as required by Applicable Law, as otherwise expressly contemplated by this Agreement or as consented to by STX in writing (such consent not to be unreasonably withheld, conditioned or delayed), during the Interim Period, each of Eros, England Holdings 2 and Merger Sub (x) shall use reasonable best efforts to, and shall cause its Subsidiaries to use reasonable best efforts to, (1) carry on their respective businesses in all material respects in the ordinary course consistent with past practice and (2) maintain and preserve intact their respective business organizations, employees and advantageous business relationships and (y) shall not, and shall not permit any of its Subsidiaries to:

(a)             amend its memorandum of association, articles of association or comparable organizational documents (whether by merger, consolidation or otherwise) other than with respect to the Eros Share Issuance and the Amended Eros Articles of Association;

(b)            (i) other than dividends and distributions by a direct or indirect Subsidiary of an Eros Party to such Eros Party or one of its Subsidiaries, declare, set aside or pay any dividends on, make any other distributions in respect of, or enter into any agreement with respect to the voting of, any of its capital stock, (ii) split, combine or reclassify any of its capital stock or issue or authorize the issuance of any other securities in respect of, in lieu of or in substitution for shares of its capital stock or (iii) purchase, redeem or otherwise acquire any shares of capital stock of an Eros Party or any of its Subsidiaries or any other securities thereof or any rights, warrants or options to acquire any such shares or other securities, in the case of each of clauses (ii) and (iii), other than, solely with respect to the capital stock or other securities of such Eros Party’s wholly owned Subsidiaries, actions or transactions solely between such Eros Party and its wholly owned Subsidiaries, or among the wholly owned Subsidiaries of such Eros Party;

(c)             issue, deliver, sell, pledge or otherwise encumber or subject to any Lien any shares of its capital stock, any other voting securities or any securities convertible into, or any rights, warrants or options to acquire, any such shares, voting securities or convertible securities (other than (i) pursuant to the Eros Convertible Notes or the Eros Equity Facility, (ii) in connection with the exercise or settlement of Eros Equity Awards outstanding as of the date of this Agreement in accordance with their present terms, (iii) as required by any Eros

50 

 

Benefit Plan in effect on the date of this Agreement or entered into or amended in accordance with the terms of this Agreement and (iv) solely with respect to the capital stock or other securities of Eros’s wholly owned Subsidiaries, transactions solely between Eros and its wholly owned Subsidiaries, or among Eros’s wholly owned Subsidiaries);

(d)            incur any capital expenditures or any obligations or liabilities in respect thereof, except for (i) those contemplated by the capital expenditure budget for the period from the date of this Agreement through December 31, 2020, and made available to Eros prior to the date hereof and (ii) any unbudgeted capital expenditures not to exceed $5,000,000 individually or in the aggregate;

(e)             (i) acquire, directly or indirectly, any equity interests in or securities of, or make any investment in or any loan or capital contribution to, any Person, or acquire a substantial portion of the assets or business of any Person (or any division or line of business thereof), including in each case by merger, consolidation, acquisition of stock or assets or otherwise, or (ii) otherwise acquire any material assets, other than in the ordinary course of business consistent with past practice, except, in the case of each of clauses (i) and (ii), for transactions solely between such Eros Party and its Subsidiaries, or among such Eros Party’s Subsidiaries;

(f)             transfer, sell, lease, sublease, license, exchange, mortgage, pledge, surrender, divest, cancel, abandon, allow to lapse or otherwise dispose of, or create or incur any Lien, other than a Permitted Lien, on any Eros Party’s or any of their respective Subsidiaries’ material assets, properties, interests or businesses, or grant any option with respect to any of the foregoing, other than the license by such Eros Party or its Subsidiaries of content for theatrical or digital distribution in the ordinary course of business consistent with past practice;

(g)            create, incur or assume any indebtedness for borrowed money or issue any debt securities or any right to acquire debt securities, assume, guarantee, endorse or otherwise become liable or responsible (whether directly, contingently or otherwise) for the indebtedness of another Person, enter into any agreement to maintain any financial statement condition of another Person or enter into any arrangement having the economic effect of any of the foregoing, other than (i) pursuant to borrowings under (x) facilities in existence as of the date hereof or (y) any refinancing, substitution or replacement thereof, in each case, so long as such refinanced, substitute or replacement indebtedness does not impose or result in additional restrictions or limitations in any material respect on, and does not result in any net increase in the outstanding or available borrowings of, such Eros Party and its Subsidiaries compared to the existing agreements, facilities or indebtedness so refinanced, substituted or replaced, (ii) entering into capital leases in the ordinary course of business consistent with past practice, or (iii) any inter-company indebtedness solely between such Eros Party and its Subsidiaries, or among such Eros Party’s Subsidiaries, which, in each case with respect to clauses (i) through (iii), do not prohibit or limit the transactions contemplated by this Agreement and do not include any termination, default or payment related to the transactions contemplated by this Agreement;

51 

 

(h)            except as set forth in Section 5.2(h) of the Eros Disclosure Letter or as required by any Applicable Law or by any Eros Benefit Plan as in effect on the date of this Agreement or entered into or amended in accordance with the terms of this Agreement, (i) increase the compensation or benefits of any current or former employee, officer, director or other individual service provider of such Eros Party or any of its Subsidiaries, other than (A) increases made in the ordinary course of business consistent with past practice or (B) any ordinary course amendment or modification that does not result in a material enhancement of the compensation or benefits due under the applicable Eros Benefit Plan as in effect on the date hereof, (ii) accelerate the vesting or payment of any compensation or benefits of any current or former employee, officer, director or individual service provider of such Eros Party or any of its Subsidiaries, (iii) provide any funding for any rabbi trust or similar arrangement, or take any other action to fund or secure the payment of any compensation or benefit, or (iv) grant or pay to any current or former employee, officer, director or other individual service provider of such Eros Party or any of its Subsidiaries any right to receive any severance, change in control, retention, termination or similar compensation or benefits or any increases therein, other than any such payment payable pursuant to the terms of an Eros Benefit Plan in effect as of the date hereof;

(i)              hire employees with an annual base salary of $250,000 or higher or enter into a separation agreement with any employee with an annual base salary of $250,000 or higher of such Eros Party or its Subsidiaries;

(j)              except as required by Applicable Law, recognize any labor union, works council, or other labor organization as the bargaining representative of any employees of such Eros Party or its Subsidiaries;

(k)            implement or announce any location closings or material employee layoffs;

(l)              change any of its material methods of accounting or accounting practice or policy, except as required by concurrent changes in IFRS or Applicable Law;

(m)           initiate, settle, or make a binding offer or proposal to settle, any Action involving (i) injunctive relief or equitable remedies or (ii) the payment of any amounts in excess of $5,000,000;

(n)            (i) make, change or revoke any Tax election (other than the making of any election in the ordinary course of business consistent with past practice), (ii) change any material accounting method in respect of Taxes, (iii) enter into any Tax allocation, Tax indemnification, separation, sharing or similar agreement or arrangement (other than (x) any such agreement or arrangement solely between or among Eros and/or any of its Subsidiaries or (y) commercial agreements entered into in the ordinary course of business and the primary purpose of which is not related to Taxes), (iv) extend the statute of limitations with respect to any material Tax matter (other than in connection with an automatic extension of time within which to file a Tax Return that is validly obtained in the ordinary course of business), (v) amend any material Tax Return or (vi) settle, compromise or abandon any material Tax claims or liabilities if such settlement, compromise or abandonment involves the payment or surrender by Eros or its Subsidiaries of an amount in excess of the amount accrued or reserved, as applicable, therefor in the most recent balance sheet included in the Eros Financial Statements;

52 

 

(o)            amend, modify, terminate (excluding terminations upon expiration of the term thereof in accordance with their terms) or renew any Eros Material Contract or waive, release or assign any material rights, claims or benefits of Eros or its Subsidiaries under any Eros Material Contract, or enter into any Contract or agreement other than in the ordinary course of business consistent with past practice;

(p)            adopt a plan of complete or partial liquidation, dissolution, merger, consolidation, restructuring, recapitalization or other reorganization of an Eros Party or any of its Subsidiaries (other than the Merger); or

(q)            authorize, or agree or commit to take, any of the foregoing actions.

Section 5.3.        No Right to Control or Direct Operations. Nothing contained in this Agreement is intended to or will give Eros, England Holdings 2 or Merger Sub, directly or indirectly, the right to control or direct the operations of STX or its Subsidiaries prior to the Effective Time, and nothing contained in this Agreement is intended to or will give STX, directly or indirectly, the right to control or direct the operations of Eros or its Subsidiaries prior to the Effective Time, in each case, in violation of Applicable Law, including the Antitrust Laws. Prior to the Effective Time, each of Eros, England Holdings 2, Merger Sub and STX shall exercise, consistent with the terms and conditions of this Agreement, complete control and supervision over its and its Subsidiaries’ operations.

Section 5.4.        No Solicitation. Each of STX and the Eros Parties agrees that during the Interim Period, it shall not, and shall cause its Subsidiaries and its and their officers, directors and employees, and will use reasonable best efforts to cause its and its Subsidiaries’ other Representatives not to, directly or indirectly, (a) solicit, initiate, knowingly encourage (including by way of furnishing information) or accept any inquiry, proposal or offer that constitutes or could reasonably be expected to lead to an Acquisition Proposal or (b) participate in any discussions, negotiations or other communications regarding (except to notify a Person (or group of Persons) that makes any inquiry, offer or proposal of the existence of the provisions of this Section 5.4), or furnish to any other Person (or group of Persons) any information with respect to, or otherwise cooperate in any way, assist or participate in, facilitate or encourage the submission of, any proposal that constitutes, or could reasonably be expected to lead to, an Acquisition Proposal. Each of STX and the Eros Parties immediately shall cease and cause to be terminated all existing discussions, negotiations and other communications with any Persons (or group of Persons) conducted prior to the date of this Agreement with respect to any of the foregoing, shall promptly terminate access to any electronic data room that has been made available to any third party in connection with any potential Acquisition Proposal, and shall promptly request the return or destruction of any material or information provided to any such Person prior to the date hereof. Each of STX and the Eros Parties shall notify the other party promptly, but in any event within twenty-four (24) hours of becoming so aware, orally and in writing if any such Acquisition Proposal, or any inquiry or other contact with any Person with respect thereto, is made. Any such notice shall indicate in reasonable detail the identity of the Person making such Acquisition Proposal, inquiry or other contact and the terms and conditions of such Acquisition Proposal, inquiry or other contact. Each of STX and the Eros Parties shall not, and shall cause its Subsidiaries not to, release any Person from, or waive any provision of, any confidentiality or standstill agreement to which it or any of its Subsidiaries is a party,

53 

 

without the prior written consent of the other party. For purposes of this Agreement, “Acquisition Proposal” means any offer or proposal for, or any indication of interest in, any of the following (other than the Merger and the other transactions contemplated by this Agreement): (i) any direct or indirect acquisition or purchase of all or any portion of the assets, shares or other equity or ownership interests of STX or Eros, as applicable, or any of its respective Subsidiaries, (ii) any merger, consolidation or other business combination relating to STX or Eros, as applicable, or any of its respective Subsidiaries or (iii) any recapitalization, equity financing (other than the Eros PIPE Financing and the Pre-Closing Class E Subscription), reorganization or other extraordinary business transaction involving or otherwise relating to STX or Eros, as applicable, or any of its Subsidiaries.

Section 5.5.        STX Requisite Stockholder Approval; STX Stockholder Notice.

(a)             Contemporaneously with the execution of this Agreement, STX shall deliver to Eros a true and complete copy of the STX Stockholders Consent duly executed by the stockholders of STX sufficient to constitute the STX Requisite Stockholder Approval.

(b)            Promptly upon obtaining the STX Requisite Stockholder Approval, STX shall prepare (and shall provide Eros with a reasonable opportunity to review and comment on) and, as soon as reasonably practicable, send to all holders of record of voting securities of STX on the record date for the STX Stockholders Consent that did not execute the STX Stockholders Consent the notices required pursuant to Section 228(e) of the DGCL, the STX Certificate of Incorporation and the STX Stockholders Agreement.

Section 5.6.        Eros Requisite Shareholder Approval and England Holdings 2 Requisite Shareholder Approval. Contemporaneously with the execution of this Agreement, Eros shall deliver to STX a true and complete copy of the Eros Shareholders Consent duly executed by the stockholders of Eros sufficient to constitute the Eros Transaction Shareholder Approval. Concurrently with the execution of this Agreement, England Holdings 2 has obtained the England Holdings 2 Requisite Shareholder Approval and shall deliver to STX a true and complete copy of the England Holdings 2 Requisite Shareholder Approval duly executed by the stockholder of England Holdings 2 sufficient to constitute the England Holdings 2 Requisite Shareholder Approval. Eros shall, as promptly as reasonably practicable after obtaining the Eros Articles Shareholder Approval (and in any event before the one-month statutory deadline), duly file the Amended Eros Articles of Association with the Companies Registry of the Isle of Man. For the avoidance of doubt, but without limiting the obligations of Eros under this Section 5.6, the Closing (and the obligations of the parties to effect the Merger) shall not be conditioned on obtaining the Eros Articles Shareholder Approval.

Section 5.7.        [RESERVED].

Section 5.8.        Termination of Certain Agreements. Prior to the Closing:

(a)             STX shall take all actions necessary to cause any stockholders agreement, voting agreement, investor rights agreement or similar agreement to which it is a party with any holder of STX Capital Stock or otherwise concerning the STX Capital Stock, and any written or

54 

 

oral Contract, including any management, advisory or consulting agreement to which it is party with any holder of STX Capital Stock or Related Party of STX or any of its Subsidiaries, other than those Contracts set forth on Section 5.8(a) of the STX Disclosure Letter, to be terminated as of the Effective Time without any further liability or obligation on the part of STX or any of its Subsidiaries; and

(b)            Eros shall take all actions necessary to cause any stockholders agreement, voting agreement, investor rights agreement or similar agreement to which it is a party with any security holder of Eros, and any written or oral Contract, including any management, advisory or consulting agreement to which it is party with any security holder of Eros or Related Party of Eros or any of its Subsidiaries, other than those Contracts set forth on Section 5.8(b) of the Eros Disclosure Letter, to be terminated as of the Effective Time without any further liability or obligation on the part of Eros or any of its Subsidiaries.

Section 5.9.        Access to Information; Confidentiality. Subject to the confidentiality agreement, dated as of July 10, 2019, between STX and Eros (the “Confidentiality Agreement”) and to Applicable Law, and solely for the purposes of furthering the Merger, upon reasonable notice, STX shall, and shall cause its Subsidiaries to, and Eros shall, and shall cause the Subsidiaries of Eros to, afford to the other party and to the officers, employees and Representatives of such other party, reasonable access, upon reasonable advance notice during normal business hours during the Interim Period, to all of its and their respective properties, books, Contracts, commitments, senior personnel and records (provided that such access shall not unreasonably interfere with the business or operations of such party and shall be conducted under the supervision of the other party’s personnel), and during such period, STX shall, and shall cause its Subsidiaries to, and Eros shall, and shall cause the Subsidiaries of Eros to, furnish promptly to the other party all information concerning its and their business, properties and senior personnel as such other party may reasonably request upon reasonable advance notice and the furnishing of such information shall be conducted during normal business hours; provided that the foregoing shall not require STX or Eros to disclose any information pursuant to this Section 5.9 to the extent that in the reasonable good faith judgment of such party, (a) any Applicable Law requires such party or its Subsidiaries to restrict or prohibit access to any such information or (b) disclosure of any such information or document would result in the loss of attorney-client privilege, attorney work product or other relevant legal privilege; provided, further, that, with respect to the foregoing clauses (a) and (b), STX or Eros, as applicable, shall use its commercially reasonable efforts to (i) obtain the required consent of any third party necessary to provide such disclosure, (ii) communicate, to the extent feasible, the applicable information in a way that would not violate Applicable Law or jeopardize such privilege, or otherwise develop an alternative to providing such information so as to address such matters that is reasonably acceptable to the other party and (iii) utilize the procedures of a joint defense or common interest agreement or implement such other techniques if the parties determine that doing so would reasonably permit the disclosure of such information without violating Applicable Law or jeopardizing such privilege, including designating certain portions of such information as being provided on an outside-counsel basis only. No review pursuant to this Section 5.9 shall affect any representation or warranty given by the other party hereto. Any information provided or made available pursuant to this Section 5.9 shall be governed by the terms and conditions of the Confidentiality Agreement.

55 

 

Section 5.10.     Reasonable Best Efforts.

(a)             Subject to the terms and conditions of this Agreement, Eros and the STX will cooperate with each other and use (and will cause their respective Subsidiaries and Affiliates to use) their respective reasonable best efforts to consummate the transactions contemplated by this Agreement and to cause the conditions to the Merger set forth in Article VI to be satisfied as promptly as reasonably practicable, including using all reasonable best efforts to accomplish the following as promptly as reasonably practicable: (i) the obtaining of all actions or non-actions, consents, approvals, registrations, waivers, permits, authorizations, orders, expirations or terminations of waiting periods and other confirmations from any Governmental Authority or other Person that are or may become necessary, proper or advisable in connection with the consummation of the transactions contemplated by this Agreement, including the Merger, (ii) the preparation and making of all registrations, filings, forms, notices, petitions, statements, submissions of information, applications and other documents (including filings with Governmental Authorities) that are or may become necessary, proper or advisable in connection with the consummation of the transactions contemplated by this Agreement, including the Merger, (iii) the taking of all steps as may be necessary, proper or advisable to obtain an approval from, or to avoid an Action by, any Governmental Authority or other Person in connection with the consummation of the transactions contemplated by this Agreement, including the Merger, (iv) the defending of any lawsuits or other Actions, whether judicial or administrative, challenging this Agreement or that would otherwise prevent or delay the consummation of the transactions contemplated by this Agreement, including the Merger, performed or consummated by each party in accordance with the terms of this Agreement, including seeking to have any stay, temporary restraining order or injunction entered by any court or other Governmental Authority vacated or reversed, and such steps shall include proposing, negotiating, committing to and effecting, by consent decree, hold separate order or otherwise, the sale, divestiture, limitation or disposition of such assets or business of Eros, STX and their respective Subsidiaries and Affiliates, including entering into customary ancillary agreements on commercially reasonable terms relating to any such sale, divestiture or disposition of such assets or businesses (provided, that none of Eros, STX or their respective Subsidiaries and Affiliates shall be required to propose, negotiate, commit to or effect any such sale, divestiture, limitation or disposition of assets or businesses or ancillary agreements unless it shall be conditioned in all respects upon the prior or concurrent occurrence of the Closing), and (v) the execution and delivery of any additional instruments that are or may become reasonably necessary, proper or advisable to consummate the transactions contemplated by this Agreement, including the Merger, and to carry out fully the purposes of this Agreement. Each of Eros and STX shall, in consultation and cooperation with the other and as promptly as reasonably practicable, but in no event later than seven (7) Business Days after the date of this Agreement, make or cause to be made its respective filing under the HSR Act and any other applications and filings as reasonably determined by Eros and STX under other applicable Antitrust Laws with respect to the transactions contemplated by this Agreement, as promptly as practicable, but in no event later than as required by Applicable Law. Neither Eros nor STX will withdraw any such filings or applications without the prior written consent of the other party. Filings made under the HSR Act shall specifically request early termination of the waiting period thereunder (to the extent then available).

56 

 

(b)            In furtherance of the foregoing Section 5.10(a), the parties shall use reasonable best efforts to, and shall cooperate in good faith with one another to, identify any third party consents (or notices) under any Contracts that are necessary or desirable for the consummation of the Merger. Each of the parties shall use reasonable best efforts to obtain any such third-party consent (or deliver any such notices) in the event that the parties mutually agree to seek such consent; provided, however, without the prior written consent of the other party, neither Eros nor STX, nor any of their respective Subsidiaries or Affiliates, will grant or offer to grant any material accommodation or concession (financial or otherwise), or make any material payment, to any third party in connection with seeking or obtaining any such contractual consent. In addition, in connection with and without limiting the efforts referenced in Section 5.10(a), the parties shall jointly develop, and each of the parties shall consult and cooperate in all respects with one another, and consider in good faith the views of one another, in connection with the form and content of any analyses, appearances, presentations, memoranda, briefs, arguments, opinions and proposals made or submitted by or on behalf of any party, hereto in connection with proceedings under or relating to any Antitrust Law prior to their submission. Each of Eros and STX shall (i) furnish to the other such necessary information and reasonable assistance as the other may request in connection with the preparation of any governmental filings, submissions or other documents, (ii) promptly inform the other of any such filing, submission or other document and of any communication with or from any Governmental Authority or any official, representative or staff thereof regarding the transactions contemplated by this Agreement, and permit the other to review and discuss in advance, and consider in good faith the views, and secure the participation, of the other in connection with any such filing, submission, document or communication (provided, however, that copies of filings made under the HSR Act need not be shared) and (iii) cooperate in responding as promptly as reasonably practicable to any investigation or other inquiry from a Governmental Authority or any official, representative or staff thereof or in connection with any Action initiated by a Governmental Authority or private party, including promptly notifying the other party of any such investigation, inquiry or Action, and consulting in advance before making any presentations or submissions to a Governmental Authority or any official, representative or staff thereof, or, in connection with any Action initiated by a private party, to any other Person. In addition, each of Eros and STX shall promptly inform and consult with the other in advance of any meeting, conference or communication with any Governmental Authority or any official, representative or staff thereof, or, in connection with any Action by a private party, with any other Person, and to the extent not prohibited by Applicable Law or by the applicable Governmental Authority or other Person, not participate or attend any meeting or conference, or engage in any communication, with any Governmental Authority or any official, representative or staff thereof or such other Person in respect of the transactions contemplated by this Agreement without the other party unless it reasonably consults with the other party in advance and gives the other party a reasonable opportunity to attend and participate therein, and in the event one party is prohibited from, or unable to participate, attend or engage in, any such meeting, conference or communication, keep such party apprised with respect thereto. Each party shall furnish to the other copies of all filings (except filings made under the HSR Act), submissions, correspondence and communications between it and its Affiliates and their respective Representatives, on the one hand, and any Governmental Authority or any official, representative or staff thereof (or any other Person in connection with any Action initiated by a private party), on the other hand, with respect to the transactions contemplated by this Agreement. Each party may, as it deems advisable and

57 

 

necessary, reasonably designate material provided to the other party as “Outside Counsel Only Material” and also may reasonably redact the material as necessary to (A) remove personally or competitively sensitive information, (B) remove references concerning the valuation of a party and its Subsidiaries conducted in connection with the approval and adoption of this Agreement and the negotiations and investigations leading thereto, (C) comply with contractual arrangements, (D) prevent the loss of a legal privilege or (E) comply with Applicable Law.

(c)             Each of the parties agrees that during the Interim Period it shall not, and shall ensure that none of its Subsidiaries or controlled Affiliates shall, consummate, enter into any agreement providing for, or announce, any investment, acquisition, divestiture or other business combination (i) that would reasonably be expected to materially delay or prevent the consummation of the transactions contemplated by this Agreement or (ii) involving any Person or business competitive with the businesses of the other party and its Subsidiaries.

Section 5.11.     Indemnification, Exculpation and Insurance.

(a)             Eros agrees that all rights to indemnification and exculpation from liabilities, including advancement of expenses, for acts or omissions occurring at or prior to the Effective Time now existing in favor of the current or former directors, officers or employees of STX (the “D&O Indemnified Parties”) as provided in the STX Certificate of Incorporation, the Bylaws of STX or any indemnification contract between such directors, officers or employees and STX (in each case, as in effect on the date of this Agreement or entered after the date of this Agreement in accordance with Section 5.1) shall survive the Merger and shall continue in full force and effect, it being the intent of the parties that the D&O Indemnified Parties shall continue to be entitled to such exculpation and indemnification to the full extent of Applicable Law. For a period of six (6) years from the Effective Time, the Surviving Corporation shall, and Eros shall cause the Surviving Corporation to, maintain in effect the exculpation, indemnification and advancement of expenses equivalent to the provisions of the STX Certificate of Incorporation and Bylaws of STX as in effect immediately prior to the Effective Time with respect to acts or omissions occurring prior to the Effective Time and shall not amend, repeal or otherwise modify any such provisions in any manner that would adversely affect the rights thereunder of any D&O Indemnified Parties; provided, that all rights to indemnification in respect of any claim made for indemnification within such period shall continue until the disposition of such action or resolution of such claim. From and after the Effective Time, Eros shall guarantee and stand surety for, and shall cause the Surviving Corporation to honor, in accordance with their respective terms, each of the covenants contained in this Section 5.11(a).

(b)            Prior to the Effective Time, STX shall or, if STX is unable to, Eros shall cause the Surviving Corporation as of or after the Effective Time to, purchase a six (6)-year prepaid “tail” policy, with terms, conditions, retentions and limits of liability that are no less favorable than the coverage provided under STX’s existing policies of directors’ and officers’ liability insurance and fiduciary liability insurance, with respect to matters arising on or before the Effective Time (including in connection with this Agreement and the transactions or actions contemplated by this Agreement), and Eros shall cause such policy to be maintained in full force and effect, for its full term, and cause all obligations thereunder to be honored by the Surviving

58 

 

Corporation, and no other party shall have any further obligation to purchase or pay for insurance hereunder; provided, that STX shall not pay, and the Surviving Corporation shall not be required to pay, in excess of 300% of the last annual premium paid by STX prior to the date of this Agreement in respect of such “tail” policy. If STX or the Surviving Corporation for any reason fail to obtain such “tail” insurance policies prior to, as of or after the Effective Time, Eros shall, for a period of six (6) years from the Effective Time, cause the Surviving Corporation to maintain in effect the current policies of directors’ and officers’ liability insurance and fiduciary liability insurance maintained by STX with respect to matters arising on or before the Effective Time; provided, that, after the Effective Time, Eros shall not be required to pay in any one year a premium in excess of 300% of the last annual premium paid by STX prior to the date of this Agreement in respect of the coverage required to be obtained pursuant hereto, but in such case shall purchase as much coverage as reasonably practicable for such amount.

(c)             The covenants contained in this Section 5.11 are intended to be for the benefit of, and shall be enforceable by, each of the D&O Indemnified Parties and their respective heirs and shall not be deemed exclusive of any other rights to which any such Person is entitled, whether pursuant to Applicable Law, contract or otherwise. The obligations set forth in this Section 5.11 may not be terminated, modified or amended in any manner that adversely affects any D&O Indemnified Party.

(d)            In the event that Eros or the Surviving Corporation or any of their respective successors or assigns (i) consolidates with or merges into any other Person and shall not be the continuing or surviving company or entity of such consolidation or merger or (ii) transfers or conveys all or substantially all of its properties and assets to any Person, then, and in each such case, proper provision shall be made so that the successors or assigns of Eros or the Surviving Corporation, as the case may be, shall assume the obligations set forth in this Section 5.11. The obligations of the Surviving Corporation and Eros pursuant to this Section 5.11 shall be joint and several.

Section 5.12.     Fees and Expenses. Except as set forth in this Section 5.12 and in Section 7.1(d), all fees and expenses incurred in connection with the Merger, this Agreement and the transactions contemplated by this Agreement shall be paid by the party incurring such fees or expenses, whether or not the Merger is consummated, except that each of Eros and STX shall bear and pay one-half of the costs and expenses (other than the fees and expenses of each party’s attorneys and accountants, which shall be borne by the party incurring such expenses) incurred by the parties in connection with the filings of the premerger notification and report forms under the HSR Act and similar Antitrust Laws of other jurisdictions (including filing fees).

Section 5.13.     Public Announcements. Eros and STX shall consult with each other before issuing any press release or making any public statement with respect to this Agreement or the transactions contemplated hereby and shall not issue any such press release or make any such public statement without the prior consent of the other, such consent not to be unreasonably withheld, conditioned or delayed. Notwithstanding the foregoing, the first sentence of this Section 5.13 shall not apply to (a) any press release or public statement required by Applicable Law or any listing agreement with any national securities exchange, provided, that the party making the release or statement has used its reasonable best efforts to consult with the other party, (b) any press release or public statement containing content with respect to this Agreement

59 

 

or the transactions contemplated hereby substantially consistent with content included in any press release or public statement that has been previously consented to by the other party or otherwise exempted from this Section 5.13, (c) any disclosure of information concerning this Agreement in connection with litigation between the parties regarding this Agreement and (d) any communications with holders of any securities of STX, in their capacities as such, to the extent necessary in connection with the consummation of the transactions contemplated by this Agreement.

Section 5.14.     NYSE Listing. Eros shall use reasonable best efforts to cause the Eros A Ordinary Shares issuable pursuant to the CVRs to be approved for listing on the NYSE, subject to official notice of issuance, prior to the Closing Date.

Section 5.15.     Takeover Statutes. If any antitakeover or similar statute or regulation is or may become applicable to the transactions contemplated by this Agreement, each of the parties hereto and its respective Board of Directors shall (a) grant such approvals and take all such actions as are legally permissible so that the transactions contemplated hereby may be consummated as promptly as practicable on the terms contemplated hereby and (b) otherwise act to eliminate or minimize the effects of any such statute or regulation on the transactions contemplated hereby.

Section 5.16.     Conveyance Taxes. Eros and STX shall cooperate in the preparation, execution and filing of all Tax Returns, questionnaires, applications or other documents regarding any real property transfer, sales, use, transfer, value added, stock transfer and stamp Taxes, any transfer, recording, registration and other fees or any similar Taxes which become payable in connection with the transactions contemplated by this Agreement that are required or permitted to be filed on or before the Effective Time.

Section 5.17.     Employee Matters.

(a)             Eros and STX shall cooperate in good faith in reviewing, evaluating and analyzing the Eros Benefit Plans and STX Benefit Plans with a view towards developing appropriate new benefit plans, or selecting the Eros Benefit Plans and/or STX Benefit Plans, as applicable, that will apply with respect to employees of Eros and its Subsidiaries (including the Surviving Corporation and its Subsidiaries) after the Effective Time (collectively, the “New Benefit Plans”). To the extent benefit transition or integration after the Effective Time is desired by the appropriate members of management following the Effective Time, the New Benefit Plans will, to the extent permitted by Applicable Law, and among other things, (i) treat similarly situated employees of Eros, STX and their respective Subsidiaries on a substantially equivalent basis, taking into account all relevant factors, including duties, geographic location, tenure, qualifications and abilities, and (ii) not discriminate between employees who were covered by Eros Benefit Plans, on the one hand, and those covered by STX Benefit Plans, on the other hand, at the Effective Time.

(b)            For purposes of eligibility, participation, vesting and determination of the level of benefits (except (i) for purposes of benefit accrual under any defined benefit pension or similar plan, (ii) to the extent that such credit would result in a duplication of benefits, or (iii) under any plan that is grandfathered or frozen) under the New Benefit Plans, service with or

60 

 

credited by Eros, STX or any of their respective Subsidiaries or predecessors credited under the Eros Benefit Plans or STX Benefit Plans for continuing employees of STX and its Subsidiaries or continuing employees of Eros or its Subsidiaries, as applicable, shall be treated as service under the applicable New Benefit Plans to the same extent and for the same purpose that such service was taken into account under the analogous STX Benefit Plan or Eros Benefit Plan prior to the Effective Time. With respect to any New Benefit Plan in which any employees of Eros or STX (or their Subsidiaries) immediately prior to the Effective Time first become eligible to participate on or after the Effective Time, and in which such employees did not participate prior to the Effective Time, Eros shall use commercially reasonable efforts to: (A) waive all preexisting conditions, exclusions and waiting periods with respect to participation and coverage requirements applicable to such employees and their eligible dependents, except to the extent such pre-existing conditions, exclusions or waiting periods would apply under the analogous Eros Benefit Plan or STX Benefit Plan, as the case may be, and (B) provide each such employee and his or her eligible dependents with credit for any co-payments and deductibles paid prior to the Effective Time (or, if later, prior to the time such employee commenced participation in the New Benefit Plan) under an Eros Benefit Plan or STX Benefit Plan (to the same extent that such credit was given under the analogous STX or Eros Benefit Plan) in satisfying any applicable deductible or out-of-pocket requirements under any New Benefit Plan in which such employee first become eligible to participate after the Effective Time.

(c)             Eros and STX shall cooperate in good faith to mutually determine, no later than five (5) Business Days before the Closing Date, whether any 401(k) plans maintained by STX or any of its Subsidiaries or by Eros or any of its Subsidiaries shall be terminated effective as of the day immediately preceding the date STX becomes a member of the same controlled group of corporations (as defined in Section 414(b) of the Code) as Eros (the “Plan Termination Date”). Following any such mutual determination to terminate such a 401(k) plan (the “Terminating 401(k) Plan”), STX, Eros, or its Subsidiary, as applicable, shall (i) cause written resolutions of the applicable board of directors (or similar governing body) to be adopted to terminate the Terminating 401(k) Plan and to fully vest all participants under the Terminating 401(k) Plan, such termination and vesting to be effective no later than the Plan Termination Date and (ii) make all employee and employer contributions to the Terminating 401(k) Plan on behalf of all participants under the plan for all periods of service prior to the Plan Termination Date, including such contributions that would have been made on behalf of such employees had the transactions contemplated hereby not occurred (regardless of any service or end-of-year employment requirements) but prorated for the portion of the plan year that ends on the Plan Termination Date. Eros or STX, as applicable, shall cause the sponsor of the Terminating 401(k) Plan to provide the other party with an advance copy of such proposed resolutions (and any related documents) and a reasonable opportunity to comment thereon prior to its adoption or execution. Eros and STX shall cooperate and take all such other actions as are reasonably necessary in furtherance of terminating the Terminating 401(k) Plan and causing participants in the Terminating 401(k) Plan to become participants in the appropriate remaining 401(k) plan of Eros, STX or its respective Subsidiary, including causing such replacement plan to accept rollovers of account balances (including outstanding plan loans) from the Terminating 401(k) Plan at the employees’ election.

61 

 

(d)            Without limitation to the agreements set forth in Section 1.6: (i) nothing in this Section 5.17 shall confer upon any employee, officer, director or consultant of Eros or STX or any of their Subsidiaries or Affiliates any right to continue in the employ or service of the Surviving Corporation, STX, Eros or any Subsidiary or Affiliate thereof, or shall interfere with or restrict in any way the rights of the Surviving Corporation, STX, Eros or any Subsidiary or Affiliate thereof to discharge or terminate the services of any employee, officer, director or consultant of Eros or STX or any of their Subsidiaries or Affiliates at any time for any reason whatsoever, with or without cause; and (ii) nothing in this Agreement shall be deemed to (i) establish, amend, or modify any STX Benefit Plan, Eros Benefit Plan, New Benefit Plan or any other benefit or employment plan, program, agreement or arrangement or (ii) alter or limit the ability of the Surviving Corporation or any of its Subsidiaries or Affiliates to amend, modify or terminate any particular STX Benefit Plan, Eros Benefit Plan, New Benefit Plan or any other benefit or employment plan, program, agreement or arrangement after the Effective Time. Without limiting the generality of Section 8.6, nothing in this Section 5.17, express or implied, is intended to or shall confer upon any Person, including any current or former employee, officer, director or consultant of Eros or STX or any of their Subsidiaries or Affiliates, any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement, including but not limited to the provisions of this Section 5.17.

Section 5.18.     Section 280G Matters. STX shall (a) use commercially reasonable efforts to obtain, no less than five (5) Business Days prior to the Closing, a waiver from each “disqualified individual” (within the meaning of Section 280G of the Code and the regulations thereunder) that shall provide that, if the requisite stockholder approval under Section 280G(b)(5)(B) of the Code and the regulations thereunder is not obtained, no payments or benefits that would separately or in the aggregate constitute “excess parachute payments” (within the meaning of Section 280G of the Code and the regulations thereunder) with respect to such disqualified individual in the absence of such stockholder approval shall be payable to or retained by such disqualified individual to the extent such excess parachute payments would not be deductible by reason of the application of Section 280G of the Code or would result in the imposition of excise Taxes under Section 4999 of the Code upon such disqualified individual; and (b) deliver, no less than four (4) Business Days prior to the Closing, to the stockholders of STX a disclosure statement in a form which satisfies the disclosure obligations under Section 280G(b)(5)(B) of the Code and the regulations thereunder, and which solicits and recommends that the shareholders vote in favor of the transactions disclosed therein through a vote meeting the requirements of Section 280G(b)(5)(B) of the Code and the regulations thereunder, and which provides for a voting process that is intended to be completed no later than the day prior to the Closing Date. STX shall provide Eros and its Representatives with a copy of the form of such waiver and such disclosure statement, all “parachute payment” calculations and all other relevant documents for its review and approval (which approval shall not be unreasonably withheld) no less than five (5) Business Days prior to delivery to each such disqualified individual and to stockholders of STX, respectively, and STX shall consider in good faith all reasonable comments timely provided by STX or its Representatives.

Section 5.19.     Certain Litigation. Each party shall promptly advise the other of any litigation commenced after the date hereof against such party or any of its directors or officers (in their capacity as such) by any stockholders of such party (on their own behalf or on behalf of such party) relating to this Agreement or the transactions contemplated hereby, and shall keep

62 

 

the other parties reasonably informed regarding any such litigation. Such party shall give the other parties the opportunity to participate in the defense or settlement of any such stockholder litigation, and no such settlement shall be agreed to without the other party’s prior consent (which consent shall not be unreasonably withheld, conditioned or delayed). In the event of, and to the extent of, any conflict or overlap between the provisions of this Section 5.19 and Section 5.1, Section 5.2 or Section 5.10, the provisions of this Section 5.19 shall control.

Section 5.20.     Merger Sub Actions. Concurrently with the execution of this Agreement, England Holdings 2, as the sole member of Merger Sub shall adopt this Agreement and the Merger. Eros shall cause Merger Sub to comply with its obligations under this Agreement.

Section 5.21.     Spreadsheet. Not less than three (3) Business Days prior to the Closing, STX shall deliver to Eros a spreadsheet (the “Spreadsheet”), setting forth the following information, in form and substance reasonably satisfactory to Eros and accompanied by documentation reasonably satisfactory to Eros in support of the calculation of the information set forth therein:

(a)             the number of shares and corresponding ownership percentage of each holder of STX Preferred Stock, on a class-by-class basis, that will be held by each such holder as of immediately prior to the Effective Time, together with a calculation of the aggregate accrued entitlements of such holders to any liquidation preference or exit payment as of the Effective Time, in each case as of immediately prior to the Effective Time; and

(b)            the number of CVRs of each class issuable to each such holder of STX Preferred Stock in respect of such holder’s shares of STX Preferred Stock.

Section 5.22.     Management Equity Compensation Plan. Eros and STX shall cooperate in good faith to prepare, or cause to be prepared, a mutually agreeable management equity compensation plan, which shall have an aggregate pool of equity of not less than 40,000,000 shares of Eros A Ordinary Shares, and shall otherwise be substantially in the form of the Eros International Plc 2017 Restricted Share and Restricted Stock Unit Plan, for adoption by the Eros Board immediately following the Effective Time.

Section 5.23.     CVR Agreements; Nonregistrable CVRs.

(a)             At or prior to the Closing, Eros will execute and deliver, and will use commercially reasonable efforts to ensure that the Rights Agent party to each of the CVR Agreements executes and delivers, the CVR Agreements, subject to any reasonable revisions to the CVR Agreements that are requested by the Rights Agent and that are not, individually or in the aggregate, detrimental to any Holder (as defined in the respective CVR Agreement) (other than in immaterial respects) and reasonably satisfactory to the stockholders representative party thereto.

(b)            Prior to the Closing, Eros and STX shall cooperate, including by making changes to the form of the CVR Agreements (provided, that such revisions do not adversely affect any rights to payment or issuance of Eros A Ordinary Shares under the CVR Agreements), as necessary to ensure that the CVRs are not subject to registration under the Securities Act, the Exchange Act or any applicable state securities or “blue sky” laws.

63 

 

Section 5.24.     Pre-Closing Class E Subscription. Prior to the Closing, STX shall consummate the sale and purchase of the STX Class E Preferred Stock on the terms and conditions pursuant to the Class E Share Purchase Agreement, by and among STX and the purchasers party thereto, substantially in the form attached here on Exhibit K (the consummation of the transactions contemplated thereby, the “Pre-Closing Class E Subscription”) and shall take all other necessary action pursuant to the Pre-Closing Class E Subscription, Applicable Law and the organizational documents of STX to consummate the Pre-Closing Class E Subscription effective prior to the Closing.

Section 5.25.     Eros Convertible Notes Amendment. Prior to the Closing, Eros shall use commercially reasonable efforts to obtain an amendment to the Eros Convertible Notes in form and substance reasonably satisfactory to each of Eros and STX such that Section 7(c) (Holder’s Right of Adjusted Conversion Price) and Section 10 (Redemptions) of the Eros Convertible Notes shall not apply with respect to the transactions contemplated by this Agreement or the Eros Share Issuance.

Section 5.26.     Eros Pre-Closing Equity Financing. At or prior to the Closing, Eros shall consummate the Eros Pre-Closing Equity Financing for aggregate gross cash proceeds to Eros of at least $35,000,000, of which not less than $20,000,000 shall be drawn from the Eros Equity Facility, all in accordance with the PIPE Subscription Agreement.

Section 5.27.     Provision Respecting Representation of STX. Each of the parties hereto hereby agrees, on its own behalf and on behalf of its directors, members, partners, stockholders, officers, employees and Affiliates (including the Surviving Corporation and its Subsidiaries following the Closing), that Kirkland & Ellis LLP (or any successor) and Appleby (Isle of Man) LLC (or any successor) may serve as counsel to (a) (i) STX and (ii) each of STX’s stockholders and their respective Affiliates (other than STX and its Subsidiaries) (individually and collectively, the “STX Group”), on the one hand, and (b) STX and its Subsidiaries, on the other hand, in connection with the negotiation, preparation, execution and delivery of this Agreement and the consummation of the transactions contemplated hereby, and that, following consummation of the transactions contemplated hereby, Kirkland & Ellis LLP (or any successor) and Appleby (Isle of Man) LLC (or any successor) may serve as counsel to STX, the STX Group or any director, member, partner, stockholder, officer, employee or Affiliate of the STX Group, in connection with any litigation, claim or obligation arising out of or relating to this Agreement or the transactions contemplated by this Agreement notwithstanding such prior representation of STX and its Subsidiaries, and each of the parties hereto hereby consents thereto and waives any conflict of interest arising therefrom, and each of such parties shall cause any Affiliate (including the Surviving Corporation and its Subsidiaries following the Closing) thereof to consent to and waive any conflict of interest arising from such representation. Each of the parties hereto hereby irrevocably acknowledges and agrees that all communications prior to the Closing between STX and its Subsidiaries and/or the STX Group, on the one hand, and their external legal counsel, including Kirkland & Ellis LLP and Appleby (Isle of Man) LLC, on the other hand, made in connection with the negotiation, preparation, execution, delivery and performance under, or any dispute or proceeding arising out of or relating to, this Agreement, any agreements contemplated by this Agreement or the transactions contemplated hereby or thereby, or any matter relating to

64 

 

any of the foregoing, are privileged communications between STX, its Subsidiaries and the STX Group and such counsel (collectively, the “Privileged Communications”) and after the Closing shall belong solely to the STX Group. From and after the Closing, none of STX (including the Surviving Corporation and its Subsidiaries following the Closing), its Subsidiaries, Eros or any Person purporting to act on behalf of or through STX or its Subsidiaries shall have access to or will seek to obtain such communications, whether by seeking a waiver of the attorney-client privilege or through any other means. To the extent that files in respect of any Privileged Communications constitute property of the client, only the STX Group shall hold such property rights. As to any such Privileged Communications prior to the Closing Date, Eros, STX (including the Surviving Corporation and its Subsidiaries following the Closing), and each of its Subsidiaries together with any of their respective Affiliates, successors or assigns, further agree that no such party may use or rely on any of the Privileged Communications in any action against or involving any of the parties hereto after the Closing.

Article VI
CONDITIONS PRECEDENT

Section 6.1.        Conditions to Each Party’s Obligation to Effect the Merger. The respective obligation of each party to effect the Merger is subject to the satisfaction, or waiver in whole or in part (to the extent permitted by Applicable Law), on or prior to the Closing Date of the following conditions:

(a)             HSR Act. Any applicable waiting period (and any extension thereof) under the HSR Act relating to the consummation of the Merger shall have expired or early termination thereof shall have been granted.

(b)            Other Approvals. Any authorization or consent from a Governmental Authority required to be obtained with respect to the Merger under any Antitrust Law as set forth on Section 6.1(c) of the Eros Disclosure Letter shall have been obtained and shall remain in full force and effect.

(c)             No Injunctions or Restraints. No Governmental Authority of competent jurisdiction shall have issued or entered any permanent or preliminary Order after the date of this Agreement, and no Applicable Law shall have been enacted or promulgated after the date of this Agreement, in each case, that (whether temporary or permanent) is then in effect and has the effect of enjoining or otherwise prohibiting or making illegal the consummation of the Merger.

(d)            Eros PIPE Financing. The Eros PIPE Financing shall have been consummated or shall consummate substantially concurrently with the Closing.

(e)             Stock Exchange Listing. The Eros A Ordinary Shares to be issued in the Eros Share Issuance shall have been approved for listing on the NYSE, subject to official notice of issuance.

(f)             STX Lender Consents. The STX Lender Consents shall remain in full force and effect.

65 

 

(g)            Pre-Closing Class E Subscription. The Pre-Closing Class E Subscription shall have been consummated.

(h)            Eros Pre-Closing Equity Financing. The Eros Pre-Closing Equity Financing, in an aggregate amount no less than $35,000,000, shall have been consummated or consummate substantially concurrently with the Closing.

(i)              STX Paydown of Indebtedness. An amount equal to $21,500,000 from the cash proceeds of the Eros PIPE Financing shall be used to repay a portion of the outstanding Indebtedness of STX set forth on a Section 6.1(i) of the STX Disclosure Letter.

Section 6.2.        Conditions to Obligations of the Eros Parties. The obligation of the Eros Parties to effect the Merger is further subject to satisfaction, or waiver in whole or in part (to the extent permitted by Applicable Law), of the following conditions:

(a)             Representations and Warranties. (i) The representations and warranties of STX contained in Section 3.1, Section 3.2 and Section 3.22 shall be true and correct as of the Closing Date as though made on the Closing Date (except to the extent such representations and warranties expressly relate to a specific date or the date of this Agreement, in which case such representations and warranties, shall be true and correct as of such date); (ii) the representations and warranties of STX contained in Section 3.4 shall be true and correct as of the Closing Date as though made on the Closing Date (except to the extent such representations and warranties expressly relate to a specific date or the date of this Agreement, in which case such representations and warranties, shall be true and correct as of such date), except for any inaccuracies that, individually or in the aggregate, are de minimis; (iii) the representations and warranties of STX contained in Section 3.7(b) shall be true and correct in all respects as of the Closing Date as though made on the Closing Date; and (iv) each of the other representations and warranties of STX contained in this Agreement (without giving effect to any limitation as to “materiality,” “Material Adverse Effect” or any similar qualification set forth therein) shall be true and correct as of the Closing Date as though made on the Closing Date (except to the extent such representations and warranties expressly relate to a specific date or the date of this Agreement, in which case such representations and warranties shall be true and correct as of such date), except where the failure to be so true and correct does not, and would not reasonably be expected to, individually or in the aggregate, have a Material Adverse Effect on STX.

(b)            Performance of Obligations of STX. STX shall have performed in all material respects all obligations required to be performed by it under this Agreement at or prior to the Closing Date.

(c)             No Material Adverse Effect. There shall not have occurred a Material Adverse Effect on STX.

(d)            Officer’s Certificate. Eros shall have received an officer’s certificate duly executed by the Chief Executive Officer or the Chief Financial Officer of STX to the effect that the conditions set forth in Section 6.2(a) and Section 6.2(b) have been satisfied.

66 

 

(e)             Eros Investors’ Rights Agreement. Eros shall have received an executed counterpart of the Eros Investors’ Rights Agreement, duly executed by each party thereto other than Eros and the members of the Eros Founder Group, and the Eros Investors’ Rights Agreement shall remain in full force and effect.

(f)             Registration Rights Agreement. Eros shall have received an executed counterpart of the Registration Rights Agreement, duly executed by each party thereto other than Eros and the members of the Eros Founder Group.

(g)            FIRPTA Certificate. STX shall have delivered to Eros (i) a properly executed certificate of STX certifying that STX is not, and has not been, a United States real property holding corporation within the meaning of Section 897(c)(2) of the Code during the applicable period specified in Section 897(c)(1)(A)(ii) of the Code, which certificate complies with the requirements of Section 1445 of the Code, and (ii) a form of notice to the IRS prepared in accordance with the requirements of Treasury Regulation Section 1.897-2(h)(2), each in substantially the form attached hereto as Exhibit L.

(h)            CVR Agreements. Eros shall have received executed counterparts of the CVR Agreements, duly executed by each party thereto other than Eros and the Rights Agent party thereto.

Section 6.3.        Conditions to Obligations of STX. The obligation of STX to effect the Merger is further subject to satisfaction, or waiver in whole or in part (to the extent permitted by Applicable Law), of the following conditions:

(a)             Representations and Warranties. (i) The representations and warranties of the Eros Parties and Merger Sub contained in Section 4.1, Section 4.2, Section 4.24 and Section 4.25 shall be true and correct as of the Closing Date as though made on the Closing Date (except to the extent such representations and warranties expressly relate to a specific date or the date of this Agreement, in which case such representations and warranties, shall be true and correct as of such date); (ii) the representations and warranties of Eros contained Section 4.4 shall be true and correct as of the Closing Date as though made on the Closing Date (except to the extent such representations and warranties expressly relate to a specific date or the date of this Agreement, in which case such representations and warranties, shall be true and correct as of such date), except for any inaccuracies that, individually or in the aggregate, are de minimis; (iii) the representations and warranties of Eros contained in Section 4.7(b) shall be true and correct in all respects as of the Closing Date as though made on the Closing Date; and (iv) each of the other representations and warranties of the Eros Parties and Merger Sub contained in this Agreement (without giving effect to any limitation as to “materiality,” “Material Adverse Effect” or any similar qualification set forth therein) shall be true and correct as of the Closing Date as though made on the Closing Date (except to the extent such representations and warranties expressly relate to a specific date or the date of this Agreement, in which case such representations and warranties shall be true and correct as of such date), except where the failure to be so true and correct does not, and would not reasonably be expected to, individually or in the aggregate, have a Material Adverse Effect on the Eros Parties.

67 

 

(b)            Performance of Obligations of the Eros Parties. Each Eros Party shall have performed in all material respects all obligations required to be performed by it under this Agreement at or prior to the Closing Date.

(c)             No Material Adverse Effect. There shall not have occurred a Material Adverse Effect on Eros.

(d)            Officer’s Certificate. STX shall have received an officer’s certificate duly executed by the Chief Executive Officer or the Chief Financial Officer of Eros to the effect that the conditions set forth in Section 6.3(a) and Section 6.3(b) have been satisfied.

(e)             Eros Investors’ Rights Agreement. STX shall have received an executed counterpart of the Eros Investors’ Rights Agreement, duly executed by Eros, the members of the Eros Founder Group party, each of the holders of the CVRs and the New Investors, and the Eros Investors’ Rights Agreement shall remain in full force and effect.

(f)             Registration Rights Agreement. STX shall have received an executed counterpart of the Registration Rights Agreement, duly executed by Eros, the members of the Eros Founder Group, the holders of the CVRs and the New Investors party thereto.

(g)            CVR Agreements. The CVR Agreements shall have been duly executed and delivered by Eros and the Rights Agent party thereto.

Article VII
TERMINATION, AMENDMENT AND WAIVER

Section 7.1.        Termination. This Agreement may be terminated at any time prior to the Effective Time, and whether before or after receipt of the STX Requisite Stockholder Approval, the Eros Requisite Shareholder Approval or the England Holdings 2 Requisite Shareholder Approval:

(a)             by mutual written consent of STX and Eros;

(b)            by either STX or Eros, if:

(i)              the Merger shall not have been consummated by August 17, 2020 (the “Outside Date”); provided, that if as of two (2) Business Days prior to the Outside Date, any of the conditions set forth in Section 6.1(a), Section 6.1(b) or Section 6.1(c) (solely as it relates to any Antitrust Laws or Orders entered thereunder) shall not be satisfied or waived but all other conditions set forth in Section 6.1 shall have been and remain satisfied or waived (other than those that by their terms are to be fulfilled at the Closing, provided that each such condition would be capable of being fulfilled if the Closing were to occur on such date), then the Outside Date shall automatically be extended, without the need for any action by STX, Eros, England Holdings 2 or Merger Sub, to November 13, 2020 (and any reference to the Outside Date in this Agreement shall be deemed to be November 13, 2020); provided, further, the right to terminate this Agreement pursuant to this Section 7.1(b)(i) shall not be available to any party if a material breach by such party of any of its obligations under this Agreement results in the failure to satisfy a condition set forth in Article VI;

68 

 

(ii)            (A) prior to the Effective Time, any Governmental Authority of competent jurisdiction shall have issued or entered any Order after the date of this Agreement or any Applicable Law shall have been enacted or promulgated after the date of this Agreement that has the effect of permanently restraining, enjoining or otherwise prohibiting the Merger, and in the case of such an Order, such Order shall have become final and non-appealable, or (B) any expiration, termination, authorization or consent from a Governmental Authority required to be obtained pursuant to Section 6.1(a) or Section 6.1(b) shall have been denied and such denial shall have become final and non-appealable; provided, that the right to terminate this Agreement under this Section 7.1(b)(ii) shall not be available to a party if such party has failed to comply with its obligations under Section 5.10 in any material respect;

(c)             by STX (provided that STX is not then in breach of any representation, warranty, covenant or other agreement contained in this Agreement, which breach would result in the failure of a condition set forth in Section 6.2(a), Section 6.2(b) or Section 6.2(c)), if Eros shall have breached or failed to perform any of its representations, warranties, covenants or other agreements contained in this Agreement, which breach or failure to perform (i) would result in the failure of a condition set forth in Section 6.3(a), Section 6.3(b) or Section 6.3(c) and (ii) is incapable of being cured by Eros or is not cured within thirty (30) days of receipt of a written notice thereof from STX.

(d)            by Eros (provided that Eros is not then in breach of any representation, warranty, covenant or other agreement contained in this Agreement, which breach would result in the failure of a condition set forth in Section 6.3(a), Section 6.3(b) or Section 6.3(c)), if STX shall have breached or failed to perform any of its representations, warranties, covenants or other agreements contained in this Agreement, which breach or failure to perform (i) would result in the failure of a condition set forth in Section 6.2(a), Section 6.2(b) or Section 6.2(c) and (ii) is incapable of being cured by STX or is not cured within thirty (30) days of receipt of a written notice thereof from Eros; and

Section 7.2.        Effect of Termination. In the event of termination of this Agreement as provided in Section 7.1, this Agreement shall forthwith become void, and there shall be no liability or obligation on the part of any of the parties, except (a) the provisions of this Section 7.1(d), Section 5.12, Section 5.13, and Article VIII shall survive any such termination of this Agreement and no such termination shall relieve either party from any liability or obligation under such provisions and (b) nothing contained herein shall relieve any party from liability for any Willful Breach hereof or actual fraud (as defined under the laws of the State of Delaware) occurring prior to such termination.

Section 7.3.        Amendment. Subject to compliance with Applicable Law, this Agreement may be amended by the parties hereto at any time before or after the STX Requisite Stockholder Approval, the Eros Requisite Shareholder Approval or the England Holdings 2 Requisite Shareholder Approval; provided that any amendment of this Agreement that requires approval by the stockholders of STX or approval by the shareholders of Eros under Applicable Law shall be subject to such approval. This Agreement may not be amended except by an instrument in writing signed on behalf of each of the parties hereto and duly approved by the parties’ respective Boards of Directors or a duly authorized committee thereof.

69 

 

Section 7.4.        Extension; Waiver. At any time prior to the Effective Time, a party may, subject to the proviso of the first sentence of Section 7.3 (and for this purpose treating any waiver referred to below as an amendment), (a) extend the time for the performance of any of the obligations or other acts of the other parties, (b) waive any inaccuracies in the representations and warranties of the other parties contained in this Agreement or in any document delivered pursuant to this Agreement, (c) waive compliance by the other party with any of the agreements or conditions for the benefit of such party contained in this Agreement or (d) waive the satisfaction of any of the conditions contained in this Agreement. No extension or waiver by STX or Eros shall require the approval of the stockholders of STX or shareholders of Eros, respectively, unless such approval is required by Applicable Law. Any agreement on the part of a party hereto to any such extension or waiver shall be valid only if set forth in an instrument in

writing signed on behalf of such party. Any extension or waiver given in compliance with this Section 7.4 or failure to insist on strict compliance with an obligation, covenant, agreement or condition shall not operate as a waiver of, or estoppel with respect to, any subsequent or other failure.

Article VIII
GENERAL PROVISIONS

Section 8.1.        Non-survival of Representations and Warranties. None of the representations and warranties in this Agreement or in any instrument delivered pursuant to this Agreement shall survive the Closing. This Section 8.1 shall not limit any covenant or agreement of the parties that, by its terms, contemplates performance after the Closing, each of which shall survive the Closing in accordance with its terms.

Section 8.2.        Notices. All notices, requests, claims, demands and other communications under this Agreement shall be in writing and shall be deemed given (i) if delivered personally, upon such delivery, (ii) if delivered by electronic mail, when confirmation of successful transmission is received or (iii) if sent by Federal Express or other nationally-recognized overnight courier, upon delivery or refusal of delivery, to the parties at the following addresses (or at such other address for a party as shall be specified by like notice):

(a)             if to Eros, England Holdings 2 or Merger Sub to:

Eros International Plc

First Names House

Victoria Road

Douglas

Isle of Man IM2 4DF

British Isles

Attention:Mark Carbeck, Chief Corporate and Strategy Officer
Email:mark.carbeck@erosintl.com

70 

 

with a copy (which shall not constitute notice) to:

Gibson, Dunn & Crutcher LLP
333 South Grand Avenue
Los Angeles, California 90071-3197

Attention:Kevin Masuda
Peter Wardle
Email:kmasuda@gibsondunn.com
pwardle@gibsondunn.com

(b)            if to STX, to:

STX Filmworks, Inc.

3900 W. Alameda Ave., 32nd Floor

Burbank, California 91505

Attention:Noah Fogelson
Email:nfogelson@stxentertainment.com

with a copy (which shall not constitute notice) to:

Kirkland & Ellis LLP
555 South Flower Street, Suite 3700
Los Angeles, California 90071

Attention:Rick C. Madden, P.C.
Jennifer Yapp
Email:rick.madden@kirkland.com
jennifer.yapp@kirkland.com

 

Section 8.3.        Definitions. For purposes of this Agreement:

(a)             Accredited Investor” means an “accredited investor” as such term is defined in Rule 501(a) of Regulation D under the Securities Act;

(b)            Affiliate” means, with respect to any Person, another Person that directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, such first Person, where “control” means the possession, directly or indirectly, of the power to direct or cause the direction of the management policies of a Person, whether through the ownership of voting securities, by contract, as trustee or executor, or otherwise;

(c)             Anti-Corruption Laws” means the U.S. Foreign Corrupt Practices Act of 1977, as amended, the U.S. Travel Act, the U.K. Bribery Act 2010, laws promulgated in accordance with the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions or any other Applicable Law relating to anti-corruption or anti-bribery;

71 

 

(d)            Business Day” means any day other than a Saturday, Sunday or federal holiday, or a day on which banks in Los Angeles, California or London, United Kingdom are authorized or obligated by law to close;

(e)             Bylaws of England Holdings 2” means the Bylaws of England Holdings 2, adopted as of March 20, 2020;

(f)             Bylaws of STX ” means the Second Amended and Restated Bylaws of STX, adopted as of September 8, 2017;

(g)            Code” means the Internal Revenue Code of 1986, as amended from time to time;

(h)            Companies Act” means the Companies Act 2006 of the Isle of Man as in effect from time to time;

(i)              Contract” means any contract, lease, licenses, note, mortgage, indentures, commitment or other agreement, instrument or arrangements (in each case including any amendments and other modifications thereto), whether written or oral, that is or purports to be legally binding;

(j)              EIML Debt” means the instruments set forth on Section 4.17(a)(iii) of the Eros Disclosure Letter;

(k)            England Holdings 2 Certificate of Incorporation” means the Certificate of Incorporation of England Holdings 2 filed with the Secretary of State of Delaware on March 20, 2020;

(l)              Environmental Laws” means all Applicable Laws relating to pollution or protection of the environment, natural resources, including natural resource damages, or, as it relates to exposure to Hazardous Materials, human health and safety, including Applicable Laws relating to Releases of, or exposure to, Hazardous Materials, and to the manufacture, processing, distribution, use, treatment, storage, transport or handling of Hazardous Materials;

(m)           ERISA” means the United States Employee Retirement Income Security Act of 1974, as amended;

(n)            ERISA Affiliate” means, with respect to any entity, trade or business, any other entity, trade or business that is a member of a group described in Section 414(b), (c), (m) or (o) of the Code or Section 4001(b)(1) of ERISA that includes the first entity, trade or business, or that is a member of the same “controlled group” as the first entity, trade or business pursuant to Section 4001(a)(14) of ERISA;

(o)            Eros Articles of Association” means the Articles of Association of Eros (adopted by resolution passed on 20th December 2019), as in effect on the date hereof;

72 

 

(p)            Eros Benefit Plan” means each employee, officer, director or other individual service provider compensation or benefit plan, program, arrangement or agreement, whether or not written, including any employee welfare benefit plan within the meaning of Section 3(1) of ERISA (whether or not such plan is subject to ERISA), any employee pension benefit plan within the meaning of Section 3(2) of ERISA (whether or not such plan is subject to ERISA) and any bonus, incentive, profit sharing, deferred compensation, vacation, stock purchase, equity or equity-based, separation or severance, termination, retention, employment, consulting or other service, transaction, change in control or fringe benefit plan, program, arrangement or agreement that is sponsored, maintained or contributed to by Eros or any of its Subsidiaries or which Eros or any of its Subsidiaries is obligated to sponsor, maintain or contribute to, or as to which Eros or any of its Subsidiaries has or could reasonably be expected to have any liability;

(q)            Eros Convertible Notes” means Eros’s Senior Convertible Notes due September 27, 2020, in the aggregate principal amount of $27,500,000;

(r)             Eros Equity Awards” means the Eros Options and the Eros RSU Awards;

(s)             Eros Equity Facility” means, collectively, (i) that certain Subscription Agreement between Eros and the purchaser party thereto, dated January 20, 2020, and (ii) any other subscription agreement having substantially identical terms as the subscription agreement described in the foregoing clause (i) entered into between Eros and another purchaser after the date hereof and prior to the Closing Date for an aggregate commitment (inclusive of the subscription agreement described in the foregoing clause (i)) not to exceed $100,000,000;

(t)              Eros Founder Group” means the “Permitted Holders” as defined in Article 22.1 of the Eros Articles of Association;

(u)            Eros Leased Real Property” means all leasehold or subleasehold estates and other rights to use or occupy any land, buildings, structures, improvements, fixtures or other interest in real property held by Eros or any of its Subsidiaries;

(v)            Eros Option” means each compensatory option to purchase Eros Ordinary Shares;

(w)           Eros Owned Real Property” means all land, together with all buildings, structures, improvements and fixtures located thereon, and all easements and other rights and interests appurtenant thereto, owned by Eros or any of its Subsidiaries;

(x)            Eros Parties” means Eros and England Holdings 2.

73 

 

(y)            Eros RSU Award” each award of restricted stock units relating to Eros Ordinary Shares;

(z)             Exit Payment” has the meaning ascribed to such term in the STX Certificate of Incorporation;

(aa)          Governmental Authority” means any United States or non-United States federal, state, local or supranational government, any court, legislative, administrative, regulatory or other governmental agency, commission or authority or any non-governmental self-regulatory agency, commission, authority or similar body, including any arbitrator (public or private);

(bb)         Hazardous Materials” means any material, substance, chemical or waste (or combination thereof) that is listed, defined,

designated, regulated or classified as hazardous, toxic, radioactive, dangerous, a pollutant, a contaminant, a per- or polyfluoroalkyl substance, petroleum, oil, asbestos, or words of similar meaning or effect under any Applicable Law relating to pollution, waste, the environment, health, safety, or natural resources;

(cc)          Immediate Family,” with respect to a specified Person, means such Person’s spouse, parents or children, including adoptive relationships and relationships through marriage, or any other relative of such Person that shares such Person’s home;

(dd)         Intellectual Property” means intellectual property rights arising from or associated with the following, whether protected, created or arising under the laws of the United States or any other jurisdiction: (i) trade names, trademarks and service marks (registered and unregistered), domain names, trade dress rights, and applications (including intent to use applications and similar reservations of marks and all goodwill associated therewith) to register any of the foregoing (collectively, “Marks”); (ii) patents, utility models and any statutory rights with respect to the protection of inventions, and all applications for any of the foregoing (collectively, “Patents”); (iii) copyrights (registered and unregistered) and applications for registration, published an unpublished works of authorship, including software, digital libraries, social media and Internet website pages (collectively, “Copyrights”); (iv) trade secrets, know-how, inventions, methods, processes and processing instructions, technical data, specifications, research and development information, technology including rights and licenses, product roadmaps, customer lists and any other information, in each case to the extent any of the foregoing derives economic value (actual or potential) from not being known to other persons who can obtain economic value from its disclosure or use, excluding any Copyrights or Patents that may cover or protect any of the foregoing (collectively, “Trade Secrets”); and (v) to the extent protectable under law, moral rights, publicity rights, data, database rights, electronic data processing, passwords, access and other rights with respect to social media and networking accounts, and subscribers, archives, and server traffic logs relating to any websites; and (vi) any other proprietary or intellectual property rights of any kind or nature;

74 

 

(ee)          International Trade Laws” means all Applicable Laws relating to export controls, imports, customs, sanctions, and anti-boycott measures, including the laws and regulations administered or enforced by the U.S. Department of Commerce, U.S. Department of Treasury Office of Foreign Assets Control (“OFAC”), U.S. International Trade Commission, U.S. Customs and Border Protection, U.S. Immigration and Customs Enforcement, and their predecessor or successor agencies;

(ff)           IT Assets” means computers, computer software, firmware, middleware, servers, workstations, routers, hubs, switches, data communications lines and other information technology equipment or systems;

(gg)         Knowledge” means, with respect to Eros or STX, as applicable, the actual knowledge of Eros’s or STX’s, as applicable, Chairman,

Chief Executive Officer, Chief Financial Officer, Chief Corporate and Strategy Officer, Chief Operating Officer, General Counsel and Chief Human Resources Officer (or equivalent officer) after having made reasonable inquiry of those employees of Eros (and its respective Subsidiaries) or STX (and its respective Subsidiaries), as applicable, primarily responsible for such matters;

(hh)         Leases” means all leases, subleases, licenses, concessions and other agreements (written or oral) pursuant to which STX, Eros or either of their subsidiaries holds any STX Leased Real Property or Eros Leased Real Property, as applicable;

(ii)            Liquidation Value” has the meaning ascribed to such term in the STX Certificate of Incorporation;

(jj)            Material Adverse Effect” on a STX or an Eros Party means any change, event, occurrence or development (each, a “Change”) that has had, or would reasonably be expected to have, individually or in the aggregate with all other Changes, a material adverse effect on the business, financial condition or results of operations of such STX and its Subsidiaries, taken as a whole, or Eros and its Subsidiaries (without giving effect to the Merger), taken as a whole, respectively, excluding any Change to the extent that it results from or arises out of (i) general economic or political conditions or securities, credit, financial or other capital markets conditions, in each case in the United States or any foreign jurisdiction; (ii) any failure, in and of itself, by STX or Eros, respectively, to meet any internal or published projections, forecasts, estimates or predictions in respect of revenues, earnings or other financial metrics for any period (it being understood that the facts or occurrences giving rise to or contributing to such failure may be taken into account in determining whether there has been or will be, a Material Adverse Effect on STX or Eros, respectively, unless otherwise excluded in this definition of “Material Adverse Effect”); (iii) the identity of STX (in the case of Eros) or Eros (in the case of STX) or the public announcement of the Merger or any of the other transactions contemplated by this Agreement, including any litigation resulting or arising therefrom or with respect thereto or the impact thereof on the relationships of STX or Eros, respectively, and its Subsidiaries, with employees, customers, suppliers, partners or financing sources (except that this clause (iii) shall

75 

 

not apply with respect to the representations or warranties in Section 3.3, in the case of STX, and Section 4.3, in the case of Eros, to the extent that such representations and warranties address the consequences of the execution and delivery, or the public announcement of, this Agreement), or compliance with or performance of this Agreement; (iv) any change, in and of itself, in the market price or trading volume of the securities of Eros (it being understood that the facts or occurrences giving rise to or contributing to such change may be taken into account in determining whether there has been or will be, a Material Adverse Effect on Eros, unless otherwise excluded in this definition of “Material Adverse Effect”); (v) any change in Applicable Law, GAAP (or authoritative interpretation or enforcement thereof) or IFRS (or authoritative interpretation or enforcement thereof); (vi) geopolitical conditions, the outbreak or escalation of hostilities, any acts of war, sabotage or terrorism, or any escalation or worsening of any such acts of war, sabotage or terrorism, or any trade wars or sanctions, or any outbreak, pandemic or epidemic of disease (including, for the avoidance of doubt, novel coronavirus (COVID-19)); (vii) any hurricane, tornado, flood, earthquake or other natural disaster; (viii) any changes, including in credit ratings or credit outlook, generally affecting the industries in which STX or Eros operates; (ix) any action required by, or agreed to in writing by the parties in connection with, Section 5.10 of this Agreement or (x) any action or omission consented to or approved in writing by the other party or otherwise expressly required by this Agreement; provided, that the exclusions in clauses (i), (v), (vi), (vii) and (viii) shall not apply to the extent the Changes set forth therein have a disproportionate impact on STX and its Subsidiaries, or Eros and its Subsidiaries (without giving effect to the Merger), as applicable, relative to other participants in the industries in which STX and its Subsidiaries, or Eros and its Subsidiaries (without giving effect to the Merger), respectively, operate;

(kk)         Multiemployer Plan” means any plan that is a multiemployer plan, as defined in Section 3(37) or 4001(a)(3) of ERISA;

(ll)            Multiple Employer Plan” means any plan that has two or more contributing sponsors at least two of whom are not under common control, within the meaning of Section 4063 of ERISA;

(mm)      Order” means an injunction or other decree, order, judgment, injunction, writ, stipulation or award;

(nn)         Permit” means any license, permit, authorization, certificate of authority, qualification, consent, approval, concession, waiver, exemption, franchise, registration or similar document or authority that has been issued or granted by any Governmental Authority;

(oo)         Permitted Liens” means all liens, charges, encumbrances, mortgages, deeds of trust and security agreements disclosed in any Eros Filed SEC Documents or STX Financial Statements, together with the following (without duplication): (i) Liens imposed by Applicable Law, such as and mechanics and materialmen Liens arising or incurred in the ordinary course of business, in each case for sums not due and payable as of the Closing Date or being contested in good faith by appropriate proceedings or such other Liens arising out of judgments or awards against STX or Eros, as the

76 

 

case may be, with respect to which STX or Eros, respectively, shall then be proceeding with an appeal or other proceedings for review if adequate reserves with respect thereto are maintained on the books of STX or Eros, as the case may be, in accordance with GAAP or IFRS, respectively; (ii) Liens for Taxes not yet delinquent as of the Closing Date or which are being contested in good faith by appropriate proceedings diligently conducted, if adequate reserves with respect thereto are maintained on the books of STX and its Subsidiaries or Eros and its Subsidiaries, as the case may be, in accordance with GAAP or IFRS, respectively; (iii) zoning, entitlement, building and other land use regulations imposed by Governmental Authorities, which are not violated by the current use or occupancy of such real property or the operation of the business thereon; (iv) covenants, conditions, restrictions, easements, rights-of-way, encroachments and other similar matters affecting title to any real property that does not materially impair the occupancy or use of such real property; (v) Liens that, individually or in the aggregate, (A) are not substantial in character, amount or extent in relation to the applicable property and (B) do not materially and adversely impact the current or contemplated use, utility or value of any such property or otherwise materially and adversely impair the present or contemplated business operations thereon or in respect thereof; (vi) Liens arising under workers’ compensation, unemployment insurance, social security, retirement and similar legislation; (vii) purchase money Liens and Liens securing rental payments under capital lease arrangements entered into in the ordinary course of business; (viii) leases, subleases, licenses and occupancy agreements by STX or Eros, as the case may be, as landlord, sublandlord or licensor; (ix) with respect to leased property, all liens, charges and encumbrances existing on the date of the applicable lease, and all mortgages and deeds of trust now or hereafter placed on the leased property by the third-party landlord; (x) deposits to secure the performance of bids, trade contracts, leases, statutory obligations, surety and appeal bonds, performance bonds and other obligations of a like nature incurred in the ordinary course of business consistent with past practice; (xi) Liens securing judgments for the payment of money (provided that an appropriate Action has been commenced in connection with such judgment); (xii) non-exclusive licenses and covenants not to sue granted to third parties in the ordinary course of business; and (xiii) Liens pursuant to the STX Credit Facilities and the EIML Debt.

(pp)         Person” means a natural person, corporation, partnership, limited liability company, joint venture, association, trust, unincorporated organization or other entity;

(qq)         Personal Data” means any information about an identifiable individual that alone or in combination with other information could be used to identify an individual, and includes information that is defined as “personal data,” “personally identifiable information,” “individually identifiable health information,” “protected health information” or “personal information” under any Applicable Law;

(rr)           Process” or “Processing” means any operation or set of operations which is performed on Personal Data or on sets of Personal Data, whether or not by automated means, such as the receipt, access, acquisition, collection, recording, organization, compilation, structuring, storage, adaptation or alteration, retrieval, consultation, use, disclosure by transfer, transmission, dissemination or otherwise making available, alignment or combination, restriction, disposal, erasure or destruction;

77 

 

(ss)          Registration Rights Agreement” means the registration rights agreement substantially in the form attached hereto as Exhibit M;

(tt)            Related Documents” means the Eros Investors’ Rights Agreement, the Registration Rights Agreement, the CVR Agreements and such other agreements and documents contemplated by this Agreement, as amended, modified or supplemented from time to time;

(uu)         Related Party” means, with respect to any specified Person: (i) any Affiliate of such specified Person, or any director, executive officer, general partner or managing member of such Affiliate; (ii) any Person who serves or within the past five years has served as a director, executive officer, partner, member or

in a similar capacity of such specified Person; (iii) any member of the Immediate Family of a Person described in clause (ii); or (iv) any other Person who holds, individually or together with any Affiliate of such Person and any member(s) of such Person’s Immediate Family, more than 5% of the outstanding voting equity or ownership interests of such specified Person;

(vv)         Release” means any release, spill, emission, leaking, injection, deposit, disposal, discharge, dispersal, leaching or migration into the environment, including the atmosphere, soil, surface water, groundwater, drinking water supply, or property;

(ww)      Representatives” means, with respect to any Person, the directors, officers, employees, consultants, financial advisors, accountants, legal counsel, investment bankers and other agents, advisors and representatives of such Person;

(xx)         Sanctioned Person” means (i) any Person listed in any Sanctions-related list of designated Persons maintained by OFAC or the U.S. Department of State, the United Nations Security Council, the European Union or Her Majesty’s Treasury of the United Kingdom, or any European Union member state, (ii) any Person located, organized or resident in a country or territory which, at the applicable time, is the subject or target of comprehensive Sanctions (at the time of this Agreement, Crimea, Cuba, Iran, North Korea, Sudan and Syria) or (iii) any Person 50% or more owned or otherwise controlled by any such Person or Persons described in the foregoing clauses (i) and (ii);

(yy)         Sanctions” means economic or financial sanctions or trade embargoes imposed, administered or enforced from time to time by the U.S. government through OFAC or the U.S. Department of State, the United Nations Security Council, the European Union or any European Union member state, Her Majesty’s Treasury of the United Kingdom;

(zz)          SEC” means the United States Securities and Exchange Commission;

78 

 

(aaa)       STX Benefit Plan” means each current or former employee, officer director, or individual service provider compensation or benefit plan, program, arrangement or agreement, whether or not written, including any employee welfare benefit plan within the meaning of Section 3(1) of ERISA (whether or not such plan is subject to ERISA), any employee pension benefit plan within the meaning of Section 3(2) of ERISA (whether or not such plan is subject to ERISA) and any bonus, incentive, profit sharing, deferred compensation, vacation, stock purchase, equity or equity-based compensation, separation or severance, termination, retention, employment, consulting or other service, transaction or change in control or fringe benefit plan, program, arrangement or agreement that is sponsored, maintained or contributed to by STX or any of its Subsidiaries or which STX or any of its Subsidiaries is obligated to sponsor, maintain or contribute to, or as to which STX or any of its Subsidiaries has or could reasonably be expected to have any liability;

(bbb)      STX Capital Stock” means, collectively and as applicable, the STX Preferred Stock and the STX Common Stock;

(ccc)       STX Certificate of Incorporation” means the Third Amended and Restated Certificate of Incorporation of STX filed with the Secretary of State of Delaware on February 8, 2019, as amended by Amendment No. 1, dated August 23, 3019, as the same may be amended pursuant to the Pre-Closing Class E Subscription;

(ddd)      STX Class A Preferred Stock” means the Class A Convertible Preferred Stock, $0.01 par value per share, of STX;

(eee)       STX Class B Preferred Stock” means the Class B Convertible Preferred Stock, $0.01 par value per share, of STX;

(fff)         STX Class C Preferred Stock” means the Class C Convertible Preferred Stock, $0.01 par value per share, of STX;

(ggg)      STX Class D Preferred Stock” means the Class D Convertible Preferred Stock, $0.01 par value per share, of STX;

(hhh)      STX Class E Preferred Stock” means the Class E Convertible Preferred Stock, $0.01 par value per share, of STX, if and when issued in connection with the Pre-Closing Class E Subscription;

(iii)          STX Common Stock” means the common stock, $0.01 par value per share, of STX;

(jjj)          STX Credit Facilities” means the STX JPM Credit Facility and the STX Mezzanine Credit Facility;

79 

 

(kkk)      STX Equity Plan” means, collectively, the STX Filmworks, LLC Amended and Restated 2012 Equity Incentive Plan, as amended by Amendment to STX Filmworks, LLC Amended and Restated 2012 Equity Incentive Plan, the STX Filmworks, Inc. 2014 Equity Incentive Plan and the STX Filmworks, Inc. 2017 Equity Incentive Plan.

(lll)          STX Exhibitor Warrants” means, collectively, the warrants issued pursuant to any of the Warrant Agreements dated March 3 2014, between STX and each of Regal Entertainment Group and American Multi-Cinema, Inc.

(mmm)STX JPM Credit Facility” means the Second Amended and Restated Credit, Security, Guaranty and Pledge

Agreement (Corporate and Production Facility) dated as of October 7, 2016 by and among STX Financing, LLC, as Borrower, STX, as Parent, the Guarantors referred to therein, the Lenders referred to therein and JPMorgan Chase Bank, N.A., as Administrative Agent and Issuing Bank (together with all Fundamental Documents as defined therein), as amended by Amendment No. 1 to Second Amended and Restated Credit, Security, Guaranty and Pledge Agreement, dated as of June 2, 2017, as amended by Amendment No. 2 to Second Amended and Restated Credit, Security, Guaranty and Pledge Agreement, dated as of October 4, 2017, as amended by Waiver and Amendment No. 3 to Second Amended and Restated Credit, Security, Guaranty and Pledge Agreement, dated as of February 22, 2018, as amended by Amendment No. 4 to Second Amended and Restated Credit, Security, Guaranty, and Pledge Agreement, dated as of February 11, 2019;

(nnn)      STX Leased Real Property” means all leasehold or subleasehold estates and other rights to use or occupy any land, buildings, structures, improvements, fixtures or other interest in real property held by STX or its Subsidiaries;

(ooo)      STX Lender Consents” means (i) the written consent of the Required Lenders (as defined in the STX JPM Credit Facility) to the Merger and the related transactions, dated as of the date hereof and attached hereto as Exhibit N-1 and (ii) the written consent of the Required Lenders (as defined in the STX Mezzanine Credit Facility) to the Merger and the related transactions, dated as of the date hereof and attached hereto as Exhibit N-2;

(ppp)      STX Mezzanine Credit Facility” means the Second Amended and Restated Subordinated Credit, Security, Guaranty and Pledge Agreement dated as of October 7, 2016 by and among STX Financing, LLC, as Borrower, STX, as Parent, the Guarantors referred to therein, the Lenders referred to therein and Red Fish Blue Fish, LLC, as administrative agent, as amended by Amendment No. 1, dated March 2, 2018 (together with all Fundamental Documents as defined therein);

(qqq)      STX Option” means a compensatory option to purchase shares of STX Common Stock.

80 

 

(rrr)         STX Preferred Stock” means, collectively and as applicable, the STX Class E Preferred Stock, STX Class D Preferred Stock, STX Class C Preferred Stock, STX Class B Preferred Stock, STX Class A Preferred Stock.

(sss)        STX RSU Award” means an award of restricted stock units relating to STX Common Stock.

(ttt)          STX Stockholders Agreement” means that certain Third Amended and Restated Stockholders Agreement, dated as of February 11, 2019, among STX and the stockholders of STX party thereto, as amended by Amendment No. 1, dated on or around the date hereof;

(uuu)      Subsidiary” means, with respect to any Person, any Person with respect to which such first Person directly or indirectly owns or purports to own, beneficially or of record, (i) an amount of voting securities or other interests in such second Person that is sufficient to enable such first Person to elect at least a majority of the members of such second Person’s board of directors or comparable governing body or (ii) at least 50% of the outstanding equity, voting or financial interests in such second Person;

(vvv)      Tax Return” means any return, declaration, statement, claim for refund, election, certificate, estimate, report, form or information return relating to Taxes filed or submitted or required to be filed or submitted with any Governmental Authority (or third party if required by Applicable Laws), including any attachments or schedules thereto and any amendments thereof;

(www)  Taxes” or “Tax” means all taxes, charges, fees, levies or other assessments in the nature of a tax imposed by any governmental authority, including any income, gross receipts, license, severance, occupation, premium, environmental (including taxes under former Code Section 59A), customs, duties, profits, disability, alternative or add-on minimum, estimated, withholding, payroll, employment, unemployment insurance, social security (or similar), excise, sales, use, value-added, occupancy, franchise, real property, personal property, business and occupation, mercantile, windfall profits, capital stock, stamp, transfer, workmen’s compensation, amounts due under any Applicable Laws governing escheat or unclaimed property or other taxes, charges, fees, levies or other assessments in the nature of a tax, together with any interest, penalties, additions to tax or additional amounts imposed by any Governmental Authority with respect thereto, whether disputed or not;

(xxx)      Taxing Authority” means any Governmental Authority responsible for the administration, assessment or collection of any Taxes; and

(yyy)      Willful Breach” means a deliberate material breach or failure to perform that is the consequence of an act or omission of a party with the knowledge that such act or omission would cause a material breach of this Agreement.

81 

 

Section 8.4.        Interpretation.

(a)             When a reference is made in this Agreement to an Article, Section or Exhibit, such reference shall be to an Article or Section of, or an Exhibit to, this Agreement, unless otherwise indicated. Whenever the words “include,” “includes” or “including” are used in this Agreement, they shall be deemed to be followed by the words “without limitation.” The words “hereof,” “hereto,” “hereby,” “herein” and “hereunder” and words of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement. The term “or” is not exclusive and shall be deemed to be “and/or.” The word “extent” in the phrase “to the extent” shall mean the degree to which a subject or other thing extends, and such phrase shall not mean simply “if.” All terms defined in this Agreement shall have the defined meanings when used in any certificate or other document made or

delivered pursuant hereto unless otherwise defined, or except as otherwise expressly provided, therein. Words in this Agreement describing the singular number shall be deemed to include the plural and vice versa, and words in this Agreement denoting any gender shall be deemed to include all genders. Any statute defined or referred to herein or in any agreement or instrument that is referred to herein shall mean such statute as from time to time amended, unless otherwise specifically indicated. References to a Person are also to its permitted successors and permitted assigns. Unless otherwise specifically indicated, all references to “dollars” and “$” will be deemed references to the lawful money of the United States of America.

(b)            Except with respect to Section 5.13, whenever a consent or approval of STX or an Eros Party is required under this Agreement, such consent or approval may be executed and delivered only in writing and only by an authorized officer of STX with respect to STX, and Eros with respect to Eros, England Holdings 2 or Merger Sub.

Section 8.5.        Counterparts; Electronic Signature. This Agreement may be executed in one or more counterparts, all of which shall be considered one and the same agreement and shall become effective when one or more counterparts have been signed by each of the parties hereto and delivered to the other parties. This Agreement may be executed by facsimile, .pdf or other similar means of electronic signature and a facsimile, .pdf or other electronic signature shall constitute an original for all purposes.

Section 8.6.        Entire Agreement; No Third-Party Beneficiaries. This Agreement (including the documents, exhibits, schedules, disclosure letters and instruments referred to herein), taken together with the Confidentiality Agreement, (a) constitutes the entire agreement, and supersedes all prior agreements and understandings, both written and oral, among Eros, England Holdings 2, Merger Sub and STX with respect to the Merger and the other transactions contemplated by this Agreement, and (b) is not intended to, and does not, confer upon any Person other than the parties hereto any rights or remedies hereunder, other than as provided in Section 5.11. The representations and warranties in this Agreement are the product of negotiations among the parties hereto and are for the sole benefit of the parties hereto. Any inaccuracies in such representations and warranties are subject to waiver by the parties hereto in accordance with Section 7.4 without notice or liability to any other Person. In some instances, the representations and warranties in this Agreement may represent an allocation among the parties hereto of risks associated with particular matters regardless of the knowledge of any of the parties hereto. Consequently, Persons other than the parties hereto may not rely on the representations and warranties in this Agreement as characterizations of actual facts or circumstances as of the date of this Agreement or as of any other date.

82 

 

Section 8.7.        Assignment. Neither this Agreement nor any of the rights, interests or obligations under this Agreement shall be assigned or delegated, in whole or in part, by operation of law or otherwise by any of the parties without the prior written consent of the other parties. Any purported assignment in violation of the preceding sentence shall be void. Subject to the preceding two sentences, this Agreement will be binding upon, inure to the benefit of and be enforceable by the parties and their respective successors and assigns.

Section 8.8.        Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, regardless of the laws that might otherwise govern under any applicable principles of conflicts of laws thereof.

Section 8.9.        Waiver of Jury Trial. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE IT HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT AND ANY OF THE AGREEMENTS DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (B) IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF SUCH WAIVER, (C) IT MAKES SUCH WAIVER VOLUNTARILY AND (D) IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVER AND CERTIFICATIONS IN THIS SECTION 8.9.

Section 8.10.     Specific Enforcement. The parties acknowledge and agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached, and that monetary damages, even if available, would not be an adequate remedy therefor. It is accordingly agreed that the parties shall be entitled to seek an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the performance of terms and provisions of this Agreement in any court referred to in Section 8.11, without proof of actual damages (and each party hereby waives any requirement for the securing or posting of any bond in connection with such remedy), this being in addition to any other remedy to which they are entitled at law or in equity. The parties further agree not to assert that a remedy of specific enforcement is unenforceable, invalid, contrary to law or inequitable for any reason, nor to assert that a remedy of monetary damages would provide an adequate remedy for any such breach.

83 

 

Section 8.11.     Jurisdiction. Each of the parties irrevocably agrees that any legal action or proceeding arising out of or relating to this Agreement brought by any party or its Affiliates against any other party or its Affiliates shall be brought and determined in the Court of Chancery of the State of Delaware, provided, that if (and only if) such court finds it lacks subject matter jurisdiction, then any such legal action or proceeding may be brought in any federal court located in the State of Delaware or if (and only if) each of such Court of Chancery for the State of Delaware and such federal court finds it lacks subject matter jurisdiction, any other Delaware state court. Each of the parties hereby irrevocably submits to the jurisdiction of the aforesaid courts for itself and with respect to its property, generally and unconditionally, with regard to any such action or proceeding arising out of or relating to this Agreement and the transactions contemplated hereby. Each of the parties agrees not to commence any action, suit or proceeding relating thereto except in the courts described above in Delaware, other than actions in any court

of competent jurisdiction to enforce any judgment, decree or award rendered by any such court in Delaware as described herein. Each of the parties further agrees that notice as provided herein shall constitute sufficient service of process and the parties further waive any argument that such service is insufficient. Each of the parties hereby irrevocably and unconditionally waives, and agrees not to assert, by way of motion or as a defense, counterclaim or otherwise, in any action or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby, (a) any claim that it is not personally subject to the jurisdiction of the courts in Delaware as described herein for any reason, (b) that it or its property is exempt or immune from jurisdiction of any such court or from any legal process commenced in such courts (whether through service of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise) and (c) that (i) the suit, action or proceeding in any such court is brought in an inconvenient forum, (ii) the venue of such suit, action or proceeding is improper or (iii) this Agreement, or the subject matter hereof, may not be enforced in or by such courts.

Section 8.12.     Headings, etc. The headings, table of contents and index of defined terms contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement.

Section 8.13.     Severability. If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any rule of law or public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as either the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party or such party waives its rights under this Section 8.13 with respect thereto. Upon a determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible to the fullest extent permitted by Applicable Law in an acceptable manner to the end that the transactions contemplated hereby are fulfilled to the extent possible.

Section 8.14.     No Presumption Against Drafting Party. Each of Eros, England Holdings 2, Merger Sub and STX acknowledges that each party to this Agreement has been represented by counsel in connection with this Agreement and the transactions contemplated by this Agreement. Accordingly, any rule of law or any legal decision that would require interpretation of any claimed ambiguities in this Agreement against the drafting party has no application and is expressly waived.

Remainder of page intentionally left blank.

84 

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed by their duly authorized representatives as of the date first above written.

EROS INTERNATIONAL PLC

By: /s/ Kishore Lulla           

Name:    Kishore Lulla

Title:Executive Chairman and Group Chief
Executive Officer and Managing Director

 

 

Signature Page to Agreement and Plan of Merger

 

 

ENGLAND HOLDINGS 2, inc.

By: /s/ Kishore Lulla             

Name:    Kishore Lulla

Title:       President

 

 

Signature Page to Agreement and Plan of Merger

 

england merger corp.

By: /s/ Kishore Lulla             

Name:    Kishore Lulla

Title:       President

 

 

Signature Page to Agreement and Plan of Merger

 

 

STX FILMWORKS, INC.

By: /s/ Noah Fogelson            

Name:    Noah Fogelson

Title:       Executive Vice President, General

Counsel and Secretary

 

 

Signature Page to Agreement and Plan of Merger

 

Exhibit 4.31

VOTING AND SUPPORT AGREEMENT

This VOTING AND SUPPORT AGREEMENT (this “Agreement”), dated as of April 17, 2020, is by and among STX Filmworks, Inc., a Delaware corporation (“STX”), and the Persons set forth on Schedule I attached hereto (each, a “Shareholder”).

WHEREAS, each Shareholder is, as of the date hereof, the beneficial owner (as defined in Rule 13d-3 under the U.S. Securities Exchange Act of 1934, as amended (the “Exchange Act”), which meaning will apply for all purposes of this Agreement) of the number of A ordinary shares, £0.30 par value, and B ordinary shares, £0.30 par value (collectively, the “Shares”), of Eros International Plc, a company limited by shares incorporated under the laws of the Isle of Man (“Eros”), in each case, as set forth opposite the name of such Shareholder on Schedule I hereto (the “Owned Eros Shares”);

WHEREAS, STX and Eros have entered into an Agreement and Plan of Merger, dated as of the date hereof, in the form attached hereto as Exhibit A and as may be amended, supplemented or otherwise modified from time to time (the “Merger Agreement”), which provides, among other things, for the merger of England Merger Corp., a Delaware corporation and indirect wholly owned subsidiary of Eros (“Merger Sub”) with and into STX with STX as the surviving company (the “Merger”) upon the terms and subject to the conditions set forth in the Merger Agreement (capitalized terms used herein without definition shall have the respective meanings specified in the Merger Agreement); and

WHEREAS, as a condition to the willingness of STX to enter into the Merger Agreement and as an inducement and in consideration therefor, STX has required that each Shareholder, and each Shareholder has (solely in such Shareholder’s capacity as a beneficial owner of such Shareholder’s Securities and/or other Equity Interests in Eros) agreed to, enter into this Agreement.

NOW, THEREFORE, in consideration of the foregoing and the mutual covenants and agreements set forth herein, and intending to be legally bound hereby, the parties hereto agree as follows:

SECTION 1.         Representations and Warranties of Shareholder. Each Shareholder hereby severally and not jointly represents and warrants to STX as follows:

(a)Such Shareholder (i) is the beneficial owner of the Owned Eros Shares (together with any additional Shares or other voting securities of Eros of which such Shareholder may be deemed to have legal and/or beneficial ownership as of the date hereof or acquires legal and/or beneficial ownership after the date hereof, including, without limitation, by purchase, as a result of a stock dividend, stock split, recapitalization, combination, reclassification, exchange or change of such shares, or upon exercise or conversion of any securities, which such Shareholder may acquire at any time in the future during the term of this Agreement, such “Shareholder’s Securities”) set forth opposite such Shareholder’s name on Schedule I to this Agreement, free and clear of liens other than as created by this Agreement and (ii) as of the date hereof, except for the Owned Eros Shares, neither holds nor has any beneficial ownership interest in any other shares of Eros’s capital stock or any option, warrant, right or other voting securities convertible, exchangeable or exercisable therefor or other instrument, obligation or right the value of which is based on any of the foregoing (each, an “Equity Interest”). Such Shareholder has either sole power or shared power solely with another Shareholder party to this Agreement to (i) vote, dispose or direct the voting and disposition, (ii) demand or direct the demand for appraisal rights and (iii) agree to all of the matters set forth in this Agreement, in each case with respect to all of such Shareholder’s Securities, with no limitations, qualifications or restrictions on such rights, subject to applicable federal

  

 

securities laws and the terms of this Agreement. Such Shareholder’s Securities are not subject to any voting trust agreement or other Contract or agreement to which such Shareholder is a party restricting or otherwise relating to the voting or Transfer (as defined below) of such Shareholder’s Securities. Such Shareholder has not appointed or granted any proxy or power of attorney that is still in effect with respect to any of such Shareholder’s Securities, except as contemplated by this Agreement.

(b)Each such Shareholder which is a body corporate is duly organized/incorporated, validly existing and in good standing under the laws of the jurisdiction of its formation/incorporation and has all requisite power and authority to execute and deliver this Agreement and to perform its obligations hereunder; each such Shareholder who is a natural person has full legal power and capacity to execute and deliver this Agreement and to perform such Shareholder’s obligations hereunder. The execution, delivery and performance of this Agreement by each such Shareholder which is a body corporate, the performance by such Shareholder of its obligations hereunder and the performance by such Shareholder of the transactions contemplated hereby have been duly and validly authorized by such Shareholder and no other actions or proceedings on the part of such Shareholder are necessary to authorize the execution and delivery by such Shareholder of this Agreement, the performance by such Shareholder of its obligations hereunder or the performance by such Shareholder of the transactions contemplated hereby.
(c)This Agreement has been duly executed and delivered by such Shareholder and, assuming this Agreement constitutes a legal, valid and binding obligation of STX, this Agreement constitutes a legal, valid and binding obligation of such Shareholder, enforceable against such Shareholder in accordance with its terms, subject to bankruptcy, insolvency (including all applicable legal requirements relating to fraudulent transfers), reorganization, moratorium and similar legal requirements of general applicability relating to or affecting creditors’ rights and subject to general principles of equity.
(d)Except for the applicable requirements of the Exchange Act, (i) and assuming compliance with the applicable provisions of the U.S. Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the rules and regulations promulgated thereunder (the “HSR Act”), if applicable, and any applicable filing, notification or approval in any foreign jurisdiction required by Antitrust Laws, no filing with, and no permit, authorization, consent or approval of, any Governmental Authority is necessary on the part of such Shareholder for the execution, delivery and performance of this Agreement by such Shareholder or the performance by such Shareholder of the transactions contemplated hereby and (ii) neither the execution, delivery or performance of this Agreement by such Shareholder nor the performance by such Shareholder of the transactions contemplated hereby nor compliance by such Shareholder with any of the provisions hereof shall (A) conflict with or violate, any provision of the organizational documents of any such Shareholder which is an entity, (B) result in any breach or violation of, or constitute a default (or an event which, with notice or lapse of time or both, would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, or result in the creation of a lien on such property or asset of such Shareholder pursuant to, any Contract to which such Shareholder is a party or by which such Shareholder or any property or asset of such Shareholder is bound or affected, except for such violations, defaults or conflicts as would not, individually or in the aggregate, prevent or materially delay the performance by such Shareholder of any of its obligations under this Agreement or (C) violate any order, writ, injunction, decree, statute, rule or regulation applicable to such Shareholder or any of such Shareholder’s properties or assets.

2 

 
(e)There is no action, suit, investigation, complaint or other proceeding pending against any such Shareholder or, to the knowledge of such Shareholder, any other Person or, to the knowledge of such Shareholder, threatened against any Shareholder or any other Person that restricts or prohibits (or, if successful, would restrict or prohibit) the exercise by STX of its rights under this Agreement or the performance by any party of its obligations under this Agreement.
(f)Such Shareholder has received and reviewed a copy of the Merger Agreement. Such Shareholder understands and acknowledges that STX is entering into the Merger Agreement in reliance upon such Shareholder’s execution, delivery and performance of this Agreement.
(g)No broker, investment bank, financial advisor or other person is entitled to any broker’s, finder’s, financial adviser’s or similar fee or commission in connection with the transactions contemplated by this Agreement based upon arrangements made by or on behalf of such Shareholder (it being understood that arrangements of Eros or its other Affiliates shall not be deemed to be an arrangement of such Shareholder).

SECTION 2.         Representations and Warranties of STX. STX hereby represents and warrants to each Shareholder as follows:

(a)STX is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware, and STX has the requisite power and authority, as the case may be, to execute and deliver and perform its obligations under this Agreement and the Merger Agreement and to perform the transactions contemplated hereby and thereby, and STX has taken all necessary action to duly authorize the execution, delivery and performance of this Agreement and the Merger Agreement.
(b)This Agreement and the Merger Agreement have been duly authorized, executed and delivered by STX, and, assuming this Agreement and the Merger Agreement constitute legal, valid and binding obligations of the other parties thereto, constitute the legal, valid and binding obligations of STX, are enforceable against STX in accordance with their terms, subject to bankruptcy, insolvency (including all legal requirements relating to fraudulent transfers), reorganization, moratorium and similar laws of general applicability relating to or affecting creditors’ rights and subject to general principles of equity.
(c)Assuming compliance with the applicable provisions of the HSR Act, if applicable, and any applicable filing, notification or approval in any foreign jurisdiction required by Antitrust Laws, the execution and delivery of this Agreement and the Merger Agreement by STX, and the performance of the transactions contemplated by this Agreement and the Merger Agreement, will not: (i) conflict with or violate any provision of the organizational documents of STX, (ii) cause a violation, or a default, by STX of any applicable legal requirement or decree, order or judgment applicable to STX, or to which STX is subject; or (iii) conflict with, result in a breach of, or constitute a default on the part of STX under any contract, trust, commitment, agreement, understanding, arrangement or restriction of any kind to which STX is a party or by which STX or its assets are bound, except for such violations, defaults or conflicts as would not, individually or in the aggregate, prevent or materially delay the performance by STX or

3 

 

any of its obligations under this Agreement and the Merger Agreement. Except as may be required by the Exchange Act, any “anti-takeover” laws or the DGCL, in connection with the HSR Act and any filing, notification or approval in any foreign jurisdiction required by Antitrust Laws, STX is not required to make any filing with or give any notice to, or to obtain any consent or approval from, any Person at or prior to the performance of the transactions contemplated in connection with the execution and delivery of this Agreement or the Merger Agreement by STX or the performance by STX of the Merger and the other transactions contemplated by the Merger Agreement, other than such filings, notifications, approvals, notices or consents that, if not obtained, made or given, would not, individually or in the aggregate, prevent or materially delay the performance by STX of any of its obligations under this Agreement and the Merger Agreement.

SECTION 3.         Transfer of the Shares; Other Actions.

(a)Prior to the Termination Date (as defined below), except as otherwise expressly provided herein (including pursuant to this Section 3 or Section 4) or in the Merger Agreement, each Shareholder shall not, and shall cause each of its Subsidiaries (if applicable) not to: (i) transfer, assign, sell, gift-over, hedge, charge or otherwise dispose (whether by sale, liquidation, dissolution, dividend or distribution) of, enter into any derivative arrangement with respect to, or create any lien or encumbrance on or enter into any agreement with respect to any of the foregoing (“Transfer”), any or all of such Shareholder’s Securities, provided that nothing contained herein shall prohibit (A) the net settlement of the Shareholder’s options to purchase Eros Ordinary Shares (to pay the exercise price thereof and any tax withholding obligations), (B) the net settlement of the Shareholder’s restricted stock units (including performance-based restricted stock units, if applicable) settled in Eros Ordinary Shares (to pay any tax withholding obligations), (C) the exercise of the Shareholder’s options to purchase Eros Ordinary Shares, to the extent such options would expire prior to the Effective Time, (D) the sale of a sufficient number of Eros Ordinary Shares acquired upon exercise of the Shareholder’s options pursuant to the foregoing clause (C) or upon the settlement of the Shareholder’s restricted stock units, in each case as would generate sales proceeds sufficient to pay the aggregate applicable exercise price of shares then exercised under such options and the taxes payable by the Shareholder as a result of such exercise or settlement, (E) any Transfer where the Shareholder retains sole direct and indirect voting control over such Shareholder’s Securities through the Termination Date, or (F) any Transfer to another member of the Eros Founder Group; (ii) solicit, initiate, endorse, encourage or facilitate the making by any Person (other than the other parties to the Merger Agreement) of any Acquisition Proposal; (iii) enter into any contract, option or other agreement, arrangement or understanding with respect to any Transfer of any or all of such Shareholder’s Securities; (iv) grant any proxy, power-of-attorney or other authorization or consent with respect to any of such Shareholder’s Securities with respect to any matter that is in contravention of the obligations of such Shareholder under this Agreement with respect to such Shareholder’s Securities; (v) deposit any of such Shareholder’s Securities into a voting trust, or enter into a voting agreement or arrangement with respect to any Equity Interests, including such Shareholder’s Securities, in contravention of the obligations of such Shareholder under this Agreement with respect to such Shareholder’s Securities; or (vi) knowingly take or cause the taking of any other action that would materially restrict or prevent the performance of such Shareholder’s obligations hereunder, excluding any bankruptcy filing. Any action taken in violation of the foregoing sentence shall be null and void ab initio. If any involuntary Transfer of any of such Shareholder’s Securities

4 

 

shall occur (including, but not limited to, a sale by Shareholder’s trustee in any bankruptcy, or a sale to a purchaser at any creditor’s or court sale), the transferee (which term, as used herein, shall include any and all transferees and subsequent transferees of the initial transferee) shall take and hold such Shareholder’s Securities subject to all of the restrictions, liabilities and rights under this Agreement, which shall continue in full force and effect until the Termination Date.

(b)Prior to the Termination Date, each Shareholder shall not enter into any discussion, negotiation, agreement, arrangement or understanding concerning any of the foregoing (other than this Agreement) or knowingly encourage, assist, solicit, seek or seek to cause any person to undertake any action inconsistent with this Section 3.
(c)Prior to the Termination Date, in the event that a Shareholder acquires legal or beneficial ownership of, or the power to vote or direct the voting of, any additional Shares or other voting interests with respect to Eros, such Shares or voting interests shall, without further action of the parties, be deemed such Shareholder’s Securities and subject to the provisions of this Agreement, and the number of Shares held by such Shareholder set forth on Schedule I attached hereto will be deemed amended accordingly and such Shares or voting interests shall automatically become subject to the terms of this Agreement. Each Shareholder shall promptly notify STX and Eros of any such event.

SECTION 4.         Voting of Shares.

(a)Prior to the Termination Date, and without in any way limiting such Shareholder’s right to vote such Shareholder’s Securities in its sole discretion on any other matters unrelated to the Merger that may be submitted to a shareholder vote, consent or other approval, at every annual, special or other meeting of Eros’s shareholders called, and at every adjournment or postponement thereof, each Shareholder (in such Shareholder’s capacity as a holder of such Shareholder’s Securities) shall, or shall cause the registered holder on any applicable record date to, (i) appear at each such meeting or otherwise cause all of such Shareholder’s Securities entitled to vote to be counted as present thereat for purposes of calculating a quorum and (ii) vote all of such Shareholder’s Securities entitled to vote (A) to the extent a vote is held on the matter, in favor of (1) the adoption of the Merger Agreement and the approval of the Merger and the other transactions contemplated by the Merger Agreement and (2) the adoption and approval of the Amended Eros Articles of Association and (B) against (w) any action or agreement which would reasonably be expected to result in any of the conditions to Eros’s obligations to complete the Merger set forth in Article VI of the Merger Agreement not being fulfilled, (x) any Acquisition Proposal, (y) any change in the present capitalization or dividend policy of Eros or any amendment or other change to Eros’s articles of association, except with respect to the Amended Eros Articles of Association or if approved by STX and (z) any other change in Eros’s corporate structure or business that would require STX’s consent pursuant to Section 5.2 of the Merger Agreement, unless approved by STX.
(b)Each Shareholder hereby agrees to, and hereby irrevocably consents, without a meeting and without prior notice, pursuant to the Companies Act 2006 and article 58 of the Eros Articles of Association, to the passing of the resolutions set forth in Exhibit B attached hereto (the “Written Resolution”), and each Shareholder will deliver such executed Written Resolution within 2 hours following the execution of the Merger Agreement, and will promptly cause a copy of such executed Written Resolution to be delivered to STX and Eros.

5 

 
(c)Notwithstanding the foregoing, each Shareholder shall retain at all times the right to vote such Shareholder’s Securities held by it in its sole discretion and without any other limitation on those matters other than those set forth in Section 4(a)(ii) or Section 4(b) that are at any time or from time to time presented for consideration to Eros’s shareholders.
(d)The obligations set forth in this Section 4 shall apply to each Shareholder unless and until the Termination Date shall have occurred, at which time such obligations shall terminate and be of no further force or effect.

SECTION 5.         Directors and Officers. Notwithstanding any provision of this Agreement to the contrary, this Agreement shall apply to each Shareholder solely in such Shareholder’s capacity as a holder of such Shareholder’s Securities and/or other Equity Interests in Eros and not in such Shareholder’s or any partner, officer, employee or Affiliate of Shareholder’s capacity as a director, officer or employee of Eros or any of its Subsidiaries or in such Shareholder’s or any partner, officer, employee or Affiliate of such Shareholder’s capacity as a trustee or fiduciary of any employee benefit plan or trust.

SECTION 6.         Further Assurances. Each party shall execute and deliver any additional documents and take such further actions that are reasonably necessary to carry out all of its obligations under the provisions hereof.

SECTION 7.         Termination.

(a)This Agreement, and all rights and obligations of the parties hereunder, shall terminate immediately without any notice or other action by any Person, upon the earliest to occur of the following (the date of such termination, the “Termination Date”):
(i)termination of the Merger Agreement in accordance with its terms;
(ii)the Effective Time;

(iii)           subject to compliance with Section 3(a), the date on which each Shareholder ceases to own such Shareholder’s Securities and/or any other Equity Interests in Eros; or

(iv)the mutual written consent of STX and each Shareholder.
(b)Sections 7(b), 8 and 10 hereof shall survive the termination of this Agreement.

SECTION 8.         Expenses. All fees and expenses incurred in connection with the negotiation and execution of this Agreement and the transactions contemplated hereby shall be paid by the party incurring such fees and expenses, whether or not the Merger is completed.

SECTION 9.         Public Announcements. Eros and each Shareholder (in its capacity as a Shareholder of Eros and/or signatory to this Agreement) shall only make public announcements regarding this Agreement and the transactions contemplated hereby that are consistent with the public statements made by STX and Eros in connection with this Agreement, the Merger Agreement and the transactions contemplated thereby, and only with the prior written consent of Eros and STX. Each Shareholder (i) consents to and authorizes the publication and disclosure by STX and its Affiliates, and/or by Eros, of its

6 

 

identity and holding of such Shareholder’s Securities and the nature of its commitments and obligations under this Agreement in any disclosure required by the SEC or other Governmental Authority, and (ii) agrees promptly to give to STX or Eros, after written request therefor, any information it may reasonably require for the preparation of any such disclosure documents. STX consents to and authorizes the publication and disclosure by each Shareholder of the nature of its commitments and obligations under this Agreement and such other matters as may be required in connection with the Merger in any Form 20-F, Form 6-K or other disclosure required by the SEC or other Governmental Authority to be made by any Shareholder in connection with the Merger.

SECTION 10.      Miscellaneous.

(a)              Notices. All notices and other communications hereunder must be in writing and will be deemed to have been duly delivered and received hereunder (i) four Business Days after being sent by registered or certified mail, return receipt requested, postage prepaid; (ii) one Business Day after being sent for next Business Day delivery, fees prepaid, via a reputable nationwide overnight courier service; or (iii) immediately upon delivery by hand or by electronic mail (with a written or electronic confirmation of successful transmission), to STX in accordance with Section 8.2 of the Merger Agreement and to a Shareholder at its address or e-mail address set forth on Schedule I attached hereto (or at such other address or e-mail address for a party as shall be specified by like notice).

(b)             Headings. The headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement.

(c)              Counterparts. This Agreement and any amendments hereto may be executed in one or more counterparts, all of which will be considered one and the same agreement and will become effective when one or more counterparts have been signed by each of the parties and delivered to the other parties, it being understood that all parties need not sign the same counterpart. Any such counterpart, to the extent delivered by fax or .pdf, .tif, .gif, .jpg or similar attachment to electronic mail (any such delivery, an “Electronic Delivery”), will be treated in all manner and respects as an original executed counterpart and will be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person. No party may raise the use of an Electronic Delivery to deliver a signature, or the fact that any signature or agreement or instrument was transmitted or communicated through the use of an Electronic Delivery, as a defense to the formation of a contract, and each party forever waives any such defense, except to the extent such defense relates to lack of authenticity.

(d)             Entire Agreement. This Agreement constitutes the entire understanding and agreement between or among the parties as to the matters covered herein and supersedes and replaces any prior understanding or agreement between or among the parties as to the matters covered herein and supersedes and replaces any prior understanding, agreement or statement of intent, in each case, written or oral, of any and every nature with respect thereto.

(e)              Contracts (Rights of Third Parties) Act 2001. This Agreement shall be binding upon and inure solely to the benefit of the parties hereto and their respective permitted assigns and successors, and nothing herein, express or implied, is intended to or shall create any right enforceable by any person who is not a party to it under the Contracts (Rights of Third Parties) Act 2001, but this Section 10(e) does not affect any right or remedy of a third party that exists or is available apart from that Act.

(f)              Governing Law, Jurisdiction, Process Agents.

(i)This Agreement shall be governed by and construed in accordance with the laws of the Isle of Man.

7 

 
(ii)Any claim, action, suit or proceeding (whether in contract or tort) seeking to enforce any provision of, or based on any matter arising out of or in connection with, this Agreement or the transactions contemplated hereby shall be heard and determined in the courts of the Isle of Man, and each of the parties hereto hereby consents to the exclusive jurisdiction of such courts and irrevocably waives, to the fullest extent permitted by law, any objection that it may now or hereafter have to the laying of venue of any such claim, action, suit or proceeding in any such court or that any such claim, action, suit or proceeding that is brought in any such court has been brought in an inconvenient forum.
(iii)Subject to applicable law, process in any such claim, action, suit or proceeding may be served on any party anywhere in the world, whether within or without the jurisdiction of any such court. Without limiting the foregoing and subject to applicable law, each party agrees that service of process on such party as provided in Section 10(a) shall be deemed effective service of process on such party. Nothing herein shall affect the right of any party to serve legal process in any other manner permitted by law or at equity.
(iv)Without prejudice to any other mode of service under any relevant law, each Shareholder irrevocably appoints IQEQ (Isle of Man) Limited of First Names House, Victoria Road, Douglas, Isle of Man IM2 4DF as its process agent to receive and to acknowledge on its behalf service of any proceedings in the Isle of Man. If for any reason the agent named above (or its successor) no longer serves as agent of the relevant party for this purpose, such party shall promptly appoint a successor agent and notify the other parties thereof, provided that until the other parties have received such notification, the other parties shall be entitled to treat the agent named above as the agent of the relevant party for the purposes of this Section 10(f). Each party agrees that any such legal process shall be sufficiently served on it if delivered to the relevant agent for service at its address for the time being in the Isle of Man whether or not such agent gives notice thereof to such party.

(g)             Assignment. Other than in connection with any Transfer permitted by Section 3, no party may assign either this Agreement or any of its rights, interests, or obligations hereunder without the prior written approval of the other parties hereto, except that STX will have the right to assign all or any portion of its rights and obligations pursuant to this Agreement to any party to whom it has assigned any of its rights, interests or obligations under the Merger Agreement; provided, however, that STX may assign, in its sole discretion and without the consent of any other party, any or all of its rights and interests hereunder to one or more direct or indirect wholly-owned Subsidiaries of STX in connection with the assignment of the rights, interests and obligations of STX under the Merger Agreement to such indirect wholly-owned Subsidiaries of STX in accordance with the terms of the Merger Agreement, and any such assignee may thereafter assign, in its sole discretion and without the consent of any other party, any or all of its rights, interests and obligations hereunder to one or more additional direct or indirect wholly-owned Subsidiaries of STX in connection with the assignment of the rights, interests and obligations of such assignee under the Merger Agreement to such additional direct or indirect wholly-owned Subsidiaries of STX in accordance with the terms of the Merger Agreement; provided, that no such assignment shall relieve STX of any of its obligations under this Agreement. Any assignment in violation of the preceding sentence shall be void. Subject to the preceding two sentences, this Agreement will be binding upon, inure to the benefit of, and be enforceable by, the parties and their respective successors and permitted assigns.

8 

 

(h)             Severability of Provisions. In the event that any provision of this Agreement, or the application thereof, becomes or is declared by a court of competent jurisdiction to be illegal, void or unenforceable, the remainder of this Agreement will continue in full force and effect and the application of such provision to other Persons or circumstances will be interpreted so as reasonably to effect the intent of the parties. The parties further agree to replace such void or unenforceable provision of this Agreement with a valid and enforceable provision that will achieve, to the extent possible, the economic, business and other purposes of such void or unenforceable provision.

(i)               Specific Performance. The parties agree that irreparable damage for which monetary damages, even if available, would not be an adequate remedy would occur in the event that the parties hereto do not perform the provisions of this Agreement (including any party failing to take such actions as are required of it hereunder in order to perform this Agreement) in accordance with its specified terms or otherwise breach such provisions. The parties hereto acknowledge and agree that, (A) the parties hereto will be entitled, in addition to any other remedy to which they are entitled at law or in equity, to an injunction, specific performance and other equitable relief to prevent breaches (or threatened breaches) of this Agreement and to enforce specifically the terms and provisions hereof; and (B) the right of specific enforcement is an integral part of this Agreement and, without that right, STX would not have entered into this Agreement. It is accordingly agreed that each party shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement, this being in addition to any other remedy to which they are entitled at law or in equity and any party seeking an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement will not be required to provide any bond or other security in connection with such injunction or enforcement, and each party irrevocably waives any right that it may have to require the obtaining, furnishing or posting of any such bond or other security.

(j)               Amendment. No amendment or modification of this Agreement shall be effective unless it shall be in writing and signed by each of the parties hereto, and no waiver or consent hereunder shall be effective against any party unless it shall be in writing and signed by such party.

(k)             Binding Nature. This Agreement shall be binding upon, and shall be enforceable by and inure solely to the benefit of, the parties hereto and their respective successors and permitted assigns.

(l)               No Recourse. STX agrees that no Shareholder will be liable for claims, losses, damages, expenses and other liabilities or obligations resulting from or related to the Merger Agreement or the Merger (other than any liability for claims, losses, damages, expenses and other liabilities or obligations solely to the extent arising under, and in accordance with the terms of, this Agreement, provided, that, in no event shall such claims, losses, damages, expenses or other liabilities or obligations include consequential, indirect, special or similar damages). In no event shall any Shareholder have any liability hereunder with respect to another Shareholder’s representations, warranties, liabilities or obligations hereunder.

(m)            No Presumption. This Agreement shall be construed as if drafted jointly by the parties, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provisions of this Agreement.

(n)             No Agreement Until Executed. This Agreement shall not be effective unless and until (i) the Merger Agreement is executed by all parties thereto and (ii) this Agreement is executed by all parties hereto.

9 

 

(o)             No Ownership Interest. Nothing contained in this Agreement shall be deemed to vest in STX any direct or indirect ownership or incidence of ownership of or with respect to such Shareholder’s Securities. All rights, ownership and economic benefits of and relating to such Shareholder’s Securities shall remain vested in and belong to such Shareholder, and STX shall not have any authority to manage, direct, restrict, regulate, govern, or administer any of the policies or operations of Eros or exercise any power or authority to direct any Shareholder in the voting of any of such Shareholder’s Securities, except as otherwise specifically provided herein.

[Signature pages follow]

10 

 

SIGNATURE PAGE TO
VOTING AND SUPPORT AGREEMENT

IN WITNESS WHEREOF, STX and each Shareholder have caused this Agreement to be duly executed and delivered as a deed as of the date first written above.

 

EXECUTED and DELIVERED as a deed by STX FILMWORKS, INC. acting by:

 

 

)

)

)

 

 

/s/ Noah Fogelson                     

  Director/Authorised Signatory
 

 

 

  

 

SIGNATURE PAGE TO
VOTING AND SUPPORT AGREEMENT

 

 

SIGNED and DELIVERED as a DEED by KISHORE LULLA in the presence of:

 

 

/s/ Rayaan Shah               

)

)

)

 

 

/s/ Kishore Lulla               

 
Witness signature
Name:  Rayaan Shah
Address: [Address]
Occupation: Self Employed
       

 

 

  

 

 

SIGNATURE PAGE TO
VOTING AND SUPPORT AGREEMENT

 

 

SIGNED and DELIVERED as a DEED by RISHIKA LULLA SINGH in the presence of:

 

 

/s/ Rayaan Shah               

)

)

)

 

 

/s/ Rishika Lulla Singh               

 
Witness signature
Name:  Rayaan Shah
Address: [Address]
Occupation: Self Employed
       

 

 

 

 

 

  

 

 

SIGNATURE PAGE TO
VOTING AND SUPPORT AGREEMENT

 

EXECUTED and DELIVERED as a deed by BEECH INVESTMENTS LIMITED acting by:

)

)

)

 

 

/s/ Joel Smith               

 

Name: Joel Smith

Title: Director

)

)

)

/s/ Simon Kleis               
 

Name: Simon Kleis

Title: Director

 

 

 

 

 

 

   

 

 

SIGNATURE PAGE TO
VOTING AND SUPPORT AGREEMENT

 

EXECUTED and DELIVERED as a deed by EROS VENTURES LIMITED acting by:

)

)

)

By: CDS International Limited, its sole director

 

/s/ Joel Smith               

 

Name: Joel Smith

Title: Authorised Signatory

)

)

)

/s/ Simon Kleis               
 

Name: Simon Kleis

Title: Authorised Signatory

 

 

 

  

 

SCHEDULE I

Name / Address / E-mail Address Shareholder’s Securities

Kishore Lulla

 

[Address]

 

317,304 A ordinary shares, £0.30 par value

 

9,377,037 B ordinary shares, £0.30 par value

Rishika Lulla Singh

[Address]

248,083 A ordinary shares, £0.30 par value

 

2,476,000 B ordinary shares, £0.30 par value

 

Beech Investments Limited

 

[Address]

318,818 A ordinary shares, £0.30 par value

 

8,046,048 B ordinary shares, £0.30 par value

Eros Ventures Limited

 

[Address]

 

0 A ordinary shares, £0.30 par value

 

0 B ordinary shares, £0.30 par value

 

 

Exhibit 4.32 

 

SUBSCRIPTION AGREEMENT

This SUBSCRIPTION AGREEMENT (this “Agreement”) is made as of April 17, 2020, by and between Eros International Plc, an Isle of Man company limited by shares (the “Company”), and each Purchaser identified on the signature pages hereto (each, an “Initial Purchaser” and, together with any other person or entity executing a Joinder after the date hereof, collectively, the “Purchasers”).

WHEREAS, concurrently with the execution of this Agreement, the Company is entering into that certain Agreement and Plan of Merger, dated as of the date hereof (the “Merger Agreement”), by and among the Company, England Holdings 2, Inc., a Delaware corporation and indirect wholly owned subsidiary of the Company (“England Holdings 2”), England Merger Corp., a Delaware corporation and direct wholly owned subsidiary of England Holdings 2 (“Merger Sub”), and STX Filmworks, Inc., a Delaware corporation (“STX”), pursuant to which Merger Sub will merge with and into STX, with STX continuing as the surviving company and an indirect wholly owned subsidiary of the Company in such merger (the “Merger”); and

WHEREAS, in connection with the Merger, the Company desires to issue and allot, and the Purchasers desire to subscribe for and purchase, upon the terms and conditions stated in this Agreement, an aggregate of $75,000,000 of the Company’s A Ordinary Shares, par value £0.30 per share (the “Company A Ordinary Shares”), in a private placement transaction.

NOW, THEREFORE, in consideration of the premises, and of the representations, warranties, covenants and agreements set forth herein, and intending to be legally bound hereby, the parties hereto agree as follows:

1.               Purchase and Allotment of Company A Ordinary Shares.

(a)             Subject to the terms and conditions hereof, the Company shall issue and allot to each Purchaser, and each Purchaser severally, but not jointly, shall subscribe for and purchase from the Company on the Closing Date (as defined below), a number of Company A Ordinary Shares, rounded down to the nearest whole share, equal to (i) the aggregate purchase price for the Company A Ordinary Shares to be purchased by such Purchaser hereunder set forth across from such Purchaser’s name on Schedule I attached hereto (with respect to each Purchaser, the “Purchase Price”) divided by (ii) the Per Share Price; provided, that in the event any Purchaser that is a stockholder of STX enters into this Agreement following the date hereof pursuant to a joinder agreement, substantially in the form attached hereto as Exhibit A (the “Joinder”), the Purchase Price of each Initial Purchaser hereunder shall be reduced by an amount that is equal to the proportionate share of such new investment based on the initial Purchase Price of such Initial Purchaser hereunder, and Schedule I shall be amended accordingly and automatically without any action by the Company or any Purchaser. The “Per Share Price” shall be equal to the lowest of (x) $2.60 (the “Base Price”), (y) the weighted average of the purchase price of all purchases comprising the Eros Pre-Closing Equity Financing (as defined below) and (z) the VWAP of the Company A Ordinary Shares for the ten (10) full Trading Days immediately prior to the Closing Date (the “Pre-Closing VWAP”); provided, however, that if the Pre-Closing VWAP is greater than $3.25, then the Per Share Price shall be equal to the average of the Base Price and the Pre-Closing VWAP. For purposes of this Agreement:

 

 

(i)              Trading Day” means any day on which the Company A Ordinary Shares are actually traded on the principal securities exchange or securities market on which the Company A Ordinary Shares are then listed.

(ii)            VWAP” means, for any security as of any date(s), the dollar volume-weighted average price for such security on the principal securities exchange or securities market on which such security is then traded during the period beginning at 9:30:01 a.m., New York time, and ending at 4:00:00 p.m., New York time, as reported by Bloomberg through its “HP” function (set to weighted average) or, if the foregoing does not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the electronic bulletin board for such security during the period beginning at 9:30:01 a.m., New York time, and ending at 4:00:00 p.m., New York time, as reported by Bloomberg, or, if no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the highest closing bid price and the lowest closing ask price of any of the market makers for such security as reported by OTC Markets Group Inc. If the VWAP cannot be calculated for such security on such date(s) on any of the foregoing bases, the VWAP of such security on such date(s) shall be the fair market value thereof on such date(s) as reasonably determined by a nationally recognized independent investment banking firm mutually agreed between the Company and STX.

(b)            Notwithstanding Section 1(a), if at any time from and including the Closing Date through and including the three (3) month anniversary of the Closing Date, the Company issues additional Company A Ordinary Shares (in each case, other than the Dilutive Issuance Exceptions) at a price per share, or issues any instrument convertible or exchangeable or exercisable for additional Company A Ordinary Shares (an “A Share Equivalent”) (in each case, other than the Dilutive Issuance Exceptions) at a conversion, exchange or exercise price per share that is less than the Per Share Price (such price, the “Dilutive Issuance Price” and such issuance, a “Dilutive Issuance”), then, on each such occurrence, the Company shall promptly thereafter issue to each Purchaser, for no additional consideration, such incremental number of additional Company A Ordinary Shares, rounded down to the nearest whole share, equal to the difference between (x) the aggregate number of A Ordinary Shares that would have been issued to the Purchaser hereunder at the Closing had the Per Share Price then been equal to such Dilutive Issuance Price, minus (y) the number of Company A Ordinary Shares that have been previously issued or are due to be issued to such Purchaser pursuant to Section 1(a) and this Section 1(b) through and including the date of the applicable Dilutive Issuance. Notwithstanding anything herein to the contrary, this Section 1(b) shall not apply to any of the following (each, a “Dilutive Issuance Exception”): (i) Company A Ordinary Shares or A Share Equivalents issued by reason of a dividend, stock split, split-up or similar distribution made pro rata on outstanding Company A Ordinary Shares; (ii) Company A Ordinary Shares or A Share Equivalents issued as compensation to employees or directors of, or consultants or advisors to, the Company or any of its subsidiaries pursuant to a plan, agreement or arrangement in place as of the Effective Time; (iii) Company A Ordinary Shares issued upon the exercise, settlement or conversion pursuant to their terms of A Share Equivalents that are outstanding as of the Closing or issued after the Closing in accordance with the foregoing clause (ii); or (iv) Company A Ordinary Shares issued pursuant to the Equity Facility (as defined below) to satisfy in whole or in part the Company’s obligation hereunder to consummate the Eros Post-Closing Equity Financing (as defined below).

 

 

2.               Closing.

(a)             The closing of the sale and purchase of the Company A Ordinary Shares (the “Closing”) contemplated under this Agreement shall take place at the offices of Gibson, Dunn and Crutcher LLP, 333 South Grand Avenue, Los Angeles, California 90071, on the date of, and substantially concurrently with, the consummation of the Merger pursuant to the Merger Agreement, after the satisfaction or (to the extent permitted by applicable law) waiver of the conditions to the Closing set forth in Section 3 below, or at such different time or date to be agreed in writing by the Company and the Purchasers (the date of the Closing, the “Closing Date”).

(b)            On the Closing Date, (i) each Purchaser shall pay its Purchase Price to the Company for the Company A Ordinary Shares to be issued and sold to such Purchaser at the Closing, by wire transfer of immediately available funds in accordance with the Company’s written wire instructions provided at least two business days prior to the Closing, and (ii) the Company shall deliver to each Purchaser in book entry-form the Company A Ordinary Shares which such Purchaser is purchasing hereunder.

3.               Closing Conditions.

(a)             The respective obligation of each party to consummate the transactions contemplated by this Agreement is subject to the satisfaction or waiver in whole or in part (to the extent permitted by applicable law), on or prior to the Closing Date of the following conditions:

(i)              the Merger shall have been consummated in accordance with the terms of the Merger Agreement;

(ii)            the STX Lender Consents (as defined in the Merger Agreement) shall remain in full force and effect;

(iii)          the Purchasers shall have delivered or stand ready and willing to deliver, upon the terms and conditions stated in this Agreement, an aggregate of at least $75,000,000 of the Company A Ordinary Shares from the Company; provided, however, that no Purchaser may rely on the failure of this Section 3(a)(iii) to be satisfied if such Purchaser’s breach of this Agreement shall have been a cause of such failure;

(iv)          the Eros Pre-Closing Equity Financing shall have been consummated or shall be consummated substantially concurrently with the Closing for aggregate proceeds of not less than $35,000,000;

(v)            the condition to closing of the Merger set forth in Section 6.1(i) of the Merger Agreement shall be satisfied, or substantially contemporaneously with the closing of this Agreement will be satisfied, without giving effect to any waiver thereof pursuant to the Merger Agreement;

 

 

(vi)          there shall not have been enacted or promulgated any order, judgment, injunction, decree, writ, stipulation, determination or award, in each case, entered by or with any court or governmental agency or body of competent jurisdiction, domestic or foreign, nor any statute, rule or regulation, in either case, enjoining or prohibiting the consummation of the transactions contemplated hereby; and

(vii)        the Company A Ordinary Shares to be issued at the Closing hereunder shall have been approved for listing on the New York Stock Exchange, subject to official notice of issuance.

(b)            The obligation of each Purchaser to effect the Closing is also subject to the satisfaction or waiver in whole or in part (to the extent permitted by applicable law), on or prior to the Closing Date, of the following conditions:

(i)              (A) the representations and warranties of the Company contained in Section 5 (other than in subsection (e)) of this Agreement shall be true and correct as of the Closing Date as though made on the Closing Date (except to the extent such representations and warranties expressly relate to a specific date or the date of this Agreement, in which case such representations and warranties shall be true and correct as of such date); and (B) the Merger Agreement Representations (as defined below) shall be true and correct to the extent provided in Section 6.3(a) of the Merger Agreement.

(ii)            The Company shall have performed in all material respects all obligations required to be performed by it under this Agreement at or prior to the Closing Date.

(iii)          The Merger Agreement (as in effect on the date hereof) shall not have been amended, modified or supplemented in a manner that would reasonably be expected to materially and adversely affect the rights or economic benefits that such Purchaser would reasonably expect to receive under this Agreement, unless such Purchaser has consented in writing to such amendment, modification or supplementation.

(c)             The obligation of the Company to effect the Closing is also subject to the satisfaction or waiver in whole or in part (to the extent permitted by applicable law), on or prior to the Closing Date, of the following conditions:

(i)              (A) the representations and warranties of each Purchaser contained in Sections 6(a), 6(b) and 6(m) of this Agreement shall be true and correct as of the Closing Date as though made on the Closing Date (except to the extent such representations and warranties expressly relate to a specific date or the date of this Agreement, in which case such representations and warranties shall be true and correct as of such date); and (B) the other representations and warranties of each Purchaser contained in this Agreement (without giving effect to any limitation as to “materiality,” “Purchaser Material Adverse Effect” or any similar qualification set forth therein) shall be true and correct as of the Closing Date as though made on the Closing Date (except to the extent such representations and warranties expressly relate to a specific date or the date of this Agreement, in which case such representations and warranties shall be true and correct as of such date), except where the failure to be so true and correct does not, and would not reasonably be expected to, individually or in the aggregate, have a material adverse effect on the ability of such Purchaser to consummate the transactions contemplated by this Agreement (a “Purchaser Material Adverse Effect”).

 

 

(ii)            Such Purchaser shall have performed in all material respects all obligations required to be performed by it under this Agreement at or prior to the Closing Date.

4.               Further Assurances; Covenants.

(a)             The parties hereto shall execute and deliver such additional documents and take such additional actions as the parties reasonably may deem to be practical and necessary in order to consummate the transactions as contemplated by this Agreement.

(b)            At or prior to the Closing, the Company shall take all necessary action to issue and allot, in accordance with the immediately following sentence, an additional amount of Company A Ordinary Shares for an aggregate purchase price of at least $35,000,000 in cash (the “Eros Pre-Closing Equity Financing”). No issuance or allotment of Company A Ordinary Shares shall be deemed part of or to contribute to the Eros Pre-Closing Equity Financing unless (i) pursuant to (A) that certain Subscription Agreement, dated January 20, 2020, between the Company and the purchaser party thereto or (B) any other subscription agreement having substantially identical terms as the subscription agreement described in the foregoing clause (i)(A) entered into between the Company and another purchaser after the date hereof and prior to the Closing Date for an aggregate commitment (inclusive of the subscription agreement described in the foregoing clause (i)(A)) not to exceed $100,000,000 (collectively, the “Equity Facility”) or (ii) consented to in advance by the Purchasers purchasing at least a majority of the $75,000,000 of Company A Ordinary Shares to be purchased hereunder, such consent not to be unreasonably withheld, conditioned or delayed (it being acknowledged and agreed that it shall be reasonable for any Purchaser to withhold its consent to an issuance or allotment the economic terms of which are more favorable to the subscriber or purchaser thereof than the terms of this Agreement are to the Purchasers or if such subscriber or purchaser is or, immediately prior to the consummation of the Merger, was a stockholder of STX) (any source of financing described in this clause (ii), an “Alternative Equity Source”); provided that no less than $20,000,000 of the Eros Pre-Closing Equity Financing shall be obtained pursuant to the Equity Facility.

(c)             On or prior to the ninetieth (90th) day after the Closing Date, the Company shall take all necessary action to issue and allot, pursuant to the Equity Facility or an Alternative Equity Source, an additional amount of Company A Ordinary Shares for an aggregate purchase price of at least $15,000,000 in cash, less the amount, if any, by which the Eros Pre-Closing Equity Financing exceeded $35,000,000 (the “Eros Post-Closing Equity Financing”). For avoidance of doubt, no portion of the Eros Post-Closing Equity Financing obtained from an Alternative Equity Source shall constitute a Dilutive Issuance Exception.

(d)            If the original commitment under any Equity Facility is not fully exhausted following the consummation of the Eros Pre-Closing Equity Financing and Eros Post-Closing Equity Financing, then, from and after the ninetieth (90th) day after the Closing Date, the Company shall not issue or allot, or agree or commit to issue or allot, any additional Company A Ordinary Shares pursuant to any Equity Facility without the approval of 75% of the directors of the Company then in office.

 

 

(e)             From the date hereof until the later of (i) the end of the Restricted Period (as defined in the Lockup Agreement (as defined below)) or (ii) the Settlement Date (as defined in the Class E CVR Agreement (as defined in the Merger Agreement)), none of the Company, its controlled affiliates or any of its or their respective representatives (collectively, a “Company Party”) shall enter into any agreement, arrangement, commitment, instrument or understanding, whether written or oral (a “Side Agreement”), with any Purchaser, Purchaser’s affiliates or its or their respective representatives (collectively, a “Purchaser Party”) that has the purpose or effect of providing to such Purchaser differential or unique benefits in respect of its investment in the Company by virtue of this Agreement or the consummation of the Merger as compared to the benefits to be received by all other Purchasers in respect of their respective investments in the Company by virtue of this Agreement or the consummation of the Merger (other than as set forth in this Agreement, the Merger Agreement or any agreement referenced therein, or any modification or alteration to rights set forth in such agreements that are not held by the Purchasers generally (such as board nomination rights)) unless all Purchasers are offered the opportunity to enter into the same or a substantively identical Side Agreement.

5.               Company Representations and Warranties. Except as set forth in any Form 20-F or Form 6-K filed with the United States Securities and Exchange Commission since January 1, 2017 and publicly available prior to the date of this Agreement (as amended or supplemented prior to the date of this Agreement, the “Company SEC Documents”) (excluding any disclosures in any risk factors section, in any section related to forward-looking statements and other disclosures that are cautionary, predictive or forward-looking in nature), the Company represents and warrants to each Purchaser as of the date hereof, and, on the occurrence of the Closing, as of the Closing Date, that:

(a)             The Company is duly incorporated and is validly existing and in good standing as a company limited by shares under the laws of Isle of Man and has the requisite corporate power and authority to enter into this Agreement and to consummate the transactions contemplated hereby.

(b)            This Agreement has been duly authorized, executed and delivered by the Company and, assuming the due authorization, execution and delivery of this Agreement by each Purchaser, constitutes a legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except that (i) such enforcement may be subject to applicable bankruptcy, insolvency, examinership, fraudulent transfer, reorganization, moratorium and similar applicable laws affecting creditors’ rights generally and (ii) equitable remedies of specific performance and injunctive and other forms of equitable relief may be subject to equitable defenses and to the discretion of the court before which any proceeding therefor may be brought (collectively, the “Enforceability Exceptions”).

(c)             The execution, delivery and performance by the Company of this Agreement does not and will not conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance upon any of the property or assets of the Company or any of its subsidiaries pursuant to the terms of: (i) the Memorandum and Articles of Association of the Company; (ii) any indenture, mortgage, deed of trust, loan agreement, lease, license, permit or other agreement or instrument to which the Company or any of its subsidiaries is a party or by

 

 

which the Company or any of its subsidiaries is bound or to which any of the property or assets of the Company is subject; or (iii) any statute or any judgment, order, rule or regulation of any court or governmental agency or body, domestic or foreign, having jurisdiction over the Company or any of its properties, other than, in the case of clauses (ii) and (iii), any such conflicts, violations, defaults, liens, charges or encumbrances that, individually or in the aggregate, would not reasonably be expected to have a material adverse effect on the ability of the Company to consummate the transactions contemplated by this Agreement.

(d)            Except for the Company’s arrangement with Citigroup Global Markets, Inc. and STX’s arrangement with PJT Partners, Inc., the Company has not entered into (and is not aware that STX has entered into) any agreement or arrangement entitling any agent, broker, investment banker, financial advisor or other person to any broker’s or finder’s fee or any other commission or similar fee in connection with the transactions contemplated by this Agreement for which such Purchaser could become liable (it being understood that such Purchaser will effectively bear its pro rata share of any such expenses indirectly as a result of its investment in the Company).

(e)             Each of the representations and warranties of the Company set forth in the Merger Agreement is incorporated by reference herein, mutatis mutandis (collectively, the “Merger Agreement Representations”).

(f)             The Company A Ordinary Shares to be issued hereunder have been duly authorized and, when issued and delivered to such Purchaser against full payment therefor in accordance with the terms of this Agreement, will be validly issued, fully paid and not subject to any call by the Company and will rank pari passu with all other Company A Ordinary Shares, and such issuance is not subject to any preemptive or similar rights under the Company’s Articles of Association, the laws of the Isle of Man or otherwise.

(g)            No Company Party has entered into any Side Agreement with any Purchaser Party.

6.               Purchaser Representations and Warranties. Each Purchaser, severally and not jointly or jointly and severally, represents and warrants to the Company as of the date hereof and, on the occurrence of the Closing, as of the Closing Date, that:

(a)             Such Purchaser has been duly formed or incorporated and is validly existing and in good standing under the laws of its jurisdiction of incorporation or formation with all requisite organizational, corporate or other power, as the case may be, and authority to enter into this Agreement and to consummate the transactions contemplated hereby.

(b)            This Agreement has been duly authorized, executed and delivered by such Purchaser and, assuming the due authorization, execution and delivery of this Agreement by the Company, constitutes the legal, valid and binding obligation of such Purchaser, enforceable against such Purchaser in accordance with its terms, subject to the Enforceability Exceptions.

 

 

(c)             The execution, delivery and performance by such Purchaser of this Agreement does not and will not conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance upon any of the property or assets of such Purchaser pursuant to the terms of: (i) its organizational documents; (ii) any indenture, mortgage, deed of trust, loan agreement, lease, license, permit or other agreement or instrument to which such Purchaser is a party or by which such Purchaser is bound or to which any of the property or assets of such Purchaser is subject; or (iii) any statute or any judgment, order, rule or regulation of any court or governmental agency or body, domestic or foreign, having jurisdiction over such Purchaser or any of its properties, other than, in the case of clauses (ii) and (iii), any such conflicts, violations, defaults, liens, charges or encumbrances that, individually or in the aggregate, would not reasonably be expected to have a Purchaser Material Adverse Effect.

(d)            Such Purchaser is an “accredited investor” (within the meaning of Rule 501(a) under the Securities Act of 1933, as amended (the “Securities Act”)), in each case, satisfying the requirements set forth on Schedule II, and is acquiring the Company A Ordinary Shares only for its own account and not for the account of others, and not on behalf of any other account or person or with a view to, or for offer or sale in connection with, any distribution thereof in violation of the Securities Act (and shall provide the requested information on Schedule II following the signature page hereto).

(e)             Such Purchaser understands that the Company A Ordinary Shares are being offered in a transaction not involving any public offering within the meaning of the Securities Act and that the Company A Ordinary Shares have not been registered under the Securities Act. Such Purchaser understands that the Company A Ordinary Shares may not be resold, transferred, pledged or otherwise disposed of by the Purchaser absent an effective registration statement under the Securities Act, except (i) to the Company or a subsidiary thereof, (ii) to non-U.S. persons pursuant to offers and sales that occur outside the United States within the meaning of Regulation S under the Securities Act or (iii) pursuant to another applicable exemption from the registration requirements of the Securities Act, and in each of cases (i) and (iii), in accordance with any applicable securities or “blue sky” laws of the states and other jurisdictions of the United States, and that any book entry account or certificate representing the Company A Ordinary Shares shall contain a legend to such effect substantially consistent with the legend set forth in Section 7(b) hereof. Such Purchaser acknowledges that Rule 144 under the Securities Act (“Rule 144”) will not be available as of the Closing with respect to the resale of the Company A Ordinary Shares purchased hereunder, and when and if such Company A Ordinary Shares may be disposed of without registration under the Securities Act in reliance on Rule 144, the amount of such Company A Ordinary Shares that may be disposed of may be limited in accordance with the terms and conditions of Rule 144. Such Purchaser understands and agrees that such Purchaser may not be able to readily resell the Company A Ordinary Shares and may be required to bear the financial risk of an investment in the Company A Ordinary Shares for an indefinite period of time. Such Purchaser understands that it has been advised to consult legal counsel prior to making any offer, resale, pledge or transfer of any of the Company A Ordinary Shares.

(f)             Such Purchaser understands and agrees that such Purchaser is purchasing Company A Ordinary Shares directly from the Company. Such Purchaser further acknowledges that there have been no representations, warranties, covenants and agreements made to such Purchaser with respect to the Company A Ordinary Shares purchased hereunder by the Company or its affiliates or its or their respective shareholders, control persons, officers, directors or other

 

 

representatives, or by STX or their affiliates or any of their respective shareholders, control persons, officers, directors or other representatives, expressly or by implication, other than those representations, warranties, covenants and agreements of the Company expressly included in this Agreement.

(g)            Such Purchaser acknowledges and agrees that such Purchaser has received such information as such Purchaser deems necessary in order to make an investment decision with respect to the Company A Ordinary Shares. Without limiting the generality of the foregoing, such Purchaser acknowledges that it (i) has had the opportunity to review the Company SEC Documents; and (ii) has reviewed certain business and legal due diligence materials with respect to the Company and STX provided to such Purchaser by the Company and STX, respectively. Such Purchaser represents and agrees that such Purchaser and such Purchaser’s professional advisor(s), if any, have had the full opportunity to ask such questions, receive such answers and obtain such information as such Purchaser and such Purchaser’s professional advisor(s), if any, have deemed necessary to make an investment decision with respect to the Company A Ordinary Shares.

(h)            Such Purchaser acknowledges that it is aware that there are substantial risks incident to the purchase and ownership of the Company A Ordinary Shares, including those set forth in the Company SEC Documents. Such Purchaser has such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of an investment in the Company A Ordinary Shares, and such Purchaser has sought such accounting, legal and tax advice as such Purchaser has considered necessary to make an informed investment decision. Alone, or together with any professional advisor(s), such Purchaser has adequately analyzed and fully considered the risks of an investment in the Company A Ordinary Shares and determined that the Company A Ordinary Shares are a suitable investment for such Purchaser and that such Purchaser is able at this time and in the foreseeable future to bear the economic risk of a total loss of such Purchaser’s investment in the Company. The Purchaser acknowledges specifically that a possibility of total loss exists.

(i)              Such Purchaser understands and agrees that no federal or state agency has passed upon or endorsed the merits of the offering of the Company A Ordinary Shares or made any findings or determination as to the fairness of this investment.

(j)              Neither such Purchaser nor any of its directors, officers, or employees is (i) subject to comprehensive sanctions by virtue of their designation to a list of restricted persons, including the U.S. Department of the Treasury’s Office of Foreign Assets Control (“OFAC”) List of Specially Designated Nationals and Blocked Person; (ii) located in, organized under the law of or ordinarily resident in a Sanctioned Jurisdiction (Cuba, Iran, North Korea, Syria, and the Crimea region of Ukraine); or (iii) a non-U.S. shell bank or providing banking services indirectly to a non-U.S. shell bank. Such Purchaser agrees to provide law enforcement agencies, if requested thereby, such records as required by applicable law, provided that such Purchaser is permitted to do so under applicable law. If such Purchaser is a financial institution subject to the Bank Secrecy Act (31 U.S.C. Section 5311 et seq.) (the “BSA”), as amended by the USA PATRIOT Act of 2001 (the “PATRIOT Act”), and its implementing regulations (collectively, the “BSA/PATRIOT Act”), such Purchaser maintains policies and procedures reasonably designed to comply with applicable obligations under the BSA/PATRIOT Act. To the extent

 

 

required by applicable law, such Purchaser maintains policies and procedures reasonably designed to ensure compliance with OFAC sanctions. To the extent required by applicable law, such Purchaser maintains policies and procedures reasonably designed to ensure that the funds held by such Purchaser and used to purchase the Company A Ordinary Shares were (and will be) legally derived.

(k)            Such Purchaser has and will have sufficient unrestricted funds to pay the Purchase Price in full pursuant to Section 2 at the Closing.

(l)              Assuming such Purchaser will hold no more than 10% of the Company’s issued and outstanding voting securities after giving effect to the Merger (including the private placements contemplated thereby), the Purchaser qualifies for the “acquisition solely for the purpose of investment exemption” under 16 C.F.R. § 802.9, and such Purchaser’s acquisition of the Company A Ordinary Shares is therefore exempt from the requirements of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.

(m)           Such Purchaser has not entered into any agreement or arrangement entitling any agent, broker, investment banker, financial advisor or other person to any broker’s or finder’s fee or any other commission or similar fee in connection with the transactions contemplated by this Agreement.

7.               Delivery of Securities.

(a)             The Company shall register each Purchaser as the owner of the Company A Ordinary Shares purchased by such Purchaser hereunder in the appropriate books and records of the Company and with the Company’s transfer agent by book entry on or promptly after the date of the Closing.

(b)            Each register and book entry for the Company A Ordinary Shares purchased hereunder shall contain a notation, and each certificate (if any) ever evidencing such Company A Ordinary Shares shall, so long as they are not registered under the Securities Act, be stamped or otherwise imprinted with a legend, in substantially the following form:

“THE SHARES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS AND MAY NOT BE OFFERED OR SOLD WITHIN THE UNITED STATES OR TO, OR FOR THE BENEFIT OF, U.S. PERSONS IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THE SHARES UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAW OR AN EXEMPTION FROM SUCH REGISTRATION UNDER THE SECURITIES ACT AND EACH APPLICABLE STATE SECURITIES LAW. THE ISSUER OF THESE SHARES MAY REQUIRE AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE ISSUER THAT SUCH OFFER, SALE OR OTHER TRANSFER COMPLIES WITH THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES

 

 

LAWS. THE SALE, PLEDGE, HYPOTHECATION, OR TRANSFER OF THE SHARES ARE SUBJECT TO THE TERMS AND CONDITIONS OF A CERTAIN SUBSCRIPTION AGREEMENT AND LOCKUP AGREEMENT BY AND AMONG THE HOLDER AND THE OTHER PARTIES THERETO. COPIES OF SUCH AGREEMENTS MAY BE OBTAINED UPON WRITTEN REQUEST TO THE SECRETARY OF THE COMPANY.”

8.               Lockup Agreement; Investors’ Rights Agreement; Registration Rights Agreement;

(a)             Concurrently with the execution of this Agreement and as a condition to the effectiveness of this Agreement, each Purchaser has entered into a lockup agreement with the Company substantially in the form attached hereto as Exhibit B (the “Lockup Agreement”).

(b)            At the Closing, each of the parties hereto shall execute and deliver (i) the Eros Investors’ Rights Agreement (as defined in the Merger Agreement and substantially in the form attached hereto as Exhibit C) and (ii) the Registration Rights Agreement (as defined in the Merger Agreement and substantially in the form attached hereto as Exhibit D).

9.               Termination. This Agreement shall terminate and be void and of no further force and effect, and all rights and obligations of the parties hereunder shall terminate without any further liability on the part of any party in respect thereof, upon the earliest to occur of (a) such date and time as the Merger Agreement is terminated in accordance with its terms prior to the Effective Time (as defined therein) or (b) the mutual written agreement of each of the parties hereto to terminate this Agreement. If the Merger Agreement is so terminated, the Company shall promptly notify the Purchasers of such termination. For avoidance of doubt, this Agreement will survive the consummation of the Merger if it occurs.

10.            Notices. All notices, requests, claims, demands and other communications under this Agreement shall be in writing and shall be deemed given (i) if delivered personally, upon such delivery, (ii) if delivered by electronic mail, when confirmation of successful transmission is received or (iii) if sent by Federal Express or other nationally-recognized overnight courier, upon delivery or refusal of delivery, to the parties at the following addresses (or at such other address for a party as shall be specified by like notice):

(a)             if to the Company:

Eros International Plc
First Names House

Victoria Road

Douglas

Isle of Man IM2 4DF

British Isles

Attention:Mark Carbeck, Chief Corporate and Strategy Officer
Email:mark.carbeck@erosintl.com

 

 

with a copy (which shall not constitute notice) to:

Gibson, Dunn & Crutcher LLP
333 South Grand Avenue
Los Angeles, California 90071-3197

Attention:Kevin Masuda
Peter Wardle
Email:kmasuda@gibsondunn.com
pwardle@gibsondunn.com

(b)            if to a Purchaser, to the address set forth below such Purchaser’s signature on its signature page hereto.

11.            Miscellaneous.

(a)             Neither this Agreement nor any of the rights, interests or obligations under this Agreement shall be assigned or delegated, in whole or in part, by operation of law or otherwise by any of the parties without the prior written consent of the other parties; provided that, without the prior written consent of any other parties, any Purchaser may assign its rights under this Agreement to any of its affiliates or any of its or its affiliates’ affiliated investment funds so long as such assignee expressly makes the representations and warranties of such Purchaser to the Company and expressly agrees to perform all obligations of such Purchaser hereunder prior to or upon the effectiveness of any such assignment; provided further, that no such assignment shall relieve such Purchaser of any of its obligations hereunder. Any purported assignment in violation of the preceding sentence shall be void. Subject to the preceding two sentences, this Agreement will be binding upon, inure to the benefit of and be enforceable by the parties and their respective successors and permitted assigns.

(b)            The Company may request from any Purchaser such additional information as the Company may deem necessary to evaluate the eligibility of such Purchaser to acquire the Company A Ordinary Shares, and each Purchaser shall provide such information as may reasonably be requested, to the extent readily available and to the extent consistent with its internal policies and procedures.

(c)             Each Purchaser acknowledges that the Company will rely on the acknowledgments, understandings, agreements, representations and warranties contained in this Agreement. Prior to the Closing, each Purchaser agrees to promptly notify the Company if any of the acknowledgments, understandings, agreements, representations and warranties made by such Purchaser are no longer accurate.

(d)            All the agreements, representations and warranties made by each party hereto in this Agreement shall survive the Closing; provided, however, that, with respect to this Agreement, the Merger Agreement Representations shall terminate at, and shall not survive, the Closing.

(e)             This Agreement (including the Schedules and Exhibits hereto), the Merger Agreement (solely to the extent incorporated by reference herein), and that certain Class E Share Purchase Agreement, dated as of the date hereof, by and between STX and each Purchaser (as

 

 

defined therein) party thereto (solely to the extent applicable to the Purchasers’ respective rights inter sese and, for avoidance of doubt, not as relates to the Company) constitute the entire agreement of the parties, and supersedes all other prior agreements, understandings, representations and warranties, both written and oral, among the parties, with respect to the subject matter hereof. This Agreement shall not confer any rights or remedies upon any person other than the parties hereto, and their respective successors and permitted assigns.

(f)             Except as otherwise provided herein, this Agreement shall be binding upon, and inure to the benefit of, the parties hereto and their heirs, executors, administrators, successors, legal representatives, and permitted assigns, and the agreements, representations, warranties, covenants and acknowledgments contained herein shall be deemed to be made by, and be binding upon, such heirs, executors, administrators, successors, legal representatives and permitted assigns.

(g)            The provisions of this Agreement may be amended and waived only with the prior written consent of the Company and each of the Purchasers; provided, that no such prior written consent shall be necessary to add one or more additional Purchasers as parties to this Agreement upon receipt of an executed Joinder by such additional Purchaser(s) and amend Schedule I accordingly in the manner set forth in Section 1(a); provided, further, that, any party hereto, on its behalf and not on behalf of any other party hereto, may (i) extend the time for the performance of any of the obligations or other acts of the other parties hereto, (ii) to the extent permitted by applicable law, waive any inaccuracies in the representations and warranties contained herein by any other party or in any document, certificate or writing delivered pursuant hereto by any other applicable party or (iii) to the extent permitted by applicable law, waive compliance with any of the agreements or conditions contained herein, provided that any such extension or waiver described in the foregoing clauses (i) to (iii) by the Company shall be made in compliance with Section 4(e). Any agreement on the part of any party to any such extension or waiver shall be valid only if set forth in an instrument in writing signed on behalf of such party. The failure of any party to this Agreement to exercise any of its rights under this Agreement or otherwise shall not constitute a waiver by such party of such right.

(h)            If any provision of this Agreement shall be invalid, illegal or unenforceable, the validity, legality or enforceability of the remaining provisions of this Agreement shall not in any way be affected or impaired thereby and shall continue in full force and effect so long as either the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party or such party waives its rights under this Section 11(g) with respect thereto. Upon a determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible to the fullest extent permitted by applicable law in an acceptable manner to the end that the transactions contemplated hereby are fulfilled to the extent possible.

(i)              This Agreement may be executed in one or more counterparts, all of which shall be considered one and the same agreement and shall become effective when one or more counterparts have been signed by each of the parties hereto and delivered to the other parties. This Agreement may be executed by facsimile, .pdf or other similar means of electronic signature and a facsimile, .pdf or other electronic signature shall constitute an original for all purposes.

 

 

(j)              The parties acknowledge and agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached, and that monetary damages, even if available, would not be an adequate remedy therefor. It is accordingly agreed that the parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the performance of terms and provisions of this Agreement in any court referred to in Section 11(l), without proof of actual damages (and each party hereby waives any requirement for the securing or posting of any bond in connection with such remedy), this being in addition to any other remedy to which they are entitled at law or in equity. The parties further agree not to assert that a remedy of specific enforcement is unenforceable, invalid, contrary to law or inequitable for any reason, nor to assert that a remedy of monetary damages would provide an adequate remedy for any such breach.

(k)            This Agreement shall be governed by and construed in accordance with the laws of the state of Delaware without regard to the conflict of law principles thereof that would result in the application of any other jurisdiction’s laws.

(l)              EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE IT HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT AND ANY OF THE AGREEMENTS DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (B) IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF SUCH WAIVER, (C) IT MAKES SUCH WAIVER VOLUNTARILY AND (D) IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVER AND CERTIFICATIONS IN THIS SECTION 11(k).

(m)           Subject to Section 11(n), each of the parties irrevocably agrees that any legal action or proceeding arising out of or relating to this Agreement brought by any party or its affiliates against any other party or its affiliates shall be brought and determined in the Court of Chancery of the State of Delaware, provided, that if (and only if) such court finds it lacks subject matter jurisdiction, then any such legal action or proceeding may be brought in any federal court located in the State of Delaware or if (and only if) each of such Court of Chancery for the State of Delaware and such federal court finds it lacks subject matter jurisdiction, any other Delaware state court. Each of the parties hereby irrevocably submits to the jurisdiction of the aforesaid courts for itself and with respect to its property, generally and unconditionally, with regard to any such action or proceeding arising out of or relating to this Agreement and the transactions

 

 

contemplated hereby. Subject to Section 11(n), each of the parties agrees not to commence any action, suit or proceeding relating thereto except in the courts described above in Delaware, other than actions in any court of competent jurisdiction to enforce any judgment, decree or award rendered by any such court in Delaware as described herein. Each of the parties further agrees that notice as provided herein shall constitute sufficient service of process and the parties further waive any argument that such service is insufficient. Each of the parties hereby irrevocably and unconditionally waives, and agrees not to assert, by way of motion or as a defense, counterclaim or otherwise, in any action or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby, (a) any claim that it is not personally subject to the jurisdiction of the courts in Delaware as described herein for any reason, (b) that it or its property is exempt or immune from jurisdiction of any such court or from any legal process commenced in such courts (whether through service of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise) and (c) that (i) the suit, action or proceeding in any such court is brought in an inconvenient forum, (ii) the venue of such suit, action or proceeding is improper or (iii) this Agreement, or the subject matter hereof, may not be enforced in or by such courts.

(n)            If and to the extent that any legal action or proceeding arising out of or relating to this Agreement relates to the rectification of the Company’s register of members or book entry account or the enforcement of Section 11(j) (but otherwise without prejudice to the provisions of Section 11(m)), each of the parties irrevocably agrees that the courts of the Isle of Man shall have jurisdiction to hear and decide such legal action or proceeding and, for this purpose only, each of the parties hereby irrevocably submits to the jurisdiction of the aforesaid courts for itself and with respect to its property, generally and unconditionally, with regard to any such legal action or proceeding.

(o)            The Company and each Purchaser acknowledge that each party to this Agreement has been represented by counsel in connection with this Agreement and the transactions contemplated by this Agreement. Accordingly, any rule of law or any legal decision that would require interpretation of any claimed ambiguities in this Agreement against the drafting party has no application and is expressly waived.

Signature pages follow.

 

 

IN WITNESS WHEREOF, the Company has executed or caused this Agreement to be executed by its duly authorized representative as of the date set forth above.

 

EROS INTERNATIONAL PLC

By: /s/ Kishore Lulla                         

Name:  Kishore Lulla

Title:    Executive Chairman and Group Chief
Executive Officer and Managing Director

 

 

Signature Page to Subscription Agreement

 

 

IN WITNESS WHEREOF, the undersigned Purchaser has executed or caused this Agreement to be executed by its duly authorized representative as of the date set forth above.

 

Name of Purchaser:

MARCO ALLIANCE LIMITED

By: /s/ Yuan Bing          

Name:  Yuan Bing

Title:    Director

 

Purchase Price: $ 26,500,000.00         

 

 

Address for Notices:

 

[Address]

 

with a copy (which shall not constitute notice) to:

 

[Address]

 

 

 

 

 

 

 

 

 

Signature Page to Subscription Agreement

 

 

IN WITNESS WHEREOF, the undersigned Purchaser has executed or caused this Agreement to be executed by its duly authorized representative as of the date set forth above.

 

Name of Purchaser:

TPG GROWTH IV OSCARS, L.P.

By:TPG Growth GenPar IV, L.P.
its general partner
By:TPG Growth GenPar IV Advisors, LLC
its general partner

By: /s/ David Mossé                         

Name:  David Mossé

Title:    Vice President

 

Purchase Price: $ 26,500,000.00         

 

 

Address for Notices:

 

[Address]

 

with a copy (which shall not constitute notice) to:

 

[Address]

 

 

 

 

 

Signature Page to Subscription Agreement

 

 

IN WITNESS WHEREOF, the undersigned Purchaser has executed or caused this Agreement to be executed by its duly authorized representative as of the date set forth above.

 

Name of Purchaser:

PCCW MEDIA LIMITED

By: /s/ LEE Hoi Yee, Janice          

Name:  LEE Hoi Yee, Janice

Title:    Director

 

Purchase Price: $ 9,000,000           

 

 

Address for Notices:

 

[Address]

 

with a copy (which shall not constitute notice) to:

 

[Address]

 

 

 

 

 

 

 

Signature Page to Subscription Agreement

 

 

IN WITNESS WHEREOF, the undersigned Purchaser has executed or caused this Agreement to be executed by its duly authorized representative as of the date set forth above.

 

Name of Purchaser:

BLACK FISH BLUE FISH, LLC

By: /s/ Derek Arend                       

Name:  Derek Arend

Title:    President

 

Purchase Price: $ 6,000,000.00        

 

 

Address for Notices:

 

[Address]

 

with a copy (which shall not constitute notice) to:

 

[Address]

 

 

 

 

 

Signature Page to Subscription Agreement

 

 

IN WITNESS WHEREOF, the undersigned Purchaser has executed or caused this Agreement to be executed by its duly authorized representative as of the date set forth above.

 

Name of Purchaser:

LIBERTY GLOBAL INCORPORATED
LIMITED

By: /s/ Jeremy Evans                  

Name:  Jeremy Evans

Title:    Director

 

Purchase Price: $ 3,000,000.00     

 

 

Address for Notices:

 

[Address]

 

with a copy (which shall not constitute notice) to:

 

[Address]

 

 

 

 

Signature Page to Subscription Agreement

 

 

IN WITNESS WHEREOF, the undersigned Purchaser has executed or caused this Agreement to be executed by its duly authorized representative as of the date set forth above.

 

Name of Purchaser:

PTOLEMY CAPITAL, LLC

By: /s/ Mitchell Otolski                 

Name:  Mitchell Otolski

Title:    Agent

 

Purchase Price: $ 2,000,000.00       

 

 

Address for Notices:

 

[Address]

 

with a copy (which shall not constitute notice) to:

 

[Address]

 

 

 

 

 

Signature Page to Subscription Agreement

 

 

IN WITNESS WHEREOF, the undersigned Purchaser has executed or caused this Agreement to be executed by its duly authorized representative as of the date set forth above.

 

Name of Purchaser:

 

/s/ Andrew Warren                          

Andrew Warren

 

 

Purchase Price: $ 2,000,000.00         

 

 

Address for Notices:

 

[Address]

 

with a copy (which shall not constitute notice) to:

 

[Address]

 

 

 

 

Signature Page to Subscription Agreement

 

SCHEDULE I

PURCHASE PRICE

 

Purchaser Purchase Price Jurisdiction of Organization
Marco Alliance Limited  $26,500,000.00 British Virgin Islands
TPG Growth IV Oscars, L.P.  $26,500,000.00 Delaware
PCCW Media Limited  $9,000,000.00 Hong Kong
Black Fish Blue Fish, LLC  $6,000,000.00 Delaware
Liberty Global Incorporated Limited  $3,000,000.00 U.K., England and Wales
Ptolemy Capital, LLC  $2,000,000.00 Delaware
Andrew Warren  $2,000,000.00 N/A
Total: $75,000,000.00 -

 

 

 

 

 

Exhibit 4.33

AMENDMENT NO. 1 TO SUBSCRIPTION AGREEMENT

This AMENDMENT TO SUBSCRIPTION AGREEMENT, dated as of July 21, 2020 (this “Amendment”), is entered into by Eros International Plc, an Isle of Man company limited by shares (the “Company”).

WHEREAS, the Company and the Initial Purchasers previously entered into that certain Subscription Agreement, dated as of April 17, 2020 (the “Subscription Agreement”);

WHEREAS, pursuant to Section 1(a) of the Subscription Agreement, the Company may amend Schedule I of the Subscription Agreement without any action by any Purchaser, to give effect to the entry into the Subscription Agreement by certain Purchasers pursuant to the Joinders; and

WHEREAS, in connection with the foregoing, the Company desires to amend the Subscription Agreement as provided herein.

NOW, THEREFORE, in consideration of the premises and the mutual agreements and covenants hereinafter set forth, the receipt and sufficiency of which are hereby acknowledged, the Company hereby agrees as follows:

1.                  Definitions. Capitalized terms used but not defined in this Amendment shall have the meanings ascribed to them in the Subscription Agreement.

2.                  Amendment of Schedule I of the Subscription Agreement. Schedule I of the Subscription Agreement is hereby deleted in its entirety and replaced with Schedule I attached to this Amendment.

3.                  No Other Modification. Except to the extent specifically amended herein or supplemented hereby, the Subscription Agreement remains unchanged and in full force and effect, and this Amendment will be governed by and subject to the terms of the Subscription Agreement, as amended by this Amendment. From and after the date of this Amendment, each reference in the Subscription Agreement to “this Agreement,” “hereof,” “hereunder” or words of like import, and all references to the Subscription Agreement in any and all agreements, instruments, documents, notes, certificates and other writings of every kind of nature (other than in this Amendment or as otherwise expressly provided) will be deemed to mean the Subscription Agreement, as amended by this Amendment, whether or not this Amendment is expressly referenced.

4.                  Other Terms. The provisions of Section 11 of the Subscription Agreement are incorporated herein by reference and shall apply to the terms and provisions of this Amendment and the Company hereto, mutatis mutandis.

 

[Signature Page Follows]

 

 

IN WITNESS WHEREOF, the Company caused this Amendment No. 1 to Subscription Agreement to be executed by its duly authorized representative as of the date first written above.

  EROS INTERNATIONAL PLC
       
       
  By: /s/ Kishore Lulla
    Name: Kishore Lulla
    Title: Executive Chairman and Group
      Chief Executive Officer

 

[Signature Page - Amendment No. 1 to Subscription Agreement]

 

 

 

Schedule I

PURCHASE PRICE

 

Purchaser Purchase Price Jurisdiction of Organization
Marco Alliance Limited $24,533,229.42 British Virgin Islands
TPG Growth IV Oscars, L.P. $24,533,229.42 Delaware
PCCW Media Limited $8,332,040.19 Hong Kong
Black Fish Blue Fish, LLC  $5,554,693.45 Delaware
Liberty Global Ventures Limited $2,777,346.73 U.K., England and Wales
PE Fund LP $1,979,168.40 Delaware
Ptolemy Capital, LLC  $1,851,564.48 Delaware
Andrew Warren $1,851,564.48 N/A
Boston Fern Investment Limited $1,399,917.37 British Virgin Islands
Lakeside Investment Management Ltd. $817,367.86 British Virgin Islands
Anna Standish $391,772.39 N/A
Ever Star Trading Limited $325,753.42 British Virgin Islands
Codelouf Ltd. $163,473.57 Guernsey
Per Utnegaard & Partners GmbH $163,473.57 Switzerland
Cheng Kar Shing $163,274.62 N/A
Palace Global Investments Ltd. $162,130.63 Bahamas
Total: $75,000,000.00 -

 

 

Exhibit 4.34

 

CLASS E CONTINGENT VALUE RIGHTS AGREEMENT

This CLASS E CONTINGENT VALUE RIGHTS AGREEMENT, dated as of [●], 2020 (this “Agreement”), is entered into by and among Eros International Plc, an Isle of Man company limited by shares (“Parent”), STX Filmworks, Inc., a Delaware corporation (the “Company”), Fortis Advisors LLC, a Delaware limited liability company, solely in its capacity as representative of the former holders of the Shares (in such capacity, the “Stockholders’ Representative”), and Computershare Inc., a Delaware corporation, and its wholly-owned subsidiary, Computershare Trust Company, N.A., a federally chartered trust company, collectively as rights agent (the “Rights Agent”) and as initial CVR Registrar (as defined herein).

WITNESSETH:

WHEREAS, the Company, Parent, England Holdings 2, Inc., a Delaware corporation and indirect wholly-owned Subsidiary of Parent (“England Holdings 2”), England Merger 1 Corp. (f/k/a England Merger Corp.), a Delaware corporation and a direct wholly-owned Subsidiary of England Holdings 2 (“Merger Sub”), have entered into an Agreement and Plan of Merger (as the same may be amended, modified or supplemented from time to time, the “Merger Agreement”), dated as of April 17, 2020, pursuant to which Merger Sub merged with and into the Company (the “Merger”), with the Company surviving the Merger, as an indirect wholly-owned Subsidiary of Parent;

WHEREAS, pursuant to the Merger Agreement, Parent agreed to issue to holders of record of shares of Class E Convertible Preferred Stock, par value $0.01 per share, of the Company (the “Shares”) outstanding immediately prior to the effective time of the Merger (the “Effective Time”), a number of contingent value rights (the “CVRs”) as hereinafter described; and

WHEREAS, each holder of Shares as of immediately prior to the Effective Time, will receive, among other things, as merger consideration, the right to receive upon the Effective Time a number of CVRs in such amount as set forth in Article II of the Merger Agreement.

NOW, THEREFORE, for and in consideration of the premises and the consummation of the transactions referred to above, it is mutually covenanted and agreed, for the equal and proportionate benefit of all Holders (as hereinafter defined), as follows:

Article I
DEFINITIONS

Section 1.1      Definitions.

(a)                For all purposes of this Agreement, except as otherwise expressly provided or unless the context otherwise requires:

(i)                 the terms defined in this Article I have the meanings assigned to them in this Article I, and include the plural as well as the singular;

1 

 

(ii)               the words “herein,” “hereof” and “hereunder” and other words of similar import refer to this Agreement as a whole and not to any particular Article, Section or other subdivision;

(iii)             unless the context otherwise requires, words describing the singular number shall include the plural and vice versa, words denoting any gender shall include all genders and words denoting natural Persons shall include corporations, partnerships and other Persons and vice versa;

(iv)             the term “Affiliate” when used with respect to the Company shall, after the Effective Time, include Parent and its Subsidiaries and Affiliates; and

(v)               all references to “including” shall be deemed to mean including without limitation.

(b)               Capitalized terms used but not otherwise defined herein shall have the meanings ascribed thereto in the Merger Agreement. The following terms shall have the meanings ascribed to them as follows:

Affiliate” means, with respect to any specified Person, (i) any other Person that directly or indirectly through one or more intermediaries controls, or is controlled by, or is under common control with, such specified Person (for the purposes of this definition, “control” (including, with correlative meanings, the terms “controlling,” “controlled by” and “under common control with”), as used with respect to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of such Person, whether through the ownership of voting securities, by agreement or otherwise) and (ii) with respect to any natural person, any Member of the Immediate Family of such natural person. Notwithstanding the foregoing, for purposes hereof, (i) none of the Holders, the Company, or any of their respective Subsidiaries shall be considered Affiliates of any portfolio company (or Subsidiary thereof) in which any Holder or any of its affiliated investment funds have made a debt or equity investment, and (ii) no Holder or any of its Affiliates shall be considered an Affiliate of (a) Parent or any of its Subsidiaries or (b) any other Holders or their respective Affiliates (except to the extent such Holders are otherwise Affiliates under this definition without regard to their status as Holders).

Agreement” has the meaning set forth in the Preamble.

Aggregate CVR Shares” means the aggregate number of underlying Parent A Shares issuable in respect of all CVRs.

Appraisal Shares” has the meaning set forth in Section 4.2(h).

Available Class E Merger Consideration CVR Shares” means the Merger Consideration CVR Share Cap.

Base Price” means $2.60.

2 

 

Change of Control Transaction” means the occurrence of (i) an acquisition by any Person, including any syndicate or group deemed to be a “person” under Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, of beneficial ownership, directly or indirectly, through purchase, merger or other acquisition transaction or series of purchases, mergers or other acquisition transactions of shares or comparable equity interests of Parent entitling that Person to fifty percent (50%) or more of the total voting power of all such shares or comparable equity interests of Parent; or (ii) the consolidation or merger of Parent with or into any other Person, any merger of another Person into Parent, or any conveyance, transfer, sale, lease or other disposition of all or substantially all of Parent’s properties, business or assets, other than (in the case of this clause (ii) only) (1) any transaction (x) that does not result in any reclassification, conversion, exchange or cancellation of outstanding shares or comparable equity interests of Parent, and (y) pursuant to which holders of Parent’s shares or comparable equity interest immediately prior to such transaction have the right to exercise, directly or indirectly, fifty percent (50%) or more of the total voting power of all shares or comparable equity interest of the continuing or surviving Person immediately after such transaction, or (2) any merger solely for the purpose of changing Parent’s jurisdiction of formation and resulting in a reclassification, conversion or exchange of outstanding shares or comparable equity interests into shares or comparable equity interest of the surviving entity with substantially identical rights.

Class A CVR” means the contingent value rights issued by Parent with respect to the Class A Convertible Preferred Stock, par value $0.01 of the Company, pursuant to the Merger Agreement and the Class A CVR Agreement.

Class A CVR Agreement” means the Class A CVR Agreement, dated as of the date hereof, by and among Parent, the Company, the stockholders’ representative thereunder and the rights agent thereunder.

Class A CVR Shares” means the underlying Parent A Shares issuable in respect of the Class A CVRs.

Class B CVR” means the contingent value rights issued by Parent with respect to the Class B Convertible Preferred Stock, par value $0.01 of the Company, pursuant to the Merger Agreement and the Class B CVR Agreement.

Class B CVR Agreement” means the Class B CVR Agreement, dated as of the date hereof, by and among Parent, the Company, the stockholders’ representative thereunder and the rights agent thereunder.

Class B CVR Shares” means the underlying Parent A Shares issuable in respect of the Class B CVRs.

Class C CVR” means the contingent value rights issued by Parent with respect to the Class C Convertible Preferred Stock, par value $0.01 of the Company, pursuant to the Merger Agreement and the Class C CVR Agreement.

Class C CVR Agreement” means the Class C CVR Agreement, dated as of the date hereof, by and among Parent, the Company, the stockholders’ representative thereunder and the rights agent thereunder.

3 

 

Class C CVR Shares” means the underlying Parent A Shares issuable in respect of the Class C CVRs.

Class D CVR” means the contingent value rights issued by Parent with respect to the Class D Convertible Preferred Stock, par value $0.01 of the Company, pursuant to the Merger Agreement and the Class D CVR Agreement.

Class D CVR Agreement” means the Class D CVR Agreement, dated as of the date hereof, by and among Parent, the Company, the stockholders’ representative thereunder and the rights agent thereunder.

Class D CVR Shares” means the underlying Parent A Shares issuable in respect of the Class D CVRs.

Code” means the Internal Revenue Code of 1986, as amended from time to time.

Company” has the meaning set forth in the Preamble.

CVR” means a contingent value right issued by Parent with respect to the Shares, pursuant to the Merger Agreement and this Agreement.

CVR Shares” has the meaning set forth in Section 3.4(b).

CVR Register” has the meaning set forth in Section 3.3(b).

CVR Registrar” has the meaning set forth in Section 3.3(b).

Effective Time” has the meaning set forth in the Recitals.

Eros Pre-Closing Equity Financing” has the meaning ascribed in the PIPE Agreement.

Final Settlement Time” has the meaning set forth in Section 3.2(b).

Funds” has the meaning set forth in Section 7.12.

Fully Diluted Parent Shares” means, as of immediately prior to the Effective Time, the sum of (without duplication) (i) the aggregate number of Parent Ordinary Shares then outstanding, plus (ii) the aggregate number of Parent Ordinary Shares subject to issuance pursuant to then outstanding In-the-Money Parent Options (whether or not vested), plus (iii) the aggregate number of Parent Ordinary Shares subject to issuance pursuant to then outstanding Parent RSU Awards (whether or not vested), plus (iv) the aggregate number of Parent Ordinary Shares then subject to issuance pursuant to the Parent Convertible Notes assuming full conversion thereof at a conversion price of $2.60; provided, however, that, notwithstanding the foregoing, Fully Diluted Parent Shares shall not include any Parent Ordinary Shares issuable pursuant to the Eros Pre-Closing Equity Financing. For the avoidance of doubt, Fully Diluted Parent Shares shall be calculated prior to, and without giving effect to, the PIPE Investment.

Holder” means a Person in whose name a CVR is registered in the CVR Register.

4 

 

In-the-Money Parent Options” means an Eros Option (as defined in the Merger Agreement) having a per Parent Ordinary Share exercise price less than the Parent Trading Price.

Investors’ Rights Agreement” means the Investors’ Rights Agreement, entered into on or around the date hereof, by and among Parent, certain shareholders of Parent and the investors party thereto.

Law” with respect to any Person, means (a) all provisions of all laws, statutes, ordinances, rules, regulations, permits, certificates or orders of any governmental authority applicable to such Person or any of its assets or property or to which such Person or any of its assets or property is subject, and (b) all judgments, injunctions, orders and decrees of all courts and arbitrators in proceedings or actions in which such Person is a party or by which it or any of its assets or properties is or may be bound or subject.

Lock-Up Agreement” has the meaning set forth in Section 3.4(c).

Members of the Immediate Family” means, with respect to any individual, each spouse or child or other descendants of such individual, each trust created solely for the benefit of one or more of the aforementioned Persons and their spouses and each custodian or guardian of any property of one or more of the aforementioned Persons in his capacity as such custodian or guardian.

Merger” has the meaning set forth in the Recitals.

Merger Agreement” has the meaning set forth in the Recitals.

Merger Consideration CVRs” means the CVRs, the Class D CVRs, the Class C CVRs, the Class B CVRs and the Class A CVRs.

Merger Consideration CVR Share Cap” means a number of Parent A Shares equal to the Fully Diluted Parent Shares.

Merger Consideration CVR Shares” means the Aggregate CVR Shares, the Class D CVR Shares, the Class C CVR Shares, the Class B CVR Shares and the Class A CVR Shares.

Merger Sub” has the meaning set forth in the Recitals.

Organizational Documents” has the meaning set forth in Section 2.1(a).

Parent” has the meaning set forth in the Preamble.

Parent A Shares” means the A Ordinary Shares, par value £0.30 per share, of Parent.

Parent B Shares” means the B Ordinary Shares, par value £0.30 per share, of Parent.

Parent Convertible Notes” means Parent’s Senior Convertible Notes due September 27, 2020 in the original aggregate principal amount of $27,500,000.

Parent Option” means a compensatory option to purchase Parent Ordinary Shares.

5 

 

Parent Ordinary Shares” means, collectively, the Parent A Shares and the Parent B Shares.

Parent Proceedings” has the meaning set forth in Section 7.5(a).

Parent RSU Award” means an award of restricted stock units relating to Parent Ordinary Shares.

Parent Trading Price” means the VWAP for one Parent A Share for the twenty (20) consecutive full Trading Days ending on the full Trading Day immediately preceding the Effective Time (as adjusted as appropriate to reflect any stock splits, stock dividends, combinations, reorganizations, classifications or similar events).

Permitted Transfer” means: (i) the transfer (upon the death of the Holder) by will or intestacy; (ii) transfer by instrument to an inter vivos or testamentary trust in which the CVRs are to be passed to beneficiaries upon the death of the trustee; (iii) transfers made pursuant to a court order of a court of competent jurisdiction (such as in connection with divorce, bankruptcy or liquidation); (iv) if the Holder is a partnership or limited liability company, a distribution by the transferring partnership or limited liability company to its partners or members, as applicable; (v) a transfer made by operation of law (including a consolidation or merger) or in connection with the dissolution, liquidation or termination of any corporation, limited liability company, partnership or other entity; or (vi) a transfer by any Holder to one or more of its Affiliates or affiliated investment funds of any of its Affiliates.

Permitted Transferee” means a Person who receives a CVR pursuant to a Permitted Transfer and otherwise in accordance with this Agreement.

Person” means any individual, corporation (including not-for-profit), general or limited partnership, limited liability company, joint venture, estate, trust, association, organization, Governmental Authority or other entity of any kind or nature.

PIPE Agreement” means that certain Subscription Agreement, made as of April 17, 2020, by and among Parent and each Person defined therein as a “Purchaser.”

PIPE Investment” means the purchase of Parent A Shares pursuant to the PIPE Agreement.

PIPE Lock-Up Agreement” has the meaning set forth in Section 3.4(c).

Pre-Closing VWAP” means the VWAP of the Parent A Shares for the 10 Trading Days ending on the end of the Trading Day immediately preceding the Closing.

Pre-Settlement VWAP” means the VWAP of the Parent A Shares for the 10 Trading Days ending on the end of the Trading Day immediately preceding the Settlement Date; provided, that for purposes of determining the CVR Shares issuable as of any time prior to the Settlement Date, the reference to “the Trading Day immediately preceding the Settlement Date” in this definition shall be deemed a reference to “the Trading Day immediately preceding the applicable time of determination”.

6 

 

Rights Agent” means the Rights Agent named in the first paragraph of this Agreement, until a successor Rights Agent shall have become such pursuant to the applicable provisions of this Agreement, and thereafter “Rights Agent” shall mean such successor Rights Agent.

Settlement Date” shall mean the date that is the earlier to occur of (a) the later to occur of (i) the first time that the Merger Consideration CVR Shares have been registered for resale pursuant to an effective registration statement under the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder, and (ii) the 75th calendar day after the Closing and (b) the occurrence of the Settlement Outside Date.

Settlement Outside Date” means the date that is six (6) months after the Closing; provided that the Settlement Outside Date may be extended (but only once) by holders of a majority of the CVRs; provided, further, that such majority must include each such holder that, together with its Affiliates, purchased $15 million or more of Parent A Shares in the PIPE Investment.

Shares” has the meaning set forth in the Recitals.

Stockholders’ Representative” has the meaning set forth in the Preamble.

STX Purchase Price” means the lowest of (i) the Base Price, (ii) the volume weighted average of the purchase price of all purchases comprising the Eros Pre-Closing Equity Financing and (iii) the Pre-Closing VWAP; provided, however, that if the Pre-Closing VWAP is greater than $3.25, then the STX Purchase Price shall be the average of the Base Price and the Pre-Closing VWAP.

Subsidiary” of any Person shall mean any corporation or other entity of which securities or other ownership interests having ordinary voting power sufficient to elect a majority of the board of directors or comparable governing body are beneficially owned, directly or indirectly, by such Person, and any corporation or other entity that is otherwise controlled by such Person.

Taxes” or “Tax” means all taxes, charges, fees, levies or other assessments in the nature of a tax imposed by any governmental authority, including any income, gross receipts, license, severance, occupation, premium, environmental (including taxes under former Code Section 59A), customs, duties, profits, disability, alternative or add-on minimum, estimated, withholding, payroll, employment, unemployment insurance, social security (or similar), excise, sales, use, value-added, occupancy, franchise, real property, personal property, business and occupation, mercantile, windfall profits, capital stock, stamp, transfer, workmen’s compensation, amounts due under any applicable laws governing escheat or unclaimed property or other taxes, charges, fees, levies or other assessments in the nature of a tax, together with any interest, penalties, additions to tax or additional amounts imposed by any Governmental Authority with respect thereto, whether disputed or not.

Trading Day” means, with respect to any referenced security, any day on which such security is actually traded on the principal securities exchange or securities market on which such security is then listed.

7 

 

VWAP” means, for any security as of any date(s), the dollar volume-weighted average price for such security on the principal securities exchange or securities market on which such security is then listed during the period beginning at 9:30:01 a.m., New York time, and ending at 4:00:00 p.m., New York time, as reported by Bloomberg through its “HP” function (sets to weighted average) or, if the foregoing does not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the electronic bulletin board for such security during the period beginning at 9:30:01 a.m., New York time, and ending at 4:00:00 p.m., New York time, as reported by Bloomberg, or, if no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the highest closing bid price and the lowest closing ask price of any of the market makers for such security as reported by OTC Markets Group Inc. If the VWAP cannot be calculated for such security on such date(s) on any of the foregoing bases, the VWAP of such security on such date(s) shall be the fair market value thereof on such date(s) as reasonably determined by a nationally recognized independent investment banking firm mutually agreed between Parent and the Stockholders’ Representative.

Article II
OPERATION OF PARENT

Section 2.1      Operation of Parent.

From the Effective Time until the Settlement Date, Parent shall not, and shall cause its Subsidiaries and Affiliates not to:

(a)                after the effectiveness of the Amended Articles (as defined in the Investors’ Rights Agreement), effect any action that requires approval by the shareholders of Parent under Parent’s Memorandum of Association or Articles of Association (the “Organizational Documents”) or applicable Law; or

(b)               prior to the effectiveness of Amended Articles, take any action set forth in Section 4.3(c) of the Investors’ Rights Agreement as in effect on the date hereof,

without, in each such case, obtaining the consent thereto of holders of such class and number of Merger Consideration CVRs (including the CVRs hereunder) that, together with the shares of Parent actually voted (at a meeting or by resolution) with respect to such action and assuming all Merger Consideration CVR Shares were outstanding Parent A Shares and voted, would be required to approve such action under the Organizational Documents, applicable Law or Section 4.3(c) of the Investors’ Rights Agreement, as applicable. For purposes of the foregoing consent rights, the number of Merger Consideration CVR Shares underlying the Merger Consideration CVRs as of any time prior to the Settlement Date shall be calculated as set forth below in Article III and in Article III of the Class D CVR Agreement with respect to the Class D CVRs, Article III of the Class C CVR Agreement with respect to the Class C CVRs, Article III of the Class B CVR Agreement with respect to the Class B CVRs and Article III of the Class A CVR Agreement with respect to the Class A CVRs.

8 

 

Article III
CVRS

Section 3.1      Issuance of CVRs; Appointment of Rights Agent; Reservation of Shares.

(a)                The CVRs shall be issued pursuant to the Merger Agreement at the time and in the manner set forth in the Merger Agreement. The registration on the books and records of Parent and administration of the CVRs shall be handled pursuant to this Agreement in the manner set forth in this Agreement.

(b)               Parent hereby appoints the Rights Agent to act as rights agent for the CVRs in accordance with the instructions hereinafter set forth in this Agreement, and the Rights Agent hereby accepts such appointment.

(c)                From the date hereof until the issuance of the Aggregate CVR Shares in accordance with the terms hereof, Parent shall reserve and keep available out of its authorized but unissued share capital, for the purpose of effecting the issuance of the CVR Shares hereunder, a number of Parent A Shares equal to the Merger Consideration CVR Share Cap, minus the number of CVR Shares, if any, previously issued in accordance with the terms of this Agreement; and if at any time during such period the number of authorized but unissued Parent A Shares shall not be sufficient to effect the issuance of the Aggregate CVR Shares in full, Parent shall take all such action as may be necessary to increase its authorized but unissued share capital as shall be sufficient for such purposes.

Section 3.2      Nontransferable; Expiration.

(a)                The CVRs shall not be sold, assigned, transferred, pledged, encumbered or in any other manner transferred or disposed of, in whole or in part, other than to a Permitted Transferee. Any purported transfer of a CVR to anyone other than a Permitted Transferee shall be null and void ab initio.

(b)               Subject to Section 3.4(c), the CVRs shall expire on the Settlement Date upon the registration of the CVR Shares in the respective names of the Holders entitled thereto and shall thereafter be of no force or effect following such registration; provided that, if any CVR Shares are not so registered on the Settlement Date, then the CVRs in respect thereof shall not expire until the registration of such CVR Shares in the respective names of the Holders entitled thereto (the time of registration thereof, the “Final Settlement Time”).

Section 3.3      No Certificate; Registration; Registration of Transfer; Change of Address.

(a)                The CVRs shall not be evidenced by a certificate or other instrument.

9 

 

(b)               Upon receipt from Parent of the names and addresses of each Holder and the number of CVRs held by such Holder, the Rights Agent shall keep a register (the “CVR Register”) for the registration of CVRs in a book-entry position for each Holder of a CVR. The CVR Register shall set forth the name and address of each Holder, and the number of CVRs held by such Holder and Tax Identification Number of each Holder. Each of Parent and the Stockholders’ Representative may receive and inspect a copy of the CVR Register, from time to time, upon written request made to the CVR Registrar. Within five (5) Business Days after receipt of such request, the CVR Registrar shall deliver a copy of the CVR Register, as then in effect, to Parent and the Stockholders’ Representative at the address set forth in Section 7.1. The Rights Agent is hereby initially appointed “CVR Registrar” for the purpose of registering CVRs and transfers of CVRs as herein provided.

(c)                Subject to the restrictions set forth in Section 3.2, every request made to transfer a CVR must be in writing and accompanied by a written instrument or instruments of transfer and any other reasonably requested documentation in form reasonably satisfactory to Parent and the CVR Registrar, duly executed by the registered Holder or Holders thereof or by the duly appointed legal representative thereof or by a duly authorized attorney. A request for a transfer of a CVR shall be accompanied by documentation establishing that the transfer is to a Permitted Transferee and shall thereafter be supplemented with and any other information as may be reasonably requested by Parent or the CVR Registrar (including opinions of counsel, if appropriate). Upon receipt of such written notice, the CVR Registrar shall, subject to its reasonable determination that the transfer instrument is in proper form and the transfer otherwise complies with the other terms and conditions herein on its face, without investigation or inquiry by the Rights Agent, register the transfer of the CVRs in the CVR Register. All duly transferred CVRs registered in the CVR Register shall be the valid obligations of Parent, evidencing the same rights and entitling the transferee to the same benefits and rights under this Agreement as those held by the transferor immediately prior to such transfer. No transfer of a CVR shall be valid until registered in the CVR Register, and any transfer not duly registered in the CVR Register will be void ab initio (unless the transfer was permissible hereunder and such failure to be duly registered is attributable to the fault of the CVR Registrar). Any transfer or assignment of the CVRs shall be without charge by Parent or the CVR Registrar (other than the cost of any Tax which shall be the responsibility of the transferor) to the Holder.

(d)               A Holder may make a written request to the CVR Registrar to change such Holder’s address of record in the CVR Register. The written request must be duly executed by the Holder and accompanied by such other evidence of the Holder’s identity or interest in the CVR as reasonably requested by the Rights Agent. Upon receipt of such written notice, the CVR Registrar is hereby authorized to, and shall promptly, record the change of address in the CVR Register.

(e)                The Stockholders’ Representative may make a written request to the Rights Agent for a list containing the names, addresses and number of CVRs of the Holders that are registered in the CVR Register. Within five (5) Business Days following the date of receipt by the Rights Agent of such request, the CVR Registrar shall deliver a copy of such list to the Stockholders’ Representative.

Section 3.4      Issuance Procedures.

10 

 

(a)                On the Settlement Date, Parent shall issue, and cause to be deposited with the Rights Agent, a number of Parent A Shares equal to the Aggregate CVR Shares. On the Settlement Date or as promptly as practicable thereafter, subject to Section 3.4(c) below, the Rights Agent shall cause the applicable number of CVR Shares to be registered in the name of each of the Holders as reflected in the CVR Register as of the close of business on the last Business Day prior to such issuance date.

(b)               The number of Parent A Shares issued in respect of each CVR from the Available Class E Merger Consideration CVR Shares (the “CVR Shares”) shall be equal to (i) the quotient obtained by dividing $2,750 by the lesser of (A) the STX Purchase Price and (B) the Pre-Settlement VWAP minus (ii) the quotient obtained by dividing $1,000 by the STX Purchase Price; provided, that the number of Parent A Shares allocated to the CVRs shall be pro-rated in the event there are insufficient Available Class E Merger Consideration CVR Shares remaining for allocation to the CVRs. For all purposes above, fractional CVRs shall represent a proportionate number of CVR Shares; provided, however, that no fractional Parent A Shares (or certificate or scrip representing the same) shall be issued upon the settlement of any CVRs hereunder. Notwithstanding any other provision of this Agreement, each Holder of CVRs who would otherwise have been entitled to receive a fraction of a Parent A Share upon settlement of such Holder’s CVRs hereunder (after aggregating all CVRs of such Holder that are subject to this Agreement) shall receive, in lieu thereof, an amount of cash (rounded to the nearest whole cent), without interest, equal to such fractional amount multiplied by the lesser of the STX Purchase Price and the Pre-Settlement VWAP. Whenever a payment for fractional Parent A Shares or fractional shares is to be made by the Rights Agent under any section of this Agreement, Parent shall (i) promptly deliver to the Rights Agent a certificate setting forth the amount of any such payment and calculation related thereto and (ii) cash in the amount of such payment to the Rights Agent by wire transfer of immediately available funds to make such payment to the applicable Holder by check mailed to such Holder as reflected in the CVR Register or by wire transfer of immediately available funds. The Rights Agent shall not be liable to any Holder or Parent for the amount of any cash payment made to such Holder on behalf of Parent in accordance with the amount set forth in such certificate.

(c)                Parent’s obligation to issue and cause to be deposited with the Rights Agent the applicable number of CVR Shares, and the Rights Agent’s obligation to cause the applicable number of CVR Shares to be registered in the name of a Holder upon receipt of the applicable number of CVR Shares shall be conditioned on the execution and delivery by such Holder of a lockup agreement with Parent, substantially in the form attached hereto as Exhibit A (a “Lock-Up Agreement”); provided, however, that the Rights Agent’s obligation to cause the applicable number of CVR Shares to be registered in the name of a Holder upon receipt of the applicable number of CVR Shares to a Holder shall not be conditioned on the execution and delivery by such Holder of a Lock-Up Agreement if (i) such Holder or any of its Affiliates shall have entered into a lockup agreement with Parent in connection with the PIPE Investment (such lockup agreement, a “PIPE Lock-Up Agreement”) or (ii) the Settlement Date is the Settlement Outside Date and the Merger consideration CVR Shares have not been, as of such date, registered for resale pursuant to an effective registration statement under the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder; provided, further, that Rights Agent shall have no duty to act without the written instruction of Parent with respect to the foregoing.

11 

 

(d)               Without limiting the other provisions of this Agreement, if at any time during the period between the execution of this Agreement and the Settlement Date (or if applicable, the Final Settlement Time), any change in the number or type of outstanding Parent A Shares shall occur as a result of a reclassification, recapitalization, exchange, stock split (including a reverse stock split), combination or readjustment of capital stock, shares or any stock dividend or stock distribution with a record date during such period (including any such reclassification, recapitalization, exchange, stock split, combination or readjustment of capital stock, shares or any stock dividend or stock distribution in connection with a consolidation, merger or combination in which Parent is the continuing or surviving corporation), the CVR Shares and any other similarly dependent items, as the case may be, shall be appropriately equitably adjusted to provide the same economic effect as contemplated by this Agreement prior to such event; provided that nothing in this Section 3.4(d) shall be construed to permit any party to take any action that is otherwise prohibited or restricted by any other provision of this Agreement.

(e)                If, at any time prior to the Settlement Date (or, if applicable, the Final Settlement Time) Parent effects any Change of Control Transaction, then, upon any Settlement Date, each Holder shall have the right to receive, on the Settlement Date, for each CVR Share that would have been issuable upon the Settlement Date the same consideration (in the same amount and form) per Parent A Share payable to the holders thereof in such Change of Control Transaction. For purposes hereof, the determination of Pre-Settlement VWAP shall be appropriately adjusted to refer to such consideration instead of Parent A Shares. If holders of Parent A Shares are given any right of election as to the securities, cash or property to be received in such Change of Control Transaction, then each Holder shall be given the same right of election. To the extent necessary to effectuate the foregoing provisions, Parent shall ensure that any successor to Parent or the surviving entity in such Change of Control Transaction shall agree to be bound by the terms of this Agreement. In the event that the Final Settlement Time occurs after the Settlement Date, references herein to Settlement Date shall mean as promptly as practicable following the Change of Control Transaction.

Section 3.5      CVR Rights

(a)                Subject to Section 2.1, except as provided in Section 3.5(b), the CVRs shall not have any voting rights and shall not represent any equity or ownership interest in Parent, in any constituent company to the Merger, any Affiliate of Parent or any other Person.

(b)               The CVRs shall entitle each Holder, at the Settlement Date and subject to any applicable withholding Taxes, to a payment per Parent A Share issued thereunder, without interest, equal (as to both amount and form of consideration) to all dividends or other distributions of any kind declared per Parent A Share of the CVR Shares with a record date after the Closing and prior to the Settlement Date. Any dividends or other distributions of any kind made in respect of the CVR Shares will be delivered promptly to the Rights Agent to be held in escrow with respect to the CVRs (the “CVR Income”) treating the CVR Shares for this purpose as if the Aggregate CVR Shares were then outstanding. On the Settlement Date, the Rights Agent shall deliver to each Holder, concurrent with the issuance to such Holder of the applicable CVR Shares, the CVR Income earned in respect of each such CVR Share, less any applicable withholding Taxes.

12 

 

Article IV
THE RIGHTS AGENT

Section 4.1      Certain Duties and Responsibilities.

The Rights Agent shall not have any liability for any actions taken or not taken by the Rights Agent in connection with the execution, acceptance, administration, exercise and performance of its duties under this Agreement, except to the extent of its willful misconduct, bad faith or gross negligence (in each case as determined by a final, non-appealable judgment of a court of competent jurisdiction). No provision of this Agreement shall require the Rights Agent to expend or risk its own funds or otherwise incur any financial liability in the performance of any of its duties hereunder or in the exercise of any of its rights or powers.

Section 4.2      Certain Rights of Rights Agent.

The Rights Agent undertakes to perform such duties and only such duties as are specifically set forth in this Agreement, and no implied covenants or obligations shall be read into this Agreement against the Rights Agent. In addition:

(a)                the Rights Agent may rely and shall be protected and held harmless by Parent in and shall not incur any liability in acting or refraining from acting in connection with its performance under this Agreement upon any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order or other paper or document reasonably believed by it to be genuine and to have been signed or presented by the proper party or parties, except to the extent of its willful misconduct, bad faith or gross negligence (in each case as determined by a final, non-appealable judgment of a court of competent jurisdiction);

(b)               the Rights Agent may consult with legal counsel selected by it, and the Rights Agent shall incur no liability for or in respect of any action taken, suffered or omitted to be taken by it in the absence of bad faith, gross negligence or willful misconduct and in accordance with such advice or opinion. The reasonable costs of such counsel’s services shall be paid to the Rights Agent in accordance with Section 4.2(g) below. The Rights Agent may perform any and all of its duties through its agents, representatives, custodians and/or nominees and the Rights Agent shall not be answerable or accountable for any act, omission, default, neglect or misconduct of any such agents, representatives, custodians and/or nominees or for any loss to Parent or the Company, to the Holders or any other Person resulting from any such act, omission, default, neglect or misconduct, absent gross negligence, willful misconduct or bad faith on the part of the Rights Agent, such agents, representatives, custodians and/or nominees (which gross negligence, willful misconduct or bad faith must be determined by a final, non-appealable judgment of a court of competent jurisdiction);

13 

 

(c)                if the Rights Agent becomes involved in litigation on account of this Agreement, it shall have the right to retain counsel and shall be entitled to reimbursement for all reasonable and documented out-of-pocket costs and expenses related thereto as provided in this Section 4.2(c) and Section 4.2(g) hereof; provided, however, that the Rights Agent shall not be entitled to any such reimbursement to the extent such litigation ultimately determines that the Rights Agent acted with willful misconduct, bad faith or gross negligence. In the event that conflicting demands are made upon the Rights Agent for any situation addressed or not addressed in this Agreement, the Rights Agent may withhold performance of the terms of this Agreement until such time as said conflicting demands shall have been withdrawn or the rights of the respective parties shall have been settled by court adjudication, arbitration, joint order or otherwise;

(d)               the permissive rights of the Rights Agent to do things enumerated in this Agreement shall not be construed as a duty;

(e)                the Rights Agent shall not be required to give any note or surety in respect of the execution of such powers or otherwise in respect of the premises;

(f)                Parent agrees to indemnify the Rights Agent for, and hold the Rights Agent harmless against, any loss, liability, claim, demands, suits or expense arising out of or in connection with the Rights Agent’s duties under this Agreement, including the costs and expenses of defending the Rights Agent against any claims, charges, demands, suits or loss, unless such loss shall have been determined by a court of competent jurisdiction to be a result of the Rights Agent’s willful misconduct, bad faith or gross negligence (in each case as determined by a court of competent jurisdiction); provided, however, that the Rights Agent’s aggregate liability with respect to, arising from, or arising in connection with this Agreement, or from all services provided or omitted to be provided under this Agreement, whether in contract, in tort, or otherwise, is limited to, and shall not exceed, the amounts paid hereunder by Parent to the Rights Agent as fees and charges (but not including reimbursable expenses) in the 12 months preceding the event for which recovery is sought. The provisions under this Section 4.2 and Section 4.1 above shall survive the settlement of the CVRs and the termination of this Agreement and the resignation, replacement or removal of the Rights Agent. To the extent the Rights Agent is entitled to indemnification hereunder, the reasonable and documented out-of-pocket costs and expenses of the Rights Agent incurred in enforcing this right of indemnification shall be paid by Parent;

(g)               Parent agrees to pay to the Rights Agent reasonable compensation for all services rendered by it hereunder in accordance with a fee schedule to be mutually agreed upon in writing between Parent and the Rights Agent and, from time to time, to reimburse the Rights Agent for all of its reasonable, customary and documented out-of-pocket expenses (including reasonable fees and expenses of the Rights Agent’s counsel) and other disbursements incurred in the preparation, delivery, negotiation, amendment, administration and execution of this Agreement and the exercise and performance of its duties hereunder. Without limiting any of its rights to compensation or reimbursement under this Agreement, the Rights Agent shall deliver to Parent the final invoice for the Rights Agent fees and costs (which shall include a reasonable estimate of all remaining fees and expenses) at a reasonable time prior to the date of delivery of the CVR Shares. An invoice for any reasonable and documented out-of-pocket expenses and per item fees realized will be rendered and payable as mutually agreed upon in writing between Parent and the Rights Agent. For the avoidance of doubt, and notwithstanding anything to the contrary herein, in no event shall Parent be required to indemnify or otherwise reimburse the Rights Agent for any income or similar taxes of the Rights Agent (or an of its Affiliates) in connection with the performance of its duties hereunder;

14 

 

(h)               For avoidance of doubt, no CVRs shall be issued in respect of any shares of capital stock of the Company as to which the holder thereof as of immediately prior to the Effective Time properly demands appraisal in accordance with, and who complies in all respects with, Section 262 of the Delaware General Corporation Law (such shares, “Appraisal Shares” and such statutory section, “Section 262”); provided, however, that notwithstanding the foregoing, (i) the CVRs that would have been issuable in respect of Appraisal Shares but for their status as such shall be deemed to be outstanding for purposes of determining the number of CVR Shares to be issued per CVR and (ii) if any holder of Appraisal Shares shall fail to perfect or otherwise waive, withdraw or lose the right to appraisal under Section 262 with respect to any Appraisal Shares (whether before or after the Settlement Date), then the CVRs issuable in respect of such Appraisal Shares shall be deemed to have been issued to such holder as of the Effective Time and to entitle such holder to all rights of a Holder hereunder with respect thereto, including the right to receive the CVR Shares and CVR Income in respect thereof upon the Settlement Date in accordance with the other provisions of this Agreement;

(i)                 whenever the Rights Agent shall reasonably require that a matter be proved or established prior to taking, suffering or omitting any action hereunder, the Rights Agent may rely upon a signed certificate from an authorized officer of Parent, and the Rights Agent shall incur no liability and be held harmless by Parent for or in respect of any action taken, suffered or omitted to be taken by it under the provisions of this Agreement in reliance upon and in accordance with such certificate;

(j)                 the permissive rights of the Rights Agent to do things enumerated in this Agreement shall not be construed as a duty;

(k)               the Rights Agent shall not be required to give any note or surety in respect of the execution of its powers hereunder or otherwise in respect of the premises;

(l)                 the Rights Agent shall not be liable for or by reason of, and shall be held harmless by Parent with respect to any of the statements of fact or recitals contained in this Agreement or any certificate delivered by Parent under this Agreement and shall not be required to verify the same, but all such statements and recitals are and shall be deemed to have been made by Parent only;

(m)             the Rights Agent shall have no liability and shall be held harmless by Parent in respect of the validity of this Agreement or the execution and delivery hereof (except the due execution and delivery hereof by the Rights Agent and the enforceability of this Agreement against the Rights Agent assuming the due execution and delivery hereof by the other parties hereto), nor shall it be responsible for any breach by Parent of any covenant or condition contained in this Agreement;

(n)               anything to the contrary notwithstanding, the Rights Agent shall not be liable for any special, punitive, consequential, indirect or incidental loss or damage of any kind whatsoever (including lost profits) arising out of any act or failure to act hereunder, even if the Rights Agent has been advised of the likelihood of such loss or damage or has foreseen the possibility or likelihood of such damages;

15 

 

(o)               the Rights Agent shall not be deemed to have knowledge of any event of which it was required to receive notice from Parent or the Stockholders’ Representative hereunder and did not receive such notice, and the Rights Agent shall be fully protected and shall incur no liability for failing to take action in connection therewith, unless and until it has received such required notice in writing;

(p)               the Rights Agent and any affiliate of the Rights Agent may buy, sell or deal in any of securities of Parent or the Company or become pecuniarily interested in any transaction in which Parent or the Company may be interested, or contract with or lend money to Parent or the Company or otherwise act as fully and freely as though it were not Rights Agent under this Agreement, subject to applicable Law (including applicable securities Laws). Nothing herein shall preclude the Rights Agent from acting in any other capacity for Parent or the Company or for any other legal entity;

(q)               the Rights Agent shall act hereunder solely as agent for Parent and it shall not assume any obligations or relationship of agency or trust with any of the Holders or any other Person;

(r)                 the Rights Agent shall not be deemed to have knowledge of a change in authorized officers or duly authorized representatives of any Person without notice of such change, and the Rights Agent shall be fully protected and shall incur no liability for failing to take action in connection therewith, unless and until it has received such notice in writing;

(s)                the Rights Agent shall not have any duty or responsibility in the case of the receipt of any written demand from any Holder with respect to any action or default by Parent, including, without limiting the generality of the foregoing, any duty or responsibility to initiate or attempt to initiate any proceedings at law or otherwise or to make any demand upon Parent; and

(t)                 the Rights Agent shall have no duty or obligation under any Section of this Agreement that requires the payment of taxes or charges by the Parent or Holder in connection with the Rights Agent’s performance of such duty or obligation, unless and until the Rights Agent is reasonably satisfied that all such taxes and/or charges have been paid.

Section 4.3      Resignation and Removal; Appointment of Successor.

(a)                The Rights Agent may resign at any time by giving written notice thereof to Parent and the Stockholders’ Representative specifying a date when such resignation shall take effect, which notice shall be sent at least thirty (30) days’ prior to the date so specified. In the event any transfer agency relationship in effect between the Parent and the Rights Agent terminates, the Rights Agent will be deemed to have resigned automatically and be discharged from its duties under this Agreement as of the effective date of such termination. Parent may terminate the Rights Agent at any time by giving written notice thereof to the Rights Agent and the Stockholders’ Representative specifying a date when such termination shall take effect, which notice shall be sent at least thirty (30) days prior to the date so specified.

(b)               If the Rights Agent shall resign, be removed or become incapable of acting, Parent and the Stockholders’ Representative shall promptly appoint a qualified successor Rights Agent. The successor Rights Agent so appointed shall, forthwith upon its acceptance of such appointment in accordance with this Section 4.3(b), become the successor Rights Agent.

16 

 

(c)                Parent shall give notice of each resignation and each removal of a Rights Agent and each appointment of a successor Rights Agent by mailing written notice of such event through electronic mail, to the Stockholders’ Representative. The Stockholders’ Representative shall forward such notice to the Holders. If Parent fails to send such notice within ten (10) days after acceptance of appointment by a successor Rights Agent, the successor Rights Agent shall cause such notice to be mailed and electronically transmitted at the expense of Parent.

(d)               If a successor Rights Agent has not been appointed and has not accepted such appointment by the end of the thirty (30) day period, the Stockholders’ Representative or the Rights Agent may (but shall not be obligated to) apply to a court of competent jurisdiction for the appointment of a successor Rights Agent, and the reasonable documented out-of-pocket costs, expenses (including reasonable attorneys’ fees which are incurred in connection with such a proceeding) shall be paid in accordance with Section 4.2(g) hereof. Any such successor to the Rights Agent shall agree to be bound by the terms of this Agreement and shall, upon receipt of the all relevant books and records relating thereto, become the Rights Agent hereunder. Upon delivery of all of the relevant books and records, pursuant to the terms of this Section 4.3(d) to a successor Rights Agent, the Rights Agent shall thereafter be discharged from any further obligations hereunder. Without limiting any of the rights or immunities of the Rights Agent under this Agreement, the Rights Agent is hereby authorized, in any and all events, to comply with and obey any and all final judgments, orders and decrees of any court of competent jurisdiction which may be filed, entered or issued, and all final arbitration awards and, if it shall so comply or obey, it shall not be liable to any other person by reason of such compliance or obedience.

Section 4.4      Acceptance of Appointment by Successor.

(a)                Every successor Rights Agent appointed hereunder shall execute, acknowledge and deliver to Parent, the Stockholders’ Representative and to the retiring Rights Agent an instrument accepting such appointment and a counterpart of this Agreement, and thereupon such successor Rights Agent, without any further act, deed or conveyance, shall become vested with all the rights, powers, trusts and duties of the retiring Rights Agent; but, on request of Parent, the Stockholders’ Representative or the successor Rights Agent, such retiring Rights Agent shall execute and deliver an instrument transferring to such successor Rights Agent all the rights, powers and trusts of the retiring Rights Agent but such retiring Rights Agent shall not be required to make any additional expenditure or assume any additional liability in connection with the foregoing.

Article V
COVENANTS AND REPRESENTATIONS

Section 5.1      List of Holders.

Parent shall furnish or cause to be furnished to the Rights Agent in such form as Parent receives from the Company prior to the Effective Time (or other agent performing similar services for Parent or its Affiliates), the names, addresses, shareholdings and tax certification (T.I.N.) of the record holders of Shares eligible to receive CVRs pursuant to the Merger Agreement reasonably promptly following the Effective Time.

17 

 

Section 5.2      Delivery of CVR Shares.

The Rights Agent shall cause the applicable number of CVR Shares to be registered in the names of the Holders upon receipt thereof in the manner provided for in Section 3.4 and in accordance with the terms of this Agreement, and each of the Stockholders’ Representative and Parent shall use reasonable efforts to cause the Rights Agent to do so.

Section 5.3      Assignment.

(a)                Except for assignments occurring through operation of law, Parent and the Company shall not, in whole or in part, assign any of their rights or obligations under this Agreement.

Section 5.4      Tax Treatment.

Unless (x) Parent has determined, based on advice from a “Big 4” accounting firm or nationally recognized tax counsel and after consulting with the Stockholders’ Representative in connection with obtaining such advice and making such determination, that the Intended Tax Treatment (as defined below) is not supported by a “more likely than not” or higher standard or (y) reporting in a manner consistent with the Intended Tax Treatment would require that Parent establish a reserve on its financial statements, each of Parent and each Holder shall and shall cause its Affiliates to (i) treat the CVRs as equity for applicable U.S. federal income tax purposes and to treat the settlement of the CVRs for CVR Shares as a recapitalization under Section 368(a)(1)(E) of the Code for U.S. federal income tax purposes (the “Intended Tax Treatment”) and (ii) file U.S federal income tax returns (if any such tax returns are required to be filed) in a manner consistent with the Intended Tax Treatment.

Article VI
AMENDMENTS

Section 6.1      Amendments Without Consent of Holders or Stockholders’ Representative.

(a)                Without the consent of any Holders, Parent, the Stockholders’ Representative (upon written instruction from the Holders holding a majority of the CVRs) and the Rights Agent, at any time and from time to time, may enter into one or more amendments hereto, for any of the following purposes only:

(i)                 to evidence the succession of another Person selected in accordance with Section 4.3(b) as a successor Rights Agent and the assumption by any successor of the covenants and obligations of the Rights Agent herein;

18 

 

(ii)               to evidence the termination of the CVR Registrar and the succession of another Person as a successor CVR Registrar and the assumption by any successor of the obligations of the CVR Registrar herein; or

(iii)             to add, eliminate or change any provisions of this Agreement, even if such addition, elimination or change is in any way adverse to the interests of the Holders; provided, that if such addition, elimination or change is materially adverse to the rights of holders of any other Merger Consideration CVRs, then instruction from the holders of such other Merger Consideration CVRs representing a majority of the Merger Consideration CVR Shares in respect thereof shall also be necessary; provided, further, if such addition, elimination or change adversely affects the rights and obligations of any Holder in a disproportionate manner to the other Holders hereunder, then instruction from each such affected Holder shall also be necessary; or

(iv)             as necessary to ensure that the CVRs are not subject to registration under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

(b)               Any other amendment to this Agreement shall be made by Parent, the Stockholders’ Representative (upon written instruction of each of the Holders of CVRs) and the Rights Agent.

(c)                Promptly after the execution by Parent, Stockholders Representative and the Rights Agent of any amendment pursuant to the provisions of this Section 6.1, Parent shall mail or cause to be mailed a written notice thereof by electronic mail to the Stockholders’ Representative and by first-class mail and electronic mail to the Holders at their addresses as they shall appear on the CVR Register, setting forth in general terms the substance of such amendment.

Section 6.2      Execution of Amendments; Effect of Amendments.

Prior to executing any amendment permitted by this Article VI, the Rights Agent shall be entitled to receive, and shall be fully protected in relying upon, a certificate from an appropriate officer of Parent or, if requested by the Rights Agent, an opinion of counsel selected by Parent and reasonably acceptable to Rights Agent stating that the execution of such amendment is authorized or permitted by this Agreement. The Rights Agent may, but is not obligated to, enter into any such amendment that affects the Rights Agent’s own rights, privileges, covenants or duties under this Agreement. Upon the execution of any amendment under this Article VI, this Agreement shall be modified in accordance therewith, such amendment shall form a part of this Agreement for all purposes and every Holder shall be bound thereby. No supplement or amendment to this Agreement shall be effective unless duly executed by the Rights Agent, Parent and the Stockholders’ Representative.

19 

 

Article VII
OTHER PROVISIONS OF GENERAL APPLICATION

Section 7.1      Notices to the Rights Agent, Parent and the Stockholders’ Representative.

Any notice, request, instruction or other document to be given hereunder by any party to the others shall be in writing and delivered personally or sent by registered or certified mail, postage prepaid, by electronic mail (except with respect to the Rights Agent), by facsimile transmission only with respect to the Rights Agent or overnight courier, provided that with respect to notices deliverable to the Stockholders’ Representative, such notices shall be delivered solely via electronic mail or facsimile:

If to Parent or the Company:

Eros International Plc

First Names House

Victoria Road

Douglas

Isle of Man IM2 4DF

British Isles

Attention:Mark Carbeck, Chief Corporate and Strategy Officer
Email:mark.carbeck@erosintl.com

with a copy (which shall not constitute notice) to:

Gibson, Dunn & Crutcher LLP
333 South Grand Avenue
Los Angeles, California 90071-3197

Attention:Kevin Masuda
Peter Wardle

Email: kmasuda@gibsondunn.com
pwardle@gibsondunn.com

 

If to the Rights Agent:

Computershare Trust Company, N.A.,

Computershare Inc.

150 Royall Street

Canton, MA 02021

Attention: Client Services

Facsimile: (781) 575-3146

 

If to the Stockholders’ Representative:

Fortis Advisors LLC

Attention: Notices Department (Project World Cup)

Email: notices@fortisrep.com

20 

 

Facsimile: (858) 408-1843

with a copy (which shall not constitute notice) to:

Kirkland & Ellis LLP
555 South Flower Street, Suite 3700
Los Angeles, California 90071
Attention: Rick C. Madden, P.C.
Email: rick.madden@kirkland.com

 

or to such other persons or addresses as may be designated in writing by the party to receive such notice as provided above. Any notice, request, instruction or other document given as provided above shall be deemed given to the receiving party upon actual receipt, if delivered personally; three (3) business days after deposit in the mail, if sent by registered or certified mail; upon confirmation of successful transmission if sent by electronic mail; or on the next business day after deposit with an overnight courier, if sent by an overnight courier.

Section 7.2      Effect of Headings; Construction.

The headings herein are for convenience of reference only, do not constitute part of this Agreement and shall not be deemed to limit or otherwise affect any of the provisions of this Agreement. Where a reference in this Agreement is made to a Section or Exhibit, such reference shall be to a Section of or Exhibit to this Agreement unless otherwise indicated.

Section 7.3      Successors and Assigns.

All covenants and agreements in this Agreement by any party hereto shall bind its successors and permitted assigns, whether so expressed or not.

Section 7.4      Benefits of Agreement.

Nothing in this Agreement, express or implied, shall give to any Person (other than the Holders, the parties hereto and their permitted successors and assigns hereunder) any benefit or any legal or equitable right, remedy or claim under this Agreement or under any covenant or provision herein contained, all such covenants and provisions being for the sole benefit of the Holders, the parties hereto and their permitted successors and assigns. For the avoidance of doubt, the Holders shall be considered express third party beneficiaries of this Agreement.

Section 7.5      Governing Law and Venue; Waiver of Jury Trial.

(a)                THIS AGREEMENT SHALL BE DEEMED TO BE MADE IN AND IN ALL RESPECTS SHALL BE INTERPRETED, CONSTRUED AND GOVERNED BY AND IN ACCORDANCE WITH THE LAW OF THE STATE OF DELAWARE WITHOUT REGARD TO THE CONFLICT OF LAW PRINCIPLES THEREOF THAT WOULD RESULT IN THE APPLICATION OF ANY OTHER JURISDICTION’S LAWS. The parties hereby irrevocably submit to the personal jurisdiction of the courts of the State of Delaware and the federal courts of the United States of America located in the State of Delaware solely in respect of the interpretation and enforcement of the provisions of this Agreement and of the documents

21 

 

referred to in this Agreement, and in respect of the transactions contemplated hereby, and hereby waive, and agree not to assert, as a defense in any action, suit or proceeding for the interpretation or enforcement of this Agreement or of any such document, that it is not subject thereto or that such action, suit or proceeding may not be brought or is not maintainable in said courts or that the venue thereof may not be appropriate or that this Agreement or any such document may not be enforced in or by such courts, and the parties hereto irrevocably agree that all claims relating to such action, proceeding or transactions shall be heard and determined in such a Delaware state or federal court. The parties hereby consent to and grant any such court jurisdiction over the person of such parties and, to the extent permitted by Law, over the subject matter of such dispute and agree that mailing of process or other papers in connection with any such action or proceeding in the manner provided in Section 7.1 or in such other manner as may be permitted by Law shall be valid and sufficient service thereof. If and to the extent that any action, suit or proceeding relates to the rectification of Parent’s register of members or the enforcement of Section 2.1 (“Parent Proceedings”) (but otherwise without prejudice to the provisions of this Section 7.5(a)), each party irrevocably agrees that the courts of the Isle of Man shall have jurisdiction to hear and decide such Parent Proceedings and, for this purpose only, each party irrevocably submits to the jurisdiction of the such courts.

(b)               EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT, OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (i) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (ii) EACH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (iii) EACH PARTY MAKES THIS WAIVER VOLUNTARILY, AND (iv) EACH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS Section 7.5.

Section 7.6      Severability Clause.

The provisions of this Agreement shall be deemed severable and the invalidity or unenforceability of any provision shall not affect the validity or enforceability of the other provisions of this Agreement. If any provision of this Agreement, or the application of such provision to any Person or any circumstance, is invalid or unenforceable, (a) a suitable and equitable provision shall be substituted therefor in order to carry out, so far as may be valid and enforceable, the intent and purpose of such invalid or unenforceable provision and (b) the remainder of this Agreement and the application of such provision to other Persons or circumstances shall not be affected by such invalidity or unenforceability, nor shall such invalidity or unenforceability affect the validity or enforceability of such provision, or the application of such provision, in any other jurisdiction; provided, however, that if an excluded provision shall affect the rights, immunities, liabilities, duties or obligations of the Rights Agent, the Rights Agent shall be entitled to resign immediately written notice to the Parent in accordance with Section 4.2.

22 

 

Section 7.7      Counterparts.

This Agreement may be executed in any number of counterparts, each such counterpart being deemed to be an original instrument, and all such counterparts shall together constitute the same agreement.

Section 7.8      Termination.

This Agreement shall terminate and be of no further force or effect, and the parties hereto shall have no liability hereunder, upon consummation of the issuance and delivery to the Holders of all of the Parent A Shares to which they are entitled pursuant to and in accordance with Section 3.4; provided, Article I, Article IV and this Article VII shall survive.

Section 7.9      Withholding.

Notwithstanding anything to the contrary in this Agreement, Parent, the Rights Agent and their respective agents, shall be entitled to deduct and withhold from any amounts otherwise payable to any Person pursuant to this Agreement such amounts as it is required to deduct and withhold with respect to the making of such payment under the Code or any provision of applicable Tax law; provided, however, that other than in respect of compensatory withholding or backup withholding, withholding as a result of the failure to provide the certificate set forth in Section 6.2(g) of the Merger Agreement or withholding in respect of CVR Income, Parent or the Rights Agent, as applicable, shall use commercially reasonable efforts to provide written notice to the Stockholders’ Representative no later than two (2) Business Days prior to any such withholding or deduction in respect of a Holder and to allow the Holder the opportunity to provide any Tax forms, reports or certificates as may be permitted by Applicable Laws to reduce or eliminate such withholding or deduction. Any amounts so withheld and properly remitted to the applicable Governmental Authority shall be treated for all purposes of this Agreement as having been paid to the Person in respect of which such deduction and withholding was made. In the case of any withholding from any payments not payable in cash, Parent or its agent shall withhold or shall cause to be withheld an amount of such payment having a fair market value equal to the withholding obligation to be satisfied in respect of such payment at the time such amount is withheld (provided that if any cash is otherwise payable to the relevant payee, such withholding shall be made first from such cash), and shall be treated as having paid such amount to the Person in respect of which such amount is withheld.

Section 7.10  Entire Agreement.

This Agreement, the letter agreement between Parent and the Rights Agent of even date herewith regarding fees payable to the Rights Agent (the “Fee Schedule”), and the Merger Agreement represent the entire understanding of Parent, the Company and the Stockholders’ Representative with reference to the CVRs, and, as between such Persons, this Agreement supersedes any and all other oral or written agreements hereto made with respect to the CVRs, except for the Merger Agreement. Notwithstanding the reference to any other document in this Agreement, the Rights Agent shall not be deemed to have knowledge of, or have any duty to

23 

 

ascertain or inquire into, the existence, the content, or the terms and conditions of any other agreement, instrument or document, in each case, to which the Rights Agent is not a party, whether or not such agreement, instrument or document, as the case may be, is referenced in this Agreement. This Agreement and the Fee Schedule represent the entire understanding of the Rights Agent with reference to the CVRs and the performance of the Rights Agent’s duties, its immunities and rights with respect thereto, and with respect to the Rights Agent, this Agreement and the Fee Schedule supersede any and all other oral or written agreements heretofore made with respect to the CVRs. If and to the extent that any provision of this Agreement is inconsistent or conflicts with the Merger Agreement, this Agreement shall govern and be controlling, and this Agreement may be amended, modified, supplemented or altered only in accordance with the terms of Article VII. No party shall be bound by, or be liable for, any alleged representation, promise, inducement or statement of intention not contained herein.

Section 7.11  Force Majeure.

Notwithstanding anything to the contrary contained herein, the Rights Agent shall not be liable for any delays or failures in performance to the extent resulting from acts beyond its reasonable control including, without limitation, acts of God, epidemics, pandemics, terrorist acts, breakdowns, interruptions or malfunctions of any communications or computer facilities, or loss of data due to power failures or mechanical difficulties with information storage or retrieval systems, labor difficulties, war or civil unrest; provided, that the Rights Agent shall use reasonable commercial efforts to resume performance as soon as practicable. If any such act or event occurs, the Rights Agent shall give prompt written notice to Parent and the Stockholders’ Representative, stating the nature of the act or event and action being taken to avoid or minimize its effect.

Section 7.12  Funds.

All funds received by the Rights Agent under this Agreement that are to be distributed or applied by the Rights Agent in the performance of services hereunder (the “Funds”) shall be held by the Rights Agent as agent for Parent and deposited in one or more bank accounts to be maintained by the Rights Agent in its name as agent for Parent. Until paid pursuant to the terms of this Agreement, the Rights Agent will hold the Funds through such accounts in: deposit accounts of commercial banks with Tier 1 capital exceeding $1 billion or with an average rating above investment grade by S&P (LT Local Issuer Credit Rating), Moody’s (Long Term Rating) and Fitch Ratings, Inc. (LT Issuer Default Rating) (each as reported by Bloomberg Finance L.P.). The Rights Agent shall have no responsibility or liability for any diminution of the Funds that may result from any deposit made by the Rights Agent in accordance with this paragraph, including any losses resulting from a default by any bank, financial institution or other third party. The Rights Agent may from time to time receive interest, dividends or other earnings in connection with such deposits. The Rights Agent shall not be obligated to pay such interest, dividends or earnings to the Parent, any Holder or any other Person.

 

[Remainder of Page Intentionally Left Blank.]

24 

 

IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed on its behalf by its duly authorized officers as of the day and year first above written.

EROS INTERNATIONAL PLC


By: ___________________________________________
Name:
Title:

 

[Signature Page to Class E CVR Agreement]

 

 

STX FILMWORKS, INC.

 

By: _______________________________
Name:
Title:

 

[Signature Page to Class E CVR Agreement]

 

 

FORTIS ADVISORS LLC

 

By: _______________________________
Name:
Title:

[Signature Page to Class E CVR Agreement]

 

 

COMPUTERSHARE TRUST

COMPANY, N.A. AND COMPUTERSHARE INC.

On behalf of both entities

By: ________________________________

Name:
Title:

 

[Signature Page to Class E CVR Agreement]

Exhibit 4.35

 

CLASS D CONTINGENT VALUE RIGHTS AGREEMENT

This CLASS D CONTINGENT VALUE RIGHTS AGREEMENT, dated as of [●], 2020 (this “Agreement”), is entered into by and among Eros International Plc, an Isle of Man company limited by shares (“Parent”), STX Filmworks, Inc., a Delaware corporation (the “Company”), Fortis Advisors LLC, a Delaware limited liability company, solely in its capacity as representative of the former holders of the Shares (in such capacity, the “Stockholders’ Representative”), and Computershare Inc., a Delaware corporation, and its wholly-owned subsidiary, Computershare Trust Company, N.A., a federally chartered trust company, collectively as rights agent (the “Rights Agent”) and as initial CVR Registrar (as defined herein).

WITNESSETH:

WHEREAS, the Company, Parent, England Holdings 2, Inc., a Delaware corporation and indirect wholly-owned Subsidiary of Parent (“England Holdings 2”), England Merger 1 Corp. (f/k/a England Merger Corp.), a Delaware corporation and a direct wholly-owned Subsidiary of England Holdings 2 (“Merger Sub”), have entered into an Agreement and Plan of Merger (as the same may be amended, modified or supplemented from time to time, the “Merger Agreement”), dated as of April 17, 2020, pursuant to which Merger Sub merged with and into the Company (the “Merger”), with the Company surviving the Merger, as an indirect wholly-owned Subsidiary of Parent;

WHEREAS, pursuant to the Merger Agreement, Parent agreed to issue to holders of record of shares of Class D Convertible Preferred Stock, par value $0.01 per share, of the Company (the “Shares”) outstanding immediately prior to the effective time of the Merger (the “Effective Time”), a number of contingent value rights (the “CVRs”) as hereinafter described; and

WHEREAS, each holder of Shares as of immediately prior to the Effective Time, will receive, among other things, as merger consideration, the right to receive upon the Effective Time a number of CVRs in such amount as set forth in Article II of the Merger Agreement.

NOW, THEREFORE, for and in consideration of the premises and the consummation of the transactions referred to above, it is mutually covenanted and agreed, for the equal and proportionate benefit of all Holders (as hereinafter defined), as follows:

Article I
DEFINITIONS

Section 1.1      Definitions.

(a)                For all purposes of this Agreement, except as otherwise expressly provided or unless the context otherwise requires:

(i)                 the terms defined in this Article I have the meanings assigned to them in this Article I, and include the plural as well as the singular;

1 

 

(ii)               the words “herein,” “hereof” and “hereunder” and other words of similar import refer to this Agreement as a whole and not to any particular Article, Section or other subdivision;

(iii)             unless the context otherwise requires, words describing the singular number shall include the plural and vice versa, words denoting any gender shall include all genders and words denoting natural Persons shall include corporations, partnerships and other Persons and vice versa;

(iv)             the term “Affiliate” when used with respect to the Company shall, after the Effective Time, include Parent and its Subsidiaries and Affiliates; and

(v)               all references to “including” shall be deemed to mean including without limitation.

(b)               Capitalized terms used but not otherwise defined herein shall have the meanings ascribed thereto in the Merger Agreement. The following terms shall have the meanings ascribed to them as follows:

Affiliate” means, with respect to any specified Person, (i) any other Person that directly or indirectly through one or more intermediaries controls, or is controlled by, or is under common control with, such specified Person (for the purposes of this definition, “control” (including, with correlative meanings, the terms “controlling,” “controlled by” and “under common control with”), as used with respect to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of such Person, whether through the ownership of voting securities, by agreement or otherwise) and (ii) with respect to any natural person, any Member of the Immediate Family of such natural person. Notwithstanding the foregoing, for purposes hereof, (i) none of the Holders, the Company, or any of their respective Subsidiaries shall be considered Affiliates of any portfolio company (or Subsidiary thereof) in which any Holder or any of its affiliated investment funds have made a debt or equity investment, and (ii) no Holder or any of its Affiliates shall be considered an Affiliate of (a) Parent or any of its Subsidiaries or (b) any other Holders or their respective Affiliates (except to the extent such Holders are otherwise Affiliates under this definition without regard to their status as Holders).

Agreement” has the meaning set forth in the Preamble.

Aggregate CVR Shares” means the aggregate number of underlying Parent A Shares issuable in respect of all CVRs.

Appraisal Shares” has the meaning set forth in Section 4.2(h).

Available Class D Merger Consideration CVR Shares” means the Merger Consideration CVR Share Cap minus the Parent A Shares issued to the Class E CVRs.

Base Price” means $2.60.

2 

 

Change of Control Transaction” means the occurrence of (i) an acquisition by any Person, including any syndicate or group deemed to be a “person” under Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, of beneficial ownership, directly or indirectly, through purchase, merger or other acquisition transaction or series of purchases, mergers or other acquisition transactions of shares or comparable equity interests of Parent entitling that Person to fifty percent (50%) or more of the total voting power of all such shares or comparable equity interests of Parent; or (ii) the consolidation or merger of Parent with or into any other Person, any merger of another Person into Parent, or any conveyance, transfer, sale, lease or other disposition of all or substantially all of Parent’s properties, business or assets, other than (in the case of this clause (ii) only) (1) any transaction (x) that does not result in any reclassification, conversion, exchange or cancellation of outstanding shares or comparable equity interests of Parent, and (y) pursuant to which holders of Parent’s shares or comparable equity interest immediately prior to such transaction have the right to exercise, directly or indirectly, fifty percent (50%) or more of the total voting power of all shares or comparable equity interest of the continuing or surviving Person immediately after such transaction, or (2) any merger solely for the purpose of changing Parent’s jurisdiction of formation and resulting in a reclassification, conversion or exchange of outstanding shares or comparable equity interests into shares or comparable equity interest of the surviving entity with substantially identical rights.

Class A CVR” means the contingent value rights issued by Parent with respect to the Class A Convertible Preferred Stock, par value $0.01 of the Company, pursuant to the Merger Agreement and the Class A CVR Agreement.

Class A CVR Agreement” means the Class A CVR Agreement, dated as of the date hereof, by and among Parent, the Company, the stockholders’ representative thereunder and the rights agent thereunder.

Class A CVR Shares” means the underlying Parent A Shares issuable in respect of the Class A CVRs.

Class B CVR” means the contingent value rights issued by Parent with respect to the Class B Convertible Preferred Stock, par value $0.01 of the Company, pursuant to the Merger Agreement and the Class B CVR Agreement.

Class B CVR Agreement” means the Class B CVR Agreement, dated as of the date hereof, by and among Parent, the Company, the stockholders’ representative thereunder and the rights agent thereunder.

Class B CVR Shares” means the underlying Parent A Shares issuable in respect of the Class B CVRs.

Class C CVR” means the contingent value rights issued by Parent with respect to the Class C Convertible Preferred Stock, par value $0.01 of the Company, pursuant to the Merger Agreement and the Class C CVR Agreement.

Class C CVR Agreement” means the Class C CVR Agreement, dated as of the date hereof, by and among Parent, the Company, the stockholders’ representative thereunder and the rights agent thereunder.

3 

 

Class C CVR Shares” means the underlying Parent A Shares issuable in respect of the Class C CVRs.

Class E CVR” means the contingent value rights issued by Parent with respect to the Class E Convertible Preferred Stock, par value $0.01 of the Company, pursuant to the Merger Agreement and the Class E CVR Agreement.

Class E CVR Agreement” means the Class E CVR Agreement, dated as of the date hereof, by and among Parent, the Company, the stockholders’ representative thereunder and the rights agent thereunder.

Class E CVR Shares” means the underlying Parent A Shares issuable in respect of the Class E CVRs.

Code” means the Internal Revenue Code of 1986, as amended from time to time.

Company” has the meaning set forth in the Preamble.

CVR” means a contingent value right issued by Parent with respect to the Shares, pursuant to the Merger Agreement and this Agreement.

CVR Shares” has the meaning set forth in Section 3.4(b).

CVR Register” has the meaning set forth in Section 3.3(b).

CVR Registrar” has the meaning set forth in Section 3.3(b).

Effective Time” has the meaning set forth in the Recitals.

Eros Pre-Closing Equity Financing” has the meaning ascribed in the PIPE Agreement.

Final Settlement Time” has the meaning set forth in Section 3.2(b).

Funds” has the meaning set forth in ‎Section 7.12.

Fully Diluted Parent Shares” means, as of immediately prior to the Effective Time, the sum of (without duplication) (i) the aggregate number of Parent Ordinary Shares then outstanding, plus (ii) the aggregate number of Parent Ordinary Shares subject to issuance pursuant to then outstanding In-the-Money Parent Options (whether or not vested), plus (iii) the aggregate number of Parent Ordinary Shares subject to issuance pursuant to then outstanding Parent RSU Awards (whether or not vested), plus (iv) the aggregate number of Parent Ordinary Shares then subject to issuance pursuant to the Parent Convertible Notes assuming full conversion thereof at a conversion price of $2.60; provided, however, that, notwithstanding the foregoing, Fully Diluted Parent Shares shall not include any Parent Ordinary Shares issuable pursuant to the Eros Pre-Closing Equity Financing. For the avoidance of doubt, Fully Diluted Parent Shares shall be calculated prior to, and without giving effect to, the PIPE Investment.

Holder” means a Person in whose name a CVR is registered in the CVR Register.

4 

 

In-the-Money Parent Options” means an Eros Option (as defined in the Merger Agreement) having a per Parent Ordinary Share exercise price less than the Parent Trading Price.

Investors’ Rights Agreement” means the Investors’ Rights Agreement, entered into on or around the date hereof, by and among Parent, certain shareholders of Parent and the investors party thereto.

Law” with respect to any Person, means (a) all provisions of all laws, statutes, ordinances, rules, regulations, permits, certificates or orders of any governmental authority applicable to such Person or any of its assets or property or to which such Person or any of its assets or property is subject, and (b) all judgments, injunctions, orders and decrees of all courts and arbitrators in proceedings or actions in which such Person is a party or by which it or any of its assets or properties is or may be bound or subject.

Lock-Up Agreement” has the meaning set forth in Section 3.4(c).

Members of the Immediate Family” means, with respect to any individual, each spouse or child or other descendants of such individual, each trust created solely for the benefit of one or more of the aforementioned Persons and their spouses and each custodian or guardian of any property of one or more of the aforementioned Persons in his capacity as such custodian or guardian.

Merger” has the meaning set forth in the Recitals.

Merger Agreement” has the meaning set forth in the Recitals.

Merger Consideration CVRs” means the CVRs, the Class E CVRs, the Class C CVRs, the Class B CVRs and the Class A CVRs.

Merger Consideration CVR Share Cap” means a number of Parent A Shares equal to the Fully Diluted Parent Shares.

Merger Consideration CVR Shares” means the Aggregate CVR Shares, the Class E CVR Shares, the Class C CVR Shares, the Class B CVR Shares and the Class A CVR Shares.

Merger Sub” has the meaning set forth in the Recitals.

Organizational Documents” has the meaning set forth in Section 2.1(a).

Parent” has the meaning set forth in the Preamble.

Parent A Shares” means the A Ordinary Shares, par value £0.30 per share, of Parent.

Parent B Shares” means the B Ordinary Shares, par value £0.30 per share, of Parent.

Parent Convertible Notes” means Parent’s Senior Convertible Notes due September 27, 2020 in the original aggregate principal amount of $27,500,000.

Parent Option” means a compensatory option to purchase Parent Ordinary Shares.

5 

 

Parent Ordinary Shares” means, collectively, the Parent A Shares and the Parent B Shares.

Parent Proceedings” has the meaning set forth in Section 7.5(a).

Parent RSU Award” means an award of restricted stock units relating to Parent Ordinary Shares.

Parent Trading Price” means the VWAP for one Parent A Share for the twenty (20) consecutive full Trading Days ending on the full Trading Day immediately preceding the Effective Time (as adjusted as appropriate to reflect any stock splits, stock dividends, combinations, reorganizations, classifications or similar events).

Permitted Transfer” means: (i) the transfer (upon the death of the Holder) by will or intestacy; (ii) transfer by instrument to an inter vivos or testamentary trust in which the CVRs are to be passed to beneficiaries upon the death of the trustee; (iii) transfers made pursuant to a court order of a court of competent jurisdiction (such as in connection with divorce, bankruptcy or liquidation); (iv) if the Holder is a partnership or limited liability company, a distribution by the transferring partnership or limited liability company to its partners or members, as applicable; (v) a transfer made by operation of law (including a consolidation or merger) or in connection with the dissolution, liquidation or termination of any corporation, limited liability company, partnership or other entity; or (vi) a transfer by any Holder to one or more of its Affiliates or affiliated investment funds of any of its Affiliates.

Permitted Transferee” means a Person who receives a CVR pursuant to a Permitted Transfer and otherwise in accordance with this Agreement.

Person” means any individual, corporation (including not-for-profit), general or limited partnership, limited liability company, joint venture, estate, trust, association, organization, Governmental Authority or other entity of any kind or nature.

PIPE Agreement” means that certain Subscription Agreement, made as of April 17, 2020, by and among Parent and each Person defined therein as a “Purchaser.”

PIPE Investment” means the purchase of Parent A Shares pursuant to the PIPE Agreement.

PIPE Lock-Up Agreement” has the meaning set forth in Section 3.4(c).

Pre-Closing VWAP” means the VWAP of the Parent A Shares for the 10 Trading Days ending on the end of the Trading Day immediately preceding the Closing.

Pre-Settlement VWAP” means the VWAP of the Parent A Shares for the 10 Trading Days ending on the end of the Trading Day immediately preceding the Settlement Date; provided, that for purposes of determining the CVR Shares issuable as of any time prior to the Settlement Date, the reference to “the Trading Day immediately preceding the Settlement Date” in this definition shall be deemed a reference to “the Trading Day immediately preceding the applicable time of determination”.

6 

 

Reference Price” means a price per share equal to the lesser of (x) the Pre-Settlement VWAP and (y) the Upper Collar Price; provided, that if the Pre-Settlement VWAP is equal to or greater than $4, then the Reference Price will equal the average of the Pre-Settlement VWAP and the Upper Collar Price.

Rights Agent” means the Rights Agent named in the first paragraph of this Agreement, until a successor Rights Agent shall have become such pursuant to the applicable provisions of this Agreement, and thereafter “Rights Agent” shall mean such successor Rights Agent.

Settlement Date” shall mean the date that is the earlier to occur of (a) the later to occur of (i) the first time that the Merger Consideration CVR Shares have been registered for resale pursuant to an effective registration statement under the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder, and (ii) the 75th calendar day after the Closing and (b) the occurrence of the Settlement Outside Date.

Settlement Outside Date” means the date that is six (6) months after the Closing; provided that the Settlement Outside Date may be extended (but only once) by holders of a majority of the Class E CVRs; provided, further, that such majority must include each such holder that, together with its Affiliates, purchased $15 million or more of Parent A Shares in the PIPE Investment.

Shares” has the meaning set forth in the Recitals.

Stockholders’ Representative” has the meaning set forth in the Preamble.

STX Purchase Price” means the lowest of (i) the Base Price, (ii) the volume weighted average of the purchase price of all purchases comprising the Eros Pre-Closing Equity Financing and (iii) the Pre-Closing VWAP; provided, however, that if the Pre-Closing VWAP is greater than $3.25, then the STX Purchase Price shall be the average of the Base Price and the Pre-Closing VWAP.

Subsidiary” of any Person shall mean any corporation or other entity of which securities or other ownership interests having ordinary voting power sufficient to elect a majority of the board of directors or comparable governing body are beneficially owned, directly or indirectly, by such Person, and any corporation or other entity that is otherwise controlled by such Person.

Taxes” or “Tax” means all taxes, charges, fees, levies or other assessments in the nature of a tax imposed by any governmental authority, including any income, gross receipts, license, severance, occupation, premium, environmental (including taxes under former Code Section 59A), customs, duties, profits, disability, alternative or add-on minimum, estimated, withholding, payroll, employment, unemployment insurance, social security (or similar), excise, sales, use, value-added, occupancy, franchise, real property, personal property, business and occupation, mercantile, windfall profits, capital stock, stamp, transfer, workmen’s compensation, amounts due under any applicable laws governing escheat or unclaimed property or other taxes, charges, fees, levies or other assessments in the nature of a tax, together with any interest, penalties, additions to tax or additional amounts imposed by any Governmental Authority with respect thereto, whether disputed or not.

7 

 

Trading Day” means, with respect to any referenced security, any day on which such security is actually traded on the principal securities exchange or securities market on which such security is then listed.

Upper Collar Price” means the quotient of the STX Purchase Price, divided by one and one-half (1.5).

VWAP” means, for any security as of any date(s), the dollar volume-weighted average price for such security on the principal securities exchange or securities market on which such security is then listed during the period beginning at 9:30:01 a.m., New York time, and ending at 4:00:00 p.m., New York time, as reported by Bloomberg through its “HP” function (sets to weighted average) or, if the foregoing does not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the electronic bulletin board for such security during the period beginning at 9:30:01 a.m., New York time, and ending at 4:00:00 p.m., New York time, as reported by Bloomberg, or, if no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the highest closing bid price and the lowest closing ask price of any of the market makers for such security as reported by OTC Markets Group Inc. If the VWAP cannot be calculated for such security on such date(s) on any of the foregoing bases, the VWAP of such security on such date(s) shall be the fair market value thereof on such date(s) as reasonably determined by a nationally recognized independent investment banking firm mutually agreed between Parent and the Stockholders’ Representative.

Article II
OPERATION OF PARENT

Section 2.1      Operation of Parent.

From the Effective Time until the Settlement Date, Parent shall not, and shall cause its Subsidiaries and Affiliates not to:

(a)                after the effectiveness of the Amended Articles (as defined in the Investors’ Rights Agreement), effect any action that requires approval by the shareholders of Parent under Parent’s Memorandum of Association or Articles of Association (the “Organizational Documents”) or applicable Law; or

(b)               prior to the effectiveness of Amended Articles, take any action set forth in Section 4.3(c) of the Investors’ Rights Agreement as in effect on the date hereof,

without, in each such case, obtaining the consent thereto of holders of such class and number of Merger Consideration CVRs (including the CVRs hereunder) that, together with the shares of Parent actually voted (at a meeting or by resolution) with respect to such action and assuming all Merger Consideration CVR Shares were outstanding Parent A Shares and voted, would be required to approve such action under the Organizational Documents, applicable Law or Section 4.3(c) of the Investors’ Rights Agreement, as applicable. For purposes of the foregoing consent rights, the number of Merger Consideration CVR Shares underlying the Merger Consideration CVRs as of any time prior to the Settlement Date shall be calculated as set forth below in Article III and in Article III of the Class E CVR Agreement with respect to the Class E CVRs, Article III of the Class C CVR Agreement with respect to the Class C CVRs, Article III of the Class B CVR Agreement with respect to the Class B CVRs and Article III of the Class A CVR Agreement with respect to the Class A CVRs.

8 

 

Article III
CVRS

Section 3.1      Issuance of CVRs; Appointment of Rights Agent; Reservation of Shares.

(a)                The CVRs shall be issued pursuant to the Merger Agreement at the time and in the manner set forth in the Merger Agreement. The registration on the books and records of Parent and administration of the CVRs shall be handled pursuant to this Agreement in the manner set forth in this Agreement.

(b)               Parent hereby appoints the Rights Agent to act as rights agent for the CVRs in accordance with the instructions hereinafter set forth in this Agreement, and the Rights Agent hereby accepts such appointment.

(c)                From the date hereof until the issuance of the Aggregate CVR Shares in accordance with the terms hereof, Parent shall reserve and keep available out of its authorized but unissued share capital, for the purpose of effecting the issuance of the CVR Shares hereunder, a number of Parent A Shares equal to the Merger Consideration CVR Share Cap, minus the number of CVR Shares, if any, previously issued in accordance with the terms of this Agreement; and if at any time during such period the number of authorized but unissued Parent A Shares shall not be sufficient to effect the issuance of the Aggregate CVR Shares in full, Parent shall take all such action as may be necessary to increase its authorized but unissued share capital as shall be sufficient for such purposes.

Section 3.2      Nontransferable; Expiration.

(a)                The CVRs shall not be sold, assigned, transferred, pledged, encumbered or in any other manner transferred or disposed of, in whole or in part, other than to a Permitted Transferee. Any purported transfer of a CVR to anyone other than a Permitted Transferee shall be null and void ab initio.

(b)               Subject to Section 3.4(c), the CVRs shall expire on the Settlement Date upon the registration of the CVR Shares in the respective names of the Holders entitled thereto and shall thereafter be of no force or effect following such registration; provided that, if any CVR Shares are not so registered on the Settlement Date, then the CVRs in respect thereof shall not expire until the registration of such CVR Shares in the respective names of the Holders entitled thereto (the time of registration thereof, the “Final Settlement Time”).

Section 3.3      No Certificate; Registration; Registration of Transfer; Change of Address.

(a)                The CVRs shall not be evidenced by a certificate or other instrument.

9 

 

(b)               Upon receipt from Parent of the names and addresses of each Holder and the number of CVRs held by such Holder, the Rights Agent shall keep a register (the “CVR Register”) for the registration of CVRs in a book-entry position for each Holder of a CVR. The CVR Register shall set forth the name and address of each Holder, and the number of CVRs held by such Holder and Tax Identification Number of each Holder. Each of Parent and the Stockholders’ Representative may receive and inspect a copy of the CVR Register, from time to time, upon written request made to the CVR Registrar. Within five (5) Business Days after receipt of such request, the CVR Registrar shall deliver a copy of the CVR Register, as then in effect, to Parent and the Stockholders’ Representative at the address set forth in Section 7.1. The Rights Agent is hereby initially appointed “CVR Registrar” for the purpose of registering CVRs and transfers of CVRs as herein provided.

(c)                Subject to the restrictions set forth in Section 3.2, every request made to transfer a CVR must be in writing and accompanied by a written instrument or instruments of transfer and any other reasonably requested documentation in form reasonably satisfactory to Parent and the CVR Registrar, duly executed by the registered Holder or Holders thereof or by the duly appointed legal representative thereof or by a duly authorized attorney. A request for a transfer of a CVR shall be accompanied by documentation establishing that the transfer is to a Permitted Transferee and shall thereafter be supplemented with and any other information as may be reasonably requested by Parent or the CVR Registrar (including opinions of counsel, if appropriate). Upon receipt of such written notice, the CVR Registrar shall, subject to its reasonable determination that the transfer instrument is in proper form and the transfer otherwise complies with the other terms and conditions herein on its face, without investigation or inquiry by the Rights Agent, register the transfer of the CVRs in the CVR Register. All duly transferred CVRs registered in the CVR Register shall be the valid obligations of Parent, evidencing the same rights and entitling the transferee to the same benefits and rights under this Agreement as those held by the transferor immediately prior to such transfer. No transfer of a CVR shall be valid until registered in the CVR Register, and any transfer not duly registered in the CVR Register will be void ab initio (unless the transfer was permissible hereunder and such failure to be duly registered is attributable to the fault of the CVR Registrar). Any transfer or assignment of the CVRs shall be without charge by Parent or the CVR Registrar (other than the cost of any Tax which shall be the responsibility of the transferor) to the Holder.

(d)               A Holder may make a written request to the CVR Registrar to change such Holder’s address of record in the CVR Register. The written request must be duly executed by the Holder and accompanied by such other evidence of the Holder’s identity or interest in the CVR as reasonably requested by the Rights Agent. Upon receipt of such written notice, the CVR Registrar is hereby authorized to, and shall promptly, record the change of address in the CVR Register.

(e)                The Stockholders’ Representative may make a written request to the Rights Agent for a list containing the names, addresses and number of CVRs of the Holders that are registered in the CVR Register. Within five (5) Business Days following the date of receipt by the Rights Agent of such request, the CVR Registrar shall deliver a copy of such list to the Stockholders’ Representative.

Section 3.4      Issuance Procedures.

10 

 

(a)                On the Settlement Date, Parent shall issue, and cause to be deposited with the Rights Agent, a number of Parent A Shares equal to the Aggregate CVR Shares. On the Settlement Date or as promptly as practicable thereafter, subject to Section 3.4(c) below, the Rights Agent shall cause the applicable number of CVR Shares to be registered in the name of each of the Holders as reflected in the CVR Register as of the close of business on the last Business Day prior to such issuance date.

(b)               The number of Parent A Shares issued in respect of each CVR from the Available Class D Merger Consideration CVR Shares (the “CVR Shares”) shall be equal to the quotient obtained by dividing $1,000 by the Reference Price; provided, that the number of Parent A Shares allocated to the CVRs shall be pro-rated in the event there are insufficient Available Class D Merger Consideration CVR Shares remaining for allocation to the CVRs. For all purposes above, fractional CVRs shall represent a proportionate number of CVR Shares; provided, however, that no fractional Parent A Shares (or certificate or scrip representing the same) shall be issued upon the settlement of any CVRs hereunder. Notwithstanding any other provision of this Agreement, each Holder of CVRs who would otherwise have been entitled to receive a fraction of a Parent A Share upon settlement of such Holder’s CVRs hereunder (after aggregating all CVRs of such Holder that are subject to this Agreement) shall receive, in lieu thereof, an amount of cash (rounded to the nearest whole cent), without interest, equal to such fractional amount multiplied by the Reference Price. Whenever a payment for fractional Parent A Shares or fractional shares is to be made by the Rights Agent under any section of this Agreement, Parent shall (i) promptly deliver to the Rights Agent a certificate setting forth the amount of any such payment and calculation related thereto and (ii) cash in the amount of such payment to the Rights Agent by wire transfer of immediately available funds to make such payment to the applicable Holder by check mailed to such Holder as reflected in the CVR Register or by wire transfer of immediately available funds. The Rights Agent shall not be liable to any Holder or Parent for the amount of any cash payment made to such Holder on behalf of Parent in accordance with the amount set forth in such certificate.

(c)                Parent’s obligation to issue and cause to be deposited with the Rights Agent the applicable number of CVR Shares, and the Rights Agent’s obligation to cause the applicable number of CVR Shares to be registered in the name of a Holder upon receipt of the applicable number of CVR Shares shall be conditioned on the execution and delivery by such Holder of a lockup agreement with Parent, substantially in the form attached hereto as Exhibit A (a “Lock-Up Agreement”); provided, however, that the Rights Agent’s obligation to cause the applicable number of CVR Shares to be registered in the name of a Holder upon receipt of the applicable number of CVR Shares to a Holder shall not be conditioned on the execution and delivery by such Holder of a Lock-Up Agreement if (i) such Holder or any of its Affiliates shall have entered into a lockup agreement with Parent in connection with the PIPE Investment (such lockup agreement, a “PIPE Lock-Up Agreement”) or (ii) the Settlement Date is the Settlement Outside Date and the Merger consideration CVR Shares have not been, as of such date, registered for resale pursuant to an effective registration statement under the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder; provided, further, that Rights Agent shall have no duty to act without the written instruction of Parent with respect to the foregoing.

11 

 

(d)               Without limiting the other provisions of this Agreement, if at any time during the period between the execution of this Agreement and the Settlement Date (or if applicable, the Final Settlement Time), any change in the number or type of outstanding Parent A Shares shall occur as a result of a reclassification, recapitalization, exchange, stock split (including a reverse stock split), combination or readjustment of capital stock, shares or any stock dividend or stock distribution with a record date during such period (including any such reclassification, recapitalization, exchange, stock split, combination or readjustment of capital stock, shares or any stock dividend or stock distribution in connection with a consolidation, merger or combination in which Parent is the continuing or surviving corporation), the CVR Shares and any other similarly dependent items, as the case may be, shall be appropriately equitably adjusted to provide the same economic effect as contemplated by this Agreement prior to such event; provided that nothing in this Section 3.4(d) shall be construed to permit any party to take any action that is otherwise prohibited or restricted by any other provision of this Agreement.

(e)                If, at any time prior to the Settlement Date (or, if applicable, the Final Settlement Time) Parent effects any Change of Control Transaction, then, upon any Settlement Date, each Holder shall have the right to receive, on the Settlement Date, for each CVR Share that would have been issuable upon the Settlement Date the same consideration (in the same amount and form) per Parent A Share payable to the holders thereof in such Change of Control Transaction. For purposes hereof, the determination of Pre-Settlement VWAP shall be appropriately adjusted to refer to such consideration instead of Parent A Shares. If holders of Parent A Shares are given any right of election as to the securities, cash or property to be received in such Change of Control Transaction, then each Holder shall be given the same right of election. To the extent necessary to effectuate the foregoing provisions, Parent shall ensure that any successor to Parent or the surviving entity in such Change of Control Transaction shall agree to be bound by the terms of this Agreement. In the event that the Final Settlement Time occurs after the Settlement Date, references herein to Settlement Date shall mean as promptly as practicable following the Change of Control Transaction.

Section 3.5      CVR Rights

(a)                Subject to Section 2.1, except as provided in Section 3.5(b), the CVRs shall not have any voting rights and shall not represent any equity or ownership interest in Parent, in any constituent company to the Merger, any Affiliate of Parent or any other Person.

(b)               The CVRs shall entitle each Holder, at the Settlement Date and subject to any applicable withholding Taxes, to a payment per Parent A Share issued thereunder, without interest, equal (as to both amount and form of consideration) to all dividends or other distributions of any kind declared per Parent A Share of the CVR Shares with a record date after the Closing and prior to the Settlement Date. Any dividends or other distributions of any kind made in respect of the CVR Shares will be delivered promptly to the Rights Agent to be held in escrow with respect to the CVRs (the “CVR Income”) treating the CVR Shares for this purpose as if the Aggregate CVR Shares were then outstanding. On the Settlement Date, the Rights Agent shall deliver to each Holder, concurrent with the issuance to such Holder of the applicable CVR Shares, the CVR Income earned in respect of each such CVR Share, less any applicable withholding Taxes.

12 

 

Article IV
THE RIGHTS AGENT

Section 4.1      Certain Duties and Responsibilities.

The Rights Agent shall not have any liability for any actions taken or not taken by the Rights Agent in connection with the execution, acceptance, administration, exercise and performance of its duties under this Agreement, except to the extent of its willful misconduct, bad faith or gross negligence (in each case as determined by a final, non-appealable judgment of a court of competent jurisdiction). No provision of this Agreement shall require the Rights Agent to expend or risk its own funds or otherwise incur any financial liability in the performance of any of its duties hereunder or in the exercise of any of its rights or powers.

Section 4.2      Certain Rights of Rights Agent.

The Rights Agent undertakes to perform such duties and only such duties as are specifically set forth in this Agreement, and no implied covenants or obligations shall be read into this Agreement against the Rights Agent. In addition:

(a)                the Rights Agent may rely and shall be protected and held harmless by Parent in and shall not incur any liability in acting or refraining from acting in connection with its performance under this Agreement upon any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order or other paper or document reasonably believed by it to be genuine and to have been signed or presented by the proper party or parties, except to the extent of its willful misconduct, bad faith or gross negligence (in each case as determined by a final, non-appealable judgment of a court of competent jurisdiction);

(b)               the Rights Agent may consult with legal counsel selected by it, and the Rights Agent shall incur no liability for or in respect of any action taken, suffered or omitted to be taken by it in the absence of bad faith, gross negligence or willful misconduct and in accordance with such advice or opinion. The reasonable costs of such counsel’s services shall be paid to the Rights Agent in accordance with Section 4.2(g) below. The Rights Agent may perform any and all of its duties through its agents, representatives, custodians and/or nominees and the Rights Agent shall not be answerable or accountable for any act, omission, default, neglect or misconduct of any such agents, representatives, custodians and/or nominees or for any loss to Parent or the Company, to the Holders or any other Person resulting from any such act, omission, default, neglect or misconduct, absent gross negligence, willful misconduct or bad faith on the part of the Rights Agent, such agents, representatives, custodians and/or nominees (which gross negligence, willful misconduct or bad faith must be determined by a final, non-appealable judgment of a court of competent jurisdiction);

(c)                if the Rights Agent becomes involved in litigation on account of this Agreement, it shall have the right to retain counsel and shall be entitled to reimbursement for all reasonable and documented out-of-pocket costs and expenses related thereto as provided in this Section 4.2(c) and Section 4.2(g) hereof; provided, however, that the Rights Agent shall not be entitled to any such reimbursement to the extent such litigation ultimately determines that the Rights Agent acted with willful misconduct, bad faith or gross negligence. In the event that conflicting demands are made upon the Rights Agent for any situation addressed or not addressed in this Agreement, the Rights Agent may withhold performance of the terms of this Agreement until such time as said conflicting demands shall have been withdrawn or the rights of the respective parties shall have been settled by court adjudication, arbitration, joint order or otherwise;

13 

 

(d)               the permissive rights of the Rights Agent to do things enumerated in this Agreement shall not be construed as a duty;

(e)                the Rights Agent shall not be required to give any note or surety in respect of the execution of such powers or otherwise in respect of the premises;

(f)                Parent agrees to indemnify the Rights Agent for, and hold the Rights Agent harmless against, any loss, liability, claim, demands, suits or expense arising out of or in connection with the Rights Agent’s duties under this Agreement, including the costs and expenses of defending the Rights Agent against any claims, charges, demands, suits or loss, unless such loss shall have been determined by a court of competent jurisdiction to be a result of the Rights Agent’s willful misconduct, bad faith or gross negligence (in each case as determined by a court of competent jurisdiction); provided, however, that the Rights Agent’s aggregate liability with respect to, arising from, or arising in connection with this Agreement, or from all services provided or omitted to be provided under this Agreement, whether in contract, in tort, or otherwise, is limited to, and shall not exceed, the amounts paid hereunder by Parent to the Rights Agent as fees and charges (but not including reimbursable expenses) in the 12 months preceding the event for which recovery is sought. The provisions under this Section 4.2 and ‎Section 4.1 above shall survive the settlement of the CVRs and the termination of this Agreement and the resignation, replacement or removal of the Rights Agent. To the extent the Rights Agent is entitled to indemnification hereunder, the reasonable and documented out-of-pocket costs and expenses of the Rights Agent incurred in enforcing this right of indemnification shall be paid by Parent;

(g)               Parent agrees to pay to the Rights Agent reasonable compensation for all services rendered by it hereunder in accordance with a fee schedule to be mutually agreed upon in writing between Parent and the Rights Agent and, from time to time, to reimburse the Rights Agent for all of its reasonable, customary and documented out-of-pocket expenses (including reasonable fees and expenses of the Rights Agent’s counsel) and other disbursements incurred in the preparation, delivery, negotiation, amendment, administration and execution of this Agreement and the exercise and performance of its duties hereunder. Without limiting any of its rights to compensation or reimbursement under this Agreement, the Rights Agent shall deliver to Parent the final invoice for the Rights Agent fees and costs (which shall include a reasonable estimate of all remaining fees and expenses) at a reasonable time prior to the date of delivery of the CVR Shares. An invoice for any reasonable and documented out-of-pocket expenses and per item fees realized will be rendered and payable as mutually agreed upon in writing between Parent and the Rights Agent. For the avoidance of doubt, and notwithstanding anything to the contrary herein, in no event shall Parent be required to indemnify or otherwise reimburse the Rights Agent for any income or similar taxes of the Rights Agent (or an of its Affiliates) in connection with the performance of its duties hereunder;

14 

 

(h)               For avoidance of doubt, no CVRs shall be issued in respect of any shares of capital stock of the Company as to which the holder thereof as of immediately prior to the Effective Time properly demands appraisal in accordance with, and who complies in all respects with, Section 262 of the Delaware General Corporation Law (such shares, “Appraisal Shares” and such statutory section, “Section 262”); provided, however, that notwithstanding the foregoing, (i) the CVRs that would have been issuable in respect of Appraisal Shares but for their status as such shall be deemed to be outstanding for purposes of determining the number of CVR Shares to be issued per CVR and (ii) if any holder of Appraisal Shares shall fail to perfect or otherwise waive, withdraw or lose the right to appraisal under Section 262 with respect to any Appraisal Shares (whether before or after the Settlement Date), then the CVRs issuable in respect of such Appraisal Shares shall be deemed to have been issued to such holder as of the Effective Time and to entitle such holder to all rights of a Holder hereunder with respect thereto, including the right to receive the CVR Shares and CVR Income in respect thereof upon the Settlement Date in accordance with the other provisions of this Agreement;

(i)                 whenever the Rights Agent shall reasonably require that a matter be proved or established prior to taking, suffering or omitting any action hereunder, the Rights Agent may rely upon a signed certificate from an authorized officer of Parent, and the Rights Agent shall incur no liability and be held harmless by Parent for or in respect of any action taken, suffered or omitted to be taken by it under the provisions of this Agreement in reliance upon and in accordance with such certificate;

(j)                 the permissive rights of the Rights Agent to do things enumerated in this Agreement shall not be construed as a duty;

(k)               the Rights Agent shall not be required to give any note or surety in respect of the execution of its powers hereunder or otherwise in respect of the premises;

(l)                 the Rights Agent shall not be liable for or by reason of, and shall be held harmless by Parent with respect to any of the statements of fact or recitals contained in this Agreement or any certificate delivered by Parent under this Agreement and shall not be required to verify the same, but all such statements and recitals are and shall be deemed to have been made by Parent only;

(m)             the Rights Agent shall have no liability and shall be held harmless by Parent in respect of the validity of this Agreement or the execution and delivery hereof (except the due execution and delivery hereof by the Rights Agent and the enforceability of this Agreement against the Rights Agent assuming the due execution and delivery hereof by the other parties hereto), nor shall it be responsible for any breach by Parent of any covenant or condition contained in this Agreement;

(n)               anything to the contrary notwithstanding, the Rights Agent shall not be liable for any special, punitive, consequential, indirect or incidental loss or damage of any kind whatsoever (including lost profits) arising out of any act or failure to act hereunder, even if the Rights Agent has been advised of the likelihood of such loss or damage or has foreseen the possibility or likelihood of such damages;

15 

 

(o)               the Rights Agent shall not be deemed to have knowledge of any event of which it was required to receive notice from Parent or the Stockholders’ Representative hereunder and did not receive such notice, and the Rights Agent shall be fully protected and shall incur no liability for failing to take action in connection therewith, unless and until it has received such required notice in writing;

(p)               the Rights Agent and any affiliate of the Rights Agent may buy, sell or deal in any of securities of Parent or the Company or become pecuniarily interested in any transaction in which Parent or the Company may be interested, or contract with or lend money to Parent or the Company or otherwise act as fully and freely as though it were not Rights Agent under this Agreement, subject to applicable Law (including applicable securities Laws). Nothing herein shall preclude the Rights Agent from acting in any other capacity for Parent or the Company or for any other legal entity;

(q)               the Rights Agent shall act hereunder solely as agent for Parent and it shall not assume any obligations or relationship of agency or trust with any of the Holders or any other Person;

(r)                 the Rights Agent shall not be deemed to have knowledge of a change in authorized officers or duly authorized representatives of any Person without notice of such change, and the Rights Agent shall be fully protected and shall incur no liability for failing to take action in connection therewith, unless and until it has received such notice in writing;

(s)                the Rights Agent shall not have any duty or responsibility in the case of the receipt of any written demand from any Holder with respect to any action or default by Parent, including, without limiting the generality of the foregoing, any duty or responsibility to initiate or attempt to initiate any proceedings at law or otherwise or to make any demand upon Parent; and

(t)                 the Rights Agent shall have no duty or obligation under any Section of this Agreement that requires the payment of taxes or charges by the Parent or Holder in connection with the Rights Agent’s performance of such duty or obligation, unless and until the Rights Agent is reasonably satisfied that all such taxes and/or charges have been paid.

Section 4.3      Resignation and Removal; Appointment of Successor.

(a)                The Rights Agent may resign at any time by giving written notice thereof to Parent and the Stockholders’ Representative specifying a date when such resignation shall take effect, which notice shall be sent at least thirty (30) days’ prior to the date so specified. In the event any transfer agency relationship in effect between the Parent and the Rights Agent terminates, the Rights Agent will be deemed to have resigned automatically and be discharged from its duties under this Agreement as of the effective date of such termination. Parent may terminate the Rights Agent at any time by giving written notice thereof to the Rights Agent and the Stockholders’ Representative specifying a date when such termination shall take effect, which notice shall be sent at least thirty (30) days prior to the date so specified.

(b)               If the Rights Agent shall resign, be removed or become incapable of acting, Parent and the Stockholders’ Representative shall promptly appoint a qualified successor Rights Agent. The successor Rights Agent so appointed shall, forthwith upon its acceptance of such appointment in accordance with this Section 4.3(b), become the successor Rights Agent.

16 

 

(c)                Parent shall give notice of each resignation and each removal of a Rights Agent and each appointment of a successor Rights Agent by mailing written notice of such event through electronic mail, to the Stockholders’ Representative. The Stockholders’ Representative shall forward such notice to the Holders. If Parent fails to send such notice within ten (10) days after acceptance of appointment by a successor Rights Agent, the successor Rights Agent shall cause such notice to be mailed and electronically transmitted at the expense of Parent.

(d)               If a successor Rights Agent has not been appointed and has not accepted such appointment by the end of the thirty (30) day period, the Stockholders’ Representative or the Rights Agent may (but shall not be obligated to) apply to a court of competent jurisdiction for the appointment of a successor Rights Agent, and the reasonable documented out-of-pocket costs, expenses (including reasonable attorneys’ fees which are incurred in connection with such a proceeding) shall be paid in accordance with Section 4.2(g) hereof. Any such successor to the Rights Agent shall agree to be bound by the terms of this Agreement and shall, upon receipt of the all relevant books and records relating thereto, become the Rights Agent hereunder. Upon delivery of all of the relevant books and records, pursuant to the terms of this Section 4.3(d) to a successor Rights Agent, the Rights Agent shall thereafter be discharged from any further obligations hereunder. Without limiting any of the rights or immunities of the Rights Agent under this Agreement, the Rights Agent is hereby authorized, in any and all events, to comply with and obey any and all final judgments, orders and decrees of any court of competent jurisdiction which may be filed, entered or issued, and all final arbitration awards and, if it shall so comply or obey, it shall not be liable to any other person by reason of such compliance or obedience.

Section 4.4      Acceptance of Appointment by Successor.

(a)                Every successor Rights Agent appointed hereunder shall execute, acknowledge and deliver to Parent, the Stockholders’ Representative and to the retiring Rights Agent an instrument accepting such appointment and a counterpart of this Agreement, and thereupon such successor Rights Agent, without any further act, deed or conveyance, shall become vested with all the rights, powers, trusts and duties of the retiring Rights Agent; but, on request of Parent, the Stockholders’ Representative or the successor Rights Agent, such retiring Rights Agent shall execute and deliver an instrument transferring to such successor Rights Agent all the rights, powers and trusts of the retiring Rights Agent but such retiring Rights Agent shall not be required to make any additional expenditure or assume any additional liability in connection with the foregoing.

Article V
COVENANTS AND REPRESENTATIONS

Section 5.1      List of Holders.

Parent shall furnish or cause to be furnished to the Rights Agent in such form as Parent receives from the Company prior to the Effective Time (or other agent performing similar services for Parent or its Affiliates), the names, addresses, shareholdings and tax certification (T.I.N.) of the record holders of Shares eligible to receive CVRs pursuant to the Merger Agreement reasonably promptly following the Effective Time.

17 

 

Section 5.2      Delivery of CVR Shares.

The Rights Agent shall cause the applicable number of CVR Shares to be registered in the names of the Holders upon receipt thereof in the manner provided for in Section 3.4 and in accordance with the terms of this Agreement, and each of the Stockholders’ Representative and Parent shall use reasonable efforts to cause the Rights Agent to do so.

Section 5.3      Assignment.

(a)                Except for assignments occurring through operation of law, Parent and the Company shall not, in whole or in part, assign any of their rights or obligations under this Agreement.

Section 5.4      Tax Treatment.

Unless (x) Parent has determined, based on advice from a “Big 4” accounting firm or nationally recognized tax counsel and after consulting with the Stockholders’ Representative in connection with obtaining such advice and making such determination, that the Intended Tax Treatment (as defined below) is not supported by a “more likely than not” or higher standard or (y) reporting in a manner consistent with the Intended Tax Treatment would require that Parent establish a reserve on its financial statements, each of Parent and each Holder shall and shall cause its Affiliates to (i) treat the CVRs as equity for applicable U.S. federal income tax purposes and to treat the settlement of the CVRs for CVR Shares as a recapitalization under Section 368(a)(1)(E) of the Code for U.S. federal income tax purposes (the “Intended Tax Treatment”) and (ii) file U.S federal income tax returns (if any such tax returns are required to be filed) in a manner consistent with the Intended Tax Treatment.

Article VI
AMENDMENTS

Section 6.1      Amendments Without Consent of Holders or Stockholders’ Representative.

(a)                Without the consent of any Holders, Parent, the Stockholders’ Representative (upon written instruction from the Holders holding a majority of the CVRs) and the Rights Agent, at any time and from time to time, may enter into one or more amendments hereto, for any of the following purposes only:

(i)                 to evidence the succession of another Person selected in accordance with Section 4.3(b) as a successor Rights Agent and the assumption by any successor of the covenants and obligations of the Rights Agent herein;

18 

 

(ii)               to evidence the termination of the CVR Registrar and the succession of another Person as a successor CVR Registrar and the assumption by any successor of the obligations of the CVR Registrar herein; or

(iii)             to add, eliminate or change any provisions of this Agreement, even if such addition, elimination or change is in any way adverse to the interests of the Holders; provided, that if such addition, elimination or change is materially adverse to the rights of holders of any other Merger Consideration CVRs, then instruction from the holders of such other Merger Consideration CVRs representing a majority of the Merger Consideration CVR Shares in respect thereof shall also be necessary; provided, further, if such addition, elimination or change adversely affects the rights and obligations of any Holder in a disproportionate manner to the other Holders hereunder, then instruction from each such affected Holder shall also be necessary; or

(iv)             as necessary to ensure that the CVRs are not subject to registration under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

(b)               Any other amendment to this Agreement shall be made by Parent, the Stockholders’ Representative (upon written instruction of each of the Holders of CVRs) and the Rights Agent.

(c)                Promptly after the execution by Parent, Stockholders Representative and the Rights Agent of any amendment pursuant to the provisions of this Section 6.1, Parent shall mail or cause to be mailed a written notice thereof by electronic mail to the Stockholders’ Representative and by first-class mail and electronic mail to the Holders at their addresses as they shall appear on the CVR Register, setting forth in general terms the substance of such amendment.

Section 6.2      Execution of Amendments; Effect of Amendments.

Prior to executing any amendment permitted by this ‎‎‎Article VI, the Rights Agent shall be entitled to receive, and shall be fully protected in relying upon, a certificate from an appropriate officer of Parent or, if requested by the Rights Agent, an opinion of counsel selected by Parent and reasonably acceptable to Rights Agent stating that the execution of such amendment is authorized or permitted by this Agreement. The Rights Agent may, but is not obligated to, enter into any such amendment that affects the Rights Agent’s own rights, privileges, covenants or duties under this Agreement. Upon the execution of any amendment under this Article VI, this Agreement shall be modified in accordance therewith, such amendment shall form a part of this Agreement for all purposes and every Holder shall be bound thereby. No supplement or amendment to this Agreement shall be effective unless duly executed by the Rights Agent, Parent and the Stockholders’ Representative.

19 

 

Article VII
OTHER PROVISIONS OF GENERAL APPLICATION

Section 7.1      Notices to the Rights Agent, Parent and the Stockholders’ Representative.

Any notice, request, instruction or other document to be given hereunder by any party to the others shall be in writing and delivered personally or sent by registered or certified mail, postage prepaid, by electronic mail (except with respect to the Rights Agent), by facsimile transmission only with respect to the Rights Agent or overnight courier, provided that with respect to notices deliverable to the Stockholders’ Representative, such notices shall be delivered solely via electronic mail or facsimile:

If to Parent or the Company:

Eros International Plc

First Names House

Victoria Road

Douglas

Isle of Man IM2 4DF

British Isles

Attention:Mark Carbeck, Chief Corporate and Strategy Officer
Email:mark.carbeck@erosintl.com

with a copy (which shall not constitute notice) to:

Gibson, Dunn & Crutcher LLP
333 South Grand Avenue
Los Angeles, California 90071-3197

Attention:Kevin Masuda
Peter Wardle

Email: kmasuda@gibsondunn.com
pwardle@gibsondunn.com

 

If to the Rights Agent:

Computershare Trust Company, N.A.,

Computershare Inc.

150 Royall Street

Canton, MA 02021

Attention: Client Services

Facsimile: (781) 575-3146

 

If to the Stockholders’ Representative:

Fortis Advisors LLC

Attention: Notices Department (Project World Cup)

Email: notices@fortisrep.com

20 

 

Facsimile: (858) 408-1843

with a copy (which shall not constitute notice) to:

Kirkland & Ellis LLP
555 South Flower Street, Suite 3700
Los Angeles, California 90071
Attention: Rick C. Madden, P.C.
Email: rick.madden@kirkland.com

 

or to such other persons or addresses as may be designated in writing by the party to receive such notice as provided above. Any notice, request, instruction or other document given as provided above shall be deemed given to the receiving party upon actual receipt, if delivered personally; three (3) business days after deposit in the mail, if sent by registered or certified mail; upon confirmation of successful transmission if sent by electronic mail; or on the next business day after deposit with an overnight courier, if sent by an overnight courier.

Section 7.2      Effect of Headings; Construction.

The headings herein are for convenience of reference only, do not constitute part of this Agreement and shall not be deemed to limit or otherwise affect any of the provisions of this Agreement. Where a reference in this Agreement is made to a Section or Exhibit, such reference shall be to a Section of or Exhibit to this Agreement unless otherwise indicated.

Section 7.3      Successors and Assigns.

All covenants and agreements in this Agreement by any party hereto shall bind its successors and permitted assigns, whether so expressed or not.

Section 7.4      Benefits of Agreement.

Nothing in this Agreement, express or implied, shall give to any Person (other than the Holders, the parties hereto and their permitted successors and assigns hereunder) any benefit or any legal or equitable right, remedy or claim under this Agreement or under any covenant or provision herein contained, all such covenants and provisions being for the sole benefit of the Holders, the parties hereto and their permitted successors and assigns. For the avoidance of doubt, the Holders shall be considered express third party beneficiaries of this Agreement.

Section 7.5      Governing Law and Venue; Waiver of Jury Trial.

(a)                THIS AGREEMENT SHALL BE DEEMED TO BE MADE IN AND IN ALL RESPECTS SHALL BE INTERPRETED, CONSTRUED AND GOVERNED BY AND IN ACCORDANCE WITH THE LAW OF THE STATE OF DELAWARE WITHOUT REGARD TO THE CONFLICT OF LAW PRINCIPLES THEREOF THAT WOULD RESULT IN THE APPLICATION OF ANY OTHER JURISDICTION’S LAWS. The parties hereby irrevocably submit to the personal jurisdiction of the courts of the State of Delaware and the federal courts of the United States of America located in the State of Delaware solely in respect of the interpretation and enforcement of the provisions of this Agreement and of the documents

21 

 

referred to in this Agreement, and in respect of the transactions contemplated hereby, and hereby waive, and agree not to assert, as a defense in any action, suit or proceeding for the interpretation or enforcement of this Agreement or of any such document, that it is not subject thereto or that such action, suit or proceeding may not be brought or is not maintainable in said courts or that the venue thereof may not be appropriate or that this Agreement or any such document may not be enforced in or by such courts, and the parties hereto irrevocably agree that all claims relating to such action, proceeding or transactions shall be heard and determined in such a Delaware state or federal court. The parties hereby consent to and grant any such court jurisdiction over the person of such parties and, to the extent permitted by Law, over the subject matter of such dispute and agree that mailing of process or other papers in connection with any such action or proceeding in the manner provided in Section 7.1 or in such other manner as may be permitted by Law shall be valid and sufficient service thereof. If and to the extent that any action, suit or proceeding relates to the rectification of Parent’s register of members or the enforcement of Section 2.1 (“Parent Proceedings”) (but otherwise without prejudice to the provisions of this Section 7.5(a)), each party irrevocably agrees that the courts of the Isle of Man shall have jurisdiction to hear and decide such Parent Proceedings and, for this purpose only, each party irrevocably submits to the jurisdiction of the such courts.

(b)               EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT, OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (i) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (ii) EACH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (iii) EACH PARTY MAKES THIS WAIVER VOLUNTARILY, AND (iv) EACH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS Section 7.5.

Section 7.6      Severability Clause.

The provisions of this Agreement shall be deemed severable and the invalidity or unenforceability of any provision shall not affect the validity or enforceability of the other provisions of this Agreement. If any provision of this Agreement, or the application of such provision to any Person or any circumstance, is invalid or unenforceable, (a) a suitable and equitable provision shall be substituted therefor in order to carry out, so far as may be valid and enforceable, the intent and purpose of such invalid or unenforceable provision and (b) the remainder of this Agreement and the application of such provision to other Persons or circumstances shall not be affected by such invalidity or unenforceability, nor shall such invalidity or unenforceability affect the validity or enforceability of such provision, or the application of such provision, in any other jurisdiction; provided, however, that if an excluded provision shall affect the rights, immunities, liabilities, duties or obligations of the Rights Agent, the Rights Agent shall be entitled to resign immediately written notice to the Parent in accordance with Section 4.2.

22 

 

Section 7.7      Counterparts.

This Agreement may be executed in any number of counterparts, each such counterpart being deemed to be an original instrument, and all such counterparts shall together constitute the same agreement.

Section 7.8      Termination.

This Agreement shall terminate and be of no further force or effect, and the parties hereto shall have no liability hereunder, upon consummation of the issuance and delivery to the Holders of all of the Parent A Shares to which they are entitled pursuant to and in accordance with Section 3.4; provided, Article I, Article IV and this Article VII shall survive.

Section 7.9      Withholding.

Notwithstanding anything to the contrary in this Agreement, Parent, the Rights Agent and their respective agents, shall be entitled to deduct and withhold from any amounts otherwise payable to any Person pursuant to this Agreement such amounts as it is required to deduct and withhold with respect to the making of such payment under the Code or any provision of applicable Tax law; provided, however, that other than in respect of compensatory withholding or backup withholding, withholding as a result of the failure to provide the certificate set forth in Section 6.2(g) of the Merger Agreement or withholding in respect of CVR Income, Parent or the Rights Agent, as applicable, shall use commercially reasonable efforts to provide written notice to the Stockholders’ Representative no later than two (2) Business Days prior to any such withholding or deduction in respect of a Holder and to allow the Holder the opportunity to provide any Tax forms, reports or certificates as may be permitted by Applicable Laws to reduce or eliminate such withholding or deduction. Any amounts so withheld and properly remitted to the applicable Governmental Authority shall be treated for all purposes of this Agreement as having been paid to the Person in respect of which such deduction and withholding was made. In the case of any withholding from any payments not payable in cash, Parent or its agent shall withhold or shall cause to be withheld an amount of such payment having a fair market value equal to the withholding obligation to be satisfied in respect of such payment at the time such amount is withheld (provided that if any cash is otherwise payable to the relevant payee, such withholding shall be made first from such cash), and shall be treated as having paid such amount to the Person in respect of which such amount is withheld.

Section 7.10  Entire Agreement.

This Agreement, the letter agreement between Parent and the Rights Agent of even date herewith regarding fees payable to the Rights Agent (the “Fee Schedule”), and the Merger Agreement represent the entire understanding of Parent, the Company and the Stockholders’ Representative with reference to the CVRs, and, as between such Persons, this Agreement supersedes any and all other oral or written agreements hereto made with respect to the CVRs, except for the Merger Agreement. Notwithstanding the reference to any other document in this Agreement, the Rights Agent shall not be deemed to have knowledge of, or have any duty to

23 

 

ascertain or inquire into, the existence, the content, or the terms and conditions of any other agreement, instrument or document, in each case, to which the Rights Agent is not a party, whether or not such agreement, instrument or document, as the case may be, is referenced in this Agreement. This Agreement and the Fee Schedule represent the entire understanding of the Rights Agent with reference to the CVRs and the performance of the Rights Agent’s duties, its immunities and rights with respect thereto, and with respect to the Rights Agent, this Agreement and the Fee Schedule supersede any and all other oral or written agreements heretofore made with respect to the CVRs. If and to the extent that any provision of this Agreement is inconsistent or conflicts with the Merger Agreement, this Agreement shall govern and be controlling, and this Agreement may be amended, modified, supplemented or altered only in accordance with the terms of Article VII. No party shall be bound by, or be liable for, any alleged representation, promise, inducement or statement of intention not contained herein.

Section 7.11  Force Majeure.

Notwithstanding anything to the contrary contained herein, the Rights Agent shall not be liable for any delays or failures in performance to the extent resulting from acts beyond its reasonable control including, without limitation, acts of God, epidemics, pandemics, terrorist acts, breakdowns, interruptions or malfunctions of any communications or computer facilities, or loss of data due to power failures or mechanical difficulties with information storage or retrieval systems, labor difficulties, war or civil unrest; provided, that the Rights Agent shall use reasonable commercial efforts to resume performance as soon as practicable. If any such act or event occurs, the Rights Agent shall give prompt written notice to Parent and the Stockholders’ Representative, stating the nature of the act or event and action being taken to avoid or minimize its effect.

Section 7.12  Funds.

All funds received by the Rights Agent under this Agreement that are to be distributed or applied by the Rights Agent in the performance of services hereunder (the “Funds”) shall be held by the Rights Agent as agent for Parent and deposited in one or more bank accounts to be maintained by the Rights Agent in its name as agent for Parent. Until paid pursuant to the terms of this Agreement, the Rights Agent will hold the Funds through such accounts in: deposit accounts of commercial banks with Tier 1 capital exceeding $1 billion or with an average rating above investment grade by S&P (LT Local Issuer Credit Rating), Moody’s (Long Term Rating) and Fitch Ratings, Inc. (LT Issuer Default Rating) (each as reported by Bloomberg Finance L.P.). The Rights Agent shall have no responsibility or liability for any diminution of the Funds that may result from any deposit made by the Rights Agent in accordance with this paragraph, including any losses resulting from a default by any bank, financial institution or other third party. The Rights Agent may from time to time receive interest, dividends or other earnings in connection with such deposits. The Rights Agent shall not be obligated to pay such interest, dividends or earnings to the Parent, any Holder or any other Person.

 

[Remainder of Page Intentionally Left Blank.]

24 

 

IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed on its behalf by its duly authorized officers as of the day and year first above written.

EROS INTERNATIONAL PLC


By: ___________________________________________
Name:
Title:

 

[Signature Page to Class D CVR Agreement]

 

 

 

STX FILMWORKS, INC.

 

By: _______________________________
Name:
Title:

[Signature Page to Class D CVR Agreement]

 

 

 

FORTIS ADVISORS LLC

 

By: _______________________________
Name:
Title:

[Signature Page to Class D CVR Agreement]

 

 

 

COMPUTERSHARE TRUST

COMPANY, N.A. AND COMPUTERSHARE INC.

On behalf of both entities

By: ________________________________

Name:
Title:

 

[Signature Page to Class D CVR Agreement]

Exhibit 4.36

 

CLASS C CONTINGENT VALUE RIGHTS AGREEMENT

This CLASS C CONTINGENT VALUE RIGHTS AGREEMENT, dated as of [●], 2020 (this “Agreement”), is entered into by and among Eros International Plc, an Isle of Man company limited by shares (“Parent”), STX Filmworks, Inc., a Delaware corporation (the “Company”), Fortis Advisors LLC, a Delaware limited liability company, solely in its capacity as representative of the former holders of the Shares (in such capacity, the “Stockholders’ Representative”), and Computershare Inc., a Delaware corporation, and its wholly-owned subsidiary, Computershare Trust Company, N.A., a federally chartered trust company, collectively as rights agent (the “Rights Agent”) and as initial CVR Registrar (as defined herein).

WITNESSETH:

WHEREAS, the Company, Parent, England Holdings 2, Inc., a Delaware corporation and indirect wholly-owned Subsidiary of Parent (“England Holdings 2”), England Merger 1 Corp. (f/k/a England Merger Corp.), a Delaware corporation and a direct wholly-owned Subsidiary of England Holdings 2 (“Merger Sub”), have entered into an Agreement and Plan of Merger (as the same may be amended, modified or supplemented from time to time, the “Merger Agreement”), dated as of April 17, 2020, pursuant to which Merger Sub merged with and into the Company (the “Merger”), with the Company surviving the Merger, as an indirect wholly-owned Subsidiary of Parent;

WHEREAS, pursuant to the Merger Agreement, Parent agreed to issue to holders of record of shares of Class C Convertible Preferred Stock, par value $0.01 per share, of the Company (the “Shares”) outstanding immediately prior to the effective time of the Merger (the “Effective Time”), a number of contingent value rights (the “CVRs”) as hereinafter described; and

WHEREAS, each holder of Shares as of immediately prior to the Effective Time, will receive, among other things, as merger consideration, the right to receive upon the Effective Time a number of CVRs in such amount as set forth in Article II of the Merger Agreement.

NOW, THEREFORE, for and in consideration of the premises and the consummation of the transactions referred to above, it is mutually covenanted and agreed, for the equal and proportionate benefit of all Holders (as hereinafter defined), as follows:

Article I
DEFINITIONS

Section 1.1      Definitions.

(a)                For all purposes of this Agreement, except as otherwise expressly provided or unless the context otherwise requires:

(i)                 the terms defined in this Article I have the meanings assigned to them in this Article I, and include the plural as well as the singular;

1 

 

(ii)               the words “herein,” “hereof” and “hereunder” and other words of similar import refer to this Agreement as a whole and not to any particular Article, Section or other subdivision;

(iii)             unless the context otherwise requires, words describing the singular number shall include the plural and vice versa, words denoting any gender shall include all genders and words denoting natural Persons shall include corporations, partnerships and other Persons and vice versa;

(iv)             the term “Affiliate” when used with respect to the Company shall, after the Effective Time, include Parent and its Subsidiaries and Affiliates; and

(v)               all references to “including” shall be deemed to mean including without limitation.

(b)               Capitalized terms used but not otherwise defined herein shall have the meanings ascribed thereto in the Merger Agreement. The following terms shall have the meanings ascribed to them as follows:

Affiliate” means, with respect to any specified Person, (i) any other Person that directly or indirectly through one or more intermediaries controls, or is controlled by, or is under common control with, such specified Person (for the purposes of this definition, “control” (including, with correlative meanings, the terms “controlling,” “controlled by” and “under common control with”), as used with respect to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of such Person, whether through the ownership of voting securities, by agreement or otherwise) and (ii) with respect to any natural person, any Member of the Immediate Family of such natural person. Notwithstanding the foregoing, for purposes hereof, (i) none of the Holders, the Company, or any of their respective Subsidiaries shall be considered Affiliates of any portfolio company (or Subsidiary thereof) in which any Holder or any of its affiliated investment funds have made a debt or equity investment, and (ii) no Holder or any of its Affiliates shall be considered an Affiliate of (a) Parent or any of its Subsidiaries or (b) any other Holders or their respective Affiliates (except to the extent such Holders are otherwise Affiliates under this definition without regard to their status as Holders).

Agreement” has the meaning set forth in the Preamble.

Aggregate CVR Shares” means the aggregate number of underlying Parent A Shares issuable in respect of all CVRs.

Appraisal Shares” has the meaning set forth in Section 4.2(h).

Available Class C Merger Consideration CVR Shares” means the Merger Consideration CVR Share Cap minus the Parent A Shares issued to the Class E CVRs and the Class D CVRs.

Base Price” means $2.60.

2 

 

Change of Control Transaction” means the occurrence of (i) an acquisition by any Person, including any syndicate or group deemed to be a “person” under Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, of beneficial ownership, directly or indirectly, through purchase, merger or other acquisition transaction or series of purchases, mergers or other acquisition transactions of shares or comparable equity interests of Parent entitling that Person to fifty percent (50%) or more of the total voting power of all such shares or comparable equity interests of Parent; or (ii) the consolidation or merger of Parent with or into any other Person, any merger of another Person into Parent, or any conveyance, transfer, sale, lease or other disposition of all or substantially all of Parent’s properties, business or assets, other than (in the case of this clause (ii) only) (1) any transaction (x) that does not result in any reclassification, conversion, exchange or cancellation of outstanding shares or comparable equity interests of Parent, and (y) pursuant to which holders of Parent’s shares or comparable equity interest immediately prior to such transaction have the right to exercise, directly or indirectly, fifty percent (50%) or more of the total voting power of all shares or comparable equity interest of the continuing or surviving Person immediately after such transaction, or (2) any merger solely for the purpose of changing Parent’s jurisdiction of formation and resulting in a reclassification, conversion or exchange of outstanding shares or comparable equity interests into shares or comparable equity interest of the surviving entity with substantially identical rights.

Class A CVR” means the contingent value rights issued by Parent with respect to the Class A Convertible Preferred Stock, par value $0.01 of the Company, pursuant to the Merger Agreement and the Class A CVR Agreement.

Class A CVR Agreement” means the Class A CVR Agreement, dated as of the date hereof, by and among Parent, the Company, the stockholders’ representative thereunder and the rights agent thereunder.

Class A CVR Shares” means the underlying Parent A Shares issuable in respect of the Class A CVRs.

Class B CVR” means the contingent value rights issued by Parent with respect to the Class B Convertible Preferred Stock, par value $0.01 of the Company, pursuant to the Merger Agreement and the Class B CVR Agreement.

Class B CVR Agreement” means the Class B CVR Agreement, dated as of the date hereof, by and among Parent, the Company, the stockholders’ representative thereunder and the rights agent thereunder.

Class B CVR Shares” means the underlying Parent A Shares issuable in respect of the Class B CVRs.

Class D CVR” means the contingent value rights issued by Parent with respect to the Class D Convertible Preferred Stock, par value $0.01 of the Company, pursuant to the Merger Agreement and the Class D CVR Agreement.

Class D CVR Agreement” means the Class D CVR Agreement, dated as of the date hereof, by and among Parent, the Company, the stockholders’ representative thereunder and the rights agent thereunder.

3 

 

Class D CVR Shares” means the underlying Parent A Shares issuable in respect of the Class D CVRs.

Class E CVR” means the contingent value rights issued by Parent with respect to the Class E Convertible Preferred Stock, par value $0.01 of the Company, pursuant to the Merger Agreement and the Class E CVR Agreement.

Class E CVR Agreement” means the Class E CVR Agreement, dated as of the date hereof, by and among Parent, the Company, the stockholders’ representative thereunder and the rights agent thereunder.

Class E CVR Shares” means the underlying Parent A Shares issuable in respect of the Class E CVRs.

Code” means the Internal Revenue Code of 1986, as amended from time to time.

Company” has the meaning set forth in the Preamble.

CVR” means a contingent value right issued by Parent with respect to the Shares, pursuant to the Merger Agreement and this Agreement.

CVR Shares” has the meaning set forth in Section 3.4(b).

CVR Register” has the meaning set forth in Section 3.3(b).

CVR Registrar” has the meaning set forth in Section 3.3(b).

Effective Time” has the meaning set forth in the Recitals.

Eros Pre-Closing Equity Financing” has the meaning ascribed in the PIPE Agreement.

Final Settlement Time” has the meaning set forth in Section 3.2(b).

Funds” has the meaning set forth in Section 7.12.

Fully Diluted Parent Shares” means, as of immediately prior to the Effective Time, the sum of (without duplication) (i) the aggregate number of Parent Ordinary Shares then outstanding, plus (ii) the aggregate number of Parent Ordinary Shares subject to issuance pursuant to then outstanding In-the-Money Parent Options (whether or not vested), plus (iii) the aggregate number of Parent Ordinary Shares subject to issuance pursuant to then outstanding Parent RSU Awards (whether or not vested), plus (iv) the aggregate number of Parent Ordinary Shares then subject to issuance pursuant to the Parent Convertible Notes assuming full conversion thereof at a conversion price of $2.60; provided, however, that, notwithstanding the foregoing, Fully Diluted Parent Shares shall not include any Parent Ordinary Shares issuable pursuant to the Eros Pre-Closing Equity Financing. For the avoidance of doubt, Fully Diluted Parent Shares shall be calculated prior to, and without giving effect to, the PIPE Investment.

Holder” means a Person in whose name a CVR is registered in the CVR Register.

4 

 

In-the-Money Parent Options” means an Eros Option (as defined in the Merger Agreement) having a per Parent Ordinary Share exercise price less than the Parent Trading Price.

Investors’ Rights Agreement” means the Investors’ Rights Agreement, entered into on or around the date hereof, by and among Parent, certain shareholders of Parent and the investors party thereto.

Law” with respect to any Person, means (a) all provisions of all laws, statutes, ordinances, rules, regulations, permits, certificates or orders of any governmental authority applicable to such Person or any of its assets or property or to which such Person or any of its assets or property is subject, and (b) all judgments, injunctions, orders and decrees of all courts and arbitrators in proceedings or actions in which such Person is a party or by which it or any of its assets or properties is or may be bound or subject.

Lock-Up Agreement” has the meaning set forth in Section 3.4(c).

Members of the Immediate Family” means, with respect to any individual, each spouse or child or other descendants of such individual, each trust created solely for the benefit of one or more of the aforementioned Persons and their spouses and each custodian or guardian of any property of one or more of the aforementioned Persons in his capacity as such custodian or guardian.

Merger” has the meaning set forth in the Recitals.

Merger Agreement” has the meaning set forth in the Recitals.

Merger Consideration CVRs” means the CVRs, the Class E CVRs, the Class D CVRs, the Class B CVRs and the Class A CVRs.

Merger Consideration CVR Share Cap” means a number of Parent A Shares equal to the Fully Diluted Parent Shares.

Merger Consideration CVR Shares” means the Aggregate CVR Shares, the Class E CVR Shares, the Class D CVR Shares, the Class B CVR Shares and the Class A CVR Shares.

Merger Sub” has the meaning set forth in the Recitals.

Organizational Documents” has the meaning set forth in Section 2.1(a).

Parent” has the meaning set forth in the Preamble.

Parent A Shares” means the A Ordinary Shares, par value £0.30 per share, of Parent.

Parent B Shares” means the B Ordinary Shares, par value £0.30 per share, of Parent.

Parent Convertible Notes” means Parent’s Senior Convertible Notes due September 27, 2020 in the original aggregate principal amount of $27,500,000.

Parent Option” means a compensatory option to purchase Parent Ordinary Shares.

5 

 

Parent Ordinary Shares” means, collectively, the Parent A Shares and the Parent B Shares.

Parent Proceedings” has the meaning set forth in Section 7.5(a).

Parent RSU Award” means an award of restricted stock units relating to Parent Ordinary Shares.

Parent Trading Price” means the VWAP for one Parent A Share for the twenty (20) consecutive full Trading Days ending on the full Trading Day immediately preceding the Effective Time (as adjusted as appropriate to reflect any stock splits, stock dividends, combinations, reorganizations, classifications or similar events).

Permitted Transfer” means: (i) the transfer (upon the death of the Holder) by will or intestacy; (ii) transfer by instrument to an inter vivos or testamentary trust in which the CVRs are to be passed to beneficiaries upon the death of the trustee; (iii) transfers made pursuant to a court order of a court of competent jurisdiction (such as in connection with divorce, bankruptcy or liquidation); (iv) if the Holder is a partnership or limited liability company, a distribution by the transferring partnership or limited liability company to its partners or members, as applicable; (v) a transfer made by operation of law (including a consolidation or merger) or in connection with the dissolution, liquidation or termination of any corporation, limited liability company, partnership or other entity; or (vi) a transfer by any Holder to one or more of its Affiliates or affiliated investment funds of any of its Affiliates.

Permitted Transferee” means a Person who receives a CVR pursuant to a Permitted Transfer and otherwise in accordance with this Agreement.

Person” means any individual, corporation (including not-for-profit), general or limited partnership, limited liability company, joint venture, estate, trust, association, organization, Governmental Authority or other entity of any kind or nature.

PIPE Agreement” means that certain Subscription Agreement, made as of April 17, 2020, by and among Parent and each Person defined therein as a “Purchaser.”

PIPE Investment” means the purchase of Parent A Shares pursuant to the PIPE Agreement.

PIPE Lock-Up Agreement” has the meaning set forth in Section 3.4(c).

Pre-Closing VWAP” means the VWAP of the Parent A Shares for the 10 Trading Days ending on the end of the Trading Day immediately preceding the Closing.

Pre-Settlement VWAP” means the VWAP of the Parent A Shares for the 10 Trading Days ending on the end of the Trading Day immediately preceding the Settlement Date; provided, that for purposes of determining the CVR Shares issuable as of any time prior to the Settlement Date, the reference to “the Trading Day immediately preceding the Settlement Date” in this definition shall be deemed a reference to “the Trading Day immediately preceding the applicable time of determination”.

6 

 

Reference Price” means a price per share equal to the lesser of (x) the Pre-Settlement VWAP and (y) the Upper Collar Price; provided, that if the Pre-Settlement VWAP is equal to or greater than $4, then the Reference Price will equal the average of the Pre-Settlement VWAP and the Upper Collar Price.

Rights Agent” means the Rights Agent named in the first paragraph of this Agreement, until a successor Rights Agent shall have become such pursuant to the applicable provisions of this Agreement, and thereafter “Rights Agent” shall mean such successor Rights Agent.

Settlement Date” shall mean the date that is the earlier to occur of (a) the later to occur of (i) the first time that the Merger Consideration CVR Shares have been registered for resale pursuant to an effective registration statement under the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder, and (ii) the 75th calendar day after the Closing and (b) the occurrence of the Settlement Outside Date.

Settlement Outside Date” means the date that is six (6) months after the Closing; provided that the Settlement Outside Date may be extended (but only once) by holders of a majority of the Class E CVRs; provided, further, that such majority must include each such holder that, together with its Affiliates, purchased $15 million or more of Parent A Shares in the PIPE Investment.

Shares” has the meaning set forth in the Recitals.

Stockholders’ Representative” has the meaning set forth in the Preamble.

STX Purchase Price” means the lowest of (i) the Base Price, (ii) the volume weighted average of the purchase price of all purchases comprising the Eros Pre-Closing Equity Financing and (iii) the Pre-Closing VWAP; provided, however, that if the Pre-Closing VWAP is greater than $3.25, then the STX Purchase Price shall be the average of the Base Price and the Pre-Closing VWAP.

Subsidiary” of any Person shall mean any corporation or other entity of which securities or other ownership interests having ordinary voting power sufficient to elect a majority of the board of directors or comparable governing body are beneficially owned, directly or indirectly, by such Person, and any corporation or other entity that is otherwise controlled by such Person.

Taxes” or “Tax” means all taxes, charges, fees, levies or other assessments in the nature of a tax imposed by any governmental authority, including any income, gross receipts, license, severance, occupation, premium, environmental (including taxes under former Code Section 59A), customs, duties, profits, disability, alternative or add-on minimum, estimated, withholding, payroll, employment, unemployment insurance, social security (or similar), excise, sales, use, value-added, occupancy, franchise, real property, personal property, business and occupation, mercantile, windfall profits, capital stock, stamp, transfer, workmen’s compensation, amounts due under any applicable laws governing escheat or unclaimed property or other taxes, charges, fees, levies or other assessments in the nature of a tax, together with any interest, penalties, additions to tax or additional amounts imposed by any Governmental Authority with respect thereto, whether disputed or not.

7 

 

Trading Day” means, with respect to any referenced security, any day on which such security is actually traded on the principal securities exchange or securities market on which such security is then listed.

Upper Collar Price” means the quotient of the STX Purchase Price, divided by one and one-half (1.5).

VWAP” means, for any security as of any date(s), the dollar volume-weighted average price for such security on the principal securities exchange or securities market on which such security is then listed during the period beginning at 9:30:01 a.m., New York time, and ending at 4:00:00 p.m., New York time, as reported by Bloomberg through its “HP” function (sets to weighted average) or, if the foregoing does not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the electronic bulletin board for such security during the period beginning at 9:30:01 a.m., New York time, and ending at 4:00:00 p.m., New York time, as reported by Bloomberg, or, if no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the highest closing bid price and the lowest closing ask price of any of the market makers for such security as reported by OTC Markets Group Inc. If the VWAP cannot be calculated for such security on such date(s) on any of the foregoing bases, the VWAP of such security on such date(s) shall be the fair market value thereof on such date(s) as reasonably determined by a nationally recognized independent investment banking firm mutually agreed between Parent and the Stockholders’ Representative.

Article II
OPERATION OF PARENT

Section 2.1      Operation of Parent.

From the Effective Time until the Settlement Date, Parent shall not, and shall cause its Subsidiaries and Affiliates not to:

(a)                after the effectiveness of the Amended Articles (as defined in the Investors’ Rights Agreement), effect any action that requires approval by the shareholders of Parent under Parent’s Memorandum of Association or Articles of Association (the “Organizational Documents”) or applicable Law; or

(b)               prior to the effectiveness of Amended Articles, take any action set forth in Section 4.3(c) of the Investors’ Rights Agreement as in effect on the date hereof,

without, in each such case, obtaining the consent thereto of holders of such class and number of Merger Consideration CVRs (including the CVRs hereunder) that, together with the shares of Parent actually voted (at a meeting or by resolution) with respect to such action and assuming all Merger Consideration CVR Shares were outstanding Parent A Shares and voted, would be required to approve such action under the Organizational Documents, applicable Law or Section 4.3(c) of the Investors’ Rights Agreement, as applicable. For purposes of the foregoing consent rights, the number of Merger Consideration CVR Shares underlying the Merger Consideration CVRs as of any time prior to the Settlement Date shall be calculated as set forth below in Article III and in Article III of the Class E CVR Agreement with respect to the Class E CVRs, Article III of the Class D CVR Agreement with respect to the Class D CVRs, Article III of the Class B CVR Agreement with respect to the Class B CVRs and Article III of the Class A CVR Agreement with respect to the Class A CVRs.

8 

 

Article III
CVRS

Section 3.1      Issuance of CVRs; Appointment of Rights Agent; Reservation of Shares.

(a)                The CVRs shall be issued pursuant to the Merger Agreement at the time and in the manner set forth in the Merger Agreement. The registration on the books and records of Parent and administration of the CVRs shall be handled pursuant to this Agreement in the manner set forth in this Agreement.

(b)               Parent hereby appoints the Rights Agent to act as rights agent for the CVRs in accordance with the instructions hereinafter set forth in this Agreement, and the Rights Agent hereby accepts such appointment.

(c)                From the date hereof until the issuance of the Aggregate CVR Shares in accordance with the terms hereof, Parent shall reserve and keep available out of its authorized but unissued share capital, for the purpose of effecting the issuance of the CVR Shares hereunder, a number of Parent A Shares equal to the Merger Consideration CVR Share Cap, minus the number of CVR Shares, if any, previously issued in accordance with the terms of this Agreement; and if at any time during such period the number of authorized but unissued Parent A Shares shall not be sufficient to effect the issuance of the Aggregate CVR Shares in full, Parent shall take all such action as may be necessary to increase its authorized but unissued share capital as shall be sufficient for such purposes.

Section 3.2      Nontransferable; Expiration.

(a)                The CVRs shall not be sold, assigned, transferred, pledged, encumbered or in any other manner transferred or disposed of, in whole or in part, other than to a Permitted Transferee. Any purported transfer of a CVR to anyone other than a Permitted Transferee shall be null and void ab initio.

(b)               Subject to Section 3.4(c), the CVRs shall expire on the Settlement Date upon the registration of the CVR Shares in the respective names of the Holders entitled thereto and shall thereafter be of no force or effect following such registration; provided that, if any CVR Shares are not so registered on the Settlement Date, then the CVRs in respect thereof shall not expire until the registration of such CVR Shares in the respective names of the Holders entitled thereto (the time of registration thereof, the “Final Settlement Time”).

Section 3.3      No Certificate; Registration; Registration of Transfer; Change of Address.

(a)                The CVRs shall not be evidenced by a certificate or other instrument.

9 

 

(b)               Upon receipt from Parent of the names and addresses of each Holder and the number of CVRs held by such Holder, the Rights Agent shall keep a register (the “CVR Register”) for the registration of CVRs in a book-entry position for each Holder of a CVR. The CVR Register shall set forth the name and address of each Holder, and the number of CVRs held by such Holder and Tax Identification Number of each Holder. Each of Parent and the Stockholders’ Representative may receive and inspect a copy of the CVR Register, from time to time, upon written request made to the CVR Registrar. Within five (5) Business Days after receipt of such request, the CVR Registrar shall deliver a copy of the CVR Register, as then in effect, to Parent and the Stockholders’ Representative at the address set forth in Section 7.1. The Rights Agent is hereby initially appointed “CVR Registrar” for the purpose of registering CVRs and transfers of CVRs as herein provided.

(c)                Subject to the restrictions set forth in Section 3.2, every request made to transfer a CVR must be in writing and accompanied by a written instrument or instruments of transfer and any other reasonably requested documentation in form reasonably satisfactory to Parent and the CVR Registrar, duly executed by the registered Holder or Holders thereof or by the duly appointed legal representative thereof or by a duly authorized attorney. A request for a transfer of a CVR shall be accompanied by documentation establishing that the transfer is to a Permitted Transferee and shall thereafter be supplemented with and any other information as may be reasonably requested by Parent or the CVR Registrar (including opinions of counsel, if appropriate). Upon receipt of such written notice, the CVR Registrar shall, subject to its reasonable determination that the transfer instrument is in proper form and the transfer otherwise complies with the other terms and conditions herein on its face, without investigation or inquiry by the Rights Agent, register the transfer of the CVRs in the CVR Register. All duly transferred CVRs registered in the CVR Register shall be the valid obligations of Parent, evidencing the same rights and entitling the transferee to the same benefits and rights under this Agreement as those held by the transferor immediately prior to such transfer. No transfer of a CVR shall be valid until registered in the CVR Register, and any transfer not duly registered in the CVR Register will be void ab initio (unless the transfer was permissible hereunder and such failure to be duly registered is attributable to the fault of the CVR Registrar). Any transfer or assignment of the CVRs shall be without charge by Parent or the CVR Registrar (other than the cost of any Tax which shall be the responsibility of the transferor) to the Holder.

(d)               A Holder may make a written request to the CVR Registrar to change such Holder’s address of record in the CVR Register. The written request must be duly executed by the Holder and accompanied by such other evidence of the Holder’s identity or interest in the CVR as reasonably requested by the Rights Agent. Upon receipt of such written notice, the CVR Registrar is hereby authorized to, and shall promptly, record the change of address in the CVR Register.

(e)                The Stockholders’ Representative may make a written request to the Rights Agent for a list containing the names, addresses and number of CVRs of the Holders that are registered in the CVR Register. Within five (5) Business Days following the date of receipt by the Rights Agent of such request, the CVR Registrar shall deliver a copy of such list to the Stockholders’ Representative.

Section 3.4      Issuance Procedures.

10 

 

(a)                On the Settlement Date, Parent shall issue, and cause to be deposited with the Rights Agent, a number of Parent A Shares equal to the Aggregate CVR Shares. On the Settlement Date or as promptly as practicable thereafter, subject to Section 3.4(c) below, the Rights Agent shall cause the applicable number of CVR Shares to be registered in the name of each of the Holders as reflected in the CVR Register as of the close of business on the last Business Day prior to such issuance date.

(b)               The number of Parent A Shares issued in respect of each CVR from the Available Class C Merger Consideration CVR Shares (the “CVR Shares”) shall be equal to the quotient obtained by dividing $1,000 by the Reference Price; provided, that the number of Parent A Shares allocated to the CVRs shall be pro-rated in the event there are insufficient Available Class C Merger Consideration CVR Shares remaining for allocation to the CVRs. For all purposes above, fractional CVRs shall represent a proportionate number of CVR Shares; provided, however, that no fractional Parent A Shares (or certificate or scrip representing the same) shall be issued upon the settlement of any CVRs hereunder. Notwithstanding any other provision of this Agreement, each Holder of CVRs who would otherwise have been entitled to receive a fraction of a Parent A Share upon settlement of such Holder’s CVRs hereunder (after aggregating all CVRs of such Holder that are subject to this Agreement) shall receive, in lieu thereof, an amount of cash (rounded to the nearest whole cent), without interest, equal to such fractional amount multiplied by the Reference Price. Whenever a payment for fractional Parent A Shares or fractional shares is to be made by the Rights Agent under any section of this Agreement, Parent shall (i) promptly deliver to the Rights Agent a certificate setting forth the amount of any such payment and calculation related thereto and (ii) cash in the amount of such payment to the Rights Agent by wire transfer of immediately available funds to make such payment to the applicable Holder by check mailed to such Holder as reflected in the CVR Register or by wire transfer of immediately available funds. The Rights Agent shall not be liable to any Holder or Parent for the amount of any cash payment made to such Holder on behalf of Parent in accordance with the amount set forth in such certificate.

(c)                Parent’s obligation to issue and cause to be deposited with the Rights Agent the applicable number of CVR Shares, and the Rights Agent’s obligation to cause the applicable number of CVR Shares to be registered in the name of a Holder upon receipt of the applicable number of CVR Shares shall be conditioned on the execution and delivery by such Holder of a lockup agreement with Parent, substantially in the form attached hereto as Exhibit A (a “Lock-Up Agreement”); provided, however, that the Rights Agent’s obligation to cause the applicable number of CVR Shares to be registered in the name of a Holder upon receipt of the applicable number of CVR Shares to a Holder shall not be conditioned on the execution and delivery by such Holder of a Lock-Up Agreement if (i) such Holder or any of its Affiliates shall have entered into a lockup agreement with Parent in connection with the PIPE Investment (such lockup agreement, a “PIPE Lock-Up Agreement”) or (ii) the Settlement Date is the Settlement Outside Date and the Merger consideration CVR Shares have not been, as of such date, registered for resale pursuant to an effective registration statement under the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder; provided, further, that Rights Agent shall have no duty to act without the written instruction of Parent with respect to the foregoing.

11 

 

(d)               Without limiting the other provisions of this Agreement, if at any time during the period between the execution of this Agreement and the Settlement Date (or if applicable, the Final Settlement Time), any change in the number or type of outstanding Parent A Shares shall occur as a result of a reclassification, recapitalization, exchange, stock split (including a reverse stock split), combination or readjustment of capital stock, shares or any stock dividend or stock distribution with a record date during such period (including any such reclassification, recapitalization, exchange, stock split, combination or readjustment of capital stock, shares or any stock dividend or stock distribution in connection with a consolidation, merger or combination in which Parent is the continuing or surviving corporation), the CVR Shares and any other similarly dependent items, as the case may be, shall be appropriately equitably adjusted to provide the same economic effect as contemplated by this Agreement prior to such event; provided that nothing in this Section 3.4(d) shall be construed to permit any party to take any action that is otherwise prohibited or restricted by any other provision of this Agreement.

(e)                If, at any time prior to the Settlement Date (or, if applicable, the Final Settlement Time) Parent effects any Change of Control Transaction, then, upon any Settlement Date, each Holder shall have the right to receive, on the Settlement Date, for each CVR Share that would have been issuable upon the Settlement Date the same consideration (in the same amount and form) per Parent A Share payable to the holders thereof in such Change of Control Transaction. For purposes hereof, the determination of Pre-Settlement VWAP shall be appropriately adjusted to refer to such consideration instead of Parent A Shares. If holders of Parent A Shares are given any right of election as to the securities, cash or property to be received in such Change of Control Transaction, then each Holder shall be given the same right of election. To the extent necessary to effectuate the foregoing provisions, Parent shall ensure that any successor to Parent or the surviving entity in such Change of Control Transaction shall agree to be bound by the terms of this Agreement. In the event that the Final Settlement Time occurs after the Settlement Date, references herein to Settlement Date shall mean as promptly as practicable following the Change of Control Transaction.

Section 3.5      CVR Rights

(a)                Subject to Section 2.1, except as provided in Section 3.5(b), the CVRs shall not have any voting rights and shall not represent any equity or ownership interest in Parent, in any constituent company to the Merger, any Affiliate of Parent or any other Person.

(b)               The CVRs shall entitle each Holder, at the Settlement Date and subject to any applicable withholding Taxes, to a payment per Parent A Share issued thereunder, without interest, equal (as to both amount and form of consideration) to all dividends or other distributions of any kind declared per Parent A Share of the CVR Shares with a record date after the Closing and prior to the Settlement Date. Any dividends or other distributions of any kind made in respect of the CVR Shares will be delivered promptly to the Rights Agent to be held in escrow with respect to the CVRs (the “CVR Income”) treating the CVR Shares for this purpose as if the Aggregate CVR Shares were then outstanding. On the Settlement Date, the Rights Agent shall deliver to each Holder, concurrent with the issuance to such Holder of the applicable CVR Shares, the CVR Income earned in respect of each such CVR Share, less any applicable withholding Taxes.

12 

 

Article IV
THE RIGHTS AGENT

Section 4.1      Certain Duties and Responsibilities.

The Rights Agent shall not have any liability for any actions taken or not taken by the Rights Agent in connection with the execution, acceptance, administration, exercise and performance of its duties under this Agreement, except to the extent of its willful misconduct, bad faith or gross negligence (in each case as determined by a final, non-appealable judgment of a court of competent jurisdiction). No provision of this Agreement shall require the Rights Agent to expend or risk its own funds or otherwise incur any financial liability in the performance of any of its duties hereunder or in the exercise of any of its rights or powers.

Section 4.2      Certain Rights of Rights Agent.

The Rights Agent undertakes to perform such duties and only such duties as are specifically set forth in this Agreement, and no implied covenants or obligations shall be read into this Agreement against the Rights Agent. In addition:

(a)                the Rights Agent may rely and shall be protected and held harmless by Parent in and shall not incur any liability in acting or refraining from acting in connection with its performance under this Agreement upon any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order or other paper or document reasonably believed by it to be genuine and to have been signed or presented by the proper party or parties, except to the extent of its willful misconduct, bad faith or gross negligence (in each case as determined by a final, non-appealable judgment of a court of competent jurisdiction);

(b)               the Rights Agent may consult with legal counsel selected by it, and the Rights Agent shall incur no liability for or in respect of any action taken, suffered or omitted to be taken by it in the absence of bad faith, gross negligence or willful misconduct and in accordance with such advice or opinion. The reasonable costs of such counsel’s services shall be paid to the Rights Agent in accordance with Section 4.2(g) below. The Rights Agent may perform any and all of its duties through its agents, representatives, custodians and/or nominees and the Rights Agent shall not be answerable or accountable for any act, omission, default, neglect or misconduct of any such agents, representatives, custodians and/or nominees or for any loss to Parent or the Company, to the Holders or any other Person resulting from any such act, omission, default, neglect or misconduct, absent gross negligence, willful misconduct or bad faith on the part of the Rights Agent, such agents, representatives, custodians and/or nominees (which gross negligence, willful misconduct or bad faith must be determined by a final, non-appealable judgment of a court of competent jurisdiction);

(c)                if the Rights Agent becomes involved in litigation on account of this Agreement, it shall have the right to retain counsel and shall be entitled to reimbursement for all reasonable and documented out-of-pocket costs and expenses related thereto as provided in this Section 4.2(c) and Section 4.2(g) hereof; provided, however, that the Rights Agent shall not be entitled to any such reimbursement to the extent such litigation ultimately determines that the Rights Agent acted with willful misconduct, bad faith or gross negligence. In the event that conflicting demands are made upon the Rights Agent for any situation addressed or not addressed in this Agreement, the Rights Agent may withhold performance of the terms of this Agreement until such time as said conflicting demands shall have been withdrawn or the rights of the respective parties shall have been settled by court adjudication, arbitration, joint order or otherwise;

13 

 

(d)               the permissive rights of the Rights Agent to do things enumerated in this Agreement shall not be construed as a duty;

(e)                the Rights Agent shall not be required to give any note or surety in respect of the execution of such powers or otherwise in respect of the premises;

(f)                Parent agrees to indemnify the Rights Agent for, and hold the Rights Agent harmless against, any loss, liability, claim, demands, suits or expense arising out of or in connection with the Rights Agent’s duties under this Agreement, including the costs and expenses of defending the Rights Agent against any claims, charges, demands, suits or loss, unless such loss shall have been determined by a court of competent jurisdiction to be a result of the Rights Agent’s willful misconduct, bad faith or gross negligence (in each case as determined by a court of competent jurisdiction); provided, however, that the Rights Agent’s aggregate liability with respect to, arising from, or arising in connection with this Agreement, or from all services provided or omitted to be provided under this Agreement, whether in contract, in tort, or otherwise, is limited to, and shall not exceed, the amounts paid hereunder by Parent to the Rights Agent as fees and charges (but not including reimbursable expenses) in the 12 months preceding the event for which recovery is sought. The provisions under this Section 4.2 and Section 4.1 above shall survive the settlement of the CVRs and the termination of this Agreement and the resignation, replacement or removal of the Rights Agent. To the extent the Rights Agent is entitled to indemnification hereunder, the reasonable and documented out-of-pocket costs and expenses of the Rights Agent incurred in enforcing this right of indemnification shall be paid by Parent;

(g)               Parent agrees to pay to the Rights Agent reasonable compensation for all services rendered by it hereunder in accordance with a fee schedule to be mutually agreed upon in writing between Parent and the Rights Agent and, from time to time, to reimburse the Rights Agent for all of its reasonable, customary and documented out-of-pocket expenses (including reasonable fees and expenses of the Rights Agent’s counsel) and other disbursements incurred in the preparation, delivery, negotiation, amendment, administration and execution of this Agreement and the exercise and performance of its duties hereunder. Without limiting any of its rights to compensation or reimbursement under this Agreement, the Rights Agent shall deliver to Parent the final invoice for the Rights Agent fees and costs (which shall include a reasonable estimate of all remaining fees and expenses) at a reasonable time prior to the date of delivery of the CVR Shares. An invoice for any reasonable and documented out-of-pocket expenses and per item fees realized will be rendered and payable as mutually agreed upon in writing between Parent and the Rights Agent. For the avoidance of doubt, and notwithstanding anything to the contrary herein, in no event shall Parent be required to indemnify or otherwise reimburse the Rights Agent for any income or similar taxes of the Rights Agent (or an of its Affiliates) in connection with the performance of its duties hereunder;

14 

 

(h)               For avoidance of doubt, no CVRs shall be issued in respect of any shares of capital stock of the Company as to which the holder thereof as of immediately prior to the Effective Time properly demands appraisal in accordance with, and who complies in all respects with, Section 262 of the Delaware General Corporation Law (such shares, “Appraisal Shares” and such statutory section, “Section 262”); provided, however, that notwithstanding the foregoing, (i) the CVRs that would have been issuable in respect of Appraisal Shares but for their status as such shall be deemed to be outstanding for purposes of determining the number of CVR Shares to be issued per CVR and (ii) if any holder of Appraisal Shares shall fail to perfect or otherwise waive, withdraw or lose the right to appraisal under Section 262 with respect to any Appraisal Shares (whether before or after the Settlement Date), then the CVRs issuable in respect of such Appraisal Shares shall be deemed to have been issued to such holder as of the Effective Time and to entitle such holder to all rights of a Holder hereunder with respect thereto, including the right to receive the CVR Shares and CVR Income in respect thereof upon the Settlement Date in accordance with the other provisions of this Agreement;

(i)                 whenever the Rights Agent shall reasonably require that a matter be proved or established prior to taking, suffering or omitting any action hereunder, the Rights Agent may rely upon a signed certificate from an authorized officer of Parent, and the Rights Agent shall incur no liability and be held harmless by Parent for or in respect of any action taken, suffered or omitted to be taken by it under the provisions of this Agreement in reliance upon and in accordance with such certificate;

(j)                 the permissive rights of the Rights Agent to do things enumerated in this Agreement shall not be construed as a duty;

(k)               the Rights Agent shall not be required to give any note or surety in respect of the execution of its powers hereunder or otherwise in respect of the premises;

(l)                 the Rights Agent shall not be liable for or by reason of, and shall be held harmless by Parent with respect to any of the statements of fact or recitals contained in this Agreement or any certificate delivered by Parent under this Agreement and shall not be required to verify the same, but all such statements and recitals are and shall be deemed to have been made by Parent only;

(m)             the Rights Agent shall have no liability and shall be held harmless by Parent in respect of the validity of this Agreement or the execution and delivery hereof (except the due execution and delivery hereof by the Rights Agent and the enforceability of this Agreement against the Rights Agent assuming the due execution and delivery hereof by the other parties hereto), nor shall it be responsible for any breach by Parent of any covenant or condition contained in this Agreement;

(n)               anything to the contrary notwithstanding, the Rights Agent shall not be liable for any special, punitive, consequential, indirect or incidental loss or damage of any kind whatsoever (including lost profits) arising out of any act or failure to act hereunder, even if the Rights Agent has been advised of the likelihood of such loss or damage or has foreseen the possibility or likelihood of such damages;

15 

 

(o)               the Rights Agent shall not be deemed to have knowledge of any event of which it was required to receive notice from Parent or the Stockholders’ Representative hereunder and did not receive such notice, and the Rights Agent shall be fully protected and shall incur no liability for failing to take action in connection therewith, unless and until it has received such required notice in writing;

(p)               the Rights Agent and any affiliate of the Rights Agent may buy, sell or deal in any of securities of Parent or the Company or become pecuniarily interested in any transaction in which Parent or the Company may be interested, or contract with or lend money to Parent or the Company or otherwise act as fully and freely as though it were not Rights Agent under this Agreement, subject to applicable Law (including applicable securities Laws). Nothing herein shall preclude the Rights Agent from acting in any other capacity for Parent or the Company or for any other legal entity;

(q)               the Rights Agent shall act hereunder solely as agent for Parent and it shall not assume any obligations or relationship of agency or trust with any of the Holders or any other Person;

(r)                 the Rights Agent shall not be deemed to have knowledge of a change in authorized officers or duly authorized representatives of any Person without notice of such change, and the Rights Agent shall be fully protected and shall incur no liability for failing to take action in connection therewith, unless and until it has received such notice in writing;

(s)                the Rights Agent shall not have any duty or responsibility in the case of the receipt of any written demand from any Holder with respect to any action or default by Parent, including, without limiting the generality of the foregoing, any duty or responsibility to initiate or attempt to initiate any proceedings at law or otherwise or to make any demand upon Parent; and

(t)                 the Rights Agent shall have no duty or obligation under any Section of this Agreement that requires the payment of taxes or charges by the Parent or Holder in connection with the Rights Agent’s performance of such duty or obligation, unless and until the Rights Agent is reasonably satisfied that all such taxes and/or charges have been paid.

Section 4.3      Resignation and Removal; Appointment of Successor.

(a)                The Rights Agent may resign at any time by giving written notice thereof to Parent and the Stockholders’ Representative specifying a date when such resignation shall take effect, which notice shall be sent at least thirty (30) days’ prior to the date so specified. In the event any transfer agency relationship in effect between the Parent and the Rights Agent terminates, the Rights Agent will be deemed to have resigned automatically and be discharged from its duties under this Agreement as of the effective date of such termination. Parent may terminate the Rights Agent at any time by giving written notice thereof to the Rights Agent and the Stockholders’ Representative specifying a date when such termination shall take effect, which notice shall be sent at least thirty (30) days prior to the date so specified.

(b)               If the Rights Agent shall resign, be removed or become incapable of acting, Parent and the Stockholders’ Representative shall promptly appoint a qualified successor Rights Agent. The successor Rights Agent so appointed shall, forthwith upon its acceptance of such appointment in accordance with this Section 4.3(b), become the successor Rights Agent.

16 

 

(c)                Parent shall give notice of each resignation and each removal of a Rights Agent and each appointment of a successor Rights Agent by mailing written notice of such event through electronic mail, to the Stockholders’ Representative. The Stockholders’ Representative shall forward such notice to the Holders. If Parent fails to send such notice within ten (10) days after acceptance of appointment by a successor Rights Agent, the successor Rights Agent shall cause such notice to be mailed and electronically transmitted at the expense of Parent.

(d)               If a successor Rights Agent has not been appointed and has not accepted such appointment by the end of the thirty (30) day period, the Stockholders’ Representative or the Rights Agent may (but shall not be obligated to) apply to a court of competent jurisdiction for the appointment of a successor Rights Agent, and the reasonable documented out-of-pocket costs, expenses (including reasonable attorneys’ fees which are incurred in connection with such a proceeding) shall be paid in accordance with Section 4.2(g) hereof. Any such successor to the Rights Agent shall agree to be bound by the terms of this Agreement and shall, upon receipt of the all relevant books and records relating thereto, become the Rights Agent hereunder. Upon delivery of all of the relevant books and records, pursuant to the terms of this Section 4.3(d) to a successor Rights Agent, the Rights Agent shall thereafter be discharged from any further obligations hereunder. Without limiting any of the rights or immunities of the Rights Agent under this Agreement, the Rights Agent is hereby authorized, in any and all events, to comply with and obey any and all final judgments, orders and decrees of any court of competent jurisdiction which may be filed, entered or issued, and all final arbitration awards and, if it shall so comply or obey, it shall not be liable to any other person by reason of such compliance or obedience.

Section 4.4      Acceptance of Appointment by Successor.

(a)                Every successor Rights Agent appointed hereunder shall execute, acknowledge and deliver to Parent, the Stockholders’ Representative and to the retiring Rights Agent an instrument accepting such appointment and a counterpart of this Agreement, and thereupon such successor Rights Agent, without any further act, deed or conveyance, shall become vested with all the rights, powers, trusts and duties of the retiring Rights Agent; but, on request of Parent, the Stockholders’ Representative or the successor Rights Agent, such retiring Rights Agent shall execute and deliver an instrument transferring to such successor Rights Agent all the rights, powers and trusts of the retiring Rights Agent but such retiring Rights Agent shall not be required to make any additional expenditure or assume any additional liability in connection with the foregoing.

Article V
COVENANTS AND REPRESENTATIONS

Section 5.1      List of Holders.

Parent shall furnish or cause to be furnished to the Rights Agent in such form as Parent receives from the Company prior to the Effective Time (or other agent performing similar services for Parent or its Affiliates), the names, addresses, shareholdings and tax certification (T.I.N.) of the record holders of Shares eligible to receive CVRs pursuant to the Merger Agreement reasonably promptly following the Effective Time.

17 

 

Section 5.2      Delivery of CVR Shares.

The Rights Agent shall cause the applicable number of CVR Shares to be registered in the names of the Holders upon receipt thereof in the manner provided for in Section 3.4 and in accordance with the terms of this Agreement, and each of the Stockholders’ Representative and Parent shall use reasonable efforts to cause the Rights Agent to do so.

Section 5.3      Assignment.

(a)                Except for assignments occurring through operation of law, Parent and the Company shall not, in whole or in part, assign any of their rights or obligations under this Agreement.

Section 5.4      Tax Treatment.

Unless (x) Parent has determined, based on advice from a “Big 4” accounting firm or nationally recognized tax counsel and after consulting with the Stockholders’ Representative in connection with obtaining such advice and making such determination, that the Intended Tax Treatment (as defined below) is not supported by a “more likely than not” or higher standard or (y) reporting in a manner consistent with the Intended Tax Treatment would require that Parent establish a reserve on its financial statements, each of Parent and each Holder shall and shall cause its Affiliates to (i) treat the CVRs as equity for applicable U.S. federal income tax purposes and to treat the settlement of the CVRs for CVR Shares as a recapitalization under Section 368(a)(1)(E) of the Code for U.S. federal income tax purposes (the “Intended Tax Treatment”) and (ii) file U.S federal income tax returns (if any such tax returns are required to be filed) in a manner consistent with the Intended Tax Treatment.

Article VI
AMENDMENTS

Section 6.1      Amendments Without Consent of Holders or Stockholders’ Representative.

(a)                Without the consent of any Holders, Parent, the Stockholders’ Representative (upon written instruction from the Holders holding a majority of the CVRs) and the Rights Agent, at any time and from time to time, may enter into one or more amendments hereto, for any of the following purposes only:

(i)                 to evidence the succession of another Person selected in accordance with Section 4.3(b) as a successor Rights Agent and the assumption by any successor of the covenants and obligations of the Rights Agent herein;

18 

 

(ii)               to evidence the termination of the CVR Registrar and the succession of another Person as a successor CVR Registrar and the assumption by any successor of the obligations of the CVR Registrar herein; or

(iii)             to add, eliminate or change any provisions of this Agreement, even if such addition, elimination or change is in any way adverse to the interests of the Holders; provided, that if such addition, elimination or change is materially adverse to the rights of holders of any other Merger Consideration CVRs, then instruction from the holders of such other Merger Consideration CVRs representing a majority of the Merger Consideration CVR Shares in respect thereof shall also be necessary; provided, further, if such addition, elimination or change adversely affects the rights and obligations of any Holder in a disproportionate manner to the other Holders hereunder, then instruction from each such affected Holder shall also be necessary; or

(iv)             as necessary to ensure that the CVRs are not subject to registration under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

(b)               Any other amendment to this Agreement shall be made by Parent, the Stockholders’ Representative (upon written instruction of each of the Holders of CVRs) and the Rights Agent.

(c)                Promptly after the execution by Parent, Stockholders Representative and the Rights Agent of any amendment pursuant to the provisions of this Section 6.1, Parent shall mail or cause to be mailed a written notice thereof by electronic mail to the Stockholders’ Representative and by first-class mail and electronic mail to the Holders at their addresses as they shall appear on the CVR Register, setting forth in general terms the substance of such amendment.

Section 6.2      Execution of Amendments; Effect of Amendments.

Prior to executing any amendment permitted by this Article VI, the Rights Agent shall be entitled to receive, and shall be fully protected in relying upon, a certificate from an appropriate officer of Parent or, if requested by the Rights Agent, an opinion of counsel selected by Parent and reasonably acceptable to Rights Agent stating that the execution of such amendment is authorized or permitted by this Agreement. The Rights Agent may, but is not obligated to, enter into any such amendment that affects the Rights Agent’s own rights, privileges, covenants or duties under this Agreement. Upon the execution of any amendment under this Article VI, this Agreement shall be modified in accordance therewith, such amendment shall form a part of this Agreement for all purposes and every Holder shall be bound thereby. No supplement or amendment to this Agreement shall be effective unless duly executed by the Rights Agent, Parent and the Stockholders’ Representative.

19 

 

Article VII
OTHER PROVISIONS OF GENERAL APPLICATION

Section 7.1      Notices to the Rights Agent, Parent and the Stockholders’ Representative.

Any notice, request, instruction or other document to be given hereunder by any party to the others shall be in writing and delivered personally or sent by registered or certified mail, postage prepaid, by electronic mail (except with respect to the Rights Agent), by facsimile transmission only with respect to the Rights Agent or overnight courier, provided that with respect to notices deliverable to the Stockholders’ Representative, such notices shall be delivered solely via electronic mail or facsimile:

If to Parent or the Company:

Eros International Plc

First Names House

Victoria Road

Douglas

Isle of Man IM2 4DF

British Isles

Attention:Mark Carbeck, Chief Corporate and Strategy Officer
Email:mark.carbeck@erosintl.com

with a copy (which shall not constitute notice) to:

Gibson, Dunn & Crutcher LLP
333 South Grand Avenue
Los Angeles, California 90071-3197

Attention:Kevin Masuda
Peter Wardle

Email: kmasuda@gibsondunn.com
pwardle@gibsondunn.com

 

If to the Rights Agent:

Computershare Trust Company, N.A.,

Computershare Inc.

150 Royall Street

Canton, MA 02021

Attention: Client Services

Facsimile: (781) 575-3146

 

If to the Stockholders’ Representative:

Fortis Advisors LLC

Attention: Notices Department (Project World Cup)

Email: notices@fortisrep.com

20 

 

Facsimile: (858) 408-1843

with a copy (which shall not constitute notice) to:

Kirkland & Ellis LLP
555 South Flower Street, Suite 3700
Los Angeles, California 90071
Attention: Rick C. Madden, P.C.
Email: rick.madden@kirkland.com

 

or to such other persons or addresses as may be designated in writing by the party to receive such notice as provided above. Any notice, request, instruction or other document given as provided above shall be deemed given to the receiving party upon actual receipt, if delivered personally; three (3) business days after deposit in the mail, if sent by registered or certified mail; upon confirmation of successful transmission if sent by electronic mail; or on the next business day after deposit with an overnight courier, if sent by an overnight courier.

Section 7.2      Effect of Headings; Construction.

The headings herein are for convenience of reference only, do not constitute part of this Agreement and shall not be deemed to limit or otherwise affect any of the provisions of this Agreement. Where a reference in this Agreement is made to a Section or Exhibit, such reference shall be to a Section of or Exhibit to this Agreement unless otherwise indicated.

Section 7.3      Successors and Assigns.

All covenants and agreements in this Agreement by any party hereto shall bind its successors and permitted assigns, whether so expressed or not.

Section 7.4      Benefits of Agreement.

Nothing in this Agreement, express or implied, shall give to any Person (other than the Holders, the parties hereto and their permitted successors and assigns hereunder) any benefit or any legal or equitable right, remedy or claim under this Agreement or under any covenant or provision herein contained, all such covenants and provisions being for the sole benefit of the Holders, the parties hereto and their permitted successors and assigns. For the avoidance of doubt, the Holders shall be considered express third party beneficiaries of this Agreement.

Section 7.5      Governing Law and Venue; Waiver of Jury Trial.

(a)                THIS AGREEMENT SHALL BE DEEMED TO BE MADE IN AND IN ALL RESPECTS SHALL BE INTERPRETED, CONSTRUED AND GOVERNED BY AND IN ACCORDANCE WITH THE LAW OF THE STATE OF DELAWARE WITHOUT REGARD TO THE CONFLICT OF LAW PRINCIPLES THEREOF THAT WOULD RESULT IN THE APPLICATION OF ANY OTHER JURISDICTION’S LAWS. The parties hereby irrevocably submit to the personal jurisdiction of the courts of the State of Delaware and the federal courts of the United States of America located in the State of Delaware solely in respect of the interpretation and enforcement of the provisions of this Agreement and of the documents

21 

 

referred to in this Agreement, and in respect of the transactions contemplated hereby, and hereby waive, and agree not to assert, as a defense in any action, suit or proceeding for the interpretation or enforcement of this Agreement or of any such document, that it is not subject thereto or that such action, suit or proceeding may not be brought or is not maintainable in said courts or that the venue thereof may not be appropriate or that this Agreement or any such document may not be enforced in or by such courts, and the parties hereto irrevocably agree that all claims relating to such action, proceeding or transactions shall be heard and determined in such a Delaware state or federal court. The parties hereby consent to and grant any such court jurisdiction over the person of such parties and, to the extent permitted by Law, over the subject matter of such dispute and agree that mailing of process or other papers in connection with any such action or proceeding in the manner provided in Section 7.1 or in such other manner as may be permitted by Law shall be valid and sufficient service thereof. If and to the extent that any action, suit or proceeding relates to the rectification of Parent’s register of members or the enforcement of Section 2.1 (“Parent Proceedings”) (but otherwise without prejudice to the provisions of this Section 7.5(a)), each party irrevocably agrees that the courts of the Isle of Man shall have jurisdiction to hear and decide such Parent Proceedings and, for this purpose only, each party irrevocably submits to the jurisdiction of the such courts.

(b)               EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT, OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (i) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (ii) EACH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (iii) EACH PARTY MAKES THIS WAIVER VOLUNTARILY, AND (iv) EACH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS Section 7.5.

Section 7.6      Severability Clause.

The provisions of this Agreement shall be deemed severable and the invalidity or unenforceability of any provision shall not affect the validity or enforceability of the other provisions of this Agreement. If any provision of this Agreement, or the application of such provision to any Person or any circumstance, is invalid or unenforceable, (a) a suitable and equitable provision shall be substituted therefor in order to carry out, so far as may be valid and enforceable, the intent and purpose of such invalid or unenforceable provision and (b) the remainder of this Agreement and the application of such provision to other Persons or circumstances shall not be affected by such invalidity or unenforceability, nor shall such invalidity or unenforceability affect the validity or enforceability of such provision, or the application of such provision, in any other jurisdiction; provided, however, that if an excluded provision shall affect the rights, immunities, liabilities, duties or obligations of the Rights Agent, the Rights Agent shall be entitled to resign immediately written notice to the Parent in accordance with Section 4.2.

22 

 

Section 7.7      Counterparts.

This Agreement may be executed in any number of counterparts, each such counterpart being deemed to be an original instrument, and all such counterparts shall together constitute the same agreement.

Section 7.8      Termination.

This Agreement shall terminate and be of no further force or effect, and the parties hereto shall have no liability hereunder, upon consummation of the issuance and delivery to the Holders of all of the Parent A Shares to which they are entitled pursuant to and in accordance with Section 3.4; provided, Article I, Article IV and this Article VII shall survive.

Section 7.9      Withholding.

Notwithstanding anything to the contrary in this Agreement, Parent, the Rights Agent and their respective agents, shall be entitled to deduct and withhold from any amounts otherwise payable to any Person pursuant to this Agreement such amounts as it is required to deduct and withhold with respect to the making of such payment under the Code or any provision of applicable Tax law; provided, however, that other than in respect of compensatory withholding or backup withholding, withholding as a result of the failure to provide the certificate set forth in Section 6.2(g) of the Merger Agreement or withholding in respect of CVR Income, Parent or the Rights Agent, as applicable, shall use commercially reasonable efforts to provide written notice to the Stockholders’ Representative no later than two (2) Business Days prior to any such withholding or deduction in respect of a Holder and to allow the Holder the opportunity to provide any Tax forms, reports or certificates as may be permitted by Applicable Laws to reduce or eliminate such withholding or deduction. Any amounts so withheld and properly remitted to the applicable Governmental Authority shall be treated for all purposes of this Agreement as having been paid to the Person in respect of which such deduction and withholding was made. In the case of any withholding from any payments not payable in cash, Parent or its agent shall withhold or shall cause to be withheld an amount of such payment having a fair market value equal to the withholding obligation to be satisfied in respect of such payment at the time such amount is withheld (provided that if any cash is otherwise payable to the relevant payee, such withholding shall be made first from such cash), and shall be treated as having paid such amount to the Person in respect of which such amount is withheld.

Section 7.10  Entire Agreement.

This Agreement, the letter agreement between Parent and the Rights Agent of even date herewith regarding fees payable to the Rights Agent (the “Fee Schedule”), and the Merger Agreement represent the entire understanding of Parent, the Company and the Stockholders’ Representative with reference to the CVRs, and, as between such Persons, this Agreement supersedes any and all other oral or written agreements hereto made with respect to the CVRs, except for the Merger Agreement. Notwithstanding the reference to any other document in this Agreement, the Rights Agent shall not be deemed to have knowledge of, or have any duty to

23 

 

ascertain or inquire into, the existence, the content, or the terms and conditions of any other agreement, instrument or document, in each case, to which the Rights Agent is not a party, whether or not such agreement, instrument or document, as the case may be, is referenced in this Agreement. This Agreement and the Fee Schedule represent the entire understanding of the Rights Agent with reference to the CVRs and the performance of the Rights Agent’s duties, its immunities and rights with respect thereto, and with respect to the Rights Agent, this Agreement and the Fee Schedule supersede any and all other oral or written agreements heretofore made with respect to the CVRs. If and to the extent that any provision of this Agreement is inconsistent or conflicts with the Merger Agreement, this Agreement shall govern and be controlling, and this Agreement may be amended, modified, supplemented or altered only in accordance with the terms of Article VII. No party shall be bound by, or be liable for, any alleged representation, promise, inducement or statement of intention not contained herein.

Section 7.11  Force Majeure.

Notwithstanding anything to the contrary contained herein, the Rights Agent shall not be liable for any delays or failures in performance to the extent resulting from acts beyond its reasonable control including, without limitation, acts of God, epidemics, pandemics, terrorist acts, breakdowns, interruptions or malfunctions of any communications or computer facilities, or loss of data due to power failures or mechanical difficulties with information storage or retrieval systems, labor difficulties, war or civil unrest; provided, that the Rights Agent shall use reasonable commercial efforts to resume performance as soon as practicable. If any such act or event occurs, the Rights Agent shall give prompt written notice to Parent and the Stockholders’ Representative, stating the nature of the act or event and action being taken to avoid or minimize its effect.

Section 7.12  Funds.

All funds received by the Rights Agent under this Agreement that are to be distributed or applied by the Rights Agent in the performance of services hereunder (the “Funds”) shall be held by the Rights Agent as agent for Parent and deposited in one or more bank accounts to be maintained by the Rights Agent in its name as agent for Parent. Until paid pursuant to the terms of this Agreement, the Rights Agent will hold the Funds through such accounts in: deposit accounts of commercial banks with Tier 1 capital exceeding $1 billion or with an average rating above investment grade by S&P (LT Local Issuer Credit Rating), Moody’s (Long Term Rating) and Fitch Ratings, Inc. (LT Issuer Default Rating) (each as reported by Bloomberg Finance L.P.). The Rights Agent shall have no responsibility or liability for any diminution of the Funds that may result from any deposit made by the Rights Agent in accordance with this paragraph, including any losses resulting from a default by any bank, financial institution or other third party. The Rights Agent may from time to time receive interest, dividends or other earnings in connection with such deposits. The Rights Agent shall not be obligated to pay such interest, dividends or earnings to the Parent, any Holder or any other Person.

 

[Remainder of Page Intentionally Left Blank.]

24 

 

IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed on its behalf by its duly authorized officers as of the day and year first above written.

EROS INTERNATIONAL PLC


By: ___________________________________________
Name:
Title:

 

[Signature Page to Class C CVR Agreement]

 

 

STX FILMWORKS, INC.

 

By: _______________________________
Name:
Title:

[Signature Page to Class C CVR Agreement]

 

 

FORTIS ADVISORS LLC

 

By: _______________________________
Name:
Title:

[Signature Page to Class C CVR Agreement]

 

 

COMPUTERSHARE TRUST

COMPANY, N.A. AND COMPUTERSHARE INC.

On behalf of both entities

By: ________________________________

Name:
Title:

[Signature Page to Class C CVR Agreement]

Exhibit 4.37

 

CLASS B CONTINGENT VALUE RIGHTS AGREEMENT

This CLASS B CONTINGENT VALUE RIGHTS AGREEMENT, dated as of [●], 2020 (this “Agreement”), is entered into by and among Eros International Plc, an Isle of Man company limited by shares (“Parent”), STX Filmworks, Inc., a Delaware corporation (the “Company”), Fortis Advisors LLC, a Delaware limited liability company, solely in its capacity as representative of the former holders of the Shares (in such capacity, the “Stockholders’ Representative”), and Computershare Inc., a Delaware corporation, and its wholly-owned subsidiary, Computershare Trust Company, N.A., a federally chartered trust company, collectively as rights agent (the “Rights Agent”) and as initial CVR Registrar (as defined herein).

WITNESSETH:

WHEREAS, the Company, Parent, England Holdings 2, Inc., a Delaware corporation and indirect wholly-owned Subsidiary of Parent (“England Holdings 2”), England Merger 1 Corp. (f/k/a England Merger Corp.), a Delaware corporation and a direct wholly-owned Subsidiary of England Holdings 2 (“Merger Sub”), have entered into an Agreement and Plan of Merger (as the same may be amended, modified or supplemented from time to time, the “Merger Agreement”), dated as of April 17, 2020, pursuant to which Merger Sub merged with and into the Company (the “Merger”), with the Company surviving the Merger, as an indirect wholly-owned Subsidiary of Parent;

WHEREAS, pursuant to the Merger Agreement, Parent agreed to issue to holders of record of shares of Class B Convertible Preferred Stock, par value $0.01 per share, of the Company (the “Shares”) outstanding immediately prior to the effective time of the Merger (the “Effective Time”), a number of contingent value rights (the “CVRs”) as hereinafter described; and

WHEREAS, each holder of Shares as of immediately prior to the Effective Time, will receive, among other things, as merger consideration, the right to receive upon the Effective Time a number of CVRs in such amount as set forth in Article II of the Merger Agreement.

NOW, THEREFORE, for and in consideration of the premises and the consummation of the transactions referred to above, it is mutually covenanted and agreed, for the equal and proportionate benefit of all Holders (as hereinafter defined), as follows:

Article I
DEFINITIONS

Section 1.1      Definitions.

(a)                For all purposes of this Agreement, except as otherwise expressly provided or unless the context otherwise requires:

(i)                 the terms defined in this Article I have the meanings assigned to them in this Article I, and include the plural as well as the singular;

1 

 

(ii)               the words “herein,” “hereof” and “hereunder” and other words of similar import refer to this Agreement as a whole and not to any particular Article, Section or other subdivision;

(iii)             unless the context otherwise requires, words describing the singular number shall include the plural and vice versa, words denoting any gender shall include all genders and words denoting natural Persons shall include corporations, partnerships and other Persons and vice versa;

(iv)             the term “Affiliate” when used with respect to the Company shall, after the Effective Time, include Parent and its Subsidiaries and Affiliates; and

(v)               all references to “including” shall be deemed to mean including without limitation.

(b)               Capitalized terms used but not otherwise defined herein shall have the meanings ascribed thereto in the Merger Agreement. The following terms shall have the meanings ascribed to them as follows:

Affiliate” means, with respect to any specified Person, (i) any other Person that directly or indirectly through one or more intermediaries controls, or is controlled by, or is under common control with, such specified Person (for the purposes of this definition, “control” (including, with correlative meanings, the terms “controlling,” “controlled by” and “under common control with”), as used with respect to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of such Person, whether through the ownership of voting securities, by agreement or otherwise) and (ii) with respect to any natural person, any Member of the Immediate Family of such natural person. Notwithstanding the foregoing, for purposes hereof, (i) none of the Holders, the Company, or any of their respective Subsidiaries shall be considered Affiliates of any portfolio company (or Subsidiary thereof) in which any Holder or any of its affiliated investment funds have made a debt or equity investment, and (ii) no Holder or any of its Affiliates shall be considered an Affiliate of (a) Parent or any of its Subsidiaries or (b) any other Holders or their respective Affiliates (except to the extent such Holders are otherwise Affiliates under this definition without regard to their status as Holders).

Agreement” has the meaning set forth in the Preamble.

Aggregate CVR Shares” means the aggregate number of underlying Parent A Shares issuable in respect of all CVRs.

Appraisal Shares” has the meaning set forth in Section 4.2(h).

Available Class B Merger Consideration CVR Shares” means the Merger Consideration CVR Share Cap minus the Parent A Shares issued to the Class E CVRs, the Class D CVRs and the Class C CVRs.

Base Price” means $2.60.

2 

 

Change of Control Transaction” means the occurrence of (i) an acquisition by any Person, including any syndicate or group deemed to be a “person” under Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, of beneficial ownership, directly or indirectly, through purchase, merger or other acquisition transaction or series of purchases, mergers or other acquisition transactions of shares or comparable equity interests of Parent entitling that Person to fifty percent (50%) or more of the total voting power of all such shares or comparable equity interests of Parent; or (ii) the consolidation or merger of Parent with or into any other Person, any merger of another Person into Parent, or any conveyance, transfer, sale, lease or other disposition of all or substantially all of Parent’s properties, business or assets, other than (in the case of this clause (ii) only) (1) any transaction (x) that does not result in any reclassification, conversion, exchange or cancellation of outstanding shares or comparable equity interests of Parent, and (y) pursuant to which holders of Parent’s shares or comparable equity interest immediately prior to such transaction have the right to exercise, directly or indirectly, fifty percent (50%) or more of the total voting power of all shares or comparable equity interest of the continuing or surviving Person immediately after such transaction, or (2) any merger solely for the purpose of changing Parent’s jurisdiction of formation and resulting in a reclassification, conversion or exchange of outstanding shares or comparable equity interests into shares or comparable equity interest of the surviving entity with substantially identical rights.

Class A CVR” means the contingent value rights issued by Parent with respect to the Class A Convertible Preferred Stock, par value $0.01 of the Company, pursuant to the Merger Agreement and the Class A CVR Agreement.

Class A CVR Agreement” means the Class A CVR Agreement, dated as of the date hereof, by and among Parent, the Company, the stockholders’ representative thereunder and the rights agent thereunder.

Class A CVR Shares” means the underlying Parent A Shares issuable in respect of the Class A CVRs.

Class C CVR” means the contingent value rights issued by Parent with respect to the Class C Convertible Preferred Stock, par value $0.01 of the Company, pursuant to the Merger Agreement and the Class C CVR Agreement.

Class C CVR Agreement” means the Class C CVR Agreement, dated as of the date hereof, by and among Parent, the Company, the stockholders’ representative thereunder and the rights agent thereunder.

Class C CVR Shares” means the underlying Parent A Shares issuable in respect of the Class C CVRs.

Class D CVR” means the contingent value rights issued by Parent with respect to the Class D Convertible Preferred Stock, par value $0.01 of the Company, pursuant to the Merger Agreement and the Class D CVR Agreement.

Class D CVR Agreement” means the Class D CVR Agreement, dated as of the date hereof, by and among Parent, the Company, the stockholders’ representative thereunder and the rights agent thereunder.

3 

 

Class D CVR Shares” means the underlying Parent A Shares issuable in respect of the Class D CVRs.

Class E CVR” means the contingent value rights issued by Parent with respect to the Class E Convertible Preferred Stock, par value $0.01 of the Company, pursuant to the Merger Agreement and the Class E CVR Agreement.

Class E CVR Agreement” means the Class E CVR Agreement, dated as of the date hereof, by and among Parent, the Company, the stockholders’ representative thereunder and the rights agent thereunder.

Class E CVR Shares” means the underlying Parent A Shares issuable in respect of the Class E CVRs.

Code” means the Internal Revenue Code of 1986, as amended from time to time.

Company” has the meaning set forth in the Preamble.

CVR” means a contingent value right issued by Parent with respect to the Shares, pursuant to the Merger Agreement and this Agreement.

CVR Shares” has the meaning set forth in Section 3.4(b).

CVR Register” has the meaning set forth in Section 3.3(b).

CVR Registrar” has the meaning set forth in Section 3.3(b).

Effective Time” has the meaning set forth in the Recitals.

Eros Pre-Closing Equity Financing” has the meaning ascribed in the PIPE Agreement.

Final Settlement Time” has the meaning set forth in Section 3.2(b).

Funds” has the meaning set forth in Section 7.12.

Fully Diluted Parent Shares” means, as of immediately prior to the Effective Time, the sum of (without duplication) (i) the aggregate number of Parent Ordinary Shares then outstanding, plus (ii) the aggregate number of Parent Ordinary Shares subject to issuance pursuant to then outstanding In-the-Money Parent Options (whether or not vested), plus (iii) the aggregate number of Parent Ordinary Shares subject to issuance pursuant to then outstanding Parent RSU Awards (whether or not vested), plus (iv) the aggregate number of Parent Ordinary Shares then subject to issuance pursuant to the Parent Convertible Notes assuming full conversion thereof at a conversion price of $2.60; provided, however, that, notwithstanding the foregoing, Fully Diluted Parent Shares shall not include any Parent Ordinary Shares issuable pursuant to the Eros Pre-Closing Equity Financing. For the avoidance of doubt, Fully Diluted Parent Shares shall be calculated prior to, and without giving effect to, the PIPE Investment.

Holder” means a Person in whose name a CVR is registered in the CVR Register.

4 

 

In-the-Money Parent Options” means an Eros Option (as defined in the Merger Agreement) having a per Parent Ordinary Share exercise price less than the Parent Trading Price.

Investors’ Rights Agreement” means the Investors’ Rights Agreement, entered into on or around the date hereof, by and among Parent, certain shareholders of Parent and the investors party thereto.

Law” with respect to any Person, means (a) all provisions of all laws, statutes, ordinances, rules, regulations, permits, certificates or orders of any governmental authority applicable to such Person or any of its assets or property or to which such Person or any of its assets or property is subject, and (b) all judgments, injunctions, orders and decrees of all courts and arbitrators in proceedings or actions in which such Person is a party or by which it or any of its assets or properties is or may be bound or subject.

Lock-Up Agreement” has the meaning set forth in Section 3.4(c).

Members of the Immediate Family” means, with respect to any individual, each spouse or child or other descendants of such individual, each trust created solely for the benefit of one or more of the aforementioned Persons and their spouses and each custodian or guardian of any property of one or more of the aforementioned Persons in his capacity as such custodian or guardian.

Merger” has the meaning set forth in the Recitals.

Merger Agreement” has the meaning set forth in the Recitals.

Merger Consideration CVRs” means the CVRs, the Class E CVRs, the Class D CVRs, the Class C CVRs and the Class A CVRs.

Merger Consideration CVR Share Cap” means a number of Parent A Shares equal to the Fully Diluted Parent Shares.

Merger Consideration CVR Shares” means the Aggregate CVR Shares, the Class E CVR Shares, the Class D CVR Shares, the Class C CVR Shares and the Class A CVR Shares.

Merger Sub” has the meaning set forth in the Recitals.

Organizational Documents” has the meaning set forth in Section 2.1(a).

Parent” has the meaning set forth in the Preamble.

Parent A Shares” means the A Ordinary Shares, par value £0.30 per share, of Parent.

Parent B Shares” means the B Ordinary Shares, par value £0.30 per share, of Parent.

Parent Convertible Notes” means Parent’s Senior Convertible Notes due September 27, 2020 in the original aggregate principal amount of $27,500,000.

Parent Option” means a compensatory option to purchase Parent Ordinary Shares.

5 

 

Parent Ordinary Shares” means, collectively, the Parent A Shares and the Parent B Shares.

Parent Proceedings” has the meaning set forth in Section 7.5(a).

Parent RSU Award” means an award of restricted stock units relating to Parent Ordinary Shares.

Parent Trading Price” means the VWAP for one Parent A Share for the twenty (20) consecutive full Trading Days ending on the full Trading Day immediately preceding the Effective Time (as adjusted as appropriate to reflect any stock splits, stock dividends, combinations, reorganizations, classifications or similar events).

Permitted Transfer” means: (i) the transfer (upon the death of the Holder) by will or intestacy; (ii) transfer by instrument to an inter vivos or testamentary trust in which the CVRs are to be passed to beneficiaries upon the death of the trustee; (iii) transfers made pursuant to a court order of a court of competent jurisdiction (such as in connection with divorce, bankruptcy or liquidation); (iv) if the Holder is a partnership or limited liability company, a distribution by the transferring partnership or limited liability company to its partners or members, as applicable; (v) a transfer made by operation of law (including a consolidation or merger) or in connection with the dissolution, liquidation or termination of any corporation, limited liability company, partnership or other entity; or (vi) a transfer by any Holder to one or more of its Affiliates or affiliated investment funds of any of its Affiliates.

Permitted Transferee” means a Person who receives a CVR pursuant to a Permitted Transfer and otherwise in accordance with this Agreement.

Person” means any individual, corporation (including not-for-profit), general or limited partnership, limited liability company, joint venture, estate, trust, association, organization, Governmental Authority or other entity of any kind or nature.

PIPE Agreement” means that certain Subscription Agreement, made as of April 17, 2020, by and among Parent and each Person defined therein as a “Purchaser.”

PIPE Investment” means the purchase of Parent A Shares pursuant to the PIPE Agreement.

PIPE Lock-Up Agreement” has the meaning set forth in Section 3.4(c).

Pre-Closing VWAP” means the VWAP of the Parent A Shares for the 10 Trading Days ending on the end of the Trading Day immediately preceding the Closing.

Pre-Settlement VWAP” means the VWAP of the Parent A Shares for the 10 Trading Days ending on the end of the Trading Day immediately preceding the Settlement Date; provided, that for purposes of determining the CVR Shares issuable as of any time prior to the Settlement Date, the reference to “the Trading Day immediately preceding the Settlement Date” in this definition shall be deemed a reference to “the Trading Day immediately preceding the applicable time of determination”.

6 

 

Reference Price” means a price per share equal to the lesser of (x) the Pre-Settlement VWAP and (y) the Upper Collar Price; provided, that if the Pre-Settlement VWAP is equal to or greater than $4, then the Reference Price will equal the average of the Pre-Settlement VWAP and the Upper Collar Price.

Rights Agent” means the Rights Agent named in the first paragraph of this Agreement, until a successor Rights Agent shall have become such pursuant to the applicable provisions of this Agreement, and thereafter “Rights Agent” shall mean such successor Rights Agent.

Settlement Date” shall mean the date that is the earlier to occur of (a) the later to occur of (i) the first time that the Merger Consideration CVR Shares have been registered for resale pursuant to an effective registration statement under the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder, and (ii) the 75th calendar day after the Closing and (b) the occurrence of the Settlement Outside Date.

Settlement Outside Date” means the date that is six (6) months after the Closing; provided that the Settlement Outside Date may be extended (but only once) by holders of a majority of the Class E CVRs; provided, further, that such majority must include each such holder that, together with its Affiliates, purchased $15 million or more of Parent A Shares in the PIPE Investment.

Shares” has the meaning set forth in the Recitals.

Stockholders’ Representative” has the meaning set forth in the Preamble.

STX Purchase Price” means the lowest of (i) the Base Price, (ii) the volume weighted average of the purchase price of all purchases comprising the Eros Pre-Closing Equity Financing and (iii) the Pre-Closing VWAP; provided, however, that if the Pre-Closing VWAP is greater than $3.25, then the STX Purchase Price shall be the average of the Base Price and the Pre-Closing VWAP.

Subsidiary” of any Person shall mean any corporation or other entity of which securities or other ownership interests having ordinary voting power sufficient to elect a majority of the board of directors or comparable governing body are beneficially owned, directly or indirectly, by such Person, and any corporation or other entity that is otherwise controlled by such Person.

Taxes” or “Tax” means all taxes, charges, fees, levies or other assessments in the nature of a tax imposed by any governmental authority, including any income, gross receipts, license, severance, occupation, premium, environmental (including taxes under former Code Section 59A), customs, duties, profits, disability, alternative or add-on minimum, estimated, withholding, payroll, employment, unemployment insurance, social security (or similar), excise, sales, use, value-added, occupancy, franchise, real property, personal property, business and occupation, mercantile, windfall profits, capital stock, stamp, transfer, workmen’s compensation, amounts due under any applicable laws governing escheat or unclaimed property or other taxes, charges, fees, levies or other assessments in the nature of a tax, together with any interest, penalties, additions to tax or additional amounts imposed by any Governmental Authority with respect thereto, whether disputed or not.

7 

 

Trading Day” means, with respect to any referenced security, any day on which such security is actually traded on the principal securities exchange or securities market on which such security is then listed.

Upper Collar Price” means the quotient of the STX Purchase Price, divided by one and one-half (1.5).

VWAP” means, for any security as of any date(s), the dollar volume-weighted average price for such security on the principal securities exchange or securities market on which such security is then listed during the period beginning at 9:30:01 a.m., New York time, and ending at 4:00:00 p.m., New York time, as reported by Bloomberg through its “HP” function (sets to weighted average) or, if the foregoing does not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the electronic bulletin board for such security during the period beginning at 9:30:01 a.m., New York time, and ending at 4:00:00 p.m., New York time, as reported by Bloomberg, or, if no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the highest closing bid price and the lowest closing ask price of any of the market makers for such security as reported by OTC Markets Group Inc. If the VWAP cannot be calculated for such security on such date(s) on any of the foregoing bases, the VWAP of such security on such date(s) shall be the fair market value thereof on such date(s) as reasonably determined by a nationally recognized independent investment banking firm mutually agreed between Parent and the Stockholders’ Representative.

Article II
OPERATION OF PARENT

Section 2.1      Operation of Parent.

From the Effective Time until the Settlement Date, Parent shall not, and shall cause its Subsidiaries and Affiliates not to:

(a)                after the effectiveness of the Amended Articles (as defined in the Investors’ Rights Agreement), effect any action that requires approval by the shareholders of Parent under Parent’s Memorandum of Association or Articles of Association (the “Organizational Documents”) or applicable Law; or

(b)               prior to the effectiveness of Amended Articles, take any action set forth in Section 4.3(c) of the Investors’ Rights Agreement as in effect on the date hereof,

without, in each such case, obtaining the consent thereto of holders of such class and number of Merger Consideration CVRs (including the CVRs hereunder) that, together with the shares of Parent actually voted (at a meeting or by resolution) with respect to such action and assuming all Merger Consideration CVR Shares were outstanding Parent A Shares and voted, would be required to approve such action under the Organizational Documents, applicable Law or Section 4.3(c) of the Investors’ Rights Agreement, as applicable. For purposes of the foregoing consent rights, the number of Merger Consideration CVR Shares underlying the Merger Consideration CVRs as of any time prior to the Settlement Date shall be calculated as set forth below in Article III and in Article III of the Class E CVR Agreement with respect to the Class E CVRs, Article III of the Class D CVR Agreement with respect to the Class D CVRs, Article III of the Class C CVR Agreement with respect to the Class C CVRs and Article III of the Class A CVR Agreement with respect to the Class A CVRs.

8 

 

Article III
CVRS

Section 3.1      Issuance of CVRs; Appointment of Rights Agent; Reservation of Shares.

(a)                The CVRs shall be issued pursuant to the Merger Agreement at the time and in the manner set forth in the Merger Agreement. The registration on the books and records of Parent and administration of the CVRs shall be handled pursuant to this Agreement in the manner set forth in this Agreement.

(b)               Parent hereby appoints the Rights Agent to act as rights agent for the CVRs in accordance with the instructions hereinafter set forth in this Agreement, and the Rights Agent hereby accepts such appointment.

(c)                From the date hereof until the issuance of the Aggregate CVR Shares in accordance with the terms hereof, Parent shall reserve and keep available out of its authorized but unissued share capital, for the purpose of effecting the issuance of the CVR Shares hereunder, a number of Parent A Shares equal to the Merger Consideration CVR Share Cap, minus the number of CVR Shares, if any, previously issued in accordance with the terms of this Agreement; and if at any time during such period the number of authorized but unissued Parent A Shares shall not be sufficient to effect the issuance of the Aggregate CVR Shares in full, Parent shall take all such action as may be necessary to increase its authorized but unissued share capital as shall be sufficient for such purposes.

Section 3.2      Nontransferable; Expiration.

(a)                The CVRs shall not be sold, assigned, transferred, pledged, encumbered or in any other manner transferred or disposed of, in whole or in part, other than to a Permitted Transferee. Any purported transfer of a CVR to anyone other than a Permitted Transferee shall be null and void ab initio.

(b)               Subject to Section 3.4(c), the CVRs shall expire on the Settlement Date upon the registration of the CVR Shares in the respective names of the Holders entitled thereto and shall thereafter be of no force or effect following such registration; provided that, if any CVR Shares are not so registered on the Settlement Date, then the CVRs in respect thereof shall not expire until the registration of such CVR Shares in the respective names of the Holders entitled thereto (the time of registration thereof, the “Final Settlement Time”).

Section 3.3      No Certificate; Registration; Registration of Transfer; Change of Address.

(a)                The CVRs shall not be evidenced by a certificate or other instrument.

9 

 

(b)               Upon receipt from Parent of the names and addresses of each Holder and the number of CVRs held by such Holder, the Rights Agent shall keep a register (the “CVR Register”) for the registration of CVRs in a book-entry position for each Holder of a CVR. The CVR Register shall set forth the name and address of each Holder, and the number of CVRs held by such Holder and Tax Identification Number of each Holder. Each of Parent and the Stockholders’ Representative may receive and inspect a copy of the CVR Register, from time to time, upon written request made to the CVR Registrar. Within five (5) Business Days after receipt of such request, the CVR Registrar shall deliver a copy of the CVR Register, as then in effect, to Parent and the Stockholders’ Representative at the address set forth in Section 7.1. The Rights Agent is hereby initially appointed “CVR Registrar” for the purpose of registering CVRs and transfers of CVRs as herein provided.

(c)                Subject to the restrictions set forth in Section 3.2, every request made to transfer a CVR must be in writing and accompanied by a written instrument or instruments of transfer and any other reasonably requested documentation in form reasonably satisfactory to Parent and the CVR Registrar, duly executed by the registered Holder or Holders thereof or by the duly appointed legal representative thereof or by a duly authorized attorney. A request for a transfer of a CVR shall be accompanied by documentation establishing that the transfer is to a Permitted Transferee and shall thereafter be supplemented with and any other information as may be reasonably requested by Parent or the CVR Registrar (including opinions of counsel, if appropriate). Upon receipt of such written notice, the CVR Registrar shall, subject to its reasonable determination that the transfer instrument is in proper form and the transfer otherwise complies with the other terms and conditions herein on its face, without investigation or inquiry by the Rights Agent, register the transfer of the CVRs in the CVR Register. All duly transferred CVRs registered in the CVR Register shall be the valid obligations of Parent, evidencing the same rights and entitling the transferee to the same benefits and rights under this Agreement as those held by the transferor immediately prior to such transfer. No transfer of a CVR shall be valid until registered in the CVR Register, and any transfer not duly registered in the CVR Register will be void ab initio (unless the transfer was permissible hereunder and such failure to be duly registered is attributable to the fault of the CVR Registrar). Any transfer or assignment of the CVRs shall be without charge by Parent or the CVR Registrar (other than the cost of any Tax which shall be the responsibility of the transferor) to the Holder.

(d)               A Holder may make a written request to the CVR Registrar to change such Holder’s address of record in the CVR Register. The written request must be duly executed by the Holder and accompanied by such other evidence of the Holder’s identity or interest in the CVR as reasonably requested by the Rights Agent. Upon receipt of such written notice, the CVR Registrar is hereby authorized to, and shall promptly, record the change of address in the CVR Register.

(e)                The Stockholders’ Representative may make a written request to the Rights Agent for a list containing the names, addresses and number of CVRs of the Holders that are registered in the CVR Register. Within five (5) Business Days following the date of receipt by the Rights Agent of such request, the CVR Registrar shall deliver a copy of such list to the Stockholders’ Representative.

Section 3.4      Issuance Procedures.

10 

 

(a)                On the Settlement Date, Parent shall issue, and cause to be deposited with the Rights Agent, a number of Parent A Shares equal to the Aggregate CVR Shares. On the Settlement Date or as promptly as practicable thereafter, subject to Section 3.4(c) below, the Rights Agent shall cause the applicable number of CVR Shares to be registered in the name of each of the Holders as reflected in the CVR Register as of the close of business on the last Business Day prior to such issuance date.

(b)               The number of Parent A Shares issued in respect of each CVR from the Available Class B Merger Consideration CVR Shares (the “CVR Shares”) shall be equal to the quotient obtained by dividing $1,000 by the Reference Price; provided, that the number of Parent A Shares allocated to the CVRs shall be pro-rated in the event there are insufficient Available Class B Merger Consideration CVR Shares remaining for allocation to the CVRs. For all purposes above, fractional CVRs shall represent a proportionate number of CVR Shares; provided, however, that no fractional Parent A Shares (or certificate or scrip representing the same) shall be issued upon the settlement of any CVRs hereunder. Notwithstanding any other provision of this Agreement, each Holder of CVRs who would otherwise have been entitled to receive a fraction of a Parent A Share upon settlement of such Holder’s CVRs hereunder (after aggregating all CVRs of such Holder that are subject to this Agreement) shall receive, in lieu thereof, an amount of cash (rounded to the nearest whole cent), without interest, equal to such fractional amount multiplied by the Reference Price. Whenever a payment for fractional Parent A Shares or fractional shares is to be made by the Rights Agent under any section of this Agreement, Parent shall (i) promptly deliver to the Rights Agent a certificate setting forth the amount of any such payment and calculation related thereto and (ii) cash in the amount of such payment to the Rights Agent by wire transfer of immediately available funds to make such payment to the applicable Holder by check mailed to such Holder as reflected in the CVR Register or by wire transfer of immediately available funds. The Rights Agent shall not be liable to any Holder or Parent for the amount of any cash payment made to such Holder on behalf of Parent in accordance with the amount set forth in such certificate.

(c)                Parent’s obligation to issue and cause to be deposited with the Rights Agent the applicable number of CVR Shares, and the Rights Agent’s obligation to cause the applicable number of CVR Shares to be registered in the name of a Holder upon receipt of the applicable number of CVR Shares shall be conditioned on the execution and delivery by such Holder of a lockup agreement with Parent, substantially in the form attached hereto as Exhibit A (a “Lock-Up Agreement”); provided, however, that the Rights Agent’s obligation to cause the applicable number of CVR Shares to be registered in the name of a Holder upon receipt of the applicable number of CVR Shares to a Holder shall not be conditioned on the execution and delivery by such Holder of a Lock-Up Agreement if (i) such Holder or any of its Affiliates shall have entered into a lockup agreement with Parent in connection with the PIPE Investment (such lockup agreement, a “PIPE Lock-Up Agreement”) or (ii) the Settlement Date is the Settlement Outside Date and the Merger consideration CVR Shares have not been, as of such date, registered for resale pursuant to an effective registration statement under the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder; provided, further, that Rights Agent shall have no duty to act without the written instruction of Parent with respect to the foregoing.

11 

 

(d)               Without limiting the other provisions of this Agreement, if at any time during the period between the execution of this Agreement and the Settlement Date (or if applicable, the Final Settlement Time), any change in the number or type of outstanding Parent A Shares shall occur as a result of a reclassification, recapitalization, exchange, stock split (including a reverse stock split), combination or readjustment of capital stock, shares or any stock dividend or stock distribution with a record date during such period (including any such reclassification, recapitalization, exchange, stock split, combination or readjustment of capital stock, shares or any stock dividend or stock distribution in connection with a consolidation, merger or combination in which Parent is the continuing or surviving corporation), the CVR Shares and any other similarly dependent items, as the case may be, shall be appropriately equitably adjusted to provide the same economic effect as contemplated by this Agreement prior to such event; provided that nothing in this Section 3.4(d) shall be construed to permit any party to take any action that is otherwise prohibited or restricted by any other provision of this Agreement.

(e)                If, at any time prior to the Settlement Date (or, if applicable, the Final Settlement Time) Parent effects any Change of Control Transaction, then, upon any Settlement Date, each Holder shall have the right to receive, on the Settlement Date, for each CVR Share that would have been issuable upon the Settlement Date the same consideration (in the same amount and form) per Parent A Share payable to the holders thereof in such Change of Control Transaction. For purposes hereof, the determination of Pre-Settlement VWAP shall be appropriately adjusted to refer to such consideration instead of Parent A Shares. If holders of Parent A Shares are given any right of election as to the securities, cash or property to be received in such Change of Control Transaction, then each Holder shall be given the same right of election. To the extent necessary to effectuate the foregoing provisions, Parent shall ensure that any successor to Parent or the surviving entity in such Change of Control Transaction shall agree to be bound by the terms of this Agreement. In the event that the Final Settlement Time occurs after the Settlement Date, references herein to Settlement Date shall mean as promptly as practicable following the Change of Control Transaction.

Section 3.5      CVR Rights

(a)                Subject to Section 2.1, except as provided in Section 3.5(b), the CVRs shall not have any voting rights and shall not represent any equity or ownership interest in Parent, in any constituent company to the Merger, any Affiliate of Parent or any other Person.

(b)               The CVRs shall entitle each Holder, at the Settlement Date and subject to any applicable withholding Taxes, to a payment per Parent A Share issued thereunder, without interest, equal (as to both amount and form of consideration) to all dividends or other distributions of any kind declared per Parent A Share of the CVR Shares with a record date after the Closing and prior to the Settlement Date. Any dividends or other distributions of any kind made in respect of the CVR Shares will be delivered promptly to the Rights Agent to be held in escrow with respect to the CVRs (the “CVR Income”) treating the CVR Shares for this purpose as if the Aggregate CVR Shares were then outstanding. On the Settlement Date, the Rights Agent shall deliver to each Holder, concurrent with the issuance to such Holder of the applicable CVR Shares, the CVR Income earned in respect of each such CVR Share, less any applicable withholding Taxes.

12 

 

Article IV
THE RIGHTS AGENT

Section 4.1      Certain Duties and Responsibilities.

The Rights Agent shall not have any liability for any actions taken or not taken by the Rights Agent in connection with the execution, acceptance, administration, exercise and performance of its duties under this Agreement, except to the extent of its willful misconduct, bad faith or gross negligence (in each case as determined by a final, non-appealable judgment of a court of competent jurisdiction). No provision of this Agreement shall require the Rights Agent to expend or risk its own funds or otherwise incur any financial liability in the performance of any of its duties hereunder or in the exercise of any of its rights or powers.

Section 4.2      Certain Rights of Rights Agent.

The Rights Agent undertakes to perform such duties and only such duties as are specifically set forth in this Agreement, and no implied covenants or obligations shall be read into this Agreement against the Rights Agent. In addition:

(a)                the Rights Agent may rely and shall be protected and held harmless by Parent in and shall not incur any liability in acting or refraining from acting in connection with its performance under this Agreement upon any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order or other paper or document reasonably believed by it to be genuine and to have been signed or presented by the proper party or parties, except to the extent of its willful misconduct, bad faith or gross negligence (in each case as determined by a final, non-appealable judgment of a court of competent jurisdiction);

(b)               the Rights Agent may consult with legal counsel selected by it, and the Rights Agent shall incur no liability for or in respect of any action taken, suffered or omitted to be taken by it in the absence of bad faith, gross negligence or willful misconduct and in accordance with such advice or opinion. The reasonable costs of such counsel’s services shall be paid to the Rights Agent in accordance with Section 4.2(g) below. The Rights Agent may perform any and all of its duties through its agents, representatives, custodians and/or nominees and the Rights Agent shall not be answerable or accountable for any act, omission, default, neglect or misconduct of any such agents, representatives, custodians and/or nominees or for any loss to Parent or the Company, to the Holders or any other Person resulting from any such act, omission, default, neglect or misconduct, absent gross negligence, willful misconduct or bad faith on the part of the Rights Agent, such agents, representatives, custodians and/or nominees (which gross negligence, willful misconduct or bad faith must be determined by a final, non-appealable judgment of a court of competent jurisdiction);

13 

 

(c)                if the Rights Agent becomes involved in litigation on account of this Agreement, it shall have the right to retain counsel and shall be entitled to reimbursement for all reasonable and documented out-of-pocket costs and expenses related thereto as provided in this Section 4.2(c) and Section 4.2(g) hereof; provided, however, that the Rights Agent shall not be entitled to any such reimbursement to the extent such litigation ultimately determines that the Rights Agent acted with willful misconduct, bad faith or gross negligence. In the event that conflicting demands are made upon the Rights Agent for any situation addressed or not addressed in this Agreement, the Rights Agent may withhold performance of the terms of this Agreement until such time as said conflicting demands shall have been withdrawn or the rights of the respective parties shall have been settled by court adjudication, arbitration, joint order or otherwise;

(d)               the permissive rights of the Rights Agent to do things enumerated in this Agreement shall not be construed as a duty;

(e)                the Rights Agent shall not be required to give any note or surety in respect of the execution of such powers or otherwise in respect of the premises;

(f)                Parent agrees to indemnify the Rights Agent for, and hold the Rights Agent harmless against, any loss, liability, claim, demands, suits or expense arising out of or in connection with the Rights Agent’s duties under this Agreement, including the costs and expenses of defending the Rights Agent against any claims, charges, demands, suits or loss, unless such loss shall have been determined by a court of competent jurisdiction to be a result of the Rights Agent’s willful misconduct, bad faith or gross negligence (in each case as determined by a court of competent jurisdiction); provided, however, that the Rights Agent’s aggregate liability with respect to, arising from, or arising in connection with this Agreement, or from all services provided or omitted to be provided under this Agreement, whether in contract, in tort, or otherwise, is limited to, and shall not exceed, the amounts paid hereunder by Parent to the Rights Agent as fees and charges (but not including reimbursable expenses) in the 12 months preceding the event for which recovery is sought. The provisions under this Section 4.2 and Section 4.1 above shall survive the settlement of the CVRs and the termination of this Agreement and the resignation, replacement or removal of the Rights Agent. To the extent the Rights Agent is entitled to indemnification hereunder, the reasonable and documented out-of-pocket costs and expenses of the Rights Agent incurred in enforcing this right of indemnification shall be paid by Parent;

(g)               Parent agrees to pay to the Rights Agent reasonable compensation for all services rendered by it hereunder in accordance with a fee schedule to be mutually agreed upon in writing between Parent and the Rights Agent and, from time to time, to reimburse the Rights Agent for all of its reasonable, customary and documented out-of-pocket expenses (including reasonable fees and expenses of the Rights Agent’s counsel) and other disbursements incurred in the preparation, delivery, negotiation, amendment, administration and execution of this Agreement and the exercise and performance of its duties hereunder. Without limiting any of its rights to compensation or reimbursement under this Agreement, the Rights Agent shall deliver to Parent the final invoice for the Rights Agent fees and costs (which shall include a reasonable estimate of all remaining fees and expenses) at a reasonable time prior to the date of delivery of the CVR Shares. An invoice for any reasonable and documented out-of-pocket expenses and per item fees realized will be rendered and payable as mutually agreed upon in writing between Parent and the Rights Agent. For the avoidance of doubt, and notwithstanding anything to the contrary herein, in no event shall Parent be required to indemnify or otherwise reimburse the Rights Agent for any income or similar taxes of the Rights Agent (or an of its Affiliates) in connection with the performance of its duties hereunder;

14 

 

(h)               For avoidance of doubt, no CVRs shall be issued in respect of any shares of capital stock of the Company as to which the holder thereof as of immediately prior to the Effective Time properly demands appraisal in accordance with, and who complies in all respects with, Section 262 of the Delaware General Corporation Law (such shares, “Appraisal Shares” and such statutory section, “Section 262”); provided, however, that notwithstanding the foregoing, (i) the CVRs that would have been issuable in respect of Appraisal Shares but for their status as such shall be deemed to be outstanding for purposes of determining the number of CVR Shares to be issued per CVR and (ii) if any holder of Appraisal Shares shall fail to perfect or otherwise waive, withdraw or lose the right to appraisal under Section 262 with respect to any Appraisal Shares (whether before or after the Settlement Date), then the CVRs issuable in respect of such Appraisal Shares shall be deemed to have been issued to such holder as of the Effective Time and to entitle such holder to all rights of a Holder hereunder with respect thereto, including the right to receive the CVR Shares and CVR Income in respect thereof upon the Settlement Date in accordance with the other provisions of this Agreement;

(i)                 whenever the Rights Agent shall reasonably require that a matter be proved or established prior to taking, suffering or omitting any action hereunder, the Rights Agent may rely upon a signed certificate from an authorized officer of Parent, and the Rights Agent shall incur no liability and be held harmless by Parent for or in respect of any action taken, suffered or omitted to be taken by it under the provisions of this Agreement in reliance upon and in accordance with such certificate;

(j)                 the permissive rights of the Rights Agent to do things enumerated in this Agreement shall not be construed as a duty;

(k)               the Rights Agent shall not be required to give any note or surety in respect of the execution of its powers hereunder or otherwise in respect of the premises;

(l)                 the Rights Agent shall not be liable for or by reason of, and shall be held harmless by Parent with respect to any of the statements of fact or recitals contained in this Agreement or any certificate delivered by Parent under this Agreement and shall not be required to verify the same, but all such statements and recitals are and shall be deemed to have been made by Parent only;

(m)             the Rights Agent shall have no liability and shall be held harmless by Parent in respect of the validity of this Agreement or the execution and delivery hereof (except the due execution and delivery hereof by the Rights Agent and the enforceability of this Agreement against the Rights Agent assuming the due execution and delivery hereof by the other parties hereto), nor shall it be responsible for any breach by Parent of any covenant or condition contained in this Agreement;

(n)               anything to the contrary notwithstanding, the Rights Agent shall not be liable for any special, punitive, consequential, indirect or incidental loss or damage of any kind whatsoever (including lost profits) arising out of any act or failure to act hereunder, even if the Rights Agent has been advised of the likelihood of such loss or damage or has foreseen the possibility or likelihood of such damages;

15 

 

(o)               the Rights Agent shall not be deemed to have knowledge of any event of which it was required to receive notice from Parent or the Stockholders’ Representative hereunder and did not receive such notice, and the Rights Agent shall be fully protected and shall incur no liability for failing to take action in connection therewith, unless and until it has received such required notice in writing;

(p)               the Rights Agent and any affiliate of the Rights Agent may buy, sell or deal in any of securities of Parent or the Company or become pecuniarily interested in any transaction in which Parent or the Company may be interested, or contract with or lend money to Parent or the Company or otherwise act as fully and freely as though it were not Rights Agent under this Agreement, subject to applicable Law (including applicable securities Laws). Nothing herein shall preclude the Rights Agent from acting in any other capacity for Parent or the Company or for any other legal entity;

(q)               the Rights Agent shall act hereunder solely as agent for Parent and it shall not assume any obligations or relationship of agency or trust with any of the Holders or any other Person;

(r)                 the Rights Agent shall not be deemed to have knowledge of a change in authorized officers or duly authorized representatives of any Person without notice of such change, and the Rights Agent shall be fully protected and shall incur no liability for failing to take action in connection therewith, unless and until it has received such notice in writing;

(s)                the Rights Agent shall not have any duty or responsibility in the case of the receipt of any written demand from any Holder with respect to any action or default by Parent, including, without limiting the generality of the foregoing, any duty or responsibility to initiate or attempt to initiate any proceedings at law or otherwise or to make any demand upon Parent; and

(t)                 the Rights Agent shall have no duty or obligation under any Section of this Agreement that requires the payment of taxes or charges by the Parent or Holder in connection with the Rights Agent’s performance of such duty or obligation, unless and until the Rights Agent is reasonably satisfied that all such taxes and/or charges have been paid.

Section 4.3      Resignation and Removal; Appointment of Successor.

(a)                The Rights Agent may resign at any time by giving written notice thereof to Parent and the Stockholders’ Representative specifying a date when such resignation shall take effect, which notice shall be sent at least thirty (30) days’ prior to the date so specified. In the event any transfer agency relationship in effect between the Parent and the Rights Agent terminates, the Rights Agent will be deemed to have resigned automatically and be discharged from its duties under this Agreement as of the effective date of such termination. Parent may terminate the Rights Agent at any time by giving written notice thereof to the Rights Agent and the Stockholders’ Representative specifying a date when such termination shall take effect, which notice shall be sent at least thirty (30) days prior to the date so specified.

(b)               If the Rights Agent shall resign, be removed or become incapable of acting, Parent and the Stockholders’ Representative shall promptly appoint a qualified successor Rights Agent. The successor Rights Agent so appointed shall, forthwith upon its acceptance of such appointment in accordance with this Section 4.3(b), become the successor Rights Agent.

16 

 

(c)                Parent shall give notice of each resignation and each removal of a Rights Agent and each appointment of a successor Rights Agent by mailing written notice of such event through electronic mail, to the Stockholders’ Representative. The Stockholders’ Representative shall forward such notice to the Holders. If Parent fails to send such notice within ten (10) days after acceptance of appointment by a successor Rights Agent, the successor Rights Agent shall cause such notice to be mailed and electronically transmitted at the expense of Parent.

(d)               If a successor Rights Agent has not been appointed and has not accepted such appointment by the end of the thirty (30) day period, the Stockholders’ Representative or the Rights Agent may (but shall not be obligated to) apply to a court of competent jurisdiction for the appointment of a successor Rights Agent, and the reasonable documented out-of-pocket costs, expenses (including reasonable attorneys’ fees which are incurred in connection with such a proceeding) shall be paid in accordance with Section 4.2(g) hereof. Any such successor to the Rights Agent shall agree to be bound by the terms of this Agreement and shall, upon receipt of the all relevant books and records relating thereto, become the Rights Agent hereunder. Upon delivery of all of the relevant books and records, pursuant to the terms of this Section 4.3(d) to a successor Rights Agent, the Rights Agent shall thereafter be discharged from any further obligations hereunder. Without limiting any of the rights or immunities of the Rights Agent under this Agreement, the Rights Agent is hereby authorized, in any and all events, to comply with and obey any and all final judgments, orders and decrees of any court of competent jurisdiction which may be filed, entered or issued, and all final arbitration awards and, if it shall so comply or obey, it shall not be liable to any other person by reason of such compliance or obedience.

Section 4.4      Acceptance of Appointment by Successor.

(a)                Every successor Rights Agent appointed hereunder shall execute, acknowledge and deliver to Parent, the Stockholders’ Representative and to the retiring Rights Agent an instrument accepting such appointment and a counterpart of this Agreement, and thereupon such successor Rights Agent, without any further act, deed or conveyance, shall become vested with all the rights, powers, trusts and duties of the retiring Rights Agent; but, on request of Parent, the Stockholders’ Representative or the successor Rights Agent, such retiring Rights Agent shall execute and deliver an instrument transferring to such successor Rights Agent all the rights, powers and trusts of the retiring Rights Agent but such retiring Rights Agent shall not be required to make any additional expenditure or assume any additional liability in connection with the foregoing.

Article V
COVENANTS AND REPRESENTATIONS

Section 5.1      List of Holders.

Parent shall furnish or cause to be furnished to the Rights Agent in such form as Parent receives from the Company prior to the Effective Time (or other agent performing similar services for Parent or its Affiliates), the names, addresses, shareholdings and tax certification (T.I.N.) of the record holders of Shares eligible to receive CVRs pursuant to the Merger Agreement reasonably promptly following the Effective Time.

17 

 

Section 5.2      Delivery of CVR Shares.

The Rights Agent shall cause the applicable number of CVR Shares to be registered in the names of the Holders upon receipt thereof in the manner provided for in Section 3.4 and in accordance with the terms of this Agreement, and each of the Stockholders’ Representative and Parent shall use reasonable efforts to cause the Rights Agent to do so.

Section 5.3      Assignment.

(a)                Except for assignments occurring through operation of law, Parent and the Company shall not, in whole or in part, assign any of their rights or obligations under this Agreement.

Section 5.4      Tax Treatment.

Unless (x) Parent has determined, based on advice from a “Big 4” accounting firm or nationally recognized tax counsel and after consulting with the Stockholders’ Representative in connection with obtaining such advice and making such determination, that the Intended Tax Treatment (as defined below) is not supported by a “more likely than not” or higher standard or (y) reporting in a manner consistent with the Intended Tax Treatment would require that Parent establish a reserve on its financial statements, each of Parent and each Holder shall and shall cause its Affiliates to (i) treat the CVRs as equity for applicable U.S. federal income tax purposes and to treat the settlement of the CVRs for CVR Shares as a recapitalization under Section 368(a)(1)(E) of the Code for U.S. federal income tax purposes (the “Intended Tax Treatment”) and (ii) file U.S federal income tax returns (if any such tax returns are required to be filed) in a manner consistent with the Intended Tax Treatment.

Article VI
AMENDMENTS

Section 6.1      Amendments Without Consent of Holders or Stockholders’ Representative.

(a)                Without the consent of any Holders, Parent, the Stockholders’ Representative (upon written instruction from the Holders holding a majority of the CVRs) and the Rights Agent, at any time and from time to time, may enter into one or more amendments hereto, for any of the following purposes only:

(i)                 to evidence the succession of another Person selected in accordance with Section 4.3(b) as a successor Rights Agent and the assumption by any successor of the covenants and obligations of the Rights Agent herein;

18 

 

(ii)               to evidence the termination of the CVR Registrar and the succession of another Person as a successor CVR Registrar and the assumption by any successor of the obligations of the CVR Registrar herein; or

(iii)             to add, eliminate or change any provisions of this Agreement, even if such addition, elimination or change is in any way adverse to the interests of the Holders; provided, that if such addition, elimination or change is materially adverse to the rights of holders of any other Merger Consideration CVRs, then instruction from the holders of such other Merger Consideration CVRs representing a majority of the Merger Consideration CVR Shares in respect thereof shall also be necessary; provided, further, if such addition, elimination or change adversely affects the rights and obligations of any Holder in a disproportionate manner to the other Holders hereunder, then instruction from each such affected Holder shall also be necessary; or

(iv)             as necessary to ensure that the CVRs are not subject to registration under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

(b)               Any other amendment to this Agreement shall be made by Parent, the Stockholders’ Representative (upon written instruction of each of the Holders of CVRs) and the Rights Agent.

(c)                Promptly after the execution by Parent, Stockholders Representative and the Rights Agent of any amendment pursuant to the provisions of this Section 6.1, Parent shall mail or cause to be mailed a written notice thereof by electronic mail to the Stockholders’ Representative and by first-class mail and electronic mail to the Holders at their addresses as they shall appear on the CVR Register, setting forth in general terms the substance of such amendment.

Section 6.2      Execution of Amendments; Effect of Amendments.

Prior to executing any amendment permitted by this Article VI, the Rights Agent shall be entitled to receive, and shall be fully protected in relying upon, a certificate from an appropriate officer of Parent or, if requested by the Rights Agent, an opinion of counsel selected by Parent and reasonably acceptable to Rights Agent stating that the execution of such amendment is authorized or permitted by this Agreement. The Rights Agent may, but is not obligated to, enter into any such amendment that affects the Rights Agent’s own rights, privileges, covenants or duties under this Agreement. Upon the execution of any amendment under this Article VI, this Agreement shall be modified in accordance therewith, such amendment shall form a part of this Agreement for all purposes and every Holder shall be bound thereby. No supplement or amendment to this Agreement shall be effective unless duly executed by the Rights Agent, Parent and the Stockholders’ Representative.

19 

 

Article VII
OTHER PROVISIONS OF GENERAL APPLICATION

Section 7.1      Notices to the Rights Agent, Parent and the Stockholders’ Representative.

Any notice, request, instruction or other document to be given hereunder by any party to the others shall be in writing and delivered personally or sent by registered or certified mail, postage prepaid, by electronic mail (except with respect to the Rights Agent), by facsimile transmission only with respect to the Rights Agent or overnight courier, provided that with respect to notices deliverable to the Stockholders’ Representative, such notices shall be delivered solely via electronic mail or facsimile:

If to Parent or the Company:

Eros International Plc

First Names House

Victoria Road

Douglas

Isle of Man IM2 4DF

British Isles

Attention:Mark Carbeck, Chief Corporate and Strategy Officer
Email:mark.carbeck@erosintl.com

with a copy (which shall not constitute notice) to:

Gibson, Dunn & Crutcher LLP
333 South Grand Avenue
Los Angeles, California 90071-3197

Attention:Kevin Masuda
Peter Wardle

Email: kmasuda@gibsondunn.com
pwardle@gibsondunn.com

 

If to the Rights Agent:

Computershare Trust Company, N.A.,

Computershare Inc.

150 Royall Street

Canton, MA 02021

Attention: Client Services

Facsimile: (781) 575-3146

 

If to the Stockholders’ Representative:

Fortis Advisors LLC

Attention: Notices Department (Project World Cup)

Email: notices@fortisrep.com

20 

 

Facsimile: (858) 408-1843

with a copy (which shall not constitute notice) to:

Kirkland & Ellis LLP
555 South Flower Street, Suite 3700
Los Angeles, California 90071
Attention: Rick C. Madden, P.C.
Email: rick.madden@kirkland.com

 

or to such other persons or addresses as may be designated in writing by the party to receive such notice as provided above. Any notice, request, instruction or other document given as provided above shall be deemed given to the receiving party upon actual receipt, if delivered personally; three (3) business days after deposit in the mail, if sent by registered or certified mail; upon confirmation of successful transmission if sent by electronic mail; or on the next business day after deposit with an overnight courier, if sent by an overnight courier.

Section 7.2      Effect of Headings; Construction.

The headings herein are for convenience of reference only, do not constitute part of this Agreement and shall not be deemed to limit or otherwise affect any of the provisions of this Agreement. Where a reference in this Agreement is made to a Section or Exhibit, such reference shall be to a Section of or Exhibit to this Agreement unless otherwise indicated.

Section 7.3      Successors and Assigns.

All covenants and agreements in this Agreement by any party hereto shall bind its successors and permitted assigns, whether so expressed or not.

Section 7.4      Benefits of Agreement.

Nothing in this Agreement, express or implied, shall give to any Person (other than the Holders, the parties hereto and their permitted successors and assigns hereunder) any benefit or any legal or equitable right, remedy or claim under this Agreement or under any covenant or provision herein contained, all such covenants and provisions being for the sole benefit of the Holders, the parties hereto and their permitted successors and assigns. For the avoidance of doubt, the Holders shall be considered express third party beneficiaries of this Agreement.

Section 7.5      Governing Law and Venue; Waiver of Jury Trial.

(a)                THIS AGREEMENT SHALL BE DEEMED TO BE MADE IN AND IN ALL RESPECTS SHALL BE INTERPRETED, CONSTRUED AND GOVERNED BY AND IN ACCORDANCE WITH THE LAW OF THE STATE OF DELAWARE WITHOUT REGARD TO THE CONFLICT OF LAW PRINCIPLES THEREOF THAT WOULD RESULT IN THE APPLICATION OF ANY OTHER JURISDICTION’S LAWS. The parties hereby irrevocably submit to the personal jurisdiction of the courts of the State of Delaware and the federal courts of the United States of America located in the State of Delaware solely in respect of the interpretation and enforcement of the provisions of this Agreement and of the documents

21 

 

referred to in this Agreement, and in respect of the transactions contemplated hereby, and hereby waive, and agree not to assert, as a defense in any action, suit or proceeding for the interpretation or enforcement of this Agreement or of any such document, that it is not subject thereto or that such action, suit or proceeding may not be brought or is not maintainable in said courts or that the venue thereof may not be appropriate or that this Agreement or any such document may not be enforced in or by such courts, and the parties hereto irrevocably agree that all claims relating to such action, proceeding or transactions shall be heard and determined in such a Delaware state or federal court. The parties hereby consent to and grant any such court jurisdiction over the person of such parties and, to the extent permitted by Law, over the subject matter of such dispute and agree that mailing of process or other papers in connection with any such action or proceeding in the manner provided in Section 7.1 or in such other manner as may be permitted by Law shall be valid and sufficient service thereof. If and to the extent that any action, suit or proceeding relates to the rectification of Parent’s register of members or the enforcement of Section 2.1 (“Parent Proceedings”) (but otherwise without prejudice to the provisions of this Section 7.5(a)), each party irrevocably agrees that the courts of the Isle of Man shall have jurisdiction to hear and decide such Parent Proceedings and, for this purpose only, each party irrevocably submits to the jurisdiction of the such courts.

(b)               EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT, OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (i) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (ii) EACH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (iii) EACH PARTY MAKES THIS WAIVER VOLUNTARILY, AND (iv) EACH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS Section 7.5.

Section 7.6      Severability Clause.

The provisions of this Agreement shall be deemed severable and the invalidity or unenforceability of any provision shall not affect the validity or enforceability of the other provisions of this Agreement. If any provision of this Agreement, or the application of such provision to any Person or any circumstance, is invalid or unenforceable, (a) a suitable and equitable provision shall be substituted therefor in order to carry out, so far as may be valid and enforceable, the intent and purpose of such invalid or unenforceable provision and (b) the remainder of this Agreement and the application of such provision to other Persons or circumstances shall not be affected by such invalidity or unenforceability, nor shall such invalidity or unenforceability affect the validity or enforceability of such provision, or the application of such provision, in any other jurisdiction; provided, however, that if an excluded provision shall affect the rights, immunities, liabilities, duties or obligations of the Rights Agent, the Rights Agent shall be entitled to resign immediately written notice to the Parent in accordance with Section 4.2.

22 

 

Section 7.7      Counterparts.

This Agreement may be executed in any number of counterparts, each such counterpart being deemed to be an original instrument, and all such counterparts shall together constitute the same agreement.

Section 7.8      Termination.

This Agreement shall terminate and be of no further force or effect, and the parties hereto shall have no liability hereunder, upon consummation of the issuance and delivery to the Holders of all of the Parent A Shares to which they are entitled pursuant to and in accordance with Section 3.4; provided, Article I, Article IV and this Article VII shall survive.

Section 7.9      Withholding.

Notwithstanding anything to the contrary in this Agreement, Parent, the Rights Agent and their respective agents, shall be entitled to deduct and withhold from any amounts otherwise payable to any Person pursuant to this Agreement such amounts as it is required to deduct and withhold with respect to the making of such payment under the Code or any provision of applicable Tax law; provided, however, that other than in respect of compensatory withholding or backup withholding, withholding as a result of the failure to provide the certificate set forth in Section 6.2(g) of the Merger Agreement or withholding in respect of CVR Income, Parent or the Rights Agent, as applicable, shall use commercially reasonable efforts to provide written notice to the Stockholders’ Representative no later than two (2) Business Days prior to any such withholding or deduction in respect of a Holder and to allow the Holder the opportunity to provide any Tax forms, reports or certificates as may be permitted by Applicable Laws to reduce or eliminate such withholding or deduction. Any amounts so withheld and properly remitted to the applicable Governmental Authority shall be treated for all purposes of this Agreement as having been paid to the Person in respect of which such deduction and withholding was made. In the case of any withholding from any payments not payable in cash, Parent or its agent shall withhold or shall cause to be withheld an amount of such payment having a fair market value equal to the withholding obligation to be satisfied in respect of such payment at the time such amount is withheld (provided that if any cash is otherwise payable to the relevant payee, such withholding shall be made first from such cash), and shall be treated as having paid such amount to the Person in respect of which such amount is withheld.

Section 7.10  Entire Agreement.

This Agreement, the letter agreement between Parent and the Rights Agent of even date herewith regarding fees payable to the Rights Agent (the “Fee Schedule”), and the Merger Agreement represent the entire understanding of Parent, the Company and the Stockholders’ Representative with reference to the CVRs, and, as between such Persons, this Agreement supersedes any and all other oral or written agreements hereto made with respect to the CVRs, except for the Merger Agreement. Notwithstanding the reference to any other document in this Agreement, the Rights Agent shall not be deemed to have knowledge of, or have any duty to

23 

 

ascertain or inquire into, the existence, the content, or the terms and conditions of any other agreement, instrument or document, in each case, to which the Rights Agent is not a party, whether or not such agreement, instrument or document, as the case may be, is referenced in this Agreement. This Agreement and the Fee Schedule represent the entire understanding of the Rights Agent with reference to the CVRs and the performance of the Rights Agent’s duties, its immunities and rights with respect thereto, and with respect to the Rights Agent, this Agreement and the Fee Schedule supersede any and all other oral or written agreements heretofore made with respect to the CVRs. If and to the extent that any provision of this Agreement is inconsistent or conflicts with the Merger Agreement, this Agreement shall govern and be controlling, and this Agreement may be amended, modified, supplemented or altered only in accordance with the terms of Article VII. No party shall be bound by, or be liable for, any alleged representation, promise, inducement or statement of intention not contained herein.

Section 7.11  Force Majeure.

Notwithstanding anything to the contrary contained herein, the Rights Agent shall not be liable for any delays or failures in performance to the extent resulting from acts beyond its reasonable control including, without limitation, acts of God, epidemics, pandemics, terrorist acts, breakdowns, interruptions or malfunctions of any communications or computer facilities, or loss of data due to power failures or mechanical difficulties with information storage or retrieval systems, labor difficulties, war or civil unrest; provided, that the Rights Agent shall use reasonable commercial efforts to resume performance as soon as practicable. If any such act or event occurs, the Rights Agent shall give prompt written notice to Parent and the Stockholders’ Representative, stating the nature of the act or event and action being taken to avoid or minimize its effect.

Section 7.12  Funds.

All funds received by the Rights Agent under this Agreement that are to be distributed or applied by the Rights Agent in the performance of services hereunder (the “Funds”) shall be held by the Rights Agent as agent for Parent and deposited in one or more bank accounts to be maintained by the Rights Agent in its name as agent for Parent. Until paid pursuant to the terms of this Agreement, the Rights Agent will hold the Funds through such accounts in: deposit accounts of commercial banks with Tier 1 capital exceeding $1 billion or with an average rating above investment grade by S&P (LT Local Issuer Credit Rating), Moody’s (Long Term Rating) and Fitch Ratings, Inc. (LT Issuer Default Rating) (each as reported by Bloomberg Finance L.P.). The Rights Agent shall have no responsibility or liability for any diminution of the Funds that may result from any deposit made by the Rights Agent in accordance with this paragraph, including any losses resulting from a default by any bank, financial institution or other third party. The Rights Agent may from time to time receive interest, dividends or other earnings in connection with such deposits. The Rights Agent shall not be obligated to pay such interest, dividends or earnings to the Parent, any Holder or any other Person.

 

[Remainder of Page Intentionally Left Blank.]

24 

 

IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed on its behalf by its duly authorized officers as of the day and year first above written.

EROS INTERNATIONAL PLC


By: ___________________________________________
Name:
Title:

[Signature Page to Class B CVR Agreement]

 

 

STX FILMWORKS, INC.

 

By: _______________________________
Name:
Title:

[Signature Page to Class B CVR Agreement]

 

 

FORTIS ADVISORS LLC

 

By: _______________________________
Name:
Title:

[Signature Page to Class B CVR Agreement]

 

 

COMPUTERSHARE TRUST

COMPANY, N.A. AND COMPUTERSHARE INC.

On behalf of both entities

By: ________________________________

Name:
Title:

[Signature Page to Class B CVR Agreement]

Exhibit 4.38

 

CLASS A CONTINGENT VALUE RIGHTS AGREEMENT

This CLASS A CONTINGENT VALUE RIGHTS AGREEMENT, dated as of [●], 2020 (this “Agreement”), is entered into by and among Eros International Plc, an Isle of Man company limited by shares (“Parent”), STX Filmworks, Inc., a Delaware corporation (the “Company”), Fortis Advisors LLC, a Delaware limited liability company, solely in its capacity as representative of the former holders of the Shares (in such capacity, the “Stockholders’ Representative”), and Computershare Inc., a Delaware corporation, and its wholly-owned subsidiary, Computershare Trust Company, N.A., a federally chartered trust company, collectively as rights agent (the “Rights Agent”) and as initial CVR Registrar (as defined herein).

WITNESSETH:

WHEREAS, the Company, Parent, England Holdings 2, Inc., a Delaware corporation and indirect wholly-owned Subsidiary of Parent (“England Holdings 2”), England Merger 1 Corp. (f/k/a England Merger Corp.), a Delaware corporation and a direct wholly-owned Subsidiary of England Holdings 2 (“Merger Sub”), have entered into an Agreement and Plan of Merger (as the same may be amended, modified or supplemented from time to time, the “Merger Agreement”), dated as of April 17, 2020, pursuant to which Merger Sub merged with and into the Company (the “Merger”), with the Company surviving the Merger, as an indirect wholly-owned Subsidiary of Parent;

WHEREAS, pursuant to the Merger Agreement, Parent agreed to issue to holders of record of shares of Class A Convertible Preferred Stock, par value $0.01 per share, of the Company (the “Shares”) outstanding immediately prior to the effective time of the Merger (the “Effective Time”), a number of contingent value rights (the “CVRs”) as hereinafter described; and

WHEREAS, each holder of Shares as of immediately prior to the Effective Time, will receive, among other things, as merger consideration, the right to receive upon the Effective Time a number of CVRs in such amount as set forth in Article II of the Merger Agreement.

NOW, THEREFORE, for and in consideration of the premises and the consummation of the transactions referred to above, it is mutually covenanted and agreed, for the equal and proportionate benefit of all Holders (as hereinafter defined), as follows:

Article I
DEFINITIONS

Section 1.1      Definitions.

(a)                For all purposes of this Agreement, except as otherwise expressly provided or unless the context otherwise requires:

(i)                 the terms defined in this Article I have the meanings assigned to them in this Article I, and include the plural as well as the singular;

1 

 

(ii)               the words “herein,” “hereof” and “hereunder” and other words of similar import refer to this Agreement as a whole and not to any particular Article, Section or other subdivision;

(iii)             unless the context otherwise requires, words describing the singular number shall include the plural and vice versa, words denoting any gender shall include all genders and words denoting natural Persons shall include corporations, partnerships and other Persons and vice versa;

(iv)             the term “Affiliate” when used with respect to the Company shall, after the Effective Time, include Parent and its Subsidiaries and Affiliates; and

(v)               all references to “including” shall be deemed to mean including without limitation.

(b)               Capitalized terms used but not otherwise defined herein shall have the meanings ascribed thereto in the Merger Agreement. The following terms shall have the meanings ascribed to them as follows:

Affiliate” means, with respect to any specified Person, (i) any other Person that directly or indirectly through one or more intermediaries controls, or is controlled by, or is under common control with, such specified Person (for the purposes of this definition, “control” (including, with correlative meanings, the terms “controlling,” “controlled by” and “under common control with”), as used with respect to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of such Person, whether through the ownership of voting securities, by agreement or otherwise) and (ii) with respect to any natural person, any Member of the Immediate Family of such natural person. Notwithstanding the foregoing, for purposes hereof, (i) none of the Holders, the Company, or any of their respective Subsidiaries shall be considered Affiliates of any portfolio company (or Subsidiary thereof) in which any Holder or any of its affiliated investment funds have made a debt or equity investment, and (ii) no Holder or any of its Affiliates shall be considered an Affiliate of (a) Parent or any of its Subsidiaries or (b) any other Holders or their respective Affiliates (except to the extent such Holders are otherwise Affiliates under this definition without regard to their status as Holders).

Agreement” has the meaning set forth in the Preamble.

Aggregate CVR Shares” means the aggregate number of underlying Parent A Shares issuable in respect of all CVRs.

Appraisal Shares” has the meaning set forth in Section 4.2(h).

Available Class A Merger Consideration CVR Shares” means the Merger Consideration CVR Share Cap minus the Parent A Shares issued to the Class E CVRs, the Class D CVRs, the Class C CVRs and the Class B CVRs.

Base Price” means $2.60.

2 

 

Change of Control Transaction” means the occurrence of (i) an acquisition by any Person, including any syndicate or group deemed to be a “person” under Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, of beneficial ownership, directly or indirectly, through purchase, merger or other acquisition transaction or series of purchases, mergers or other acquisition transactions of shares or comparable equity interests of Parent entitling that Person to fifty percent (50%) or more of the total voting power of all such shares or comparable equity interests of Parent; or (ii) the consolidation or merger of Parent with or into any other Person, any merger of another Person into Parent, or any conveyance, transfer, sale, lease or other disposition of all or substantially all of Parent’s properties, business or assets, other than (in the case of this clause (ii) only) (1) any transaction (x) that does not result in any reclassification, conversion, exchange or cancellation of outstanding shares or comparable equity interests of Parent, and (y) pursuant to which holders of Parent’s shares or comparable equity interest immediately prior to such transaction have the right to exercise, directly or indirectly, fifty percent (50%) or more of the total voting power of all shares or comparable equity interest of the continuing or surviving Person immediately after such transaction, or (2) any merger solely for the purpose of changing Parent’s jurisdiction of formation and resulting in a reclassification, conversion or exchange of outstanding shares or comparable equity interests into shares or comparable equity interest of the surviving entity with substantially identical rights.

Class B CVR” means the contingent value rights issued by Parent with respect to the Class B Convertible Preferred Stock, par value $0.01 of the Company, pursuant to the Merger Agreement and the Class B CVR Agreement.

Class B CVR Agreement” means the Class B CVR Agreement, dated as of the date hereof, by and among Parent, the Company, the stockholders’ representative thereunder and the rights agent thereunder.

Class B CVR Shares” means the underlying Parent A Shares issuable in respect of the Class B CVRs.

Class C CVR” means the contingent value rights issued by Parent with respect to the Class C Convertible Preferred Stock, par value $0.01 of the Company, pursuant to the Merger Agreement and the Class C CVR Agreement.

Class C CVR Agreement” means the Class C CVR Agreement, dated as of the date hereof, by and among Parent, the Company, the stockholders’ representative thereunder and the rights agent thereunder.

Class C CVR Shares” means the underlying Parent A Shares issuable in respect of the Class C CVRs.

Class D CVR” means the contingent value rights issued by Parent with respect to the Class D Convertible Preferred Stock, par value $0.01 of the Company, pursuant to the Merger Agreement and the Class D CVR Agreement.

Class D CVR Agreement” means the Class D CVR Agreement, dated as of the date hereof, by and among Parent, the Company, the stockholders’ representative thereunder and the rights agent thereunder.

3 

 

Class D CVR Shares” means the underlying Parent A Shares issuable in respect of the Class D CVRs.

Class E CVR” means the contingent value rights issued by Parent with respect to the Class E Convertible Preferred Stock, par value $0.01 of the Company, pursuant to the Merger Agreement and the Class E CVR Agreement.

Class E CVR Agreement” means the Class E CVR Agreement, dated as of the date hereof, by and among Parent, the Company, the stockholders’ representative thereunder and the rights agent thereunder.

Class E CVR Shares” means the underlying Parent A Shares issuable in respect of the Class E CVRs.

Code” means the Internal Revenue Code of 1986, as amended from time to time.

Company” has the meaning set forth in the Preamble.

CVR” means a contingent value right issued by Parent with respect to the Shares, pursuant to the Merger Agreement and this Agreement.

CVR Shares” has the meaning set forth in Section 3.4(b).

CVR Register” has the meaning set forth in Section 3.3(b).

CVR Registrar” has the meaning set forth in Section 3.3(b).

Effective Time” has the meaning set forth in the Recitals.

Eros Pre-Closing Equity Financing” has the meaning ascribed in the PIPE Agreement.

Final Settlement Time” has the meaning set forth in Section 3.2(b).

Funds” has the meaning set forth in Section 7.12.

Fully Diluted Parent Shares” means, as of immediately prior to the Effective Time, the sum of (without duplication) (i) the aggregate number of Parent Ordinary Shares then outstanding, plus (ii) the aggregate number of Parent Ordinary Shares subject to issuance pursuant to then outstanding In-the-Money Parent Options (whether or not vested), plus (iii) the aggregate number of Parent Ordinary Shares subject to issuance pursuant to then outstanding Parent RSU Awards (whether or not vested), plus (iv) the aggregate number of Parent Ordinary Shares then subject to issuance pursuant to the Parent Convertible Notes assuming full conversion thereof at a conversion price of $2.60; provided, however, that, notwithstanding the foregoing, Fully Diluted Parent Shares shall not include any Parent Ordinary Shares issuable pursuant to the Eros Pre-Closing Equity Financing. For the avoidance of doubt, Fully Diluted Parent Shares shall be calculated prior to, and without giving effect to, the PIPE Investment.

Holder” means a Person in whose name a CVR is registered in the CVR Register.

4 

 

In-the-Money Parent Options” means an Eros Option (as defined in the Merger Agreement) having a per Parent Ordinary Share exercise price less than the Parent Trading Price.

Investors’ Rights Agreement” means the Investors’ Rights Agreement, entered into on or around the date hereof, by and among Parent, certain shareholders of Parent and the investors party thereto.

Law” with respect to any Person, means (a) all provisions of all laws, statutes, ordinances, rules, regulations, permits, certificates or orders of any governmental authority applicable to such Person or any of its assets or property or to which such Person or any of its assets or property is subject, and (b) all judgments, injunctions, orders and decrees of all courts and arbitrators in proceedings or actions in which such Person is a party or by which it or any of its assets or properties is or may be bound or subject.

Lock-Up Agreement” has the meaning set forth in Section 3.4(c).

Members of the Immediate Family” means, with respect to any individual, each spouse or child or other descendants of such individual, each trust created solely for the benefit of one or more of the aforementioned Persons and their spouses and each custodian or guardian of any property of one or more of the aforementioned Persons in his capacity as such custodian or guardian.

Merger” has the meaning set forth in the Recitals.

Merger Agreement” has the meaning set forth in the Recitals.

Merger Consideration CVRs” means the CVRs, the Class E CVRs, the Class D CVRs, the Class C CVRs and the Class B CVRs.

Merger Consideration CVR Share Cap” means a number of Parent A Shares equal to the Fully Diluted Parent Shares.

Merger Consideration CVR Shares” means the Aggregate CVR Shares, the Class E CVR Shares, the Class D CVR Shares, the Class C CVR Shares and the Class B CVR Shares.

Merger Sub” has the meaning set forth in the Recitals.

Organizational Documents” has the meaning set forth in Section 2.1(a).

Parent” has the meaning set forth in the Preamble.

Parent A Shares” means the A Ordinary Shares, par value £0.30 per share, of Parent.

Parent B Shares” means the B Ordinary Shares, par value £0.30 per share, of Parent.

Parent Convertible Notes” means Parent’s Senior Convertible Notes due September 27, 2020 in the original aggregate principal amount of $27,500,000.

Parent Option” means a compensatory option to purchase Parent Ordinary Shares.

5 

 

Parent Ordinary Shares” means, collectively, the Parent A Shares and the Parent B Shares.

Parent Proceedings” has the meaning set forth in Section 7.5(a).

Parent RSU Award” means an award of restricted stock units relating to Parent Ordinary Shares.

Parent Trading Price” means the VWAP for one Parent A Share for the twenty (20) consecutive full Trading Days ending on the full Trading Day immediately preceding the Effective Time (as adjusted as appropriate to reflect any stock splits, stock dividends, combinations, reorganizations, classifications or similar events).

Permitted Transfer” means: (i) the transfer (upon the death of the Holder) by will or intestacy; (ii) transfer by instrument to an inter vivos or testamentary trust in which the CVRs are to be passed to beneficiaries upon the death of the trustee; (iii) transfers made pursuant to a court order of a court of competent jurisdiction (such as in connection with divorce, bankruptcy or liquidation); (iv) if the Holder is a partnership or limited liability company, a distribution by the transferring partnership or limited liability company to its partners or members, as applicable; (v) a transfer made by operation of law (including a consolidation or merger) or in connection with the dissolution, liquidation or termination of any corporation, limited liability company, partnership or other entity; or (vi) a transfer by any Holder to one or more of its Affiliates or affiliated investment funds of any of its Affiliates.

Permitted Transferee” means a Person who receives a CVR pursuant to a Permitted Transfer and otherwise in accordance with this Agreement.

Person” means any individual, corporation (including not-for-profit), general or limited partnership, limited liability company, joint venture, estate, trust, association, organization, Governmental Authority or other entity of any kind or nature.

PIPE Agreement” means that certain Subscription Agreement, made as of April 17, 2020, by and among Parent and each Person defined therein as a “Purchaser.”

PIPE Investment” means the purchase of Parent A Shares pursuant to the PIPE Agreement.

PIPE Lock-Up Agreement” has the meaning set forth in Section 3.4(c).

Pre-Closing VWAP” means the VWAP of the Parent A Shares for the 10 Trading Days ending on the end of the Trading Day immediately preceding the Closing.

Pre-Settlement VWAP” means the VWAP of the Parent A Shares for the 10 Trading Days ending on the end of the Trading Day immediately preceding the Settlement Date; provided, that for purposes of determining the CVR Shares issuable as of any time prior to the Settlement Date, the reference to “the Trading Day immediately preceding the Settlement Date” in this definition shall be deemed a reference to “the Trading Day immediately preceding the applicable time of determination”.

6 

 

Reference Price” means a price per share equal to the lesser of (x) the Pre-Settlement VWAP and (y) the Upper Collar Price; provided, that if the Pre-Settlement VWAP is equal to or greater than $4, then the Reference Price will equal the average of the Pre-Settlement VWAP and the Upper Collar Price.

Rights Agent” means the Rights Agent named in the first paragraph of this Agreement, until a successor Rights Agent shall have become such pursuant to the applicable provisions of this Agreement, and thereafter “Rights Agent” shall mean such successor Rights Agent.

Settlement Date” shall mean the date that is the earlier to occur of (a) the later to occur of (i) the first time that the Merger Consideration CVR Shares have been registered for resale pursuant to an effective registration statement under the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder, and (ii) the 75th calendar day after the Closing and (b) the occurrence of the Settlement Outside Date.

Settlement Outside Date” means the date that is six (6) months after the Closing; provided that the Settlement Outside Date may be extended (but only once) by holders of a majority of the Class E CVRs; provided, further, that such majority must include each such holder that, together with its Affiliates, purchased $15 million or more of Parent A Shares in the PIPE Investment.

Shares” has the meaning set forth in the Recitals.

Stockholders’ Representative” has the meaning set forth in the Preamble.

STX Purchase Price” means the lowest of (i) the Base Price, (ii) the volume weighted average of the purchase price of all purchases comprising the Eros Pre-Closing Equity Financing and (iii) the Pre-Closing VWAP; provided, however, that if the Pre-Closing VWAP is greater than $3.25, then the STX Purchase Price shall be the average of the Base Price and the Pre-Closing VWAP.

Subsidiary” of any Person shall mean any corporation or other entity of which securities or other ownership interests having ordinary voting power sufficient to elect a majority of the board of directors or comparable governing body are beneficially owned, directly or indirectly, by such Person, and any corporation or other entity that is otherwise controlled by such Person.

Taxes” or “Tax” means all taxes, charges, fees, levies or other assessments in the nature of a tax imposed by any governmental authority, including any income, gross receipts, license, severance, occupation, premium, environmental (including taxes under former Code Section 59A), customs, duties, profits, disability, alternative or add-on minimum, estimated, withholding, payroll, employment, unemployment insurance, social security (or similar), excise, sales, use, value-added, occupancy, franchise, real property, personal property, business and occupation, mercantile, windfall profits, capital stock, stamp, transfer, workmen’s compensation, amounts due under any applicable laws governing escheat or unclaimed property or other taxes, charges, fees, levies or other assessments in the nature of a tax, together with any interest, penalties, additions to tax or additional amounts imposed by any Governmental Authority with respect thereto, whether disputed or not.

7 

 

Trading Day” means, with respect to any referenced security, any day on which such security is actually traded on the principal securities exchange or securities market on which such security is then listed.

Upper Collar Price” means the quotient of the STX Purchase Price, divided by one and one-half (1.5).

VWAP” means, for any security as of any date(s), the dollar volume-weighted average price for such security on the principal securities exchange or securities market on which such security is then listed during the period beginning at 9:30:01 a.m., New York time, and ending at 4:00:00 p.m., New York time, as reported by Bloomberg through its “HP” function (sets to weighted average) or, if the foregoing does not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the electronic bulletin board for such security during the period beginning at 9:30:01 a.m., New York time, and ending at 4:00:00 p.m., New York time, as reported by Bloomberg, or, if no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the highest closing bid price and the lowest closing ask price of any of the market makers for such security as reported by OTC Markets Group Inc. If the VWAP cannot be calculated for such security on such date(s) on any of the foregoing bases, the VWAP of such security on such date(s) shall be the fair market value thereof on such date(s) as reasonably determined by a nationally recognized independent investment banking firm mutually agreed between Parent and the Stockholders’ Representative.

Article II
OPERATION OF PARENT

Section 2.1      Operation of Parent.

From the Effective Time until the Settlement Date, Parent shall not, and shall cause its Subsidiaries and Affiliates not to:

(a)                after the effectiveness of the Amended Articles (as defined in the Investors’ Rights Agreement), effect any action that requires approval by the shareholders of Parent under Parent’s Memorandum of Association or Articles of Association (the “Organizational Documents”) or applicable Law; or

(b)               prior to the effectiveness of Amended Articles, take any action set forth in Section 4.3(c) of the Investors’ Rights Agreement as in effect on the date hereof,

without, in each such case, obtaining the consent thereto of holders of such class and number of Merger Consideration CVRs (including the CVRs hereunder) that, together with the shares of Parent actually voted (at a meeting or by resolution) with respect to such action and assuming all Merger Consideration CVR Shares were outstanding Parent A Shares and voted, would be required to approve such action under the Organizational Documents, applicable Law or Section 4.3(c) of the Investors’ Rights Agreement, as applicable. For purposes of the foregoing consent rights, the number of Merger Consideration CVR Shares underlying the Merger Consideration CVRs as of any time prior to the Settlement Date shall be calculated as set forth below in Article III and in Article III of the Class E CVR Agreement with respect to the Class E CVRs, Article III of the Class D CVR Agreement with respect to the Class D CVRs, Article III of the Class C CVR Agreement with respect to the Class C CVRs and Article III of the Class B CVR Agreement with respect to the Class B CVRs.

8 

 

Article III
CVRS

Section 3.1      Issuance of CVRs; Appointment of Rights Agent; Reservation of Shares.

(a)                The CVRs shall be issued pursuant to the Merger Agreement at the time and in the manner set forth in the Merger Agreement. The registration on the books and records of Parent and administration of the CVRs shall be handled pursuant to this Agreement in the manner set forth in this Agreement.

(b)               Parent hereby appoints the Rights Agent to act as rights agent for the CVRs in accordance with the instructions hereinafter set forth in this Agreement, and the Rights Agent hereby accepts such appointment.

(c)                From the date hereof until the issuance of the Aggregate CVR Shares in accordance with the terms hereof, Parent shall reserve and keep available out of its authorized but unissued share capital, for the purpose of effecting the issuance of the CVR Shares hereunder, a number of Parent A Shares equal to the Merger Consideration CVR Share Cap, minus the number of CVR Shares, if any, previously issued in accordance with the terms of this Agreement; and if at any time during such period the number of authorized but unissued Parent A Shares shall not be sufficient to effect the issuance of the Aggregate CVR Shares in full, Parent shall take all such action as may be necessary to increase its authorized but unissued share capital as shall be sufficient for such purposes.

Section 3.2      Nontransferable; Expiration.

(a)                The CVRs shall not be sold, assigned, transferred, pledged, encumbered or in any other manner transferred or disposed of, in whole or in part, other than to a Permitted Transferee. Any purported transfer of a CVR to anyone other than a Permitted Transferee shall be null and void ab initio.

(b)               Subject to Section 3.4(c), the CVRs shall expire on the Settlement Date upon the registration of the CVR Shares in the respective names of the Holders entitled thereto and shall thereafter be of no force or effect following such registration; provided that, if any CVR Shares are not so registered on the Settlement Date, then the CVRs in respect thereof shall not expire until the registration of such CVR Shares in the respective names of the Holders entitled thereto (the time of registration thereof, the “Final Settlement Time”).

Section 3.3      No Certificate; Registration; Registration of Transfer; Change of Address.

(a)                The CVRs shall not be evidenced by a certificate or other instrument.

9 

 

(b)               Upon receipt from Parent of the names and addresses of each Holder and the number of CVRs held by such Holder, the Rights Agent shall keep a register (the “CVR Register”) for the registration of CVRs in a book-entry position for each Holder of a CVR. The CVR Register shall set forth the name and address of each Holder, and the number of CVRs held by such Holder and Tax Identification Number of each Holder. Each of Parent and the Stockholders’ Representative may receive and inspect a copy of the CVR Register, from time to time, upon written request made to the CVR Registrar. Within five (5) Business Days after receipt of such request, the CVR Registrar shall deliver a copy of the CVR Register, as then in effect, to Parent and the Stockholders’ Representative at the address set forth in Section 7.1. The Rights Agent is hereby initially appointed “CVR Registrar” for the purpose of registering CVRs and transfers of CVRs as herein provided.

(c)                Subject to the restrictions set forth in Section 3.2, every request made to transfer a CVR must be in writing and accompanied by a written instrument or instruments of transfer and any other reasonably requested documentation in form reasonably satisfactory to Parent and the CVR Registrar, duly executed by the registered Holder or Holders thereof or by the duly appointed legal representative thereof or by a duly authorized attorney. A request for a transfer of a CVR shall be accompanied by documentation establishing that the transfer is to a Permitted Transferee and shall thereafter be supplemented with and any other information as may be reasonably requested by Parent or the CVR Registrar (including opinions of counsel, if appropriate). Upon receipt of such written notice, the CVR Registrar shall, subject to its reasonable determination that the transfer instrument is in proper form and the transfer otherwise complies with the other terms and conditions herein on its face, without investigation or inquiry by the Rights Agent, register the transfer of the CVRs in the CVR Register. All duly transferred CVRs registered in the CVR Register shall be the valid obligations of Parent, evidencing the same rights and entitling the transferee to the same benefits and rights under this Agreement as those held by the transferor immediately prior to such transfer. No transfer of a CVR shall be valid until registered in the CVR Register, and any transfer not duly registered in the CVR Register will be void ab initio (unless the transfer was permissible hereunder and such failure to be duly registered is attributable to the fault of the CVR Registrar). Any transfer or assignment of the CVRs shall be without charge by Parent or the CVR Registrar (other than the cost of any Tax which shall be the responsibility of the transferor) to the Holder.

(d)               A Holder may make a written request to the CVR Registrar to change such Holder’s address of record in the CVR Register. The written request must be duly executed by the Holder and accompanied by such other evidence of the Holder’s identity or interest in the CVR as reasonably requested by the Rights Agent. Upon receipt of such written notice, the CVR Registrar is hereby authorized to, and shall promptly, record the change of address in the CVR Register.

(e)                The Stockholders’ Representative may make a written request to the Rights Agent for a list containing the names, addresses and number of CVRs of the Holders that are registered in the CVR Register. Within five (5) Business Days following the date of receipt by the Rights Agent of such request, the CVR Registrar shall deliver a copy of such list to the Stockholders’ Representative.

Section 3.4      Issuance Procedures.

10 

 

(a)                On the Settlement Date, Parent shall issue, and cause to be deposited with the Rights Agent, a number of Parent A Shares equal to the Aggregate CVR Shares. On the Settlement Date or as promptly as practicable thereafter, subject to Section 3.4(c) below, the Rights Agent shall cause the applicable number of CVR Shares to be registered in the name of each of the Holders as reflected in the CVR Register as of the close of business on the last Business Day prior to such issuance date.

(b)               The number of Parent A Shares issued in respect of each CVR from the Available Class A Merger Consideration CVR Shares (the “CVR Shares”) shall be equal to the quotient obtained by dividing $1,000 by the Reference Price; provided, that the number of Parent A Shares allocated to the CVRs shall be pro-rated in the event there are insufficient Available Class A Merger Consideration CVR Shares remaining for allocation to the CVRs. For all purposes above, fractional CVRs shall represent a proportionate number of CVR Shares; provided, however, that no fractional Parent A Shares (or certificate or scrip representing the same) shall be issued upon the settlement of any CVRs hereunder. Notwithstanding any other provision of this Agreement, each Holder of CVRs who would otherwise have been entitled to receive a fraction of a Parent A Share upon settlement of such Holder’s CVRs hereunder (after aggregating all CVRs of such Holder that are subject to this Agreement) shall receive, in lieu thereof, an amount of cash (rounded to the nearest whole cent), without interest, equal to such fractional amount multiplied by the Reference Price. Whenever a payment for fractional Parent A Shares or fractional shares is to be made by the Rights Agent under any section of this Agreement, Parent shall (i) promptly deliver to the Rights Agent a certificate setting forth the amount of any such payment and calculation related thereto and (ii) cash in the amount of such payment to the Rights Agent by wire transfer of immediately available funds to make such payment to the applicable Holder by check mailed to such Holder as reflected in the CVR Register or by wire transfer of immediately available funds. The Rights Agent shall not be liable to any Holder or Parent for the amount of any cash payment made to such Holder on behalf of Parent in accordance with the amount set forth in such certificate.

(c)                Parent’s obligation to issue and cause to be deposited with the Rights Agent the applicable number of CVR Shares, and the Rights Agent’s obligation to cause the applicable number of CVR Shares to be registered in the name of a Holder upon receipt of the applicable number of CVR Shares shall be conditioned on the execution and delivery by such Holder of a lockup agreement with Parent, substantially in the form attached hereto as Exhibit A (a “Lock-Up Agreement”); provided, however, that the Rights Agent’s obligation to cause the applicable number of CVR Shares to be registered in the name of a Holder upon receipt of the applicable number of CVR Shares to a Holder shall not be conditioned on the execution and delivery by such Holder of a Lock-Up Agreement if (i) such Holder or any of its Affiliates shall have entered into a lockup agreement with Parent in connection with the PIPE Investment (such lockup agreement, a “PIPE Lock-Up Agreement”) or (ii) the Settlement Date is the Settlement Outside Date and the Merger consideration CVR Shares have not been, as of such date, registered for resale pursuant to an effective registration statement under the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder; provided, further, that Rights Agent shall have no duty to act without the written instruction of Parent with respect to the foregoing.

11 

 

(d)               Without limiting the other provisions of this Agreement, if at any time during the period between the execution of this Agreement and the Settlement Date (or if applicable, the Final Settlement Time), any change in the number or type of outstanding Parent A Shares shall occur as a result of a reclassification, recapitalization, exchange, stock split (including a reverse stock split), combination or readjustment of capital stock, shares or any stock dividend or stock distribution with a record date during such period (including any such reclassification, recapitalization, exchange, stock split, combination or readjustment of capital stock, shares or any stock dividend or stock distribution in connection with a consolidation, merger or combination in which Parent is the continuing or surviving corporation), the CVR Shares and any other similarly dependent items, as the case may be, shall be appropriately equitably adjusted to provide the same economic effect as contemplated by this Agreement prior to such event; provided that nothing in this Section 3.4(d) shall be construed to permit any party to take any action that is otherwise prohibited or restricted by any other provision of this Agreement.

(e)                If, at any time prior to the Settlement Date (or, if applicable, the Final Settlement Time) Parent effects any Change of Control Transaction, then, upon any Settlement Date, each Holder shall have the right to receive, on the Settlement Date, for each CVR Share that would have been issuable upon the Settlement Date the same consideration (in the same amount and form) per Parent A Share payable to the holders thereof in such Change of Control Transaction. For purposes hereof, the determination of Pre-Settlement VWAP shall be appropriately adjusted to refer to such consideration instead of Parent A Shares. If holders of Parent A Shares are given any right of election as to the securities, cash or property to be received in such Change of Control Transaction, then each Holder shall be given the same right of election. To the extent necessary to effectuate the foregoing provisions, Parent shall ensure that any successor to Parent or the surviving entity in such Change of Control Transaction shall agree to be bound by the terms of this Agreement. In the event that the Final Settlement Time occurs after the Settlement Date, references herein to Settlement Date shall mean as promptly as practicable following the Change of Control Transaction.

Section 3.5      CVR Rights

(a)                Subject to Section 2.1, except as provided in Section 3.5(b), the CVRs shall not have any voting rights and shall not represent any equity or ownership interest in Parent, in any constituent company to the Merger, any Affiliate of Parent or any other Person.

(b)               The CVRs shall entitle each Holder, at the Settlement Date and subject to any applicable withholding Taxes, to a payment per Parent A Share issued thereunder, without interest, equal (as to both amount and form of consideration) to all dividends or other distributions of any kind declared per Parent A Share of the CVR Shares with a record date after the Closing and prior to the Settlement Date. Any dividends or other distributions of any kind made in respect of the CVR Shares will be delivered promptly to the Rights Agent to be held in escrow with respect to the CVRs (the “CVR Income”) treating the CVR Shares for this purpose as if the Aggregate CVR Shares were then outstanding. On the Settlement Date, the Rights Agent shall deliver to each Holder, concurrent with the issuance to such Holder of the applicable CVR Shares, the CVR Income earned in respect of each such CVR Share, less any applicable withholding Taxes.

12 

 

Article IV
THE RIGHTS AGENT

Section 4.1      Certain Duties and Responsibilities.

The Rights Agent shall not have any liability for any actions taken or not taken by the Rights Agent in connection with the execution, acceptance, administration, exercise and performance of its duties under this Agreement, except to the extent of its willful misconduct, bad faith or gross negligence (in each case as determined by a final, non-appealable judgment of a court of competent jurisdiction). No provision of this Agreement shall require the Rights Agent to expend or risk its own funds or otherwise incur any financial liability in the performance of any of its duties hereunder or in the exercise of any of its rights or powers.

Section 4.2      Certain Rights of Rights Agent.

The Rights Agent undertakes to perform such duties and only such duties as are specifically set forth in this Agreement, and no implied covenants or obligations shall be read into this Agreement against the Rights Agent. In addition:

(a)                the Rights Agent may rely and shall be protected and held harmless by Parent in and shall not incur any liability in acting or refraining from acting in connection with its performance under this Agreement upon any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order or other paper or document reasonably believed by it to be genuine and to have been signed or presented by the proper party or parties, except to the extent of its willful misconduct, bad faith or gross negligence (in each case as determined by a final, non-appealable judgment of a court of competent jurisdiction);

(b)               the Rights Agent may consult with legal counsel selected by it, and the Rights Agent shall incur no liability for or in respect of any action taken, suffered or omitted to be taken by it in the absence of bad faith, gross negligence or willful misconduct and in accordance with such advice or opinion. The reasonable costs of such counsel’s services shall be paid to the Rights Agent in accordance with Section 4.2(g) below. The Rights Agent may perform any and all of its duties through its agents, representatives, custodians and/or nominees and the Rights Agent shall not be answerable or accountable for any act, omission, default, neglect or misconduct of any such agents, representatives, custodians and/or nominees or for any loss to Parent or the Company, to the Holders or any other Person resulting from any such act, omission, default, neglect or misconduct, absent gross negligence, willful misconduct or bad faith on the part of the Rights Agent, such agents, representatives, custodians and/or nominees (which gross negligence, willful misconduct or bad faith must be determined by a final, non-appealable judgment of a court of competent jurisdiction);

(c)                if the Rights Agent becomes involved in litigation on account of this Agreement, it shall have the right to retain counsel and shall be entitled to reimbursement for all reasonable and documented out-of-pocket costs and expenses related thereto as provided in this Section 4.2(c) and Section 4.2(g) hereof; provided, however, that the Rights Agent shall not be entitled to any such reimbursement to the extent such litigation ultimately determines that the Rights Agent acted with willful misconduct, bad faith or gross negligence. In the event that conflicting demands are made upon the Rights Agent for any situation addressed or not addressed in this Agreement, the Rights Agent may withhold performance of the terms of this Agreement until such time as said conflicting demands shall have been withdrawn or the rights of the respective parties shall have been settled by court adjudication, arbitration, joint order or otherwise;

13 

 

(d)               the permissive rights of the Rights Agent to do things enumerated in this Agreement shall not be construed as a duty;

(e)                the Rights Agent shall not be required to give any note or surety in respect of the execution of such powers or otherwise in respect of the premises;

(f)                Parent agrees to indemnify the Rights Agent for, and hold the Rights Agent harmless against, any loss, liability, claim, demands, suits or expense arising out of or in connection with the Rights Agent’s duties under this Agreement, including the costs and expenses of defending the Rights Agent against any claims, charges, demands, suits or loss, unless such loss shall have been determined by a court of competent jurisdiction to be a result of the Rights Agent’s willful misconduct, bad faith or gross negligence (in each case as determined by a court of competent jurisdiction); provided, however, that the Rights Agent’s aggregate liability with respect to, arising from, or arising in connection with this Agreement, or from all services provided or omitted to be provided under this Agreement, whether in contract, in tort, or otherwise, is limited to, and shall not exceed, the amounts paid hereunder by Parent to the Rights Agent as fees and charges (but not including reimbursable expenses) in the 12 months preceding the event for which recovery is sought. The provisions under this Section 4.2 and Section 4.1 above shall survive the settlement of the CVRs and the termination of this Agreement and the resignation, replacement or removal of the Rights Agent. To the extent the Rights Agent is entitled to indemnification hereunder, the reasonable and documented out-of-pocket costs and expenses of the Rights Agent incurred in enforcing this right of indemnification shall be paid by Parent;

(g)               Parent agrees to pay to the Rights Agent reasonable compensation for all services rendered by it hereunder in accordance with a fee schedule to be mutually agreed upon in writing between Parent and the Rights Agent and, from time to time, to reimburse the Rights Agent for all of its reasonable, customary and documented out-of-pocket expenses (including reasonable fees and expenses of the Rights Agent’s counsel) and other disbursements incurred in the preparation, delivery, negotiation, amendment, administration and execution of this Agreement and the exercise and performance of its duties hereunder. Without limiting any of its rights to compensation or reimbursement under this Agreement, the Rights Agent shall deliver to Parent the final invoice for the Rights Agent fees and costs (which shall include a reasonable estimate of all remaining fees and expenses) at a reasonable time prior to the date of delivery of the CVR Shares. An invoice for any reasonable and documented out-of-pocket expenses and per item fees realized will be rendered and payable as mutually agreed upon in writing between Parent and the Rights Agent. For the avoidance of doubt, and notwithstanding anything to the contrary herein, in no event shall Parent be required to indemnify or otherwise reimburse the Rights Agent for any income or similar taxes of the Rights Agent (or an of its Affiliates) in connection with the performance of its duties hereunder;

14 

 

(h)               For avoidance of doubt, no CVRs shall be issued in respect of any shares of capital stock of the Company as to which the holder thereof as of immediately prior to the Effective Time properly demands appraisal in accordance with, and who complies in all respects with, Section 262 of the Delaware General Corporation Law (such shares, “Appraisal Shares” and such statutory section, “Section 262”); provided, however, that notwithstanding the foregoing, (i) the CVRs that would have been issuable in respect of Appraisal Shares but for their status as such shall be deemed to be outstanding for purposes of determining the number of CVR Shares to be issued per CVR and (ii) if any holder of Appraisal Shares shall fail to perfect or otherwise waive, withdraw or lose the right to appraisal under Section 262 with respect to any Appraisal Shares (whether before or after the Settlement Date), then the CVRs issuable in respect of such Appraisal Shares shall be deemed to have been issued to such holder as of the Effective Time and to entitle such holder to all rights of a Holder hereunder with respect thereto, including the right to receive the CVR Shares and CVR Income in respect thereof upon the Settlement Date in accordance with the other provisions of this Agreement;

(i)                 whenever the Rights Agent shall reasonably require that a matter be proved or established prior to taking, suffering or omitting any action hereunder, the Rights Agent may rely upon a signed certificate from an authorized officer of Parent, and the Rights Agent shall incur no liability and be held harmless by Parent for or in respect of any action taken, suffered or omitted to be taken by it under the provisions of this Agreement in reliance upon and in accordance with such certificate;

(j)                 the permissive rights of the Rights Agent to do things enumerated in this Agreement shall not be construed as a duty;

(k)               the Rights Agent shall not be required to give any note or surety in respect of the execution of its powers hereunder or otherwise in respect of the premises;

(l)                 the Rights Agent shall not be liable for or by reason of, and shall be held harmless by Parent with respect to any of the statements of fact or recitals contained in this Agreement or any certificate delivered by Parent under this Agreement and shall not be required to verify the same, but all such statements and recitals are and shall be deemed to have been made by Parent only;

(m)             the Rights Agent shall have no liability and shall be held harmless by Parent in respect of the validity of this Agreement or the execution and delivery hereof (except the due execution and delivery hereof by the Rights Agent and the enforceability of this Agreement against the Rights Agent assuming the due execution and delivery hereof by the other parties hereto), nor shall it be responsible for any breach by Parent of any covenant or condition contained in this Agreement;

(n)               anything to the contrary notwithstanding, the Rights Agent shall not be liable for any special, punitive, consequential, indirect or incidental loss or damage of any kind whatsoever (including lost profits) arising out of any act or failure to act hereunder, even if the Rights Agent has been advised of the likelihood of such loss or damage or has foreseen the possibility or likelihood of such damages;

15 

 

(o)               the Rights Agent shall not be deemed to have knowledge of any event of which it was required to receive notice from Parent or the Stockholders’ Representative hereunder and did not receive such notice, and the Rights Agent shall be fully protected and shall incur no liability for failing to take action in connection therewith, unless and until it has received such required notice in writing;

(p)               the Rights Agent and any affiliate of the Rights Agent may buy, sell or deal in any of securities of Parent or the Company or become pecuniarily interested in any transaction in which Parent or the Company may be interested, or contract with or lend money to Parent or the Company or otherwise act as fully and freely as though it were not Rights Agent under this Agreement, subject to applicable Law (including applicable securities Laws). Nothing herein shall preclude the Rights Agent from acting in any other capacity for Parent or the Company or for any other legal entity;

(q)               the Rights Agent shall act hereunder solely as agent for Parent and it shall not assume any obligations or relationship of agency or trust with any of the Holders or any other Person;

(r)                 the Rights Agent shall not be deemed to have knowledge of a change in authorized officers or duly authorized representatives of any Person without notice of such change, and the Rights Agent shall be fully protected and shall incur no liability for failing to take action in connection therewith, unless and until it has received such notice in writing;

(s)                the Rights Agent shall not have any duty or responsibility in the case of the receipt of any written demand from any Holder with respect to any action or default by Parent, including, without limiting the generality of the foregoing, any duty or responsibility to initiate or attempt to initiate any proceedings at law or otherwise or to make any demand upon Parent; and

(t)                 the Rights Agent shall have no duty or obligation under any Section of this Agreement that requires the payment of taxes or charges by the Parent or Holder in connection with the Rights Agent’s performance of such duty or obligation, unless and until the Rights Agent is reasonably satisfied that all such taxes and/or charges have been paid.

Section 4.3      Resignation and Removal; Appointment of Successor.

(a)                The Rights Agent may resign at any time by giving written notice thereof to Parent and the Stockholders’ Representative specifying a date when such resignation shall take effect, which notice shall be sent at least thirty (30) days’ prior to the date so specified. In the event any transfer agency relationship in effect between the Parent and the Rights Agent terminates, the Rights Agent will be deemed to have resigned automatically and be discharged from its duties under this Agreement as of the effective date of such termination. Parent may terminate the Rights Agent at any time by giving written notice thereof to the Rights Agent and the Stockholders’ Representative specifying a date when such termination shall take effect, which notice shall be sent at least thirty (30) days prior to the date so specified.

(b)               If the Rights Agent shall resign, be removed or become incapable of acting, Parent and the Stockholders’ Representative shall promptly appoint a qualified successor Rights Agent. The successor Rights Agent so appointed shall, forthwith upon its acceptance of such appointment in accordance with this Section 4.3(b), become the successor Rights Agent.

16 

 

(c)                Parent shall give notice of each resignation and each removal of a Rights Agent and each appointment of a successor Rights Agent by mailing written notice of such event through electronic mail, to the Stockholders’ Representative. The Stockholders’ Representative shall forward such notice to the Holders. If Parent fails to send such notice within ten (10) days after acceptance of appointment by a successor Rights Agent, the successor Rights Agent shall cause such notice to be mailed and electronically transmitted at the expense of Parent.

(d)               If a successor Rights Agent has not been appointed and has not accepted such appointment by the end of the thirty (30) day period, the Stockholders’ Representative or the Rights Agent may (but shall not be obligated to) apply to a court of competent jurisdiction for the appointment of a successor Rights Agent, and the reasonable documented out-of-pocket costs, expenses (including reasonable attorneys’ fees which are incurred in connection with such a proceeding) shall be paid in accordance with Section 4.2(g) hereof. Any such successor to the Rights Agent shall agree to be bound by the terms of this Agreement and shall, upon receipt of the all relevant books and records relating thereto, become the Rights Agent hereunder. Upon delivery of all of the relevant books and records, pursuant to the terms of this Section 4.3(d) to a successor Rights Agent, the Rights Agent shall thereafter be discharged from any further obligations hereunder. Without limiting any of the rights or immunities of the Rights Agent under this Agreement, the Rights Agent is hereby authorized, in any and all events, to comply with and obey any and all final judgments, orders and decrees of any court of competent jurisdiction which may be filed, entered or issued, and all final arbitration awards and, if it shall so comply or obey, it shall not be liable to any other person by reason of such compliance or obedience.

Section 4.4      Acceptance of Appointment by Successor.

(a)                Every successor Rights Agent appointed hereunder shall execute, acknowledge and deliver to Parent, the Stockholders’ Representative and to the retiring Rights Agent an instrument accepting such appointment and a counterpart of this Agreement, and thereupon such successor Rights Agent, without any further act, deed or conveyance, shall become vested with all the rights, powers, trusts and duties of the retiring Rights Agent; but, on request of Parent, the Stockholders’ Representative or the successor Rights Agent, such retiring Rights Agent shall execute and deliver an instrument transferring to such successor Rights Agent all the rights, powers and trusts of the retiring Rights Agent but such retiring Rights Agent shall not be required to make any additional expenditure or assume any additional liability in connection with the foregoing.

Article V
COVENANTS AND REPRESENTATIONS

Section 5.1      List of Holders.

Parent shall furnish or cause to be furnished to the Rights Agent in such form as Parent receives from the Company prior to the Effective Time (or other agent performing similar services for Parent or its Affiliates), the names, addresses, shareholdings and tax certification (T.I.N.) of the record holders of Shares eligible to receive CVRs pursuant to the Merger Agreement reasonably promptly following the Effective Time.

17 

 

Section 5.2      Delivery of CVR Shares.

The Rights Agent shall cause the applicable number of CVR Shares to be registered in the names of the Holders upon receipt thereof in the manner provided for in Section 3.4 and in accordance with the terms of this Agreement, and each of the Stockholders’ Representative and Parent shall use reasonable efforts to cause the Rights Agent to do so.

Section 5.3      Assignment.

(a)                Except for assignments occurring through operation of law, Parent and the Company shall not, in whole or in part, assign any of their rights or obligations under this Agreement.

Section 5.4      Tax Treatment.

Unless (x) Parent has determined, based on advice from a “Big 4” accounting firm or nationally recognized tax counsel and after consulting with the Stockholders’ Representative in connection with obtaining such advice and making such determination, that the Intended Tax Treatment (as defined below) is not supported by a “more likely than not” or higher standard or (y) reporting in a manner consistent with the Intended Tax Treatment would require that Parent establish a reserve on its financial statements, each of Parent and each Holder shall and shall cause its Affiliates to (i) treat the CVRs as equity for applicable U.S. federal income tax purposes and to treat the settlement of the CVRs for CVR Shares as a recapitalization under Section 368(a)(1)(E) of the Code for U.S. federal income tax purposes (the “Intended Tax Treatment”) and (ii) file U.S federal income tax returns (if any such tax returns are required to be filed) in a manner consistent with the Intended Tax Treatment.

Article VI
AMENDMENTS

Section 6.1      Amendments Without Consent of Holders or Stockholders’ Representative.

(a)                Without the consent of any Holders, Parent, the Stockholders’ Representative (upon written instruction from the Holders holding a majority of the CVRs) and the Rights Agent, at any time and from time to time, may enter into one or more amendments hereto, for any of the following purposes only:

(i)                 to evidence the succession of another Person selected in accordance with Section 4.3(b) as a successor Rights Agent and the assumption by any successor of the covenants and obligations of the Rights Agent herein;

18 

 

(ii)               to evidence the termination of the CVR Registrar and the succession of another Person as a successor CVR Registrar and the assumption by any successor of the obligations of the CVR Registrar herein; or

(iii)             to add, eliminate or change any provisions of this Agreement, even if such addition, elimination or change is in any way adverse to the interests of the Holders; provided, that if such addition, elimination or change is materially adverse to the rights of holders of any other Merger Consideration CVRs, then instruction from the holders of such other Merger Consideration CVRs representing a majority of the Merger Consideration CVR Shares in respect thereof shall also be necessary; provided, further, if such addition, elimination or change adversely affects the rights and obligations of any Holder in a disproportionate manner to the other Holders hereunder, then instruction from each such affected Holder shall also be necessary; or

(iv)             as necessary to ensure that the CVRs are not subject to registration under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

(b)               Any other amendment to this Agreement shall be made by Parent, the Stockholders’ Representative (upon written instruction of each of the Holders of CVRs) and the Rights Agent.

(c)                Promptly after the execution by Parent, Stockholders Representative and the Rights Agent of any amendment pursuant to the provisions of this Section 6.1, Parent shall mail or cause to be mailed a written notice thereof by electronic mail to the Stockholders’ Representative and by first-class mail and electronic mail to the Holders at their addresses as they shall appear on the CVR Register, setting forth in general terms the substance of such amendment.

Section 6.2      Execution of Amendments; Effect of Amendments.

Prior to executing any amendment permitted by this Article VI, the Rights Agent shall be entitled to receive, and shall be fully protected in relying upon, a certificate from an appropriate officer of Parent or, if requested by the Rights Agent, an opinion of counsel selected by Parent and reasonably acceptable to Rights Agent stating that the execution of such amendment is authorized or permitted by this Agreement. The Rights Agent may, but is not obligated to, enter into any such amendment that affects the Rights Agent’s own rights, privileges, covenants or duties under this Agreement. Upon the execution of any amendment under this Article VI, this Agreement shall be modified in accordance therewith, such amendment shall form a part of this Agreement for all purposes and every Holder shall be bound thereby. No supplement or amendment to this Agreement shall be effective unless duly executed by the Rights Agent, Parent and the Stockholders’ Representative.

19 

 

Article VII
OTHER PROVISIONS OF GENERAL APPLICATION

Section 7.1      Notices to the Rights Agent, Parent and the Stockholders’ Representative.

Any notice, request, instruction or other document to be given hereunder by any party to the others shall be in writing and delivered personally or sent by registered or certified mail, postage prepaid, by electronic mail (except with respect to the Rights Agent), by facsimile transmission only with respect to the Rights Agent or overnight courier, provided that with respect to notices deliverable to the Stockholders’ Representative, such notices shall be delivered solely via electronic mail or facsimile:

If to Parent or the Company:

Eros International Plc

First Names House

Victoria Road

Douglas

Isle of Man IM2 4DF

British Isles

Attention:Mark Carbeck, Chief Corporate and Strategy Officer
Email:mark.carbeck@erosintl.com

with a copy (which shall not constitute notice) to:

Gibson, Dunn & Crutcher LLP
333 South Grand Avenue
Los Angeles, California 90071-3197

Attention:Kevin Masuda
Peter Wardle

Email: kmasuda@gibsondunn.com
pwardle@gibsondunn.com

 

If to the Rights Agent:

Computershare Trust Company, N.A.,

Computershare Inc.

150 Royall Street

Canton, MA 02021

Attention: Client Services

Facsimile: (781) 575-3146

 

If to the Stockholders’ Representative:

Fortis Advisors LLC

Attention: Notices Department (Project World Cup)

Email: notices@fortisrep.com

20 

 

Facsimile: (858) 408-1843

with a copy (which shall not constitute notice) to:

Kirkland & Ellis LLP
555 South Flower Street, Suite 3700
Los Angeles, California 90071
Attention: Rick C. Madden, P.C.
Email: rick.madden@kirkland.com

 

or to such other persons or addresses as may be designated in writing by the party to receive such notice as provided above. Any notice, request, instruction or other document given as provided above shall be deemed given to the receiving party upon actual receipt, if delivered personally; three (3) business days after deposit in the mail, if sent by registered or certified mail; upon confirmation of successful transmission if sent by electronic mail; or on the next business day after deposit with an overnight courier, if sent by an overnight courier.

Section 7.2      Effect of Headings; Construction.

The headings herein are for convenience of reference only, do not constitute part of this Agreement and shall not be deemed to limit or otherwise affect any of the provisions of this Agreement. Where a reference in this Agreement is made to a Section or Exhibit, such reference shall be to a Section of or Exhibit to this Agreement unless otherwise indicated.

Section 7.3      Successors and Assigns.

All covenants and agreements in this Agreement by any party hereto shall bind its successors and permitted assigns, whether so expressed or not.

Section 7.4      Benefits of Agreement.

Nothing in this Agreement, express or implied, shall give to any Person (other than the Holders, the parties hereto and their permitted successors and assigns hereunder) any benefit or any legal or equitable right, remedy or claim under this Agreement or under any covenant or provision herein contained, all such covenants and provisions being for the sole benefit of the Holders, the parties hereto and their permitted successors and assigns. For the avoidance of doubt, the Holders shall be considered express third party beneficiaries of this Agreement.

Section 7.5      Governing Law and Venue; Waiver of Jury Trial.

(a)                THIS AGREEMENT SHALL BE DEEMED TO BE MADE IN AND IN ALL RESPECTS SHALL BE INTERPRETED, CONSTRUED AND GOVERNED BY AND IN ACCORDANCE WITH THE LAW OF THE STATE OF DELAWARE WITHOUT REGARD TO THE CONFLICT OF LAW PRINCIPLES THEREOF THAT WOULD RESULT IN THE APPLICATION OF ANY OTHER JURISDICTION’S LAWS. The parties hereby irrevocably submit to the personal jurisdiction of the courts of the State of Delaware and the federal courts of the United States of America located in the State of Delaware solely in respect of the interpretation and enforcement of the provisions of this Agreement and of the documents

21 

 

referred to in this Agreement, and in respect of the transactions contemplated hereby, and hereby waive, and agree not to assert, as a defense in any action, suit or proceeding for the interpretation or enforcement of this Agreement or of any such document, that it is not subject thereto or that such action, suit or proceeding may not be brought or is not maintainable in said courts or that the venue thereof may not be appropriate or that this Agreement or any such document may not be enforced in or by such courts, and the parties hereto irrevocably agree that all claims relating to such action, proceeding or transactions shall be heard and determined in such a Delaware state or federal court. The parties hereby consent to and grant any such court jurisdiction over the person of such parties and, to the extent permitted by Law, over the subject matter of such dispute and agree that mailing of process or other papers in connection with any such action or proceeding in the manner provided in Section 7.1 or in such other manner as may be permitted by Law shall be valid and sufficient service thereof. If and to the extent that any action, suit or proceeding relates to the rectification of Parent’s register of members or the enforcement of Section 2.1 (“Parent Proceedings”) (but otherwise without prejudice to the provisions of this Section 7.5(a)), each party irrevocably agrees that the courts of the Isle of Man shall have jurisdiction to hear and decide such Parent Proceedings and, for this purpose only, each party irrevocably submits to the jurisdiction of the such courts.

(b)               EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT, OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (i) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (ii) EACH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (iii) EACH PARTY MAKES THIS WAIVER VOLUNTARILY, AND (iv) EACH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS Section 7.5.

Section 7.6      Severability Clause.

The provisions of this Agreement shall be deemed severable and the invalidity or unenforceability of any provision shall not affect the validity or enforceability of the other provisions of this Agreement. If any provision of this Agreement, or the application of such provision to any Person or any circumstance, is invalid or unenforceable, (a) a suitable and equitable provision shall be substituted therefor in order to carry out, so far as may be valid and enforceable, the intent and purpose of such invalid or unenforceable provision and (b) the remainder of this Agreement and the application of such provision to other Persons or circumstances shall not be affected by such invalidity or unenforceability, nor shall such invalidity or unenforceability affect the validity or enforceability of such provision, or the application of such provision, in any other jurisdiction; provided, however, that if an excluded provision shall affect the rights, immunities, liabilities, duties or obligations of the Rights Agent, the Rights Agent shall be entitled to resign immediately written notice to the Parent in accordance with Section 4.2.

22 

 

Section 7.7      Counterparts.

This Agreement may be executed in any number of counterparts, each such counterpart being deemed to be an original instrument, and all such counterparts shall together constitute the same agreement.

Section 7.8      Termination.

This Agreement shall terminate and be of no further force or effect, and the parties hereto shall have no liability hereunder, upon consummation of the issuance and delivery to the Holders of all of the Parent A Shares to which they are entitled pursuant to and in accordance with Section 3.4; provided, Article I, Article IV and this Article VII shall survive.

Section 7.9      Withholding.

Notwithstanding anything to the contrary in this Agreement, Parent, the Rights Agent and their respective agents, shall be entitled to deduct and withhold from any amounts otherwise payable to any Person pursuant to this Agreement such amounts as it is required to deduct and withhold with respect to the making of such payment under the Code or any provision of applicable Tax law; provided, however, that other than in respect of compensatory withholding or backup withholding, withholding as a result of the failure to provide the certificate set forth in Section 6.2(g) of the Merger Agreement or withholding in respect of CVR Income, Parent or the Rights Agent, as applicable, shall use commercially reasonable efforts to provide written notice to the Stockholders’ Representative no later than two (2) Business Days prior to any such withholding or deduction in respect of a Holder and to allow the Holder the opportunity to provide any Tax forms, reports or certificates as may be permitted by Applicable Laws to reduce or eliminate such withholding or deduction. Any amounts so withheld and properly remitted to the applicable Governmental Authority shall be treated for all purposes of this Agreement as having been paid to the Person in respect of which such deduction and withholding was made. In the case of any withholding from any payments not payable in cash, Parent or its agent shall withhold or shall cause to be withheld an amount of such payment having a fair market value equal to the withholding obligation to be satisfied in respect of such payment at the time such amount is withheld (provided that if any cash is otherwise payable to the relevant payee, such withholding shall be made first from such cash), and shall be treated as having paid such amount to the Person in respect of which such amount is withheld.

Section 7.10  Entire Agreement.

This Agreement, the letter agreement between Parent and the Rights Agent of even date herewith regarding fees payable to the Rights Agent (the “Fee Schedule”), and the Merger Agreement represent the entire understanding of Parent, the Company and the Stockholders’ Representative with reference to the CVRs, and, as between such Persons, this Agreement supersedes any and all other oral or written agreements hereto made with respect to the CVRs, except for the Merger Agreement. Notwithstanding the reference to any other document in this Agreement, the Rights Agent shall not be deemed to have knowledge of, or have any duty to

23 

 

ascertain or inquire into, the existence, the content, or the terms and conditions of any other agreement, instrument or document, in each case, to which the Rights Agent is not a party, whether or not such agreement, instrument or document, as the case may be, is referenced in this Agreement. This Agreement and the Fee Schedule represent the entire understanding of the Rights Agent with reference to the CVRs and the performance of the Rights Agent’s duties, its immunities and rights with respect thereto, and with respect to the Rights Agent, this Agreement and the Fee Schedule supersede any and all other oral or written agreements heretofore made with respect to the CVRs. If and to the extent that any provision of this Agreement is inconsistent or conflicts with the Merger Agreement, this Agreement shall govern and be controlling, and this Agreement may be amended, modified, supplemented or altered only in accordance with the terms of Article VII. No party shall be bound by, or be liable for, any alleged representation, promise, inducement or statement of intention not contained herein.

Section 7.11  Force Majeure.

Notwithstanding anything to the contrary contained herein, the Rights Agent shall not be liable for any delays or failures in performance to the extent resulting from acts beyond its reasonable control including, without limitation, acts of God, epidemics, pandemics, terrorist acts, breakdowns, interruptions or malfunctions of any communications or computer facilities, or loss of data due to power failures or mechanical difficulties with information storage or retrieval systems, labor difficulties, war or civil unrest; provided, that the Rights Agent shall use reasonable commercial efforts to resume performance as soon as practicable. If any such act or event occurs, the Rights Agent shall give prompt written notice to Parent and the Stockholders’ Representative, stating the nature of the act or event and action being taken to avoid or minimize its effect.

Section 7.12  Funds.

All funds received by the Rights Agent under this Agreement that are to be distributed or applied by the Rights Agent in the performance of services hereunder (the “Funds”) shall be held by the Rights Agent as agent for Parent and deposited in one or more bank accounts to be maintained by the Rights Agent in its name as agent for Parent. Until paid pursuant to the terms of this Agreement, the Rights Agent will hold the Funds through such accounts in: deposit accounts of commercial banks with Tier 1 capital exceeding $1 billion or with an average rating above investment grade by S&P (LT Local Issuer Credit Rating), Moody’s (Long Term Rating) and Fitch Ratings, Inc. (LT Issuer Default Rating) (each as reported by Bloomberg Finance L.P.). The Rights Agent shall have no responsibility or liability for any diminution of the Funds that may result from any deposit made by the Rights Agent in accordance with this paragraph, including any losses resulting from a default by any bank, financial institution or other third party. The Rights Agent may from time to time receive interest, dividends or other earnings in connection with such deposits. The Rights Agent shall not be obligated to pay such interest, dividends or earnings to the Parent, any Holder or any other Person.

 

[Remainder of Page Intentionally Left Blank.]

24 

 

IN WITNESS WHEREOF, each of the parties has caused this Agreement to be executed on its behalf by its duly authorized officers as of the day and year first above written.

EROS INTERNATIONAL PLC


By: ___________________________________________
Name:
Title:

 

[Signature Page to Class A CVR Agreement]

 

 

STX FILMWORKS, INC.

 

By: _______________________________
Name:
Title:

[Signature Page to Class A CVR Agreement]

 

 

FORTIS ADVISORS LLC

 

By: _______________________________
Name:
Title:

[Signature Page to Class A CVR Agreement]

 

 

COMPUTERSHARE TRUST

COMPANY, N.A. AND COMPUTERSHARE INC.

On behalf of both entities

By: ________________________________

Name:
Title:

 

 

[Signature Page to Class A CVR Agreement]

Exhibit 4.39

 

 

INVESTORS’ RIGHTS AGREEMENT

by and among

 

EROS INTERNATIONAL PLC,

 

EROS FOUNDER GROUP,

 

AND

 

THE OTHER PARTIES NAMED HEREIN

 

 

Dated as of [__________], 2020

 

 

 

 

 

 

table of contents

      Page
Article I DEFINITIONS 1
  Section 1.1 Definitions 1
  Section 1.2 General Interpretive Principles 7
Article II REPRESENTATIONS AND WARRANTIES 7
  Section 2.1 Representations and Warranties of the Investors 7
  Section 2.2 Entitlement of the Company and the Investors to Rely on Representations and Warranties 8
  Section 2.3 Representations and Warranties of the Company 8
Article III MANAGEMENT 9
  Section 3.1 Board Representation Rights of the Hony Investor 9
  Section 3.2 Board Representation Rights of the Eros Founder Group 10
  Section 3.3 Committees of the Board 12
  Section 3.4 Board Observer Rights of the Liberty Investor 14
Article IV MINORITY PROTECTIONS 15
  Section 4.1 Restrictions on Certain Actions of the Eros Founder Group 15
  Section 4.2 Amended Articles 16
  Section 4.3 Consent Rights Pending Effectiveness of the Amended Articles 16
Article V REGISTRATION RIGHTS 18
  Section 5.1 Investors Registration Rights Agreement 18
Article VI ADDITIONAL AGREEMENTS OF THE PARTIES 18
  Section 6.1 Indemnity and Liability. 18
  Section 6.2 Access to Information and Personnel; Regulatory Examinations 20
  Section 6.3 Confidentiality 21
  Section 6.4 U.S. Tax Matters. 22

i 

 
  Section 6.5 Certain Other Matters. 23
       
Article VII MISCELLANEOUS 24
  Section 7.1 Freedom to Pursue Opportunities. 24
  Section 7.2 Entire Agreement 25
  Section 7.3 Governing Law; Submission to Jurisdiction; Waiver of Jury Trial. 25
  Section 7.4 Obligations; Remedies 26
  Section 7.5 Amendment and Waiver. 26
  Section 7.6 Binding Effect; Assignment 26
  Section 7.7 Termination 26
  Section 7.8 Non-Recourse 27
  Section 7.9 Notices 27
  Section 7.10 Severability 29
  Section 7.11 Headings 29
  Section 7.12 Contracts (Rights of Third Parties) Act 2001 29
  Section 7.13 Recapitalizations; Exchanges, Etc 29
  Section 7.14 Counterparts 29
Exhibit A - Form of Investors Registration Rights Agreement  

ii 

 

investors’ rights AGREEMENT

This INVESTORS’ RIGHTS AGREEMENT (as the same may be amended from time to time in accordance with its terms, the “Agreement”) is made as of [____], 2020, by and among (i) Eros International Plc, an Isle of Man public company limited by shares (the “Company”); (ii) the Eros Founder Group; and (iii) each of the Persons set forth on Schedule 1 attached hereto (collectively, the “New Investors” and together with each member of the Eros Founder Group, the “Investors” and each, an “Investor”); provided that each Minority New Investor (as defined below) has executed this Agreement only in respect of, and shall only be bound by the obligations, and entitled to the benefit of the rights, arising under Article I, Article II, Section 3.4 (to the extent applicable by its terms to such Minority New Investor), Article V, Article VI and Article VII hereof.

WHEREAS, in connection with the transactions contemplated by the Agreement and Plan of Merger, dated as of April 17, 2020, by and among the Company, England Holdings 2, Inc., a Delaware corporation (“England Holdings 2”), an indirect wholly owned Subsidiary of the Company, England Merger Corp., a Delaware corporation and a direct wholly owned subsidiary of England Holdings 2 and indirect wholly owned Subsidiary of the Company, and STX Filmworks, Inc., a Delaware corporation (as may be amended, restated, supplemented and/or otherwise modified from time to time, the “Merger Agreement”), the parties hereto have agreed to enter into this Agreement.

THEREFORE, in consideration of the mutual covenants and agreements contained herein, the parties mutually agree as follows:

Article I

DEFINITIONS

Section 1.1 Definitions. As used in this Agreement, the following terms shall have the meanings set forth below:

A Ordinary Shares” means the A ordinary shares of the Company, par value £0.30 per share.

Affiliate” means (i) with respect to any Person, any other Person that controls, is controlled by, or is under common control with such Person, (ii) with respect to any Person that is a natural person, any Member of the Immediate Family of such natural person and (iii) with respect to any New Investor, any affiliated investment fund of such New Investor or of any of its Affiliates. The term “control,” as used with respect to any Person, means the power to direct or cause the direction of the management and policies of such Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise. “Controlled” and “controlling” have meanings correlative to the foregoing. Notwithstanding the foregoing, for purposes hereof, none of the Investors, the Company, or any of their respective Subsidiaries shall be considered Affiliates of any portfolio company (or Subsidiary thereof) in which the Investors or any of their or their Affiliates’ respective affiliated investment funds have made a debt or equity investment, and no Investor or any of its Affiliates shall be considered an Affiliate of (a) the Company or any of its Subsidiaries or (b) any other Investor or their respective Affiliates.

1 

 

Aggregate Investor Voting Percentage” means, as of any determination date with respect to any one or more Investors, a fraction (expressed as a percentage), with the numerator being the aggregate number of votes with respect to the Shares beneficially owned by such Investor(s) and its (or their) Affiliates, and the denominator of which is the aggregate number of votes with respect to all Shares then outstanding; provided that, whenever a reference to the Aggregate Investor Voting Percentage of any Person or Persons is accompanied by the phrase “(giving effect to the CVRs),” then the number of Shares beneficially owned by such Person or Persons shall be deemed to include the A Ordinary Shares issuable pursuant to CVRs held by such Person or Person as of the applicable time of determination and the number of Shares outstanding shall be deemed to include all Merger Consideration CVR Shares to the extent not already issued and allotted to the holders of CVRs.

Agreement” has the meaning set forth in the Preamble.

Audit Committee” has the meaning set forth in Section 3.3(a).

B Ordinary Share” means B ordinary shares of the Company, par value £0.30 per share.

beneficial ownership” and “beneficially own” and similar terms have the meaning set forth in Rule 13d-3 under the Exchange Act; provided, however, that no Investor shall be deemed to beneficially own any securities of the Company held by any other Investor solely by virtue of the provisions of this Agreement (other than this definition which shall be deemed to be read for this purpose without the proviso hereto); provided, further, that whenever a reference to any Person’s or Persons’ beneficial ownership of Shares is accompanied by the phrase “(giving effect to the CVRs),” then the number of Shares beneficially owned by such Person or Persons shall be deemed to include the A Ordinary Shares that would be issuable pursuant to CVRs held by such Person or Persons as of the applicable time of determination under the terms of the applicable CVR Agreement.

Board” means the Board of Directors of the Company.

CFC” has the meaning set forth in set forth in Section 6.4(a).

Change in Control” means any transaction or series of related transactions (whether by merger, consolidation, recapitalization, liquidation or sale or transfer of Shares or assets (including equity securities of the Subsidiaries) or otherwise) as a result of which any Person or group, within the meaning of Section 13(d)(3) of the Exchange Act (other than members of the Eros Founder Group and their respective Affiliates), obtains or would obtain ownership, directly or indirectly, of (i) Shares that represent more than 50% of the total voting power of the outstanding capital stock of the Company or applicable successor entity or (ii) all or substantially all of the assets of the Company and its Subsidiaries on a consolidated basis.

Class E CVR Agreement” has the meaning set forth in the Merger Agreement.

Code” has the meaning set forth in Section 6.4(a).

2 

 

Company” has the meaning set forth in the Preamble, except that, as used in Section 6.4, “Company” shall have the meaning set forth in Section 6.4(a).

Company Articles” means the Amended and Restated Articles of Association of the Company, as may be amended, supplemented or otherwise modified from time to time.

CVRs” has the meaning ascribed to such term in the Merger Agreement.

CVR Agreement” has the meaning ascribed to such term in the Merger Agreement.

Director” means any of the individuals elected or appointed to serve on the Board as a director of the Company.

Effective Time” has the meaning ascribed to such term in the Merger Agreement.

Effective Time Equity” means, with respect to any one or more Investors, the number of Shares beneficially owned by such Investor(s) as of immediately following the Effective Time (subject to appropriate adjustment for any stock splits, stock dividends, combinations, recapitalizations and the like); provided that, with respect to any New Investor, solely for purposes of this definition, the Shares beneficially owned by such New Investor shall be deemed to include all Merger Consideration CVR Shares underlying CVRs held by such New Investor, calculated as of the Settlement Date; provided further, that with respect to the Eros Founder Group, solely for purposes of this definition, the Shares beneficially owned by the Eros Founder Group shall not include any Shares underlying, or issuable pursuant to, any equity awards granted to members of the Eros Founder Group as compensation at or as of immediately following the Effective Time.

EIML” means Eros International Media Ltd.

EIML Committee” has the meaning set forth in Section 3.3(c).

Equity Securities” means, with respect to the Company, (i) Shares, (ii) obligations, evidences of indebtedness or other securities or interests, in each case that are convertible or exchangeable into Shares, (iii) warrants, options or other rights to purchase or otherwise acquire Shares, (iv) any capital stock of the Company issued or issuable upon the exercise, conversion, or exchange of any of the securities referred to in clauses (i) through (iii) above, or (v) any securities issued or issuable directly or indirectly with respect to the securities referred to in clauses (i) through (iv) above by way of share dividend or shares split or in connection with a combination of shares, recapitalization, reclassification, merger, consolidation or other reorganization. As to any particular securities constituting Shares, such securities will cease to be Shares when they have been (1) effectively registered under the 1933 Securities Act and disposed of in accordance with the registration statement or prospectus covering them, (2) distributed to the public through a broker, dealer or market maker pursuant to Rule 144 under the 1933 Securities Act (or any similar or equivalent provision then in force), or (3) repurchased or otherwise acquired by the Company.

Eros Designated Directors” has the meaning ascribed in the Merger Agreement.

3 

 

Eros Founder Group” means, collectively, (i) Eros Ventures Limited; (ii) Beech Investments Limited; (iii) the trustees for the time being of the Ganges Trust; (iv) Kishore Lulla and his estate, guardian, or conservator; (v) the other descendants of Arjan Lulla and their respective estates, guardians or conservators; (vi) the trustees, solely in their respective capacities as such, of any Family Trust; and (vii) any custodian or bare nominee for any person within (i) – (vi) inclusive and any of their respective Affiliates who beneficially own Shares from time to time. Any determination, appointment, designation, consent or approval to be made, given or withheld by the Eros Founder Group in its capacity as such under this Agreement shall be made, given or withheld by Kishore Lulla or such other Person(s) as may be designated by Kishore Lulla in writing from time to time.

Eros Nominee” has the meaning set forth in Section 3.2(a).

Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder, as the same may be amended from time to time.

Family Trust” means any trust the sole beneficiaries of which are (i) Kishore Lulla, his spouse, any of their descendants, spouses of any descendants and their respective estates, guardians, or conservators or (ii) the other descendants of Arjan Lulla and their respective estates, guardians or conservators.

FCPA” has the meaning set forth in Section 6.5(c).

Hony Investor” means, collectively, Great Mission International Limited, Marco Alliance Limited, and their respective Affiliates.  Any determination, appointment, designation, consent or approval to be made, given or withheld by the Hony Investor in its capacity as such under this Agreement shall be made, given or withheld by Marco Alliance Limited or such other Person(s) as may be designated by Marco Alliance Limited in writing from time to time.

Hony Nominee” has the meaning set forth in Section 3.1(a).

IFRS” means International Financial Reporting Standards promulgated by the International Accounting Standards Board (which includes standards and interpretations approved by the International Accounting Standards Board and International Accounting Standards issued under previous constitutions), together with its pronouncements thereon from time to time.

Indemnified Liabilities” has the meaning set forth in Section 6.1.

Indemnified Party” has the meaning set forth in Section 6.1.

Indemnitees” has the meaning set forth in Section 6.1.

Independent Committee” has the meaning set forth in Section 3.3(b).

Independent Director” means a Director who qualifies, as of the date of such Director’s election or appointment to the Board and as of any other date on which the determination is being made, as an “Independent Director” under Rule 10A-3 under the Exchange Act, as well as any other requirement of the U.S. securities laws or the listing standards of a U.S. national securities exchange that is then applicable to the Company, as determined by the Board.

4 

 

Investors” has the meaning set forth in the Preamble.

Investors Registration Rights Agreement” has the meaning set forth in Section 5.1.

Law,” with respect to any Person, means (a) all provisions of all laws, statutes, ordinances, rules, regulations, permits, certificates or orders of any governmental authority applicable to such Person or any of its assets or property or to which such Person or any of its assets or property is subject, and (b) all judgments, injunctions, orders and decrees of all courts and arbitrators in proceedings or actions in which such Person is a party or by which it or any of its assets or properties is or may be bound or subject.

Liberty Investor” means, collectively, Liberty Global Incorporated Limited and its Affiliates. Any determination, appointment, designation, consent or approval to be made, given or withheld by the Liberty Investor in its capacity as such under this Agreement shall be made, given or withheld by Liberty Global Incorporated Limited or such other Person(s) as may be designated by Liberty Global Incorporated Limited in writing from time to time.

Members of the Immediate Family” means, with respect to any natural person, (i) each spouse or child or other descendants of such person, (ii) each trust created solely for the benefit of one or more persons referred to in clause (i) and any of their respective spouses, and (iii) each custodian or guardian of any property of any person referred to in clauses (i) or (ii) in such custodian’s or guardian’s capacity as such.

Merger Consideration CVR Shares” has the meaning ascribed to such term in the Class E CVR Agreement.

Minority New Investor” means Liberty Global Incorporated Limited.

Necessary Action” means, with respect to any party and a specified result, all actions (to the extent such actions are permitted by Law and within such party’s control) necessary to cause such result, including (i) voting or providing a written resolution or proxy with respect to the Shares, (ii) causing the adoption of shareholders’ resolutions and amendments to the organizational documents of the Company, (iii) executing agreements and instruments and (iv) making, or causing to be made, with governmental, administrative or regulatory authorities, all filings, registrations or similar actions that are required to achieve such result.

Nominating Committee” has the meaning set forth in Section 3.3(a).

Observer” has the meaning set forth in Section 3.4.

Organizational Documents” has the meaning set forth in Section 4.3(a).

Person” means an individual, partnership, corporation, business trust, joint stock company, trust, unincorporated association, joint venture, limited liability company or any other entity of whatever nature, and shall include any successor (by merger or otherwise) of such entity.

5 

 

PFIC” has the meaning set forth in Section 6.4(b).

Proprietary Information” has the meaning set forth in Section 6.3.

Public Offering” means any public offering and sale of equity securities of the Company or any successor to the Company for cash pursuant to an effective registration statement (other than on Form F-4, F-8 or a comparable form) under the Securities Act.

Remuneration Committee” has the meaning set forth in Section 3.3(a).

Representatives” has the meaning set forth in Section 6.3(i).

Rule 144” means Rule 144 under the Securities Act (or any successor rule or regulation).

SEC” means the United States Securities and Exchange Commission.

Securities Act” means the U.S. Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder, as the same may be amended from time to time.

Settlement Date” has the meaning ascribed to such term in the Class E CVR Agreement.

Shareholder” means each member of the Eros Founder Group and each of the New Investors and their respective Affiliates, in each case so long as such Person owns Shares.

Shares” means, collectively, A Ordinary Shares and B Ordinary Shares, of the Company, and any securities into which such shares shall have been changed or any securities resulting from any reclassification or recapitalization of such shares.

Stock Exchange” means the New York Stock Exchange or other national securities exchange or interdealer quotation system on which the Shares are at any time listed or quoted.

STX Designated Directors” has the meaning ascribed in the Merger Agreement.

Subsidiary” means, with respect to any Person, any corporation, partnership, trust, limited liability company or other non-corporate business enterprise in which such Person (or another Subsidiary of such Person) holds stock or other ownership interests representing (a) more than fifty percent (50%) of the voting power of all outstanding stock or ownership interests of such entity, (b) the right to receive more than fifty percent (50%) of the net assets of such entity available for distribution to the holders of outstanding stock or ownership interests upon a liquidation or dissolution of such entity or (c) a general or managing partnership interest in such entity.

Transfer” means, with respect to any Shares, a direct or indirect transfer (including through one or more transfers), sale, exchange, assignment, pledge, hypothecation or other encumbrance or other disposition of such Shares, including the grant of an option or other right, whether directly or indirectly, whether voluntarily, involuntarily or by operation of Law. “Transferred”, “Transferring” and “Transferee” shall each have a correlative meaning to the term “Transfer.

6 

 

Section 1.2 General Interpretive Principles. The name assigned to this Agreement and the section captions used herein are for convenience of reference only and shall not be construed to affect the meaning, construction or effect hereof. Unless otherwise specified, the terms “hereof,” “herein” and similar terms refer to this Agreement as a whole, and references herein to Articles or Sections refer to Articles or Sections of this Agreement. For purposes of this Agreement, the words, “include,” “includes” and “including,” when used herein, shall be deemed in each case to be followed by the words “without limitation.” The terms “dollars” and “$” shall mean United States dollars. Except as otherwise set forth herein, Shares underlying unexercised options that have been issued by the Company shall not be deemed “outstanding” for any purposes in this Agreement. The parties hereto have participated jointly in the negotiation and drafting of this Agreement. If an ambiguity or question of intent or interpretation arises, this Agreement will be construed as if drafted jointly by the parties and no presumption or burden of proof will arise favoring or disfavoring any party because of the authorship of any provision of this Agreement.

Article II

REPRESENTATIONS AND WARRANTIES

Section 2.1 Representations and Warranties of the Investors. Each Investor, severally and not jointly, hereby represents and warrants to the Company, and each other Investor that on the date hereof:

(a)       This Agreement has been duly authorized, executed and delivered by such Investor and, assuming the due execution and delivery of this Agreement by the other parties hereto, this Agreement constitutes the valid and binding obligation of such Investor, enforceable against such Investor in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar Laws affecting the enforcement of creditors’ rights generally and by the effect of general principles of equity (regardless of whether enforcement is considered in a proceeding in equity or at Law).

(b)       The execution, delivery and performance by such Investor of this Agreement and the agreements contemplated hereby and the consummation by such Investor of the transactions contemplated hereby do not and will not, with or without the giving of notice or the passage of time or both: (i) violate the provisions of any Law, rule or regulation applicable to such Investor or his, her or its properties or assets; (ii) violate any judgment, decree, order or award of any court, governmental or quasi-governmental agency or arbitrator applicable to such Investor or his, her or its properties or assets; or (iii) result in any breach of any terms or conditions of, or constitute a default under, any contract, agreement or instrument to which such Investor is a party or by which such Investor or his, her or its properties or assets are bound.

7 

 

(c)       Such Investor understands that the Shares may not be sold, Transferred, or otherwise disposed of without registration under the Securities Act or an exemption therefrom, and that in the absence of an effective registration statement covering the Shares or an available exemption from registration under the Securities Act, Shares must be held indefinitely.

Section 2.2 Entitlement of the Company and the Investors to Rely on Representations and Warranties. The representations and warranties contained in Section 2.1 may be relied upon by the Company, and by the other Investors, in connection with the entering into of this Agreement. Without limiting the foregoing, each Investor agrees to give the Company prompt written notice in the event that any representation of such Investor contained in Section 2.1 ceases to be true at any time following the date hereof.

Section 2.3 Representations and Warranties of the Company. The Company hereby represents and warrants to the Investors that as of the date of this Agreement:

(a)       It is a company limited by shares duly organized, validly existing and in good standing under the laws of the Isle of Man, it has full power and authority to execute, deliver and perform this Agreement and to consummate the transactions contemplated hereby, and the execution, delivery and performance by it of this Agreement and the consummation of the transactions contemplated hereby have been duly authorized by all necessary corporate action.

(b)       This Agreement has been duly and validly executed and delivered by the Company and constitutes a legal and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar Laws affecting the enforcement of creditors’ rights generally and by the effect of general principles of equity (regardless of whether enforcement is considered in a proceeding in equity or at Law).

(c)       The execution, delivery and performance by the Company of this Agreement and the consummation by the Company of the transactions contemplated hereby do not and will not, with or without the giving of notice or the passage of time or both, (i) violate any provision of Law, rule or regulation applicable to the Company or its properties or assets, (ii) violate any judgment, decree, order or award of any court, governmental or quasi-governmental agency or arbitrator applicable to the Company or its properties or assets or (iii) result in any breach of any terms or conditions of, or constitute a default under, any contract, agreement or instrument to which the Company is a party or by which it or its properties or assets are bound.

(d)       The Company does not engage in the design, fabrication, development, testing, production or manufacture of critical technologies within the meaning of the Defense Production Act of 1950, as amended, including all implementing regulations thereof.

8 

 

Article III

MANAGEMENT

Section 3.1 Board Representation Rights of the Hony Investor. Notwithstanding anything to the contrary in this Agreement, the provisions of this Section 3.1 constitute an agreement between the Company, on the one hand, and the Hony Investor, on the other hand, and shall not constitute an agreement to which any other Investor is bound; provided that this Section 3.1 shall not be amended in any manner that has a material and disproportionate effect on the Eros Founder Group vis-à-vis the New Investors without the written consent of the Eros Founder Group.

(a)       Nomination Right. From the Effective Time until the earlier of (i) the third (3rd) anniversary of the Effective Time or (ii) the first such time after the Settlement Date that the Hony Investor ceases to beneficially own (giving effect to the CVRs) 50% of its Effective Time Equity, the Hony Investor shall have the right to nominate up to four (4) Directors (each a “Hony Nominee”), and the number of directorships constituting the full Board shall not exceed nine (9) without the approval of the Hony Investor; provided that at all times at least one (1) of the Hony Nominees shall be (or, if not yet serving on the Board as a Director, shall if elected qualify as) an Independent Director. The Hony Investor may elect to terminate or suspend such nomination right by written notice to the Company at any time. As of the Effective Time, the four Hony Nominees shall initially be the four STX Designated Directors. Whenever the Board is divided into classes of Directors serving staggered terms, unless the Hony Investor otherwise consents in writing, the Hony Nominees shall be allocated among such classes as nearly equal as possible; provided that the allocation of the STX Designated Directors to their respective classes as of the Effective Time in the manner set forth in the Merger Agreement shall be deemed to satisfy this sentence with respect to such Hony Nominees.

(b)       Company Assurances. The Company shall (and shall cause its Subsidiaries to) cooperate in facilitating the nomination rights described in Section 3.1(a), including (i) taking all Necessary Action to nominate each Hony Nominee as part of the slate that is included in any proxy statement (or similar document) of the Company in respect of any meeting of shareholders at which Directors are to be elected (other than, if applicable, when no Hony Nominee is allocated to the class of Directors to be elected at such meeting), (ii) providing the highest level of support for the election of each such Hony Nominee as the Company provides to any other individual standing for election as a Director as part of the Company’s slate of nominees, (iii) not nominating for any election a number of Directors (inclusive of Hony Nominees standing for election) that exceeds the number of directorships to be elected in such election and (iv) not (x) soliciting proxies or participating in a solicitation or (y) knowingly assisting, cooperating with, or encouraging any Person in any effort or attempt, in either case, reasonably likely to interfere with the election of a Hony Nominee as a Director.

9 

 

(c)       Vacancies. If a vacancy on the Board is caused by the death, retirement, resignation or removal of any Director who was a Hony Nominee and the Hony Investor would be entitled to nominate a Hony Nominee in respect of such vacancy as of suchtime, then the Hony Investor shall, to the fullest extent permitted by applicable Law, have the exclusive right to nominate a replacement to fill such vacancy for the remainder of the deceased, retired, resigned or removed, as applicable, Director’s term, and the Company shall take all Necessary Action to cause such replacement to be appointed to the Board as a Director (at which point such replacement shall attain the status of a Hony Nominee for all other purposes of this Section 3.1).

 

(d)       Committees. For so long as the Hony Investor has the right to nominate Hony Nominees pursuant to Section 3.1(a), the Company shall take all Necessary Action to appoint (i) two (2) Hony Nominees (at least one of whom must be an Independent Director) to each of the Audit Committee and Nominating Committee, and the number of Directors serving on either such committee shall be four (4) without the prior approval of the Hony Investor and (ii) one (1) Hony Nominee to the Remuneration Committee, and the number of Directors serving on such committee shall not exceed three (3) without the prior approval of the Hony Investor.

(e)       Actions Requiring Board Approval. From the Effective Time until the earlier of (x) the third (3rd) anniversary of the Effective Time or (y) the first such time after the Settlement Date that the Hony Investor ceases to beneficially own (giving effect to the CVRs) 50% of its Effective Time Equity, the following actions by the Company or any of its Subsidiaries shall require the approval of the majority of the Board, including at least one (1) Hony Nominee:

(i)       Hiring or terminating the chief executive officer, chief financial officer or president (including any co-president) of the Company.

(f)       Indemnification Agreement. The Company and its Subsidiaries shall enter into customary director and officer indemnification agreements with each Hony Nominee elected or appointed to serve on the Board as a Director. Such customary indemnification agreements shall be in a form to be mutually agreed by the Company and the Hony Investor prior to the Effective Time, and each of the Company and the Hony Investor shall negotiate in good faith with respect to such form prior to the Effective Time.

Section 3.2 Board Representation Rights of the Eros Founder Group. Notwithstanding anything to the contrary in this Agreement, the provisions of this Section 3.2 constitute an agreement between the Company, on the one hand, and the Eros Founder Group, on the other hand, and shall not constitute an agreement to which any other Investor is bound; provided that this Section 3.2 shall not be amended in any manner that has a material and disproportionate effect on the New Investors vis-à-vis the Eros Founder Group without the written consent of New Investors that beneficially own (giving effect to the CVRs) a majority of the voting power of the Shares beneficially owned (giving effect to the CVRs) by all New Investors in the aggregate.

10 

 

(a)       Nomination Right. From the Effective Time until the earlier of (i) the third (3rd) anniversary of the Effective Time or (ii) the first such time that the Eros Founder Group ceases to beneficially own 50% of its Effective Time Equity, the Eros Founder Group shall have the right to nominate four (4) Directors (each, an “Eros Nominee”), and the number of directorships constituting the full Board shall not exceed nine (9) without the approval of the Eros Founder Group; provided that at all times at least one (1) of the Eros Nominees shall be (or, if not yet serving on the Board as a Director, shall if elected qualify as) an Independent Director. As of the Effective Time, the four Eros Nominees shall initially be the four Eros Designated Directors. Whenever the Board is divided into classes of Directors serving staggered terms, unless the Eros Founder Group otherwise consents in writing, the Eros Nominees shall be allocated among such classes as nearly equal as possible; provided that the allocation of the Eros Designated Directors to their respective classes as of the Effective Time in the manner set forth in the Merger Agreement shall be deemed to satisfy this sentence with respect to such Eros Nominees.

(b)       Company Assurances. The Company shall (and shall cause its Subsidiaries to) cooperate in facilitating the nomination rights described in Section 3.2(a), including (i) taking all Necessary Action to nominate each Eros Nominee as part of the slate that is included in any proxy statement (or similar document) of the Company in respect of any meeting of shareholders at which Directors are to be elected (other than, if applicable, when no Eros Nominee is allocated to the class of Directors to be elected at such meeting), (ii) providing the highest level of support for the election of each such Eros Nominee as the Company provides to any other individual standing for election as a Director as part of the Company’s slate of nominees, (iii) not nominating for any election a number of Directors (inclusive of Eros Nominees standing for election) that exceeds the number of directorships to be elected in such election and (iv) not (x) soliciting proxies or participating in a solicitation or (y) knowingly assisting, cooperating with, or encouraging any Person in any effort or attempt, in either case, reasonably likely to interfere with the election of an Eros Nominee as a Director.

(c)       Vacancies. If a vacancy on the Board is caused by the death, retirement, resignation or removal of any Director who was an Eros Nominee and the Eros Founder Group would be entitled to nominate an Eros Nominee in respect of such vacancy as of such time, then the Eros Founder Group shall, to the fullest extent permitted by applicable Law, have the exclusive right to nominate a replacement to fill such vacancy for the remainder of the deceased, retired, resigned or removed, as applicable, Director’s term, and the Company shall take all Necessary Action to cause such replacement to be appointed to the Board as a Director (at which point such replacement shall attain the status of an Eros Nominee for all other purposes of this Section 3.2).

(d)       Committees. For so long as the Eros Founder Group has the right to nominate Eros Nominees pursuant to Section 3.2(a), the Company shall take all Necessary Action to appoint (i) two (2) Eros Nominees (at least one of whom must be an Independent Director) to each of the Audit Committee and Nominating Committee, and the number of Directors serving on either such committee shall not exceed four (4) without the prior approval of the Eros Founder Group and (ii) one (1) Eros Nominee to the Remuneration Committee, and the number of Directors serving on such committee shall not exceed three (3) without the prior approval of the Eros Founder Group.

11 

 

(e)       Actions Requiring Board Approval. From the Effective Time until the earlier of (x) the third (3rd) anniversary of the Effective Time or (y) the first such time that the Eros Founder Group ceases to beneficially own 50% of its Effective Time Equity, the following actions by the Company or any of its Subsidiaries shall require the approval of the majority of the Board, including at least one (1) Eros Nominee that is not an Independent Director:

(i)       Entering into or effecting a Change in Control.

(ii)       Initiating a voluntary liquidation, dissolution, receivership, bankruptcy or other insolvency proceeding involving the Company or any Subsidiary of that Company that is a “significant subsidiary” as defined in Rule 1-02 of Regulation S-X under the Exchange Act.

(iii)       Making any material change in the nature of the business conducted by the Company and its Subsidiaries.

(iv)       Hiring or terminating the chief executive officer, chief financial officer or president (including any co-president) of the Company.

(v)       Adopting the annual business plan (including operating budget) of the Company and its Subsidiaries.

(f)       Chairman Emeritus. If Kishore Lulla ceases to serve as a Director, he shall thereafter hold the title of Chairman Emeritus of the Board until his death, retirement or resignation. The Chairman Emeritus shall be entitled to attend meetings of the Board but shall not have any authority to vote at such meetings or otherwise to take any action binding on the Board or the Company in his capacity as Chairman Emeritus, except to the extent such authority is specifically delegated to him by the then-serving Board in compliance with the Company Articles and applicable Law.

Section 3.3 Committees of the Board.

(a)       The Company shall establish and maintain an audit committee of the Board (the “Audit Committee”), a nominating and governance committee of the Board (the “Nominating Committee”), a remuneration committee of the Board (the “Remuneration Committee”) and such other Board committees as the Board deems appropriate from time to time or as may be required by applicable law or the Stock Exchange rules. The committees shall have such duties and responsibilities as are customary for such committees, subject to the provisions of this Agreement. In the event of a tie vote on any matter before the Audit Committee or Nominating Committee the Company shall take all Necessary Action so that the Independent Director(s) then serving on such committee shall be entitled to cast a tie-breaking vote. The initial composition of the Audit Committee, Nominating Committee and Remuneration Committee at the Effective Time shall be as set forth in the following clauses (i)-(iii) until thereafter modified by action of the Board (upon the recommendation of the Nominating Committee):

12 

 

(i)       The Audit Committee shall initially consist of [●], [●], [●] and [●].

(ii)       The Nominating Committee shall initially consist of [●], [●], [●] and [●].

(iii)       The Remuneration Committee shall initially consist of [●], [●] and [●].

(b)       The Company shall establish and maintain an independent committee of the Board (the “Independent Committee”) to review and approve certain actions by the Company and its Subsidiaries. The Independent Committee shall consist entirely of each of the Independent Directors that are disinterested and independent with respect to the matter in question (it being acknowledged that a Director may qualify as an Independent Director hereunder for general purposes but lack independence with respect to a particular transaction or the parties interested therein); provided that, if an Independent Director previously appointed to the Independent Committee is interested or lacks independence with respect to a particular matter, it shall not be necessary to remove such Independent Director from the Independent Committee so long as such Independent Director recuses himself or herself from all discussions, deliberations and approvals with respect to such matter, and in such case all references herein to approval by a majority of the members of the Independent Committee or similar phrasing shall be deemed to refer to approval by a majority of the members of the Independent Committee other than such recused Independent Directors. The Independent Committee shall meet as needed, may confer and consult with the Board as the Independent Committee deems necessary or appropriate to fulfill its duties and obligations, and shall report its findings and decisions to the Board reasonably promptly as determined by the Independent Committee to be appropriate to fulfill its duties and obligations and, if applicable, taking into account the confidentiality of its deliberations pending final determination on any matter under consideration.

(c)       The Company shall establish and maintain a committee of the Board (the “EIML Committee”) to review and approve all actions by the Company and its Subsidiaries with respect to EIML. The EIML Committee shall consist only of Directors who are Eros Nominees and who are not Independent Directors and shall include Kishore Lulla for so long as he serves as a Director. The EIML Committee shall have full and exclusive power and authority to take or cause to be taken, on behalf of the Company and in its name, any and all actions and decisions required or permitted to be taken by the Company in respect of EIML, and any and all actions taken by the Company and its Subsidiaries with respect to EIML shall require the prior written consent of a majority of the members of the EIML Committee (including Kishore Lulla for so long as he serves as a Director). Such actions include, without limitation, the voting or disposition of any shares of capital stock or other ownership interests of EIML held by the Company or any of its Subsidiaries from time to time; the nomination, appointment and/or election of the directors and officers of EIML; and any decisions regarding changes in the management personnel of EIML. Notwithstanding the foregoing, (x) any provision of the Company Articles or this Agreement that requires the additional approval of the Independent Committee or any or certain holders of Shares with respect to agreements or transactions between the Company or any of its Subsidiaries, on the one hand, and any member of the Eros Founder Group from time to time, on the other hand, shall continue to apply to the extent of such provisions’ respective terms with respect to agreements or transactions between EIML, on the one hand, and any member of the Eros Founder Group from time to time, on the other hand and (y) the EIML Committee shall not take or cause or permit to be taken, or agree or commit to take, any of the following actions without, in each case, the prior approval of Directors comprising a majority of the full Board:

13 

 

(i)       Liquidating, dissolving or winding up the affairs of EIML, or effecting any merger or consolidation of EIML.

(ii)       Amending, altering or repealing any provision of the organizational documents of EIML if such amendment, alteration or repeal would adversely affect the rights of the Shareholders other than the Eros Founder Group, unless such amendment, alteration or repeal would adversely affect the rights of the Eros Founder Group in the same manner.

(iii)       Creating or issuing any equity security of, or security convertible into or exchangeable or exercisable for, equity securities of EIML.

(iv)       Redeeming any equity security of, or security convertible into or exchangeable or exercisable for, equity securities of EIML.

(v)       Incurring any indebtedness for borrowed money of EIML in excess of $100 million.

(vi)       Selling, leasing or otherwise disposing of all or substantially all of the assets of EIML in one or a series of transactions.

Section 3.4 Board Observer Rights of the Liberty Investor. Notwithstanding anything to the contrary in this Agreement, the provisions of this Section 3.4 constitute an agreement between the Company, on the one hand, and the Liberty Investor, on the other hand, and shall not constitute an agreement to which any other Investor is bound. From the Effective Time until the earlier of (x) the third (3rd) anniversary of the Effective Time or (y) the first such time after the Settlement Date that the Liberty Investor ceases to beneficially own (giving effect to the CVRs) at least 50% of its Effective Time Equity, the Company agrees that the Liberty Investor shall have the right, but not the obligation, from time to time in the Liberty Investor’s sole discretion, to appoint one (1) person (an “Observer”) to serve as a non-voting observer of the Board. Subject to the immediately following sentence, whenever the Liberty Investor has the right, and exercises its right, to appoint an Observer pursuant to the preceding sentence, the Company shall (a) invite such Observer to attend all meetings of the Board in a nonvoting observer capacity and (b) provide such Observer, as, if and when distributed generally to the Independent Directors, copies of all meeting notices, meeting minutes, written resolutions executed by the Board, and other materials prepared for consideration at any meeting of the Board; provided that, as a condition to the Company’s obligations under this sentence, such Observer shall agree (in writing, if so requested by the Company) to hold in confidence and trust and to act in a fiduciary manner with respect to all Proprietary Information. Notwithstanding the

14 

 

immediately prior sentence, the Company shall have the right to exclude an Observer from access to any material or meeting, or portion of either thereof, if the Company reasonably determines in good faith (i) that there exists actual adversity between the interests of the Liberty Investor, on the one hand, and the Company, on the other hand, with respect to the matters from which the Observer is to be excluded or (ii) with the advice of counsel that such exclusion is necessary to preserve attorney-client, work product or similar privilege or to comply with the terms and conditions of confidentiality agreements with third parties or applicable Law; provided that any such exclusion shall be limited to only the portion of the materials or meetings, as applicable, which gives rise to such reason for exclusion. The Company agrees and acknowledges that any Observer may share with the Liberty Investor any Proprietary Information such Observer obtains in its capacity as such; provided that the Liberty Investor shall be bound by Section 6.3 with respect thereto. The Company also agrees and acknowledges that the Liberty Investor shall not have any rights under this Section 3.4 (or access to any material nonpublic information of the Company pursuant to this Section 3.4) unless and until the Liberty Investor affirmatively appoints an Observer in writing.

Article IV

MINORITY PROTECTIONS

Section 4.1 Restrictions on Certain Actions of the Eros Founder Group.

(a)       In each election of Directors at a time when the Eros Founder Group has the right to nominate Eros Nominees pursuant to Section 3.2(a), each member of the Eros Founder Group shall (i) have the right to vote its Shares in its sole discretion with respect to the election of such Eros Nominees and (ii) with respect to all other directorships to be elected in such election, vote its Shares proportionately to the vote of all holders of Shares who are not members of the Eros Founder Group; provided that, for purposes of determining any such proportional vote prior to the Settlement Date, the Merger Consideration CVR Shares shall be deemed to be outstanding A Ordinary Shares and to have been voted in accordance with the consents of holders of CVRs required by Section 4.3(c).

(b)       During the period from the date of this Agreement until the third (3rd) anniversary of the Effective Time, no member of the Eros Founder Group shall, without the prior approval of the Independent Committee, acquire beneficial ownership of any Equity Security of the Company or convert any of its A Ordinary Shares into B Ordinary Shares pursuant to the Company Articles if, as a result thereof, the members of the Eros Founder Group would, in the aggregate, beneficially own a majority of the voting power of the then outstanding Shares (treating all Equity Securities beneficially owned by any member of the Eros Founder Group and that are not Shares as if converted, exchanged or exercised for the Shares underlying such Equity Securities (but, for clarity, not assuming any voluntary conversion of any such underlying A Ordinary Shares to B Ordinary Shares except to the extent notice of such conversion has been delivered by a member of the Eros Founder Group in accordance with the Company Articles)).

15 

 

Section 4.2 Amended Articles. Unless effected prior to the Effective Time, (a) the Company shall take all Necessary Action to cause the Company Articles to be amended in the form attached to the Merger Agreement as Exhibit J thereto (the “Amended Articles”) and (b) each Investor that is not a Minority New Investor hereby agrees that it shall take all Necessary Action to vote or cause to be voted all Shares it has the power to vote or cause the voting of in favor of the approval of the Amended Articles, whether at any meeting at which a resolution to approve the Amended Articles is submitted to the shareholders of the Company or by consenting in writing to any such resolution in lieu of a meeting, as applicable. For avoidance of doubt, the foregoing covenants shall remain in full force and effect notwithstanding any failure of the Company to obtain the requisite approval of the holders of Shares at any meeting of shareholders or pursuant to any publicly or privately made consent solicitation.

Section 4.3 Consent Rights Pending Effectiveness of the Amended Articles. The provisions of this Section 4.3 shall apply prior to the effectiveness of the Amended Articles, but at no time thereafter.

(a)       The Company shall not, and shall cause its Subsidiaries not to, directly or indirectly, take any of the following actions without the prior approval of the holders of a majority of the outstanding A Ordinary Shares:

(i)       amending, supplementing or otherwise modifying the provisions of this Article IV;

(ii)       amending, supplementing or otherwise modifying (whether by merger or otherwise) the Company’s Memorandum of Association or the Company Articles (collectively, the “Organizational Documents”) in a manner that would affect the relative rights of holders of B Ordinary Shares vis-à-vis holders of A Ordinary Shares, except to adopt the Amended Articles;

(iii)       entering into any agreement or effecting any transaction or series of related transactions providing for consideration to the holders of B Ordinary Shares that is in a different amount or form per share than the consideration provided to the holders of A Ordinary Shares in such transaction;

(iv)       any action that would have the effect of increasing the relative voting power of the then outstanding B Ordinary Shares vis-à-vis the then outstanding A Ordinary Shares; provided that, for avoidance of doubt, this Section 4.3(a)(iv) expressly does not include the acquisition by the Eros Founder Group of additional A Ordinary Shares from time to time (but, if such Shares are acquired directly from the Company or any of its Subsidiaries, such acquisition shall be subject to Section 4.3 (a)(vi)) and/or the conversion from time to time of any A Ordinary Shares then held by the Eros Founder Group into B Ordinary Shares (but any such conversion remaining subject to Section 4.1(b));

(v)       issuing additional B Ordinary Shares (other than upon conversion of A Ordinary Shares, but any such conversion remaining subject to Section 4.1(b)) to any member of the Eros Founder Group;

16 

 

(vi)       entering into any agreement or amending any existing agreement or effecting any transaction or series of related transactions between the Company or any of its Subsidiaries, on the one hand, and any member of the Eros Founder Group from time to time, on the other hand, except for (A) awards of equity-based compensation approved by the Remuneration Committee and granted in the ordinary course of business to members of the Eros Founder Group who are also members of the Company’s senior management, (B) arms’ length transactions the material terms of which are approved in advance by the Independent Committee and (C) any agreements or arrangements existing on the date hereof, the material terms of which are publicly disclosed in the Eros Filed SEC Documents (as defined in the Merger Agreement) prior to the date hereof; or

(vii)       agreeing or otherwise committing (whether or not in writing) to take any of the foregoing.

(b)       The Company shall not, and shall cause its Subsidiaries not to, directly or indirectly, take any of the following actions without the prior approval of the majority of the members of the Independent Committee:

(i)       amending, supplementing or otherwise modifying (whether by merger or otherwise) any Organizational Document in a manner that would affect the relative rights of holders of B Ordinary Shares vis-à-vis holders of A Ordinary Shares, except to adopt the Amended Articles;

(ii)       entering into any agreement or effecting any transaction or series of related transactions providing for consideration to the holders of B Ordinary Shares that is in a different amount or form per share than the consideration provided to the holders of A Ordinary Shares in such transaction;

(iii)       entering into any agreement or amending any existing agreement or effecting any transaction or series of related transactions between the Company or any of its Subsidiaries, on the one hand, and any member of the Eros Founder Group from time to time, on the other hand, except for (A) awards of equity-based compensation approved by the Remuneration Committee and granted in the ordinary course of business to members of the Eros Founder Group who are also members of the Company’s senior management and (B) any agreements or arrangements existing on the date hereof, the material terms of which are publicly disclosed in the Eros Filed SEC Documents prior to the date hereof; or

(iv)       agreeing or otherwise committing (whether or not in writing) to take any of the foregoing.

(c)       From the date hereof until the Settlement Date, the Company shall not, and shall cause its Subsidiaries not to, directly or indirectly, take any of the following actions:

(i)       each of the actions set forth in Section 4.3(a) (but, for avoidance of doubt, subject to the exceptions set forth therein);

17 

 

(ii)       effect any election or removal of Directors by the holders of Shares; or

(iii)       effect any other action upon the approval of holders of Shares;

without, in each case, obtaining the consent thereto of holders of such number and class of CVRs that, together with the Shares actually voted (at a meeting or by resolution) with respect to such action and assuming all Merger Consideration CVR Shares were outstanding A Ordinary Shares and voted, would be required to approve such action pursuant to the Organizational Documents, Section 4.3(a) (if applicable) or other applicable Law.

(d)       Notwithstanding anything to the contrary in this Agreement, (i) at any time that this Section 4.3 remains in effect, any New Investor may relinquish the benefits of and right to enforce this Section 4.3 (in whole, but not in part) as to itself upon written notice to the Company and (ii) from and after any such relinquishment, this Section 4.3 shall constitute an agreement between the Company, the Eros Founder Group and the remaining New Investors that have not exercised their right to so relinquish this Section 4.3, and this Section 4.3 shall not constitute an agreement for the benefit of or enforceable by such relinquishing New Investor.

Article V

REGISTRATION RIGHTS

Section 5.1 Investors Registration Rights Agreement. The Company shall grant to each Investor the registration rights set forth in the Registration Rights Agreement attached as Exhibit A hereto (the “Investors Registration Rights Agreement”).

Article VI

ADDITIONAL AGREEMENTS OF THE PARTIES

Section 6.1 Indemnity and Liability.

(a)       The Company hereby indemnifies and agrees to exonerate and hold each of the Investors and each of their respective shareholders, members, affiliates, directors, officers, fiduciaries, managers, controlling persons, employees, representatives, and agents and each of the partners, shareholders, members, affiliates, directors, officers, fiduciaries, managers, controlling persons, employees, representatives, and agents of each of the foregoing (collectively, the “Indemnitees”), each of whom is an intended third party beneficiary of this Agreement and may specifically enforce the Company’s obligations hereunder, free and harmless from and against any and all actions, causes of action, suits, claims, liabilities, losses, damages and out-of-pocket costs and expenses or any other amounts in connection therewith, including without limitation all actual out-of-pocket attorneys’ fees and expenses (collectively, the “Indemnified Liabilities”), incurred by the Indemnitees or any of them as a result of, arising out of, or in any way relating to this Agreement or any claim, cause of action or suit against the Investor or any

18 

 

Indemnitee solely by reason of the Investor’s status as such under this Agreement, except for any breach of this Agreement by such Investor or such Investor’s respective Indemnitee or any Indemnified Liabilities arising from or primarily related to such Indemnitee’s willful misconduct, fraud or gross negligence, or filings with the SEC describing its ownership in the Company, or in connection with any Public Offering where information provided by an Investor is the cause of any claim relating to that Public Offering. If and to the extent that the foregoing undertaking may be unavailable or unenforceable for any reason, the Company hereby agrees to make the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities that is permissible under applicable Law. For purposes of this Section 6.1, none of the circumstances described in the limitations contained in the immediately preceding sentence shall be deemed to apply absent a final non-appealable judgment of a court of competent jurisdiction to such effect, in which case to the extent any such limitation is so determined to apply to any Indemnitee as to any previously advanced indemnity payments made by the Company, then such payments shall be repaid by such Indemnitee to the Company.

(b)       Any Indemnified Party may, at its own expense, retain separate counsel to participate in such defense, and in any action, claim, suit, investigation or proceeding in which the Company, on the one hand, and an Indemnified Party, on the other hand, is, or is reasonably likely to become, a party. An Indemnified Party shall have the right to employ one (1) separate counsel in each applicable jurisdiction at the expense of the Company and to control its own defense of such action, claim, suit, investigation or proceeding if, in the reasonable opinion of counsel to such Indemnified Party, a conflict or potential conflict exists between the Company, on the one hand, and such Indemnified Party, on the other hand, that would make such separate representation advisable. The Company agrees that it will not, without the prior written consent of the applicable Indemnified Party, settle, compromise or consent to the entry of any judgment in any pending or threatened claim, suit, investigation, action or proceeding relating to the matters contemplated hereby (if any Indemnified Party is a party thereto or has been threatened to be made a party thereto) unless such settlement, compromise or consent includes an unconditional release of the applicable Indemnified Party and each other Indemnified Party from all liability arising or that may arise out of such claim, suit, investigation, action or proceeding.

(c)       The rights of any Indemnitee to indemnification hereunder will be in addition to any other rights any such Person may have under any other agreement or instrument referenced above or any other agreement or instrument to which such Indemnitee is or becomes a party or is or otherwise becomes a beneficiary or under Law or regulation. The Company hereby agrees that it is the indemnitor of first resort (i.e., its obligations to any Indemnitee under this Agreement are primary and any obligation of any Investor (or any Affiliate thereof (other than the Company)) to provide advancement or indemnification for the same Indemnified Liabilities (including all interest, assessment and other charges paid or payable in connection with or in respect of such Indemnified Liabilities) incurred by Indemnitee are secondary), and if any Investor (or any Affiliate thereof other than the Company) pays or causes to be paid, for any reason, any amounts otherwise indemnifiable hereunder or under any other indemnification agreement

19 

 

(whether pursuant to contract, bylaws or charter or the equivalent governing document) with any Indemnitee, then (i) such Investor shall be fully subrogated to all rights of the Indemnitee with respect to such payment, and (ii) the Company shall reimburse such Investor (or such other Affiliate) for the payments actually made. The Company hereby unconditionally and irrevocably waives, relinquishes and releases (and covenants and agrees not to exercise, and to cause each of its Affiliates not to exercise), any claims or rights that the Company may now have or hereafter acquire against any Indemnitee (in any capacity) that arise from or relate to the existence, payment, performance or enforcement of the Company’s obligations under this Agreement or under any indemnification obligation (whether pursuant to any other contract, any organizational document or otherwise), including any right of subrogation, reimbursement, exoneration, contribution or indemnification and any right to participate in any claim or remedy of any Indemnitee against any Indemnitee, whether such claim, remedy or right arises in equity or under contract, statute, common law or otherwise, including any right to claim, take or receive from any Indemnitee, directly or indirectly, in cash or other property or by set-off or in any other manner, any payment or security or other credit support on account of such claim, remedy or right. Except as specifically provided otherwise in this Agreement, none of the Indemnitees will be liable to the Company or any of its Affiliates for any act or omission suffered or taken by such Indemnitee that does not constitute willful misconduct, fraud or gross negligence.

Section 6.2 Access to Information and Personnel; Regulatory Examinations. Notwithstanding anything to the contrary in this Agreement, the provisions of this Section 6.2 constitute an agreement between the Company, on the one hand, and the Hony Investor and the Eros Founder Group, on the other hand, and shall not constitute an agreement to which any other Investor is bound.

(a)       For so long as the Hony Investor has the right to nominate Hony Nominees pursuant to Section 3.1(a), the Company will deliver, or will cause to be delivered, the following to the Hony Investor, and for so long as the Eros Founder Group is entitled to nominate at least one Director pursuant to Section 3.2(a), the Company will deliver, or will cause to be delivered, the following to the Eros Founder Group:

(i)       unaudited consolidated quarterly financial reports of the Company and its consolidated subsidiaries prepared in accordance with IFRS for the first three fiscal quarters of each year, which shall be provided no later than 45 days following the end of such fiscal quarter;

(ii)       audited consolidated annual financial reports of the Company and its consolidated subsidiaries prepared in accordance with IFRS, which shall be provided no later than the date upon which the Form 20-F for the Company is due for such fiscal year;

(iii)       the annual business plan (including operating budget and capital expenditure presented on a monthly basis); and

20 

 

(iv)       such other information and data as the Hony Investor or the Eros Founder Group may reasonably request in connection with its ownership of Shares, including, but not limited to any information necessary to assist the Hony Investor or any member of the Eros Founder Group, as the case may be, in preparing its tax, regulatory or other similar filings or as otherwise required for administrative purposes.

(b)       The Company shall, and shall cause its Subsidiaries to, provide (in each case upon reasonable advance notice during normal business hours and under the supervision of appropriate Company personnel) the Hony Investor or the Eros Founder Group, as applicable, or any governmental authority having jurisdiction over the Hony Investor and its Affiliates, the Eros Founder Group and its Affiliates or the Company reasonable access to all books, records, policies and procedures, internal audit and compliance reports, and to officers, personnel, accountants and other representatives of the Company and its Subsidiaries and their respective businesses, whether located in the United States or outside the United States, including without limitation the right to audit any of such books, records, policies and procedures, and reports and to make copies therefrom. The Company shall provide, upon reasonable advance notice during normal business hours and under the supervision of appropriate Company personnel, the Hony Investor and Eros Founder Group with access to any materials viewed by any governmental authority if requested by the Hony Investor or the Eros Founder Group and if permitted by applicable Law.

Section 6.3 Confidentiality. Each Investor shall maintain the confidentiality of any confidential and proprietary information of the Company and its Subsidiaries (“Proprietary Information”) using the same standard of care, but in no event less than reasonable care, as it applies to its own confidential information, except (i) for any Proprietary Information which is publicly available (other than as a result of dissemination by such Investor, its Representatives or, in the case of the Liberty Investor, its Observer(s)) or a matter of public knowledge generally, (ii) if the release of such Proprietary Information is ordered pursuant to a subpoena or other order from a court of competent jurisdiction, following delivery of prior written notice to the Company (to the extent permitted under applicable Law), or (iii) for Proprietary Information that was known to such Investor prior to its disclosure by the Company, or becomes known by such Investor, in each case on a non-confidential basis, without, to such Investor’s knowledge, breach of any third party’s confidentiality obligations. Each Investor further acknowledges and agrees that it shall not disclose any Proprietary Information to any Person, except that Proprietary Information may be disclosed:

(i)       to its and its Affiliates’ directors, officers, employees, stockholders, members, partners, agents, counsel, investment advisers or other representatives (all such persons being collectively referred to as “Representatives”) in the normal course of the performance of their duties to the Investor or its Affiliates; provided that such recipient agrees to be bound by a confidentiality agreement consistent with the provisions hereunder or is otherwise bound under Law or contract to a duty of confidentiality to the Investor or its Affiliate;

21 

 

(ii)       to any regulatory authority to which such Investor or any of its Affiliates is subject or with which it has regular dealings in connection with a general regulatory inquiry not specifically targeted at the Company; provided that to the extent legally permissible and practicable, such Investor gives prior notice of such disclosure to the Company, and provided, further, that such authority is advised of the confidential nature of such information;

(iii)       to the extent related to the tax treatment and tax structure of the transactions contemplated by this Agreement (including all materials of any kind, such as opinions or other tax analyses that the Company, its Affiliates or any of its Representatives have provided to such Investor relating to such tax treatment and tax structure); provided that the foregoing does not constitute an authorization to disclose the identity of any existing or future party to the transactions contemplated by this Agreement or their Affiliates or Representatives, or, except to the extent relating to such tax structure or tax treatment, any specific pricing terms or commercial or financial information; or

(iv)       if the prior written consent of the Board shall have been obtained.

Nothing contained herein shall prevent the use (subject, to the extent possible, to a protective order) of Proprietary Information in connection with the assertion or defense of any claim by or against the Company or any Investor.

Section 6.4 U.S. Tax Matters.

(a)       Controlled Foreign Corporation. The Company shall, at the request of any Investor that is (or a direct or indirect owner of which is) a “United States shareholder” (as defined in Section 951(b) of the U.S. Internal Revenue Code of 1986, as amended (or any successor thereto) (the “Code”)) with respect to the Company and that is not classified as a partnership for United States federal income tax purposes, and at such Investor’s sole cost and expense, use commercially reasonable efforts to provide any information reasonably requested by such Investor that the Company has in its possession (or that is reasonably available from the Company’s tax advisors) that is reasonably necessary to enable such Investor to determine the Company’s status as a controlled foreign corporation within the meaning of Section 957 of the Code (a “CFC”) and, if such Investor reasonably determines that the Company is a CFC (and informs the Company of such determination and, upon request of the Company, provides such information to the Company that forms the basis of such determination), to enable such Investor to determine whether any portion of the Company’s income is “subpart F income” (as defined in Section 952 of the Code) or income described in Section 951A of the Code. For purposes of this paragraph (a), the term “Company” shall mean the Company and any of its Subsidiaries.

22 

 

(b)       Passive Foreign Investment Company. The Company shall, at the request of any Investor that is (or a direct or indirect owner of which is) a United States person within the meaning of Section 7701(a)(30) of the Code and that has an Aggregate Investor Voting Percentage (giving effect to the CVRs) equal to at least 2%, use commercially reasonable efforts to provide any information reasonably requested by such Investor that the Company has in its possession (or that is reasonably available from the Company’s tax advisors) to enable such Investor or such Investor’s direct or indirect owners to determine the Company’s status as a “passive foreign investment company” within the meaning of Section 1297 of the Code (a “PFIC”) and, if the Company is a PFIC during any taxable year and the Board so determines, to enable such Investor (or such Investor’s direct or indirect owners) to make a “Qualified Electing Fund” election pursuant to Section 1295 of the Code or file a “Protective Statement” pursuant to Treasury Regulation Section 1.1295-3. If the Company provides such information to any such Investor, the Company shall provide such information to any other Investor that is (or a direct or indirect owner of which is) a United States person within the meaning of Section 7701(a)(30) of the Code and that requests such information (notwithstanding its Aggregate Investor Voting Percentage). Notwithstanding the foregoing, Investors shall cease to have any rights, and the Company shall cease to have any obligations, under this paragraph (b) on the third (3rd) anniversary of the Effective Time.

Section 6.5 Certain Other Matters.

(a)       Neither the Company nor any of its Subsidiaries shall enter into any contract, agreement, arrangement or understanding containing any provision or covenant that purports to, or could reasonably be expected to, limit in any respect the ability of any Investor or any of their respective Affiliates or portfolio companies to (i) sell any products or services of or to any other Person or in any geographic region, (ii) engage in any line of business, (iii) compete with or obtain products or services from any Person or (iv) provide products or services to the Company or any of its Subsidiaries.

(b)       Notwithstanding anything in this Agreement (but subject to applicable Laws, including applicable securities Laws), none of the provisions of this Agreement, other than the confidentiality provisions contained herein, shall in any way limit any Affiliate or portfolio company of any Investor from engaging in any brokerage, investment advisory, financial advisory, anti-raid advisory, principaling, merger advisory, financing, asset management, trading, market making, arbitrage, investment activity and other similar activities conducted in the ordinary course of their business.

(c)       The Company covenants and agrees that it shall not (and shall not permit any of its Subsidiaries or Affiliates or any of its or their respective directors, officers, managers, employees, independent contractors, representatives or agents to) promise, authorize or make any payment to, or otherwise contribute any item of value to, directly or indirectly, to any third party, including any Non-U.S. Official (as such term is defined in the U.S. Foreign Corrupt Practices Act of 1977, as amended (the “FCPA”)), in each case, in violation of the FCPA, the U.K. Bribery Act, or any other applicable anti-bribery or anti-corruption Law. The Company further represents that it shall (and shall cause each of its Subsidiaries and Affiliates to) cease all of its or their respective activities, as well as remediate any actions taken by the Company, its Subsidiaries or Affiliates, or any of their respective directors, officers, managers, employees, independent contractors, representatives or agents in violation of the FCPA, the U.K. Bribery Act, or any other applicable anti-bribery or anti-corruption Law. The Company further represents that it

23 

 

shall (and shall cause each of its Subsidiaries and Affiliates to) maintain systems of internal controls (including, but not limited to, accounting systems, purchasing systems and billing systems) to ensure compliance with the FCPA, the U.K. Bribery Act, or any other applicable anti-bribery or anti-corruption Law. Upon request, the Company agrees to provide to any Investor an annual certification concerning the Company’s compliance with applicable anti-corruption Laws. The Company shall, and shall cause any direct or indirect Subsidiary or entity controlled by it, whether now in existence or formed in the future, to comply with the FCPA. The Company shall use its best efforts to cause any direct or indirect Subsidiary, whether now in existence or formed in the future, to comply in all material respects with all applicable Laws.

Article VII

MISCELLANEOUS

Section 7.1 Freedom to Pursue Opportunities.

(a)       Without in any way limiting their obligations under Section 7.5, the parties expressly acknowledge and agree that: (i) each Investor, its Affiliates and its and their affiliated investment funds, and each Director, has the right to, and shall have no duty (contractual or otherwise) not to, directly or indirectly engage in the same or similar business activities or lines of business as the Company or any of its Subsidiaries, on its own account, or in partnership with, or as an employee, officer, director or stockholder of any other Person, including those lines of business deemed to be competing with the Company or any of its Subsidiaries; (ii) none of the Company, any of its Subsidiaries or any of the Company’s shareholders shall have any rights in and to the business ventures of any Investor, its Affiliates and its and their affiliated investment funds, or any Director, or the income or profits derived therefrom; (iii) each Investor, its Affiliates and its and their affiliated investment funds, and each Director, may do business with any potential or actual customer or supplier of the Company or any of its Subsidiaries or may employ or otherwise engage any officer or employee of the Company or any of its Subsidiaries; and (iv) in the event that an Investor, it Affiliates and its and their affiliated investment funds, or any Director, acquires knowledge of a potential transaction or matter that may be an opportunity for the Company, any of its Subsidiaries, or any other shareholder of the Company, such Investor, Affiliate, affiliated investment fund or Director shall, to the fullest extent permitted by applicable Law, have no duty (fiduciary, contractual or otherwise) to communicate or present such opportunity to the Company, any of its Subsidiaries, or any such shareholder, as the case may be, and, notwithstanding any provision of this Agreement to the contrary, shall not be liable to the Company, any of its Subsidiaries, or any other shareholder of the Company (or their respective Affiliates) for breach of any duty (fiduciary, contractual or otherwise) by reason of the fact that such Investor, Affiliate, affiliated investment fund or Director directly or indirectly, pursues or acquires such opportunity for itself, directs such opportunity to another Person, or does not present such opportunity to the Company, any of its Subsidiaries, or any other shareholder of the Company; provided that the foregoing shall not apply to any Director with respect to any business opportunity first presented to such Director expressly in his or her capacity as such. For the avoidance of doubt, any actions taken, directly or indirectly, by any publicly traded Affiliate (or any of its officers, directors or employees) of an Investor shall not be deemed to be an action taken by such Investor.

24 

 

(b)       Each Investor hereby, to the fullest extent permitted by applicable Law, acknowledges and agrees that, (i) in the event of any conflict of interest between the Company or any of its Subsidiaries, on the one hand, and such Investor or any of its Affiliates, on the other hand, such Investor or Affiliate may act in such Investor’s or Affiliate’s best interest and (ii) no Investor shall be obligated (A) to reveal to the Company or any of its Subsidiaries confidential information belonging to or relating to the business of such Investor, its Affiliates or its or their respective portfolio companies (or any Subsidiary thereof) or (B) to recommend or take any action in its capacity as an Investor that prefers the interest of the Company or any of its Subsidiaries over the interest of such Investor, its Affiliates or its or their respective portfolio companies (or any Subsidiary thereof).

 

Section 7.2 Entire Agreement. This Agreement, together with the Investors Registration Rights Agreement and all of the other exhibits, annexes and schedules hereto and thereto, constitute the entire understanding and agreement between or among the parties as to the matters covered herein and therein and supersede and replace any prior understanding, agreement or statement of intent between or among the parties as to the matters covered herein and therein. In the event of any inconsistency between this Agreement and any document executed or delivered to effect the purposes of this Agreement, including, without limitation, the Organizational Documents or comparable governing documents of any other company, this Agreement shall govern as between or among the parties hereto.

Section 7.3 Governing Law; Submission to Jurisdiction; Waiver of Jury Trial.

(a)       This Agreement shall be governed by and construed in accordance with the laws of the Isle of Man applicable to contracts entered into and performed entirely within the Isle of Man.

(b)       Any claim, action, suit or proceeding (whether in contract or tort) seeking to enforce any provision of, or based on any matter arising out of or in connection with, this Agreement or the transactions contemplated hereby shall be heard and determined in the courts of the Isle of Man, and each of the parties hereto hereby consents to the exclusive jurisdiction of such courts and irrevocably waives, to the fullest extent permitted by Law, any objection that it may now or hereafter have to the laying of venue of any such claim, action, suit or proceeding in any such court or that any such claim, action, suit or proceeding that is brought in any such court has been brought in an inconvenient forum.

(c)       Subject to applicable Law, process in any such claim, action, suit or proceeding may be served on any party anywhere in the world, whether within or without the jurisdiction of any such court. Without limiting the foregoing and subject to applicable Law, each party agrees that service of process on such party as provided in Section 7.9 shall be deemed effective service of process on such party. Nothing herein shall affect the right of any party to serve legal process in any other manner permitted by Law or at equity.

25 

 

Section 7.4 Obligations; Remedies. The Company and the Investors shall be entitled to enforce their rights under this Agreement specifically, to recover damages by reason of any breach of any provision of this Agreement (including, without limitation, costs of enforcement) and to exercise all other rights existing in their favor. The parties hereto agree and acknowledge that money damages may not be an adequate remedy for any breach of the provisions of this Agreement, and that the Company or any Investor may in its sole discretion apply to any court of Law or equity of competent jurisdiction for specific performance or injunctive relief (without posting a bond or other security) in order to enforce or prevent any violation of the provisions of this Agreement. All remedies, either under this Agreement or by Law or otherwise afforded to any party, shall be cumulative and not alternative. All obligations hereunder shall be satisfied in full without set-off, defense or counterclaim.

Section 7.5 Amendment and Waiver.

(a)       The terms and provisions of this Agreement may be modified or amended at any time and from time to time only by the written agreement of the Company and each Investor (or, with respect to any such terms and provisions to which only some Investors are parties, such Investors). No purported waiver of any term or provision of this Agreement shall be valid or effective unless set forth in an instrument in writing signed on behalf of the party against which such waiver is sought to be enforced. Any amendment, modification or waiver effected in accordance with the foregoing shall be effective and binding on the Company and the Investors (or, with respect to any such terms and provisions to which only some Investors are parties, such Investors).

(b)       Any failure by any party at any time to enforce any of the provisions of this Agreement, or single or partial enforcement of any rights, powers or remedies conferred by this Agreement, shall not be construed a waiver of such provision or any other provisions hereof, or preclude any other or further exercise thereof.

Section 7.6 Binding Effect; Assignment. The rights and obligations under this Agreement shall not be assignable without the prior written consent of the Investors, and any attempted assignment of rights or obligations in violation of this Section 7.6 shall be null and void.

Section 7.7 Termination. This Agreement shall terminate automatically (without any action by any party hereto) as to each Investor when such Investor ceases to hold any Shares or CVRs; provided, however, for the avoidance of doubt, that any rights particular to any one or more Investors, but not all Investors, contingent upon having at least a specified Aggregate Investor Voting Percentage or percentage of Effective Time Equity shall terminate as to such particular Investor or Investors when it or they, as applicable, cease to have such Aggregate Investor Voting Percentage or percentage of Effective Time Equity, respectively. In the event of any termination of this Agreement as provided in this Section 7.7, this Agreement (and all rights and obligations hereunder) shall forthwith become wholly void and of no further force or effect as to such Investor (except for Section 6.1, Section 6.3 and this Article VII) and there shall be no liability on the part of any parties hereto or their respective officers or directors with respect to such Investor. Notwithstanding the foregoing, no party hereto shall be relieved from liability for any willful breach of this Agreement.

26 

 

Section 7.8 Non-Recourse. Notwithstanding anything to the contrary that may be expressed or implied in this Agreement or any document or instrument delivered in connection herewith, and notwithstanding the fact that certain of the Investors may be partnerships or limited liability companies, by its acceptance of the benefits of this Agreement, the Company and each Investor covenants, agrees and acknowledges that no Person (other than the parties hereto) has any obligations hereunder, and that no recourse under this Agreement or any documents or instruments delivered in connection with this Agreement shall be had against any current or future director, officer, employee, general or limited partner or member of any Investor or of any Affiliate, portfolio company (or Subsidiary thereof) of any Investor or of any of its Affiliates, or any assignee of any of the foregoing, whether by the enforcement of any assessment or by any legal or equitable proceeding, or by virtue of any statute, regulation or other applicable Law, it being expressly agreed and acknowledged that no personal liability whatsoever shall attach to, be imposed on or otherwise be incurred by any former, current and future equity holders, controlling persons, directors, officers, employees, agents, Affiliates, members, managers, general or limited partners, portfolio companies (or Subsidiaries thereof) or assignees of the Investor or any former, current or future shareholder, controlling person, director, officer, employee, general or limited partner, member, manager, Affiliate, portfolio company (or Subsidiary thereof), agent or assignee of any of the foregoing, as such for any obligation of any Investor under this Agreement or any documents or instruments delivered in connection with this Agreement for any claim based on, in respect of or by reason of such obligations or their creation.

Section 7.9 Notices. All notices, requests, claims, demands and other communications under this Agreement shall be in writing and shall be deemed given (i) if delivered personally, upon such delivery, (ii) if delivered by electronic mail, when confirmation of successful transmission is received or (iii) if sent by Federal Express or other nationally-recognized overnight courier, upon delivery or refusal of delivery, to the parties at the following addresses (or at such other address for a party as shall be specified by like notice):

if to the Company, to:

Eros International Plc
First Names House

Victoria Road

Douglas

Isle of Man IM2 4DF

British Isles

Attention:Mark Carbeck, Chief Corporate and Strategy Officer
Email:mark.carbeck@erosintl.com

27 

 

with a copy (which shall not constitute notice) to:

Gibson, Dunn & Crutcher LLP

333 South Grand Avenue

Los Angeles, California 90071-3197

U.S.A.

Attention:Kevin Masuda
Peter Wardle
Email:kmasuda@gibsondunn.com
pwardle@gibsondunn.com

 

if to the Eros Founder Group, to:

 

3902 & 3903 Tower A

Business Central Tower

Dubai Internet City

Sheikh Zayed Road

Dubai, U.A.E.

Attention:Kishore Lulla
Rishika Lulla Singh
Email:klulla@erosintl.com; rishika.lulla@erosnow.com

 

with a copy (which shall not constitute notice) to:

Gibson, Dunn & Crutcher LLP

333 South Grand Avenue

Los Angeles, California 90071-3197

U.S.A.

Attention:Kevin Masuda
Peter Wardle
Email:kmasuda@gibsondunn.com
pwardle@gibsondunn.com

 

if to the Hony Investor, to:

Marco Alliance Limited and Great Mission International Limited

Suite 2701, One Exchange Square Central

Hong Kong

Attention:Ms. ZhiFang Cui
Email:cuizf@honycapital.com

 

with a copy (which shall not constitute written notice) to:

 

Paul, Weiss, Rifkind, Wharton & Garrison LLP

Beijing Representative Office

Unit 5201, Fortune Financial Center, 5 Dongsanhuan Zhonglu

Chaoyang District, Beijing 100020

China

Attention:Greg Liu
Email:gliu@paulweiss.com

28 

 

if to the Liberty Investor, to:

161 Hammersmith Road

Hammersmith

London W6 8BS United Kingdom

Attention:Simon Freer
Email:sfreer@libertyglobal.com
LegalUS@libertyglobal.com

if to any other party, to the contact information set forth below such party’s signature on its signature page hereto.

Section 7.10 Severability. If any portion of this Agreement shall be declared void or unenforceable by any court or administrative body of competent jurisdiction, then, so long as no party is deprived of the benefits of this Agreement in any material respect, such portion shall be deemed severable from the remainder of this Agreement, which shall continue in all respects valid and enforceable.

Section 7.11 Headings. The headings and subheadings in this Agreement are included for convenience and identification only and are in no way intended to describe, interpret, define or limit the scope, extent or intent of this Agreement or any provision hereto.

Section 7.12 Contracts (Rights of Third Parties) Act 2001. This Agreement shall be binding upon and inure solely to the benefit of the parties hereto and their respective permitted assigns and successors, and, except as provided in Section 6.1 and Section 7.8, nothing herein, express or implied, is intended to or shall create any right enforceable by any person who is not a party to it under the Contracts (Rights of the Third Parties) Act 2001, but this Section 7.12 does not affect any right or remedy of a third party that exists or is available apart from that Act.

Section 7.13 Recapitalizations; Exchanges, Etc. The provisions of this Agreement shall apply to the full extent set forth herein with respect to the Shares, to any and all shares of capital stock of the Company or any successor or assign of the Company (whether by merger, consolidation, sale of assets or otherwise) which may be issued in respect of, in exchange for, or in substitution of the Shares, by reason of a stock dividend, stock split, stock issuance, reverse stock split, combination, recapitalization, reclassification, merger, consolidation or otherwise.

Section 7.14 Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original, but all of which together shall constitute a single instrument. Copies of executed counterparts transmitted by telecopy or other electronic transmission service shall be considered original executed counterparts for purposes of this Section 7.14.

[The remainder of this page intentionally left blank]

 

 

 

29 

 

[Signature pages to follow.]

 

 

 

SCHEDULE 1

 

·[______]
·[______]

Exhibit 4.40

 

This REGISTRATION RIGHTS AGREEMENT (as the same may be amended from time to time in accordance with its terms, the “Agreement”) is made as of [●], 2020, by and among (i) Eros International Plc, an Isle of Man company limited by shares (the “Company”), (ii) each of the Persons set forth on Schedule 1 attached hereto with respect to the A Shares (as defined below) held by such Person, including A Shares to be purchased pursuant to that certain subscription agreement, dated as of April 17, 2020, by and between the Company and each of the purchaser parties thereto, or issuable to such Person upon settlement of the contingent value rights (the “CVRs”) received by such Person pursuant to the Merger Agreement (as defined below), in each case as set forth opposite each such Person’s name on Schedule 1 attached hereto (collectively, together with their Permitted Assignees (as defined herein), the “STX Holders” and each, a “STX Holder”) and (iii) each of the Persons set forth on Schedule 2 attached hereto with respect to the A Shares set forth opposite each such Person’s name on Schedule 2 attached hereto (collectively, the “Original Holders” and each, an “Original Holder”). The STX Holders and the Original Holders, together with their Permitted Assignees, are collectively referred to herein as “Holders” and each, a “Holder”.

WHEREAS, in connection with the transactions contemplated by the Agreement and Plan of Merger (the “Merger Agreement”), dated as of April 17, 2020, by and among the Company, England Holdings 2, Inc., a Delaware corporation (“England Holdings 2”), an indirect wholly owned subsidiary of the Company, England Merger Corp., a Delaware corporation and a direct wholly owned subsidiary of England Holdings 2 and indirect wholly owned subsidiary of the Company, and STX Filmworks, Inc., a Delaware corporation, the parties hereto have agreed to enter into this Agreement pursuant to which the Company has agreed to grant the STX Holders and the Original Holders certain registration rights with respect to the Company’s A Shares held by the STX Holders and the Original Holders as more fully set forth herein.

THEREFORE, in consideration of the mutual covenants and agreements contained herein, the parties mutually agree as follows:

ARTICLE I

DEFINITIONS

Section 1.1 Certain Definitions. As used in this Agreement, capitalized terms not otherwise defined herein shall have the meanings ascribed to them below:

A Shares” means the A Ordinary Shares, par value £0.30 per share, of the Company, and any equity securities issued or issuable in exchange for or with respect to the A Shares by way of a stock dividend, stock split or combination of shares or in connection with a reclassification, recapitalization, merger, consolidation or other reorganization or otherwise.

 

 

 

Affiliate” means, with respect to any specified Person, any other Person who or which, directly or indirectly, controls, is controlled by, or is under common control with, such specified Person.

Automatic Shelf Registration Statement” means an “automatic shelf registration statement” as defined in Rule 405 promulgated under the Securities Act.

Block Trade” means an offering and/or sale of Registrable Securities by any Holder to one or more financial institutions in an underwritten registered shelf take-down transaction in the form of a bought deal, a block trade or a direct sale that does not include any substantial marketing efforts by the Company or its management prior to pricing.

Business Day” means any day that is not a Saturday, Sunday or other day on which banks are required or authorized by law to be closed in The City of New York.

Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

FINRA” means the Financial Industry Regulatory Authority, Inc.

Initiating Shelf Take-Down Holder” has the meaning set forth in Section 2.1(d)(i).

Issuer Free Writing Prospectus” means an issuer free writing prospectus, as defined in Rule 433 under the Securities Act, relating to an offer of Registrable Securities.

Majority Participating Holders” means Participating Holders holding more than 50% of the Registrable Securities proposed to be included in any offering of Registrable Securities by such Participating Holders pursuant to Section 2.2 or Section 2.3.

Majority STX Holders” means STX Holders holding more than 50% of the STX Securities proposed to be included in the Shelf Registration Statement (as defined below) pursuant to Section 2.1 hereof.

Participating Holder” means a Holder who shall have properly submitted a written request for inclusion of such Holder’s Registrable Securities in a registration pursuant to Section 2.2 or 2.3 hereof.

Permitted Assignee” has the meaning set forth in Section 4.8.

Person” means any individual, corporation, partnership, limited liability company, limited liability partnership, syndicate, person, trust, association, organization or other entity or any governmental or regulatory body or other agency or authority or political subdivision thereof, including any successor, by merger or otherwise, of any of the foregoing.

Registrable Securities” means (a) A Shares held by the Original Holders as of the date hereof and set forth on Schedule 2 attached hereto, (b) A Shares issued or issuable, directly or indirectly, in exchange for or with respect to the A Shares referenced in clause (a) above, (c) any other A Shares owned or hereafter acquired by the Original Holders and (d) the STX Securities. Any particular Registrable Securities shall cease to be Registrable Securities when such Registrable Securities have been transferred by a Holder to any transferee that is not a Permitted Assignee.

 

 

 

Registration Expenses” means all fees and expenses incurred in connection with the Company’s performance of or compliance with the provisions of Article II, including, without limitation: (a) all registration, listing, qualification and filing fees (including FINRA filing fees), (b) fees and expenses of compliance with state securities or “blue sky” laws (including reasonable counsel fees in connection with the preparation of a blue sky and legal investment survey and FINRA filings), (c) printing and copying expenses, (d) messenger and delivery expenses, (e) expenses incurred in connection with any road show, (f) fees and disbursements of counsel for the Company, (g) with respect to each registration, the reasonable fees and disbursements of one counsel for the Participating Holder(s) selected by the Majority Participating Holders or one counsel for the STX Holders selected by the Majority STX Holders, as applicable, (h) fees and disbursements of independent public accountants, including the expenses of any audit or “comfort” letter, and fees and expenses of other persons, including special experts, retained by the Company, (i) underwriter fees, excluding discounts and commissions, and any other expenses which are customarily borne by the issuer or seller of securities in a public equity offering and (j) all internal expenses of the Company (including all salaries and expenses of officers and employees performing legal or accounting duties).

SEC” means the Securities and Exchange Commission.

Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

Shelf Registration” has the meaning set forth in Section 2.1(a).

Shelf Registration Statement” has the meaning set forth in Section 2.1(a).

STX Securities” means all A Shares (i) owned by the STX Holders as of the date hereof or (ii) to be received by the STX Holders upon settlement of the CVRs, in each case as set forth on Schedule 1 attached hereto,

Underwritten Shelf Take-Down” has the meaning set forth in Section 2.1(d)(i).

Underwritten Shelf Take-Down Notice” has the meaning set forth in Section 2.1(d)(ii).

Underwritten Shelf Take-Down Request” has the meaning set forth in Section 2.1(d)(i).

ARTICLE II

REGISTRATION RIGHTS

Section 2.1 Shelf Registration.

 

 

 

 

(a)       Shelf Registration. As soon as reasonably practicable after the consummation of the transactions contemplated by the Merger Agreement (the “Closing”), but in any event no later than the 60th day following such Closing, the Company shall prepare and file with the SEC a registration statement on Form F-1 or Form F-3 or an equivalent general registration form then in effect (the “Shelf Registration Statement”) providing for the resale from time to time on a delayed or continuous basis pursuant to Rule 415 under the Securities Act by the STX Holders of all STX Securities. If at the time of filing of the Shelf Registration Statement the Company is eligible for use of an Automatic Shelf Registration Statement, then such shelf registration statement shall be filed as an Automatic Shelf Registration Statement. The Shelf Registration Statement described in this Section 2.1(a) shall relate to the offer and sale of the STX Securities by the STX Holders thereof from time to time in accordance with the methods of distribution set forth in the applicable Shelf Registration Statement (hereinafter the “Shelf Registration”). The Company shall use its commercially reasonable efforts to address any comments from the SEC regarding such Shelf Registration Statement. The Shelf Registration Statement shall cover to the extent allowable under the Securities Act and the rules promulgated thereunder, such indeterminate number of additional A Shares resulting from stock splits, stock dividends or similar transactions with respect to the STX Securities. The Company shall use its commercially reasonable efforts to cause the Shelf Registration Statement to become effective under the Securities Act as promptly as practicable following the initial filing thereof.

(b)       Continued Effectiveness. Except as provided herein, the Company shall use its commercially reasonable efforts to keep the Shelf Registration Statement continuously effective pursuant to the rules, regulations or instructions under the Securities Act until the earliest of (i) the date as of which all of the STX Securities specified in such Shelf Registration Statement have been sold pursuant to such Shelf Registration Statement or another Registration Statement filed under the Securities Act, (ii) such shorter period as all of the STX Holders with respect to such Shelf Registration shall agree in writing and (iii) the four-year anniversary of the date of effectiveness of the Shelf Registration Statement.

 

(c)       Certain Undertakings. Notwithstanding any other provisions of this Agreement to the contrary, the Company shall cause (i) the Shelf Registration Statement (as of the effective date of such Shelf Registration Statement), any amendment thereof (as of the effective date thereof) or supplement thereto (as of its date) not to contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein not misleading, and (ii) any related prospectus (including any preliminary prospectus) or Issuer Free Writing Prospectus and any amendment thereof or supplement thereto, as of its date, not to contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances in which they were made, not misleading; provided, however, the Company shall have no such obligations or liabilities with respect to any written information pertaining to any STX Holder and furnished in writing to the Company by or on behalf of such STX Holder specifically for inclusion therein. The Company agrees, to the extent necessary, to supplement or make amendments to each Shelf Registration Statement if required by applicable law, or as may reasonably be requested by any STX Holder.

 

(d)       Underwritten Shelf Take-Downs.

 

 

 

 

(i)An underwritten offering or sale of STX Securities pursuant this Section 2.1 (each, an “Underwritten Shelf Take-Down”) may be initiated by any STX Holder (or STX Holders, as the case may be) (an “Initiating Shelf Take-Down Holder”) that has STX Securities registered for sale on the Shelf Registration Statement with an aggregate value of $20 million or greater (based on the market price of the A Shares as of the date of such request (an “Underwritten Shelf Take-Down Request”)). The Company shall effect such Underwritten Shelf Take-Down as promptly as practicable in accordance with this Agreement and shall amend or supplement the Shelf Registration Statement for such purpose as soon as practicable. No such Initiating Shelf Take-Down Holder shall be required to permit the offer and sale of Registrable Securities by Original Holders in connection with any such Underwritten Shelf Take-Down initiated by such Initiating Shelf Take-Down Holder(s).

 

(ii)Promptly upon delivery of such Underwritten Shelf Take-Down Request (but in no event more than two Business Days thereafter), the Company shall promptly deliver a written notice (an “Underwritten Shelf Take-Down Notice”) of such Underwritten Shelf Take-Down to all STX Holders (other than the Initiating Shelf Take-Down Holder(s)), which notice shall state that the material terms of such proposed Underwritten Shelf Take-Down, to the extent known, as well as the identity of the Initiating Shelf Take-Down Holder(s), are available upon request, and the Company shall include in such Underwritten Shelf Take-Down all such STX Securities of such STX Holders for which the Company has received written requests for inclusion therein within three Business Days after the date that such Underwritten Shelf Take-Down Notice has been delivered; provided, that if the managing underwriter or underwriters of any proposed Underwritten Shelf Take-Down informs the Company and the STX Holders that have requested to participate in such Underwritten Shelf Take-Down that, in its or their good faith opinion, the number of securities requested to be included in such registration by the STX Holders exceeds the largest number that can be sold in an orderly manner in such offering within a price range acceptable to the Initiating Shelf Take-Down Holder(s), then the aggregate number of securities to be included in such Underwritten Shelf Take-Down shall be the number of STX Securities that, in the opinion of such managing underwriter or underwriters, can be sold without having such adverse effect on such Underwritten Shelf Take-Down, which number shall be allocated on a pro rata basis based on the relative number of STX Securities so requested to be included by each such STX Holder. The Initiating Shelf Take-Down Holder shall have the right to select the managing underwriter or underwriters to administer such offering; provided, that, in each case, each such underwriter is reasonably

 

 

 

satisfactory to the Company; provided further, that, in the case of a Block Trade, any nationally recognized investment banking firm shall be considered satisfactory unless the Company notifies the Initiating Shelf Take-Down Holder of any investment bank that would not be considered reasonably satisfactory prior to the issuance of the Underwritten Shelf Take-Down Notice. No Holder of securities of the Company shall be permitted to include such Holder’s securities in any Underwritten Shelf Take-Down except for STX Holders who timely request, in accordance with this clause (ii), to include STX Securities in such Underwritten Shelf Take-Down. The price, underwriting discount and other financial terms for the STX Securities shall be determined by the Initiating Shelf Take-Down Holder participating in such Underwritten Shelf Take-Down.

 

(iii)The Company shall pay all Registration Expenses in connection with the Shelf Registration or any Underwritten Shelf Take-Down, whether or not such Shelf Registration becomes effective or such Underwritten Shelf Take-Down is completed and whether or not all or any portion of the STX Securities originally requested to be included in such Underwritten Shelf Take-Down are ultimately included. Each STX Holder shall be permitted to withdraw all or part of its STX Securities from an Underwritten Shelf Take-Down at any time prior to the execution of the underwriting agreement in connection with such Underwritten Shelf Take-Down. Notwithstanding the foregoing, in connection with any Underwritten Shelf Take-Down, each STX Holder shall pay all underwriting discounts and commissions pro rata in accordance with the number of STX Securities sold in the offering by such STX Holder and transfer taxes, if any, attributable to the sale of such STX Holder’s STX Securities.

 

(iv)The Company shall not be obligated to effect more than one Underwritten Shelf Takedown that is not a Block Trade or more than four Block Trades under Section 2.1(d) in any calendar year.

 

(v)In the case of any Underwritten Shelf Take-Down, all securities to be included in such Underwritten Shelf Take-Down shall be subject to an underwriting agreement and no STX Holder may participate in such Underwritten Shelf Take-Down unless such STX Holder agrees to sell such STX Holder’s securities on the basis provided therein and completes and executes all reasonable questionnaires, and other documents, including custody agreements and powers of attorney, that must be executed in connection therewith, and provides such other information to the Company or the underwriter as may be necessary to register such STX Holder’s securities.

 

 

 

 

(e)       Notwithstanding anything else to the contrary herein, to the extent the Company is unable to comply with its obligations under this Section 2.1, Section 2.3 below or Section 2.5 below, in each case in connection with the exercise by a STX Holder of its rights under Section 2.3 below, and such inability is primarily related to any duplicative registration of Registrable Securities on the Shelf Registration Statement and any additional registration statement filed by the Company, such inability to comply will not be deemed to be a breach of or other violation by the Company of any of its obligations under this Agreement.

Section 2.2 Demand Registrations.

(a) (i) Subject to Section 2.2(c), at any time or from time to time after the three-month anniversary of the date hereof, one or more Original Holders shall have the right to require the Company to file a registration statement under the Securities Act covering Registrable Securities with an aggregate value of $20 million or greater (based on the market price of the A Shares as of the date of the Demand Registration Request (as defined below)), by delivering a written request therefor to the Company specifying the number of Registrable Securities to be included in such registration by such Original Holders and the intended method of distribution thereof. All such requests by any Original Holder pursuant to this Section 2.2(a)(i) are referred to as “Demand Registration Requests,” the registrations so requested are referred to as “Demand Registrations” and the Original Holders making such demand for registration are referred to as the “Initiating Holders.” As promptly as practicable, but no later than ten days after receipt of a Demand Registration Request, the Company shall give written notice (a “Demand Exercise Notice”) of such Demand Registration Request to all Holders of record of Registrable Securities other than the Initiating Holders.

(ii)       The Company shall, subject to Sections 2.4 and 2.8, include in a Demand Registration (A) the Registrable Securities of the Initiating Holders and (B) the Registrable Securities of any other Holder that shall have made a written request to the Company within the time limits specified below for inclusion in such registration. Any such request from the other Holders must be delivered to the Company within 15 days after the receipt of the Demand Exercise Notice and must specify the maximum number of Registrable Securities intended to be disposed of by such other Holder.

(iii)       The Company, as expeditiously as possible but subject to Section 2.2(c), shall use its commercially reasonable efforts to effect such Demand Registration.

(b)       Registrations under this Section 2.2 shall be on such appropriate registration form of the SEC for the disposition of such Registrable Securities in accordance with the intended method of disposition thereof, which form shall be selected by the Company.

 

(c)       The Demand Registration rights granted in Section 2.2(a) to the Original Holders are subject to the following limitations:

(i)       the Company shall not be required to cause a registration pursuant to Section 2.2(a) to be filed within 90 days, or to be declared effective within a period of 180 days, after the effective date of any other registration statement of the Company filed pursuant to the Securities Act;

 

 

 

(ii)       if any registration of Registrable Securities of an Original Holder would require disclosure of information not otherwise then required by law to be publicly disclosed and, in the good faith judgment of the board of directors of the Company, such disclosure is reasonably likely to adversely affect any material financing, acquisition, corporate reorganization or merger or other material transaction or event involving the Company or otherwise have a material adverse effect on the Company (a “Valid Business Reason”), the Company may postpone the filing of or withdraw a registration statement relating to a Demand Registration Request until such Valid Business Reason no longer exists, but in no event shall the Company avail itself of such right for more than 120 days, in the aggregate, in any period of 365 consecutive days (such period of postponement or withdrawal under this clause (ii), the “Postponement Period”); and the Company shall give notice to the Participating Holder(s) of its determination to postpone or withdraw a registration statement and of the fact that the Valid Business Reason for such postponement or withdrawal no longer exists, in each case, promptly after the occurrence thereof; and

(iii)       the Company shall not be obligated to effect more than five Demand Registrations under Section 2.2(a).

If the Company shall give any notice of postponement or withdrawal of any registration statement pursuant to clause (ii) above, the Company shall not register any equity security of the Company during the period of postponement or withdrawal. Each Original Holder agrees that, upon receipt of any notice from the Company that the Company has determined to withdraw any registration statement pursuant to clause (ii) above, such Original Holder will discontinue its disposition of Registrable Securities pursuant to such registration statement. If the Company shall have withdrawn or prematurely terminated a registration statement filed under Section 2.2(a)(i), the Company shall not be considered to have effected an effective registration for the purposes of this Agreement until the Company shall have filed a new registration statement covering the Registrable Securities covered by the withdrawn registration statement and such registration statement shall have been declared effective and shall not have been withdrawn. If the Company shall give any notice of withdrawal or postponement of a registration statement pursuant to clause (ii) above, at such time as the Valid Business Reason that caused such withdrawal or postponement no longer exists (but in no event more than 180 days after the date of the postponement or withdrawal), the Company shall use its commercially reasonable efforts to effect the registration under the Securities Act of the Registrable Securities covered by the withdrawn or postponed registration statement in accordance with this Section 2.2.

(d)       The Company may, subject to Sections 2.4 and 2.8, elect to include in any registration statement and offering made pursuant to Section 2.2(a), (i) authorized but unissued A Shares or A Shares held by the Company as treasury shares and/or (ii) any other A Shares that are requested to be included in such registration pursuant to the exercise of piggyback rights granted by the Company that are not inconsistent with the rights granted in, or that do not otherwise conflict with the terms of, this Agreement (“Additional Piggyback Rights”); provided, however, that such inclusion shall be permitted only to the extent that it is pursuant to and subject to the terms of the underwriting agreement or arrangements, if any, entered into by the Participating Holders.

 

 

 

(e)       Any Holder may withdraw its Registrable Securities from a Demand Registration at any time. If all such Holders do so, the Company shall cease all efforts to secure registration and such registration nonetheless shall be deemed a Demand Registration for purposes of this Section 2.2 unless (i) the withdrawal is made following withdrawal or postponement of such registration by the Company pursuant to a Valid Business Reason as contemplated by Section 2.2(c)(ii), (ii) the withdrawal is based on the reasonable determination of the Initiating Holders that there has been, since the date of the Demand Registration Request, a material adverse change in the business or prospects of the Company or (iii) the Initiating Holders have paid or reimbursed the Company for all of the reasonable out-of-pocket fees and expenses incurred by the Company in connection with the withdrawn registration.

(f)       A Demand Registration shall not be deemed to have been effected and shall not count as such (i) unless a registration statement with respect thereto has become effective and has remained effective for a period of at least 180 days or such shorter period during which all Registrable Securities covered by such registration statement have been sold or withdrawn, or, if such registration statement relates to an underwritten offering, such longer period as, in the reasonable opinion of counsel for the underwriter(s), is required by law for delivery of a prospectus in connection with the sale of Registrable Securities by an underwriter or dealer, (ii) if, after the registration statement with respect thereto has become effective, it becomes subject to any stop order, injunction or other order or requirement of the SEC or other governmental agency or court for any reason, (iii) if it is withdrawn by the Company pursuant to a Valid Business Reason as contemplated by Section 2.2(c) or (iv) if the conditions to closing specified in the purchase agreement or underwriting agreement entered into in connection with such Demand Registration are not satisfied, other than solely by reason of some act or omission of the Participating Holders.

(g)       In connection with any Demand Registration, the Initiating Holders may designate the lead managing underwriter in connection with such registration and each other managing underwriter for such registration, provided, that, in each case, each such underwriter is reasonably satisfactory to the Company.

Section 2.3 Piggyback Registrations.

(a)       If, at any time, the Company proposes or is required to register any of its equity securities under the Securities Act (other than pursuant to (i) a registration on Form F-4 or Form F-8 or any successor or similar form which is then in effect or (ii) the Shelf Registration Statement under Section 2.1) on a registration statement on Form F-1 or Form F-3 or an equivalent general registration form then in effect, whether or not for its own account, the Company shall give prompt written notice of its intention to do so to each Holder of record of Registrable Securities. Upon the written request of any such Holder, made within 15 days following the receipt of any such written notice (which request shall specify the maximum number of Registrable Securities intended to be disposed of by such Holder and the intended method of distribution thereof), the Company shall, subject to Sections 2.3(b), 2.4 and 2.8, use commercially reasonable efforts to cause all such Registrable Securities to be included in the registration statement with the securities that the Company at the time proposes to register to permit the sale or other disposition by such Holders in accordance with the intended method of distribution thereof of the Registrable Securities to be so registered. No registration of Registrable Securities effected under this Section 2.3(a) shall relieve the Company of its obligations to effect Demand Registrations under Section 2.2, subject to the conditions for a Demand Registration set forth in Section 2.2(c).

 

 

 

(b)       If, at any time after giving written notice of its intention to register any equity securities and prior to the effective date of the registration statement filed in connection with such registration, the Company shall determine for any reason not to register or to delay registration of such equity securities, the Company will give written notice of such determination to each Holder of record of Registrable Securities and (i) in the case of a determination not to register, shall be relieved of its obligation to register any Registrable Securities in connection with such abandoned registration, without prejudice, however, to the rights of Holders under Section 2.2 and (ii) in the case of a determination to delay such registration of its equity securities, shall be permitted to delay the registration of such Registrable Securities for the same period as the delay in registering such other equity securities.

(c)       Any Holder shall have the right to withdraw its request for inclusion of its Registrable Securities in any registration statement pursuant to this Section 2.3 by giving written notice to the Company of its request to withdraw. Such request must be made in writing prior to the earlier of the execution of the underwriting agreement or the execution of the custody agreement with respect to such registration. Such withdrawal shall be irrevocable and, after making such withdrawal, a Holder shall no longer have any right to include Registrable Securities in the registration as to which such withdrawal was made.

Section 2.4 Priority in Registrations.

(a)       If any requested registration made pursuant to Section 2.2 involves an underwritten offering and the lead managing underwriter of such offering (the “Manager”) shall advise the Company that, in its view, the number of securities requested to be included in such registration by the Participating Holders or any other persons, including those A Shares to be included in such registration by the Company, exceeds the largest number (the “Section 2.4(a) Sale Number”) that can be sold in an orderly manner in such offering within a price range acceptable to the Majority Participating Holders, the Company shall use commercially reasonable efforts to include in such registration:

(i)       first, all Registrable Securities requested to be included in such registration by the Participating Holders; provided, however, that, if the number of such Registrable Securities exceeds the Section 2.4(a) Sale Number, the number of such Registrable Securities (not to exceed the Section 2.4(a) Sale Number) to be included in such registration shall be allocated on a pro rata basis among all Participating Holders based on the number of Registrable Securities requested to be included by each such Participating Holder in relation to the number of Registrable Securities requested to be included by all Participating Holders;

(ii)       second, to the extent that the number of securities to be included pursuant to clause (i) of this Section 2.4(a) is less than the Section 2.4(a) Sale Number, the remaining shares to be included in such registration shall be allocated on a pro rata basis among all holders requesting that securities be included in such registration pursuant to the exercise of Additional Piggyback Rights (“Piggyback Shares”), based on the aggregate number of Piggyback Shares requested to be included by each holder requesting inclusion in relation to the aggregate number of Piggyback Shares requested to be included by all holders requesting inclusion, up to the Section 2.4(a) Sale Number; and

 

 

 

(iii)       third, to the extent that the number of securities to be included pursuant to clauses (i) and (ii) of this Section 2.4(a) is less than the Section 2.4(a) Sale Number, any securities that the Company proposes to register, up to the Section 2.4(a) Sale Number.

If, as a result of the proration provisions of this Section 2.4(a), any Participating Holder shall not be entitled to include all Registrable Securities in a registration that such Participating Holder has requested be included, such Participating Holder may elect to withdraw its request to include Registrable Securities in such registration or may reduce the number requested to be included; provided, however, that (A) such request must be made in writing prior to the earlier of the execution of the underwriting agreement or the execution of the custody agreement with respect to such registration and (B) such withdrawal shall be irrevocable and, after making such withdrawal, such Participating Holder shall no longer have any right to include Registrable Securities in the registration as to which such withdrawal was made.

(b)       If any registration pursuant to Section 2.3 involves an underwritten offering that was proposed by the Company and the Manager shall advise the Company that, in its view, the number of securities requested to be included in such registration exceeds the number (the “Section 2.4(b) Sale Number”) that can be sold in an orderly manner in such registration within a price range acceptable to the Company, the Company shall include in such registration:

(i)       first, all A Shares that the Company proposes to register for its own account; and

(ii)       second, to the extent that the number of securities to be included pursuant to clause (i) of this Section 2.4(b) is less than the Section 2.4(b) Sale Number, the remaining shares to be included in such registration shall be allocated on a pro rata basis among all holders requesting that Registrable Securities or Piggyback Shares be included in such registration pursuant to the exercise of piggyback rights pursuant to Section 2.3 of this Agreement or Additional Piggyback Rights, based on the aggregate number of Registrable Securities and Piggyback Shares requested to be included by each holder requesting inclusion in relation to the aggregate number of Registrable Securities and Piggyback Shares requested to be included by all holders requesting inclusion, up to the Section 2.4(b) Sale Number.

(c)       If any registration pursuant to Section 2.3 involves an underwritten offering that was proposed by holders of securities of the Company that have the right to require such registration pursuant to an agreement entered into by the Company in accordance with Section 3.3 (“Additional Demand Rights”) and the Manager shall advise the Company that, in its view, the number of securities requested to be included in such registration exceeds the number (the “Section 2.4(c) Sale Number”) that can be sold in an orderly manner in such registration within a price range acceptable to the Company, the Company shall include in such registration:

 

 

 

(i)       first, all securities requested to be included in such registration by the holders of Additional Demand Rights (“Additional Registrable Securities”); provided, however, that, if the number of such Additional Registrable Securities exceeds the Section 2.4(c) Sale Number, the number of such Additional Registrable Securities (not to exceed the Section 2.4(c) Sale Number) to be included in such registration shall be allocated on a pro rata basis among all holders of Additional Registrable Securities requesting that Additional Registrable Securities be included in such registration, based on the number of Additional Registrable Securities requested to be included by each such holder requesting inclusion in relation to the number of Additional Registrable Securities requested to be included by all of such holders requesting inclusion;

(ii)       second, to the extent that the number of securities to be included pursuant to clause (i) of this Section 2.4(c) is less than the Section 2.4(c) Sale Number, on a pro rata basis among all holders requesting that Registrable Securities or Piggyback Shares be included in such registration pursuant to the exercise of piggyback rights pursuant to Section 2.3 or Additional Piggyback Rights, based on the aggregate number of Registrable Securities and Piggyback Shares requested to be included by each holder requesting inclusion in relation to the aggregate number of Registrable Securities and Piggyback Shares requested to be included by all holders requesting inclusion, up to the Section 2.4(c) Sale Number; and

(iii)       third, to the extent that the number of securities to be included pursuant to clauses (i) and (ii) of this Section 2.4(c) is less than the Section 2.4(c) Sale Number, any A Shares that the Company proposes to register for its own account, up to the Section 2.4(c) Sale Number.

Section 2.5 Registration Procedures. Whenever the Company is required by the provisions of this Agreement to use commercially reasonable efforts to effect or cause the registration of any Registrable Securities under the Securities Act as provided in this Agreement, the Company, as expeditiously as possible, and in each case subject to Section 2.1(e) hereof:

(a)       shall prepare and file with the SEC the requisite registration statement, which shall comply as to form in all material respects with the requirements of the applicable form and shall include all financial statements required by the SEC to be filed therewith, and use commercially reasonable efforts to cause such registration statement to become and remain effective (provided, however, that before filing a registration statement or prospectus or any amendments or supplements thereto, or comparable statements under securities or blue sky laws of any jurisdiction, or any Issuer Free Writing Prospectus related thereto, the Company will furnish to (i) with respect to a registration pursuant to Section 2.2 or 2.3, one counsel for the Participating Holders (selected by the Majority Participating Holders) and to the lead managing underwriter, if any, or (ii) with respect to the Shelf Registration Statement, one counsel for the STX Holders (selected by the Majority STX Holders), copies of all such documents proposed to be filed (including all exhibits thereto), which documents will be subject to the reasonable review and comment of such counsel, and the Company shall not file any registration statement or amendment thereto, any prospectus or supplement thereto or any Issuer Free Writing Prospectus related thereto to which such parties shall reasonably object);

 

 

 

(b)       shall prepare and file with the SEC such amendments and supplements to such registration statement and the prospectus used in connection therewith as may be necessary to keep such registration statement effective for such period as any Participating Holder or STX Holder, as applicable, shall reasonably request and to comply with the provisions of the Securities Act with respect to the sale or other disposition of all Registrable Securities covered by such registration statement in accordance with the intended methods of disposition set forth in such registration statement;

(c)       shall furnish, without charge, to each Participating Holder and each underwriter, if any, of the securities covered by such registration statement and to each STX Holder, as applicable, such number of copies of such registration statement, each amendment thereto, the prospectus included in such registration statement, each preliminary prospectus and each Issuer Free Writing Prospectus utilized in connection therewith, all in conformity with the requirements of the Securities Act, and such other documents as such Participating Holder or STX Holder, as applicable, and underwriter reasonably may request in order to facilitate the public sale or other disposition of the Registrable Securities or STX Securities owned by such Participating Holder or STX Holder, and shall consent to the use in accordance with all applicable law of each such registration statement, each amendment thereto, each such prospectus, preliminary prospectus or Issuer Free Writing Prospectus by each such Participating Holder and the underwriters, if any, or each STX Holder, as applicable, in connection with the offering and sale of the securities covered by such registration statement or prospectus;

(d)       shall use commercially reasonable efforts to register or qualify the Registrable Securities or STX Securities covered by such registration statement under such other securities or “blue sky” laws of such jurisdictions as any Participating Holder, any managing underwriter, if any, or any STX Holder reasonably shall request, and do any and all other acts and things that may be reasonably necessary or advisable to enable such Participating Holder or underwriter, if any, or such STX Holder to consummate the disposition of the securities in such jurisdictions; provided, however, that in no event shall the Company be required to (i) qualify to do business as a foreign corporation in any jurisdiction where, but for the requirements of this Section 2.5(d), it would not be required to be so qualified, (ii) subject itself to taxation in any such jurisdiction or (iii) consent to general service of process in any such jurisdiction;

(e)       shall promptly notify each Participating Holder and each managing underwriter, if any, or each STX Holder, as applicable:

(i)       when the registration statement, any pre-effective amendment, the prospectus or any prospectus supplement related thereto, any post-effective amendment to the registration statement or any Issuer Free Writing Prospectus has been filed and, with respect to the registration statement or any post-effective amendment, when the same has become effective;

(ii)       of any request by the SEC or state securities authority for amendments or supplements to the registration statement or the prospectus related thereto or for additional information;

 

 

 

(iii)       of the issuance or threatened issuance by the SEC of any stop order suspending the effectiveness of the registration statement or the initiation or threatening of any proceedings for that purpose;

(iv)       of the receipt by the Company of any notification with respect to the suspension of the qualification of any Registrable Securities or STX Securities for sale under the securities or blue sky laws of any jurisdiction or the initiation of any proceeding for such purpose; and

(v)       of the existence of any fact of which the Company becomes aware which results in the registration statement, the prospectus related thereto, any document incorporated therein by reference, any Issuer Free Writing Prospectus or the information conveyed to any purchaser at the time of sale to such purchaser containing an untrue statement of a material fact or omitting to state a material fact required to be stated therein or necessary to make any statement therein not misleading;

provided, however, that if the notification relates to an event described in clause (v), the Company, subject to the provisions of Section 2.2(c), promptly shall prepare and file with the SEC, and furnish to each seller and each underwriter, if any, a reasonable number of copies of, a prospectus supplemented or amended so that, as thereafter delivered to the purchasers of such securities, such prospectus shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading;

(f)       shall comply with all applicable rules and regulations of the SEC, and make generally available to its security holders, as soon as reasonably practicable after the effective date of the registration statement (and in any event within 90 days after the end of the 12-month period described hereafter), an earnings statement, which need not be audited, covering a period of at least 12 consecutive months beginning with the first day of the Company’s first calendar quarter after the effective date of the registration statement, which earnings statement shall satisfy the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder;

(g)       shall use commercially reasonable efforts to cause all securities covered by such registration statement to be authorized to be listed on a national securities exchange if shares of the particular class of securities are at that time, or will be immediately following the offering, listed on such exchange;

(h)       shall provide and cause to be maintained a transfer agent and registrar for all such securities covered by such registration statement not later than the effective date of such registration statement;

(i)       shall enter into such customary agreements (including, if applicable, an underwriting agreement) and take such other actions as the Majority Participating Holders or the Majority STX Holders, as applicable, shall reasonably request in order to expedite or facilitate the disposition of such securities (it being understood that the applicable holders of the securities that are to be distributed by any underwriters shall be parties to any such underwriting agreement);

 

 

 

(j)       shall use commercially reasonable efforts to obtain an opinion from the Company’s counsel and a “comfort” letter from the Company’s independent public accountants in customary form and covering such matters as are customarily covered by such opinions and “comfort” letters delivered to underwriters in underwritten public offerings, which opinion and letter shall be reasonably satisfactory to the underwriter, if any;

(k)       shall use commercially reasonable efforts to obtain the withdrawal of any order suspending the effectiveness of the registration statement;

(l)       shall provide a CUSIP number for all Registrable Securities and STX Securities, not later than the effective date of the applicable registration statement;

(m)       shall make reasonably available its employees and personnel for participation in “road shows” and other marketing efforts and otherwise provide reasonable assistance to the underwriters, taking into account the needs of the Company’s businesses and the requirements of the marketing process, in the marketing of Registrable Securities in any underwritten offering;

(n)       shall promptly prior to the filing of any Issuer Free Writing Prospectus, provide copies of such document to counsel for the Participating Holders or the STX Holders, as applicable, and to each managing underwriter, if any, and make the Company’s representatives reasonably available for discussion of such document and make such changes in such document concerning the Participating Holders or the STX Holders, as applicable, prior to the filing thereof as counsel for such Participating Holders, STX Holders or underwriters may reasonably request;

(o)       shall cooperate with the Participating Holders or the STX Holders, as applicable, and the managing underwriter, if any, to facilitate the timely preparation and delivery of certificates not bearing any restrictive legends representing the Registrable Securities to be sold, and cause such Registrable Securities to be issued in such denominations and registered in such names in accordance with the underwriting agreement prior to any sale of Registrable Securities to the underwriters or, if not an underwritten offering, in accordance with the instructions of the Participating Holders or STX Holders at least three Business Days prior to any sale of Registrable Securities and instruct any transfer agent and registrar of Registrable Securities to release any stop transfer orders in respect thereof;

(p)       shall cooperate with each Participating Holder or STX Holder, as applicable, and each underwriter or agent participating in the disposition of such Registrable Securities and their respective counsel in connection with any filings required to be made with FINRA; and

(q)       shall take all other reasonable steps necessary to effect the registration and disposition of the Registrable Securities as required hereby.

The Company may require as a condition precedent to the Company’s obligations under this Section 2.5 that each Participating Holder or STX Holder as to which any registration is being effected furnish the Company such information in writing regarding such Participating Holder or STX Holder and the distribution of its Registrable Securities or STX Securities, as applicable, as the Company from time to time reasonably may request. Each Participating Holder or STX Holder agrees that upon receipt of any notice from the Company under Section 2.5(e)(v), such Participating Holder or STX Holder will discontinue its disposition of securities pursuant to the registration statement covering such securities until such Participating Holder’s or STX Holder’s receipt of the copies of the supplemented or amended prospectus. In the event the Company shall give any such notice, the applicable period set forth in Section 2.5(b) shall be extended by the number of days during such period from and including the date of the giving of such notice to and including the date when each Participating Holder or STX Holder shall have received the copies of the supplemented or amended prospectus.

 

 

 

Section 2.6 Automatic Shelf Registration Statements. To the extent the Company is a well-known seasoned issuer as defined in Rule 405 under the Securities Act (a “WKSI”) at the time any Demand Registration Request is submitted to the Company, and such Demand Registration Request requests that the Company file an automatic shelf registration statement as defined in Rule 405 under the Securities Act (an “automatic shelf registration statement”) on Form F-3, the Company shall file an automatic shelf registration statement that covers those Registrable Securities that are requested to be registered. The Company shall use commercially reasonable efforts to remain a WKSI and not become an ineligible issuer (as defined in Rule 405 under the Securities Act) during the period during which such automatic shelf registration statement is required to remain effective. If the Company does not pay the filing fee covering the Registrable Securities at the time the automatic shelf registration statement is filed, the Company shall pay such fee at such time or times as the Registrable Securities are to be sold. If the automatic shelf registration statement has been outstanding for at least three years, at the end of the third year the Company shall refile a new automatic shelf registration statement covering the Registrable Securities. If at any time when the Company is required to re-evaluate its WKSI status, the Company determines that it is not a WKSI, the Company shall use commercially reasonable efforts to refile the shelf registration statement on Form F-3 and, if such form is not available, Form F-1, and keep such registration statement effective during the period during which such registration statement is required to be kept effective hereunder.

Section 2.7 Registration Expenses.

(a)       The Company shall pay all Registration Expenses (i) with respect to any Demand Registration, whether or not it becomes effective or remains effective for the period contemplated by Section 2.5(b), (ii) with respect to any registration effected under Section 2.1 and (iii) with respect to any registration effected under Section 2.3.

(b)       Notwithstanding the foregoing, (i) the provisions of this Section 2.7 shall be deemed amended to the extent necessary to cause these expense provisions to comply with “blue sky” laws of each state in which the offering is made and (ii) in connection with any registration hereunder, each Participating Holder shall pay all underwriting discounts and commissions pro rata in accordance with the number of Registrable Securities sold in the offering by such Participating Holder and transfer taxes, if any, attributable to the sale of such Participating Holder’s Registrable Securities.

Section 2.8 Underwritten Demand Offerings.

(a)       If requested by the underwriters for any underwritten offering by the Original Holders pursuant to a Demand Registration, the Company shall enter into a customary underwriting agreement with the underwriters. Such underwriting agreement shall be satisfactory in form and substance to the Company and the Majority Participating Holders and shall contain such representations and warranties by, and such other agreements on the part of, the Company and such other terms as are generally prevailing in agreements of that type. Any Participating Holder shall be a party to such underwriting agreement and, at its option, may require that any or all of the conditions precedent to the obligations of such underwriters under such underwriting agreement be conditions precedent to the obligations of such Participating Holder; provided, however, that the Company shall not be required to make any representations or warranties with respect to written information specifically provided by a Participating Holder for inclusion in the registration statement.

 

 

 

(b)       In the case of a registration pursuant to Section 2.3, if the Company shall have determined to enter into an underwriting agreement in connection therewith, any Registrable Securities to be included in such registration shall be subject to such underwriting agreement. Any Participating Holder may, at its option, require that any or all of the conditions precedent to the obligations of such underwriters under such underwriting agreement be conditions precedent to the obligations of such Participating Holder.

(c)       In the case of any Demand Registration pursuant to an underwritten offering, or, in the case of a registration under Section 2.3, if the Company has determined to enter into an underwriting agreement in connection therewith, all securities to be included in such registration shall be subject to an underwriting agreement and no Person may participate in such registration unless such Person agrees to sell such Person’s securities on the basis provided therein and, subject to the provisions of this Section 2.8, completes and executes all reasonable questionnaires, and other documents, including custody agreements and powers of attorney, that must be executed in connection therewith, and provides such other information to the Company or the underwriter as may be necessary to register such Person’s securities.

Section 2.9 Holdback Agreements. Each Participating Holder, each STX Holder participating in an Underwritten Shelf Take-Down and each other holder of 1% or more of the outstanding A Shares at the time of an offering hereunder that is party hereto agrees, to the extent requested in writing by a managing underwriter, if any, of any registration hereunder, not to sell, transfer or otherwise dispose of, including any sale pursuant to Rule 144 under the Securities Act, any A Shares, or any other equity security of the Company or any security convertible into or exchangeable or exercisable for any equity security of the Company other than as part of such underwritten public offering during the time period reasonably requested by the managing underwriter, not to exceed (a) 90 days, in the case of an Underwritten Shelf Take-Down that is not a Block Trade or underwritten offering pursuant to Section 2.2 or Section 2.3 or (b) 60 days, in the case of a Block Trade.

Section 2.10 No Required Sale. Nothing in this Agreement shall be deemed to create an independent obligation on the part of any Holder to sell any Registrable Securities pursuant to any effective registration statement.

Section 2.11 Indemnification.

(a)       In the event of any registration of any securities of the Company under the Securities Act pursuant to Article II, the Company will, and hereby agrees to, indemnify and hold harmless, to the fullest extent permitted by law, each Participating Holder or STX Holder, as applicable, its directors, officers, Affiliates, (and the directors and officers thereof), and each other Person, if any, who controls such holder within the meaning of the Securities Act, from and against any and all losses, claims, damages, expenses or liabilities, joint or several, actions or proceedings (whether commenced or threatened) and expenses (including reasonable fees of counsel and any amounts paid in any settlement effected with the Company’s consent) to which each such indemnified party may become subject under the Securities Act or otherwise in respect thereof (collectively, “Losses”), insofar as such Losses arise out of or are based upon any untrue statement or alleged untrue statement of a material fact or omission or alleged omission to state a

 

 

 

material fact necessary to be stated or necessary in order to make the statements, in light of the circumstances under which they were made, not misleading, in any registration statement under which such securities were registered under the Securities Act, or amendment thereof or supplement thereto, or in any preliminary, final or summary prospectus or any amendment or supplement thereto, together with the documents incorporated by reference therein, or any Issuer Free Writing Prospectus utilized in connection therewith, and the Company will reimburse any such indemnified party for any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such Loss as such expenses are incurred; provided, however, that the Company shall not be liable to any such indemnified party in any such case to the extent such Loss arises out of or is based upon any untrue statement or alleged untrue statement of a material fact or omission or alleged omission of a material fact made in such registration statement or amendment thereof or supplement thereto or in any such prospectus or any preliminary, final or summary prospectus or Issuer Free Writing Prospectus in reliance upon and in conformity with written information furnished to the Company by or on behalf of such indemnified party specifically for use therein.

(b)       Each Holder whose Registrable Securities are included in the securities as to which any registration under Article II is being effected shall, severally and not jointly, indemnify and hold harmless (in the same manner and to the same extent as set forth in paragraph (a) of this Section 2.11), to the fullest extent permitted by law, the Company, its officers and directors, each Person controlling the Company within the meaning of the Securities Act and all other prospective sellers and their respective directors, officers, Affiliates and respective controlling Persons with respect to any untrue statement or alleged untrue statement of any material fact in, or omission or alleged omission of any material fact from, such registration statement, any preliminary, final or summary prospectus contained therein, or any amendment or supplement thereto, or any Issuer Free Writing Prospectus utilized in connection therewith, if such statement or alleged statement or omission or alleged omission was made in reliance upon and in conformity with written information furnished to the Company or its representatives by or on behalf of such holder specifically for use therein and reimburse such indemnified party for any legal or other expenses reasonably incurred in connection with investigating or defending any such Loss as such expenses are incurred; provided, however, that the aggregate amount that any such holder shall be required to pay pursuant to this Section 2.11 shall in no case be greater than the amount of the net proceeds received by such holder upon the sale of the securities pursuant to the registration statement giving rise to such claim. Such indemnity and reimbursement of expenses shall remain in full force and effect regardless of any investigation made by or on behalf of such indemnified party and shall survive the transfer of such securities by such holder.

(c)       Any Person entitled to indemnification under this Agreement promptly shall notify the indemnifying party in writing of the commencement of any action or proceeding with respect to which a claim for indemnification may be made pursuant to this Section 2.11, but the failure of any such Person to provide such notice shall not relieve the indemnifying party of its obligations under the preceding paragraphs of this Section 2.11, except to the extent the indemnifying party is materially prejudiced thereby, and shall not relieve the indemnifying party from any liability that it may have to any such Person otherwise than under this Article II. In case any action or proceeding is brought against an indemnified party and it shall notify the indemnifying party of the commencement thereof, the indemnifying party shall be entitled to

 

 

 

participate therein and, unless in the reasonable opinion of outside counsel to the indemnified party a conflict of interest between such indemnified and indemnifying parties may exist in respect of such claim, to assume the defense thereof jointly with any other indemnifying party similarly notified, to the extent that it chooses, with counsel reasonably satisfactory to such indemnified party, and after notice from the indemnifying party to such indemnified party that it so chooses, the indemnifying party shall not be liable to such indemnified party for any legal or other expenses subsequently incurred by such indemnified party in connection with the defense thereof other than reasonable costs of investigation; provided, however, that (i) if the indemnifying party fails to take reasonable steps necessary to defend diligently the action or proceeding within 20 days after receiving notice from such indemnified party, (ii) if such indemnified party who is a defendant in any action or proceeding that is also brought against the indemnifying party reasonably shall have concluded that there may be one or more legal defenses available to such indemnified party that are not available to the indemnifying party or (iii) if representation of both parties by the same counsel is otherwise inappropriate under applicable standards of professional conduct, then, in any such case, the indemnified party shall have the right to assume or continue its own defense as set forth above (but with no more than one firm of counsel for all indemnified parties) and the indemnifying party shall be liable for any expenses therefor. Without the written consent of the indemnified party, which consent shall not be unreasonably withheld, no indemnifying party shall effect the settlement or compromise of, or consent to the entry of any judgment with respect to, any pending or threatened action or claim in respect of which indemnification or contribution may be sought hereunder, whether or not the indemnified party is an actual or potential party to such action or claim, unless such settlement, compromise or judgment (A) includes an unconditional release of the indemnified party from all liability arising out of such action or claim and (B) does not include a statement as to or an admission of fault, culpability or a failure to act, by or on behalf of any indemnified party.

(d)       If for any reason the foregoing indemnity is unavailable or is insufficient to hold harmless an indemnified party under Section 2.11(a), (b) or (c), then each indemnifying party shall contribute to the amount paid or payable by such indemnified party as a result of any Loss in such proportion as is appropriate to reflect the relative fault of the indemnifying party, on the one hand, and the indemnified party, on the other hand, with respect to such offering of securities. The relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the indemnifying party or the indemnified party and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such untrue statement or omission. If, however, the allocation provided in the second preceding sentence is not permitted by applicable law, then each indemnifying party shall contribute to the amount paid or payable by such indemnified party in such proportion as is appropriate to reflect not only such relative faults but also the relative benefits of the indemnifying party and the indemnified party as well as any other relevant equitable considerations. The parties hereto agree that it would not be just and equitable if contributions pursuant to this Section 2.11(d) were to be determined by pro rata allocation or by any other method of allocation which does not take account of the equitable considerations referred to in the preceding sentences of this Section 2.11(d). The amount paid or payable in respect of any Loss shall be deemed to include any legal or other third party expenses reasonably incurred by such indemnified party in connection with investigating or defending any such Loss. No Person guilty of fraudulent misrepresentation within the meaning of Section 11(f) of the Securities Act shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation. Notwithstanding anything in this Section 2.11(d) to the contrary, no indemnifying party other than the Company shall be required pursuant to this Section 2.11(d) to contribute any amount in excess of the net proceeds received by such indemnifying party from the sale of securities in the offering to which the losses, claims, damages, expenses or liabilities of the indemnified parties relate, less the amount of any indemnification payment made by such indemnifying party pursuant to Sections 2.11(b) and (c).

 

 

 

(e)       The indemnity and contribution agreements contained herein shall be in addition to any other rights to indemnification or contribution which any indemnified party may have pursuant to law or contract and shall remain operative and in full force and effect regardless of any investigation made or omitted by or on behalf of any indemnified party and shall survive the transfer of the Registrable Securities by any such party.

ARTICLE III

GENERAL

Section 3.1 Company Filings. The Company covenants that, so long as it remains subject to the reporting provisions of the Exchange Act, it will timely file the reports required to be filed by it under the Securities Act or the Exchange Act or, if it is not required to file such reports, upon the request of any Holder it shall make publicly available other information so long as necessary to permit sales of such Registrable Securities in compliance with Rule 144 under the Securities Act, all to the extent required from time to time to enable such Holder to sell Registrable Securities without registration under the Securities Act within the limitation of the exemptions provided by Rule 144 under the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the SEC. Upon the request of any Holder, the Company will deliver to such Holder a written statement as to whether it has complied with such requirements.

Section 3.2 Nominees for Beneficial Owners. If securities are held by a nominee for the beneficial owner thereof, the beneficial owner thereof may, at its option, be treated as the holder of such securities for purposes of any request or other action by any holder or holders pursuant to this Agreement or any determination of any number or percentage of shares constituting securities held by any holder or holders contemplated by this Agreement; provided, that the Company shall have received assurances reasonably satisfactory to it of such beneficial ownership.

Section 3.3 No Inconsistent Agreements. The rights granted to the Holders hereunder do not in any way conflict with and are not inconsistent with any other agreements to which the Company is a party or by which it is bound.

ARTICLE IV

MISCELLANEOUS

Section 4.1 Amendment and Waiver.

(a)       Any provision of this Agreement may be amended or waived if, and only if, such amendment or waiver is in writing and is signed, in the case of an amendment, by (i) the Company, (ii) the Original Holders who hold a majority of the Registrable Securities then outstanding and held by the Original Holders and (iii) the STX Holders who hold a majority of the Registrable Securities then outstanding and held by the STX Holders or, in the case of a waiver, by the party or parties against whom the waiver is to be effective, in an instrument specifically designated as an amendment or waiver hereto; provided, however, that a waiver by (i) the Original Holders shall require the consent of Original Holders who hold a majority of the

 

 

 

Registrable Securities then outstanding and held by the Original Holders and (ii) the STX Holders shall require the consent of STX Holders who hold a majority of the Registrable Securities then outstanding and held by the STX Holders; provided further, that any amendment that affects any Holder in a manner that is materially and adversely disproportionate to the impact of such amendment on other Holders (but taking into account any specific differences between the rights of the Original Holders and the rights of the STX Holders provided under this Agreement as in effect on the date hereof) may only be made with the prior written consent of such affected Holder.

(b)       No failure or delay of any party in exercising any right or remedy hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such right or power, or any course of conduct, preclude any other or further exercise thereof or the exercise of any other right or power. The rights and remedies of the parties hereunder are cumulative and are not exclusive of any rights or remedies which they would otherwise have hereunder.

Section 4.2 Notices. All notices and other communications hereunder shall be in writing and shall be deemed duly given (a) on the date of delivery if delivered personally, (b) upon receipt of confirmation of successful transmission if delivered by electronic mail, (c) on the first Business Day following the date of dispatch if delivered utilizing a next-day service by a recognized next-day courier or (d) on the earlier of confirmed receipt or the fifth Business Day following the date of mailing if delivered by registered or certified mail, return receipt requested, postage prepaid. All notices hereunder shall be delivered to the addresses set forth below, or pursuant to such other instructions as may be designated in writing by the party to receive such notice:

(i)       if to any Original Holder or STX Holder, to its last known address appearing on the books of the Company maintained for such purpose;

 

(ii)       if to the Company, to:

 

Eros International Plc

First Names House

Victoria Road

Douglas

Isle of Man IM2 4DF

British Isles

Attention: Mark Carbeck, Chief Corporate and Strategy Officer

Email: mark.carbeck@erosintl.com

or such other address as the Company or the applicable holder shall have specified to the other party in writing in accordance with this Section 4.2.

 

 

 

Section 4.3 Interpretation. When a reference is made in this Agreement to a Section or Article, such reference shall be to a Section or Article of this Agreement unless otherwise indicated. The headings contained in this Agreement are for convenience of reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. All words used in this Agreement will be construed to be of such gender or number as the circumstances require. The word “including” and words of similar import when used in this Agreement will mean “including, without limitation,” unless otherwise specified. Each of the parties hereto acknowledges that it has been represented by counsel in connection with this Agreement and the transactions contemplated by this Agreement. Accordingly, any rule of law or any legal decision that would require interpretation of any claimed ambiguities in this Agreement against the drafting party has no application and is expressly waived.

Section 4.4 Entire Agreement. This Agreement constitutes the entire agreement, and supersedes all prior written agreements, arrangements, communications and understandings and all prior and contemporaneous oral agreements, arrangements, communications and understandings between the parties with respect to the subject matter hereof and thereof.

Section 4.5 No Third-Party Beneficiaries. Except as provided in Section 2.11, nothing in this Agreement, express or implied, is intended to or shall confer upon any Person other than the parties and their respective successors and permitted assigns any legal or equitable right, benefit or remedy of any nature under or by reason of this Agreement.

Section 4.6 Governing Law. This Agreement and all disputes or controversies arising out of or relating to this Agreement or the transactions contemplated hereby shall be governed by, and construed in accordance with, the internal laws of the State of New York, without regard to the laws of any other jurisdiction that might be applied because of the conflicts of laws principles of the State of New York.

Section 4.7 Submission to Jurisdiction. Each of the parties irrevocably agrees that any legal action or proceeding arising out of or relating to this Agreement brought by any other party or its successors or assigns shall be brought and determined in any New York State or federal court, and each of the parties hereby irrevocably submits to the exclusive jurisdiction of the aforesaid courts for itself and with respect to its property, generally and unconditionally, with regard to any such action or proceeding arising out of or relating to this Agreement and the transactions contemplated hereby. Each of the parties agrees not to commence any action, suit or proceeding relating thereto except in the courts described above in New York, other than actions in any court of competent jurisdiction to enforce any judgment, decree or award rendered by any such court in New York as described herein. Each of the parties further agrees that notice as provided herein shall constitute sufficient service of process and the parties further waive any argument that such service is insufficient. Each of the parties hereby irrevocably and unconditionally waives, and agrees not to assert, by way of motion or as a defense, counterclaim or otherwise, in any action or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby, (a) any claim that it is not personally subject to the jurisdiction of the courts in New York as described herein for any reason, (b) that it or its property is exempt or immune from jurisdiction of any such court or from any legal process commenced in such courts (whether through service of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise) and (c) that (i) the suit, action or proceeding in any such court is brought in an inconvenient forum, (ii) the venue of such suit, action or proceeding is improper or (iii) this Agreement, or the subject matter hereof, may not be enforced in or by such courts.

 

 

 

Section 4.8 Successors, Assigns and Transferees. The rights and obligations of each party hereto may not be assigned, in whole or in part, without the written consent of the Company; provided, however, that notwithstanding the foregoing, the rights and obligations set forth herein may be assigned, in whole or in part, by any Original Holder or STX Holder to any of its Affiliates, and such transferee shall, with the consent of the transferring holder, be treated as an “Original Holder” or “STX Holder,” as applicable, for all purposes of this Agreement (each Person to whom the rights and obligations are assigned in compliance with this Section 4.8 is a “Permitted Assignee” and all such Persons, collectively, are “Permitted Assignees”); provided, further, that such transferee shall only be admitted as a party hereunder upon its, his or her execution and delivery of a joinder agreement in substantially the form attached as Exhibit A hereto, agreeing to be bound by the terms and conditions of this Agreement as if such Person were a party hereto.

Section 4.9 Enforcement. The parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. Accordingly, each of the parties shall be entitled to specific performance of the terms hereof, including an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in any New York State or federal court, this being in addition to any other remedy to which such party is entitled at law or in equity. Each of the parties hereby further waives (a) any defense in any action for specific performance that a remedy at law would be adequate and (b) any requirement under any law to post security as a prerequisite to obtaining equitable relief.

Section 4.10 Severability. Whenever possible, each provision or portion of any provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision or portion of any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability shall not affect any other provision or portion of any provision in such jurisdiction, and this Agreement shall be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision or portion of any provision had never been contained herein.

Section 4.11 Waiver of Jury Trial. EACH OF THE PARTIES TO THIS AGREEMENT HEREBY IRREVOCABLY WAIVES ALL RIGHT TO A TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.

Section 4.12 Counterparts. This Agreement may be executed in two or more counterparts, all of which shall be considered one and the same instrument and shall become effective when one or more counterparts have been signed by each of the parties and delivered to the other parties.

Section 4.13 Facsimile or .pdf Signature. This Agreement may be executed by facsimile or .pdf signature and a facsimile or .pdf signature shall constitute an original for all purposes.

Section 4.14 Time of Essence. Time is of the essence with regard to all dates and time periods set forth or referred to in this Agreement.

Signature pages follow.

 

 

[Signature pages to follow.]

 

 

Schedule 1

 

STX Holders

 

Name STX Securities
   
   
   

 

 

 

 

Schedule 2

 

Original Holders

 

Name Registrable Securities
   
   
   

 

 

 

 

 

 

 

Exhibit 8.1

 

SUBSIDIARIES OF EROS INTERNATIONAL PLC

 

Registrant’s consolidated subsidiaries are shown below together with the percentage of voting securities owned as of the date of this filing, and the state or jurisdiction of organization of each subsidiary. The names have been omitted for subsidiaries which, if considered in the aggregate as a single subsidiary, do not constitute a significant subsidiary.

 

 

    Date   Country of
Incorporation
  % of voting
rights held
Copsale Limited   June 2006   BVI   100.00
Eros Australia Pty Limited   June 2006   Australia   100.00
Eros International Films Private Limited   June 2006   India   100.00
Eros International Limited   June 2006   U.K.   100.00
Eros International Media Limited   June 2006   India   62.31
Eros International USA Inc   June 2006   U.S.   100.00
Eros Network Limited   June 2006   U.K.   100.00
Eros Worldwide FZ-LLC   June 2006   UAE   100.00
Big Screen Entertainment Private Limited   January 2007   India   64.00
EyeQube Studios Private Limited   January 2008   India   99.99
Acacia Investments Holdings Limited   April 2008   IOM   100.00
Eros International Pte Limited   August 2010   Singapore   100.00
Digicine Pte. Limited   March 2012   Singapore   100.00
Colour Yellow Productions Private Limited   May 2014   India   50.00
Eros Digital FZ LLC   September 2015   UAE   100.00
Eros Digital Limited   July 2016   IOM   100.00
Eros Films Limited   November 2016   IOM   100.00
Universal Power Systems Private Limited   August 2015   India   100.00
England Merger 1, Corp   March 2020   U.S.   100.00
England Holdings 2,Inc   March 2020   U.S.   100.00
England Holdings 3,Inc   March 2020   U.S.   100.00

Exhibit 12.1

 

PRINCIPAL EXECUTIVE OFFICER CERTIFICATION

 

I, Kishore Lulla, certify that:

 

1.       I have reviewed this annual report on Form 20-F of Eros International Plc (the “Company”);

 

2.       Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.       Based on my knowledge, the consolidated financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;

 

4.       The Company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have:

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c. Evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d. Disclosed in this report any change in the Company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting; and

 

5.       The Company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company’s auditors and the audit committee of the Company’s Board of Directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information; and

 

  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting.

 

Date: July 30, 2020

 

 

Name: Kishore Lulla

Title: Executive Chairman and Group
Chief Executive Officer and Managing Director

 

Exhibit 12.2

 

PRINCIPAL FINANCIAL OFFICER CERTIFICATION

 

I, Prem Parameswaran, certify that:

 

1. I have reviewed this annual report on Form 20-F of Eros International Plc (the “Company”);

 

2.       Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.       Based on my knowledge, the consolidated financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;

 

4.       The Company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have:

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c. Evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d. Disclosed in this report any change in the Company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting; and

 

5.       The Company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company’s auditors and the audit committee of the Company’s Board of Directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information; and

 

  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting.

 

Date: July 30, 2020

 

 

Name: Prem Parameswaran

Title: Executive Director, President of North America &
Group Chief Financial Officer

Exhibit 13.1

 

Certification of the Principal Executive Officer
Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

In connection with the annual report of Eros International Plc (the “Company”) on Form 20-F for the year ended March 31, 2020 accompanying this Certification, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Kishore Lulla, Group Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

  (1) I am the Group Chief Executive Officer of the Company;

 

  (2) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (3) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: July 30, 2020

 

 

Name: Kishore Lulla

Title: Executive Chairman and Group
Chief Executive Officer and Managing Director

Exhibit 13.2

 

Certification of the Principal Financial Officer
Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

In connection with the annual report of Eros International Plc (the “Company”) on Form 20-F for the year ended March 31, 2020 accompanying this Certification, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Prem Parameswaran, Group Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

  (1) I am the Group Chief Financial Officer of the Company;

 

  (2) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (3) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: July 30, 2020

 

 

Name: Prem Parameswaran

Title: Executive Director, President of North America &
Group Chief Financial Officer

v3.20.2
Cover
12 Months Ended
Mar. 31, 2020
shares
Statement Line Items [Line Items]  
Document Type 20-F
Amendment Flag false
Document Annual Report true
Document Transition Report false
Document Shell Company Report false
Document Period End Date Mar. 31, 2020
Document Fiscal Period Focus FY
Document Fiscal Year Focus 2020
Current Fiscal Year End Date --03-31
Entity File Number 001-36176
Entity Registrant Name Eros International PLC
Entity Central Index Key 0001532981
Entity Incorporation, State or Country Code Y8
Title of 12(b) Security A ordinary share, par value GBP 0.30 per share
Trading Symbol EROS
Security Exchange Name NYSE
Entity Well-known Seasoned Issuer No
Entity Voluntary Filers No
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Accelerated Filer
Entity Emerging Growth Company false
Entity Shell Company false
'A' Ordinary Shares  
Statement Line Items [Line Items]  
Entity Common Stock, Shares Outstanding 127,116,702
"B" Ordinary Shares  
Statement Line Items [Line Items]  
Entity Common Stock, Shares Outstanding 19,899,085
v3.20.2
Consolidated Statetments of Financial Position - USD ($)
$ in Thousands
Mar. 31, 2020
Mar. 31, 2019
Current assets    
Inventories $ 0 $ 435
Trade and other receivables, fair value 94,749 125,229
Trade and other receivables, amortised cost 12,504 79,916
Investments 3,802 1,042
Cash and cash equivalents [1] 2,563 89,117
Restricted deposits 4,787 55,858
Total current assets 118,405 351,597
Non-current assets    
Property and equipment 9,234 10,921
Right-of-use-assets 1,512
Intangible assets - content 461,889 706,572
Intangible assets - others 2,935 3,794
Investments 140 2,650
Trade and other receivables, amortised cost 10,761 10,065
Income tax receivable 1,975 1,284
Restricted deposits 63 756
Deferred income tax assets 742 1,263
Total non-current assets 489,251 737,305
Total assets 607,656 1,088,902
Current liabilities    
Trade and other payables 90,941 83,487
Acceptances 1,858 8,366
Short-term borrowings, fair value 23,100 68,349
Short-term borrowings, amortised cost 93,758 140,559
Derivative financial instruments 620
Lease liabilities 723
Current income tax payable 14,900 17,291
Total current liabilities 225,280 318,672
Non-current liabilities    
Long-term borrowings at amortised cost 62,114 71,920
Lease liabilities 830
Other long-term liabilities 8,258 13,898
Deferred income tax liabilities 2,688 27,427
Total non-current liabilities 73,890 113,245
Total liabilities 299,170 431,917
Equity    
Share capital 66,727 39,326
Share premium 673,717 580,013
Reserves (405,665) (2,202)
Other components of equity (85,660) (79,696)
JSOP reserve (15,985)
Equity attributable to equity holders of Eros International Plc 249,119 521,456
Non-controlling interest 59,367 135,529
Total equity 308,486 656,985
Total liabilities and shareholder's equity $ 607,656 $ 1,088,902
[1] Includes $Nil (2019: $46,666) of restricted deposits.
v3.20.2
Consolidated Statements of Income/(Loss) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Profit or loss [abstract]      
Revenue $ 155,452 $ 270,126 $ 261,253
Cost of sales 81,725 155,396 134,708
Gross profit 73,727 114,730 126,545
Administrative costs 144,319 87,134 68,029
Operating (loss)/profit before impairment loss (70,592) 27,596 58,516
Impairment loss (431,200) (423,335)
Operating profit/(loss) (501,792) (395,739) 58,516
Finance costs (20,771) (24,093) (19,668)
Finance income 11,992 16,419 1,855
Net finance costs (8,779) (7,674) (17,813)
Other gains/(losses) (3,314) 288 (41,321)
Loss before tax (513,887) (403,125) (618)
Income tax 22,183 (7,328) (9,127)
Loss for the year (491,704) (410,453) (9,745)
Attributable to:      
Equity holders of Eros International Plc (418,992) (423,867) (22,575)
Non-controlling interest (72,712) 13,414 12,830
Loss for the year $ (491,704) $ (410,453) $ (9,745)
(Loss) per share (cents)      
Basic/(loss) per share $ (389.6) $ (599.5) $ (36.3)
Diluted/(loss) per share $ (389.6) $ (599.5) $ (36.3)
v3.20.2
Consolidated Statements of Comprehensive Income/(Loss) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Statement of comprehensive income [abstract]      
(Loss) for the year $ (491,704) $ (410,453) $ (9,745)
Items that will not be subsequently reclassified to profit or loss      
Changes in fair value of investments (1,860) (24,687)
Revaluation of property and equipment 1,745
Items that will be subsequently reclassified to profit or loss      
Exchange differences on translating foreign operations (8,031) (13,934) (1,153)
Exchange differences on revaluation of property and equipment (156) 78 6
Reclassification of cash flow hedge to consolidated statements of income 375
Fair value gain/(loss) on trade account receivable (FVTOCI) 2,014 (4,664)
Total other comprehensive loss for the year (8,033) (41,462) (772)
Total comprehensive loss for the year, net of tax (499,737) (451,915) (10,517)
Attributable to:      
Equity holders of Eros International Plc (423,130) (459,321) (23,106)
Non-controlling interest $ (76,607) $ 7,406 $ 12,589
v3.20.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Cash flow from operating activities:      
(Loss) before tax $ (513,887) $ (403,125) $ (618)
Adjustments for:      
Depreciation 891 1,049 1,265
Depreciation on ROU 1,677
Share based payments 22,268 21,561 17,918
Amortization of intangible film and content rights 64,451 130,155 115,285
Amortization of other intangible assets 894 1,214 1,726
Other non-cash items 100,118 58,438 50,119
Impairment loss 431,200 423,335
Net finance costs 17,085 20,901 18,745
(Gain) on sale of available-for-sale financial assets 1,253 (37)
Loss/(gain) on sale of property and equipment 70 97 (2)
Movement in trade and other receivables (87,885) (179,784) (91,317)
Movement in inventories (99) (219)
Movement in trade and other payables 1,995 22,166 (1,215)
Cash generated from operations 38,767 95,871 111,687
Interest paid (14,890) (13,347) (20,761)
Income taxes paid (5,249) (7,558) (7,683)
Net cash generated from operating activities 18,628 74,966 83,243
Cash flows from investing activities      
Purchase of current Investment (4,013) (1,005)
Proceeds from sale of non-current Investment 650
Purchase of property and equipment (60) (380) (913)
Proceeds from disposal of property and equipment 82 6 70
Investment in restricted deposits held with banks (8,530) (53,507) (27)
Restricted deposits matured 59,780 3,952
Deconsolidation/acquisition of cash and cash equivalent in subsidiary (9)
Purchase of intangible film rights and content rights (132,139) (107,722) (186,757)
Purchase of other intangible assets (338) (907) (321)
Interest received 4,132 1,830 2,537
Net cash (used in) investing activities (80,436) (157,733) (185,420)
Cash flows from financing activities      
Proceeds from issue of share capital, net of transaction costs 5,164 54,820 16,645
Proceeds from issue of shares by subsidiary 17 77 556
Investment in shares of subsidiary (2,892) 40,221
Share application money received pending allotment 18,000
(Repayment of)/proceeds from/short term debt with maturity less than three months (net) 211
Proceeds from short term debt 56,337 103,365 48,249
Repayment of short term debt (76,672) (59,014) (43,785)
Proceeds from long term debt, net of transaction costs of Nil (2018: Nil and 2017: $384) 111,278
Payment of lease liability (1,579)
Repayment of long term debt (7,553) (12,239) (113,960)
Net cash (used in)/ generated from financing activities (24,286) 84,117 77,415
Net increase/(decrease) in cash and cash equivalents (86,094) 1,350 (24,762)
Effects of exchange rate changes on cash and cash equivalents (460) 5 257
Cash and cash equivalents at beginning of year 89,117 [1] 87,762 112,267
Cash and cash equivalents at end of year 2,563 [1] 89,117 [1] 87,762
Long-Term Borrowings      
Reconciliation of Liabilities arising from Financing activities      
Liabilities arising from financing activities, beginning of period 147,254 [2] 188,909 [3]  
Impact on adoption of IFRS 16 [2] (251)    
Considered in cash flow (net) (7,553) [2] (12,239) [3]  
Net finance cost in relation to convertible notes 4,245 [2] 10,682 [3]  
Shares issued in lieu of convertible notes (82,967) [2] (49,741) [3]  
Movement in derivative financial instruments  
Borrowing for purchase of property and equipment, net [3]   424  
Amortization of debt issuance cost 249 [2] 415 [3]  
Transfer of long-term loan to short-term loan [3]   (5,555)  
Changes in fair value of convertible notes measured at fair value through profit and loss 10,374 [2] 21,398 [3]  
Exchange adjustment (1,998) [2] (7,039) [3]  
Liabilities arising from financing activities, end of period 69,353 [2] 147,254 [2] 188,909 [3]
Short-Term Borrowings      
Reconciliation of Liabilities arising from Financing activities      
Liabilities arising from financing activities, beginning of period [4] 142,560 96,653  
Considered in cash flow (net) [4] (20,335) 44,351  
Net finance cost in relation to convertible notes 1,272 [4]  
Shares issued in lieu of convertible notes (8,786) [4]  
Movement in derivative financial instruments 902 [4]  
Borrowing for purchase of property and equipment, net    
Amortization of debt issuance cost 43 [4]  
Transfer of long-term loan to short-term loan [4]   5,555  
Changes in fair value of convertible notes measured at fair value through profit and loss 5,613 [4]  
Exchange adjustment [4] (8,270) (4,901)  
Liabilities arising from financing activities, end of period [4] 111,477 142,560 96,653
Liabilities arising from Financing Activities      
Reconciliation of Liabilities arising from Financing activities      
Liabilities arising from financing activities, beginning of period 289,814 285,562  
Impact on adoption of IFRS 16 (251)    
Considered in cash flow (net) (27,888) 32,112  
Net finance cost in relation to convertible notes 5,517 10,682  
Shares issued in lieu of convertible notes (91,753) (49,741)  
Movement in derivative financial instruments 902 [4]  
Borrowing for purchase of property and equipment, net   424  
Amortization of debt issuance cost 292 415  
Transfer of long-term loan to short-term loan    
Changes in fair value of convertible notes measured at fair value through profit and loss 15,987 21,398  
Exchange adjustment (10,888) (11,940)  
Liabilities arising from financing activities, end of period $ 180,330 $ 289,814 $ 285,562
[1] Includes $Nil (2019: $46,666) of restricted deposits.
[2] Including current portion of long-term debt.
[3] Including current portion and derivative financial instruments.
[4] Including acceptances and derivative financial instruments.
v3.20.2
Consolidated Statements of Cash Flows (Parenthetical) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Statement of cash flows [abstract]      
Transaction costs $ 384
Interest paid and capitalized $ 5,481 $ 9,607 $ 11,722
v3.20.2
Consolidated Statements of Changes in Equity - USD ($)
$ in Thousands
Share Capital
Share Premium Account
Currency Translation Reserve
Available for Sale Fair Value Reserves
Revaluation Reserve
Hedging Reserve
Reserves
JSOP Reserve
Share Application Reserve
Equity Attributable to Shareholders of EROS International PLC
Non-Controlling Interest
Total
Balance at beginning of period at Mar. 31, 2017 $ 31,877 $ 399,686 $ (55,810) $ 6,238 $ 1,829 $ (375) $ 436,997 $ (15,985)   $ 804,457 $ 79,091 $ 883,548
Profit/(Loss) for the year             (22,575)     (22,575) 12,830 (9,745)
Other comprehensive income/(loss) for the year     (912)   6 375       (531) (241) (772)
Total comprehensive income/(loss) for the year     (912)   6 $ 375 (22,575)     (23,106) 12,589 (10,517)
Issue of shares 555 15,874               16,429   16,429
Share based compensation             17,316     17,316 602 17,918
Shares issued on exercise of employee stock options and awards 277 8,894         (8,955)     216   216
Changes in ownership interest in subsidiaries that do not result in a loss of control             209     209 40,568 40,777
Loss of control in a subsidiary                     4,878 4,878
Shares pending for allotment                 $ 18,000 18,000   18,000
Shares issued in lieu of convertible notes 2,625 29,543               32,168   32,168
Balance at end of period at Mar. 31, 2018 35,334 453,997 (56,722) 6,238 1,835   422,992 (15,985) 18,000 865,689 137,728 1,003,417
Adoption of IFRS at Mar. 31, 2019     (34)       (14,270)     (14,304) (3,520) (17,824)
Profit/(Loss) for the year             (423,867)     (423,867) 13,414 (410,453)
Other comprehensive income/(loss) for the year     (7,423) (24,687) 1,097   (4,441)     (35,454) (6,008) (41,462)
Total comprehensive income/(loss) for the year     (7,423) (24,687) 1,097   (428,308)     (459,321) 7,406 (451,915)
Issue of shares 1,948 70,718             $ (18,000) 54,666   54,666
Share based compensation             21,118     21,118 443 21,561
Shares issued on exercise of employee stock options and awards 302 7,299         (7,447)     154   154
Issue out of treasury shares                      
Changes in ownership interest in subsidiaries that do not result in a loss of control             3,713     3,713 (6,528) (2,815)
Shares pending for allotment                      
Shares issued in lieu of convertible notes 1,742 47,999               49,741   49,741
Balance at end of period at Mar. 31, 2019 39,326 580,013 (64,179) (18,449) 2,932   (2,202) (15,985)   521,456 135,529 656,985
Profit/(Loss) for the year             (418,992)     (418,992) (72,712) (491,704)
Other comprehensive income/(loss) for the year     (3,948) (1,860) (156)   1,826     (4,138) (3,895) (8,033)
Total comprehensive income/(loss) for the year     (3,948) (1,860) (156)   (417,166)     (423,130) (76,607) (499,737)
Share based compensation             22,207     22,207 61 22,268
Shares issued on exercise of employee stock options and awards 3,505 4,896         (8,137)     264   264
Shares issued in lieu of cash 2,079 8,971               11,050   11,050
Payables settled by issuance of shares 3,296 22,590               25,886   25,886
Issue out of treasury shares               15,985        
Changes in ownership interest in subsidiaries that do not result in a loss of control             (367)     (367) 384 17
Closure of JSOP Trust   (15,985)           15,985        
Shares pending for allotment                      
Shares issued in lieu of convertible notes 18,521 73,232               91,753   91,753
Balance at end of period at Mar. 31, 2020 $ 66,727 $ 673,717 $ (68,127) $ (20,309) $ 2,776   $ (405,665)   $ 249,119 $ 59,367 $ 308,486
v3.20.2
Nature of Operations, General Information and Basis of Presentation
12 Months Ended
Mar. 31, 2020
Nature Of Operations General Information And Basis Of Presentation  
Nature of Operations, General Information and Basis of Presentation
1 NATURE OF OPERATIONS, GENERAL INFORMATION AND BASIS OF PREPARATION

 

 

Eros International Plc (“Eros” or the “Company”) and its subsidiaries’ (together with Eros, the “Group”) principal activities include the acquisition, co-production, distribution of Indian films and provision of related production services, including visual special effects, for filmed entertainment sector . Eros International Plc is the Group’s ultimate parent company. It is incorporated and domiciled in the Isle of Man. The address of Eros International Plc’s registered office is First Names House, Victoria Road, Douglas, Isle of Man IM2 4DF.

 

The consolidated financial statements of the Group have been prepared in accordance with International Financial Reporting Standards (“IFRSs”), as issued by the International Accounting Standards Board (IASB). The financial statements have been prepared on accrual basis and under the historical cost convention on a going concern basis, with the exception of:

 

  A) revaluation of certain properties and equipment
  B) certain financial instruments and assets acquired and liabilities assumed in a business combination that have been measured at fair value as required by relevant IFRSs
  C) Employee stock option plans which have been recognized at fair value
  D) Certain employee benefit plans, which are measured based on actuarial assumptions
  E) Trade receivables and Investments recorded at Fair Value Through Profit and Loss (FVTPL) and Fair Value Through Other Comprehensive Income (FVOCI)

 

The Group’s accounting policies as set out below have been applied consistently throughout the Group to all the periods presented, unless otherwise stated. The financial statements of Eros and each of its subsidiaries are measured using the currency of the primary economic environment in which these entities operate (i.e. the functional currency). The consolidated financial statements are presented in US Dollars (USD) which is the presentation currency of the Company and has been rounded off to the nearest thousands.

 

The consolidated financial statements for the year ended March 31, 2020 were approved by the Eros Board of Directors and authorized for issue on July 30, 2020.

 

 

v3.20.2
Going Concern
12 Months Ended
Mar. 31, 2020
Going Concern  
Going Concern
2 GLOBAL PANDEMIC, GOING CONCERN AND IMPAIRMENT OF NON-CURRENT ASSETS

 

2(a) GLOBAL PANDEMIC

 

In December 2019, a novel strain of coronavirus (‘Global Pandemic’or ‘COVID-19’) emerged in Wuhan, Hubei Province, China. While initially the outbreak was largely concentrated in China and caused significant disruptions to its economy, it has now spread to several other countries, and infections have been reported globally including India, United Kingdom, United States, Dubai, Singapore and Australia where the group through its offices distributes the films theatrically. In response to the public health risks associated with the COVID-19, the Government of the aforesaid countries has announced nation-wide lockdown which resulted in the closure of all the theatres in the respective geographies and caused disruptions in the production and availability of content, including delayed, or in some cases, shortened or cancelled theatrical releases. The lockdown has affected the Group’s ability to generate revenues from the monetization of Indian film content in various distribution channels through agreements with commercial theatre operators. Also refer to note 2 (c), wherein the Group has recorded an impairment charge of $ 431,200 for the year ended March 31, 2020. In addition, refer to note 19, wherein the Group has recorded credit impairment loss of $ 103,109 for the year ended March 31, 2020.

 

The extent of the adverse impact on the Group’s financial and operational results will be dictated by the length of time that such disruptions continue, which will, in turn, depend on the currently unknowable duration of COVID-19 and among other things, the impact of governmental actions imposed in response to the pandemic and individuals’ and companies’ risk tolerance regarding health matters going forward. The Group’s business also could be significantly affected even after reopening of certain operations, should the disruptions caused by the COVID-19 lead to changes in consumer behaviour (such as social distancing), which the Group currently believes will be temporary.

 

The Group is continuously monitoring the rapidly evolving situation and its potential impacts on the Group’s financial position, results of operations, liquidity, and cash flows.

 

2(b) GOING CONCERN ASSUMPTION

 

The Group meets its day to day working capital requirements and funds its investment in content and film rights primarily through a variety of cash generated from operations, banking arrangements, de-recognition of financial assets and strategic alternatives.

 

The Group is dependent upon external borrowings for its working capital needs and investment in content and film rights. Under the terms of such banking arrangements, the Group is able to draw down in the local currencies of its operating businesses.

 

The borrowings (as set out in Note 22) are subject to individual covenants and a negative pledge that restricts the Group’s ability to incur liens, security interests or similar encumbrances or arrangements on its assets. During the current year, there had been a credit rating downgrade of our Indian listed subsidiary due to delay in repayment of loan instalments.

 

As at March 31, 2020, Group’s borrowings were $ 178,972, of which $ 117,097 is repayable in fiscal 2021. In addition, the Group has opted for moratorium as per Reserve Bank of India guidelines 2019-2020/2392 on account of global pandemic wherein all the instalments due from 1 March 2020 to 31 August 2020 will be converted  to short-term borrowing post moratorium period.

 

Further, the Group has reported a negative net current assets position on the balance sheet date.

 

The Group continue to experience significant net loss for fiscal 2020. The Group has incurred loss amounting $491,704 for the year ended March 31, 2020 [after considering the impact of an impairment loss amounting $431,200 as described in Note 2 (c)] when compared to net loss of $ $410,453 [after considering the impact of an impairment loss amounting $423,355 as described in Note 2 (c)] and $9,745 respectively for the year ended March 31, 2019 and 2018.

 

Despite these uncertainties, and uncertainties arising from the global pandemic, which have been explained in detail in Note 2 (a), the management continues to adopt the going concern basis in preparing the consolidated financial statements as of March 31, 2020 in accordance with IFRS as issued by the IASB, which assumes that the Group will be able to discharge all its liabilities, including mandatory repayment of the banking facilities, as disclosed in Note 31, as they fall due on account of:

 

a)On September 26, 2019, the Group entered into a definitive agreement with an institutional investor to procure additional funding of $25,000 through the issuance of senior convertible notes, resulting enhanced liquidity to the Group. Subsequent to the reporting period, the Company fully paid the outstanding balance of senior convertible notes by conversion into A ordinary shares.

 

b)On April 17, 2020, the Group entered into an Agreement and plan of merger with STX Filmworks, Inc, a Delaware corporation (“STX”) – a Company that specializes in producing, financing, distributing and marketing film, television and digital content. This merger will help create a pre-eminent global media company, which can develop local and international premium content at scale and across many platforms.

 

As the result of this merger, (i) new investors and existing STX equity investors are expected to contribute incremental equity financing of $125,000 (of which $35,000 is received as on the date of issuance of the financial statements] and (ii) a line of undrawn credit facility totaling to ~$ 100,000 from a large financial institution/s with a moratorium of 5 years will be available to the combined company.

 

In addition, the Group expects the combined company to be uniquely positioned to benefit from the accelerating consumption of premium digital content in the world’s most important growth markets with robust capital structure and experienced management team. The combined company is also expected to generate operating synergies within 24 months of closing of the merger transaction, stemming from integration and scale benefits, optimization of global content distribution and enhanced monetization of the Eros Now platform.

 

c)The Group have continued to generate a positive operating cash flow before incurring capital expenditures for the year ended March 31, 2020, 2019 and 2018, respectively.

  

2(c) IMPAIRMENT OF NON- CURRENT ASSETS

 

Impairment reviews in respect of goodwill and indefinite-lived intangible assets are performed annually. More regular reviews, and impairment reviews in respect of other non-current assets, are performed if events indicate that an impairment review is necessary. Examples of such triggering events would include a significant planned restructuring, a major change in market conditions or technology, reduction in market capitalization, expectations of future operating losses, or negative cash flows. The asset or Cash Generating Unit (CGU) is impaired if carrying amount of the CGU exceeds its recoverable amount.

 

The group performed impairment assessment as of March 31, 2020. The recoverable amount of the cash generating unit was determined based on value in use.

 

Value in use was determined based on future cash flows after considering current economic conditions and trends, estimated future operating results, growth rates (which is lower than those considered in previous years) and anticipated future economic conditions. The approach and key (unobservable) assumptions used to determine the cash generating unit’s value in use were as follows:

 

Assumptions   As at
March 31, 2020
    As at
March 31, 2019
 
Growth rate applied beyond approved forecast period     4%       4%  
Pre-tax discount rate     20%       21%  

 

The Company considered it appropriate to undertake an impairment assessment with reference to the estimated cash flows for the period of four years developed using internal forecast and extrapolated for the fifth year. The growth rates used in the value in use calculation reflect those inherent within the Company’s internal forecast, which is primarily a function of the future assumptions, past performance and management’s expectation of future developments through fiscal 2024.

 

Accordingly, the Group recorded an impairment loss, totaling to $431,200 and $423,335 as an exceptional item, being significant and non-recurring in nature, within the Statement of Income for the year ended March 31, 2020 and March 31, 2019 respectively. Impairment loss is mainly due to changes in the market conditions, including lower projected volume when compared to prior year/s on account of ongoing global pandemic. The aforesaid impairment loss was allocated to Intangible assets - content. [Refer Note 15]

 

Sensitivity to key assumptions

 

The change in the key following assumptions used in the impairment review would, in isolation, lead to an increase in impairment loss recognized by followings amounts as at March 31, 2020 (Although it should be noted that these sensitivities do not take account of potential mitigating actions)

 

    (in millions)  
    As at March 31, 2020     As at March 31, 2019  
Increase in discount rate by 1%     52       54  
Decrease in long term growth rate applied beyond approved forecast period by 1%     67       30  
Decrease in projected volume by 1%     44       63  

 

v3.20.2
Summary of Significant Accounting Policies
12 Months Ended
Mar. 31, 2020
Summary Of Significant Accounting Policies  
Summary of Significant Accounting Policies
3 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

3.1. Overall considerations

 

The significant accounting policies that have been used in the preparation of these consolidated financial statements are summarized below. Financial statements are subject to the application of significant accounting estimates and judgments. These are summarized in Note 37.

 

Significant new accounting pronouncement

 

New accounting standard IFRS 16, "Leases"

 

Effective April 1, 2019, IFRS 16, Leases, was adopted by the Group on April 1, 2019. The impact of adopting this new standards on the financial statements at April 1, 2019 are disclosed in note 38.

 

The Company adopted IFRS 16, Leases, which specifies how to recognize, measure, present and disclose leases. The standard provides a single accounting model, requiring the recognition of assets and liabilities for all major leases previously classified as “operating leases”.

 

The Company applied the “Modified Retrospective Approach” on the date of initial application (April 1, 2019) and the comparatives for the year ended March 31, 2019 have not been retrospectively adjusted. As of April 1, 2019, no cumulative adjustments have been recorded to the retained earnings.

 

As such the Company recognizes a lease liability and a corresponding right of use asset, at the lease commencement date. The right-of-use asset is initially measured at cost, based on the initial amount of the lease liability. The assets are depreciated to the earlier of the end of the useful life of the right-of-use asset or the lease term using the straight-line method as this most closely reflects the expected pattern of consumption of the future economic benefits. The lease term includes periods covered by an option to extend if the Company is reasonably certain to exercise that option. In addition, the right-of-use asset is periodically adjusted for certain re-measurements of the lease liability. There is no impact on transition in opening balance of retained earnings as at April 1, 2019 because of the transition method applied. Further comparatives were not restated.

 

3.2. Basis of consolidation

 

The financial statements of the Group consolidates results of the Company and entities controlled by the Company and its subsidiary undertakings. Control exists when the Company, directly or indirectly, has existing rights that give the Company the current ability to direct the activities which affect the entity’s returns; the Company is exposed to or has rights to a return which may vary depending on the entity’s performance; and the Company has the ability to use its powers to affect its own returns from its involvement with the entity.

 

Unrealized gains on transactions within the Group are eliminated. Unrealized losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred. Amounts reported in the financial statements of subsidiaries have been adjusted where necessary to ensure consistency with the accounting policies adopted by the Group.

 

Business combinations are accounted for under the acquisition method. The purchase method involves the recognition at fair value of all identifiable assets and liabilities, including contingent liabilities of the subsidiary, at the acquisition date, regardless of whether or not they were recorded in the financial statements of the subsidiary prior to acquisition. On initial recognition, the assets and liabilities of the subsidiary are included in the consolidated statement of financial position at their fair values. Transaction costs that the company incurs in connection with a business combination such as finder’s fees, legal fees, due diligence fees, and other professional and consulting fees are expensed as incurred. Goodwill is stated after separating out identifiable intangible assets. Goodwill represents the excess of acquisition cost over the fair value of the Group’s share of the identifiable net assets of the acquired subsidiary at the date of acquisition. Gain on bargain purchase is recognized immediately after acquisition in the consolidated statement of income.

 

Changes in controlling interest in a subsidiary that do not result in gaining or losing control are not business combinations as defined by IFRS 3. The Group adopts the “equity transaction method” which regards the transaction as a realignment of the interests of the different equity holders in the Group. Under the equity transaction method an increase or decrease in the Group’s ownership interest is accounted for as follows:

  the non-controlling component of equity is adjusted to reflect the non-controlling interest revised share of the net carrying value of the subsidiaries net assets;
  the difference between the consideration received or paid and the adjustment to non-controlling interests is debited or credited to a different component of equity — merger reserves;
  no adjustment is made to the carrying amount of goodwill or the subsidiaries’ net assets as reported in the consolidated financial statements; and
  no gain or loss is reported in the consolidated statements of income.

 

Loss of control policy

 

When a change in the Group’s ownership interest in a subsidiary results in a loss of control over the subsidiary, the assets and liabilities of the subsidiary including any goodwill are derecognized and a gain or loss arising thereto is accounted within Statement of Income. Amounts previously recognized in other comprehensive income in respect of that entity are also reclassified to Statement of Income.

 

3.3. Segment reporting

 

IFRS 8 Operating Segments (“IFRS 8”) requires operating segments to be identified on the same basis as is used internally for the review of performance and allocation of resources by the Group’s chief operating decision maker, which is the Group’s CEO and MD. The revenues of films are earned over various formats; all such formats are functional activities of filmed entertainment and these activities take place on an integrated basis. The management team reviews the financial information on an integrated basis for the Group as a whole. The management team also monitors performance separately for individual films for at least 12 months after the theatrical release. Certain resources such as publicity and advertising, and the cost of a film are also reviewed globally.

 

Eros has identified four geographic areas, consisting of its main geographic areas (India, North America and Europe), together with the rest of the world.

 

3.4. Revenue

 

Effective April 1, 2018, the Group has applied IFRS 15 ‘Revenue from Contracts with Customers’ which establishes a comprehensive framework for determining whether, how much and when revenue is to be recognized. IFRS 15 replaces IAS 18 ‘Revenue’, IAS 11 ‘Construction Contracts’ and certain revenue related interpretations and the cumulative effect of initial application is recognised as an adjustment to the opening balance of retained earnings at April 1, 2018. The comparative information for the year ended March 31, 2018 continues to be reported under IAS 18 and IAS 11. Refer note 3.4 – Summary of Significant accounting policies – Revenue recognition in the Annual report of the Group for the year ended March 31, 2019, for revenue recognition policy as per IAS 18 and IAS 11.

 

To determine whether to recognise revenue, the Group follows a 5-step process:

 

  a) Identifying the contract with a customer
  b) Identifying the performance obligations
  c) Determining the transaction price
  d) Allocating the transaction price to the performance obligations
  e) Recognising revenue when/as performance obligation(s) are satisfied

 

Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration which the Group expects to receive in exchange for those products or services. To ensure collectability of such consideration and financial stability of the counterparty, the Group performs certain standard Know Your Client (KYC) procedures based on their geographic locations and evaluates trend of past collection from such locations.

 

Revenue is measured based on the transaction price, which is the consideration, adjusted for any discounts and incentives, if any, as specified in the contract with the customer. Revenue also excludes taxes collected from customers. In case of revenues which are subject to change, the Group estimates the amount to be received using the “most likely amount” approach, or the “expected value” approach, as appropriate. This amount is then included in the Group’s estimate of the transaction price only if it is highly probable that a significant reversal of revenue will not occur once any uncertainty surrounding the bonus is resolved. In making this assessment the Group considers its historical performance on similar contracts.

 

The Group recognises contract liabilities for consideration received in respect of unsatisfied performance obligations and reports these amounts as other liabilities in the statement of financial position (see Note 24). Similarly, if the Group satisfies a performance obligation before it receives the consideration, the Group recognises either a contract asset or a receivable in its statement of financial position, depending on whether something other than the passage of time is required before the consideration is due

 

The following criteria apply in respect of various revenue streams within filmed entertainment:

 

  In arrangements for theatrical distribution, contracted minimum guarantees are recognized on the theatrical release date. The Group’s share of box office receipts in excess of the minimum guarantee is recognized at the point as the box office receipts gets accrued.
  In arrangements for television syndication, license fees received in advance which do not meet all the above criteria, including commencement of the availability for broadcast under the terms of the related licensing agreement, are included in contract liability until the criteria for recognition is met.  Further in arrangements where the license fees received in advance is for a period of 12 months or more from the commencement, the company computes significant discounting component at imputed rate of interest on advances received and recognizes within net finance cost in the statement of income. . Accumulated contract liability (deferred revenue) is recognized upon commencement of availability for broadcast.
  In arrangements for catalogue sales, the Group recognizes revenue if revenue recognition criteria’s such as a valid sales contract exists, all content is delivered and the customer start generating economic benefits from them, the Group is reasonably certain on collectability, and the Group’s contractual obligations are complete and are met. Considering the arrangement with catalogue customers provide for a contractual deferred payment terms up to a year and in many cases the payments often fall behind contractual terms, revenues from catalogue sales are recognized net of financing component calculated at imputed market rate of interest on the gross receivables. The re-measurement of such financing period at each balance sheet date and related gains or losses is recognized within administrative costs in the Statement of Income. Unwinding of the such discount is recognized using effective interest rate within net finance cost in the Statement of Income.
  Digital and ancillary media revenues are recognized at the earlier of when the content is accessed or declared. Fees received for access to the specified and unspecified future content through digital and ancillary media, including usage of over-the-top platform developed by the Group, is recognized on straight line basis over the period of the service contract. Billing in excess of the revenue recognized is shown as contract liability
  DVD, CD and video distribution revenue is recognized on the date the product is delivered or if licensed in line with the above criteria. Visual effects, production and other fees for services rendered by the Group and overhead recharges are recognized in the period in which they are earned and in certain cases, the stage of production is used to determine the proportion recognized in the period.
  In arrangement for production services, including visual special effects (VFX), and other technical services to clients, the Group recognizes revenue if revenue recognition criteria’s such as a valid sales contract exists, IP is delivered and the Group is reasonably certain on collectability. Revenue is recognized as the services are delivered based on acceptance of the services performed by the customer.

  

3.5. Goodwill

 

Goodwill represents the excess of the consideration transferred in a business combination over the fair value of the Group’s share of the identifiable net assets acquired. Goodwill is carried at cost less accumulated impairment losses. Gain on bargain purchase is recognized immediately after acquisition in the consolidated statement of income.

 

3.6. Intangible assets

 

Identifiable intangible assets are recognised when the Group controls the asset, it is probable that future economic benefits attributed to the asset will flow to the Group and the cost of the asset can be reliably measured. Intangible assets acquired by the Group are stated at cost less accumulated amortization less impairment loss, if any, except those acquired as part of a business combination, which are shown at fair value at the date of acquisition less accumulated amortization less impairment loss, if any (Film production cost and content advances are transferred to film and content rights at the point at which content is first exploited). “Eros” (the “Trade name”) is considered to have an indefinite life because of the institutional nature of the corporate brand name, its proven ability to maintain market leadership and the Group’s commitment to develop, enhance and retain its value. The carrying value is reviewed at least annually for impairment and adjusted to recoverable amount if required.

 

Content

 

Investments in films and associated rights, including acquired rights and distribution advances in respect of completed films, are stated at cost less amortization less provision for impairment. Costs include production costs, overhead and capitalized interest costs net of any amounts received from third party investors. A charge is made to write down the cost of completed rights over the estimated useful lives, writing off more in year one which recognizes initial income flows and then the balance over a period of up to nine years, except where the asset is not yet available for exploitation. The average life of the assets is the lesser of 10 years or the remaining life of the content rights. The amortization charge is recognized in the consolidated statement of income within cost of sales. The determination of useful life is based upon management’s judgment and includes assumptions on the timing and future estimated revenues to be generated by these assets, which are summarized in Note 37.3.

 

Others

 

Other intangible assets, which comprise internally generated and acquired software used within the Group’s digital, home entertainment and internal accounting activities, are stated at cost less amortization less provision for impairment. A charge is made to write down the cost of completed rights over the estimated useful lives except where the asset is not yet available for exploitation. The average life of below intangible assets ranges from 3-6 years. The amortization charge is recognized in the consolidated statements of income within administrative expenses as stated below:

 

    Life of
asset
    Rate of
amortization
% straight line
per annum
 
Information technology assets     3 years       33  
Other intangibles     3 - 6 years       17 – 33  

 

Subsequent expenditure

 

Expenditure on capitalized intangible assets subsequent to the original expenditure is included only when it increases the future economic benefits embodied in the specific asset to which it relates.

 

Information technology assets

 

An internally generated intangible asset arising from the Group’s software development activities that is expected to be completed is recognized only if all the following criteria are met:

  an asset is created that can be identified (such as software and new processes);
  it is probable that the asset created will generate future economic benefits; and
  the development cost can be measured reliably.

 

When these criteria are met and there are appropriate resources to complete development, the expenditure is capitalized at cost. Where these criteria are not met development expenditure is recognized as an expense in the period in which it is incurred. Internally generated intangible assets are amortized over their useful economic life from the date that they start generating future economic benefits.

 

3.7. Impairment testing of goodwill, other intangible assets and property and Equipment

 

For the purposes of assessing impairment, assets are grouped at the lowest levels for which there are separately identifiable cash flows (cash-generating units). As a result, some assets are tested individually for impairment and some are tested at the cash-generating unit level. Goodwill is allocated to those cash-generating units that are expected to benefit from synergies of the related business combination and represent the lowest level within the Group at which Management monitors the related cash flows.

 

Goodwill and Trade names are tested for impairment at least annually. All other individual assets or cash-generating units are tested for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Management believes that due to change in the key assumptions with respect to volume growth and discount rate has resulted in impairment of Goodwill and Trade name.

 

An impairment loss is recognized for the amount by which the asset’s or cash-generating unit’s carrying amount exceeds its recoverable amount. The recoverable amount is the higher of fair value, reflecting market conditions less costs to sell, and value in use based on an internal discounted cash flow evaluation. Impairment losses recognized for cash-generating units, to which goodwill has been allocated, are credited initially to the carrying amount of goodwill. Any remaining impairment loss is charged pro rata to the other assets in the cash generating unit.

 

Film and content rights are stated at the lower of unamortized cost and estimated recoverable amounts. In accordance with IAS 36 Impairment of Assets, film content costs are assessed for indication of impairment on a library basis as the nature of the Group’s business, the contracts it has in place and the markets it operates in do not yet make an ongoing individual film evaluation feasible with reasonable certainty. Impairment losses on content advances are recognized when film production does not seem viable and refund of the advance is not probable.

 

With the exception of goodwill, all assets are subsequently reassessed for indications that an impairment loss previously recognized may no longer exist.

 

3.8. Property and equipment

 

Property and equipment are stated at historical cost less accumulated depreciation and impairment. Land and freehold buildings are shown at what Management believes to be their fair value, based on, among other things, periodic but at least triennial valuations by an external independent valuer, less subsequent depreciation for freehold buildings.

 

Any accumulated depreciation at the date of revaluation is eliminated against the gross carrying amount of the asset and the net amount is restated to the revalued amount. Increases in the carrying amount arising on revaluation of freehold land and buildings are credited to other reserves in shareholders’ equity through other comprehensive income. Decreases that offset previous increases are charged against other reserves.

 

Depreciation is provided to write-off the cost of all property and equipment to their residual value as stated below:

 

      Life of
Asset
    Rate of
depreciation
% WDV
per annum
Freehold building     60 years     2-10
Furniture and fittings and equipment     5 years     15-20
Vehicles and machinery     3-5 years     20-30

 

Material residual value estimates are updated as required, but at least annually, whether or not the asset is revalued.

 

Advance paid towards the acquisition or improvement of property and equipment not ready for use before the reporting date are disclosed as capital work-in-progress.

 

3.9. Inventories

 

Inventories primarily comprise of music CDs and DVDs, and are valued at the lower of cost and net realizable value. Cost in respect of goods for resale is defined as purchase price, including appropriate labor costs and other overhead costs. Costs in respect of raw materials is purchase price.

 

Purchase price is assigned using a weighted average basis. Net realizable value is defined as anticipated selling price or anticipated revenue less cost to completion.

 

3.10. Cash and cash equivalents

 

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term highly liquid investments which are readily convertible into known amounts of cash and are subject to insignificant risk of changes in value. Bank overdrafts are shown within “Borrowings” in “Current liabilities” on the statement of financial position.

 

3.11. Restricted deposits held with banks

 

Deposits held with banks as security for overdraft facilities are included in restricted deposits held with bank.

 

3.12. Financial instruments

 

A financial instrument is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity.

 

  i. Recognition, initial measurement and derecognition

 

Financial assets and liabilities are recognised when the Group becomes a party to the contractual provisions of the instrument. Financial assets and liabilities are initially measured at fair value. Transaction costs that are directly attributable to the acquisition or issue of financial assets and financial liabilities (other than financial assets and financial liabilities at fair value through profit or loss) are added to or deducted from the fair value measured on initial recognition of financial assets or financial liability.

 

The transaction costs directly attributable to the acquisition of financial assets and financial liabilities at fair value through profit and loss are immediately recognised in the Consolidated Statement of Income.

 

A financial asset is primarily derecognised (i.e. removed from the Group’s statement of financial position) when:

 

  a) The rights to receive cash flows from the asset have expired, or

 

  b) The Group has transferred its rights to receive cash flows under an eligible transaction.

 

A financial liability is derecognised when the obligation under the liability is discharged or cancelled or expires.

 

  ii. Classification

 

For the purpose of subsequent measurement, financial assets are classified into the following categories upon initial recognition:

 

  Debt instruments at amortised cost
  Debt instruments at fair value through other comprehensive income (FVTOCI)
  Debt instruments, derivatives and equity instruments at fair value through profit or loss (FVTPL)
  Equity instruments measured at fair value through other comprehensive income (FVTOCI)
  Equity instruments measured at fair value profit or loss (FVTPL)

 

The classification depends on the entity’s business model for managing the financial assets and the contractual terms of the cash flows.

 

Debt instruments at amortised cost

 

A ‘debt instrument’ is measured at the amortised cost if both the following conditions are met:

 

  1. The asset is held within a business model whose objective is to hold assets for collecting contractual cash flows, and

 

  2. Contractual terms of the asset give rise on specified dates to cash flows that are solely payments of principal and interest (“SPPI”) on the principal amount outstanding.

 

After initial measurement, such financial assets are subsequently measured at amortised cost using the effective interest rate (the “EIR”) method. The effective interest rate is the rate that exactly discounts future cash receipts or payments through the expected life of the financial instrument, or where appropriate, a shorter period.

 

Amortised cost is calculated by taking into account any discount or premium on acquisition and fees or costs that are an integral part of the EIR. The EIR amortisation is included in finance income/other income in the Consolidated Statement of Income . The losses arising from impairment are recognised in the Consolidated Statement of Income .

 

Debt instruments at fair value through other comprehensive income

 

A ‘debt instrument’ is classified as at the FVTOCI if both of the following criteria are met:

 

  1. The objective of the business model is achieved both by collecting contractual cash flows and selling the financial assets, and

 

  2. The asset’s contractual cash flows represent SPPI.

 

Debt instruments at fair value through profit or loss

 

FVTPL is a residual category for debt instruments. Any debt instrument, which does not meet the criteria for categorization as at amortized cost or as FVTOCI, is classified as at FVTPL.

 

Equity instruments

 

All equity investments in scope of IFRS 9 are measured at fair value. Equity instruments which are held for trading are classified as at FVTPL with all changes recognised in the Consolidated Statement of Income

 

For all other equity instruments, the Group may make an irrevocable election to present in OCI, the subsequent changes in the fair value. The Group makes such election on an instrument-by-instrument basis. If the Group decides to classify an equity instrument as at FVTOCI, then all fair value changes on the instrument, excluding dividends and impairment loss, are recognised in OCI. There is no recycling of the amounts from the OCI to the Consolidated Statement of Income , even on sale of the investment. However, the Group may transfer the cumulative gain or loss within categories of equity.

 

  iii. Impairment of financial assets

 

In accordance with IFRS 9, the Group applies the expected credit loss (“ECL”) model for measurement and recognition of impairment loss on financial assets and credit risk exposures.

 

ECL is the difference between all contractual cash flows that are due to the Group in accordance with the contract and all the cash flows that the entity expects to receive (i.e., all cash shortfalls), discounted at the EIR of the instrument. Lifetime ECL are the expected credit losses resulting from all possible default events over the expected life of a financial instrument. The 12-month ECL is a portion of the lifetime ECL which results from default events that are possible within 12 months after the reporting date.

 

The Group follows ‘simplified approach’ for recognition of impairment loss allowance on trade receivables, which do not have a significant financing component as per IFRS 15. Simplified approach does not require the Group to track changes in credit risk. Rather, it recognises impairment loss allowance based on lifetime ECL at each reporting date, right from its initial recognition.

 

For recognition of impairment loss on other financial assets and risk exposure, the Group determines that whether there has been a significant increase in the credit risk since initial recognition. If credit risk has not increased significantly, 12-month ECL is used to provide for impairment loss. However, if credit risk has increased significantly, lifetime ECL is used. If, in a subsequent period, credit quality of the instrument improves such that there is no longer a significant increase in credit risk since initial recognition, then the entity reverts to recognising impairment loss allowance based on 12-month ECL.

 

ECL impairment loss allowance (or reversal) recognised during the period is recognised as income/ expense in the Consolidated Statement of Income

 

  iv. Classification and subsequent measurement of financial liabilities

 

All financial liabilities are recognised initially at fair value, adjusted by directly attributable transaction costs.

 

The measurement of financial liabilities depends on their classification, as described below:

 

  Financial liabilities at fair value through profit or loss

 

Financial liabilities at fair value through profit or loss include financial liabilities held for trading and financial liabilities designated upon initial recognition as at fair value through profit or loss. Financial liabilities are classified as held for trading if they are incurred for the purpose of repurchasing in the near term. The Group does not have any financial liabilities classified at fair value through profit or loss.

 

  Financial liabilities measured at amortised cost

 

After initial recognition, interest-bearing loans and borrowings are subsequently measured at amortised cost using the EIR method. Gains and losses are recognised in the Consolidated Statement of Income when the liabilities are derecognised.

 

Amortised cost is calculated by taking into account any discount or premium on acquisition and fees or costs that are an integral part of the EIR. The EIR amortisation is included as finance costs in the Consolidated Statement of Income

 

3.13. Derivative financial instruments
 

The Group uses derivative financial instruments (“derivatives”) to reduce its exposure to interest rate movements.

 

Derivatives are initially recognized at fair value at the date the derivative contracts are entered into and are subsequently re-measured to their fair value at the end of each reporting period. The resulting gain or loss is recognized in consolidated statements of income immediately.

 

3.14. Provisions

 

Provisions are recognized when the Group has a present legal or constructive obligation as a result of a past event, it is more likely than not that an outflow of resources will be required to settle the obligations and can be reliably measured. Provisions are measured at management’s best estimate of the expenditure required to settle the obligations at the statement of financial position date and are discounted to present value where the effect is material.

 

3.15. Leases
 

 

Measurement and recognition of leases

 

The Company considers whether contract is,or contains a lease. A lease is defined as ‘a contract, or part of a contract, that conveys the right to use an asset (the underlying asset) for a period of time in exchange for consideration’.

 

To apply this definition the Company assesses whether the contract meets three key evaluations which are whether:

  a) the contract contains an identified asset, which is either explicitly identified in the contract or implicitly specified by being identified at the time the asset is made available to the Company
  b) the Company has the right to obtain substantially all of the economic benefits from use of the identified asset throughout the period of use, considering its rights within the defined scope of the contract.

  c) the Company has the right to direct the use of the identified asset throughout the period of use. The Company assess whether it has the right to direct ‘how and for what purpose’ the asset is used throughout the period of use.

 

Company as a lessee

 

At lease commencement date, the Company recognises a right-of-use asset and a lease liability on the balance sheet. The right-of-use asset is measured at cost, which is made up of the initial measurement of the lease liability, any initial direct costs incurred by the Company and any lease payments made in advance of the lease commencement date.

 

The Company depreciates the right-of-use assets on a straight-line basis from the lease commencement date to the earlier of the end of the useful life of the right-of-use asset or the end of the lease term period. The Company also assesses the right-of-use asset for impairment when such indicators exist.

 

At the commencement date, the Company measures the lease liability at the present value of the lease payments unpaid at that date, discounted using the interest rate implicit in the lease if that rate is readily available or the Company’s incremental borrowing rate.

 

Lease payments included in the measurement of the lease liability are made up of fixed payments (including in substance fixed), and payments arising from options reasonably certain to be exercised. Subsequent to initial measurement, the liability will be reduced for payments made and increased for interest expenses. It is remeasured to reflect any reassessment or modification.

 

The Company has elected to account for short-term leases and leases of low-value assets using the exemption given under IFRS 16. Instead of recognising a right-of-use asset and lease liability, the payments in relation to these are recognised as an expense in profit or loss on a straight-line basis over the lease term or on another systematic basis if that basis is more representative of the pattern of the Company’s benefit.

 

Company as a lessor

Lease income from operating leases where the company is lessor is recognised in income on straight line basis over the lease term.

 

3.16. Taxation

 

Taxation on profit and loss comprises current income tax and deferred income tax. Tax is recognized in the consolidated statement of income except to the extent that it relates to items recognized directly in equity or other comprehensive income in which case it is recognized in equity or other comprehensive income.

 

Current income tax is provided at amounts expected to be paid (or recovered) using the tax rates and laws that have been enacted at the reporting date along with any adjustment relating to tax payable in previous years.

 

Deferred income tax is provided in full, using the liability method, on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the consolidated financial statements. Deferred income tax is provided at amounts expected to be paid (or recovered) using the tax rates and laws that have been enacted or substantively enacted at the statement of financial position date and are expected to apply when the related deferred income tax asset is realized or the deferred income tax liability is settled in the appropriate territory.

 

Deferred income tax in respect of undistributed earnings of subsidiaries is recognized except where the Group is able to control the timing of the reversal of the temporary difference and that the temporary difference will not reverse in the foreseeable future. Deferred income tax assets are recognized to the extent that it is probable that future taxable profit will be available against which temporary differences can be utilized.

 

Deferred income tax assets and deferred income tax liabilities are offset if, and only if the Group has a legally enforceable right to set off current tax assets against current tax liabilities and the deferred tax assets and the deferred tax liabilities relate to income taxes levied by the same taxation authority on either the same taxable entity or different taxable entities which intend either to settle current tax liabilities and assets on a net basis, or to realize the assets and settle the liabilities simultaneously, in each future period in which significant amounts of deferred tax liabilities or assets are expected to be settled or recovered.

 

3.17. Employee benefits
 

The Group operates defined contribution pension plans and healthcare and insurance plans on behalf of its employees. The amounts due are all expensed as they fall due.

 

In accordance with IFRS 2 “Share Based Payments”, the fair value of shares or options granted is recognized as personnel costs with a corresponding increase in equity. The fair value is measured at the grant date and spread over the period during which the recipient becomes unconditionally entitled to payment unless forfeited or surrendered.

 

The fair value of share options granted is measured using the Black Scholes model or a Monte-Carlo simulation model, each taking into account the terms and conditions upon which the grants are made. At each statement of financial position date, the Group revises its estimate of the number of equity instruments expected to vest as a result of non-market-based vesting conditions. The amount recognized as an expense is adjusted to reflect the revised estimate of the number of equity instruments that are expected to become exercisable, with a corresponding adjustment to equity reserves. None of the Group plans feature any options for cash settlements.

 

Upon exercise of share options, the proceeds received net of any directly attributable transaction costs up to the nominal value of the shares are allocated to share capital with any excess being recorded as share premium.

 

3.18. Foreign currencies

 

Transactions in foreign currencies are translated at the rates of exchange prevailing on the dates of the transactions. Monetary assets and liabilities in foreign currencies are translated at the prevailing rates of exchange at the reporting date. Non-monetary items that are measured at historical cost in a foreign currency are translated at the exchange rate at the date of the transaction. Non-monetary items that are measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value was determined.

 

Any exchange differences arising on the settlement of monetary items or on translating monetary items at rates different from those at which they were initially recorded are recognized in the income statement in the period in which they arise. Non-monetary items carried at fair value that are denominated in foreign currencies are translated at rates prevailing at the date when the fair value was determined. Non-monetary items that are measured in terms of historical cost in a foreign currency are not retranslated.

 

The assets and liabilities in the financial statements of foreign subsidiaries and related goodwill are translated at the prevailing rate of exchange at the statement of financial position date. Income and expenses are translated at the monthly average rate. The exchange differences arising from the retranslation of the foreign operations are recognized in other comprehensive income and taken in to the “currency translation reserve” in equity. On disposal of a foreign operation the cumulative translation differences (including, if applicable, gains and losses on related hedges) are transferred to the consolidated statement of income as part of the gain or loss on disposal.

 

3.19. Equity shares

 

Equity shares are classified as equity. The Group defers costs in issuing or acquiring its own equity instruments to the extent they are incremental costs directly attributable to an equity transaction that otherwise would have been avoided.  Such costs are accounted for as a deduction from equity (net of any related income tax benefit) upon completion of the equity transaction. The costs of an equity transaction which is abandoned is recognized as an expense.

 

3.20. Earnings per share

 

Basic earnings per share is computed using the weighted average number of ordinary shares outstanding during the period. Diluted earnings per share is computed by considering the impact of the potential issuance of ordinary shares, using the treasury stock method, on the weighted average number of shares outstanding during the period except where the results would be anti-dilutive.

 

3.21. Current/Non-current classification

 

The Group presents assets and liabilities in the statement of financial position based on current/non-current classification.

 

An asset is current when it is:

 

  Expected to be realised or intended to sold or consumed in the normal operating cycle (*)
  Held primarily for the purpose of trading
  Expected to be realised within twelve months after the reporting period or
  Cash or cash equivalent unless restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period

 

All other assets are classified as non-current.

 

(*) The operating cycle for the business activities of the Group is considered to be twelve months except in case of catalogue sales, which have been ascertained as two years for the purpose of current / non-current classification of assets.

 

A liability is current when:

 

  It is expected to be settled in the normal operating cycle
  It is held primarily for the purpose of trading
  It is due to be settled within twelve months after the reporting period or
  There is no unconditional right to defer the settlement of the liability for at least twelve months after the reporting period

 

The Group classifies all other liabilities as non-current. Deferred tax assets and liabilities are classified as non-current assets and liabilities.

 

v3.20.2
Acquisitions, Changes in Ownership Interest in Subsidiary and Deconsolidation
12 Months Ended
Mar. 31, 2020
Acquisitions Changes In Ownership Interest In Subsidiary And Deconsolidation  
Acquisition, Changes in Ownership Interest in Subsidiary and Deconsolidation
4 ACQUISITION, CHANGES IN OWNERSHIP INTEREST IN SUBSIDIARY AND DECONSOLIDATION

 

Changes in ownership interest in a subsidiary

 

As of March 31, 2020, EIML has 479,614 (2019: 757,886), stock option outstanding under the India IPO Plan. In the year ended March 31, 2020, 121,496 (2019: 536,263) options were exercised at a weighted average exercise price of INR 10 (2019: INR 10) per share.

 

Deconsolidation

 

During fiscal 2018, the Group had divested its 51 percent equity interest in Ayngaran Group to the non-controlling investee. The sale of the 51 percent equity interest in the majority-owned subsidiary resulted in a loss of control of the subsidiary, and therefore it was deconsolidated from the Company's financial statements during fiscal 2018.

 

The Company recognised loss of $14,649 on the deconsolidation, measured as the fair value of the consideration received for the 51 percent equity interest in the former subsidiary and the fair value of the financial asset retained in the former subsidiary on deconsolidation. Of the above, loss of $457 resulted on account of recording the retained financial assets at fair value. The aforesaid loss was recorded within other gains/(losses), net in Statement of Income.

 

v3.20.2
Business Segmental Data
12 Months Ended
Mar. 31, 2020
Business Segmental Data  
Business Segmental Data
5 BUSINESS SEGMENTAL DATA

 

The Group acquires, co-produces, distributes and provides production services, including visual special effects (VFX) in respect of Indian films in multiple formats worldwide. Film advances is monitored and strategic decisions around the business operations are made based on the filmed entertainment sector, whether it is new release, library or services. Hence, the Management identifies only one operating segment in the business, filmed entertainment. We distribute our film content to the Indian population in India, the South Asian diaspora worldwide and to non-Indian consumers who view Indian films that are subtitled or dubbed in local languages. As a result of these distribution activities, Eros has identified four geographic markets: India, North America, Europe and the Rest of the world.

 

    Year ended March 31  
    2020     2019     2018  
    (in thousands)  
Revenue by region of domicile of Group’s operation                        
India   $ 41,119     $ 100,387     $ 98,073  
Europe     26,927       63,196       27,028  
North America     1,309       1,759       1,244  
Rest of the world     86,097       104,784       134,908  
Total Revenue (*)   $ 155,452     $ 270,126     $ 261,253  

 

Revenue of $85,793 (2019: $81,409 and 2018: $103,263) from the United Arab Emirates and is included within Rest of the world and revenue of $26,927 (2019: $63,196 and 2018: $27,028) from the United Kingdom and Isle of Man are included under Europe in the above table.

 

    Year ended March 31  
    2020     2019     2018  
    (in thousands)  
Revenue by region of domicile of customer’s location                        
India   $ 44,887     $ 116,078     $ 109,986  
Europe     94,887       2,345       7,739  
North America     6,078       5,682       5,147  
Rest of the world     9,600       146,021       138,381  
Total Revenue (*)   $ 155,452     $ 270,126     $ 261,253  

 

Revenue of $1,329 (2019: $62,527 and 2018: $67,993) from the United Arab Emirates and $ 5,240 from China are included within Rest of the world and revenue of $81,465 (2019: $1,180 and 2018: $5,200) from United Kingdom is included under Europe in the above table.

 

For the year ended March 31, 2020, March 31, 2019 and March 31, 2018, two customers accounted for more than 10% of the Group’s total revenues

 

    Year ended March 31  
    2020     2019     2018  
    (in thousands)  
Revenue by source                        
Theatrical   $ 10,586     $ 69,542     $ 79,069  
Satellite Content licensing     7,112       77,453       97,168  
Digital and other ancillary(*)     137,754       123,131       85,016  
Total Revenue(**)   $ 155,452     $ 270,126     $ 261,253  

 

(*) the ancillary includes revenue from providing producer support and VFX services to customers

 

(**) Net of significant discounting component $5,558 (2019: $34,467 and 2018: $ 6,816 ). [Refer Note 19].

 

Segment assets by region of domicile of Group’s operation:

 

    Total     India     North
America
    Europe     Rest of the
World
 
    (in thousands)  
Non-current assets(*)                                        
As of March 31, 2020   $ 475,633     $ 152,340     $ 1     $ 25,860     $ 297,432  
As of March 31, 2019   $ 722,043     $ 336,431     $ 4     $ 34,217     $ 351,391  

 

Segment assets of $292,109 (2019: $295,685) in the United Arab Emirates is included under Rest of the world and segment assets of $25,601 (2019: $32,287) and $259 (2019: $1,903) in the United Kingdom and IOM respectively is included under Europe in the above table.

 

(*) Non-current assets include property and equipment, right of use assets, intangibles assets (content and others) and restricted deposit by geographic area.

 

v3.20.2
Nature of Expenses
12 Months Ended
Mar. 31, 2020
Nature Of Expenses  
Nature of Expenses
6 NATURE OF EXPENSES

 

(Loss)/Profit for the year is arrived at after the following are charged to the consolidate statements of income:

 

   Year ended March 31 
   2020   2019   2018 
   (in thousands) 
Publicity and advertisement costs   $11,452   $19,779   $12,684 
Film distribution costs    1,320    5,462    6,739 
Amortization expenses [Refer note 15]    64,451    130,155    115,285 
Personnel costs [Refer note 7]    36,697    37,015    35,661 
Rent expenses    391    1,916    1,359 
Legal and professional expenses    4,615    6,980    8,204 
Provision for trade and other receivables            1,968 
Bad debt            2,772 
Credit impairment loss, net [Refer note 19]    97,551    25,741    4,308 
Depreciation and amortization of other intangibles    3,462    2,263    2,991 
Impairment charge on goodwill            1,205 
Impairment loss on content advances            353 
Impairment loss on advances to content vendors        7,284     
Others    6,105    5,935    9,208 
   $226,044   $242,530   $202,737 
Cost of services  $81,725   $155,396   $134,708 
Administrative costs  $144,319   $87,134   $68,029 

 

v3.20.2
Personnel Costs
12 Months Ended
Mar. 31, 2020
Personnel Costs Abstract  
Personnel Costs
7 PERSONNEL COSTS

 

    Year ended March 31  
    2020     2019     2018  
    (in thousands)  
Salaries   $ 13,781     $ 14,591     $ 16,790  
Social security and other employment charges     617       831       916  
Salaries and other charges     14,398       15,422       17,706  
Share based compensation (Refer note 27)     22,268       21,561       17,918  
Pension charges     31       32       37  
    $ 36,697     $ 37,015     $ 35,661  

 

    Year ended March 31  
Key management compensation   2020     2019     2018  
    (in thousands)  
Salaries   $ 4,395     $ 4,010     $ 4,919  
Share based compensation     19,829       13,859       11,519  
Pension charges     23       21       16  
    $ 24,247     $ 17,890     $ 16,454  

 

v3.20.2
Net Finance Costs
12 Months Ended
Mar. 31, 2020
Net Finance Costs  
Net Finance Costs
8 NET FINANCE COSTS

 

    Year ended March 31  
    2020     2019     2018  
    (in thousands)  
Interest on borrowings (*)   $ 29,474     $ 33,530     $ 32,556  
Reclassification of cash flow hedge to consolidated statements of income                 375  
Total interest expense (*)     29,474       33,530       32,931  
Capitalized interest on eligible film rights and content advances     (8,703 )     (9,437 )     (13,263 )
Total finance costs     20,771       24,093       19,668  
Less: Interest income                        
Unwinding of interest     (9,807 )     (13,227 )     (932 )
Bank deposits     (2,185 )     (3,192 )     (923 )
Total finance income     (11,992 )     (16,419 )     (1,855 )
    $ 8,779     $ 7,674     $ 17,813  

 

For the year ended March 31, 2020, the capitalization rate of interest was 11.00% (2019: 10.21% and 2018:11.56%).

 

(*) includes interest expense in respect of financial liabilities classified at fair value through profit or loss $5,517 (2019: $10,682 and 2018: $4,338), significant discounting on long-term advance from customers $1,501 (2019: $458) and leases $184.

 

v3.20.2
Other (Gains)/Losses
12 Months Ended
Mar. 31, 2020
Other Gainslosses  
Other (Gains)/Losses
9 OTHER GAINS/(LOSSES)

 

    Year ended March 31  
    2020     2019     2018  
    (in thousands)  
Foreign exchange (loss)/gain, net   $ 5,650     $ 5,610     $ (6,250 )
Gain/(loss) on sale of property and equipment and other Intangibles     (70 )     (97 )     2  
Gain/(loss) on available-for-sale financial assets (Refer note 17)     (1,253     37        
Impairment charge on available -for- sale financial assets (Refer note 17)                 (2,436 )
(Loss) on de-recognition of financial assets measured at amortized cost net (*)     (5,285 )     (5,988 )     (3,562 )
Mark to market gain/(loss) on derivative financial instrument measured at fair value through profit and loss account (Refer note 25)           (902 )      
(Loss) on settlement of derivative financial instruments                 (586 )
(Loss) on financial liability (convertible notes) measured at fair value through profit and loss account (Refer note 22)     (15,987 )     (21,398 )     (13,840 )
(Loss) on deconsolidation of a subsidiary (Refer note 4)                 (14,649 )
Reversal of expected credit loss (Refer note 19)     10,382       20,698        
Liabilities no longer required, written-back     2,487                
Credit from Government of India     760       2,328        
    $ (3,316 )   $ 288     $ (41,321 )

 

(*) Arising on assignment and novation of trade receivables and trade payables with no-recourse. Derecognition of aforesaid financial assets/liabilities measured at amortized cost is to mitigate both credit risk and liquidity risk (Refer Note 31).

 

v3.20.2
Income Tax Expense
12 Months Ended
Mar. 31, 2020
Income Tax Expense  
Income Tax Expense
10 INCOME TAX EXPENSE

 

    Year ended March 31  
    2020     2019     2018  
    (in thousands)  
Current income tax expense   $ 1,800     $ 17,372     $ 5,556  
Deferred income tax (benefit) / charge     (23,983 )     (10,044 )     3,571  
Income tax expenses   $ (22,183 )   $ 7,328     $ 9,127  

 

Reconciliation of tax charge

 

    Year ended March 31  
    2020     2019     2018  
    (in thousands)  
(Loss) before tax   $ (513,887 )   $ (403,125 )   $ (618 )
Income tax (benefit)/expense at tax rates applicable to individual entities (#)     (44,763 )     6,814       7,358  
Tax effect of:                        
Effect of unrecognised tax asset (*)     29,898             657  
Changes in tax rates on temporary differences brought forward     (7,476 )     232       (168 )
Items not deductible for income tax     5       688       486  
Adjustment in respect of current income tax of previous years           (762 )      
Others     153       356       794  
Income tax expense   $ (22,183 )   $ 7,328     $ 9,127  

 

(#) Domestic tax is Nil as the Company is subject to income tax in Isle of Man at a rate of zero percent. Foreign taxes are based on applicable tax rates in each subsidiary jurisdiction.

 

(*) In view of tax losses on Company’s Indian listed subsidiary, deferred tax assets on deductible temporary differences have been recognised to the extent of deferred tax liability on taxable temporary difference on account of lack of sufficient certainty of future earnings against which such deferred tax asset can be realised. Unrecognised tax asset in respect of tax losses and deductible temporary differences of $118,793 is $29,898.

 

v3.20.2
Deferred Income Tax Assets and Liabilities
12 Months Ended
Mar. 31, 2020
Deferred Income Tax Assets And Liabilities  
Deferred Income Tax Assets and Liabilities
11 DEFERRED INCOME TAX ASSETS AND LIABILITIES

 

Changes in deferred income tax assets and liabilities

 

    As At March 31, 2020  
    Opening
Balance
    Recognized
in
statements of income
    Exchange
Difference
    Closing
Balance
 
       
Deferred tax assets:                                
Minimum alternate tax carry-forward   $ 88     $ 2     $ (6 )   $ 84  
Property and equipment     76       120       (9 )     187  
Credit impairment loss     5,044       (3,740 )     (918 )     386  
Current advances and film production           11,791       (2,916 )     8,875  
Others     3,281       (4,328 )     2,167       1,120  
Total income deferred tax asset   $ 8,489     $ 3,845     $ (1,682 )   $ 10,652  
Deferred income tax liabilities:                                
Property and equipment     (624 )     38       520       (66 )
Content advances and film production     34,029       20,100       1,397       (12,532 )
Total deferred income tax liability   $ (34,653 )   $ 20,138     $ 1,917     $ (12,598 )
                                 
Net deferred tax (liability)   $ (26,164 )   $ 23,983     $ 235   $ (1,946 )
As at March 31, 2020                                
Deferred income tax asset                           $ 742  
Deferred income tax liability                           $ (2,688 )

 

          As At March 31, 2019  
    Opening
Balance
    Impact of adoption of
IFRS 9
    Recognized in
statements of income
    Exchange
Difference
    Closing
Balance
 
    (in thousands)  
Deferred tax assets:                                        
Minimum alternate tax carry-forward   $ 927           $ (778 )   $ (61 )   $ 88  
Property and equipment     83             (2 )     (5 )     76  
Credit impairment loss           673       4,385       (14 )     5,044  
Others     2,442             984       (116 )     3,310  
Total income deferred tax asset   $ 3,452       673     $ 4,589     $ (196 )   $ 8,518  
Deferred income tax liabilities:                                        
Property and equipment     (776 )           142       10       (624 )
Intangible assets     (41,815 )           5,313       2,473       (34,029 )
Others     (29 )                       (29 )
Total deferred income tax liability     (42,620 )         $ 5,455     $ 2,483     $ (34,682 )
                                         
Net deferred tax (liability)     (39,168 )     673     $ 10,044     $ 2,287     $ (26,164 )
As at March 31, 2019                                        
Deferred income tax asset                                   $ 1,263  
Deferred income tax liability                                   $ (27,427 )

 

Deferred tax is calculated in full on all temporary differences under the liability method using the local tax rate of the country in which the timing difference occurs.

 

Deferred tax assets have been recognised on the basis that there is reasonable certainty of profitability to utilize the available losses and tax credits. However, in view of tax losses on Group’s Indian listed subsidiary, deferred tax assets on deductible temporary differences have been recognised to the extent of deferred tax liability on taxable temporary difference on account of lack of sufficient certainty of future earnings against which such deferred tax asset can be realised.

 

Deferred tax liabilities to the extent of $21,390 (2019: $49,163 and 2018: $43,962) have not been provided on the undistributed earnings of subsidiaries as Eros is able to control the timing of the reversal of the temporary difference and it is probable that the temporary difference will not reverse in the foreseeable future.

 

The excess tax paid under MAT provisions over and above normal tax liability can be carried forward and setoff against future tax liabilities computed under normal tax provisions. The Indian subsidiaries were required to pay MAT in the past years and accordingly, a deferred tax asset of $84 (2019: $88 and 2018: $927) has been recognised in the consolidated financial position, which can be carried forward for a period of fifteen assessment years immediately succeeding the assessment year in which it becomes allowable.

 

v3.20.2
Earnings Per Share
12 Months Ended
Mar. 31, 2020
Earnings Per Share  
Earnings Per Share (EPS)
12 EARNINGS PER SHARE (EPS)

 

    2020     2019     2018  
    Basic     Diluted     Basic     Diluted     Basic     Diluted  
    (in thousands, except number of shares and earnings per share)  
(Loss)/earnings                                                
(Loss)attributable to the equity holders of the parent   $ (418,992 )     (418,992 )   $ (423,867 )     (423,867 )   $ (22,575 )   $ (22,575
Potential dilutive effect related to share based compensation scheme in subsidiary undertaking                       (197 )           (475 )
Adjusted earnings attributable to equity holders of the parent   $ (418,992 )     (418,992 )   $ (423,867 )     (424,064 )   $ (22,575 )   $ (23,050 )
Number of shares                                                
Weighted average number of shares     107,532,584       107,532,584       70,706,579       70,706,579       62,151,155       62,151,155  
Potential dilutive effect related to share based compensation scheme             8,237,299             1,463,640             1,331,211  
Adjusted weighted average number of shares     107,532,584       115,769,883       70,706,579       72,170,219       62,151,155       63,482,366  
(Loss) per share                                                
(Loss) attributable to the equity holders of the parent per share (cents)     (389.6 )     (389.6 )     (599.5 )     (599.5 )     (36.3 )     (36.3 )

 

 

The above table does not split the earnings per share separately for the ‘A’ ordinary 30p shares and the ‘B’ ordinary 30p shares as there is no variation in their entitlement to participate in undistributed earnings.

 

The Company excludes options with exercise prices that are greater than the average market price from the calculation of diluted EPS because their effect would be anti-dilutive. In the year ended March 31, 2020, 601,667 shares were not included in diluted earnings per share (2019: 1,957,035). Since there is loss for the fiscal year 2019, the potential equity shares resulting from dilutive options are not considered as dilutive and hence, the Diluted EPS is same as Basic EPS.

 

Further, the Company have excluded convertible notes 13,888,889 shares because of their effect was anti-dilutive (2019 : 7,567,962).

 

v3.20.2
Property and Equipment
12 Months Ended
Mar. 31, 2020
Property And Equipment  
Property and Equipment
13 PROPERTY AND EQUIPMENT

 

    As At March 31, 2020  
    Land
and
Building
    Furniture,
fittings and
equipment
    Vehicles     Machinery     Total  
    (in thousands)  
Opening net carrying amount   $ 9,562     $ 199     $ 549     $ 601     $ 10,911  
Exchange difference     (480 )     (8 )     (29 )     (7 )     (524 )
Additions     30                   31       61  
Adjustment on Adoption of IFRS 16                       (243 )     (243 )
Disposals           (2 )     (116 )     (2 )     (120 )
Adjustment of depreciation on disposal           1       28       2       31  
Depreciation charge     (579 )     (49 )     (132 )     (131 )     (891 )
Balance as at March 31, 2020   $ 8,533     $ 141     $ 300     $ 251     $ 9,225  
Capital work-in-progress                                   $ 9  
Net carrying value as at March 31, 2020                                   $ 9,234  

 

    As At March 31, 2020  
    (in thousands)  
Cost or valuation   $ 13,408     $ 1,749     $ 1,244     $ 4,032     $ 20,433  
Accumulated depreciation     (4,875 )     (1,608 )     (944 )     (3,781 )     (11,208 )
Net carrying amount   $ 8,533     $ 141     $ 300     $ 251     $ 9,225  
Capital work-in-progress                                   $ 9  
Net carrying value as at March 31, 2020                                   $ 9,234  

 

    As At March 31, 2019  
    Land
and
Building
    Furniture,
fittings and
equipment
    Vehicles     Machinery     Total  
    (in thousands)  
Opening net carrying amount   $ 8,481     $ 348     $ 698     $ 476     $ 10,003  
Exchange difference     (292 )     (12 )     (43 )     (12 )     (359 )
Revaluation     1,745                         1,745  
Additions     207       16       116       394       733  
Reclassification and other adjustment             (61 )     2             (59 )
Disposals     (449 )     (56 )           (65 )     (570 )
Adjustment of depreciation on disposal     367       39             61       467  
Depreciation charge     (497 )     (75 )     (224 )     (253 )     (1,049 )
Balance as at March 31, 2019   $ 9,562     $ 199     $ 549     $ 601     $ 10,911  
Capital work-in-progress                                   $ 10  
Net carrying value as at March 31, 2019                                   $ 10,921  

 

    As At March 31, 2019  
    (in thousands)  
Cost or valuation   $ 13,858     $ 1,759     $ 1,389     $ 4,318     $ 21,324  
Accumulated depreciation     (4,296 )     (1,560 )     (840 )     (3,717 )     (10,413 )
Net carrying amount   $ 9,562     $ 199     $ 549     $ 601     $ 10,911  
Capital work-in-progress                                   $ 10  
Net carrying value as at March 31, 2019                                   $ 10,921  

 

Property and equipment with a net carrying amount of $ 8,189 (2019: $6,685) have been pledged to secure borrowings (Refer Note 22).

 

Land and buildings were revalued as at March 31, 2019 by independent valuers on the basis of market value. Fair values were estimated based on recent market transactions, which were then adjusted for specific conditions relating to the land and buildings. As at March 31, 2020, had land and buildings of the Group been carried at historical cost less accumulated depreciation, their carrying amount would have been $4,337 (2019: $4,983).

 

Capital work-in-progress of $9 (2019: $10) primarily related to Machinery cost in Company’s leased premises.

 

v3.20.2
Goodwill and Trademark
12 Months Ended
Mar. 31, 2020
Goodwill And Trademark  
Goodwill and Trademark
14 GOODWILL AND TRADEMARK

 

Goodwill and Trademark   Amount in US$  
Balance as at March 31, 2019   $  
Balance as at March 31, 2020   $  

 

v3.20.2
Intangible Content Assets
12 Months Ended
Mar. 31, 2020
Intangible Content Assets  
Intangible Content Assets
15 INTANGIBLE CONTENT ASSETS

 

    Gross
Content
Assets
    Accumulated
Amortization
    Impairment
Loss
    Content
Assets
 
As at March 31, 2020                                
Film and content rights   $ 1,835,263     $ (975,774 )   $ (557,510 )   $ 301,979  
Content advances     427,046             (274,325 )     152,721  
Film productions     12,089             (4,900 )     7,189  
Non-current content assets   $ 2,274,398     $ (975,774 )   $ (836,735 )   $ 461,889  
                                 
As at March 31, 2019                                
Film and content rights   $ 1,675,406       (954,628 )     (366,703 )   $ 354,075  
Content advances     378,268             (38,832 )     339,436  
Film productions     13,061                   13,061  
Non-current content assets   $ 2,066,735       (954,628 )     (405,535 )   $ 706,572  

 

    As At ended March 31  
    2020     2019  
    (in thousands)  
Film productions                
Opening balance   $ 13,061     $ 10,867  
Additions     9,314       3,413  
Exchange difference     (751 )     (775 )
Impairment loss (Refer to Note 2 (c))     (4,900 )      
Transfer to film and content rights     (9,535 )     (444 )
Closing balance   $ 7,189     $ 13,061  
                 
Content advances                
Opening balance   $ 339,436     $ 349,568  
Additions (*) (**)     255,940       261,002  
Reclassifications           (65 )
Exchange difference     (9,484 )     (12,314 )
Impairment loss (Refer to Note 2 (c))     (235,493 )     (38,832 )
Transfer to film and content rights     (197,678 )     (219,923 )
Closing balance   $ 152,721     $ 339,436  
                 
Film and content rights                
Opening balance   $ 354,075     $ 638,108  
Amortization     (64,451 )     (130,155 )
Exchange difference     (4,486 )     (7,542 )
Impairment loss (Refer to Note 2 (c))     (190,807 )     (366,703 )
Transfer from inventory     435        
Transfer from film productions and content advances     207,213       220,367  
Closing balance   $ 301,979     $ 354,075  

 

Film and content rights with a carrying amount of $123,180 (2019: $310,996) have been pledged against secured borrowings (Refer Note 22).

 

(*)represents non-cash movement on account of de-recognition of financial liabilities amounting to $90,118 (2019: $160,615) [Refer Note 31].

 

(**) capital creditors amounting $24,513 were settled by issuance of A Ordinary Shares, [Refer note 26].

 

v3.20.2
Intangible Assets - Other
12 Months Ended
Mar. 31, 2020
Intangible Assets - Other  
Intangible Assets - Other
16 INTANGIBLE ASSETS- OTHER

 

Other intangibles comprise of software and other intangibles used within the Group’s digital and home entertainment activities and internal accounting activities.

 

The changes in other intangible assets are as follows:

 

    As At March 31, 2020  
    (in thousands)  
    Information
technology
assets
    Other
intangibles
    Total  
Opening net carrying amount as on March 31, 2019   $ 1,204     $ 2,590     $ 3,794  
Exchange difference           (137 )     (137 )
Additions                  
Disposal and reclassification     (59 )     (4 )     (63 )
Amortization charge     (39 )     (855 )     (894 )
Sub- total     1,106       1,594       2,700  
Intangibles under development                 235  
Closing net carrying amount as on March 31, 2020   $ 1,106     $ 1,594     $ 2,935  

 

   As At March 31, 2020 
   (in thousands) 
Cost or valuation as on March 31, 2019   $5,055   $6,466   $11,521 
Accumulated amortization    (3,949)   (4,872)   (8,821)
Net carrying amount as on March 31, 2020   $1,106   $1,594   $2,700 
Intangibles Under Development            $235 
Net carrying value as at March 31, 2020            $2,935 

 

    As At March 31, 2019  
    (in thousands)  
    Information
 technology
assets
    Other
intangibles
    Total  
Opening net carrying amount as on March 31, 2018   $ 1,449     $ 3,831     $ 5,280  
Exchange difference           (148 )     (148 )
Additions           907       907  
Disposal and reclassification     59       (1,090 )     (1,031 )
Amortization charge     (304 )     (910 )     (1,214 )
Closing net carrying amount as on March 31, 2019   $ 1,204     $ 2,590     $ 3,794  

 

    As At March 31, 2019  
    (in thousands)  
Cost or valuation as on March 31, 2019   $ 5,114     $ 6,607     $ 11,721  
Accumulated amortization     (3,910 )     (4,017 )     (7,927 )
Net carrying amount as on March 31, 2019   $ 1,204     $ 2,590     $ 3,794  

 

Other intangible assets with a carrying amount of $57 (2019: $92) have been pledged against secured borrowings (Refer Note 22).

 

v3.20.2
Available-For-Sale Financial Assets
12 Months Ended
Mar. 31, 2020
Available-for-sale Financial Assets  
Available-For-Sale Financial Assets
17 AVAILABLE-FOR-SALE FINANCIAL ASSETS

 

    As At March 31  
    2020     2019  
      (in thousands)          
Non-Current investments                
Valuable Technologies Limited   $ 140     $ 2,000  
LMB Holdings Limited           650  
    $ 140     $ 2,650  

Current investments

Polyxo Global Limited

  $ 225     $ 1,042  
Plutus Opportunities Fund Limited     3,577        
    $ 3,942     $ 3,692  

 

The movement in the financial assets is as follows:

 

    Financial Assets
at FVTPL
    Financial Assets
at FVTOCI
 
       
As at March 31, 2018   $ 27,257     $  
Reclassification (refer note 29)     (27,257 )     27,257  
Additions     1,005       80  
Fair valuation gain / (loss)     37       (24,687  
As at March 31, 2019     1,042     $ 2,650  
Additions/(Disposal)     4,013       (650 )
Fair valuation gain / (loss)     (1,253 )     (1,860 )
As at March 31, 2020   $ 3,808     $ 140  

 

Eros acquired an interest in Valuable Technologies Limited (“Valuable”) in the year ended March 31, 2009. Valuable manages and operates a number of companies within media and entertainment, technology and infrastructure. These companies include “UFO Moviez”, the leading provider of Digital projection solutions for cinemas in India and “Impact” whose business is theatrical ticketing and sales data. As at March 31, 2020 and March 31, 2019, Eros owns 7.2% of Valuable’s equity. For the year ended March 31, 2020 and March 31, 2019, management has used the latest available financial statements, which shows decrease in revenue and increase in losses compared to prior years. Accordingly, the fair value has been computed using the Net Asset Value method. Management has used an estimate of 30% for the discount for lack of liquidity (DLOL). DLOL reflects the ease of investor's ability to liquidate its business interest. As per Eros’s stake of 7.2%, the estimated fair value (Non- Marketable and Non-Control Basis) is arrived at $140.

 

Acacia Investments Holdings Limited (“Acacia”) is a dormant holding company and owns 12.97% of L.M.B Holdings Limited (“LMB”) which through its subsidiaries operates satellite television channels, such as “B4U Music”, “B4U Movies” and “The Movie House Channel”. As of March 31, 2020, and prior, the Group had no Board representation, no involvement in policy decision making, did not provide input in respect of technical know-how and had no material contract with LMB or its subsidiaries nor did they have the power to exert significant influence. Until the year ended March 31, 2018, due to the range of potential outcomes for the investment was estimated using level 3 inputs, using guideline public companies method with revenue multiple. The Management has concluded the sale of their stake in “LMB Holdings Limited” at $650 in the month of July 2019.

 

Investments in these unquoted equity investments are not held for trading. Instead, they are medium or long-term strategic purpose fair value of the investment has been derived based on the information and closing statement received from funds.

 

v3.20.2
Inventories
12 Months Ended
Mar. 31, 2020
Inventories - Schedule Of Inventories  
Inventories
18 INVENTORIES

 

    As At March 31  
    2020     2019  
    (in thousands)  
Goods for resale   $     $ 435  
    $     $ 435  

 

During the year ended March 31, 2020, inventory of Nil (2019: $93 and 2018: $290) was recognised in the consolidated statements of income as an expense. In addition to the year the company has charged Nil (2019 : $69) as expense in statement of income as a result of the write down of inventories. Inventories with a carrying amount of $NIL (2019: $435) have been pledged as security for certain of the Group’s borrowings (Refer note 22).

 

v3.20.2
Trade and Other Receivables
12 Months Ended
Mar. 31, 2020
Trade And Other Receivables  
Trade and Other Receivables
19   TRADE AND OTHER RECEIVABLES

 

    As at  
    March 31,
2020
    March 31,
2019
 
Trade accounts receivables at fair value (*)                
Trade accounts receivables   $ 138,869       156,026  
Credit impairment (loss)     (41,470 )     (26,133 )
Fair Value gain/(loss)     (2,650 )     (4,664 )
Trade accounts receivables net     94,749       125,229  
                 
Trade accounts receivables at amortised cost                
Trade accounts receivables   $ 77,772     $ 86,331  
Credit impairment (loss)     (70,853 )     (15,202 )
Trade accounts receivables net     6,919       71,129  
                 
Total Trade accounts receivables   $ 101,668     $ 196,358  
                 
Balance with statutory authorities     6,568       7,672  
Accrued interest     92       2,188  
Advance to content vendor     1,373       3,462  
Prepaid charges     2,578       1,790  
Unbilled revenues     553       1,717  
Other receivables     5,182       2,023  
Trade and other receivables   $ 118,014     $ 215,210  
                 
Current     107,253       205,145  
Non-current     10,761       10,065  
    $ 118,014     $ 215,210  

 

(*) Business model is achieved both by collecting contractual cash flows and de-recognition of financial assets arising on assignment and novation transaction. (Refer Note 31)

 

The age of account receivables net of credit of credit impairment loss are past due but not impaired were as follows:

 

    As at  
    March 31,
2020
    March 31,
2019
 
Not more than three months   $ 15,097     $ 44,687  
More than three months but not more than six months     11,764       15,948  
More than six months but not more than one year     14,896       15,310  
More than one year     4,899       8,796  
    $ 46,656     $ 84,741  

 

Trade and other receivables with a net carrying amount of $29,969 (2019: $83,991) have been pledged against secured borrowings (Refer Note 22).

 

The movement in the allowances for expected credit losses is as follows:

 

    Year ended  
    March 31, 2020  
    Trade
Receivables
    Other
Receivables
    Total
Receivables
 
Balance as on April 1, 2019   $ 41,335     $ 447     $ 41,782  
Charged to operations     103,109             103,109  
Unwinding of expected credit loss (included in finance income)     (9,807 )           (9,807 )
Reversal of expected credit loss (included in other gains/(losses))     (10,382 )           (10,382 )
Bad debts     (6,743 )           (6,743 )
Translation adjustment     (5,189 )             (5,189 )
Balance at the end of the year   $ 112,323     $ 447     $ 112,770  

 

The movement in the allowances for expected credit losses is as follows:

 

    Year ended  
    March 31, 2019  
    Trade
Receivables
    Other
Receivables
    Total
Receivables
 
Balance at the beginning of the period   $ 10,193     $     $ 10,193  
Impact of adoption of IFRS 9     18,050       447       18,497  
Balance as on April 1, 2018     28,243       447       28,690  
Charged to operations     60,208       7,284       67,492  
Unwinding of expected credit loss (included in finance income)     (13,227 )           (13,227 )
Reversal of expected credit loss (included in other gains/(losses))     (20,698 )           (20,698 )
Translation adjustment     (160 )           (160 )
Bad debts     (13,031 )     (7,284 )     (20,315 )
Balance at the end of the year   $ 41,335     $ 447     $ 41,782  

 

v3.20.2
Trade and Other Payables
12 Months Ended
Mar. 31, 2020
Trade And Other Payables  
Trade and Other Payables
20 TRADE AND OTHER PAYABLES

 

    As At March 31  
    2020     2019  
    (in thousands)  
Trade accounts payable(*)   $ 21,030     $ 25,299  
Accruals and other payables (includes creditors for content assets of $ 29,937 (2019: $16,139))     43,809       32,888  
Contract liability (deferred revenue)     9,827       12,260  
Accrued interest     3,106       2,395  
Value added taxes and other taxes payable     13,169       10,645  
    $ 90,941     $ 83,487  

 

(*) Includes settlement of payables through issuance of shares (Refer note 27). and de-recognition of financial liabilities arising on assignment and novation transaction [Refer note 31]

 

The carrying amount of trade and other payables are considered a reasonable approximation of fair value.

 

v3.20.2
Cash and Cash Equivalents
12 Months Ended
Mar. 31, 2020
Cash And Cash Equivalents  
Cash and Cash Equivalents
21 CASH AND CASH EQUIVALENTS

 

Cash and cash equivalents consist of cash on hand and balance with banks (including balances in current account and demand deposits). Cash and cash equivalents included in the statements of cash flows comprise the following amounts in the statement of financial position.

 

    As At March 31  
    2020     2019  
    (in thousands)  
Cash at bank and in hand   $ 2,563     $ 89,117  
    $ 2,563     $ 89,117  

 

v3.20.2
Borrowings
12 Months Ended
Mar. 31, 2020
Borrowings Disclosure Abstract  
Borrowings
22 BORROWINGS

 

An analysis of long-term borrowings is shown in the table below.

 

    Nominal           As at March 31,  
    Interest Rate     Maturity     2020     2019  
                (in thousands)  
Asset backed borrowings                            
Vehicle loan   2.5 - 9.5%     2017-22     $ 127     $ 382  
Term loan   MCLR +3.2% - 4.50%     2019-22       6,843       12,947  
Term loan   BR + 2.75%     2020-21       509       1,083  
Term loan   10.39% - 13.75%     2020-23             251  
                $ 7,479     $ 14,663  
Unsecured borrowings                            
Retail bond   6.50%     2021-22       62,274       65,215  
Convertible notes(1)   14.23%     2020-21             68,349  
                $ 62,274     $ 133,564  
                             
Cumulative effect of unamortised costs                 (399 )     (691 )
Instalments due within one year:                            
Convertible notes(2)                       (68,349 )
Others                 (7,240 )     (7,267 )
                $ 62,114     $ 71,920  
                             
Long-term borrowings at amortised cost               $ 62,114     $ 71,920  

 

Bank prime lending rate and marginal cost lending rate (“BPLR” & “MCLR”) is the Indian equivalent to LIBOR. Asset backed borrowings are secured by fixed and floating charges over certain Group assets.

 

Analysis of short-term borrowings

 

    Nominal   As at March 31,  
    interest rate (%)   2020     2019  
        (in thousands)  
Asset backed borrowings                    
Export credit, bill discounting and overdraft   MCLR +.40% to 6%   $ 37,755     $ 32,078  
Export credit, bill discounting and overdraft   Base Rate + 0.5% to 1%     3,442       3,533  
Export credit, bill discounting and overdraft   6.01% - 15.25%     28,773       26,719  
Convertible notes(1)   9.96%     23,100        
Short- term loan(3)   3.25% - 16.45%     16,548       70,962  
        $ 109,618     $ 133,292  
Unsecured borrowings                    
Instalments due within one year on long-term borrowing         7,240       75,616  
        $ 116,858     $ 208,908  
                     
Short-term borrowings at fair value         23,100       68,349  
Short-term borrowings at amortised cost       $ 93,758     $ 140,559  

 

1.

Eros International Plc. (“issuer”) issued Senior Convertible Notes (SCN or convertible notes) on December 06, 2017 amounting to $122,500 principal amount and option to purchase warrants up to 2,000 of A ordinary share for a term of 6 months at an offer price of $100,000 by private placement. The notes are payable in equal installments of $3,500 per month for 35 months starting December 31, 2017. The installments can be paid either in cash or can be converted into A ordinary equity shares of the issuer at the option of the issuer as per the terms of the arrangement. The notes are fully paid as at the date of reporting. Further, Eros International Plc. (“issuer”) issued Senior Convertible Notes (SCN or convertible notes) on September 25, 2019 amounting to $27,500 principal amount. The maturity date of convertible is September 26, 2020. The installments will be converted into A ordinary equity shares of the issuer at the option of the issuer as per the terms of the arrangement.

 

The holder of the notes can defer the payment of the amount due on any instalment dates to another instalment date as well as has the right to accelerate the payment on the notes as per the terms of the agreement

 

The Company has classified the instrument as a financial liability at fair value through profit or loss. The Company the Monte-Carlo simulation model to obtain the fair value of the convertible notes. Fair value of the financial liability outstanding as at the date of reporting is $23,100 (2019: $68,349)

 

The mark-to-market loss and interest expense for the year ended March 31, 2020 was $15,987 (2019: $21,398) and $ 5,517 (2019: $10,682) have been recognized within other gain/(losses) and net finance cost, respectively, net in the Statement of Income..

 

2. Secured by pledge of shares held in the Group’s majority owned subsidiary, Eros International Media Limited, India.

  

3.

For the twelve months ended March 31, 2020 capitalization rate of interest was 11.00% (2019: 10.21%) 

 

4.

Borrowing agreements are subjected to covenant clause, whereby the Company is required to meet certain key financial ratios and those remaining unfulfilled resulted in disclosure of the outstanding balance with the aforesaid banking institution as a current liability as of March 31, 2020. Management is in the process of renewal of the aforesaid borrowing arrangement with the bank/s and is expecting that a revised loan sanction letter will be in place in the coming quarter/s. 

 

Fair value of the long-term borrowings as at March 31, 2020 is $ 43,964 (2019: $140,968). Fair values of long-term financial liabilities except retail bonds and convertibles notes have been determined by calculating their present values at the reporting date, using fixed effective market interest rates available to the Companies within the Group. As at March 31, 2020, the fair value of retail bond amounting to $36,897 (2019: $59,313) has been determined using quoted prices from the London Stock Exchange and the fair value of senior convertible notes has been determined at $23,100 (2019: $68,349) by an independent valuation expert using Monte-Carlo simulation model. Carrying amount of short-term borrowings are considered a reasonable approximation of fair value.

 

Reconciliation of fair value measurement of convertible notes:

 

    March 3, 2020  
Particulars   (in thousands)  
As at March 31,2019   $ 68,349  
Interest     5,517  
‘A’ ordinary shares issued in lieu of convertible notes     (91,753 )
Receipt from convertible notes     25,000  
Loss on fair value of convertible notes     15,987  
 As at March 31, 2020   $ 23,100  

 

 

v3.20.2
Acceptances
12 Months Ended
Mar. 31, 2020
Acceptances - Schedule Of Other Financial Liabilities  
Acceptances
23 ACCEPTANCES

 

    As At March 31  
    2020     2019  
    (in thousands)  
Payable under the film financing arrangements   $ 1,858     $ 8,366  
    $ 1,858     $ 8,366  

 

Acceptances comprise of short-term credit availed from financial institutions for payment to film producers for film co-production arrangement entered by the group. The carrying value of acceptances are considered a reasonable approximation of fair value.

 

v3.20.2
Other Long-Term Liabilities
12 Months Ended
Mar. 31, 2020
Other Long-term Liabilities  
Other Long-Term Liabilities
24 OTHER LONG -TERM LIABILITIES

 

    As At March 31  
    2020     2019  
    (in thousands)  
Contract liability (deferred revenue)(*)   $ 7,793     $ 13,271  
Employee benefit obligation     465       627  
    $ 8,258     $ 13,898  

 

(*) includes significant discounting on long-term advances from customers $1,925 (2019: 458)

 

v3.20.2
Derivative Financial Instruments
12 Months Ended
Mar. 31, 2020
Derivative Financial Instruments  
Derivative Financial Instruments
25 DERIVATIVE FINANCIAL INSTRUMENTS

 

    As At March 31  
    2020     2019  
    (in thousands)  
Current            
Derivative liabilities – Held for trading                
Interest rate cap   $     $ (620
    $     $ 620  

 

The above interest rate derivative instruments are not designated in a hedging relationship. They are carried at fair value through profit or loss. (Refer Note 9).

 

v3.20.2
Issued Share Capital
12 Months Ended
Mar. 31, 2020
Issued Share Capital  
Issued Share Capital
26 ISSUED SHARE CAPITAL

 

    Number of
Shares
    GBP  
Authorized             (in thousands)  
                 
Ordinary shares of 30p each at March 31, 2019     150,000,000       45,000  
Ordinary shares of 30p each at March 31, 2020 (*)     200,000,000       60,000  

 

(*) The Company increased authorized number of shares to 200,000,000 on September 25, 2019.

 

    Number of Shares     USD  
Allotted, called up and fully paid   A Ordinary 
30p Shares(*)
    B Ordinary 
30p Shares(*)
    (in thousands)  
As at March 31, 2018     55,718,423       9,712,715     $ 35,334  
Issue of shares in the quarter ended June 30, 2018     2,747,645             1,138  
Issue of shares in the quarter ended September 30, 2018     3,773,385             1,471  
Issue of shares in the quarter ended December 31, 2018     1,659,767             641  
Transfer of B Ordinary to A Ordinary share     1,500,000       (1,500,000 )      
Issue of shares in the quarter ended March 31, 2019     1,892,518             742  
As at March 31, 2019     67,291,738       8,212,715     $ 39,326  
Issue of shares in the quarter ended June 30, 2019     4,192,459             1,598  
Issue of shares in the quarter ended September 30, 2019     25,956,283       7,044,210       12,276  
Issue of shares in the quarter ended December 31, 2019     16,250,661             6,747  
Issue of shares in the quarter ended March 31, 2020     13,425,561       4,642,160       6,780  
As at March 31, 2020     127,116,702       19,899,085       66,727  

 

(*) Each A ordinary shares is entitled to one vote on all matters and each B shares is entitled to ten votes.

 

The Company issued A and B Ordinary shares as follows:

 

    A Ordinary     B Ordinary  
    For the year ended     For the year ended  
    March
  31, 2020
    March 31,
2019
    March 31,
2020
    March 31,
2019
 
Issuance to Founders Group (1) (7)           1,769,911       4,878,050        
Issuance towards settlement of Convertible notes (2)     49,185,958       4,411,359              
Exercise against Restricted Share Unit/ Management scheme (3)     2,728,181       770,541       6,808,320        
Issuance towards Reliance Industries Limited (4)           3,111,088              
2015 Share Plan (5)     132,013       10,416              
Issuance to vendors (8)     6,475,600                    
Issuance towards equity infusion from funds (6)     1,303,212                    
Total     59,824,964       10,073,315       11,686,370        

 

(1) Average price of A Ordinary Shares at NIL price (March 2019: $14.69)and B Ordinary Shares at $1.64 (March 2019:Nil)

(2) Average exercise price of A Ordinary Shares $1.87 (March 2019: $11.28)

(3) 2,728,181 A Ordinary shares (March 2019: 183,000) at NIL(March 2019: $0.39) and 6,808,320 B Ordinary shares (March 2019: Nil) exercised at NIL price March 2019: Nil)

(4) Average exercise price of A Ordinary Shares NIL (March 2019: $15)

(5) Average exercise price A Ordinary Shares $2 (March 2019: $7.92)

(6) Average exercise price A Ordinary Shares $3.22 (March 2019: Nil)

(7) Includes 4,176,830 B Ordinary shares issued against advance received ($6,150) as of March 31, 2019 and $700 received during the year and $1,150 payables settled by issuance of 701,220 B Ordinary shares

(8) Includes payables settled by issuance 100,000 A Ordinary shares issued to a consultant at an average exercised price at $2.23 (March 2019: NIL) and 6,375,600 A Ordinary Shares towards payables settlement at an average exercised price at $3.14 (March 2019: Nil)

v3.20.2
Share Based Compensation Plans
12 Months Ended
Mar. 31, 2020
Share Based Compensation Plans  
Share Based Compensation Plans
27 SHARE BASED COMPENSATION PLANS

 

The compensation cost recognised with respect to all outstanding plans and by grant of shares, which are all equity settled instruments, is as follows:

 

    Year ended March 31  
    2020     2019     2018  
    (in thousands)  
IPO India Plan   $ 145     $ 1,198     $ 1,572  
JSOP Plan                 615  
Option award scheme 2012                 197  
2014 Share Plan           47       (22 )
2015 Share Plan(*)     1,976       3,059       100  
Other share option awards(**)     7,829       5,346       7,283  
Management scheme (staff share grant) (***)     12,318       11,911       8,173  
    $ 22,268     $ 21,561     $ 17,918  

 

(*) includes 674,045 options granted towards Share Plan 2015 during twelve months ended March 31, 2020 at an exercise price of $ 2 per share and average grant date fair value of $ 0.82 per share. In February 2020, the exercise price of said options were modified to GBP 0.3, resulting in incremental fair value of $ 0.55 per share. In addition, includes 233,364 and 622,035 options granted in prior year/s and wherein the exercise price was modified to $ 2 per share and GBP 0.3 per share, respectively, resulting in incremental fair value of $ 0.55-0.63 per share and $ 1.18 per share, respectively.

 

(**) includes Restricted Share Unit (RSU) and Other share option plans. In respect of 4,899,280 units/options granted towards RSU during twelve months ended March 31, 2020, intrinsic value $ 1.94 per share approximates grant date fair value. Includes 873,000 options accelerated for immediate vesting as against original vesting period of 3 years, resulting in incremental at grant date fair value of $1.64 per share.

 

(***) includes 10,230,320 shares granted twelve months ended March 31, 2020 to management personnel at intrinsic value $ 1.94 per share approximates grant date fair value.

 

Joint Stock Ownership Plan (JSOP)

 

In April 2012, the Company established a controlled trust called the Eros International Plc Employee Benefit Trust (“JSOP Trust”). The JSOP Trust purchased 2,000,164 shares of the Company out of funds borrowed from the Company and repayable on demand. The Company’s Board, Nomination and Remuneration Committee recommends to the JSOP Trust certain employees, officers and key management personnel, to whom the JSOP Trust will be required to grant shares from its holdings at nominal price. Such shares are then held by the JSOP Trust and the scheme is referred to as the “JSOP Plan.” The shares held by the JSOP Trust are reported as a reduction in stockholders’ equity and termed as ‘JSOP reserves’.

 

The movement in the shares held by the JSOP Trust is given below:

 

    Year ended March 31  
    2020     2019     2018  
Shares held at the beginning of the year     384,862       1,146,955       1,146,955  
Shares granted                  
Shares exercised (*)                  
Shares forfeiture/lapsed     (384,862 )     (762,093 )      
Shares held at the end of the year           384,862       1,146,955  
Unallocated shares held by trust     1,253,656       868,794       106,701  
            1,253,656       1,253,656  

 

(*) During the year unallocated shares held by the trust were issued to the content vendor at $3.6 per share.

 

Employee Stock Option Plans

 

A summary of the general terms of the grants under stock option plans and stock awards are as follows:

 

    Range of
exercise prices
 
IPO India Plan     INR 10 – 150  
2014 Share Plan     $16.25–$18.30  
2015 Share Plan     $2-33.12 & GBP 0.3  
Other share option plans     $16.00  
RSU     Nil-0.3 GBP  
Management Share Award      

 

Employees covered under the stock option plans are granted an option to purchase shares of the Company at the respective exercise prices, subject to fulfillment of vesting conditions (generally service conditions). These options generally vest in tranches over a period of one to five years from the date of grant. Upon vesting, the employees can acquire one share for every option. The maximum contractual term for these stock option plans ranges between two to ten years.

 

The activity in these employee stock option plans is summarized below:

 

        Year ended March 31
        2020   2019   2018
    Name of Plan   Number
of
shares
  Weighted
average
exercise
price
  Number
of
shares
  Weighted
average
exercise
price
  Number
of
shares
  Weighted
average
exercise
price
Outstanding at the beginning of the year   IPO India Plan   757,886   INR 32.17   1,624,035   INR 28.85   2,108,063   INR 34.96
Granted                   863,320     10.00
Exercised       (121,496)     10.00   (536,263)     10.00   (1,113,160)     32.19
Forfeited and lapsed       (156,775)     10.00   (329,886)     51.66   (234,188)     10.00
Outstanding at the end of the year       479,615     45.03   757,886     32.17   1,624,035     28.85
Exercisable at the end of the year       325,740   INR 61.56   289,002   INR 68.13   501,122   INR 65.14
                                   
Outstanding at the beginning of the year   JSOP Plan   384,862   $ 11.00   1,146,955   $ 16.22   1,146,955   $ 16.22
Granted                      
Exercised                      
Forfeited and lapsed       (384,862)     11.00   (762,093)     18.86      
Outstanding at the end of the year         $   384,862   $ 11.00   1,146,955   $ 16.22
Exercisable at the end of the year         $   384,862   $ 11.00   728,736   $ 11.00
                                   
Outstanding at the beginning of the year   Option award scheme 2012     $   674,045   $ 11.00   674,045   $ 11.00
Granted                      
Exercised                      
Forfeited and lapsed             (674,045)     11.00      
Outstanding at the end of the year                   674,045     11.00
Exercisable at the end of the year                     449,363   $ 11.00
                                   
Outstanding at the beginning of the year   2014 Share Plan   399,999   $ 17.79   399,999   $ 17.79   723,749    $ 18.06
Granted                      
Exercised                      
Forfeited and lapsed                   (323,750)     18.39
Outstanding at the end of the year       399,999     17.79   399,999     17.79   399,999     17.79
Exercisable at the end of the year       399,999   $ 17.79   399,999   $ 17.79   289,583   $ 17.67
                                   
Outstanding at the beginning of the year (i)   2015 Share Plan   1,290,399   $ 14.68   211,250   $ 16.21   233,750   $ 16.23
Granted (ii)       674,045     0.38   1,305,399     14.86      
Exercised       (132,013)     2.00   (10,416)     7.92   (10,208   8.71
Forfeited and lapsed       (233,333)     16.18   (215,834)     18.23   (12,292   14.64
Outstanding at the end of the year       1,599,098     2.69   1,290,399     14.68   211,250     16.21
Exercisable at the end of the year       1,549,098   $ 2.72   981,545   $ 14.66   181,354   $ 17.36
                                   
Outstanding at the beginning of the year   Other share option plans   500,000   $ 16.00   500,000   $ 18.88   500,000     18.88
Granted                          
Exercised                          
Forfeited and lapsed       (500,000)      16.00              
Outstanding at the end of the year             500,000     16.00   500,000     18.88
Exercisable at the end of the year         $   400,000   $ 16.00   300,000   $ 18.88
                                   
Outstanding at the beginning of the year   RSU   505,945       837,590       182,725    
Granted (iii)       4,899,280     0.06   211,567       1,044,290    
Exercised       (2,088,181)       (450,541)       (366,491)    
Forfeited and lapsed       (37,447)       (92,672)       (22,934)    
Outstanding at the end of the year       3,279,597     0.1   505,944       837,590    
Exercisable at the end of the year       311,740       34,416       119,150    
                                   
Outstanding at the beginning of the year   Management Scheme   2,593,333       1,513,333       1,130,000    
Granted (iv)       10,230,320       1,400,000       700,000    
Exercised (v)       (7,448,320)       (320,000)       (316,667    
Forfeited and lapsed       (320,000)                
Outstanding at the end of the year       5,055,333     0.01   2,593,333       1,513,333    
Exercisable at the end of the year       890,000     0.03   516,667       173,333    

 

(i) includes 233,364 and 622,035 options granted in prior year/s and wherein the exercise price was modified to $ 2 per share and GBP 0.3 per share, respectively.

(ii) Options granted in during the year, wherein the exercise price was modified to GBP 0.3 per share

(iii) Out of above, 873,000 RSU were accelerated for immediate vesting as against original vesting period of 3 years.

(iv) Includes 6,808,320 B Ordinary shares granted on July 12, 2019 and February 28, 2020, respectively

(v) Includes issuance of 6,808,320 B Ordinary treasury shares

 

The following table summarizes information about outstanding stock options:

 

    Year ended March 31  
    2020     2019     2018  
Name of Plan   Weighted
average
remaining
life
(Years)
    Weighted
average
exercise
price
    Weighted
average
remaining
life
(Years)
    Weighted
average
exercise
price
    Weighted
average
remaining
life
(Years)
    Weighted
average
exercise
price
 
IPO India Plan     6.30     INR* 45.03       7.70     INR* 32.17       8.11     INR* 35.0  
JSOP Plan         $       3.05     $ 11.00       3.93     $ 16.19  
Option award scheme 2012         $           $       3.75     $ 11.00  
2014 Share Plan     1.25     $ 17.79       2.25     $ 17.79       5.96     $ 17.79  
2015 Share Plan     5.00     $ 2.69       6.01     $ 14.68       6.06     $ 16.21  
Other share option plans         $       1.87     $ 16.00       2.87     $ 18.88  
RSU     9.36     $       6.00     $       5.60     $  
Management Scheme     8.94     $ 0.1       6.00     $       5.56     $  

 

 *INR – Indian Rupees

 

2015 Share Plan

 

The following table summarizes information about inputs to the fair valuation model for options granted during the year:

 

    Inputs  
Expected volatility(1)     108.2%  
Option life (Years)     2.6  
Dividend yield     0%  
Risk free rate     0.3  
Range of exercise price of the granted options at the grant date(2)   $ 0.38  

 

(1) The expected volatility of all other options is based on the historic share price volatility of the Company over time periods comparable to the time from the grant date to the maturity dates of the options.
(2) Fair value of options granted under all other schemes is measured using a Black Scholes model.

 

v3.20.2
Joint Stock Ownership Plan Reserve (JSOP Reserve)
12 Months Ended
Mar. 31, 2020
Joint Stock Ownership Plan Reserve  
Joint Stock Ownership Plan Reserve (JSOP Reserve)
28 JOINT STOCK OWNERSHIP PLAN RESERVE (JSOP Reserve)

 

    (in thousands)  
Balance at April 1, 2018   $ (15,985 )
Issue out of treasury shares      
Balance at April 1, 2019   $ (15,985 )
Issue out of treasury shares     15,985  
Balance at March 31, 2020   $  

 

The JSOP Reserve represents the cost of shares issued by Eros International Plc and held by the JSOP Trust to satisfy the requirements of the JSOP Plan (Refer Note 27).  On June 5, 2014, the Board approved discretionary vesting of 20% of the applicable JSOP shares. In the current year Nil (2019: 868,794) ‘A’ ordinary shares held by the JSOP Trust were eligible to be issued to employees.

 

The number of shares held by the JSOP Trust at March 31, 2020 was Nil ‘A’ Ordinary shares (2019: 1,253,656 ‘A’ Ordinary shares).

 

v3.20.2
Other Components of Equity
12 Months Ended
Mar. 31, 2020
Other Components Of Equity  
Other Components of Equity
29 OTHER COMPONENTS OF EQUITY

 

   As at March 31
(in thousands)
 
   2020   2019   2018 
Movement in hedging reserve:               
Opening balance  $   $   $(375)
Reclassified to consolidated statements of income           375 
Closing balance  $   $   $ 
                
Movement in revaluation reserve:               
Opening balance  $2,932   $1,835   $1,829 
Net gain recognised on revaluation of property and equipment       1,019     
Impact of translation difference   (156)   78    6 
Closing balance  $2,776   $2,932   $1,835 
                
Movement in available for sale fair value reserve:               
Opening balance  $(18,449)  $6,238   $6,238 
Impairment loss on available-for-sale financial assets   (1,860)   (24,687)    
Closing balance  $(20,309)  $(18,449)  $6,238 
                
Movement in Foreign currency translation reserves               
Opening balance  $(64,179)  $(56,722)  $(55,810)
Adoption of IFRS 9 (net of tax)       (34)    
Other comprehensive loss due to translation of foreign operations (*)   (3,948)   (7,423)   (912)
Closing balance  $(68,127)  $(64,179)  $(56,722)
                
Total other components of equity  $(85,660)  $(79,696)  $(48,649)

  

(*) includes movement in foreign currency translation reserves arising on account of deconsolidation $Nil (2019: Nil, 2018: $502) of financial asset.

 

v3.20.2
Significant Non-Cash Expenses
12 Months Ended
Mar. 31, 2020
Significant Non-cash Expenses  
Significant Non-Cash Expenses
30 SIGNIFICANT NON-CASH EXPENSES

 

Significant non-cash expenses, except loss on sale of assets, share based compensation, depreciation and amortization were as follows:

 

    As at March 31  
    2020     2019     2018  
    (in thousands)  
Unrealised foreign exchange loss / (gain)   $ (4,458 )   $ (3,329 )   $ 5,466  
Credit impairment loss, net     82,920       26,283       3,376  
Impairment charge on available-for-sale financial assets     1,253             2,436  
Net losses on de-recognition of financial assets measured at amortized cost, net     5,285       5,988       3,562  
Mark to market gain on derivative financial instrument measured at fair value through profit and loss           902        
Loss on settlement of derivative financial instruments                 586  
Loss on financial liability (convertible notes) measures at fair value through profit and loss     15,987       21,398       13,840  
Loss on deconsolidation of a subsidiary                 14,649  
Provisions for trade and other receivables     -             4,740  
Provision no longer required, written-back     (2,636 )     (120 )     (124 )
Impairment loss on advances content vendors     -       7,284       353  
Impairment loss                 1,205  
Significant discounting on deferred revenue     1,501              
Others     266       32       30  
    $ 100,118     $ 58,438     $ 50,119  
v3.20.2
Financial Instruments and Risk Management
12 Months Ended
Mar. 31, 2020
Financial Instruments And Risk Management  
Financial Instruments and Risk Management
31 FINANCIAL INSTRUMENTS AND RISK MANAGEMENT

 

The Group has established objectives concerning the holding and use of financial instruments. The underlying basis of these objectives is to manage the financial risks faced by the Group.

 

Formal policies and guidelines have been set to achieve these objectives. The Group does not enter into speculative arrangements or trade in financial instruments and it is the Group’s policy not to enter into complex financial instruments unless there are specific identified risks for which such instruments help mitigate uncertainties.

 

Management of Capital Risk and Financial Risk

 

The Group manages its capital to ensure that entities in the Group will be able to continue as a going concern while maximizing the return to shareholders through the optimization of the debt and equity balance. The capital structure of the Group consists of debt, which includes the cash and cash equivalents, borrowings and equity attributable to equity holders of Eros, comprising issued capital, reserves and retained earnings as disclosed in Notes 21, 22 and 26 and the consolidated statement of changes in equity.

 

The gearing ratio at the end of the reporting period was as follows:

 

    As at March 31  
    2020     2019  
    (in thousands)  
Debt (net of debt issuance cost of $399 (2019: $691))   $ 178,972     $ 280,828  
Cash and cash equivalents (*)     2,563       135,783  
Net debt     176,409       145,045  
Equity     308,486       656,985  
Net debt to equity ratio     57.2%       22.1%  

(*) includes $Nil (2019: $46,666) of restricted deposits.

 

Debt is defined as long and short-term borrowings (excluding derivatives). Equity includes all capital and reserves of the Group that are managed as capital.

 

Categories of financial instruments

 

    2020     2019  
    (in thousands)  
Financial assets                
Available-for-sale investments   $ 3,942     $ 3,692  
Other financial assets (1)     116,281       351,477  
    $ 120,223     $ 355,169  
Financial liabilities at amortized cost                
Trade payables and acceptances excluding value added tax and other tax payables   $ 79,630     $ 81,208  
Borrowings excluding Senior Convertible Notes     155,872       212,479  
Financial Liabilities at fair value through profit or loss                
Derivatives at fair value through profit or loss - held for trading           620  
Senior convertible Notes at fair value through profit or loss     23,100       68,349  
    $ 258,602     $ 362,656  

 

(1) Other financial assets include loans and receivables, excluding prepaid charges and statutory receivables, and includes cash and cash equivalents and restricted deposits held with banks.

 

Financial risk management objectives

 

Based on the operations of the Group throughout the world, the management considers that the key financial risks that it faces are credit risk, currency risk, liquidity risk and interest rate risk. The objectives under each of these risks are as follows:

  · credit risk: minimize the risk of default and concentration.
  · currency risk: reduce exposure to foreign exchange movements principally between U.S. dollar, Indian Rupee and GBP.
  · liquidity risk: ensure adequate funding to support working capital and future capital expenditure requirements.
  · interest rate risk: mitigate risk of significant change in market rates on the cash flow of issued variable rate debt.

 

Credit risk

 

Trading credit risk is managed on a country by country basis by the use of credit checks on new clients and individual credit limits, where appropriate, together with regular updates on any changes in the trading partner’s situation. In a number of cases trading partners will be required to make advance payments or minimum guarantee payments before delivery of any goods. The Group reviews reports received from third parties and in certain cases as a matter of course reserve the right within the contracts it enters into to request an independent third - party audit of the revenue reporting. Further, in many of the catalogue sales, the trading partners have extended payment terms of up to a year and often fall behind contractual payment terms, thus payment cycle extends to 18 to 24 months. With respect to catalogue and other customers with a long trading history with the Group and who have contracted and paid significant amounts in the past without any prior history of bad debt, the Group closely monitors the same revised payment plans to assure collections. In case of new customer onboarding, the Group follows certain standard Know Your Client (KYC) procedures to ascertain financial stability of the counterparty and follows internal policies to not make ongoing sales to such new customers who are not reasonably current with their payments.

 

The Group from time to time will have significant concentration of credit risk in relation to individual theatrical releases, television syndication deals, music licenses, or producer/ VFX services. This risk is mitigated by contractual terms which seek to stagger receipts, de-recognition of financial assets and/or the release or airing of content. As at March 31, 2020, 40.1% (2019: 20.4%) of trade account receivables were represented by the top five debtors and for the year ended March 31, 2020, a loss on de-recognition of financial assets amounting to $5,285 (2019: 5,988 and 2018: 3,562) arising on assignment and novation of trade receivable and trade payables with no recourse have been recognized in the statement of Income within other gains/(losses), net. The maximum exposure to credit risk is that shown within the statements of financial position, net of credit impairment loss $112,323 (2019: $41,335, 2018: $10,193). The maximum credit exposure on financial guarantees given by the Group for various financial facilities is described in Note 32.

 

As at March 31, 2020, the Group did not hold any material collateral or other credit enhancements to cover its credit risks associated with its financial assets.

 

Currency risk

 

The Group operates throughout the world with significant operations in India, the British Isles, the United States of America and the United Arab Emirates. As a result it faces both translation and transaction currency risks which are principally mitigated by matching foreign currency revenues and costs wherever possible.

 

The Group’s major revenues are denominated in U.S. Dollars, Indian Rupees and British pounds sterling which are matched where possible to its costs so that these act as an automatic hedge against foreign currency exchange movements.

 

The Group has identified that it will need to utilize hedge transactions to mitigate any risks in movements between the U.S. Dollar and the Indian Rupee and has adopted an agreed set of principles that will be used when entering into any such transactions. No such transactions have been entered into to date and the Group has managed foreign currency exposure to date by seeking to match foreign currency inflows and outflows as much as possible. Details of the foreign currency borrowings that the Group uses to mitigate risk are shown within Interest Risk disclosures.

 

As at the reporting date there were no outstanding forward foreign exchange contracts. Further, in fiscal 2020, the Company did not hedge foreign exchange exposure towards foreign currency borrowings. The Group adopts a policy of borrowing where appropriate in the local currency as a hedge against translation risk. The table below shows the Group’s net foreign currency monetary assets and liabilities position in the main foreign currencies, translated to USD equivalents, as at the year-end:

 

        Net Balance
    USD   GBP   Other
        (in thousands)
As at March 31, 2020   (3,895)   (65,446)   (182)
As at March 31, 2019   (6,117)   (61,927)   (2,317)

 

The above exposure to foreign currency arises where a consolidated entity holds monetary assets and liabilities denominated in a currency different to the functional currency of that entity.

 

A uniform decrease of 10% in exchange rates against all foreign currencies in position as of March 31, 2020 would have increased the Company’s net loss before tax by approximately $6,952 (2019: gain of $7,036 and 2018: gain of $5,935). An equal and opposite impact would be experienced in the event of an increase by a similar percentage.

 

Our sensitivity to foreign currency has increased during the year ended March 31, 2020 as a result of an increase in liabilities compared to assets denominated in foreign currency over the comparative period. In Management’s opinion, the sensitivity analysis is unrepresentative of the inherent foreign exchange risk because the exposure at the end of the reporting period does not reflect the exposure during the year.

 

Liquidity risk

 

The Group manages liquidity risk by maintaining adequate reserves and agreed committed banking facilities. Management of working capital takes account of film release dates and payment terms agreed with customers.

 

An analysis of short-term and long-term borrowings is set out in Note 22. Set out below is a maturity analysis for non-derivative and derivative financial liabilities. The amounts disclosed are based on contractual undiscounted cash flows. The table includes both interest and principal cash flows. To the extent that interest flows are floating rate, the undiscounted amount is derived from interest rates as at March 31, in each year.

 

    Total     Less than
1 year
    1-3
years
    3-5
years
    More than
5 years
 
    (in thousands)  
As at March 31, 2020                                        
Borrowing principal payments(1)   $ 179,371     $ 117,097     $ 62,274     $     $  
Borrowing interest payments     23741       17,500       6,241              
Acceptances     1,858       1,858                    
Trade and other payables     90,941       90,941                    
Minimum lease payments     1,716       822       894                  

 

    Total     Less than
1 year
    1-3
years
    3-5
years
    More than
5 years
 
    (in thousands)  
As at March 31, 2019                                        
Borrowing principal payments(1)   $ 281,519     $ 209,180     $ 72,339     $     $  
Borrowing interest payments     29,016       21,820       7,196              
Derivative financial instruments     620       620                    
Acceptances     8,366       8,366                    
Trade and other payables     83,487       83,487                    
Minimum lease payments     2,956       1,480       1,360       116          

 

(1)   Excludes cumulative effect of unamortized costs.

 

At March 31, 2020, the Group had facilities available of $181,340 (2019: $290,353) and had net undrawn amounts of $111 (2019: $468) available.

 

In addition, the Group has issued financial guarantees amounting to $33 (2019: $51) in the ordinary course of business, having maturity dates up to the next 12 months. The Group did not earn any fees to provide such guarantees. It does not anticipate any liability on these guarantees as it expects that most of these will expire unused.

 

Interest rate risk

 

The Group is exposed to interest rate risk because entities in the Group borrow funds at both fixed and floating interest rates. The risk is managed by maintaining an appropriate mix between fixed, capped and floating rate borrowings, and by the use of interest rate swap contracts and forward interest rate contracts. Hedging activities are evaluated to align with interest rate views to ensure the most cost effective hedging strategies are applied.

 

Currency, Maturity and Nature of Interest Rate of the Nominal Value of Borrowings

 

    As at March 31  
    2020     %     2019     %  
    (in thousands, except percentages)  
Currency                                
U.S. Dollar   $ 49,182       27.4%     $ 148,201       52.6%  
Great British Pounds Sterling     62,274       34.7%       65,215       23.2%  
Indian Rupees     67,915       37.9%       68,103       24.2%  
Total   $ 179,371       100.0%     $ 281,519       100.0%  
                                 
Maturity                                
Due before one year   $ 117,097       64.3%     $ 209,180       74.3%  
Due between one and three years     62,274       34.7%       72,339       25.7%  
Due between four and five years                        
Due after five years                        
    $ 179,371       100.0%     $ 281,519       100.0%  
Nature of rates                                
Fixed interest rate   $ 96,904       54.0%     $ 205,156       72.9%  
Floating rate     82,467       46.0%       76,363       27.1%  
Total   $ 179,371       100.0%     $ 281,519       100.0%  

 

At 1% increase in underlying bank rates would lead to increase in the Company’s net loss before tax by $ 895 for the year ended March 31, 2020 (2019: $1,029) on net income. An equal and opposite impact would be felt if rates fell by 1%.

 

This analysis assumes that all other variables, in particular foreign currency and credit ratings, remain constant.

 

Under the interest swap contracts, we have agreed to exchange the difference between fixed and floating rate interest amounts calculated on an agreed notional principal amount. Such contracts enable us to mitigate the risk of changing interest rates on the cash flow of issued variable rate debt.

 

The fair value of interest rate derivatives which comprise derivatives at fair value through profit and loss is determined as the present value of future cash flows estimated and discounted based on the applicable yield curves derived from quoted interest rates.

 

Financial instruments — disclosure of fair value measurement level

 

Disclosures of fair value measurements are grouped into the following levels:

  · Level 1 fair value measurements derived from unadjusted quoted prices in active markets for identical assets or liabilities;
  · Level 2 fair value measurements derived from inputs, other than quoted prices included within Level 1, that are observable for the asset or liability, either directly (as prices) or indirectly (derived from prices); and
  · Level 3 fair value measurements derived from valuation techniques that include inputs for the asset or liability that are not based on observable market data.

 

The table below presents assets and liabilities measured at fair value on a recurring basis, which are all category level 2:

 

    As at March 31, 2020
    (in thousands)
Description of type of financial assets   Gross amount of
recognized financial assets
  Gross amount of recognized
financial liabilities offset in the
statement of financial position
  Net amounts financial assets
presented in the statement
of financial position
Derivative assets      
Trade and other receivables   94,749     94,749
Investments at FVTPL   3,802     3,802
Investments at FVTOCI   140     140
Total   98,691     98,691

 

Description of type of financial liabilities   Gross amount of
recognized financial liabilities
  Gross amount of recognized
financial assets offset in the
statement of financial position
  Net amounts financial liabilities
presented in the statement
of financial position
Derivative liabilities      
Long-term borrowings at fair value   23,100     23,100
Total   23,100     23,100

 

    As at March 31, 2019
    (in thousands)
Description of type of financial assets   Gross amount of
recognized financial assets
  Gross amount of recognized
financial liabilities offset in the
statement of financial position
  Net amounts financial assets
presented in the statement
of financial position
Derivative assets      
Trade and other receivables   125,229     125,229
Investments at FVTPL   1,042     1,042
Investments at FVTOCI   2,650     2,650
Total   128,921     128,921

 

Description of type of financial liabilities   Gross amount of
recognized financial liabilities
  Gross amount of recognized
financial assets offset in the
statement of financial position
  Net amounts financial liabilities
presented in the statement
of financial position
Derivative liabilities   620     620
Long-term borrowings at fair value   68,349     68,349
Total   68,969     68,969

 

None of the above derivative instruments is designated in a hedging relationship. A net loss of Nil (loss in 2019: $902) in respect of the above derivative instruments has been recognized in the consolidated statements of income within other gain/(loss), net. Fair value of interest rate derivative involving interest rate options and cross currency swap is estimated as the present value of the estimated future cash flows based on observable yield curves using an option pricing model.

 

Management uses valuation techniques in measuring the fair value of financial instruments, where active market quotes are not available. In applying the valuation techniques, management makes maximum use of market inputs, and uses estimates and assumptions that are, as far as possible, consistent with observable data that market participants would use in pricing the instrument. Where applicable data is not observable, management uses its best estimate about the assumptions that market participants would make. These estimates may vary from the actual prices that would be achieved in an arm’s length transaction at the reporting date.

 

There were no transfers between any Levels in any of the years.

 

v3.20.2
Contractual Obligations and Commitments
12 Months Ended
Mar. 31, 2020
Contractual Obligations And Commitments  
Contractual Obligations and Commitments
32 CONTRACTUAL OBLIGATIONS AND COMMITMENTS

 

Eros’ material contractual obligations are comprised of contracts related to content commitments.

 

    Total  
    (in thousands)  
As at March 31, 2020   $ 450,469  
         
As at March 31, 2019   $ 301,660  

 

The Group has provided certain stand-by letters of credit amounting to $Nil (2019: $53,565) which are in the nature of performance guarantees issued while entering into film co-production contracts and are valid until funding obligations under these contracts are met. These guarantees, issued in connection with the aforementioned content commitments, and included in the table above have varying maturity dates and are expected to fall due within a period of one to three years.

 

In addition, the Group has issued financial guarantees amounting to $33 (2019: $51) in the ordinary course of business, and included in the table above, having varying maturity dates up to the next 12 months. The Group is only called upon to satisfy a guarantee when the guaranteed party fails to meet its obligations. The Group did not earn any fee to provide such guarantees. It does not anticipate any liability on these guarantees as it expects that most of these will expire unused.

 

v3.20.2
Contingent Liabilities
12 Months Ended
Mar. 31, 2020
Contingent Liabilities  
Contingent Liabilities
33 CONTINGENT LIABILITIES

 

  1. Eros has received several show causes notices and assessment order from Service Tax Authorities in India levying amounts to be paid on account of several grounds of non-compliance with the Service Tax Laws. An amount aggregating to $56,064 (net of monies paid under protest $1,790 and including interest and penalty) for the periods under dispute on account of service tax arising on temporary transfer of copyright services and certain other related matters have been considered contingent. Eros has filed an appeal against the said order before the authorities. Considering the facts and nature of levies and the ad-interim protection for service tax levy for a certain period granted by the Honorable High Court of Mumbai, the Group expects that the final outcome of this matter will be favorable. There is no further update on this matters as preliminary hearing is yet to begin. Accordingly, based on the assessment made after taking appropriate legal advice, no additional liability has been recorded in Group’s consolidated financial statements.

 

  2. Eros has received several assessment orders and demand notices from value added tax and sales tax authorities in India. Several revised orders have been received during the year. Eros has considered an amount equal to $2,631 (net of monies paid under protest $137 and including interest and penalty) for the periods under dispute as contingent. Eros has appealed against each of the orders outstanding, and such appeals are pending before relevant tax authorities. Though, uncertainties are inherent in the final outcome of these matters, the Group believes, based on assessment made after taking legal advice, that the final outcome of the matters will be favorable. Accordingly, no additional liability has been recorded in Group’s consolidated financial statements.

 

  3. Eros has received several assessment orders and demand notices from Income Tax Authorities in India. The orders are on account of disallowance of certain expenditures claimed by the Company. Eros has considered an amount equal to $ 139 for the period under dispute as contingent. Eros has contested the said cases and believes that there will not be any significant liability on the Group as the misstatements were bonafide and without any wrongful intentions and do not invite penalty. However, uncertainties are inherent in the final outcome of these matters and hence, after taking appropriate legal advice, Group has considered the amount as contingent liability.

 

  4. On September 29, 2017, the Company filed a lawsuit against Mangrove Partners, Manuel P. Asensio, GeoInvesting, LLC, and other individuals and entities alleging the defendants and other co-conspirators disseminated material false, misleading, and defamatory information about the Company and are engaging in other misconduct that has harmed the Company. On May 31, 2018, the Company filed an amended complaint that added two new defendants and expanded the scope of the Company’s initial allegations. The amended complaint alleges that Mangrove Partners and many of its co-conspirators held substantial short positions in the Company’s stock and profited when its share price declined in response to their multi-year disinformation campaign. The Company seeks damages and injunctive relief for defamation, civil conspiracy, and tortious interference, including but not limited to interference with its customers, producers, distributors, investors, and lenders. On March 12, 2019, the Supreme Court of the State of New York entered a Decision and Order granting defendants’ motions to dismiss. On March 13, 2019, the Company filed a Notice of Appeal against the said order.

 

  5. Beginning on June 21, 2019, the Company was named a defendant in three substantially similar putative class action lawsuits filed in federal court in California and New Jersey by purported shareholders of the Company. The lawsuits allege that the Company and certain individual defendants violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 by making false and/or misleading statements regarding the Company’s accounting for trade receivables. On September 27, 2019, the putative class action filed in California was transferred to the United States District Court for the District of New Jersey. On April 14, 2020, the three putative class actions were consolidated and a lead plaintiff was appointed. On July 1, 2020, the court-appointed lead plaintiff filed a consolidated complaint. The Company expects to file a motion to dismiss, which is due August 28, 2020.

 

From time to time, Eros is involved in legal proceedings arising in the ordinary course of its business, typically intellectual property litigation and infringement claims related to the Group’s feature films and other commercial activities, which could cause it to incur expenses or prevent it from releasing a film. While the resolution of these matters cannot be predicted with certainty, the Group does not believe, based on current knowledge or information available, that any existing legal proceedings or claims are likely to have a material and adverse effect on its financial position, results of operations or cash flows.

 

There were no other material ongoing litigations at March 31, 2020 and March 31, 2019.

 

v3.20.2
Related Party Transactions
12 Months Ended
Mar. 31, 2020
Related Party Transactions  
Related Party Transactions
34 RELATED PARTY TRANSACTIONS

 

        As at
March 31,2020
    As at
March 31,2019
 
    Details of   (in thousands)  
    Transaction   Liability     Asset     Liability     Asset  
Red Bridge Group Limited   President fees   $ 648     $     $ 648     $  
550 County Avenue   Rent/Deposit     156             499       135  
NextGen Films Private Limited (*)   Purchase/Sale                       41,470  
Everest Entertainment LLP   Purchase/Sale     557             574        
Beech Investments Limited   Advance     592             500        
Lulla Family   Rent/Deposit     487       356       243       841  
Lulla Family   Salary     4,155             3,279        
Lulla Family   Advance                 6,150        
Lulla Family   Advance     500             500        
Xfinite Global Plc   Sale     3,812             6,500        

 

The Lulla family refers to late Mr. Arjan Lulla, Mr. Kishore Lulla, Mr. Sunil Lulla, Mrs. Manjula Lulla, Mrs. Krishika Lulla, Mrs. Rishika Lulla Singh, and Ms. Riddhima Lulla and Mr. Swaneet Singh.

Pursuant to a lease agreement that expired on March 31, 2020, the lease requires Eros International Media Limited to pay $4 each month under this lease. Eros International Media Limited leases apartments for studio use at Kailash Plaza, 3rd Floor, Opp. Laxmi Industrial Estate, Andheri (W), Mumbai, from Manjula K. Lulla, the wife of Kishore Lulla. The lease was renewed on April 1, 2020 for a further period of one year on the same terms.

Pursuant to a lease agreement that expires on September 30, 2021, the lease requires Eros International Media Limited to pay $4 each month under this lease. Eros International Media Limited leases for use as executive accommodations the property Aumkar Bungalow, Gandhi Gram Road, Juhu, Mumbai, from Sunil Lulla.

Pursuant to a lease agreement that expired on January 4, 2020, Eros International Media Limited leases office premise for studio use at Supreme Chambers, 5th Floor, Andheri (W), Mumbai from Kishore and Sunil Lulla. Beginning January 2015, the lease requires Eros International Media Limited to pay $82 each month under this lease. The lease was renewed on January 5, 2020 for a further period of five years on the same terms.

Pursuant to an agreement the Group entered into with Redbridge Group Limited on June 27, 2006, the Group agreed to pay an annual fee set each year of $Nil, $186 and $270 in the respective years ended March 31, 2020, 2019 and 2018, for the services of Arjan Lulla, the father of Kishore Lulla and Sunil Lulla, grandfather of Mrs. Rishika Lulla Singh, uncle of Vijay Ahuja and Surender Sadhwani and an employee of Redbridge Group Limited. The agreement makes Arjan Lulla honorary life president and provides for services including attendance at Board meetings, entrepreneurial leadership and assistance in setting the Group’s strategy. Arjan Lulla passed away in December 2018 Redbridge Group Limited is an entity owned indirectly by a discretionary trust of which Kishore Lulla is a potential beneficiary.

 

The Group has engaged in transactions with NextGen Films Private Limited, an entity owned by the husband of Puja Rajani, sister of Kishore Lulla and Sunil Lulla, which with effect from September 19, 2019 ceased to be a related party, each of which involved the purchase and sale of film rights. In the period ended September 19, 2019, NextGen Films Private Limited sold film rights $ 393 (2019: $1,109, 2018: $$7,760) to the Group, and purchased film rights, including production services, of Nil (2019: Nil and 2018: $Nil). The Group advanced $2,113 (2019: $6,192, 2018: $19,025) to NextGen Films Private Limited for film co-production and received refund of $Nil (2019: $Nil, 2018: $6,114) on abandonment of certain film projects. With effect from September 19, 2019, NextGen Films Private Limited ceased to be a related party having a balance of $47,742 towards film content advances.

The Group also engaged in transactions with Everest Entertainment LLP entity owned by the brother of Manjula K. Lulla, wife of Kishore Lulla, which is involved in the purchase and sale of film rights. In March 31, 2020, Everest Entertainment LLP sold film rights of $18 (2019: 1,260, 2018: 166) to the Group and purchased film rights of $ Nil (2019: $ 314).

Mrs. Manjula Lulla, the wife of Kishore Lulla, is an employee of Eros International Plc. and is entitled to a salary of $147 per annum (2019: $144 and 2018: $139). Mrs. Krishika Lulla, the wife of Sunil Lulla, is an employee of EIML and is entitled to a salary of $121 per annum (2019: $123, 2018: $133). Ms. Riddhima Lulla, the daughter of Kishore Lulla, is an employee of Eros Digital FZ LLC and is entitled to a salary of $300 per annum (2019: $213, 2018: $90) which is borne by Eros Worldwide LLC.

All of the amounts outstanding are unsecured and will be settled in cash.

As at March 31, 2020, the Group has provided performance guarantee to a bank amounting to $Nil (2019: $8,000, 2018: $8,000) in connection with funding commitments. under film co-production agreements with NextGen Films Private Limited and having varying maturity dates up to the next 12 months. The Group did not earn any fee to provide such guarantees.

(*) With effect from September 19, 2019, NextGen Films Private Limited ceased to be a related party.

License Arrangement with Xfinite Global Plc

The Group has engaged in transactions with Xfinite Global Plc, a subsidiary of Eros Investment Limited on which it has significant influence. The Group has accounted $12,776 (2019: $1,413, 2018: $ Nil) as revenue during the year ended March 31, 2020.

 

v3.20.2
Major Consolidated Entities
12 Months Ended
Mar. 31, 2020
Major Consolidated Entities  
Major Consolidated Entities
35 MAJOR CONSOLIDATED ENTITIES

 

    Date     Country of
Incorporation
    % of voting
rights held
 
Copsale Limited     June 2006       BVI       100.00  
Eros Australia Pty Limited     June 2006       Australia       100.00  
Eros International Films Private Limited     June 2006       India       100.00  
Eros International Limited     June 2006       U.K.       100.00  
Eros International Media Limited     June 2006       India       62.31  
Eros International USA Inc     June 2006       U.S.       100.00  
Eros Network Limited     June 2006       U.K.       100.00  
Eros Worldwide FZ-LLC     June 2006       UAE       100.00  
Big Screen Entertainment Private Limited     January 2007       India       64.00  
EyeQube Studios Private Limited     January 2008       India       99.99  
Acacia Investments Holdings Limited     April 2008       IOM       100.00  
Eros International Pte Limited     August 2010       Singapore       100.00  
Digicine Pte. Limited     March 2012       Singapore       100.00  
Colour Yellow Productions Private Limited     May 2014       India       50.00  
Eros Digital FZ LLC     September 2015       UAE       100.00  
Eros Digital Limited     July 2016       IOM       100.00  
Eros Films Limited     November 2016       IOM       100.00  
Universal Power Systems Private Limited     August 2015       India       100.00  
England Merger 1, Corp     March 2020       U.S.       100.00  
England Holdings 2,Inc     March 2020       U.S.       100.00  
England Holdings 3,Inc     March 2020       U.S.       100.00  

 

All of the companies were involved with the distribution of film content and associated media. All the companies are indirectly owned with the exception of Eros Network Limited, Eros Worldwide FZ-LLC and Eros International Pte Ltd.

 

In fiscal year 2020, Group shareholding of Eros International Media Ltd decreased to 62.31% (2019: 62.39%) The change in shareholding was due to exercise of 0.08% ESOP by the employees.

 

In fiscal year 2020, the Group has pledged 38.40% of its holding in Eros International Media Limited as security for certain of the Group’s borrowings (See Note 22).

 

v3.20.2
Non-Controlling Interest
12 Months Ended
Mar. 31, 2020
Non-controlling Interest  
Non-Controlling Interest
36 NON-CONTROLLING INTERESTS

 

Details of subsidiary that have material non-controlling interests

 

The Group has a number of subsidiaries held directly and indirectly which operate and are incorporated around the world. Note 35 to the financial statements lists details of the major consolidated entities and the interests in these subsidiaries. The non-controlling interests that are material to the Group relate to Eros International Media Limited and its subsidiaries whose principal place of business is in India.

 

The table below shows the summarized financial information of Eros International Media Limited and its subsidiaries (EIML) as at March 31, 2020, non-controlling interests held an economic interest by virtue of shareholding of 37.69% (March 2019: 37.61%). The change in shareholding was due to exercise of 0.08% (March 2019: 0.11%)  ESOP by employees. The summarized financial information represents amounts before inter-company eliminations.

 

   Year ended March 31 
   (in thousands) 
EIML  2020   2019 
Current assets   $170,724   $183,944 
Non-current assets    152,059    385,463 
Current liabilities    (147,004)   (158,182)
Non-current liabilities    (21,285)   (53,210)
Total net assets attributable   $154,494   $358,015 
Equity attributable to owners of the Group   $95,127   $222,486 
Equity attributable to non-controlling interests   $59,367   $135,529 
           
Revenue   $119,821   $149,969 
Expenses (including impairment of $ 208,931)    (313,660)   (114,709)
Profit for the year   $(193,839)  $35,260 
Profit attributable to the owners of the Group   $(121,127)  $21,846 
Profit attributable to non-controlling interests   $(72,712)  $13,414 
           
Other comprehensive (loss)/income during the year   $(9,861)  $(12,500)
Total comprehensive income during the year   $(203,700)  $22,760 
Total comprehensive income attributable to the owners of the Group    (127,093)   15,354 
Total comprehensive income attributable to non-controlling interests    (76,607)   7,406 
           
Net cash inflow from operating activities   $7,654   $50,470 
Net cash outflow from investing activities    (13,635)   (37,729 
Net cash inflow from financing activities    (12,901)   (14,462)
Net cash (outflow)/inflow   $(18,882)  $36,008 

 

No dividends were paid to non-controlling interests during the year ended March 31, 2020. (2019: Nil).

 

v3.20.2
Significant Accounting Estimates and Judgments
12 Months Ended
Mar. 31, 2020
Significant Accounting Estimates And Judgments  
Significant Accounting Estimates and Judgments
37 SIGNIFICANT ACCOUNTING ESTIMATES AND JUDGMENTS

 

Estimates and judgments are evaluated on a regular basis and are based on historical experience and other factors, such as expectations of future events that are believed to be reasonable under the present circumstances.

 

The Group makes estimates and assumptions concerning the future. These estimates, by definition, will rarely equal the related actual results. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the financial year are highlighted below:

 

37.1. Basis of consolidation
 

The Group evaluates arrangements with special purpose vehicles in accordance with of IFRS 10 – Consolidated Financial Statements to establish how transactions with such entities should be accounted for. This requires a judgment over control such that it is exposed, or has rights, to variable returns and can influence the returns attached to the arrangements.

 

37.2. Impairment of non- current assets
 

The Group tests annually whether its non- current assets have suffered impairment, in accordance with its accounting policy. The recoverable amount of cash-generating units has been determined based on value in use calculations. We use market related information and estimates (generally risk adjusted discounted cash flows) to determine value in use. Cash flow projections take into account past experience and represent management’s best estimate about future developments. Key assumptions on which management has based its determination of fair value less costs to sell and value in use includes estimated volume growth, long-term growth rates, weighted average cost of capital and tax rates. These estimates, includes the methodology used, can have a material impact on the respective values and ultimately the amount of any impairment, if any. The Group also compared the value in use determined above to the stock price on the balance sheet date plus a control premium for broadcasting sector based on 5 years historical period to validate the amount of impairment recorded in the consolidated financial statements.

 

37.3. Intangible assets
 

The Group is required to identify and assess the useful life of intangible assets and determine their income generating life. Judgment is required in determining this and then providing an amortization rate to match this life as well as considering the recoverability or conversion of advances made in respect of securing film content or the services of talent associated with film production.

 

Accounting for the film content requires Management’s judgment as it relates to total revenues to be received and costs to be incurred throughout the life of each film or its license period, whichever is the shorter. These judgments are used to determine the amortization of capitalized film content costs. The Group uses a stepped method of amortization on first release film content writing off more in year one which recognizes initial income flows and then the balance over a period of up to nine years. In the case of film content that is acquired by the Group after its initial exploitation, commonly referred to as Library, amortization is spread evenly over the lesser of 10 years or the license period. Management’s policy is based upon factors such as historical performance of similar films, the star power of the lead actors and actresses and others. Management regularly reviews, and revises when necessary, its estimates, which may result in a change in the rate of amortization and/or a write down of the asset to the recoverable amount.

 

The Group tests annually whether intangible assets have suffered any impairment, in accordance with the accounting policy. These calculations require judgments and estimates to be made, and, in the event of an unforeseen event these judgments and assumptions would need to be revised and the value of the intangible assets could be affected. There may be instances where the useful life of an asset is shortened to reflect the uncertainty of its estimated income generating life. This is particularly the case when acquiring assets in markets that the Group has not previously exploited.

 

37.4. Credit impairment losses

 

 

In case of catalogue and producer/ VFX services , the Group provides contractual deferred payment terms up to a year to the partners. Further, in several instances the catalogue customers fall behind contractual payment terms. The Group estimates credit impairment losses based on historical experience of collection from catalogue customers multiplied by the incremental borrowing rate applicable to the group of similar class of customer by geography. Incremental borrowing rate has been calculated considering applicable class of corporate bond in the United States specific to such customers and further adjusted the same for the relevant Country Risk Premium as such amount is invested in US dollar in those countries.

 

37.5. Investment in equity shares (Financial Assets) at FVOCI
 

The Group follows the guidance of IFRS 9 – Financial Instruments: to determine the fair value of its investment in equity instruments, which have been measured using net assets value method based on financial information of the investee company. The aforesaid financial information is available with the lag of 2 years. Further a discount for lack of liquidity of 30% is applied which reflects ease of investors ability to liquidate.

 

37.6. Income taxes and deferred taxation
 

The Group is subject to income taxes in various jurisdictions. Judgment is required in determining the worldwide provision for income taxes. We are subject to tax assessment in certain jurisdictions. Significant judgment is involved in determining the provision for income taxes including judgment on whether the tax positions are probable of being sustained in tax assessments.

 

Judgment is also required when determining whether the Group should recognize a deferred tax asset, based on whether the Management considers there is sufficient certainty in future earnings to justify the carry forward of assets created by tax losses and tax credits. Judgment is also required when determining whether the Group should recognize a deferred tax liability on undistributed earnings of subsidiaries. Where the ultimate outcome is different than that which was initially recorded there will be an impact on the income tax and deferred tax provisions.

 

37.7. Share-based payments
 

The Group is required to evaluate the terms to determine whether share-based payment is equity settled or cash settled. Judgment is required to do this evaluation. Further, the Group is required to measure the fair value of equity settled transactions with employees at the grant date of the equity instruments. The fair value is determined principally by using the Black Scholes model and/or Monte Carlo Simulation Models which require assumptions regarding risk free interest rates, share price volatility, the expected term and other variables. The basis and assumptions used in these calculations are disclosed within Note 27. The aforementioned inputs entered in to the option valuation model that we use to determine the fair value of our share awards are subjective estimates and changes to these estimates will cause the fair value of our share-based awards and related share- based compensations expense we record to vary.

 

37.8. Business combinations and deconsolidation

 

Business combinations are accounted for using the acquisition method under the provisions of IFRS 3 (Revised), “Business Combinations”.

 

The cost of an acquisition is measured at the fair value of the assets transferred, equity instruments issued and liabilities incurred at the date of acquisition. The cost of the acquisition also includes the fair value of any contingent consideration. Identifiable tangible and intangible assets acquired and liabilities and contingent liabilities assumed in a business combination are measured initially at their fair value on the date of acquisition. Significant estimates are required to be made in determining the value of contingent consideration and intangible assets.

 

During fiscal 2018, the Group divested its 51 percent equity interest in Ayngaran Group to the non-controlling investee. The Group recorded the financial asset retained in the former subsidiary on deconsolidation at its fair value and recorded a loss of $500. The discounting of the financial asset was determined using associated credit risk for similar instrument.

 

37.9 . Financial liabilities at fair value through profit and loss

 

The Group has classified the convertible note as a financial liability at fair value through profit or loss and used the valuation models i.e. Black and Scholes and Monte-Carlo simulations to obtain the fair value of share warrant and convertible notes. Key assumptions on which external valuation experts has based their determination of fair value includes risk free rate, weighted average cost of capital, future volatility, proportion of debt to be converted into equity shares. These estimates, includes the methodology used, can have a material impact on the respective values and ultimately the amount of financial liability.

 

37.10 . Leases

 

IFRS 16 requires Company to make certain judgements and estimations, and those that are significant are disclosed below:

  · establishing whether or not it is reasonably certain that an extension option/termination option will be exercised - In determining the lease term, management considers all facts and circumstances that create an economic incentive to exercise an extension option,or not exercise a termination option. Extension options (or periods after termination options) are only included in the lease term if the lease is reasonably certain to be extended (or not terminated). The following factors are normally the most relevant
  o If there are significant penalties to terminate (or not extend), the Company is typically reasonably certain to extend (or not terminate).
  o If any leasehold improvements are expected to have a significant remaining value, the Company is typically reasonably certain to extend (or not terminate).
  o Otherwise, the Company considers other factors including historical lease durations and the costs and business disruption required to replace the leased asset.
  · calculating the appropriate discount rate – Incremental borrowing rate is considered for discounting the future lease payments, in cases where a rate is not implicit in the lease. For such assessment, the Company considers the market risk free interest rates, currency and credit risk premium.

 

v3.20.2
New Standards Adopted as at April 1, 2019
12 Months Ended
Mar. 31, 2020
New Standards Adopted As At April 1 2019  
New Standards Adopted as at April 1, 2019
38 NEW STANDARDS ADOPTED AS AT APRIL 1, 2019

 

On April 1, 2019, the Group adopted New accounting standard IFRS 16, "Leases". which specifies how to recognize, measure, present and disclose leases. The standard provides a single accounting model, requiring the recognition of assets and liabilities for all major leases previously classified as “operating leases”.

 

The Group applied the “Modified Retrospective Approach” on the date of initial application (April 1, 2019) and has decided to use the approach that allows the right-of-use asset to be recognized at an amount equal to the liability as at the date of initial application and hence, no adjustments to retained earnings were required. Accordingly, comparatives for the year ended March 31, 2019 have not been retrospectively adjusted.

 

As such the Company recognizes a lease liability and a corresponding right of use asset, at the lease commencement date. The right-of-use asset is initially measured at cost, based on the initial amount of the lease liability and adjusted for prepaid expense or accrued liability outstanding at the end of previous year. The assets are depreciated to the earlier of the end of the useful life of the right-of-use asset or the lease term using the straight-line method as this most closely reflects the expected pattern of consumption of the future economic benefits. The lease term includes periods covered by an option to extend if the Company is reasonably certain to exercise that option. In addition, the right-of-use asset is periodically adjusted for certain re-measurements of the lease liability. There is no impact on transition in opening balance of retained earnings as at April 1, 2019 because of the transition method applied.

 

Right of Use Assets

  

Gross Carrying Value  Premises   Equipment   Total 
On adoption of IFRS 16*  $2,531    307    2,838 
Additions   398    71    469 
Termination/retirements            
Balance as at March 31, 2020  $2,929    378    3,307 
Accumulated depreciation               
Balance as at April 1, 2019       62    62 
Depreciation   1,557    120    1,677 
Disposals/retirements            
Net Translation adjustments   36    20    56 
Balance as at March 31, 2020   1,593    202    1,795 
                
Net Carrying value as at March 31, 2020  $1,336    176    1,512 

 

Premises are under operating lease arrangement and Equipment are acquired under finance lease arrangement.

 

Lease Liabilities

 

Particulars Total
On adoption of IFRS 16* $ 2,618
Additions   469
Finance Expense   184
Payment of lease liabilities $ (1,579)
Premature Retirements  
Translation adjustments   (139)
Balance as at March 31, 2020 $ 1,553

 

*The difference in the number accounted on adoption of IFRS 16 is due to Prepaid expenses outstanding last year reduced from Other Receivables amounting to $ 164.

The Weighted average incremental borrowing rate applied to lease liabilities as at April 1, 2019 is 12% for India location and 7.45% for UAE location.

 

Future minimum lease payments

 

Future minimum lease payments due as of March 31, 2020 is as below:

 

   Lease payments   Interest   Net Present Value 
Within than one year  $822   $99   $723 
1 - 3 years   894    64    830 
3 - 5 years            
   $1,716   $163    1,553 

  

Future minimum lease payments due as of March 31, 2019 is as below:

 

   Lease payments   Interest   Net Present Value 
Within than one year  $1,480   $161   $1,319 
1 - 3 years   1,360    154    1,206 
3 - 5 years   116    23    93 
   $2,956   $338   $2,618 
v3.20.2
Standards Not Yet Adopted
12 Months Ended
Mar. 31, 2020
Standards Not Yet Adopted Abstract  
Standards Not Yet Adopted
39 STANDARDS NOT YET ADOPTED

 

Standards, amendments and Interpretations to existing Standards that are not yet effective and have not been adopted early by the Group

 

At the date of authorization of these financial statements, several new, but not yet effective, accounting standards, amendments to existing standards, and interpretations have been published by the IASB. None of these standards, amendments or interpretations have been adopted early by the Group.

 

Management anticipates that all relevant pronouncements will be adopted for the first period beginning on or after the effective date of the pronouncement. New Standards, amendments and Interpretations neither adopted nor listed below have not been disclosed as they are not expected to have a material impact on the Group’s financial statements.

Those which are considered to be relevant to the Company’s operations are set out below.

 

i. In October 2018, the IASB issued amendments to IFRS 3 “Business Combinations” regarding the definition of a “Business.” The amendments:

 

    clarify that to be considered a business, an acquired set of activities and assets must include, at a minimum, an input and a substantive process that together significantly contribute to the ability to create outputs;

 

    narrow the definitions of a business and of outputs by focusing on goods and services provided to customers and by removing the reference to an ability to reduce costs;

 

    add guidance and illustrative examples to help entities assess whether a substantive process has been acquired;

 

    remove the assessment of whether market participants are capable of replacing any missing inputs or processes and continuing to produce outputs; and

 

    add an optional concentration test that permits a simplified assessment of whether an acquired set of activities and assets is not a business.

The above amendments are effective for business combinations for which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after January 1, 2020.

The Company is currently evaluating the impact of these amendments on its consolidated financial statements.

 

ii. In October 2018, the IASB issued amendments to IAS 1 “Presentation of Financial Statements” (“IAS 1”) and IAS 8 “Accounting Policies, Changes in Accounting Estimates and Errors ” (“IAS 8”) which revised the definition of “Material.” Three aspects of the new definition should especially be noted, as described below:

 

    Obscuring. The existing definition only focused on omitting or misstating information, however, the Board concluded that obscuring material information with information that can be omitted can have a similar effect. Although the term obscuring is new in the definition, it was already part of IAS 1 (IAS 1.30A);

 

    Could reasonably be expected to influence. The existing definition referred to “could influence” which the Board felt might be understood as requiring too much information as almost anything “could influence” the decisions of some users even if the possibility is remote;

 

    Primary users. The existing definition referred only to ‘users’ which again the Board feared might be understood too broadly as requiring them to consider all possible users of financial statements when deciding what information to disclose.

The amendments highlight five ways in which material information can be obscured:

 

    if the language regarding a material item, transaction or other event is vague or unclear;

 

    if information regarding a material item, transaction or other event is scattered in different places in the financial statements;

 

    if dissimilar items, transactions or other events are inappropriately aggregated;

 

    if similar items, transactions or other events are inappropriately disaggregated; and

 

    if material information is hidden by immaterial information to the extent that it becomes unclear what information is material.

The new definition of material and the accompanying explanatory paragraphs are contained in IAS 1. The definition of material in IAS 8 has been replaced with a reference to IAS 1. The amendments are effective for annual reporting periods beginning on or after January 1, 2020. Earlier application is permitted.

The amendments are effective for annual reporting periods beginning on or after January 1, 2020. Earlier application is permitted.

The Company is currently evaluating the impact of these amendments on its consolidated financial statements.

 

iii.   On May 14, 2020, the IASB issued amendment to IAS 37 by specifying that the ‘cost of fulfilling’ a contract comprises the ‘costs that relate directly to the contract’. Costs that relate directly to a contract consist of both the incremental costs of fulfilling that contract (examples would be direct labour or materials) and an allocation of other costs that relate directly to fulfilling contracts (an example would be the allocation of the depreciation charge for an item of property, plant and equipment used in fulfilling the contract).

 

The Company is currently evaluating the impact of these amendments on its consolidated financial statements.

 

The amendments are effective for annual periods beginning on or after 1 January 2022. Early application is permitted

 

iv.   In January 23, 2020, the IASB issued amendments to IAS 1 “Presentation of Financial Statements” (“IAS 1”) to clarify the classification criteria of liabilities in the statement of financial position. The most significant changes are listed below:

 

  · Classification of liabilities as current or non-current should be based on rights to defer settlement that are in existence at the end of the reporting period

 

  · Classification of a liability is unaffected by the likelihood that the entity will exercise its right to defer settlement of the liability for at least twelve months after the reporting period’. That is, management’s intention to settle in the short run does not impact the classification.

 

  · ‘Settlement’ is defined as the extinguishment of a liability with cash, other economic resources or an entity’s own equity instruments.

 

  · Clarifies that if the right to defer settlement is conditional on the compliance with covenants the right exists if the conditions are met at the end of the reporting period,

 

  · Clarifies that if a liability has terms that could, at the option of the counterparty, result in its settlement by the transfer of the entity’s own equity instruments, these terms do not affect its classification as current or non-current if the entity recognises the option separately as an equity instrument applying IAS 32 Financial Instruments: Presentation.

 

The amendments are effective for annual reporting periods beginning on or after January 1, 2022. Earlier application is permitted.

 

The Company is currently evaluating the impact of these amendments on its consolidated financial statements.

 

v3.20.2
Subsequent Events
12 Months Ended
Mar. 31, 2020
Subsequent Events  
Subsequent Events
40 SUBSEQUENT EVENTS

 

MERGER

 

On April 17, 2020, Eros International Plc (“Eros”) entered into the Merger Agreement with STX Filmworks, Inc., a Delaware corporation (“STX”). Pursuant to closing of the merger, STX will merge with a newly formed subsidiary of Eros and will survive as a wholly owned subsidiary of Eros. As merger consideration, Eros will issue to the former stockholders of STX a number of A ordinary shares equal in the aggregate to the total number of Eros ordinary shares outstanding on a fully diluted basis as of immediately prior to the effective time of the merger.

 

 

STX Entertainment is a fully integrated global media company specializing in the production, marketing, and distribution of talent-driven motion picture, television and multimedia content. It is the first major entertainment and media company to be launched at this scale in Hollywood in more than twenty years.

 

The group expects that the combined company will be uniquely positioned to benefit from the accelerating consumption of premium digital content in the world’s most important growth markets with robust capital structure and experienced management team. The combined company is also expected to generate an operating synergies within 24 months of closing of the merger transaction, stemming from integration and scale benefits, optimization of global content distribution and enhanced monetization of the Eros Now platform. In connection with the merger, $125,000 of incremental equity will also be contributed to the combined company by new equity investors and existing STX equity investors.

 

The Merger Agreement was approved unanimously by the Boards of Directors of both companies and the closing of the merger is subject to regulatory approvals and other customary closing conditions.

 

The Company is in the process of evaluating accounting implication in respect of the aforesaid merger transaction.

 

v3.20.2
Summary of Significant Accounting Policies (Policies)
12 Months Ended
Mar. 31, 2020
Summary Of Significant Accounting Policies  
Basis of Consolidation

 

3.2. Basis of consolidation

 

The financial statements of the Group consolidates results of the Company and entities controlled by the Company and its subsidiary undertakings. Control exists when the Company, directly or indirectly, has existing rights that give the Company the current ability to direct the activities which affect the entity’s returns; the Company is exposed to or has rights to a return which may vary depending on the entity’s performance; and the Company has the ability to use its powers to affect its own returns from its involvement with the entity.

 

Unrealized gains on transactions within the Group are eliminated. Unrealized losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred. Amounts reported in the financial statements of subsidiaries have been adjusted where necessary to ensure consistency with the accounting policies adopted by the Group.

 

Business combinations are accounted for under the acquisition method. The purchase method involves the recognition at fair value of all identifiable assets and liabilities, including contingent liabilities of the subsidiary, at the acquisition date, regardless of whether or not they were recorded in the financial statements of the subsidiary prior to acquisition. On initial recognition, the assets and liabilities of the subsidiary are included in the consolidated statement of financial position at their fair values. Transaction costs that the company incurs in connection with a business combination such as finder’s fees, legal fees, due diligence fees, and other professional and consulting fees are expensed as incurred. Goodwill is stated after separating out identifiable intangible assets. Goodwill represents the excess of acquisition cost over the fair value of the Group’s share of the identifiable net assets of the acquired subsidiary at the date of acquisition. Gain on bargain purchase is recognized immediately after acquisition in the consolidated statement of income.

 

Changes in controlling interest in a subsidiary that do not result in gaining or losing control are not business combinations as defined by IFRS 3. The Group adopts the “equity transaction method” which regards the transaction as a realignment of the interests of the different equity holders in the Group. Under the equity transaction method an increase or decrease in the Group’s ownership interest is accounted for as follows:

  the non-controlling component of equity is adjusted to reflect the non-controlling interest revised share of the net carrying value of the subsidiaries net assets;
  the difference between the consideration received or paid and the adjustment to non-controlling interests is debited or credited to a different component of equity — merger reserves;
  no adjustment is made to the carrying amount of goodwill or the subsidiaries’ net assets as reported in the consolidated financial statements; and
  no gain or loss is reported in the consolidated statements of income.

 

Loss of control policy

 

When a change in the Group’s ownership interest in a subsidiary results in a loss of control over the subsidiary, the assets and liabilities of the subsidiary including any goodwill are derecognized and a gain or loss arising thereto is accounted within Statement of Income. Amounts previously recognized in other comprehensive income in respect of that entity are also reclassified to Statement of Income.

Segment Reporting

 

3.3. Segment reporting

 

IFRS 8 Operating Segments (“IFRS 8”) requires operating segments to be identified on the same basis as is used internally for the review of performance and allocation of resources by the Group’s chief operating decision maker, which is the Group’s CEO and MD. The revenues of films are earned over various formats; all such formats are functional activities of filmed entertainment and these activities take place on an integrated basis. The management team reviews the financial information on an integrated basis for the Group as a whole. The management team also monitors performance separately for individual films for at least 12 months after the theatrical release. Certain resources such as publicity and advertising, and the cost of a film are also reviewed globally.

 

Eros has identified four geographic areas, consisting of its main geographic areas (India, North America and Europe), together with the rest of the world.

Revenue

 

3.4. Revenue

 

Effective April 1, 2018, the Group has applied IFRS 15 ‘Revenue from Contracts with Customers’ which establishes a comprehensive framework for determining whether, how much and when revenue is to be recognized. IFRS 15 replaces IAS 18 ‘Revenue’, IAS 11 ‘Construction Contracts’ and certain revenue related interpretations and the cumulative effect of initial application is recognised as an adjustment to the opening balance of retained earnings at April 1, 2018. The comparative information for the year ended March 31, 2018 continues to be reported under IAS 18 and IAS 11. Refer note 3.4 – Summary of Significant accounting policies – Revenue recognition in the Annual report of the Group for the year ended March 31, 2019, for revenue recognition policy as per IAS 18 and IAS 11.

 

To determine whether to recognise revenue, the Group follows a 5-step process:

 

  a) Identifying the contract with a customer
  b) Identifying the performance obligations
  c) Determining the transaction price
  d) Allocating the transaction price to the performance obligations
  e) Recognising revenue when/as performance obligation(s) are satisfied

 

Revenue is recognized upon transfer of control of promised products or services to customers in an amount that reflects the consideration which the Group expects to receive in exchange for those products or services. To ensure collectability of such consideration and financial stability of the counterparty, the Group performs certain standard Know Your Client (KYC) procedures based on their geographic locations and evaluates trend of past collection from such locations.

 

Revenue is measured based on the transaction price, which is the consideration, adjusted for any discounts and incentives, if any, as specified in the contract with the customer. Revenue also excludes taxes collected from customers. In case of revenues which are subject to change, the Group estimates the amount to be received using the “most likely amount” approach, or the “expected value” approach, as appropriate. This amount is then included in the Group’s estimate of the transaction price only if it is highly probable that a significant reversal of revenue will not occur once any uncertainty surrounding the bonus is resolved. In making this assessment the Group considers its historical performance on similar contracts.

 

The Group recognises contract liabilities for consideration received in respect of unsatisfied performance obligations and reports these amounts as other liabilities in the statement of financial position (see Note 24). Similarly, if the Group satisfies a performance obligation before it receives the consideration, the Group recognises either a contract asset or a receivable in its statement of financial position, depending on whether something other than the passage of time is required before the consideration is due

 

The following criteria apply in respect of various revenue streams within filmed entertainment:

 

  In arrangements for theatrical distribution, contracted minimum guarantees are recognized on the theatrical release date. The Group’s share of box office receipts in excess of the minimum guarantee is recognized at the point as the box office receipts gets accrued.
  In arrangements for television syndication, license fees received in advance which do not meet all the above criteria, including commencement of the availability for broadcast under the terms of the related licensing agreement, are included in contract liability until the criteria for recognition is met.  Further in arrangements where the license fees received in advance is for a period of 12 months or more from the commencement, the company computes significant discounting component at imputed rate of interest on advances received and recognizes within net finance cost in the statement of income. . Accumulated contract liability (deferred revenue) is recognized upon commencement of availability for broadcast.
  In arrangements for catalogue sales, the Group recognizes revenue if revenue recognition criteria’s such as a valid sales contract exists, all content is delivered and the customer start generating economic benefits from them, the Group is reasonably certain on collectability, and the Group’s contractual obligations are complete and are met. Considering the arrangement with catalogue customers provide for a contractual deferred payment terms up to a year and in many cases the payments often fall behind contractual terms, revenues from catalogue sales are recognized net of financing component calculated at imputed market rate of interest on the gross receivables. The re-measurement of such financing period at each balance sheet date and related gains or losses is recognized within administrative costs in the Statement of Income. Unwinding of the such discount is recognized using effective interest rate within net finance cost in the Statement of Income.
  Digital and ancillary media revenues are recognized at the earlier of when the content is accessed or declared. Fees received for access to the specified and unspecified future content through digital and ancillary media, including usage of over-the-top platform developed by the Group, is recognized on straight line basis over the period of the service contract. Billing in excess of the revenue recognized is shown as contract liability
  DVD, CD and video distribution revenue is recognized on the date the product is delivered or if licensed in line with the above criteria. Visual effects, production and other fees for services rendered by the Group and overhead recharges are recognized in the period in which they are earned and in certain cases, the stage of production is used to determine the proportion recognized in the period.
  In arrangement for production services, including visual special effects (VFX), and other technical services to clients, the Group recognizes revenue if revenue recognition criteria’s such as a valid sales contract exists, IP is delivered and the Group is reasonably certain on collectability. Revenue is recognized as the services are delivered based on acceptance of the services performed by the customer.

  

Goodwill

  

3.5. Goodwill

 

Goodwill represents the excess of the consideration transferred in a business combination over the fair value of the Group’s share of the identifiable net assets acquired. Goodwill is carried at cost less accumulated impairment losses. Gain on bargain purchase is recognized immediately after acquisition in the consolidated statement of income.

Intangible Assets

 

3.6. Intangible assets

 

Identifiable intangible assets are recognised when the Group controls the asset, it is probable that future economic benefits attributed to the asset will flow to the Group and the cost of the asset can be reliably measured. Intangible assets acquired by the Group are stated at cost less accumulated amortization less impairment loss, if any, except those acquired as part of a business combination, which are shown at fair value at the date of acquisition less accumulated amortization less impairment loss, if any (Film production cost and content advances are transferred to film and content rights at the point at which content is first exploited). “Eros” (the “Trade name”) is considered to have an indefinite life because of the institutional nature of the corporate brand name, its proven ability to maintain market leadership and the Group’s commitment to develop, enhance and retain its value. The carrying value is reviewed at least annually for impairment and adjusted to recoverable amount if required.

 

Content

 

Investments in films and associated rights, including acquired rights and distribution advances in respect of completed films, are stated at cost less amortization less provision for impairment. Costs include production costs, overhead and capitalized interest costs net of any amounts received from third party investors. A charge is made to write down the cost of completed rights over the estimated useful lives, writing off more in year one which recognizes initial income flows and then the balance over a period of up to nine years, except where the asset is not yet available for exploitation. The average life of the assets is the lesser of 10 years or the remaining life of the content rights. The amortization charge is recognized in the consolidated statement of income within cost of sales. The determination of useful life is based upon management’s judgment and includes assumptions on the timing and future estimated revenues to be generated by these assets, which are summarized in Note 37.3.

 

Others

 

Other intangible assets, which comprise internally generated and acquired software used within the Group’s digital, home entertainment and internal accounting activities, are stated at cost less amortization less provision for impairment. A charge is made to write down the cost of completed rights over the estimated useful lives except where the asset is not yet available for exploitation. The average life of below intangible assets ranges from 3-6 years. The amortization charge is recognized in the consolidated statements of income within administrative expenses as stated below:

 

    Life of
asset
    Rate of
amortization
% straight line
per annum
 
Information technology assets     3 years       33  
Other intangibles     3 - 6 years       17 – 33  

 

Subsequent expenditure

 

Expenditure on capitalized intangible assets subsequent to the original expenditure is included only when it increases the future economic benefits embodied in the specific asset to which it relates.

 

Information technology assets

 

An internally generated intangible asset arising from the Group’s software development activities that is expected to be completed is recognized only if all the following criteria are met:

  an asset is created that can be identified (such as software and new processes);
  it is probable that the asset created will generate future economic benefits; and
  the development cost can be measured reliably.

 

When these criteria are met and there are appropriate resources to complete development, the expenditure is capitalized at cost. Where these criteria are not met development expenditure is recognized as an expense in the period in which it is incurred. Internally generated intangible assets are amortized over their useful economic life from the date that they start generating future economic benefits.

Impairment Testing of Goodwill, Other Intangible Assets and Property and Equipment

 

3.7. Impairment testing of goodwill, other intangible assets and property and Equipment

 

For the purposes of assessing impairment, assets are grouped at the lowest levels for which there are separately identifiable cash flows (cash-generating units). As a result, some assets are tested individually for impairment and some are tested at the cash-generating unit level. Goodwill is allocated to those cash-generating units that are expected to benefit from synergies of the related business combination and represent the lowest level within the Group at which Management monitors the related cash flows.

 

Goodwill and Trade names are tested for impairment at least annually. All other individual assets or cash-generating units are tested for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Management believes that due to change in the key assumptions with respect to volume growth and discount rate has resulted in impairment of Goodwill and Trade name.

 

An impairment loss is recognized for the amount by which the asset’s or cash-generating unit’s carrying amount exceeds its recoverable amount. The recoverable amount is the higher of fair value, reflecting market conditions less costs to sell, and value in use based on an internal discounted cash flow evaluation. Impairment losses recognized for cash-generating units, to which goodwill has been allocated, are credited initially to the carrying amount of goodwill. Any remaining impairment loss is charged pro rata to the other assets in the cash generating unit.

 

Film and content rights are stated at the lower of unamortized cost and estimated recoverable amounts. In accordance with IAS 36 Impairment of Assets, film content costs are assessed for indication of impairment on a library basis as the nature of the Group’s business, the contracts it has in place and the markets it operates in do not yet make an ongoing individual film evaluation feasible with reasonable certainty. Impairment losses on content advances are recognized when film production does not seem viable and refund of the advance is not probable.

 

With the exception of goodwill, all assets are subsequently reassessed for indications that an impairment loss previously recognized may no longer exist.

Property and Equipment

 

3.8. Property and equipment

 

Property and equipment are stated at historical cost less accumulated depreciation and impairment. Land and freehold buildings are shown at what Management believes to be their fair value, based on, among other things, periodic but at least triennial valuations by an external independent valuer, less subsequent depreciation for freehold buildings.

 

Any accumulated depreciation at the date of revaluation is eliminated against the gross carrying amount of the asset and the net amount is restated to the revalued amount. Increases in the carrying amount arising on revaluation of freehold land and buildings are credited to other reserves in shareholders’ equity through other comprehensive income. Decreases that offset previous increases are charged against other reserves.

 

Depreciation is provided to write-off the cost of all property and equipment to their residual value as stated below:

 

      Life of
Asset
    Rate of
depreciation
% WDV
per annum
Freehold building     60 years     2-10
Furniture and fittings and equipment     5 years     15-20
Vehicles and machinery     3-5 years     20-30

 

Material residual value estimates are updated as required, but at least annually, whether or not the asset is revalued.

 

Advance paid towards the acquisition or improvement of property and equipment not ready for use before the reporting date are disclosed as capital work-in-progress.

Inventories

 

3.9. Inventories

 

Inventories primarily comprise of music CDs and DVDs, and are valued at the lower of cost and net realizable value. Cost in respect of goods for resale is defined as purchase price, including appropriate labor costs and other overhead costs. Costs in respect of raw materials is purchase price.

 

Purchase price is assigned using a weighted average basis. Net realizable value is defined as anticipated selling price or anticipated revenue less cost to completion.

Cash and Cash Equivalents

 

3.10. Cash and cash equivalents

 

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term highly liquid investments which are readily convertible into known amounts of cash and are subject to insignificant risk of changes in value. Bank overdrafts are shown within “Borrowings” in “Current liabilities” on the statement of financial position.

Restricted Deposits held with Banks

 

3.11. Restricted deposits held with banks

 

Deposits held with banks as security for overdraft facilities are included in restricted deposits held with bank.

Financial Instruments

 

3.12. Financial instruments

 

A financial instrument is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity.

 

  i. Recognition, initial measurement and derecognition

 

Financial assets and liabilities are recognised when the Group becomes a party to the contractual provisions of the instrument. Financial assets and liabilities are initially measured at fair value. Transaction costs that are directly attributable to the acquisition or issue of financial assets and financial liabilities (other than financial assets and financial liabilities at fair value through profit or loss) are added to or deducted from the fair value measured on initial recognition of financial assets or financial liability.

 

The transaction costs directly attributable to the acquisition of financial assets and financial liabilities at fair value through profit and loss are immediately recognised in the Consolidated Statement of Income.

 

A financial asset is primarily derecognised (i.e. removed from the Group’s statement of financial position) when:

 

  a) The rights to receive cash flows from the asset have expired, or

 

  b) The Group has transferred its rights to receive cash flows under an eligible transaction.

 

A financial liability is derecognised when the obligation under the liability is discharged or cancelled or expires.

 

  ii. Classification

 

For the purpose of subsequent measurement, financial assets are classified into the following categories upon initial recognition:

 

  Debt instruments at amortised cost
  Debt instruments at fair value through other comprehensive income (FVTOCI)
  Debt instruments, derivatives and equity instruments at fair value through profit or loss (FVTPL)
  Equity instruments measured at fair value through other comprehensive income (FVTOCI)
  Equity instruments measured at fair value profit or loss (FVTPL)

 

The classification depends on the entity’s business model for managing the financial assets and the contractual terms of the cash flows.

 

Debt instruments at amortised cost

 

A ‘debt instrument’ is measured at the amortised cost if both the following conditions are met:

 

  1. The asset is held within a business model whose objective is to hold assets for collecting contractual cash flows, and

 

  2. Contractual terms of the asset give rise on specified dates to cash flows that are solely payments of principal and interest (“SPPI”) on the principal amount outstanding.

 

After initial measurement, such financial assets are subsequently measured at amortised cost using the effective interest rate (the “EIR”) method. The effective interest rate is the rate that exactly discounts future cash receipts or payments through the expected life of the financial instrument, or where appropriate, a shorter period.

 

Amortised cost is calculated by taking into account any discount or premium on acquisition and fees or costs that are an integral part of the EIR. The EIR amortisation is included in finance income/other income in the Consolidated Statement of Income . The losses arising from impairment are recognised in the Consolidated Statement of Income .

 

Debt instruments at fair value through other comprehensive income

 

A ‘debt instrument’ is classified as at the FVTOCI if both of the following criteria are met:

 

  1. The objective of the business model is achieved both by collecting contractual cash flows and selling the financial assets, and

 

  2. The asset’s contractual cash flows represent SPPI.

 

Debt instruments at fair value through profit or loss

 

FVTPL is a residual category for debt instruments. Any debt instrument, which does not meet the criteria for categorization as at amortized cost or as FVTOCI, is classified as at FVTPL.

 

Equity instruments

 

All equity investments in scope of IFRS 9 are measured at fair value. Equity instruments which are held for trading are classified as at FVTPL with all changes recognised in the Consolidated Statement of Income

 

For all other equity instruments, the Group may make an irrevocable election to present in OCI, the subsequent changes in the fair value. The Group makes such election on an instrument-by-instrument basis. If the Group decides to classify an equity instrument as at FVTOCI, then all fair value changes on the instrument, excluding dividends and impairment loss, are recognised in OCI. There is no recycling of the amounts from the OCI to the Consolidated Statement of Income , even on sale of the investment. However, the Group may transfer the cumulative gain or loss within categories of equity.

 

  iii. Impairment of financial assets

 

In accordance with IFRS 9, the Group applies the expected credit loss (“ECL”) model for measurement and recognition of impairment loss on financial assets and credit risk exposures.

 

ECL is the difference between all contractual cash flows that are due to the Group in accordance with the contract and all the cash flows that the entity expects to receive (i.e., all cash shortfalls), discounted at the EIR of the instrument. Lifetime ECL are the expected credit losses resulting from all possible default events over the expected life of a financial instrument. The 12-month ECL is a portion of the lifetime ECL which results from default events that are possible within 12 months after the reporting date.

 

The Group follows ‘simplified approach’ for recognition of impairment loss allowance on trade receivables, which do not have a significant financing component as per IFRS 15. Simplified approach does not require the Group to track changes in credit risk. Rather, it recognises impairment loss allowance based on lifetime ECL at each reporting date, right from its initial recognition.

 

For recognition of impairment loss on other financial assets and risk exposure, the Group determines that whether there has been a significant increase in the credit risk since initial recognition. If credit risk has not increased significantly, 12-month ECL is used to provide for impairment loss. However, if credit risk has increased significantly, lifetime ECL is used. If, in a subsequent period, credit quality of the instrument improves such that there is no longer a significant increase in credit risk since initial recognition, then the entity reverts to recognising impairment loss allowance based on 12-month ECL.

 

ECL impairment loss allowance (or reversal) recognised during the period is recognised as income/ expense in the Consolidated Statement of Income

 

  iv. Classification and subsequent measurement of financial liabilities

 

All financial liabilities are recognised initially at fair value, adjusted by directly attributable transaction costs.

 

The measurement of financial liabilities depends on their classification, as described below:

 

  Financial liabilities at fair value through profit or loss

 

Financial liabilities at fair value through profit or loss include financial liabilities held for trading and financial liabilities designated upon initial recognition as at fair value through profit or loss. Financial liabilities are classified as held for trading if they are incurred for the purpose of repurchasing in the near term. The Group does not have any financial liabilities classified at fair value through profit or loss.

 

  Financial liabilities measured at amortised cost

 

After initial recognition, interest-bearing loans and borrowings are subsequently measured at amortised cost using the EIR method. Gains and losses are recognised in the Consolidated Statement of Income when the liabilities are derecognised.

 

Amortised cost is calculated by taking into account any discount or premium on acquisition and fees or costs that are an integral part of the EIR. The EIR amortisation is included as finance costs in the Consolidated Statement of Income

Derivative Financial Instruments

 

3.13. Derivative financial instruments
 

The Group uses derivative financial instruments (“derivatives”) to reduce its exposure to interest rate movements.

 

Derivatives are initially recognized at fair value at the date the derivative contracts are entered into and are subsequently re-measured to their fair value at the end of each reporting period. The resulting gain or loss is recognized in consolidated statements of income immediately.

Provisions

 

3.14. Provisions

 

Provisions are recognized when the Group has a present legal or constructive obligation as a result of a past event, it is more likely than not that an outflow of resources will be required to settle the obligations and can be reliably measured. Provisions are measured at management’s best estimate of the expenditure required to settle the obligations at the statement of financial position date and are discounted to present value where the effect is material.

Leases

 

3.15. Leases
 

 

Measurement and recognition of leases

 

The Company considers whether contract is,or contains a lease. A lease is defined as ‘a contract, or part of a contract, that conveys the right to use an asset (the underlying asset) for a period of time in exchange for consideration’.

 

To apply this definition the Company assesses whether the contract meets three key evaluations which are whether:

  a) the contract contains an identified asset, which is either explicitly identified in the contract or implicitly specified by being identified at the time the asset is made available to the Company
  b) the Company has the right to obtain substantially all of the economic benefits from use of the identified asset throughout the period of use, considering its rights within the defined scope of the contract.

  c) the Company has the right to direct the use of the identified asset throughout the period of use. The Company assess whether it has the right to direct ‘how and for what purpose’ the asset is used throughout the period of use.

 

Company as a lessee

 

At lease commencement date, the Company recognises a right-of-use asset and a lease liability on the balance sheet. The right-of-use asset is measured at cost, which is made up of the initial measurement of the lease liability, any initial direct costs incurred by the Company and any lease payments made in advance of the lease commencement date.

 

The Company depreciates the right-of-use assets on a straight-line basis from the lease commencement date to the earlier of the end of the useful life of the right-of-use asset or the end of the lease term period. The Company also assesses the right-of-use asset for impairment when such indicators exist.

 

At the commencement date, the Company measures the lease liability at the present value of the lease payments unpaid at that date, discounted using the interest rate implicit in the lease if that rate is readily available or the Company’s incremental borrowing rate.

 

Lease payments included in the measurement of the lease liability are made up of fixed payments (including in substance fixed), and payments arising from options reasonably certain to be exercised. Subsequent to initial measurement, the liability will be reduced for payments made and increased for interest expenses. It is remeasured to reflect any reassessment or modification.

 

The Company has elected to account for short-term leases and leases of low-value assets using the exemption given under IFRS 16. Instead of recognising a right-of-use asset and lease liability, the payments in relation to these are recognised as an expense in profit or loss on a straight-line basis over the lease term or on another systematic basis if that basis is more representative of the pattern of the Company’s benefit.

 

Company as a lessor

Lease income from operating leases where the company is lessor is recognised in income on straight line basis over the lease term.

Taxation

 

3.16. Taxation

 

Taxation on profit and loss comprises current income tax and deferred income tax. Tax is recognized in the consolidated statement of income except to the extent that it relates to items recognized directly in equity or other comprehensive income in which case it is recognized in equity or other comprehensive income.

 

Current income tax is provided at amounts expected to be paid (or recovered) using the tax rates and laws that have been enacted at the reporting date along with any adjustment relating to tax payable in previous years.

 

Deferred income tax is provided in full, using the liability method, on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the consolidated financial statements. Deferred income tax is provided at amounts expected to be paid (or recovered) using the tax rates and laws that have been enacted or substantively enacted at the statement of financial position date and are expected to apply when the related deferred income tax asset is realized or the deferred income tax liability is settled in the appropriate territory.

 

Deferred income tax in respect of undistributed earnings of subsidiaries is recognized except where the Group is able to control the timing of the reversal of the temporary difference and that the temporary difference will not reverse in the foreseeable future. Deferred income tax assets are recognized to the extent that it is probable that future taxable profit will be available against which temporary differences can be utilized.

 

Deferred income tax assets and deferred income tax liabilities are offset if, and only if the Group has a legally enforceable right to set off current tax assets against current tax liabilities and the deferred tax assets and the deferred tax liabilities relate to income taxes levied by the same taxation authority on either the same taxable entity or different taxable entities which intend either to settle current tax liabilities and assets on a net basis, or to realize the assets and settle the liabilities simultaneously, in each future period in which significant amounts of deferred tax liabilities or assets are expected to be settled or recovered.

Employee Benefits

 

3.17. Employee benefits
 

The Group operates defined contribution pension plans and healthcare and insurance plans on behalf of its employees. The amounts due are all expensed as they fall due.

 

In accordance with IFRS 2 “Share Based Payments”, the fair value of shares or options granted is recognized as personnel costs with a corresponding increase in equity. The fair value is measured at the grant date and spread over the period during which the recipient becomes unconditionally entitled to payment unless forfeited or surrendered.

 

The fair value of share options granted is measured using the Black Scholes model or a Monte-Carlo simulation model, each taking into account the terms and conditions upon which the grants are made. At each statement of financial position date, the Group revises its estimate of the number of equity instruments expected to vest as a result of non-market-based vesting conditions. The amount recognized as an expense is adjusted to reflect the revised estimate of the number of equity instruments that are expected to become exercisable, with a corresponding adjustment to equity reserves. None of the Group plans feature any options for cash settlements.

 

Upon exercise of share options, the proceeds received net of any directly attributable transaction costs up to the nominal value of the shares are allocated to share capital with any excess being recorded as share premium.

Foreign Currencies

 

3.18. Foreign currencies

 

Transactions in foreign currencies are translated at the rates of exchange prevailing on the dates of the transactions. Monetary assets and liabilities in foreign currencies are translated at the prevailing rates of exchange at the reporting date. Non-monetary items that are measured at historical cost in a foreign currency are translated at the exchange rate at the date of the transaction. Non-monetary items that are measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value was determined.

 

Any exchange differences arising on the settlement of monetary items or on translating monetary items at rates different from those at which they were initially recorded are recognized in the income statement in the period in which they arise. Non-monetary items carried at fair value that are denominated in foreign currencies are translated at rates prevailing at the date when the fair value was determined. Non-monetary items that are measured in terms of historical cost in a foreign currency are not retranslated.

 

The assets and liabilities in the financial statements of foreign subsidiaries and related goodwill are translated at the prevailing rate of exchange at the statement of financial position date. Income and expenses are translated at the monthly average rate. The exchange differences arising from the retranslation of the foreign operations are recognized in other comprehensive income and taken in to the “currency translation reserve” in equity. On disposal of a foreign operation the cumulative translation differences (including, if applicable, gains and losses on related hedges) are transferred to the consolidated statement of income as part of the gain or loss on disposal.

Equity Shares

 

3.19. Equity shares

 

Equity shares are classified as equity. The Group defers costs in issuing or acquiring its own equity instruments to the extent they are incremental costs directly attributable to an equity transaction that otherwise would have been avoided.  Such costs are accounted for as a deduction from equity (net of any related income tax benefit) upon completion of the equity transaction. The costs of an equity transaction which is abandoned is recognized as an expense.

Earnings Per Share

 

3.20. Earnings per share

 

Basic earnings per share is computed using the weighted average number of ordinary shares outstanding during the period. Diluted earnings per share is computed by considering the impact of the potential issuance of ordinary shares, using the treasury stock method, on the weighted average number of shares outstanding during the period except where the results would be anti-dilutive.

Current/Non-current classification

 

3.21. Current/Non-current classification

 

The Group presents assets and liabilities in the statement of financial position based on current/non-current classification.

 

An asset is current when it is:

 

  Expected to be realised or intended to sold or consumed in the normal operating cycle (*)
  Held primarily for the purpose of trading
  Expected to be realised within twelve months after the reporting period or
  Cash or cash equivalent unless restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period

 

All other assets are classified as non-current.

 

(*) The operating cycle for the business activities of the Group is considered to be twelve months except in case of catalogue sales, which have been ascertained as two years for the purpose of current / non-current classification of assets.

 

A liability is current when:

 

  It is expected to be settled in the normal operating cycle
  It is held primarily for the purpose of trading
  It is due to be settled within twelve months after the reporting period or
  There is no unconditional right to defer the settlement of the liability for at least twelve months after the reporting period

 

The Group classifies all other liabilities as non-current. Deferred tax assets and liabilities are classified as non-current assets and liabilities.

 

v3.20.2
Going Concern (Tables)
12 Months Ended
Mar. 31, 2020
Going Concern  
Disclosure of Information for Cash-Generating Units
Assumptions   As at
March 31, 2020
    As at
March 31, 2019
 
Growth rate applied beyond approved forecast period     4%       4%  
Pre-tax discount rate     20%       21%  
Disclosure of Impairment Sensitivity
    (in millions)  
    As at March 31, 2020     As at March 31, 2019  
Increase in discount rate by 1%     52       54  
Decrease in long term growth rate applied beyond approved forecast period by 1%     67       30  
Decrease in projected volume by 1%     44       63  
v3.20.2
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Mar. 31, 2020
Summary Of Significant Accounting Policies  
Disclosure of Other Intangible Assets
    Life of
asset
    Rate of
amortization
% straight line
per annum
 
Information technology assets     3 years       33  
Other intangibles     3 - 6 years       17 – 33  
Disclosure of Property and Equipment
      Life of
Asset
    Rate of
depreciation
% WDV
per annum
Freehold building     60 years     2-10
Furniture and fittings and equipment     5 years     15-20
Vehicles and machinery     3-5 years     20-30
v3.20.2
Business Segmental Data (Tables)
12 Months Ended
Mar. 31, 2020
Business Segmental Data  
Schedule of Segment by Geographical Areas
    Year ended March 31  
    2020     2019     2018  
    (in thousands)  
Revenue by region of domicile of Group’s operation                        
India   $ 41,119     $ 100,387     $ 98,073  
Europe     26,927       63,196       27,028  
North America     1,309       1,759       1,244  
Rest of the world     86,097       104,784       134,908  
Total Revenue(*)   $ 155,452     $ 270,126     $ 261,253  

 

    Year ended March 31  
    2020     2019     2018  
    (in thousands)  
Revenue by region of domicile of customer’s location                        
India   $ 44,887     $ 116,078     $ 109,986  
Europe     94,887       2,345       7,739  
North America     6,078       5,682       5,147  
Rest of the world     9,600       146,021       138,381  
Total Revenue(*)   $ 155,452     $ 270,126     $ 261,253  

 

    Year ended March 31  
    2020     2019     2018  
    (in thousands)  
Revenue by source                        
Theatrical   $ 10,586     $ 69,542     $ 79,069  
Satellite Content licensing     7,112       77,453       97,168  
Digital and other ancillary(*)     137,754       123,131       85,016  
Total Revenue(**)   $ 155,452     $ 270,126     $ 261,253  

 

(*) the ancillary includes revenue from providing producer support and VFX services to customers

(**) Net of significant discounting component $5,558 (2019: $34,467 and 2018: $6,816 ). [Refer Note 19]

 

    Total     India     North
America
    Europe     Rest of the
World
 
    (in thousands)  
Non-current assets(*)                                        
As of March 31, 2020   $ 475,633     $ 152,340     $ 1     $ 25,860     $ 297,432  
As of March 31, 2019   $ 722,043     $ 336,431     $ 4     $ 34,217     $ 351,391  

 

(*) Non-current assets include property and equipment, right of use assets, intangibles assets (content and others) and restricted deposit by geographic area.

 

v3.20.2
Nature of Expenses (Tables)
12 Months Ended
Mar. 31, 2020
Nature Of Expenses  
Schedule of Nature of Expenses
    Year ended March 31  
    2020     2019     2018  
    (in thousands)  
Publicity and advertisement costs   $ 11,452     $ 19,779     $ 12,684  
Film distribution costs     1,320       5,462       6,739  
Amortization expenses     64,451       130,155       115,285  
Personnel costs (Refer note 7)     36,697       37,015       35,661  
Rent expenses     391       1,916       1,359  
Legal and professional expenses     4,615       6,980       8,204  
Provision for trade and other receivables                 1,968  
Bad debt                 2,772  
Credit impairment loss, net [Refer note 19]     97,551       25,741       4,308  
Depreciation and amortization of other intangibles     3,462       2,263       2,991  
Impairment charge on goodwill                 1,205  
Impairment loss on content advances                 353  
Impairment loss on advances to content vendors           7,284        
Others     6,105       5,935       9,208  
    $ 226,044     $ 242,530     $ 202,737  
Cost of services    $ 81,725     $ 155,396     $ 134,708  
Administrative costs   $ 144,319     $ 87,134     $ 68,029  
v3.20.2
Personnel Costs (Tables)
12 Months Ended
Mar. 31, 2020
Personnel Costs Abstract  
Schedule of Personnel Costs
    Year ended March 31  
    2020     2019     2018  
    (in thousands)  
Salaries   $ 13,781     $ 14,591     $ 16,790  
Social security and other employment charges     617       831       916  
Salaries and other charges     14,398       15,422       17,706  
Share based compensation (Refer Note 27)     22,268       21,561       17,918  
Pension charges     31       32       37  
    $ 36,697     $ 37,015     $ 35,661  
Schedule of Key Management Compensation
    Year ended March 31  
Key management compensation   2020     2019     2018  
    (in thousands)  
Salaries   $ 4,395     $ 4,010     $ 4,919  
Share based compensation     19,829       13,859       11,519  
Pension charges     23       21       16  
    $ 24,247     $ 17,890     $ 16,454  
v3.20.2
Net Finance Costs (Tables)
12 Months Ended
Mar. 31, 2020
Net Finance Costs  
Schedule of Net Finance Costs
    Year ended March 31  
    2020     2019     2018  
    (in thousands)  
Interest on borrowings(*)   $ 29,474     $ 33,530     $ 32,556  
Reclassification of cash flow hedge to consolidated statements of income                 375  
Total interest expense(*)     29,474       33,530       32,931  
Capitalized interest on eligible film rights and content advances     (8,703 )     (9,437 )     (13,263 )
Total finance costs     20,771       24,093       19,668  
Less: Interest income                        
Unwinding of interest     (9,807 )     (13,227 )     (932 )
Bank deposits     (2,185 )     (3,192 )     (923 )
Total finance income     (11,992 )     (16,419 )     (1,855 )
    $ 8,779     $ 7,674     $ 17,813  

 

(*) includes interest expense in respect of financial liabilities classified at fair value through profit or loss $5,517 (2019: $10,682 and 2018: $4,338), significant discounting on long-term advance from customers $1,501 (2019: $458) and leases $ x (2019: $ x and 2018: $ x)

 

v3.20.2
Other (Gains)/Losses (Tables)
12 Months Ended
Mar. 31, 2020
Other Gainslosses  
Schedule of Other (Gains)/Losses

    Year ended March 31  
    2020     2019     2018  
    (in thousands)  
Foreign exchange (loss)/gain, net   $ 5,650     $ 5,610     $ (6,250 )
Gain/(loss) on sale of property and equipment and other Intangibles     (70 )     (97 )     2  
Gain/(loss) on available-for-sale financial assets (Refer note 17)     (1,253     37        
Impairment charge on available -for- sale financial assets (Refer note 17)                 (2,436 )
(Loss) on de-recognition of financial assets measured at amortized cost net (*)     (5,285 )     (5,988 )     (3,562 )
Mark to market gain/(loss) on derivative financial instrument measured at fair value through profit and loss account (Refer note 25)           (902 )      
(Loss) on settlement of derivative financial instruments                 (586 )
(Loss) on financial liability (convertible notes) measured at fair value through profit and loss account (Refer note 22)     (15,987 )     (21,398 )     (13,840 )
(Loss) on deconsolidation of a subsidiary (Refer note 4)                 (14,649 )
Reversal of expected credit loss (Refer note 19)     10,382       20,698        
Liabilities no longer required, written-back     2,487                
Credit from Government of India     760       2,328        
    $ (3,316 )   $ 288     $ (41,321 )

 

(*) Arising on assignment and novation of trade receivables and trade payables with no-recourse. Derecognition of aforesaid financial assets/liabilities measured at amortized cost is to mitigate both credit risk and liquidity risk (Refer Note 31).

 

v3.20.2
Income Tax Expense (Tables)
12 Months Ended
Mar. 31, 2020
Income Tax Expense  
Schedule of Income Tax Expense
    Year ended March 31  
    2020     2019     2018  
    (in thousands)  
Current income tax expense   $ 1,800     $ 17,372     $ 5,556  
Deferred income tax (benefit) / charge     (23,983 )     (10,044 )     3,571  
Income tax expenses   $ (22,183 )   $ 7,328     $ 9,127  
Schedule of Reconciliation of Income Tax Expense
    Year ended March 31  
    2020     2019     2018  
    (in thousands)  
(Loss) before tax   $ (513,887 )   $ (403,125 )   $ (618 )
Income tax (benefit)/expense at tax rates applicable to individual entities (#)     (44,763 )     6,814       7,358  
Tax effect of:                        
Effect of unrecognised tax asset (*)     29,898             657  
Changes in tax rates on temporary differences brought forward     (7,476 )     232       (168 )
Items not deductible for income tax     5       688       486  
Adjustment in respect of current income tax of previous years           (762 )      
Others     153       356       794  
Income tax expense   $ (22,183 )   $ 7,328     $ 9,127  

 

(#) Domestic tax is Nil as the Company is subject to income tax in Isle of Man at a rate of zero percent. Foreign taxes are based on applicable tax rates in each subsidiary jurisdiction.

 

(*) In view of tax losses on Company’s Indian listed subsidiary, deferred tax assets on deductible temporary differences have been recognised to the extent of deferred tax liability on taxable temporary difference on account of lack of sufficient certainty of future earnings against which such deferred tax asset can be realised. Unrecognised tax asset in respect of tax losses and deductible temporary differences of $118,793 is $29,898.

 

v3.20.2
Deferred Income Tax Assets and Liabilities (Tables)
12 Months Ended
Mar. 31, 2020
Deferred Income Tax Assets And Liabilities  
Disclosure of Movement in Deferred Tax Assets and Liabilities
    As At March 31, 2020  
    Opening
Balance
    Recognized
in
statements of income
    Exchange
Difference
    Closing
Balance
 
       
Deferred tax assets:                                
Minimum alternate tax carry-forward   $ 88     $ 2     $ (6 )   $ 84  
Property and equipment     76       120       (9 )     187  
Credit impairment loss     5,044       (3,740 )     (918 )     386  
Current advances and film production           11,791       (2,916 )     8,875  
Others     3,281       (4,328 )     2,167       1,120  
Total income deferred tax asset   $ 8,489     $ 3,845     $ (1,682 )   $ 10,652  
Deferred income tax liabilities:                                
Property and equipment     (624 )     38       520       (66 )
Content advances and film production     34,029       20,100       1,397       (12,532 )
Total deferred income tax liability   $ (34,653 )   $ 20,138     $ 1,917     $ (12,598 )
                                 
Net deferred tax (liability)   $ (26,164 )   $ 23,983     $ 235   $ (1,946 )
As at March 31, 2020                                
Deferred income tax asset                           $ 742  
Deferred income tax liability                           $ (2,688 )

 

          As At March 31, 2019  
    Opening
Balance
    Impact of adoption of IFRS 9     Recognized
in consolidated
statements of income
    Exchange
Difference
    Closing
Balance
 
    (in thousands)  
Deferred tax assets:                                        
Minimum alternate tax carry-forward   $ 927           $ (778 )   $ (61 )   $ 88  
Property and equipment     83             (2 )     (5 )     76  
Credit impairment loss           673       4,385       (14 )     5,044  
Others     2,442             984       (116 )     3,310  
Total income deferred tax asset   $ 3,452       673     $ 4,589     $ (196 )   $ 8,518  
Deferred income tax liabilities:                                        
Property and equipment     (776 )           142       10       (624 )
Intangible assets     (41,815 )           5,313       2,473       (34,029 )
Others     (29 )                       (29 )
Total deferred income tax liability     (42,620 )         $ 5,455     $ 2,483     $ (34,682 )
                                         
Net deferred tax (liability)     (39,168 )     673     $ 10,044     $ 2,287     $ (26,164 )
As at March 31, 2019                                        
Deferred income tax asset                                   $ 1,263  
Deferred income tax liability                                   $ (27,427 )
v3.20.2
Earnings Per Share (EPS) (Tables)
12 Months Ended
Mar. 31, 2020
Earnings Per Share  
Schedule of Earnings Per Share
    2020     2019     2018  
    Basic     Diluted     Basic     Diluted     Basic     Diluted  
    (in thousands, except number of shares and earnings per share)  
(Loss)/earnings                                                
(Loss)attributable to the equity holders of the parent   $ (418,992 )     (418,992 )   $ (423,867 )     (423,867 )   $ (22,575 )   $ (22,575
Potential dilutive effect related to share based compensation scheme in subsidiary undertaking                       (197 )           (475 )
Adjusted earnings attributable to equity holders of the parent   $ (418,992 )     (418,992 )   $ (423,867 )     (424,064 )   $ (22,575 )   $ (23,050 )
Number of shares                                                
Weighted average number of shares     107,532,584       107,532,584       70,706,579       70,706,579       62,151,155       62,151,155  
Potential dilutive effect related to share based compensation scheme             8,237,299             1,463,640             1,331,211  
Adjusted weighted average number of shares     107,532,584       115,769,883       70,706,579       72,170,219       62,151,155       63,482,366  
(Loss) per share                                                
(Loss) attributable to the equity holders of the parent per share (cents)     (389.6 )     (389.6 )     (599.5 )     (599.5 )     (36.3 )     (36.3 )
v3.20.2
Property and Equipment (Tables)
12 Months Ended
Mar. 31, 2020
Property And Equipment  
Schedule of Changes in Property and Equipment
    As At March 31, 2020  
    Land
and
Building
    Furniture,
fittings and
equipment
    Vehicles     Machinery     Total  
    (in thousands)  
Opening net carrying amount   $ 9,562     $ 199     $ 549     $ 601     $ 10,911  
Exchange difference     (480 )     (8 )     (29 )     (7 )     (524 )
Additions     30                   31       61  
Adjustment on Adoption of IFRS 16                       (243 )     (243 )
Disposals           (2 )     (116 )     (2 )     (120 )
Adjustment of depreciation on disposal           1       28       2       31  
Depreciation charge     (579 )     (49 )     (132 )     (131 )     (891 )
Balance as at March 31, 2020   $ 8,533     $ 141     $ 300     $ 251     $ 9,225  
Capital work-in-progress                                   $ 9  
Net carrying value as at March 31, 2020                                   $ 9,234  

 

    As At March 31, 2019  
    Land
and
Building
    Furniture,
fittings and
equipment
    Vehicles     Machinery     Total  
    (in thousands)  
Opening net carrying amount   $ 8,481     $ 348     $ 698     $ 476     $ 10,003  
Exchange difference     (292 )     (12 )     (43 )     (12 )     (359 )
Revaluation     1,745                         1,745  
Additions     207       16       116       394       733  
Reclassification and other adjustment             (61 )     2             (59 )
Disposals     (449 )     (56 )           (65 )     (570 )
Adjustment of depreciation on disposal     367       39             61       467  
Depreciation charge     (497 )     (75 )     (224 )     (253 )     (1,049 )
Balance as at March 31, 2019   $ 9,562     $ 199     $ 549     $ 601     $ 10,911  
Capital work-in-progress                                   $ 10  
Net carrying value as at March 31, 2019                                   $ 10,921  
Schedule of Carrying Value of Property and Equipment
    As At March 31, 2020  
    (in thousands)  
Cost or valuation   $ 13,408     $ 1,749     $ 1,244     $ 4,032     $ 20,433  
Accumulated depreciation     (4,875 )     (1,608 )     (944 )     (3,781 )     (11,208 )
Net carrying amount   $ 8,533     $ 141     $ 300     $ 251     $ 9,225  
Capital work-in-progress                                   $ 9  
Net carrying value as at March 31, 2020                                   $ 9,234  

 

    As At March 31, 2019  
    (in thousands)  
Cost or valuation   $ 13,858     $ 1,759     $ 1,389     $ 4,318     $ 21,324  
Accumulated depreciation     (4,296 )     (1,560 )     (840 )     (3,717 )     (10,413 )
Net carrying amount   $ 9,562     $ 199     $ 549     $ 601     $ 10,911  
Capital work-in-progress                                   $ 10  
Net carrying value as at March 31, 2019                                   $ 10,921  
v3.20.2
Goodwill and Trademark (Tables)
12 Months Ended
Mar. 31, 2020
Goodwill And Trademark  
Schedule of Reconciliation of Changes in Goodwill
Goodwill   Amount in US$  
Balance as at March 31, 2019   $  
Balance as at March 31, 2020   $  
v3.20.2
Intangible Content Assets (Tables)
12 Months Ended
Mar. 31, 2020
Intangible Content Assets  
Schedule of Intangible Content Assets
    Gross
Content
Assets
    Accumulated
Amortization
    Impairment
Loss
    Content
Assets
 
As at March 31, 2020                                
Film and content rights   $ 1,835,263     $ (975,774 )   $ (557,510 )   $ 301,979  
Content advances     427,046             (274,325 )     152,721  
Film productions     12,089             (4,900 )     7,189  
Non-current content assets   $ 2,274,398     $ (975,774 )   $ (836,735 )   $ 461,889  
                                 
As at March 31, 2019                                
Film and content rights   $ 1,675,406       (954,628 )     (366,703 )   $ 354,075  
Content advances     378,268             (38,832 )     339,436  
Film productions     13,061                   13,061  
Non-current content assets   $ 2,066,735       (954,628 )     (405,535 )   $ 706,572  
Schedule of Reconciliation of Changes in Intangible Content Assets
    As At ended March 31  
    2020     2019  
    (in thousands)  
Film productions                
Opening balance   $ 13,061     $ 10,867  
Additions     9,314       3,413  
Exchange difference     (751 )     (775 )
Impairment loss (Refer to Note 2 (c))     (4,900 )      
Transfer to film and content rights     (9,535 )     (444 )
Closing balance   $ 7,189     $ 13,061  
                 
Content advances                
Opening balance   $ 339,436     $ 349,568  
Additions (*) (**)     255,940       261,002  
Reclassifications           (65 )
Exchange difference     (9,484 )     (12,314 )
Impairment loss (Refer to Note 2 (c))     (235,493 )     (38,832 )
Transfer to film and content rights     (197,678 )     (219,923 )
Closing balance   $ 152,721     $ 339,436  
                 
Film and content rights                
Opening balance   $ 354,075     $ 638,108  
Amortization     (64,451 )     (130,155 )
Exchange difference     (4,486 )     (7,542 )
Impairment loss (Refer to Note 2 (c))     (190,807 )     (366,703 )
Transfer from inventory     435        
Transfer from film productions and content advances     207,213       220,367  
Closing balance   $ 301,979     $ 354,075  

 

(*)represents non-cash movement on account of de-recognition of financial liabilities amounting to $90,118 (2019: $160,615) [Refer Note 31].

 

(**) capital creditors amounting $24,513 were settled by issuance of A Ordinary Shares, [Refer note 27].

v3.20.2
Intangible Assets - Other (Tables)
12 Months Ended
Mar. 31, 2020
Intangible Assets - Other  
Schedule of Reconciliation of Changes to Other Intangible Assets
    As At March 31, 2020  
    (in thousands)  
    Information
technology
assets
    Other
intangibles
    Total  
Opening net carrying amount as on March 31, 2019   $ 1,204     $ 2,590     $ 3,794  
Exchange difference           (137 )     (137 )
Additions                  
Disposal and reclassification     (59 )     (4 )     (63 )
Amortization charge     (39 )     (855 )     (894 )
Sub- total     1,106       1,594       2,700  
Intangibles under development                 235  
Closing net carrying amount as on March 31, 2020   $ 1,106     $ 1,594     $ 2,935  

 

    As At March 31, 2019  
    (in thousands)  
    Information
 technology
assets
    Other
intangibles
    Total  
Opening net carrying amount as on March 31, 2018   $ 1,449     $ 3,831     $ 5,280  
Exchange difference           (148 )     (148 )
Additions           907       907  
Disposal and reclassification     59       (1,090 )     (1,031 )
Amortization charge     (304 )     (910 )     (1,214 )
Closing net carrying amount as on March 31, 2019   $ 1,204     $ 2,590     $ 3,794  
Schedule of Other Intangible Assets

   As At March 31, 2020 
   (in thousands) 
Cost or valuation as on March 31, 2019   $5,055   $6,466   $11,521 
Accumulated amortization    (3,949)   (4,872)   (8,821)
Net carrying amount as on March 31, 2020   $1,106   $1,594   $2,700 
Intangibles Under Development            $235 
Net carrying value as at March 31, 2020            $2,935 

 

    As At March 31, 2019  
    (in thousands)  
Cost or valuation as on March 31, 2019   $ 5,114     $ 6,607     $ 11,721  
Accumulated amortization     (3,910 )     (4,017 )     (7,927 )
Net carrying amount as on March 31, 2019   $ 1,204     $ 2,590     $ 3,794  
v3.20.2
Available-For-Sale Financial Assets (Tables)
12 Months Ended
Mar. 31, 2020
Available-for-sale Financial Assets  
Schedule of Available-For-Sale Financial Assets
    As At March 31  
    2020     2019  
    (in thousands)  
Non – Current Investments                
Valuable Technologies Limited   $ 140     $ 2,000  
LMB Holdings Limited           650  
    $ 140     $ 2,650  

Current Investments

Polyxo Global Limited

  $ 225     $ 1,042  
Plutus Opportunities Fund Limited     3,577        
    $ 3,942     $ 3,692  
Disclosure of Measurements of Financial Assets
    Financial Assets
at FVTPL
    Financial Assets
at FVTOCI
 
       
As at March 31, 2018   $ 27,257     $  
Reclassification (refer note 29)     (27,257 )     27,257  
Additions     1,005       80  
Fair valuation gain / (loss)     37       (24,687  
As at March 31, 2019     1,042     $ 2,650  
Additions/(Disposal)     4,013       (650 )
Fair valuation gain / (loss)     (1,253 )     (1,860 )
As at March 31, 2020   $ 3,802     $ 140  
v3.20.2
Inventories (Tables)
12 Months Ended
Mar. 31, 2020
Inventories - Schedule Of Inventories  
Schedule of Inventories
    As At March 31  
    2020     2019  
    (in thousands)  
Goods for resale   $     $ 435  
    $     $ 435  
v3.20.2
Trade and Other Receivables (Tables)
12 Months Ended
Mar. 31, 2020
Trade And Other Receivables  
Schedule of Trade and Other Receivables
    As at  
    March 31,
2020
    March 31,
2019
 
Trade accounts receivables at fair value (*)                
Trade accounts receivables   $ 138,869       156,026  
Credit impairment (loss)     (41,470 )     (26,133 )
Fair Value gain/(loss)     (2,650 )     (4,664 )
Trade accounts receivables net     94,749       125,229  
                 
Trade accounts receivables at amortised cost                
Trade accounts receivables   $ 77,772     $ 86,331  
Credit impairment (loss)     (70,853 )     (15,202 )
Trade accounts receivables net     6,919       71,129  
                 
Total Trade accounts receivables   $ 101,668     $ 196,358  
                 
Balance with statutory authorities     6,568       7,672  
Accrued interest     92       2,188  
Advance to content vendor     1,373       3,462  
Prepaid charges     2,578       1,790  
Unbilled revenues     553       1,717  
Other receivables     5,182       2,023  
Trade and other receivables   $ 118,014     $ 215,210  
                 
Current     107,253       205,145  
Non-current     10,761       10,065  
    $ 118,014     $ 215,210  

 

(*) Business model is achieved both by collecting contractual cash flows and de-recognition of financial assets arising on assignment and novation transaction. (Refer Note 31)

Schedule of Age of Financial Assets Past Due but not Impaired
    As at  
    March 31,
2020
    March 31,
2019
 
Not more than three months   $ 15,097     $ 44,687  
More than three months but not more than six months     11,764       15,948  
More than six months but not more than one year     14,896       15,310  
More than one year     4,899       8,796  
    $ 46,656     $ 84,741  
Schedule of Movement in Trade and Other Receivables for Expected Credit Losses

    Year ended  
    March 31, 2020  
    Trade
Receivables
    Other
Receivables
    Total
Receivables
 
Balance as on April 1, 2019   $ 41,335     $ 447     $ 41,782  
Charged to operations     103,109             103,109  
Unwinding of expected credit loss (included in finance income)     (9,807 )           (9,807 )
Reversal of expected credit loss (included in other gains/(losses))     (10,382 )           (10,382 )
Bad debts     (6,743 )           (6,743 )
Translation adjustment     (5,189 )             (5,189 )
Balance at the end of the year   $ 112,323     $ 447     $ 112,770  

 

    Year ended  
    March 31, 2019  
    Trade
Receivables
    Other
Receivables
    Total
Receivables
 
Balance at the beginning of the period   $ 10,193     $     $ 10,193  
Impact of adoption of IFRS 9     18,050       447       18,497  
Balance as on April 1, 2018     28,243       447       28,690  
Charged to operations     60,208       7,284       67,492  
Unwinding of expected credit loss (included in finance income)     (13,227 )           (13,227 )
Reversal of expected credit loss (included in other gains/(losses))     (20,698 )           (20,698 )
Translation adjustment     (160 )           (160 )
Bad debts     (13,031 )     (7,284 )     (20,315 )
Balance at the end of the year   $ 41,335     $ 447     $ 41,782  
v3.20.2
Trade and Other Payables (Tables)
12 Months Ended
Mar. 31, 2020
Trade And Other Payables  
Schedule of Trade and Other Payables
    As At March 31  
    2020     2019  
    (in thousands)  
Trade accounts payable(*)   $ 21,030     $ 25,299  
Accruals and other payables (includes creditors for content assets of $ 29,937 (2019: $16,139))     43,809       32,888  
Contract liability (deferred revenue)     9,827       12,260  
Accrued interest     3,106       2,395  
Value added taxes and other taxes payable     13,169       10,645  
    $ 90,941     $ 83,487  

 

(*) Includes settlement of payables through issuance of shares (Refer note 27). and de-recognition of financial liabilities arising on assignment and novation transaction [Refer note 31]

 

v3.20.2
Cash and Cash Equivalents (Tables)
12 Months Ended
Mar. 31, 2020
Cash And Cash Equivalents  
Schedule of Cash and Cash Equivalents
    As At March 31  
    2020     2019  
    (in thousands)  
Cash at bank and in hand   $ 2,563     $ 89,117  
    $ 2,563     $ 89,117  
v3.20.2
Borrowings (Tables)
12 Months Ended
Mar. 31, 2020
Borrowings Disclosure Abstract  
Schedule of Detailed Information about Borrowings
    Nominal           As at March 31,  
    Interest Rate     Maturity     2020     2019  
                (in thousands)  
Asset backed borrowings                            
Vehicle loan   2.5 - 9.5%     2017-22     $ 127     $ 382  
Term loan   MCLR +3.2% - 4.50%     2019-22       6,843       12,947  
Term loan   BR + 2.75%     2020-21       509       1,083  
Term loan   10.39% - 13.75%     2020-23             251  
                $ 7,479     $ 14,663  
Unsecured borrowings                            
Retail bond   6.50%     2021-22       62,274       65,215  
Convertible notes(1)   14.23%     2020-21             68,349  
                $ 62,274     $ 133,564  
                             
Cumulative effect of unamortised costs                 (399 )     (691 )
Instalments due within one year:                            
Convertible notes(2)                       (68,349 )
Others                 (7,240 )     (7,267 )
                $ 62,114     $ 71,920  
                             
Long-term borrowings at amortised cost               $ 62,114     $ 71,920  

 

Analysis of short-term borrowings

 

    Nominal   As at March 31,  
    interest rate (%)   2020     2019  
        (in thousands)  
Asset backed borrowings                    
Export credit, bill discounting and overdraft   MCLR +.40% to 6%   $ 37,755     $ 32,078  
Export credit, bill discounting and overdraft   Base Rate + 0.5% to 1%     3,442       3,533  
Export credit, bill discounting and overdraft   6.01% - 15.25%     28,773       26,719  
Convertible notes(1)   9.96%     23,100        
Short- term loan(3)   3.25% - 16.45%     16,548       70,962  
        $ 109,618     $ 133,292  
Unsecured borrowings                    
Instalments due within one year on long-term borrowing         7,240       75,616  
        $ 116,858     $ 208,908  
                     
Short-term borrowings at fair value         23,100       68,349  
Short-term borrowings at amortised cost       $ 93,758     $ 140,559  

 

(1) Eros International Plc. (“issuer”) issued Senior Convertible Notes (SCN or convertible notes) on December 06, 2017 amounting to $122,500 principal amount and option to purchase warrants up to 2,000 of A ordinary share for a term of 6 months at an offer price of $100,000 by private placement. The notes are payable in equal installments of $3,500 per month for 35 months starting December 31, 2017. The installments can be paid either in cash or can be converted into A ordinary equity shares of the issuer at the option of the issuer as per the terms of the arrangement. The notes are fully paid as at the date of reporting.

 

2. Eros International Plc. (“issuer”) issued Senior Convertible Notes (SCN or convertible notes) on September 25, 2019 amounting to $27,500 principal amount. The maturity date of convertible is September 26, 2020. The installments will be converted into A ordinary equity shares of the issuer at the option of the issuer as per the terms of the arrangement.

 

The holder of the notes can defer the payment of the amount due on any instalment dates to another instalment date as well as has the right to accelerate the payment on the notes as per the terms of the agreement

 

The Company has classified the instrument as a financial liability at fair value through profit or loss. The Company has used the Black – Scholes option pricing model to value the share warrants exercisable within six months and the Monte-Carlo simulation model to obtain the fair value of the convertible notes. Fair value of the financial liability outstanding as at the date of reporting is $23,100 (2019: $68,349)

 

The mark-to-market loss and interest expense for the year ended March 31, 2020 $5,517 (2019: $21,398) and $15,987 (2019: $10,682) have been recognized within other gain/(losses) and net finance cost, respectively, net in the Statement of Income.

 

3. Secured by pledge of shares held in the Group’s majority owned subsidiary, Eros International Media Limited, India.
 
4. For the twelve months ended March 31, 2020 capitalization rate of interest was 10.15% (2019: 10.21%)

 

Schedule of Fair Value Measurement of Convertible Notes
    March 3, 2020  
Particulars   (in thousands)  
As at March 31,2019   $ 68,349  
Interest     5,517  
‘A’ ordinary shares issued in lieu of convertible notes     (91,753 )
Receipt from convertible notes     25,000  
Loss on fair value of convertible notes     15,987  
 As at March 31, 2020   $ 23,100  
v3.20.2
Acceptances (Tables)
12 Months Ended
Mar. 31, 2020
Acceptances - Schedule Of Other Financial Liabilities  
Schedule of Other Financial Liabilities
    As At March 31  
    2020     2019  
    (in thousands)  
Payable under the film financing arrangements   $ 1,858     $ 8,366  
    $ 1,858     $ 8,366  
v3.20.2
Other Long-Term Liabilities (Tables)
12 Months Ended
Mar. 31, 2020
Other Long-term Liabilities  
Schedule of Other Long-Term Liabilities
    As At March 31  
    2020     2019  
    (in thousands)  
Contract liability (deferred revenue)(*)   $ 7,793     $ 13,271  
Employee benefit obligation     465       627  
    $ 8,258     $ 13,898  

 

(*) includes significant discounting on long-term advances from customers $1,925 (2019: 458)

 

v3.20.2
Derivative Financial Instruments (Tables)
12 Months Ended
Mar. 31, 2020
Derivative Financial Instruments  
Schedule of Derivative Financial Instruments
    As At March 31  
    2020     2019  
    (in thousands)  
Current            
Derivative liabilities – Held for trading                
Interest rate cap   $     $ (620
    $     $ 620  
v3.20.2
Issued Share Capital (Tables)
12 Months Ended
Mar. 31, 2020
Issued Share Capital  
Schedule of Issued Share Capital
    Number of
Shares
    GBP  
Authorized             (in thousands)  
                 
Ordinary shares of 30p each at March 31, 2019     150,000,000       45,000  
Ordinary shares of 30p each at March 31, 2020 (*)     200,000,000       60,000  

 

(*) The Company increased authorized number of shares to 200,000,000 on September 25, 2019.

 

    Number of Shares     USD  
Allotted, called up and fully paid   A Ordinary 
30p Shares(*)
    B Ordinary 
30p Shares(*)
    (in thousands)  
As at March 31, 2018     55,718,423       9,712,715     $ 35,334  
Issue of shares in the quarter ended June 30, 2018     2,747,645             1,138  
Issue of shares in the quarter ended September 30, 2018     3,773,385             1,471  
Issue of shares in the quarter ended December 31, 2018     1,659,767             641  
Transfer of B Ordinary to A Ordinary share     1,500,000       (1,500,000 )      
Issue of shares in the quarter ended March 31, 2019     1,892,518             742  
As at March 31, 2019     67,291,738       8,212,715     $ 39,326  
Issue of shares in the quarter ended June 30, 2019     4,192,459             1,598  
Issue of shares in the quarter ended September 30, 2019     25,956,283       7,044,210       12,276  
Issue of shares in the quarter ended December 31, 2019     16,250,661             6,747  
Issue of shares in the quarter ended March 31, 2020     13,425,561       4,642,160       6,780  
As at March 31, 2020     127,116,702       19,899,085       66,727  

 

(*) Each A ordinary shares is entitled to one vote on all matters and each B shares is entitled to ten votes.

 

    A Ordinary     B Ordinary  
    For the year ended     For the year ended  
    March
  31, 2020
    March 31,
2019
    March 31,
2020
    March 31,
2019
 
Issuance to Founders Group (1) (7)           1,769,911       4,878,050        
Issuance towards settlement of Convertible notes (2)     49,185,958       4,411,359              
Exercise against Restricted Share Unit/ Management scheme (3)     2,728,181       770,541       6,808,320        
Issuance towards Reliance Industries Limited (4)           3,111,088              
2015 Share Plan (5)     132,013       10,416              
Issuance to vendors (8)     6,475,600                    
Issuance towards equity infusion from funds (6)     1,303,212                    
Total     59,824,964       10,073,315       11,686,370        

 

(1) Average price of A Ordinary Shares at NIL price (March 2019: $14.69)and B Ordinary Shares at $1.64 (March 2019:Nil)

(2) Average exercise price of A Ordinary Shares $1.87 (March 2019: $11.28)

(3) 2,728,181 A Ordinary shares (March 2019: 183,000) at NIL(March 2019: $0.39) and 6,808,320 B Ordinary shares (March 2019: Nil) exercised at NIL price March 2019: Nil)

(4) Average exercise price of A Ordinary Shares NIL (March 2019: $15)

(5) Average exercise price A Ordinary Shares $2 (March 2019: $7.92)

(6) Average exercise price A Ordinary Shares $3.22 (March 2019: Nil)

(7) Includes 4,176,830 B Ordinary shares issued against advance received ($6,150) as of March 31, 2019 and $700 received during the year and $1,150 payables settled by issuance of 701,220 B Ordinary shares

(8) Includes payables settled by issuance 100,000 A Ordinary shares issued to a consultant at an average exercised price at $2.23 (March 2019: NIL) and 6,375,600 A Ordinary Shares towards payables settlement at an average exercised price at $3.14 (March 2019: Nil)

v3.20.2
Share Based Compensation Plans (Tables)
12 Months Ended
Mar. 31, 2020
Share Based Compensation Plans  
Schedule of Compensation Cost Recognized
    Year ended March 31  
    2020     2019     2018  
    (in thousands)  
IPO India Plan   $ 145     $ 1,198     $ 1,572  
JSOP Plan                 615  
Option award scheme 2012                 197  
2014 Share Plan           47       (22 )
2015 Share Plan(*)     1,976       3,059       100  
Other share option awards(**)     7,829       5,346       7,283  
Management scheme (staff share grant) (***)     12,318       11,911       8,173  
    $ 22,268     $ 21,561     $ 17,918  

 

(*) includes 674,045 options granted towards Share Plan 2015 during twelve months ended March 31, 2020 at an exercise price of $ 2 per share and average grant date fair value of $ 0.82 per share. In February 2020, the exercise price of said options were modified to GBP 0.3, resulting in incremental fair value of $ 0.55 per share. In addition, includes 233,364 and 622,035 options granted in prior year/s and wherein the exercise price was modified to $ 2 per share and GBP 0.3 per share, respectively, resulting in incremental fair value of $ 0.55-0.63 per share and $ 1.18 per share, respectively.

 

(**) includes Restricted Share Unit (RSU) and Other share option plans. In respect of 4,899,280 units/options granted towards RSU during twelve months ended March 31, 2020, intrinsic value $ 1.94 per share approximates grant date fair value. Includes 873,000 options accelerated for immediate vesting as against original vesting period of 3 years, resulting in incremental fair value of $1.64 per share.

 

(***) includes 10,230,320 shares granted twelve months ended March 31, 2020 to management personnel at intrinsic value $1.94 per share approximates grant date fair value.

 

Schedule of Movement in Shares Held by the Joint Stock Ownership Plan Trust

    Year ended March 31  
    2020     2019     2018  
Shares held at the beginning of the year     384,862       1,146,955       1,146,955  
Shares granted                  
Shares exercised (*)                  
Shares forfeiture/lapsed     (384,862 )     (762,093 )      
Shares held at the end of the year           384,862       1,146,955  
Unallocated shares held by trust     1,253,656       868,794       106,701  
            1,253,656       1,253,656  

 

(*) During the year unallocated shares held by the trust were issued to the content vendor at $3.6 per share.

Schedule of Range of Exercise Prices of Grants under Stock Option Plans and Stock Awards
    Range of
exercise prices
 
IPO India Plan     INR 10 – 150  
2014 Share Plan     $16.25–$18.30  
2015 Share Plan     $2-33.12 & GBP 0.3  
Other share option plans     $16.00  
RSU      
Management Share Award      

 

Schedule of Employee Stock Option Plan Activity
        Year ended March 31
        2020   2019   2018
    Name of Plan   Number
of
shares
  Weighted
average
exercise
price
  Number
of
shares
  Weighted
average
exercise
price
  Number
of
shares
  Weighted
average
exercise
price
Outstanding at the beginning of the year   IPO India Plan   757,886   INR 32.17   1,624,035   INR 28.85   2,108,063   INR 34.96
Granted                   863,320     10.00
Exercised       (121,496)     10.00   (536,263)     10.00   (1,113,160)     32.19
Forfeited and lapsed       (156,775)     10.00   (329,886)     51.66   (234,188)     10.00
Outstanding at the end of the year       479,615     45.03   757,886     32.17   1,624,035     28.85
Exercisable at the end of the year       325,740   INR 61.56   289,002   INR 68.13   501,122   INR 65.14
                                   
Outstanding at the beginning of the year   JSOP Plan   384,862   $ 11.00   1,146,955   $ 16.22   1,146,955   $ 16.22
Granted                      
Exercised                      
Forfeited and lapsed       (384,862)     11.00   (762,093)     18.86      
Outstanding at the end of the year         $   384,862   $ 11.00   1,146,955   $ 16.22
Exercisable at the end of the year         $   384,862   $ 11.00   728,736   $ 11.00
                                   
Outstanding at the beginning of the year   Option award scheme 2012     $   674,045   $ 11.00   674,045   $ 11.00
Granted                      
Exercised                      
Forfeited and lapsed             (674,045)     11.00      
Outstanding at the end of the year                   674,045     11.00
Exercisable at the end of the year                     449,363   $ 11.00
                                   
Outstanding at the beginning of the year   2014 Share Plan   399,999   $ 17.79   399,999   $ 17.79   723,749    $ 18.06
Granted                      
Exercised                      
Forfeited and lapsed                   (323,750)     18.39
Outstanding at the end of the year       399,999     17.79   399,999     17.79   399,999     17.79
Exercisable at the end of the year       399,999   $ 17.79   399,999   $ 17.79   289,583   $ 17.67
                                   
Outstanding at the beginning of the year (i)   2015 Share Plan   1,290,399   $ 14.68   211,250   $ 16.21   233,750   $ 16.23
Granted (ii)       674,045     0.38   1,305,399     14.86      
Exercised       (132,013)     2.00   (10,416)     7.92   (10,208   8.71
Forfeited and lapsed        (233,333)     16.18   (215,834)     18.23   (12,292   14.64
Outstanding at the end of the year       1,599,098     2.69   1,290,399     14.68   211,250     16.21
Exercisable at the end of the year       1,549,098   $ 2.72   981,545   $ 14.66   181,354   $ 17.36
                                   
Outstanding at the beginning of the year   Other share option plans   500,000   $ 16.00   500,000   $ 18.88   500,000     18.88
Granted                          
Exercised                          
Forfeited and lapsed       (500,000)      16.00              
Outstanding at the end of the year             500,000     16.00   500,000     18.88
Exercisable at the end of the year         $   400,000   $ 16.00   300,000   $ 18.88
                                   
Outstanding at the beginning of the year   RSU   505,945       837,590       182,725    
Granted (iii)       4,899,280     0.06   211,567       1,044,290    
Exercised       (2,088,181)       (450,541)       (366,491)    
Forfeited and lapsed       (37,447)       (92,672)       (22,934)    
Outstanding at the end of the year       3,279,597     0.1   505,944       837,590    
Exercisable at the end of the year       311,740       34,416       119,150    
                                   
Outstanding at the beginning of the year   Management Scheme   2,593,333       1,513,333       1,130,000    
Granted (iv)       10,230,320       1,400,000       700,000    
Exercised (v)       (7,448,320)       (320,000)       (316,667    
Forfeited and lapsed       (320,000)                
Outstanding at the end of the year       5,055,333     0.01   2,593,333       1,513,333    
Exercisable at the end of the year       890,000     0.03   516,667       173,333    

 

(i) includes 233,364 and 622,035 options granted in prior year/s and wherein the exercise price was modified to $ 2 per share and GBP 0.3 per share, respectively.

(ii) Options granted in during the year, wherein the exercise price was modified to GBP 0.3 per share

(iii) Out of above, 873,000 RSU were accelerated for immediate vesting as against original vesting period of 3 years.

(iv) Includes 6,808,320 B Ordinary shares granted on July 12, 2019 and February 28, 2020, respectively

(v) Includes issuance of 6,808,320 B Ordinary treasury shares

 

Schedule of Number and Weighted Average Remaining Life
    Year ended March 31  
    2020     2019     2018  
Name of Plan   Weighted
average
remaining
life
(Years)
    Weighted
average
exercise
price
    Weighted
average
remaining
life
(Years)
    Weighted
average
exercise
price
    Weighted
average
remaining
life
(Years)
    Weighted
average
exercise
price
 
IPO India Plan     6.30     INR* 45.03       7.70     INR* 32.17       8.11     INR* 35.0  
JSOP Plan         $       3.05     $ 11.00       3.93     $ 16.19  
Option award scheme 2012         $           $       3.75     $ 11.00  
2014 Share Plan     1.25     $ 17.79       2.25     $ 17.79       5.96     $ 17.79  
2015 Share Plan     5.00     $ 2.69       6.01     $ 14.68       6.06     $ 16.21  
Other share option plans         $       1.87     $ 16.00       2.87     $ 18.88  
RSU     9.36     $       6.00     $       5.60     $  
Management Scheme     8.94     $ 0.1       6.00     $       5.56     $  

 

*INR – Indian Rupees

Schedule of Inputs to Fair Valuation Model
    Inputs  
Expected volatility(1)     108.2%  
Option life (Years)     2.6  
Dividend yield     0%  
Risk free rate     0.3  
Range of exercise price of the granted options at the grant date(2)   $ 0.38  

 

(1) The expected volatility of all other options is based on the historic share price volatility of the Company over time periods comparable to the time from the grant date to the maturity dates of the options.
(2) Fair value of options granted under all other schemes is measured using a Black Scholes model.

 

v3.20.2
Joint Stock Ownership Plan Reserve (Tables)
12 Months Ended
Mar. 31, 2020
Joint Stock Ownership Plan Reserve Abstract  
Schedule of Joint Stock Ownership Plan Reserve (JSOP Reserve)
    (in thousands)  
Balance at April 1, 2018   $ (15,985 )
Issue out of treasury shares      
Balance at April 1, 2019   $ (15,985 )
Issue out of treasury shares     15,985  
Balance at March 31, 2020   $  
v3.20.2
Other Components of Equity (Tables)
12 Months Ended
Mar. 31, 2020
Other Components Of Equity  
Schedule of Other Components of Equity

   As at March 31
(in thousands)
 
   2020   2019   2018 
Movement in hedging reserve:               
Opening balance  $   $   $(375)
Reclassified to consolidated statements of income           375 
Closing balance  $   $   $ 
                
Movement in revaluation reserve:               
Opening balance  $2,932   $1,835   $1,829 
Net gain recognised on revaluation of property and equipment       1,019     
Impact of translation difference   (156)   78    6 
Closing balance  $2,776   $2,932   $1,835 
                
Movement in available for sale fair value reserve:               
Opening balance  $(18,449)  $6,238   $6,238 
Impairment loss on available-for-sale financial assets   (1,860)   (24,687)    
Closing balance  $(20,309)  $(18,449)  $6,238 
                
Movement in Foreign currency translation reserves               
Opening balance  $(64,179)  $(56,722)  $(55,810)
Adoption of IFRS 9 (net of tax)       (34)    
Other comprehensive loss due to translation of foreign operations (*)   (3,948)   (7,423)   (912)
Closing balance  $(68,127)  $(64,179)  $(56,722)
                
Total other components of equity  $(85,660)  $(79,696)  $(48,649)

  

(*) includes movement in foreign currency translation reserves arising on account of deconsolidation $Nil (2019: Nil, 2018: $502) of financial asset.

v3.20.2
Significant Non-Cash Expenses (Tables)
12 Months Ended
Mar. 31, 2020
Significant Non-cash Expenses  
Schedule of Significant Non-Cash Expenses
    As at March 31  
    2020     2019     2018  
    (in thousands)  
Unrealised foreign exchange loss / (gain)   $ (4,458 )   $ (3,329 )   $ 5,466  
Credit impairment loss, net     82,920       26,283       3,376  
Impairment charge on available-for-sale financial assets     1,253             2,436  
Net losses on de-recognition of financial assets measured at amortized cost, net     5,285       5,988       3,562  
Mark to market gain on derivative financial instrument measured at fair value through profit and loss           902        
Loss on settlement of derivative financial instruments                 586  
Loss on financial liability (convertible notes) measures at fair value through profit and loss     15,987       21,398       13,840  
Loss on deconsolidation of a subsidiary                 14,649  
Provisions for trade and other receivables     -             4,740  
Provision no longer required, written-back     (2,636 )     (120 )     (124 )
Impairment loss on advances content vendors     -       7,284       353  
Impairment loss                 1,205  
Significant discounting on deferred revenue     1,501              
Others     266       32       30  
    $ 100,118     $ 58,438     $ 50,119  
v3.20.2
Financial Instruments and Risk Management (Tables)
12 Months Ended
Mar. 31, 2020
Financial Instruments And Risk Management  
Disclosure of Detailed Information about Financial Instruments
    As at March 31  
    2020     2019  
    (in thousands)  
Debt (net of debt issuance cost of $399 (2019: $691))   $ 178,972     $ 280,828  
Cash and cash equivalents (*)     2,563       135,783  
Net debt     176,409       145,045  
Equity     308,486       656,985  
Net debt to equity ratio     57.2%       22.1%  

 

(*) includes $Nil (2019: $46,666) of restricted deposits.

 

Disclosure of Financial Assets and Financial Liabilities
    2020     2019  
    (in thousands)  
Financial assets                
Available-for-sale investments   $ 3,942     $ 3,692  
Other financial assets (1)     116,281       351,477  
    $ 120,223     $ 355,169  
Financial liabilities at amortized cost                
Trade payables and acceptances excluding value added tax and other tax payables   $ 79,630     $ 81,208  
Borrowings excluding Senior Convertible Notes     155,872       212,479  
Financial Liabilities at fair value through profit or loss                
Derivatives at fair value through profit or loss - held for trading           620  
Senior convertible Notes at fair value through profit or loss     23,100       68,349  
    $ 258,602     $ 362,656  

 

(1) Other financial assets include loans and receivables, excluding prepaid charges and statutory receivables, and includes cash and cash equivalents and restricted deposits held with banks.

 

Disclosure of Foreign Currency Risk Exposure
        Net Balance
    USD   GBP   Other
        (in thousands)
As at March 31, 2020   (3,895)   (65,446)   (182)
As at March 31, 2019   (6,117)   (61,927)   (2,317)

 

Disclosure of Maturity Analysis for Non-Derivative and Derivative Financial Liabilities
    Total     Less than
1 year
    1-3
years
    3-5
years
    More than
5 years
 
    (in thousands)  
As at March 31, 2020                                        
Borrowing principal payments(1)   $ 179,371     $ 117,097     $ 62,274     $     $  
Borrowing interest payments     23741       17,500       6,241              
Acceptances     1,858       1,858                    
Trade and other payables     90,941       90,941                    
Minimum lease payments     1,716       822       894                  

 

    Total     Less than
1 year
    1-3
years
    3-5
years
    More than
5 years
 
    (in thousands)  
As at March 31, 2019                                        
Borrowing principal payments(1)   $ 281,519     $ 209,180     $ 72,339     $     $  
Borrowing interest payments     29,016       21,820       7,196              
Derivative financial instruments     620       620                    
Acceptances     8,366       8,366                    
Trade and other payables     83,487       83,487                    
Minimum lease payments     2,956       1,480       1,360       116          

 

(1)   Excludes cumulative effect of unamortized costs.

Disclosure of Currency, Maturity and Nature of Interest Rate of Borrowings
    As at March 31  
    2020     %     2019     %  
    (in thousands, except percentages)  
Currency                                
U.S. Dollar   $ 49,182       27.4%     $ 148,201       52.6%  
Great British Pounds Sterling     62,274       34.7%       65,215       23.2%  
Indian Rupees     67,915       37.9%       68,103       24.2%  
Total   $ 179,371       100.0%     $ 281,519       100.0%  
                                 
Maturity                                
Due before one year   $ 117,097       64.3%     $ 209,180       74.3%  
Due between one and three years     62,274       34.7%       72,339       25.7%  
Due between four and five years                        
Due after five years                        
    $ 179,371       100.0%     $ 281,519       100.0%  
Nature of rates                                
Fixed interest rate   $ 96,904       54.0%     $ 205,156       72.9%  
Floating rate     82,467       46.0%       76,363       27.1%  
Total   $ 179,371       100.0%     $ 281,519       100.0%  

 

Disclosure of Fair Value Measurements of Assets and Liabilities
    As at March 31, 2020
    (in thousands)
Description of type of financial assets   Gross amount of
recognized financial assets
  Gross amount of recognized
financial liabilities offset in the
statement of financial position
  Net amounts financial assets
presented in the statement
of financial position
Derivative assets      
Trade and other receivables   94,749     94,749
Investments at FVTPL   3,802     3,802
Investments at FVTOCI   140     140
Total   98,691     98,691

 

Description of type of financial liabilities   Gross amount of
recognized financial liabilities
  Gross amount of recognized
financial assets offset in the
statement of financial position
  Net amounts financial liabilities
presented in the statement
of financial position
Derivative liabilities      
Long-term borrowings at fair value   23,100     23,100
Total   23,100     23,100

 

    As at March 31, 2019
    (in thousands)
Description of type of financial assets   Gross amount of
recognized financial assets
  Gross amount of recognized
financial liabilities offset in the
statement of financial position
  Net amounts financial assets
presented in the statement
of financial position
Derivative assets      
Trade and other receivables   125,229     125,229
Investments at FVTPL   1,042     1,042
Investments at FVTOCI   2,650     2,650
Total   128,921     128,921

 

Description of type of financial liabilities   Gross amount of
recognized financial liabilities
  Gross amount of recognized
financial assets offset in the
statement of financial position
  Net amounts financial liabilities
presented in the statement
of financial position
Derivative liabilities   620     620
Long-term borrowings at fair value   68,349     68,349
Total   68,969     68,969

 

v3.20.2
Contractual Obligations and Commitments (Tables)
12 Months Ended
Mar. 31, 2020
Contractual Obligations And Commitments  
Disclosure of Contractual Obligations Related to Content Commitments
    Total  
    (in thousands)  
As at March 31, 2020   $ 450,469  
         
As at March 31, 2019   $ 301,660  

 

v3.20.2
Related Party Transactions (Tables)
12 Months Ended
Mar. 31, 2020
Related Party Transactions  
Disclosure of Transactions Between Related Parties
        As at
March 31,2020
    As at
March 31,2019
 
    Details of   (in thousands)  
    Transaction   Liability     Asset     Liability     Asset  
Red Bridge Group Limited   President fees   $ 648     $     $ 648     $  
550 County Avenue   Rent/Deposit     156             499       135  
NextGen Films Private Limited (*)   Purchase/Sale                       41,470  
Everest Entertainment LLP   Purchase/Sale     557             574        
Beech Investments Limited   Advance     592             500        
Lulla Family   Rent/Deposit     487       356       243       841  
Lulla Family   Salary     4,155             3,279        
Lulla Family   Advance                 6,150        
Lulla Family   Advance     500             500        
Xfinite Global Plc   Sale     3,812             6,500        

 

v3.20.2
Major Consolidated Entities (Tables)
12 Months Ended
Mar. 31, 2020
Major Consolidated Entities  
Disclosure of Major Consolidated Entities
    Date     Country of
Incorporation
    % of voting
rights held
 
Copsale Limited     June 2006       BVI       100.00  
Eros Australia Pty Limited     June 2006       Australia       100.00  
Eros International Films Private Limited     June 2006       India       100.00  
Eros International Limited     June 2006       U.K.       100.00  
Eros International Media Limited     June 2006       India       62.31  
Eros International USA Inc     June 2006       U.S.       100.00  
Eros Network Limited     June 2006       U.K.       100.00  
Eros Worldwide FZ-LLC     June 2006       UAE       100.00  
Big Screen Entertainment Private Limited     January 2007       India       64.00  
EyeQube Studios Private Limited     January 2008       India       99.99  
Acacia Investments Holdings Limited     April 2008       IOM       100.00  
Eros International Pte Limited     August 2010       Singapore       100.00  
Digicine Pte. Limited     March 2012       Singapore       100.00  
Colour Yellow Productions Private Limited     May 2014       India       50.00  
Eros Digital FZ LLC     September 2015       UAE       100.00  
Eros Digital Limited     July 2016       IOM       100.00  
Eros Films Limited     November 2016       IOM       100.00  
Universal Power Systems Private Limited     August 2015       India       100.00  
England Merger 1, Corp     March 2020       U.S.       100.00  
England Holdings 2,Inc     March 2020       U.S.       100.00  
England Holdings 3,Inc     March 2020       U.S.       100.00  

 

v3.20.2
Non-Controlling Interest (Tables)
12 Months Ended
Mar. 31, 2020
Non-controlling Interest  
Disclosure of Non-Controlling Interest
   Year ended March 31 
   (in thousands) 
EIML  2020   2019 
Current assets   $170,724   $183,944 
Non-current assets    152,059    385,463 
Current liabilities    (147,004)   (158,182)
Non-current liabilities    (21,285)   (53,210)
Total net assets attributable   $154,494   $358,015 
Equity attributable to owners of the Group   $95,127   $222,486 
Equity attributable to non-controlling interests   $59,367   $135,529 
           
Revenue   $119,821   $149,969 
Expenses (including impairment of $ 208,931)    (313,660)   (114,709)
Profit for the year   $(193,839)  $35,260 
Profit attributable to the owners of the Group   $(121,127)  $21,846 
Profit attributable to non-controlling interests   $(72,712)  $13,414 
           
Other comprehensive (loss)/income during the year   $(9,861)  $(12,500)
Total comprehensive income during the year   $(203,700)  $22,760 
Total comprehensive income attributable to the owners of the Group    (127,093)   15,354 
Total comprehensive income attributable to non-controlling interests    (76,607)   7,406 
           
Net cash inflow from operating activities   $7,654   $50,470 
Net cash outflow from investing activities    (13,635)   (37,729 
Net cash inflow from financing activities    (12,901)   (14,462)
Net cash (outflow)/inflow   $(18,882)  $36,008 
v3.20.2
New Standards Adopted as at April 1, 2019 (Tables)
12 Months Ended
Mar. 31, 2020
New Standards Adopted As At April 1 2019  
Disclosure of Right-of-Use Asset to be Recognized Equal to Liability
 Gross Carrying Value   Premises     Equipment     Total  
On adoption of IFRS 16*   $ 2,531       307       2,838  
Additions     398       71       469  
Termination/retirements                  
Balance as at March 31, 2020   $ 2,929       378       3,307  
Accumulated depreciation                        
Balance as at April 1, 2019           62       62  
Depreciation     1,557       120       1,677  
Disposals/retirements                  
Net Translation adjustments     36       20       56  
Balance as at March 31, 2020     1,593       202       1,795  
Net Carrying value as at March 31, 2020   $ 1,336       176       1,512  

 

Particulars Total
On adoption of IFRS 16* $ 2,618
Additions   469
Finance Expense   184
Payment of lease liabilities $ (1,579)
Premature Retirements  
Translation adjustments   (139)
Balance as at March 31, 2020 $ 1,553

 

*The difference in the number accounted on adoption of IFRS 16 is due to Prepaid expenses outstanding last year reduced from Other Receivables amounting to $164.

Disclosure of Future Minimum Operating Lease Rental Payments

Future minimum lease payments due as of March 31, 2020 is as below:

 

   Lease payments   Interest   Net Present Value 
Within than one year  $822   $99   $723 
1 - 3 years   894    64    830 
3 - 5 years            
   $1,716   $163    1,553 

  

Future minimum lease payments due as of March 31, 2019 is as below:

 

   Lease payments   Interest   Net Present Value 
Within than one year  $1,480   $161   $1,319 
1 - 3 years   1,360    154    1,206 
3 - 5 years   116    23    93 
   $2,956   $338   $2,618 
v3.20.2
Going Concern - Disclosure of Information for Cash-Generating Units (Details)
Mar. 31, 2020
Mar. 31, 2019
Going Concern    
Growth rate applied beyond approved forecast period 4.00% 4.00%
Pre-tax discount rate 20.00% 21.00%
v3.20.2
Going Concern - Disclosure of Impairment Sensitivity (Details) - Non-Current Assets - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Increase in Discount Rate    
Statement Line Items [Line Items]    
Effect of assumptions on impairment loss (in millions) $ 52,000 $ 54,000
Sensitivity to key assumptions on impairment loss, rate 1.00% 1.00%
Decrease in Long Term Growth Rate Applied Beyond Approved Forecast Period    
Statement Line Items [Line Items]    
Effect of assumptions on impairment loss (in millions) $ 67,000 $ 30,000
Sensitivity to key assumptions on impairment loss, rate 1.00% 1.00%
Decrease in Projected Volume    
Statement Line Items [Line Items]    
Effect of assumptions on impairment loss (in millions) $ 44,000 $ 63,000
Sensitivity to key assumptions on impairment loss, rate 1.00% 1.00%
v3.20.2
Going Concern (Details Narrative) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Apr. 17, 2020
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Statement Line Items [Line Items]        
Borrowings   $ 178,972 $ 281,519  
Current borrowings repayable in fiscal 2021   $ 117,097    
Explanation of period over which management has projected cash flows   The growth rates used in the value in use calculation reflect those inherent within the Company's internal forecast, which is primarily a function of the future assumptions, past performance and management's expectation of future developments through fiscal 2024.    
Impairment loss   $ (431,200) (423,335)
Loss for the year   (491,704) $ (410,453) $ (9,745)
Cash received as consideration in a business combination   35,000    
Impairment charge   103,109    
Agreement and Plan of Merger | STX Filmworks, Inc.        
Statement Line Items [Line Items]        
Contingent consideration recognised as of business combination $ 125,000      
Contingent consideration arrangements As the result of this merger, (i) new investors and existing STX equity investors are expected to contribute incremental equity financing of $125,000 (of which $35,000 is received as on the date of issuance of the financial statements] and (ii) a line of undrawn credit facility totalling to ~$ 100,000 from a large financial institution with a moratorium of 5 years will be available to the combined company.      
Intangible Assets - Trademark        
Statement Line Items [Line Items]        
Goodwill and intangible assets   17,800    
Intangible Assets - Content        
Statement Line Items [Line Items]        
Goodwill and intangible assets   $ 405,535    
v3.20.2
Summary of Significant Accounting Policies - Disclosure of Other Intangible Assets (Details)
12 Months Ended
Mar. 31, 2020
Information Technology Assets  
Disclosure of detailed information about intangible assets [line items]  
Other intangible assets, life of asset 3 years
Other intangible assets, rate of amortization % straight line per annum 33.00%
Other Intangible Assets | Bottom of Range  
Disclosure of detailed information about intangible assets [line items]  
Other intangible assets, life of asset 3 years
Other intangible assets, rate of amortization % straight line per annum 17.00%
Other Intangible Assets | Top of Range  
Disclosure of detailed information about intangible assets [line items]  
Other intangible assets, life of asset 6 years
Other intangible assets, rate of amortization % straight line per annum 33.00%
v3.20.2
Summary of Significant Accounting Policies - Schedule of Property, Plant and Equipment (Details)
12 Months Ended
Mar. 31, 2020
Freehold Building  
Disclosure of detailed information about property, plant and equipment [line items]  
Property & equipment, life of asset 60 years
Freehold Building | Bottom of Range  
Disclosure of detailed information about property, plant and equipment [line items]  
Property & equipment, rate of depreciation % WDV per annum 2.00%
Freehold Building | Top of Range  
Disclosure of detailed information about property, plant and equipment [line items]  
Property & equipment, rate of depreciation % WDV per annum 10.00%
Furniture, Fittings and Equipment  
Disclosure of detailed information about property, plant and equipment [line items]  
Property & equipment, life of asset 5 years
Furniture, Fittings and Equipment | Bottom of Range  
Disclosure of detailed information about property, plant and equipment [line items]  
Property & equipment, rate of depreciation % WDV per annum 15.00%
Furniture, Fittings and Equipment | Top of Range  
Disclosure of detailed information about property, plant and equipment [line items]  
Property & equipment, rate of depreciation % WDV per annum 20.00%
Vehicles and Machinery | Bottom of Range  
Disclosure of detailed information about property, plant and equipment [line items]  
Property & equipment, life of asset 3 years
Property & equipment, rate of depreciation % WDV per annum 20.00%
Vehicles and Machinery | Top of Range  
Disclosure of detailed information about property, plant and equipment [line items]  
Property & equipment, life of asset 5 years
Property & equipment, rate of depreciation % WDV per annum 30.00%
v3.20.2
Summary of Significant Accounting Policies (Details Narrative) - Other Intangible Assets
12 Months Ended
Mar. 31, 2020
Bottom of Range  
Disclosure of detailed information about intangible assets [line items]  
Other intangible assets, life of asset 3 years
Top of Range  
Disclosure of detailed information about intangible assets [line items]  
Other intangible assets, life of asset 6 years
v3.20.2
Acquisition, Changes in Ownership Interest in Subsidiary and Deconsolidation (Details Narrative)
$ / shares in Units, $ in Thousands
12 Months Ended
Mar. 31, 2020
shares
$ / shares
Mar. 31, 2019
shares
$ / shares
Mar. 31, 2018
USD ($)
shares
Mar. 31, 2017
shares
Disclosure of detailed information about business combination [line items]        
Equity interest, divested     51.00%  
Ayngaran Group        
Disclosure of detailed information about business combination [line items]        
Equity interest, divested     51.00%  
Loss recognized in deconsolidation | $     $ (14,649)  
Fair value of subsidiary that ceased to be consolidated | $     $ 457  
IPO India Plan        
Disclosure of detailed information about business combination [line items]        
Stock options outstanding 479,615 757,886 1,624,035 2,108,063
Stock options exercised 121,496 536,263 1,113,160  
Eros International Media Limited | IPO India Plan        
Disclosure of detailed information about business combination [line items]        
Stock options outstanding 479,614 757,886    
Stock options exercised 121,496 536,263    
Stock options exercised, price per share | $ / shares [1] $ 10.00 $ 10.00    
[1] INR - Indian Rupees
v3.20.2
Business Segmental Data - Schedule of Segment by Geographical Areas (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Disclosure of geographical areas [line items]      
Revenue $ 155,452 $ 270,126 $ 261,253
Non-current assets 489,251 737,305  
Groups Operation      
Disclosure of geographical areas [line items]      
Non-current assets [1] 474,809 722,043  
Theatrical      
Disclosure of geographical areas [line items]      
Revenue 10,586 69,542 79,069
Satellite Content Licensing      
Disclosure of geographical areas [line items]      
Revenue 7,112 77,453 97,168
Digital and Other Ancillary      
Disclosure of geographical areas [line items]      
Revenue [2] 137,754 123,131 85,016
India | Groups Operation      
Disclosure of geographical areas [line items]      
Revenue 41,119 100,387 98,073
Non-current assets [1] 152,340 336,431  
India | Customer Location      
Disclosure of geographical areas [line items]      
Revenue 44,887 116,078 109,986
Europe | Groups Operation      
Disclosure of geographical areas [line items]      
Revenue 26,927 63,196 27,028
Non-current assets [1] 25,860 34,217  
Europe | Customer Location      
Disclosure of geographical areas [line items]      
Revenue 94,887 2,345 7,739
North America | Groups Operation      
Disclosure of geographical areas [line items]      
Revenue 1,309 1,759 1,244
Non-current assets [1] 1 4  
North America | Customer Location      
Disclosure of geographical areas [line items]      
Revenue 6,078 5,682 5,147
Rest of the World | Groups Operation      
Disclosure of geographical areas [line items]      
Revenue 86,097 104,784 134,908
Non-current assets [1] 297,432 351,391  
Rest of the World | Customer Location      
Disclosure of geographical areas [line items]      
Revenue $ 9,600 $ 146,021 $ 138,381
[1] Non-current assets include property and equipment, right of use assets, intangibles assets (content and others) and restricted deposit by geographic area.
[2] The ancillary includes revenue from providing producer support and VFX services to customers
v3.20.2
Business Segmental Data (Details Narrative) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Disclosure of geographical areas [line items]      
Revenue $ 155,452 $ 270,126 $ 261,253
Non-current assets 489,251 737,305  
Groups Operation      
Disclosure of geographical areas [line items]      
Non-current assets [1] 474,809 722,043  
Customers      
Disclosure of geographical areas [line items]      
Revenue discount component 5,558 34,467 6,816
United Arab Emirates | Groups Operation      
Disclosure of geographical areas [line items]      
Revenue 85,793 81,409 103,263
Non-current assets 292,109 295,685  
United Arab Emirates | Customer Location      
Disclosure of geographical areas [line items]      
Revenue 1,329 62,527 67,993
United Kingdom | Groups Operation      
Disclosure of geographical areas [line items]      
Revenue 26,927 63,196 27,028
Non-current assets 25,601 32,287  
United Kingdom | Customer Location      
Disclosure of geographical areas [line items]      
Revenue 81,465 1,180 $ 5,200
China | Customer Location      
Disclosure of geographical areas [line items]      
Revenue 5,240    
Isle of Man | Groups Operation      
Disclosure of geographical areas [line items]      
Non-current assets $ 259 $ 1,903  
[1] Non-current assets include property and equipment, right of use assets, intangibles assets (content and others) and restricted deposit by geographic area.
v3.20.2
Nature of Expenses - Schedule of Nature of Expenses (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Expense by Nature      
Publicity and advertisement costs $ 11,452 $ 19,779 $ 12,684
Film distribution costs 1,320 5,462 6,739
Amortisation expenses 64,451 130,155 115,285
Cost of sales 81,725 155,396 134,708
Personnel costs 36,697 37,015 35,661
Rent expenses 391 1,916 1,359
Legal and professional expenses 4,615 6,980 8,204
Provision for trade and other receivables 1,968
Bad debt 2,772
Credit impairment loss, net 97,551 25,741 4,308
Depreciation and amortization of other intangibles 3,462 2,263 2,991
Impairment charge on goodwill (Refer note 14) 1,205
Impairment loss on content advances 353
Impairment loss on advances to content vendors 7,284
Other expenses 6,105 5,935 9,208
Administrative costs 144,319 87,134 68,029
Expenses by nature $ 226,044 $ 242,530 $ 202,737
v3.20.2
Personnel Costs - Schedule of Personnel Costs (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Statement Line Items [Line Items]      
Salaries $ 36,697 $ 37,015 $ 35,661
Share based compensation (Refer Note 27) 22,268 21,561 17,918
Personnel Costs      
Statement Line Items [Line Items]      
Salaries 13,781 14,591 16,790
Social security and other employment charges 617 831 916
Salaries and other charges 14,398 15,422 17,706
Share based compensation (Refer Note 27) 22,268 21,561 17,918
Pension charges 31 32 37
Personnel costs $ 36,697 $ 37,015 $ 35,661
v3.20.2
Personnel Costs - Schedule of Key Management Compensation (Details) - Key Management Compensation - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Disclosure of transactions between related parties [line items]      
Salaries $ 4,395 $ 4,010 $ 4,919
Share based compensation 19,829 13,859 11,519
Pension charges 23 21 16
Key management compensation $ 24,247 $ 17,890 $ 16,454
v3.20.2
Net Finance Costs - Schedule of Finance Costs (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Finance Costs      
Interest on borrowings [1] $ 29,474 $ 33,530 $ 32,556
Reclassification of cash flow hedge to consolidated statements of income 375
Total interest expense [1] 29,474 33,530 32,931
Capitalized interest on eligible film rights and content advances (8,703) (9,437) (13,263)
Total finance costs 20,771 24,093 19,668
Less: Interest Income      
Unwinding of interest (9,807) (13,227) (932)
Bank deposits (2,185) (3,192) (923)
Total finance income (11,992) (16,419) (1,855)
Net finance costs $ 8,779 $ 7,674 $ 17,813
[1] Includes interest expense in respect of financial liabilities classified at fair value through profit or loss and significant discounting on long-term advance from customers
v3.20.2
Net Finance Costs (Details Narrative) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Net Finance Costs      
Capitalized rate of interest 11.00% 10.21% 11.56%
Interest expense $ 5,517 $ 10,682 $ 4,338
Unwinding of advance from customers 1,501 458  
Lease interest expense $ 184
v3.20.2
Other (Gains) Losses - Schedule of Other (Gains) Losses (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Other Gainslosses      
Foreign exchange (loss)/gain, net $ 5,652 $ 5,610 $ (6,250)
Gain/(loss) on sale of property and equipment and other intangibles (70) (97) 2
Gain/(loss) on available-for-sale financial assets (1,253) 37
Impairment charge on available-for-sale financial assets (2,436)
(Loss) on de-recognition of financial assets measured at amortized cost net (*) [1] (5,285) (5,988) (3,562)
Mark to market gain/(loss) on derivative financial instrument measured at fair value through profit and loss account (902)
(Loss) on settlement of derivative financial instruments (586)
(Loss) on financial liability (convertible notes) measured at fair value through profit and loss account (15,987) (21,398) (13,840)
(Loss) on deconsolidation of a subsidiary (14,649)
Reversal of expected credit loss 10,382 20,698
Liabilities no longer required, written back 2,487
Credit from Government of India 760 2,328
Other (Gains)/Losses $ (3,314) $ 288 $ (41,321)
[1] Arising on assignment and novation of trade receivables and trade payables with no-recourse. Derecognition of aforesaid financial assets/liabilities measured at amortized cost is to mitigate both credit risk and liquidity risk.
v3.20.2
Income Tax Expense - Schedule of Income Tax Expense (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Income Tax Expense      
Current income tax expense $ 1,800 $ 17,372 $ 5,556
Deferred income tax (benefit)/charge (23,983) (10,044) 3,571
Income tax expense $ (22,183) $ 7,328 $ 9,127
v3.20.2
Income Tax Expense - Schedule of Reconciliation of Tax Expense (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Income Tax Expense      
(Loss) Profit before tax $ (513,887) $ (403,125) $ (618)
Income tax (benefit)/expense at tax rates applicable to individual entities [1] (44,763) 6,814 7,358
Tax effect of:      
Effect of unrecognised tax asset 29,898 [2] 657 [2]
Changes in tax rates on temporary differences brought forward (7,476) 232 (168)
Items not deductible for income tax 5 688 486
Adjustments in respect of current income tax of previous years (762)
Others 153 356 794
Income tax expense $ (22,183) $ 7,328 $ 9,127
[1] Domestic tax is Nil as the Company is subject to income tax in Isle of Man at a rate of zero percent. Foreign taxes are based on applicable tax rates in each subsidiary jurisdiction.
[2] In view of tax losses on Company’s Indian listed subsidiary, deferred tax assets on deductible temporary differences have been recognised to the extent of deferred tax liability on taxable temporary difference on account of lack of sufficient certainty of future earnings against which such deferred tax asset can be realised. Unrecognised tax asset in respect of tax losses and deductible temporary differences of $118,793 is $29,898.
v3.20.2
Deferred Income Tax Assets and Liabilities - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]    
Deferred Tax Liabilities/Assets, beginning balance $ (26,164) $ (39,168)
Impact of adoption of IFRS 9   673
Recognized in statements of income 23,983 10,044
Exchange Difference 235 2,287
Deferred Tax Liabilities/Assets, closing balance (1,946) (26,164)
Deferred income tax asset 742 1,263
Deferred income tax liability 2,688 27,427
Deferred Tax Liabilities    
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]    
Deferred Tax Liabilities/Assets, beginning balance (34,653) (42,620)
Impact of adoption of IFRS 9  
Recognized in statements of income 20,138 5,455
Exchange Difference 1,917 2,483
Deferred Tax Liabilities/Assets, closing balance (12,598) (34,653)
Property and Equipment | Deferred Tax Liabilities    
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]    
Deferred Tax Liabilities/Assets, beginning balance (624) (776)
Impact of adoption of IFRS 9  
Recognized in statements of income (38) 142
Exchange Difference 520 10
Deferred Tax Liabilities/Assets, closing balance (66) (624)
Content Advances and Film Production    
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]    
Deferred Tax Liabilities/Assets, beginning balance (34,029) (41,815)
Recognized in statements of income 20,100 5,313
Exchange Difference 1,397 2,473
Deferred Tax Liabilities/Assets, closing balance (12,532) (34,029)
Deferred Tax Assets    
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]    
Deferred Tax Liabilities/Assets, beginning balance 8,489 3,452
Impact of adoption of IFRS 9   673
Recognized in statements of income 3,845 4,589
Exchange Difference (1,682) (196)
Deferred Tax Liabilities/Assets, closing balance 10,652 8,489
Deferred Tax Assets | Minimum Alternate Tax Carry-Forward    
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]    
Deferred Tax Liabilities/Assets, beginning balance 88 927
Impact of adoption of IFRS 9  
Recognized in statements of income 2 (778)
Exchange Difference (6) (61)
Deferred Tax Liabilities/Assets, closing balance 84 88
Deferred Tax Assets | Property and Equipment    
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]    
Deferred Tax Liabilities/Assets, beginning balance 76 83
Impact of adoption of IFRS 9  
Recognized in statements of income 120 (2)
Exchange Difference (9) (5)
Deferred Tax Liabilities/Assets, closing balance 187 76
Deferred Tax Assets | Credit Impairment Loss    
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]    
Deferred Tax Liabilities/Assets, beginning balance 5,044
Impact of adoption of IFRS 9   673
Recognized in statements of income (3,740) 4,385
Exchange Difference (918) (14)
Deferred Tax Liabilities/Assets, closing balance 386 5,044
Deferred Tax Assets | Content Advances and Film Production    
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]    
Deferred Tax Liabilities/Assets, beginning balance  
Recognized in statements of income 11,791  
Exchange Difference (2,916)  
Deferred Tax Liabilities/Assets, closing balance 8,875
Deferred Tax Assets | Others    
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]    
Deferred Tax Liabilities/Assets, beginning balance 3,281 2,442
Impact of adoption of IFRS 9  
Recognized in statements of income (4,328) 984
Exchange Difference 2,167 (116)
Deferred Tax Liabilities/Assets, closing balance $ 1,120 $ 3,281
v3.20.2
Deferred Income Tax Assets and Liabilities (Details Narrative) - USD ($)
$ in Thousands
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Deferred Income Tax Assets And Liabilities      
Deferred tax liabilities which have not been provided on the undistributed earnings of subsidiaries $ 21,390 $ 49,163 $ 43,962
Deferred tax asset, recognized in balance sheet $ 82 $ 84 $ 927
v3.20.2
Earnings Per Share - Schedule of Earnings Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Number of Shares      
Potential dilutive effect related to share based compensation scheme 6,101,667 1,957,035  
Earnings per Share Attributable to Equity Holders      
(Loss) attributable to the equity holders of the parent per share (cents), basic $ (389.6) $ (599.5) $ (36.3)
(Loss) attributable to the equity holders of the parent per share (cents), diluted $ (389.6) $ (599.5) $ (36.3)
Basic      
Earnings      
(Loss) attributable to the equity holders of the parent $ (418,992) $ (423,867) $ (22,575)
Potential dilutive effect related to share based compensation scheme in subsidiary undertaking
Adjusted earnings attributable to equity holders of the parent $ (418,992) $ (423,867) $ (22,575)
Number of Shares      
Weighted average number of shares 107,532,584 70,706,579 62,151,155
Potential dilutive effect related to share based compensation scheme
Adjusted weighted average number of shares 107,532,584 70,706,579 62,151,155
Earnings per Share Attributable to Equity Holders      
(Loss) attributable to the equity holders of the parent per share (cents), basic $ (389.6) $ (599.5) $ (36.3)
Diluted      
Earnings      
(Loss) attributable to the equity holders of the parent $ (418,992) $ (22,575)
Potential dilutive effect related to share based compensation scheme in subsidiary undertaking (475)
Adjusted earnings attributable to equity holders of the parent $ (418,992) $ (23,050)
Number of Shares      
Weighted average number of shares 107,532,584 62,151,155
Potential dilutive effect related to share based compensation scheme 8,237,299 1,331,211
Adjusted weighted average number of shares 115,769,883 63,482,366
Earnings per Share Attributable to Equity Holders      
(Loss) attributable to the equity holders of the parent per share (cents), diluted $ (389.6) $ (36.3)
v3.20.2
Earnings Per Share (Details Narrative) - shares
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Earnings Per Share    
Shares not included in diluted earnings per share 6,101,667 1,957,035
Convertible note shares not included in diluted earnings per share 13,888,889 7,567,962
v3.20.2
Property and Equipment - Schedule of Changes in Property and Equipment (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Disclosure of detailed information about property, plant and equipment [line items]    
Opening net carrying amount $ 10,921  
Closing net carrying amount 9,234 $ 10,921
Land and Buildings    
Disclosure of detailed information about property, plant and equipment [line items]    
Opening net carrying amount 9,562 8,481
Exchange difference (480) (292)
Revaluation   1,745
Additions 30 207
Disposals   (449)
Adjustment of depreciation on disposal   367
Depreciation charge (579) (497)
Closing net carrying amount 8,533 9,562
Furniture, Fittings and Equipment    
Disclosure of detailed information about property, plant and equipment [line items]    
Opening net carrying amount 199 348
Exchange difference (8) (12)
Additions   16
Reclassification and other adjustments   (61)
Disposals (2) (56)
Adjustment of depreciation on disposal 1 39
Depreciation charge (49) (75)
Closing net carrying amount 141 199
Vehicles    
Disclosure of detailed information about property, plant and equipment [line items]    
Opening net carrying amount 549 698
Exchange difference (29) (43)
Additions   116
Reclassification and other adjustments   2
Disposals (116)  
Adjustment of depreciation on disposal 28  
Depreciation charge (132) (224)
Closing net carrying amount 300 549
Machinery    
Disclosure of detailed information about property, plant and equipment [line items]    
Opening net carrying amount 601 476
Exchange difference (7) (12)
Additions 31 394
Adjustment on Adoption of IFRS 16 (243)  
Disposals (2) (65)
Adjustment of depreciation on disposal 2 61
Depreciation charge (131) (253)
Closing net carrying amount 251 601
Total Property, Plant and Equipment    
Disclosure of detailed information about property, plant and equipment [line items]    
Opening net carrying amount 10,911 10,003
Exchange difference (524) (359)
Revaluation   1,745
Additions 61 733
Adjustment on Adoption of IFRS 16 (243)  
Reclassification and other adjustments   (59)
Disposals (120) (570)
Adjustment of depreciation on disposal 31 467
Depreciation charge (891) (1,049)
Closing net carrying amount $ 9,225 $ 10,911
v3.20.2
Property and Equipment - Schedule of Carrying Value of Property and Equipment (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Disclosure of detailed information about property, plant and equipment [line items]      
Cost or valuation $ 9,225 $ 10,911  
Capital work in progress 9 10  
Net carrying amount 9,234 10,921  
Gross Carrying Amount      
Disclosure of detailed information about property, plant and equipment [line items]      
Cost or valuation 20,433 21,324  
Accumulated Depreciation      
Disclosure of detailed information about property, plant and equipment [line items]      
Cost or valuation (11,208) (10,413)  
Land and Buildings      
Disclosure of detailed information about property, plant and equipment [line items]      
Net carrying amount 8,533 9,562 $ 8,481
Land and Buildings | Gross Carrying Amount      
Disclosure of detailed information about property, plant and equipment [line items]      
Cost or valuation 13,408 13,858  
Land and Buildings | Accumulated Depreciation      
Disclosure of detailed information about property, plant and equipment [line items]      
Cost or valuation (4,875) (4,296)  
Furniture, Fittings and Equipment      
Disclosure of detailed information about property, plant and equipment [line items]      
Net carrying amount 141 199 348
Furniture, Fittings and Equipment | Gross Carrying Amount      
Disclosure of detailed information about property, plant and equipment [line items]      
Cost or valuation 1,749 1,759  
Furniture, Fittings and Equipment | Accumulated Depreciation      
Disclosure of detailed information about property, plant and equipment [line items]      
Cost or valuation (1,608) (1,560)  
Vehicles      
Disclosure of detailed information about property, plant and equipment [line items]      
Net carrying amount 300 549 698
Vehicles | Gross Carrying Amount      
Disclosure of detailed information about property, plant and equipment [line items]      
Cost or valuation 1,244 1,389  
Vehicles | Accumulated Depreciation      
Disclosure of detailed information about property, plant and equipment [line items]      
Cost or valuation (944) (840)  
Machinery      
Disclosure of detailed information about property, plant and equipment [line items]      
Net carrying amount 251 601 $ 476
Machinery | Gross Carrying Amount      
Disclosure of detailed information about property, plant and equipment [line items]      
Cost or valuation 4,032 4,318  
Machinery | Accumulated Depreciation      
Disclosure of detailed information about property, plant and equipment [line items]      
Cost or valuation $ (3,781) $ (3,717)  
v3.20.2
Property and Equipment (Details Narrative) - USD ($)
$ in Thousands
Mar. 31, 2020
Mar. 31, 2019
Property And Equipment    
Property, plant and equipment pledged to secure borrowings $ 8,189 $ 6,685
Fair value estimated on recent market transactions, then adjusted, carrying amount 4,337 4,983
Capital work in progress $ 9 $ 10
v3.20.2
Goodwill and Trademark - Schedule of Reconciliation of Changes in Goodwill and Trade Name (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Disclosure of reconciliation of changes in goodwill [line items]      
Impairment $ 1,205
Goodwil      
Disclosure of reconciliation of changes in goodwill [line items]      
Goodwill, beginning balance 0    
Impairment    
Goodwill, ending balance $ 0 $ 0  
v3.20.2
Intangible Content Assets - Schedule of Intangible Content Assets (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Disclosure of detailed information about intangible assets [line items]      
Content assets $ 461,889 $ 706,572  
Impairment of intangible assets (431,200) (423,335)
Gross Carrying Amount      
Disclosure of detailed information about intangible assets [line items]      
Content assets 2,274,398 2,066,735  
Accumulated Depreciation      
Disclosure of detailed information about intangible assets [line items]      
Content assets (975,773) (954,628)  
Impairment Loss      
Disclosure of detailed information about intangible assets [line items]      
Impairment of intangible assets (836,735) (405,535)  
Film and Content Rights      
Disclosure of detailed information about intangible assets [line items]      
Content assets 301,979 354,075  
Impairment of intangible assets (557,510) (366,703)  
Film and Content Rights | Gross Carrying Amount      
Disclosure of detailed information about intangible assets [line items]      
Content assets 1,835,263 1,675,406  
Film and Content Rights | Accumulated Depreciation      
Disclosure of detailed information about intangible assets [line items]      
Content assets (975,774) (954,628)  
Content Advances      
Disclosure of detailed information about intangible assets [line items]      
Content assets 152,721 339,436  
Impairment of intangible assets (274,325) (38,832)  
Content Advances | Gross Carrying Amount      
Disclosure of detailed information about intangible assets [line items]      
Content assets 427,046 378,268  
Content Advances | Accumulated Depreciation      
Disclosure of detailed information about intangible assets [line items]      
Content assets  
Film Productions      
Disclosure of detailed information about intangible assets [line items]      
Content assets 7,189 13,061  
Impairment of intangible assets (4,900)  
Film Productions | Gross Carrying Amount      
Disclosure of detailed information about intangible assets [line items]      
Content assets 12,089 13,061  
Film Productions | Accumulated Depreciation      
Disclosure of detailed information about intangible assets [line items]      
Content assets  
v3.20.2
Intangible Content Assets - Schedule of Reconciliation of Changes in Intangible Content Assets (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Disclosure of detailed information about intangible assets [line items]      
Additions   $ 907  
Exchange difference $ (137) (148)  
Deconsolidation     $ (4,878)
Film Productions      
Disclosure of detailed information about intangible assets [line items]      
Intangible - content assets, beginning balance 13,061 10,867  
Additions 9,314 3,413  
Exchange difference (751) (775)  
Impairment loss (4,900)    
Transfer to film and content rights (9,535) (444)  
Intangible - content assets, ending balance 7,189 13,061 10,867
Content Advances      
Disclosure of detailed information about intangible assets [line items]      
Intangible - content assets, beginning balance 339,436 349,568  
Additions [1] 255,940 261,002  
Reclassification   (65)  
Exchange difference (9,484) (12,314)  
Impairment loss (235,493) (38,832)  
Transfer to film and content rights (197,678) (219,923)  
Intangible - content assets, ending balance 152,721 339,436 349,568
Film and Content Rights      
Disclosure of detailed information about intangible assets [line items]      
Intangible - content assets, beginning balance 354,075 638,108  
Amortization (64,451) (130,155)  
Exchange difference (4,486) (7,542)  
Impairment loss (190,807) (366,703)  
Transfer from inventory 435    
Transfer from film production and content advances 207,213 220,367  
Intangible - content assets, ending balance $ 301,979 $ 354,075 $ 638,108
[1] Represents non-cash movement on account of de-recognition of financial liabilities.
v3.20.2
Intangible Content Assets (Details Narrative) - Film and Content Rights - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Disclosure of detailed information about intangible assets [line items]    
Intangible assets pledged against secured borrowings $ 123,180 $ 310,996
De-recognition of financial liabilities 90,118 $ 160,615
Capital creditors settled by issuance of shares, value $ 24,513  
v3.20.2
Intangible Assets - Other - Schedule of Reconciliation of Changes to Other Intangible Assets (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]    
Other intangible assets, beginning balance $ 3,794 $ 5,280
Exchange difference (137) (148)
Disposals and reclassification (63) (1,031)
Additions   907
Amortization charge (894) (1,214)
Intangibles under development 235  
Other intangible assets, ending balance 2,935 3,794
Information Technology Assets    
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]    
Other intangible assets, beginning balance 1,204 1,449
Disposals and reclassification (59) (59)
Amortization charge (39) (304)
Other intangible assets, ending balance 1,106 1,204
Other Intangible Assets    
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]    
Other intangible assets, beginning balance 2,590 3,831
Exchange difference (137) (148)
Disposals and reclassification (4) (1,090)
Additions   907
Amortization charge (855) (910)
Other intangible assets, ending balance $ 1,594 $ 2,590
v3.20.2
Intangible Assets - Other - Schedule of Other Intangible Assets (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Disclosure of detailed information about intangible assets [line items]      
Other intangible assets $ 2,935 $ 3,794 $ 5,280
Gross Carrying Amount      
Disclosure of detailed information about intangible assets [line items]      
Other intangible assets 11,756 11,721  
Accumulated Depreciation      
Disclosure of detailed information about intangible assets [line items]      
Other intangible assets (8,821) (7,927)  
Net Carrying Value      
Disclosure of detailed information about intangible assets [line items]      
Other intangible assets 2,935 3,794  
Information Technology Assets      
Disclosure of detailed information about intangible assets [line items]      
Other intangible assets 1,106 1,204 1,449
Information Technology Assets | Gross Carrying Amount      
Disclosure of detailed information about intangible assets [line items]      
Other intangible assets 5,055 5,114  
Information Technology Assets | Accumulated Depreciation      
Disclosure of detailed information about intangible assets [line items]      
Other intangible assets (3,949) (3,910)  
Other Intangible Assets      
Disclosure of detailed information about intangible assets [line items]      
Other intangible assets 1,594 2,590 $ 3,831
Other Intangible Assets | Gross Carrying Amount      
Disclosure of detailed information about intangible assets [line items]      
Other intangible assets 6,466 6,607  
Other Intangible Assets | Accumulated Depreciation      
Disclosure of detailed information about intangible assets [line items]      
Other intangible assets (4,872) $ (4,017)  
Intangibles Under Development      
Disclosure of detailed information about intangible assets [line items]      
Other intangible assets $ 235    
v3.20.2
Intangible Assets - Other (Details Narrative) - USD ($)
$ in Thousands
Mar. 31, 2020
Mar. 31, 2019
Other Intangible Assets    
Disclosure of detailed information about intangible assets [line items]    
Other intangible assets pledged against secured borrowings $ 57 $ 92
v3.20.2
Available-For-Sale Financial Assets - Schedule of Available-For-Sale Financial Assets (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Mar. 31, 2019
Disclosure of financial assets [line items]    
Non-current available-for-sale financial assets $ 140 $ 2,650
Current available-for-sale financial assets 3,942 3,692
Financial Assets Available-For-Sale | Plutus Opportunities Fund Limited    
Disclosure of financial assets [line items]    
Current available-for-sale financial assets 3,577
Financial Assets Available-For-Sale | Polyxo Global Limited    
Disclosure of financial assets [line items]    
Current available-for-sale financial assets 225 1,042
Financial Assets Available-For-Sale | LMB Holdings Limited    
Disclosure of financial assets [line items]    
Non-current available-for-sale financial assets 650
Financial Assets Available-For-Sale | Valuable Technologies Limited    
Disclosure of financial assets [line items]    
Non-current available-for-sale financial assets $ 140 $ 2,000
v3.20.2
Available-For-Sale Financial Assets - Disclosure of Measurements of Financial Assets (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Financial Assets Measured through FVTPL    
Statement Line Items [Line Items]    
Available-for-sale financial assets, beginning of period $ 1,042 $ 27,257
Reclassifications   (27,257)
Additions 4,013 1,005
Fair value gain/(loss) (1,253) 37
Total gain or (losses)    
Available-for-sale financial assets, end of period 3,802 1,042
Financial Assets Measured through FVTOCI    
Statement Line Items [Line Items]    
Available-for-sale financial assets, beginning of period 2,650 0
Reclassifications   27,257
Additions   80
Disposals (650)  
Fair value gain/(loss) (1,860) (24,687)
Total gain or (losses)    
Available-for-sale financial assets, end of period $ 140 $ 2,650
v3.20.2
Available-For-Sale Financial Assets (Details Narrative) - Financial Assets Available-For-Sale - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2019
Mar. 31, 2020
Acacia Investments Holdings Limited    
Disclosure of financial assets [line items]    
Ownership interest, description Acacia Investments Holdings Limited ("Acacia") is a dormant holding company and owns 12.97% of L.M.B Holdings Limited ("LMB") which through its subsidiaries operates satellite television channels, such as B4U Music, B4U Movies and the Movie House Channel.  
Fair value of sale of investment $ 650  
Valuable Technologies Limited    
Disclosure of financial assets [line items]    
Proportion of ownership interest 7.20%  
Method used to account for investment Net Asset Value  
Fair value of amount of investment   $ 140
v3.20.2
Inventories - Schedule of Inventories (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Mar. 31, 2019
Inventories - Schedule Of Inventories    
Goods for resale $ 0 $ 435
Inventories $ 0 $ 435
v3.20.2
Inventories (Details Narrative) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Inventories - Schedule Of Inventories    
Inventory recognized as an expense $ 0 $ 93
Write down of inventory 0 69
Inventory pledged as security $ 0 $ 435
v3.20.2
Trade and Other Receivables - Schedule of Trade and Other Receivables (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Mar. 31, 2019
Statement Line Items [Line Items]    
Credit impairment (loss) $ 112,322 $ 41,335
Current 12,504 79,916
Non-current 10,761 10,065
Trade Accounts Receivable at Fair Value    
Statement Line Items [Line Items]    
Trade accounts receivables [1] 138,869 156,026
Credit impairment (loss) [1] (41,470) (26,133)
Fair Value gain/(loss) [1] (2,650) (4,664)
Trade accounts receivables net [1] 94,749 125,229
Trade Accounts Receivable at Amortised Cost    
Statement Line Items [Line Items]    
Trade accounts receivables 77,772 86,331
Credit impairment (loss) (70,853) (15,202)
Trade accounts receivables net 6,919 71,129
Trade Receivables    
Statement Line Items [Line Items]    
Balance with statutory authorities 6,568 7,672
Accrued interest 92 2,188
Advance to content vendor 1,373 3,462
Prepaid charges 2,578 1,790
Unbilled revenues 553 1,717
Other receivables 5,182 2,023
Trade and other receivables 118,014 215,210
Current 107,253 205,145
Non-current $ 10,761 $ 10,065
[1] Business model is achieved both by collecting contractual cash flows and de-recognition of financial assets arising on assignment and novation transaction.
v3.20.2
Trade and Other Receivables - Schedule of Age of Financial Assets Past Due but not Impaired (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Mar. 31, 2019
Disclosure of financial assets that are either past due or impaired [line items]    
Financial assets that are past due $ 120,223 $ 355,168
Financial Assets Past Due but not Impaired    
Disclosure of financial assets that are either past due or impaired [line items]    
Financial assets that are past due 46,656 84,741
Financial Assets Past Due but not Impaired | Not more than three months    
Disclosure of financial assets that are either past due or impaired [line items]    
Financial assets that are past due 15,097 44,687
Financial Assets Past Due but not Impaired | More than three months but not more than six months    
Disclosure of financial assets that are either past due or impaired [line items]    
Financial assets that are past due 11,764 15,948
Financial Assets Past Due but not Impaired | More than six months but not more than one year    
Disclosure of financial assets that are either past due or impaired [line items]    
Financial assets that are past due 14,896 15,310
Financial Assets Past Due but not Impaired | More than one year    
Disclosure of financial assets that are either past due or impaired [line items]    
Financial assets that are past due $ 4,899 $ 8,796
v3.20.2
Trade and Other Receivables - Schedule of Movement in Trade and Other Receivables for Expected Credit Losses (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Trade Receivables    
Statement Line Items [Line Items]    
Allowance for credit loss, beginning of period $ 41,335 $ 10,193
Impact of adoption of IFRS 9   18,050
Charged to operations 103,109 60,208
Unwinding of expected credit loss (included in finance income) (9,807) (13,227)
Reversal of expected credit loss (included in other gains/(losses)) (10,382) (20,698)
Bad debts (6,743) (13,031)
Translation adjustment (5,189) (160)
Allowance for credit loss, end of period 112,323 41,335
Other Receivables    
Statement Line Items [Line Items]    
Allowance for credit loss, beginning of period 447
Impact of adoption of IFRS 9   447
Charged to operations 7,284
Unwinding of expected credit loss (included in finance income)
Reversal of expected credit loss (included in other gains/(losses))
Bad debts (7,284)
Translation adjustment (46)
Allowance for credit loss, end of period 401 447
Total Receivables    
Statement Line Items [Line Items]    
Allowance for credit loss, beginning of period 41,782 10,193
Impact of adoption of IFRS 9   18,497
Charged to operations 103,109 67,492
Unwinding of expected credit loss (included in finance income) (9,807) (13,227)
Reversal of expected credit loss (included in other gains/(losses)) (10,382) (20,698)
Bad debts (6,743) (20,315)
Translation adjustment (5,189) (160)
Allowance for credit loss, end of period $ 112,770 $ 41,782
v3.20.2
Trade and Other Receivables (Details Narrative) - USD ($)
$ in Thousands
Mar. 31, 2020
Mar. 31, 2019
Trade And Other Receivables    
Trade and other accounts receivable pledged as security $ 29,969 $ 83,991
v3.20.2
Trade and Other Payables - Schedule of Trade and Other Payables (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Mar. 31, 2019
Trade And Other Payables    
Trade account payables [1] $ 21,030 $ 25,299
Accruals and other payables 43,809 32,888
Contract liability (deferred revenue) 9,827 12,260
Accrued Interest 3,106 2,395
Value added taxes and other taxes payable 13,169 10,645
Trade and other payables $ 90,941 $ 83,487
[1] Netted of payables through issuance of shares.
v3.20.2
Trade and Other Payables (Details Narrative) - USD ($)
$ in Thousands
Mar. 31, 2020
Mar. 31, 2019
Trade And Other Payables    
Creditors for content assets $ 29,937 $ 16,139
v3.20.2
Cash and Cash Equivalents - Schedule of Cash and Cash Equivalents (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2017
Cash And Cash Equivalents        
Cash at bank and in hand $ 2,563 $ 89,117    
Cash and cash equivalents $ 2,563 [1] $ 89,117 [1] $ 87,762 $ 112,267
[1] Includes $Nil (2019: $46,666) of restricted deposits.
v3.20.2
Borrowings - Schedule of Detailed Information about Borrowings (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Disclosure of detailed information about borrowings [line items]    
Long-term borrowings $ 62,114 $ 71,920
Unsecured long-term borrowings 62,274 133,564
Short-term borrowings 93,758 140,559
Long-Term Borrowings | Installments Due Within One Year, Convertible Notes    
Disclosure of detailed information about borrowings [line items]    
Unamortized costs (68,349) [1]
Long-Term Borrowings | Installments Due Within One Year, Others    
Disclosure of detailed information about borrowings [line items]    
Unamortized costs (7,267) (7,267)
Long-Term Borrowings | Vehicle Loan    
Disclosure of detailed information about borrowings [line items]    
Long-term borrowings $ 127 $ 382
Interest rate, basis 2.5 - 9.5% 2.5 - 9.5%
Maturity 2017-22 2017-22
Long-Term Borrowings | Term Loan #1    
Disclosure of detailed information about borrowings [line items]    
Long-term borrowings $ 6,843 $ 12,947
Interest rate, basis MCLR +3.2% - 4.50% MCLR +3.2% - 4.50%
Maturity 2019-22 2019-22
Long-Term Borrowings | Term Loan #2    
Disclosure of detailed information about borrowings [line items]    
Long-term borrowings $ 509 $ 1,083
Interest rate, basis BR+2.75% BR+2.75%
Maturity 2020-21 2020-21
Long-Term Borrowings | Term Loan #3    
Disclosure of detailed information about borrowings [line items]    
Long-term borrowings $ 251
Interest rate, basis 10.39% - 13.75% 10.39% - 13.75%
Maturity 2020-23 2020-23
Long-Term Borrowings | Retail Bond    
Disclosure of detailed information about borrowings [line items]    
Unsecured long-term borrowings $ 62,274 $ 65,215
Interest rate, basis 6.50% 6.50%
Maturity 2021-22 2021-22
Long-Term Borrowings | Convertible Notes    
Disclosure of detailed information about borrowings [line items]    
Unsecured long-term borrowings $ 68,349 [2]
Interest rate, basis 14.23% 14.23%
Maturity 2020-21 2020-21
Long-Term Borrowings | Cumulative Effect of Unamortized Costs    
Disclosure of detailed information about borrowings [line items]    
Unamortized costs $ (399) $ (691)
Long-Term Borrowings | Long-Term Borrowings at Amortized Cost    
Disclosure of detailed information about borrowings [line items]    
Unamortized costs (62,114) (71,920)
Short-Term Borrowings | Installments Due Within One Year on Long-Term Borrowings    
Disclosure of detailed information about borrowings [line items]    
Short-term unsecured borrowings 7,240 75,616
Short-Term Borrowings | Convertible Notes    
Disclosure of detailed information about borrowings [line items]    
Short-term borrowings $ 23,100
Interest rate, basis 9.96%  
Short-Term Borrowings | Export Credit, Bill Discounting and Overdraft    
Disclosure of detailed information about borrowings [line items]    
Short-term borrowings $ 37,755 $ 32,078
Interest rate, basis MCLR +.40% to 6% MCLR +.40% to 6%
Short-Term Borrowings | Export Credit, Bill Discounting and Overdraft #2    
Disclosure of detailed information about borrowings [line items]    
Short-term borrowings $ 3,442 $ 3,533
Interest rate, basis Base Rate + 0.5% to 1% Base Rate + 0.5% to 1%
Short-Term Borrowings | Export Credit, Bill Discounting and Overdraft #3    
Disclosure of detailed information about borrowings [line items]    
Short-term borrowings $ 28,773 $ 26,719
Interest rate, basis 6.01% - 15.25% 6.01% - 15.25%
Short-Term Borrowings | Short-Term Loan #1    
Disclosure of detailed information about borrowings [line items]    
Short-term borrowings [3] $ 16,548 $ 70,962
Interest rate, basis 3.25% - 16.45% 3.25% - 16.45%
Short-Term Borrowings | Total Short-Term Borrowings    
Disclosure of detailed information about borrowings [line items]    
Short-term borrowings $ 116,858 $ 208,908
Short-Term Borrowings | Short-Term Borrowings at Amortized Cost    
Disclosure of detailed information about borrowings [line items]    
Short-term borrowings 93,758 140,559
Short-Term Borrowings | Short-Term Borrowings at Fair Value    
Disclosure of detailed information about borrowings [line items]    
Short-term borrowings $ 23,100 $ 68,349
[1] Eros International Plc. issued Senior Convertible Notes (SCN or convertible notes) on September 25, 2019 amounting to $27,500 principal amount. The maturity date of convertible is September 26, 2020. The installments will be converted into A ordinary equity shares of the issuer at the option of the issuer as per the terms of the arrangement.
[2] Eros International Plc. ("issuer") issued Senior Convertible Notes (SCN or convertible notes) on December 06, 2017 amounting to $122,500 principal amount and option to purchase warrants up to 2,000 of A ordinary share for a term of 6 months at an offer price of $100,000 by private placement. The notes are payable in equal installments of $3,500 per month for 35 months. The installments can be paid either in cash or can be converted into A ordinary equity shares of the issuer at the option of the issuer as per the terms of the arrangement.
[3] Secured by pledge of shares held in the Group's majority owned subsidiary, Eros International Media Limited, India
v3.20.2
Borrowings - Schedule of Fair Value Measurement of Convertible Notes (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Statement Line Items [Line Items]      
Beginning balance as at March 31, 2019 $ 281,519    
Interest [1] 29,474 $ 33,530 $ 32,556
'A' ordinary shares issued in lieu of convertible notes 91,753 49,741 32,168
Receipt from convertible notes $ 111,278
Ending balance as at March 31, 2020 178,972 281,519  
Long-Term and Short-Term Borrowings      
Statement Line Items [Line Items]      
Beginning balance as at March 31, 2019 68,349    
Interest 5,517    
'A' ordinary shares issued in lieu of convertible notes (91,753)    
Receipt from convertible notes 25,000    
Loss on fair value of convertible notes 15,987    
Ending balance as at March 31, 2020 $ 23,100 $ 68,349  
[1] Includes interest expense in respect of financial liabilities classified at fair value through profit or loss and significant discounting on long-term advance from customers
v3.20.2
Borrowings (Details Narrative) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2017
Borrowings Disclosure Abstract      
Fair value of financial liability, recognized at date of issue     $ 100,055
Fair value of financial liability outstanding $ 23,100 $ 68,349  
Mark-to-market loss 15,987 21,398  
Mark-to-market loss, net finance cost $ 5,517 $ 10,682  
Borrowings, interest rate 100.00% 10.21%  
Fair value of long-term borrowings $ 43,964 $ 140,968  
Fair value of retail bond 36,897 59,313  
Fair value of senior convertible notes $ 23,100 68,349  
Senior convertible notes issued     $ 122,500
Option to purchase warrants, description     Option to purchase warrants up to 2,000 of A ordinary share for a term of 6 months at an offer price of $100,000 by private placement.
Monthly payments on convertible notes     $ 3,500
Proceeds from issuance of convertible notes   $ 27,500  
v3.20.2
Acceptances - Schedule of Other Financial Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Mar. 31, 2019
Acceptances - Schedule Of Other Financial Liabilities    
Payable under the film financing arrangements $ 1,858 $ 8,366
Acceptances $ 1,858 $ 8,366
v3.20.2
Other Long-Term Liabilities - Schedule of Other Long-Term Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Mar. 31, 2019
Other Long-term Liabilities    
Deferred revenue [1] $ 7,793 $ 13,271
Employee benefit obligation 465 627
Other long-term liabilities 8,258 13,898
Discount on long-term advances from customers $ 1,925 $ 458
[1] Includes significant discounting on long-term advances from customers
v3.20.2
Derivative Financial Instruments - Schedule of Derivative Financial Instruments (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Mar. 31, 2019
Derivative Financial Instruments    
Interest rate cap   $ (620)
Current derivative liabilities held for trading $ 620
v3.20.2
Issued Share Capital - Schedule of Issued Share Capital (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Disclosure of classes of share capital [line items]                      
Shares issued, value $ 6,780 $ 6,747 $ 12,276 $ 1,598 $ 742 $ 641 $ 1,471 $ 1,138      
Share capital $ 66,727       $ 39,326       $ 66,727 $ 39,326  
Ordinary shares authorized 200,000,000 [1]       150,000,000       200,000,000 [1] 150,000,000  
Ordinary shares authorized, value $ 60,000       $ 45,000       $ 60,000 $ 45,000  
'A' Ordinary Shares                      
Disclosure of classes of share capital [line items]                      
Ordinary shares allotted, called up and fully paid [2] 127,116,702       67,291,738       127,116,702 67,291,738 55,718,423
Shares issued 13,425,561 16,250,661 [2] 25,956,283 [2] 4,192,459 [2] 1,892,518 [2] 1,659,767 [2] 3,773,385 [2] 2,747,645 [2] 59,824,964 10,073,315  
'A' Ordinary Shares | Issuance Toward Equity Infusion From Funds                      
Disclosure of classes of share capital [line items]                      
Shares issued                 1,303,212 [3]  
Average exercise price                 $ 3.22    
'A' Ordinary Shares | Issuance to Vendors                      
Disclosure of classes of share capital [line items]                      
Shares issued [4]                 6,475,600    
'A' Ordinary Shares | 2015 Share Plan                      
Disclosure of classes of share capital [line items]                      
Shares issued [5]                 132,013 10,416  
Average exercise price                 $ 2.00 $ 7.92  
'A' Ordinary Shares | Issuance Towards Reliance Industries Limited                      
Disclosure of classes of share capital [line items]                      
Shares issued                 3,111,088 [6]  
Average exercise price                   $ 15.00  
'A' Ordinary Shares | Exercise Against Restricted Share Unit/Management Scheme                      
Disclosure of classes of share capital [line items]                      
Shares issued [7]                 2,728,181 770,541  
Average exercise price                   $ 0.39  
Shares exercised                 2,828,181 183,000  
Shares issued to settle payables [8]                 6,475,600    
'A' Ordinary Shares | Issuance Towards Settlement Of Convertible Notes                      
Disclosure of classes of share capital [line items]                      
Shares issued [9]                 49,185,958 4,411,359  
Average exercise price                 $ 1.87 $ 11.28  
'A' Ordinary Shares | Issuance To Founders Group                      
Disclosure of classes of share capital [line items]                      
Shares issued                 1,769,911 [10],[11]  
Average exercise price                 $ 14.69  
'A' Ordinary Shares | Transfer of B Ordinary to A Ordinary Share                      
Disclosure of classes of share capital [line items]                      
Ordinary shares allotted, called up and fully paid [2]         1,500,000         1,500,000  
"B" Ordinary Shares                      
Disclosure of classes of share capital [line items]                      
Ordinary shares allotted, called up and fully paid [2] 19,899,085               19,899,085    
Shares issued 4,642,160       [2] [2] [2] [2] 11,686,370    
"B" Ordinary Shares | Exercise Against Restricted Share Unit/Management Scheme                      
Disclosure of classes of share capital [line items]                      
Shares issued [7]                 6,808,320    
"B" Ordinary Shares | Issuance To Founders Group                      
Disclosure of classes of share capital [line items]                      
Shares issued [10],[11]                 4,878,050    
Average exercise price                 $ 1.64    
Shares issued against advance received                 4,451,210    
Advance received $ 6,150               $ 6,150    
Amount payable $ 1,150               $ 1,150    
'B' Ordinary Shares                      
Disclosure of classes of share capital [line items]                      
Ordinary shares allotted, called up and fully paid [2]         8,212,715         8,212,715 9,712,715
Shares issued [2]   7,044,210              
'B' Ordinary Shares | Transfer of B Ordinary to A Ordinary Share                      
Disclosure of classes of share capital [line items]                      
Ordinary shares allotted, called up and fully paid [2]         1,500,000         1,500,000  
[1] The Company increased authroized number of shares to 200,000,000 on September 25, 2019.
[2] Each A ordinary shares is entitled to one vote on all matters and each B shares shares is entitled to ten votes.
[3] Average exercise price A Ordinary Shares $3.22 (March 2019: Nil)
[4] Includes payables settled by issuance 100,000 A Ordinary shares issued to a consultant at an average exercised price at $2.23 (March 2019: NIL) and 6,375,600 A Ordinary Shares towards payables settlement at an average exercised price at $3.14 (March 2019: Nil)
[5] Average exercise price A Ordinary Shares $2 (March 2019: $7.92)
[6] Average exercise price of A Ordinary Shares NIL (March 2019: $15)
[7] 2,728,182 A Ordinary shares (March 2019: 183,000) at NIL(March 2019: $0.39) and 6,808,320 B Ordinary shares (March 2019: Nil) exercised at NIL price March 2019: Nil)
[8] 100,000 shares issued to a consultant at an average exercise price of $2.23 and 6,375,600 issued towards payables settlement at an average exercise price of $3.14.
[9] Average exercise price of A Ordinary Shares $1.87 (March 2019: $11.28)
[10] Average price of A Ordinary Shares at NIL price (March 2019: $14.69)and B Ordinary Shares at $1.64 (March 2019:Nil)
[11] Includes 4,176,830 B Ordinary shares issued against advance received ($6,150) as of March 31, 2019 and $700 received during the year and $1,150 payables settled by issuance of 701,220 B Ordinary shares
v3.20.2
Share Based Compensation Plans - Schedule of Compensation Cost Recognized (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Compensation cost recognized $ 22,268 $ 21,561 $ 17,918
IPO India Plan      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Compensation cost recognized 145 1,198 1,572
JSOP Plan      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Compensation cost recognized 615
Option Award Scheme 2012      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Compensation cost recognized 197
2014 Share Plan      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Compensation cost recognized 47 (22)
2015 Share Plan      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Compensation cost recognized [1] 1,976 3,059 100
Other Share Option Plans      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Compensation cost recognized [2] 7,829 5,346 7,283
Management Scheme (Staff Share Grant)      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Compensation cost recognized [3] $ 12,318 $ 11,911 $ 8,173
[1] includes 674,045 options granted towards Share Plan 2015 during twelve months ended March 31, 2020 at an exercise price of $ 2 per share and average grant date fair value of $ 0.82 per share. In February 2020, the exercise price of said options were modified to GBP 0.3, resulting in incremental fair value of $ 0.55 per share. In addition, includes 233,364 and 622,035 options granted in prior year/s and wherein the exercise price was modified to $ 2 per share and GBP 0.3 per share, respectively, resulting in incremental fair value of $ 0.55-0.63 per share and $ 1.18 per share, respectively.
[2] includes Restricted Share Unit (RSU) and Other share option plans. In respect of 4,899,280 units/options granted towards RSU during twelve months ended March 31, 2020, intrinsic value $ 1.94 per share approximates grant date fair value. Includes 873,000 options accelerated for immediate vesting as against original vesting period of 3 years, resulting in incremental at grant date fair value of $ $1.64 per share.
[3] includes 10,230,320 shares granted twelve months ended March 31, 2020 to management personnel at intrinsic value $ 1.94 per share approximates grant date fair value.
v3.20.2
Share Based Compensation Plans - Schedule of Movement in Shares Held by the Joint Stock Ownership Plan Trust (Details) - JSOP Trust - shares
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Shares held at beginning of period 384,862 1,146,955 1,146,955
Shares granted    
Shares exercised (384,862)  
Shares forfeiture/lapsed (762,093)
Shares held at ending of period 0 384,862 1,146,955
Unallocated shares held by trust 1,253,656 868,794 [1] 106,701 [1]
Total shares held at end of period   1,253,656 1,253,656
[1] During the year unallocated shares held by the trust were issued to the content vendor at $3.6 per share.
v3.20.2
Share Based Compensation Plans - Schedule of Range of Exercise Prices of Grants under Stock Option Plans (Details) - $ / shares
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
IPO India Plan      
Disclosure of range of exercise prices of outstanding share options [line items]      
Range of exercise prices [1] $ 10.00
IPO India Plan | Bottom of Range      
Disclosure of range of exercise prices of outstanding share options [line items]      
Range of exercise prices [1] 10.00    
IPO India Plan | Top of Range      
Disclosure of range of exercise prices of outstanding share options [line items]      
Range of exercise prices [1] 150.00    
JSOP Plan      
Disclosure of range of exercise prices of outstanding share options [line items]      
Range of exercise prices
2014 Share Plan      
Disclosure of range of exercise prices of outstanding share options [line items]      
Range of exercise prices
2014 Share Plan | Bottom of Range      
Disclosure of range of exercise prices of outstanding share options [line items]      
Range of exercise prices 16.25    
2014 Share Plan | Top of Range      
Disclosure of range of exercise prices of outstanding share options [line items]      
Range of exercise prices 18.30    
2015 Share Plan      
Disclosure of range of exercise prices of outstanding share options [line items]      
Range of exercise prices 0.38 [2] 14.86
2015 Share Plan | Bottom of Range      
Disclosure of range of exercise prices of outstanding share options [line items]      
Range of exercise prices 2    
2015 Share Plan | Top of Range      
Disclosure of range of exercise prices of outstanding share options [line items]      
Range of exercise prices 33.12    
Other Share Option Plans      
Disclosure of range of exercise prices of outstanding share options [line items]      
Range of exercise prices
Restricted Stock Unit      
Disclosure of range of exercise prices of outstanding share options [line items]      
Range of exercise prices $ 0.3 [2]
[1] INR - Indian Rupees
[2] GBP - Great Britain Pound
v3.20.2
Share Based Compensation Plans - Schedule of Employee Stock Option Plan Activity (Details)
12 Months Ended
Mar. 31, 2020
shares
$ / shares
Mar. 31, 2019
shares
$ / shares
Mar. 31, 2018
shares
$ / shares
IPO India Plan      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Number of shares, outstanding at beginning of period | shares 757,886 1,624,035 2,108,063
Number of shares, granted | shares 863,320
Number of shares, exercised | shares (121,496) (536,263) (1,113,160)
Number of shares, forfeited and lapsed | shares (156,775) (329,886) (234,188)
Number of shares, outstanding at ending of period | shares 479,615 757,886 1,624,035
Number of shares, exercisable at ending of period | shares 325,740 289,002 501,122
Weighted average exercise price, outstanding at beginning of period | $ / shares $ 32.17 [1] $ 35.00 [1] $ 34.96
Weighted average exercise price, granted | $ / shares [1] 10.00
Weighted average exercise price, exercised | $ / shares [1] 10.00 10.00 32.19
Weighted average exercise price, forfeited and lapsed | $ / shares [1] 10.00 51.66 10.00
Weighted average exercise price, outstanding at end of period | $ / shares [1] 45.03 32.17 35.00
Weighted average exercise price, exercisable at ending of period | $ / shares [1] $ 61.56 $ 68.13 $ 65.14
JSOP Plan      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Number of shares, outstanding at beginning of period | shares 384,862 1,146,965 1,146,955
Number of shares, granted | shares
Number of shares, exercised | shares
Number of shares, forfeited and lapsed | shares (384,862) (762,093)
Number of shares, outstanding at ending of period | shares 384,862 1,146,965
Number of shares, exercisable at ending of period | shares 384,862 728,736
Weighted average exercise price, outstanding at beginning of period | $ / shares $ 11.00 $ 16.19 $ 16.22
Weighted average exercise price, granted | $ / shares
Weighted average exercise price, exercised | $ / shares
Weighted average exercise price, forfeited and lapsed | $ / shares 11.00 18.86
Weighted average exercise price, outstanding at end of period | $ / shares 11.00 16.19
Weighted average exercise price, exercisable at ending of period | $ / shares $ 11.00 $ 11.00
Option Award Scheme 2012      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Number of shares, outstanding at beginning of period | shares 674,045 674,045
Number of shares, granted | shares
Number of shares, exercised | shares
Number of shares, forfeited and lapsed | shares (674,045)
Number of shares, outstanding at ending of period | shares 674,045
Number of shares, exercisable at ending of period | shares 449,363
Weighted average exercise price, outstanding at beginning of period | $ / shares $ 11.00 $ 11.00
Weighted average exercise price, granted | $ / shares
Weighted average exercise price, exercised | $ / shares
Weighted average exercise price, forfeited and lapsed | $ / shares 11.00
Weighted average exercise price, outstanding at end of period | $ / shares 11.00
Weighted average exercise price, exercisable at ending of period | $ / shares $ 11.00
2014 Share Plan      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Number of shares, outstanding at beginning of period | shares 399,999 399,999 723,749
Number of shares, granted | shares
Number of shares, exercised | shares
Number of shares, forfeited and lapsed | shares (323,750)
Number of shares, outstanding at ending of period | shares 399,999 399,999 399,999
Number of shares, exercisable at ending of period | shares 399,999 399,999 289,583
Weighted average exercise price, outstanding at beginning of period | $ / shares $ 17.79 $ 17.79 $ 18.06
Weighted average exercise price, granted | $ / shares
Weighted average exercise price, exercised | $ / shares
Weighted average exercise price, forfeited and lapsed | $ / shares 18.39
Weighted average exercise price, outstanding at end of period | $ / shares 17.79 17.79 17.79
Weighted average exercise price, exercisable at ending of period | $ / shares $ 17.79 $ 17.79 $ 17.67
2015 Share Plan      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Number of shares, outstanding at beginning of period | shares [2] 1,290,399 211,250 233,750
Number of shares, granted | shares 674,045 [3] 1,305,399 [3]
Number of shares, exercised | shares (132,013) (10,416) (10,208)
Number of shares, forfeited and lapsed | shares (233,333) (215,834) (12,292)
Number of shares, outstanding at ending of period | shares 1,599,098 1,290,399 [2] 211,250 [2]
Number of shares, exercisable at ending of period | shares 1,549,098 981,545 181,354
Weighted average exercise price, outstanding at beginning of period | $ / shares $ 14.68 $ 16.21 $ 16.23
Weighted average exercise price, granted | $ / shares 0.38 [4] 14.86
Weighted average exercise price, exercised | $ / shares 2.00 7.92 8.71
Weighted average exercise price, forfeited and lapsed | $ / shares 16.18 18.23 14.64
Weighted average exercise price, outstanding at end of period | $ / shares 2.69 14.68 16.21
Weighted average exercise price, exercisable at ending of period | $ / shares $ 2.72 $ 14.66 $ 17.36
Other Share Option Plans      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Number of shares, outstanding at beginning of period | shares 500,000 500,000 500,000
Number of shares, granted | shares
Number of shares, exercised | shares
Number of shares, forfeited and lapsed | shares (500,000)
Number of shares, outstanding at ending of period | shares 500,000 500,000
Number of shares, exercisable at ending of period | shares 400,000 300,000
Weighted average exercise price, outstanding at beginning of period | $ / shares $ 16.00 $ 18.88 $ 18.88
Weighted average exercise price, granted | $ / shares
Weighted average exercise price, exercised | $ / shares
Weighted average exercise price, forfeited and lapsed | $ / shares 16.00
Weighted average exercise price, outstanding at end of period | $ / shares 16.00 18.88
Weighted average exercise price, exercisable at ending of period | $ / shares $ 16.00 $ 18.88
Restricted Stock Unit      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Number of shares, outstanding at beginning of period | shares 505,944 837,590 182,725
Number of shares, granted | shares [5] 4,899,280 211,567 1,044,290
Number of shares, exercised | shares (2,088,181) (450,541) (366,491)
Number of shares, forfeited and lapsed | shares (37,447) (92,672) (22,934)
Number of shares, outstanding at ending of period | shares 3,279,597 505,944 837,590
Number of shares, exercisable at ending of period | shares 311,740 34,416 119,150
Weighted average exercise price, outstanding at beginning of period | $ / shares
Weighted average exercise price, granted | $ / shares 0.3 [4]
Weighted average exercise price, exercised | $ / shares
Weighted average exercise price, forfeited and lapsed | $ / shares
Weighted average exercise price, outstanding at end of period | $ / shares
Weighted average exercise price, exercisable at ending of period | $ / shares
Management Scheme      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Number of shares, outstanding at beginning of period | shares 2,593,333 1,513,333 1,130,000
Number of shares, granted | shares [6] 10,230,320 1,400,000 700,000
Number of shares, exercised | shares [7] (7,448,320) (320,000) (316,667)
Number of shares, forfeited and lapsed | shares (320,000)
Number of shares, outstanding at ending of period | shares 5,055,333 2,593,333 1,513,333
Number of shares, exercisable at ending of period | shares 890,000 516,667 173,333
Weighted average exercise price, outstanding at beginning of period | $ / shares
Weighted average exercise price, granted | $ / shares
Weighted average exercise price, exercised | $ / shares
Weighted average exercise price, forfeited and lapsed | $ / shares
Weighted average exercise price, outstanding at end of period | $ / shares 0.01
Weighted average exercise price, exercisable at ending of period | $ / shares $ 0.03
[1] INR - Indian Rupees
[2] includes 233,364 and 622,035 options granted in prior year/s and wherein the exercise price was modified to $ 2 per share and GBP 0.3 per share, respectively.
[3] Options granted in during the year, wherein the exercise price was modified to GBP 0.3 per share
[4] GBP - Great Britain Pound
[5] Out of above, 873,000 RSU were accelerated for immediate vesting as against original vesting period of 3 years.
[6] Includes 6,808,320 B Ordinary shares granted on July 12, 2019 and February 28, 2020, respectively
[7] Includes issuance of 6,808,320 B Ordinary treasury shares
v3.20.2
Share Based Compensation Plans - Schedule of Number and Weighted Average Remaining Life (Details) - $ / shares
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2017
IPO India Plan        
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]        
Weighted average remaining life (years) 6 years 3 months 7 years 8 months 8 years 1 month  
Weighted average exercise price $ 45.03 [1] $ 32.17 [1] $ 35.00 [1] $ 34.96
JSOP Plan        
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]        
Weighted average remaining life (years) 3 years 1 month 3 years 11 months  
Weighted average exercise price $ 11.00 $ 16.19 16.22
Option Award Scheme 2012        
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]        
Weighted average remaining life (years)     3 years 9 months  
Weighted average exercise price $ 11.00 11.00
2014 Share Plan        
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]        
Weighted average remaining life (years) 1 year 3 months 2 years 3 months 5 years 11 months  
Weighted average exercise price $ 17.79 $ 17.79 $ 17.79 18.06
2015 Share Plan        
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]        
Weighted average remaining life (years) 5 years 6 years 1 month 6 years 1 month  
Weighted average exercise price $ 2.69 $ 14.68 $ 16.21 16.23
Other Share Option Plans        
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]        
Weighted average remaining life (years)   1 year 10 months 2 years 10 months  
Weighted average exercise price $ 16.00 $ 18.88 18.88
Management Scheme        
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]        
Weighted average remaining life (years) 8 years 11 months 6 years 5 years 6 months  
Weighted average exercise price $ 0.01
Restricted Stock Unit        
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]        
Weighted average remaining life (years) 9 years 4 months 6 years 5 years 7 months  
Weighted average exercise price
[1] INR - Indian Rupees
v3.20.2
Share Based Compensation Plans - Schedule of Inputs to Fair Valuation Model (Details) - 2015 Share Plan
12 Months Ended
Mar. 31, 2020
yr
$ / shares
Statement Line Items [Line Items]  
Expected volatility 108.20% [1]
Option life (Years) | yr 2.6
Dividend yield 0.00%
Risk free rate 0.30%
Range of exercise price of the granted options at the grant date | $ / shares $ 0.38 [2]
[1] The expected volatility of all other options is based on the historic share price volatility of the Company over time periods comparable to the time from the grant date to the maturity dates of the options.
[2] Fair value of options granted under all other schemes is measured using a Black Scholes model.
v3.20.2
Share Based Compensation Plans (Details Narrative)
Mar. 31, 2013
shares
JSOP Trust  
Statement Line Items [Line Items]  
Stock issued 2,000,164
v3.20.2
Joint Stock Ownership Plan Reserve - Schedule of Joint Stock Ownership Plan Reserve (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Statement Line Items [Line Items]    
Balance at beginning of period $ 656,985 $ 1,003,417
Balance at end of period 308,486 656,985
JSOP Reserve    
Statement Line Items [Line Items]    
Balance at beginning of period (15,985) (15,985)
Issue out of treasury shares 15,985
Balance at end of period $ (15,985)
v3.20.2
Joint Stock Ownership Plan Reserve (Details Narrative) - 'A' Ordinary Shares - JSOP Trust - shares
Mar. 31, 2020
Mar. 31, 2019
Statement Line Items [Line Items]    
Ordinary shares eligible for issue 868,794
Discretionary vesting of shares 20.00% 20.00%
Shares held by the Trust 1,253,656
v3.20.2
Other Components of Equity - Schedule of Other Components of Equity (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Disclosure of reserves within equity [line items]      
Movement in reserve, opening balance $ (79,696) $ (48,649)  
Reclassified to consolidated statements of income $ 375
Impact of translation difference 5,652 5,610 (6,250)
Impairment loss on available-for-sale financial assets (2,436)
Other comprehensive loss due to translation of foreign operations (8,031) (13,934) (1,153)
Movement in reserve, ending balance (85,660) (79,696) (48,649)
Hedging Reserve      
Disclosure of reserves within equity [line items]      
Movement in reserve, opening balance (375)
Reclassified to consolidated statements of income 375
Movement in reserve, ending balance
Revaluation Reserve      
Disclosure of reserves within equity [line items]      
Movement in reserve, opening balance 2,932 1,835 1,829
Gain recognized on revaluation of property and equipment   1,019  
Impact of translation difference (156) 78 6
Movement in reserve, ending balance 2,776 2,932 1,835
Available for Sale Fair Value Reserves      
Disclosure of reserves within equity [line items]      
Movement in reserve, opening balance (18,449) 6,238 6,238
Impairment loss on available-for-sale financial assets (1,860) (24,687)
Movement in reserve, ending balance (20,309) (18,449) 6,238
Currency Translation Reserve      
Disclosure of reserves within equity [line items]      
Movement in reserve, opening balance (64,179) (56,722) (55,810)
Adoption of IFRS 9 (net of tax)   (34)  
Other comprehensive loss due to translation of foreign operations [1] (3,948) (7,423) (912)
Movement in reserve, ending balance $ (68,127) $ (64,179) $ (56,722)
[1] Includes movement in foreign currency translation reserves arising on account of deconsolidation of financial asset.
v3.20.2
Other Components of Equity (Details Narrative) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Other Components Of Equity      
Movement in foreign currency translation reserves $ 502
v3.20.2
Significant Non-Cash Expenses - Schedule of Significant Non-Cash Expenses (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Significant Non-cash Expenses      
Unrealized foreign exchange loss/(gain) $ (4,458) $ (3,329) $ 5,466
Credit impairment loss, net 82,920 26,283 3,376
Impairment loss on available-for-sale financial assets 2,436
Net Losses on de-recognition of financial assets measured at amortized cost, net [1] 5,285 5,988 3,562
Mark to market gain on derivative financial instrument measured at fair value through profit and loss 902
(Loss) on settlement of derivative financial instruments 586
Loss on financial liability (convertible notes) measures at fair value through profit and loss 15,987 21,398 13,840
Loss on deconsolidation of a subsidiary 14,649
Provisions for trade and other receivables 4,740
Provision no longer required, written-back (2,636) (120) (124)
Impairment loss on advances content vendors 7,284 353
Impairment loss     1,205
Significant discounting on deferred revenue 1,501
Others 266 32 30
Other non-cash items $ 100,118 $ 58,438 $ 50,119
[1] Arising on assignment and novation of trade receivables and trade payables with no-recourse. Derecognition of aforesaid financial assets/liabilities measured at amortized cost is to mitigate both credit risk and liquidity risk.
v3.20.2
Financial Instruments and Risk Management - Disclosure of Detailed Information about Financial Instruments (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2017
Financial Instruments And Risk Management        
Debt (net of debt issuance cost of $399 (2019: $691)) $ 178,972 $ 280,828    
Cash and cash equivalents (*) 2,563 [1] 89,117 [1] $ 87,762 $ 112,267
Net debt 176,409 145,045    
Equity $ 308,486 $ 656,985 $ 1,003,417 $ 883,548
Net debt to equity ratio 57.20% 22.10%    
[1] Includes $Nil (2019: $46,666) of restricted deposits.
v3.20.2
Financial Instruments and Risk Management - Disclosure of Financial Assets (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Mar. 31, 2019
Disclosure of financial assets [line items]    
Financial Assets $ 120,223 $ 355,168
Financial Assets Available-For-Sale    
Disclosure of financial assets [line items]    
Financial Assets 3,942 3,692
Other Financial Assets    
Disclosure of financial assets [line items]    
Financial Assets [1] $ 116,281 $ 351,477
[1] Other financial assets include loans and receivables, excluding prepaid charges and statutory receivables, and includes cash and cash equivalents and restricted deposits held with banks.
v3.20.2
Financial Instruments and Risk Management - Disclosure of Financial Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Mar. 31, 2019
Disclosure of financial liabilities [line items]    
Financial liabilities at fair value through profit or loss $ 258,602 $ 362,656
Financial Liabilities at Amortised Cost | Borrowings    
Disclosure of financial liabilities [line items]    
Financial Liabilities at amortized cost 155,872 212,479
Financial Liabilities at Amortised Cost | Trade Payables and Acceptances Excluding Value Added Tax and Other Tax Payables    
Disclosure of financial liabilities [line items]    
Financial Liabilities at amortized cost 79,630 81,208
Financial liabilities at fair value through profit or loss that meet definition of held for trading, category | Senior Convertible Notes at Fair Value through Profit or Loss    
Disclosure of financial liabilities [line items]    
Financial liabilities at fair value through profit or loss 23,100 68,349
Financial liabilities at fair value through profit or loss that meet definition of held for trading, category | Derivatives at Fair Value Through Profit of Loss    
Disclosure of financial liabilities [line items]    
Financial liabilities at fair value through profit or loss $ 620
v3.20.2
Financial Instruments and Risk Management - Disclosure of Foreign Currency Risk Exposure (Details) - Currency Risk - USD ($)
$ in Thousands
Mar. 31, 2020
Mar. 31, 2019
U.S. Dollar    
Disclosure of nature and extent of risks arising from financial instruments [line items]    
Foreign currency monetary assets and liabilities position $ (3,895) $ (6,117)
Great British Pounds Sterling    
Disclosure of nature and extent of risks arising from financial instruments [line items]    
Foreign currency monetary assets and liabilities position (65,446) (61,927)
Other    
Disclosure of nature and extent of risks arising from financial instruments [line items]    
Foreign currency monetary assets and liabilities position $ (182) $ (2,317)
v3.20.2
Financial Instruments and Risk Management - Maturity Analysis of Non-Derivative and Derivative Liabilities (Details) - Liquidity Risk - USD ($)
$ in Thousands
Mar. 31, 2020
Mar. 31, 2019
Disclosure of maturity analysis for derivative financial liabilities [line items]    
Borrowing principal payments [1] $ 179,371 $ 281,519 [2]
Borrowing interest payments 23,741 29,016
Derivative financial instruments 620
Acceptances 1,858 8,366
Trade and other payables 90,941 83,487
Minimum lease payments 1,716 2,956
Less than 1 Year    
Disclosure of maturity analysis for derivative financial liabilities [line items]    
Borrowing principal payments [1] 117,097 209,180 [2]
Borrowing interest payments 17,500 21,820
Derivative financial instruments 620
Acceptances 1,858 8,366
Trade and other payables 90,941 83,487
Minimum lease payments 822 1,480
1-3 Years    
Disclosure of maturity analysis for derivative financial liabilities [line items]    
Borrowing principal payments [1] 62,274 72,339 [2]
Borrowing interest payments 6,241 7,196
Derivative financial instruments
Acceptances
Trade and other payables
Minimum lease payments 894 1,360
3-5 Years    
Disclosure of maturity analysis for derivative financial liabilities [line items]    
Borrowing principal payments [1]
Borrowing interest payments
Derivative financial instruments
Acceptances
Trade and other payables
Minimum lease payments 116
More than 5 Years    
Disclosure of maturity analysis for derivative financial liabilities [line items]    
Borrowing principal payments
Borrowing interest payments
Derivative financial instruments
Acceptances
Trade and other payables
Minimum lease payments
[1] Excludes cumulative effect of unamortized costs.
[2] Includes senior convertible bonds, which are payable in cash at the option of the issuer.
v3.20.2
Financial Instruments and Risk Management - Disclosure of Currency, Maturity and Interest Rate of Borrowings (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Mar. 31, 2019
Disclosure of detailed information about borrowings [line items]    
Borrowings $ 178,972 $ 281,519
Borrowings, interest rate 100.00% 10.21%
Fixed Interest Rate    
Disclosure of detailed information about borrowings [line items]    
Borrowings $ 96,904 $ 205,156
Borrowings, interest rate 54.00% 72.90%
Floating Rate    
Disclosure of detailed information about borrowings [line items]    
Borrowings $ 82,467 $ 76,363
Borrowings, interest rate 46.00% 27.10%
Less than 1 Year    
Disclosure of detailed information about borrowings [line items]    
Borrowings $ 117,097 $ 209,180
Borrowings, interest rate 64.30% 74.30%
1-3 Years    
Disclosure of detailed information about borrowings [line items]    
Borrowings $ 62,274 $ 72,339
Borrowings, interest rate 34.70% 25.70%
4 and 5 Years    
Disclosure of detailed information about borrowings [line items]    
Borrowings
Borrowings, interest rate
More than 5 Years    
Disclosure of detailed information about borrowings [line items]    
Borrowings
Borrowings, interest rate
U.S. Dollar    
Disclosure of detailed information about borrowings [line items]    
Borrowings $ 49,182 $ 148,201
Borrowings, interest rate 27.40% 52.60%
Great British Pounds Sterling    
Disclosure of detailed information about borrowings [line items]    
Borrowings $ 62,274 $ 65,215
Borrowings, interest rate 34.70% 23.20%
Indian Rupees    
Disclosure of detailed information about borrowings [line items]    
Borrowings $ 67,915 $ 68,103
Borrowings, interest rate 37.90% 24.20%
v3.20.2
Financial Instruments and Risk Management - Disclosure of Fair Value Measurements of Assets (Details) - Recurring Fair Value Measurement - Level 2 of Fair Value Hierarchy - USD ($)
$ in Thousands
Mar. 31, 2020
Mar. 31, 2019
Disclosure of fair value measurement of assets [line items]    
Gross amount of recognized financial assets
Gross amount of recognized financial liabilities offset in the statement of financial position
Net amounts financial assets presented in the statement of financial position
Fair value of financial assets 98,691 128,921
Trade and Other Receivables    
Disclosure of fair value measurement of assets [line items]    
Gross amount of recognized financial assets 94,749 125,229
Gross amount of recognized financial liabilities offset in the statement of financial position
Net amounts financial assets presented in the statement of financial position 94,749 125,229
Investments at FVTPL    
Disclosure of fair value measurement of assets [line items]    
Gross amount of recognized financial assets 3,802 1,042
Gross amount of recognized financial liabilities offset in the statement of financial position
Net amounts financial assets presented in the statement of financial position 3,802 1,042
Investments at FVTOCI    
Disclosure of fair value measurement of assets [line items]    
Gross amount of recognized financial assets 140 2,650
Gross amount of recognized financial liabilities offset in the statement of financial position
Net amounts financial assets presented in the statement of financial position $ 140 $ 2,650
v3.20.2
Financial Instruments and Risk Management - Disclosure of Fair Value Measurements of Liabilities (Details) - Recurring Fair Value Measurement - Level 2 of Fair Value Hierarchy - USD ($)
$ in Thousands
Mar. 31, 2020
Mar. 31, 2019
Disclosure of fair value measurement of liabilities [line items]    
Gross amount of recognized financial liabilities $ 620
Gross amount of recognized financial assets offest in the statement of financial position
Net amounts financial liabilities presented in the statement of financial position 620
Fair value of financial liabilities 23,100 68,969
Borrowings at Fair Value    
Disclosure of fair value measurement of liabilities [line items]    
Gross amount of recognized financial liabilities 23,100 68,349
Gross amount of recognized financial assets offest in the statement of financial position
Net amounts financial liabilities presented in the statement of financial position $ 23,100 $ 68,349
v3.20.2
Financial Instruments and Risk Management (Details Narrative) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2017
Disclosure of detailed information about financial instruments [line items]        
(Loss) on de-recognition of financial assets measured at amortized cost net (*) [1] $ (5,285) $ (5,988) $ (3,562)  
Financial guarantees 33 51    
Loss on derivative instruments $ 902    
Credit Risk        
Disclosure of detailed information about financial instruments [line items]        
Concentration of credit risk 40.10% 20.40%    
(Loss) on de-recognition of financial assets measured at amortized cost net (*) $ (5,285) $ (5,988) (3,562)  
Exposure to credit risk 112,323 41,335 10,193  
Currency Risk        
Disclosure of detailed information about financial instruments [line items]        
Gain (Loss) in foreign exchange rates in position 6,952 7,036 $ 5,935 $ (3,775)
Liquidity Risk        
Disclosure of detailed information about financial instruments [line items]        
Credit facility 181,340 290,353    
Undrawn amounts 111 468    
Financial guarantees 33 51    
Interest Rate Risk        
Disclosure of detailed information about financial instruments [line items]        
Exposure to interest rate risk $ 895 $ 1,029    
[1] Arising on assignment and novation of trade receivables and trade payables with no-recourse. Derecognition of aforesaid financial assets/liabilities measured at amortized cost is to mitigate both credit risk and liquidity risk.
v3.20.2
Contractual Obligations and Commitments - Disclosure of Contractual Obligations Related to Content Commitments (Details) - USD ($)
$ in Thousands
Mar. 31, 2020
Mar. 31, 2019
Contractual Obligations And Commitments    
Contractual obligations $ 450,469 $ 301,660
v3.20.2
Contractual Obligations and Commitments (Details Narrative) - USD ($)
$ in Thousands
Mar. 31, 2020
Mar. 31, 2019
Contractual Obligations And Commitments    
Standby letters of credit $ 53,565
Financial guarantees $ 33 $ 51
v3.20.2
Contingent Liabilities (Details Narrative) - Tax Contingent Liability
$ in Thousands
Mar. 31, 2020
USD ($)
Statement Line Items [Line Items]  
Contingent liabilities $ 56,064
India  
Statement Line Items [Line Items]  
Contingent liabilities $ 2,631 [1]
[1] Net of monies paid under protest $137 and including interest and penalty.
v3.20.2
Related Party Transactions - Disclosure of Transactions between Related Parties (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Red Bridge Group Limited    
Disclosure of transactions between related parties [line items]    
Details of Transaction President fees President fees
Related party liabilities $ 648 $ 648
Related party assets
550 County Avenue    
Disclosure of transactions between related parties [line items]    
Details of Transaction Rent/Deposit Rent/Deposit
Related party liabilities $ 156 $ 499
Related party assets $ 135
NextGen Films Private Limited    
Disclosure of transactions between related parties [line items]    
Details of Transaction Purchase/Sale Purchase/Sale
Related party liabilities
Related party assets $ 41,470
Everest Entertainment LLP    
Disclosure of transactions between related parties [line items]    
Details of Transaction Purchase/Sale Purchase/Sale
Related party liabilities $ 557 $ 574
Related party assets
Beech Investments Limited    
Disclosure of transactions between related parties [line items]    
Details of Transaction Advance Advance
Related party liabilities $ 592 $ 500
Related party assets
Lulla Family #1    
Disclosure of transactions between related parties [line items]    
Details of Transaction Rent/Deposit Rent/Deposit
Related party liabilities $ 487 $ 243
Related party assets $ 356 $ 841
Lulla Family #2    
Disclosure of transactions between related parties [line items]    
Details of Transaction Salary Salary
Related party liabilities $ 4,155 $ 3,279
Related party assets
Lula Family #3    
Disclosure of transactions between related parties [line items]    
Details of Transaction Advance Advance
Related party liabilities $ 6,150
Related party assets
Lulla Family #4    
Disclosure of transactions between related parties [line items]    
Details of Transaction Advance Advance
Related party liabilities $ 500 $ 500
Related party assets
Xfinite Global Plc    
Disclosure of transactions between related parties [line items]    
Details of Transaction Sale Sale
Related party liabilities $ 3,812 $ 6,500
Related party assets
v3.20.2
Related Party Transactions (Details Narrative) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2016
Disclosure of transactions between related parties [line items]        
Film rights, acquired   $ 907    
Short-term borrowings $ 93,758 $ 140,559    
Short-term borrowings, interest rate 100.00% 10.21%    
Salaries $ 36,697 $ 37,015 $ 35,661  
Film rights purchased 132,139 107,722 186,757  
Deferred revenue 9,827 12,260    
Supreme Chambers, 5th Floor        
Disclosure of transactions between related parties [line items]        
Monthly lease payment $ 83      
Lease agreement, description Pursuant to a lease agreement that expires on January 4, 2020, Eros International Media Limited leases office premise for studio use at Supreme Chambers, 5th Floor, Andheri (W), Mumbai from Kishore and Sunil Lulla. Beginning January 2015, the lease requires Eros International Media Limited to pay $83 each month under this lease.      
Red Bridge Group Limited        
Disclosure of transactions between related parties [line items]        
Compensation for services 186 270  
NextGen Films Private Limited        
Disclosure of transactions between related parties [line items]        
Film rights, acquired 393 1,109 7,760  
Performance guarantee to bank in connection with funding commitments 8,000 8,000  
Advances for film co-production 2,113 6,192 19,025  
Refunds on abandonment of certain film projects 6,114  
Film content advances 47,742      
Everest Entertainment LLP        
Disclosure of transactions between related parties [line items]        
Film rights sold 18 1,260 166  
Film rights purchased 314    
Eros International Plc        
Disclosure of transactions between related parties [line items]        
Salaries 147 144 139  
Manjula Lulla with Eros International Plc.        
Disclosure of transactions between related parties [line items]        
Salaries 147 144 139  
Krishika Lulla with EIML        
Disclosure of transactions between related parties [line items]        
Salaries 121 123 133  
Riddhima Lulla with Eros Digital FZ LLC        
Disclosure of transactions between related parties [line items]        
Salaries 300 213 $ 90  
Xfinite Global Plc        
Disclosure of transactions between related parties [line items]        
Revenue from license fees 12,776 $ 1,413    
Eros International Media Limited        
Disclosure of transactions between related parties [line items]        
Monthly lease payment $ 4     $ 61
Lease agreement, description Pursuant to a lease agreement that expired on March 31, 2019, the lease requires Eros International Media Limited to pay $4 each month under this lease. Eros International Media Limited leases apartments for studio use at Kailash Plaza, 3rd Floor, Opp. Laxmi Industrial Estate, Andheri (W), Mumbai, from Manjula K. Lulla, the wife of Kishore Lulla. The lease was renewed on April 1, 2020 for a further period of one year on the same terms. Pursuant to a lease agreement that expired on September 30, 2021, the lease requires Eros International Media Limited to pay $4 each month under this lease. Eros International Media Limited leases for use as executive accommodations the property Aumkar Bungalow, Gandhi Gram Road, Juhu, Mumbai, from Sunil Lulla.      
v3.20.2
Major Consolidated Entities - Disclosure of Major Consolidated Entities (Details)
12 Months Ended
Mar. 31, 2020
Copsale Limited  
Disclosure of information about consolidated structured entities [line items]  
Date of incorporation Jun. 01, 2006
Country of incorporation BVI
Percent of voting rights held 100.00%
Eros Australia Pty Limited  
Disclosure of information about consolidated structured entities [line items]  
Date of incorporation Jun. 01, 2006
Country of incorporation Australia
Percent of voting rights held 100.00%
Eros International Films Private Limited  
Disclosure of information about consolidated structured entities [line items]  
Date of incorporation Jun. 01, 2006
Country of incorporation India
Percent of voting rights held 100.00%
Eros International Limited  
Disclosure of information about consolidated structured entities [line items]  
Date of incorporation Jun. 01, 2006
Country of incorporation U.K.
Percent of voting rights held 100.00%
Eros International Media Limited  
Disclosure of information about consolidated structured entities [line items]  
Date of incorporation Jun. 01, 2006
Country of incorporation India
Percent of voting rights held 62.31%
Eros International USA Inc.  
Disclosure of information about consolidated structured entities [line items]  
Date of incorporation Jun. 01, 2006
Country of incorporation U.S.
Percent of voting rights held 100.00%
Eros Network Limited  
Disclosure of information about consolidated structured entities [line items]  
Date of incorporation Jun. 01, 2006
Country of incorporation U.K.
Percent of voting rights held 100.00%
Eros Worldwide FZ-LLC  
Disclosure of information about consolidated structured entities [line items]  
Date of incorporation Jun. 01, 2006
Country of incorporation UAE
Percent of voting rights held 100.00%
Big Screen Entertainment Private Limited  
Disclosure of information about consolidated structured entities [line items]  
Date of incorporation Jan. 01, 2007
Country of incorporation India
Percent of voting rights held 64.00%
EyeQube Studios Private Limited  
Disclosure of information about consolidated structured entities [line items]  
Date of incorporation Jan. 01, 2008
Country of incorporation India
Percent of voting rights held 99.99%
Acacia Investments Holdings Limited  
Disclosure of information about consolidated structured entities [line items]  
Date of incorporation Apr. 01, 2008
Country of incorporation IOM
Percent of voting rights held 100.00%
Eros International Pte Limited  
Disclosure of information about consolidated structured entities [line items]  
Date of incorporation Aug. 01, 2010
Country of incorporation Singapore
Percent of voting rights held 100.00%
Digicine Pte. Limited  
Disclosure of information about consolidated structured entities [line items]  
Date of incorporation Mar. 01, 2012
Country of incorporation Singapore
Percent of voting rights held 100.00%
Colour Yellow Productions Private Limited  
Disclosure of information about consolidated structured entities [line items]  
Date of incorporation May 01, 2014
Country of incorporation India
Percent of voting rights held 50.00%
Eros Digital FZ LLC  
Disclosure of information about consolidated structured entities [line items]  
Date of incorporation Sep. 01, 2015
Country of incorporation UAE
Percent of voting rights held 100.00%
Eros Digital Limited  
Disclosure of information about consolidated structured entities [line items]  
Date of incorporation Jul. 01, 2016
Country of incorporation IOM
Percent of voting rights held 100.00%
Eros Films Limited  
Disclosure of information about consolidated structured entities [line items]  
Date of incorporation Nov. 01, 2016
Country of incorporation IOM
Percent of voting rights held 100.00%
Universal Power Systems Private Limited  
Disclosure of information about consolidated structured entities [line items]  
Date of incorporation Aug. 01, 2015
Country of incorporation India
Percent of voting rights held 100.00%
England Merger 1, Corp  
Disclosure of information about consolidated structured entities [line items]  
Date of incorporation Mar. 01, 2020
Country of incorporation U.S.
Percent of voting rights held 100.00%
England Holdings 2, Inc.  
Disclosure of information about consolidated structured entities [line items]  
Date of incorporation Mar. 01, 2020
Country of incorporation U.S.
Percent of voting rights held 100.00%
England Holdings 3, Inc.  
Disclosure of information about consolidated structured entities [line items]  
Date of incorporation Mar. 01, 2020
Country of incorporation U.S.
Percent of voting rights held 100.00%
v3.20.2
Major Consolidated Entities (Details Narrative) - Eros International Media Limited
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Disclosure of information about consolidated structured entities [line items]    
Rate of reduction of holdings 62.31% 62.39%
Rate of security pledged against certain borrowings 38.40%  
Change in shareholding, description The change in shareholding was due to exercise of 0.08% ESOP by the employees.  
v3.20.2
Non-Controlling Interest - Disclosure of Non-Controlling Interest (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Disclosure of subsidiaries [line items]      
Current assets $ 118,405 $ 351,597  
Non-current assets 489,251 737,305  
Current liabilities (225,280) (318,672)  
Non-current liabilities (73,890) (113,245)  
Total net assets attributable 607,656 1,088,902  
Equity attributable to owners of the Group 249,119 521,456  
Equity attributable to non-controlling interests 59,367 135,529  
Revenue 155,452 270,126 $ 261,253
Expenses (226,044) (242,530) (202,737)
Profit/(Loss) for the year (491,704) (410,453) (9,745)
Profit attributable to the owners of the Group (418,992) (423,867) (22,575)
Profit attributable to non-controlling interests (72,712) 13,414 12,830
Other comprehensive (loss)/income during the year (8,033) (41,462) (772)
Total comprehensive income during the year (499,737) (451,915) (10,517)
Total comprehensive income attributable to the owners of the Group (423,130) (459,321) (23,106)
Total comprehensive income attributable to non-controlling interests (76,607) 7,406 12,589
Net cash inflow from operating activities 18,628 74,966 83,243
Net cash outflow from investing activities (80,436) (157,733) (185,420)
Net cash inflow from financing activities (24,286) 84,117 77,415
Net cash (outflow)inflow (86,094) 1,350 $ (24,762)
Subsidiaries with Material Non-Controlling Interests | EIML      
Disclosure of subsidiaries [line items]      
Current assets 170,724 183,944  
Non-current assets 152,059 385,463  
Current liabilities (147,004) (158,182)  
Non-current liabilities (21,285) (53,210)  
Total net assets attributable 154,494 358,015  
Equity attributable to owners of the Group 95,127 222,486  
Equity attributable to non-controlling interests 59,367 135,529  
Revenue 119,821 149,969  
Expenses (313,660) (114,709)  
Profit/(Loss) for the year (193,839) 35,260  
Profit attributable to the owners of the Group (121,127) 21,846  
Profit attributable to non-controlling interests (72,712) 13,414  
Other comprehensive (loss)/income during the year (9,861) (12,500)  
Total comprehensive income during the year (203,700) 22,760  
Total comprehensive income attributable to the owners of the Group (127,093) 15,354  
Total comprehensive income attributable to non-controlling interests (76,607) 7,406  
Net cash inflow from operating activities 7,654 50,470  
Net cash outflow from investing activities (13,635) (37,729)  
Net cash inflow from financing activities (12,901) (14,462)  
Net cash (outflow)inflow $ (18,882) $ 36,008  
v3.20.2
Non-Controlling Interest (Details Narrative)
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Non-controlling Interest    
Non-controlling interest, rate 37.69% 37.61%
Exercise of ESOP by employees, rate 0.08% 0.11%
v3.20.2
Significant Accounting Estimates and Judgments (Details Narrative) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2018
Mar. 31, 2019
Significant Accounting Estimates And Judgments      
Intangible assets, period of amortization Amortization is spread evenly over the lesser of 10 years or the license period.    
Loss recognized in deconsolidation   $ 500  
Equity interest, divested   51.00%  
Credit impairment (loss) $ 112,322   $ 41,335
v3.20.2
New Standards Adopted as at April 1, 2019 - Disclosure of Right-of-Use Assets to be Recognized Equal to Liability (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Statement Line Items [Line Items]      
Balance at April 1, 2020    
Depreciation 1,677
Balance at March 31, 2020 1,512  
Payment of lease liabilities 1,579
Lease Liabilities      
Statement Line Items [Line Items]      
On adoption of IFRS 16 [1] 2,618    
Net translation adjustment (139)    
Additions 469    
Finance expense 184    
Payment of lease liabilities 1,579    
Premises | Gross Carrying Amount      
Statement Line Items [Line Items]      
On adoption of IFRS 16 [1] 2,531    
Additions to right-of-use 398    
Balance at April 1, 2020 2,929    
Balance at March 31, 2020   2,929  
Premises | Accumulated Depreciation      
Statement Line Items [Line Items]      
Balance at April 1, 2020    
Depreciation 1,557    
Net translation adjustment 36    
Balance at March 31, 2020 1,593  
Premises | Net Carrying Value      
Statement Line Items [Line Items]      
Balance at March 31, 2020 1,336    
Equipment | Gross Carrying Amount      
Statement Line Items [Line Items]      
On adoption of IFRS 16 [1] 307    
Additions to right-of-use 71    
Balance at April 1, 2020 378    
Balance at March 31, 2020   378  
Equipment | Accumulated Depreciation      
Statement Line Items [Line Items]      
Balance at April 1, 2020 62    
Depreciation 120    
Net translation adjustment 20    
Balance at March 31, 2020 202 62  
Equipment | Net Carrying Value      
Statement Line Items [Line Items]      
Balance at March 31, 2020 176    
Total | Gross Carrying Amount      
Statement Line Items [Line Items]      
On adoption of IFRS 16 [1] 2,838    
Additions to right-of-use 469    
Balance at April 1, 2020 3,307    
Balance at March 31, 2020   3,307  
Total | Accumulated Depreciation      
Statement Line Items [Line Items]      
Balance at April 1, 2020 62    
Depreciation 1,677    
Net translation adjustment 56    
Balance at March 31, 2020 1,795 $ 62  
Total | Net Carrying Value      
Statement Line Items [Line Items]      
Balance at March 31, 2020 $ 1,512    
[1] The difference in the number accounted on adoption of IFRS 16 is due to Prepaid expenses outstanding last year reduced from Other Receivables amounting to $ 164.
v3.20.2
New Standards Adopted as at April 1, 2019 - Disclosure of Future Minimum Operating Lease Rental Payments (Details) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Statement Line Items [Line Items]    
Minimum lease payables under non-cancellable operating leases $ 1,716 $ 2,956
Lease expense 160 338
Net present value 1,553 2,618
Less than 1 Year    
Statement Line Items [Line Items]    
Minimum lease payables under non-cancellable operating leases 822 1,480
Lease expense 99 161
Net present value 723 1,319
1-3 Years    
Statement Line Items [Line Items]    
Minimum lease payables under non-cancellable operating leases 894 1,360
Lease expense 64 154
Net present value 830 1,206
3-5 Years    
Statement Line Items [Line Items]    
Minimum lease payables under non-cancellable operating leases 116
Lease expense 23
Net present value $ 93
v3.20.2
Standards Not Yet Adopted (Details Narrative) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2019
Mar. 31, 2020
Statement Line Items [Line Items]    
Right of use assets $ 1,512
Standards Not Yet Adopted | IFRS 16 - Leases    
Statement Line Items [Line Items]    
Future minimum lease payments 1,848  
Right of use assets $ 1,590  
v3.20.2
Subsequent Events (Details Narrative)
$ in Thousands
Apr. 17, 2020
USD ($)
Agreement and Plan of Merger | STX Filmworks, Inc.  
Statement Line Items [Line Items]  
Contingent consideration recognised as of business combination $ 125,000